PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Garcia-Manyes, S; Giganti, D; Badilla, CL; Lezamiz, A; Perales-Calvo, J; Beedle, AEM; Fernandez, JM				Garcia-Manyes, Sergi; Giganti, David; Badilla, Carmen L.; Lezamiz, Ainhoa; Perales-Calvo, Judit; Beedle, Amy E. M.; Fernandez, Julio M.			Single-molecule Force Spectroscopy Predicts a Misfolded, Domain-swapped Conformation in human D-Crystallin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); cataract; crystallin; protein misfolding; single-molecule biophysics	GAMMA-D-CRYSTALLIN; MULTIDOMAIN PROTEINS; ALPHA(1)-ANTITRYPSIN DEFICIENCY; CONGENITAL CATARACTS; CLAMP SPECTROSCOPY; AMYLOID FIBRILS; IN-VITRO; AGGREGATION; EVOLUTION; MUTANT	Cataract is a protein misfolding disease where the size of the aggregate is directly related to the severity of the disorder. However, the molecular mechanisms that trigger the onset of aggregation remain unknown. Here we use a combination of protein engineering techniques and single-molecule force spectroscopy using atomic force microscopy to study the individual unfolding pathways of the human D-crystallin, a multidomain protein that must remain correctly folded during the entire lifetime to guarantee lens transparency. When stretching individual polyproteins containing two neighboring HD-crystallin monomers, we captured an anomalous misfolded conformation in which the 1 and 2 strands of the N terminus domain of two adjacent monomers swap. This experimentally elusive domain-swapped conformation is likely to be responsible for the increase in molecular aggregation that we measure in vitro. Our results demonstrate the power of force spectroscopy at capturing rare misfolded conformations with potential implications for the understanding of the molecular onset of protein aggregation.	[Garcia-Manyes, Sergi; Lezamiz, Ainhoa; Perales-Calvo, Judit; Beedle, Amy E. M.] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Garcia-Manyes, Sergi; Lezamiz, Ainhoa; Perales-Calvo, Judit; Beedle, Amy E. M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Giganti, David; Badilla, Carmen L.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of London; King's College London; University of London; King's College London; Columbia University	Garcia-Manyes, S (corresponding author), Kings Coll London, Dept Phys, London WC2R 2LS, England.; Garcia-Manyes, S (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	sergi.garcia-manyes@kcl.ac.uk		beedle, amy/0000-0001-9908-0597; Garcia-Manyes, Sergi/0000-0001-5140-2606	Marie Curie Intra-European Fellowships for Career Development Grant [329308]; Marie Curie Carrier Integration Grants [293462]; Biotechnology and Biological Sciences Research Council [BB/J00992X/1]; Engineering and Physical Sciences Research Council [K00641X/1]; Royal Society [RG120038]; National Institutes of Health [HL66030, HL61228]; BBSRC [BB/J00992X/1] Funding Source: UKRI; EPSRC [EP/K00641X/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/K00641X/1, 1406913] Funding Source: researchfish	Marie Curie Intra-European Fellowships for Career Development Grant; Marie Curie Carrier Integration Grants; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Marie Curie Intra-European Fellowships for Career Development Grant 329308 (to J. P. C.); Marie Curie Carrier Integration Grants 293462, Biotechnology and Biological Sciences Research Council Grant BB/J00992X/1, and Engineering and Physical Sciences Research Council Grant K00641X/1 (to S. G. M.); Royal Society Grant RG120038 (to S. G. M.); and National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Fernandez JM, 2010, SPRINGER SER CHEM PH, V96, P317, DOI 10.1007/978-3-642-02597-6_17; Fernandez VI, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3252982; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Itoh K, 2008, P NATL ACAD SCI USA, V105, P13865, DOI 10.1073/pnas.0804512105; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mayr EM, 1997, J MOL BIOL, V269, P260, DOI 10.1006/jmbi.1997.1033; MAYR EM, 1994, J MOL BIOL, V235, P84, DOI 10.1016/S0022-2836(05)80017-8; Mohr BG, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816367; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Mulligan VK, 2013, PROTEINS, V81, P1285, DOI 10.1002/prot.24285; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Peng Q, 2009, J AM CHEM SOC, V131, P14050, DOI 10.1021/ja903589t; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Ramanujam V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094513; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Sikora M, 2011, PROTEINS, V79, P1786, DOI 10.1002/prot.23001; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Slingsby C, 2014, PROG BIOPHYS MOL BIO, V115, P52, DOI 10.1016/j.pbiomolbio.2014.02.006; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wang YZ, 2010, ECS TRANSACTIONS, V33, P487, DOI 10.1149/1.3481638; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109	56	27	29	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4226	4235		10.1074/jbc.M115.673871	http://dx.doi.org/10.1074/jbc.M115.673871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703476	Green Published, hybrid			2022-12-28	WOS:000371338400045
J	Goretsky, T; Bradford, EM; Ryu, H; Tahir, M; Moyer, MP; Gao, TY; Li, LH; Barrett, TA				Goretsky, Tatiana; Bradford, Emily M.; Ryu, Hyunji; Tahir, Maryam; Moyer, Mary Pat; Gao, Tianyan; Li, Linheng; Barrett, Terrence A.			A Cytosolic Multiprotein Complex Containing p85 alpha Is Required for beta-Catenin Activation in Colitis and Colitis-associated Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (B-catenin); -catenin; colitis; colorectal cancer; phosphatidylinositide 3-kinase (PI 3-kinase); signal transduction; stem cells	PHOSPHOINOSITIDE 3-KINASE; MICE LACKING; WNT; CELLS; STEM; INSIGHTS; SUBUNIT; PI3K; HYPOGLYCEMIA; PERSPECTIVE	Wnt/-catenin signaling is required for crypt structure maintenance. We previously observed nuclear accumulation of Ser-552 phosphorylated -catenin (p-Cat(Ser-552)) in intestinal epithelial cells (IEC) during colitis and colitis-associated cancer. Data here delineate a novel multiprotein cytosolic complex (MCC) involved in -catenin signaling in the intestine. The MCC contains p85, the class IA subunit of PI3K, along with -catenin, 14-3-3, Akt, and p110. MCC levels in IEC increase in colitis and colitis-associated cancer patients. IEC-specific p85-deficient (p85(IEC)) mice develop more severe dextran sodium sulfate colitis due to delayed ulcer healing and reduced epithelial -catenin activation. In colonic IEC, p85 deficiency did not alter PI3K signaling. In vitro shRNA depletion of individual complex members disrupts the MCC and reduces -catenin signaling. Despite worse colitis, p85(IEC) mice have reduced tumor burden after azoxymethane/dextran sodium sulfate treatment. Together the data indicate that the -catenin MCC is needed for mucosal repair and carcinogenesis. This novel MCC may be an attractive therapeutic target in preventing cancer in colitis patients.	[Goretsky, Tatiana; Bradford, Emily M.; Tahir, Maryam; Barrett, Terrence A.] Univ Kentucky, Div Gastroenterol, Dept Internal Med, 800 Rose St,NM649, Lexington, KY 40536 USA; [Ryu, Hyunji] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Moyer, Mary Pat] INCELL Corp, San Antonio, TX 78249 USA; [Gao, Tianyan] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Li, Linheng] Univ Kansas, Sch Med, Dept Pathol & Lab Med, Stowers Inst Med Res, Kansas City, KS 66160 USA	University of Kentucky; Washington University (WUSTL); University of Kentucky; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Barrett, TA (corresponding author), Univ Kentucky, Div Gastroenterol, Dept Internal Med, 800 Rose St,NM649, Lexington, KY 40536 USA.	t.barrett@uky.edu		Bradford, Emily/0000-0002-4711-5628; Barrett, Terrence/0000-0001-6428-3271; Ryu, Stacy Hyunji/0000-0002-5448-339X; Li, Linheng/0000-0001-9963-430X	Institutional Development Award (IDA) from NIGMS of the National Institutes of Health [8 P20 GM103527-05]; NATIONAL CANCER INSTITUTE [T32CA080621, P30CA177558, P30CA060553, R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	Institutional Development Award (IDA) from NIGMS of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Tissue processing was supported by an Institutional Development Award (IDA) from the NIGMS of the National Institutes of Health under Grant 8 P20 GM103527-05.	Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brown JB, 2011, INFECT IMMUN, V79, P1863, DOI 10.1128/IAI.01025-10; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COOPER HS, 1993, LAB INVEST, V69, P238; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Garcia Z, 2006, EMBO J, V25, P4740, DOI 10.1038/sj.emboj.7601324; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Liu JY, 2013, BIOCHEM BIOPH RES CO, V434, P760, DOI 10.1016/j.bbrc.2013.03.135; McCarthy FM, 2005, J PROTEOME RES, V4, P316, DOI 10.1021/pr049842d; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Neal CL, 2012, ONCOGENE, V31, P897, DOI 10.1038/onc.2011.284; Nusse R, 2012, COLD SPRING HARB PER, V4, P1192; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Tureckova J, 2006, INT J MOL MED, V17, P69; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5	37	6	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4166	4177		10.1074/jbc.M115.669416	http://dx.doi.org/10.1074/jbc.M115.669416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26565021	hybrid, Green Published			2022-12-28	WOS:000371338400040
J	Kushwaha, P; Khedgikar, V; Sharma, D; Yuen, T; Gautam, J; Ahmad, N; Karvande, A; Mishra, PR; Trivedi, PK; Sun, L; Bhadada, SK; Zaidi, M; Trivedi, R				Kushwaha, Priyanka; Khedgikar, Vikram; Sharma, Deepika; Yuen, Tony; Gautam, Jyoti; Ahmad, Naseer; Karvande, Anirudha; Mishra, Prabhat R.; Trivedi, Prabodh K.; Sun, Li; Bhadada, Sanjay K.; Zaidi, Mone; Trivedi, Ritu			MicroRNA 874-3p Exerts Skeletal Anabolic Effects Epigenetically during Weaning by Suppressing Hdac1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; bone; bone morphogenetic protein (BMP); cell differentiation; drug discovery; gene silencing; histone deacetylase 1 (HDAC1); microRNA (miRNA); osteoblast; osteoporosis	CELL-PROLIFERATION; BONE-FORMATION; DIFFERENTIATION; LACTATION; OXYTOCIN	Embryonic skeletogenesis and postnatal bone development require the transfer of calcium from the mother to the offspring during pregnancy and lactation. Therefore, bone resorption in the mother becomes elevated during these periods, resulting in significant maternal skeletal loss. There follows an anabolic phase around weaning during which there is a remarkable recovery of the maternal skeleton. However, the mechanism(s) of this anabolic response remain(s) largely unknown. We identified eight differentially expressed miRNAs by array profiling, of which miR-874-3p was highly expressed at weaning, a time when bone loss was noted to recover. We report that this weaning-associated miRNA is an anabolic target. Therefore, an agomir of miR-874-3p induced osteoblast differentiation and mineralization. These actions were mediated through the inhibition of Hdac1 expression and enhanced Runx2 transcriptional activation. When injected in vivo, the agomir significantly increased osteoblastogenesis and mineralization, reversed bone loss caused by ovariectomy, and increased bone strength. We speculate that elevated miR-874-3p expression during weaning enhances bone formation and that this miRNA may become a therapeutic target for conditions of bone loss.	[Kushwaha, Priyanka; Khedgikar, Vikram; Gautam, Jyoti; Ahmad, Naseer; Karvande, Anirudha; Trivedi, Ritu] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India; [Kushwaha, Priyanka] CSIR, Cent Drug Res Inst, Acad Sci & Innovat Res, Lucknow 226031, Uttar Pradesh, India; [Mishra, Prabhat R.] CSIR, Cent Drug Res Inst, Div Pharmaceut, Lucknow 226031, Uttar Pradesh, India; [Sharma, Deepika] Natl Bot Res Inst, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India; [Yuen, Tony; Sun, Li; Zaidi, Mone] Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; [Bhadada, Sanjay K.] Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Chandigarh 160012, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Icahn School of Medicine at Mount Sinai; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Trivedi, R (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.; Zaidi, M (corresponding author), Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA.	mone.zaidi@mountsinai.org; ritu_trivedi@cdri.res.in	Mishra, Prabhat Ranjan/C-3814-2009	Gautam, Jyoti/0000-0003-2961-9547	CSIR [BSC0201]; Department of Biotechnology [DBT-GAP0127]; National Institutes of Health [DK80459, AG40132, AR06592, AR06066]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065932, R01AR067066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040132] Funding Source: NIH RePORTER	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by CSIR Grant BSC0201 and Department of Biotechnology Grant DBT-GAP0127 (to R. T.); National Institutes of Health Grants DK80459 (to M. Z. and L. S.), AG40132 (to M. Z.), AR06592 (to M. Z.), and AR06066 (to M. Z). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; Bolzetta F, 2014, BONE, V68, P41, DOI 10.1016/j.bone.2014.08.001; Di Benedetto A, 2014, P NATL ACAD SCI USA, V111, P16502, DOI 10.1073/pnas.1419349111; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104; Gautam J, 2014, BRIT J NUTR, V111, P1811, DOI 10.1017/S0007114514000051; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kureel J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.4; Kushwaha P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.350; Lebel E, 2014, J OSTEOPOROS, V2014, DOI 10.1155/2014/897182; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Liu XS, 2012, J BONE MINER RES, V27, P865, DOI 10.1002/jbmr.1503; Liu X, 2009, BIOCHEM BIOPH RES CO, V388, P161, DOI 10.1016/j.bbrc.2009.07.148; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Miller SC, 1998, ANAT REC, V251, P265, DOI 10.1002/(SICI)1097-0185(199806)251:2<265::AID-AR16>3.0.CO;2-M; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Sashidhara KV, 2013, J MED CHEM, V56, P109, DOI 10.1021/jm301281e; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Zhang JF, 2011, MOL BIOL CELL, V22, P3955, DOI 10.1091/mbc.E11-04-0356; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao X, 2014, J BONE MINER METAB, V32, P221, DOI 10.1007/s00774-013-0537-7	35	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3959	3966		10.1074/jbc.M115.687152	http://dx.doi.org/10.1074/jbc.M115.687152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26663087	Green Published, hybrid			2022-12-28	WOS:000371338400023
J	Shakerley, NL; Chandrasekaran, A; Trebak, M; Miller, BA; Melendez, JA				Shakerley, Nicole L.; Chandrasekaran, Akshaya; Trebak, Mohamed; Miller, Barbara A.; Melendez, J. Andres			Francisella tularensis Catalase Restricts Immune Function by Impairing TRPM2 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; bacterial pathogenesis; calcium channel; catalase; cellular immune response; hydrogen peroxide; infection; macrophage; Francisella	2-AMINOETHOXYDIPHENYL BORATE 2-APB; BLOOD MONONUCLEAR-CELLS; MELASTATIN 2 TRPM2; HYDROGEN-PEROXIDE; HUMAN MACROPHAGES; OXIDATIVE STRESS; CALCIUM-ENTRY; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; PERITONEAL-MACROPHAGES	As an innate defense mechanism, macrophages produce reactive oxygen species that weaken pathogens and serve as secondary messengers involved in immune function. The Gram-negative bacterium Francisella tularensis utilizes its antioxidant armature to limit the host immune response, but the mechanism behind this suppression is not defined. Here we establish that F. tularensis limits Ca2+ entry in macrophages, thereby limiting actin reorganization and IL-6 production in a redox-dependent fashion. Wild type (live vaccine strain) or catalase-deficient F. tularensis (katG) show distinct profiles in their H2O2 scavenging rates, 1 and 0.015 pm/s, respectively. Murine alveolar macrophages infected with katG display abnormally high basal intracellular Ca2+ concentration that did not increase further in response to H2O2. Additionally, katG-infected macrophages displayed limited Ca2+ influx in response to ionomycin, as a result of ionophore H2O2 sensitivity. Exogenously added H2O2 or H2O2 generated by katG likely oxidizes ionomycin and alters its ability to transport Ca2+. Basal increases in cytosolic Ca2+ and insensitivity to H2O2-mediated Ca2+ entry in katG-infected cells are reversed by the Ca2+ channel inhibitors 2-aminoethyl diphenylborinate and SKF-96365. 2-Aminoethyl diphenylborinate but not SKF-96365 abrogated katG-dependent increases in macrophage actin remodeling and IL-6 secretion, suggesting a role for H2O2-mediated Ca2+ entry through the transient receptor potential melastatin 2 (TRPM2) channel in macrophages. Indeed, increases in basal Ca2+, actin polymerization, and IL-6 production are reversed in TRPM2-null macrophages infected with katG. Together, our findings provide compelling evidence that F. tularensis catalase restricts reactive oxygen species to temper macrophage TRPM2-mediated Ca2+ signaling and limit host immune function.	[Shakerley, Nicole L.; Chandrasekaran, Akshaya; Trebak, Mohamed; Melendez, J. Andres] SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Trebak, Mohamed] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Melendez, JA (corresponding author), Coll Nanoscale Sci, 257 Fuller Rd, Albany, NY 12203 USA.; Melendez, JA (corresponding author), Coll Engn, 257 Fuller Rd, Albany, NY 12203 USA.	jmelendez@sunypoly.edu	Shakerley, Nicole L/C-1245-2015; Chandrasekaran, Akshaya/AAB-5252-2020	Shakerley, Nicole L/0000-0002-7880-3343; Chandrasekaran, Akshaya/0000-0003-0535-6623; Melendez, Juan/0000-0001-8021-3097	NIAID, National Institutes of Health [PO1AI056320]; National Institutes of Health [R01HL097111, R01HL123364]; American Heart Association [14GRNT18880008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funded by NIAID, National Institutes of Health Grant PO1AI056320 (to J. A. M.). This study was also supported in part by National Institutes of Health Grants R01HL097111 and R01HL123364 and American Heart Association Grant 14GRNT18880008 (to M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Khodor S, 2010, CELL MICROBIOL, V12, P1604, DOI 10.1111/j.1462-5822.2010.01494.x; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Asare R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00145; Asare R, 2010, ENVIRON MICROBIOL, V12, P2559, DOI 10.1111/j.1462-2920.2010.02229.x; Azenabor AA, 2009, IMMUNOBIOLOGY, V214, P143, DOI 10.1016/j.imbio.2008.06.001; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Cremer TJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00013; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Gao GF, 2014, J CLIN INVEST, V124, P4989, DOI 10.1172/JCI76042; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; KIM E, 1992, INFECT IMMUN, V60, P1244, DOI 10.1128/IAI.60.3.1244-1248.1992; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Lindgren H, 2011, INFECT IMMUN, V79, P1218, DOI 10.1128/IAI.01116-10; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Paranavitana C, 2008, FEMS IMMUNOL MED MIC, V54, P92, DOI 10.1111/j.1574-695X.2008.00456.x; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Perraud AL, 2004, MOL IMMUNOL, V41, P657, DOI 10.1016/j.molimm.2004.04.013; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; RADDASSI K, 1994, CELL IMMUNOL, V153, P443, DOI 10.1006/cimm.1994.1041; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Song MY, 2011, ANTIOXID REDOX SIGN, V15, P1549, DOI 10.1089/ars.2010.3648; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tano JY, 2011, BIOCHEM BIOPH RES CO, V407, P432, DOI 10.1016/j.bbrc.2011.03.048; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Vonkavaara M, 2008, CELL MICROBIOL, V10, P1327, DOI 10.1111/j.1462-5822.2008.01129.x; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Yang RL, 2014, PATHOG DIS, V70, P51, DOI 10.1111/2049-632X.12075; Ye YX, 2012, INT IMMUNOPHARMACOL, V12, P384, DOI 10.1016/j.intimp.2011.12.011; Zou J, 2013, AM J PHYSIOL-CELL PH, V305, pC61, DOI 10.1152/ajpcell.00390.2012	77	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3871	3881		10.1074/jbc.M115.706879	http://dx.doi.org/10.1074/jbc.M115.706879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26679996	hybrid, Green Published			2022-12-28	WOS:000371338400016
J	Shen, XM; Brengman, J; Neubauer, D; Sine, SM; Engel, AG				Shen, Xin-Ming; Brengman, Joan; Neubauer, David; Sine, Steven M.; Engel, Andrew G.			Investigation of Congenital Myasthenia Reveals Functional Asymmetry of Invariant Acetylcholine Receptor (AChR) Cys-loop Aspartates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; nicotinic acetylcholine receptors (nAChR); patch clamp; receptor structure-function; structure-function; Cys-loop receptor superfamily; congenital myasthenic syndrome; invariant Cys-loop aspartate; invariant pre-M1 arginine; mutant cycle analysis	DELTA-SUBUNIT MUTATION; AGONIST BINDING; SINGLE-CHANNEL; GABA(A) RECEPTOR; END-PLATE; RESIDUES; TRANSMITTER; ACTIVATION; PROTEINS; DOMAIN	We identify two heteroallelic mutations in the acetylcholine receptor -subunit from a patient with severe myasthenic symptoms since birth: a novel D140N mutation in the signature Cys-loop and a mutation in intron 7 of the -subunit gene that disrupts splicing of exon 8. The mutated Asp residue, which determines the disease phenotype, is conserved in all eukaryotic members of the Cys-loop receptor superfamily. Studies of the mutant acetylcholine receptor expressed in HEK 293 cells reveal that D140N attenuates cell surface expression and apparent channel gating, predicting a reduced magnitude and an accelerated decay of the synaptic response, thus reducing the safety margin for neuromuscular transmission. Substituting Asn for Asp at equivalent positions in the -, -, and E-subunits also suppresses apparent channel gating, but the suppression is much greater in the -subunit. Mutant cycle analysis applied to single and pairwise mutations reveals that Asp-138 is energetically coupled to Arg-209 in the neighboring pre-M1 domain. Our findings suggest that the conserved Asp-138 and Arg-209 contribute to a principal pathway that functionally links the ligand binding and pore domains.	[Shen, Xin-Ming; Brengman, Joan; Sine, Steven M.; Engel, Andrew G.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Shen, Xin-Ming; Brengman, Joan; Sine, Steven M.; Engel, Andrew G.] Mayo Clin, Neuromuscular Res Lab, Rochester, MN 55905 USA; [Neubauer, David] Univ Childrens Hosp, Dept Pediat Neurol, Ljubljana 1525, Slovenia; [Sine, Steven M.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University Medical Centre Ljubljana; Mayo Clinic	Shen, XM (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.; Shen, XM (corresponding author), Mayo Clin, Neuromuscular Res Lab, Rochester, MN 55905 USA.	shen.xinming@mayo.edu			National Institutes of Health [NS6277, NS31744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS006277, R01NS031744, R37NS031744, R01NS006277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS6277 (to A. G. E.) and NS31744 (to S. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Colquhoun David, 1995, P397; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; KARLIN A, 1983, J BIOL CHEM, V258, P6678; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; MATHIE A, 1987, PROC R SOC SER B-BIO, V232, P239, DOI 10.1098/rspb.1987.0072; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; PENNEFATHER P, 1981, J GEN PHYSIOL, V78, P313, DOI 10.1085/jgp.78.3.313; Pless SA, 2011, J BIOL CHEM, V286, P35129, DOI 10.1074/jbc.M111.269027; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Shen XM, 2008, J CLIN INVEST, V118, P1867, DOI 10.1172/JCI34527; Shen XM, 2005, BRAIN, V128, P345, DOI 10.1093/brain/awh364; Shen XM, 2002, NEUROLOGY, V59, P1881, DOI 10.1212/01.WNL.0000042422.87384.2F; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	35	7	7	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3291	3301		10.1074/jbc.M115.683995	http://dx.doi.org/10.1074/jbc.M115.683995			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26698174	Green Published, hybrid			2022-12-28	WOS:000370854500015
J	Abd Alla, J; Graemer, M; Fu, XB; Quitterer, U				Abd Alla, Joshua; Graemer, Muriel; Fu, Xuebin; Quitterer, Ursula			Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN-2; PPAR-GAMMA; LIPID-METABOLISM; GENE-EXPRESSION; HEART-FAILURE; ADIPONECTIN; ALPHA; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION	Impairment of myocardial fatty acid substrate metabolism is characteristic of late-stage heart failure and has limited treatment options. Here, we investigated whether inhibition of G-protein-coupled receptor kinase 2 (GRK2) could counteract the disturbed substrate metabolism of late-stage heart failure. The heart failure-like substrate metabolism was reproduced in a novel transgenic model of myocardium-specific expression of fatty acid synthase (FASN), the major palmitate-synthesizing enzyme. The increased fatty acid utilization of FASN transgenic neonatal cardiomyocytes rapidly switched to a heart failure phenotype in an adult-like lipogenic milieu. Similarly, adult FASN transgenic mice developed signs of heart failure. The development of disturbed substrate utilization of FASN transgenic cardiomyocytes and signs of heart failure were retarded by the transgenic expression of GRKInh, a peptide inhibitor of GRK2. Cardioprotective GRK2 inhibition required an intact ERK axis, which blunted the induction of cardiotoxic transcripts, in part by enhanced serine 273 phosphorylation of Pparg (peroxisome proliferator-activated receptor gamma). Conversely, the dual-specific GRK2 and ERK cascade inhibitor, RKIP (Raf kinase inhibitor protein), triggered dysfunctional cardiomyocyte energetics and the expression of heart failure-promoting Pparg-regulated genes. Thus, GRK2 inhibition is a novel approach that targets the dysfunctional substrate metabolism of the failing heart.	[Abd Alla, Joshua; Graemer, Muriel; Fu, Xuebin; Quitterer, Ursula] ETH, Mol Pharmacol Unit, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8057 Zurich, Switzerland; [Fu, Xuebin] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Quitterer, Ursula] Univ Zurich, Inst Pharmacol & Toxicol, Dept Med, CH-8057 Zurich, Switzerland	ETH Zurich; University of Bern; University of Zurich	Quitterer, U (corresponding author), ETH, Mol Pharmacol Unit, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch	Fu, Xuebin/B-6591-2018; Fu, Xuebin/AAH-9622-2019	Fu, Xuebin/0000-0002-7232-3576; Fu, Xuebin/0000-0002-1281-2466	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant [31-140679]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant	This work was supported in part by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant 31-140679 (to U. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Abd Alla J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00148; Abd Alla J, 2010, INTEGR BIOL-UK, V2, P209, DOI 10.1039/b922592g; AbdAlla Said, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P190; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Berthiaume JM, 2010, AM J PHYSIOL-HEART C, V299, pH410, DOI 10.1152/ajpheart.00270.2010; Biagi PL, 1999, MECH AGEING DEV, V107, P181, DOI 10.1016/S0047-6374(98)00148-1; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chatham JC, 2012, CIRC RES, V111, P666, DOI 10.1161/CIRCRESAHA.112.277392; Chemaly ER, 2011, J MOL CELL CARDIOL, V51, P144, DOI 10.1016/j.yjmcc.2011.04.006; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chou IP, 2014, EUR J NUTR, V53, P907, DOI 10.1007/s00394-013-0594-7; Dadson K, 2015, J MOL CELL CARDIOL, V86, P102, DOI 10.1016/j.yjmcc.2015.06.020; Dy GK, 2013, CA-CANCER J CLIN, V63, P249, DOI 10.3322/caac.21184; Frankel DS, 2009, J AM COLL CARDIOL, V53, P754, DOI 10.1016/j.jacc.2008.07.073; Fu XB, 2013, J BIOL CHEM, V288, P7738, DOI 10.1074/jbc.M112.428078; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kujiraoka T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000361; Lahey R, 2014, CIRCULATION, V130, P1790, DOI 10.1161/CIRCULATIONAHA.114.011687; Lee HJ, 2015, STEM CELLS, V33, P2182, DOI 10.1002/stem.2020; Li N, 2010, J CARDIOVASC PHARM, V55, P161, DOI 10.1097/01.fjc.0000365898.92719.f0; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09530; Liu L, 2014, J BIOL CHEM, V289, P29881, DOI 10.1074/jbc.M114.601864; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Lucas E, 2014, BBA-MOL BASIS DIS, V1842, P2448, DOI 10.1016/j.bbadis.2014.09.004; Marfella R, 2009, J LIPID RES, V50, P2314, DOI 10.1194/jlr.P900032-JLR200; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Murholm M, 2010, BBA-GEN SUBJECTS, V1800, P619, DOI 10.1016/j.bbagen.2010.03.008; Nakou ES, 2013, INT J CARDIOL, V170, P96, DOI 10.1016/j.ijcard.2013.10.038; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; O'Shea KM, 2010, AM J PHYSIOL-HEART C, V298, pH1639, DOI 10.1152/ajpheart.00957.2009; Park TS, 2012, HEART FAIL CLIN, V8, P633, DOI 10.1016/j.hfc.2012.06.003; Piguet AC, 2010, CLIN SCI, V118, P401, DOI 10.1042/CS20090313; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Razani B, 2011, J BIOL CHEM, V286, P30949, DOI 10.1074/jbc.M111.230508; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Taegtmeyer H, 2011, J MOL CELL CARDIOL, V50, P2, DOI 10.1016/j.yjmcc.2010.09.014; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wang YJ, 2015, CIRCULATION, V131, P1392, DOI 10.1161/CIRCULATIONAHA.114.015248; WITTELS B, 1968, J CLIN INVEST, V47, P1787, DOI 10.1172/JCI105868; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109	59	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2583	2600		10.1074/jbc.M115.702688	http://dx.doi.org/10.1074/jbc.M115.702688			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26670611	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000369626900005
J	Horton, JR; Engstrom, A; Zoeller, EL; Liu, X; Shanks, JR; Zhang, X; Johns, MA; Vertino, PM; Fu, HA; Cheng, XD				Horton, John R.; Engstrom, Amanda; Zoeller, Elizabeth L.; Liu, Xu; Shanks, John R.; Zhang, Xing; Johns, Margaret A.; Vertino, Paula M.; Fu, Haian; Cheng, Xiaodong			Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE INHIBITOR; CELL-PROLIFERATION; ANTITUMOR-ACTIVITY; CANCER; BINDING; POTENT; RBP2; EZH2; METHYLATION; RECOGNITION	The KDM5/JARID1 family of Fe(II)- and alpha-ketoglutarate-dependent demethylases remove methyl groups from tri- and dimethylated lysine 4 of histone H3. Accumulating evidence from primary tumors and model systems supports a role for KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) as oncogenic drivers. The KDM5 family is unique among the Jumonji domain-containing histone demethylases in that there is an atypical insertion of a DNA-binding ARID domain and a histone-binding PHD domain into the Jumonji domain, which separates the catalytic domain into two fragments (JmjN and JmjC). Here we demonstrate that internal deletion of the ARID and PHD1 domains has a negligible effect on in vitro enzymatic kinetics of the KDM5 family of enzymes. We present a crystal structure of the linked JmjN-JmjC domain from KDM5A, which reveals that the linked domain fully reconstitutes the cofactor (metal ion and alpha-ketoglutarate) binding characteristics of other structurally characterized Jumonji domain demethylases. Docking studies with GSK-J1, a selective inhibitor of the KDM6/ KDM5 subfamilies, identify critical residues for binding of the inhibitor to the reconstituted KDM5 Jumonji domain. Further, we found that GSK-J1 inhibited the demethylase activity of KDM5C with 8.5-fold increased potency compared with that of KDM5B at 1 mM alpha-ketoglutarate. In contrast, JIB-04 (a paninhibitor of the Jumonji demethylase superfamily) had the opposite effect and was similar to 8-fold more potent against KDM5B than against KDM5C. Interestingly, the relative selectivity of JIB-04 toward KDM5B over KDM5C in vitro translates to a similar to 10-50-fold greater growth-inhibitory activity against breast cancer cell lines. These data define the minimal requirements for enzymatic activity of the KDM5 family to be the linked JmjN-JmjC domain coupled with the immediate C-terminal helical zinc-binding domain and provide structural characterization of the linked JmjN-JmjC domain for the KDM5 family, which should prove useful in the design of KDM5 demethylase inhibitors with improved potency and selectivity.	[Horton, John R.; Liu, Xu; Shanks, John R.; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Johns, Margaret A.; Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Vertino, Paula M.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Engstrom, Amanda] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA; [Zoeller, Elizabeth L.] Emory Univ, Grad Program Canc Biol, Atlanta, GA 30322 USA; [Johns, Margaret A.; Fu, Haian] Emory Univ, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA; [Vertino, Paula M.; Fu, Haian; Cheng, Xiaodong] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University	Cheng, XD (corresponding author), Emory Univ, Dept Biochem, Atlanta, GA 30322 USA.; Cheng, XD (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	xcheng@emory.edu	Horton, John R/ABB-4770-2020; Liu, Xu/AAB-9392-2021	Liu, Xu/0000-0003-2252-7148; Horton, John/0000-0001-9749-8068; Engstrom, Amanda/0000-0002-6796-2752	NCI, National Institutes of Health (NIH), under NCI Chemical Biology Consortium Contract [HHSN261200800001E]; NIH [GM114306-01, CA077337, F31 CA186511]; Winship Cancer Institute of Emory University Cancer Center Support Grant [P30-CA138292]; Arthur and Sarah Merrill Foundation; NIGMS, NIH [T32 GM008367-26]; NATIONAL CANCER INSTITUTE [F31CA186511, P30CA138292, R01CA077337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114306] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH), under NCI Chemical Biology Consortium Contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winship Cancer Institute of Emory University Cancer Center Support Grant; Arthur and Sarah Merrill Foundation; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part with Federal funds from NCI, National Institutes of Health (NIH), under NCI Chemical Biology Consortium Contract HHSN261200800001E (to H. F.), NIH Grants GM114306-01 (to X. C.) and CA077337 (to P. M. V.), developmental funds from the Winship Cancer Institute of Emory University Cancer Center Support Grant P30-CA138292 (to P. M. V. and X. C.) and funds from the Arthur and Sarah Merrill Foundation (to X. C.). The Department of Biochemistry of Emory University School of Medicine supported the use of the Southeast Regional Collaborative Access Team synchrotron beamlines at the Advanced Photon Source of Argonne National Laboratory. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, NIH, Training Grant T32 GM008367-26.; Supported by NIH Predoctoral Fellowship F31 CA186511.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bertino EM, 2011, EXPERT OPIN INV DRUG, V20, P1151, DOI 10.1517/13543784.2011.594437; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/NCHEMBIO.1817, 10.1038/nchembio.1817]; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; Cao J, 2014, CELL REP, V6, P868, DOI 10.1016/j.celrep.2014.02.004; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Chen Q, 2013, 2013 SEVENTH INTERNATIONAL CONFERENCE ON INTERNET COMPUTING FOR ENGINEERING AND SCIENCE (ICICSE 2013), P9, DOI 10.1109/ICICSE.2013.10; Cheng XD, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P210; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Koehler C, 2008, BIOMOL NMR ASSIGM, V2, P9, DOI 10.1007/s12104-007-9071-7; Kristensen LH, 2012, FEBS J, V279, P1905, DOI 10.1111/j.1742-4658.2012.08567.x; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Maes T, 2015, EPIGENOMICS-UK, V7, P609, DOI [10.2217/EPI.15.9, 10.2217/epi.15.9]; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martinez S, 2015, J BIOL CHEM, V290, P20702, DOI 10.1074/jbc.R115.648691; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Pilke ES, 2015, DRUG DISCOV TODAY, V20, P743, DOI 10.1016/j.drudis.2014.12.013; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Roy TW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm1031; Ryan RJH, 2012, SCIENCE, V336, P1513, DOI 10.1126/science.1223730; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Torres IO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7204; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Upadhyay AK, 2012, J MOL BIOL, V416, P319, DOI 10.1016/j.jmb.2011.12.036; Van Rechem C, 2015, CANCER DISCOV, V5, P255, DOI 10.1158/2159-8290.CD-14-1326; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Waters NJ, 2015, J CONTROL RELEASE, V220, P758, DOI 10.1016/j.jconrel.2015.09.023; Wong SHK, 2015, CANCER CELL, V28, P198, DOI 10.1016/j.ccell.2015.06.003; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251	74	74	80	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2631	2646		10.1074/jbc.M115.698449	http://dx.doi.org/10.1074/jbc.M115.698449			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26645689	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000369626900009
J	Romani, B; Baygloo, NS; Hamidi-Fard, M; Aghasadeghi, MR; Allahbakhshi, E				Romani, Bizhan; Baygloo, Nima Shaykh; Hamidi-Fard, Mojtaba; Aghasadeghi, Mohammad Reza; Allahbakhshi, Elham			HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; HISTONE DEACETYLASES; REPLICATION; TRANSCRIPTION; INHIBITION; ACTIVATION; PROMOTER; MODULATE; TARGETS	Mechanisms underlying HIV-1 latency remain among the most crucial questions that need to be answered to adopt strategies for purging the latent viral reservoirs. Here we show that HIV-1 accessory protein Vpr induces depletion of class I HDACs, including HDAC1, 2, 3, and 8, to overcome latency in macrophages. We found that Vpr binds and depletes chromatin-associated class I HDACs through a VprBP-dependent mechanism, with HDAC3 as the most affected class I HDAC. De novo expression of Vpr in infected macrophages induced depletion of HDAC1 and 3 on the HIV-1 LTR that was associated with hyperacetylation of histones on the HIV-1 LTR. As a result of hyperacetylation of histones on HIV-1 promotor, the virus established an active promotor and this contributed to the acute infection of macrophages. Collectively, HIV-1 Vpr down-regulates class I HDACs on chromatin to counteract latent infections of macrophages.	[Romani, Bizhan; Baygloo, Nima Shaykh] Univ Isfahan, Dept Biol, Fac Sci, Esfahan 8174673441, Iran; [Romani, Bizhan; Allahbakhshi, Elham] Ahvaz Jundishapur Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Ahvaz 6135715794, Iran; [Hamidi-Fard, Mojtaba; Aghasadeghi, Mohammad Reza] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran 1316943551, Iran	University of Isfahan; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Allahbakhshi, E (corresponding author), Ahvaz Jundishapur Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Ahvaz 6135715794, Iran.; Aghasadeghi, MR (corresponding author), Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran 1316943551, Iran.	mrasadeghi@pasteur.ac.ir; abakhshi_e@ajums.ac.ir	/J-9114-2017; aghasadeghi, mohammad reza/K-9497-2017	/0000-0003-3399-3590; aghasadeghi, mohammad reza/0000-0003-2186-0774	Ahvaz Jundishapur University of Medical Sciences	Ahvaz Jundishapur University of Medical Sciences	This work was supported by research grants from Ahvaz Jundishapur University of Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barton KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102684; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Iijima K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-83; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Kaur M, 2012, NUCLEIC ACIDS RES, V40, P7332, DOI 10.1093/nar/gks366; Kim K, 2012, MOL CELL BIOL, V32, P783, DOI 10.1128/MCB.06037-11; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; LEVY DN, 1995, J VIROL, V69, P1243, DOI 10.1128/JVI.69.2.1243-1252.1995; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Lezin A, 2007, BLOOD, V110, P3722, DOI 10.1182/blood-2007-04-085076; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Pickering S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003895; Romani B, 2015, J BIOL CHEM, V290, P17380, DOI 10.1074/jbc.M115.641522; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	39	27	29	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2696	2711		10.1074/jbc.M115.689018	http://dx.doi.org/10.1074/jbc.M115.689018			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26679995	hybrid, Green Published			2022-12-28	WOS:000369626900013
J	Floor, SN; Condon, KJ; Sharma, D; Jankowsky, E; Doudna, JA				Floor, Stephen N.; Condon, Kendall J.; Sharma, Deepak; Jankowsky, Eckhard; Doudna, Jennifer A.			Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING PROTEIN; TRANSLATION; YEAST; MUTATIONS; REVEALS; DED1	DEAD-box proteins utilize ATP to bind and remodel RNA and RNA-protein complexes. All DEAD-box proteins share a conserved core that consists of two RecA-like domains. The core is flanked by subfamily-specific extensions of idiosyncratic function. The Ded1/DDX3 subfamily of DEAD-box proteins is of particular interest as members function during protein translation, are essential for viability, and are frequently altered in human malignancies. Here, we define the function of the subfamily-specific extensions of the human DEAD-box protein DDX3. We describe the crystal structure of the subfamily-specific core of wild-typeDDX3 at 2.2 angstrom resolution, alone and in the presence of AMP or nonhydrolyzable ATP. These structures illustrate a unique interdomain interaction between the two ATPase domains in which the C-terminal domain clashes with the RNA-binding surface. Destabilizing this interaction accelerates RNA duplex unwinding, suggesting that it is present in solution and inhibitory for catalysis. We use this core fragment of DDX3 to test the function of two recurrent medulloblastoma variants of DDX3 and find that both inactivate the protein in vitro and in vivo. Taken together, these results redefine the structural and functional core of the DDX3 subfamily of DEAD-box proteins.	[Floor, Stephen N.; Condon, Kendall J.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 708A Stanley Hall, Berkeley, CA 94720 USA; [Floor, Stephen N.; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Sharma, Deepak; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Sharma, Deepak; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Case Western Reserve University; Case Western Reserve University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 708A Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Sharma, Deepak/GPT-1692-2022	Jankowsky, Eckhard/0000-0001-7677-7412; /0000-0002-9515-8892; Sharma, Deepak/0000-0001-8436-1759; Floor, Stephen/0000-0002-9965-9694	University of California Office of the President, Multicampus Research Programs and Initiatives Grant [MR-15-328599]; Program for Breakthrough Biomedical Research - Sandler Foundation; NIGMS National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R35GM118088, R01GM099720, P41GM103311] Funding Source: NIH RePORTER	University of California Office of the President, Multicampus Research Programs and Initiatives Grant(University of California System); Program for Breakthrough Biomedical Research - Sandler Foundation; NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angie Hilliker and the lab of Jasper Rine for help with the yeast experiments and for sharing yeast strains, Kaihong Zhou and Alison Smith for early protein characterization, Yoon-Jae Cho for advice regarding the medulloblastoma variants, and Yun Bai for critical reading of the manuscript. Structural data were collected at Beamline 8.3.1 of the Advanced Light Source at the Lawrence Berkeley National Laboratory, which acknowledges support from the University of California Office of the President, Multicampus Research Programs and Initiatives Grant MR-15-328599, and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. Molecular dynamics starting models were preprocessed with the UCSF Chimera package, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS National Institutes of Health Grant P41-GM103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Buchwald G, 2013, P NATL ACAD SCI USA, V110, pE4611, DOI 10.1073/pnas.1314684110; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epling LB, 2015, J MOL BIOL, V427, P1779, DOI 10.1016/j.jmb.2015.02.015; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Hubstenberger A, 2013, DEV CELL, V27, P161, DOI 10.1016/j.devcel.2013.09.024; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacewicz A, 2014, NUCLEIC ACIDS RES, V42, P12885, DOI 10.1093/nar/gku930; Jankowsky E, 2010, METHODS MOL BIOL, V587, P245, DOI 10.1007/978-1-60327-355-8_18; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lai MC, 2016, FEBS J, V283, P88, DOI 10.1111/febs.13553; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Ohnishi S, 2009, PROTEINS, V74, P133, DOI 10.1002/prot.22138; Ojha J, 2015, BRIT J HAEMATOL, V169, P445, DOI 10.1111/bjh.13211; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Putnam AA, 2015, MOL CELL, V59, P541, DOI 10.1016/j.molcel.2015.06.030; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Sen ND, 2015, GENOME RES, V25, P1196, DOI 10.1101/gr.191601.115; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Senissar M, 2014, NUCLEIC ACIDS RES, V42, P10005, DOI 10.1093/nar/gku584; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang ZM, 2013, CELL REP, V5, P1269, DOI 10.1016/j.celrep.2013.10.047	63	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2412	2421		10.1074/jbc.M115.700625	http://dx.doi.org/10.1074/jbc.M115.700625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26598523	Green Published, hybrid			2022-12-28	WOS:000369610400030
J	Kado, Y; Mizohata, E; Nagatoishi, S; Iijima, M; Shinoda, K; Miyafusa, T; Nakayama, T; Yoshizumi, T; Sugiyama, A; Kawamura, T; Lee, YH; Matsumura, H; Doi, H; Fujitani, H; Kodama, T; Shibasaki, Y; Tsumoto, K; Inoue, T				Kado, Yuji; Mizohata, Eiichi; Nagatoishi, Satoru; Iijima, Mariko; Shinoda, Keiko; Miyafusa, Takamitsu; Nakayama, Taisuke; Yoshizumi, Takuma; Sugiyama, Akira; Kawamura, Takeshi; Lee, Young-Hun; Matsumura, Hiroyoshi; Doi, Hirofumi; Fujitani, Hideaki; Kodama, Tatsuhiko; Shibasaki, Yoshikazu; Tsumoto, Kouhei; Inoue, Tsuyoshi			Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5 STRUCTURAL, FUNCTIONAL, AND MOLECULAR DYNAMICS SIMULATION ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; FACTOR RECEPTOR; CANCER-CELLS; FACTOR-ALPHA; AMPHIREGULIN; INHIBITORS; REFINEMENT; LIGANDS	Epiregulin (EPR) is a ligand of the epidermal growth factor (EGF) family that upon binding to its epidermal growth factor receptor (EGFR) stimulates proliferative signaling, especially in colon cancer cells. Here, we describe the three-dimensional structure of the EPR antibody (the 9E5(Fab) fragment) in the presence and absence of EPR. Among the six complementarity-determining regions (CDRs), CDR1-3 in the light chain and CDR2 in the heavy chain predominantly recognize EPR. In particular, CDR3 in the heavy chain dramatically moves with cis-trans isomerization of Pro(103). A molecular dynamics simulation and mutational analyses revealed that Arg(40) in EPR is a key residue for the specific binding of 9E5 IgG. From isothermal titration calorimetry analysis, the dissociation constant was determined to be 6.5 nM. Surface plasmon resonance analysis revealed that the dissociation rate of 9E5 IgG is extremely slow. The superimposed structure of 9E5(Fab).EPR on the known complex structure of EGF.EGFR showed that the 9E5(Fab) paratope overlaps with Domains I and III on the EGFR, which reveals that the 9E5(Fab).EPR complex could not bind to the EGFR. The 9E5 antibody will also be useful in medicine as a neutralizing antibody specific for colon cancer.	[Kado, Yuji; Mizohata, Eiichi; Nakayama, Taisuke; Yoshizumi, Takuma; Matsumura, Hiroyoshi; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Div Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan; [Kado, Yuji] Osaka Univ, Interdisciplinary Program Biomed Sci, Inst Acad Initiat, 1-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Nagatoishi, Satoru; Miyafusa, Takamitsu; Tsumoto, Kouhei] Univ Tokyo, Med Prote Lab, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Iijima, Mariko; Shinoda, Keiko; Sugiyama, Akira; Kawamura, Takeshi; Lee, Young-Hun; Doi, Hirofumi; Fujitani, Hideaki; Kodama, Tatsuhiko; Shibasaki, Yoshikazu] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Number 34 Komaba, Tokyo 1538904, Japan; [Nakayama, Taisuke] Ritsumeikan Univ, Coll Life Sci, 1-1-1 Nojihigashi, Shiga 5258577, Japan	Osaka University; Osaka University; University of Tokyo; University of Tokyo; Ritsumeikan University	Inoue, T (corresponding author), Osaka Univ, Grad Sch Engn, Div Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Med Prote Lab, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tsumoto@ims.u-tokyo.ac.jp; inouet@chem.eng.osaka-u.ac.jp	Satoru, NAGATOISHI/AAY-8198-2021; Miyafusa, Takamitsu/N-2753-2016	Satoru, NAGATOISHI/0000-0002-0794-3963; Miyafusa, Takamitsu/0000-0001-9819-1519	Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI) [24770096, 25282230]; MEXT Strategic Programs for Innovative Research Supercomputational Life Science Grants [hp130006, hp140228]; Grants-in-Aid for Scientific Research [24109017] Funding Source: KAKEN	Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI); MEXT Strategic Programs for Innovative Research Supercomputational Life Science Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, and Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI) 24770096 and 25282230. The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by MEXT Strategic Programs for Innovative Research Supercomputational Life Science Grants hp130006 and hp140228.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baba I, 2000, CANCER RES, V60, P6886; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DEFEOJONES D, 1989, MOL CELL BIOL, V9, P4083, DOI 10.1128/MCB.9.9.4083; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Freimann S, 2004, BIOCHEM PHARMACOL, V68, P989, DOI 10.1016/j.bcp.2004.05.027; Fujitani H, 2009, J CHEM THEORY COMPUT, V5, P1155, DOI 10.1021/ct8005437; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Komurasaki T, 1997, ONCOGENE, V15, P2841, DOI 10.1038/sj.onc.1201458; Lee YH, 2013, BIOCHEM BIOPH RES CO, V441, P1011, DOI 10.1016/j.bbrc.2013.11.014; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moulin A, 2014, PROTEIN SCI, V23, P1698, DOI 10.1002/pro.2548; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sato K, 2003, FEBS LETT, V553, P232, DOI 10.1016/S0014-5793(03)01005-6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Staelens S, 2006, J BIOL CHEM, V281, P2225, DOI 10.1074/jbc.M508191200; Torring N, 2005, PROSTATE, V64, P1, DOI 10.1002/pros.20214; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	40	10	10	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2319	2330		10.1074/jbc.M115.656009	http://dx.doi.org/10.1074/jbc.M115.656009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26627827	Green Published, hybrid			2022-12-28	WOS:000369610400022
J	Zou, XT; Meng, J; Li, L; Han, WH; Li, CY; Zhong, R; Miao, XX; Cai, J; Zhang, Y; Zhu, DH				Zou, Xiaoting; Meng, Jiao; Li, Li; Han, Wanhong; Li, Changyin; Zhong, Ran; Miao, Xuexia; Cai, Jun; Zhang, Yong; Zhu, Dahai			Acetoacetate Accelerates Muscle Regeneration and Ameliorates Muscular Dystrophy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ATP CITRATE LYASE; KETONE-BODIES; CELL-PROLIFERATION; STEM-CELLS; IN-VITRO; SUCCINATE-DEHYDROGENASE; FUMARATE-HYDRATASE; GLUCOSE-METABOLISM; SATELLITE CELLS	Acetoacetate (AA) is a ketone body and acts as a fuel to supply energy for cellular activity of various tissues. Here, we uncovered a novel function of AA in promoting muscle cell proliferation. Notably, the functional role of AA in regulating muscle cell function is further evidenced by its capability to accelerate muscle regeneration in normal mice, and it ameliorates muscular dystrophy in mdx mice. Mechanistically, our data from multiparameter analyses consistently support the notion that AA plays a non-metabolic role in regulating muscle cell function. Finally, we show that AA exerts its function through activation of the MEK1-ERK1/2-cyclin D1 pathway, revealing a novel mechanism in which AA serves as a signaling metabolite in mediating muscle cell function. Our findings highlight the profound functions of a small metabolite as signaling molecule in mammalian cells.	[Zou, Xiaoting; Meng, Jiao; Li, Li; Han, Wanhong; Li, Changyin; Zhong, Ran; Zhang, Yong; Zhu, Dahai] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Zou, Xiaoting; Meng, Jiao; Li, Li; Han, Wanhong; Li, Changyin; Zhong, Ran; Zhang, Yong; Zhu, Dahai] Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Miao, Xuexia; Cai, Jun] Chinese Acad Sci, Key Lab Genom & Precis Med, China Gastrointestinal Canc Res Ctr, Beijing Inst Genom, Beijing 100101, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, Y; Zhu, DH (corresponding author), Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Zhang, Y; Zhu, DH (corresponding author), Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	dr_zhangyong@126.com; dhzhu@pumc.edu.cn	Zhu, Dahai/ABA-5315-2021; Zhang, Yong/AAH-6147-2021	Meng, Jiao/0000-0001-9645-758X	National Basic Research Program of China [2011CBA01104, 2015CB943103, 2014CB964703]; National Natural Science Foundation of China [31471289, 31030041]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China restricted to cancer development and suggesting that metab-Grants 2011CBA01104, 2015CB943103, and 2014CB964703 and National Natural Science Foundation of China Grants 31471289 and 31030041. The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmegeed MA, 2004, J PHARMACOL EXP THER, V310, P728, DOI 10.1124/jpet.104.066522; Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Areta JL, 2014, NUTR RES, V34, P1000, DOI 10.1016/j.nutres.2014.09.011; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Averous J, 2012, EXP CELL RES, V318, P217, DOI 10.1016/j.yexcr.2011.10.015; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BALASSE EO, 1971, J CLIN INVEST, V50, P801, DOI 10.1172/JCI106551; Bardella C, 2011, J PATHOL, V225, P4, DOI 10.1002/path.2932; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bhagavati S, 2008, CURR STEM CELL RES T, V3, P219, DOI 10.2174/157488808785740343; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Chen YW, 2010, INT J BIOCHEM CELL B, V42, P2072, DOI 10.1016/j.biocel.2010.09.017; CREMER JE, 1971, BIOCHEM J, V122, P135, DOI 10.1042/bj1220135; Creuzet S, 1998, EXP CELL RES, V243, P241, DOI 10.1006/excr.1998.4100; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Endo T, 2007, REGEN MED, V2, P243, DOI 10.2217/17460751.2.3.243; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FENSELAU A, 1974, LIFE SCI, V15, P811, DOI 10.1016/0024-3205(74)90519-0; FENSELAU A, 1974, BIOCHEMISTRY-US, V13, P3884, DOI 10.1021/bi00716a010; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Garedew A, 2012, CELL METAB, V15, P466, DOI 10.1016/j.cmet.2012.03.003; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hoffman WH, 2002, NEUROSCI LETT, V334, P71, DOI 10.1016/S0304-3940(02)00816-9; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jain SK, 1999, DIABETES, V48, P1850, DOI 10.2337/diabetes.48.9.1850; Jain SK, 2003, DIABETES CARE, V26, P2139, DOI 10.2337/diacare.26.7.2139; Jorquera R, 2001, HUM MOL GENET, V10, P1741, DOI 10.1093/hmg/10.17.1741; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kyriakidis DA, 2009, AMINO ACIDS, V37, P443, DOI 10.1007/s00726-009-0241-z; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Li XY, 2011, BIOESSAYS, V33, P485, DOI 10.1002/bies.201100026; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Mohanty S, 2005, INDIAN J MED RES, V122, P425; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; Nordli DR, 2001, PEDIATRICS, V108, P129, DOI 10.1542/peds.108.1.129; Oermann EK, 2012, SEMIN CELL DEV BIOL, V23, P370, DOI 10.1016/j.semcdb.2012.01.013; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; PALMER TN, 1993, BIOCHEM MOL BIOL INT, V29, P255; Pan JW, 1999, EPILEPSIA, V40, P703, DOI 10.1111/j.1528-1157.1999.tb00766.x; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; Pollard PJ, 2009, SCIENCE, V324, P192, DOI 10.1126/science.1173362; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROUS S, 1980, INT J BIOCHEM, V11, P337, DOI 10.1016/0020-711X(80)90302-X; ROUS S, 1973, FEBS LETT, V37, P231, DOI 10.1016/0014-5793(73)80466-1; Russell RR, 1997, J CLIN INVEST, V100, P2892, DOI 10.1172/JCI119838; Samartsev VN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P598, DOI 10.1134/S0006297910050093; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Uehara Y, 2002, DIABETES, V51, P2922, DOI 10.2337/diabetes.51.10.2922; Usas A, 2011, MEDICINA-LITHUANIA, V47, P469, DOI 10.3390/medicina47090068; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang M, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00085; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	87	39	39	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2181	2195		10.1074/jbc.M115.676510	http://dx.doi.org/10.1074/jbc.M115.676510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645687	Green Published, hybrid			2022-12-28	WOS:000369610400012
J	Ehrhardt, A; Chung, WJ; Pyle, LC; Wang, W; Nowotarski, K; Mulvihill, CM; Rannjeesingh, M; Hong, J; Velu, SE; Lewis, HA; Atwell, S; Aller, S; Bear, CE; Lukacs, GL; Kirk, KL; Sorscher, EJ				Ehrhardt, Annette; Chung, W. Joon; Pyle, Louise C.; Wang, Wei; Nowotarski, Krzysztof; Mulvihill, Cory M.; Rannjeesingh, Mohabir; Hong, Jeong; Velu, Sadanandan E.; Lewis, Hal A.; Atwell, Shane; Aller, Steve; Bear, Christine E.; Lukacs, Gergely L.; Kirk, Kevin L.; Sorscher, Eric J.			Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; CHLORIDE CHANNEL; CHRONIC RHINOSINUSITIS; ALTERNATING ACCESS; DOMAIN; POTENTIATOR; ACTIVATORS; MUTATIONS; SUBUNIT; COMPLEX	In this study, we present data indicating a robust and specific domain interaction between the cystic fibrosis transmembrane conductance regulator (CFTR) first cytosolic loop (CL1) and nucleotide binding domain 1 (NBD1) that allows ion transport to proceed in a regulated fashion. We used co-precipitation and ELISA to establish the molecular contact and showed that binding kinetics were not altered by the common clinical mutation F508del. Both intrinsic ATPase activity and CFTR channel gating were inhibited severely by CL1 peptide, suggesting that NBD1/CL1 binding is a crucial requirement for ATP hydrolysis and channel function. In addition to cystic fibrosis, CFTR dysregulation has been implicated in the pathogenesis of prevalent diseases such as chronic obstructive pulmonary disease, acquired rhinosinusitis, pancreatitis, and lethal secretory diarrhea (e.g. cholera). On the basis of clinical relevance of the CFTR as a therapeutic target, a cell-free drug screen was established to identify modulators of NBD1/CL1 channel activity independent of F508del CFTR and pharmacologic rescue. Our findings support a targetable mechanism of CFTR regulation in which conformational changes in the NBDs cause reorientation of transmembrane domains via interactions with CL1 and result in channel gating.	[Ehrhardt, Annette; Chung, W. Joon; Pyle, Louise C.; Hong, Jeong; Aller, Steve; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Chung, W. Joon] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Wang, Wei; Nowotarski, Krzysztof; Hong, Jeong; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cellular Integrat & Dev Biol, Birmingham, AL 35294 USA; [Aller, Steve] Univ Alabama Birmingham, Dept Pharmacol, Birmingham, AL 35294 USA; [Velu, Sadanandan E.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Ehrhardt, Annette; Sorscher, Eric J.] Emory Univ, Dept Pediat, 1760 Haygood Dr,Suite 280, Atlanta, GA 30322 USA; [Mulvihill, Cory M.; Rannjeesingh, Mohabir; Bear, Christine E.] Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Lewis, Hal A.] Bristol Myers Squibb Co, Princeton, NJ 08543 USA; [Atwell, Shane] Eli Lilly & Co, San Diego, CA 92121 USA; [Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Lukacs, Gergely L.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Bristol-Myers Squibb; Eli Lilly; University of Toronto; University of Toronto; McGill University	Sorscher, EJ (corresponding author), Emory Univ, Dept Pediat, 1760 Haygood Dr,Suite 280, Atlanta, GA 30322 USA.	esorscher@emory.edu	Pyle, Louise C/AAR-3513-2021	Pyle, Louise C/0000-0002-8933-9320; Sorscher, Eric J./0000-0001-9341-3354; Lukacs, Gergely/0000-0003-0900-0675; Velu, Sadanandan/0000-0002-0342-2378; Aller, Stephen/0000-0003-0379-5534	Cystic Fibrosis Foundation; National Institutes of Health [P30DK72482]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cystic Fibrosis Foundation and National Institutes of Health Grant P30DK72482 (to E. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Brymora A., 2004, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB1705S22; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; CSERHATI T, 1995, PEPTIDES, V16, P165, DOI 10.1016/0196-9781(94)00134-R; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lerch MM, 2010, DIGEST DIS, V28, P324, DOI 10.1159/000319408; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Namkung W, 2013, MOL PHARMACOL, V84, P384, DOI 10.1124/mol.113.086348; Naren Anjaparavanda P, 2002, Methods Mol Med, V70, P175; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2011, J BIOL CHEM, V286, P15215, DOI 10.1074/jbc.M110.184267; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Pinto JM, 2008, LARYNGOSCOPE, V118, P2067, DOI 10.1097/MLG.0b013e3181805147; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Stanwood GD, 2008, MOL PHARMACOL, V74, P317, DOI 10.1124/mol.108.049098; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	53	12	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1854	1865		10.1074/jbc.M115.704809	http://dx.doi.org/10.1074/jbc.M115.704809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627831	hybrid, Green Published			2022-12-28	WOS:000368620700025
J	Zhao, AH; Tu, LN; Mukai, C; Sirivelu, MP; Pillai, VV; Morohaku, K; Cohen, R; Selvaraj, V				Zhao, Amy H.; Tu, Lan N.; Mukai, Chinatsu; Sirivelu, Madhu P.; Pillai, Viju V.; Morohaku, Kanako; Cohen, Roy; Selvaraj, Vimal			Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; PERMEABILITY TRANSITION PORE; PROTOPORPHYRIN-IX; 5-AMINOLEVULINIC ACID; MEMBRANE-PROTEIN; OUTER-MEMBRANE; COPROPORPHYRINOGEN OXIDASE; ERYTHROLEUKEMIA-CELLS; PHOTODYNAMIC THERAPY	Function of the mammalian translocator protein (TSPO; previously known as the peripheral benzodiazepine receptor) remains unclear because its presumed role in steroidogenesis and mitochondrial permeability transition established using pharmacological methods has been refuted in recent genetic studies. Protoporphyrin IX (PPIX) is considered a conserved endogenous ligand for TSPO. In bacteria, TSPO was identified to regulate tetrapyrrole metabolism and chemical catalysis of PPIX in the presence of light, and in vertebrates, TSPO function has been linked to porphyrin transport and heme biosynthesis. Positive correlation between high TSPO expression in cancer cells and susceptibility to photodynamic therapy based on their increased ability to convert the precursor 5-aminolevulinic acid (ALA) to PPIX appeared to reinforce this mechanism. In this study, we used TSPO knock-out (Tspo(-/-)) mice, primary cells, and different tumor cell lines to examine the role of TSPO in erythropoiesis, heme levels, PPIX biosynthesis, phototoxic cell death, and mitochondrial bioenergetic homeostasis. In contrast to expectations, our results demonstrate that TSPO deficiency does not adversely affect erythropoiesis, heme biosynthesis, bio-conversion of ALA to PPIX, and porphyrin-mediated phototoxic cell death. TSPO expression levels in cancer cells do not correlate with their ability to convert ALA to PPIX. In fibroblasts, we observed that TSPO deficiency decreased the oxygen consumption rate and mitochondrial membrane potential (Delta psi m) indicative of a cellular metabolic shift, without a negative impact on porphyrin biosynthetic capability. Based on these findings, we conclude that mammalian TSPO does not have a critical physiological function related to PPIX and heme biosynthesis.	[Zhao, Amy H.; Tu, Lan N.; Pillai, Viju V.; Morohaku, Kanako; Selvaraj, Vimal] Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14853 USA; [Mukai, Chinatsu; Cohen, Roy] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Sirivelu, Madhu P.] Univ Penn, Coll Vet Med, Dept Clin Pathol, Philadelphia, PA 19104 USA; [Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, 204 Morrison Hall,507 Tower Rd, Ithaca, NY 14853 USA	Cornell University; Cornell University; University of Pennsylvania; Cornell University	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, 204 Morrison Hall,507 Tower Rd, Ithaca, NY 14853 USA.	vs88@cornell.edu	Pillai, Viju/L-7557-2019; Selvaraj, Vimal/AAC-2853-2022	Pillai, Viju/0000-0002-2696-0451; Mukai, Chinatsu/0000-0003-0080-9371	Cornell College of Agriculture and Life Sciences; Jane E Brody undergraduate research award; Dextra undergraduate research endowment fund; Vietnam Education Foundation; Cornell Center for Vertebrate Genomics	Cornell College of Agriculture and Life Sciences; Jane E Brody undergraduate research award; Dextra undergraduate research endowment fund; Vietnam Education Foundation; Cornell Center for Vertebrate Genomics	This work was supported by funds from the Cornell College of Agriculture and Life Sciences (startup funds to V. S.); the Jane E Brody undergraduate research award and the Dextra undergraduate research endowment fund (to A. H. Z.); and fellowships from the Vietnam Education Foundation and the Cornell Center for Vertebrate Genomics (to L. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Austin CJD, 2013, INT J BIOCHEM CELL B, V45, P1212, DOI 10.1016/j.biocel.2013.03.004; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Bisland SK, 2007, LASER SURG MED, V39, P678, DOI 10.1002/lsm.20544; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; CLARKE GD, 1980, NATURE, V287, P160, DOI 10.1038/287160a0; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Galiegue S, 2004, CLIN CANCER RES, V10, P2058, DOI 10.1158/1078-0432.CCR-03-0988; Gavish M, 1999, PHARMACOL REV, V51, P629; Ginter C, 2013, BIOCHEMISTRY-US, V52, P3609, DOI 10.1021/bi400364z; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hardwick M, 1999, CANCER RES, V59, P831; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; Krieg RC, 2002, PHOTOCHEM PHOTOBIOL, V76, P518, DOI 10.1562/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; LARCHER JC, 1989, EUR J PHARMACOL, V161, P197, DOI 10.1016/0014-2999(89)90843-1; Li F, 2015, PHARMACOL RES, V99, P404, DOI 10.1016/j.phrs.2015.03.022; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Li G, 1999, BRIT J CANCER, V80, P676, DOI 10.1038/sj.bjc.6690409; Lin R, 2014, AGING CELL, V13, P507, DOI 10.1111/acel.12200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maaser K, 2002, CLIN CANCER RES, V8, P3205; Maaser K, 2005, CLIN CANCER RES, V11, P1751, DOI 10.1158/1078-0432.CCR-04-1955; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Morohaku K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074509; MORRISON GR, 1965, ANAL CHEM, V37, P1124, DOI 10.1021/ac60228a014; Nakazawa F, 2009, GENE EXPR PATTERNS, V9, P114, DOI 10.1016/j.gep.2008.09.005; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Rampon C, 2009, FASEB J, V23, P4181, DOI 10.1096/fj.09-129262; RATCLIFFE SL, 1995, BRIT J CANCER, V71, P300, DOI 10.1038/bjc.1995.60; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Selvaraj V, 2015, MOL ENDOCRINOL, V29, P490, DOI 10.1210/me.2015-1033; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Sileikyte J, 2011, J BIOL CHEM, V286, P1046, DOI 10.1074/jbc.M110.172486; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; TAKETANI S, 1995, J BIOCHEM-TOKYO, V117, P875, DOI 10.1093/oxfordjournals.jbchem.a124790; Taketani S, 2001, EUR J BIOCHEM, V268, P1705, DOI 10.1046/j.1432-1327.2001.02045.x; Tu LN, 2015, ENDOCRINOLOGY, V156, P1033, DOI 10.1210/en.2014-1707; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Verma A, 1998, MOL MED, V4, P40, DOI 10.1007/BF03401728; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; WANG JKT, 1984, P NATL ACAD SCI-BIOL, V81, P3770, DOI 10.1073/pnas.81.12.3770; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Yeliseev AA, 1999, J BIOL CHEM, V274, P21234, DOI 10.1074/jbc.274.30.21234	60	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1591	1603		10.1074/jbc.M115.686360	http://dx.doi.org/10.1074/jbc.M115.686360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627829	Green Published, hybrid			2022-12-28	WOS:000368620700004
J	Fenyk, S; Dixon, CH; Gittens, WH; Townsend, PD; Sharples, GJ; Palsson, LO; Takken, FLW; Cann, MJ				Fenyk, Stepan; Dixon, Christopher H.; Gittens, William H.; Townsend, Philip D.; Sharples, Gary J.; Palsson, Lars-Olof; Takken, Frank L. W.; Cann, Martin J.			The Tomato Nucleotide-binding Leucine-rich Repeat Immune Receptor I-2 Couples DNA-binding to Nucleotide-binding Domain Nucleotide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; REPLICATION ORIGIN RECOGNITION; PROTEIN-STRUCTURE PREDICTION; NB-ARC DOMAIN; RESISTANCE PROTEIN; NUCLEAR ACCUMULATION; DISEASE-RESISTANCE; DEFENSE REGULATORS; ATPASE ACTIVITY; GENE-PRODUCTS	Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable plants to recognize and respond to pathogen attack. Previously, we demonstrated that the Rx1 NLR of potato is able to bind and bend DNA in vitro. DNA binding in situ requires its genuine activation following pathogen perception. However, it is unknown whether other NLR proteins are also able to bind DNA. Nor is it known how DNA binding relates to the ATPase activity intrinsic to NLR switch function required to immune activation. Here we investigate these issues using a recombinant protein corresponding to the N-terminal coiled-coil and nucleotide- binding domain regions of the I-2 NLR of tomato. Wild type I-2 protein bound nucleic acids with a preference of ssDNA approximate to dsDNA > ssRNA, which is distinct from Rx1. I-2 induced bending and melting of DNA. Notably, ATP enhanced DNA binding relative to ADP in the wild type protein, the null P-loop mutant K207R, and the autoactive mutant S233F. DNA binding was found to activate the intrinsic ATPase activity of I-2. Because DNA binding by I-2 was decreased in the presence of ADP when compared with ATP, a cyclic mechanism emerges; activated ATP-associated I-2 binds to DNA, which enhances ATP hydrolysis, releasing ADP-bound I-2 from the DNA. Thus DNA binding is a general property of at least a subset of NLR proteins, and NLR activation is directly linked to its activity at DNA.	[Fenyk, Stepan; Dixon, Christopher H.; Gittens, William H.; Townsend, Philip D.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England; [Fenyk, Stepan; Dixon, Christopher H.; Gittens, William H.; Townsend, Philip D.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Palsson, Lars-Olof] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, NL-1098 XH Amsterdam, Netherlands	Durham University; Durham University; Durham University; University of Amsterdam	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Pålsson, Lars-Olof A/F-3877-2012; Townsend, Phiip/J-3761-2018; Sharples, Gary/B-8638-2016; Takken, Frank/C-8051-2012	Pålsson, Lars-Olof A/0000-0003-3592-8506; Townsend, Phiip/0000-0001-9235-3492; Sharples, Gary/0000-0003-2495-0062; Gittens, William/0000-0002-3830-1218; Takken, Frank/0000-0003-2655-3108	Biotechnology and Biological Sciences Research Council [BB/M007405/1]; European Union; BBSRC [BB/M007405/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1220464] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/M007405/1 (to M.J.C., G.J.S., and L.-O.P.) and European Union-funded Integrated Project BIOEXPLOIT (to F.L.W.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fenyk S, 2015, J BIOL CHEM, V290, P24945, DOI 10.1074/jbc.M115.672121; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P777, DOI 10.1080/00021369.1974.10861230; Gabriels SHEJ, 2007, PLANT J, V50, P14, DOI 10.1111/j.1365-313X.2007.03027.x; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Gaudreault M, 2009, METHODS MOL BIOL, V543, P15, DOI 10.1007/978-1-60327-015-1_2; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; Green V, 2013, MOL MICROBIOL, V89, P1240, DOI 10.1111/mmi.12343; Griebel T, 2014, TRENDS IMMUNOL, V35, P562, DOI 10.1016/j.it.2014.09.005; GRINVALD A, 1974, ANAL BIOCHEM, V59, P583, DOI 10.1016/0003-2697(74)90312-1; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lee DG, 2000, EMBO J, V19, P4774, DOI 10.1093/emboj/19.17.4774; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Ma Lisong, 2013, Front Plant Sci, V4, P94, DOI 10.3389/fpls.2013.00094; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nishimura MT, 2015, CELL, V161, P957, DOI 10.1016/j.cell.2015.05.017; PARKHURST KM, 1995, BIOCHEMISTRY-US, V34, P285, DOI 10.1021/bi00001a035; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Vamosi G, 1996, BIOPHYS J, V71, P972, DOI 10.1016/S0006-3495(96)79300-1; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wiermer M, 2010, NUCLEUS-PHILA, V1, P332, DOI 10.4161/nucl.1.4.12109; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	66	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1137	1147		10.1074/jbc.M115.698589	http://dx.doi.org/10.1074/jbc.M115.698589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601946	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000368068300010
J	Barnwal, B; Karlberg, H; Mirazimi, A; Tan, YJ				Barnwal, Bhaskar; Karlberg, Helen; Mirazimi, Ali; Tan, Yee-Joo			The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; CELL-DEATH; NSS PROTEIN; INTERFERON; INDUCTION; COUNTERACTS; CASPASES; PATHWAYS; PATHOGENESIS; INHIBITORS	Viruses have developed distinct strategies to overcome the host defense system. Regulation of apoptosis in response to viral infection is important for virus survival and dissemination. Like other viruses, Crimean-Congo hemorrhagic fever virus (CCHFV) is known to regulate apoptosis. This study, for the first time, suggests that the non-structural protein NSs of CCHFV, a member of the genus Nairovirus, induces apoptosis. In this report, we demonstrated the expression of CCHFV NSs, which contains 150 amino acid residues, in CCHFV-infected cells. CCHFV NSs undergoes active degradation during infection. We further demonstrated that ectopic expression of CCHFV NSs induces apoptosis, as reflected by caspase-3/7 activity and cleaved poly(ADP-ribose) polymerase, in different cell lines that support CCHFV replication. Using specific inhibitors, we showed that CCHFV NSs induces apoptosis via both intrinsic and extrinsic pathways. The minimal active region of the CCHFV NSs protein was determined to be 93-140 amino acid residues. Using alanine scanning, we demonstrated that Leu-127 and Leu-135 are the key residues for NSs-induced apoptosis. Interestingly, CCHFV NSs co-localizes in mitochondria and also disrupts the mitochondrial membrane potential. We also demonstrated that Leu-127 and Leu-135 are important residues for disruption of the mitochondrial membrane potential by NSs. Therefore, these results indicate that the C terminus of CCHFV NSs triggers mitochondrial membrane permeabilization, leading to activation of caspases, which, ultimately, leads to apoptosis. Given that multiple factors contribute to apoptosis during CCHFV infection, further studies are needed to define the involvement of CCHFV NSs in regulating apoptosis in infected cells.	[Barnwal, Bhaskar; Tan, Yee-Joo] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117548, Singapore; [Barnwal, Bhaskar] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Karlberg, Helen; Mirazimi, Ali] Publ Hlth Agcy Sweden, S-17182 Solna, Sweden; [Mirazimi, Ali] Karolinska Inst, S-17177 Stockholm, Sweden; [Mirazimi, Ali] Natl Vet Inst, S-75651 Uppsala, Sweden	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Public Health Agency of Sweden; Karolinska Institutet; National Veterinary Institute SVA	Tan, YJ (corresponding author), MD4,5 Sci Dr,2, Singapore 117597, Singapore.	Yee_Joo_TAN@NUHS.edu.sg		Tan, Yee-Joo/0000-0002-2278-4497; , Ali/0000-0003-2371-6055	NUS/NUHS [R-182-000-156-720, R-182-000-156-133]; Agency for Science, Technology, and Research	NUS/NUHS; Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR))	This work was supported by NUS/NUHS Startup Grants R-182-000-156-720 and R-182-000-156-133 (to Y. J. T.) and intramural funds from the Agency for Science, Technology, and Research. The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Aweya JJ, 2013, VIRUS RES, V172, P24, DOI 10.1016/j.virusres.2012.12.005; Barry G, 2014, J GEN VIROL, V95, P1640, DOI 10.1099/vir.0.065425-0; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; FULLER F, 1982, J VIROL, V41, P643, DOI 10.1128/JVI.41.2.643-648.1982; Gaddy DF, 2005, J VIROL, V79, P4170, DOI 10.1128/JVI.79.7.4170-4179.2005; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hewson R, 2004, VIRUS RES, V102, P185, DOI 10.1016/j.virusres.2003.12.035; Irusta PM, 2003, CURR OPIN CELL BIOL, V15, P700, DOI 10.1016/j.ceb.2003.10.007; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karlberg H, 2015, J GEN VIROL, V96, P538, DOI 10.1099/jgv.0.000011; Karlberg H, 2011, J BIOL CHEM, V286, P3227, DOI 10.1074/jbc.M110.149369; Keshtkar-Jahromi M, 2011, ANTIVIR RES, V90, P85, DOI 10.1016/j.antiviral.2011.02.010; Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Li GY, 2010, MICROBIOL IMMUNOL, V54, P20, DOI 10.1111/j.1348-0421.2009.00178.x; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029712; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Tan YX, 2007, J VIROL, V81, P6346, DOI 10.1128/JVI.00090-07; Tan ZH, 2010, J MED VIROL, V82, P467, DOI 10.1002/jmv.21709; TARODI B, 1994, VIROLOGY, V201, P404, DOI 10.1006/viro.1994.1309; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Terasaki K, 2013, J VIROL, V87, P676, DOI 10.1128/JVI.02192-12; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; van Knippenberg I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064137; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Xu FL, 2008, J GEN VIROL, V89, P2175, DOI 10.1099/vir.0.2008/001644-0	46	45	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					582	592		10.1074/jbc.M115.667436	http://dx.doi.org/10.1074/jbc.M115.667436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26574543	Green Published, hybrid			2022-12-28	WOS:000367830500007
J	Palty, R; Isacoff, EY				Palty, Raz; Isacoff, Ehud Y.			Cooperative Binding of Stromal Interaction Molecule 1 (STIM1) to the N and C Termini of Calcium Release-activated Calcium Modulator 1 (Orai1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); gating; ion channel; stromal interaction molecule 1 (STIM1)	CRAC CHANNEL ACTIVATION; OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; DOMAIN; PROTEIN; SENSOR; OLIGOMERIZATION; CONFORMATION; DEPLETION; COUPLES	Calcium flux through store-operated calcium entry is a central regulator of intracellular calcium signaling. The two key components of the store-operated calcium release-activated calcium channel are the Ca2+-sensing protein stromal interaction molecule 1 (STIM1) and the channel pore-forming protein Orai1. During store-operated calcium entry activation, calcium depletion from the endoplasmic reticulum triggers a series of conformational changes in STIM1 that unmask a minimal Orai1-activating domain (CRAC activation region (CAD)). To gate Orai1 channels, the exposed STIM1-activating domain binds to two sites in Orai1, one in the N terminus and one in the C terminus. Whether the two sites operate as distinct binding domains or cooperate in CAD binding is unknown. In this study, we show that the N and C-terminal domains of Orai1 synergistically contribute to the interaction with STIM1 and couple STIM1 binding with channel gating and modulation of ion selectivity.	[Palty, Raz; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Palty, Raz/HCH-3978-2022; isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	American Heart Association Postdoctoral Fellowship [13POST14000008]; National Institutes of Health [R01 NS35549]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Postdoctoral Fellowship 13POST14000008 (to R.P.) and National Institutes of Health Grant R01 NS35549 (to E.Y.I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yu F, 2011, J BIOL CHEM, V286, P8375, DOI 10.1074/jbc.M110.188789; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	31	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					334	341		10.1074/jbc.M115.685289	http://dx.doi.org/10.1074/jbc.M115.685289			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546674	hybrid, Green Published			2022-12-28	WOS:000367589500026
J	Schmid-Burgk, JL; Chauhan, D; Schmidt, T; Ebert, TS; Reinhardt, J; Endl, E; Hornung, V				Schmid-Burgk, Jonathan L.; Chauhan, Dhruv; Schmidt, Tobias; Ebert, Thomas S.; Reinhardt, Julia; Endl, Elmar; Hornung, Veit			A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase 1 (CASP1); cell death; inflammasome; inflammation; NLRP3; NEK7; genetic screen; pyroptosis	PROTEIN-KINASES; HUMAN-CELLS; CYTOKINESIS; RECOGNITION; FAMILY	Inflammasomes are high molecular weight protein complexes that assemble in the cytosol upon pathogen encounter. This results in caspase-1-dependent pro-inflammatory cytokine maturation, as well as a special type of cell death, known as pyroptosis. The Nlrp3 inflammasome plays a pivotal role in pathogen defense, but at the same time, its activity has also been implicated in many common sterile inflammatory conditions. To this effect, several studies have identified Nlrp3 inflammasome engagement in a number of common human diseases such as atherosclerosis, type 2 diabetes, Alzheimer disease, or gout. Although it has been shown that known Nlrp3 stimuli converge on potassium ion efflux upstream of Nlrp3 activation, the exact molecular mechanism of Nlrp3 activation remains elusive. Here, we describe a genome-wide CRISPR/Cas9 screen in immortalized mouse macrophages aiming at the unbiased identification of gene products involved in Nlrp3 inflammasome activation. We employed a FACS-based screen for Nlrp3-dependent cell death, using the ionophoric compound nigericin as a potassium efflux-inducing stimulus. Using a genome-wide guide RNA (gRNA) library, we found that targeting Nek7 rescued macrophages from nigericin-induced lethality. Subsequent studies revealed that murine macrophages deficient in Nek7 displayed a largely blunted Nlrp3 inflammasome response, whereas Aim2-mediated inflammasome activation proved to be fully intact. Although the mechanism of Nek7 functioning upstream of Nlrp3 yet remains elusive, these studies provide a first genetic handle of a component that specifically functions upstream of Nlrp3.	[Schmid-Burgk, Jonathan L.; Chauhan, Dhruv; Schmidt, Tobias; Ebert, Thomas S.; Endl, Elmar; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Mol Med, D-53127 Bonn, Germany; [Reinhardt, Julia] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Hornung, Veit] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Hornung, Veit] Univ Munich, Dept Biochem, D-81377 Munich, Germany	University of Bonn; University of Bonn; University of Munich; University of Munich	Hornung, V (corresponding author), Univ Munich, Gene Ctr, D-81377 Munich, Germany.	hornung@genzentrum.lmu.de	Hornung, Veit/C-3565-2012; Schmid-Burgk, Jonathan/GSN-3512-2022	Hornung, Veit/0000-0002-4150-194X; Schmid-Burgk, Jonathan/0000-0003-0988-2487; Schmidt, Tobias/0000-0003-3102-3515	European Research Council [647858-GENESIS]; Deutsche Forschungsgemeinschaft [EXC1023]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported European Research Council Grant 647858-GENESIS and Deutsche Forschungsgemeinschaft Grant EXC1023. The authors declare that they have no conflicts of interest with the contents of this article.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cohen S, 2013, BBA-MOL CELL RES, V1833, P1104, DOI 10.1016/j.bbamcr.2012.12.021; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Jakobs Christopher, 2013, Methods Mol Biol, V1040, P103, DOI 10.1007/978-1-62703-523-1_9; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Schmidt T, 2016, METHODS MOL BIOL, V1338, P261, DOI 10.1007/978-1-4939-2932-0_19; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	27	265	274	4	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					103	109		10.1074/jbc.C115.700492	http://dx.doi.org/10.1074/jbc.C115.700492			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26553871	Green Published, hybrid			2022-12-28	WOS:000367589500008
J	Koga, T; Suico, MA; Shimasaki, S; Watanabe, E; Kai, Y; Koyama, K; Omachi, K; Morino-Koga, S; Sato, T; Shuto, T; Mori, K; Hino, S; Nakao, M; Kai, H				Koga, Tomoaki; Suico, Mary Ann; Shimasaki, Shogo; Watanabe, Eriko; Kai, Yukari; Koyama, Kosuke; Omachi, Kohei; Morino-Koga, Saori; Sato, Takashi; Shuto, Tsuyoshi; Mori, Kazutoshi; Hino, Shinjiro; Nakao, Mitsuyoshi; Kai, Hirofumi			Endoplasmic Reticulum (ER) Stress Induces Sirtuin 1 (SIRT1) Expression via the PI3K-Akt-GSK3 beta Signaling Pathway and Promotes Hepatocellular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NEGATIVE REGULATOR; INDUCTION; ATF6; METABOLISM; STEATOSIS; CELLS; LIFE	Sirtuin 1 (SIRT1), an NAD(+)-dependent histone deacetylase, plays crucial roles in various biological processes including longevity, stress response, and cell survival. Endoplasmic reticulum (ER) stress is caused by dysfunction of ER homeostasis and exacerbates various diseases including diabetes, fatty liver, and chronic obstructive pulmonary disease. Although several reports have shown that SIRT1 negatively regulates ER stress and ER stress-induced responses in vitro and in vivo, the effect of ER stress on SIRT1 is less explored. In this study, we showed that ER stress induced SIRT1 expression in vitro and in vivo. We further determined the molecular mechanisms of how ER stress induces SIRT1 expression. Surprisingly, the conventional ER stress-activated transcription factors XBP1, ATF4, and ATF6 seem to be dispensable for SIRT1 induction. Based on inhibitor screening experiments with SIRT1 promoter, we found that the PI3K-Akt-GSK3 beta signaling pathway is required for SIRT1 induction by ER stress. Moreover, we showed that pharmacological inhibition of SIRT1 by EX527 inhibited the ER stress-induced cellular death in vitro and severe hepatocellular injury in vivo, indicating a detrimental role of SIRT1 in ER stress-induced damage responses. Collectively, these data suggest that SIRT1 expression is up-regulated by ER stress and contributes to ER stress-induced cellular damage.	[Koga, Tomoaki; Suico, Mary Ann; Shimasaki, Shogo; Watanabe, Eriko; Kai, Yukari; Koyama, Kosuke; Omachi, Kohei; Morino-Koga, Saori; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Koga, Tomoaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Hino, Shinjiro; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Chuo Ku, Kumamoto 8600811, Japan	Kumamoto University; Juntendo University; Kyoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Mori, Kazutoshi/AAW-5449-2020; Omachi, Kohei/GPX-9286-2022; Omachi, Kohei/ABB-2844-2020; Sato, Takashi/AHB-5258-2022	Sato, Takashi/0000-0003-4203-0999; Shuto, Tsuyoshi/0000-0003-1275-4988; Suico, Mary Ann/0000-0002-6751-8352	Ministry of Education, Science, Sports and Culture of Japan [19390045]; Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit); Japan Society for the Promotion of Science [20-8140]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Education, Science, Sports and Culture of Japan Grant 19390045, the Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit) (to H. K.), and Japan Society for the Promotion of Science Research Fellowship Grant-in-aid 20-8140 (to T. K.). The authors declare no conflict of interest.	Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Jung TW, 2012, BIOCHEM BIOPH RES CO, V422, P229, DOI 10.1016/j.bbrc.2012.04.129; Koga T, 2005, FEBS LETT, V579, P2811, DOI 10.1016/j.febslet.2005.04.015; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Raynes Rachel, 2013, Genes Cancer, V4, P172, DOI 10.1177/1947601913484497; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Taura M, 2010, CANCER SCI, V101, P1610, DOI 10.1111/j.1349-7006.2010.01567.x; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang FM, 2011, EXP HEMATOL, V39, P999, DOI 10.1016/j.exphem.2011.06.007; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Winnay JN, 2014, P NATL ACAD SCI USA, V111, P1192, DOI 10.1073/pnas.1322564111; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang W, 2015, CELL SIGNAL, V27, P436, DOI 10.1016/j.cellsig.2014.12.010	36	55	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30366	30374		10.1074/jbc.M115.664169	http://dx.doi.org/10.1074/jbc.M115.664169			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26499802	Green Published, hybrid			2022-12-28	WOS:000366738200015
J	Sorensen, AB; Madsen, JJ; Svensson, LA; Pedersen, AA; Ostergaard, H; Overgaard, MT; Olsen, OH; Gandhi, PS				Sorensen, Anders B.; Madsen, Jesper J.; Svensson, L. Anders; Pedersen, Anette A.; Ostergaard, Henrik; Overgaard, Michael T.; Olsen, Ole H.; Gandhi, Prafull S.			Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; SUBSTRATE-ASSISTED ACTIVATION; CRYSTAL-STRUCTURE; DRAMATIC ENHANCEMENT; CATALYTIC-ACTIVITY; NA+ BINDING; FACTOR IXA; DYNAMICS; SITE; COFACTOR	The complex of coagulation factor VIIa (FVIIa), a trypsin-like serine protease, and membrane-bound tissue factor (TF) initiates blood coagulation upon vascular injury. Binding of TF to FVIIa promotes allosteric conformational changes in the FVIIa protease domain and improves its catalytic properties. Extensive studies have revealed two putative pathways for this allosteric communication. Here we provide further details of this allosteric communication by investigating FVIIa loop swap variants containing the 170 loop of trypsin that display TF-independent enhanced activity. Using x-ray crystallography, we show that the introduced 170 loop from trypsin directly interacts with the FVIIa active site, stabilizing segment 215-217 and activation loop 3, leading to enhanced activity. Molecular dynamics simulations and novel fluorescence quenching studies support that segment 215-217 conformation is pivotal to the enhanced activity of the FVIIa variants. We speculate that the allosteric regulation of FVIIa activity by TF binding follows a similar path in conjunction with protease domainNterminus insertion, suggesting a more complete molecular basis of TF-mediated allosteric enhancement of FVIIa activity.	[Sorensen, Anders B.; Madsen, Jesper J.; Svensson, L. Anders; Pedersen, Anette A.; Ostergaard, Henrik; Olsen, Ole H.; Gandhi, Prafull S.] Novo Nordisk AS, Global Res, DK-2760 Malov, Denmark; [Sorensen, Anders B.; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Madsen, Jesper J.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Madsen, Jesper J.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA	Novo Nordisk; Aalborg University; Technical University of Denmark; University of Chicago	Gandhi, PS (corresponding author), Novo Nordisk AS, Prot Interact, Novo Nordisk Pk G8 2-61, DK-2760 Malov, Denmark.	pgan@novonordisk.com	Madsen, Jesper J/E-7233-2015; Madsen, Jesper Jonasson/AAU-5858-2020; Overgaard, Michael Toft/E-1354-2011	Madsen, Jesper J/0000-0003-1411-9080; Madsen, Jesper Jonasson/0000-0003-1411-9080; Overgaard, Michael Toft/0000-0002-1423-2481	Danish Agency for Science, Technology and Innovation; Novo Nordisk Research and Development Science Talent Attraction and Recruitment (STAR) program	Danish Agency for Science, Technology and Innovation; Novo Nordisk Research and Development Science Talent Attraction and Recruitment (STAR) program	Supported by grants from the Danish Agency for Science, Technology and Innovation and the Novo Nordisk Research and Development Science Talent Attraction and Recruitment (STAR) program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; COHEN GH, 1981, J MOL BIOL, V148, P449, DOI 10.1016/0022-2836(81)90186-8; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8757, DOI 10.1021/bi00195a017; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lakowicz J.R., 2007, PRINCIPLES FLUORESCE, P277; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; LUTZ HP, 1983, HELV CHIM ACTA, V66, P1929, DOI 10.1002/hlca.19830660704; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madsen JJ, 2015, J THROMB HAEMOST, V13, P262, DOI 10.1111/jth.12791; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCallum CD, 1996, J BIOL CHEM, V271, P28168, DOI 10.1074/jbc.271.45.28168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; Page MJ, 2006, BIOCHEMISTRY-US, V45, P2987, DOI 10.1021/bi052481a; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 2011, FRONT BIOSCI-LANDMRK, V16, P3156, DOI 10.2741/3903; Persson E, 2009, FEBS J, V276, P3099, DOI 10.1111/j.1742-4658.2009.07028.x; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Salonen LM, 2009, ANGEW CHEM INT EDIT, V48, P811, DOI 10.1002/anie.200804695; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Soejima K, 2001, J BIOL CHEM, V276, P17229, DOI 10.1074/jbc.M009206200; Song HJ, 2014, J BIOL CHEM, V289, P35388, DOI 10.1074/jbc.M114.614297; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zogg T, 2009, STRUCTURE, V17, P1669, DOI 10.1016/j.str.2009.10.011	56	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4671	4683		10.1074/jbc.M115.698613	http://dx.doi.org/10.1074/jbc.M115.698613			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694616	Green Published, hybrid			2022-12-28	WOS:000371604600034
J	Ogawa, N; Kurokawa, T; Fujiwara, K; Polat, OK; Badr, H; Takahashi, N; Mori, Y				Ogawa, Nozomi; Kurokawa, Tatsuki; Fujiwara, Kenji; Polat, Onur Kerem; Badr, Heba; Takahashi, Nobuaki; Mori, Yasuo			Functional and Structural Divergence in Human TRPV1 Channel Subunits by Oxidative Cysteine Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; pain; post-translational modification (PTM); reactive oxygen species (ROS); redox regulation; transient receptor potential channels (TRP channels); disulfide bond	RECEPTOR POTENTIAL CHANNELS; TRANSIENT RECEPTOR; CAPSAICIN RECEPTOR; ION-CHANNEL; VANILLOID RECEPTOR; RESINIFERATOXIN BINDING; INFLAMMATORY PAIN; DISULFIDE BOND; ACTIVATION; TRPA1	Transient receptor potential vanilloid 1 (TRPV1) channel is a tetrameric protein that acts as a sensor for noxious stimuli such as heat and for diverse inflammatory mediators such as oxidative stress to mediate nociception in a subset of sensory neurons. In TRPV1 oxidation sensing, cysteine (Cys) oxidation has been considered as the principle mechanism; however, its biochemical basis remains elusive. Here, we characterize the oxidative status of Cys residues in differential redox environments and propose a model of TRPV1 activation by oxidation. Through employing a combination of non-reducing SDS-PAGE, electrophysiology, and mass spectrometry we have identified the formation of subunit dimers carrying a stable intersubunit disulfide bond between Cys-258 and Cys-742 of human TRPV1 (hTRPV1). C258S and C742S hTRPV1 mutants have a decreased protein half-life, reflecting the role of the intersubunit disulfide bond in supporting channel stability. Interestingly, the C258S hTRPV1 mutant shows an abolished response to oxidants. Mass spectrometric analysis of Cys residues of hTRPV1 treated with hydrogen peroxide shows that Cys-258 is highly sensitive to oxidation. Our results suggest that Cys-258 residues are heterogeneously modified in the hTRPV1 tetrameric complex and comprise Cys-258 with free thiol for oxidation sensing and Cys-258, which is involved in the disulfide bond for assisting subunit dimerization. Thus, the hTRPV1 channel has a heterogeneous subunit composition in terms of both redox status and function.	[Ogawa, Nozomi; Kurokawa, Tatsuki; Fujiwara, Kenji; Polat, Onur Kerem; Badr, Heba; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Takahashi, Nobuaki] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Studies, Kyoto 6158510, Japan	Kyoto University; Harvard University; Harvard Medical School; Kyoto University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Mol Biol Lab, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Polat, Onur Kerem/AAK-3761-2021; Takahashi, Nobuaki/AAG-9411-2019	Takahashi, Nobuaki/0000-0002-0606-3921	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26111004]; Japan Society for the Promotion of Science [24249017]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas "Oxygen biology: a new criterion for integrated understanding of life" 26111004 of the Ministry of Education, Culture, Sports, Science, and Technology, Japan and Grant-in-aid for Scientific Research (A) 24249017 of the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bezerra MM, 2007, N-S ARCH PHARMACOL, V374, P265, DOI 10.1007/s00210-006-0123-9; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flynn R, 2014, J BIOL CHEM, V289, P16675, DOI 10.1074/jbc.M114.558668; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong C, 2015, PFLUG ARCH EUR J PHY, V467, P703, DOI 10.1007/s00424-014-1540-0; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; KERRIDGE D, 1958, J GEN MICROBIOL, V19, P497, DOI 10.1099/00221287-19-3-497; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kozai D, 2014, ANTIOXID REDOX SIGN, V21, P971, DOI 10.1089/ars.2013.5616; Lee YM, 2008, EXP DERMATOL, V17, P864, DOI 10.1111/j.1600-0625.2008.00738.x; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Liu BY, 2013, PULM PHARMACOL THER, V26, P364, DOI 10.1016/j.pupt.2013.01.010; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Ryle A. P., 1954, BIOCHEM J, V58, pv; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; SZALLASI A, 1993, J PHARMACOL EXP THER, V266, P678; SZALLASI A, 1993, N-S ARCH PHARMACOL, V347, P84; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toth BI, 2011, J INVEST DERMATOL, V131, P1095, DOI 10.1038/jid.2010.421; Vyklicky L, 2002, NEUROSCIENCE, V111, P435, DOI 10.1016/S0306-4522(02)00051-9; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; WHIFFEN AJ, 1948, J BACTERIOL, V56, P283, DOI 10.1128/JB.56.3.283-291.1948; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wo ZG, 1996, MOL PHARMACOL, V50, P770; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zissimopoulos S, 2013, J CELL SCI, V126, P5042, DOI 10.1242/jcs.133538; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	58	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4197	4210		10.1074/jbc.M115.700278	http://dx.doi.org/10.1074/jbc.M115.700278			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702055	Green Published, hybrid			2022-12-28	WOS:000371338400043
J	Park, G; Tan, JQ; Garcia, G; Kang, YY; Salvesen, G; Zhang, ZH				Park, Goonho; Tan, Jieqiong; Garcia, Guillermina; Kang, Yunyi; Salvesen, Guy; Zhang, Zhuohua			Regulation of Histone Acetylation by Autophagy in Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone acetylation; histone deacetylase (HDAC); neurodegenerative disease; neurotoxin	IN-VIVO; MOUSE MODEL; CELLS; NEUROTOXICITY; INHIBITORS; REVEALS; PATHWAY	Parkinson disease (PD) is the most common age-dependent neurodegenerative movement disorder. Accumulated evidence indicates both environmental and genetic factors play important roles in PD pathogenesis, but the potential interaction between environment and genetics in PD etiology remains largely elusive. Here, we report that PD-related neurotoxins induce both expression and acetylation of multiple sites of histones in cultured human cells and mouse midbrain dopaminergic (DA) neurons. Consistently, levels of histone acetylation are markedly higher in midbrain DA neurons of PD patients compared to those of their matched control individuals. Further analysis reveals that multiple histone deacetylases (HDACs) are concurrently decreased in 1-methyl-4-phenylpyridinium (MPP+)-treated cells and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse brains, as well as midbrain tissues of human PD patients. Finally, inhibition of histone acetyltransferase (HAT) protects, whereas inhibition of HDAC1 and HDAC2 potentiates, MPP+-induced cell death. Pharmacological and genetic inhibition of autophagy suppresses MPP+-induced HDACs degradation. The study reveals that PD environmental factors induce HDACs degradation and histone acetylation increase in DA neurons via autophagy and identifies an epigenetic mechanism in PD pathogenesis.	[Park, Goonho; Salvesen, Guy; Zhang, Zhuohua] Sanford Burnham Med Res Inst, Grad Program Biomed Sci, La Jolla, CA 92037 USA; [Park, Goonho] Univ Calif San Diego, La Jolla, CA 92037 USA; [Tan, Jieqiong; Zhang, Zhuohua] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Garcia, Guillermina; Kang, Yunyi; Salvesen, Guy; Zhang, Zhuohua] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Central South University; Sanford Burnham Prebys Medical Discovery Institute	Zhang, ZH (corresponding author), Cent S Univ, Xiangya Med Sch, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn			National Institutes of Health [NS057289]; Natural Science Foundation of China [313300257, 81429002, 81161120498]; Ministry of Science and Technology [2011CB51000]; "111 Program" of Foreign Expert Bureau of China [B10036]; Mogam Science Scholarship Foundation; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); "111 Program" of Foreign Expert Bureau of China; Mogam Science Scholarship Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057289 (to Z. Z.), Natural Science Foundation of China Grants 313300257, 81429002, and 81161120498 (to Z. Z.), "973 Program" of Ministry of Science and Technology Grant 2011CB51000 (to Z. Z.), "111 Program" of Foreign Expert Bureau of China Grant B10036 (to Z. Z.), and the Mogam Science Scholarship Foundation (to G. P.). The authors declare that they have no competing interests.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Gu XL, 2013, NEUROBIOL AGING, V34, P1069, DOI 10.1016/j.neurobiolaging.2012.10.013; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hung KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091074; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Song C, 2011, NEUROTOXICOLOGY, V32, P586, DOI 10.1016/j.neuro.2011.05.018; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	32	83	87	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3531	3540		10.1074/jbc.M115.675488	http://dx.doi.org/10.1074/jbc.M115.675488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26699403	Green Published, hybrid			2022-12-28	WOS:000370854500033
J	Abdesselem, H; Madani, A; Hani, A; Al-Noubi, M; Goswami, N; Ben Hamidane, H; Billing, AM; Pasquier, J; Bonkowski, MS; Halabi, N; Dalloul, R; Sheriff, MZ; Mesaeli, N; ElRayess, M; Sinclair, DA; Graumann, J; Mazloum, NA				Abdesselem, Houari; Madani, Aisha; Hani, Ahmad; Al-Noubi, Muna; Goswami, Neha; Ben Hamidane, Hisham; Billing, Anja M.; Pasquier, Jennifer; Bonkowski, Michael S.; Halabi, Najeeb; Dalloul, Rajaa; Sheriff, Mohamed Z.; Mesaeli, Nasrin; ElRayess, Mohamed; Sinclair, David A.; Graumann, Johannes; Mazloum, Nayef A.			SIRT1 Limits Adipocyte Hyperplasia through c-Myc Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; WHITE ADIPOSE-TISSUE; CELL-CULTURE; PPAR-GAMMA; METABOLIC-DISORDERS; INSULIN-RESISTANCE; GENE-EXPRESSION; AMINO-ACIDS; FAT; OBESITY	The expansion of fat mass in the obese state is due to increased adipocyte hypertrophy and hyperplasia. The molecular mechanism that drives adipocyte hyperplasia remains unknown. The NAD(+)-dependent protein deacetylase sirtuin 1 (SIRT1), a key regulator of mammalian metabolism, maintains proper metabolic functions in many tissues, counteracting obesity. Here we report that differentiated adipocytes are hyperplastic when SIRT1 is knocked down stably in mouse 3T3-L1 preadipocytes. This phenotype is associated with dysregulated adipocyte metabolism and enhanced inflammation. We also demonstrate that SIRT1 is a key regulator of proliferation in preadipocytes. Quantitative proteomics reveal that the c-Myc pathway is altered to drive enhanced proliferation in SIRT1-silenced 3T3-L1 cells. Moreover, c-Myc is hyperacetylated, levels of p27 are reduced, and cyclin-dependent kinase 2 (CDK2) is activated upon SIRT1 reduction. Remarkably, differentiating SIRT1-silenced preadipocytes exhibit enhanced mitotic clonal expansion accompanied by reduced levels of p27 as well as elevated levels of CCAAT/enhancer-binding protein beta (C/EBP beta) and c-Myc, which is also hyperacetylated. c-Myc activation and enhanced proliferation phenotype are also found to be SIRT1-dependent in proliferating mouse embryonic fibroblasts and differentiating human SW872 preadipocytes. Reducing both SIRT1 and c-Myc expression in 3T3-L1 cells simultaneously does not induce the adipocyte hyperplasia phenotype, confirming that SIRT1 controls adipocyte hyperplasia through c-Myc regulation. A better understanding of the molecular mechanisms of adipocyte hyperplasia will open new avenues toward understanding obesity.	[Abdesselem, Houari; Madani, Aisha; Hani, Ahmad; Dalloul, Rajaa; Sheriff, Mohamed Z.; Mazloum, Nayef A.] Qatar Fdn, Weill Cornell Med Qatar, Dept Microbiol & Immunol, POB 24144, Doha, Qatar; [Al-Noubi, Muna; Goswami, Neha; Ben Hamidane, Hisham; Billing, Anja M.; Mesaeli, Nasrin; Graumann, Johannes] Qatar Fdn, Weill Cornell Med Qatar, Dept Biochem, POB 24144, Doha, Qatar; [Pasquier, Jennifer; Halabi, Najeeb] Qatar Fdn, Weill Cornell Med Qatar, Dept Med Genet, POB 24144, Doha, Qatar; [Bonkowski, Michael S.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [ElRayess, Mohamed] Antidoping Lab Qatar, Life Sci Res Div, POB 27775, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Harvard Medical School; Anti Doping Laboratory (Qatar)	Mazloum, NA (corresponding author), Qatar Fdn, Weill Cornell Med Qatar, Dept Microbiol & Immunol, POB 24144, Doha, Qatar.	nam2016@qatar-med.cornell.edu	Elrayess, Mohamed/AAE-8804-2019; Halabi, Najeeb/AAX-8250-2020; Graumann, Johannes/C-5241-2008	Elrayess, Mohamed/0000-0003-3803-4604; Halabi, Najeeb/0000-0002-9345-6132; Graumann, Johannes/0000-0002-3015-5850; Billing, Anja/0000-0002-5770-5496; Madani, Aisha/0000-0002-3803-8384; Pasquier, Jennifer/0000-0002-2465-7942; Sinclair, David/0000-0002-9936-436X; Ben Hamidane, Hisham/0000-0003-4615-6142; Bonkowski, Michael/0000-0003-3416-4612	Biomedical Research Program funds of Weill Cornell Medicine in Qatar by Qatar Foundation; NATIONAL INSTITUTE ON AGING [R37AG028730] Funding Source: NIH RePORTER	Biomedical Research Program funds of Weill Cornell Medicine in Qatar by Qatar Foundation(Qatar Foundation (QF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by Biomedical Research Program funds of Weill Cornell Medicine in Qatar, a program funded by the Qatar Foundation. D.A.S. is a consultant to and/or inventor on patents licensed to GlaxoSmithKline, OvaScience, Cohbar, Segterra, MetroBiotech, and Liberty Biosecurity. M. B. is a consultant for OvaScience.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Erener S, 2012, MOL ENDOCRINOL, V26, P79, DOI 10.1210/me.2011-1163; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guennoun A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0480-6; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ibarrola N, 2003, ANAL CHEM, V75, P6043, DOI 10.1021/ac034931f; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Liberski AR, 2013, J PROTEOME RES, V12, P3233, DOI 10.1021/pr400099j; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167	41	27	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2119	2135		10.1074/jbc.M115.675645	http://dx.doi.org/10.1074/jbc.M115.675645			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26655722	hybrid, Green Published			2022-12-28	WOS:000369610400007
J	Kayukawa, T; Nagamine, K; Ito, Y; Nishita, Y; Ishikawa, Y; Shinoda, T				Kayukawa, Takumi; Nagamine, Keisuke; Ito, Yuka; Nishita, Yoshinori; Ishikawa, Yukio; Shinoda, Tetsuro			Kruppel Homolog 1 Inhibits Insect Metamorphosis via Direct Transcriptional Repression of Broad-Complex, a Pupal Specifier Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; METHOPRENE-TOLERANT; TRIBOLIUM-CASTANEUM; TOBACCO HORNWORM; MANDUCA-SEXTA; EXPRESSION; SILKWORM; EPIDERMIS	The Broad-Complex gene (BR-C) encodes transcription factors that dictate larval-pupal metamorphosis in insects. The expression of BR-C is induced by molting hormone (20-hydroxyecdysone (20E)), and this induction is repressed by juvenile hormone (JH), which exists during the premature larval stage. Kriippel homolog 1 gene (Kr-hi) has been known as a JH-early inducible gene responsible for repression of metamorphosis; however, the functional relationship between Kr-hl and repression of BR-C has remained unclear. To elucidate this relationship, we analyzed cis-and trans elements involved in the repression of BR-C using a Bombyx mori cell line. In the cells, as observed in larvae, JH induced the expression of Kr-hl and concurrently suppressed 20E -induced expression of BR-C. Forced expression of Kr-hl repressed the 20E-dependent activation of the BR-C promoter in the absence of JH, and Kr-hl RNAi inhibited the JH-mediated repression, suggesting that Kr-hl controlled the repression of BR-C. A survey of the upstream sequence of BR-C gene revealed a Kr -hl binding site (KBS) in the BR-C promoter. When KBS was deleted from the promoter, the repression of BR-C was abolished, Electrophoresis mobility shift demonstrated that two Kr -hl molecules bound to KBS in the BR-C promoter. Based on these results, we conclude that Kr-hl protein molecules directly bind to the KBS sequence in the BR-C promoter and thereby repress 20E -dependent activation of the pupal specifier, BR-C. This study has revealed a considerable portion of the picture of JH signaling pathways from the reception of JH to the repression of metamorphosis.	[Kayukawa, Takumi; Nagamine, Keisuke; Ito, Yuka; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Ohwashi 1-2, Tsukuba, Ibaraki 3058634, Japan; [Nagamine, Keisuke; Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Entomol, Bunkyo Ku, Tokyo 1138657, Japan; [Nishita, Yoshinori] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Nishita, Yoshinori] Hokkaido Univ, Fac Sci, Ctr Genome Dynam, Sapporo, Hokkaido 0600810, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; Hokkaido University; Hokkaido University	Kayukawa, T (corresponding author), Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Ohwashi 1-2, Tsukuba, Ibaraki 3058634, Japan.	kayu@affrc.go.jp	Ishikawa, Yukio/J-5676-2019; Nishita, Yoshinori/S-8888-2018	Ishikawa, Yukio/0000-0003-3067-2513; 	JSPS KAKENHI [25850230]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant 25850230 (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; DIBELLO PR, 1991, GENETICS, V129, P385; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kayukawa T, 2015, APPL ENTOMOL ZOOL, V50, P383, DOI 10.1007/s13355-015-0345-8; Kayukawa T, 2014, DEV BIOL, V388, P48, DOI 10.1016/j.ydbio.2014.01.022; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; KISS I, 1988, GENETICS, V118, P247; KISS I, 1976, NATURE, V262, P136, DOI 10.1038/262136a0; Kobayashi I, 2011, ARCH INSECT BIOCHEM, V76, P195, DOI 10.1002/arch.20402; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Lozano J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004769; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nagamine K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-539; Nishita Y, 2004, GENE, V339, P161, DOI 10.1016/j.gene.2004.06.039; Nishita Y, 2014, INSECT MOL BIOL, V23, P341, DOI 10.1111/imb.12085; Nishita Y, 2006, INSECT BIOCHEM MOLEC, V36, P779, DOI 10.1016/j.ibmb.2006.07.005; PANKRATZ MJ, 1989, NATURE, V341, P337, DOI 10.1038/341337a0; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; Sailsbery JK, 2012, MOL BIOL EVOL, V29, P1301, DOI 10.1093/molbev/msr288; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Spokony RF, 2007, DEV GENES EVOL, V217, P499, DOI 10.1007/s00427-007-0159-y; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zhou XF, 2004, J EXP BIOL, V207, P1151, DOI 10.1242/jeb.00855	42	85	93	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1751	1762		10.1074/jbc.M115.686121	http://dx.doi.org/10.1074/jbc.M115.686121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26518872	Green Published, hybrid			2022-12-28	WOS:000368620700017
J	Park, YG; Jung, MC; Song, H; Jeong, KW; Bang, E; Hwang, GS; Kim, Y				Park, Young-Guen; Jung, Min-Cheol; Song, Heesang; Jeong, Ki-Woong; Bang, Eunjung; Hwang, Geunn-Sook; Kim, Yangmee			Novel Structural Components Contribute to the High Thermal Stability of Acyl Carrier Protein from Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; BACKBONE DYNAMICS; NMR; HOLO; RESIDUES; BIOSYNTHESIS; RESISTANCE; RELAXATION; FAECIUM; INSIGHT	Enterococcus faecalis is a Gram-positive, commensal bacterium that lives in the gastrointestinal tracts of humans and other mammals. It causes severe infections because of high antibiotic resistance. E. faecalis can endure extremes of temperature and pH. Acyl carrier protein (ACP) is a key element in the biosynthesis of fatty acids responsible for acyl group shuttling and delivery. In this study, to understand the origin of high thermal stabilities of E. faecalis ACP (Ef-ACP), its solution structure was investigated for the first time. CD experiments showed that the melting temperature of Ef-ACP is 78.8 degrees C, which is much higher than that of Escherichia coliACP(67.2 degrees C). The overall structure of Ef-ACP shows the common ACP folding pattern consisting of four alpha-helices (helix I (residues 3-17), helix II (residues 39-53), helix III (residues 60-64), and helix IV (residues 68-78)) connected by three loops. Unique Ef-ACP structural features include a hydrophobic interaction between Phe(45) in helix II and Phe(18) in the alpha(1)alpha(2) loop and a hydrogen bonding between Ser(15) in helix I and Ile(20) in the alpha(1)alpha(2) loop, resulting in its high thermal stability. Phe(45)-mediated hydrophobic packing may block acyl chain binding subpocket II entry. Furthermore, Ser(58) in the alpha(2)alpha(3) loop in Ef-ACP, which usually constitutes a proline in other ACPs, exhibited slow conformational exchanges, resulting in the movement of the helix III outside the structure to accommodate a longer acyl chain in the acyl binding cavity. These results might provide insights into the development of antibiotics against pathogenic drug-resistant E. faecalis strains.	[Park, Young-Guen; Jung, Min-Cheol; Song, Heesang; Jeong, Ki-Woong; Kim, Yangmee] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Park, Young-Guen; Jung, Min-Cheol; Song, Heesang; Jeong, Ki-Woong; Kim, Yangmee] Konkuk Univ, Bio Mol Informat Ctr, Seoul 143701, South Korea; [Bang, Eunjung; Hwang, Geunn-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Seoul 120140, South Korea	Konkuk University; Konkuk University; Korea Basic Science Institute (KBSI)	Kim, Y (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea.	ymkim@konkuk.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2013R1A1A2058021]; Priority Research Centers Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2009-0093824]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Priority Research Centers Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by Basic Science Research Program Grant 2013R1A1A2058021 and Priority Research Centers Program Grant 2009-0093824 through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREC M, 1995, PROTEIN SCI, V4, P983; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Brusic Vladimir, 2005, Expert Rev Clin Immunol, V1, P145, DOI 10.1586/1744666X.1.1.145; Chan DI, 2010, J BIOL CHEM, V285, P30558, DOI 10.1074/jbc.M110.128298; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cronan JE, 2006, NAT CHEM BIOL, V2, P232, DOI 10.1038/nchembio0506-232; Cronan JE, 2004, CHEM BIOL, V11, P1601, DOI 10.1016/j.chembiol.2004.11.011; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GEIGER O, 1991, J BACTERIOL, V173, P2872, DOI 10.1128/JB.173.9.2872-2878.1991; Goddard T.D., 2004, SPARKY 3; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HEATON MP, 1994, J BACTERIOL, V176, P681, DOI 10.1128/jb.176.3.681-690.1994; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P6135, DOI 10.1021/bi00416a046; HORVATH LA, 1994, PROTEIN SCI, V3, P103; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jeong KW, 2014, BIOCHEMISTRY-US, V53, P4814, DOI 10.1021/bi5003844; Jeong KW, 2009, J NAT PROD, V72, P719, DOI 10.1021/np800698d; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Kuch A, 2012, J ANTIMICROB CHEMOTH, V67, P551, DOI 10.1093/jac/dkr544; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Laport MS, 2003, CURR MICROBIOL, V46, P313, DOI 10.1007/s00284-002-3828-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee JY, 2012, EUR J MED CHEM, V47, P261, DOI 10.1016/j.ejmech.2011.10.052; Lee J, 2013, BIOCHEMISTRY-US, V52, P2492, DOI 10.1021/bi301641b; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Lim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020549; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Orr KE, 2002, J HOSP INFECT, V50, P133, DOI 10.1053/jhin.2001.1137; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Perez DR, 2015, BIOCHEMISTRY-US, V54, P2205, DOI 10.1021/bi5014563; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Seedat J, 2006, ANTIMICROB AGENTS CH, V50, P4217, DOI 10.1128/AAC.00518-06; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Uauy R, 2000, P NUTR SOC, V59, P3, DOI 10.1017/S0029665100000021; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Wade JJ, 1997, EUR J CLIN MICROBIOL, V16, P113, DOI 10.1007/BF01709469; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	66	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1692	1702		10.1074/jbc.M115.674408	http://dx.doi.org/10.1074/jbc.M115.674408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631734	hybrid, Green Published			2022-12-28	WOS:000368620700013
J	Shi, JX; He, Y; Hewett, SJ; Hewett, JA				Shi, Jingxue; He, Yan; Hewett, Sandra J.; Hewett, James A.			Interleukin 1 beta Regulation of the System x(c)(-), Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTINE TRANSPORT ACTIVITY; HUMAN BREAST-CANCER; MESSENGER-RNA; EXTRACELLULAR GLUTAMATE; CYSTINE/GLUTAMATE TRANSPORTER; HUMAN-FIBROBLASTS; OXIDATIVE STRESS; NITRIC-OXIDE; EXPRESSION; INDUCTION	System x(c)(-) is a heteromeric amino acid cystine/glutamate antiporter that is constitutively expressed by cells of the CNS, where it functions in the maintenance of intracellular glutathione and extracellular glutamate levels. We recently determined that the cytokine, IL -1 beta, increases the activity of system x(c)(-) in CNS astrocytes secondary to an up -regulation of its substrate specific light chain, xCT, and that this occurs, in part, at the level of transcription. However, an in silica analysis of the murine xCT 3'-UTR identified numerous copies of adenine- and uridine-rich elements, raising the possibility that undefined transacting factors governing mRNA stability and translation may also contribute to xCT expression. Here we show that IL-1p increases the level of mRNA encoding xCT in primary cultures of astrocytes isolated from mouse cortex in association with an increase in xCT mRNA halt -life. Additionally, IL-113 induces HuR translocation from the nucleus to the cytoplasm. RNA immunoprecipitation analysis reveals that HuR binds directly to the 3'-UTR of xCT in an IL-1 beta-dependent manner. Knockdown of endogenous HuR protein abrogates the IL-1 beta-mediated increase in xCT mRNA half-life, whereas overexpression of HuR in unstimulated primary mouse astrocytes doubles the half-life of constitutive xCT mRNA. This latter effect is accompanied by an increase in xCT protein levels, as well as a functional increase in system x(c)(-) activity. Altogether, these data support a critical role for HuR in mediating the IL-1-induced stabilization of astrocyte xCT mRNA.	[Hewett, James A.] Syracuse Univ, Dept Biol, 107 Coll Ple, Syracuse, NY 13244 USA; [Hewett, James A.] Syracuse Univ, Program Neurosci, 107 Coll Ple, Syracuse, NY 13244 USA	Syracuse University; Syracuse University	Hewett, JA (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Ple, Syracuse, NY 13244 USA.; Hewett, JA (corresponding author), Syracuse Univ, Program Neurosci, 107 Coll Ple, Syracuse, NY 13244 USA.	jhewett@syr.edu			National Institutes of Health [R01NS051445]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS051445 (to S. J. H. and J. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Baker DA, 2002, AMINO ACIDS, V23, P161, DOI 10.1007/s00726-001-0122-6; Baker DA, 2002, J NEUROSCI, V22, P9134; Baker DA, 2008, NEUROPSYCHOPHARMACOL, V33, P1760, DOI 10.1038/sj.npp.1301532; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BANNAI S, 1984, J BIOL CHEM, V259, P2435; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Bentea E, 2015, PROG NEURO-PSYCHOPH, V59, P49, DOI 10.1016/j.pnpbp.2015.01.010; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bridges CC, 2001, INVEST OPHTH VIS SCI, V42, P47; Bridges R, 2012, PHARMACOL REV, V64, P780, DOI 10.1124/pr.110.003889; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Domingues AMD, 2010, NEUROCHEM INT, V57, P359, DOI 10.1016/j.neuint.2010.03.024; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Dun Y, 2006, CELL TISSUE RES, V324, P189, DOI 10.1007/s00441-005-0116-x; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Habib E, 2015, REDOX BIOL, V5, P33, DOI 10.1016/j.redox.2015.03.003; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; He Y, 2015, GLIA, V63, P1568, DOI 10.1002/glia.22828; Hewett JA, 1999, J NEUROSCI RES, V56, P189, DOI 10.1002/(SICI)1097-4547(19990415)56:2<189::AID-JNR8>3.3.CO;2-2; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jackman NA, 2012, ASN NEURO, V4, P23, DOI 10.1042/AN20110030; Jackman NA, 2010, GLIA, V58, P1806, DOI 10.1002/glia.21050; Jin SH, 2007, EUR J PHARMACOL, V558, P14, DOI 10.1016/j.ejphar.2006.11.060; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Lewerenz J, 2014, ANTIOXID REDOX SIGN, V20, P2907, DOI 10.1089/ars.2013.5455; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Martin L, 2015, ONCOGENE, V34, P4211, DOI 10.1038/onc.2014.352; Massie A, 2015, J NEUROCHEM, V135, P1062, DOI 10.1111/jnc.13348; Massie A, 2011, FASEB J, V25, P1359, DOI 10.1096/fj.10-177212; Melendez RI, 2005, J PHARMACOL EXP THER, V314, P139, DOI 10.1124/jpet.104.081521; MIURA K, 1992, AM J PHYSIOL, V262, pC50, DOI 10.1152/ajpcell.1992.262.1.C50; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; Mysona B, 2009, CELL TISSUE RES, V335, P477, DOI 10.1007/s00441-008-0742-1; Okamura M, 2015, GENES-BASEL, V6, P124, DOI 10.3390/genes6010124; Okano HJ, 1997, J NEUROSCI, V17, P3024; Sakakura Y, 2007, J LEUKOCYTE BIOL, V81, P974, DOI 10.1189/jlb.0606385; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Sato H, 2001, J BIOL CHEM, V276, P10407, DOI 10.1074/jbc.M007216200; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2001, BIOCHEM BIOPH RES CO, V282, P1132, DOI 10.1006/bbrc.2001.4703; TAKADA A, 1984, J BIOL CHEM, V259, P2441; Tomi M, 2003, GLIA, V43, P208, DOI 10.1002/glia.10253; Uliasz TF, 2012, METHODS MOL BIOL, V814, P61, DOI 10.1007/978-1-61779-452-0_5; Untergasser A., 2008, TITRATION ADENOVIRAL; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; WATANABE H, 1987, J EXP MED, V165, P628, DOI 10.1084/jem.165.3.628	71	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1643	1651		10.1074/jbc.M115.697821	http://dx.doi.org/10.1074/jbc.M115.697821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601945	hybrid, Green Published			2022-12-28	WOS:000368620700009
J	Prajapati, RK; Sengupta, S; Rudra, P; Mukhopadhyay, J				Prajapati, Ranjit Kumar; Sengupta, Shreya; Rudra, Paulami; Mukhopadhyay, Jayanta			Bacillus subtilis delta Factor Functions as a Transcriptional Regulator by Facilitating the Open Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; RNA-POLYMERASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STREPTOCOCCUS-MUTANS; PROMOTER SELECTIVITY; SUBUNIT; DNA; PROTEIN; ELONGATION	Most bacterial RNA polymerases (RNAP) contain five conserved subunits, viz. 2 alpha , beta, beta ', and omega. However, in many Grampositive bacteria, especially in fermicutes, RNAP is associated with an additional factor, called delta. For over three decades since its identification, it had been thought that delta functioned as a subunit of RNAP to enhance the level of transcripts by recycling RNAP. In support of the previous observations, we also find that delta is involved in recycling of RNAP by releasing the RNA from the ternary complex. We further show that delta binds to RNA and is able to recycle RNAP when the length of the nascent RNA reaches a critical length. However, in this work we decipher a new function of delta. Performing biochemical and mutational analysis, we show that Bacillus subtilis delta binds to DNA immediately upstream of the promoter element at A-rich sequences on the abrB and rrnB1 promoters and facilitates open complex formation. As a result, delta facilitates RNAP to initiate transcription in the second scale, compared with minute scale in the absence of delta. Using transcription assay, we show that delta-mediated recycling of RNAP cannot be the sole reason for the enhancement of transcript yield. Our observation that delta does not bind to RNAP holo enzyme but is required to bind to DNA upstream of the -35 promoter element for transcription activation suggests that delta functions as a transcriptional regulator.	[Prajapati, Ranjit Kumar; Sengupta, Shreya; Rudra, Paulami; Mukhopadhyay, Jayanta] Bose Inst, Dept Chem, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute	Mukhopadhyay, J (corresponding author), Bose Inst, Dept Chem, Kolkata 700009, India.	jayanta@jcbose.ac.in	Rudra, Paulami/ABD-2534-2022	Prajapati, Ranjit/0000-0002-9294-3537	Department of Biotechnology, Ministry of Science and Technology, India [BT/PR5345/MED/29/648/2012, BT/PR5270/BRB/10/1066/2012]; CSIR India	Department of Biotechnology, Ministry of Science and Technology, India; CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Research Grants BT/PR5345/MED/29/648/2012 and BT/PR5270/BRB/10/1066/2012 from the Department of Biotechnology, Ministry of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of fellowships from CSIR India.	Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Banerjee R, 2015, J BACTERIOL, V197, P646, DOI 10.1128/JB.02445-14; CHOY HE, 1995, EMBO J, V14, P4523, DOI 10.1002/j.1460-2075.1995.tb00131.x; DAUBENDIEK SL, 1995, J AM CHEM SOC, V117, P7818, DOI 10.1021/ja00134a032; Davydova EK, 2003, P NATL ACAD SCI USA, V100, P9250, DOI 10.1073/pnas.1133325100; de Saro FJL, 1999, J BIOL CHEM, V274, P15953, DOI 10.1074/jbc.274.22.15953; Demo G, 2014, J STRUCT BIOL, V187, P174, DOI 10.1016/j.jsb.2014.06.001; DESARO FJL, 1995, J MOL BIOL, V252, P189, DOI 10.1006/jmbi.1995.0487; DICKEL CD, 1980, BIOCHEM BIOPH RES CO, V95, P1789, DOI 10.1016/S0006-291X(80)80106-9; DOBINSON KF, 1987, BIOCHEMISTRY-US, V26, P8206, DOI 10.1021/bi00399a028; Gao HC, 2004, CURR MICROBIOL, V48, P401, DOI 10.1007/s00284-003-4229-8; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; HYDE EI, 1986, J BIOL CHEM, V261, P6565; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; Kolb KE, 2014, J BIOL CHEM, V289, P1151, DOI 10.1074/jbc.M113.521393; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Motackova V, 2010, PROTEINS, V78, P1807, DOI 10.1002/prot.22708; Mukhopadhyay J, 2003, METHOD ENZYMOL, V371, P144; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; PERO J, 1975, P NATL ACAD SCI USA, V72, P1589, DOI 10.1073/pnas.72.4.1589; Quinones M, 2006, J BIOL CHEM, V281, P39407, DOI 10.1074/jbc.M609694200; Rabatinova A, 2013, J BACTERIOL, V195, P2603, DOI 10.1128/JB.00188-13; Rudra P, 2015, NUCLEIC ACIDS RES, V43, P5855, DOI 10.1093/nar/gkv516; Sambrook J., 2001, MOL CLONING LAB MANU; STEWART GC, 1983, NUCLEIC ACIDS RES, V11, P6289, DOI 10.1093/nar/11.18.6289; STRAUCH MA, 1989, MOL MICROBIOL, V3, P1203, DOI 10.1111/j.1365-2958.1989.tb00270.x; TJIAN R, 1977, EUR J BIOCHEM, V74, P149, DOI 10.1111/j.1432-1033.1977.tb11376.x; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Weiss A, 2014, INFECT IMMUN, V82, P1424, DOI 10.1128/IAI.01508-14; WILLIAMSON VM, 1979, MOL GEN GENET, V174, P47, DOI 10.1007/BF00433304; Xue XL, 2012, MICROBIOL-SGM, V158, P191, DOI 10.1099/mic.0.047936-0; Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10; Yang X, 2008, PROTEIN EXPRES PURIF, V59, P86, DOI 10.1016/j.pep.2008.01.006	37	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1064	1075		10.1074/jbc.M115.686170	http://dx.doi.org/10.1074/jbc.M115.686170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26546673	Green Published, hybrid			2022-12-28	WOS:000368068300004
J	Shah, S; Mostafa, MM; McWhae, A; Traves, SL; Newton, R				Shah, Suharsh; Mostafa, Mahmoud M.; McWhae, Andrew; Traves, Suzanne L.; Newton, Robert			Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dual-specificity phosphoprotein phosphatase; glucocorticoid; inflammation; mitogen-activated protein kinase (MAPK); tumor necrosis factor (TNF); anti-inflammatory; DUSP1; feed-forward control	ALPHA-MESSENGER-RNA; AU-RICH ELEMENTS; INNATE IMMUNE-RESPONSES; EPITHELIAL-CELLS; MAST-CELLS; P38 MAPK; GLUCOCORTICOID-RECEPTOR; CYTOKINE SECRETION; SIGNALING PATHWAYS; BINDING-PROTEIN	Background: ZFP36 negatively regulates AU-rich element-containing mRNAs. Results: DUSP1 silencing increases ZFP36 expression and enhances negative feed-forward control of TNF. Conclusion: MAPK inhibition initially attenuates TNF mRNA, but reduced feed-forward control subsequently produces an increase. Significance: Understanding such networks is essential to develop novel anti-inflammatory therapies or understand TNF repression by glucocorticoids, which may not require DUSP1 or ZFP36 expression. TNF is central to inflammation and may play a role in the pathogenesis of asthma. The 3-untranslated region of the TNF transcript contains AU-rich elements (AREs) that are targeted by the RNA-binding protein, tristetraprolin (also known as zinc finger protein 36 (ZFP36)), which is itself up-regulated by inflammatory stimuli, to promote mRNA degradation. Using primary human bronchial epithelial and pulmonary epithelial A549 cells, we confirm that interleukin-1 (IL1B) induces expression of dual-specificity phosphatase 1 (DUSP1), ZFP36, and TNF. Whereas IL1B-induced DUSP1 is involved in feedback control of MAPK pathways, ZFP36 exerts negative (incoherent) feed-forward control of TNF mRNA and protein expression. DUSP1 silencing increased IL1B-induced ZFP36 expression at 2 h and profoundly repressed TNF mRNA at 6 h. This was partly due to increased TNF mRNA degradation, an effect that was reduced by ZFP36 silencing. This confirms a regulatory network, whereby DUSP1-dependent negative feedback control reduces feed-forward control by ZFP36. Conversely, whereas DUSP1 overexpression and inhibition of MAPKs prevented IL1B-induced expression of ZFP36, this was associated with increased TNF mRNA expression at 6 h, an effect that was predominantly due to elevated transcription. This points to MAPK-dependent feed-forward control of TNF involving ZFP36-dependent and -independent mechanisms. In terms of repression by dexamethasone, neither silencing of DUSP1, silencing of ZFP36, nor silencing of both together prevented the repression of IL1B-induced TNF expression, thereby demonstrating the need for further repressive mechanisms by anti-inflammatory glucocorticoids. In summary, these data illustrate why understanding the competing effects of feedback and feed-forward control is relevant to the development of novel anti-inflammatory therapies.	[Shah, Suharsh; Mostafa, Mahmoud M.; McWhae, Andrew; Traves, Suzanne L.; Newton, Robert] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	Newton, Robert/C-6814-2012	Newton, Robert/0000-0002-4919-8498; Mostafa, Mahmoud/0000-0001-6377-911X	Canadian Institutes of Health Research [MOP68828, 125918]; Lung Association of Alberta; North West Territories Studentship; University of Calgary Studentship; Canadian Fund for Innovation; Alberta Science and Research Authority; AstraZeneca; GlaxoSmithKline; Alberta Innovates [201500268] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta; North West Territories Studentship; University of Calgary Studentship; Canadian Fund for Innovation; Alberta Science and Research Authority; AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Alberta Innovates	This research was supported by Canadian Institutes of Health Research Grants MOP68828 and 125918 (to R. N.) and by Lung Association of Alberta and the North West Territories and University of Calgary Studentships (to S. S.). Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund for Innovation and the Alberta Science and Research Authority. Work in the laboratory of R. N. was also supported by grants from AstraZeneca and GlaxoSmithKline. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Aslam N, 2011, J BIOL CHEM, V286, P3767, DOI 10.1074/jbc.M110.168757; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Baumgartner RA, 1996, J IMMUNOL, V157, P4087; BISSONNETTE EY, 1995, CLIN EXP IMMUNOL, V102, P78; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Clark AR, 2009, ARTHRITIS RHEUM-US, V60, P3513, DOI 10.1002/art.24919; Crawford EK, 1997, J BIOL CHEM, V272, P21120, DOI 10.1074/jbc.272.34.21120; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Holden NS, 2007, BRIT J PHARMACOL, V152, P891, DOI 10.1038/sj.bjp.0707457; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Huotari N, 2012, APMIS, V120, P988, DOI 10.1111/j.1600-0463.2012.02927.x; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Jalonen U, 2005, BIOCHEM PHARMACOL, V69, P733, DOI 10.1016/j.bcp.2004.11.027; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Khair OA, 1996, EUR RESPIR J, V9, P1913, DOI 10.1183/09031936.96.09091913; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lippert U, 2000, EXP DERMATOL, V9, P118, DOI 10.1034/j.1600-0625.2000.009002118.x; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Manetsch M, 2012, CELL SIGNAL, V24, P907, DOI 10.1016/j.cellsig.2011.12.013; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Prabhala P, 2015, AM J PHYSIOL-LUNG C, V308, pL973, DOI 10.1152/ajplung.00219.2014; Qiu LQ, 2015, J LEUKOCYTE BIOL, V97, P723, DOI 10.1189/jlb.3A0214-106R; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shi JX, 2014, INT IMMUNOPHARMACOL, V22, P480, DOI 10.1016/j.intimp.2014.07.031; Smallie T, 2015, J IMMUNOL, V195, P277, DOI 10.4049/jimmunol.1402830; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; Solomon KA, 1997, J IMMUNOL, V159, P4524; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; WILLIAMS CMM, 1995, IMMUNOLOGY, V86, P244; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zhao Y, 2004, INFLAMM RES, V53, P664, DOI 10.1007/s00011-004-1309-6	66	19	20	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					110	125		10.1074/jbc.M115.697599	http://dx.doi.org/10.1074/jbc.M115.697599			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546680	Green Published, hybrid			2022-12-28	WOS:000367589500009
J	Gupta, S; Prasad, GVRK; Mukhopadhaya, A				Gupta, Shelly; Prasad, G. V. R. Krishna; Mukhopadhaya, Arunika			Vibrio cholerae Porin OmpU Induces Caspase-independent Programmed Cell Death upon Translocation to the Host Cell Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; CYTOCHROME-C; PHOSPHATIDYLSERINE EXPOSURE; MOLECULAR CHARACTERIZATION; NECROTIC CELLS; APOPTOSIS; RELEASE; ACTIVATION; NECROSIS; MECHANISMS	Porins, a major class of outer membrane proteins in Gram-negative bacteria, primarily act as transport channels. OmpU is one of the major porins of human pathogen, Vibrio cholerae. In the present study, we show that V. cholerae OmpU has the ability to induce target cell death. Although OmpU-mediated cell death shows some characteristics of apoptosis, such as flipping of phosphatidylserine in the membrane as well as cell size shrinkage and increased cell granularity, it does not show the caspase-3 activation and DNA laddering pattern typical of apoptotic cells. Increased release of lactate dehydrogenase in OmpU-treated cells indicates that the OmpU-mediated cell death also has characteristics of necrosis. Further, we show that the mechanism of OmpU-mediated cell death involves major mitochondrial changes in the target cells. We observe that OmpU treatment leads to the disruption of mitochondrial membrane potential, resulting in the release of cytochrome c and apoptosis-inducing factor (AIF). AIF translocates to the host cell nucleus, implying that it has a crucial role in OmpU-mediated cell death. Finally, we observe that OmpU translocates to the target cell mitochondria, where it directly initiates mitochondrial changes leading to mitochondrial membrane permeability transition and AIF release. Partial blocking of AIF release by cyclosporine A in OmpU-treated cells further suggests that OmpU may be inducing the opening of the mitochondrial permeability transition pore. All of these results lead us to the conclusion that OmpU induces cell death in target cells in a programmed manner in which mitochondria play a central role.	[Gupta, Shelly; Prasad, G. V. R. Krishna; Mukhopadhaya, Arunika] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Mohali 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhaya, A (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India.	arunika@iisermohali.ac.in	Prasad, G V R Krishna/ABO-5555-2022	Gupta, Shelly/0000-0002-0814-9606; Mukhopadhaya, Arunika/0000-0003-2121-7885	Department of Biotechnology, India [BT/PR1205/MED/29/318/2011]; Indian Institute of Science Education and Research Mohali	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Institute of Science Education and Research Mohali	This work was supported by Department of Biotechnology, India, Grant BT/PR1205/MED/29/318/2011 (to A. M.) and funding from the Indian Institute of Science Education and Research Mohali. The authors declare that they have no conflicts of interest with the contents of this article.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Alurkar V, 1997, INFECT IMMUN, V65, P2382, DOI 10.1128/IAI.65.6.2382-2388.1997; Andrade R, 2010, BIOL CELL, V102, P25, DOI 10.1042/BC20090077; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Buommino E, 1999, INFECT IMMUN, V67, P4794, DOI 10.1128/IAI.67.9.4794-4800.1999; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Crawford JA, 1998, MOL MICROBIOL, V29, P235, DOI 10.1046/j.1365-2958.1998.00925.x; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Goel AK, 2010, WORLD J MICROB BIOT, V26, P281, DOI 10.1007/s11274-009-0171-7; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Hirt UA, 2000, J IMMUNOL, V164, P6520, DOI 10.4049/jimmunol.164.12.6520; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khan J, 2015, IMMUNOBIOLOGY, V220, P1199, DOI 10.1016/j.imbio.2015.06.009; Khan J, 2012, PROTEIN EXPRES PURIF, V85, P204, DOI 10.1016/j.pep.2012.08.005; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li YZ, 1999, MOL MED, V5, P232, DOI 10.1007/BF03402120; Lin CF, 2010, TOXINS, V2, P2158, DOI 10.3390/toxins2082158; Lorenzo HK, 2004, FEBS LETT, V557, P14, DOI 10.1016/S0014-5793(03)01464-9; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Marino G, 2013, CELL RES, V23, P1247, DOI 10.1038/cr.2013.115; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Nakasone N, 1998, INFECT IMMUN, V66, P4726, DOI 10.1128/IAI.66.10.4726-4728.1998; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Paauw A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-158; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Provenzano D, 2001, J BACTERIOL, V183, P3652, DOI 10.1128/JB.183.12.3652-3662.2001; Sakharwade SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076583; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Volbracht C, 2001, MOL MED, V7, P36, DOI 10.1007/BF03401837; Von Ahsen O, 2000, CELL DEATH DIFFER, V7, P1192, DOI 10.1038/sj.cdd.4400782; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Wickman GR, 2013, CELL DEATH DIFFER, V20, P1293, DOI 10.1038/cdd.2013.69; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	67	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31051	31068		10.1074/jbc.M115.670182	http://dx.doi.org/10.1074/jbc.M115.670182			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26559970	hybrid, Green Published			2022-12-28	WOS:000367199000034
J	Guo, JF; Lv, J; Liu, M; Tang, H				Guo, Junfei; Lv, Jing; Liu, Min; Tang, Hua			miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; MESENCHYMAL TRANSITION; ACTIVATION; GROWTH; REPRESSION; BIOMARKERS; MIGRATION; INVASION; OOCYTES; DICER	MicroRNAs (miRNAs) are a class of post-transcriptional regulators of gene expression, and AGO2 is essential for miRNA activity. In this study, we focused on the regulation of AGO2 by miR-346 and the consequences in cervical cancer cells. miR-346 enhanced the expression of AGO2, resulting in the increased activity of other miRNAs and contributing to the malignancy of HeLa cells. GRSF1 participated in the regulation of AGO2 by miR-346, and the middle sequence of miR-346 was vital for the synergy effect of miR-346 and GRSF1. We determined that miR-346 promoted the migration and invasion of HeLa cells. In summary, we are the first to report that AGO2 is regulated positively by miRNA and that GRSF1 participates in the miRNA pathway.	[Guo, Junfei; Lv, Jing; Liu, Min; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China	Tianjin Medical University	Tang, H (corresponding author), 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	htang2002@yahoo.com			National Natural Science Foundation of China [31270818, 91029714, 31071191]; Natural Science Foundation of Tianjin Grant [12JCZDJC25100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin Grant	This work was supported in part by National Natural Science Foundation of China Grants 31270818, 91029714, and 31071191 and Natural Science Foundation of Tianjin Grant 12JCZDJC25100. The authors declare that they have no conflicts of interest with the contents of this article.	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Banno K, 2014, SCI WORLD J, DOI 10.1155/2014/178075; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bian XJ, 2014, TUMOR BIOL, V35, P11571, DOI 10.1007/s13277-014-2462-3; Bumrungthai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127109; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Dasari S, 2015, CLIN CHIM ACTA, V445, P7, DOI 10.1016/j.cca.2015.03.005; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Goodman A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2372; Lopez AJG, 2014, INT J MOL SCI, V15, P15700, DOI 10.3390/ijms150915700; Hauptmann J, 2013, NAT STRUCT MOL BIOL, V20, P814, DOI 10.1038/nsmb.2577; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kash JC, 2002, J VIROL, V76, P10417, DOI 10.1128/JVI.76.20.10417-10426.2002; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Long MJ, 2012, CANCER LETT, V324, P186, DOI 10.1016/j.canlet.2012.05.022; Martinez NJ, 2013, RNA, V19, P605, DOI 10.1261/rna.036434.112; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Poria D. K., 2015, ONCOGENE; Prodromaki E, 2015, CELL ONCOL, V38, P307, DOI 10.1007/s13402-015-0231-y; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Song G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15793; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Voller D, 2013, BRIT J CANCER, V109, P3116, DOI 10.1038/bjc.2013.646; Wang M, 2014, INT J ONCOL, V45, P362, DOI 10.3892/ijo.2014.2413; Ye ZL, 2015, J CANCER, V6, P877, DOI 10.7150/jca.11735; Zhang J, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.11; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zhang YJ, 2014, RNA, V20, P1878, DOI 10.1261/rna.045633.114	39	57	61	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30342	30350		10.1074/jbc.M115.691857	http://dx.doi.org/10.1074/jbc.M115.691857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26518874	hybrid, Green Published			2022-12-28	WOS:000366738200013
J	Lartey, LJ; Werneck-de-Castro, JP; O-Sullivan, I; Unterman, TG; Bianco, AC				Lartey, Lattoya J.; Werneck-de-Castro, Joao Pedro; O-Sullivan, InSug; Unterman, Terry G.; Bianco, Antonio C.			Coupling between Nutrient Availability and Thyroid Hormone Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; TRANSCRIPTION FACTOR FOXO1; SKELETAL-MUSCLE; AKT INHIBITOR; INSULIN; STIMULATION; STARVATION; NEUROENDOCRINE; INACTIVATION; HOMEOSTASIS	The activity of the thyroid gland is stimulated by food availability via leptin-induced thyrotropin-releasing hormone/thyroid-stimulating hormone expression. Here we show that food availability also stimulates thyroid hormone activation by accelerating the conversion of thyroxine to triiodothyronine via type 2 deiodinase in mouse skeletal muscle and in a cell model transitioning from 0.1 to 10% FBS. The underlying mechanism is transcriptional derepression of DIO2 through the mTORC2 pathway as defined in rictor knockdown cells. In cells kept in 0.1% FBS, there is DIO2 inhibition via FOXO1 binding to the DIO2 promoter. Repression of DIO2 by FOXO1 was confirmed using its specific inhibitor AS1842856 or adenoviral infection of constitutively active FOXO1. ChIP studies indicate that 4 h after 10% FBS-containing medium, FOXO1 binding markedly decreases, and the DIO2 promoter is activated. Studies in the insulin receptor FOXO1 KO mouse indicate that insulin is a key signaling molecule in this process. We conclude that FOXO1 represses DIO2 during fasting and that derepression occurs via nutritional activation of the PI3K-mTORC2-Akt pathway.	[Lartey, Lattoya J.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Werneck-de-Castro, Joao Pedro; Bianco, Antonio C.] Rush Univ, Div Endocrinol & Metab, Dept Internal Med, Ctr Med, Chicago, IL 60612 USA; [Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, BR-21941599 Rio De Janeiro, Brazil; [Werneck-de-Castro, Joao Pedro] Univ Fed Rio de Janeiro, Sch Phys Educ & Sports, BR-21941599 Rio De Janeiro, Brazil; [O-Sullivan, InSug; Unterman, Terry G.] Univ Illinois, Coll Med, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [O-Sullivan, InSug; Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA	University of Miami; Rush University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bianco, AC (corresponding author), Rush Univ, Div Endocrinol & Metab, Dept Internal Med, Ctr Med, 1735 W Harrison St,Cohn Bldg Rm 212, Chicago, IL 60612 USA.	abianco@deiodinase.org	Bianco, Antonio/AAK-6336-2020	Bianco, Antonio/0000-0001-7737-6813; Werneck-de-Castro, Joao Pedro/0000-0001-9242-7930; O-Sullivan, InSug/0000-0003-0161-2028	National Institutes of Health, NIDDK [DK65055]; Department of Veterans Affairs Merit Review Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065055] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health, NIDDK, Grant DK65055 and by a grant from the Department of Veterans Affairs Merit Review Program (to T. G. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Drigo RAE, 2011, MOL ENDOCRINOL, V25, P2065, DOI 10.1210/me.2011-1061; Drigo RAE, 2011, INT J BIOCHEM CELL B, V43, P1432, DOI 10.1016/j.biocel.2011.05.016; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bianco AC, 2014, THYROID, V24, P88, DOI 10.1089/thy.2013.0109; Bianco AC, 2011, ENDOCRINOLOGY, V152, P3306, DOI 10.1210/en.2011-1104; Boelen A, 2008, THYROID, V18, P123, DOI 10.1089/thy.2007.0253; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; BURGER AG, 1980, ACTA ENDOCRINOL-COP, V93, P322, DOI 10.1530/acta.0.0930322; Carol H, 2010, PEDIATR BLOOD CANCER, V55, P1329, DOI 10.1002/pbc.22710; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; Da-Silva WS, 2007, DIABETES, V56, P767, DOI 10.2337/db06-1488; Dentice M, 2014, CELL METAB, V20, P1038, DOI 10.1016/j.cmet.2014.10.009; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ferrara AM, 2013, ENDOCRINOLOGY, V154, P2533, DOI 10.1210/en.2012-2031; Fonseca TL, 2014, DIABETES, V63, P1594, DOI 10.2337/db13-1768; Frost RA, 2011, PHYSIOLOGY, V26, P83, DOI 10.1152/physiol.00044.2010; Gereben B, 2005, THYROID, V15, P855, DOI 10.1089/thy.2005.15.855; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Grozovsky R, 2009, ENDOCRINOLOGY, V150, P1976, DOI 10.1210/en.2008-0938; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hall JA, 2010, ENDOCRINOLOGY, V151, P4573, DOI 10.1210/en.2010-0511; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heemstra KA, 2009, J CLIN ENDOCR METAB, V94, P2144, DOI 10.1210/jc.2008-2520; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; KINLAW WB, 1985, J CLIN INVEST, V75, P1238, DOI 10.1172/JCI111821; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martinez-deMena R, 2005, J MOL ENDOCRINOL, V34, P139, DOI 10.1677/jme.1.01568; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; MILLS I, 1987, BIOCHEM BIOPH RES CO, V143, P81, DOI 10.1016/0006-291X(87)90632-2; MILLS I, 1989, AM J PHYSIOL, V256, pE74, DOI 10.1152/ajpendo.1989.256.1.E74; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; OBRIAN JT, 1980, METABOLISM, V29, P721, DOI 10.1016/0026-0495(80)90193-6; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Sagar GDV, 2007, MOL CELL BIOL, V27, P4774, DOI 10.1128/MCB.00283-07; Schebendach JE, 1997, ANN NY ACAD SCI, V817, P110, DOI 10.1111/j.1749-6632.1997.tb48200.x; Simonides WS, 2008, THYROID, V18, P205, DOI 10.1089/thy.2007.0256; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vella KR, 2011, CELL METAB, V14, P780, DOI 10.1016/j.cmet.2011.10.009; Werneck-de-Castro JP, 2015, ENDOCRINOLOGY, V156, P3842, DOI 10.1210/en.2015-1246; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	52	30	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30551	30561		10.1074/jbc.M115.665505	http://dx.doi.org/10.1074/jbc.M115.665505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26499800	hybrid, Green Published			2022-12-28	WOS:000366738200030
J	Bahl, S; Parashar, S; Malhotra, H; Raje, M; Mukhopadhyay, A				Bahl, Surbhi; Parashar, Smriti; Malhotra, Himanshu; Raje, Manoj; Mukhopadhyay, Amitabha			Functional Characterization of Monomeric GTPase Rab1 in the Secretory Pathway of Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRYPANOSOMA-BRUCEI; HEMOGLOBIN ENDOCYTOSIS; ENTAMOEBA-HISTOLYTICA; MEMBRANE TRAFFICKING; VESICULAR TRANSPORT; GOLGI COMPARTMENTS; ACID-PHOSPHATASE; FLAGELLAR POCKET; ANGIOTENSIN-II	Leishmania secretes a large number of its effectors to the extracellular milieu. However, regulation of the secretory pathway in Leishmania is not well characterized. Here, we report the cloning, expression, and characterization of the Rab1 homologue from Leishmania. We have found that LdRab1 localizes in Golgi in Leishmania. To understand the role of LdRab1 in the secretory pathway of Leishmania, we have generated transgenic parasites overexpressing GFP-LdRab1:WT, GFP-LdRab1:Q67L (a GTPase-deficient dominant positive mutant of Rab1), and GFP-LdRab1:S22N (a GDP-locked dominant negative mutant of Rab1). Surprisingly, our results have shown that overexpression of GFP-LdRab1:Q67L or GFP-LdRab1:S22N does not disrupt the trafficking and localization of hemoglobin receptor in Leishmania. To determine whether the Rab1-dependent secretory pathway is conserved in parasites, we have analyzed the role of LdRab1 in the secretion of secretory acid phosphatase and Ldgp63 in Leishmania. Our results have shown that overexpression of GFP-LdRab1:Q67L or GFP-LdRab1:S22N significantly inhibits the secretion of secretory acid phosphatase by Leishmania. We have also found that overexpression of GFP-LdRab1: Q67L or GFP-LdRab1:S22N retains RFP-Ldgp63 in Golgi and blocks the secretion of Ldgp63, whereas the trafficking of RFP-Ldgp63 in GFP-LdRab1:WT-expressing cells is unaltered in comparison with control cells. Taken together, our results have shown that the Rab1-regulated secretory pathway is well conserved, and hemoglobin receptor trafficking follows an Rab1-independent secretory pathway in Leishmania.	[Bahl, Surbhi; Parashar, Smriti; Mukhopadhyay, Amitabha] Natl Inst Immunol, New Delhi 110067, India; [Malhotra, Himanshu; Raje, Manoj] Inst Microbial Technol, Chandigarh 160036, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in			Department of Biotechnology, Government of India; J.C. Bose Fellowship from the Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); J.C. Bose Fellowship from the Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	These studies were supported by grants from the Department of Biotechnology, Government of India and a J.C. Bose Fellowship from the Department of Science and Technology, Government of India (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Council of Scientific and Industrial Research, Government of India.	Agarwal S, 2013, BBA-MOL CELL RES, V1833, P1065, DOI 10.1016/j.bbamcr.2013.01.006; Armstrong J, 2000, GENOME BIOL, V1; Bakalara N, 1995, EXP PARASITOL, V81, P302, DOI 10.1006/expr.1995.1121; BATES PA, 1989, EXP PARASITOL, V68, P335, DOI 10.1016/0014-4894(89)90115-X; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CAPPAI R, 1993, MOL BIOCHEM PARASIT, V62, P73, DOI 10.1016/0166-6851(93)90179-2; CHANG KP, 1983, INT REV CYTOL, P267; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Dhir V, 2004, MOL BIOCHEM PARASIT, V137, P253, DOI 10.1016/j.molbiopara.2004.06.007; Elias M, 2009, J EUKARYOT MICROBIOL, V56, P348, DOI 10.1111/j.1550-7408.2009.00408.x; Ellis M, 2002, J BIOL CHEM, V277, P27968, DOI 10.1074/jbc.M202047200; Evans KJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/892817; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; FONG D, 1982, P NATL ACAD SCI-BIOL, V79, P7366, DOI 10.1073/pnas.79.23.7366; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Guha R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006406; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; ILG T, 1991, P NATL ACAD SCI USA, V88, P8774, DOI 10.1073/pnas.88.19.8774; Isnard A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00072; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; Kelly JX, 2003, MOL BIOCHEM PARASIT, V126, P43, DOI 10.1016/S0166-6851(02)00248-7; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Langford TD, 2002, EXP PARASITOL, V101, P13, DOI 10.1016/S0014-4894(02)00037-1; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Manning-Cela R, 2003, CELL MICROBIOL, V5, P921, DOI 10.1046/j.1462-5822.2003.00332.x; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Patel N, 2008, P NATL ACAD SCI USA, V105, P3980, DOI 10.1073/pnas.0800404105; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Rodman JS, 2000, J CELL SCI, V113, P183; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stenmark H, 2001, GENOME BIOL, V2; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Vinke FP, 2011, BIOCHEM J, V433, P423, DOI 10.1042/BJ20101540; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	61	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29993	30005		10.1074/jbc.M115.670018	http://dx.doi.org/10.1074/jbc.M115.670018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26499792	hybrid, Green Published			2022-12-28	WOS:000366614700031
J	Watanabe, M; Suzuki, Y; Uchida, K; Miyazaki, N; Murata, K; Matsumoto, S; Kakizaki, H; Tominaga, M				Watanabe, Masaki; Suzuki, Yoshiro; Uchida, Kunitoshi; Miyazaki, Naoyuki; Murata, Kazuyoshi; Matsumoto, Seiji; Kakizaki, Hidehiro; Tominaga, Makoto			Trpm7 Protein Contributes to Intercellular Junction Formation in Mouse Urothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER EPITHELIUM; MG2+ HOMEOSTASIS; CELL-ADHESION; CHANNELS; MEMBRANE; CYSTITIS; DELETION; RELEASE; DISEASE; MURINE	Trpm7 is a divalent cation-permeable channel that has been reported to be involved in magnesium homeostasis as well as cellular adhesion and migration. We generated urothelium-specific Trpm7 knock-out (KO) mice to reveal the function of Trpm7 in vivo. A Trpm7 KO was induced by tamoxifen and was confirmed by genomic PCR and immunohistochemistry. By using patch clamp recordings in primary urothelial cells, we observed that Mg2+-inhibitable cation currents as well as acid-inducible currents were significantly smaller in Trpm7 KO urothelial cells than in cells from control mice. Assessment of voiding behavior indicated a significantly smaller voided volume in Trpm7 KO mice (mean voided volume 0.28 +/- 0.08 g in KO mice and 0.36 +/- 0.04 g in control mice, p < 0.05, n = 6-8). Histological analysis showed partial but substantial edema in the submucosal layer of Trpm7 KO mice, most likely due to inflammation. The expression of proinflammatory cytokines TNF-alpha and IL-1 beta was significantly higher in Trpm7 KO bladders than in controls. In transmission electron microscopic analysis, immature intercellular junctions were observed in Trpm7 KO urothelium but not in control mice. These results suggest that Trpm7 is involved in the formation of intercellular junctions in mouse urothelium. Immature intercellular junctions in Trpm7 knock-out mice might lead to a disruption of barrier function resulting in inflammation and hypersensitive bladder afferent nerves that may affect voiding behavior in vivo.	[Watanabe, Masaki; Suzuki, Yoshiro; Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Watanabe, Masaki; Matsumoto, Seiji; Kakizaki, Hidehiro] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido 0788510, Japan; [Suzuki, Yoshiro; Uchida, Kunitoshi; Tominaga, Makoto] SOKENDAI Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan; [Miyazaki, Naoyuki; Murata, Kazuyoshi] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Asahikawa Medical College; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Suzuki, Y (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	yoshiro@nips.ac.jp; tominaga@nips.ac.jp	Miyazaki, Naoyuki/P-3436-2018; Miyazaki, Naoyuki/D-7435-2012	Miyazaki, Naoyuki/0000-0002-4880-7300; Miyazaki, Naoyuki/0000-0002-4880-7300; Matsumoto, Seiji/0000-0002-9941-3758; SUZUKI, YOSHIRO/0000-0003-0010-1867; Murata, Kazuyoshi/0000-0001-9446-3652	Ministry of Education, Culture, Sports, Science, and Technology in Japan [23249012]; Grants-in-Aid for Scientific Research [15K08199] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology in Japan Grant 23249012 (to M. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Apodaca G, 2003, AM J PHYSIOL-RENAL, V284, pF966, DOI 10.1152/ajprenal.00359.2002; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Everaerts W, 2010, AM J PHYSIOL-RENAL, V298, pF692, DOI 10.1152/ajprenal.00599.2009; Fleig A, 2014, HANDB EXP PHARMACOL, V222, P521, DOI 10.1007/978-3-642-54215-2_21; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Izgi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072067; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kreft ME, 2009, ANN NY ACAD SCI, V1152, P18, DOI 10.1111/j.1749-6632.2008.04004.x; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; MINSKY BD, 1978, J CELL BIOL, V77, P685, DOI 10.1083/jcb.77.3.685; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Numata T, 2008, J BIOL CHEM, V283, P15097, DOI 10.1074/jbc.M709261200; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Sokabe T, 2010, J BIOL CHEM, V285, P18749, DOI 10.1074/jbc.M110.103606; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Sugino Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00317; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Wood R, 2001, J UROLOGY, V165, P653, DOI 10.1097/00005392-200102000-00089; Yu WQ, 2011, AM J PHYSIOL-RENAL, V300, pF49, DOI 10.1152/ajprenal.00349.2010	34	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29882	29892		10.1074/jbc.M115.667899	http://dx.doi.org/10.1074/jbc.M115.667899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26504086	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000366614700021
J	Horsman, JW; Miller, DL				Horsman, Joseph W.; Miller, Dana L.			Mitochondrial Sulfide Quinone Oxidoreductase Prevents Activation of the Unfolded Protein Response in Hydrogen Sulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); eukaryotic initiation factor 2 (eIF2); hydrogen sulfide; proteostasis; translation initiation	MOLECULAR-MECHANISMS; DIETARY RESTRICTION; TRANSLATION; PROTEOSTASIS; EUKARYOTES; INITIATION; OXIDATION; HYPOXIA; ELEGANS; CYCLE	Hydrogen sulfide (H2S) is an endogenously produced gaseous molecule with important roles in cellular signaling. In mammals, exogenous H2S improves survival of ischemia/reperfusion. We have previously shown that exposure to H2S increases the lifespan and thermotolerance in Caenorhabditis elegans, and improves protein homeostasis in low oxygen. The mitochondrial SQRD-1 (sulfide quinone oxidoreductase) protein is a highly conserved enzyme involved in H2S metabolism. SQRD-1 is generally considered important to detoxify H2S. Here, we show that SQRD-1 is also required to maintain protein translation in H2S. In sqrd-1 mutant animals, exposure to H2S leads to phosphorylation of eIF2 and inhibition of protein synthesis. In contrast, global protein translation is not altered in wild-type animals exposed to lethally high H2S or in hif-1(ia04) mutants that die when exposed to low H2S. We demonstrate that both gcn-2 and pek-1 kinases are involved in the H2S-induced phosphorylation of eIF2. Both ER and mitochondrial stress responses are activated in sqrd-1 mutant animals exposed to H2S, but not in wild-type animals. We speculate that SQRD-1 activity in H2S may coordinate proteostasis responses in multiple cellular compartments.	[Horsman, Joseph W.; Miller, Dana L.] Univ Washington, Dept Biochem, Sch Med, UW Mailbox 357350, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Miller, DL (corresponding author), Univ Washington, Dept Biochem, Sch Med, UW Mailbox 357350, Seattle, WA 98195 USA.	DLM16@uw.edu		Miller, Dana/0000-0003-3983-0493	NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R00AG033050, R01AG044378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Vivien McKay for expert advice that was essential for us to complete polysome profiling experiments, and Dr. Kate Stoll, who performed initial polysome profile experiments. Dr. Malene Hansen (Sanford Burnham Institute) provided valuable advice for metabolic labeling experiments. We would like to thank the Miller lab for insightful comments on the manuscript. Some strains were provided by the Caenorhabditis Genetic Stock Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Bos EM, 2015, BRIT J PHARMACOL, V172, P1479, DOI 10.1111/bph.12869; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fawcett EM, 2015, AGING CELL, V14, P92, DOI 10.1111/acel.12301; Fawcett EM, 2012, JOVE-J VIS EXP, DOI 10.3791/4088; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x; Kim H, 2013, AM J PHYSIOL-CELL PH, V305, pC1257, DOI 10.1152/ajpcell.00176.2013; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; LEROUX A, 1982, P NATL ACAD SCI-BIOL, V79, P2147, DOI 10.1073/pnas.79.7.2147; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; MARTIN TE, 1973, EXP CELL RES, V80, P496, DOI 10.1016/0014-4827(73)90333-9; Milby TH, 1999, AM J IND MED, V35, P192, DOI 10.1002/(SICI)1097-0274(199902)35:2<192::AID-AJIM11>3.3.CO;2-3; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Miller DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025476; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Olson KR, 2014, NITRIC OXIDE-BIOL CH, V41, P11, DOI 10.1016/j.niox.2014.05.012; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Riddle D. L., 1998, TRENDS CELL BIOL, V8, P92; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sherman MY, 2013, TRENDS BIOCHEM SCI, V38, P585, DOI 10.1016/j.tibs.2013.09.003; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Talaei F, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-1; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	40	13	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5320	5325		10.1074/jbc.M115.697102	http://dx.doi.org/10.1074/jbc.M115.697102			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26677221	Green Published, hybrid			2022-12-28	WOS:000371640600041
J	Shestov, AA; Mancuso, A; Lee, SC; Guo, LL; Nelson, DS; Roman, JC; Henry, PG; Leeper, DB; Blair, IA; Glickson, JD				Shestov, Alexander A.; Mancuso, Anthony; Lee, Seung-Cheol; Guo, Lili; Nelson, David S.; Roman, Jeffrey C.; Henry, Pierre-Gilles; Leeper, Dennis B.; Blair, Ian A.; Glickson, Jerry D.			Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by C-13 NMR Spectroscopy of Perfused Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergy; cancer biology; glucose metabolism; glutaminase; isotopic tracer; mathematical modeling; metabolism; mitochondrial metabolism; nuclear magnetic resonance (NMR); transport	MITOCHONDRIAL PYRUVATE CARRIER; KETOGLUTARATE GLUTAMATE EXCHANGE; CITRIC-ACID CYCLE; ALPHA-KETOGLUTARATE; HUMAN BRAIN; TCA CYCLE; IN-VIVO; GLIOMA-CELLS; RAT HEARTS; FLUX	A network model for the determination of tumor metabolic fluxes from C-13 NMR kinetic isotopomer data has been developed and validated with perfused human DB-1 melanoma cells carrying the BRAF V600E mutation, which promotes oxidative metabolism. The model generated in the bonded cumomer formalism describes key pathways of tumor intermediary metabolism and yields dynamic curves for positional isotopic enrichment and spin-spin multiplets. Cells attached to microcarrier beads were perfused with 26 mm [1,6-C-13(2)]glucose under normoxic conditions at 37 degrees C and monitored by C-13 NMR spectroscopy. Excellent agreement between model-predicted and experimentally measured values of the rates of oxygen and glucose consumption, lactate production, and glutamate pool size validated the model. ATP production by glycolytic and oxidative metabolism were compared under hyperglycemic normoxic conditions; 51% of the energy came from oxidative phosphorylation and 49% came from glycolysis. Even though the rate of glutamine uptake was approximate to 50% of the tricarboxylic acid cycle flux, the rate of ATP production from glutamine was essentially zero (no glutaminolysis). De novo fatty acid production was approximate to 6% of the tricarboxylic acid cycle flux. The oxidative pentose phosphate pathway flux was 3.6% of glycolysis, and three non-oxidative pentose phosphate pathway exchange fluxes were calculated. Mass spectrometry was then used to compare fluxes through various pathways under hyperglycemic (26 mm) and euglycemic (5 mm) conditions. Under euglycemic conditions glutamine uptake doubled, but ATP production from glutamine did not significantly change. A new parameter measuring the Warburg effect (the ratio of lactate production flux to pyruvate influx through the mitochondrial pyruvate carrier) was calculated to be 21, close to upper limit of oxidative metabolism.	[Shestov, Alexander A.; Lee, Seung-Cheol; Nelson, David S.; Roman, Jeffrey C.; Glickson, Jerry D.] Perelman Sch Med, Dept Radiol, Lab Mol Imaging, Philadelphia, PA 19104 USA; [Mancuso, Anthony] Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Mancuso, Anthony] Perelman Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA; [Glickson, Jerry D.] Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Guo, Lili; Blair, Ian A.] Perelman Sch Med, Dept Syst Pharmacol, Philadelphia, PA 19104 USA; [Henry, Pierre-Gilles] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Leeper, Dennis B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; Jefferson University	Shestov, AA (corresponding author), Univ Penn, Sch Med, Lab Mol Imaging, Dept Radiol, B-6 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.; Glickson, JD (corresponding author), Univ Penn, Dept Radiol, B-6 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	ashestov@mail.med.upenn.edu; glickson@mail.med.upenn.edu	Glickson, Jerry/AAR-7116-2021		National Institutes of Health [R01 CA129544, R01 CA172820]; NATIONAL CANCER INSTITUTE [R01CA172820, R01CA129544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01 CA129544 (to J. D. G.) and R01 CA172820 (to J. D. G.).	Beckmann N, 1995, CARBON 13 NMR SPECTR, P269; Befroy DE, 2014, NAT MED, V20, P98, DOI 10.1038/nm.3415; Berg J. M., 2002, BIOCHEMISTRY-US, P1; Berliner L. J., 1999, IN VIVO CARBON 13 NM, P1; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; CHATHAM JC, 1995, J BIOL CHEM, V270, P7999, DOI 10.1074/jbc.270.14.7999; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Glickson J. D., 1996, ENCY NUCL MAGNETIC R, P1209; Gruetter R, 2001, AM J PHYSIOL-ENDOC M, V281, pE100, DOI 10.1152/ajpendo.2001.281.1.E100; Halestrap AP, 2012, CELL METAB, V16, P141, DOI 10.1016/j.cmet.2012.07.013; Hensley CT, 2015, J CLIN INVEST, V125, P495, DOI 10.1172/JCI79188; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; HILL LL, 1991, CANCER RES, V51, P4937; Jeffrey FMH, 1999, AM J PHYSIOL-ENDOC M, V277, pE1111, DOI 10.1152/ajpendo.1999.277.6.E1111; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jucker BM, 1998, J BIOL CHEM, V273, P12187, DOI 10.1074/jbc.273.20.12187; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kunnecke B., 1995, CARBON 13 NMR SPECTR, P159; Le A, 2013, METHODS MOL BIOL, V1012, P213, DOI 10.1007/978-1-62703-429-6_14; LEEPER DB, 1994, INT J RADIAT ONCOL, V28, P935, DOI 10.1016/0360-3016(94)90114-7; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; Mancuso A, 2005, MAGN RESON MED, V54, P67, DOI 10.1002/mrm.20545; Mancuso A, 2004, BIOTECHNOL BIOENG, V87, P835, DOI 10.1002/bit.20191; MANCUSO A, 1990, BIO-TECHNOL, V8, P1282, DOI 10.1038/nbt1290-1282; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; MASON GF, 1992, J CEREBR BLOOD F MET, V12, P434, DOI 10.1038/jcbfm.1992.61; MCNAMARA R, 1994, NMR BIOMED, V7, P237, DOI 10.1002/nbm.1940070507; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; MUZYKANTOV VS, 1986, REACT KINET CATAL L, V32, P307, DOI 10.1007/BF02068328; PORTAIS JC, 1993, EUR J BIOCHEM, V217, P457, DOI 10.1111/j.1432-1033.1993.tb18265.x; Rajagopalan KN, 2011, J NUCL MED, V52, P1005, DOI 10.2967/jnumed.110.084244; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Shestov AA, 2013, ADV EXP MED BIOL, V765, P265, DOI 10.1007/978-1-4614-4989-8_37; Shestov AA, 2007, J NEUROSCI RES, V85, P3294, DOI 10.1002/jnr.21269; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shestov AA, 2013, WIRES SYST BIOL MED, V5, P733, DOI 10.1002/wsbm.1238; Shestov AA, 2012, NEUROCHEM RES, V37, P2388, DOI 10.1007/s11064-012-0782-5; SHUNGU DC, 1992, MAGN RESON MED, V28, P105, DOI 10.1002/mrm.1910280111; TANNOCK IF, 1989, CANCER RES, V49, P4373; VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228; Wahl ML, 2002, MOL CANCER THER, V1, P617; WEISS RG, 1993, CIRCULATION, V87, P270, DOI 10.1161/01.CIR.87.1.270; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yu X, 1995, BIOPHYS J, V69, P2090, DOI 10.1016/S0006-3495(95)80080-9	53	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5157	5171		10.1074/jbc.M115.701862	http://dx.doi.org/10.1074/jbc.M115.701862			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26703469	Green Published, hybrid			2022-12-28	WOS:000371640600028
J	Hafver, TL; Hodne, K; Wanichawan, P; Aronsen, JM; Dalhus, B; Lunde, PK; Lunde, M; Martinsen, M; Enger, UH; Fuller, W; Sjaastad, I; Louch, WE; Sejersted, OM; Carlson, CR				Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Aronsen, Jan Magnus; Dalhus, Bjorn; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Fuller, William; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein			Protein Phosphatase 1c Associated with the Cardiac Sodium Calcium Exchanger 1 Regulates Its Activity by Dephosphorylating Serine 68-phosphorylatedPhospholemman	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; STRUCTURAL BASIS; DEPENDENT REGULATION; MOLECULAR-BASIS; CA2+ REGULATION; ION-TRANSPORT; PHOSPHOLEMMAN; PHOSPHORYLATION; BINDING	The sodium (Na+)-calcium (Ca2+) exchanger 1 (NCX1) is an important regulator of intracellular Ca2+ homeostasis. Serine 68-phosphorylated phospholemman (pSer-68-PLM) inhibits NCX1 activity. In the context of Na+/K+-ATPase (NKA) regulation, pSer-68-PLM is dephosphorylated by protein phosphatase 1 (PP1). PP1 also associates with NCX1; however, the molecular basis of this association is unknown. In this study, we aimed to analyze the mechanisms of PP1 targeting to the NCX1-pSer-68-PLM complex and hypothesized that a direct and functional NCX1-PP1 interaction is a prerequisite for pSer-68-PLM dephosphorylation. Using a variety of molecular techniques, we show that PP1 catalytic subunit (PP1c) co-localized, co-fractionated, and co-immunoprecipitated with NCX1 in rat cardiomyocytes, left ventricle lysates, and HEK293 cells. Bioinformatic analysis, immunoprecipitations, mutagenesis, pulldown experiments, and peptide arrays constrained PP1c anchoring to the K(I/V) FF motif in the first Ca2+ binding domain (CBD) 1 in NCX1. This binding site is also partially in agreement with the extended PP1-binding motif K(V/I) FF-X5-8 Phi(1)Phi(2)-X8-9-R. The cytosolic loop of NCX1, containing the K(I/V) FF motif, had no effect on PP1 activity in an in vitro assay. Dephosphorylation of pSer-68-PLM in HEK293 cells was not observed when NCX1 was absent, when the K(I/V) FF motif was mutated, or when the PLM-and PP1c-binding sites were separated (mimicking calpain cleavage of NCX1). Co-expression of PLM and NCX1 inhibited NCX1 current (both modes). Moreover, co-expression of PLM with NCX1(F407P) (mutated K(I/V) FF motif) resulted in the current being completely abolished. In conclusion, NCX1 is a substrate-specifying PP1c regulator protein, indirectly regulating NCX1 activity through pSer-68-PLM dephosphorylation.	[Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Aronsen, Jan Magnus; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Oslo Univ Hosp, Expt Med Res Inst, Kirkeveien 166, N-0450 Oslo, Norway; [Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Aronsen, Jan Magnus; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, N-0450 Oslo, Norway; [Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, KG Jebsen Cardiac Res Ctr, N-0316 Oslo, Norway; [Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, Ctr Heart Failure Res, N-0316 Oslo, Norway; [Hodne, Kjetil] Norwegian Univ Life Sci NMBU, Dept Basic Sci & Aquat Med, N-0454 Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Dalhus, Bjorn] Oslo Univ Hosp, Rikshosp, Dept Microbiol, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, N-0424 Oslo, Norway; [Fuller, William] Univ Dundee, Cardiovasc & Diabet Med, Sch Med, Dundee DD1 9SY, Scotland	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway; University of Oslo; University of Dundee	Carlson, CR (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Kirkeveien 166, N-0450 Oslo, Norway.	c.r.carlson@medisin.uio.no	Dalhus, Bjørn/AAK-2895-2020	Hodne, Kjetil/0000-0001-8528-9728; Fuller, William/0000-0002-5883-4433	South-Eastern Norway Regional Health Authority; Norwegian National Health Association; Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen; Simon Fougner Hartmann's Family Fund, Denmark; Anders Jahre's Fund; South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grants [2012085, 2015095]; British Heart Foundation [PG/12/6/29366, PG/10/93/28650, FS/13/22/30126] Funding Source: researchfish; Medical Research Council [1218481] Funding Source: researchfish	South-Eastern Norway Regional Health Authority; Norwegian National Health Association; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen; Simon Fougner Hartmann's Family Fund, Denmark; Anders Jahre's Fund; South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grants; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the South-Eastern Norway Regional Health Authority, the Norwegian National Health Association, Research Council of Norway, Stiftelsen Kristian Gerhard Jebsen, the Simon Fougner Hartmann's Family Fund, Denmark, and Anders Jahre's Fund for the promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grants 2012085 and 2015095.	Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boens S, 2013, METHODS MOL BIOL, V1053, P271, DOI 10.1007/978-1-62703-562-0_16; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Brattelid T, 2007, J MOL CELL CARDIOL, V43, P767, DOI 10.1016/j.yjmcc.2007.08.019; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; Choy MS, 2012, BIOCHEM SOC T, V40, P969, DOI 10.1042/BST20120094; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; El-Armouche A, 2011, FASEB J, V25, P4467, DOI 10.1096/fj.11-184903; Frank R, 1996, Methods Mol Biol, V66, P149; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Han F, 2010, AM J PHYSIOL-CELL PH, V299, pC1363, DOI 10.1152/ajpcell.00027.2010; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2012, J BIOL CHEM, V287, P31641, DOI 10.1074/jbc.R112.353573; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Lu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024724; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; McAvoy Thomas, 2010, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1818s92; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; O'Connell N, 2012, STRUCTURE, V20, P1746, DOI 10.1016/j.str.2012.08.003; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Panigrahi AK, 2011, MOL CELL BIOL, V31, P4335, DOI 10.1128/MCB.06075-11; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pogwizd SM, 1999, CIRC RES, V85, P1009; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Ren XY, 2008, BIOCHEMISTRY-US, V47, P6081, DOI 10.1021/bi800177t; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P103, DOI 10.1196/annals.1387.036; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wanichawan P, 2014, J BIOL CHEM, V289, P33984, DOI 10.1074/jbc.M114.602581; Wanichawan P, 2011, AM J PHYSIOL-CELL PH, V300, pC989, DOI 10.1152/ajpcell.00196.2010; Wypijewski KJ, 2013, J BIOL CHEM, V288, P13808, DOI 10.1074/jbc.M113.460956; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005; Zhang XQ, 2003, AM J PHYSIOL-HEART C, V284, pH225, DOI 10.1152/ajpheart.00698.2002; Zhang XQ, 2011, AM J PHYSIOL-CELL PH, V301, pC833, DOI 10.1152/ajpcell.00069.2011; Zhang XQ, 2009, AM J PHYSIOL-CELL PH, V296, pC911, DOI 10.1152/ajpcell.00196.2008	64	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4561	4579		10.1074/jbc.M115.677898	http://dx.doi.org/10.1074/jbc.M115.677898			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26668322	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000371604600025
J	Kastrati, I; Siklos, MI; Calderon-Gierszal, EL; El-Shennawy, L; Georgieva, G; Thayer, EN; Thatcher, GRJ; Frasor, J				Kastrati, Irida; Siklos, Marton I.; Calderon-Gierszal, Esther L.; El-Shennawy, Lamiaa; Georgieva, Gergana; Thayer, Emily N.; Thatcher, Gregory R. J.; Frasor, Jonna			Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; chemical modification; drug action; inflammation; inhibitor; NFB; covalent modification; cysteine; dimethyl fumarate; mammosphere	NF-KAPPA-B; STEM-CELLS; ACID ESTERS; DNA-BINDING; TNF-ALPHA; ACTIVATION; EXPRESSION; SUBUNIT; KINASE; IKK	In breast tumors, activation of the nuclear factor B (NFB) pathway promotes survival, migration, invasion, angiogenesis, stem cell-like properties, and resistance to therapyall phenotypes of aggressive disease where therapy options remain limited. Adding an anti-inflammatory/anti-NFB agent to breast cancer treatment would be beneficial, but no such drug is approved as either a monotherapy or adjuvant therapy. To address this need, we examined whether dimethyl fumarate (DMF), an anti-inflammatory drug already in clinical use for multiple sclerosis, can inhibit the NFB pathway. We found that DMF effectively blocks NFB activity in multiple breast cancer cell lines and abrogates NFB-dependent mammosphere formation, indicating that DMF has anti-cancer stem cell properties. In addition, DMF inhibits cell proliferation and significantly impairs xenograft tumor growth. Mechanistically, DMF prevents p65 nuclear translocation and attenuates its DNA binding activity but has no effect on upstream proteins in the NFB pathway. Dimethyl succinate, the inactive analog of DMF that lacks the electrophilic double bond of fumarate, is unable to inhibit NFB activity. Also, the cell-permeable thiol N-acetyl l-cysteine, reverses DMF inhibition of the NFB pathway, supporting the notion that the electrophile, DMF, acts via covalent modification. To determine whether DMF interacts directly with p65, we synthesized and used a novel chemical probe of DMF by incorporating an alkyne functionality and found that DMF covalently modifies p65, with cysteine 38 being essential for the activity of DMF. These results establish DMF as an NFB inhibitor with anti-tumor activity that may add therapeutic value in the treatment of aggressive breast cancers.	[Kastrati, Irida; Calderon-Gierszal, Esther L.; El-Shennawy, Lamiaa; Georgieva, Gergana; Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,E202 MSB,MC901, Chicago, IL 60612 USA; [Siklos, Marton I.; Thayer, Emily N.; Thatcher, Gregory R. J.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kastrati, I (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,E202 MSB,MC901, Chicago, IL 60612 USA.	ikastr2@uic.edu	Kastrati, Irida/L-4641-2019	Kastrati, Irida/0000-0002-8086-1411	National Institutes of Health [R01 CA130932, R01 CA200669, R01 CA121107]; Susan G. Komen for the Cure [PDF12229484]; NATIONAL CANCER INSTITUTE [R01CA130932, R01CA200669, R01CA121107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA130932 and R01 CA200669 (to J. F.) and R01 CA121107 (to G. R. J. T.) and by Postdoctoral Fellowship Grant PDF12229484 from Susan G. Komen for the Cure (to I. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anand P, 2008, CANCER RES, V68, P8861, DOI 10.1158/0008-5472.CAN-08-1902; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garber K, 2006, NAT BIOTECHNOL, V24, P127, DOI 10.1038/nbt0206-127; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; Gotz MG, 2008, J MED CHEM, V51, P2816, DOI 10.1021/jm701311r; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Hoefnagel JJ, 2003, BRIT J DERMATOL, V149, P363, DOI 10.1046/j.1365-2133.2003.05433.x; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnstone PAS, 2002, CURR PROB CANCER, V26, P282, DOI 10.1067/mcn.2002.129997; Jones RL, 2011, J CLIN PATHOL, V64, P130, DOI 10.1136/jcp.2010.082966; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kastrati I, 2015, ONCOGENE, V34, P2309, DOI 10.1038/onc.2014.180; Kastrati I, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1868-7; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Mah R, 2014, BIOORG MED CHEM LETT, V24, P33, DOI 10.1016/j.bmcl.2013.10.003; Marcotte D, 2013, BIOORGAN MED CHEM, V21, P4011, DOI 10.1016/j.bmc.2013.04.019; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Pradhan M, 2012, MOL CELL BIOL, V32, P569, DOI 10.1128/MCB.05869-11; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; Seidel P, 2009, AM J PHYSIOL-LUNG C, V297, pL326, DOI 10.1152/ajplung.90624.2008; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tamura R, 2012, BIOSCI BIOTECH BIOCH, V76, P2360, DOI 10.1271/bbb.120619; Vandermeeren M, 2001, J INVEST DERMATOL, V116, P124, DOI 10.1046/j.1523-1747.2001.00211.x; Velasco-Velazquez MA, 2011, AM J PATHOL, V179, P2, DOI 10.1016/j.ajpath.2011.03.005; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yamamoto M, 2008, J MED CHEM, V51, P5780, DOI 10.1021/jm8006245; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	52	84	85	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3639	3647		10.1074/jbc.M115.679704	http://dx.doi.org/10.1074/jbc.M115.679704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26683377	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000370854500041
J	Kim, DH; Hwang, JS; Lee, IH; Nam, ST; Hong, J; Zhang, P; Lu, LF; Lee, J; Seok, H; Pothoulakis, C; Lamont, JT; Kim, H				Kim, Dae Hong; Hwang, Jae Sam; Lee, Ik Hwan; Nam, Seung Taek; Hong, Ji; Zhang, Peng; Lu, Li Fang; Lee, Junguee; Seok, Heon; Pothoulakis, Charalabos; Lamont, John Thomas; Kim, Ho			The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; cell cycle; cell proliferation; epidermal growth factor (EGF); epithelial cell; inflammation; peptides; proteasome; protein degradation; ubiquitylation (ubiquitination)	EPIDERMAL-GROWTH-FACTOR; CLOSTRIDIUM-DIFFICILE TOXIN; ULCERATIVE-COLITIS; UBIQUITIN LIGASE; INTESTINAL INFLAMMATION; INTERACTING PROTEIN; CROHNS-DISEASE; BOWEL-DISEASE; APOPTOSIS; DEGRADATION	The epithelial cells of the gut form a physical barrier against the luminal contents. The collapse of this barrier causes inflammation, and its therapeutic restoration can protect the gut against inflammation. EGF enhances mucosal barrier function and increases colonocyte proliferation, thereby ameliorating inflammatory responses in the gut. Based on our previous finding that the insect peptide CopA3 promotes neuronal growth, we herein tested whether CopA3 could increase the cell proliferation of colonocytes, enhance mucosal barrier function, and ameliorate gut inflammation. Our results revealed that CopA3 significantly increased epithelial cell proliferation in mouse colonic crypts and also enhanced colonic epithelial barrier function. Moreover, CopA3 treatment ameliorated Clostridium difficile toxin As-induced inflammation responses in the mouse small intestine (acute enteritis) and completely blocked inflammatory responses and subsequent lethality in the dextran sulfate sodium-induced mouse model of chronic colitis. The marked CopA3-induced increase of colonocyte proliferation was found to require rapid protein degradation of p21(Cip1/Waf1), and an in vitro ubiquitination assay revealed that CopA3 directly facilitated ubiquitin ligase activity against p21(Cip1/Waf1). Taken together, our findings indicate that the insect peptide CopA3 prevents gut inflammation by increasing epithelial cell proliferation and mucosal barrier function.	[Kim, Dae Hong; Lee, Ik Hwan; Nam, Seung Taek; Hong, Ji; Zhang, Peng; Lu, Li Fang; Kim, Ho] Daejin Univ, Coll Nat Sci, Dept Life Sci, Pochon 487711, Gyeonggido, South Korea; [Hwang, Jae Sam] Natl Acad Agr Sci, Dept Agr Biol, RDA, Wonju 55365, South Korea; [Lee, Junguee] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Pathol, Daeheung Ro 64, Daejeon 301723, South Korea; [Seok, Heon] Jungwon Univ, Dept Biomed Engn, Goesan 367700, Chungcheongbukd, South Korea; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Lamont, John Thomas] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA	Daejin University; Rural Development Administration (RDA), Republic of Korea; Catholic University of Korea; Jungwon University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, H (corresponding author), Daejin Univ, Dept Life Sci & Chem, Coll Nat Sci, Pochon, Gyeonggido, South Korea.	hokim@daejin.ac.kr	Kim, Daehong/AAP-7488-2021	Kim, Daehong/0000-0002-1253-8946	Rural Development Administration, Republic of Korea [PJ011043022015]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Next-Generation BioGreen 21 Program (no, PJ011043022015), Rural Development Administration, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Alscher KT, 2001, AM J PHYSIOL-GASTR L, V281, pG569, DOI 10.1152/ajpgi.2001.281.2.G569; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Drucker DJ, 1999, AM J PHYSIOL-GASTR L, V276, pG79, DOI 10.1152/ajpgi.1999.276.1.G79; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; HARPER JW, 1993, CELL, V75, P805; Iwamoto M, 1996, J PATHOL, V180, P152; Izawa H, 2005, INT J ONCOL, V27, P69; Jeffers M, 2002, GASTROENTEROLOGY, V123, P1151, DOI 10.1053/gast.2002.36041; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kang BR, 2012, BMB REP, V45, P85, DOI 10.5483/BMBRep.2012.45.2.85; Kang JK, 2011, ANTIMICROB AGENTS CH, V55, P4850, DOI 10.1128/AAC.00177-11; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim DH, 2014, BIOCHEM BIOPH RES CO, V448, P292, DOI 10.1016/j.bbrc.2014.04.105; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kim H, 2007, GASTROENTEROLOGY, V133, P875, DOI 10.1053/j.gastro.2007.06.063; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Literakova P, 2010, J CHROMATOGR SCI, V48, P436, DOI 10.1093/chromsci/48.6.436; Nam ST, 2013, BIOCHEM BIOPH RES CO, V437, P35, DOI 10.1016/j.bbrc.2013.06.031; Newman B, 2005, CURR OPIN GASTROEN, V21, P401; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; PLAYFORD RJ, 1995, GUT, V37, P595, DOI 10.1136/gut.37.5.595; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Riegler M, 1997, AM J PHYSIOL-GASTR L, V273, pG1014, DOI 10.1152/ajpgi.1997.273.5.G1014; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Shin JS, 2008, INT J ONCOL, V32, P435; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Wong NACS, 2003, HUM PATHOL, V34, P580, DOI 10.1016/S0046-8177(03)00125-4; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	41	18	20	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3209	3223		10.1074/jbc.M115.682856	http://dx.doi.org/10.1074/jbc.M115.682856			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26655716	Green Published, hybrid			2022-12-28	WOS:000370854500009
J	Ritchie, MK; Johnson, LC; Clodfelter, JE; Pemble, CW; Fulp, BE; Furdui, CM; Kridel, SJ; Lowther, WT				Ritchie, Melissa K.; Johnson, Lynnette C.; Clodfelter, Jill E.; Pemble, Charles W.; Fulp, Brian E.; Furdui, Cristina M.; Kridel, Steven J.; Lowther, W. Todd			Crystal Structure and Substrate Specificity of Human Thioesterase 2: INSIGHTS INTO THE MOLECULAR BASIS FOR THE MODULATION OF FATTY ACID SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; fatty acid synthase (FAS); hydrolase; lipid metabolism; serine esterase; thioesterase	RAT MAMMARY-GLAND; PRODUCT SPECIFICITY; ESCHERICHIA-COLI; ACYL-COA; PROTEIN; CARRIER; PURIFICATION; ENZYME; SYNTHETASE; OVEREXPRESSION	The type I fatty acid synthase (FASN) is responsible for the de novo synthesis of palmitate. Chain length selection and release is performed by the C-terminal thioesterase domain (TE1). FASN expression is up-regulated in cancer, and its activity levels are controlled by gene dosage and transcriptional and post-translational mechanisms. In addition, the chain length of fatty acids produced by FASN is controlled by a type II thioesterase called TE2 (E.C. 3.1.2.14). TE2 has been implicated in breast cancer and generates a broad lipid distribution within milk. The molecular basis for the ability of the TE2 to compete with TE1 for the acyl chain attached to the acyl carrier protein (ACP) domain of FASN is unknown. Herein, we show that human TE1 efficiently hydrolyzes acyl-CoA substrate mimetics. In contrast, TE2 prefers an engineered human acyl-ACP substrate and readily releases short chain fatty acids from full-length FASN during turnover. The 2.8 crystal structure of TE2 reveals a novel capping domain insert within the / hydrolase core. This domain is reminiscent of capping domains of type II thioesterases involved in polyketide synthesis. The structure also reveals that the capping domain had collapsed onto the active site containing the Ser-101-His-237-Asp-212 catalytic triad. This observation suggests that the capping domain opens to enable the ACP domain to dock and to place the acyl chain and 4-phosphopantetheinyl-linker arm correctly for catalysis. Thus, the ability of TE2 to prematurely release fatty acids from FASN parallels the role of editing thioesterases involved in polyketide and non-ribosomal peptide synthase synthases.	[Ritchie, Melissa K.; Johnson, Lynnette C.; Clodfelter, Jill E.; Pemble, Charles W.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Ritchie, Melissa K.; Johnson, Lynnette C.; Clodfelter, Jill E.; Pemble, Charles W.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Kridel, Steven J.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Fulp, Brian E.; Furdui, Cristina M.; Kridel, Steven J.; Lowther, W. Todd] Wake Forest Baptist Med Ctr, Ctr Comprehens Canc, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Lowther, WT (corresponding author), Wake Forest Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wakehealth.edu		Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health [R01CA411401]; Comprehensive Cancer Center of Wake Forest Baptist Medical Center (NCI Cancer Center Support Grant) [P30CA012197]; Department of Defense [PC08165]; NATIONAL CANCER INSTITUTE [R01CA161503, P30CA012197, R01CA114104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center of Wake Forest Baptist Medical Center (NCI Cancer Center Support Grant); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA411401 (NCI), Comprehensive Cancer Center of Wake Forest Baptist Medical Center (NCI Cancer Center Support Grant P30CA012197), and the Department of Defense (PC08165). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; BUCHBINDER JL, 1995, PROTEINS, V22, P73, DOI 10.1002/prot.340220111; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Condurso HL, 2012, NAT PROD REP, V29, P1099, DOI 10.1039/c2np20023f; Cox RJ, 2002, J CHEM SOC PERK T 1, P1644, DOI 10.1039/b204633b; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; DILS R R, 1980, Biochemical Society Transactions, V8, P292; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOSTER RJ, 1985, J BIOL CHEM, V260, P1386; German JB, 2011, MATERN CHILD NUTR, V7, P2, DOI 10.1111/j.1740-8709.2011.00300.x; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Hunt MC, 2014, BIOCHIMIE, V98, P45, DOI 10.1016/j.biochi.2013.12.018; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Jensen-Urstad APL, 2013, J LIPID RES, V54, P1848, DOI 10.1194/jlr.M036103; Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017; Joshi AK, 2005, BIOCHEMISTRY-US, V44, P4100, DOI 10.1021/bi047856r; Keatinge-Clay AT, 2012, NAT PROD REP, V29, P1050, DOI 10.1039/c2np20019h; Knudsen J, 1981, Methods Enzymol, V71 Pt C, P200, DOI 10.1016/0076-6879(81)71028-0; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; LIBERTINI LJ, 1980, BIOCHIM BIOPHYS ACTA, V618, P185, DOI 10.1016/0005-2760(80)90024-7; LIN CY, 1978, J BIOL CHEM, V253, P1954; Little Joy L., 2008, V49, P169, DOI 10.1007/978-1-4020-8831-5_7; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Martin MA, 2012, MATERN CHILD NUTR, V8, P404, DOI 10.1111/j.1740-8709.2012.00412.x; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MIKKELSEN J, 1987, J BIOL CHEM, V262, P1570; Molnos J, 2003, ANAL BIOCHEM, V319, P171, DOI 10.1016/S0003-2697(03)00327-0; NAGGERT J, 1991, BIOCHEM J, V273, P787, DOI 10.1042/bj2730787; NOLIN JM, 1982, J ENDOCRINOL, V94, P251, DOI 10.1677/joe.0.0940251; PAWLAK J, 1986, CANCER RES, V46, P4712; PAZIRANDEH M, 1989, J BIOL CHEM, V264, P18195; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; POWELL GL, 1981, J BIOL CHEM, V256, P2740; ROGERS L, 1982, J BIOL CHEM, V257, P880; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Shanklin J, 2000, PROTEIN EXPRES PURIF, V18, P355, DOI 10.1006/prep.2000.1206; SMITH S, 1984, J NATL CANCER I, V73, P323, DOI 10.1093/jnci/73.2.323; THOMPSON BJ, 1985, PEDIATR RES, V19, P139, DOI 10.1203/00006450-198501000-00036; Whicher JR, 2011, J BIOL CHEM, V286, P22558, DOI 10.1074/jbc.M110.213512; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITKOWSKI A, 1991, J BIOL CHEM, V266, P18514; WITKOWSKI A, 1992, J BIOL CHEM, V267, P18488; Wu Xi, 2014, Advances in Biological Regulation, V54, P214, DOI 10.1016/j.jbior.2013.09.004; Yamashita Atsushi, 2014, Biology (Basel), V3, P801, DOI 10.3390/biology3040801; Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010; Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6	54	21	22	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3520	3530		10.1074/jbc.M115.702597	http://dx.doi.org/10.1074/jbc.M115.702597			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663084	hybrid, Green Published			2022-12-28	WOS:000370854500032
J	Jiang, H; Salmon, RM; Upton, PD; Wei, ZQ; Lawera, A; Davenport, AP; Morrell, NW; Li, W				Jiang, He; Salmon, Richard M.; Upton, Paul D.; Wei, Zhenquan; Lawera, Aleksandra; Davenport, Anthony P.; Morrell, Nicholas W.; Li, Wei			The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY ARTERIAL-HYPERTENSION; BMP9; ALK1; IDENTIFICATION; ACTIVATION; EXPRESSION; RECEPTORS; GROWTH; QUIESCENCE; COMPLEX	BMP10 is highly expressed in the developing heart and plays essential roles in cardiogenesis. BMP10 deletion in mice results in embryonic lethality because of impaired cardiac development. In adults, BMP10 expression is restricted to the right atrium, though ventricular hypertrophy is accompanied by increased BMP10 expression in a rat hypertension model. However, reports of BMP10 activity in the circulation are inconclusive. In particular, it is not known whether in vivo secreted BMP10 is active or whether additional factors are required to achieve its bioactivity. It has been shown that high-affinity binding of the BMP10 prodomain to the mature ligand inhibits BMP10 signaling activity in C2C12 cells, and it was proposed that prodomain-bound BMP10 (pBMP10) complex is latent. In this study, we demonstrated that the BMP10 prodomain did not inhibit BMP10 signaling activity in multiple endothelial cells, and that recombinant human pBMP10 complex, expressed in mammalian cells and purified under native conditions, was fully active. In addition, both BMP10 in human plasma and BMP10 secreted from the mouse right atrium were fully active. Finally, we confirmed that active BMP10 secreted from mouse right atrium was in the prodomain-bound form. Our data suggest that circulating BMP10 in adults is fully active and that the reported vascular quiescence function of BMP10 in vivo is due to the direct activity of pBMP10 and does not require an additional activation step. Moreover, being an active ligand, recombinant pBMP10 may have therapeutic potential as an endothelial-selective BMP ligand, in conditions characterized by loss of BMP9/10 signaling.	[Jiang, He; Salmon, Richard M.; Upton, Paul D.; Wei, Zhenquan; Lawera, Aleksandra; Davenport, Anthony P.; Morrell, Nicholas W.; Li, Wei] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England; [Wei, Zhenquan] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Shanghai Jiao Tong University	Morrell, NW (corresponding author), Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.	nwm23@cam.ac.uk; wl225@cam.ac.uk	wei, wei/HHR-8613-2022; Davenport, Anthony Peter/A-5773-2008	Salmon, Richard/0000-0001-6327-5341; Morrell, Nicholas/0000-0001-5700-9792; Davenport, Anthony Peter/0000-0002-2096-3117	British Heart Foundation [PG/12/54/29734, CH/09/001/25945]; Cambridge Wellcome Trust 4-year Ph.D Programme in Metabolic and Cardiovascular Disease; MRC [G1000847, G0800784] Funding Source: UKRI; British Heart Foundation [PG/15/39/31519] Funding Source: researchfish; Medical Research Council [G1000847, G0800784] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cambridge Wellcome Trust 4-year Ph.D Programme in Metabolic and Cardiovascular Disease; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grants PG/12/54/29734 (to W. L., P. D. U., and N. W. M.) and CH/09/001/25945 (to N. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Cambridge Wellcome Trust 4-year Ph.D Programme in Metabolic and Cardiovascular Disease.	Bendell JC, 2014, CLIN CANCER RES, V20, P480, DOI 10.1158/1078-0432.CCR-13-1840; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Li W, 1997, J BIOL CHEM, V272, P22253, DOI 10.1074/jbc.272.35.22253; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Nakano N, 2007, AM J PHYSIOL-HEART C, V293, pH3396, DOI 10.1152/ajpheart.00311.2007; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Panchenko MP, 1996, AM J PHYSIOL-LUNG C, V270, pL547, DOI 10.1152/ajplung.1996.270.4.L547; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Wei ZQ, 2014, J BIOL CHEM, V289, P31150, DOI 10.1074/jbc.M114.579771; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001	32	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2954	2966		10.1074/jbc.M115.683292	http://dx.doi.org/10.1074/jbc.M115.683292			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26631724	Green Published, hybrid			2022-12-28	WOS:000369626900032
J	Lee, CC; Julian, MC; Tiller, KE; Meng, FL; DuConge, SE; Akter, R; Raleigh, DP; Tessier, PM				Lee, Christine C.; Julian, Mark C.; Tiller, Kathryn E.; Meng, Fanling; DuConge, Sarah E.; Akter, Rehana; Raleigh, Daniel P.; Tessier, Peter M.			Design and Optimization of Anti-amyloid Domain Antibodies Specific for beta-Amyloid and Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; PRION PROTEIN; PHAGE DISPLAY; FIBRILLAR OLIGOMERS; ALZHEIMERS-DISEASE; CHARGED MUTATIONS; AGGREGATION; CONFORMATION; GENERATION; INHIBITION	Antibodies with conformational specificity are important for detecting and interfering with polypeptide aggregation linked to several human disorders. We are developing a motif-grafting approach for designing lead antibody candidates specific for amyloid-forming polypeptides such as the Alzheimer peptide (A beta). This approach involves grafting amyloidogenic peptide segments into the complementarity-determining regions (CDRs) of single-domain (V-H) antibodies. Here we have investigated the impact of polar mutations inserted at the edges of a large hydrophobic A beta 42 peptide segment (A beta residues 17-42) in CDR3 on the solubility and conformational specificity of the corresponding V-H domains. We find that V-H expression and solubility are strongly enhanced by introducing multiple negatively charged or asparagine residues at the edges of CDR3, whereas other polar mutations are less effective (glutamine and serine) or ineffective (threonine, lysine, and arginine). Moreover, A beta V-H domains with negatively charged CDR3 mutations show significant preference for recognizing A beta fibrils relative to A beta monomers, whereas the same V-H domains with other polar CDR3 mutations recognize both A beta conformers. We observe similar behavior for a V-H domain grafted with a large hydrophobic peptide from islet amyloid polypeptide (residues 8-37) that contains negatively charged mutations at the edges of CDR3. These findings highlight the sensitivity of antibody binding and solubility to residues at the edges of CDRs, and provide guidelines for designing other grafted antibody fragments with hydrophobic binding loops.	[Lee, Christine C.; Julian, Mark C.; Tiller, Kathryn E.; Meng, Fanling; DuConge, Sarah E.; Tessier, Peter M.] Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Akter, Rehana; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tessier, PM (corresponding author), Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022		National Institutes of Health [R01GM104130, R01GM078114]; National Science Foundation [0954450, 1159943]; Pew Charitable Trust; New York Capital Region Research Alliance; Richard Baruch M.D. Chair; MedImmune; Eli Lilly; Bristol-Myers Squibb; Janssen; Merck; Genentech; Amgen; Pfizer; Adimab; Abbvie; Roche; Boehringer Ingelheim; Bayer; Abbott; DuPont; Schrodinger; Novo Nordisk; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104130, R01GM078114] Funding Source: NIH RePORTER; Directorate For Engineering [1159943, 0954450] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pew Charitable Trust; New York Capital Region Research Alliance; Richard Baruch M.D. Chair; MedImmune(AstraZenecaMedimmune); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Genentech(Roche HoldingGenentech); Amgen(Amgen); Pfizer(Pfizer); Adimab; Abbvie(AbbVie); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Abbott(Abbott Laboratories); DuPont; Schrodinger(Austrian Science Fund (FWF)); Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM104130 (to P. M. T.) and R01GM078114 (to D. P. R.), National Science Foundation CBET Grants 0954450 and 1159943 (to P. M. T.), grants from the Pew Charitable Trust (Pew Scholars Award in Biomedical Sciences (to P. M. T.), New York Capital Region Research Alliance (to P. M. T.), and Richard Baruch M.D. Chair (to P. M. T). P. M. T. has received consulting fees and/or honorariums for presentations of this and/or related research findings at MedImmune, Eli Lilly, Bristol-Myers Squibb, Janssen, Merck, Genentech, Amgen, Pfizer, Adimab, Abbvie, Roche, Boehringer Ingelheim, Bayer, Abbott, DuPont, Schrodinger, and Novo Nordisk. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Baumketner A, 2008, P NATL ACAD SCI USA, V105, P6027, DOI 10.1073/pnas.0708193105; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; Chan JCC, 2012, TOP CURR CHEM, V306, P47, DOI 10.1007/128_2011_154; Chang HJ, 2014, STRUCTURE, V22, P9, DOI 10.1016/j.str.2013.10.005; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Droste P, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0146-8; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; GLENNER GG, 1988, BIOCHEM BIOPH RES CO, V155, P608, DOI 10.1016/S0006-291X(88)80538-2; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Klooster Rinse, 2012, Methods Mol Biol, V911, P241, DOI 10.1007/978-1-61779-968-6_15; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Ladiwala ARA, 2012, P NATL ACAD SCI USA, V109, P19965, DOI 10.1073/pnas.1208797109; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lu XM, 2014, J PEPT SCI, V20, P860, DOI 10.1002/psc.2677; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Perchiacca JM, 2014, PROTEIN ENG DES SEL, V27, P29, DOI 10.1093/protein/gzt058; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Solomon B, 2005, VACCINE, V23, P2327, DOI 10.1016/j.vaccine.2005.01.034; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Tycko R, 2000, CURR OPIN CHEM BIOL, V4, P500, DOI 10.1016/S1367-5931(00)00123-X; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Vaikath NN, 2015, NEUROBIOL DIS, V79, P81, DOI 10.1016/j.nbd.2015.04.009; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Vasilevko V, 2010, NEUROBIOL DIS, V39, P301, DOI 10.1016/j.nbd.2010.04.014; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang XP, 2009, FEBS LETT, V583, P579, DOI 10.1016/j.febslet.2008.12.064; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Williams SM, 2015, JOVE-J VIS EXP, DOI 10.3791/52584; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wilson DR, 1998, CAN J MICROBIOL, V44, P313, DOI 10.1139/cjm-44-4-313; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Yuan ZN, 2013, NEURAL REGEN RES, V8, P3107, DOI 10.3969/j.issn.1673-5374.2013.33.004; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	78	31	31	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2858	2873		10.1074/jbc.M115.682336	http://dx.doi.org/10.1074/jbc.M115.682336			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26601942	Green Published, hybrid			2022-12-28	WOS:000369626900025
J	Monian, P; Jiang, XJ				Monian, Prashant; Jiang, Xuejun			The Cellular Apoptosis Susceptibility Protein ( CAS) Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; SEGREGATION GENE CSE1; CASPASE ACTIVATION; CHROMOSOME SEGREGATION; MUSCLE DIFFERENTIATION; NUCLEOTIDE EXCHANGE; DEATH RECEPTORS; CANCER GENOMICS; NEURONAL DEATH; HUMAN HOMOLOG	A signature event during the cell intrinsic apoptotic pathway is mitochondrial outer membrane permeabilization, leading to formation of the apoptosome, a caspase activation complex. The cellular apoptosis susceptibility protein (CAS) can facilitate apoptosome assembly by stimulating nucleotide exchange on Apaf-1 following binding of cytochrome c. We report here that CAS expression itself is up-regulated during tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-induced apoptosis, and knockdown of CAS renders cells resistant to TRAIL. We find that TRAIL induces up-regulation of CAS in a posttranscriptional, caspase-8-dependent manner through degradation of cIAP1, an E3 ligase that targets CAS for ubiquitin-dependent proteasomal degradation. We identified a novel signaling pathway whereby caspase-8 engages a feedforward cascade that leads to CAS up-regulation and amplifies the apoptotic signal. Furthermore, in silico analysis revealed that expression of CAS is up-regulated at both the mRNA and DNA levels in human breast tumors, consistent with its role in promoting cell proliferation. Overexpression of various oncogenes led to CAS upregulation in non-transformed cells. Intriguingly, oncogene-induced CAS up-regulation also resulted in greater susceptibility to TRAIL-induced cell death, consistent with its proapoptotic function. These findings suggest that CAS plays contrasting roles in proliferation and apoptosis and that overexpression of CAS in tumors could serve as a potential biomarker to guide therapeutic choices.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	jiangx@mskcc.org	Monian, Prashant/J-7414-2019		William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research of the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; National Institutes of Health [P30 CA008748, R01GM113013, R01CA166413]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA166413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113013] Funding Source: NIH RePORTER	William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research of the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research of the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; a Cycle for Survival grant; National Institutes of Health Cancer Center Core Grant P30 CA008748; and National Institutes of Health Grants R01GM113013 and R01CA166413 (to X. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bar-Shira A, 2002, CANCER RES, V62, P6803; Bera TK, 2001, MOL CELL BIOL, V21, P7020, DOI 10.1128/MCB.21.20.7020-7024.2001; Boni R, 1999, AM J DERMATOPATH, V21, P125, DOI 10.1097/00000372-199904000-00003; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Brustmann H, 2004, GYNECOL ONCOL, V92, P268, DOI 10.1016/j.ygyno.2003.10.029; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guicciardi ME, 2011, EXP CELL RES, V317, P107, DOI 10.1016/j.yexcr.2010.10.005; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Jia L, 2001, BLOOD, V98, P414, DOI 10.1182/blood.V98.2.414; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Wellmann A, 2001, INT J MOL MED, V7, P489; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	60	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2379	2388		10.1074/jbc.M115.685008	http://dx.doi.org/10.1074/jbc.M115.685008			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26668314	hybrid, Green Published			2022-12-28	WOS:000369610400027
J	Cadwell, CM; Jenkins, PM; Bennett, V; Kowalczyk, AP				Cadwell, Chantel M.; Jenkins, Paul M.; Bennett, Vann; Kowalczyk, Andrew P.			Ankyrin-G Inhibits Endocytosis of Cadherin Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VE-CADHERIN; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; ALPHA-CATENIN; P120 CATENIN; P120-CATENIN; BINDING; INTERNALIZATION; ADHESION	Dynamic regulation of endothelial cell adhesion is central to vascular development and maintenance. Furthermore, altered endothelial adhesion is implicated in numerous diseases. Therefore, normal vascular patterning and maintenance require tight regulation of endothelial cell adhesion dynamics. However, the mechanisms that control junctional plasticity are not fully understood. Vascular endothelial cadherin (VE-cadherin) is an adhesive protein found in adherens junctions of endothelial cells. VE-cadherin mediates adhesion through trans interactions formed by its extracellular domain. Trans binding is followed by cis interactions that laterally cluster the cadherin in junctions. VE-cadherin is linked to the actin cytoskeleton through cytoplasmic interactions with beta- and alpha-catenin, which serve to increase adhesive strength. Furthermore, p120-catenin binds to the cytoplasmic tail of cadherin and stabilizes it at the plasma membrane. Here we report that induced cis dimerization of VE-cadherin inhibits endocytosis independent of both p120 binding and trans interactions. However, we find that ankyrin-G, a protein that links membrane proteins to the spectrin-actin cytoskeleton, associates with VE-cadherin and inhibits its endocytosis. Ankyrin-G inhibits VE-cadherin endocytosis independent of p120 binding. We propose a model in which ankyrin-G associates with and inhibits the endocytosis of VE-cadherin cis dimers. Our findings support a novel mechanism for regulation of VE-cadherin endocytosis through ankyrin association with cadherin engaged in lateral interactions.	[Cadwell, Chantel M.] Emory Univ, Sch Med, Biochem Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Jenkins, Paul M.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem Cell Biol & Neurobiol, Durham, NC 27710 USA	Emory University; Emory University; Emory University; Emory University; Duke University; Howard Hughes Medical Institute	Kowalczyk, AP (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Cell Biol, Atlanta, GA 30322 USA.	akowalc@emory.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823	National Institutes of Health [RO1AR050501, RO1AR048266]; American Heart Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048266, R01AR050501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants RO1AR050501 and RO1AR048266 (to A.P.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship from the American Heart Association.	Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Brasch J, 2011, J MOL BIOL, V408, P57, DOI 10.1016/j.jmb.2011.01.031; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Hordijk PL, 1999, J CELL SCI, V112, P1915; Jefford G, 2000, J BIOL CHEM, V275, P27726; Jenkins PM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500301; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Song GJ, 2005, MOL ENDOCRINOL, V19, P2859, DOI 10.1210/me.2005-0133; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tseng WC, 2015, P NATL ACAD SCI USA, V112, P1214, DOI 10.1073/pnas.1417989112; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	40	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					691	704		10.1074/jbc.M115.648386	http://dx.doi.org/10.1074/jbc.M115.648386			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26574545	Green Published, hybrid			2022-12-28	WOS:000367830500018
J	Kryvalap, Y; Lo, CW; Manuylova, E; Baldzizhar, R; Jospe, N; Czyzyk, J				Kryvalap, Yury; Lo, Chi-Wen; Manuylova, Ekaterina; Baldzizhar, Raman; Jospe, Nicholas; Czyzyk, Jan			Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; beta cell (B-cell); pancreatic islet; serpin; Type 1 diabetes	ADULT MICE; APOPTOSIS; TURNOVER; MASS; INHIBITOR; EXOCRINE; PROTECTS; REGENERATION; PROGENITORS; NEOGENESIS	Type 1 diabetes mellitus (T1D) is characterized by a heightened antibody (Ab) response to pancreatic islet self-antigens, which is a biomarker of progressive islet pathology. We recently identified a novel antibody to clade B serpin that reduces islet-associated T cell accumulation and is linked to the delayed onset of T1D. As natural immunity to clade B arises early in life, we hypothesized that it may influence islet development during that time. To test this possibility healthy young Balb/c male mice were injected with serpin B13 mAb or IgG control and examined for the number and cellularity of pancreatic islets by immunofluorescence and FACS. Beta cell proliferation was assessed by measuring nucleotide analog 5-ethynyl-2-deoxyuridine (5-EdU) incorporation into the DNA and islet Reg gene expression was measured by real time PCR. Human studies involved measuring anti-serpin B13 autoantibodies by Luminex. We found that injecting anti-serpin B13 monoclonal Ab enhanced beta cell proliferation and Reg gene expression, induced the generation of approximate to 80 pancreatic islets per animal, and ultimately led to increase in the beta cell mass. These findings are relevant to human T1D because our analysis of subjects just diagnosed with T1D revealed an association between baseline anti-serpin activity and slower residual beta cell function decline in the first year after the onset of diabetes. Our findings reveal a new role for the anti-serpin immunological response in promoting adaptive changes in the endocrine pancreas and suggests that enhancement of this response could potentially help impede the progression of T1D in humans.	[Kryvalap, Yury; Lo, Chi-Wen; Baldzizhar, Raman; Czyzyk, Jan] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Manuylova, Ekaterina] Univ Rochester, Div Endocrinol Diabet & Metab, Rochester, NY 14642 USA; [Jospe, Nicholas] Univ Rochester, Div Pediat Endocrinol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Czyzyk, J (corresponding author), 601 Elmwood Ave, Rochester, NY 14642 USA.	jan_czyzyk@URMC.rochester.edu			Juvenile Diabetes Research Foundation [17-2013-428]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085499, U01DK061058, U01DK061010, U01DK107014, U01DK103266, U01DK085465, U01DK106984, U01DK103153, U01DK085476] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Juvenile Diabetes Research Foundation Grant 17-2013-428 (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abts HF, 1999, J MOL BIOL, V293, P29, DOI 10.1006/jmbi.1999.3159; Baldzizhar R, 2013, J BIOL CHEM, V288, P1612, DOI 10.1074/jbc.M112.409664; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Cacoub P, 2001, ARTHRITIS RHEUM, V44, P1836, DOI 10.1002/1529-0131(200108)44:8<1836::AID-ART321>3.0.CO;2-Y; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Czyzyk J, 2012, J IMMUNOL, V188, P6319, DOI 10.4049/jimmunol.1200467; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; HARTMANN K, 1989, EXP CLIN ENDOCRINOL, V93, P225, DOI 10.1055/s-0029-1210861; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; Jones LC, 2001, DIABETES, V50, pS186, DOI 10.2337/diabetes.50.2007.S186; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Millet I, 2006, J AUTOIMMUN, V26, P7, DOI 10.1016/j.jaut.2005.10.005; Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Phillips JM, 2007, DIABETES, V56, P634, DOI 10.2337/db06-0832; Pittenger GL, 2009, CURR PROTEIN PEPT SC, V10, P37, DOI 10.2174/138920309787315211; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Reichert M, 2013, NAT PROTOC, V8, P1354, DOI 10.1038/nprot.2013.079; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Weir GC, 2011, DIABETES, V60, P2018, DOI 10.2337/db10-1808; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072132; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	37	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					266	278		10.1074/jbc.M115.687848	http://dx.doi.org/10.1074/jbc.M115.687848			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578518	Green Published, hybrid			2022-12-28	WOS:000367589500021
J	Abu-Remaileh, M; Joy-Dodson, E; Schueler-Furman, O; Aqeilan, RI				Abu-Remaileh, Muhannad; Joy-Dodson, Emma; Schueler-Furman, Ora; Aqeilan, Rami I.			Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOMAIN-CONTAINING OXIDOREDUCTASE; FRAGILE SITE FRA16D; COPY NUMBER VARIATION; PROLINE-RICH LIGAND; GENE WWOX; CONTAINING PROTEINS; POTENTIAL ROLE; EXPRESSION; ASSOCIATION; EPILEPSY	WW domain-containing oxidoreductase (WWOX), originally marked as a likely tumor suppressor gene, has over the years become recognized for its role in a much wider range of cellular activities. Phenotypic effects displayed in animal studies, along with resolution of WWOX's architecture, fold, and binding partners, point to the protein's multifaceted biological functions. Results from a series of complementary experiments seem to indicate WWOX's involvement in metabolic regulation. More recently, clinical studies involving cases of severe encephalopathy suggest that WWOX also plays a part in controlling CNS development, further expanding our understanding of the breadth and complexity of WWOX behavior. Here we present a short overview of the various approaches taken to study this dynamic gene, emphasizing the most recent findings regarding WWOX's metabolic-and CNS-associated functions and their underlying molecular basis.	[Abu-Remaileh, Muhannad; Aqeilan, Rami I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Immunol & Canc Res, IL-91120 Jerusalem, Israel; [Joy-Dodson, Emma; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Aqeilan, RI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	ramiaq@mail.huji.ac.il	Aqeilan, Rami/R-4443-2016; Aqeilan, Rami/AAT-7785-2020; Schueler-Furman, Ora/AAC-5932-2020	Aqeilan, Rami/0000-0002-6034-023X; Schueler-Furman, Ora/0000-0002-1624-0362; Abu-Remaileh, Muhannad/0000-0003-4962-3826				Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Abdeen SK, 2013, J CELL PHYSIOL, V228, P1377, DOI 10.1002/jcp.24308; Abdel-Salam G, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-12; Abu-Odeh M, 2014, P NATL ACAD SCI USA, V111, pE4716, DOI 10.1073/pnas.1409252111; Abu-Odeh M, 2014, J BIOL CHEM, V289, P8865, DOI 10.1074/jbc.M113.506790; Abu-Remaileh M, 2014, CELL DEATH DIFFER, V21, P1805, DOI 10.1038/cdd.2014.95; Abu-Remaileh M, 2014, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014; Abu-Remaileh M, 2015, EXP BIOL MED, V240, P345, DOI 10.1177/1535370214561956; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2014, CELL MOL LIFE SCI, V71, P4589, DOI 10.1007/s00018-014-1724-y; Aqeilan RI, 2009, ENDOCRINOLOGY, V150, P1530, DOI 10.1210/en.2008-1087; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Bandmann O, 2010, NEUROBIOL DIS, V40, P58, DOI 10.1016/j.nbd.2010.05.017; Baugh L, 2015, TUBERCULOSIS, V95, P142, DOI 10.1016/j.tube.2014.12.003; Bednarek AK, 2000, CANCER RES, V60, P2140; Ben-Salem S, 2015, J MOL NEUROSCI, V56, P17, DOI 10.1007/s12031-014-0463-8; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen ST, 2004, NEUROSCIENCE, V124, P831, DOI 10.1016/j.neuroscience.2003.12.036; Choo A, 2015, GENE CHROMOSOME CANC, V54, P745, DOI 10.1002/gcc.22286; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dayan S, 2013, GENE CHROMOSOME CANC, V52, P823, DOI 10.1002/gcc.22078; Del Mare S, 2009, J CELL BIOCHEM, V108, P737, DOI 10.1002/jcb.22298; Dodson EJ, 2015, EXP BIOL MED, V240, P351, DOI 10.1177/1535370214566558; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Farooq A, 2015, EXP BIOL MED, V240, P361, DOI 10.1177/1535370214561586; Ferguson BW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-593; Gao G, 2014, CELL MOL LIFE SCI, V71, P4601, DOI 10.1007/s00018-014-1753-6; Gardenswartz A, 2014, EXP BIOL MED, V239, P253, DOI 10.1177/1535370213519213; Gribaa M, 2007, BRAIN, V130, P1921, DOI 10.1093/brain/awm078; Guler G, 2007, CLIN CANCER RES, V13, P6115, DOI 10.1158/1078-0432.CCR-07-1282; Hazan I, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1008288; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Krummel KA, 2002, GENE CHROMOSOME CANC, V34, P154, DOI 10.1002/gcc.10047; Le Tallec B, 2013, CELL REP, V4, P420, DOI 10.1016/j.celrep.2013.07.003; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; Ludes-Meyers JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007775; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mallaret M, 2014, BRAIN, V137, P411, DOI 10.1093/brain/awt338; McDonald CB, 2012, J MOL BIOL, V422, P58, DOI 10.1016/j.jmb.2012.05.015; Mignot C, 2015, J MED GENET, V52, P61, DOI 10.1136/jmedgenet-2014-102748; Nunez MI, 2006, J MOL HISTOL, V37, P115, DOI 10.1007/s10735-006-9046-5; O'Keefe LV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136356; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Richards RI, 2015, EXP BIOL MED, V240, P338, DOI 10.1177/1535370214565990; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Salah Z, 2010, FUTURE ONCOL, V6, P249, DOI [10.2217/fon.09.152, 10.2217/FON.09.152]; Schuchardt BJ, 2013, BIOCHEMISTRY-US, V52, P9223, DOI 10.1021/bi400987k; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Suzuki H, 2009, GENES BRAIN BEHAV, V8, P650, DOI 10.1111/j.1601-183X.2009.00502.x; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Tabarki B, 2015, AM J MED GENET A, V167, P3209, DOI 10.1002/ajmg.a.37363; Tabarki B, 2015, EXP BIOL MED, V240, P400, DOI 10.1177/1535370214561952; Tsuruwaka Y, 2015, PEERJ, V3, DOI 10.7717/peerj.727; Valduga M, 2015, J HUM GENET, V60, P267, DOI 10.1038/jhg.2015.17; Wang HY, 2012, CELL DEATH DIFFER, V19, P1049, DOI 10.1038/cdd.2011.188; Yang L, 2015, COPD, V12, P494, DOI 10.3109/15412555.2014.948993; Yang L, 2013, HUM MOL GENET, V22, P1886, DOI 10.1093/hmg/ddt019; Yu K, 2014, INT J CANCER, V135, P1687, DOI 10.1002/ijc.28815	78	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30728	30735		10.1074/jbc.R115.676346	http://dx.doi.org/10.1074/jbc.R115.676346			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26499798	hybrid, Green Published			2022-12-28	WOS:000367199000007
J	Kus, K; Rakus, K; Boutier, M; Tsigkri, T; Gabriel, L; Vanderplasschen, A; Athanasiadis, A				Kus, Krzysztof; Rakus, Krzysztof; Boutier, Maxime; Tsigkri, Theokliti; Gabriel, Luisa; Vanderplasschen, Alain; Athanasiadis, Alekos			The Structure of the Cyprinid herpesvirus 3 ORF112-Z alpha center dot Z-DNA Complex Reveals a Mechanism of Nucleic Acids Recognition Conserved with E3L, a Poxvirus Inhibitor of Interferon Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Z-DNA-BINDING; Z-ALPHA DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASE; STRESS GRANULES; VIRUS; GENOME; PKR; KOI; STABILIZATION	In vertebrate species, the innate immune system down-regulates protein translation in response to viral infection through the action of the double-stranded RNA (dsRNA)-activated protein kinase (PKR). In some teleost species another protein kinase, Z-DNA-dependent protein kinase (PKZ), plays a similar role but instead of dsRNA binding domains, PKZ has Z alpha domains. These domains recognize the left-handed conformer of dsDNA and dsRNA known as Z-DNA/Z-RNA. Cyprinid herpesvirus 3 infects common and koi carp, which have PKZ, and encodes the ORF112 protein that itself bears a Z alpha domain, a putative competitive inhibitor of PKZ. Here we present the crystal structure of ORF112-Z alpha in complex with an 18-bpCpGDNA repeat, at 1.5 angstrom. We demonstrate that the bound DNA is in the left-handed conformation and identify key interactions for the specificity of ORF112. Localization of ORF112 protein in stress granules induced in Cyprinid herpesvirus 3-infected fish cells suggests a functional behavior similar to that of Z alpha domains of the interferon-regulated, nucleic acid surveillance proteins ADAR1 and DAI.	[Kus, Krzysztof; Tsigkri, Theokliti; Gabriel, Luisa; Athanasiadis, Alekos] Inst Gulbenkian Ciencias, P-2781156 Oeiras, Portugal; [Rakus, Krzysztof; Boutier, Maxime; Vanderplasschen, Alain] Univ Liege, Fundamental & Appl Res Anim & Hlth, Dept Infect & Parasit Dis, Immunol Vaccinol Lab,Fac Vet Med, B-4000 Liege, Belgium	Instituto Gulbenkian de Ciencia; University of Liege	Athanasiadis, A (corresponding author), Inst Gulbenkian Ciencias, Prot Nucle Acids Interact Grp, P-2781156 Oeiras, Portugal.	alekos@igc.gulbenkian.pt	Athanasiadis, Alekos/F-2038-2011	Athanasiadis, Alekos/0000-0003-1526-0000; Kus, Krzysztof/0000-0003-4791-9658; Gabriel, Luisa/0000-0001-9153-219X; Boutier, Maxime/0000-0001-7388-233X	Fundacao para a Ciencia ea Tecnologia [PTDC/BIA-PRO/112962/2009, IF/00641/2013]; European Community [283570]	Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission)	This work was supported by Fundacao para a Ciencia ea Tecnologia Grants PTDC/BIA-PRO/112962/2009 and IF/00641/2013 (to A. A.) and SFRH/BD/51626/2011 (to K. K.). The research leading to these results received funding from European Community Seventh Framework Program Grant FP7/2007-2013 under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki T, 2007, J VIROL, V81, P5058, DOI 10.1128/JVI.00146-07; Athanasiadis A, 2012, SEMIN CELL DEV BIOL, V23, P275, DOI 10.1016/j.semcdb.2011.11.001; Ban C, 1996, BIOPHYS J, V71, P1215, DOI 10.1016/S0006-3495(96)79350-5; Bergan V, 2008, FEBS J, V275, P184, DOI 10.1111/j.1742-4658.2007.06188.x; BRENNAN RG, 1986, J BIOMOL STRUCT DYN, V3, P649, DOI 10.1080/07391102.1986.10508453; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Costes B, 2008, J VIROL, V82, P4955, DOI 10.1128/JVI.00211-08; Davison AJ, 2013, J VIROL, V87, P2908, DOI 10.1128/JVI.03206-12; de Rosa M, 2013, NUCLEIC ACIDS RES, V41, P9924, DOI 10.1093/nar/gkt743; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; DeLano W.L, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; Haig DM, 1998, IMMUNOLOGY, V93, P335, DOI 10.1046/j.1365-2567.1998.00438.x; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahmann JD, 2004, P NATL ACAD SCI USA, V101, P2712, DOI 10.1073/pnas.0308612100; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kim D, 2014, NUCLEIC ACIDS RES, V42, P5937, DOI 10.1093/nar/gku189; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le VH, 2013, ANAL BIOCHEM, V434, P233, DOI 10.1016/j.ab.2012.11.030; Michel B, 2010, J GEN VIROL, V91, P452, DOI 10.1099/vir.0.015198-0; Neukirch M, 1999, BULL EUR ASSN FISH P, V19, P221; Ng SK, 2013, NUCLEIC ACIDS RES, V41, P9786, DOI 10.1093/nar/gkt750; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Rakus K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-85; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Rothenburg S, 2005, P NATL ACAD SCI USA, V102, P1602, DOI 10.1073/pnas.0408714102; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Smith S, 2014, CYTOKINE GROWTH F R, V25, P745, DOI 10.1016/j.cytogfr.2014.07.019; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tome AR, 2013, J VIROL, V87, P3998, DOI 10.1128/JVI.03116-12; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; White SD, 2012, J VIROL, V86, P5895, DOI 10.1128/JVI.06889-11	43	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30713	30725		10.1074/jbc.M115.679407	http://dx.doi.org/10.1074/jbc.M115.679407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26559969	Green Published, hybrid			2022-12-28	WOS:000367199000005
J	Chauss, D; Brennan, LA; Bakina, O; Kantorow, M				Chauss, Daniel; Brennan, Lisa A.; Bakina, Olga; Kantorow, Marc			Integrin alpha V beta 5-mediated Removal of Apoptotic Cell Debris by the Eye Lens and Its Inhibition by UV Light Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; IN-VIVO EXPOSURE; EPITHELIAL-CELLS; ULTRAVIOLET-LIGHT; MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; NUCLEAR CATARACT; ALPHA-CRYSTALLIN; VISION LOSS; RAT LENS	Accumulation of apoptotic material is toxic and associated with cataract and other disease states. Identification of mechanisms that prevent accumulation of apoptotic debris is important for establishing the etiology of these diseases. The ocular lens is routinely assaulted by UV light that causes lens cell apoptosis and is associated with cataract formation. To date, no molecular mechanism for removal of toxic apoptotic debris has been identified in the lens. Vesicular debris within lens cells exposed to UV light has been observed raising speculation that lens cells themselves could act as phagocytes to remove toxic apoptotic debris. However, phagocytosis has not been confirmed as a function of the intact eye lens, and no mechanism for lens phagocytosis has been established. Here, we demonstrate that the eye lens is capable of phagocytizing extracellular lens cell debris. Using high throughput RNA sequencing and bioinformatics analysis, we establish that lens epithelial cells express members of the integrin alpha V beta 5-mediated phagocytosis pathway and that internalized cell debris co-localizes with alpha V beta 5 and with RAB7 and Rab-interacting lysosomal protein that are required for phagosome maturation and fusion with lysosomes. We demonstrate that the alpha V beta 5 receptor is required for lens epithelial cell phagocytosis and that UV light treatment of lens epithelial cells results in damage to the alpha V beta 5 receptor with concomitant loss of phagocytosis. These data suggest that loss of alpha V beta 5-mediated phagocytosis by the eye lens could result in accumulation of toxic cell debris that could contribute to UV light-induced cataract formation.	[Chauss, Daniel; Brennan, Lisa A.; Bakina, Olga; Kantorow, Marc] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Kantorow, M (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, 777 Glades Rd, Boca Raton, FL 33431 USA.	mkantoro@health.fau.edu		Chauss, Daniel/0000-0002-8343-0860	National Institutes of Health from NEI [EY13022]; NATIONAL EYE INSTITUTE [R01EY013022] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY13022 from NEI (to M. K.) and a gift from The Rand Eye Institute, Deerfield Beach, FL (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Alison G, 2006, Ophthalmol Clin North Am, V19, P415; Abraham AG, 2010, INVEST OPHTH VIS SCI, V51, P3919, DOI 10.1167/iovs.09-4557; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Balasubramanian D., 2000, J OCUL PHARMACOL TH, V16, P285; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Brennan LA, 2009, MOL VIS, V15, P985; Brennan LA, 2009, BBA-GEN SUBJECTS, V1790, P1665, DOI 10.1016/j.bbagen.2009.08.011; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; Brennan LA, 2012, MOL VIS, V18, P1773; Brennan Lisa Ann, 2012, Front Biosci (Elite Ed), V4, P141; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chandler HL, 2010, INVEST OPHTH VIS SCI, V51, P172, DOI 10.1167/iovs.09-3996; Chauss D, 2014, G3-GENES GENOM GENET, V4, P1515, DOI 10.1534/g3.114.012120; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Dawes LJ, 2007, MOL VIS, V13, P1181; Delamere NA, 2009, EXP EYE RES, V88, P140, DOI 10.1016/j.exer.2008.05.005; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813; Gagen D., 2003, INVEST OPHTH VIS SCI, V54, P5000; Galichanin K, 2010, EXP EYE RES, V91, P369, DOI 10.1016/j.exer.2010.06.009; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Giblin FJ, 2011, INVEST OPHTH VIS SCI, V52, P3667, DOI 10.1167/iovs.10-6885; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hawse JR, 2005, MOL VIS, V11, P274; HIGHTOWER KR, 1995, CURR EYE RES, V14, P71, DOI 10.3109/02713689508999916; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kronschlager M, 2013, CURR EYE RES, V38, P880, DOI 10.3109/02713683.2013.783079; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Lin H, 1998, INVEST OPHTH VIS SCI, V39, P1703; Liu K, 2015, P NATL ACAD SCI USA, V112, P1071, DOI 10.1073/pnas.1404059112; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Luzio JP, 2000, J CELL SCI, V113, P1515; Mamuya FA, 2014, J CELL MOL MED, V18, P656, DOI 10.1111/jcmm.12213; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; MENKO AS, 1984, DEV BIOL, V103, P129, DOI 10.1016/0012-1606(84)90014-9; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Meyer LM, 2014, ACTA OPHTHALMOL, V92, P635, DOI 10.1111/aos.12376; Meyer LM, 2009, EXP EYE RES, V89, P833, DOI 10.1016/j.exer.2009.07.020; Michael R, 1998, INVEST OPHTH VIS SCI, V39, P2681; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Petersen A, 2007, CURR EYE RES, V32, P871, DOI 10.1080/02713680701642327; Petrovski G, 2011, ACTA OPHTHALMOL, V89, pE30, DOI 10.1111/j.1755-3768.2010.02047.x; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Qingxian Lu, 2010, Front Biol (Beijing), V5, P227; RACZ P, 1988, OPHTHALMIC RES, V20, P10, DOI 10.1159/000266248; Reddy VN, 2004, EXP EYE RES, V79, P859, DOI 10.1016/j.exer.2004.04.005; REDDY VN, 1990, EXP EYE RES, V50, P771, DOI 10.1016/0014-4835(90)90127-G; Rogers CS, 2004, EXP EYE RES, V78, P1007, DOI 10.1016/j.exer.2003.12.011; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Sasaki H, 1998, INVEST OPHTH VIS SCI, V39, P544; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Shui YB, 2000, EXP EYE RES, V71, P609, DOI 10.1006/exer.2000.0917; Singh S, 2007, BIOCHEM BIOPH RES CO, V364, P540, DOI 10.1016/j.bbrc.2007.10.049; Talebizadeh N, 2014, ACTA OPHTHALMOL, V92, P769, DOI 10.1111/aos.12407; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; TRUSCOTT RJW, 1977, BIOCHIM BIOPHYS ACTA, V492, P43, DOI 10.1016/0005-2795(77)90212-4; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wignes JA, 2013, EXP EYE RES, V115, P263, DOI 10.1016/j.exer.2013.06.026; Wong TY, 2014, BRIT J OPHTHALMOL, V98, P599, DOI 10.1136/bjophthalmol-2013-304047; Wu H., 2011, FREE RADIC BIOL MED, V51, P2108; Wu HL, 2014, J BIOL CHEM, V289, P36125, DOI 10.1074/jbc.M114.620047; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xing KY, 2002, EXP EYE RES, V74, P113, DOI 10.1006/exer.2001.1103; Yam JCS, 2014, INT OPHTHALMOL, V34, P383, DOI 10.1007/s10792-013-9791-x; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zigman S., 1995, OPTOMETRY VISION SCI, V72, P899	92	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30253	30266		10.1074/jbc.M115.688390	http://dx.doi.org/10.1074/jbc.M115.688390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26527683	Green Published, hybrid			2022-12-28	WOS:000366738200005
J	Dong, L; Zou, HC; Yuan, C; Hong, YH; Kuklev, DV; Smith, WL				Dong, Liang; Zou, Hechang; Yuan, Chong; Hong, Yu H.; Kuklev, Dmitry V.; Smith, William L.			Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cyclooxygenase (COX); eicosanoid; fatty acid; prostaglandin; docosahexaenoic acid; eicosapentaenoic acid; half-sites; -3 fatty acid; palmitic acid	PROSTAGLANDIN-H SYNTHASE; ENDOCANNABINOID OXYGENATION; CROSS-TALK; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; SEQUENCE HOMODIMER; PATHWAYS; PEROXIDASE; MONOMERS; COX-2	Prostaglandin endoperoxide H synthases (PGHSs), also called cyclooxygenases (COXs), convert arachidonic acid (AA) to PGH(2). PGHS-1 and PGHS-2 are conformational heterodimers, each composed of an (E-allo) and a catalytic (E-cat) monomer. Previous studies suggested that the binding to E-allo of saturated or monounsaturated fatty acids (FAs) that are not COX substrates differentially regulate PGHS-1 versus PGHS-2. Here, we substantiate and expand this concept to include polyunsaturated FAs known to modulate COX activities. Non-substrate FAs like palmitic acid bind E-allo of PGHSs stimulating human (hu) PGHS-2 but inhibiting huPGHS-1. We find the maximal effects of non-substrate FAs on both huPGHSs occurring at the same physiologically relevant FA/AA ratio of approximate to 20. This inverse allosteric regulation likely underlies the ability of PGHS-2 to operate at low AA concentrations, when PGHS-1 is effectively latent. Unlike FAs tested previously, we observe that C-22 FAs, including -3 fish oil FAs, have higher affinities for E-cat than E-allo subunits of PGHSs. Curiously, C-20 -3 eicosapentaenoate preferentially binds E-cat of huPGHS-1 but E-allo of huPGHS-2. PGE(2) production decreases 50% when fish oil consumption produces tissue EPA/AA ratios of 0.2. However, 50% inhibition of huPGHS-1 itself is only seen with -3 FA/AA ratios of 5.0. This suggests that fish oil-enriched diets disfavor AA oxygenation by altering the composition of the FA pool in which PGHS-1 functions. The distinctive binding specificities of PGHS subunits permit different combinations of non-esterified FAs, which can be manipulated dietarily, to regulate AA binding to E-allo and/or E-cat thereby controlling COX activities.	[Dong, Liang; Zou, Hechang; Yuan, Chong; Hong, Yu H.; Kuklev, Dmitry V.; Smith, William L.] Univ Michigan, Dept Biol Chem, 5301 MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Zou, He/GXH-0280-2022		National Institutes of Health [GM68848, CA130810, HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM68848, CA130810, and HL117798. W. L. S. serves a consultant for Cayman Chemical Co., products from which were used in this study. The other authors have no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; HABIB A, 1993, J BIOL CHEM, V268, P23448; Jiang Y, 2014, CANCER PREV RES, V7, P1011, DOI 10.1158/1940-6207.CAPR-14-0134; Jump DB, 2012, J LIPID RES, V53, P2525, DOI 10.1194/jlr.R027904; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kingma PB, 1998, BIOCHEMISTRY-US, V37, P3250, DOI 10.1021/bi972520l; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; Kuklev DV, 2013, J LIPID RES, V54, P1906, DOI 10.1194/jlr.M037192; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Lapicque F, 2000, CLIN PHARMACOKINET, V39, P369, DOI 10.2165/00003088-200039050-00005; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Liu W, 2006, FASEB J, V20, P1097, DOI 10.1096/fj.05-5273com; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; McIntosh AL, 2010, J BIOL CHEM, V285, P18693, DOI 10.1074/jbc.M109.079897; Muth-Selbach US, 1999, ANESTHESIOLOGY, V91, P231, DOI 10.1097/00000542-199907000-00032; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; OTTO JC, 1993, J BIOL CHEM, V268, P18234; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Surette ME, 1998, BIOCHEM J, V330, P915; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wada M, 2009, J BIOL CHEM, V284, P30742, DOI 10.1074/jbc.M109.052415; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	49	49	50	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4069	4078		10.1074/jbc.M115.698001	http://dx.doi.org/10.1074/jbc.M115.698001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703471	Green Published, hybrid			2022-12-28	WOS:000371338400032
J	Richter, JP; Goroncy, AK; Ronimus, RS; Sutherland-Smith, AJ				Richter, Jan P.; Goroncy, Alexander K.; Ronimus, Ron S.; Sutherland-Smith, Andrew J.			The Structural and Functional Characterization of Mammalian ADP-dependent Glucokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP; AMP; enzyme structure; glucokinase; glucose metabolism; x-ray crystallography; ADP-dependent glucokinase; NMR spectroscopy; glucose-6-phosphate; ribokinase	PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; HYPERTHERMOPHILIC ARCHAEON; CONFORMATIONAL-CHANGE; MOLECULAR-GRAPHICS; SUGAR KINASES; RESOLUTION; PROTEINS; HORIKOSHII	The enzyme-catalyzed phosphorylation of glucose to glucose-6-phosphate is a reaction central to the metabolism of all life. ADP-dependent glucokinase (ADPGK) catalyzes glucose-6-phosphate production, utilizing ADP as a phosphoryl donor in contrast to the more well characterized ATP-requiring hexokinases. ADPGK is found in Archaea and metazoa; in Archaea, ADPGK participates in a glycolytic role, but a function in most eukaryotic cell types remains unknown. We have determined structures of the eukaryotic ADPGK revealing a ribokinase-like tertiary fold similar to archaeal orthologues but with significant differences in some secondary structural elements. Both the unliganded and the AMP-bound ADPGK structures are in the open conformation. The structures reveal the presence of a disulfide bond between conserved cysteines that is positioned at the nucleotide-binding loop of eukaryotic ADPGK. The AMP-bound ADPGK structure defines the nucleotide-binding site with one of the disulfide bond cysteines coordinating the AMP with its main chain atoms, a nucleotide-binding motif that appears unique to eukaryotic ADPGKs. Key amino acids at the active site are structurally conserved between mammalian and archaeal ADPGK, and site-directed mutagenesis has confirmed residues essential for enzymatic activity. ADPGK is substrate inhibited by high glucose concentration and shows high specificity for glucose, with no activity for other sugars, as determined by NMR spectroscopy, including 2-deoxyglucose, the glucose analogue used for tumor detection by positron emission tomography.	[Richter, Jan P.; Goroncy, Alexander K.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Fundamental Sci, Palmerston North 4410, New Zealand; [Ronimus, Ron S.] AgResearch Ltd, Palmerston North 4442, New Zealand	Massey University; AgResearch - New Zealand	Ronimus, RS (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Anim Nutr & Hlth, Tennent Dr,Private Bag 11008, Palmerston North 4442, New Zealand.; Sutherland-Smith, AJ (corresponding author), Massey Univ, Inst Fundamental Sci, Tennent Dr, Palmerston North 4442, New Zealand.	ron.ronimus@agresearch.co.nz; A.J.Sutherland-Smith@massey.ac.nz	Sutherland-Smith, Andrew/F-1813-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428; Goroncy, Alexander/0000-0002-9192-174X; Ronimus, Ron/0000-0001-8669-5840	Royal Society of New Zealand Marsden Fund; New Zealand Synchrotron Group; Massey University	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Synchrotron Group; Massey University	This work was supported by the Royal Society of New Zealand Marsden Fund, New Zealand Synchrotron Group, and Massey University. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labes A, 2003, ARCH MICROBIOL, V180, P69, DOI 10.1007/s00203-003-0563-2; Li J, 2012, J STRUCT BIOL, V177, P578, DOI 10.1016/j.jsb.2011.12.010; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Merino F, 2011, GENE DUPLICATION, P237; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oriuchi N, 2006, CANCER SCI, V97, P1291, DOI 10.1111/j.1349-7006.2006.00341.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065267; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Verhees CH, 2002, BIOCHEM J, V366, P121, DOI 10.1042/BJ20011597; Zhu L, 2013, SCIENCE, V342, P429, DOI 10.1126/science.1245011	37	17	17	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3694	3704		10.1074/jbc.M115.679902	http://dx.doi.org/10.1074/jbc.M115.679902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26555263	Green Published, hybrid			2022-12-28	WOS:000371338400002
J	Yang, LH; Gao, ZX; Hu, LP; Wu, GR; Yang, XW; Zhang, LH; Zhu, Y; Wong, BS; Xin, W; Sy, MS; Li, CY				Yang, Liheng; Gao, Zhenxing; Hu, Lipeng; Wu, Guiru; Yang, Xiaowen; Zhang, Lihua; Zhu, Ying; Wong, Boon-Seng; Xin, Wei; Sy, Man-Sun; Li, Chaoyang			Glycosylphosphatidylinositol Anchor Modification Machinery Deficiency Is Responsible for the Formation of Pro-Prion Protein (PrP) in BxPC-3 Protein and Increases Cancer Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell surface; glycosylphosphatidylinositol (GPI anchor); pancreatic cancer; prion; GPI anchor synthesis; cancer cell motility; pancreatic ductal adenocarcinoma cell; prion protein	MENTAL-RETARDATION SYNDROME; GPI-ANCHOR; GASTRIC-CANCER; INTELLECTUAL DISABILITY; CAUSE HYPERPHOSPHATASIA; PANCREATIC-CANCER; SYNTHESIS PATHWAY; PIGV MUTATIONS; POOR-PROGNOSIS; BREAST-CANCER	The normal cellular prion protein (PrP) is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein. However, in pancreatic ductal adenocarcinoma cell lines, such as BxPC-3, PrP exists as a pro-PrP retaining its glycosylphosphatidylinositol (GPI) peptide signaling sequence. Here, we report the identification of another pancreatic ductal adenocarcinoma cell line, AsPC-1, which expresses a mature GPI-anchored PrP. Comparison of the 24 genes involved in the GPI anchor modification pathway between AsPC-1 and BxPC-3 revealed 15 of the 24 genes, including PGAP1 and PIG-F, were down-regulated in the latter cells. We also identified six missense mutations in DPM2, PIG-C, PIG-N, and PIG-P alongside eight silent mutations. When BxPC-3 cells were fused with Chinese hamster ovary (CHO) cells, which lack endogenous PrP, pro-PrP was successfully converted into mature GPI-anchored PrP. Expression of the individual gene, such as PGAP1, PIG-F, or PIG-C, into BxPC-3 cells does not result in phosphoinositide-specific phospholipase C sensitivity of PrP. However, when PIG-F but not PIG-P is expressed in PGAP1-expressing BxPC-3 cells, PrP on the surface of the cells becomes phosphoinositide-specific phospholipase C-sensitive. Thus, low expression of PIG-F and PGAP1 is the major factor contributing to the accumulation of pro-PrP. More importantly, BxPC-3 cells expressing GPI-anchored PrP migrate much slower than BxPC-3 cells bearing pro-PrP. In addition, GPI-anchored PrP-bearing AsPC-1 cells also migrate slower than pro-PrP bearing BxPC-3 cells, although both cells express filamin A. Knocking out PRNP in BxPC-3 cell drastically reduces its migration. Collectively, these results show that multiple gene irregularity in BxPC-3 cells is responsible for the formation of pro-PrP, and binding of pro-PrP to filamin A contributes to enhanced tumor cell motility.	[Yang, Liheng; Gao, Zhenxing; Hu, Lipeng; Wu, Guiru] Chinese Acad Sci, Univ Chinese Acad Sci, Wuhan Inst Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Peoples R China; [Yang, Xiaowen] Jiangxi Tumor Hosp, Dept Abdominal Surg 1, Nanchang 330029, Peoples R China; [Zhang, Lihua] Southeast Univ, Zhongda Hosp, Dept Pathol, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Ying] Wuhan Univ, State Key Lab Virol, Sch Life Sci, Dept Virol, Wuhan, Peoples R China; [Wong, Boon-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Xin, Wei; Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44102 USA; [Li, Chaoyang] Chinese Acad Sci, Hubei Collaborat Innovat Ctr Ind Fermentat, Wuhan Inst Virol, State Key Lab Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan Institute of Virology, CAS; Southeast University - China; Wuhan University; National University of Singapore; Case Western Reserve University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Li, CY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Xiao Hong Shan 44, Wuhan 430071, Hubei, Peoples R China.	cyli@wh.iov.cn	Gao, Zhenxing/AAL-8244-2020; Wong, Boon-Seng/G-2759-2012	Wong, Boon-Seng/0000-0002-7118-8077	Chinese National Science Foundation [81172376, 31270209]; Nature Science Foundation of Hubei Province [2015CFA087]; Chinese Academy of Sciences 100-Talents Program; State Key Laboratory of Virology of China [2015IOV005]; WIV "One-Three-Five" Strategic Programs	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Chinese Academy of Sciences 100-Talents Program(Chinese Academy of Sciences); State Key Laboratory of Virology of China; WIV "One-Three-Five" Strategic Programs	This work was supported by Chinese National Science Foundation Grants 81172376 and 31270209, Nature Science Foundation of Hubei Province Grant 2015CFA087, Chinese Academy of Sciences 100-Talents Program, State Key Laboratory of Virology of China Grant 2015IOV005, and WIV "One-Three-Five" Strategic Programs. The authors declare that they have no conflicts of interest with the contents of this article.	Antonacopoulou AG, 2008, ANTICANCER RES, V28, P1221; Belet S, 2014, HUM MUTAT, V35, P350, DOI 10.1002/humu.22498; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Ho JC, 2006, INT J CANCER, V119, P1330, DOI 10.1002/ijc.22005; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Hu R, 2009, EXP HEMATOL, V37, P423, DOI 10.1016/j.exphem.2009.01.003; Jiang WW, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-74; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Liang J, 2009, FEBS J, V276, P685, DOI 10.1111/j.1742-4658.2008.06816.x; Maeda Y, 2006, METHOD ENZYMOL, V416, P182, DOI 10.1016/S0076-6879(06)16012-7; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Meslin F, 2007, ANN ONCOL, V18, P1793, DOI 10.1093/annonc/mdm406; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Moss J, 1999, MOL CELL BIOCHEM, V193, P109, DOI 10.1023/A:1006924514074; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Nagpal JK, 2008, MODERN PATHOL, V21, P979, DOI 10.1038/modpathol.2008.76; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Stossel TP, 2003, DEV CELL, V4, P444, DOI 10.1016/S1534-5807(03)00098-4; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Yang Liheng, 2014, Virologica Sinica, V29, P228, DOI 10.1007/s12250-014-3480-4; Yang XW, 2014, ACTA BIOCH BIOPH SIN, V46, P431, DOI 10.1093/abbs/gmu019; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhou L, 2014, INT J CANCER, V135, P2329, DOI 10.1002/ijc.28883	50	12	12	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3905	3917		10.1074/jbc.M115.705830	http://dx.doi.org/10.1074/jbc.M115.705830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26683373	Green Published, hybrid			2022-12-28	WOS:000371338400019
J	Zachos, NC; Kovbasnjuk, O; Foulke-Abel, J; In, J; Blutt, SE; de Jonge, HR; Estes, MK; Donowitz, M				Zachos, Nicholas C.; Kovbasnjuk, Olga; Foulke-Abel, Jennifer; In, Julie; Blutt, Sarah E.; de Jonge, Hugo R.; Estes, Mary K.; Donowitz, Mark			Human Enteroids/Colonoids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						differentiation; induced pluripotent stem cell (iPS cell) (iPSC); intestinal epithelium; stem cells; transport; enteroid; lgr5; organoid	STEM-CELLS; IN-VIVO; CLOSTRIDIUM-DIFFICILE; CYSTIC-FIBROSIS; HUMAN ENTEROIDS; CFTR; TISSUE; MODEL; VITRO; CULTURE	Identification of Lgr5 as the intestinal stem cell marker as well as the growth factors necessary to replicate adult intestinal stem cell division has led to the establishment of the methods to generate indefinite ex vivo primary intestinal epithelial cultures, termed mini-intestines. Primary cultures developed from isolated intestinal crypts or stem cells (termed enteroids/colonoids) and from inducible pluripotent stem cells (termed intestinal organoids) are being applied to study human intestinal physiology and pathophysiology with great expectations for translational applications, including regenerative medicine. Here we discuss the physiologic properties of these cultures, their current use in understanding diarrhea-causing host-pathogen interactions, and potential future applications.	[Zachos, Nicholas C.; Kovbasnjuk, Olga; Foulke-Abel, Jennifer; In, Julie; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA; [Blutt, Sarah E.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [de Jonge, Hugo R.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine; Erasmus University Rotterdam; Erasmus MC	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.; Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022		National Institutes of Health [U18-TR000552, T32-DK007632, R01-DK026523, R01-DK061765, P01-DK072084, R01-AI080656, P30-DK056338, P30-DK089502]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788, R01AI080656, U19AI116497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, P01DK072084, P30DK089502, R24DK099803, R01DK061765, T32DK007632, R01DK026523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants U18-TR000552, T32-DK007632, R01-DK026523, R01-DK061765, P01-DK072084, R01-AI080656, and P30-DK056338 (to M. K. E.) and P30-DK089502 (to M. D). This is the first article in the Thematic Minireview series "Modern Technologies for In-cell Biochemistry." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Bouchi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5242; Brugmann SA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt362; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Dolnikov K, 2005, ANN NY ACAD SCI, V1047, P66, DOI 10.1196/annals.1341.006; El-Nachef W, 2014, EUR J PEDIATR SURG, V24, P214, DOI 10.1055/s-0034-1376311; Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG510, DOI 10.1152/ajpgi.00091.2014; Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG497, DOI 10.1152/ajpgi.00090.2014; EVANS GS, 1992, J CELL SCI, V101, P219; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Foulke-Abel J., 2014, GASTROENTEROLOGY, V146, pA190; Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398; Ikpa PT, 2014, INT J BIOCHEM CELL B, V52, P192, DOI 10.1016/j.biocel.2014.02.008; In J, 2014, GASTROENTEROLOGY, V146, pS286; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kovbasnjuk O, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt364; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14; Leushacke M, 2014, GUT, V63, P1345, DOI 10.1136/gutjnl-2014-307204; Levin DE, 2013, J PEDIATR SURG, V48, P129, DOI 10.1016/j.jpedsurg.2012.10.029; Liu JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1492, DOI 10.1152/ajpcell.00392.2011; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Miyoshi H, 2013, CELL STEM CELL, V13, P637, DOI 10.1016/j.stem.2013.11.019; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Musch MW, 2009, AM J PHYSIOL-GASTR L, V296, pG202, DOI 10.1152/ajpgi.90350.2008; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Schwank G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076871; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Spurrier RG, 2013, CLIN GASTROENTEROL H, V11, P354, DOI 10.1016/j.cgh.2013.01.028; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wiegerinck CL, 2014, GASTROENTEROLOGY, V147, P65, DOI 10.1053/j.gastro.2014.04.002; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zachos NC, 2014, GASTROENTEROLOGY, V146, pS696	61	164	175	8	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3759	3766		10.1074/jbc.R114.635995	http://dx.doi.org/10.1074/jbc.R114.635995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26677228	hybrid, Green Published			2022-12-28	WOS:000371338400007
J	Greene, AS; Hajduk, SL				Greene, Amy Styer; Hajduk, Stephen L.			Trypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HAPTOGLOBIN-HEMOGLOBIN RECEPTOR; PROGRAMMED CELL-DEATH; MEMBRANE PERMEABILIZATION; TRYPANOCIDAL ACTIVITY; ANTIOXIDANT CAPACITY; PHOSPHATASE-ACTIVITY; GLUTATHIONE CONTENT; 3 AQUAGLYCEROPORINS; APOLIPOPROTEIN L-1	Human innate immunity against the veterinary pathogen Trypanosoma brucei brucei is conferred by trypanosome lytic factors (TLFs), against which human-infective T. brucei gambiense and T. brucei rhodesiense have evolved resistance. TLF-1 is a subclass of high density lipoprotein particles defined by two primate-specific apolipoproteins: the ion channel-forming toxin ApoL1 (apolipoprotein L1) and the hemoglobin (Hb) scavenger Hpr (haptoglobin-related protein). The role of oxidative stress in the TLF-1 lytic mechanism has been controversial. Here we show that oxidative processes are involved in TLF-1 killing of T. brucei brucei. The lipophilic antioxidant N,N'-di-phenyl-p-phenylenediamine protected TLF-1-treated T. brucei brucei from lysis. Conversely, lysis of TLF-1-treated T. brucei brucei was increased by the addition of peroxides or thiol-conjugating agents. Previously, the Hpr-Hb complex was postulated to be a source of free radicals during TLF-1 lysis. However, we found that the iron-containing heme of the Hpr-Hb complex was not involved in TLF-1 lysis. Furthermore, neither high concentrations of transferrin nor knock-out of cytosolic lipid peroxidases prevented TLF-1 lysis. Instead, purified ApoL1 was sufficient to induce lysis, and ApoL1 lysis was inhibited by the antioxidant DPPD. Swelling of TLF-1-treated T. brucei brucei was reminiscent of swelling under hypotonic stress. Moreover, TLF-1-treated T. brucei brucei became rapidly susceptible to hypotonic lysis. T. brucei brucei cells exposed to peroxides or thiol-binding agents were also sensitized to hypotonic lysis in the absence of TLF-1. We postulate that ApoL1 initiates osmotic stress at the plasma membrane, which sensitizes T. brucei brucei to oxidation-stimulated osmotic lysis.	[Greene, Amy Styer; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hajduk, SL (corresponding author), Dept Biochem & Mol Biol, 120A Life Sci Bldg, Athens, GA 30602 USA.	shajduk@bmb.uga.edu			National Institutes of Health [AI039033]; National Science Foundation Graduate Research Fellowship [2011095799]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039033, R21AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part by National Institutes of Health Grant AI039033 (to S. L. H.) and National Science Foundation Graduate Research Fellowship Grant 2011095799 (to A. L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Ascoli F, 1981, Methods Enzymol, V76, P72; Bassarak B, 2011, CELL PHYSIOL BIOCHEM, V27, P411, DOI 10.1159/000327968; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; Bursell JDH, 1996, J MEMBRANE BIOL, V154, P131, DOI 10.1007/s002329900138; Cosentino-Gomes D, 2009, FREE RADICAL BIO MED, V47, P152, DOI 10.1016/j.freeradbiomed.2009.04.020; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; DefriseQuertain F, 1996, BIOCHEM J, V314, P595, DOI 10.1042/bj3140595; DeJesus E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003317; DHONDT J, 1979, NATURE, V282, P613, DOI 10.1038/282613a0; Diaz-Elizondo J, 2006, BIOCHEM BIOPH RES CO, V350, P1076, DOI 10.1016/j.bbrc.2006.10.004; Diechtierow M, 2011, FREE RADICAL BIO MED, V51, P856, DOI 10.1016/j.freeradbiomed.2011.05.014; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; Eintracht J, 1998, BIOCHEM J, V336, P659, DOI 10.1042/bj3360659; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HAJDUK SL, 1992, PARASITOL TODAY, V8, P95, DOI 10.1016/0169-4758(92)90247-Y; Hansen DB, 2012, J MEMBRANE BIOL, V245, P77, DOI 10.1007/s00232-012-9416-8; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Higgins MK, 2013, P NATL ACAD SCI USA, V110, P1905, DOI 10.1073/pnas.1214943110; Hiller C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004075; Irigoin F, 2009, BIOCHEM J, V418, P595, DOI 10.1042/BJ20081981; Jimenez V, 2008, J CELL BIOCHEM, V105, P688, DOI 10.1002/jcb.21864; Keij JF, 1999, CYTOMETRY, V35, P48, DOI 10.1002/(SICI)1097-0320(19990101)35:1<48::AID-CYTO7>3.0.CO;2-5; Lambert IH, 2009, AM J PHYSIOL-CELL PH, V297, pC198, DOI 10.1152/ajpcell.00613.2008; Lambert IH, 2003, J MEMBRANE BIOL, V192, P19, DOI 10.1007/s00232-002-1061-1; LUSTBADER JW, 1983, J BIOL CHEM, V258, P1227; Lutje V, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006201.pub2; MESHNICK SR, 1978, J EXP MED, V148, P569, DOI 10.1084/jem.148.2.569; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Niki E, 2000, IUBMB LIFE, V50, P323, DOI 10.1080/15216540051081119; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; PENKETH PG, 1986, MOL BIOCHEM PARASIT, V20, P111, DOI 10.1016/0166-6851(86)90023-X; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Portela MPM, 2000, MOL BIOCHEM PARASIT, V110, P273, DOI 10.1016/S0166-6851(00)00277-2; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Ren Z, 2008, CARDIOVASC RES, V77, P73, DOI 10.1093/cvr/cvm031; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; Roggy JL, 1999, MOL BIOCHEM PARASIT, V98, P1, DOI 10.1016/S0166-6851(98)00114-5; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rojas-Rivera D, 2009, FEBS LETT, V583, P3485, DOI 10.1016/j.febslet.2009.10.003; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Steverding D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-78; Tamma G, 2014, J BIOL CHEM, V289, P27807, DOI 10.1074/jbc.M114.586024; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2007, J EUKARYOT MICROBIOL, V54, P448, DOI 10.1111/j.1550-7408.2007.00285.x; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; WAKS M, 1974, BIOCHEMISTRY-US, V13, P15, DOI 10.1021/bi00698a003; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Wright VP, 2009, J PHYSIOL-LONDON, V587, P5767, DOI 10.1113/jphysiol.2009.178285; Zhu LY, 2013, MOL NEUROBIOL, V48, P205, DOI 10.1007/s12035-013-8431-9	63	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3063	3075		10.1074/jbc.M115.680371	http://dx.doi.org/10.1074/jbc.M115.680371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26645690	hybrid, Green Published			2022-12-28	WOS:000369626900042
J	Davila, D; Fernandez, S; Torres-Aleman, I				Davila, David; Fernandez, Silvia; Torres-Aleman, Ignacio			Astrocyte Resilience to Oxidative Stress Induced by Insulin-like Growth Factor I (IGF-I) Involves Preserved AKT (Protein Kinase B) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR PTEN; CELL FACTOR SCF; ISCHEMIC-STROKE; REACTIVE OXYGEN; NEURONAL DEATH; TENSIN HOMOLOG; HEART-FAILURE; LIFE-SPAN; KAPPA-B	Disruption of insulin-like growth factor I (IGF-I) signaling is a key step in the development of cancer or neurodegeneration. For example, interference of the prosurvival IGF-I/AKT/FOXO3 pathway by redox activation of the stress kinases p38 and JNK is instrumental in neuronal death by oxidative stress. However, in astrocytes, IGF-I retains its protective action against oxidative stress. The molecular mechanisms underlying this cell-specific protection remain obscure but may be relevant to unveil new ways to combat IGF-I/insulin resistance. Here, we describe that, in astrocytes exposed to oxidative stress by hydrogen peroxide (H2O2), p38 activation did not inhibit AKT (protein kinase B) activation by IGF-I, which is in contrast to our previous observations in neurons. Rather, stimulation of AKT by IGF-I was significantly higher and more sustained in astrocytes than in neurons either under normal or oxidative conditions. This may be explained by phosphorylation of the phosphatase PTEN at the plasma membrane in response to IGF-I, inducing its cytosolic translocation and preserving in this way AKT activity. Stimulation of AKT by IGF-I, mimicked also by a constitutively active AKT mutant, reduced oxidative stress levels and cell death in H2O2-exposed astrocytes, boosting their neuroprotective action in co-cultured neurons. These results indicate that armoring of AKT activation by IGF-I is crucial to preserve its cytoprotective effect in astrocytes and may form part of the brain defense mechanism against oxidative stress injury.	CSIC, Inst Cajal, Dept Syst Neurosci, E-28002 Madrid, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28002, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED	Davila, D (corresponding author), Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, Calle Jose Antonio Novais 2, E-28040 Madrid, Spain.	daviddav@ucm.es	Fernandez, Silvia/Z-4848-2019; Torres Aleman, Ignacio/A-1613-2008	Torres Aleman, Ignacio/0000-0001-8107-7947	Spanish Ministry of Education and Science [SAF2001-1722, 2004-0446]; Centro de Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED)	Spanish Ministry of Education and Science(Spanish Government); Centro de Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED)	This work was supported by Grants SAF2001-1722 and 2004-0446 from Spanish Ministry of Education and Science (to I. T.-A.) and a contract from Centro de Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED) (to D. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Aleman IT, 2005, ADV EXP MED BIOL, V567, P243; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Braeckman BP, 2001, MECH AGEING DEV, V122, P673, DOI 10.1016/S0047-6374(01)00222-6; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cho JY, 2002, NEUROSCI LETT, V334, P131, DOI 10.1016/S0304-3940(02)01122-9; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Da Silva CA, 2003, FASEB J, V17, P2334, DOI 10.1096/fj.03-0136fje; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Diamond-Stanic MK, 2011, BIOCHEM BIOPH RES CO, V405, P439, DOI 10.1016/j.bbrc.2011.01.049; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Essafi Abdelkader, 2009, V462, P201, DOI 10.1007/978-1-60327-115-8_13; Fernandez S, 2008, BBA-MOL CELL RES, V1783, P803, DOI 10.1016/j.bbamcr.2007.10.020; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fragoso R, 2015, METHODS, V77-78, P75, DOI 10.1016/j.ymeth.2014.10.015; Franco C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-51; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Genis Laura, 2014, F1000Res, V3, P28, DOI 10.12688/f1000research.3-28.v2; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Grinberg YY, 2013, J NEUROCHEM, V126, P662, DOI 10.1111/jnc.12267; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Hemi R, 2011, DIABETES, V60, P1134, DOI 10.2337/db09-1323; Hernandez R, 2004, DIABETOLOGIA, V47, P1615, DOI 10.1007/s00125-004-1503-7; Hinkal G, 2008, MECH AGEING DEV, V129, P243, DOI 10.1016/j.mad.2008.02.005; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Kumphune S, 2013, CURR PHARM DESIGN, V19, P5742, DOI 10.2174/1381612811319320009; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li W, 2014, NEUROSCIENCE, V274, P153, DOI 10.1016/j.neuroscience.2014.05.027; Linseman DA, 2002, J NEUROSCI, V22, P9287; LIU X, 1994, MOL CELL NEUROSCI, V5, P418, DOI 10.1006/mcne.1994.1052; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Oudit GY, 2008, CARDIOVASC RES, V78, P505, DOI 10.1093/cvr/cvn041; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Park SB, 2013, EUR J PHARMACOL, V721, P70, DOI 10.1016/j.ejphar.2013.09.052; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qi YJ, 2013, DIABETES, V62, P3887, DOI 10.2337/db13-0095; Ribeiro M, 2014, FREE RADICAL BIO MED, V74, P129, DOI 10.1016/j.freeradbiomed.2014.06.023; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shin JH, 2011, NEUROSCI LETT, V501, P132, DOI 10.1016/j.neulet.2011.06.061; Sperow M, 2012, J PHYSIOL-LONDON, V590, P777, DOI 10.1113/jphysiol.2011.220236; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Torres-Aleman I, 2007, EXPERT OPIN THER TAR, V11, P1535, DOI 10.1517/14728222.11.12.1535; Vargas MR, 2004, IN VIVO, V18, P269; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zhong J, 2007, NEUROCHEM INT, V51, P398, DOI 10.1016/j.neuint.2007.04.005; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	70	15	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2510	2523		10.1074/jbc.M115.695478	http://dx.doi.org/10.1074/jbc.M115.695478			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26631726	Green Published, hybrid			2022-12-28	WOS:000369610400038
J	Sharma, NR; Wang, XH; Majerciak, V; Ajiro, M; Kruhlak, M; Meyers, C; Zheng, ZM				Sharma, Nishi R.; Wang, Xiaohong; Majerciak, Vladimir; Ajiro, Masahiko; Kruhlak, Michael; Meyers, Craig; Zheng, Zhi-Ming			Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGONAUTE PROTEINS; HERPESVIRUS ORF57; GENE-EXPRESSION; RNA; LOCALIZATION; STRESS; ONCOPROTEIN; MICRORNAS; CLEAVAGE	Argonaute-2 protein (Ago2), a major component of RNA-induced silencing complex (RISC), has been viewed as a cytoplasmic protein. In this study, we demonstrated by immunofluorescence confocal microscopy that Ago2 is distributed mainly as a nuclear protein in primary human foreskin keratinocytes in monolayer cultures and their derived organotypic (raft) cultures, although it exhibits only a minimal level of nuclear distribution in continuous cell lines such as HeLa and HaCaT cells. Oncogenic human papillomavirus type 16 (HPV16) or type 18 (HPV18) infection of the keratinocytes does not affect the nuclear Ago2 distribution. Examination of human tissues reveals that Ago2 exhibits primarily as a nuclear protein in skin, normal cervix, and cervical cancer tissues, but not in larynx. Together, our data provide the first convincing evidence that the subcellular distribution of Ago2 occurs in a cell type-and tissue context-dependent manner and may correlate with its various functions in regulation of gene expression.	[Sharma, Nishi R.; Wang, Xiaohong; Majerciak, Vladimir; Zheng, Zhi-Ming] NCI, Tumor Virus RNA Biol Sect,Gene Regulat & Chromoso, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Kruhlak, Michael] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Meyers, Craig] Penn State Univ, Sch Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Zheng, ZM (corresponding author), NCI, Tumor Virus RNA Biol Sect,Gene Regulat & Chromoso, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	zhengt@exchange.nih.gov	Zheng, Zhi-Ming/L-6383-2019	Zheng, Zhi-Ming/0000-0001-5547-7912; Majerciak, Vladimir/0000-0003-2907-4583	NCI Investigator-initiated Intramural Research Project [1ZIASC010357-15]; Center for Cancer Research, NCI, National Institutes of Health; National Institutes of Health [U01 CA179724]; NATIONAL CANCER INSTITUTE [ZICBC010915, U01CA179724, ZIASC010357] Funding Source: NIH RePORTER	NCI Investigator-initiated Intramural Research Project; Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI Investigator-initiated Intramural Research Project 1ZIASC010357-15, the Center for Cancer Research, NCI, National Institutes of Health (to Z. M. Z.). This work was also supported partially by National Institutes of Health Grant U01 CA179724 (to C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Ando Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023385; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Detzer A, 2011, NUCLEIC ACIDS RES, V39, P2727, DOI 10.1093/nar/gkq1216; Doyle M, 2013, RNA, V19, P1238, DOI 10.1261/rna.039255.113; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Gagnon KT, 2012, NUCLEIC ACID THER, V22, P3, DOI 10.1089/nat.2011.0330; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kang JG, 2011, J VIROL, V85, P2620, DOI 10.1128/JVI.02144-10; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Majerciak V, 2010, J BIOL CHEM, V285, P11297, DOI 10.1074/jbc.M109.068221; Massimelli MJ, 2013, J VIROL, V87, P243, DOI 10.1128/JVI.01693-12; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wei Y, 2014, J BIOL CHEM, V289, P10270, DOI 10.1074/jbc.C113.541417; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023	21	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2302	2309		10.1074/jbc.C115.695049	http://dx.doi.org/10.1074/jbc.C115.695049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26699195	Green Published, hybrid			2022-12-28	WOS:000369610400020
J	Sinha, P; Aarnisalo, P; Chubb, R; Poulton, IJ; Guo, J; Nachtrab, G; Kimura, T; Swami, S; Saeed, H; Chen, M; Weinstein, LS; Schipani, E; Sims, NA; Kronenberg, HM; Wu, JY				Sinha, Partha; Aarnisalo, Piia; Chubb, Rhiannon; Poulton, Ingrid J.; Guo, Jun; Nachtrab, Gregory; Kimura, Takaharu; Swami, Srilatha; Saeed, Hamid; Chen, Min; Weinstein, Lee S.; Schipani, Ernestina; Sims, Natalie A.; Kronenberg, Henry M.; Wu, Joy Y.			Loss of G(s)alpha in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLASTIC CELLS; MESENCHYMAL PROGENITORS; POSTMENOPAUSAL WOMEN; INTERMITTENT PTH; PHOSPHOLIPASE-C; MINERAL DENSITY; PROTEIN-KINASE; IN-VIVO; DIFFERENTIATION; RECEPTOR	Parathyroid hormone (PTH) is an important regulator of osteoblast function and is the only anabolic therapy currently approved for treatment of osteoporosis. The PTH receptor (PTH1R) is a G protein-coupled receptor that signals via multiple G proteins including G(s)alpha. Mice expressing a constitutively active mutant PTH1R exhibited a dramatic increase in trabecular bone that was dependent upon expression of G(s)alpha in the osteoblast lineage. Postnatal removal of G(s)alpha in the osteoblast lineage (P-G(s)alpha(OsxKO) mice) yielded markedly reduced trabecular and cortical bone mass. Treatment with anabolic PTH(1-34) (80 mu g/kg/day) for 4 weeks failed to increase trabecular bone volume or cortical thickness in male and female P-G(s)alpha(OsxKO) mice. Surprisingly, in both male and female mice, PTH administration significantly increased osteoblast numbers and bone formation rate in both control and P-G(s)alpha(OsxKO) mice. In mice that express a mutated PTH1R that activates adenylyl cyclase and protein kinase A (PKA) via G(s)alpha but not phospholipase C via G(q/11) (D/D mice), PTH significantly enhanced bone formation, indicating that phospholipase C activation is not required for increased bone turnover in response to PTH. Therefore, although the anabolic effect of intermittent PTH treatment on trabecular bone volume is blunted by deletion of G(s)alpha in osteoblasts, PTH can stimulate osteoblast differentiation and bone formation. Together these findings suggest that alternative signaling pathways beyond G(s)alpha and G(q/11) act downstream of PTH on osteoblast differentiation.	[Sinha, Partha; Aarnisalo, Piia; Chubb, Rhiannon; Guo, Jun; Nachtrab, Gregory; Kronenberg, Henry M.; Wu, Joy Y.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Aarnisalo, Piia] Univ Helsinki, Dept Clin Chem, Helsinki 00029, Finland; [Aarnisalo, Piia] Univ Helsinki, Cent Hosp, HUSLAB, Lab Serv, Helsinki 00029, Finland; [Poulton, Ingrid J.; Sims, Natalie A.] Univ Melbourne, St Vincents Inst, Fitzroy, Vic 3065, Australia; [Poulton, Ingrid J.; Sims, Natalie A.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Kimura, Takaharu; Swami, Srilatha; Saeed, Hamid; Wu, Joy Y.] Stanford Univ, Sch Med, Div Endocrinol, 300 Pasteur Dr,S-025, Stanford, CA 94305 USA; [Chen, Min; Weinstein, Lee S.] NIDDK, NIH, Metab Dis Branch, Bethesda, MD 20892 USA; [Schipani, Ernestina] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA; [Schipani, Ernestina] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wu, JY (corresponding author), Stanford Univ, Sch Med, Div Endocrinol, 300 Pasteur Dr,S-025, Stanford, CA 94305 USA.	jywu1@stanford.edu	Sims, Natalie Ann/A-7192-2012	Sims, Natalie Ann/0000-0003-1421-8468; Weinstein, Lee/0000-0002-1899-5152	National Institutes of Health [AR054741, AR059942, AR061228, DK011794]; NIDDK Intramural Research Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065403, F32AR061228, K08AR054741, R03AR059942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313, P01DK011794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AR054741 and AR059942 (to J. Y. W.), AR061228 (to P. S.), and DK011794 (to H. M. K.) and the NIDDK Intramural Research Program (to M. C. and L. S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Guo J, 2010, ENDOCRINOLOGY, V151, P3502, DOI 10.1210/en.2009-1494; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Hsiao EC, 2010, J BONE MINER RES, V25, P584, DOI 10.1002/jbmr.3; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Kedlaya R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006627; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; PARTRIDGE NC, 1982, ENDOCRINOLOGY, V111, P178, DOI 10.1210/endo-111-1-178; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Singh ATK, 2005, ENDOCRINOLOGY, V146, P2171, DOI 10.1210/en.2004-1283; Sinha P, 2014, J BONE MINER RES, V29, P2414, DOI 10.1002/jbmr.2270; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yang DH, 2008, ENDOCRINOLOGY, V149, P1728, DOI 10.1210/en.2007-0826	50	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1631	1642		10.1074/jbc.M115.679753	http://dx.doi.org/10.1074/jbc.M115.679753			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26598522	hybrid, Green Published			2022-12-28	WOS:000368620700008
J	Walters, BT; Jensen, PF; Larraillet, V; Lin, K; Patapoff, T; Schlothauer, T; Rand, KD; Zhang, J				Walters, Benjamin T.; Jensen, Pernille F.; Larraillet, Vincent; Lin, Kevin; Patapoff, Thomas; Schlothauer, Tilman; Rand, Kasper D.; Zhang, Jennifer			Conformational Destabilization of Immunoglobulin G Increases the Low pH Binding Affinity with the Neonatal Fc Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM HALF-LIFE; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; STRUCTURAL DYNAMICS; DEPENDENT BINDING; PROTEIN; RESOLUTION; PHARMACOKINETICS	Crystallographic evidence suggests that the pH-dependent affinity of IgG molecules for the neonatal Fc receptor (FcRn) receptor primarily arises from salt bridges involving IgG histidine residues, resulting in moderate affinity at mildly acidic conditions. However, this view does not explain the diversity in affinity found in IgG variants, such as the YTE mutant (M252Y,S254T,T256E), which increases affinity to FcRn by up to 10 x. Here we compare hydrogen exchange measurements at pH 7.0 and pH 5.5 with and without FcRn bound with surface plasmon resonance estimates of dissociation constants and FcRn affinity chromatography. The combination of experimental results demonstrates that differences between an IgG and its cognate YTE mutant vary with their pH-sensitive dynamics prior to binding FcRn. The conformational dynamics of these two molecules are nearly indistinguishable upon binding FcRn. We present evidence that pH-induced destabilization in the CH2/3 domain interface of IgG increases binding affinity by breaking intramolecular H-bonds and increases side-chain adaptability in sites that form intermolecular contacts with FcRn. Our results provide new insights into the mechanism of pH-dependent affinity in IgG-FcRn interactions and exemplify the important and often ignored role of intrinsic conformational dynamics in a protein ligand, to dictate affinity for biologically important receptors.	[Walters, Benjamin T.; Zhang, Jennifer] Genentech Inc, Dept Protein Anal Chem, San Francisco, CA 94080 USA; [Walters, Benjamin T.; Patapoff, Thomas] Genentech Inc, Dept Early Stage Pharmaceut Dev, San Francisco, CA 94080 USA; [Lin, Kevin] Genentech Inc, Dept Analyt Operat, San Francisco, CA 94080 USA; [Larraillet, Vincent; Schlothauer, Tilman] Roche Innovat Ctr, Roche Pharma Res & Early Dev pRED, DE-82377 Penzberg, Germany; [Jensen, Pernille F.; Rand, Kasper D.] Univ Copenhagen, Dept Pharm, DK-1165 Copenhagen, Denmark	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Copenhagen	Walters, BT (corresponding author), Genentech Inc, Early Stage Pharmaceut Dev, 1 DNA Way,Mail Stop 56-1A, San Francisco, CA 94080 USA.	Walters.Benjamin@gene.com	Rand, Kasper/ABG-7446-2021	Rand, Kasper/0000-0002-6337-5489; Walters, Benjamin/0000-0001-5400-0696	Genentech, Inc.; Roche, Inc.; Marie Curie Actions Programme of the European Union [PCIG09-GA-2011-294214]; Danish Council for Independent Research/Natural Sciences [11-104058]	Genentech, Inc.(Roche HoldingGenentech); Roche, Inc.(Roche Holding); Marie Curie Actions Programme of the European Union; Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by Genentech, Inc. and Roche, Inc. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Grant PCIG09-GA-2011-294214 from the Marie Curie Actions Programme of the European Union and Steno Grant 11-104058 from the Danish Council for Independent Research/Natural Sciences.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bai YW, 1995, METHOD ENZYMOL, V259, P344; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borrok MJ, 2015, J BIOL CHEM, V290, P4282, DOI 10.1074/jbc.M114.603712; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Coales SJ, 2010, RAPID COMMUN MASS SP, V24, P3585, DOI 10.1002/rcm.4814; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Gouridis G, 2015, NAT STRUCT MOL BIOL, V22, P57, DOI 10.1038/nsmb.2929; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110; HVIDT A, 1963, CR TRAV LAB CARLSB, V34, P299; Jensen PF, 2015, MOL CELL PROTEOMICS, V14, P148, DOI 10.1074/mcp.M114.042044; Kabat Elvin A, 1914, SEQUENCES PROTEINS I; Kan ZY, 2011, J AM SOC MASS SPECTR, V22, P1906, DOI 10.1007/s13361-011-0236-3; Kastritis PL, 2013, CURR OPIN STRUC BIOL, V23, P868, DOI 10.1016/j.sbi.2013.07.001; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; Majumdar R, 2015, MABS-AUSTIN, V7, P84, DOI 10.4161/19420862.2014.985494; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mayne L, 2011, J AM SOC MASS SPECTR, V22, P1898, DOI 10.1007/s13361-011-0235-4; Mercier E, 2015, SCI REP-UK, V5, DOI 10.1038/srep07677; Monnet C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00039; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schlothauer T, 2013, MABS-AUSTIN, V5, P576, DOI 10.4161/mabs.24981; Schoch A, 2015, P NATL ACAD SCI USA, V112, P5997, DOI 10.1073/pnas.1408766112; Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Walters B. T., 2014, 62 ANN ASMS C MASS S; Walters BT, 2013, P NATL ACAD SCI USA, V110, P18898, DOI 10.1073/pnas.1319482110; Walters BT, 2012, J AM SOC MASS SPECTR, V23, P2132, DOI 10.1007/s13361-012-0476-x; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453	38	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1817	+		10.1074/jbc.M115.691568	http://dx.doi.org/10.1074/jbc.M115.691568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627822	Green Published, hybrid			2022-12-28	WOS:000368620700022
J	Wiencek, JR; Hirbawi, J; Yee, VC; Kalafatis, M				Wiencek, Joesph R.; Hirbawi, Jamila; Yee, Vivien C.; Kalafatis, Michael			The Dual Regulatory Role of Amino Acids Leu(480) and Gln(481) of Prothrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VA HEAVY-CHAIN; THROMBIN-CATALYZED ACTIVATION; COAGULATION FACTOR XA; HUMAN ALPHA-THROMBIN; PROTEIN-C; CRYSTAL-STRUCTURE; STRUCTURAL REQUIREMENTS; BINDING-SITE; PROEXOSITE-I; FACTOR-VIII	Prothrombin (FII) is activated to alpha-thrombin (IIa) by prothrombinase. Prothrombinase is composed of a catalytic subunit, factor Xa (fXa), and a regulatory subunit, factor Va (fVa), assembled on a membrane surface in the presence of divalent metal ions. We constructed, expressed, and purified several mutated recombinant FII (rFII) molecules within the previously determined fVa-dependent binding site for fXa (amino acid region 473-487 of FII). rFII molecules bearing overlapping deletions within this significant region first established the minimal stretch of amino acids required for the fVa-dependent recognition exosite for fXa in prothrombinase within the amino acid sequence Ser(478)-Val(479)-Leu(480)-Gln(481)-Val(482). Single, double, and triple point mutations within this stretch of rFII allowed for the identification of Leu(480) and Gln(481) as the two essential amino acids responsible for the enhanced activation of FII by prothrombinase. Unanticipated results demonstrated that although recombinant wild type alpha-thrombin and rIIa(S478A) were able to induce clotting and activate factor V and factor VIII with rates similar to the plasma-derived molecule, rIIa(SLQ -> 3AAA) with mutations S478A/L480A/Q481A was deficient in clotting activity and unable to efficiently activate the pro-cofactors. This molecule was also impaired in protein C activation. Similar results were obtained with rIIa(Delta SLQ) (where rIIa(Delta SLQ) is recombinant human alpha-thrombin with amino acids Ser(478)/Leu(480)/Gln(481) deleted). These data provide new evidence demonstrating that amino acid sequence Leu(480)-Gln(481): 1) is crucial for proper recognition of the fVa-dependent site(s) for fXa within prothrombinase on FII, required for efficient initial cleavage of FII at Arg(320); and 2) is compulsory for appropriate tethering of fV, fVIII, and protein C required for their timely activation by IIa.	[Wiencek, Joesph R.; Hirbawi, Jamila; Kalafatis, Michael] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Wiencek, Joesph R.; Hirbawi, Jamila; Kalafatis, Michael] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Yee, Vivien C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kalafatis, Michael] Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kalafatis, Michael] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Wiencek, Joesph R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1301 Med Ctr Dr, Nashville, TN 37232 USA; [Kalafatis, Michael] Cleveland State Univ, Sci & Res Ctr SR 370, Dept Chem, 2351 Euclid Ave, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Vanderbilt University; University System of Ohio; Cleveland State University	Kalafatis, M (corresponding author), Cleveland State Univ, Sci & Res Ctr SR 370, Dept Chem, 2351 Euclid Ave, Cleveland, OH 44115 USA.	m.kalafatis@csuohio.edu			Doctoral Dissertation Research Expense Award and Fellowship Program; Molecular Medicine Graduate Program Fellowship; Center for Gene Regulation in Health and Disease at Cleveland State University; Division of Research and Graduate Studies at Cleveland State University	Doctoral Dissertation Research Expense Award and Fellowship Program; Molecular Medicine Graduate Program Fellowship; Center for Gene Regulation in Health and Disease at Cleveland State University; Division of Research and Graduate Studies at Cleveland State University	This work was supported in part by Doctoral Dissertation Research Expense Award and Fellowship Program (to J. R. W.), by a Molecular Medicine Graduate Program Fellowship (to J. R. W.), by funds from the Center for Gene Regulation in Health and Disease at Cleveland State University (to M. K.), and funds from the Division of Research and Graduate Studies at Cleveland State University (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; BAJAJ SP, 1975, J BIOL CHEM, V250, P2150; Barhoover MA, 2008, BIOCHEMISTRY-US, V47, P6840, DOI 10.1021/bi800057r; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Bukys MA, 2005, J BIOL CHEM, V280, P27393, DOI 10.1074/jbc.M503435200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; BUTKOWSKI RJ, 1977, J BIOL CHEM, V252, P4942; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESMON CT, 1974, J BIOL CHEM, V249, P8045; ESMON CT, 1973, BIOCHIM BIOPHYS ACTA, V310, P289, DOI 10.1016/0005-2795(73)90034-2; ESMON CT, 1974, J BIOL CHEM, V249, P7782; ESMON CT, 1974, J BIOL CHEM, V249, P606; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FAY PJ, 1992, J BIOL CHEM, V267, P13246; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Gale AJ, 2000, BLOOD, V96, P585; Guinto E. R., 1984, J BIOL CHEM, V259, P13986; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; Hirbawi J, 2008, BIOCHEMISTRY-US, V47, P7963, DOI 10.1021/bi800593k; Hirbawi J, 2010, BIOCHEMISTRY-US, V49, P8520, DOI 10.1021/bi101097t; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Koike H, 2003, J BIOL CHEM, V278, P15015, DOI 10.1074/jbc.M208220200; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Mann K G, 1981, Ann N Y Acad Sci, V370, P378, DOI 10.1111/j.1749-6632.1981.tb29750.x; MANN K G, 1973, Series Haematologica, V6, P479; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1981, BIOCHEMISTRY-US, V20, P28, DOI 10.1021/bi00504a005; MESTERS RM, 1993, PROTEIN SCI, V2, P1482, DOI 10.1002/pro.5560020912; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Monteiro RQ, 2002, THROMB HAEMOSTASIS, V87, P288; MORITA T, 1981, METHOD ENZYMOL, V80, P303; Myles T, 2002, BLOOD, V100, P2820, DOI 10.1182/blood-2002-03-0843; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1983, J BIOL CHEM, V258, P5386; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Orban T, 2005, BIOCHEMISTRY-US, V44, P13082, DOI 10.1021/bi050891t; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; OWEN WG, 1974, J BIOL CHEM, V249, P594; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Rezaie AR, 1998, PROTEIN SCI, V7, P349; ROSING J, 1980, J BIOL CHEM, V255, P274; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Schuijt TJ, 2013, CIRCULATION, V128, P254, DOI 10.1161/CIRCULATIONAHA.113.003191; Shim JY, 2015, BIOPHYS CHEM, V199, P46, DOI 10.1016/j.bpc.2015.02.003; Simioni P, 1996, BLOOD, V88, P2101, DOI 10.1182/blood.V88.6.2101.bloodjournal8862101; Singh LS, 2003, J BIOL CHEM, V278, P28335, DOI 10.1074/jbc.M300233200; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRACY PB, 1982, BLOOD, V60, P59; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wiencek JR, 2013, J BIOL CHEM, V288, P37026, DOI 10.1074/jbc.M113.462374; WITTING JI, 1987, THROMB RES, V46, P567, DOI 10.1016/0049-3848(87)90157-5; Yegneswaran S, 2002, CHEM BIOL, V9, P485, DOI 10.1016/S1074-5521(02)00132-1; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	91	1	1	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1565	1581		10.1074/jbc.M115.691956	http://dx.doi.org/10.1074/jbc.M115.691956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601957	hybrid, Green Published			2022-12-28	WOS:000368620700002
J	Marty-Roix, R; Vladimer, GI; Pouliot, K; Weng, D; Buglione-Corbett, R; West, K; MacMicking, JD; Chee, JD; Wang, SX; Lu, S; Lien, E				Marty-Roix, Robyn; Vladimer, Gregory I.; Pouliot, Kimberly; Weng, Dan; Buglione-Corbett, Rachel; West, Kim; MacMicking, John D.; Chee, Jonathan D.; Wang, Shixia; Lu, Shan; Lien, Egil			Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOPHOSPHORYL-LIPID-A; PARTICULATE VACCINE ADJUVANTS; QUILLAJA-SAPONARIA MOLINA; HEALTHY ADULT VOLUNTEERS; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; DENDRITIC CELLS; T-CELL; ADAPTIVE IMMUNITY; ISCOMATRIX ADJUVANT	Many immunostimulants act as vaccine adjuvants via activation of the innate immune system, although in many cases it is unclear which specific molecules contribute to the stimulatory activity. QS-21 is a defined, highly purified, and soluble saponin adjuvant currently used in licensed and exploratory vaccines, including vaccines against malaria, cancer, and HIV-1. However, little is known about the mechanisms of cellular activation induced by QS-21. We observed QS-21 to elicit caspase-1-dependent IL-1 beta and IL-18 release in antigen-presenting cells such as macrophages and dendritic cells when co-stimulated with the TLR4-agonist adjuvant monophosphoryl lipid A. Furthermore, our data suggest that the ASC-NLRP3 inflammasome is responsible for QS-21-induced IL-1 beta/IL-18 release. At higher concentrations, QS-21 induced macrophage and dendritic cell death in a caspase-1-, ASC-, and NLRP3-independent manner, whereas the presence of cholesterol rescued cell viability. A nanoparticulate adjuvant that contains QS-21 as part of a heterogeneous mixture of saponins also induced IL-1 beta in an NLRP3-dependent manner. Interestingly, despite the role NLRP3 plays for cellular activation in vitro, NLRP3-deficient mice immunized with HIV-1 gp120 and QS-21 showed significantly higher levels of Th1 and Th2 antigen-specific T cell responses and increased IgG1 and IgG2c compared with wild type controls. Thus, we have identified QS-21 as a nonparticulate single molecular saponin that activates the NLRP3 inflammasome, but this signaling pathway may contribute to decreased antigenspecific responses in vivo.	[Marty-Roix, Robyn; Vladimer, Gregory I.; Pouliot, Kimberly; Weng, Dan; Lien, Egil] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, 364 Plantat St,LRB311, Worcester, MA 01605 USA; [Buglione-Corbett, Rachel; West, Kim; Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA 01605 USA; [MacMicking, John D.; Chee, Jonathan D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Lien, Egil] NTNU, Dept Canc & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Norwegian University of Science & Technology (NTNU)	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, 364 Plantat St,LRB311, Worcester, MA 01605 USA.	egil.lien@umassmed.edu	Psoinos, Rachel/AAV-7465-2021; Vladimer, Gregory/X-4547-2018	Psoinos, Rachel/0000-0001-7892-2070; Vladimer, Gregory/0000-0003-4205-7585	National Institutes of Health [5 U19 AI082676, 5 PO1 AI082274, AI095213]; National Institutes of Health through the American Recovery and Reinvestment Act [AI07538, AI117706, AI057588]; Norwegian Cancer Society; Research Council of Norway Center of Excellence [223255/F50]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213, P01AI082274, R21AI117706, R01AI057588, R01AI108834, T32AI007538, U19AI082676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the American Recovery and Reinvestment Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway Center of Excellence(Research Council of Norway); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health Grants 5 U19 AI082676 and 5 PO1 AI082274; in part by National Institutes of Health Grants AI07538, AI117706, and AI057588 through the American Recovery and Reinvestment Act (to E.L.); National Institutes of Health Grant AI095213 (to G.I.V.); funds from the Norwegian Cancer Society; and Research Council of Norway Center of Excellence Funding Scheme Project 223255/F50. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beck Z., BIOCH BIOPHYS ACTA, V1848, P775; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Bengtsson KL, 2013, EXPERT REV VACCINES, V12, P821, DOI 10.1586/14760584.2013.814822; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Bengtsson KL., 2013, NOVEL IMMUNE POTENTI, P309; BROWN LE, 1995, ARCH VIROL, V140, P635, DOI 10.1007/BF01309955; Buglione-Corbett R, 2014, HUM VACC IMMUNOTHER, V10, P1078, DOI 10.4161/hv.27907; Buglione-Corbett R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074820; CAMPBELL JB, 1992, RES IMMUNOL, V143, P526, DOI 10.1016/0923-2494(92)80064-R; Chea EK, 2012, J AM CHEM SOC, V134, P13448, DOI 10.1021/ja305121q; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; DALSGAARD K, 1974, ARCH GES VIRUSFORSCH, V44, P243, DOI 10.1007/BF01240612; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2011, J IMMUNOL, V187, P55, DOI 10.4049/jimmunol.1004114; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Fernandez-Tejada A, 2014, NAT CHEM, V6, P636, DOI [10.1038/NCHEM.1963, 10.1038/nchem.1963]; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gin DY, 2011, CURR DRUG THER, V6, P207, DOI 10.2174/157488511796391988; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kashala O, 2002, VACCINE, V20, P2263, DOI 10.1016/S0264-410X(02)00115-9; Kennedy JS, 2008, VACCINE, V26, P4420, DOI 10.1016/j.vaccine.2008.05.090; Kensil CR, 2004, FRONT BIOSCI-LANDMRK, V9, P2972, DOI 10.2741/1452; KENSIL CR, 1991, J IMMUNOL, V146, P431; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Kim SK, 1999, VACCINE, V18, P597, DOI 10.1016/S0264-410X(99)00316-3; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Krug LM, 2012, CANCER IMMUNOL IMMUN, V61, P9, DOI 10.1007/s00262-011-1083-6; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Liu D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00486; Liu G, 2002, VACCINE, V20, P2808, DOI 10.1016/S0264-410X(02)00209-8; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; McKenzie A., 2010, HUM VACCINES, V6; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; Morelli AB, 2012, J MED MICROBIOL, V61, P935, DOI 10.1099/jmm.0.040857-0; Neumann S, 2014, IMMUNOL CELL BIOL, V92, P535, DOI 10.1038/icb.2014.21; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Oliveira-Freitas E, 2006, VACCINE, V24, P3909, DOI 10.1016/j.vaccine.2006.02.034; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Pouliot K, 2014, VACCINE, V32, P5049, DOI 10.1016/j.vaccine.2014.07.010; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; SOLTYSIK S, 1995, VACCINE, V13, P1403, DOI 10.1016/0264-410X(95)00077-E; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Weeratna RD, 2005, VACCINE, V23, P5263, DOI 10.1016/j.vaccine.2005.06.024; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wilson NS, 2014, J IMMUNOL, V192, P3259, DOI 10.4049/jimmunol.1302011	75	102	110	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1123	1136		10.1074/jbc.M115.683011	http://dx.doi.org/10.1074/jbc.M115.683011			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26555265	Green Published, hybrid			2022-12-28	WOS:000368068300009
J	Sampey, GC; Saifuddin, M; Schwab, A; Barclay, R; Punya, S; Chung, MC; Hakami, RM; Zadeh, MA; Lepene, B; Klase, ZA; El-Hage, N; Young, M; Iordanskiy, S; Kashanchi, F				Sampey, Gavin C.; Saifuddin, Mohammed; Schwab, Angela; Barclay, Robert; Punya, Shreya; Chung, Myung-Chul; Hakami, Ramin M.; Zadeh, Mohammad Asad; Lepene, Benjamin; Klase, Zachary A.; El-Hage, Nazira; Young, Mary; Iordanskiy, Sergey; Kashanchi, Fatah			Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL NONCODING RNAS; TOLL-LIKE-RECEPTORS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; MONONUCLEAR-CELLS; PROTEIN-KINASE; INFECTED-CELLS	HIV-1 infection results in a chronic illness because longterm highly active antiretroviral therapy can lower viral titers to an undetectable level. However, discontinuation of therapy rapidly increases virus burden. Moreover, patients under highly active antiretroviral therapy frequently develop various metabolic disorders, neurocognitive abnormalities, and cardiovascular diseases. We have previously shown that exosomes containing trans-activating response (TAR) element RNA enhance susceptibility of undifferentiated naive cells to HIV-1 infection. This study indicates that exosomes from HIV-1-infected primary cells are highly abundant with TAR RNA as detected by RT-real time PCR. Interestingly, up to a million copies of TAR RNA/ mu l were also detected in the serum from HIV-1-infected humanized mice suggesting that TAR RNA may be stable in vivo. Incubation of exosomes from HIV-1-infected cells with primary macrophages resulted in a dramatic increase of proinflammatory cytokines, IL-6 and TNF-beta, indicating that exosomes containing TAR RNA could play a direct role in control of cytokine gene expression. The intact TAR molecule was able to bind to PKR and TLR3 effectively, whereas the 5' and 3' stems (TAR microRNAs) bound best to TLR7 and -8 and none to PKR. Binding of TAR to PKR did not result in its phosphorylation, and therefore, TAR may be a dominant negative decoy molecule in cells. The TLR binding through either TAR RNA or TAR microRNA potentially can activate the NF-kB pathway and regulate cytokine expression. Collectively, these results imply that exosomes containing TAR RNA could directly affect the proinflammatory cytokine gene expression and may explain a possible mechanism of inflammation observed in HIV-1-infected patients under cART.	[Sampey, Gavin C.; Saifuddin, Mohammed; Schwab, Angela; Barclay, Robert; Punya, Shreya; Chung, Myung-Chul; Hakami, Ramin M.; Zadeh, Mohammad Asad; Iordanskiy, Sergey; Kashanchi, Fatah] George Mason Univ, Mol Virol Lab, Manassas, VA 20110 USA; [Lepene, Benjamin] Ceres Nanosci Inc, Manassas, VA 20110 USA; [Klase, Zachary A.] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA; [El-Hage, Nazira] Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA; [Young, Mary] Georgetown Univ, Dept Med, Womens Intra Agcy HIV Study, Washington, DC 20007 USA	George Mason University; Georgetown University	Iordanskiy, S (corresponding author), George Mason Univ, Natl Ctr Biodefense & Infect Dis, Discovery Hall,Room 254W,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	siordans@gmu.edu; fkashanc@gmu.edu		Hakami, Ramin/0000-0001-7122-0164	National Institutes of Health from NIAID [U01-AI-34994]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074410, U01AI034994, R21AI113140, R21AI078859, R01AI043894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099029, F31NS086453] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Kashanchi laboratory, including Kinza Noor and Yao Akpamagbo, for experiments and assistance with the manuscript. We thank Dr. Aarthi Narayanan for MS experiments. We thank Dr. Jay Rappaport (Temple University) for the suggestion of experiments related to PKR and the RNA sizes. We also grateful to the National Institutes of Health AIDS Research and Reference Reagent Program for the contribution of important reagents. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health: U1, J1.1 and ACH-2 cells from Dr. Thomas Folks; HIV-189.6 dual-tropic viral strain from Dr. Ronald Collman; and anti-HIV-1 p24 mouse monoclonal antibody from Dr. Michael Malim. The antiretrovirals lamivudine/emtricitabine, tenofovir, indinavir, raltegravir, and maraviroc were also from AIDS Research and Reference Reagent Program. Four clinical samples utilized in this study were provided by the Washington, D.C., Metropolitan Site of the Women's Interagency HIV Study Collaborative Study Group (Principal Investigator, Mary Young). The Women's Interagency HIV Study is supported by National Institutes of Health Grant U01-AI-34994, from NIAID.	Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amaya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086745; Banks WA, 1997, LIFE SCI, V61, pPL119, DOI 10.1016/S0024-3205(97)00597-3; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bernard MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106006; Bohan Cindy A., 1992, Gene Expression, V2, P391; BREEN EC, 1990, J IMMUNOL, V144, P480; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; Chen D, 1997, BBA-MOL CELL RES, V1355, P1, DOI 10.1016/S0167-4889(96)00169-3; Coffin J. M., 2013, FIELDS VIROLOGY, P1767; Collin D, 2000, NUCLEIC ACIDS RES, V28, P3386, DOI 10.1093/nar/28.17.3386; Deminice R, 2013, NUTRITION, V29, P1326, DOI 10.1016/j.nut.2013.04.017; EDERY I, 1989, CELL, V56, P303, DOI 10.1016/0092-8674(89)90904-5; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Feleke Yeweyenhareg, 2012, Ethiop Med J, V50, P221; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; Husain B, 2012, BIOCHEMISTRY-US, V51, P8764, DOI 10.1021/bi301226h; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; LUO Y, 1993, J VIROL, V67, P5617, DOI 10.1128/JVI.67.9.5617-5622.1993; Macovei A, 2006, BIOCHEM BIOPH RES CO, V346, P1083, DOI 10.1016/j.bbrc.2006.06.023; Matusevicius D, 1996, J NEUROIMMUNOL, V66, P115, DOI 10.1016/0165-5728(96)00032-X; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Narayanan A, 2012, VIROLOGY, V432, P219, DOI 10.1016/j.virol.2012.06.007; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Navikas V, 1996, BRAIN, V119, P213, DOI 10.1093/brain/119.1.213; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; PAL R, 1991, AIDS RES HUM RETROV, V7, P707, DOI 10.1089/aid.1991.7.707; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stone S F, 2002, HIV Med, V3, P21, DOI 10.1046/j.1464-2662.2001.00096.x; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Suh HS, 2009, VIROLOGY, V392, P246, DOI 10.1016/j.virol.2009.07.001; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; UNAIDS, 2012, UNAIDS REP GLOB AIDS; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Sluis RM, 2013, CURR OPIN VIROL, V3, P700, DOI 10.1016/j.coviro.2013.07.006; Van Duyne R, 2008, VIROLOGY, V376, P308, DOI 10.1016/j.virol.2008.02.036; Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	77	139	146	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1251	1266		10.1074/jbc.M115.662171	http://dx.doi.org/10.1074/jbc.M115.662171			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26553869	hybrid, Green Published			2022-12-28	WOS:000368068300021
J	Tominaga, T; Dutta, RK; Joladarashi, D; Doi, T; Reddy, JK; Kanwar, YS				Tominaga, Tatsuya; Dutta, Rajesh K.; Joladarashi, Darukeshwara; Doi, Toshio; Reddy, Janardan K.; Kanwar, Yashpal S.			Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDOREDUCTASE/MYO-INOSITOL OXYGENASE; METABOLIC SYNDROME; OXIDATIVE STRESS; INSULIN-RESISTANCE; EPITHELIAL-CELLS; GENE-EXPRESSION; KIDNEY-DISEASE; HIGH-GLUCOSE; PROTEIN; ALBUMIN	The kidney is one of the target organs for various metabolic diseases, including diabetes, metabolic syndrome, and obesity. Most of the metabolic studies underscore glomerular pathobiology, although the tubulo-interstitial compartment has been underemphasized. This study highlights mechanisms concerning the pathobiology of tubular injury in the context of myoinositol oxygenase (Miox), a tubular enzyme. The kidneys of mice fed a high fat diet (HFD) had increased Miox expression and activity, and the latter was related to phosphorylation of serine/threonine residues. Also, expression of sterol regulatory element-binding protein1 (Srebp1) and markers of cellular/nuclear damage was increased along with accentuated apoptosis and loss of tubular brush border. Similar results were observed in cells treated with palmitate/BSA. Multiple sterol-response elements and E-box motifs were found in the miox promoter, and its activity was modulated by palmitate/BSA. Electrophoretic mobility and ChIP assays confirmed binding of Srebp to consensus sequences of the miox promoter. Exposure of palmitate/ BSA-treated cells to rapamycin normalized Miox expression and prevented Srebp1 nuclear translocation. In addition, rapamycin treatment reduced p53 expression and apoptosis. Like rapamycin, srebp siRNA reduced Miox expression. Increased expression of Miox was associated with the generation of reactive oxygen species (ROS) in kidney tubules of mice fed an HFD and cell exposed to palmitate/BSA. Both miox and srebp1 siRNAs reduced generation of ROS. Collectively, these findings suggest that HFD or fatty acids modulate transcriptional, translational, and post-translational regulation of Miox expression/activity and underscore Miox being a novel target of the transcription factor Srebp1. Conceivably, activation of the mTORC1/Srebp1/Miox pathway leads to the generation of ROS culminating into tubulo-interstitial injury in states of obesity.	[Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Doi, Toshio] Univ Tokushima, Dept Nephrol, Tokushima 770, Japan	Northwestern University; Feinberg School of Medicine; Tokushima University	Kanwar, YS (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, 300 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu	Dutta, Rajesh Kumar/J-7790-2019	Dutta, Rajesh Kumar/0000-0002-1394-0961	National Institutes of Health [DK60636]; Manpei Suzuki Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK60636 and the Manpei Suzuki Diabetes Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arici M, 2002, NEPHROL DIAL TRANSPL, V17, P1751, DOI 10.1093/ndt/17.10.1751; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Csernus K, 2005, EUR J PEDIATR, V164, P44, DOI 10.1007/s00431-004-1546-2; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jain SS, 2014, DIABETES, V63, P1907, DOI 10.2337/db13-0816; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nayak B, 2005, P NATL ACAD SCI USA, V102, P17952, DOI 10.1073/pnas.0509089102; Nayak B, 2011, J BIOL CHEM, V286, P27594, DOI 10.1074/jbc.M110.217141; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prabhu KS, 2005, J BIOL CHEM, V280, P19895, DOI 10.1074/jbc.M502621200; Redon J, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0555-z; Ritz E, 2011, CURR OPIN NEPHROL HY, V20, P44, DOI 10.1097/MNH.0b013e3283414ca1; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Ruggiero C, 2014, AM J PHYSIOL-RENAL, V306, pF896, DOI 10.1152/ajprenal.00484.2013; Sahin-Efe A, 2012, METABOLISM, V61, P1659, DOI 10.1016/j.metabol.2012.09.001; Satriano J, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gft229; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Singhal SS, 2013, J BIOL CHEM, V288, P23394, DOI 10.1074/jbc.M113.480194; Tanner RM, 2012, CURR HYPERTENS REP, V14, P152, DOI 10.1007/s11906-012-0254-y; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; THOMAS ME, 1993, AM J NEPHROL, V13, P385, DOI 10.1159/000168653; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Xie P, 2010, AM J PHYSIOL-RENAL, V298, pF1393, DOI 10.1152/ajprenal.00137.2010; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Yang QW, 2000, P NATL ACAD SCI USA, V97, P9896, DOI 10.1073/pnas.160266197; Yasuda M, 2014, BBA-MOL BASIS DIS, V1842, P1097, DOI 10.1016/j.bbadis.2014.04.001; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746	56	24	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1348	1367		10.1074/jbc.M115.698191	http://dx.doi.org/10.1074/jbc.M115.698191			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26578517	Green Published, hybrid			2022-12-28	WOS:000368068300028
J	Grabner, GF; Eichmann, TO; Wagner, B; Gao, YQ; Farzi, A; Taschler, U; Radner, FPW; Schweiger, M; Lass, A; Holzer, P; Zinser, E; Tschop, MH; Yi, CX; Zimmermann, R				Grabner, Gernot F.; Eichmann, Thomas O.; Wagner, Bernhard; Gao, Yuanqing; Farzi, Aitak; Taschler, Ulrike; Radner, Franz P. W.; Schweiger, Martina; Lass, Achim; Holzer, Peter; Zinser, Erwin; Tschoep, Matthias H.; Yi, Chun-Xia; Zimmermann, Robert			Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-induced Neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL SUSPENSION TEST; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID SYSTEM; BACTERIAL LIPOPOLYSACCHARIDE; CANNABINOID RECEPTORS; BRAIN-INJURY; ANXIETY-LIKE; MICE; INHIBITION; MEMORY	Monoglyceride lipase (MGL) is required for efficient hydrolysis of the endocannabinoid 2-arachidonoylglyerol (2-AG) in the brain generating arachidonic acid (AA) and glycerol. This metabolic function makes MGL an interesting target for the treatment of neuroinflammation, since 2-AG exhibits anti-inflammatory properties and AA is a precursor for pro-inflammatory prostaglandins. Astrocytes are an important source of AA and 2-AG, and highly express MGL. In the present study, we dissected the distinct contribution of MGL in astrocytes on brain 2-AG and AA metabolism by generating a mouse model with genetic deletion of MGL specifically in astrocytes (MKOGFAP). MKOGFAP mice exhibit moderately increased 2-AG and reduced AA levels in brain. Minor accumulation of 2-AG in the brain of MKOGFAP mice does not cause cannabinoid receptor desensitization as previously observed in mice globally lacking MGL. Importantly, MKOGFAP mice exhibit reduced brain prostaglandin E2 and pro-inflammatory cytokine levels upon peripheral lipopolysaccharide (LPS) administration. These observations indicate that MGL-mediated degradation of 2-AG in astrocytes provides AA for prostaglandin synthesis promoting LPS-induced neuroinflammation. The beneficial effect of astrocytespecific MGL-deficiency is not fully abrogated by the inverse cannabinoid receptor 1 agonist SR141716 (Rimonabant) suggesting that the anti-inflammatory effects are rather caused by reduced prostaglandin synthesis than by activation of cannabinoid receptors. In conclusion, our data demonstrate that MGL in astrocytes is an important regulator of 2-AG levels, AA availability, and neuroinflammation.	[Grabner, Gernot F.; Eichmann, Thomas O.; Taschler, Ulrike; Radner, Franz P. W.; Schweiger, Martina; Lass, Achim; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Wagner, Bernhard; Zinser, Erwin] FH Joanneum Univ Appl Sci, Inst Biomed Sci, A-8020 Graz, Austria; [Gao, Yuanqing; Tschoep, Matthias H.; Yi, Chun-Xia] Helmholtz Ctr Munich, Inst Diabet & Obes, D-85748 Garching, Germany; [Farzi, Aitak; Holzer, Peter] Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria; [Yi, Chun-Xia] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University of Graz; University of Amsterdam; Academic Medical Center Amsterdam	Zimmermann, R (corresponding author), Graz Univ, Heinrichstr 31A, A-8010 Graz, Austria.	robert.zimmermann@uni-graz.at	Lass, Achim/C-3332-2008; Holzer, Peter/F-7578-2011; Yi, Chun-Xia/J-4068-2016	Lass, Achim/0000-0002-8190-7151; Holzer, Peter/0000-0002-5754-395X; Yi, Chun-Xia/0000-0003-1184-4615; Taschler, Ulrike/0000-0001-9000-1602; Tschoep, Matthias/0000-0002-4744-371X; Radner, Franz/0000-0003-3466-0181; Zimmermann, Robert/0000-0002-7354-870X; Schweiger, Martina/0000-0002-3419-1007; Eichmann, Thomas O./0000-0002-8521-2795; Farzi, Aitak/0000-0001-9606-3871; Grabner, Gernot/0000-0002-7110-9957	Austrian Science Funds, FWF [P24294, P25193]; DK Molecular Enzymology [W901-B05 DK]; NAWI Graz; Austrian Science Fund (FWF) [W 901, P 25193, P 24294] Funding Source: researchfish	Austrian Science Funds, FWF(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); NAWI Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by grants from the Austrian Science Funds, FWF, Projects P24294 (to R. Z.) and P25193 (to A. L.), and by the DK Molecular Enzymology W901-B05 DK (to R. Z.) and NAWI Graz. The authors declare that they have no conflicts of interest with the contents of this article.	Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Berrocoso E, 2013, INT J NEUROPSYCHOPH, V16, P151, DOI 10.1017/S1461145711001842; Blankman J. L., 2009, CHEM PHYS LIPIDS, V14, P1347; Brunner SM, 2014, P NATL ACAD SCI USA, V111, P7138, DOI 10.1073/pnas.1318066111; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Crowe MS, 2015, BRIT J PHARMACOL, V172, P1700, DOI 10.1111/bph.13012; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; Farzi A, 2015, BRAIN BEHAV IMMUN, V44, P106, DOI 10.1016/j.bbi.2014.08.011; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Hollis JH, 2010, NEUROPHARMACOLOGY, V58, P730, DOI 10.1016/j.neuropharm.2009.12.016; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Kouchi Z, 2015, BIOCHEM BIOPH RES CO, V464, P603, DOI 10.1016/j.bbrc.2015.07.019; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matousek SB, 2010, J NEUROCHEM, V114, P247, DOI 10.1111/j.1471-4159.2010.06759.x; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; MontagneClavel J, 1996, SOMATOSENS MOT RES, V13, P215, DOI 10.3109/08990229609052577; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Painsipp E, 2008, GENES BRAIN BEHAV, V7, P532, DOI 10.1111/j.1601-183X.2008.00389.x; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Riebe CJ, 2011, STRESS, V14, P384, DOI 10.3109/10253890.2011.586753; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rosenberger TA, 2004, J NEUROCHEM, V88, P1168, DOI 10.1046/j.1471-4159.2003.02246.x; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Steiner AA, 2011, J PHYSIOL-LONDON, V589, P2415, DOI 10.1113/jphysiol.2010.202465; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Taschler U, 2015, BRIT J PHARMACOL, V172, P4419, DOI 10.1111/bph.13224; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Tzeng Shun-Fen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P335, DOI 10.2174/1568010054022051; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Viader A, 2015, CELL REP, V12, P798, DOI 10.1016/j.celrep.2015.06.075; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Yi CX, 2012, DIS MODEL MECH, V5, P686, DOI 10.1242/dmm.009464; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	54	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					913	923		10.1074/jbc.M115.683615	http://dx.doi.org/10.1074/jbc.M115.683615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565024	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000367830500037
J	Nakakita, S; Itoh, A; Nakakita, Y; Nonaka, Y; Ogawa, T; Nakamura, T; Nishi, N				Nakakita, Shin-ichi; Itoh, Aiko; Nakakita, Yukari; Nonaka, Yasuhiro; Ogawa, Takashi; Nakamura, Takanori; Nishi, Nozomu			Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; NUCLEOTIDE-SEQUENCE; T-CELLS; MICE; GLYCOSYLATION; PROTEIN; CHROMATOGRAPHY; RECOGNITION; SUPPRESSES; IMMUNITY	We previously showed that galectin-9 suppresses degranulation of mast cells through protein-glycan interaction with IgE. To elucidate the mechanism of the interaction in detail, we focused on identification and structural analysis of IgE glycans responsible for the galectin-9-induced suppression using mouse monoclonal IgE (TIB-141). TIB-141 in combination with the antigen induced degranulation of RBL-2H3 cells, which was almost completely inhibited by human and mouse galectin-9. Sequential digestion of TIB-141 with lysyl endopeptidase and trypsin resulted in the identification of a glycopeptide (H-Lys13-Try3; 48 amino acid residues) with a single N-linked oligosaccharide near the N terminus capable of neutralizing the effect of galectin-9 and another glycopeptide with two N-linked oligosaccharides (H-Lys13-Try1; 16 amino acid residues) having lower activity. Enzymatic elimination of the oligosaccharide chain from H-Lys13-Try3 and H-Lys13-Try1 completely abolished the activity. Removal of the C-terminal 38 amino acid residues of H-Lys13-Try3 with glutamyl endopeptidase, however, also resulted in loss of the activity. We determined the structures of N-linked oligosaccharides of H-Lys13-Try1. The galectin-9-binding fraction of pyri-dylaminated oligosaccharides contained asialo-and monosialylated bi/tri-antennary complex type oligosaccharides with a core fucose residue. The structures of the oligosaccharides were consistent with the sugar-binding specificity of galectin-9, whereas the nonbinding fraction contained monosialylated and disialylated biantennary complex type oligosaccharides with a core fucose residue. Although the oligosaccharides linked to H-Lys13-Try3 could not be fully characterized, these results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of TIB-141 to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.	[Nakakita, Shin-ichi; Nakakita, Yukari] Kagawa Univ, Div Funct Glyc, Miki, Kagawa 7610793, Japan; [Itoh, Aiko; Nishi, Nozomu] Kagawa Univ, Div Res Instrument & Equipment, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Nonaka, Yasuhiro; Ogawa, Takashi; Nakamura, Takanori] Kagawa Univ, Dept Endocrinol, Fac Med, Miki, Kagawa 7610793, Japan	Kagawa University; Kagawa University; Kagawa University	Nishi, N (corresponding author), Kagawa Univ, Div Res Instrument & Equipment, Life Sci Res Ctr, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nnishi@med.kagawa-u.ac.jp		Nishi, Nozomu/0000-0001-7050-3226; Nonaka, Yasuhiro/0000-0003-0302-5409	Japan Society for the Promotion of Science [15K06974]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (C) 15K06974 (to N. N.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; FULLMER CS, 1984, ANAL BIOCHEM, V142, P336, DOI 10.1016/0003-2697(84)90473-1; He WT, 2009, TRANSPLANTATION, V88, P782, DOI 10.1097/TP.0b013e3181b47f25; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Hua S, 2012, ANAL BIOANAL CHEM, V403, P1291, DOI 10.1007/s00216-011-5109-x; ISHIDA N, 1982, EMBO J, V1, P1117, DOI 10.1002/j.1460-2075.1982.tb01306.x; Iwaki J, 2011, BBA-GEN SUBJECTS, V1810, P643, DOI 10.1016/j.bbagen.2011.04.001; Jung ID, 2009, CELL SIGNAL, V21, P1698, DOI 10.1016/j.cellsig.2009.07.008; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; KOFLER H, 1992, MOL IMMUNOL, V29, P161, DOI 10.1016/0161-5890(92)90097-H; Linwong W, 2005, BRIT J PHARMACOL, V145, P818, DOI 10.1038/sj.bjp.0706240; LIU FT, 1982, P NATL ACAD SCI-BIOL, V79, P7852, DOI 10.1073/pnas.79.24.7852; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Nagae M, 2015, CURR OPIN STRUC BIOL, V34, P108, DOI 10.1016/j.sbi.2015.08.005; Nagae M, 2014, STRUCTURE, V22, P1711, DOI 10.1016/j.str.2014.09.009; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Pioche-Durieu C, 2005, J VIROL, V79, P13326, DOI 10.1128/JVI.79.21.13326-13337.2005; Plomp R, 2014, J PROTEOME RES, V13, P536, DOI 10.1021/pr400714w; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Sumiyoshi W, 2010, BIOSCI BIOTECH BIOCH, V74, P606, DOI 10.1271/bbb.90821; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang F, 2003, ANAL BIOCHEM, V314, P266, DOI 10.1016/S0003-2697(02)00693-0; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	36	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					968	979		10.1074/jbc.M115.694448	http://dx.doi.org/10.1074/jbc.M115.694448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582205	Green Published, hybrid			2022-12-28	WOS:000367830500042
J	Albesa-Jove, D; Comino, N; Tersa, M; Mohorko, E; Urresti, S; Dainese, E; Chiarelli, LR; Pasca, MR; Manganelli, R; Makarov, V; Riccardi, G; Svergun, DI; Glockshuber, R; Guerin, ME				Albesa-Jove, David; Comino, Natalia; Tersa, Montse; Mohorko, Elisabeth; Urresti, Saioa; Dainese, Elisa; Chiarelli, Laurent R.; Pasca, Maria Rosalia; Manganelli, Riccardo; Makarov, Vadim; Riccardi, Giovanna; Svergun, Dmitri I.; Glockshuber, Rudi; Guerin, Marcelo E.			The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; HIGH-RESOLUTION; INFLUENZA HEMAGGLUTININ; THIOREDOXIN; TUBERCULOSIS; SCATTERING; MECHANISM; SYSTEM; DSBA; TRANSFERASES	Rv2466c is a key oxidoreductase that mediates the reductive activation of TP053, a thienopyrimidine derivative that kills replicating and non-replicating Mycobacterium tuberculosis, but whose mode of action remains enigmatic. Rv2466c is a homodimer in which each subunit displays a modular architecture comprising a canonical thioredoxin-fold with a Cys(19)-Pro(20)-Trp(21)-Cys(22) motif, and an insertion consisting of a four alpha-helical bundle and a short alpha-helical hairpin. Strong evidence is provided for dramatic conformational changes during the Rv2466c redox cycle, which are essential for TP053 activity. Strikingly, a new crystal structure of the reduced form of Rv2466c revealed the binding of a C-terminal extension in alpha-helical conformation to a pocket next to the active site cysteine pair at the interface between the thioredoxin domain and the helical insertion domain. The ab initio low-resolution envelopes obtained from small angle x-ray scattering showed that the fully reduced form of Rv2466c adopts a "closed" compact conformation in solution, similar to that observed in the crystal structure. In contrast, the oxidized form of Rv2466c displays an "open" conformation, where tertiary structural changes in the alpha-helical subdomain suffice to account for the observed conformational transitions. Altogether our structural, biochemical, and biophysical data strongly support a model in which the formation of the catalytic disulfide bond upon TP053 reduction triggers local structural changes that open the substrate binding site of Rv2466c allowing the release of the activated, reduced form of TP053. Our studies suggest that similar structural changes might have a functional role in other members of the thioredoxin-fold superfamily.	[Albesa-Jove, David; Comino, Natalia; Tersa, Montse; Urresti, Saioa; Guerin, Marcelo E.] Univ Basque Country, Ctr Mixto Consejo Super Invest Cientif, Euskal Herriko Unibertsitatea, CSIC,Unidad Biofis, Leioa 48940, Bizkaia, Spain; [Albesa-Jove, David; Comino, Natalia; Tersa, Montse; Urresti, Saioa; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa 48940, Bizkaia, Spain; [Albesa-Jove, David; Guerin, Marcelo E.] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [Mohorko, Elisabeth; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Dainese, Elisa; Manganelli, Riccardo] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Chiarelli, Laurent R.; Pasca, Maria Rosalia; Riccardi, Giovanna] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Makarov, Vadim] Russian Acad Sci, AN Bakh Inst Biochem, Moscow 119071, Russia; [Svergun, Dmitri I.] DESY, Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Pavia; University of Pavia; Research Center of Biotechnology RAS; Russian Academy of Sciences; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Guerin, ME (corresponding author), Univ Basque Country, Ctr Mixto Consejo Super Invest Cientif, Euskal Herriko Unibertsitatea, CSIC,Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	mrcguerin@gmail.com	Pasca, Maria Rosalia/J-8752-2016; Albesa-Jové, David/F-5683-2016; Albesa-Jové, David/O-3822-2019; Makarov, Vadim/HGB-7756-2022; Makarov, Vadim/AAE-5483-2021; Manganelli, Riccardo/A-7361-2009; Chiarelli, Laurent Roberto/J-8368-2016; Guerin, Marcelo M/N-7245-2016	Pasca, Maria Rosalia/0000-0002-8906-4937; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Makarov, Vadim/0000-0001-8746-2694; Makarov, Vadim/0000-0001-8746-2694; Manganelli, Riccardo/0000-0003-0940-7336; Chiarelli, Laurent Roberto/0000-0003-0348-9764; Guerin, Marcelo M/0000-0001-9524-3184; Comino, Natalia/0000-0001-8924-8819; Tersa, Montse/0000-0002-2370-7776; RICCARDI, Giovanna/0000-0003-3295-0070; Urresti, Saioa/0000-0002-8678-8358	European Commission [HEALTH-F3-2011-260872, 283570]; Spanish Ministry of Economy and Competitiveness [BIO2013-49022-C2-2-R]; Basque Government	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government)	This work was supported by European Commission Contract HEALTH-F3-2011-260872, the Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R, and the Basque Government (to M. E. G.), the European Commission FP7 Programme under BioStruct-X Grant 283570, Diamond Light Source Proposals mx8302/10130, and SOLEIL Proposal 20140843. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albesa-Jove D, 2014, ACS CHEM BIOL, V9, P1567, DOI 10.1021/cb500149m; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; CARR CM, 1994, SCIENCE, V266, P234, DOI 10.1126/science.7939658; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen J, 2013, SCIENCE, V339, P130, DOI 10.1126/science.339.6116.130; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giganti D, 2013, J BIOL CHEM, V288, P29797, DOI 10.1074/jbc.M113.462705; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mazon H, 2007, J BIOL CHEM, V282, P11281, DOI 10.1074/jbc.M611177200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Neres J, 2015, ACS CHEM BIOL, V10, P705, DOI 10.1021/cb5007163; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; SINGH R, 1990, J AM CHEM SOC, V112, P1190, DOI 10.1021/ja00159a046; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WHO, 2014, GLOB TUB REP 2013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	59	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31077	31089		10.1074/jbc.M115.677039	http://dx.doi.org/10.1074/jbc.M115.677039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26546681	hybrid, Green Published			2022-12-28	WOS:000367199000036
J	Wagner, GK; Pesnot, T; Palcic, MM; Jorgensen, R				Wagner, Gerd K.; Pesnot, Thomas; Palcic, Monica M.; Jorgensen, Rene			Novel UDP-GaINAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; GROUP-A GLYCOSYLTRANSFERASE; GROUP-B; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SUBSTRATE; INHIBITORS; ANALOGS; BINDING; SUGARS	Two closely related glycosyltransferases are responsible for the final step of the biosynthesis of ABO(H) human blood group A and B antigens. The two enzymes differ by only four amino acid residues, which determine whether the enzymes transfer GalNAc from UDP-GalNAc or Gal from UDP-Gal to the H-antigen acceptor. The enzymes belong to the class of GT-A folded enzymes, grouped as GT6 in the CAZy database, and are characterized by a single domain with a metal dependent retaining reaction mechanism. However, the exact role of the four amino acid residues in the specificity of the enzymes is still unresolved. In this study, we report the first structural information of a dual specificity cis-AB blood group glycosyltransferase in complex with a synthetic UDP-GalNAc derivative. Interestingly, the GalNAc moiety adopts an unusual yet catalytically productive conformation in the binding pocket, which is different from the "tucked under" conformation previously observed for the UDPGal donor. In addition, we show that this UDP-GalNAc derivative in complex with the H-antigen acceptor provokes the same unusual binding pocket closure as seen for the corresponding UDP-Gal derivative. Despite this, the two derivatives show vastly different kinetic properties. Our results provide a important structural insight into the donor substrate specificity and utilization in blood group biosynthesis, which can very likely be exploited for the development of new glycosyltransferase inhibitors and probes.	[Wagner, Gerd K.] Kings Coll London, Fac Nat & Math Sci, Dept Chem, London SE1 1DB, England; [Pesnot, Thomas] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Palcic, Monica M.; Jorgensen, Rene] Carlsberg Lab, DK-1799 Copenhagen V, Denmark	University of London; King's College London; University of East Anglia	Jorgensen, R (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen S, Denmark.	renj@ssi.dk	Wagner, Gerd/D-4759-2013; Jørgensen, René/P-5619-2014	Wagner, Gerd/0000-0003-1086-2301; Jørgensen, René/0000-0003-0672-466X	Engineering and Physical Sciences Research Council [EP/D059186/1]; Medical Research Council [G0901746]; Danish Council for Independent Research/Natural Sciences; DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant [11-104831/FSS]; EPSRC [EP/D059186/1] Funding Source: UKRI; MRC [G0901746] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Engineering and Physical Sciences Research Council Grant EP/D059186/1 (to G. K. W.), Medical Research Council Grant G0901746 (to G. K. W.), and the Danish Council for Independent Research/Natural Sciences (FNU, to M. M. P.). The authors declare that they have no conflicts of interests of this article.; Supported by the DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant 11-104831/FSS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collier A, 2008, CHEM COMMUN, P178, DOI 10.1039/b714379f; Descroix K, 2012, J MED CHEM, V55, P2015, DOI 10.1021/jm201154p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evitt A, 2012, CHEM COMMUN, V48, P11856, DOI 10.1039/c2cc36798j; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Jorgensen R, 2013, J BIOL CHEM, V288, P26201, DOI 10.1074/jbc.M113.465963; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pesnot T, 2008, ORG BIOMOL CHEM, V6, P2884, DOI 10.1039/b805216f; Pesnot T, 2010, CHEMBIOCHEM, V11, P1392, DOI 10.1002/cbic.201000013; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Pham TTK, 2014, J BIOL CHEM, V289, P8041, DOI 10.1074/jbc.M113.545384; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; SETO NOL, 1995, EUR J BIOCHEM, V234, P323, DOI 10.1111/j.1432-1033.1995.323_c.x; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; Soya N, 2009, GLYCOBIOLOGY, V19, P1224, DOI 10.1093/glycob/cwp114; Tedaldi LM, 2012, CARBOHYD RES, V364, P22, DOI 10.1016/j.carres.2012.10.009; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Wagstaff BA, 2015, CARBOHYD RES, V404, P17, DOI 10.1016/j.carres.2014.12.005; Weadge J. T., 2008, WILEY ENCY CHEM BIOL, V2, P198; Wittmann V, 1997, J ORG CHEM, V62, P2144, DOI 10.1021/jo9620066; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yamamoto M, 2001, J BIOL CHEM, V276, P13701, DOI 10.1074/jbc.M010805200; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	44	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31162	31172		10.1074/jbc.M115.681262	http://dx.doi.org/10.1074/jbc.M115.681262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527682	hybrid, Green Published			2022-12-28	WOS:000367199000043
J	Tseng, YT; Chiou, NT; Gogiraju, R; Lin-Chao, S				Tseng, Yi-Ting; Chiou, Ni-Ting; Gogiraju, Rajinikanth; Lin-Chao, Sue			The Protein Interaction of RNA Helicase B (RhlB) and Polynucleotide Phosphorylase (PNPase) Contributes to the Homeostatic Control of Cysteine in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE ACETYLTRANSFERASE; SALMONELLA-TYPHIMURIUM; GLOBAL ANALYSIS; TERMINAL HALF; L-CYSTINE; DEGRADATION; EXOSOME; DEGRADOSOME; EXPRESSION; BINDING	PNPase, one of the major enzymes with 3' to 5' single-stranded RNA degradation and processing activities, can interact with the RNA helicase RhlB independently of RNA degradosome formation in Escherichia coli. Here, we report that loss of interaction between RhlB and PNPase impacts cysteine homeostasis in E. coli. By random mutagenesis, we identified a mutant RhlBP238L that loses 75% of its ability to interact with PNPase but retains normal interaction with RNase E and RNA, in addition to exhibiting normal helicase activity. Applying microarray analyses to an E. coli strain with impaired RNA degradosome formation, we investigated the biological consequences of a weakened interaction between RhlB and PNPase. We found significant increases in 11 of 14 genes involved in cysteine biosynthesis. Subsequent Northern blot analyses showed that the up-regulated transcripts were the result of stabilization of the cysB transcript encoding a transcriptional activator for the cys operons. Furthermore, Northern blots of PNPase or RhlB mutants showed that RhlB-PNPase plays both a catalytic and structural role in regulating cysB degradation. Cells expressing the RhlBP238L mutant exhibited an increase in intracellular cysteine and an enhanced anti-oxidative response. Collectively, this study suggests a mechanism by which bacteria use the PNPase-RhlB exosome-like complex to combat oxidative stress by modulating cysB mRNA degradation.	[Tseng, Yi-Ting; Chiou, Ni-Ting; Gogiraju, Rajinikanth; Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Tseng, Yi-Ting] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10617, Taiwan; [Chiou, Ni-Ting] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University	Lin-Chao, S (corresponding author), Acad Sinica, Inst Mol Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304; Gogiraju, Rajinikanth/0000-0003-1284-9338	Ministry of Science and Technology, Taiwan [NSC 100-2321-B-001-002, MOST 101-2311-B-001-020-MY3]; Academia Sinica [AS 034006, 022323]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Grants NSC 100-2321-B-001-002 and MOST 101-2311-B-001-020-MY3 from the Ministry of Science and Technology, Taiwan, and by Grants AS 034006 and 022323 from Academia Sinica (to S. L.-C.). The authors declare that they have no conflicts of interest with the contents of this article.	BARRETT EL, 1979, J GEN MICROBIOL, V115, P513, DOI 10.1099/00221287-115-2-513; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blum E, 1997, MOL MICROBIOL, V26, P387, DOI 10.1046/j.1365-2958.1997.5901947.x; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen XG, 2013, CELL, V153, P166, DOI 10.1016/j.cell.2013.02.037; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DENK D, 1987, J GEN MICROBIOL, V133, P515; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; Hayakawa H, 2001, BIOCHEMISTRY-US, V40, P9977, DOI 10.1021/bi010595q; Hayakawa H, 2006, BIOCHEMISTRY-US, V45, P6749, DOI 10.1021/bi052585l; Henry A, 2012, FEMS MICROBIOL LETT, V336, P139, DOI 10.1111/j.1574-6968.12000.x; HOLTKE HJ, 1995, CELL MOL BIOL, V41, P883; HRYNIEWICZ MM, 1994, J BACTERIOL, V176, P3673, DOI 10.1128/JB.176.12.3673-3682.1994; Januszyk K, 2010, ADV EXP MED BIOL, V702, P9, DOI 10.1007/978-1-4419-7841-7_2; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; KARI C, 1971, J GEN MICROBIOL, V68, P349, DOI 10.1099/00221287-68-3-349; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lascano Ramiro, 2011, P135; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mohanty BK, 2006, NUCLEIC ACIDS RES, V34, P5695, DOI 10.1093/nar/gkl684; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Nakamori S, 1998, APPL ENVIRON MICROB, V64, P1607; Nurmohamed S, 2011, J BIOL CHEM, V286, P14315, DOI 10.1074/jbc.M110.200741; OSTROWSKI J, 1991, J BACTERIOL, V173, P2212, DOI 10.1128/JB.173.7.2212-2218.1991; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Shuford CM, 2012, ANAL BIOANAL CHEM, V402, P357, DOI 10.1007/s00216-011-5416-2; Singh D, 2009, P NATL ACAD SCI USA, V106, P864, DOI 10.1073/pnas.0810205106; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; Takagi H, 1999, FEMS MICROBIOL LETT, V179, P453, DOI 10.1111/j.1574-6968.1999.tb08762.x; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Turnbull AL, 2010, RES MICROBIOL, V161, P643, DOI [10.1016/J.resmic.2010.06.004, 10.1016/j.resmic.2010.06.004]; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Wong AG, 2013, J BACTERIOL, V195, P2021, DOI 10.1128/JB.00062-13; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xiao M, 2011, MICROBIOL-SGM, V157, P1573, DOI 10.1099/mic.0.044297-0; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Zhou L, 2013, MOL BIOSYST, V9, P750, DOI 10.1039/c3mb25513a; Zilhao R, 1996, MOL MICROBIOL, V20, P1033, DOI 10.1111/j.1365-2958.1996.tb02544.x	59	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29953	29963		10.1074/jbc.M115.691881	http://dx.doi.org/10.1074/jbc.M115.691881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26494621	hybrid, Green Published			2022-12-28	WOS:000366614700027
J	Rienzo, M; Rocchi, AR; Threatt, SD; Dougherty, DA; Lummis, SCR				Rienzo, Matthew; Rocchi, Angela R.; Threatt, Stephanie D.; Dougherty, Dennis A.; Lummis, Sarah C. R.			Perturbation of Critical Prolines in Gloeobacter violaceus Ligand-gated Ion Channel (GLIC) Supports Conserved Gating Motions among Cys-loop Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop receptor; electrophysiology; non-standard mutagenesis; protein conformation; structure-function; Gloeobacter violaceus; proline analogs; non-canonical amino acid; nonsense suppression; mutagenesis	X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRANSMEMBRANE ALPHA-HELIX; ALLOSTERIC MODULATION; STRUCTURAL INSIGHTS; MECHANISM; CONFORMATION; ISOMERIZATION; TRAFFICKING; ANESTHETICS	Gloeobacter violaceus ligand-gated ion channel (GLIC) has served as a valuable structural and functional model for the eukaryotic Cys-loop receptor superfamily. In Cys-loop and other receptors, we have previously demonstrated the crucial roles played by several conserved prolines. Here we explore the role of prolines in the gating transitions of GLIC. As conventional substitutions at some positions resulted in nonfunctional proteins, we used in vivo non-canonical amino acid mutagenesis to determine the specific structural requirements at these sites. Receptors were expressed heterologously in Xenopus laevis oocytes, and whole-cell electrophysiology was used to monitor channel activity. Pro-119 in the Cys-loop, Pro-198 and Pro-203 in the M1 helix, and Pro-299 in the M4 helix were sensitive to substitution, and distinct roles in receptor activity were revealed for each. In the context of the available structural data for GLIC, the behaviors of Pro-119, Pro-203, and Pro-299 mutants are consistent with earlier proline mutagenesis work. However, the Pro-198 site displays a unique phenotype that gives evidence of the importance of the region surrounding this residue for the correct functioning of GLIC.	[Rienzo, Matthew; Threatt, Stephanie D.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA; [Rocchi, Angela R.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England	California Institute of Technology; University of Cambridge	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu		Rienzo, Matthew/0000-0002-9389-1310	National Institutes of Health [NS 34407]; Wellcome Trust [WT 81925]; National Institutes of Health/National Research Service Award Training [GM07616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health/National Research Service Award Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS 34407 (to D. A. D.) and the Wellcome Trust Grant WT 81925 (to S. C. R. L.) and by National Institutes of Health/National Research Service Award Training Grant GM07616 (to M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alqazzaz M, 2011, BIOPHYS J, V101, P2912, DOI 10.1016/j.bpj.2011.10.055; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Dang H, 2000, MOL PHARMACOL, V57, P1114; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; England PM, 1999, TETRAHEDRON LETT, V40, P6189, DOI 10.1016/S0040-4039(99)01300-3; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henault CM, 2015, J BIOL CHEM, V290, P25118, DOI 10.1074/jbc.M115.676833; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Limapichat W, 2010, J BIOL CHEM, V285, P8976, DOI 10.1074/jbc.M109.060939; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pandey AK, 2013, J AM CHEM SOC, V135, P4333, DOI 10.1021/ja3109664; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rienzo M, 2014, CHEM BIOL, V21, P1700, DOI 10.1016/j.chembiol.2014.10.019; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Tasneem A, 2005, GENOME BIOL, V6; Van Arnam EB, 2011, ACS CHEM BIOL, V6, P1063, DOI 10.1021/cb200153g; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	35	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6272	6280		10.1074/jbc.M115.694372	http://dx.doi.org/10.1074/jbc.M115.694372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26668320	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000372894200018
J	Kretschmer, I; Freudenberger, T; Twarock, S; Yamaguchi, Y; Grandoch, M; Fischer, JW				Kretschmer, Inga; Freudenberger, Till; Twarock, Soeren; Yamaguchi, Yu; Grandoch, Maria; Fischer, Jens W.			Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell-cell interaction; chemokine; fibroblast; hyaluronan; CCL11; CCL5	CANCER-ASSOCIATED FIBROBLASTS; LUNG-CANCER; SELECTIVE EXPRESSION; EOTAXIN CCL11; COLON-CANCER; TGF-BETA; GROWTH; PROMOTES; TRANSCRIPTION; EOSINOPHILS	The aim of this study was to characterize the interaction of KYSE-410, an esophageal squamous cell carcinoma cell line, and fibroblasts with respect to the extracellular matrix component hyaluronan (HA) and chemokine expression. KYSE-410 cells induced the mRNA expression of HA synthase 2 (Has2) in normal skin fibroblasts (SF) only in direct co-cultures. Parallel to Has2 mRNA, Has2 antisense RNA (Has2os2) was up-regulated in co-cultures. Knockdown of LEF1, a downstream target of Wnt signaling, abrogated Has2 and Has2os2 induction. After knockdown of Has2 in SF, significantly less -smooth muscle actin expression was detected in co-cultures. Moreover, it was investigated whether the phenotype of KYSE-410 was affected in co-culture with SF and whether Has2 knockdown in SF had an impact on KYSE-410 cells in co-culture. However, no effects on epithelial-mesenchymal transition markers, proliferation, and migration were detected. In addition to Has2 mRNA, the chemokine CCL5 was up-regulated and CCL11 was down-regulated in SF in co-culture. Furthermore, co-cultures of KYSE-410 cells and cancer-associated fibroblasts (CAF) were investigated. Similar to SF, Has2 and Ccl5 were up-regulated and Ccl11 was down-regulated in CAF in co-culture. Importantly and in contrast to SF, inhibiting HA synthesis by 4-methylumbelliferone abrogated the effect of co-culture on Ccl5 in CAF. Moreover, HA was found to promote adhesion of CD4(+) but not CD8(+) cells to xenogaft tumor tissues. In conclusion, direct co-culture of esophageal squamous cell carcinoma and fibroblasts induced stromal HA synthesis via Wnt/LEF1 and altered the chemokine profile of stromal fibroblasts, which in turn may affect the tumor immune response.	[Kretschmer, Inga; Freudenberger, Till; Twarock, Soeren; Grandoch, Maria; Fischer, Jens W.] Univ Dusseldorf, Univ Klinikum, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany; [Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA	Heinrich Heine University Dusseldorf; Sanford Burnham Prebys Medical Discovery Institute	Kretschmer, I (corresponding author), Univ Dusseldorf, Univ Klinikum, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de	Twarock, Sören/AAB-7705-2020	Twarock, Sören/0000-0001-9252-1353	Deutsche Forschungsgemeinschaft [FI682/4-1, GRK 1739]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grants FI682/4-1 and GRK 1739. The authors declare that they have no conflicts of interest with the contents of this article.	Alaniz L, 2009, CANCER LETT, V278, P9, DOI 10.1016/j.canlet.2008.12.029; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Black KE, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-23; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Cirri P, 2011, AM J CANCER RES, V1, P482; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jamieson C, 2012, INT J BIOCHEM CELL B, V44, P847, DOI 10.1016/j.biocel.2012.03.001; Jayasinghe MM, 2008, BREAST CANCER RES TR, V111, P511, DOI 10.1007/s10549-007-9802-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kataoka S, 2004, DNA CELL BIOL, V23, P549, DOI 10.1089/dna.2004.23.549; Kim SH, 2013, ANTICANCER RES, V33, P2001; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu JY, 2015, ONCOTARGET, V6, P24978, DOI 10.18632/oncotarget.4617; Liu NF, 2001, CANCER RES, V61, P5207; Maeda-Sano K, 2014, BBA-MOL CELL BIOL L, V1841, P1256, DOI 10.1016/j.bbalip.2014.05.004; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Mi ZY, 2011, CARCINOGENESIS, V32, P477, DOI 10.1093/carcin/bgr009; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Muller J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0440-y; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Pasonen-Seppanen S, 2012, HISTOCHEM CELL BIOL, V138, P895, DOI 10.1007/s00418-012-1000-x; Pirinen R, 2001, INT J CANCER, V95, P12, DOI 10.1002/1097-0215(20010120)95:1<12::AID-IJC1002>3.0.CO;2-E; Rajaram M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003789; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Sakko AJ, 2001, CANCER RES, V61, P926; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Soon PSH, 2013, ENDOCR-RELAT CANCER, V20, P1, DOI 10.1530/ERC-12-0227; Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vicent S, 2012, CANCER RES, V72, P5744, DOI 10.1158/0008-5472.CAN-12-1097; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Wan XH, 2012, CLIN CANCER RES, V18, P726, DOI 10.1158/1078-0432.CCR-11-2521; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Willenberg A, 2012, J INVEST DERMATOL, V132, P385, DOI 10.1038/jid.2011.325; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhang QF, 2015, CANCER RES, V75, P4312, DOI 10.1158/0008-5472.CAN-14-3590; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	72	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4091	4106		10.1074/jbc.M115.708909	http://dx.doi.org/10.1074/jbc.M115.708909			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26699196	Green Published, hybrid			2022-12-28	WOS:000371338400034
J	Oue, K; Zhang, J; Harada-Hada, K; Asano, S; Yamawaki, Y; Hayashiuchi, M; Furusho, H; Takata, T; Irifune, M; Hirata, M; Kanematsu, T				Oue, Kana; Zhang, Jun; Harada-Hada, Kae; Asano, Satoshi; Yamawaki, Yosuke; Hayashiuchi, Masaki; Furusho, Hisako; Takata, Takashi; Irifune, Masahiro; Hirata, Masato; Kanematsu, Takashi			Phospholipase C-related Catalytically Inactive Protein Is a New Modulator of Thermogenesis Promoted by -Adrenergic Receptors in Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipose tissue metabolism; lipolysis; obesity; uncoupling protein; thermogenesis	HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; UPSTREAM ENHANCER; BINDING-PROTEIN; FAT DEVELOPMENT; PHOSPHATASE 2A; PPAR-ALPHA; RAT; EXPRESSION; TRANSCRIPTION	Phospholipase C-related catalytically inactive protein (PRIP) was first identified as an inositol 1,4,5-trisphosphate-binding protein, and was later found to be involved in a variety of cellular events, particularly those related to protein phosphatases. We previously reported that Prip knock-out (KO) mice exhibit a lean phenotype with a small amount of white adipose tissue. In the present study, we examined whether PRIP is involved in energy metabolism, which could explain the lean phenotype, using high-fat diet (HFD)-fed mice. Prip-KO mice showed resistance to HFD-induced obesity, resulting in protection from glucose metabolism dysfunction and insulin resistance. Energy expenditure and body temperature at night were significantly higher in Prip-KO mice than in wild-type mice. Gene and protein expression of uncoupling protein 1 (UCP1), a thermogenic protein, was up-regulated in Prip-KO brown adipocytes in thermoneutral or cold environments. These phenotypes were caused by the promotion of lipolysis in Prip-KO brown adipocytes, which is triggered by up-regulation of phosphorylation of the lipolysis-related proteins hormone-sensitive lipase and perilipin, followed by activation of UCP1 and/or up-regulation of thermogenesis-related genes (e.g. peroxisome proliferator-activated receptor- coactivator-1). The results indicate that PRIP negatively regulates UCP1-mediated thermogenesis in brown adipocytes.	[Oue, Kana; Zhang, Jun; Harada-Hada, Kae; Asano, Satoshi; Yamawaki, Yosuke; Hayashiuchi, Masaki; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima 7348553, Japan; [Oue, Kana; Irifune, Masahiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Anesthesiol, Hiroshima 7348553, Japan; [Furusho, Hisako; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Zhang, Jun] Univ Tokushima, Inst Genome Res, Div Mol Biol, Tokushima 770, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Kyushu University; Tokushima University	Kanematsu, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima 7348553, Japan.	tkanema2@hiroshima-u.ac.jp	Yamawaki, Yosuke/AAE-9868-2020; Asano, Satoshi/AAQ-3817-2020; Furusho, Hisako/H-2351-2019; Yamawaki, Yosuke/Q-1796-2019; Harada, Kae/AAT-1162-2020	Yamawaki, Yosuke/0000-0002-7247-8295; Harada, Kae/0000-0001-7620-9212; Asano, Satoshi/0000-0003-1537-4307	Funding Program for Next Generation World-Leading Researchers Grant [LS087]; JSPS KAKENHI [266708090, 15H06433, 24229009]; Grants-in-Aid for Scientific Research [15K11313, 15K11039, 15H06433] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Funding Program for Next Generation World-Leading Researchers Grant LS087 (to T.K.) and JSPS KAKENHI Grants 266708090 (to T.K.), 15H06433 (to O.K.), and 24229009 (to M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Clifford GM, 1998, FEBS LETT, V435, P125, DOI 10.1016/S0014-5793(98)01052-7; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Galmozzi A, 2014, CELL REPORT, V9, P1; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Harada-Hada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098285; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hernandez A, 2011, CELL PHYSIOL BIOCHEM, V28, P969, DOI 10.1159/000335810; Hirata M, 2011, DIABETES, V60, P1926, DOI 10.2337/db10-1500; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Kitayama T, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-23; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; MCLEAN JA, 1987, MED BIOL ENG COMPUT, V25, P239; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; NICHOLLS DG, 1974, EUR J BIOCHEM, V49, P585, DOI 10.1111/j.1432-1033.1974.tb03862.x; Okumura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100559; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Umebayashi H, 2013, BIOCHEM BIOPH RES CO, V432, P268, DOI 10.1016/j.bbrc.2013.01.119; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WOOD SL, 1993, BIOCHEM J, V295, P531, DOI 10.1042/bj2950531; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	49	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4185	4196		10.1074/jbc.M115.705723	http://dx.doi.org/10.1074/jbc.M115.705723			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26706316	Green Published, hybrid			2022-12-28	WOS:000371338400042
J	Giri, J; Srivastav, S; Basu, M; Palit, S; Gupta, P; Ukil, A				Giri, Jayeeta; Srivastav, Supriya; Basu, Moumita; Palit, Shreyasi; Gupta, Purnima; Ukil, Anindita			Leishmania donovani Exploits Myeloid Cell Leukemia 1 (MCL-1) Protein to Prevent Mitochondria-dependent Host Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; B-cell lymphoma 2 (Bcl-2) family; cytochrome c; Leishmania; macrophage	TOXOPLASMA-GONDII; SIGNALING PATHWAY; CYTOCHROME-C; MACROPHAGES; ACTIVATION; INHIBITION; BCL-2; TRANSCRIPTION; INVOLVEMENT; RESISTANCE	Apoptosis is one of the mechanisms used by host cells to remove unwanted intracellular organisms, and often found to be subverted by pathogens through use of host anti-apoptotic proteins. In the present study, with the help of in vitro and in vivo approaches, we documented that the macrophage anti-apoptotic protein myeloid cell leukemia 1 (MCL-1) is exploited by the intra-macrophage parasite Leishmania donovani to protect their home from actinomycin D-induced mitochondria-dependent apoptosis. Among all the anti-apoptotic BCL-2 family members, infection preferentially up-regulated expression of MCL-1 at both the mRNA and protein levels and compared with infected control, MCL-1-silenced infected macrophages documented enhanced caspase activity and increased apoptosis when subjected to actinomycin D treatment. Phosphorylation kinetics and ChIP assay demonstrated that infection-induced MCL-1 expression was regulated by transcription factor CREB (cAMP-response element-binding protein) and silencing of CREB resulted in reduced expression of MCL-1 and increased apoptosis. During infection, MCL-1 was found to be localized in mitochondria and this was significantly reduced in Tom70-silenced macrophages, suggesting the active role of TOM70 in MCL-1 transport. In the mitochondria, MCL-1 interacts with the major pro-apoptotic protein BAK and prevents BAK-BAK homo-oligomer formation thereby preventing cytochrome c release-mediated mitochondrial dysfunction. Silencing of MCL-1 in the spleen of infected mice showed decreased parasite burden and increased induction of splenocyte apoptosis. Collectively our results showed that L. donovani exploited the macrophage anti-apoptotic protein MCL-1 to prevent BAK-mediated mitochondria-dependent apoptosis thereby protecting its niche, which is essential for disease progression.	[Giri, Jayeeta; Basu, Moumita; Gupta, Purnima; Ukil, Anindita] Univ Calcutta, Dept Biochem, Kolkata, India; [Srivastav, Supriya; Palit, Shreyasi] CSIR, Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India	University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ukil, A (corresponding author), Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.	aninditau@yahoo.com	Gupta, Purnima/AAP-8717-2020; Basu, Moumita/AAP-8728-2020	GIRI, JAYEETA/0000-0002-2688-7274; BASU, MOUMITA/0000-0001-6691-5279; Gupta, Purnima/0000-0003-4389-3024	Department of Science and Technology [SB/WEA-013/2013, SB/SO/BB-0055/2013]; Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC); Indian Council of Medical Research (ICMR), Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Science and Technology Grants SB/WEA-013/2013 and SB/SO/BB-0055/2013, the Council of Scientific and Industrial Research (CSIR), University Grants Commission (UGC), and Indian Council of Medical Research (ICMR), Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; Alli OAT, 2000, INFECT IMMUN, V68, P6431, DOI 10.1128/IAI.68.11.6431-6440.2000; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; AYALA A, 1991, J IMMUNOL, V147, P4147; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Goebel S, 2001, J CELL SCI, V114, P3495; Griffin DE, 1999, TRENDS MICROBIOL, V7, P155, DOI 10.1016/S0966-842X(99)01470-5; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kausalya S, 2001, J IMMUNOL, V166, P4721, DOI 10.4049/jimmunol.166.7.4721; Koziel J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/427021; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; McIlwain DR, 2015, CSH PERSPECT BIOL, V7; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Moshynska O, 2004, JNCI-J NATL CANCER I, V96, P673, DOI 10.1093/jnci/djh122; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Shadab Md, 2011, Mol Biol Int, V2011, P343961, DOI 10.4061/2011/343961; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Srivastav S, 2014, J BIOL CHEM, V289, P1092, DOI 10.1074/jbc.M113.496323; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Williams G T, 1994, Trends Microbiol, V2, P463, DOI 10.1016/0966-842X(94)90648-3; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	54	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3496	3507		10.1074/jbc.M115.672873	http://dx.doi.org/10.1074/jbc.M115.672873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670606	Green Published, hybrid			2022-12-28	WOS:000370854500030
J	Mizutani, T; Ishizaka, A; Nihei, C				Mizutani, Taketoshi; Ishizaka, Aya; Nihei, Coh-ichi			Transferrin Receptor 1 Facilitates Poliovirus Permeation of Mouse Brain Capillary Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSGENIC MICE; RETROGRADE TRANSPORT; TISSUE TROPISM; BARRIER; POLIOMYELITIS; INTERFERON; EXPRESSION; COMPLEX; SYSTEM	As a possible route for invasion of the CNS, circulating poliovirus (PV) in the blood is believed to traverse the blood-brain barrier (BBB), resulting in paralytic poliomyelitis. However, the underlying mechanism is poorly understood. In this study, we demonstrated that mouse transferrin receptor 1 (mTfR1) is responsible for PV attachment to the cell surface, allowing invasion into the CNS via the BBB. PV interacts with the apical domain of mTfR1 on mouse brain capillary endothelial cells (MBEC4) in a dose-dependent manner via its capsid protein (VP1). Wefound that F-G, G-H, and H-I loops in VP1 are important for this binding. However, C-D, D-E, and E-F loops in VP1-fused Venus proteins efficiently penetrate MBEC4 cells. These results imply that the VP1 functional domain responsible for cell attachment is different from that involved in viral permeation of the brain capillary endothelium. We observed that co-treatment of MBEC4 cells with excess PV particles but not dextran resulted in blockage of transferrin transport into cells. Using the Transwell in vitro BBB model, transferrin co-treatment inhibited permeation of PV into MBEC4 cells and delayed further viral permeation via mTfR1 knockdown. With mTfR1 as a positive mediator of PV-host cell attachment and PV permeation of MBEC4 cells, our results indicate a novel role of TfR1 as a cellular receptor for human PV receptor/CD155-independent PV invasion of the CNS.	[Mizutani, Taketoshi; Ishizaka, Aya; Nihei, Coh-ichi] Microbial Chem Res Fdn BIKAKEN, Inst Microbial Chem, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan		Mizutani, T (corresponding author), Microbial Chem Res Fdn BIKAKEN, Inst Microbial Chem, Virol Lab, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	mizutanit@bikaken.or.jp		Mizutani, Taketoshi/0000-0002-1329-6512; Ishizaka, Aya/0000-0003-2800-2430	Japan Society for the Promotion of Science KAKENHI Grants [25670221, 15K14413, 15K19117, 21790437, 23659235]; Japan Agency for Medical Research and Development [15545492]	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by The Japan Society for the Promotion of Science KAKENHI Grants 25670221 and 15K14413 (to T. M.), 15K19117 (to A. I.), and 21790437 and 23659235 (to C. N.) and Japan Agency for Medical Research and Development Grant 15545492 (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	AOKI J, 1994, J BIOL CHEM, V269, P8431; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bordin ES, 1955, J CONSULT PSYCHOL, V19, P9, DOI 10.1037/h0047986; BRIGHTMAN MW, 1977, EXP EYE RES, V25, P1, DOI 10.1016/S0014-4835(77)80008-0; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Dohgu S, 2000, CELL MOL NEUROBIOL, V20, P781, DOI 10.1023/A:1007015228318; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; FISHMAN JB, 1987, J NEUROSCI RES, V18, P299, DOI 10.1002/jnr.490180206; Flanagan ML, 2008, J VIROL, V82, P938, DOI 10.1128/JVI.01397-07; FRIDEN PM, 1991, P NATL ACAD SCI USA, V88, P4771, DOI 10.1073/pnas.88.11.4771; Gromeier M, 1998, J VIROL, V72, P5056, DOI 10.1128/JVI.72.6.5056-5060.1998; HASHIDA R, 1986, CELL STRUCT FUNCT, V11, P343, DOI 10.1247/csf.11.343; HORIE H, 1994, J VIROL, V68, P681, DOI 10.1128/JVI.68.2.681-688.1994; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Ishizaka A, 2012, J BIOL CHEM, V287, P11924, DOI 10.1074/jbc.M111.322792; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; KAJIGAYA S, 1985, VIROLOGY, V142, P307, DOI 10.1016/0042-6822(85)90339-3; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; KOIKE S, 1994, ARCH VIROL, V139, P351, DOI 10.1007/BF01310797; Levy HC, 2010, J VIROL, V84, P4426, DOI 10.1128/JVI.02393-09; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Mizutani T, 2015, J BIOL CHEM, V290, P18391, DOI 10.1074/jbc.M115.657155; Mizutani T, 2014, FEBS LETT, V588, P1630, DOI 10.1016/j.febslet.2014.01.067; MUNOZ A, 1984, J GEN VIROL, V65, P377, DOI 10.1099/0022-1317-65-2-377; Nakamura Y, 2012, NEUROCHEM INT, V60, P448, DOI 10.1016/j.neuint.2011.08.018; Ohka S, 1998, VIROLOGY, V250, P67, DOI 10.1006/viro.1998.9360; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Ohka S, 2009, J VIROL, V83, P4995, DOI 10.1128/JVI.02225-08; Palermo LA, 2003, J VIROL, V77, P8915, DOI 10.1128/JVI.77.16.8915-8923.2003; PARDRIDGE WM, 1986, ENDOCR REV, V7, P314, DOI 10.1210/edrv-7-3-314; PARDRIDGE WM, 1987, METABOLISM, V36, P892, DOI 10.1016/0026-0495(87)90099-0; PARDRIDGE WM, 1985, J NEUROCHEM, V45, P1141, DOI 10.1111/j.1471-4159.1985.tb05534.x; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PUTNAK JR, 1981, MICROBIOL REV, V45, P287, DOI 10.1128/MMBR.45.2.287-315.1981; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; REN R, 1992, J VIROL, V66, P296, DOI 10.1128/JVI.66.1.296-304.1992; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; SABIN AB, 1956, SCIENCE, V123, P1151, DOI 10.1126/science.123.3209.1151; SCRABA DG, 1967, J MOL BIOL, V26, P67, DOI 10.1016/0022-2836(67)90261-6; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Yang WX, 1997, VIROLOGY, V229, P421, DOI 10.1006/viro.1997.8450; Zhang SH, 1997, J VIROL, V71, P4915, DOI 10.1128/JVI.71.7.4915-4920.1997	48	18	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2829	2836		10.1074/jbc.M115.690941	http://dx.doi.org/10.1074/jbc.M115.690941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26637351	hybrid, Green Published			2022-12-28	WOS:000369626900022
J	Yan, KZ; You, LY; Degerny, C; Ghorbani, M; Liu, X; Chen, LL; Li, L; Miao, DS; Yang, XJ				Yan, Kezhi; You, Linya; Degerny, Cindy; Ghorbani, Mohammad; Liu, Xin; Chen, Lulu; Li, Lin; Miao, Dengshun; Yang, Xiang-Jiao			The Chromatin Regulator BRPF3 Preferentially Activates the HBO1 Acetyltransferase but Is Dispensable for Mouse Development and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSE GENITOPATELLAR SYNDROME; ACUTE MYELOID-LEUKEMIA; DE-NOVO MUTATIONS; HISTONE ACETYLTRANSFERASE; PHD FINGER; CAENORHABDITIS-ELEGANS; CELL-PROLIFERATION; SEGMENTAL IDENTITY; GENE-EXPRESSION; HAT COMPLEXES	To interpret epigenetic information, chromatin readers utilize various protein domains for recognition of DNA and histone modifications. Some readers possess multidomains for modification recognition and are thus multivalent. Bromodomain- and plant homeodomain-linked finger-containing protein 3 (BRPF3) is such a chromatin reader, containing two plant homeodomain-linked fingers, one bromodomain and a PWWP domain. However, its molecular and biological functions remain to be investigated. Here, we report that endogenous BRPF3 preferentially forms a tetrameric complex with HBO1 (also known as KAT7) and two other subunits but not with related acetyltransferases such as MOZ, MORF, TIP60, and MOF(also known as KAT6A, KAT6B, KAT5, and KAT8, respectively). We have also characterized a mutant mouse strain with a lacZ reporter inserted at the Brpf3 locus. Systematic analysis of beta-galactosidase activity revealed dynamic spatiotemporal expression of Brpf3 during mouse embryogenesis and high expression in the adult brain and testis. Brpf3 disruption, however, resulted in no obvious gross phenotypes. This is in stark contrast to Brpf1 and Brpf2, whose loss causes lethality at E9.5 and E15.5, respectively. In Brpf3-null mice and embryonic fibroblasts, RT-quantitative PCR uncovered no changes in levels of Brpf1 and Brpf2 transcripts, confirming no compensation from them. These results indicate that BRPF3 forms a functional tetrameric complex with HBO1 but is not required for mouse development and survival, thereby distinguishing BRPF3 from its paralogs, BRPF1 and BRPF2.	[Yan, Kezhi; You, Linya; Degerny, Cindy; Ghorbani, Mohammad; Liu, Xin; Li, Lin; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; You, Linya; Ghorbani, Mohammad; Li, Lin; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Chen, Lulu; Miao, Dengshun] Nanjing Med Univ, Dept Human Anat, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada; [You, Linya] Stanford Univ, 1201 Welch Rd,MSLS P151, Stanford, CA 94305 USA; [Degerny, Cindy] Maitre Conf Univ Paris Sud, CEA Saclay, Batiment 144,Porte 65,Point Courrier 22, F-91191 Gif Sur Yvette, France	McGill University; McGill University; McGill University; Nanjing Medical University; McGill University; Stanford University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		Miao, Dengshun/0000-0002-2682-3502; You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research-National Science Foundation of China; Fonds de Recherche Sante-National Science Foundation of China	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research-National Science Foundation of China(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante-National Science Foundation of China	This work was supported by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada (to X.-J. Y.), Canadian Institutes of Health Research-National Science Foundation of China, and Fonds de Recherche Sante-National Science Foundation of China joint research initiatives (to D. M. and X.-J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017; Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chinen Y, 2014, GENE CHROMOSOME CANC, V53, P299, DOI 10.1002/gcc.22140; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Feng Y., 2015, EMBO J, DOI 10.15252/embj.201591293; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Foy RL, 2008, J BIOL CHEM, V283, P28817, DOI 10.1074/jbc.M801407200; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Kaufmann M. H., 1994, ATLAS MOUSE DEV; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Klein BJ, 2016, NUCLEIC ACIDS RES, V44, P472, DOI 10.1093/nar/gkv1321; Klein BJ, 2014, EPIGENETICS-US, V9, P186, DOI 10.4161/epi.26792; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Lubula MY, 2014, FEBS LETT, V588, P3844, DOI 10.1016/j.febslet.2014.09.028; Lynch H, 2013, BREAST J, V19, P520, DOI 10.1111/tbj.12145; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Mishima Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6872; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; O'Meara MM, 2010, GENETICS, V186, P1497, DOI 10.1534/genetics.110.123661; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Panagopoulos I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117010; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sanchez R, 2014, BBA-GENE REGUL MECH, V1839, P676, DOI 10.1016/j.bbagrm.2014.03.011; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Simo-Riudalbas L, 2015, CANCER RES, V75, P3936, DOI 10.1158/0008-5472.CAN-14-3702; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Szakszon K, 2013, AM J MED GENET A, V161A, P884, DOI 10.1002/ajmg.a.35848; Tahmasebi S, 2013, J BIOL CHEM, V288, P12791, DOI 10.1074/jbc.M113.465443; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tham E, 2015, AM J HUM GENET, V96, P507, DOI 10.1016/j.ajhg.2015.01.016; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yan KZ, 2012, METHODS MOL BIOL, V809, P445, DOI 10.1007/978-1-61779-376-9_29; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yang XJ, 2015, BBA-MOL CELL RES, V1853, P1818, DOI 10.1016/j.bbamcr.2015.04.014; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; You LY, 2015, J BIOL CHEM, V290, P11349, DOI 10.1074/jbc.M115.643189; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	75	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2647	2663		10.1074/jbc.M115.703041	http://dx.doi.org/10.1074/jbc.M115.703041			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26677226	Green Published, hybrid			2022-12-28	WOS:000369626900010
J	Chauhan, N; Han, GS; Somashekarappa, N; Gable, K; Dunn, T; Kohlwein, SD				Chauhan, Neha; Han, Gongshe; Somashekarappa, Niranjanakumari; Gable, Kenneth; Dunn, Teresa; Kohlwein, Sepp D.			Regulation of Sphingolipid Biosynthesis by the Morphogenesis Checkpoint Kinase Swe1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; LONG-CHAIN BASES; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; HEAT-STRESS; SERINE PALMITOYLTRANSFERASE; YEAST SPHINGOLIPIDS; ORMDL3 EXPRESSION; GLOBAL ANALYSIS; PHOSPHORYLATION	Sphingolipid (SL) biosynthesis is negatively regulated by the highly conserved endoplasmic reticulum-localized Orm family proteins. Defective SL synthesis in Saccharomyces cerevisiae leads to increased phosphorylation and inhibition of Orm proteins by the kinase Ypk1. Here we present evidence that the yeast morphogenesis checkpoint kinase, Swe1, regulates SL biosynthesis independent of the Ypk1 pathway. Deletion of the Swe1 kinase renders mutant cells sensitive to serine palmitoyltransferase inhibition due to impaired sphingoid long-chain base synthesis. Based on these data and previous results, we suggest that Swe1 kinase perceives alterations in SL homeostasis, activates SL synthesis, and may thus represent the missing regulatory link that controls the SL rheostat during the cell cycle.	[Chauhan, Neha; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, BioTechMed Graz, Humboldtstr 50-2, A-8010 Graz, Austria; [Han, Gongshe; Somashekarappa, Niranjanakumari; Gable, Kenneth; Dunn, Teresa] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Chauhan, Neha] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	University of Graz; Uniformed Services University of the Health Sciences - USA; Cornell University	Kohlwein, SD (corresponding author), Graz Univ, Inst Mol Biosci, BioTechMed Graz, Humboldtstr 50-2, A-8010 Graz, Austria.; Dunn, T (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA.	teresa.dunn-giroux@usuhs.edu; sepp.kohlwein@uni-graz.at	Chauhan, Neha/X-2271-2019	Chauhan, Neha/0000-0003-1497-3359; Kohlwein, Sepp Dieter/0000-0002-1030-0598	Austrian Science Funds (FWF) [SFB F 3005, W903]; NAWI Graz; National Institutes of Health [R21HD080181]; Austrian Science Fund (FWF) [W 901, F 3005] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080181] Funding Source: NIH RePORTER	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); NAWI Graz; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Austrian Science Funds (FWF) Projects SFB F 3005 LIPOTOX and Ph.D. program W903 Molecular Enzymology and NAWI Graz (to S. D. K.) and by National Institutes of Health Grant R21HD080181 (to T. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilera-Romero A, 2014, BBA-MOL CELL BIOL L, V1841, P647, DOI 10.1016/j.bbalip.2013.10.014; Ahn SH, 2001, MOL BIOL CELL, V12, P3589, DOI 10.1091/mbc.12.11.3589; Anastasia SD, 2012, J CELL BIOL, V197, P89, DOI 10.1083/jcb.201108108; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Chauhan N, 2015, P NATL ACAD SCI USA, V112, pE1077, DOI 10.1073/pnas.1423175112; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; CHEN P, 1993, MOL GEN GENET, V236, P443, DOI 10.1007/BF00277146; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Epstein S, 2012, MOL MICROBIOL, V84, P1018, DOI 10.1111/j.1365-2958.2012.08087.x; Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Fridberg A, 2008, J CELL SCI, V121, P522, DOI 10.1242/jcs.016741; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gomez-Munoz A, 2013, BBA-MOL CELL BIOL L, V1831, P1060, DOI 10.1016/j.bbalip.2013.02.001; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Humphrey Tim, 2004, V296, P3; Iwaki S, 2005, J BIOL CHEM, V280, P6520, DOI 10.1074/jbc.M410908200; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lee JY, 1998, BIOCHEM J, V334, P457, DOI 10.1042/bj3340457; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; Lester RL, 2013, BBA-MOL CELL BIOL L, V1831, P726, DOI 10.1016/j.bbalip.2012.12.012; Leu JY, 1999, MOL CELL, V4, P805, DOI 10.1016/S1097-2765(00)80390-1; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Matmati N, 2013, J BIOL CHEM, V288, P17272, DOI 10.1074/jbc.M112.444802; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Modrak DE, 2006, MOL CANCER THER, V5, P200, DOI 10.1158/1535-7163.MCT-05-0420; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mollapour M, 2010, CELL CYCLE, V9, P2310, DOI 10.4161/cc.9.12.12054; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Sawai H, 2005, CURR PHARM DESIGN, V11, P2479, DOI 10.2174/1381612054367463; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Sinclair DA, 2006, SCIENCE, V312, P195; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Theesfeld CL, 2003, MOL BIOL CELL, V14, P3280, DOI 10.1091/mbc.e03-03-0154; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; ZHAO C, 1994, J BIOL CHEM, V269, P21480	90	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2524	2534		10.1074/jbc.M115.693200	http://dx.doi.org/10.1074/jbc.M115.693200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26634277	Green Published, hybrid			2022-12-28	WOS:000369610400039
J	Baiady, N; Padala, P; Mashahreh, B; Cohen-Kfir, E; Todd, EA; Du Pont, KE; Berndsen, CE; Wiener, R				Baiady, Nardeen; Padala, Prasanth; Mashahreh, Bayan; Cohen-Kfir, Einav; Todd, Emily A.; Du Pont, Kelly E.; Berndsen, Christopher E.; Wiener, Reuven			The Vps27/Hrs/STAM (VHS) Domain of the Signal-transducing Adaptor Molecule (STAM) Directs Associated Molecule with the SH3 Domain of STAM (AMSH) Specificity to Longer Ubiquitin Chains and Dictates the Position of Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; RECEPTOR DEGRADATION; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; STRUCTURAL BASIS; BINDING; PROTEIN; ISOPEPTIDASE; TRAFFICKING; DIUBIQUITIN	The deubiquitinating enzyme associated molecule with the SH3 domain of STAM (AMSH) is crucial for the removal of ubiquitin molecules during receptor-mediated endocytosis and lysosomal receptor sorting. AMSH interacts with signal transducing adapter molecule (STAM) 1 or 2, which enhances the activity of AMSH through an unknown mechanism. This stimulation is dependent on the ubiquitin-interacting motif of STAM. Here we investigate the specific mechanism of AMSH stimulation by STAM proteins and the role of the STAMV ps27/Hrs/STAM domain. We show that, in the presence of STAM, the length of the ubiquitin chains affects the apparent cleavage rate. Through measurement of the chain cleavage kinetics, we found that, although the k(cat) of Lys(63)-linked ubiquitin chain cleavage was comparable for di-and tri-ubiquitin, the K-m value was lower for tri-ubiquitin. This increased affinity for longer chains was dependent on the Vps27/Hrs/STAM domain of STAM and required that the substrate ubiquitin chain contain homogenous Lys(63)-linkages. In addition, STAM directed AMSH cleavage toward the distal isopeptide bond in tri-ubiquitin chains. Finally, we generated a structural model of AMSH-STAM to show how the complex binds Lys(63)-linked ubiquitin chains and cleaves at the distal end. These data show how a deubiquitinating enzyme-interacting protein dictates the efficiency and specificity of substrate cleavage.	[Baiady, Nardeen; Padala, Prasanth; Mashahreh, Bayan; Cohen-Kfir, Einav; Wiener, Reuven] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Todd, Emily A.; Du Pont, Kelly E.; Berndsen, Christopher E.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA	Hebrew University of Jerusalem; James Madison University	Wiener, R (corresponding author), Hebrew Univ Campus Ein Karem, Dept Biochem & Mol Biol, Sch Med, Botnar Bldg,Rm 119 1st Floor, IL-91120 Jerusalem, Israel.	reuvenw@ekmd.huji.ac.il		Zuccaro, Kelly E/0000-0001-8904-5106; Berndsen, Christopher/0000-0002-4285-4341	United States-Israel Binational Science Foundation [2013261]; National Science Foundation Research Experience for Undergraduates Grant [CHE-1461175]; Marie Curie Career Integration Grant [PCIG13-GA-2013-630755]; Direct For Mathematical & Physical Scien [1461175] Funding Source: National Science Foundation	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Science Foundation Research Experience for Undergraduates Grant; Marie Curie Career Integration Grant; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by United States-Israel Binational Science Foundation Grant 2013261, National Science Foundation Research Experience for Undergraduates Grant CHE-1461175, and Marie Curie Career Integration Grant PCIG13-GA-2013-630755. The authors declare that they have no conflicts of interest with the contents of this article.	Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bekes M, 2013, CELL REP, V5, P826, DOI 10.1016/j.celrep.2013.10.008; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Davies CW, 2013, BIOCHEMISTRY-US, V52, P7818, DOI 10.1021/bi401106b; Davies CW, 2011, J MOL BIOL, V413, P416, DOI 10.1016/j.jmb.2011.08.029; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Frey P. A., 2007, ENZYMATIC REACTION M, P314; Huang FT, 2013, P NATL ACAD SCI USA, V110, P15722, DOI 10.1073/pnas.1308014110; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lange A, 2012, J BIOL CHEM, V287, P18687, DOI 10.1074/jbc.M111.324954; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	48	7	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					2033	2042		10.1074/jbc.M115.689869	http://dx.doi.org/10.1074/jbc.M115.689869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601948	Green Published, hybrid			2022-12-28	WOS:000368620700038
J	Mistry, RK; Murray, TVA; Prysyazhna, O; Martin, D; Burgoyne, JR; Santos, C; Eaton, P; Shah, AM; Brewer, AC				Mistry, Rajesh K.; Murray, Thomas V. A.; Prysyazhna, Oleksandra; Martin, Daniel; Burgoyne, Joseph R.; Santos, Celio; Eaton, Philip; Shah, Ajay M.; Brewer, Alison C.			Transcriptional Regulation of Cystathionine-gamma-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; NITRIC-OXIDE; OXIDATIVE STRESS; SUBUNIT NOX4; REDOX; TRANSLATION; KINASE; GENE; EXPRESSION; SYNTHASE	The gasotransmitter, hydrogen sulfide (H2S) is recognized as an important mediator of endothelial cell homeostasis and function that impacts upon vascular tone and blood pressure. Cystathionine-gamma-lyase (CSE) is the predominant endothelial generator of H2S, and recent evidence suggests that its transcriptional expression is regulated by the reactive oxygen species, H2O2. However, the cellular source of H2O2 and the redox-dependent molecular signaling pathway that modulates this is not known. We aimed to investigate the role of Nox4, an endothelial generator of H2O2, in the regulation of CSE in endothelial cells. Both gain- and loss-of-function experiments in human endothelial cells in vitro demonstrated Nox4 to be a positive regulator of CSE transcription and protein expression. We demonstrate that this is dependent upon a heme-regulated inhibitor kinase/eIF2 alpha/activating transcription factor 4 (ATF4) signaling module. ATF4 was further demonstrated to bind directly to cis-regulatory sequences within the first intron of CSE to activate transcription. Furthermore, CSE expression was also increased in cardiac microvascular endothelial cells, isolated from endothelial-specific Nox4 transgenic mice, compared with wild-type littermate controls. Using wire myography we demonstrate that endothelial-specific Nox4 transgenic mice exhibit a hypo-contractile phenotype in response to phenylephrine that was abolished when vessels were incubated with a CSE inhibitor, propargylglycine. We, therefore, conclude that Nox4 is a positive transcriptional regulator of CSE in endothelial cells and propose that it may in turn contribute to the regulation of vascular tone via the modulation of H2S production.	[Mistry, Rajesh K.; Murray, Thomas V. A.; Martin, Daniel; Santos, Celio; Shah, Ajay M.; Brewer, Alison C.] Kings Coll London British Heart Fdn Ctr, Cardiovasc Div, 125 Coldharbour Lane, London SES 9NU, England; [Prysyazhna, Oleksandra; Burgoyne, Joseph R.; Eaton, Philip] St Thomas Hosp, Rayne Inst, Kings Coll London British Heart Fdn Ctr, Cardiovasc Div, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Brewer, AC (corresponding author), Kings Coll London British Heart Fdn Ctr Res Excel, James Black Ctr, Cardiovasc Div, London SE5 9NU, England.	alison.brewer@kcl.ac.uk	; Eaton, Philip/I-5444-2015	Murray, Thomas/0000-0003-3019-2739; Eaton, Philip/0000-0003-0748-2367; Brewer, Alison/0000-0002-1021-9888; Shah, Ajay/0000-0002-6547-0631; Prysyazhna, Oleksandra/0000-0002-0394-7000; Burgoyne, Joseph/0000-0001-7325-7382	British Heart Foundation (BHF) [FS/11/80/29330, RG/13/11/30384]; BHF Centre of Excellence Award [RE/13/2/30182]; MRC [MR/L009684/1, G0600785, G0700320, G1000458, MR/K003232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [PG/11/124/29318, RG/12/12/29872, PG/10/98/28655, PG/13/13/30018, PG/15/26/31373, FS/14/1/30551, FS/11/45/28859, RG/13/11/30384] Funding Source: researchfish; Medical Research Council [MR/L009684/1, MR/K003232/1, G1000458, G0600785, G0700320, 998501] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Centre of Excellence Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a 4-year British Heart Foundation (BHF) Master of Research/Ph.D. studentship (FS/11/80/29330), a BHF program grant RG/13/11/30384, and a BHF Centre of Excellence Award-RE/13/2/30182. The authors declare that they have no conflicts of interest with the contents of this article.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Brandes RP, 2014, J MOL CELL CARDIOL, V73, P70, DOI 10.1016/j.yjmcc.2014.02.006; Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022; BROWN SB, 1978, BIOCHEM J, V174, P901, DOI 10.1042/bj1740901; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; CHEN PF, 1994, J BIOL CHEM, V269, P25062; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; ENVER T, 1988, MOL CELL BIOL, V8, P1301, DOI 10.1128/MCB.8.3.1301; Flora SJS, 2008, INDIAN J MED RES, V128, P501; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hassan MI, 2012, BRIT J PHARMACOL, V166, P2231, DOI 10.1111/j.1476-5381.2012.01949.x; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Lin VS, 2013, P NATL ACAD SCI USA, V110, P7131, DOI 10.1073/pnas.1302193110; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sciarretta S, 2014, AUTOPHAGY, V10, P699, DOI 10.4161/auto.27955; Sciarretta S, 2013, CIRC RES, V113, P1253, DOI 10.1161/CIRCRESAHA.113.301787; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang MX, 2012, GENE EXPRESSION, V15, P235, DOI 10.3727/105221613X13571653093286; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107	54	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1774	1788		10.1074/jbc.M115.685578	http://dx.doi.org/10.1074/jbc.M115.685578			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620565	Green Published, hybrid			2022-12-28	WOS:000368620700019
J	Marubashi, S; Shimada, H; Fukuda, M; Ohbayashi, N				Marubashi, Soujiro; Shimada, Hikaru; Fukuda, Mitsunori; Ohbayashi, Norihiko			RUTBC1 Functions as a GTPase-activating Protein for Rab32/38 and Regulates Melanogenic Enzyme Trafficking in Melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; RAB GTPASES; MELANOSOME TRANSPORT; BINDING-SPECIFICITY; COMPLEX-3 BLOC-3; DOMAIN; GOLGI; SLAC2-A/MELANOPHILIN; IDENTIFICATION	Two cell type-specific Rab proteins, Rab32 and Rab38 (Rab32/38), have been proposed as regulating the trafficking of melanogenic enzymes, including tyrosinase and tyrosinase-related protein 1 (Tyrp1), to melanosomes in melanocytes. Like other GTPases, Rab32/38 function as switch molecules that cycle between a GDP-bound inactive form and a GTP-bound active form; the cycle is thought to be regulated by an activating enzyme, guanine nucleotide exchange factor (GEF), and an inactivating enzyme, GTPase-activating protein (GAP), which stimulates the GTPase activity of Rab32/38. Although BLOC-3 has already been identified as a Rab32/38-specific GEF that regulates the trafficking of tyrosinase and Tyrp1, no physiological GAP for Rab32/38 in melanocytes has ever been identified, and it has remained unclear whether Rab32/38 is involved in the trafficking of dopachrome tautomerase, another melanogenic enzyme, in mouse melanocytes. In this study we investigated RUTBC1, which was originally characterized as a Rab9-binding protein and GAP for Rab32 and Rab33B in vitro, and the results demonstrated that RUTBC1 functions as a physiological GAP for Rab32/38 in the trafficking of all three melanogenic enzymes in mouse melanocytes. The results of this study also demonstrated the involvement of Rab9A in the regulation of the RUTBC1 localization and in the trafficking of all three melanogenic enzymes. We discovered that either excess activation or inactivation of Rab32/38 achieved by manipulating RUTBC1 inhibits the trafficking of all three melanogenic enzymes. These results collectively indicate that proper spatiotemporal regulation of Rab32/38 is essential for the trafficking of all three melanogenic enzymes in mouse melanocytes.	[Marubashi, Soujiro; Shimada, Hikaru; Fukuda, Mitsunori; Ohbayashi, Norihiko] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ohbayashi, Norihiko] Univ Tsukuba, Fac Med, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan; [Ohbayashi, Norihiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan	Tohoku University; University of Tsukuba; University of Tsukuba	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp; nohbayashi@md.tsukuba.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; marubashi, soujiro/0000-0003-4729-5339	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan [15K07039, 15H04367, 15H01198]; Toray Science Foundation; Kao Melanin Workshop; Grants-in-Aid for Scientific Research [15K07039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); Kao Melanin Workshop; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 15K07039 (to N.O.) and 15H04367 and 15H01198 (to M.F.) from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan, a grant from the Toray Science Foundation (to M.F.), and a grant from the Kao Melanin Workshop (to N.O.). The authors declare that they have no conflicts of interest with the contents of this article.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dennis MK, 2015, J CELL BIOL, V209, P563, DOI 10.1083/jcb.201410026; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Ho HA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200543; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishida M, 2014, J BIOL CHEM, V289, P11059, DOI 10.1074/jbc.M114.552281; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Mahanty S, 2016, PIGM CELL MELANOMA R, V29, P43, DOI 10.1111/pcmr.12434; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Yatsu A, 2013, J INVEST DERMATOL, V133, P2237, DOI 10.1038/jid.2013.156; Zhang Z, 2014, STRUCTURE, V22, P1408, DOI 10.1016/j.str.2014.08.005; Zheng JY, 1998, J CELL SCI, V111, P1061	40	28	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1427	1440		10.1074/jbc.M115.684043	http://dx.doi.org/10.1074/jbc.M115.684043			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26620560	Green Published, hybrid			2022-12-28	WOS:000368068300033
J	Gettins, PGW; Dolmer, K				Gettins, Peter G. W.; Dolmer, Klavs			The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; LIGAND-BINDING; ALPHA(2)-MACROGLOBULIN RECEPTOR; ENDOCYTOSIS RECEPTORS; COMPLEX-FORMATION; LDL RECEPTOR; ALPHA(1)-PROTEINASE INHIBITOR; COVALENT COMPLEX; TYPE-1 COMPLEX; RAP	Plasminogen activator inhibitor 1 (PAI-1) is a serpin inhibitor of the plasminogen activators urokinase-type plasminogen activator (uPA) and tissue plasminogen activator, which binds tightly to the clearance and signaling receptor low density lipoprotein receptor-related protein 1 (LRP1) in both proteinase-complexed and uncomplexed forms. Binding sites for PAI-1 within LRP1 have been localized to CR clusters II and IV. Within cluster II, there is a strong preference for the triple CR domain fragment CR456. Previous mutagenesis studies to identify the binding site on PAI-1 for LRP1 have given conflicting results or implied small binding contributions incompatible with the high affinity PAI-1/LRP1 interaction. Using a highly sensitive solution fluorescence assay, we have examined binding of CR456 to arginine and lysine variants of PAI-1 and definitively identified the binding site as composed of four basic residues, Lys-69, Arg-76, Lys-80, and Lys-88. These are highly conserved among mammalian PAI-1s. Individual mutations result in a 13-800-fold increase in K-d values. We present evidence that binding involves engagement of CR4 by Lys-88, CR5 by Arg-76 and Lys-80, and CR6 by Lys-69, with the strongest interactions to CR5 and CR6. Collectively, the individual binding contributions account quantitatively for the overall PAI-1/LRP1 affinity. We propose that the greater efficiency of PAI-1.uPA complex binding and clearance by LRP1, compared with PAI-1 alone, is due solely to simultaneous binding of the uPA moiety in the complex to its receptor, thereby making binding of the PAI-1 moiety to LRP1 a two-dimensional surface-localized association.	[Gettins, Peter G. W.; Dolmer, Klavs] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland,M-C 669, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [R01 GM54414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM54414. The authors declare no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen OM, 2001, BIOCHEM J, V357, P289, DOI 10.1042/0264-6021:3570289; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; DUNN BM, 1981, BIOCHEMISTRY-US, V20, P7206, DOI 10.1021/bi00528a023; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Florova G, 2013, BIOCHEMISTRY-US, V52, P4697, DOI 10.1021/bi400470s; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; Jensen JK, 2006, BIOCHEM J, V399, P387, DOI 10.1042/BJ20060533; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; JUHANVAGUE I, 1984, THROMB RES, V33, P523, DOI 10.1016/0049-3848(84)90018-5; Kasza A, 1997, EUR J BIOCHEM, V248, P270, DOI 10.1111/j.1432-1033.1997.00270.x; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; OLSON D, 1992, J BIOL CHEM, V267, P9129; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OSSOWSKI L, 1991, CANCER RES, V51, P274; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; VANDERMEER BW, 1991, RESONANCE ENERGY TRA; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	46	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					800	812		10.1074/jbc.M115.688820	http://dx.doi.org/10.1074/jbc.M115.688820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26555266	hybrid, Green Published			2022-12-28	WOS:000367830500027
J	Wanrooij, PH; Tannous, E; Kumar, S; Navadgi-Patil, VM; Burgers, PM				Wanrooij, Paulina H.; Tannous, Elias; Kumar, Sandeep; Navadgi-Patil, Vasundhara M.; Burgers, Peter M.			Probing the Mec1(ATR) Checkpoint Activation Mechanism with Small Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						checkpoint control; DNA damage response; enzyme kinetics; peptides; serine; threonine protein kinase	DNA-DAMAGE CHECKPOINT; EARLY EMBRYONIC LETHALITY; C-TERMINAL TAIL; ATAXIA-TELANGIECTASIA; DISTINCT MECHANISMS; MEC1 KINASE; ATR; PROTEIN; REPLICATION; CLAMP	Yeast Mec1, the ortholog of human ATR, is the apical protein kinase that initiates the cell cycle checkpoint in response to DNA damage and replication stress. The basal activity of Mec1 kinase is activated by cell cycle phase-specific activators. Three distinct activators stimulate Mec1 kinase using an intrinsically disordered domain of the protein. These are the Ddc1 subunit of the 9-1-1 checkpoint clamp (ortholog of human and Schizosaccharomyces pombe Rad9), the replication initiator Dpb11 (ortholog of human TopBP1 and S. pombe Cut5), and the multifunctional nuclease/helicase Dna2. Here, we use small peptides to determine the requirements for Mec1 activation. For Ddc1, we identify two essential aromatic amino acids in a hydrophobic environment that when fused together are proficient activators. Using this increased insight, we have been able to identify homologous motifs in S. pombe Rad9 that can activate Mec1. Furthermore, we show that a 9-amino acid Dna2-based peptide is sufficient for Mec1 activation. Studies with mutant activators suggest that binding of an activator to Mec1 is a two-step process, the first step involving the obligatory binding of essential aromatic amino acids to Mec1, followed by an enhancement in binding energy through interactions with neighboring sequences.	[Wanrooij, Paulina H.; Tannous, Elias; Kumar, Sandeep; Navadgi-Patil, Vasundhara M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wanrooij, Paulina H.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Kumar, Sandeep] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Washington University (WUSTL); Umea University; Baylor College of Medicine	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Wanrooij, Paulina/R-1509-2019; Burgers, Peter M/AAW-6621-2021	Wanrooij, Paulina/0000-0002-8607-7564; Tannous, Elias/0000-0001-8073-1599	National Institutes of Health [GM083970]; Emil Aaltonen Foundation; Swedish Cultural Foundation in Finland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emil Aaltonen Foundation; Swedish Cultural Foundation in Finland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM083970 (to P.M.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Emil Aaltonen Foundation and the Swedish Cultural Foundation in Finland.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Brown EJ, 2000, GENE DEV, V14, P397; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Craven RJ, 2002, GENETICS, V161, P493; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; de Oliveira FMB, 2015, MOL CELL, V57, P1124, DOI 10.1016/j.molcel.2015.01.043; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2006, CELL CYCLE, V5, P1265, DOI 10.4161/cc.5.12.2834; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Ma JL, 2006, J BIOL CHEM, V281, P3954, DOI 10.1074/jbc.M507508200; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Melo JA, 2001, GENE DEV, V15, P2809; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Wanrooij PH, 2015, DNA REPAIR, V32, P17, DOI 10.1016/j.dnarep.2015.04.009; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Zhou Zhanru, 2013, ScientificWorldJournal, V2013, P458797, DOI 10.1155/2013/458797; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	40	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					393	401		10.1074/jbc.M115.687145	http://dx.doi.org/10.1074/jbc.M115.687145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26499799	hybrid, Green Published			2022-12-28	WOS:000367589500032
J	Williams, TL; Yin, YHW; Carter, CW				Williams, Tishan L.; Yin, Yuhui W.; Carter, Charles W., Jr.			Selective Inhibition of Bacterial Tryptophanyl-tRNA Synthetases by Indolmycin Is Mechanism-based	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl-tRNA synthetase; enzyme catalysis; enzyme inhibitor; inhibition mechanism; x-ray crystallography; inhibition; thermofluor; inhibition by ground-state stabilization	CRYSTAL-STRUCTURE; MG2+-ASSISTED CATALYSIS; BACILLUS-SUBTILIS; BINDING; ACTIVATION; TRPRS; ACID; STOICHIOMETRY; RECOGNITION; RESISTANCE	Indolmycin is a natural tryptophan analog that competes with tryptophan for binding to tryptophanyl-tRNA synthetase (TrpRS) enzymes. Bacterial and eukaryotic cytosolic TrpRSs have comparable affinities for tryptophan (K-m approximate to 2 m), and yet only bacterial TrpRSs are inhibited by indolmycin. Despite the similarity between these ligands, Bacillus stearothermophilus (Bs)TrpRS preferentially binds indolmycin approximate to 1500-fold more tightly than its tryptophan substrate. Kinetic characterization and crystallographic analysis of BsTrpRS allowed us to probe novel aspects of indolmycin inhibitory action. Previous work had revealed that long range coupling to residues within an allosteric region called the D1 switch of BsTrpRS positions the Mg2+ ion in a manner that allows it to assist in transition state stabilization. The Mg2+ ion in the inhibited complex forms significantly closer contacts with non-bridging oxygen atoms from each phosphate group of ATP and three water molecules than occur in the (presumably catalytically competent) pre-transition state (preTS) crystal structures. We propose that this altered coordination stabilizes a ground state Mg(2+)ATP configuration, accounting for the high affinity inhibition of BsTrpRS by indolmycin. Conversely, both the ATP configuration and Mg2+ coordination in the human cytosolic (H-c)TrpRS preTS structure differ greatly from the BsTrpRS preTS structure. The effect of these differences is that catalysis occurs via a different transition state stabilization mechanism in H(c)TrpRS with a yet-to-be determined role for Mg2+. Modeling indolmycin into the tryptophan binding site points to steric hindrance and an inability to retain the interactions used for tryptophan substrate recognition as causes for the 1000-fold weaker indolmycin affinity to H(c)TrpRS.	[Williams, Tishan L.; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yin, Yuhui W.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston	Williams, TL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	tishan.williams@gmail.com			National Institutes of Health through the NIGMS [GM90406]; NIGMS diversity supplement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227, R01GM110591, R01GM090406] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS diversity supplement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM90406 through the NIGMS (to C. W. C.) and an NIGMS diversity supplement (to T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali K., 2002, THESIS; CALVIN M, 1959, J AM CHEM SOC, V81, P5048, DOI 10.1021/ja01528a009; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Doublie S., 1993, THESIS; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gangjee A, 1996, J MED CHEM, V39, P1438, DOI 10.1021/jm950786p; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V54, P549, DOI 10.1093/jac/dkh352; Ilyin VA, 2000, PROTEIN SCI, V9, P218; Institute SAS, 2013, JMP STAT DISC SOFTW; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru T, 2001, ANTIMICROB AGENTS CH, V45, P2455, DOI 10.1128/AAC.45.9.2455-2459.2001; Kitabatake M, 2002, J BIOL CHEM, V277, P23882, DOI 10.1074/jbc.M202639200; KONRAD I, 1977, FEBS LETT, V83, P341, DOI 10.1016/0014-5793(77)81037-5; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OGILVIE A, 1975, BIOCHEM J, V152, P511, DOI 10.1042/bj1520511; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Retailleau P, 2001, ACTA CRYSTALLOGR D, V57, P1595, DOI 10.1107/S090744490101215X; Retailleau P, 2007, J MOL BIOL, V369, P108, DOI 10.1016/j.jmb.2007.01.091; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen N, 2008, NUCLEIC ACIDS RES, V36, P1288, DOI 10.1093/nar/gkm1153; Smith C, 1999, CARDIOVASC DRUG THER, V13, P123, DOI 10.1023/A:1007784109255; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Vecchione JJ, 2009, ANTIMICROB AGENTS CH, V53, P3972, DOI 10.1128/AAC.00723-09; WEBER PC, 1992, J AM CHEM SOC, V114, P3197, DOI 10.1021/ja00035a004; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; WERNER RG, 1976, EUR J BIOCHEM, V68, P1, DOI 10.1111/j.1432-1033.1976.tb10758.x; WERNER RG, 1979, ARZNEIMITTEL-FORSCH, V29-1, P59; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yin Y., 1995, THESIS; Yu YD, 2004, J BIOL CHEM, V279, P8378, DOI 10.1074/jbc.M311284200; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	41	28	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					255	265		10.1074/jbc.M115.690321	http://dx.doi.org/10.1074/jbc.M115.690321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26555258	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000367589500020
J	Li, Y; Hasenhuetl, PS; Schicker, K; Sitte, HH; Freissmuth, M; Sandtner, W				Li, Yang; Hasenhuetl, Peter S.; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter			Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTISM SPECTRUM DISORDER; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; ALTERNATING-ACCESS; MECHANISM; SEROTONIN; AMPHETAMINES; INHIBITION; IBOGAINE; MUTATION	The dopamine transporter shapes dopaminergic neurotransmission by clearing extracellular dopamine and by replenishing vesicular stores. The dopamine transporter carries an endogenous binding site for Zn2+, but the nature of the Zn2+-dependent modulation has remained elusive: both, inhibition and stimulation of DAT have been reported. Here, we exploited the high time resolution of patch-clamp recordings to examine the effects of Zn2+ on the transport cycle of DAT: we recorded peak currents associated with substrate translocation and steady-state currents reflecting the forward transport mode of DAT. Zn2+ depressed the peak current but enhanced the steady-state current through DAT. The parsimonious explanation is preferential binding of Zn2+ to the outward facing conformation of DAT, which allows for an allosteric activation of DAT, in both, the forward transport mode and substrate exchange mode. We directly confirmed that Zn2+ dissociated more rapidly from the inward-than from the outward-facing state of DAT. Finally, we formulated a kinetic model for the action of Zn2+ on DAT that emulated all current experimental observations and accounted for all previous (in part contradictory) findings. Importantly, the model predicts that the intracellular Na+ concentration determines whether substrate uptake by DAT is stimulated or inhibited by Zn2+. This prediction was directly verified. The mechanistic framework provided by the current model is of relevance for the rational design of allosteric activators of DAT. These are of interest for treating de novo loss-of-function mutations of DAT associated with neuropsychiatric disorders such as attention deficit hyperactivity disorder (ADHD).	[Li, Yang; Hasenhuetl, Peter S.; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Sandtner, W (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at	Hasenhuetl, Peter/AAG-6335-2019; Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019	Hasenhuetl, Peter/0000-0002-3121-9502; Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Schicker, Klaus/0000-0002-3068-7830; Freissmuth, Michael/0000-0001-9398-1765	Austrian Science Fund/EWE Project [P28090]; Medical University of Vienna; Chinese Scholarship Council [201308310446];  [SFB35];  [F3506];  [F3510]; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Austrian Science Fund/EWE Project; Medical University of Vienna; Chinese Scholarship Council(China Scholarship Council); ; ; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund/EWE Project P28090 (to W. S.), Project Program Grant SFB35 (Grant F3506 (to H. H. S.), F3510 (to M. F.)), and the MD/PhD program of the Medical University of Vienna (to P. S. H.), and the Chinese Scholarship Council Grant-Nr. 201308310446 (to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bjorklund NL, 2007, EUR J PHARMACOL, V565, P17, DOI 10.1016/j.ejphar.2007.02.027; Boehm S, 1999, J NEUROSCI, V19, P737; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hamilton PJ, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0002-7; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Laeuger P., 1991, ELECTROGENIC ION PUM; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Pifl C, 2004, NEUROPHARMACOLOGY, V46, P223, DOI 10.1016/j.neuropharm.2003.09.007; Pifl C, 2009, NEUROPHARMACOLOGY, V56, P531, DOI 10.1016/j.neuropharm.2008.10.009; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schmid D, 2015, BRIT J PHARMACOL, V172, P4775, DOI 10.1111/bph.12766; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sonders MS, 1997, J NEUROSCI, V17, P960; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154	29	26	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31069	31076		10.1074/jbc.M115.688275	http://dx.doi.org/10.1074/jbc.M115.688275			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26504078	Green Published, hybrid			2022-12-28	WOS:000367199000035
J	Muthusamy, S; Hong, KU; Dassanayaka, S; Hamid, T; Jones, SP				Muthusamy, Senthilkumar; Hong, Kyung U.; Dassanayaka, Sujith; Hamid, Tariq; Jones, Steven P.			E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; NUTRIENT REGULATION; FAILING HEART; BINDING-SITES; GENE; GLCNACYLATION; FAMILY; METABOLISM; PROTEINS; PROMOTER	Protein O-GlcNAcylation, which is controlled by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), has emerged as an important posttranslational modification that may factor in multiple diseases. Until recently, it was assumed that OGT/OGAprotein expression was relatively constant. Several groups, including ours, have shown that OGT and/or OGA expression changes in several pathologic contexts, yet the cis and trans elements that regulate the expression of these enzymes remain essentially unexplored. Here, we used a reporter-based assay to analyze minimal promoters and leveraged in silico modeling to nominate several candidate transcription factor binding sites in both Ogt (i.e. the gene for OGT protein) and Mgea5 (i.e. the gene for OGA protein). We noted multiple E2F binding site consensus sequences in both promoters. We performed chromatin immunoprecipitation in both human and mouse cells and found that E2F1 bound to candidate E2F binding sites in both promoters. In HEK293 cells, we overexpressed E2F1, which significantly reduced OGT and MGEA5 expression. Conversely, E2F1-deficient mouse fibroblasts had increased Ogt and Mgea5 expression. Of the known binding partners for E2F1, we queried whether retinoblastoma 1 (Rb1) might be involved. Rb1-deficient mouse embryonic fibroblasts showed increased levels of Ogt and Mgea5 expression, yet overexpression of E2F1 in the Rb1-deficient cells did not alter Ogt and Mgea5 expression, suggesting that Rb1 is required for E2F1-mediated suppression. In conclusion, this work identifies and validates some of the promoter elements for mouse Ogt and Mgea5 genes. Specifically, E2F1 negatively regulates both Ogt and Mgea5 expression in an Rb1 protein-dependent manner.	Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA; Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Jones, SP (corresponding author), 580 S Preston St,Delia Baxter Bldg 321F, Louisville, KY 40202 USA.	Steven.P.Jones@Louisville.edu	Muthusamy, Senthilkumar/Y-1353-2018; Hong, Kyung Uk/G-7145-2011; Muthusamy, Senthilkumar/G-7875-2015; Jones, Steven P./D-5092-2009; Regan, Clinton/E-6250-2012	Hong, Kyung Uk/0000-0001-6700-9470; Muthusamy, Senthilkumar/0000-0003-1603-9965; Jones, Steven P./0000-0001-5376-8089; Hamid, Tariq/0000-0002-4588-3754	National Institutes of Health [R01 HL083320, R01 HL094419, P20 GM103492, P01 HL078825]; American Heart Association (Great Rivers Affiliate) Predoctoral Fellowship [14PRE19710015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083320, R01HL094419, P01HL078825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Great Rivers Affiliate) Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL083320, R01 HL094419, P20 GM103492, and P01 HL078825 (to S. P. J.) and American Heart Association (Great Rivers Affiliate) Predoctoral Fellowship 14PRE19710015 (to S. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Foerster S, 2014, BBA-MOL BASIS DIS, V1842, P1333, DOI 10.1016/j.bbadis.2014.05.014; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2014, J BIOL CHEM, V289, P34422, DOI 10.1074/jbc.R114.609776; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Muthusamy S, 2014, J BIOL CHEM, V289, P29665, DOI 10.1074/jbc.M114.578682; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Park K, 2010, DIABETES, V59, P1845, DOI 10.2337/db09-1086; Perez-Cervera Y, 2013, FASEB J, V27, P3478, DOI 10.1096/fj.12-217984; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Srikanth B, 2010, J BIOL CHEM, V285, P34062, DOI 10.1074/jbc.M109.098996; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Valdez CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025187; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wells L, 2011, AMINO ACIDS, V40, P877, DOI 10.1007/s00726-010-0709-x; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	40	23	23	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31013	31024		10.1074/jbc.M115.677534	http://dx.doi.org/10.1074/jbc.M115.677534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527687	hybrid, Green Published			2022-12-28	WOS:000367199000031
J	Nagaoka, A; Yoshida, H; Nakamura, S; Morikawa, T; Kawabata, K; Kobayashi, M; Sakai, S; Takahashi, Y; Okada, Y; Inoue, S				Nagaoka, Aya; Yoshida, Hiroyuki; Nakamura, Sachiko; Morikawa, Tomohiko; Kawabata, Keigo; Kobayashi, Masaki; Sakai, Shingo; Takahashi, Yoshito; Okada, Yasunori; Inoue, Shintaro			Regulation of Hyaluronan (HA) Metabolism Mediated by HYBID (Hyaluronan-binding Protein Involved in HA Depolymerization, KIAA1199) and HA Synthases in Growth Factor-stimulated Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DERMAL FIBROBLASTS; BETA TGF-BETA; RHEUMATOID-ARTHRITIS; CELL-MIGRATION; MOUSE SKIN; EXPRESSION; CD44; ANGIOGENESIS; IL-1-BETA; CYTOKINES	Regulation of hyaluronan (HA) synthesis and degradation is essential to maintenance of extracellular matrix homeostasis. We recently reported that HYBID (HYaluronan-Binding protein Involved in hyaluronan Depolymerization), also called KIAA1199, plays a key role in HA depolymerization in skin and arthritic synovial fibroblasts. However, regulation of HA metabolism mediated by HYBID and HA synthases (HASs) under stimulation with growth factors remains obscure. Here we report that TGF-beta 1, basic FGF, EGF, and PDGF-BB commonly enhance total amount of HA in skin fibroblasts through up-regulation of HAS expression, but molecular size of newly producedHAis dependent on HYBID expression levels. Stimulation of HAS1/2 expression and suppression of HYBID expression by TGF-beta 1 were abrogated by blockade of the MAPK and/or Smad signaling and the PI3K-Akt signaling, respectively. In normal human skin, expression of the TGF-beta 1 receptors correlated positively with HAS2 expression and inversely with HYBID expression. On the other hand, TGF-beta 1 upregulated HAS1/2 expression but exerted only a slight suppressive effect on HYBID expression in synovial fibroblasts from the patients with osteoarthritis or rheumatoid arthritis, resultinginthe production of lower molecular weight HA compared with normal skin and synovial fibroblasts. These data demonstrate that although TGF-beta 1, basic FGF, EGF, and PDGF-BB enhance HA production in skin fibroblasts, TGF-beta 1 most efficiently contributes to production of high molecular weight HA by HAS up-regulation and HYBID down-regulation and suggests that inefficient downregulation of HYBID by TGF-beta 1 in arthritic synovial fibroblasts may be linked to accumulation of depolymerized HA in synovial fluids in arthritis patients.	[Nagaoka, Aya; Yoshida, Hiroyuki; Nakamura, Sachiko; Morikawa, Tomohiko; Kawabata, Keigo; Kobayashi, Masaki; Takahashi, Yoshito] Kao Corp, Biol Sci Res, Odawara, Kanagawa 2500002, Japan; [Sakai, Shingo] Kao Corp, Hlth Beauty Prod Res, Odawara, Kanagawa 2500002, Japan; [Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1600016, Japan; [Inoue, Shintaro] Kanebo Cosmet Inc, Chuo Ku, Tokyo 1038210, Japan	KAO Corporation; KAO Corporation; Keio University; Kanebo Cosmetics Inc.	Yoshida, H (corresponding author), Kao Corp, Biol Sci Res, 3-28,5 Chome,Kotobuki Cho, Odawara, Kanagawa 2500002, Japan.	yoshida.hiroyuki2@kao.co.jp; okada@z6.keio.jp	Inoue, Shintaro/AAR-6767-2021; Okada, Yasunori/B-5550-2014	Inoue, Shintaro/0000-0002-4996-5693; Okada, Yasunori/0000-0001-9208-4755				Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Bourguignon LYW, 2013, J DERMATOL SCI, V72, P32, DOI 10.1016/j.jdermsci.2013.05.003; Chen L, 2012, MATRIX BIOL, V31, P373, DOI 10.1016/j.matbio.2012.10.002; Ellis I, 1997, DEVELOPMENT, V124, P1593; Frenkel JS, 2014, INT WOUND J, V11, P159, DOI 10.1111/j.1742-481X.2012.01057.x; GHOSH P, 1994, CLIN EXP RHEUMATOL, V12, P75; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; Kuscu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044661; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Oguchi T, 2004, CONNECT TISSUE RES, V45, P197, DOI 10.1080/03008200490523031; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Polytarchou Kali, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P31; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Shen W, 2006, J AM SOC NEPHROL, V17, P2414, DOI 10.1681/ASN.2005111157; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Tanimoto K, 2004, J DENT RES, V83, P40, DOI 10.1177/154405910408300108; Torronen K, 2014, HISTOCHEM CELL BIOL, V141, P17, DOI 10.1007/s00418-013-1143-4; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; VUORIO E, 1982, RHEUMATOL INT, V2, P97, DOI 10.1007/BF00541160; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Yoshida H, 2014, FEBS LETT, V588, P111, DOI 10.1016/j.febslet.2013.11.017; Yoshida H, 2013, FEBS OPEN BIO, V3, P352, DOI 10.1016/j.fob.2013.08.003; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223	34	60	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30910	30923		10.1074/jbc.M115.673566	http://dx.doi.org/10.1074/jbc.M115.673566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26518873	Green Published, hybrid			2022-12-28	WOS:000367199000023
J	Borgogno, MV; Monti, MR; Zhao, WX; Sung, P; Argarana, CE; Pezza, RJ				Borgogno, Maria V.; Monti, Mariela R.; Zhao, Weixing; Sung, Patrick; Argarana, Carlos E.; Pezza, Roberto J.			Tolerance of DNA Mismatches in Dmc1 Recombinase-mediated DNA Strand Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; DNA damage; DNA recombination; homologous recombination; meiosis; DNA mismatches; DNA strand exchange; Dmc1; Hop2-Mnd1; heterologous DNA sequences	NEAREST-NEIGHBOR THERMODYNAMICS; CENTER-DOT-C; MEIOTIC RECOMBINATION; HUMAN RAD51; HOP2-MND1 COMPLEX; ESCHERICHIA-COLI; HOP2 PROTEIN; RECA PROTEIN; MEIOSIS; FAMILY	Recombination between homologous chromosomes is required for the faithful meiotic segregation of chromosomes and leads to the generation of genetic diversity. The conserved meiosis-specific Dmc1 recombinase catalyzes homologous recombination triggered by DNA double strand breaks through the exchange of parental DNA sequences. Although providing an efficient rate of DNA strand exchange between polymorphic alleles, Dmc1 must also guard against recombination between divergent sequences. How DNA mismatches affect Dmc1-mediated DNA strand exchange is not understood. We have used fluorescence resonance energy transfer to study the mechanism of Dmc1-mediated strand exchange between DNA oligonucleotides with different degrees of heterology. The efficiency of strand exchange is highly sensitive to the location, type, and distribution of mismatches. Mismatches near the 3 end of the initiating DNA strand have a small effect, whereas most mismatches near the 5 end impede strand exchange dramatically. The Hop2-Mnd1 protein complex stimulates Dmc1-catalyzed strand exchange on homologous DNA or containing a single mismatch. We observed that Dmc1 can reject divergent DNA sequences while bypassing a few mismatches in the DNA sequence. Our findings have important implications in understanding meiotic recombination. First, Dmc1 acts as an initial barrier for heterologous recombination, with the mismatch repair system providing a second level of proofreading, to ensure that ectopic sequences are not recombined. Second, Dmc1 stepping over infrequent mismatches is likely critical for allowing recombination between the polymorphic sequences of homologous chromosomes, thus contributing to gene conversion and genetic diversity.	[Borgogno, Maria V.; Monti, Mariela R.; Argarana, Carlos E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC,CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina; [Zhao, Weixing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pezza, Roberto J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73126 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Yale University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Pezza, RJ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Roberto-Pezza@omrf.org		zhao, weixing/0000-0001-5746-3696	National Institutes of Health Grants [ES015252, GM103636]; March of Dimes Grant [FY14-256]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103636] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Grant(March of Dimes); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES015252 (to P. S.) and GM103636 and March of Dimes Grant FY14-256 (to R. J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Brown J, 2003, BIOCHEM J, V371, P697, DOI 10.1042/BJ20021847; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Dumousseau M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-101; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gupta RC, 1999, MOL CELL, V4, P705, DOI 10.1016/S1097-2765(00)80381-0; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; HASSOLD T, 1979, HUM GENET, V46, P285, DOI 10.1007/BF00273312; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Moktan H, 2014, J BIOL CHEM, V289, P14682, DOI 10.1074/jbc.M114.548180; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; PATEL DJ, 1984, FED PROC, V43, P2663; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Pezza RJ, 2010, BIOPHYS J, V99, P3763, DOI 10.1016/j.bpj.2010.10.028; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Sansam CL, 2015, FEBS J, V282, P2431, DOI 10.1111/febs.13317; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharma M, 2013, J PHYS CHEM B, V117, P6194, DOI 10.1021/jp403127a; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Urena DE, 2011, J MOL BIOL, V405, P77, DOI 10.1016/j.jmb.2010.10.042; Volodin AA, 2009, J BIOL CHEM, V284, P1495, DOI 10.1074/jbc.M800612200; Voloshin ON, 1996, SCIENCE, V272, P868, DOI 10.1126/science.272.5263.868; WANG YH, 1993, J BIOL CHEM, V268, P17571; WEBSTER GD, 1990, P NATL ACAD SCI USA, V87, P6693, DOI 10.1073/pnas.87.17.6693; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924	45	9	10	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4928	4938		10.1074/jbc.M115.704718	http://dx.doi.org/10.1074/jbc.M115.704718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26709229	Green Published, hybrid			2022-12-28	WOS:000371640600009
J	Reif, R; Adawy, A; Vartak, N; Schroder, J; Gunther, G; Ghallab, A; Schmidt, M; Schormann, W; Hengstler, JG				Reif, Raymond; Adawy, Alshaimaa; Vartak, Nachiket; Schroeder, Jutta; Guenther, Georgia; Ghallab, Ahmed; Schmidt, Marcus; Schormann, Wiebke; Hengstler, Jan G.			Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear translocation; proliferation; receptor endocytosis; receptor tyrosine kinase; signal transduction	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; BREAST-CANCER; LOCALIZATION; FAMILY; INTERNALIZATION; MECHANISMS; EXPRESSION; RESISTANCE; COMPLEXES	Members of the receptor tyrosine kinase family (RTK) have been shown to be present in the nucleus of cells; however, the mechanisms underlying their trafficking to the nucleus, and their relevance once there are poorly understood. In the present study, we focus on the RTK ErbB3 and elucidate the mechanisms regulating its trafficking. We show that heregulin-stimulation induces trafficking of phosphorylated ErbB3 from the plasma membrane to the nucleus via a clathrin-independent mechanism. Nuclear import of ErbB3 occurs via importin 1, which drives the receptor through the nuclear pore complex. In the nucleus, ErbB3 interacts with transcription complexes, and thereby has a role in transcriptional regulation. Our results also demonstrate that ErbB3 nuclear localization is transient as it is exported out of the nucleus by the nuclear receptor protein crm-1. Analysis of normal, regenerating tissues, and tumors showed that ErbB3 nuclear translocation is a common event in proliferating tissues.	[Reif, Raymond; Adawy, Alshaimaa; Vartak, Nachiket; Guenther, Georgia; Ghallab, Ahmed; Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factors, Ardeystr 67, D-44139 Dortmund, Germany; [Schroeder, Jutta] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Ghallab, Ahmed] South Valley Univ, Fac Vet Med, Dept Forens Med & Toxicol, Qena 83523, Egypt; [Schmidt, Marcus] Univ Hosp, Dept Obstet & Gynecol, D-55131 Mainz, Germany; [Schormann, Wiebke] Univ Toronto, Biol Sci, Sunnybrook Res Inst, Toronto, ON M5S 1A8, Canada; [Schormann, Wiebke] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Heinrich Heine University Dusseldorf; Egyptian Knowledge Bank (EKB); South Valley University Egypt; University Hospital Mainz; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Reif, R (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Ardeystr 67, D-44139 Dortmund, Germany.	reif@ifado.de	Ghallab, Ahmed/J-3204-2015; Ghallab, Ahmed/AAT-9939-2020; Schmidt, Marcus/H-3383-2013	Ghallab, Ahmed/0000-0003-0695-3403; Ghallab, Ahmed/0000-0003-0695-3403; Schmidt, Marcus/0000-0003-1365-2414; Hengstler, Jan/0000-0002-1427-5246; Vartak, Nachiket/0000-0001-8813-4799	BMBF project Oncoprofile [01GR0816]	BMBF project Oncoprofile(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the BMBF project Oncoprofile (Grant Number 01GR0816). The authors declare that they have no conflicts of interest with the contents of this article.	Andrique L, 2012, CELL SIGNAL, V24, P1074, DOI 10.1016/j.cellsig.2012.01.002; Baulida J, 1997, EXP CELL RES, V232, P167, DOI 10.1006/excr.1997.3515; Baulida J, 1996, J BIOL CHEM, V271, P5251; Brand TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071518; Chang HY, 2014, CANCER RES, V74, P4549, DOI 10.1158/0008-5472.CAN-13-3730; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jain A, 2010, CANCER RES, V70, P1989, DOI 10.1158/0008-5472.CAN-09-3326; KITAJIMA Y, 1976, BIOCHIM BIOPHYS ACTA, V455, P452, DOI 10.1016/0005-2736(76)90317-5; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Ledoux S, 2003, CANCER RES, V63, P7284; LUND KA, 1990, J BIOL CHEM, V265, P15713; MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Raabe TD, 2004, GLIA, V45, P197, DOI 10.1002/glia.10311; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Sak MM, 2012, CARCINOGENESIS, V33, P1031, DOI 10.1093/carcin/bgs128; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, ONCOIMMUNOLOGY, V1, P1156, DOI 10.4161/onci.21653; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; SLATER TF, 1985, PHILOS T R SOC B, V311, P633, DOI 10.1098/rstb.1985.0169; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13	36	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3837	3847		10.1074/jbc.M115.686782	http://dx.doi.org/10.1074/jbc.M115.686782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26719328	Green Published, hybrid			2022-12-28	WOS:000371338400013
J	Abe, T; Hashimoto, Y; Zhuang, Y; Ge, Y; Kumano, T; Kobayashi, M				Abe, Tomoko; Hashimoto, Yoshiteru; Zhuang, Ye; Ge, Yin; Kumano, Takuto; Kobayashi, Michihiko			Peptide Bond Synthesis by a Mechanism Involving an Enzymatic Reaction and a Subsequent Chemical Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; ALANYL CARRIER PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COENZYME-A; LIGATION; BIOSYNTHESIS; ACID; LIGASE; PHENYLALANINE	We recently reported that an amide bond is unexpectedly formed by an acyl-CoA synthetase (which catalyzes the formation of a carbon-sulfur bond) when a suitable acid and L-cysteine are used as substrates. DltA, which is homologous to the adenylation domain of nonribosomal peptide synthetase, belongs to the same superfamily of adenylate-forming enzymes, which includes many kinds of enzymes, including the acyl-CoA synthetases. Here, we demonstrate that DltA synthesizes not only N-(D-alanyl)-L-cysteine (a dipeptide) but also various oligopeptides. We propose that this enzyme catalyzes peptide synthesis by the following unprecedented mechanism: (i) the formation of S-acyl-L-cysteine as an intermediate via its "enzymatic activity" and (ii) subsequent "chemical" S -> N acyl transfer in the intermediate, resulting in peptide formation. Step ii is identical to the corresponding reaction in native chemical ligation, a method of chemical peptide synthesis, whereas step i is not. To the best of our knowledge, our discovery of this peptide synthesis mechanism involving an enzymatic reaction and a subsequent chemical reaction is the first such one to be reported. This new process yields peptides without the use of a thioesterified fragment, which is required in native chemical ligation. Together with these findings, the same mechanism-dependent formation of N-acyl compounds by other members of the above-mentioned superfamily demonstrated that all members most likely form peptide/amide compounds by using this novel mechanism. Each member enzyme acts on a specific substrate; thus, not only the corresponding peptides but also new types of amide compounds can be formed.	[Abe, Tomoko; Hashimoto, Yoshiteru; Zhuang, Ye; Ge, Yin; Kumano, Takuto; Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Abe, Tomoko; Hashimoto, Yoshiteru; Zhuang, Ye; Ge, Yin; Kumano, Takuto; Kobayashi, Michihiko] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Abe, Tomoko] Tokyo Denki Univ, Sch Sci & Engn, Div Life Sci & Engn, Hatoyama, Saitama 3500394, Japan	University of Tsukuba; University of Tsukuba; Tokyo Denki University	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.; Kobayashi, M (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	kobay@agbi.tsukuba.ac.jp	Kumano, Takuto/ABC-3242-2020	Kumano, Takuto/0000-0002-9240-4074	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Bennett CS, 2007, CHEM SOC REV, V36, P1227, DOI 10.1039/b617709c; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Crich D, 2007, J AM CHEM SOC, V129, P10064, DOI 10.1021/ja072804l; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; Ingenito R, 1999, J AM CHEM SOC, V121, P11369, DOI 10.1021/ja992668n; Katano H, 2012, ANAL BIOCHEM, V421, P308, DOI 10.1016/j.ab.2011.10.031; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Kimura Y, 2004, ANAL BIOCHEM, V326, P262, DOI 10.1016/j.ab.2003.12.012; Kiriukhin MY, 2001, J BACTERIOL, V183, P2051, DOI 10.1128/JB.183.6.2051-2058.2001; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Lazos O, 2010, CHEM BIOL, V17, P160, DOI 10.1016/j.chembiol.2010.01.011; Lee S G, 1975, Methods Enzymol, V43, P585; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Mende F, 2011, ANGEW CHEM INT EDIT, V50, P1232, DOI 10.1002/anie.201005180; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; MORIHARA K, 1987, TRENDS BIOTECHNOL, V5, P164, DOI 10.1016/0167-7799(87)90090-4; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; Sewing A, 2001, ANGEW CHEM INT EDIT, V40, P3395, DOI 10.1002/1521-3773(20010917)40:18<3395::AID-ANIE3395>3.0.CO;2-G; Shang SY, 2011, P NATL ACAD SCI USA, V108, P5986, DOI 10.1073/pnas.1103118108; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Usuki H, 2011, ORG BIOMOL CHEM, V9, P2327, DOI 10.1039/c0ob00403k; Yokozeki K, 2005, J BIOTECHNOL, V115, P211, DOI 10.1016/j.jbiotec.2004.07.017; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	43	12	12	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1735	1750		10.1074/jbc.M115.700989	http://dx.doi.org/10.1074/jbc.M115.700989			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26586916	Green Published, hybrid			2022-12-28	WOS:000368620700016
J	Ham, SJ; Lee, SY; Song, S; Chung, JR; Choi, S; Chung, J				Ham, Su Jin; Lee, Soo Young; Song, Saera; Chung, Ju-Ryung; Choi, Sekyu; Chung, Jongkyeong			Interaction between RING1 (R1) and the Ubiquitin-like (UBL) Domains Is Critical for the Regulation of Parkin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE 63-LINKED POLYUBIQUITINATION; E3 LIGASE PARKIN; PATHOGENIC MUTATIONS; DAMAGED MITOCHONDRIA; DEPOLARIZED MITOCHONDRIA; AUTOINHIBITED STATE; MEDIATED MITOPHAGY; PROTEASOME SYSTEM; MONOGENIC FORMS; ACTIVATE PARKIN	Parkin is an E3 ligase that contains a ubiquitin-like (UBL) domain in the N terminus and an R1-in-between-ring-RING2 motif in the C terminus. We showed that the UBL domain specifically interacts with the R1 domain and negatively regulates Parkin E3 ligase activity, Parkin-dependent mitophagy, and Parkin translocation to the mitochondria. The binding between the UBL domain and the R1 domain was suppressed by carbonyl cyanide m-chlorophenyl hydrazone treatment or by expression of PTEN-induced putative kinase 1 (PINK1), an upstream kinase that phosphorylates Parkin at the Ser-65 residue of the UBL domain. Moreover, we demonstrated that phosphorylation of the UBL domain at Ser-65 prevents its binding to the R1 domain and promotes Parkin activities. We further showed that mitochondrial translocation of Parkin, which depends on phosphorylation at Ser-65, and interaction between the R1 domain and a mitochondrial outer membrane protein, VDAC1, are suppressed by binding of the UBL domain to the R1 domain. Interestingly, Parkin with missense mutations associated with Parkinson disease (PD) in the UBL domain, such as K27N, R33Q, and A46P, did not translocate to the mitochondria and induce E3 ligase activity by m-chlorophenyl hydrazone treatment, which correlated with the interaction between the R1 domain and the UBL domain with those PD mutations. These findings provide a molecular mechanism of how Parkin recruitment to the mitochondria and Parkin activation as an E3 ubiquitin ligase are regulated by PINK1 and explain the previously unknown mechanism of how Parkin mutations in the UBL domain cause PD pathogenesis.	[Ham, Su Jin; Chung, Jongkyeong] Seoul Natl Univ, Interdisciplinary Grad Program Genet Engn, Seoul 51742, South Korea; [Ham, Su Jin; Lee, Soo Young; Song, Saera; Choi, Sekyu; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 51742, South Korea; [Ham, Su Jin; Lee, Soo Young; Song, Saera; Choi, Sekyu; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 51742, South Korea; [Chung, Ju-Ryung; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 51742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 51742, South Korea.	jkc@snu.ac.kr	Ham, Su Jin/AAL-6391-2021	Ham, Su Jin/0000-0001-5230-3386; Choi, Sekyu/0000-0003-2928-0942	National Creative Research Initiatives grant through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning (MSIP), the Republic of Korea [2010-0018291]; BK21 Plus Program from Ministry of Education, Republic of Korea	National Creative Research Initiatives grant through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning (MSIP), the Republic of Korea; BK21 Plus Program from Ministry of Education, Republic of Korea	Supported by the National Creative Research Initiatives grant through the National Research Foundation of Korea (NRF) funded by Ministry of Science, ICT, and Future Planning (MSIP), the Republic of Korea (2010-0018291). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by BK21 Plus Program from Ministry of Education, Republic of Korea.	Aguileta MA, 2015, J BIOL CHEM, V290, P7492, DOI 10.1074/jbc.M114.614925; Baba Y, 2006, ARCH NEUROL-CHICAGO, V63, P579, DOI 10.1001/archneur.63.4.579; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Beasley SA, 2012, PROTEIN SCI, V21, P1085, DOI 10.1002/pro.2080; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; Bonifati V, 2001, FUNCT NEUROL, V16, P35; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Choi P, 2000, NEUROREPORT, V11, P2635, DOI 10.1097/00001756-200008210-00006; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Fiesel FC, 2014, J CELL SCI, V127, P3488, DOI 10.1242/jcs.147520; Gao J, 2015, ACTA BIOCH BIOPH SIN, V47, P522, DOI 10.1093/abbs/gmv044; Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2015, BBA-MOL CELL RES, V1853, P2791, DOI 10.1016/j.bbamcr.2015.02.009; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lim KL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S13; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ozawa K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02202; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Shiba-Fukushima K, 2014, J BIOL CHEM, V289, P33131, DOI 10.1074/jbc.C114.580944; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Strappazzon F, 2015, CELL DEATH DIFFER, V22, P517, DOI 10.1038/cdd.2014.190; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tashiro M, 2003, J BIOMOL NMR, V25, P153, DOI 10.1023/A:1022254432039; Terreni L, 2001, NEUROLOGY, V56, P463, DOI 10.1212/WNL.56.4.463; Tomoo K, 2008, BBA-PROTEINS PROTEOM, V1784, P1059, DOI 10.1016/j.bbapap.2008.04.009; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zheng XD, 2015, CELL RES, V25, P1087, DOI 10.1038/cr.2015.97; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	82	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1803	1816		10.1074/jbc.M115.687319	http://dx.doi.org/10.1074/jbc.M115.687319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631732	hybrid, Green Published			2022-12-28	WOS:000368620700021
J	Zhang, HD; Tang, Y; Lee, SJ; Wei, ZL; Cao, J; Richardson, CC				Zhang, Huidong; Tang, Yong; Lee, Seung-Joo; Wei, Zeliang; Cao, Jia; Richardson, Charles C.			Binding Affinities among DNA Helicase-Primase, DNA Polymerase, and Replication Intermediates in the Replisome of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAGGING-STRAND POLYMERASE; SINGLE-MOLECULE; SLIDING-CLAMP; PROTEIN; PROCESSIVITY; FORK; COMPLEXES; MECHANISM; RESIDUES; LOOP	The formation of a replication loop on the lagging strand facilitates coordinated synthesis of the leading-and lagging-DNA strands and provides a mechanism for recycling of the lagging- strand DNA polymerase. As an Okazaki fragment is completed, the loop is released, and a new loop is formed as the synthesis of a new Okazaki fragment is initiated. Loop release requires the dissociation of the complex formed by the interactions among helicase, DNA polymerase, and DNA. The completion of the Okazaki fragment may result in either a nick or a single-stranded DNA region. In the replication system of bacteriophage T7, the dissociation of the polymerase from either DNA region is faster than that observed for the dissociation of the helicase from DNA polymerase, implying that the replication loop is released more likely through the dissociation of the lagging-strand DNA from polymerase, retaining the polymerase at replication fork. Both dissociation of DNA polymerase from DNA and that of helicase from a DNA polymerase.DNA complex are much faster at a nick DNA region than the release from a ssDNA region. These results suggest that the replication loop is released as a result of the nick formed when the lagging-strand DNA polymerase encounters the previously synthesized Okazaki fragment, releasing lagging-strand DNA and retaining DNA polymerase at the replication fork for the synthesis of next Okazaki fragment.	[Zhang, Huidong; Tang, Yong; Wei, Zeliang; Cao, Jia] Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing 400038, Peoples R China; [Zhang, Huidong; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boson, MA 02115 USA	Army Medical University; Harvard University	Zhang, HD (corresponding author), Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing 400038, Peoples R China.	huidongzhang@tmmu.edu.cn; ccr@hms.harvard.edu		Zhang, Huidong/0000-0001-7845-3331	Natural Science Foundation of China [31370793, 81422041]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China Grants 31370793 and 81422041 (to H.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Etson CM, 2010, P NATL ACAD SCI USA, V107, P1900, DOI 10.1073/pnas.0912664107; Geertsema HJ, 2013, CURR OPIN STRUC BIOL, V23, P788, DOI 10.1016/j.sbi.2013.06.018; Georgescu RE, 2009, EMBO J, V28, P2981, DOI 10.1038/emboj.2009.233; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Kurth I, 2013, TRENDS BIOCHEM SCI, V38, P195, DOI 10.1016/j.tibs.2012.10.003; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Stratmann SA, 2014, CHEM SOC REV, V43, P1201, DOI 10.1039/c3cs60391a; TABOR S, 1987, J BIOL CHEM, V262, P16212; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108	26	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1472	1480		10.1074/jbc.M115.698233	http://dx.doi.org/10.1074/jbc.M115.698233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26620561	hybrid, Green Published			2022-12-28	WOS:000368068300037
J	Garcia, P; del Dedo, JE; Ayte, J; Hidalgo, E				Garcia, Patricia; Encinar del Dedo, Javier; Ayte, Jose; Hidalgo, Elena			Genome-wide Screening of Regulators of Catalase Expression ROLE OF A TRANSCRIPTION COMPLEX AND HISTONE AND tRNA MODIFICATION COMPLEXES ON ADAPTATION TO STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAF1 COMPLEX; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; STRESS RESPONSES; TRANSLATION; METHYLATION; PAP1; ELONGATION; ANTIOXIDANT; ACTIVATION	In response to environmental cues, the mitogen-activated protein kinase Sty1-driven signaling cascade activates hundreds of genes to induce a robust anti-stress cellular response in fission yeast. Thus, upon stress imposition Sty1 transiently accumulates in the nucleus where it up-regulates transcription through the Atf1 transcription factor. Several regulators of transcription and translation have been identified as important to mount an integral response to oxidative stress, such as the Spt-Ada-Gcn5-acetyl transferase or Elongator complexes, respectively. With the aim of identifying new regulators of this massive gene expression program, we have used a GFP-based protein reporter and screened a fission yeast deletion collection using flow cytometry. We find that the levels of catalase fused to GFP, both before and after a threat of peroxides, are altered in hundreds of strains lacking components of chromatin modifiers, transcription complexes, and modulators of translation. Thus, the transcription elongation complex Paf1, the histone methylase Set1-COMPASS, and the translation-related Trm112 dimers are all involved in full expression of Ctt1-GFP and in wild-type tolerance to peroxides.	[Garcia, Patricia; Encinar del Dedo, Javier; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona 08003, Spain	Pompeu Fabra University	Ayte, J (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Dr Aiguader 88, Barcelona 08003, Spain.	jose.ayte@upf.edu; elena.hidalgo@upf.edu	Garcia, Patricia/O-7561-2014; DEL DEDO, JAVIER ENCINAR/T-3837-2019; Hidalgo, Elena/K-2919-2014; ENCINAR DEL DEDO, JAVIER/L-5222-2014	Garcia, Patricia/0000-0001-7513-1847; DEL DEDO, JAVIER ENCINAR/0000-0001-6876-9957; Hidalgo, Elena/0000-0002-3768-6785; ENCINAR DEL DEDO, JAVIER/0000-0001-6876-9957	Spanish Ministry of Science and Innovation [BFU2012-32045, BFU2012-31939]; Generalitat de Catalunya (Spain) [2014-SGR-154]; ICREA Academia Award (Generalitat de Catalunya, Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); ICREA Academia Award (Generalitat de Catalunya, Spain)(ICREA)	This work was supported by the Spanish Ministry of Science and Innovation (BFU2012-32045 (to E. H.) and BFU2012-31939 (to J. A.), PLAN E and FEDER, and by 2014-SGR-154 from Generalitat de Catalunya (Spain) (to E. H. and J. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an ICREA Academia Award (Generalitat de Catalunya, Spain).	Alfa C, 1993, EXPT FISSION YEAST L; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Calvo IA, 2012, NUCLEIC ACIDS RES, V40, P4816, DOI 10.1093/nar/gks141; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fernandez-Vazquez J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003647; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guy MP, 2014, RNA BIOL, V11, P1608, DOI 10.1080/15476286.2015.1008360; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Johnsson A, 2006, EUKARYOT CELL, V5, P1337, DOI 10.1128/EC.00101-06; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Liger D, 2011, NUCLEIC ACIDS RES, V39, P6249, DOI 10.1093/nar/gkr176; Mbogning J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004029; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; Paulo E, 2014, MOL MICROBIOL, V92, P246, DOI 10.1111/mmi.12548; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Verrier L, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150045; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	38	4	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					790	799		10.1074/jbc.M115.696658	http://dx.doi.org/10.1074/jbc.M115.696658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567340	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000367830500026
J	Romes, EM; Sobhany, M; Stanley, RE				Romes, Erin M.; Sobhany, Mack; Stanley, Robin E.			The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WD-REPEAT PROTEIN; NUCLEOLAR LOCALIZATION; BIOGENESIS FACTORS; ER-ALPHA; PES1; COMPLEX; EXPRESSION; MATURATION; CANCER; WDR12	The synthesis of eukaryotic ribosomes is a complex, energetically demanding process requiring the aid of numerous non-ribosomal factors, such as the PeBoW complex. The mammalian PeBoW complex, composed of Pes1, Bop1, and WDR12, is essential for the processing of the 32S preribosomal RNA. Previous work in Saccharomyces cerevisiae has shown that release of the homologous proteins in this complex (Nop7, Erb1, and Ytm1, respectively) from preribosomal particles requires Rea1 (midasin or MDN1 in humans), a large dynein-like protein. Midasin contains a C-terminal metal ion-dependent adhesion site (MIDAS) domain that interacts with the N-terminal ubiquitin- like (UBL) domain of Ytm1/WDR12 as well as the UBL domain of Rsa4/Nle1 in a later step in the ribosome maturation pathway. Here we present the crystal structure of the UBL domain of the WDR12 homologue from S. cerevisiae at 1.7 angstrom resolution and demonstrate that human midasin binds to WDR12 as well as Nle1 through their respective UBL domains. Midasin contains a well conserved extension region upstream of the MIDAS domain required for binding WDR12 and Nle1, and the interaction is dependent upon metal ion coordination because removal of the metal or mutation of residues that coordinate the metal ion diminishes the interaction. Mammalian WDR12 displays prominent nucleolar localization that is dependent upon active ribosomal RNA transcription. Based upon these results, we propose that release of the PeBoW complex and subsequent release of Nle1 by midasin is a well conserved step in the ribosome maturation pathway in both yeast and mammalian cells.	[Romes, Erin M.; Sobhany, Mack; Stanley, Robin E.] NIEHS, Signal Transduct Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Stanley, RE (corresponding author), NIEHS, Signal Transduct Labo, NIH, Bldg 101,Rm F378,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	robin.stanley@nih.gov	Stanley, Robin/M-3008-2019; Stanley, Robin E/C-7128-2019	Stanley, Robin/0000-0002-2106-3102; Stanley, Robin E/0000-0002-2106-3102	NIEHS, National Institutes of Health; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103247] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in whole or in part by the Intramural Research Program of NIEHS, National Institutes of Health. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams NBP, 2013, J BIOL CHEM, V288, P28727, DOI 10.1074/jbc.M113.477943; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Beck-Cormier S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098507; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chantha SC, 2007, PLANTA, V225, P1107, DOI 10.1007/s00425-006-0420-z; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Garbarino JE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-18; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kressler D, 2012, BBA-MOL CELL RES, V1823, P92, DOI 10.1016/j.bbamcr.2011.06.017; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Li JP, 2013, IUBMB LIFE, V65, P1017, DOI 10.1002/iub.1228; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Moilanen AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124907; Morita E, 2007, CELL HOST MICROBE, V2, P41, DOI 10.1016/j.chom.2007.06.003; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Nakaguro M, 2015, CANCER SCI, V106, P237, DOI 10.1111/cas.12598; Nal B, 2002, GENOMICS, V79, P77, DOI 10.1006/geno.2001.6682; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Stedman A, 2015, CELL DEATH DIFFER, V22, P1865, DOI 10.1038/cdd.2015.57; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tang L, 2008, MOL BIOL CELL, V19, P2844, DOI 10.1091/mbc.E07-12-1281; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Wegrecki Marcin, 2015, Nucleic Acids Res, V43, P11017, DOI 10.1093/nar/gkv1043; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xie W, 2013, BIOCHEM BIOPH RES CO, V431, P460, DOI 10.1016/j.bbrc.2012.12.145; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042253; Zabalza M, 2015, REV ESP CARDIOL, V68, P869, DOI [10.1016/j.rec.2014.10.023, 10.1016/j.recesp.2014.10.023]; Zhang JH, 2009, ACTA BIOCH BIOPH SIN, V41, P991, DOI 10.1093/abbs/gmp096; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	56	23	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					882	893		10.1074/jbc.M115.693259	http://dx.doi.org/10.1074/jbc.M115.693259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601951	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000367830500034
J	Kotzler, MP; Withers, SG				Koetzler, Miriam P.; Withers, Stephen G.			Proteolytic Cleavage Driven by Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutamate; glycobiology; glycosidase; glycosylation; protein processing; protein splicing; proteolysis; glutamyl ester; glycosyl ester; pyroglutamate	O-GLCNAC TRANSFERASE; AGROBACTERIUM BETA-GLUCOSIDASE; ENZYME INTERMEDIATE; KINETIC-ANALYSIS; ACTIVE-SITE; MECHANISM; IDENTIFICATION; HYDROLYSIS; INHIBITORS; PEPTIDES	Proteolytic processing of human host cell factor 1 (HCF-1) to its mature form was recently shown, unexpectedly, to occur in a UDP-GlcNAc-dependent fashion within the transferase active site of O-GlcNAc-transferase (OGT) (Lazarus, M. B., Jiang, J., Kapuria, V., Bhuiyan, T., Janetzko, J., Zandberg, W. F., Vocadlo, D. J., Herr, W., and Walker, S. (2013) Science 342, 1235-1239). An interesting mechanism involving formation and then intramolecular rearrangement of a covalent glycosyl ester adduct of the HCF-1 polypeptide was proposed to account for this unprecedented proteolytic activity. However, the key intermediate remained hypothetical. Here, using a model enzyme system for which the formation of a glycosyl ester within the enzyme active site has been shown unequivocally, we show that ester formation can indeed lead to proteolysis of the adjacent peptide bond, thereby providing substantive support for the mechanism of HCF-1 processing proposed.	[Koetzler, Miriam P.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca			Natural Sciences and Engineering Research Council of Canada; Canada Council for the Arts; German Research Foundation (DFG)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Council for the Arts; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Council for the Arts, and the German Research Foundation (DFG). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON J, 1970, CARBOHYD RES, V15, P351, DOI 10.1016/S0008-6215(00)80451-6; BATTERSBY AR, 1956, J CHEM SOC, P2076, DOI 10.1039/jr9560002076; Bhuiyan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136636; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chulin AN, 2005, J PEPT SCI, V11, P175, DOI 10.1002/psc.611; HALL LD, 1971, CAN J CHEMISTRY, V49, P118, DOI 10.1139/v71-017; KHAN SA, 1984, J AM CHEM SOC, V106, P798, DOI 10.1021/ja00315a060; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; Namchuk MN, 1995, BIOCHEMISTRY-US, V34, P16194, DOI 10.1021/bi00049a035; Quesne L. W. J., 1952, J CHEM SOC, P594; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; STREET IP, 1992, BIOCHEMISTRY-US, V31, P9970, DOI 10.1021/bi00156a016; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; WAKARCHUK WW, 1988, J BACTERIOL, V170, P301, DOI 10.1128/jb.170.1.301-307.1988; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WITHERS SG, 1992, BIOCHEMISTRY-US, V31, P9979, DOI 10.1021/bi00156a017; WITHERS SG, 1988, J AM CHEM SOC, V110, P8551, DOI 10.1021/ja00233a045; WITHERS SG, 1987, J AM CHEM SOC, V109, P7530, DOI 10.1021/ja00258a047	21	7	7	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					429	434		10.1074/jbc.C115.698696	http://dx.doi.org/10.1074/jbc.C115.698696			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26515062	Green Published, hybrid			2022-12-28	WOS:000367589500038
J	Pradhan, MA; Blackford, JA; Devaiah, BN; Thompson, PS; Chow, CC; Singer, DS; Simons, SS				Pradhan, Madhumita A.; Blackford, John A., Jr.; Devaiah, Ballachanda N.; Thompson, Petria S.; Chow, Carson C.; Singer, Dinah S.; Simons, S. Stoney, Jr.			Kinetically Defined Mechanisms and Positions of Action of Two New Modulators of Glucocorticoid Receptor-regulated Gene Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclin-dependent kinase (CDK); gene expression; glucocorticoid receptor; steroid hormone; transcription factor; EC50; accelerator; decelerator; kinetically defined activity; transactivation competition assay	RNA-POLYMERASE-II; NEGATIVE ELONGATION-FACTOR; P-TEFB; PRODUCTIVE ELONGATION; NUCLEAR RECEPTORS; TERMINAL DOMAIN; IN-VIVO; PROTEIN; BRD4; TRANSACTIVATION	Most of the steps in, and many of the factors contributing to, glucocorticoid receptor (GR)-regulated gene induction are currently unknown. A competition assay, based on a validated chemical kinetic model of steroid hormone action, is now used to identify two new factors (BRD4 and negative elongation factor (NELF)-E) and to define their sites and mechanisms of action. BRD4 is a kinase involved in numerous initial steps of gene induction. Consistent with its complicated biochemistry, BRD4 is shown to alter both the maximal activity (A(max)) and the steroid concentration required for half-maximal induction (EC50) of GR-mediated gene expression by acting at a minimum of three different kinetically defined steps. The action at two of these steps is dependent on BRD4 concentration, whereas the third step requires the association of BRD4 with P-TEFb. BRD4 is also found to bind to NELF-E, a component of the NELF complex. Unexpectedly, NELF-E modifies GR induction in a manner that is independent of the NELF complex. Several of the kinetically defined steps of BRD4 in this study are proposed to be related to its known biochemical actions. However, novel actions of BRD4 and of NELF-E in GR-controlled gene induction have been uncovered. The model-based competition assay is also unique in being able to order, for the first time, the sites of action of the various reaction components: GR < Cdk9 < BRD4 induced gene < NELF-E. This ability to order factor actions will assist efforts to reduce the side effects of steroid treatments.	[Pradhan, Madhumita A.; Blackford, John A., Jr.; Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol, Bethesda, MD 20892 USA; [Devaiah, Ballachanda N.; Thompson, Petria S.; Singer, Dinah S.] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Math Biol Sect, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Simons, SS (corresponding author), NIDDK, LERB, NIH, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov		Thompson, Petria/0000-0002-3839-4303	Intramural Research Program of NIDDK; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075069] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of NIDDK and NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Blackford JA, 2014, MOL ENDOCRINOL, V28, P1194, DOI 10.1210/me.2014-1069; Blackford JA, 2012, J BIOL CHEM, V287, P40982, DOI 10.1074/jbc.M112.414805; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Chow CC, 2015, AIMS MOL SCI, V2, P101, DOI 10.3934/molsci.2015.2.101; Chow CC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004122; Chow CC, 2011, METHOD ENZYMOL, P465, DOI [10.1016/S0076-6879(11)87016-3, 10.1016/B978-0-12-381270-4.00016-0]; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; Devaiah BN, 2013, TRANSCR-AUSTIN, V4, P13, DOI 10.4161/trns.22542; Devaiah BN, 2012, J BIOL CHEM, V287, P38755, DOI 10.1074/jbc.M112.412015; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Dougherty EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030225; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Glass CK, 2000, GENE DEV, V14, P121; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; JENSEN EV, 1972, ANNU REV BIOCHEM, V41, P203, DOI 10.1146/annurev.bi.41.070172.001223; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Luo M, 2013, J BIOL CHEM, V288, P34055, DOI 10.1074/jbc.M113.512426; Luo M, 2009, HUM IMMUNOL, V70, P785, DOI 10.1016/j.humimm.2009.07.029; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Narayanan R, 2008, MOL ENDOCRINOL, V22, P2448, DOI 10.1210/me.2008-0160; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Szapary D, 1999, MOL ENDOCRINOL, V13, P2108, DOI 10.1210/me.13.12.2108; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Zhang ZH, 2013, J BIOL CHEM, V288, P42, DOI 10.1074/jbc.M112.427740; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu R, 2014, BIOCHEMISTRY-US, V53, P1753, DOI 10.1021/bi5000178	39	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					342	354		10.1074/jbc.M115.683722	http://dx.doi.org/10.1074/jbc.M115.683722			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26504077	Green Published, hybrid			2022-12-28	WOS:000367589500027
J	Wang, RS; Ding, Q; Yaqoob, U; de Assuncao, TM; Verma, VK; Hirsova, P; Cao, S; Mukhopadhyay, D; Huebert, RC; Shah, VH				Wang, Ruisi; Ding, Qian; Yaqoob, Usman; de Assuncao, Thiago M.; Verma, Vikas K.; Hirsova, Petra; Cao, Sheng; Mukhopadhyay, Debabrata; Huebert, Robert C.; Shah, Vijay H.			Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; LIVER FIBROSIS; EXTRACELLULAR EXPORT; MEDIATED ENDOCYTOSIS; GROWTH; MICROPARTICLES; MICROVESICLES; ROLES; PATHOGENESIS; ACTIVATION	Exosomes are cell-derived extracellular vesicles thought to promote intercellular communication by delivering specific content to target cells. The aim of this study was to determine whether endothelial cell (EC)-derived exosomes could regulate the phenotype of hepatic stellate cells (HSCs). Initial microarray studies showed that fibroblast growth factor 2 induced a 2.4-fold increase in mRNA levels of sphingosine kinase 1 (SK1). Exosomes derived from an SK1-overexpressing EC line increased HSC migration 3.2-fold. Migration was not conferred by the dominant negative SK1 exosome. Incubation of HSCs with exosomes was also associated with an 8.3-fold increase in phosphorylation of AKT and 2.5-fold increase in migration. Exosomes were found to express the matrix protein and integrin ligand fibronectin (FN) by Western blot analysis and transmission electron microscopy. Blockade of the FN-integrin interaction with a CD29 neutralizing antibody or the RGD peptide attenuated exosome-induced HSC AKT phosphorylation and migration. Inhibition of endocytosis with transfection of dynamin siRNA, the dominant negative dynamin GTPase construct Dyn2K44A, or the pharmacological inhibitor Dynasore significantly attenuated exosome-induced AKT phosphorylation. SK1 levels were increased in serum exosomes derived from mice with experimental liver fibrosis, and SK1 mRNA levels were up-regulated 2.5-fold in human liver cirrhosis patient samples. Finally, S1PR2 inhibition protected mice from CCl4-induced liver fibrosis. Therefore, EC-derived SK1-containing exosomes regulate HSC signaling and migration through FN-integrin-dependent exosome adherence and dynamin-dependent exosome internalization. These findings advance our understanding of EC/HSC cross-talk and identify exosomes as a potential target to attenuate pathobiology signals.	[Wang, Ruisi] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55902 USA; [Wang, Ruisi] Mayo Clin, Dept Expt Therapeut, Rochester, MN 55902 USA; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55902 USA; [Ding, Qian; Yaqoob, Usman; de Assuncao, Thiago M.; Verma, Vikas K.; Hirsova, Petra; Cao, Sheng; Huebert, Robert C.; Shah, Vijay H.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Shah, VH (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	shah.vijay@mayo.edu	Hirsova, Petra/B-8943-2018; Verma, Vikas/I-6593-2018; Regan, Clinton/E-6250-2012	Hirsova, Petra/0000-0003-0494-0924; Verma, Vikas/0000-0003-2890-9200; 	National Institutes of Health [R01 DK59615, R01 AA021171, P30 DK84567, U01 AA21788]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100575, P30DK084567, R01DK059615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA021171, R01AA021171, U01AA021788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK59615 and R01 AA021171 (to V. H. S.). Patient samples were obtained through the support of National Institutes of Health Grants P30 DK84567 (to N. F. L.) and U01 AA21788 (to V. H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Arendt BK, 2014, ONCOTARGET, V5, P5686, DOI 10.18632/oncotarget.2159; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; de Assuncao TM, 2014, J BIOL CHEM, V289, P15798, DOI 10.1074/jbc.M113.544346; El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Giugliano S, 2015, GASTROENTEROLOGY, V148, P392, DOI 10.1053/j.gastro.2014.10.040; Henderson NC, 2013, BBA-MOL BASIS DIS, V1832, P891, DOI 10.1016/j.bbadis.2012.10.005; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Lee HD, 2014, EUR J IMMUNOL, V44, P1156, DOI 10.1002/eji.201343660; Lemoinne S, 2015, HEPATOLOGY, V61, P1041, DOI 10.1002/hep.27318; Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nojima H, 2016, J HEPATOL, V64, P60, DOI 10.1016/j.jhep.2015.07.030; Pitson SM, 2001, FEBS LETT, V509, P169; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tu KS, 2015, HEPATOLOGY, V61, P361, DOI 10.1002/hep.27251; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Yang L, 2013, J HEPATOL, V59, P114, DOI 10.1016/j.jhep.2013.02.021; Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061; Yang L, 2012, HEPATOLOGY, V56, p768A; Yaqoob U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098130; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	60	136	148	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30684	U51		10.1074/jbc.M115.671735	http://dx.doi.org/10.1074/jbc.M115.671735			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534962	Green Published, hybrid			2022-12-28	WOS:000367199000003
J	Hu, HQ; Zhou, Q; Li, ZY				Hu, Huiqing; Zhou, Qing; Li, Ziyin			SAS-4 Protein in Trypanosoma brucei Controls Life Cycle Transitions by Modulating the Length of the Flagellum Attachment Zone Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; BASAL BODY; CELL-CYCLE; CARTWHEEL PROTEIN; 9-FOLD SYMMETRY; CENTRIOLE; CYTOKINESIS; SEGREGATION; MORPHOGENESIS; BIOGENESIS	The evolutionarily conserved centriole/basal body protein SAS-4 regulates centriole duplication in metazoa and basal body duplication in flagellated and ciliated organisms. Here, we report that the SAS-4 homolog in the flagellated protozoan Trypanosoma brucei, TbSAS-4, plays an unusual role in controlling life cycle transitions by regulating the length of the flagellum attachment zone (FAZ) filament, a specialized cytoskeletal structure required for flagellum adhesion and cell morphogenesis. TbSAS-4 is concentrated at the distal tip of the FAZ filament, and depletion of TbSAS-4 in the trypomastigote form disrupts the elongation of the new FAZ filament, generating cells with a shorter FAZ associated with a longer unattached flagellum and repositioned kinetoplast and basal body, reminiscent of epimastigote-like morphology. Further, we show that TbSAS-4 associates with six additional FAZ tip proteins, and depletion of TbSAS-4 disrupts the enrichment of these FAZ tip proteins at the new FAZ tip, suggesting a role of TbSAS-4 in maintaining the integrity of this FAZ tip protein complex. Together, these results uncover a novel function of TbSAS-4 in regulating the length of the FAZ filament to control basal body positioning and life cycle transitions in T. brucei.	[Hu, Huiqing; Zhou, Qing; Li, Ziyin] Univ Texas Houston, Dept Microbiol & Mol Genet, Med Sch Houston, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Houston, Dept Microbiol & Mol Genet, Med Sch Houston, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/A-8296-2019; Regan, Clinton/E-6250-2012; Zhou, Qing/I-6223-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI101437, AI108657]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R56AI108657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI101437 and AI108657 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Esson HJ, 2012, EUKARYOT CELL, V11, P761, DOI 10.1128/EC.05287-11; GALLO JM, 1988, CELL MOTIL CYTOSKEL, V9, P175, DOI 10.1002/cm.970090209; Gheiratmand L, 2013, J BIOL CHEM, V288, P3489, DOI 10.1074/jbc.M112.417428; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gogendeau D, 2011, MOL BIOL CELL, V22, P1035, DOI 10.1091/mbc.E10-11-0901; Hayes P, 2014, J CELL BIOL, V206, P377, DOI 10.1083/jcb.201312067; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; HOARE CA, 1966, NATURE, V212, P1385, DOI 10.1038/2121385a0; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Sunter JD, 2015, J CELL SCI, V128, P3117, DOI 10.1242/jcs.171645; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	50	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30453	30463		10.1074/jbc.M115.694109	http://dx.doi.org/10.1074/jbc.M115.694109			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26504079	hybrid, Green Published			2022-12-28	WOS:000366738200022
J	Lee, JH; Park, KJ; Jang, JK; Jeon, YH; Ko, KY; Kwon, JH; Lee, SR; Kim, IY				Lee, Jea Hwang; Park, Ki Jun; Jang, Jun Ki; Jeon, Yeong Ha; Ko, Kwan Young; Kwon, Joon Hyun; Lee, Seung-Rock; Kim, Ick Young			Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE; MULTIPROTEIN COMPLEXES; QUALITY-CONTROL; PHYSIOLOGICAL ROLES; INDUCED APOPTOSIS; UBIQUITIN LIGASE; STRESS; ER; MEMBRANE; CELLS	Cytosolic valosin-containing protein (p97(VCP)) is translocated to the ER membrane by binding to selenoprotein S (SelS), which is an ER membrane protein, during endoplasmic reticulum-associated degradation (ERAD). Selenoprotein K (SelK) is another known p97(VCP)-binding selenoprotein, and the expression of both SelS and SelK is increased under ER stress. To understand the regulatory mechanisms of SelS, SelK, and p97(VCP) during ERAD, the interaction of the selenoproteins with p97(VCP) was investigated using N2a cells and HEK293 cells. Both SelS and SelK co-precipitated with p97(VCP). However, the association between SelS and SelK did not occur in the absence of p97(VCP). SelS had the ability to recruit p97(VCP) to the ER membrane but SelK did not. The interaction between SelK and p97(VCP) did not occur in SelS knockdown cells, whereas SelS interacted with p97(VCP) in the presence or absence of SelK. These results suggest that p97(VCP) is first translocated to the ER membrane via its interaction with SelS, and then SelK associates with the complex on the ER membrane. Therefore, the interaction between SelK and p97(VCP) is SelS-dependent, and the resulting ERAD complex (SelS-p97(VCP)-SelK) plays an important role in ERAD and ER stress.	[Lee, Jea Hwang; Park, Ki Jun; Jang, Jun Ki; Jeon, Yeong Ha; Ko, Kwan Young; Kwon, Joon Hyun; Kim, Ick Young] Korea Univ, Div Life Sci, Lab Cellular & Mol Biochem, Seoul 136713, South Korea; [Lee, Seung-Rock] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Res Ctr Aging & Geriatr,Dept Biochem, Gwangju 501190, South Korea; [Lee, Seung-Rock] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Res Ctr Aging & Geriatr,Dept Biomed Sci, Gwangju 501190, South Korea	Korea University; Chonnam National University; Chonnam National University	Kim, IY (corresponding author), Korea Univ, Div Life Sci, 1 5 Ka, Seoul 136713, South Korea.	ickkim@korea.ac.kr			National Research Foundation of Korea; Korean government, (MSIP) [2013R1A2A2A01067149]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government, (MSIP)	This work was supported by the National Research Foundation of Korea and a grant funded by the Korean government, (MSIP) 2013R1A2A2A01067149. The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Christensen LC, 2012, J BIOL CHEM, V287, P26388, DOI 10.1074/jbc.M112.346775; Doroudgar S, 2015, CIRC RES, V117, P536, DOI 10.1161/CIRCRESAHA.115.306993; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Du SQ, 2010, BBA-GEN SUBJECTS, V1800, P511, DOI 10.1016/j.bbagen.2010.01.005; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Jeon YH, 2014, BBA-MOL CELL RES, V1843, P1356, DOI 10.1016/j.bbamcr.2014.04.002; Jeon YH, 2013, BBA-MOL CELL RES, V1833, P2135, DOI 10.1016/j.bbamcr.2013.05.005; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim CY, 2013, J LIPID RES, V54, P2069, DOI 10.1194/jlr.M034603; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kim SJ, 2014, J BIOL CHEM, V289, P12264, DOI 10.1074/jbc.M113.523936; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kogel D, 2003, J NEUROCHEM, V87, P248, DOI 10.1046/j.1471-4159.2003.02000.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kwon JH, 2012, J IMMUNOL, V188, P5665, DOI 10.4049/jimmunol.1102306; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Lee JH, 2014, J BIOL CHEM, V289, P13758, DOI 10.1074/jbc.M113.534529; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Liu J, 2013, BIOCHEMISTRY-US, V52, P5514, DOI 10.1021/bi400741c; Liu J, 2012, PROTEIN EXPRES PURIF, V86, P27, DOI 10.1016/j.pep.2012.08.014; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Noda C, 2014, J BIOL CHEM, V289, P24304, DOI 10.1074/jbc.M114.571372; Park YH, 2012, BBA-MOL CELL RES, V1823, P2217, DOI 10.1016/j.bbamcr.2012.09.001; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Turanov AA, 2014, BIOCHEM J, V462, P555, DOI 10.1042/BJ20140076; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	49	54	57	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29941	29952		10.1074/jbc.M115.680215	http://dx.doi.org/10.1074/jbc.M115.680215			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26504085	Green Published, hybrid			2022-12-28	WOS:000366614700026
J	Nishitsuji, H; Sugiyama, R; Abe, M; Takaku, H				Nishitsuji, Hironori; Sugiyama, Ryuichi; Abe, Makoto; Takaku, Hiroshi			ATP1B3 Protein Modulates the Restriction of HIV-1 Production and Nuclear Factor kappa Light Chain Enhancer of Activated B Cells (NF-kappa B) Activation by BST-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS ENVELOPE GLYCOPROTEIN; RETROVIRUS RELEASE; PARTICLE RELEASE; DENDRITIC CELLS; MARFAN-SYNDROME; TYPE-1 HIV-1; VPU PROTEIN; TETHERIN; IDENTIFICATION; SUBUNIT	Here, we identify ATP1B3 and fibrillin-1 as novel BST-2-binding proteins. ATP1B3 depletion in HeLa cells (BST-2-positive cells), but not 293T cells (BST-2-negative cells), induced the restriction of HIV-1 production in a BST-2-dependent manner. In contrast, fibrillin-1 knockdown reduced HIV-1 production in 293T and HeLa cells in a BST-2-independent manner. Moreover, NF-kappa B activation was enhanced by siATP1B3 treatment in HIV-1-and HIV-1 triangle Vpu-infected HeLa cells. In addition, ATP1B3 silencing induced high level BST-2 expression on the surface of HeLa cells. These results indicate that ATP1B3 is a co-factor that accelerates BST-2 degradation and reduces BST-2-mediated restriction of HIV-1 production and NF-kappa B activation.	[Nishitsuji, Hironori] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba 2728516, Japan; [Sugiyama, Ryuichi; Abe, Makoto; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Res Inst, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan; [Sugiyama, Ryuichi] Yokohama City Univ, Sch Med, Dept Microbiol, Kanagawa 2360004, Japan	National Center for Global Health & Medicine - Japan; Chiba Institute of Technology; Chiba Institute of Technology; Yokohama City University	Takaku, H (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hiroshi.takaku@it-chiba.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan; Ministry of Health, Labor, and Welfare of Japan; Strategic Research Foundation from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (MEXT); Grants-in-Aid for Scientific Research [26860309] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Research Foundation from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (MEXT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for science research (C) from the Japan Society for the Promotion of Science (JSPS), Japan; by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan; and by a grant from the Strategic Research Foundation grant-aided project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (MEXT). The authors declare that they have no conflicts of interest with the contents of this article.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Caillet M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002347; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Ju XS, 2004, GENE, V331, P159, DOI 10.1016/j.gene.2004.02.018; Kielty CM, 2002, PHILOS T R SOC B, V357, P207, DOI 10.1098/rstb.2001.1029; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; Malik N, 1998, MAMM GENOME, V9, P136, DOI 10.1007/s003359900704; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morrison JH, 2014, J VIROL, V88, P3255, DOI 10.1128/JVI.03814-13; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ni J, 2012, CANCER METAST REV, V31, P779, DOI 10.1007/s10555-012-9389-1; Nishitsuji H, 2015, FEBS LETT, V589, P2019, DOI 10.1016/j.febslet.2015.06.013; Nityanandam R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004151; Pacyniak E, 2005, AIDS RES HUM RETROV, V21, P379, DOI 10.1089/aid.2005.21.379; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2006, TRAFFIC, V7, P298, DOI 10.1111/j.1600-0854.2005.00380.x; Yin X, 2014, J VIROL, V88, P1259, DOI 10.1128/JVI.03148-13	42	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4754	4762		10.1074/jbc.M115.679357	http://dx.doi.org/10.1074/jbc.M115.679357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694617	hybrid, Green Published			2022-12-28	WOS:000371604600041
J	Warne, J; Pryce, G; Hill, JM; Shi, X; Lenneras, F; Puentes, F; Kip, M; Hilditch, L; Walker, P; Simone, MI; Chan, AWE; Towers, GJ; Coker, AR; Duchen, MR; Szabadkai, G; Baker, D; Selwood, DL				Warne, Justin; Pryce, Gareth; Hill, Julia M.; Shi, Xiao; Lenneras, Felicia; Puentes, Fabiola; Kip, Maarten; Hilditch, Laura; Walker, Paul; Simone, Michela I.; Chan, A. W. Edith; Towers, Greg J.; Coker, Alun R.; Duchen, Michael R.; Szabadkai, Gyorgy; Baker, David; Selwood, David L.			Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; HUMAN CYCLOPHILIN-D; CYCLOSPORINE-A; AXONAL DEGENERATION; ATP SYNTHASE; TRIPHENYLPHOSPHONIUM CATIONS; LENTIVIRAL VECTOR; P-GLYCOPROTEIN	The mitochondrial permeability transition pore is a recognized drug target for neurodegenerative conditions such as multiple sclerosis and for ischemia-reperfusion injury in the brain and heart. The peptidylprolyl isomerase, cyclophilin D (CypD, PPIF), is a positive regulator of the pore, and genetic down-regulation or knock-out improves outcomes in disease models. Current inhibitors of peptidylprolyl isomerases show no selectivity between the tightly conserved cyclophilin paralogs and exhibit significant off-target effects, immunosuppression, and toxicity. We therefore designed and synthesized a new mitochondrially targeted CypD inhibitor, JW47, using a quinolinium cation tethered to cyclosporine. X-ray analysis was used to validate the design concept, and biological evaluation revealed selective cellular inhibition of CypD and the permeability transition pore with reduced cellular toxicity compared with cyclosporine. In an experimental autoimmune encephalomyelitis disease model of neurodegeneration in multiple sclerosis, JW47 demonstrated significant protection of axons and improved motor assessments with minimal immunosuppression. These findings suggest that selective CypD inhibition may represent a viable therapeutic strategy for MS and identify quinolinium as a mitochondrial targeting group for in vivo use.	[Warne, Justin; Pryce, Gareth; Shi, Xiao; Kip, Maarten; Simone, Michela I.; Chan, A. W. Edith; Coker, Alun R.; Selwood, David L.] UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England; [Pryce, Gareth; Lenneras, Felicia; Puentes, Fabiola; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Neuroimmunol Unit, Blizard Inst, 4 Newark St, London E1 2AT, England; [Hill, Julia M.; Duchen, Michael R.; Szabadkai, Gyorgy] UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England; [Hilditch, Laura; Towers, Greg J.] UCL, Med Res Council, Ctr Med Mol Biol, Div Infect & Immun, Mortimer St, London WC1E 6BT, England; [Walker, Paul] Cyprotex Discovery Ltd, 100 Barbirolli Sq, Manchester M2 3AB, Lancs, England; [Szabadkai, Gyorgy] Univ Padua, Dept Biomed Sci, I-35122 Padua, Italy; [Simone, Michela I.] Univ Newcastle, Sch Environm & Life Sci, Discipline Chem, Callaghan, NSW 2308, Australia	University of London; University College London; University of London; Queen Mary University London; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of Padua; University of Newcastle	Selwood, DL (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.; Baker, D (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Neuroimmunol Unit, Blizard Inst, 4 Newark St, London E1 2AT, England.	david.baker@qmul.ac.uk; d.selwood@ucl.ac.uk	Simone, Michela/AAS-7878-2020; duchen, michael/A-2116-2009; Simone, Michela I./A-6887-2011	Simone, Michela/0000-0002-1339-8236; duchen, michael/0000-0003-2548-4294; Simone, Michela I./0000-0002-1339-8236; Towers, Gregory/0000-0002-7707-0264; Szabadkai, Gyorgy/0000-0002-3006-3577; Coker, Alun/0000-0001-7385-0143; Walker, Paul/0000-0002-7840-9709; Selwood, David/0000-0002-6817-5064	FastForward; National Multiple Sclerosis Society; Wellcome Trust [090940]; Medical Research Council, a Medical Research Council Confidence in Concept Award; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Eisai UK Ltd.; British Heart Foundation; Telethon Italy; Italian Association for Cancer Research (AIRC); MRC [G0801172] Funding Source: UKRI; Medical Research Council [G0801172] Funding Source: researchfish; Wellcome Trust [108183/Z/15/Z] Funding Source: researchfish	FastForward; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, a Medical Research Council Confidence in Concept Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Eisai UK Ltd.(Eisai Co Ltd); British Heart Foundation(British Heart Foundation); Telethon Italy(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by FastForward, National Multiple Sclerosis Society, Wellcome Trust Senior Fellowship 090940 (to G. J. T.), the Medical Research Council, a Medical Research Council Confidence in Concept Award (to G. J. T. and D. S.), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Three authors (G. S., D. B., and D. L. S.) are inventors on a patent filed by the university. Through the university revenue sharing scheme, inventors may, should the invention be commercialized and in the fullness of time, receive some financial benefit.; Supported by a studentship from Eisai UK Ltd.; Supported by the British Heart Foundation, Wellcome Trust, Telethon Italy, and the Italian Association for Cancer Research (AIRC).	Al-Izki S, 2014, BRAIN, V137, P92, DOI 10.1093/brain/awt324; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALLEN SJ, 1993, CELL IMMUNOL, V146, P335, DOI 10.1006/cimm.1993.1031; AMOR S, 1994, J IMMUNOL, V153, P4349; Astin R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02467; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Barbarino JM, 2013, PHARMACOGENET GENOM, V23, P563, DOI 10.1097/FPC.0b013e328364db84; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Bart J, 2000, CANCER TREAT REV, V26, P449, DOI 10.1053/ctrv.2000.0194; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Campbell GR, 2014, MULT SCLER J, V20, P1806, DOI 10.1177/1352458514544537; Chinopoulos C, 2011, FEBS J, V278, P1112, DOI 10.1111/j.1742-4658.2011.08026.x; Chung NS, 2004, ADV DRUG DELIVER REV, V56, P1315, DOI 10.1016/j.addr.2003.12.003; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Dube H, 2012, BIOCHEM J, V441, P901, DOI 10.1042/BJ20111301; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Gaali S, 2010, ACS MED CHEM LETT, V1, P536, DOI 10.1021/ml1001272; Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gogarten W, 1998, J NEUROSURG ANESTH, V10, P101, DOI 10.1097/00008506-199804000-00006; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Hampton DW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-84; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hazelton JL, 2009, J NEUROSCI RES, V87, P1250, DOI 10.1002/jnr.21921; Hecking M, 2008, TRANSPL INT, V21, P223, DOI 10.1111/j.1432-2277.2007.00563.x; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Jackson SJ, 2009, J NEUROPATH EXP NEUR, V68, P616, DOI 10.1097/NEN.0b013e3181a41d23; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Kageyama T, 2013, J NEUROL, V260, P627, DOI 10.1007/s00415-012-6692-2; Kajitani K, 2008, PROTEINS, V70, P1635, DOI 10.1002/prot.21855; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; KAPPOS L, 1988, ANN NEUROL, V23, P56, DOI 10.1002/ana.410230110; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Leo S, 2008, ANN NY ACAD SCI, V1147, P264, DOI 10.1196/annals.1427.019; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; Liu YY, 2006, ANAL BIOCHEM, V356, P100, DOI 10.1016/j.ab.2006.04.040; Macarron R, 2011, FUTURE MED CHEM, V3, P505, DOI [10.4155/FMC.11.19, 10.4155/fmc.11.19]; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; MAKLER MT, 1990, Patent No. 4946849; Malouitre S, 2010, BIOCHEM J, V425, P137, DOI 10.1042/BJ20090332; Marta M, 2012, CNS NEUROL DISORD-DR, V11, P610, DOI 10.2174/187152712801661301; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McEwan WA, 2009, J VIROL, V83, P8270, DOI 10.1128/JVI.00670-09; Millard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013131; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; ONEILL JK, 1992, J NEUROIMMUNOL, V38, P53, DOI 10.1016/0165-5728(92)90090-8; Porteous CM, 2013, BBA-GEN SUBJECTS, V1830, P3458, DOI 10.1016/j.bbagen.2013.02.005; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Pryce G, 2014, FASEB J, V28, P117, DOI 10.1096/fj.13-239442; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Raftopoulos R, 2015, MULT SCLER J, V21, P273; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Rodrigues JR, 2007, EXP PARASITOL, V115, P19, DOI 10.1016/j.exppara.2006.05.002; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Savino C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/719407; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schlatter D, 2005, ACTA CRYSTALLOGR D, V61, P513, DOI 10.1107/S0907444905003070; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma Pradeep, 2005, Farmaco (Lausanne), V60, P870, DOI 10.1016/j.farmac.2005.08.006; Smulik JA, 2002, ORG LETT, V4, P2051, DOI 10.1021/ol0258987; Starr R, 1996, J NEUROSCI RES, V44, P328; Su K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00169; Su KG, 2012, EUR J NEUROSCI, V35, P562, DOI 10.1111/j.1460-9568.2011.07972.x; Templeton I, 2014, METHODS MOL BIOL, V1113, P471, DOI 10.1007/978-1-62703-758-7_22; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valasani KR, 2014, ACTA CRYSTALLOGR F, V70, P717, DOI 10.1107/S2053230X14009480; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOLINSKY JS, 1990, ANN NEUROL, V27, P591; Wu N, 2015, EUR REV MED PHARMACO, V19, P446; Ylinen LMJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001062; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	99	46	50	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4356	4373		10.1074/jbc.M115.700385	http://dx.doi.org/10.1074/jbc.M115.700385			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26679998	Green Published, hybrid			2022-12-28	WOS:000371604600009
J	Zhang, PW; Rayment, I; Gilbert, SP				Zhang, Pengwei; Rayment, Ivan; Gilbert, Susan P.			Fast or Slow, Either Head Can Start the Processive Run of Kinesin-2 KIF3AC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; SUPERFAMILY PROTEIN; ORGANELLE TRANSPORT; COMPLEX INTERACTS; MOTOR PROTEIN; MOUSE; DIFFERENTIATION; TRANSLOCATION; EXPRESSION; VESICLES	Mammalian KIF3AC contains two distinct motor polypeptides and is best known for its role in organelle transport in neurons. Our recent studies showed that KIF3AC is as processive as conventional kinesin-1, suggesting that their ATPase mechanochemistry may be similar. However, the presence of two different motor polypeptides in KIF3AC implies that there must be a cellular advantage for the KIF3AC heterodimer. The hypothesis tested was whether there is an intrinsic bias within KIF3AC such that either KIF3A or KIF3C initiates the processive run. To pursue these experiments, a mechanistic approach was used to compare the pre-steady-state kinetics of KIF3AC to the kinetics of homodimeric KIF3AA and KIF3CC. The results indicate that microtubule collision at 11.4 mu M(-1)s(-1) coupled with ADP release at 78 s(-1) are fast steps for homodimeric KIF3AA. In contrast, KIF3CC exhibits much slower microtubule association at 2.1 mu M(-1)s(-1) and ADP release at 8 s(-1). For KIF3AC, microtubule association at 6.6 mu M(-1)s(-1) and ADP release at 51 s(-1) are intermediate between the constants for KIF3AA and KIF3CC. These results indicate that either KIF3A or KIF3C can initiate the processive run. Surprisingly, the kinetics of the initial event of microtubule collision followed by ADP release for KIF3AC is not equivalent to 1: 1 mixtures of KIF3AA plus KIF3CC homodimers at the same motor concentration. These results reveal that the intermolecular communication within the KIF3AC heterodimer modulates entry into the processive run regardless of whether the run is initiated by the KIF3A or KIF3C motor domain.	[Zhang, Pengwei; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Zhang, Pengwei; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [R37-GM054141, R01-GM086351]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086351, R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM054141 (to S. P. G.) and R01-GM086351 (to I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Huang CF, 2012, TRAFFIC, V13, P549, DOI 10.1111/j.1600-0854.2011.01325.x; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P17382, DOI 10.1073/pnas.0708828104; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P2175, DOI 10.1073/pnas.0610939104; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Navone F, 2001, J NEUROCHEM, V77, P741, DOI 10.1046/j.1471-4159.2001.00277.x; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Prevo B, 2015, NAT CELL BIOL, V17, P1536, DOI 10.1038/ncb3263; Rank KC, 2013, BIOL CELL, V105, P1, DOI 10.1111/boc.201200044; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shimizu K, 1998, J BIOL CHEM, V273, P6591, DOI 10.1074/jbc.273.12.6591; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang PW, 2015, P NATL ACAD SCI USA, V112, P6359, DOI 10.1073/pnas.1505531112	38	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4407	4416		10.1074/jbc.M115.705970	http://dx.doi.org/10.1074/jbc.M115.705970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710851	Green Published, hybrid			2022-12-28	WOS:000371604600013
J	Shobair, M; Dagliyan, O; Kota, P; Dang, YL; He, H; Stutts, MJ; Dokholyan, NV				Shobair, Mahmoud; Dagliyan, Onur; Kota, Pradeep; Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.			Gain-of-Function Mutation W493R in the Epithelial Sodium Channel Allosterically Reconfigures Intersubunit Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; ion channel; molecular docking; molecular dynamics; protein-protein interaction; allosteric activation; channelopathies; tetramer model	NA+ CHANNEL; ION-CHANNEL; GENETIC-VARIATION; ENAC; ACTIVATION; REVEALS; SUBUNIT; ARCHITECTURE; CHOLESTEROL; INHIBITION	Sodium absorption in epithelial cells is rate-limited by the epithelial sodium channel (ENaC) activity in lung, kidney, and the distal colon. Pathophysiological conditions, such as cystic fibrosis and Liddle syndrome, result from water-electrolyte imbalance partly due to malfunction of ENaC regulation. Because the quaternary structure of ENaC is yet undetermined, the bases of pathologically linked mutations in ENaC subunits , , and are largely unknown. Here, we present a structural model of heterotetrameric ENaC (12) that is consistent with previous cross-linking results and site-directed mutagenesis experiments. By using this model, we show that the disease-causing mutation W493R rewires structural dynamics of the intersubunit interfaces (1) and (2). Changes in dynamics can allosterically propagate to the channel gate. We demonstrate that cleavage of the -subunit, which is critical for full channel activation, does not mediate activation of ENaC by W493R. Our molecular dynamics simulations led us to identify a channel-activating electrostatic interaction between (2)Arg-493 and Glu-348 at the (2) interface. By neutralizing a sodium-binding acidic patch at the (1) interface, we reduced ENaC activation of W493R by more than 2-fold. By combining homology modeling, molecular dynamics, cysteine cross-linking, and voltage clamp experiments, we propose a dynamics-driven model for the gain-of-function in ENaC by W493R. Our integrated computational and experimental approach advances our understanding of structure, dynamics, and function of ENaC in its disease-causing state.	[Shobair, Mahmoud; Dagliyan, Onur; Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dokholyan, Nikolay V.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dagliyan, Onur; Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.] Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dokholyan, NV (corresponding author), Univ N Carolina, Biochem & Biophys, Chapel Hill, NC 27599 USA.	dokh@unc.edu	Dagliyan, Onur/N-5683-2019; Dokholyan, Nikolay/D-8081-2018	Dagliyan, Onur/0000-0003-1825-1011; Dokholyan, Nikolay/0000-0002-8225-4025; Shobair, Mahmoud/0000-0003-1684-9677	National Institutes of Health [P01 HL 110873-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Program Project Grant P01 HL 110873-04. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baker SE, 2011, RESP PHYSIOL NEUROBI, V179, P212, DOI 10.1016/j.resp.2011.08.007; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Dijkink L, 2002, PFLUG ARCH EUR J PHY, V444, P549, DOI 10.1007/s00424-002-0855-4; Ding F., 2012, COMPUTATIONAL MODELI, P55, DOI [10.1007/978-1-4614-2146-7_3, DOI 10.1007/978-1-4614-2146-7_3]; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Edelheit O, 2014, FEBS J, V281, P2097, DOI 10.1111/febs.12765; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Foxx-Lupo WT, 2011, RESP PHYSIOL NEUROBI, V179, P205, DOI 10.1016/j.resp.2011.08.008; Gao Y, 2007, BIOCHEM BIOPH RES CO, V359, P143, DOI 10.1016/j.bbrc.2007.05.077; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Gwiazda K, 2015, J BIOL CHEM, V290, P17956, DOI 10.1074/jbc.M115.641688; Handschick M, 2012, J CYST FIBROS, V11, P53, DOI 10.1016/j.jcf.2011.08.008; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Haselwandter CA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003055; Howsham C., 2014, ION CHANNEL DRUG DIS, P135; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Kucher V, 2011, BIOPHYS J, V100, P1930, DOI 10.1016/j.bpj.2011.02.046; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Nury H, 2010, J MOL BIOL, V395, P1114, DOI 10.1016/j.jmb.2009.11.024; Proctor EA, 2015, CHEM SCI, V6, P1237, DOI 10.1039/c4sc01320d; Proctor EA, 2011, WIRES COMPUT MOL SCI, V1, P80, DOI 10.1002/wcms.4; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shehata Marlene F, 2009, Int Arch Med, V2, P28, DOI 10.1186/1755-7682-2-28; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stadler T, 2015, J BIOL CHEM, V290, P6316, DOI 10.1074/jbc.M114.605899; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wei SP, 2007, J MEMBRANE BIOL, V220, P21, DOI 10.1007/s00232-007-9071-7; Xu Q, 2009, PROTEIN SCI, V18, P2100, DOI 10.1002/pro.224; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yin S., 2010, INTRO PROTEIN STRUCT, P453, DOI [10.1002/9780470882207.ch20, DOI 10.1002/9780470882207.CH20]; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466	60	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3682	3692		10.1074/jbc.M115.678052	http://dx.doi.org/10.1074/jbc.M115.678052			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26668308	Green Published, hybrid			2022-12-28	WOS:000371338400001
J	Yoon, BR; Chung, YH; Yoo, SJ; Kawara, K; Kim, J; Yoo, IS; Park, CG; Kang, SW; Lee, WW				Yoon, Bo Ruem; Chung, Yeon-Ho; Yoo, Su-Jin; Kawara, Kenji; Kim, Jinhyun; Yoo, In Seol; Park, Chung-Gyu; Kang, Seong Wook; Lee, Won-Woo			Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; cellular immune response; immunoglobulin-like domain; inflammation; monocyte; B7-H3; interferon-gamma; rheumatoid arthritis; synovial fluid	SYSTEMIC-LUPUS-ERYTHEMATOSUS; B7 FAMILY-MEMBER; COSTIMULATORY MOLECULE; ACTIVATED MONOCYTES; EXPRESSION; PATHOGENESIS; INFLAMMATION; LYMPHOCYTES; CYTOKINES; RESPONSES	B7-H3, a newly identified B7 family member, has functional duality as a co-stimulator and co-inhibitor that fine-tunes T cell-mediated immune responses. Given that B7-H3 expression on human monocytes and dendritic cells is enhanced by inflammatory cytokines, its potential inmmunoregulatory role at sites of inflammation has been suggested. Further, monocytes play crucial roles in the pathophysiology of various inflammatory disorders including autoimmune diseases; however, the immunological role of B7-H3 in rheumatoid arthritis (RA) has not been defined. Thus, we aimed to investigate the possible roles of monocyte B7-H3 in the pathogenesis of RA. Synovial monocytes, but not peripheral monocytes, in RA patients predominantly express surface B7-H3. The 4Ig isoform of B7-H3 is exclusively induced on the cell surface, whereas the 2Ig B7-H3 isoform is constitutively expressed in the intracytoplasmic region of both peripheral and synovial monocytes. B7-H3 knockdown experiments reveal that surface B7-H3 has an inhibitory effect on IFN- production in CD4 memory cells. Moreover, surface B7-H3 expression on synovial monocytes inversely correlates with RA clinical parameters. Our findings demonstrate that activation-induced B7-H3 expression on synovial monocytes has the potential to inhibit Th1-mediated immune responses and immunomodulatory roles affecting RA pathogenesis.	[Yoon, Bo Ruem; Chung, Yeon-Ho; Kawara, Kenji; Park, Chung-Gyu; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, 103 Daehak Ro, Seoul 110799, South Korea; [Park, Chung-Gyu; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 110799, South Korea; [Chung, Yeon-Ho; Lee, Won-Woo] Seoul Natl Univ, Coll Med, BK21Plus Biomed Sci Project, 103 Daehak Ro, Seoul 110799, South Korea; [Yoo, Su-Jin; Kim, Jinhyun; Yoo, In Seol; Kang, Seong Wook] Chungnam Natl Univ, Sch Med, Dept Internal Med, 282 Munhwa Ro, Daejeon 301721, South Korea; [Kawara, Kenji] Tokyo Med & Dent Univ, Sch Med, Tokyo 1138510, Japan; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Biomed Res Ins,Canc Res Inst,Ischem Hypox Dis Ins, 103 Daehak Ro, Seoul 110799, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Biomed Res Inst,Inst Infect Dis, 103 Daehak Ro, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chungnam National University; Tokyo Medical & Dental University (TMDU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kang, SW (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, 282 Munhwa Ro, Daejeon 301721, South Korea.; Lee, WW (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Dept Microbiol & Immunol, 103 Daehak Ro, Seoul 110799, South Korea.	kangsw@cnuh.co.kr; wonwoolee@snu.ac.kr		Kim, Jinhyun/0000-0001-5235-2612; Kang, Seong Wook/0000-0002-0076-0822; Lee, Won-Woo/0000-0002-5347-9591	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI11C1705 (A111752)]; Seoul National University Hospital Research Fund, Republic of Korea [0420100540 (2010-1078)]	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; Seoul National University Hospital Research Fund, Republic of Korea	This work was supported in part by Grant HI11C1705 (A111752 to W.-W. L.) from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea and by Grant 0420100540 (2010-1078 to W.-W. L.) from the Seoul National University Hospital Research Fund, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Bijl M, 2001, ANN RHEUM DIS, V60, P523, DOI 10.1136/ard.60.5.523; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076965; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Fox DA, 2010, RHEUM DIS CLIN N AM, V36, P311, DOI 10.1016/j.rdc.2010.02.004; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hashiguchi M, 2012, OPEN J IMMUNOL, V2, P9, DOI [DOI 10.4236/0JI.2012.21002, 10.4236/oji.2012.21002]; Hofmeyer KA, 2008, P NATL ACAD SCI USA, V105, P10277, DOI 10.1073/pnas.0805458105; Jeannin P, 2000, IMMUNITY, V13, P303, DOI 10.1016/S1074-7613(00)00030-3; Jiang JA, 2013, J CLIN IMMUNOL, V33, P118, DOI 10.1007/s10875-012-9800-2; Katsiari CG, 2002, CLIN IMMUNOL, V103, P54, DOI 10.1006/clim.2001.5172; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024751; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Tran CN, 2008, J IMMUNOL, V180, P2989, DOI 10.4049/jimmunol.180.5.2989; Vigdorovich V, 2013, STRUCTURE, V21, P707, DOI 10.1016/j.str.2013.03.003; Walter GJ, 2013, ARTHRITIS RHEUM-US, V65, P627, DOI 10.1002/art.37832; Wong CK, 2005, RHEUMATOLOGY, V44, P989, DOI 10.1093/rheumatology/keh663; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Yoon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109775; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2005, CELL MOL IMMUNOL, V2, P307; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhou YH, 2007, TISSUE ANTIGENS, V70, P96, DOI 10.1111/j.1399-0039.2007.00853.x	39	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4048	4057		10.1074/jbc.M115.680298	http://dx.doi.org/10.1074/jbc.M115.680298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702052	hybrid, Green Published			2022-12-28	WOS:000371338400030
J	Jimenez-Perez, L; Cidad, P; Alvarez-Miguel, I; Santos-Hipolito, A; Torres-Merino, R; Alonso, E; de la Fuente, MA; Lopez-Lopez, JR; Perez-Garcia, MT				Jimenez-Perez, Laura; Cidad, Pilar; Alvarez-Miguel, Ines; Santos-Hipolito, Alba; Torres-Merino, Rebeca; Alonso, Esperanza; Angel de la Fuente, Miguel; Ramon Lopez-Lopez, Jose; Teresa Perez-Garcia, M.			Molecular Determinants of Kv1.3 Potassium Channels-induced Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; electrophysiology; mutagenesis; potassium channel; structure-function; Kv1; 3; membrane potential; tyrosine phosphorylation; voltage-dependent conformation	SMOOTH-MUSCLE-CELLS; K+ CHANNELS; ION CHANNELS; SURFACE EXPRESSION; C-TERMINUS; SUBUNITS; SWITCH; IMMUNOMODULATION; LYMPHOCYTES; TARGETS	Changes in voltage-dependent potassium channels (Kv channels) associate to proliferation in many cell types, including transfected HEK293 cells. In this system Kv1.5 overexpression decreases proliferation, whereas Kv1.3 expression increases it independently of K+ fluxes. To identify Kv1.3 domains involved in a proliferation-associated signaling mechanism(s), we constructed chimeric Kv1.3-Kv1.5 channels and point-mutant Kv1.3 channels, which were expressed as GFP- or cherry-fusion proteins. We studied their trafficking and functional expression, combining immunocytochemical and electrophysiological methods, and their impact on cell proliferation. We found that the C terminus is necessary for Kv1.3-induced proliferation. We distinguished two residues (Tyr-447 and Ser-459) whose mutation to alanine abolished proliferation. The insertion into Kv1.5 of a sequence comprising these two residues increased proliferation rate. Moreover, Kv1.3 voltage-dependent transitions from closed to open conformation induced MEK-ERK1/2-dependent Tyr-447 phosphorylation. We conclude that the mechanisms for Kv1.3-induced proliferation involve the accessibility of key docking sites at the C terminus. For one of these sites (Tyr-447) we demonstrated the contribution of MEK/ERK-dependent phosphorylation, which is regulated by voltage-induced conformational changes.	[Teresa Perez-Garcia, M.] Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Edificio IBGM,C Sanz & Fores S-N, Valladolid 47003, Spain; Univ Valladolid, Inst Biol & Genet Mol, Valladolid 47003, Spain; CSIC, Valladolid 47003, Spain; [Jimenez-Perez, Laura] Spanish Minist Econ & Competitividad, Madrid, Spain; [Alvarez-Miguel, Ines] Junta Castilla & Leon, Leon, Spain; [Torres-Merino, Rebeca] Fdn Ramon Areces, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); Spanish Ministry of Economy & Competitiveness	Perez-Garcia, MT (corresponding author), Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Edificio IBGM,C Sanz & Fores S-N, Valladolid 47003, Spain.	tperez@ibgm.uva.es	Perez-Garcia, M. Teresa/F-5173-2015; de la Fuente, Miguel A/C-7478-2013; López, José Ramón López/A-5541-2009; Cidad, Pilar/G-1904-2016	Perez-Garcia, M. Teresa/0000-0001-8540-8117; de la Fuente, Miguel A/0000-0003-4619-8756; López, José Ramón López/0000-0002-3870-421X; Cidad, Pilar/0000-0002-6338-7738; Alvarez Miguel, Ines/0000-0001-5054-2172	Ministerio de Economia y Competitividad (MINECO), Instituto de Salud Carlos III (RIC) [RD12/0042/0006]; Programa Estatal de Investigacion [BFU2013-45867-R]; Fundacion Ramon Areces [CIVP16A1843]; Consejeria de Sanidad de la Junta de Castilla y Leon [BIO/VA21/15]	Ministerio de Economia y Competitividad (MINECO), Instituto de Salud Carlos III (RIC); Programa Estatal de Investigacion; Fundacion Ramon Areces; Consejeria de Sanidad de la Junta de Castilla y Leon	This work was supported by grants from the Ministerio de Economia y Competitividad (MINECO), Instituto de Salud Carlos III (RIC, RD12/0042/0006, Red Heracles), and Programa Estatal de Investigacion (BFU2013-45867-R; to J. R. L.-L. and M. T. P.-G.), Fundacion Ramon Areces (CIVP16A1843; to M. A. d l F.), and Consejeria de Sanidad de la Junta de Castilla y Leon (BIO/VA21/15; to M. A. d l F.). The authors declare that they have no conflicts of interest with the contents of this article.	Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Barros F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00049; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; Cidad P, 2015, PFLUG ARCH EUR J PHY, V467, P1711, DOI 10.1007/s00424-014-1607-y; Cidad P, 2012, ARTERIOSCL THROM VAS, V32, P1299, DOI 10.1161/ATVBAHA.111.242727; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Erdogan A, 2005, J VASC RES, V42, P368, DOI 10.1159/000087159; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Hajdu P, 2015, MOL BIOL CELL, V26, P1640, DOI 10.1091/mbc.E14-07-1195; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Martinez-Marmol R, 2013, J CELL SCI, V126, P5681, DOI 10.1242/jcs.134825; McCormack T, 1999, J BIOL CHEM, V274, P20123, DOI 10.1074/jbc.274.29.20123; Miguel-Velado E, 2005, CIRC RES, V97, P1280, DOI 10.1161/01.RES.0000194322.91255.13; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Vautier F, 2004, GLIA, V48, P337, DOI 10.1002/glia.20088; Villalonga N, 2010, J GEN PHYSIOL, V135, P135, DOI 10.1085/jgp.200910334; Welschoff J, 2014, FASEB J, V28, P2281, DOI 10.1096/fj.13-246348; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983	36	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3569	3580		10.1074/jbc.M115.678995	http://dx.doi.org/10.1074/jbc.M115.678995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26655221	hybrid, Green Published			2022-12-28	WOS:000370854500036
J	Miyamoto, T; Kim, D; Knox, JA; Johnson, E; Mucke, L				Miyamoto, Takashi; Kim, Daniel; Knox, Joseph A.; Johnson, Erik; Mucke, Lennart			Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-beta-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED SYNAPTIC DEPRESSION; PROTEIN TRANSGENIC MICE; ALZHEIMERS-DISEASE; PRION PROTEIN; A-BETA; MOUSE MODELS; COGNITIVE IMPAIRMENTS; INDUCED NEUROTOXICITY; HIPPOCAMPAL-NEURONS; AXONAL-TRANSPORT	Diverse lines of evidence suggest that amyloid-beta (A beta) peptides causally contribute to the pathogenesis of Alzheimer disease (AD), the most frequent neurodegenerative disorder. However, the mechanisms by which A beta impairs neuronal functions remain to be fully elucidated. Previous studies showed that soluble A beta oligomers interfere with synaptic functions by depleting NMDA-type glutamate receptors (NMDARs) from the neuronal surface and that overexpression of the receptor tyrosine kinase EphB2 can counteract this process. Through pharmacological treatments and biochemical analyses of primary neuronal cultures expressing wild-type or mutant forms of EphB2, we demonstrate that this protective effect of EphB2 depends on its PDZ-binding motif and the presence of neuronal activity but not on its kinase activity. We further present evidence that the protective effect of EphB2 may be mediated by the AMPA-type glutamate receptor subunit GluA2, which can become associated with the PDZ-binding motif of EphB2 through PDZ domain-containing proteins and can promote the retention of NMDARs in the membrane. In addition, we show that the A beta-induced depletion of surface NMDARs does not depend on several factors that have been implicated in the pathogenesis of A beta-induced neuronal dysfunction, including aberrant neuronal activity, tau, prion protein (PrPC), and EphB2 itself. Thus, although EphB2 does not appear to be directly involved in the A beta-induced depletion of NMDARs, increasing its expression may counteract this pathogenic process through a neuronal activity-and PDZ-dependent regulation of AMPA-type glutamate receptors.	[Miyamoto, Takashi; Kim, Daniel; Knox, Joseph A.; Johnson, Erik; Mucke, Lennart] Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA; [Miyamoto, Takashi; Johnson, Erik; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	Lmucke@gladstone.ucsf.edu		Johnson, Erik/0000-0002-0604-2944	National Institutes of Health [NS041787]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS041787 (to L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by fellowships from the Japan Society for the Promotion of Science and the Uehara Memorial Foundation.	Alfonso S, 2014, EUR J NEUROSCI, V39, P1225, DOI 10.1111/ejn.12499; Almawi WY, 2000, NEPHROL DIAL TRANSPL, V15, P1916, DOI 10.1093/ndt/15.12.1916; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Briggs CA, 1996, NEUROPHARMACOLOGY, V35, P407, DOI 10.1016/0028-3908(96)00006-8; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Colgan LA, 2014, ANNU REV PHYSIOL, V76, P365, DOI 10.1146/annurev-physiol-021113-170400; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dawson HN, 2001, J CELL SCI, V114, P1179; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Geng DD, 2013, NEUROCHEM INT, V63, P283, DOI 10.1016/j.neuint.2013.06.016; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Malinow R, 2012, CURR OPIN NEUROBIOL, V22, P559, DOI 10.1016/j.conb.2011.09.001; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Park JE, 2013, GENES-BASEL, V4, P334, DOI 10.3390/genes4030334; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Ranasinghe KG, 2014, NEUROIMAGE-CLIN, V5, P385, DOI 10.1016/j.nicl.2014.07.006; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seward ME, 2013, J CELL SCI, V126, P1278, DOI 10.1242/jcs.1125880; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheffler-Collins SI, 2012, TRENDS NEUROSCI, V35, P293, DOI 10.1016/j.tins.2012.03.003; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tackenberg C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.129; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/NNANO.2014.254, 10.1038/nnano.2014.254]; Vossel KA, 2015, J CELL BIOL, V209, P419, DOI 10.1083/jcb.201407065; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zhang YF, 2011, J NEUROCHEM, V119, P664, DOI 10.1111/j.1471-4159.2011.07450.x	71	24	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1719	1734		10.1074/jbc.M115.666529	http://dx.doi.org/10.1074/jbc.M115.666529			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589795	Green Published, hybrid			2022-12-28	WOS:000368620700015
J	Novgorodov, SA; Riley, CL; Keffler, JA; Yu, J; Kindy, MS; Macklin, WB; Lombard, DB; Gudz, TI				Novgorodov, Sergei A.; Riley, Christopher L.; Keffler, Jarryd A.; Yu, Jin; Kindy, Mark S.; Macklin, Wendy B.; Lombard, David B.; Gudz, Tatyana I.			SIRT3 Deacetylates Ceramide Synthases IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; MANGANESE SUPEROXIDE-DISMUTASE; PERMEABILITY TRANSITION PORE; RADIATION-INDUCED APOPTOSIS; OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; CYCLOPHILIN-D; CELL-DEATH; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID BIOSYNTHESIS	Experimental evidence supports the role of mitochondrial ceramide accumulation as a cause of mitochondrial dysfunction and brain injury after stroke. Herein, we report that SIRT3 regulates mitochondrial ceramide biosynthesis via deacetylation of ceramide synthase (CerS) 1, 2, and 6. Reciprocal immunoprecipitation experiments revealed that CerS1, CerS2, and CerS6, but not CerS4, are associated with SIRT3 in cerebral mitochondria. Furthermore, CerS1, -2, and -6 are hyperacetylated in the mitochondria of SIRT3-null mice, and SIRT3 directly deacetylates the ceramide synthases in aNAD(+)-dependent manner that increases enzyme activity. Investigation of the SIRT3 role in mitochondrial response to brain ischemia/reperfusion (IR) showed that SIRT3-mediated deacetylation of ceramide synthases increased enzyme activity and ceramide accumulation after IR. Functional studies demonstrated that absence of SIRT3 rescued the IR-induced blockade of the electron transport chain at the level of complex III, attenuated mitochondrial outer membrane permeabilization, and decreased reactive oxygen species generation and protein carbonyls in mitochondria. Importantly, Sirt3 gene ablation reduced the brain injury after IR. These data support the hypothesis that IR triggers SIRT3-dependent deacetylation of ceramide synthases and the elevation of ceramide, which could inhibit complex III, leading to increased reactive oxygen species generation and brain injury. The results of these studies highlight a novel mechanism of SIRT3 involvement in modulating mitochondrial ceramide biosynthesis and suggest an important role of SIRT3 in mitochondrial dysfunction and brain injury after experimental stroke.	[Riley, Christopher L.; Kindy, Mark S.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Novgorodov, Sergei A.; Keffler, Jarryd A.; Yu, Jin; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci Med, Charleston, SC 29425 USA; [Macklin, Wendy B.] Univ Colorado, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gudz, TI (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu		Lombard, David/0000-0002-4292-0185	National Institutes of Health [R01NS083544, R01GM101171, P30 GM103339]; Veterans Affairs Merit Award [I01BX001104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101171, P30GM103339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083544] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001104, I01BX002991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R01NS083544 (to T. I. G.), R01GM101171 (to D. B. L.), and P30 GM103339 (to Lipidomics Core Facility. Medical University of South Carolina) and Veterans Affairs Merit Award I01BX001104 (to T. I. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Chan PH, 2004, STROKE, V35, P2748, DOI 10.1161/01.STR.0000143325.25610.ac; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; DIRNAGL U, 1995, J CEREBR BLOOD F MET, V15, P929, DOI 10.1038/jcbfm.1995.118; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Gillies LA, 2015, MOL BIOL CELL, V26, P339, DOI 10.1091/mbc.E13-11-0638; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Herr I, 1999, BRAIN RES, V826, P210, DOI 10.1016/S0006-8993(99)01288-3; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Hirschey MD, 2011, AGING-US, V3, P635, DOI 10.18632/aging.100339; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Keller JN, 1998, J NEUROSCI, V18, P687; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kurek K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/980815; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Li C, 2011, DIABETES RES CLIN PR, V93, P77, DOI 10.1016/j.diabres.2011.03.017; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mori T, 1999, BRAIN RES, V816, P350, DOI 10.1016/S0006-8993(98)01124-X; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Novgorodov S. A., 2011, INT J BIOCH MOL BIOL, V2, P34; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ohtani R, 2004, BRAIN RES, V1023, P31, DOI 10.1016/j.brainres.2004.07.024; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Patwardhan GA, 2016, J BIOENERG BIOMEMBR, V48, P153, DOI 10.1007/s10863-015-9602-3; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shulga N, 2010, J CELL SCI, V123, P4117, DOI 10.1242/jcs.073502; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Shulyakova N, 2014, BRAIN RES, V1587, P40, DOI 10.1016/j.brainres.2014.08.066; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85	81	48	51	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1957	1973		10.1074/jbc.M115.668228	http://dx.doi.org/10.1074/jbc.M115.668228			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620563	Green Published, hybrid			2022-12-28	WOS:000368620700033
J	Kovacevic, Z; Menezes, SV; Sahni, S; Kalinowski, DS; Bae, DH; Lane, DJR; Richardson, DR				Kovacevic, Zaklina; Menezes, Sharleen V.; Sahni, Sumit; Kalinowski, Danuta S.; Bae, Dong-Hun; Lane, Darius J. R.; Richardson, Des R.			The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EFFECTIVE ANTIPROLIFERATIVE AGENTS; ISONICOTINOYL HYDRAZONE CLASS; SELECTIVE ANTITUMOR-ACTIVITY; ACTIVATED PROTEIN-KINASE; IRON CHELATORS; PANCREATIC-CANCER; BREAST-CANCER; TGF-BETA; PHOSPHATIDYLINOSITOL 3-KINASE	N-MYC downstream-regulated gene-1 (NDRG1) is a potent growth and metastasis suppressor that acts through its inhibitory effects on a wide variety of cellular signaling pathways, including the TGF-beta pathway, protein kinase B (AKT)/PI3K pathway, RAS, etc. To investigate the hypothesis that its multiple effects could be regulated by a common upstream effector, the role of NDRG1 on the epidermal growth factor receptor (EGFR) and other members of the ErbB family, namely human epidermal growth factor receptor 2 (HER2) and human epidermal growth factor receptor 3 (HER3), was examined. We demonstrate that NDRG1 markedly decreased the expression and activation of EGFR, HER2, and HER3 in response to the epidermal growth factor (EGF) ligand, while also inhibiting formation of the EGFR/ HER2 and HER2/ HER3 heterodimers. In addition, NDRG1 also decreased activation of the downstream MAPKK in response to EGF. Moreover, novel anti-tumor agents of the di-2-pyridylketone class of thiosemicarbazones, namely di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone and di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone, which markedly up-regulate NDRG1, were found to inhibit EGFR, HER2, and HER3 expression and phosphorylation in cancer cells. However, the mechanism involved appeared dependent on NDRG1 for di-2-pyridylketone 4,4-dimethyl-3-thiosemicarba-zone, but was independent of this metastasis suppressor for di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone. This observation demonstrates that small structural changes in thiosemicarbazones result in marked alterations in molecular targeting. Collectively, these results reveal a mechanism for the extensive downstream effects on cellular signaling attributed to NDRG1. Furthermore, this study identifies a novel approach for the treatment of tumors resistant to traditional EGFR inhibitors.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Kovacevic, Zaklina/ABD-9581-2021	Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0003-0960-6415; Lane, Darius/0000-0001-8725-6903; Bae, Dong-Hun/0000-0002-4109-7190; Sahni, Sumit/0000-0002-2900-8845; Kalinowski, Danuta/0000-0002-9303-7405; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council Australia Senior Principal Research Fellowship [APP1062607]; National Health and Medical Research Council Australia Peter Doherty Early Career Fellowship [APP1037323]; National Health and Medical Research Council Australia [APP1060482]; Cancer Institute New South Wales Early Career Fellowship [12ECF2-17]; Sydney Medical School, University of Sydney; National Health and Medical Research Council [APP1048972]; National Health and Medical Research Council Australia R.D. Wright Fellowship [APP1083057]; Australian Postgraduate Award from the University of Sydney; Sydney Medical School; AMP Foundation	National Health and Medical Research Council Australia Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Fellowship; Sydney Medical School, University of Sydney(University of Sydney); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia R.D. Wright Fellowship; Australian Postgraduate Award from the University of Sydney; Sydney Medical School; AMP Foundation	This work was supported in part by National Health and Medical Research Council Australia Senior Principal Research Fellowship APP1062607 (to D.R.R.), National Health and Medical Research Council Australia Peter Doherty Early Career Fellowship APP1037323, and National Health and Medical Research Council Australia Project Grant APP1060482 (to D.R.R., Z.K., and D.S.K.). D.R.R. is a stakeholder in the companies, Oncochel Therapeutics LLC and Oncochel Therapeutics Pty Ltd., that are developing the dipyridyl thiosemicarbazone, DpC, for the treatment of cancer. D.R.R. also consults for Oncochel Therapeutics LLC and Pty Ltd.r Recipient of Cancer Institute New South Wales Early Career Fellowship 12ECF2-17. To whom correspondence may be addressed. Tel.: 61-2-90366547; Fax: 61-2-9036-6549; E-mail: zaklina. kovacevic@sydney.edu.au.r Recipient of an Early Career Research grant from Sydney Medical School, University of Sydney.r Recipient of National Health and Medical Research Council Project Grant APP1048972 and National Health and Medical Research Council Australia R.D. Wright Fellowship APP1083057.r Recipient of an Australian Postgraduate Award from the University of Sydney.r Supported by a fellowship from the Sydney Medical School and a Tomorrow Fund Award from the AMP Foundation.	Accornero P, 2010, J MOL ENDOCRINOL, V44, P115, DOI 10.1677/JME-09-0035; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Baulida J, 1996, J BIOL CHEM, V271, P5251; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chang ZG, 2012, DIGEST DIS SCI, V57, P1181, DOI 10.1007/s10620-012-2036-4; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cheng JC, 2012, J CLIN ENDOCR METAB, V97, pE1380, DOI 10.1210/jc.2011-2751; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Jansson PJ, 2015, J BIOL CHEM, V290, P9588, DOI 10.1074/jbc.M114.631283; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; KIM HH, 1994, J BIOL CHEM, V269, P24747; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2009, J MED CHEM, V52, P1459, DOI 10.1021/jm801585u; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Strzelczyk B, 2009, ANN SURG ONCOL, V16, P1287, DOI 10.1245/s10434-009-0381-0; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Troiani T, 2012, CURR DRUG TARGETS, V13, P802, DOI 10.2174/138945012800564158; Tuominen VJ, 2012, HISTOPATHOLOGY, V60, P758, DOI 10.1111/j.1365-2559.2011.04142.x; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; Vijapurkar U, 2003, EXP CELL RES, V284, P291, DOI 10.1016/S0014-4827(02)00040-X; Wang JB, 2014, ONCOTARGET, V5, P8478, DOI 10.18632/oncotarget.2328; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zaczek A, 2005, HISTOL HISTOPATHOL, V20, P1005, DOI 10.14670/HH-20.1005; Zhang Q, 2014, LUNG CANCER, V85, P339, DOI 10.1016/j.lungcan.2014.06.011	74	54	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1029	1052		10.1074/jbc.M115.689653	http://dx.doi.org/10.1074/jbc.M115.689653			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26534963	hybrid, Green Published			2022-12-28	WOS:000368068300002
J	Fite, K; Gomez-Cambronero, J				Fite, Kristen; Gomez-Cambronero, Julian			Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; METASTASIS; MIRNAS; EXPRESSION; MIGRATION; GROWTH; PLANT; PLD2	Breast cancer is a leading cause of morbidity and mortality among women. Metastasis is initiated after epithelial-mesenchymal-transition (EMT). We have found a connection between EMT markers and the expression of four microRNAs (miRs) mediated by the signaling enzyme phospholipase D (PLD). Low aggressive MCF-7 breast cancer cells have low endogenous PLD enzymatic activity and cell invasion, concomitant with high expression of miR-203, -887, and -3619 (that decrease PLD2 translation and a luciferase reporter) and miR-182 (targeting PLD1) that are, therefore, "tumor-suppressor-like" miRs. The combination miR-887 + miR-3619 abolished >90% of PLD enzymatic activity. Conversely, post-EMT MDA-MB-231 cells have low miR expression, high levels of PLD1/2, and high aggressiveness. The latter was reversed by ectopically transfecting the miRs, which was negated by silencing miRs with specific siRNAs. We determined that the molecular mechanism is that E-cadherin triggers expression of the miRs in pre-EMT cells, whereas vimentin dampens expression of the miRs in post-EMT invasive cells. This novel work identifies for the first time a set of miRs that are activated by a major pre-EMT marker and deactivated by a post-EMT marker, boosting the transition from low invasion to high invasion, as mediated by the key phospholipid metabolism enzyme PLD.	[Fite, Kristen; Gomez-Cambronero, Julian] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Gomez-Cambronero, Julian] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Gomez-Cambronero, Julian] Harvard Univ, Sch Med, Boston, MA 02115 USA	University System of Ohio; Wright State University Dayton; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gomez-Cambronero, J (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653-14]; American Heart Association [13GRNT17230097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653-14 (to J. G.-C.) and American Heart Association Grant 13GRNT17230097. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen ZG, 2014, MOL MED REP, V9, P503, DOI 10.3892/mmr.2013.1814; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Eroles P., 2015, CURR DRUG T IN PRESS; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nygaard S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-35; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x	23	31	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					719	730		10.1074/jbc.M115.686006	http://dx.doi.org/10.1074/jbc.M115.686006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567912	hybrid, Green Published			2022-12-28	WOS:000367830500020
J	Nakano, M; Fukami, T; Gotoh, S; Takamiya, M; Aoki, Y; Nakajima, M				Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Takamiya, Masataka; Aoki, Yasuhiro; Nakajima, Miki			RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-INOSINE RNA; ADENOSINE DEAMINASES; HEPATOCELLULAR-CARCINOMA; HUMAN TRANSCRIPTOME; ADAR DEAMINASES; LIVER FIBROSIS; 2 FORMS; CELLS; BINDING; CANCER	Adenosine to inosine (A-to-I) RNA editing is the most frequent type of post-transcriptional nucleotide conversion in humans, and it is catalyzed by adenosine deaminase acting on RNA(ADAR) enzymes. In this study we investigated the effect of RNA editing on human aryl hydrocarbon receptor (AhR) expression because the AhR transcript potentially forms double-stranded structures, which are targets of ADAR enzymes. In human hepatocellular carcinoma-derived Huh-7 cells, the ADAR1 knockdown reduced the RNA editing levels in the 3'-untranslated region (3'-UTR) of the AhR transcript and increased the AhR protein levels. The ADAR1 knockdown enhanced the ligand-mediated induction of CYP1A1, a gene downstream of AhR. We investigated the possibility that A-to-I RNA editing creates miRNA targeting sites in the AhR mRNA and found that the miR-378-dependent down-regulation of AhR was abolished by ADAR1 knockdown. These results indicated that the ADAR1-mediated down-regulation of AhR could be attributed to the creation of a miR-378 recognition site in the AhR3'-UTR. The interindividual differences in the RNA editing levels within the AhR 3'-UTR in a panel of 32 human liver samples were relatively small, whereas the differences in ADAR1 expression were large (220-fold). In the human liver samples a significant inverse association was observed between the miR378 and AhR protein levels, suggesting that the RNA-editing dependent down-regulation of AhR by miR-378 contributes to the variability in the constitutive hepatic expression of AhR. In conclusion, this study uncovered for the first time that A-to-I RNA editing modulates the potency of xenobiotic metabolism in the human liver.	[Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan; [Takamiya, Masataka; Aoki, Yasuhiro] Iwate Med Univ, Sch Med, Dept Legal Med, Morioka, Iwate 0208505, Japan	Kanazawa University; Iwate Medical University	Nakajima, M (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nmiki@p.kanazawa-u.ac.jp	Nakajima, Miki/C-3990-2015	Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [15H04663]; Smoking Research Foundation in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation in Japan	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (B) 15H04663 and a grant from the Smoking Research Foundation in Japan. The authors declare that they have no conflicts of interest with contents of this article.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 1997, RNA, V3, P947; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gerber A, 1997, RNA, V3, P453; HAYASHI S, 1994, CARCINOGENESIS, V15, P801, DOI 10.1093/carcin/15.5.801; Iwanari M, 2002, ARCH TOXICOL, V76, P287, DOI 10.1007/s00204-002-0340-z; Jeon TI, 2013, MOL NUTR FOOD RES, V57, P1931, DOI 10.1002/mnfr.201300071; Kallman AM, 2003, NUCLEIC ACIDS RES, V31, P4874, DOI 10.1093/nar/gkg681; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kurtz CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12911; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Ma JC, 2014, CELL PHYSIOL BIOCHEM, V34, P2266, DOI 10.1159/000369669; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Nakano M, 2015, DRUG METAB DISPOS, V43, P1450, DOI 10.1124/dmd.115.065664; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paschen W, 1996, J CEREBR BLOOD F MET, V16, P548, DOI 10.1097/00004647-199607000-00004; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pierre S, 2014, TOXICOL SCI, V137, P114, DOI 10.1093/toxsci/kft236; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Ramadoss Preeti, 2005, Expert Opin Drug Metab Toxicol, V1, P9, DOI 10.1517/17425255.1.1.9; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	42	34	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					894	903		10.1074/jbc.M115.699363	http://dx.doi.org/10.1074/jbc.M115.699363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601943	Green Published, hybrid			2022-12-28	WOS:000367830500035
J	Iwasaki, A; Sakai, K; Moriya, K; Sasaki, T; Keene, DR; Akhtar, R; Miyazono, T; Yasumura, S; Watanabe, M; Morishita, S; Sakai, T				Iwasaki, Ayumi; Sakai, Keiko; Moriya, Kei; Sasaki, Takako; Keene, Douglas R.; Akhtar, Riaz; Miyazono, Takayoshi; Yasumura, Satoshi; Watanabe, Masatoshi; Morishita, Shin; Sakai, Takao			Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; fibronectin; liver injury; lysyl oxidase; transforming growth factor beta (TGF-B); chronic hepatic fibrogenesis; conditional knockout mouse; tissue stiffness	GROWTH-FACTOR-BETA; TGF-BETA; HEPATIC-FIBROSIS; LYSYL OXIDASE; EXTRACELLULAR-MATRIX; V COLLAGEN; PROTEOLYTIC ACTIVATION; INFLAMMATION; DEPOSITION; INJURY	Fibrosis is characterized by extracellular matrix (ECM) remodeling and stiffening. However, the functional contribution of tissue stiffening to noncancer pathogenesis remains largely unknown. Fibronectin (Fn) is an ECM glycoprotein substantially expressed during tissue repair. Here we show in advanced chronic liver fibrogenesis using a mouse model lacking Fn that, unexpectedly, Fn-null livers lead to more extensive liver cirrhosis, which is accompanied by increased liver matrix stiffness and deteriorated hepatic functions. Furthermore, Fn-null livers exhibit more myofibroblast phenotypes and accumulate highly disorganized/diffuse collagenous ECM networks composed of thinner and significantly increased number of collagen fibrils during advanced chronic liver damage. Mechanistically, mutant livers show elevated local TGF-beta activity and lysyl oxidase expressions. A significant amount of active lysyl oxidase is released in Fn-null hepatic stellate cells in response to TGF-1 through canonical and noncanonical Smad such as PI3 kinase-mediated pathways. TGF-1-induced collagen fibril stiffness in Fn-null hepatic stellate cells is significantly higher compared with wild-type cells. Inhibition of lysyl oxidase significantly reduces collagen fibril stiffness, and treatment of Fn recovers collagen fibril stiffness to wild-type levels. Thus, our findings indicate an indispensable role for Fn in chronic liver fibrosis/cirrhosis in negatively regulating TGF-beta bioavailability, which in turn modulates ECM remodeling and stiffening and consequently preserves adult organ functions. Furthermore, this regulatory mechanism by Fn could be translated for a potential therapeutic target in a broader variety of chronic fibrotic diseases.	[Iwasaki, Ayumi; Sakai, Keiko; Sakai, Takao] Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England; [Sakai, Keiko; Moriya, Kei; Sakai, Takao] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Sasaki, Takako] Oita Univ, Fac Med, Dept Biochem, Oita 8795593, Japan; [Keene, Douglas R.] Shriners Hosp Children, Microimaging Ctr, Portland, OR 97231 USA; [Akhtar, Riaz] Univ Liverpool, Ctr Mat & Struct, Sch Engn, Liverpool L69 3GE, Merseyside, England; [Miyazono, Takayoshi; Yasumura, Satoshi] Toyama Univ, Dept Gastroenterol & Hepatol & Transfus Med & Cel, Toyama 9300194, Japan; [Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Biomed Engn, Yokohama, Kanagawa 2408501, Japan; [Morishita, Shin] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	University of Liverpool; Cleveland Clinic Foundation; Oita University; University of Liverpool; University of Toyama; Yokohama National University; Yokohama National University	Sakai, T (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Translat Med, Dept Mol & Clin Pharmacol, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	sakait@liverpool.ac.uk		Akhtar, Riaz/0000-0002-7963-6874; Morishita, Shin/0000-0002-9447-2679	National Institute of Diabetes and Digestive and Kidney Diseases [DK074538]; Institute of Translational Medicine of the University of Liverpool; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074538] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Institute of Translational Medicine of the University of Liverpool; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK074538 (to T. Sakai). We are also grateful to the Institute of Translational Medicine of the University of Liverpool for support (to T. Sakai). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Constandinou C, 2005, METH MOLEC MED, V117, P237; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Diehl AM, 2013, J CLIN INVEST, V123, P1858, DOI 10.1172/JCI69966; Drews F, 2008, BBA-MOL CELL RES, V1783, P34, DOI 10.1016/j.bbamcr.2007.08.004; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Forbes SJ, 2011, BEST PRACT RES CL GA, V25, P207, DOI 10.1016/j.bpg.2011.02.006; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Guyot C, 2006, INT J BIOCHEM CELL B, V38, P135, DOI 10.1016/j.biocel.2005.08.021; Hayashi H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00012; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Huang YM, 2015, AM J PATHOL, V185, P786, DOI 10.1016/j.ajpath.2014.11.002; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 1990, FIBRONECTINS; Katoh K, 1999, P NATL ACAD SCI USA, V96, P7928, DOI 10.1073/pnas.96.14.7928; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Kondou H, 2003, J HEPATOL, V39, P742, DOI 10.1016/S0168-8278(03)00377-5; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Loeys B. L., 2010, SCI TRANSL MED, V2, P20, DOI 10.1126/scitranslmed.3000488; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Madibally SV, 2003, J SURG RES, V109, P92, DOI 10.1016/S0022-4804(02)00036-7; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazzieri R, 2005, J CELL SCI, V118, P2177, DOI 10.1242/jcs.02352; Moriya K, 2012, HEPATOLOGY, V56, P311, DOI 10.1002/hep.25624; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Mosher DF, 1989, FIBRONECTIN; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; NOWACK H, 1976, J IMMUNOL METHODS, V12, P117, DOI 10.1016/0022-1759(76)90101-0; Olsen AL, 2012, GASTROENTEROLOGY, V142, P928, DOI 10.1053/j.gastro.2011.12.038; Papi M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868388; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; TIMPL R, 1982, METHOD ENZYMOL, V82, P472; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Whittaker P, 2009, BLOOD CELL MOL DIS, V42, P51, DOI 10.1016/j.bcmd.2008.10.014; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zhao RG, 2014, BIOMATERIALS, V35, P5056, DOI 10.1016/j.biomaterials.2014.02.020	73	35	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					72	88		10.1074/jbc.M115.691519	http://dx.doi.org/10.1074/jbc.M115.691519			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26553870	hybrid, Green Published			2022-12-28	WOS:000367589500006
J	Londino, JD; Gulick, D; Isenberg, JS; Mallampalli, RK				Londino, James D.; Gulick, Dexter; Isenberg, Jeffrey S.; Mallampalli, Rama K.			Cleavage of Signal Regulatory Protein alpha (SIRP alpha) Enhances Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; C-TERMINAL FRAGMENT; NF-KAPPA-B; CELL-MIGRATION; SECRETASE; ACTIVATION; CD47; SHPS-1; ADAM10; GROWTH	Signal regulatory protein alpha (SIRP alpha) is a membrane glycoprotein immunoreceptor abundant in cells of monocyte lineage. SIRP alpha ligation by a broadly expressed transmembrane protein, CD47, results in phosphorylation of the cytoplasmic immunoreceptor tyrosine-based inhibitory motifs, resulting in the inhibition of NF-kappa B signaling in macrophages. Here we observed that proteolysis of SIRP alpha during inflammation is regulated by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), resulting in the generation of a membrane-associated cleavage fragment in both THP-1 monocytes and human lung epithelia. We mapped a charge-dependent putative cleavage site near the membrane-proximal domain necessary for ADAM10-mediated cleavage. In addition, a secondary proteolytic cleavage within the membrane-associated SIRP alpha fragment by gamma-secretase was identified. Ectopic expression of a SIRP alpha mutant plasmid encoding a proteolytically resistant form in HeLa cells inhibited activation of the NF-kappa B pathway and suppressed STAT1 phosphorylation in response to TNF alpha to a greater extent than expression of wild-type SIRP alpha. Conversely, overexpression of plasmids encoding the proteolytically cleaved SIRP alpha fragments in cells resulted in enhanced STAT-1 and NF-kappa B pathway activation. Thus, the data suggest that combinatorial actions of ADAM10 and gamma-secretase on SIRP alpha cleavage promote inflammatory signaling.	[Londino, James D.; Gulick, Dexter; Isenberg, Jeffrey S.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol & Bioengn, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15213 USA; [Isenberg, Jeffrey S.] Univ Pittsburgh, Sch Med, Div Pulm,Allergy & Crit Care Med, Vasc Med Inst,Starzl Transplantat Inst,Dept Pharm, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Pulm Allergy & Crit Care Med, Dept Med, NW628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Londino, James/GXH-2306-2022; Londino, James/GXH-4404-2022; Regan, Clinton/E-6250-2012	Londino, James/0000-0001-7647-6927; 	United States Department of Veterans Affairs Merit Review Award; National Institutes of Health [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, HL114453, T32 5T32HL007563-28]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH2HL123502, R01HL098174, T32HL007563, P01HL114453, R01HL096376, R01HL112914, R01HL081784, R01HL097376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was partially supported by a United States Department of Veterans Affairs Merit Review Award and partially by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, and 1UH2HL123502 and P01 Grant HL114453 (to R. K. M.) and Grant T32 5T32HL007563-28 (to J. D. L.). The authors declare no conflict of interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams S, 1998, J IMMUNOL, V161, P1853; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Ding DR, 2014, MEDCHEMCOMM, V5, P1381, DOI 10.1039/c4md00172a; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; Fournier B, 2012, J BIOL CHEM, V287, P19386, DOI 10.1074/jbc.M111.324533; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kim EJ, 2013, INFLAMM RES, V62, P377, DOI 10.1007/s00011-013-0589-0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lee EJ, 2014, J IMMUNOL, V193, P2384, DOI 10.4049/jimmunol.1303240; Lin Y, 2012, PROTEIN EXPRES PURIF, V85, P109, DOI 10.1016/j.pep.2012.07.002; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Maretzky T, 2015, J BIOL CHEM, V290, P7416, DOI 10.1074/jbc.M114.603753; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Murai-Takebe R, 2004, J BIOL CHEM, V279, P11616, DOI 10.1074/jbc.M311463200; Neznanov N, 2003, J BIOL CHEM, V278, P3809, DOI 10.1074/jbc.M210698200; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Pan Y, 2012, J MOL ENDOCRINOL, V49, P21, DOI 10.1530/JME-11-0174; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Raymond M, 2010, EUR J IMMUNOL, V40, P3510, DOI 10.1002/eji.201040797; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Steevels TAM, 2011, EUR J IMMUNOL, V41, P575, DOI 10.1002/eji.201041179; Stenberg A, 2013, J LEUKOCYTE BIOL, V93, P403, DOI 10.1189/jlb.1110637; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Tsai RK, 2010, BLOOD CELL MOL DIS, V45, P67, DOI [10.1016/j.bcmd.2010.02.016, 10.1016/j.hcmd.2010.02.016]; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Wang L, 2012, J NEUROCHEM, V122, P834, DOI 10.1111/j.1471-4159.2012.07818.x; Yao MY, 2014, J AM SOC NEPHROL, V25, P1171, DOI 10.1681/ASN.2013040433; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436; Zhang X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00427	42	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31113	31125		10.1074/jbc.M115.682914	http://dx.doi.org/10.1074/jbc.M115.682914			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534964	Green Published, hybrid			2022-12-28	WOS:000367199000039
J	Conde, J; Yoon, JH; Choudhury, JR; Prakash, L; Prakash, S				Conde, Juan; Yoon, Jung-Hoon; Choudhury, Jayati Roy; Prakash, Louise; Prakash, Satya			Genetic Control of Replication through N1-methyladenine in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE GLYCOL RESIDUE; DNA-POLYMERASE-ETA; OXIDATIVE DEMETHYLATION; DUPLEX DNA; BYPASS; REPAIR; ZETA; ALKB; PHOTOPRODUCT; MUTAGENESIS	N1-methyl adenine (1-MeA) is formed in DNA by reaction with alkylating agents and naturally occurring methyl halides. The 1-MeA lesion impairs Watson-Crick base pairing and blocks normal DNA replication. Here we identify the translesion synthesis (TLS) DNA polymerases (Pols) required for replicating through 1-MeA in human cells and show that TLS through this lesion is mediated via three different pathways in which Pols iota and theta function in one pathway and Pols eta and zeta, respectively, function in the other two pathways. Our biochemical studies indicate that in the Pol iota/Pol theta pathway, Pol iota would carry out nucleotide insertion opposite 1-MeA from which Pol theta would extend synthesis. In the Pol eta pathway, this Pol alone would function at both the nucleotide insertion and extension steps of TLS, and in the third pathway, Pol zeta would extend from the nucleotide inserted opposite 1-MeA by an as yet unidentified Pol. Whereas by pushing 1-MeA into the syn conformation and by forming Hoogsteen base pair with the T residue, Pol iota would carry out TLS opposite 1-MeA, the ability of Pol iota to replicate through 1-MeA suggests that despite its need for Watson-Crick hydrogen bonding, Pol eta can stabilize the adduct in its active site. Remarkably, even though Pols eta and iota are quite error-prone at inserting nucleotides opposite 1-MeA, TLS opposite this lesion in human cells occurs in a highly error-free fashion. This suggests that the in vivo fidelity of TLS Pols is regulated by factors such as post-translational modifications, protein-protein interactions, and possibly others.	[Conde, Juan; Yoon, Jung-Hoon; Choudhury, Jayati Roy; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	s.prakash@utmb.edu	Regan, Clinton/E-6250-2012	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	National Institutes of Health [ES020833, ES021452]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021452, R01ES020833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES020833 and ES021452. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P12359, DOI 10.1073/pnas.0504380102; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; KAO JY, 1993, J BIOL CHEM, V268, P17787; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Kung HC, 1997, J BIOL CHEM, V272, P9227; Lee JH, 1999, P NATL ACAD SCI USA, V96, P6632, DOI 10.1073/pnas.96.12.6632; Mikhailov Sergey N, 2009, Curr Protoc Nucleic Acid Chem, VChapter 4, P1, DOI 10.1002/0471142700.nc0436s38; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	30	19	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29794	29800		10.1074/jbc.M115.693010	http://dx.doi.org/10.1074/jbc.M115.693010			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491020	Green Published, hybrid			2022-12-28	WOS:000366614700014
J	He, ZH; Xu, M; Wu, YZ; Lv, J; Fu, PC; Mi, HL				He, Zhihui; Xu, Min; Wu, Yaozong; Lv, Jing; Fu, Pengcheng; Mi, Hualing			NdhM Subunit Is Required for the Stability and the Function of NAD(P)H Dehydrogenase Complexes Involved in CO2 Uptake in Synechocystis sp Strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbon fixation; cyanobacteria; electron transfer complex; photosynthesis; respiration	CYCLIC ELECTRON-TRANSPORT; PYRIDINE-NUCLEOTIDE DEHYDROGENASE; INORGANIC CARBON TRANSPORT; DOMAIN-LIKE FOLD; NADH DEHYDROGENASE; PHOTOSYSTEM-I; THERMOSYNECHOCOCCUS-ELONGATUS; EFFICIENT OPERATION; GENE-PRODUCTS; CYANOBACTERIUM	The cyanobacterial type I NAD(P)H dehydrogenase (NDH-1) complexes play a crucial role in a variety of bioenergetic reactions such as respiration, CO2 uptake, and cyclic electron transport around photosystem I. Two types of NDH-1 complexes, NDH-1MS and NDH-1MS, are involved in the CO2 uptake system. However, the composition and function of the complexes still remain largely unknown. Here, we found that deletion of ndhM caused inactivation of NDH-1-dependent cyclic electron transport around photosystem I and abolishment of CO2 uptake, resulting in a lethal phenotype under air CO2 condition. The mutation of NdhM abolished the accumulation of the hydrophilic subunits of the NDH-1, such as NdhH, NdhI, NdhJ, and NdhK, in the thylakoid membrane, resulting in disassembly of NDH-1MS and NDH-1MS as well as NDH-1L. In contrast, the accumulation of the hydrophobic subunits was not affected in the absence of NdhM. In the cytoplasm, the NDH-1 subcomplex assembly intermediates including NdhH and NdhK were seriously affected in the ndhM mutant but not in the NdhI-deleted mutant ndhI. In vitro protein interaction analysis demonstrated that NdhM interacts with NdhK, NdhH, NdhI, and NdhJ but not with other hydrophilic subunits of the NDH-1 complex. These results suggest that NdhM localizes in the hydrophilic subcomplex of NDH-1 complexes as a core subunit and is essential for the function of NDH-1MS and NDH-1MS involved in CO2 uptake in Synechocystis sp. strain PCC 6803.	[He, Zhihui; Xu, Min; Wu, Yaozong; Mi, Hualing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China; [Lv, Jing; Fu, Pengcheng] China Univ Petr, Renewable Energy Res Ctr, 18 Fuxue Rd, Beijing 102249, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; China University of Petroleum	Mi, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	mihl@sippe.ac.cn			State Key Basic Research and Development Plant 973 [2015CB150104, 2013CB127005, 2011C13200902]; National Natural Science Foundation of China [31270286]; Shanghai Science Foundation [13DJ1400102]	State Key Basic Research and Development Plant 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science Foundation	This work was supported by State Key Basic Research and Development Plant 973 Grants 2015CB150104, 2013CB127005, and 2011C13200902; National Natural Science Foundation of China Grant 31270286; and Shanghai Science Foundation Grant 13DJ1400102. The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; BERGER S, 1993, FEBS LETT, V326, P246, DOI 10.1016/0014-5793(93)81800-F; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; Dai HL, 2013, PLANT J, V75, P858, DOI 10.1111/tpj.12251; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; He ZH, 2015, PHOTOSYNTH RES, V126, P341, DOI 10.1007/s11120-015-0090-4; Klughammer B, 1999, MOL MICROBIOL, V32, P1305, DOI 10.1046/j.1365-2958.1999.01457.x; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maeda S, 2002, MOL MICROBIOL, V43, P425, DOI 10.1046/j.1365-2958.2002.02753.x; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1992, PLANT PHYSIOL, V99, P1604, DOI 10.1104/pp.99.4.1604; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schwarz D, 2013, PLANT PHYSIOL, V163, P1191, DOI 10.1104/pp.113.224287; Shibata M, 2001, P NATL ACAD SCI USA, V98, P11789, DOI 10.1073/pnas.191258298; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WILLIAMS JGK, 1983, GENE, V24, P37, DOI 10.1016/0378-1119(83)90129-4; Wulfhorst H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103584; Xu M, 2008, PLANT CELL PHYSIOL, V49, P994, DOI 10.1093/pcp/pcn074; Yamamoto H, 2013, J BIOL CHEM, V288, P36328, DOI 10.1074/jbc.M113.511584; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang JS, 2014, J BIOL CHEM, V289, P18770, DOI 10.1074/jbc.M114.553404; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhao JH, 2014, J BIOL CHEM, V289, P26669, DOI 10.1074/jbc.M114.553925	45	14	17	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5902	5912		10.1074/jbc.M115.698084	http://dx.doi.org/10.1074/jbc.M115.698084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26703473	Green Published, hybrid			2022-12-28	WOS:000372551800036
J	Richards, J; Belasco, JG				Richards, Jamie; Belasco, Joel G.			Distinct Requirements for 5-Monophosphate-assisted RNA Cleavage by Escherichia coli RNase E and RNase G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoribonuclease; mRNA decay; ribonuclease; RNA turnover; RNA-protein interaction; 5 monophosphate; 5 terminus	MESSENGER-RNA; RIBONUCLEASE-E; IN-VIVO; PYROPHOSPHOHYDROLASE RPPH; QUATERNARY STRUCTURE; CATALYTIC DOMAIN; DEGRADATION; SPECIFICITY; PROTEIN; DECAY	RNase E and RNase G are homologous endonucleases that play important roles in RNA processing and decay in Escherichia coli and related bacterial species. Rapid mRNA degradation is facilitated by the preference of both enzymes for decay intermediates whose 5 end is monophosphorylated. In this report we identify key characteristics of RNA that influence the rate of 5-monophosphate-assisted cleavage by these two ribonucleases. In vitro, both require at least two and prefer three or more unpaired 5-terminal nucleotides for such cleavage; however, RNase G is impeded more than RNase E when fewer than four unpaired nucleotides are present at the 5 end. Each can tolerate any unpaired nucleotide (A, G, C, or U) at either of the first two positions, with only modest biases. The optimal spacing between the 5 end and the scissile phosphate appears to be eight nucleotides for RNase E but only six for RNase G. 5-Monophosphate-assisted cleavage also occurs, albeit more slowly, when that spacing is greater or at most one nucleotide shorter than the optimum, but there is no simple inverse relationship between increased spacing and the rate of cleavage. These properties are also manifested during 5-end-dependent mRNA degradation in E. coli.	NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Belasco, Joel G.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, 540 First Ave, New York, NY 10016 USA.	joel.belasco@med.nyu.edu			National Institutes of Health [R01GM035769]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Grant R01GM035769 from the National Institutes of Health (to J. G. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	APIRION D, 1978, GENETICS, V90, P659; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Briant DJ, 2003, MOL MICROBIOL, V50, P1381, DOI 10.1046/j.1365-2958.2003.03775.x; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callaghan AJ, 2003, BIOCHEMISTRY-US, V42, P13848, DOI 10.1021/bi0351099; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Garrey SM, 2011, MOL MICROBIOL, V80, P1613, DOI 10.1111/j.1365-2958.2011.07670.x; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; Kaga N, 2002, BIOSCI BIOTECH BIOCH, V66, P2216, DOI 10.1271/bbb.66.2216; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; Ow MC, 2003, MOL MICROBIOL, V49, P607, DOI 10.1046/j.1365-2958.2003.03587.x; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; Richards J, 2012, MOL MICROBIOL, V86, P1063, DOI 10.1111/mmi.12040; Spickler C, 2001, J BACTERIOL, V183, P1106, DOI 10.1128/JB.183.3.1106-1109.2001; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; TOMCSANYI T, 1985, J MOL BIOL, V185, P713, DOI 10.1016/0022-2836(85)90056-7; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Walsh AP, 2001, NUCLEIC ACIDS RES, V29, P1864, DOI 10.1093/nar/29.9.1864	33	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5038	5048		10.1074/jbc.M115.702555	http://dx.doi.org/10.1074/jbc.M115.702555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26694614	hybrid, Green Published			2022-12-28	WOS:000371640600018
J	Koiwai, K; Hartmann, MD; Linke, D; Lupas, AN; Hori, K				Koiwai, Kotaro; Hartmann, Marcus D.; Linke, Dirk; Lupas, Andrei N.; Hori, Katsutoshi			Structural Basis for Toughness and Flexibility in the C-terminal Passenger Domain of an Acinetobacter Trimeric Autotransporter Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; bacterial adhesion; crystal structure; Gram-negative bacteria; membrane protein; protein domain; protein structure; structure-function; Acinetobacter; autotransporter	NEISSERIA-MENINGITIDIS; OUTER-MEMBRANE; DIFFRACTION DATA; PROTEIN; YERSINIA; BINDING; BAUMANNII; YADA; CRYSTALLIZATION; MODEL	Trimeric autotransporter adhesins (TAAs) on the cell surface of Gram-negative pathogens mediate bacterial adhesion to host cells and extracellular matrix proteins. However, AtaA, a TAA in the nonpathogenic Acinetobacter sp. strain Tol 5, shows nonspecific high adhesiveness to abiotic material surfaces as well as to biotic surfaces. It consists of a passenger domain secreted by the C-terminal transmembrane anchor domain (TM), and the passenger domain contains an N-terminal head, N-terminal stalk, C-terminal head (Chead), and C-terminal stalk (Cstalk). The Chead-Cstalk-TM fragment, which is conserved in many Acinetobacter TAAs, has by itself the head-stalk-anchor architecture of a complete TAA. Here, we show the crystal structure of the Chead-Cstalk fragment, AtaA_C-terminal passenger domain (CPSD), providing the first view of several conserved TAA domains. The YadA-like head (Ylhead) of the fragment is capped by a unique structure (headCap), composed of three -hairpins and a connector motif; it also contains a head insert motif (HIM1) before its last inner -strand. The headCap, Ylhead, and HIM1 integrally form a stable Chead structure. Some of the major domains of the CPSD fragment are inherently flexible and provide bending sites for the fiber between segments whose toughness is ensured by topological chain exchange and hydrophobic core formation inside the trimer. Thus, although adherence assays using in-frame deletion mutants revealed that the characteristic adhesive sites of AtaA reside in its N-terminal part, the flexibility and toughness of the CPSD part provide the resilience that enables the adhesive properties of the full-length fiber across a wide range of conditions.	[Koiwai, Kotaro; Hori, Katsutoshi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Koiwai, Kotaro] High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; [Hartmann, Marcus D.; Linke, Dirk; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Linke, Dirk] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Nagoya University; High Energy Accelerator Research Organization (KEK); Max Planck Society; University of Oslo	Hori, K (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	khori@nubio.nagoya-u.ac.jp	Linke, Dirk/F-9147-2010; Hartmann, Marcus/L-8759-2019; Hori, Katsutoshi/K-5289-2012	Linke, Dirk/0000-0003-3150-6752; Hartmann, Marcus/0000-0001-6937-5677; Hori, Katsutoshi/0000-0003-1994-3124; Koiwai, Kotaro/0000-0002-9684-3699	Japan Society for the Promotion of Science through Funding Program for Next Generation World-Leading Researchers (NEXT Program); Max Planck Society; Deutsche Forschungsgemeinschaft [SFB766]	Japan Society for the Promotion of Science through Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), institutional funds of the Max Planck Society, and Grant SFB766 of the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agnew C, 2011, P NATL ACAD SCI USA, V108, P15174, DOI 10.1073/pnas.1106341108; Alvarez BH, 2008, PROTEIN ENG DES SEL, V21, P11, DOI 10.1093/protein/gzm071; Bassler J, 2015, INT J MED MICROBIOL, V305, P265, DOI 10.1016/j.ijmm.2014.12.010; Benanti EL, 2015, CELL, V161, P348, DOI 10.1016/j.cell.2015.02.044; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; Bernstein HD, 2015, MOL MICROBIOL, V97, P205, DOI 10.1111/mmi.13031; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cotter SE, 2005, J BACTERIOL, V187, P4656, DOI 10.1128/JB.187.13.4656-4664.2005; Cotter SE, 2006, J BACTERIOL, V188, P5400, DOI 10.1128/JB.00164-06; Deiss S, 2014, J STRUCT BIOL, V186, P380, DOI 10.1016/j.jsb.2014.01.013; Edwards TE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012803; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hartmann MD, 2012, P NATL ACAD SCI USA, V109, P20907, DOI 10.1073/pnas.1211872110; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Ishikawa M., 2012, PLOS ONE, V7; Ishikawa M, 2012, J BIOSCI BIOENG, V113, P719, DOI 10.1016/j.jbiosc.2012.01.011; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Leo JC, 2011, STRUCTURE, V19, P1021, DOI 10.1016/j.str.2011.03.021; Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Nummelin H, 2002, ACTA CRYSTALLOGR D, V58, P1042, DOI 10.1107/S0907444902005231; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12; Sandt CH, 2000, INFECT IMMUN, V68, P2205, DOI 10.1128/IAI.68.4.2205-2214.2000; Schutz M, 2010, INFECT IMMUN, V78, P2677, DOI 10.1128/IAI.01350-09; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wollmann P, 2006, INT J BIOL MACROMOL, V39, P3, DOI 10.1016/j.ijbiomac.2005.11.009; Xiao LW, 2012, J BASIC MICROB, V52, P598, DOI 10.1002/jobm.201100365; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142; Yu CX, 2009, J BACTERIOL, V191, P6253, DOI 10.1128/JB.00563-09	50	32	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3705	3724		10.1074/jbc.M115.701698	http://dx.doi.org/10.1074/jbc.M115.701698			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26698633	Green Published, hybrid			2022-12-28	WOS:000371338400003
J	Ren, JQ; Huo, L; Wang, WJ; Zhang, Y; Li, W; Lou, JZ; Xu, T; Feng, W				Ren, Jinqi; Huo, Lin; Wang, Wenjuan; Zhang, Yong; Li, Wei; Lou, Jizhong; Xu, Tao; Feng, Wei			Structural Correlation of the Neck Coil with the Coiled-coil (CC1)-Forkhead-associated (FHA) Tandem for Active Kinesin-3 KIF13A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intracellular trafficking; kinesin; molecular motor; structural biology; x-ray crystallography; KIF13A; neck coil	MOLECULAR-DYNAMICS; MOTOR PROTEIN; DOMAIN; DIMERIZATION; BINDING; CONFORMATIONS; PROCESSIVITY; TRANSPORT; MOTILITY; STRAIN	Processive kinesin motors often contain a coiled-coil neck that controls the directionality and processivity. However, the neck coil (NC) of kinesin-3 is too short to form a stable coiled-coil dimer. Here, we found that the coiled-coil (CC1)-forkhead-associated (FHA) tandem (that is connected to NC by Pro-390) of kinesin-3 KIF13A assembles as an extended dimer. With the removal of Pro-390, the NC-CC1 tandem of KIF13A unexpectedly forms a continuous coiled-coil dimer that can be well aligned into the CC1-FHA dimer. The reverse introduction of Pro-390 breaks the NC-CC1 coiled-coil dimer but provides the intrinsic flexibility to couple NC with the CC1-FHA tandem. Mutations of either NC, CC1, or the FHA domain all significantly impaired the motor activity. Thus, the three elements within the NC-CC1-FHA tandem of KIF13A are structurally interrelated to form a stable dimer for activating the motor. This work also provides the first direct structural evidence to support the formation of a coiled-coil neck by the short characteristic neck domain of kinesin-3.	[Ren, Jinqi; Huo, Lin; Wang, Wenjuan; Li, Wei; Xu, Tao; Feng, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Zhang, Yong; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, 15 Datun Rd, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Feng, W (corresponding author), Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	wfeng@ibp.ac.cn	Li, Wei/AAI-3871-2020	Ren, Jinqi/0000-0002-5109-2828	National Major Basic Research Program of China [2011CB910503, 2014CB910202]; National Natural Science Foundation of China [31300611, 31190062, 31470746, 31200577]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Basic Research Program of China Grants 2011CB910503 and 2014CB910202 and National Natural Science Foundation of China Grants 31300611, 31190062, 31470746, and 31200577. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Atherton J, 2014, ELIFE, V3, DOI 10.7554/eLife.03680; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brown JH, 1996, PROTEINS, V26, P134; Crevenna AH, 2008, BIOPHYS J, V95, P5216, DOI 10.1529/biophysj.108.132449; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endow SA, 1999, NAT CELL BIOL, V1, pE163, DOI 10.1038/14113; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Grummt M, 1998, EMBO J, V17, P5536, DOI 10.1093/emboj/17.19.5536; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huckaba TM, 2011, J BIOL CHEM, V286, P7457, DOI 10.1074/jbc.M110.167023; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo L, 2012, STRUCTURE, V20, P1550, DOI 10.1016/j.str.2012.07.002; Jaud J, 2006, BIOPHYS J, V91, P1407, DOI 10.1529/biophysj.105.076265; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Liu B, 2014, PROG BIOCHEM BIOPHYS, V41, P870, DOI 10.3724/SP.J.1206.2014.00073; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Martin DS, 2010, P NATL ACAD SCI USA, V107, P5453, DOI 10.1073/pnas.0914924107; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid DJ, 2005, J PEPT RES, V65, P538, DOI 10.1111/j.1399-3011.2005.00255.x; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Thormahlen M, 1998, J STRUCT BIOL, V122, P30, DOI 10.1006/jsbi.1998.3986; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tong YF, 2010, P NATL ACAD SCI USA, V107, P20346, DOI 10.1073/pnas.1009008107; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Vale RD, 2000, PHILOS T ROY SOC B, V355, P449, DOI 10.1098/rstb.2000.0586; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Woehlke G, 2000, NAT REV MOL CELL BIO, V1, P50, DOI 10.1038/35036069; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	47	8	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3581	3594		10.1074/jbc.M115.689091	http://dx.doi.org/10.1074/jbc.M115.689091			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26680000	Green Published, hybrid			2022-12-28	WOS:000370854500037
J	Sahu, U; Rangarajan, PN				Sahu, Umakant; Rangarajan, Pundi N.			Regulation of Acetate Metabolism and Acetyl Co-a Synthetase 1 (ACS1) Expression by Methanol Expression Regulator 1 (Mxr1p) in the Methylotrophic Yeast Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; metabolism; promoter; transcription factor; yeast; acetyl-CoA synthetase; Pichia pastoris; acetate metabolism	UTILIZATION PATHWAY; PHOSPHOENOLPYRUVATE CARBOXYKINASE; TRANSCRIPTION FACTOR; GENES; IDENTIFICATION	Methanol expression regulator 1 (Mxr1p) is a zinc finger protein that regulates the expression of genes encoding enzymes of the methanol utilization pathway in the methylotrophic yeast Pichia pastoris by binding to Mxr1p response elements (MXREs) present in their promoters. Here we demonstrate that Mxr1p is a key regulator of acetate metabolism as well. Mxr1p is cytosolic in cells cultured in minimal medium containing a yeast nitrogen base, ammonium sulfate, and acetate (YNBA) but localizes to the nucleus of cells cultured in YNBA supplemented with glutamate or casamino acids as well as nutrient-rich medium containing yeast extract, peptone, and acetate (YPA). Deletion of Mxr1 retards the growth of P. pastoris cultured in YNBA supplemented with casamino acids as well as YPA. Mxr1p is a key regulator of ACS1 encoding acetyl-CoA synthetase in cells cultured in YPA. A truncated Mxr1p comprising 400 N-terminal amino acids activates ACS1 expression and enhances growth, indicating a crucial role for the N-terminal activation domain during acetate metabolism. The serine 215 residue, which is known to regulate the expression of Mxr1p-activated genes in a carbon source-dependent manner, has no role in the Mxr1p-mediated activation of ACS1 expression. The ACS1 promoter contains an Mxr1p response unit (MxRU) comprising two MXREs separated by a 30-bp spacer. Mutations that abrogate MxRU function in vivo abolish Mxr1p binding to MxRU in vitro. Mxr1p-dependent activation of ACS1 expression is most efficient in cells cultured in YPA. The fact that MXREs are conserved in genes outside of the methanol utilization pathway suggests that Mxr1p may be a key regulator of multiple metabolic pathways in P. pastoris.	[Sahu, Umakant; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in			Department of Biotechnology, New Delhi, India [BT/PR3889/BRB/10/996/2011]	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This study was supported by Grant BT/PR3889/BRB/10/996/2011 from the Department of Biotechnology, New Delhi, India (to P.N.R.). The authors declare that they have no conflicts of interest with the contents of this article.	BEIER DR, 1985, MOL CELL BIOL, V5, P1743, DOI 10.1128/MCB.5.7.1743; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094	9	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3648	3657		10.1074/jbc.M115.673640	http://dx.doi.org/10.1074/jbc.M115.673640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663080	Green Published, hybrid			2022-12-28	WOS:000370854500042
J	Takegahara, N; Kim, H; Mizuno, H; Sakaue-Sawano, A; Miyawaki, A; Tomura, M; Kanagawa, O; Ishii, M; Choi, Y				Takegahara, Noriko; Kim, Hyunsoo; Mizuno, Hiroki; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Tomura, Michio; Kanagawa, Osami; Ishii, Masaru; Choi, Yongwon			Involvement of Receptor Activator of Nuclear Factor-B Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell division; cell proliferation; flow cytometry; imaging; osteoclast; incomplete cytokinesis; polyploidy	CELL-CELL FUSION; CYCLE; DIFFERENTIATION; ENDOREPLICATION; PRECURSORS; IDENTIFICATION	Osteoclasts are specialized polyploid cells that resorb bone. Upon stimulation with receptor activator of nuclear factor-B ligand (RANKL), myeloid precursors commit to becoming polyploid, largely via cell fusion. Polyploidization of osteoclasts is necessary for their bone-resorbing activity, but the mechanisms by which polyploidization is controlled remain to be determined. Here, we demonstrated that in addition to cell fusion, incomplete cytokinesis also plays a role in osteoclast polyploidization. In in vitro cultured osteoclasts derived from mice expressing the fluorescent ubiquitin-based cell cycle indicator (Fucci), RANKL induced polyploidy by incomplete cytokinesis as well as cell fusion. Polyploid cells generated by incomplete cytokinesis had the potential to subsequently undergo cell fusion. Nuclear polyploidy was also observed in osteoclasts in vivo, suggesting the involvement of incomplete cytokinesis in physiological polyploidization. Furthermore, RANKL-induced incomplete cytokinesis was reduced by inhibition of Akt, resulting in impaired multinucleated osteoclast formation. Taken together, these results reveal that RANKL-induced incomplete cytokinesis contributes to polyploidization of osteoclasts via Akt activation.	[Takegahara, Noriko] Osaka Univ, WPI Immunol Frontier Res Ctr, Next Generat Opt Immune imaging, Suita, Osaka 5650871, Japan; [Takegahara, Noriko; Kim, Hyunsoo; Choi, Yongwon] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mizuno, Hiroki; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, WPI Immunol Frontier Res Ctr, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan; [Mizuno, Hiroki; Ishii, Masaru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 5 Sanban Cho, Tokyo 1020075, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan; [Tomura, Michio] RIKEN, Lab Autoimmune Regulat, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Tomura, Michio] Osaka Ohtani Univ, Immunol Lab, Fac Pharm, 3-11-1 Nishikiorikita, Tondabayashi, Osaka 5848540, Japan; [Kanagawa, Osami] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113033, Japan	Osaka University; University of Pennsylvania; Pennsylvania Medicine; Osaka University; Japan Science & Technology Agency (JST); RIKEN; RIKEN; University of Tokyo	Choi, Y (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Takegahara, N (corresponding author), Osaka Univ, Suita, Osaka 5650871, Japan.	takegaharanor@gmail.com; ychoi3@mail.med.upenn.edu	Kim, Hyunsoo/AAP-1689-2021; Miyawaki, Atsushi/K-3569-2014; Takegahara, Noriko/AAP-1694-2021	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Uehara Memorial Foundation; Nakatomi Foundation; Tomizawa Jun-ichi and Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation; National Institutes of Health [AR055903, AR067726]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055903, R01AR067726] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H01156] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Tomizawa Jun-ichi and Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation(Takeda Science Foundation (TSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Uehara Memorial Foundation, the Nakatomi Foundation, Tomizawa Jun-ichi and Keiko Fund of the Molecular Biology Society of Japan for Young Scientists, the Pharma-link between Academia and Shionogi, the Takeda Science Foundation (to N. T.), and in part by National Institutes of Health Grants AR055903 and AR067726 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Edgar BA, 2014, NAT REV MOL CELL BIO, V15, P197, DOI 10.1038/nrm3756; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Leevers SJ, 2005, CURR OPIN CELL BIOL, V17, P604, DOI 10.1016/j.ceb.2005.09.008; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Meiyanto E, 2001, BIOCHEM BIOPH RES CO, V282, P278, DOI 10.1006/bbrc.2001.4564; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2013, DEVELOPMENT, V140, P4624, DOI 10.1242/dev.099226; Sankar U, 2004, J BONE MINER RES, V19, P1339, DOI 10.1359/JBMR.040321; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126	47	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3439	3454		10.1074/jbc.M115.677427	http://dx.doi.org/10.1074/jbc.M115.677427			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670608	hybrid, Green Published			2022-12-28	WOS:000370854500026
J	Zhang, YF; French, SL; Beyer, AL; Schneider, DA				Zhang, Yinfeng; French, Sarah L.; Beyer, Ann L.; Schneider, David A.			The Transcription Factor THO Promotes Transcription Initiation and Elongation by RNA Polymerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR EVIDENCE; YEAST GENE; COMPLEX; HPR1; EXPORT; RDNA; CELLS; SPT5; RECOMBINATION	Although ribosomal RNA represents the majority of cellular RNA, and ribosome synthesis is closely connected to cell growth and proliferation rates, a complete understanding of the factors that influence transcription of ribosomal DNA is lacking. Here, we show that the THO complex positively affects transcription by RNA polymerase I (Pol I). We found that THO physically associates with the rDNA repeat and interacts genetically with Pol I transcription initiation factors. Pol I transcription in hpr1 or tho2 null mutants is dramatically reduced to less than 20% of the WT level. Pol I occupancy of the coding region of the rDNA in THO mutants is decreased to similar to 50% of WT level. Furthermore, although the percentage of active rDNA repeats remains unaffected in the mutant cells, the overall rDNA copy number increases similar to 2-fold compared with WT. Together, these data show that perturbation of THO function impairs transcription initiation and elongation by Pol I, identifying a new cellular target for the conserved THO complex.	[Zhang, Yinfeng; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Human Genet, Kaul Human Genet Bldg,Rm 442,720 20th St S, Birmingham, AL 35294 USA; [French, Sarah L.; Beyer, Ann L.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Alabama System; University of Alabama Birmingham; University of Virginia	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Human Genet, Kaul Human Genet Bldg,Rm 442,720 20th St S, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM063952, GM084946]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063952, R01GM084946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM063952 (to A. L. B.) and GM084946 (to D. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Dominguez-Sanchez MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-77; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hobeika M, 2007, MOL BIOL CELL, V18, P2561, DOI 10.1091/mbc.E07-02-0153; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kim YH, 2006, NUCLEIC ACIDS RES, V34, P2914, DOI 10.1093/nar/gkl293; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Masayasu Nomura Y. N., 2004, TRANSCRIPTION RDNA; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Prado F, 1997, EMBO J, V16, P2826, DOI 10.1093/emboj/16.10.2826; RIGGS DL, 1990, J BIOL CHEM, V265, P7596; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Viktorovskaya OV, 2013, CELL REP, V4, P974, DOI 10.1016/j.celrep.2013.07.044; Viktorovskaya OV, 2011, J BIOL CHEM, V286, P18825, DOI 10.1074/jbc.M110.202119; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Williamson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057974; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056793; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	42	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3010	3018		10.1074/jbc.M115.673442	http://dx.doi.org/10.1074/jbc.M115.673442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26663077	Green Published, hybrid			2022-12-28	WOS:000369626900037
J	Schnoder, L; Hao, WL; Qin, YR; Liu, SR; Tomic, I; Liu, X; Fassbender, K; Liu, Y				Schnoeder, Laura; Hao, Wenlin; Qin, Yiren; Liu, Shirong; Tomic, Inge; Liu, Xu; Fassbender, Klaus; Liu, Yang			Deficiency of Neuronal p38 alpha MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE UP-REGULATION; BETA-SECRETASE; PRECURSOR PROTEIN; MEMORY DEFICITS; TRANSGENIC MICE; A-BETA; TAU PHOSPHORYLATION; OXIDATIVE STRESS; P38 KINASE; AUTOPHAGY	Amyloid beta (A beta) damages neurons and triggers microglial inflammatory activation in the Alzheimer disease (AD) brain. BACE1 is the primary enzyme in A beta generation. Neuroinflammation potentially up-regulates BACE1 expression and increases A beta production. In Alzheimer amyloid precursor protein-transgenic mice and SH-SY5Y cell models, we specifically knocked out or knocked down gene expression of mapk14, which encodes p38 alpha MAPK, a kinase sensitive to inflammatory and oxidative stimuli. Using immunological and biochemical methods, we observed that reduction of p38 alpha MAPK expression facilitated the lysosomal degradation of BACE1, decreased BACE1 protein and activity, and subsequently attenuated A beta generation in the AD mouse brain. Inhibition of p38 alpha MAPK also enhanced autophagy. Blocking autophagy by treating cells with 3-methyladenine or overexpressing dominant-negative ATG5 abolished the deficiency of the p38 alpha MAPK-induced BACE1 protein reduction in cultured cells. Thus, our study demonstrates that p38 alpha MAPK plays a critical role in the regulation of BACE1 degradation and A beta generation in AD pathogenesis.	[Schnoeder, Laura; Hao, Wenlin; Qin, Yiren; Tomic, Inge; Liu, Xu; Fassbender, Klaus; Liu, Yang] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany; [Schnoeder, Laura; Hao, Wenlin; Qin, Yiren; Tomic, Inge; Liu, Xu; Fassbender, Klaus; Liu, Yang] Univ Saarland, German Inst Dementia Prevent DIDP, D-66421 Homburg, Germany; [Liu, Shirong] Brigham & Womens Hosp, Harvard Inst Med, Ctr Neurol Dis, Boston, MA 02115 USA	Saarland University; Saarland University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liu, Y (corresponding author), Univ Saarland, Dept Neurol, D-66421 Homburg, Germany.; Liu, Y (corresponding author), Univ Saarland, German Inst Dementia Prevent DIDP, D-66421 Homburg, Germany.	a.liu@mx.uni-saarland.de	Liu, Shirong/AAB-7300-2021; Liu, Yang/GSD-5476-2022	Liu, Shirong/0000-0002-3821-9134; Liu, Yang/0000-0002-7614-4233; Fassbender, Klaus/0000-0003-3596-868X	Deutsche Forschungsgemeinschaft [LI1725/2-1]; Else Kroner-Fresenius-Stiftung [2012_A247]; Prof. Dr. Peter Theiss Wissenschaftspreis grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Prof. Dr. Peter Theiss Wissenschaftspreis grant	This work was supported by the Deutsche Forschungsgemeinschaft Grant LI1725/2-1 (to Y. L.), Else Kroner-Fresenius-Stiftung 2012_A247 (to Y. L. and K. F.), and a Prof. Dr. Peter Theiss Wissenschaftspreis 2015 grant (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alam JJ, 2015, J ALZHEIMERS DIS, V48, P219, DOI 10.3233/JAD-150277; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Criscuolo C, 2015, NEUROBIOL AGING, V36, P1303, DOI 10.1016/j.neurobiolaging.2014.11.016; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Ge YW, 2004, FASEB J, V18, P1037, DOI 10.1096/fj.03-1379fje; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Karaca I, 2014, J BIOL CHEM, V289, P16761, DOI 10.1074/jbc.M113.535500; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li YK, 2003, J NEUROSCI, V23, P1605; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Song WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136950; Sun AY, 2003, EXP NEUROL, V183, P394, DOI 10.1016/S0014-4886(03)00180-8; Taguchi T, 2000, Environ Health Prev Med, V4, P217, DOI 10.1007/BF02931261; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie K, 2013, NEUROBIOL AGING, V34, P2389, DOI 10.1016/j.neurobiolaging.2013.04.013; Xing B, 2015, J MOL NEUROSCI, V55, P509, DOI 10.1007/s12031-014-0372-x; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhong W, 2014, AUTOPHAGY, V10, P1285, DOI 10.4161/auto.28789; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	68	77	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2067	2079		10.1074/jbc.M115.695916	http://dx.doi.org/10.1074/jbc.M115.695916			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26663083	Green Published, hybrid			2022-12-28	WOS:000369610400003
J	Zheng, T; Jiang, P; Cao, B; Cheng, QX; Kong, LX; Zheng, XQ; Hu, QH; You, DL				Zheng, Tao; Jiang, Pan; Cao, Bo; Cheng, Qiuxiang; Kong, Lingxin; Zheng, Xiaoqing; Hu, Qinghai; You, Delin			DndEi Exhibits Helicase Activity Essential for DNA Phosphorothioate Modification and ATPase Activity Strongly Stimulated by DNA Substrate with a GAAC/GTTC Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-LIVIDANS; RESTRICTION SYSTEM; S-MODIFICATION; IN-VITRO; SALMONELLA; BACTERIA; MECHANISM; BACKBONE; PROTEIN; SULFUR	Phosphorothioate (PT) modification of DNA, in which the non-bridging oxygen of the backbone phosphate group is replaced by sulfur, is governed by the DndA-E proteins in prokaryotes. To better understand the biochemical mechanism of PT modification, functional analysis of the recently found PT-modifying enzyme DndEi, which has an additional domain compared with canonical DndE, from Riemerella anatipestifer is performed in this study. The additional domain is identified as a DNA helicase, and functional deletion of this domain in vivo leads to PT modification deficiency, indicating an essential role of helicase activity in PT modification. Subsequent analysis reveals that the additional domain has an ATPase activity. Intriguingly, the ATPase activity is strongly stimulated by DNA substrate containing a GAAC/GTTC motif (i.e. the motif at which PT modifications occur in R. anatipestifer) when the additional domain and the other domain (homologous to canonical DndE) are co-expressed as a full-length DndEi. These results reveal that PT modification is a biochemical process with DNA strand separation and intense ATP hydrolysis.	[Zheng, Tao; Cao, Bo; Cheng, Qiuxiang; Kong, Lingxin; Zheng, Xiaoqing; You, Delin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zheng, Tao; Cao, Bo; Cheng, Qiuxiang; Kong, Lingxin; Zheng, Xiaoqing; You, Delin] Chinese Acad Agr Sci, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Jiang, Pan; Hu, Qinghai] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200240, Peoples R China; [You, Delin] Shanghai Jiao Tong Univ, Joint Int Res Lab Metab & Dev Sci, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Shanghai Jiao Tong University	Hu, QH (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200240, Peoples R China.	huqinghai@caas.cn; dlyou@sjtu.edu.cn		Cao, Bo/0000-0002-7011-1676	National Natural Science Foundation of China [30570400, 31170085, 31070058, 31470183, 31472224, 31272590, 31400029]; Ministry of Science and Technology [2006AA02Z224, 2012CB721004, 2009ZX09501-008]; Shanghai Pujiang Program from the Science and Technology Commission of Shanghai Municipality [12PJD021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Pujiang Program from the Science and Technology Commission of Shanghai Municipality	This work was supported by grants from the National Natural Science Foundation of China (30570400, 31170085, 31070058, 31470183, 31472224, 31272590, and 31400029), the Ministry of Science and Technology (2006AA02Z224, 2012CB721004, and 2009ZX09501-008), and the Shanghai Pujiang Program from the Science and Technology Commission of Shanghai Municipality (12PJD021). The authors declare that they have no conflicts of interest with the contents of this article.	An XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051265; Barbier P, 2013, FEMS MICROBIOL LETT, V348, P26, DOI 10.1111/1574-6968.12239; Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Cao B, 2015, SCI REP-UK, V5, DOI 10.1038/srep12513; Cao B, 2014, MOL MICROBIOL, V93, P776, DOI 10.1111/mmi.12692; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; Cheng QX, 2015, MOL MICROBIOL, V97, P1186, DOI 10.1111/mmi.13096; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; Eckstein F, 2007, NAT CHEM BIOL, V3, P689, DOI 10.1038/nchembio1107-689; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Hu QH, 2013, J MICROBIOL METH, V95, P262, DOI 10.1016/j.mimet.2013.09.011; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu W, 2012, CELL RES, V22, P1203, DOI 10.1038/cr.2012.66; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tani H, 2010, BIOCHEM BIOPH RES CO, V393, P131, DOI 10.1016/j.bbrc.2010.01.100; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Xu TG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-41; Yao F, 2009, FEBS LETT, V583, P729, DOI 10.1016/j.febslet.2009.01.029; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	31	7	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1492	1500		10.1074/jbc.M115.694018	http://dx.doi.org/10.1074/jbc.M115.694018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26631733	hybrid, Green Published			2022-12-28	WOS:000368068300039
J	Schelpe, J; Monte, D; Dewitte, F; Sixma, TK; Rucktooa, P				Schelpe, Julien; Monte, Didier; Dewitte, Frederique; Sixma, Titia K.; Rucktooa, Prakash			Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; E1; ACTIVATION; E2; EXPRESSION; FAMILY; UBA6; IDENTIFICATION; DEGRADATION; PROGRESSION	FAT10 conjugation, a post-translational modification analogous to ubiquitination, specifically requires UBA6 and UBE2Z as its activating (E1) and conjugating (E2) enzymes. Interestingly, these enzymes can also function in ubiquitination. We have determined the crystal structure of UBE2Z and report how the different domains of this E2 enzyme are organized. We further combine our structural data with mutational analyses to understand how specificity is achieved in the FAT10 conjugation pathway. We show that specificity toward UBA6 and UBE2Z lies within the C-terminal CYCI tetrapeptide in FAT10. We also demonstrate that this motif slows down transfer rates for FAT10 from UBA6 onto UBE2Z.	[Schelpe, Julien; Monte, Didier; Dewitte, Frederique; Rucktooa, Prakash] Univ Lille, CNRS, UMR8576, F-59658 Villeneuve Dascq, France; [Sixma, Titia K.; Rucktooa, Prakash] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Sixma, Titia K.; Rucktooa, Prakash] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Netherlands Cancer Institute; Netherlands Cancer Institute	Rucktooa, P (corresponding author), Univ Lille, CNRS, UMR8576, 50 Ave Halley, F-59658 Villeneuve Dascq, France.	prakash.rucktooa@univ-lille1.fr		Rucktooa, Prakash/0000-0003-2050-7389; Sixma, Titia K/0000-0001-6180-0632; monte, didier/0000-0002-0613-6203	French Agence Nationale de la Recherche [ANR-12-PDOC-0032-01]; Center for Biomedical Genetics; European Research Council [249997]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Center for Biomedical Genetics; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the French Agence Nationale de la Recherche under Grant ANR-12-PDOC-0032-01 (to P. R.) and the Center for Biomedical Genetics as well as the European Research Council Advanced Grant 249997 (to T. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Bricogne G., 2011, BUSTER; Canaan A, 2014, P NATL ACAD SCI USA, V111, P5313, DOI 10.1073/pnas.1323426111; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pelzer C, 2010, SUBCELL BIOCHEM, V54, P238, DOI 10.1007/978-1-4419-6676-6_19; Petoukhov MV, 2013, INT J BIOCHEM CELL B, V45, P429, DOI 10.1016/j.biocel.2012.10.017; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Souphron J, 2008, BIOCHEMISTRY-US, V47, P8961, DOI 10.1021/bi800604c; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Theng SS, 2014, P NATL ACAD SCI USA, V111, pE5282, DOI 10.1073/pnas.1403383111; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan DW, 2010, BRIT J CANCER, V103, P961, DOI 10.1038/sj.bjc.6605870; Zhao B, 2012, ACS CHEM BIOL, V7, P2027, DOI 10.1021/cb300339p	53	20	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					630	639		10.1074/jbc.M115.671545	http://dx.doi.org/10.1074/jbc.M115.671545			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26555268	Green Published, hybrid			2022-12-28	WOS:000367830500011
J	DeBerg, HA; Brzovic, PS; Flynn, GE; Zagotta, WN; Stoll, S				DeBerg, Hannah A.; Brzovic, Peter S.; Flynn, Galen E.; Zagotta, William N.; Stoll, Stefan			Structure and Energetics of Allosteric Regulation of HCN2 Ion Channels by Cyclic Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cyclic nucleotide; electron paramagnetic resonance (EPR); electrophysiology; fluorescence anisotropy; ion channel; nuclear magnetic resonance (NMR); double electron-electron resonance (DEER)	GATED CHANNELS; LIGAND-BINDING; PACEMAKER CHANNELS; TERMINAL REGION; C-HELIX; CAMP; MECHANISM; RESIDUE; DOMAIN; REARRANGEMENTS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels play an important role in regulating electrical activity in the heart and brain. They are gated by the binding of cyclic nucleotides to a conserved, intracellular cyclic nucleotide-binding domain (CNBD), which is connected to the channel pore by a C-linker region. Binding of cyclic nucleotides increases the rate and extent of channel activation and shifts it to less hyperpolarized voltages. We probed the allosteric mechanism of different cyclic nucleotides on the CNBD and on channel gating. Electrophysiology experiments showed that cAMP, cGMP, and cCMP were effective agonists of the channel and produced similar increases in the extent of channel activation. In contrast, electron paramagnetic resonance (EPR) and nuclear magnetic resonance (NMR) on the isolated CNBD indicated that the induced conformational changes and the degrees of stabilization of the active conformation differed for the three cyclic nucleotides. We explain these results with a model where different allosteric mechanisms in the CNBD all converge to have the same effect on the C-linker and render all three cyclic nucleotides similarly potent activators of the channel.	[DeBerg, Hannah A.; Stoll, Stefan] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [DeBerg, Hannah A.; Flynn, Galen E.; Zagotta, William N.; Stoll, Stefan] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Brzovic, Peter S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Box 357290, Seattle, WA 98195 USA.	zagotta@uw.edu; stst@uw.edu	Stoll, Stefan/C-5225-2008	Stoll, Stefan/0000-0003-4255-9550	National Institutes of Health [EY010329, GM098503]; American Heart Association [14IRG18770000, 14CSA20380095]; Sackler Scholars Program in Integrative Biophysics; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Sackler Scholars Program in Integrative Biophysics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EY010329 (to W. N. Z. and S. S.), American Heart Association Grants 14IRG18770000 (to W. N. Z.) and 14CSA20380095 (to W. N. Z. and S. S.), and by a fellowship from the Sackler Scholars Program in Integrative Biophysics (to H. A. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant GM098503.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Benndorf K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002721; Carlson AE, 2013, J BIOL CHEM, V288, P33136, DOI 10.1074/jbc.M113.501759; Chowdhury S, 2013, J GEN PHYSIOL, V141, P11, DOI 10.1085/jgp.201210860; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; DeBerg HA, 2015, STRUCTURE, V23, P734, DOI 10.1016/j.str.2015.02.007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, J CHEM THEORY COMPUT, V8, P3854, DOI 10.1021/ct300113z; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Mazzolini M, 2002, BIOPHYS J, V83, P3283, DOI 10.1016/S0006-3495(02)75329-0; MILOV AD, 1984, CHEM PHYS LETT, V110, P67, DOI 10.1016/0009-2614(84)80148-7; Pannier M, 2011, J Magn Reson, V213, P316, DOI 10.1016/j.jmr.2011.08.035; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Puljung MC, 2013, J BIOL CHEM, V288, P12944, DOI 10.1074/jbc.M113.464123; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zheng J, 2015, HDB ION CHANNELS; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	45	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					371	381		10.1074/jbc.M115.696450	http://dx.doi.org/10.1074/jbc.M115.696450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559974	Green Published, hybrid			2022-12-28	WOS:000367589500030
J	Eiseler, T; Wille, C; Koehler, C; Illing, A; Seufferlein, T				Eiseler, Tim; Wille, Christoph; Koehler, Conny; Illing, Anett; Seufferlein, Thomas			Protein Kinase D2 Assembles a Multiprotein Complex at the Trans-Golgi Network to Regulate Matrix Metalloproteinase Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); metalloprotease; protein kinase D (PKD); secretion; vesicles	ADP-RIBOSYLATION FACTOR; MANNOSE 6-PHOSPHATE RECEPTORS; BAR-DOMAIN; ACTIN POLYMERIZATION; MEMBRANE-BINDING; ADAPTER COMPLEX; CELL-SURFACE; ARF FAMILY; ARFAPTIN 1; RECRUITMENT	Vesicle formation and fission are tightly regulated at the trans-Golgi network (TGN) during constitutive secretion. Two major protein families regulate these processes: members of the adenosyl-ribosylation factor family of small G-proteins (ARFs) and the protein kinase D (PKD) family of serine/threonine kinases. The functional relationship between these two key regulators of protein transport from the TGN so far is elusive. We here demonstrate the assembly of a novel functional protein complex at the TGN and its key members: cytosolic PKD2 binds ARF-like GTPase (ARL1) and shuttles ARL1 to the TGN. ARL1, in turn, localizes Arfaptin2 to the TGN. At the TGN, where PKD2 interacts with active ARF1, PKD2, and ARL1 are required for the assembly of a complex comprising of ARF1 and Arfaptin2 leading to secretion of matrix metalloproteinase-2 and -7. In conclusion, our data indicate that PKD2 is a core factor in the formation of this multiprotein complex at the TGN that controls constitutive secretion of matrix metalloproteinase cargo.	[Eiseler, Tim; Wille, Christoph; Illing, Anett; Seufferlein, Thomas] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Koehler, Conny] Univ Halle Wittenberg, Dept Internal Med 1, D-06120 Halle, Saale, Germany	Ulm University; Martin Luther University Halle Wittenberg	Eiseler, T (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany.	tim.eiseler@uniklinik-ulm.de; thomas.seufferlein@uniklinik-ulm.de	Seufferlein, Thomas TW/P-7147-2018		Deutsche Forschungsgemeinschaft [EI792/3-1, SE676/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants EI792/3-1 (to T. E.) and SE676/10-1 (to T. S.). The authors declare no conflict of interest.	Ambroggio EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062963; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Atik N, 2014, CELL STRUCT FUNCT, V39, P61, DOI 10.1247/csf.13020; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Chang L, 2013, MOL BIOL CELL, V24, P1749, DOI 10.1091/mbc.E12-09-0697; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Cruz-Garcia D, 2013, EMBO J, V32, P1717, DOI 10.1038/emboj.2013.116; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eiseler T, 2012, J BIOL CHEM, V287, P32367, DOI 10.1074/jbc.M112.370999; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kahn Richard A, 2011, Cell Logist, V1, P49; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Kunkel Maya T, 2009, Curr Protoc Chem Biol, V1, P17; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Marsh BJ, 2002, NAT REV MOL CELL BIO, V3, P789, DOI 10.1038/nrm933; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Navarro MN, 2012, BIOCHEM J, V442, P649, DOI 10.1042/BJ20111700; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Stockmann M, 2013, STEM CELL REV REP, V9, P475, DOI 10.1007/s12015-011-9329-4; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Valente C, 2012, NAT CELL BIOL, V14, P343, DOI 10.1038/ncb2445; Wille C, 2014, MOL BIOL CELL, V25, P324, DOI 10.1091/mbc.E13-06-0334; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1; Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031; Zhu YX, 1999, MOL BIOL CELL, V10, P537, DOI 10.1091/mbc.10.3.537; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	53	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					462	477		10.1074/jbc.M115.673582	http://dx.doi.org/10.1074/jbc.M115.673582			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26507660	Green Published, hybrid			2022-12-28	WOS:000367589500041
J	Guo, LL; Shestov, AA; Worth, AJ; Nath, K; Nelson, DS; Leeper, DB; Glickson, JD; Blair, IA				Guo, Lili; Shestov, Alexander A.; Worth, Andrew J.; Nath, Kavindra; Nelson, David S.; Leeper, Dennis B.; Glickson, Jerry D.; Blair, Ian A.			Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; cancer therapy; chromatography; drug action; glucose metabolism; glutamate; glutamine; glycolysis; high-performance liquid chromatography (HPLC); mass spectrometry (MS)	ALPHA-TOCOPHERYL SUCCINATE; TARGETING MITOCHONDRIA; AEROBIC GLYCOLYSIS; DRUG LONIDAMINE; OVARIAN-CANCER; TUMOR; METABOLISM; APOPTOSIS; GROWTH; CELLS	The antitumor agent lonidamine (LND; 1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid) is known to interfere with energy-yielding processes in cancer cells. However, the effect of LND on central energy metabolism has never been fully characterized. In this study, we report that a significant amount of succinate is accumulated in LND-treated cells. LND inhibits the formation of fumarate and malate and suppresses succinate-induced respiration of isolated mitochondria. Utilizing biochemical assays, we determined that LND inhibits the succinate-ubiquinone reductase activity of respiratory complex II without fully blocking succinate dehydrogenase activity. LND also induces cellular reactive oxygen species through complex II, which reduced the viability of the DB-1 melanoma cell line. The ability of LND to promote cell death was potentiated by its suppression of the pentose phosphate pathway, which resulted in inhibition of NADPH and glutathione generation. Using stable isotope tracers in combination with isotopologue analysis, we showed that LND increased glutaminolysis but decreased reductive carboxylation of glutamine-derived -ketoglutarate. Our findings on the previously uncharacterized effects of LND may provide potential combinational therapeutic approaches for targeting cancer metabolism.	[Guo, Lili; Worth, Andrew J.; Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Penn Superfund Res & Training Program Ctr, Philadelphia, PA 19104 USA; [Guo, Lili; Worth, Andrew J.; Blair, Ian A.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Shestov, Alexander A.; Nath, Kavindra; Nelson, David S.; Glickson, Jerry D.] Univ Penn, Dept Radiol, Lab Mol Imaging, Philadelphia, PA 19104 USA; [Leeper, Dennis B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Jefferson University	Glickson, JD (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiol, Blockley Hall Basement B-6,423 Guardian Dr, Philadelphia, PA 19104 USA.	glickson@mail.med.upenn.edu; ianblair@mail.med.upenn.edu	Glickson, Jerry/AAR-7116-2021		National Institutes of Health [P30ES013508, P30CA016520, T32ES019851, R01CA172820, R01CA129544]; NATIONAL CANCER INSTITUTE [R01CA129544, R01CA172820, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES019851, P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grants P30ES013508 (to I. A. B.), P30CA016520 (to I. A. B.), T32ES019851 (to I. A. B.), R01CA172820 (to J. D. G.), and R01CA129544 (to J. D. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Amadori D, 1998, BREAST CANCER RES TR, V49, P209, DOI 10.1023/A:1006063412726; Aspuria PJP, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-21; Ben-Yoseph O, 1998, J NEURO-ONCOL, V36, P149, DOI 10.1023/A:1005819604858; BENHORIN H, 1995, CANCER RES, V55, P2814; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; De Lena M, 2001, EUR J CANCER, V37, P364, DOI 10.1016/S0959-8049(00)00400-7; Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; FLORIDI A, 1983, ARCH BIOCHEM BIOPHYS, V226, P73, DOI 10.1016/0003-9861(83)90272-2; FLORIDI A, 1981, J NATL CANCER I, V66, P497; Floridi A, 1998, BIOCHEM PHARMACOL, V56, P841, DOI 10.1016/S0006-2952(98)00054-9; FLORIDI A, 1981, CANCER RES, V41, P4661; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Granchi C, 2014, BIOORG MED CHEM LETT, V24, P4915, DOI 10.1016/j.bmcl.2014.09.041; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HILL LL, 1991, CANCER RES, V51, P4937; Ivanova D, 2013, ADV CLIN EXP MED, V22, P899; Kalia VK, 2009, J CANCER RES THER, V5, P57, DOI 10.4103/0973-1482.55145; Kluckova K, 2013, BBA-BIOENERGETICS, V1827, P552, DOI 10.1016/j.bbabio.2012.10.015; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; Li N, 2013, BIOMATERIALS, V34, P3366, DOI 10.1016/j.biomaterials.2013.01.055; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Milane L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024075; Milane L, 2011, NANOMED-NANOTECHNOL, V7, P435, DOI 10.1016/j.nano.2010.12.009; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MUZYKANTOV VS, 1986, REACT KINET CATAL L, V32, P307, DOI 10.1007/BF02068328; NATALI PG, 1984, ONCOLOGY, V41, P7, DOI 10.1159/000225879; Nath K, 2015, NMR BIOMED, V28, P281, DOI 10.1002/nbm.3240; Nath K, 2013, NMR BIOMED, V26, P98, DOI 10.1002/nbm.2824; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Prabhakara S, 2008, INDIAN J MED RES, V128, P140; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rasola A, 2014, TRENDS CELL BIOL, V24, P455, DOI 10.1016/j.tcb.2014.03.005; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shestov AA, 2007, J NEUROSCI RES, V85, P3294, DOI 10.1002/jnr.21269; Shestov AA, 2012, NEUROCHEM RES, V37, P2388, DOI 10.1007/s11064-012-0782-5; Singh G, 2000, ANAL CHEM, V72, P3007, DOI 10.1021/ac000374a; Sotgia F, 2013, ONCOTARGET, V4, P1309, DOI 10.18632/oncotarget.1182; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Warburg O, 1924, BIOCHEM Z, V152, P319; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Worth AJ, 2014, J BIOL CHEM, V289, P26895, DOI 10.1074/jbc.M114.591354; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	63	98	101	2	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					42	57		10.1074/jbc.M115.697516	http://dx.doi.org/10.1074/jbc.M115.697516			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26521302	hybrid, Green Published			2022-12-28	WOS:000367589500004
J	Chen, RP; Zhang, KX; Chen, H; Zhao, XY; Wang, JQ; Li, L; Cong, YS; Ju, ZY; Xu, DK; Williams, BRG; Jia, JH; Liu, JP				Chen, Ruping; Zhang, Kexiong; Chen, Hao; Zhao, Xiaoyin; Wang, Jianqiu; Li, Li; Cong, Yusheng; Ju, Zhenyu; Xu, Dakang; Williams, Bryan R. G.; Jia, Jihui; Liu, Jun-Ping			Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BONE-MARROW FAILURE; PULMONARY-FIBROSIS; TGF-BETA; REVERSE-TRANSCRIPTASE; SHORTENED TELOMERES; GENE-EXPRESSION; POTENTIAL ROLE; I CELLS; MUTATIONS	Mutations of human telomerase RNA component (TERC) and telomerase reverse transcriptase (TERT) are associated with a subset of lung aging diseases, but the mechanisms by which TERC and TERT participate in lung diseases remain unclear. In this report, we show that knock-out (KO) of the mouse gene Terc or Tert causes pulmonary alveolar stem cell replicative senescence, epithelial impairment, formation of alveolar sacs, and characteristic inflammatory phenotype. Deficiency in TERC or TERT causes a remarkable elevation in various proinflammatory cytokines, including IL-1, IL-6, CXCL15 (human IL-8 homolog), IL-10, TNF-alpha, and monocyte chemotactic protein 1 (chemokine ligand 2 (CCL2)); decrease in TGF-beta 1 and TGF beta RI receptor in the lungs; and spillover of IL-6 and CXCL15 into the bronchoalveolar lavage fluids. In addition to increased gene expressions of alpha-smooth muscle actin and collagen 1 alpha 1, suggesting myofibroblast differentiation, TERC deficiency also leads to marked cellular infiltrations of a mononuclear cell population positive for the leukocyte common antigen CD45, low-affinity Fc receptor CD16/CD32, and pattern recognition receptor CD11b in the lungs. Our data demonstrate for the first time that telomerase deficiency triggers alveolar stem cell replicative senescence-associated low-grade inflammation, thereby driving pulmonary premature aging, alveolar sac formation, and fibrotic lesion.	[Chen, Ruping; Jia, Jihui; Liu, Jun-Ping] Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Chen, Ruping; Zhang, Kexiong; Chen, Hao; Zhao, Xiaoyin; Wang, Jianqiu; Li, Li; Cong, Yusheng; Ju, Zhenyu; Xu, Dakang; Liu, Jun-Ping] Hangzhou Normal Univ, Inst Aging Res, Sch Med, Hangzhou 311121, Zhejiang, Peoples R China; [Xu, Dakang; Williams, Bryan R. G.; Liu, Jun-Ping] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Xu, Dakang; Williams, Bryan R. G.; Liu, Jun-Ping] Monash Univ, Fac Med, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Liu, Jun-Ping] Monash Univ, Cent Clin Sch, Fac Med, Dept Immunol, Prahran, Vic 3018, Australia	Shandong University; Hangzhou Normal University; Hudson Institute of Medical Research; Monash University; Monash University	Liu, JP (corresponding author), Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.	jun-ping.liu@monash.edu	Williams, Bryan R. G./A-5021-2009; Liu, Jun-Ping/AAA-5521-2020	Williams, Bryan R. G./0000-0002-4969-1151; Liu, Jun-Ping/0000-0001-7442-2116; Zhang, Kexiong/0000-0001-9517-8386	National Basic Research Program of China [2012CB911204]; National Natural Science Foundation of China [81170313, 81272889]; National Health and Medical Research Council of Australia [1051882]; Victorian Government's Operational Infrastructure Support Program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by National Basic Research Program of China Grant 2012CB911204, National Natural Science Foundation of China Grants 81170313 and 81272889, National Health and Medical Research Council of Australia Grant 1051882, and the Victorian Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Alipio ZA, 2011, DIFFERENTIATION, V82, P89, DOI 10.1016/j.diff.2011.05.001; Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Cassar L, 2010, MOL CELL ENDOCRINOL, V320, P97, DOI 10.1016/j.mce.2010.02.002; Chang S, 2005, MUTAT RES-FUND MOL M, V576, P39, DOI 10.1016/j.mrfmmm.2004.08.020; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Degryse AL, 2012, EXP LUNG RES, V38, P124, DOI 10.3109/01902148.2012.658148; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Gansner JM, 2012, NEW ENGL J MED, V366, P1551, DOI 10.1056/NEJMc1200999; Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Huaux F, 2015, J PATHOL, V235, P698, DOI 10.1002/path.4487; Iannello A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27616; Jackson SR, 2011, AM J PHYSIOL-LUNG C, V300, pL898, DOI 10.1152/ajplung.00409.2010; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kaczorowski DJ, 2012, MOL MED, V18, P851, DOI 10.2119/molmed.2012.00011; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim JK, 2000, TOXICOL LETT, V111, P263, DOI 10.1016/S0378-4274(99)00195-2; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326; Kropski JA, 2012, AM J PHYSIOL-LUNG C, V302, pL441, DOI 10.1152/ajplung.00335.2011; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee J, 2006, AM J PHYSIOL-LUNG C, V290, pL685, DOI 10.1152/ajplung.00020.2005; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2013, AM J RESP CELL MOL, V49, P260, DOI 10.1165/rcmb.2012-0514OC; Maida Y, 2002, ONCOGENE, V21, P4071, DOI 10.1038/sj.onc.1205509; Marrone A, 2007, HAEMATOLOGICA, V92, P1013, DOI 10.3324/haematol.11407; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Nunes H, 2014, AM J RESP CRIT CARE, V189, P753, DOI 10.1164/rccm.201309-1724LE; Parry EM, 2011, BLOOD, V117, P5607, DOI 10.1182/blood-2010-11-322149; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Song XD, 2013, LAB INVEST, V93, P1219, DOI 10.1038/labinvest.2013.108; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tsang AR, 2012, AGING CELL, V11, P482, DOI 10.1111/j.1474-9726.2012.00810.x; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Waisberg DR, 2010, HUM PATHOL, V41, P385, DOI 10.1016/j.humpath.2009.08.019; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Watanabe-Takano H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127888; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yang H, 2001, CELL GROWTH DIFFER, V12, P119; Zhang FJ, 2004, AM J RESP CELL MOL, V31, P679, DOI 10.1165/rcmb.2004-0182OC; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao L, 2013, AM J PHYSIOL-LUNG C, V305, pL409, DOI 10.1152/ajplung.00032.2013; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou H, 2013, J IMMUNOL, V190, P115, DOI 10.4049/jimmunol.1202136	79	53	55	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30813	30829		10.1074/jbc.M115.681619	http://dx.doi.org/10.1074/jbc.M115.681619			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26518879	Green Published, hybrid			2022-12-28	WOS:000367199000015
J	Sabourin, J; Le Gal, L; Saurwein, L; Haefliger, JA; Raddatz, E; Allagnat, F				Sabourin, Jessica; Le Gal, Loic; Saurwein, Lisa; Haefliger, Jacques-Antoine; Raddatz, Eric; Allagnat, Florent			Store-operated Ca2+ Entry Mediated by Orai1 and TRPC1 Participates to Insulin Secretion in Rat beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PHYSIOLOGICAL SIGNIFICANCE; PANCREATIC-ISLETS; CALCIUM-CHANNELS; PLASMA-MEMBRANE; DOWN-REGULATION; CRAC CHANNELS; SMOOTH-MUSCLE; STIM1	Store-operated Ca2+ channels (SOCs) are voltage-independent Ca2+ channels activated upon depletion of the endoplasmic reticulum Ca2+ stores. Early studies suggest the contribution of such channels to Ca2+ homeostasis in insulin-secreting pancreatic beta-cells. However, their composition and contribution to glucose-stimulated insulin secretion (GSIS) remains unclear. In this study, endoplasmic reticulum Ca2+ depletion triggered by acetylcholine (ACh) or thapsigargin stimulated the formation of a ternary complex composed of Orai1, TRPC1, and STIM1, the key proteins involved in the formation of SOCs. Ca2+ imaging further revealed that Orai1 and TRPC1 are required to form functional SOCs and that these channels are activated by STIM1 in response to thapsigargin or ACh. Pharmacological SOCs inhibition or dominant negative blockade of Orai1 or TRPC1 using the specific pore mutants Orai1-E106D and TRPC1-F562A impaired GSIS in rat beta-cells and fully blocked the potentiating effect of ACh on secretion. In contrast, pharmacological or dominant negative blockade of TRPC3 had no effect on extracellular Ca2+ entry and GSIS. Finally, we observed that prolonged exposure to supraphysiological glucose concentration impaired SOCs function without altering the expression levels of STIM1, Orai1, and TRPC1. We conclude that Orai1 and TRPC1, which form SOCs regulated by STIM1, play a key role in the effect of ACh on GSIS, a process that may be impaired in type 2 diabetes.	[Sabourin, Jessica] Univ Paris 11, INSERM, UMR S1180, Univ Paris Saclay, F-92296 Chatenay Malabry, France; [Le Gal, Loic; Saurwein, Lisa; Haefliger, Jacques-Antoine; Allagnat, Florent] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Raddatz, Eric] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Sabourin, J (corresponding author), Univ Paris 11, INSERM UMR S1180, Fac Pharm, F-92296 Chatenay Malabry, France.	jessica.sabourin@u-psud.fr	Allagnat, Florent/A-4471-2017; Allagnat, Florent/X-3772-2019; Allagnat, Florent/AAY-7188-2021	Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; Haefliger, Jacques-Antoine/0000-0003-2732-1667; Sabourin, Jessica/0000-0002-2980-8455	Swiss National Science Foundation (SNSF) [31003A-155897, 310030-127633]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation (SNSF) Grants 31003A-155897 (to J.-A. H.) and 310030-127633 (to E. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Allagnat F, 2008, J BIOL CHEM, V283, P5226, DOI 10.1074/jbc.M708181200; Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; BERTRAM R, 1995, BIOPHYS J, V68, P2323, DOI 10.1016/S0006-3495(95)80414-5; Bon RS, 2013, BRIT J PHARMACOL, V170, P459, DOI 10.1111/bph.12274; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dyachok O, 2004, CELL CALCIUM, V36, P1, DOI 10.1016/j.ceca.2003.11.004; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Graham S, 2012, EXP BIOL MED, V237, P111, DOI 10.1258/ebm.2011.011208; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Heo DK, 2012, CELL SIGNAL, V24, P899, DOI 10.1016/j.cellsig.2011.12.011; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kilch T, 2013, J BIOL CHEM, V288, P1653, DOI 10.1074/jbc.M112.417246; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; Mears D, 2004, J MEMBRANE BIOL, V197, P59, DOI 10.1007/s00232-003-0642-y; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miura Y, 1997, J PHYSIOL-LONDON, V503, P387, DOI 10.1111/j.1469-7793.1997.387bh.x; Nguyen N, 2013, BBA-MOL CELL RES, V1833, P1294, DOI 10.1016/j.bbamcr.2013.02.027; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Purrello F, 1996, ACTA DIABETOL, V33, P253; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; PUTNEY JW, 1986, FASEB J, V45, P2634; Putney JW, 2005, PFLUG ARCH EUR J PHY, V451, P29, DOI 10.1007/s00424-005-1416-4; Putney JW, 2001, NATURE, V410, P648, DOI 10.1038/35070704; Qian F, 2002, DIABETES, V51, pS183, DOI 10.2337/diabetes.51.2007.S183; Reading SA, 2005, AM J PHYSIOL-HEART C, V288, pH2055, DOI 10.1152/ajpheart.00861.2004; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Sabourin J, 2012, J BIOL CHEM, V287, P26688, DOI 10.1074/jbc.M112.378588; Sabourin J, 2011, CARDIOVASC RES, V92, P226, DOI 10.1093/cvr/cvr167; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Skrzypski M, 2013, FEBS LETT, V587, P3281, DOI 10.1016/j.febslet.2013.08.025; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Tengholm A, 2000, CELL CALCIUM, V27, P43, DOI 10.1054/ceca.1999.0087; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Tian G, 2012, J BIOL CHEM, V287, P9862, DOI 10.1074/jbc.M111.292854; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	75	48	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30530	30539		10.1074/jbc.M115.682583	http://dx.doi.org/10.1074/jbc.M115.682583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26494622	hybrid, Green Published			2022-12-28	WOS:000366738200028
J	Takasugi, T; Minegishi, S; Asada, A; Saito, T; Kawahara, H; Hisanaga, SI				Takasugi, Toshiyuki; Minegishi, Seiji; Asada, Akiko; Saito, Taro; Kawahara, Hiroyuki; Hisanaga, Shin-Ichi			Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL-SPECIFIC ACTIVATOR; TUMOR-SUPPRESSOR NKX3.1; PROTEASOMAL DEGRADATION; ORNITHINE-DECARBOXYLASE; ALZHEIMERS-DISEASE; P25; CLEAVAGE; PHOSPHORYLATION; CALPAIN; COMPLEX	Cdk5 is a versatile protein kinase that is involved in various neuronal activities, such as the migration of newborn neurons, neurite outgrowth, synaptic regulation, and neurodegenerative diseases. Cdk5 requires the p35 regulatory subunit for activation. Because Cdk5 is more abundantly expressed in neurons compared with p35, the p35 protein levels determine the kinase activity of Cdk5. p35 is a protein with a short half-life that is degraded by proteasomes. Although ubiquitination of p35 has been previously reported, the degradation mechanism of p35 is not yet known. Here, we intended to identify the ubiquitination site(s) in p35. Because p35 is myristoylated at the N-terminal glycine, the possible ubiquitination sites are the lysine residues in p35. Wemutated all 23 Lys residues to Arg (p35 23R), but p35 23R was still rapidly degraded by proteasomes at a rate similar to wild-type p35. The degradation of p35 23R in primary neurons and the Cdk5 activation ability of p35 23R suggested the occurrence of ubiquitin-independent degradation of p35 in physiological conditions. We found that p35 has the amino acid sequence similar to the ubiquitin-independent degron in the NKX3.1 homeodomain transcription factor. An Ala mutation at Pro-247 in the degron-like sequence made p35 stable. These results suggest that p35 can be degraded by two degradation pathways: ubiquitin-dependent and ubiquitin-independent. The rapid degradation of p35 by two different methods would be a mechanism to suppress the production of p25, which overactivates Cdk5 to induce neuronal cell death.	[Takasugi, Toshiyuki; Minegishi, Seiji; Asada, Akiko; Saito, Taro; Hisanaga, Shin-Ichi] Tokyo Metropolitan Univ, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan; [Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Dept Biol Sci, Lab Cellular Biochem, Hachioji, Tokyo 1920397, Japan; [Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University; Tokyo Metropolitan University	Hisanaga, SI (corresponding author), Tokyo Metropolitan Univ, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		Hisanaga, Shin-ichi/0000-0002-7572-472X	Ministry of Education, Culture, Sports, Science, and Technology in Japan [25290024, 26117004]; Grants-in-Aid for Scientific Research [24112007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid For Scientific Research on Priority Area from the Ministry of Education, Culture, Sports, Science, and Technology in Japan 25290024 and 26117004 (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Benanti JA, 2012, SEMIN CELL DEV BIOL, V23, P492, DOI 10.1016/j.semcdb.2012.04.005; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Endo R, 2009, J BIOL CHEM, V284, P26029, DOI 10.1074/jbc.M109.026443; Engmann O, 2011, BIOL PSYCHIAT, V70, P159, DOI 10.1016/j.biopsych.2011.04.011; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; Ha SW, 2012, BIOCHEM BIOPH RES CO, V419, P226, DOI 10.1016/j.bbrc.2012.01.152; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Ko J, 2001, J NEUROSCI, V21, P6758; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1996, J BIOL CHEM, V271, P1538, DOI 10.1074/jbc.271.3.1538; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murakami Y, 2000, BIOCHEM BIOPH RES CO, V267, P1, DOI 10.1006/bbrc.1999.1706; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Rao V, 2012, J BIOL CHEM, V287, P36331, DOI 10.1074/jbc.M112.352823; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rei D, 2015, P NATL ACAD SCI USA, V112, P7291, DOI 10.1073/pnas.1415845112; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Saito T, 1998, BIOCHEM BIOPH RES CO, V252, P775, DOI 10.1006/bbrc.1998.9739; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sato K, 2011, J NEUROCHEM, V117, P504, DOI 10.1111/j.1471-4159.2011.07222.x; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x	57	14	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4649	4657		10.1074/jbc.M115.692871	http://dx.doi.org/10.1074/jbc.M115.692871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26631721	Green Published, hybrid			2022-12-28	WOS:000371604600032
J	Chong, WM; Hsu, SC; Kao, WT; Lo, CW; Lee, KY; Shao, JS; Chen, YH; Chang, J; Chen, SSL; Yu, MJ				Chong, Weng Man; Hsu, Shih-Chin; Kao, Wei-Ting; Lo, Chieh-Wen; Lee, Kuan-Ying; Shao, Jheng-Syuan; Chen, Yi-Hung; Chang, Justin; Chen, Steve S. -L.; Yu, Ming-Jiun			Phosphoproteomics Identified an NS5A Phosphorylation Site Involved in Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Hepatitis C virus (HCV); phosphoproteomics; phosphorylation; proteomics; casein kinase; serine 235	NONSTRUCTURAL PROTEIN 5A; VIRAL-RNA REPLICATION; KINASE-I-ALPHA; CELL-CULTURE; HYPERPHOSPHORYLATION; COMPLEX; ESTABLISHMENT; INHIBITORS; THERAPIES; SUBSTRATE	The non-structural protein 5A (NS5A) is a hepatitis C virus (HCV) protein indispensable for the viral life cycle. Many prior papers have pinpointed several serine residues in the low complexity sequence I region of NS5A responsible for NS5A phosphorylation; however, the functions of specific phosphorylation sites remained obscure. Using phosphoproteomics, we identified three phosphorylation sites (serines 222, 235, and 238) in the NS5A low complexity sequence I region. Reporter virus and replicon assays using phosphorylation-ablated alanine mutants of these sites showed that Ser-235 dominated over Ser-222 and Ser-238 in HCV replication. Immunoblotting using an Ser-235 phosphorylation-specific antibody showed a time-dependent increase in Ser-235 phosphorylation that correlated with the viral replication activity. Ser-235 phosphorylated NS5A co-localized with double-stranded RNA, consistent with its role in HCV replication. Mechanistically, Ser-235 phosphorylation probably promotes the replication complex formation via increasing NS5A interaction with the human homologue of the 33-kDa vesicle-associated membrane protein-associated protein. Casein kinase I (CKI) directly phosphorylated Ser-235 in vitro. Inhibition of CKI reduced Ser-235 phosphorylation and the HCV RNA levels in the infected cells. We concluded that NS5A Ser-235 phosphorylated by CKI probably promotes HCV replication via increasing NS5A interaction with the 33-kDa vesicle-associated membrane protein-associated protein.	[Chong, Weng Man; Hsu, Shih-Chin; Kao, Wei-Ting; Lo, Chieh-Wen; Lee, Kuan-Ying; Shao, Jheng-Syuan; Chen, Yi-Hung; Chang, Justin; Yu, Ming-Jiun] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Rm 816,1 Sec 1 Jen Ai Rd, Taipei 10051, Taiwan; [Chen, Steve S. -L.] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Yu, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Rm 816,1 Sec 1 Jen Ai Rd, Taipei 10051, Taiwan.	mjyu@ntu.edu.tw	Chen, Yi-Chen/GVU-0551-2022	Chong, Weng Man/0000-0002-5548-1628; YU, MING-JIUN/0000-0003-0393-4696	National Health Research Institutes [NHRI-EX104-10213BI]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-EX104-10213BI (to M. J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Chen YC, 2010, J VIROL, V84, P7983, DOI 10.1128/JVI.00068-10; Coito C, 2004, J VIROL, V78, P3502, DOI 10.1128/JVI.78.7.3502-3513.2004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Fridell RA, 2013, J VIROL, V87, P2320, DOI 10.1128/JVI.02861-12; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gilliver AN, 2010, J GEN VIROL, V91, P2428, DOI 10.1099/vir.0.023614-0; Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kim J, 1999, BIOCHEM BIOPH RES CO, V257, P777, DOI 10.1006/bbrc.1999.0460; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Quintavalle M, 2007, J BIOL CHEM, V282, P5536, DOI 10.1074/jbc.M610486200; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Reed KE, 1999, J BIOL CHEM, V274, P28011, DOI 10.1074/jbc.274.39.28011; Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997; Reghellin V, 2014, ANTIMICROB AGENTS CH, V58, P7128, DOI 10.1128/AAC.03293-14; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Supekova L, 2008, J BIOL CHEM, V283, P29, DOI 10.1074/jbc.M703988200; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	41	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3918	3931		10.1074/jbc.M115.675413	http://dx.doi.org/10.1074/jbc.M115.675413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702051	Green Published, hybrid			2022-12-28	WOS:000371338400020
J	Di Giacomo, M; Camaioni, A; Klinger, FG; Bonfiglio, R; Salustri, A				Di Giacomo, Monica; Camaioni, Antonella; Klinger, Francesca G.; Bonfiglio, Rita; Salustri, Antonietta			Cyclic AMP-elevating Agents Promote Cumulus Cell Survival and Hyaluronan Matrix Stability, Thereby Prolonging the Time of Mouse Oocyte Fertilizability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cyclic AMP (cAMP); extracellular matrix; fertilization; hyaluronan; cumulus cells	FOLLICLE-STIMULATING-HORMONE; EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-A; GENE-EXPRESSION PROFILES; IN-VITRO MATURATION; GRANULOSA-CELLS; PHOSPHODIESTERASE INHIBITORS; EXTRACELLULAR-MATRIX; INDUCED APOPTOSIS; DEVELOPMENTAL COMPETENCE	Cumulus cells sustain the development and fertilization of the mammalian oocyte. These cells are retained around the oocyte by a hyaluronan-rich extracellular matrix synthesized before ovulation, a process called cumulus cell-oocyte complex (COC) expansion. Hyaluronan release and dispersion of the cumulus cells progressively occur after ovulation, paralleling the decline of oocyte fertilization. We show here that, in mice, postovulatory changes of matrix are temporally correlated to cumulus cell death. Cumulus cell apoptosis and matrix disassembly also occurred in ovulated COCs cultured in vitro. COCs expanded in vitro with FSH or EGF underwent the same changes, whereas those expanded with 8-bromo-adenosine-3,5-cyclic monophosphate (8-Br-cAMP) maintained integrity for a longer time. It is noteworthy that 8-Br-cAMP treatment was also effective on ovulated COCs cultured in vitro, prolonging the vitality of the cumulus cells and the stability of the matrix from a few hours to >2 days. Stimulation of endogenous adenylate cyclase with forskolin or inhibition of phosphodiesterase with rolipram produced similar effects. The treatment with selective cAMP analogues suggests that the effects of cAMP elevation are exerted through an EPAC-independent, PKA type II-dependent signaling pathway, probably acting at the post-transcriptional level. Finally, overnight culture of ovulated COCs with 8-Br-cAMP significantly counteracted the decrease of fertilization rate, doubling the number of fertilized oocytes compared with control conditions. In conclusion, these studies suggest that cAMP-elevating agents prevent cumulus cell senescence and allow them to continue to exert beneficial effects on oocyte and sperm, thereby extending in vitro the time frame of oocyte fertilizability.	[Di Giacomo, Monica; Camaioni, Antonella; Klinger, Francesca G.; Bonfiglio, Rita; Salustri, Antonietta] Univ Roma Tor Vergata, Sect Histol & Embryol, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy	University of Rome Tor Vergata	Salustri, A (corresponding author), Univ Roma Tor Vergata, Sect Histol & Embryol, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.	salustri@med.uniroma2.it	Camaioni, Antonella/AAB-5285-2020; Klinger, Francesca Gioia/AAO-5349-2021; Camaioni, Antonella/AAB-5294-2020	Camaioni, Antonella/0000-0002-7059-2617; Klinger, Francesca Gioia/0000-0001-6744-0850; Camaioni, Antonella/0000-0002-7059-2617; Bonfiglio, Rita/0000-0003-4172-2977; Di Giacomo, Monica/0000-0002-4075-0725; SALUSTRI, ANTONIETTA/0000-0002-8731-1041				Assidi M, 2008, BIOL REPROD, V79, P209, DOI 10.1095/biolreprod.108.067686; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; CAMPBELL S, 1995, HUM REPROD, V10, P425, DOI 10.1093/oxfordjournals.humrep.a135955; Chang HC, 2005, HUM REPROD, V20, P1958, DOI 10.1093/humrep/dei003; Chen J, 2013, NAT CELL BIOL, V15, P1415, DOI 10.1038/ncb2873; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chian RC, 2004, CURR OPIN OBSTET GYN, V16, P211, DOI 10.1097/00001703-200406000-00003; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Coticchio G, 2012, INT J DEV BIOL, V56, P909, DOI 10.1387/ijdb.120135gv; D'Alessandris C, 2001, ENDOCRINOLOGY, V142, P3033, DOI 10.1210/en.142.7.3033; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De la Fuente R, 1999, HUM REPROD, V14, P3060, DOI 10.1093/humrep/14.12.3060; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; DOWNS SM, 1995, DEV BIOL, V172, P72, DOI 10.1006/dbio.1995.0006; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Familiari G, 1996, MOL REPROD DEV, V43, P392, DOI 10.1002/(SICI)1098-2795(199603)43:3<392::AID-MRD14>3.0.CO;2-3; Fan HY, 2012, MOL CELL ENDOCRINOL, V356, P74, DOI 10.1016/j.mce.2011.12.005; Fissore RA, 2002, REPRODUCTION, V124, P745, DOI 10.1530/rep.0.1240745; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Hussein TS, 2005, J CELL SCI, V118, P5257, DOI 10.1242/jcs.02644; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Ishizuya-Oka A, 2010, APOPTOSIS, V15, P350, DOI 10.1007/s10495-009-0422-y; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P162, DOI 10.1023/A:1009470206468; Keller KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048523; Lam X, 2000, BIOL REPROD, V62, P579, DOI 10.1095/biolreprod62.3.579; Leemhuis J, 2002, J PHARMACOL EXP THER, V300, P1000, DOI 10.1124/jpet.300.3.1000; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; LONGO FJ, 1980, GAMETE RES, V3, P379, DOI 10.1002/mrd.1120030409; Luciano AM, 2005, MOL REPROD DEV, V71, P389, DOI 10.1002/mrd.20304; Lopez-Campos JL, 2013, EXPERT REV RESP MED, V7, P43, DOI [10.1586/ers.13.17, 10.1586/ERS.13.17]; Lund LR, 2000, DEVELOPMENT, V127, P4481; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; MARSTON JH, 1964, J EXP ZOOL, V155, P237, DOI 10.1002/jez.1401550211; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Merriman JA, 1998, HUM REPROD, V13, P690, DOI 10.1093/humrep/13.3.690; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Naderi EH, 2009, BLOOD, V114, P608, DOI 10.1182/blood-2009-02-204883; Onoda M, 2009, HEMATOLOGY, V14, P213, DOI 10.1179/102453309X426236; Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; Ruvolo G, 2013, J ASSIST REPROD GEN, V30, P207, DOI 10.1007/s10815-013-9943-y; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G; SALUSTRI A, 1985, BIOL REPROD, V33, P797, DOI 10.1095/biolreprod33.4.797; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; SUTOVSKY P, 1995, MOL REPROD DEV, V41, P521, DOI 10.1002/mrd.1080410415; Sutton-McDowall ML, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102061; Szotys M., 2000, ANAT EMBRYOL BERL, V202, P523, DOI 10.1007/s004290000122; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TALBOT P, 1983, J EXP ZOOL, V225, P141, DOI 10.1002/jez.1402250117; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tirone E, 1997, J BIOL CHEM, V272, P4787, DOI 10.1074/jbc.272.8.4787; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tunjung WAS, 2009, BIOCHEM BIOPH RES CO, V382, P160, DOI 10.1016/j.bbrc.2009.02.163; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140; Yodoi R, 2009, ENDOCRINOLOGY, V150, P3345, DOI 10.1210/en.2008-1449; Yokoo M, 2002, BIOL REPROD, V67, P1165, DOI 10.1095/biolreprod67.4.1165; Zhang AJ, 2012, J ASSIST REPROD GEN, V29, P313, DOI 10.1007/s10815-012-9712-3; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	95	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3821	3836		10.1074/jbc.M115.680983	http://dx.doi.org/10.1074/jbc.M115.680983			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694612	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000371338400012
J	Fatehchand, K; Ren, L; Elavazhagan, S; Fang, HQ; Mo, XK; Vasilakos, JP; Dietsch, GN; Hershberg, RM; Tridandapani, S; Butchar, JP				Fatehchand, Kavin; Ren, Li; Elavazhagan, Saranya; Fang, Huiqing; Mo, Xiaokui; Vasilakos, John P.; Dietsch, Gregory N.; Hershberg, Robert M.; Tridandapani, Susheela; Butchar, Jonathan P.			Toll-like Receptor 4 Ligands Down-regulate Fc gamma Receptor IIb (Fc gamma RIIb) via MARCH3 Protein-mediated Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; Fc receptor; immunology; monocyte; signal transduction; Toll-like receptor 4 (TLR4); ubiquitylation (ubiquitination)	NON-HODGKINS-LYMPHOMA; DEPENDENT CELLULAR CYTOTOXICITY; CHRONIC LYMPHOCYTIC-LEUKEMIA; NATURAL-KILLER-CELL; IN-VIVO; RHEUMATOID-ARTHRITIS; ANTITUMOR-ACTIVITY; ANTIBODY THERAPY; MYELOID CELLS; COMBINATION IMMUNOTHERAPY	Monocytes and macrophages are critical for the effectiveness of monoclonal antibody therapy. Responses to antibody-coated tumor cells are largely mediated by Fc receptors (FcRs), which become activated upon binding to immune complexes. FcRIIb is an inhibitory FcR that negatively regulates these responses, and it is expressed on monocytes and macrophages. Therefore, deletion or down-regulation of this receptor may substantially enhance therapeutic outcomes. Here we screened a panel of Toll-like receptor (TLR) agonists and found that those selective for TLR4 and TLR8 could significantly down-regulate the expression of FcRIIb. Upon further examination, we found that treatment of monocytes with TLR4 agonists could lead to the ubiquitination of FcRIIb protein. A search of our earlier microarray database of monocytes activated with the TLR7/8 agonist R-848 (in which FcRIIb was down-regulated) revealed an up-regulation of membrane-associated ring finger (C3HC4) 3 (MARCH3), an E3 ubiquitin ligase. Therefore, we tested whether LPS treatment could up-regulate MARCH3 in monocytes and whether this E3 ligase was involved with LPS-mediated FcRIIb down-regulation. The results showed that LPS activation of TLR4 significantly increased MARCH3 expression and that siRNA against MARCH3 prevented the decrease in FcRIIb following LPS treatment. These data suggest that activation of TLR4 on monocytes can induce a rapid down-regulation of FcRIIb protein and that this involves ubiquitination.	[Fatehchand, Kavin] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Elavazhagan, Saranya; Fang, Huiqing; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Ren, Li] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130000, Jilin, Peoples R China; [Vasilakos, John P.] 3M Drug Delivery Syst Div, St Paul, MN 55144 USA; [Dietsch, Gregory N.; Hershberg, Robert M.] VentiRx Pharmaceut, Seattle, WA 98101 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Jilin University; 3M	Tridandapani, S; Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu	Butchar, Jonathan/E-2825-2011		National Institutes of Health [P01-CA095426, R01 CA162411, K12 CA133250]; Ohio State University College of Medicine McWhinney Bridge Fund Grant [244749]; American Cancer Society [IRG-67-003-47]; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA162411, K12CA133250, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University College of Medicine McWhinney Bridge Fund Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants P01-CA095426 and R01 CA162411 (to S. T.) and K12 CA133250 (to J. P. B.), Ohio State University College of Medicine McWhinney Bridge Fund Grant 244749 (to J. P. B.), and American Cancer Society Institutional Research Grant IRG-67-003-47 (to J. P. B.). J. P. V. is an employee of 3M. G. N. D. and R. M. H. are employees of VentiRx Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Ansell SM, 2006, CLIN CANCER RES, V12, P6056, DOI 10.1158/1078-0432.CCR-06-1245; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Berte R, 2001, ACTA HAEMATOL-BASEL, V106, P141, DOI 10.1159/000046607; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Byrd JC, 2001, J CLIN ONCOL, V19, P2153, DOI 10.1200/JCO.2001.19.8.2153; Chacko GW, 1996, J IMMUNOL, V157, P2234; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Davis TA, 2000, CLIN CANCER RES, V6, P2644; Duan GJ, 2014, FRONT BIOSCI-LANDMRK, V19, P904, DOI 10.2741/4256; Elavazhagan S, 2015, J IMMUNOL, V194, P2786, DOI 10.4049/jimmunol.1402316; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; Friedberg JW, 2002, BRIT J HAEMATOL, V117, P828, DOI 10.1046/j.1365-2141.2002.03535.x; Ganesan LP, 2003, J BIOL CHEM, V278, P35710, DOI 10.1074/jbc.M305078200; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Hainsworth JD, 2003, J CLIN ONCOL, V21, P1746, DOI 10.1200/JCO.2003.09.027; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; Hutchins JT, 1995, P NATL ACAD SCI USA, V92, P11980, DOI 10.1073/pnas.92.26.11980; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Khan KD, 2006, CLIN CANCER RES, V12, P7046, DOI 10.1158/1078-0432.CCR-06-1571; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MELLMAN IS, 1983, J CELL BIOL, V96, P887, DOI 10.1083/jcb.96.3.887; Minard-Colin V, 2008, BLOOD, V112, P1205, DOI 10.1182/blood-2008-01-135160; Moga E, 2008, EXP HEMATOL, V36, P69, DOI 10.1016/j.exphem.2007.08.012; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; O'Brien SM, 2001, J CLIN ONCOL, V19, P2165, DOI 10.1200/JCO.2001.19.8.2165; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Oflazoglu E, 2007, BLOOD, V110, P4370, DOI 10.1182/blood-2007-06-097014; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Radstake TRDJ, 2006, ARTHRITIS RHEUM-US, V54, P3828, DOI 10.1002/art.22275; Reddy N, 2008, BRIT J HAEMATOL, V140, P36, DOI 10.1111/j.1365-2141.2007.06841.x; Roghanian A, 2015, CANCER CELL, V27, P473, DOI 10.1016/j.ccell.2015.03.005; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Tai YT, 2005, CANCER RES, V65, P11712, DOI 10.1158/0008-5472.CAN-05-1657; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; UKKONEN P, 1986, J EXP MED, V163, P952, DOI 10.1084/jem.163.4.952; Van Roon JAG, 2003, J RHEUMATOL, V30, P648; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; VOGEL SN, 1983, J IMMUNOL, V130, P1210; Wang SZ, 2012, CANCER IMMUNOL IMMUN, V61, P49, DOI 10.1007/s00262-011-1090-7; Wijngaarden S, 2004, ARTHRITIS RHEUM-US, V50, P3878, DOI 10.1002/art.20672; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Yazawa N, 2005, P NATL ACAD SCI USA, V102, P15178, DOI 10.1073/pnas.0505539102; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	65	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3895	3904		10.1074/jbc.M115.701151	http://dx.doi.org/10.1074/jbc.M115.701151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694610	Green Published, hybrid			2022-12-28	WOS:000371338400018
J	Meiser, J; Kramer, L; Sapcariu, SC; Battello, N; Ghelfi, J; D'Herouel, AF; Skupin, A; Hiller, K				Meiser, Johannes; Kraemer, Lisa; Sapcariu, Sean C.; Battello, Nadia; Ghelfi, Jenny; D'Herouel, Aymeric Fouquier; Skupin, Alexander; Hiller, Karsten			Pro-inflammatory Macrophages Sustain Pyruvate Oxidation through Pyruvate Dehydrogenase for the Synthesis of Itaconate and to Enable Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; inflammation; macrophage; metabolic regulation; metabolism; mitochondrial metabolism; pyruvate; Itaconate	REDUCTIVE GLUTAMINE-METABOLISM; DENDRITIC CELL ACTIVATION; TUMOR-NECROSIS-FACTOR; ALPHA-KETOGLUTARATE; CANCER-CELLS; TCA CYCLE; MURINE MACROPHAGES; GLUCOSE-METABOLISM; HYPOXIA; CARBOXYLATION	Upon stimulation with Th1 cytokines or bacterial lipopolysaccharides, resting macrophages shift their phenotype toward a pro-inflammatory state as part of the innate immune response. LPS-activated macrophages undergo profound metabolic changes to adapt to these new physiological requirements. One key step to mediate this metabolic adaptation is the stabilization of HIF1, which leads to increased glycolysis and lactate release, as well as decreased oxygen consumption. HIF1 abundance can result in the induction of the gene encoding pyruvate dehydrogenase kinase 1 (PDK1), which inhibits pyruvate dehydrogenase (PDH) via phosphorylation. Therefore, it has been speculated that pyruvate oxidation through PDH is decreased in pro-inflammatory macrophages. However, to answer this open question, an in-depth analysis of this metabolic branching point was so far lacking. In this work, we applied stable isotope-assisted metabolomics techniques and demonstrate that pyruvate oxidation is maintained in mature pro-inflammatory macrophages. Glucose-derived pyruvate is oxidized via PDH to generate citrate in the mitochondria. Citrate is used for the synthesis of the antimicrobial metabolite itaconate and for lipogenesis. An increased demand for these metabolites decreases citrate oxidation through the tricarboxylic acid cycle, whereas increased glutamine uptake serves to replenish the TCA cycle. Furthermore, we found that the PDH flux is maintained by unchanged PDK1 abundance, despite the presence of HIF1. By pharmacological intervention, we demonstrate that the PDH flux is an important node for M(LPS) macrophage activation. Therefore, PDH represents a metabolic intervention point that might become a research target for translational medicine to treat chronic inflammatory diseases.	[Meiser, Johannes; Kraemer, Lisa; Sapcariu, Sean C.; Battello, Nadia; Ghelfi, Jenny; D'Herouel, Aymeric Fouquier; Skupin, Alexander; Hiller, Karsten] Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg	University of Luxembourg	Hiller, K (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Metabol Grp, 6 Ave Swing, L-4367 Belvaux, Luxembourg.	karsten.hiller@uni.lu	meiser, johannes/S-7571-2018	meiser, johannes/0000-0002-9093-6210; Hiller, Karsten/0000-0001-9322-5820; SKUPIN, Alexander/0000-0002-8955-8304	Fonds National de la Recherche Luxembourg Grant ATTRACT [A10/03]; AFR [3973022]; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	Fonds National de la Recherche Luxembourg Grant ATTRACT(Luxembourg National Research Fund); AFR(Luxembourg National Research Fund); Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	This work was supported in part by the Fonds National de la Recherche Luxembourg Grant ATTRACT A10/03 (to K. H.) and AFR-Postdoc-3973022 (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of financial support from the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health.	Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Garzetti L, 2014, J LEUKOCYTE BIOL, V95, P817, DOI 10.1189/jlb.0913485; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newsholme F, 1999, J NUTR BIOCHEM, V10, P316; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Walther JL, 2012, METAB ENG, V14, P162, DOI 10.1016/j.ymben.2011.12.004; Warburg O, 1924, NATURWISSENSCHAFTEN, V12, P1131, DOI 10.1007/BF01504608; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025	51	136	141	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3932	3946		10.1074/jbc.M115.676817	http://dx.doi.org/10.1074/jbc.M115.676817			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26679997	Green Published, hybrid			2022-12-28	WOS:000371338400021
J	Evans-Roberts, KM; Mitchenall, LA; Wall, MK; Leroux, J; Mylne, JS; Maxwell, A				Evans-Roberts, Katherine M.; Mitchenall, Lesley A.; Wall, Melisa K.; Leroux, Julie; Mylne, Joshua S.; Maxwell, Anthony			DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; DNA gyrase; DNA replication; DNA topoisomerase; plant biochemistry; quinolones	RESISTANCE-DETERMINING REGION; ESCHERICHIA-COLI; A-PROTEIN; TRANSGENIC PLANTS; NALIDIXIC-ACID; GENE; CLONING; EXPRESSION; SUBUNIT; MUTATIONS	The Arabidopsis thaliana genome contains four genes that were originally annotated as potentially encoding DNA gyrase: ATGYRA, ATGYRB1, ATGYRB2, and ATGYRB3. Although we subsequently showed that ATGYRB3 does not encode a gyrase subunit, the other three genes potentially encode subunits of a plant gyrase. We also showed evidence for the existence of supercoiling activity in A. thaliana and that the plant is sensitive to quinolone and aminocoumarin antibiotics, compounds that target DNA gyrase in bacteria. However, it was not possible at that time to show whether the A. thaliana genes encoded an active gyrase enzyme, nor whether that enzyme is indeed the target for the quinolone and aminocoumarin antibiotics. Here we show that an A. thaliana mutant resistant to the quinolone drug ciprofloxacin has a point mutation in ATGYRA. Moreover we show that, as in bacteria, the quinolone-sensitive (wild-type) allele is dominant to the resistant gene. Further we have heterologously expressed ATGYRA and ATGYRB2 in a baculovirus expression system and shown supercoiling activity of the partially purified enzyme. Expression/purification of the quinolone-resistant A. thaliana gyrase yields active enzyme that is resistant to ciprofloxacin. Taken together these experiments now show unequivocally that A. thaliana encodes an organelle-targeted DNA gyrase that is the target of the quinolone drug ciprofloxacin; this has important consequences for plant physiology and the development of herbicides.	[Evans-Roberts, Katherine M.; Mitchenall, Lesley A.; Wall, Melisa K.; Maxwell, Anthony] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Leroux, Julie; Mylne, Joshua S.] Univ Western Australia, Sch Chem & Biochem, 35 Stirling Highway, Perth, WA 6009, Australia; [Leroux, Julie; Mylne, Joshua S.] Australian Res Council Ctr Excellence Plant Energ, 35 Stirling Highway, Perth, WA 6009, Australia; [Evans-Roberts, Katherine M.] Babraham Inst Enterprise Ltd, Babraham Res Campus, Cambridge CB22 3AT, England; [Wall, Melisa K.] Princess Alexandra Hosp, Dept Emergency Med, Brisbane, Qld 4102, Australia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Western Australia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Maxwell, A (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@jic.ac.uk	Mylne, Joshua S/A-5581-2009; Mylne, Josh/GMX-4544-2022	Mylne, Joshua S/0000-0003-4957-6388; Mylne, Josh/0000-0003-4957-6388; Maxwell, Anthony/0000-0002-5756-6430; Mitchenall, Lesley/0000-0002-0063-1991	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004561/1]; John Innes Foundation; BBSRC; Syngenta (UK); Australian Research Council [FT120100013]; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta (UK)(Syngenta); Australian Research Council(Australian Research Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/J004561/1 from the Biotechnology and Biological Sciences Research Council (BBSRC) and the John Innes Foundation. This work was also was supported by a Ph.D. studentship from the BBSRC and Syngenta (UK) (to K. M. E. R.) and an Australian Research Council Future Fellowship (FT120100013) (to J. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bebear CM, 2000, ANTIMICROB AGENTS CH, V44, P2719, DOI 10.1128/AAC.44.10.2719-2727.2000; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Bush N. G., 2015, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.ESP-0010-2014, DOI 10.1128/ECOSALPLUS.ESP-0010-2014]; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chapple SDJ, 2002, J BIOTECHNOL, V95, P269, DOI 10.1016/S0168-1656(02)00023-8; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Dar MA, 2007, EUKARYOT CELL, V6, P398, DOI 10.1128/EC.00357-06; Evans-Roberts K. M., 2007, THESIS U E ANGLIA NO; Evans-Roberts KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009899; Friedman SM, 2001, ANTIMICROB AGENTS CH, V45, P2378, DOI 10.1128/AAC.45.8.2378-2380.2001; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; HALLETT P, 1990, GENE, V93, P139, DOI 10.1016/0378-1119(90)90148-K; HALLETT P, 1991, ANTIMICROB AGENTS CH, V35, P335, DOI 10.1128/AAC.35.2.335; HANE MW, 1969, J BACTERIOL, V99, P238, DOI 10.1128/JB.99.1.238-241.1969; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; REECE RJ, 1989, J BIOL CHEM, V264, P19648; ROBINSON MJ, 1991, J BIOL CHEM, V266, P14585; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wall MK, 2004, P NATL ACAD SCI USA, V101, P7821, DOI 10.1073/pnas.0400836101; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	33	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3136	3144		10.1074/jbc.M115.689554	http://dx.doi.org/10.1074/jbc.M115.689554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663076	hybrid, Green Published			2022-12-28	WOS:000370854500002
J	Patil, H; Wilks, C; Gonzalez, RW; Dhanireddy, S; Conrad-Webb, H; Bergel, M				Patil, Hemangi; Wilks, Carrie; Gonzalez, Rhiannon W.; Dhanireddy, Sudheer; Conrad-Webb, Heather; Bergel, Michael			Mitotic Activation of a Novel Histone Deacetylase 3-Linker Histone H1.3 Protein Complex by Protein Kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone deacetylase 3 (HDAC3); mitosis; mitotic spindle; protein kinase; linker histone H1; 3; protein kinase CK2	CELL-CYCLE PROGRESSION; N-COR; PHOSPHORYLATION SITE; OVARIAN-CANCER; BETA-SUBUNIT; AURORA-B; IN-VIVO; HDAC3; CHROMATIN; MITOSIS	Histone deacetylase 3 (HDAC3) and linker histone H1 are involved in both chromatin compaction and the regulation of mitotic progression. However, the mechanisms by which HDAC3 and H1 regulate mitosis and the factors controlling HDAC3 and H1 activity during mitosis are unclear. Furthermore, as of now, no association between class I, II, or IV (non-sirtuin) HDACs and linker histones has been reported. Here we describe a novel HDAC3-H1.3 complex containing silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and nuclear receptor corepressor 1 (N-CoR) that accumulated in synchronized HeLa cells in late G(2) phase and mitosis. Nonetheless, the deacetylation activity by HDAC3 in the complex was evident only in mitotic complexes. HDAC3 associated with H1.3 was highly phosphorylated on Ser-424 only during mitosis. Isolation of inactive HDAC3-H1.3 complexes from late G(2) phase cells, and phosphorylation of HDAC3 in the complexes at serine 424 by protein kinase CK2 (also known as casein kinase 2) activated the HDAC3 in vitro. In vivo, CK2 and CK2' double knockdown cells demonstrated a significant decrease in HDAC3 Ser-424 phosphorylation during mitosis. HDAC3 and H1.3 co-localized in between the chromosomes, with polar microtubules and spindle poles during metaphase through telophase, and partially co-localized with chromatin during prophase and interphase. H1 has been reported previously to associate with microtubules and, therefore, could potentially function in targeting HDAC3 to the microtubules. We suggest that phosphorylation of HDAC3 in the complex by CK2 during mitosis activates the complex for a dual role: compaction of the mitotic chromatin and regulation of polar microtubules dynamic instability.	[Patil, Hemangi; Wilks, Carrie; Gonzalez, Rhiannon W.; Dhanireddy, Sudheer; Conrad-Webb, Heather; Bergel, Michael] Texas Womans Univ, Dept Biol, 304 Adm Dr, Denton, TX 76204 USA	Texas Womans University	Bergel, M (corresponding author), Texas Womans Univ, Dept Biol, 304 Adm Dr, Denton, TX 76204 USA.	MBergel@twu.edu			Texas Woman's University Research Enhancement Program; Department of Biology	Texas Woman's University Research Enhancement Program; Department of Biology	This work was supported by grants from the Texas Woman's University Research Enhancement Program and Department of Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Bosc DG, 1999, MOL CELL BIOCHEM, V191, P213, DOI 10.1023/A:1006840329973; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Cowger JJM, 2006, BIOCHEMISTRY-US, V45, P13150, DOI 10.1021/bi060562g; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Fadri-Moskwik M, 2012, FASEB J, V26, P4057, DOI 10.1096/fj.12-206656; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Goodson ML, 2014, MOL CELL BIOL, V34, P4104, DOI 10.1128/MCB.00554-14; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; GURLEY LR, 1995, J BIOL CHEM, V270, P27653, DOI 10.1074/jbc.270.46.27653; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Herrera JE, 2000, MOL CELL BIOL, V20, P523, DOI 10.1128/MCB.20.2.523-529.2000; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Jiang YD, 2014, P NATL ACAD SCI USA, V111, P13541, DOI 10.1073/pnas.1411939111; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; LITCHFIELD DW, 1995, BBA-MOL CELL RES, V1269, P69, DOI 10.1016/0167-4889(95)00100-7; Magnaghi-Jaulin L, 2007, CANCER RES, V67, P6360, DOI 10.1158/0008-5472.CAN-06-3012; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; Medrzycki M, 2014, CANCER RES, V74, P6463, DOI 10.1158/0008-5472.CAN-13-2922; Medrzycki M, 2012, FRONT BIOSCI-LANDMRK, V17, P396, DOI 10.2741/3934; Nakayama T, 2008, J BIOL CHEM, V283, P16632, DOI 10.1074/jbc.M705764200; Ozawa Y, 2001, BLOOD, V98, P2116, DOI 10.1182/blood.V98.7.2116; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Schemies J, 2009, CANCER LETT, V280, P222, DOI 10.1016/j.canlet.2009.01.040; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Talasz H, 1996, BIOCHEMISTRY-US, V35, P1761, DOI 10.1021/bi951914e; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Yde CW, 2008, ONCOGENE, V27, P4986, DOI 10.1038/onc.2008.146; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	57	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3158	3172		10.1074/jbc.M115.643874	http://dx.doi.org/10.1074/jbc.M115.643874			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663086	Green Published, hybrid			2022-12-28	WOS:000370854500004
J	Lucero, LM; Weltzin, MM; Eaton, JB; Cooper, JF; Lindstrom, JM; Lukas, RJ; Whiteaker, P				Lucero, Linda M.; Weltzin, Maegan M.; Eaton, J. Brek; Cooper, John F.; Lindstrom, Jon M.; Lukas, Ronald J.; Whiteaker, Paul			Differential alpha 4(+)/(-)beta 2 Agonist-binding Site Contributions to alpha 4 beta 2 Nicotinic Acetylcholine Receptor Function within and between Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; CENTRAL-NERVOUS-SYSTEM; BETA-3 SUBUNITS; ALTERNATE STOICHIOMETRIES; ALPHA-4-ALPHA-4 INTERFACE; COGNITIVE FUNCTION; SMOKING-CESSATION; SAZETIDINE-A; EXPRESSION; BRAIN	Two alpha 4 beta 2 nicotinic acetylcholine receptor (alpha 4 beta 2-nAChR) isoforms exist with (alpha 4)(2)(beta 2)(3) and (alpha 4)(3)(beta 2)(2) subunit stoichiometries and high versus low agonist sensitivities (HS and LS), respectively. Both isoforms contain a pair of alpha 4(+)/(-)beta 2 agonist-binding sites. The LS isoform also contains a unique alpha 4(+)/(-)alpha 4 site with lower agonist affinity than the alpha 4(+)/(-)beta 2 sites. However, the relative roles of the conserved alpha 4(+)/(-)beta 2 agonist-binding sites in and between the isoforms have not been studied. We used a fully linked subunit concatemeric nAChR approach to express pure populations of HS or LS isoform alpha 4 beta 2*-nAChR. This approach also allowed us to mutate individual subunit interfaces, or combinations thereof, on each isoform background. We used this approach to systematically mutate a triplet of beta 2 subunit (-)-face E-loop residues to their non-conserved alpha 4 subunit counterparts or vice versa (beta 2HQT and alpha 4VFL, respectively). Mutant-nAChR constructs (and unmodified controls) were expressed in Xenopus oocytes. Acetylcholine concentration-response curves and maximum function were measured using two-electrode voltage clamp electrophysiology. Surface expression was measured with I-125-mAb 295 binding and was used to define function/nAChR. If the alpha 4(+)/(-)beta 2 sites contribute equally to function, making identical beta 2HQT substitutions at either site should produce similar functional outcomes. Instead, highly differential outcomes within the HS isoform, and between the two isoforms, were observed. In contrast, alpha 4VFL mutation effects were very similar in all positions of both isoforms. Our results indicate that the identity of subunits neighboring the otherwise equivalent alpha 4(+)/(-)beta 2 agonist sites modifies their contributions to nAChR activation and that E-loop residues are an important contributor to this neighbor effect.	[Lucero, Linda M.; Weltzin, Maegan M.; Eaton, J. Brek; Lukas, Ronald J.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Cooper, John F.; Lindstrom, Jon M.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	Barrow Neurological Institute; University of Pennsylvania	Whiteaker, P (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	paul.whiteaker@dignityhealth.org			National Institutes of Health [DA026627, DA012242, DA030929]; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012242, R21DA026627, R01DA030929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA026627 and DA012242 (to P. W.) and DA030929 (to J. M. L.) and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P. W. and R. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreo MA, 1996, J MED CHEM, V39, P817, DOI 10.1021/jm9506884; Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; ANAND R, 1991, J BIOL CHEM, V266, P11192; Brejc K, 2002, NOVART FDN SYMP, V245, P22; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dash B, 2014, J BIOL CHEM, V289, P28338, DOI 10.1074/jbc.M114.566018; Dash B, 2012, J BIOL CHEM, V287, P14259, DOI 10.1074/jbc.M111.322610; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Grupe M, 2013, BIOCHEM PHARMACOL, V86, P1487, DOI 10.1016/j.bcp.2013.09.005; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hsiao B, 2008, J NEUROPHYSIOL, V99, P999, DOI 10.1152/jn.01040.2007; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Marks MJ, 2010, J MOL NEUROSCI, V40, P96, DOI 10.1007/s12031-009-9264-x; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Rollema H, 2007, TRENDS PHARMACOL SCI, V28, P316, DOI 10.1016/j.tips.2007.05.003; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Steinlein OK, 2001, AM J MED GENET, V106, P139, DOI 10.1002/ajmg.1571; Stitzel JA, 2008, FRONT BIOSCI-LANDMRK, V13, P477, DOI 10.2741/2694; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Voineskos S, 2007, J PSYCHIATR NEUROSCI, V32, P412; Weltzin MM, 2016, NEUROPHARMACOLOGY, V102, P158, DOI 10.1016/j.neuropharm.2015.11.004; Whiteaker P, 2006, J COMP NEUROL, V499, P1016, DOI 10.1002/cne.21181; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	54	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2444	2459		10.1074/jbc.M115.684373	http://dx.doi.org/10.1074/jbc.M115.684373			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644472	Green Published, hybrid			2022-12-28	WOS:000369610400033
J	Bloemink, MJ; Melkani, GC; Bernstein, SI; Geeves, MA				Bloemink, Marieke J.; Melkani, Girish C.; Bernstein, Sanford I.; Geeves, Michael A.			The Relay/Converter Interface Influences Hydrolysis of ATP by Skeletal Muscle Myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; CONFORMATIONAL STATES; MICROGRAM QUANTITIES; KINETIC-ANALYSIS; MOLECULAR MOTOR; RECOVERY STROKE; DROSOPHILA; RELAY; ACTOMYOSIN; DOMAINS	The interface between relay and converter domain of muscle myosin is critical for optimal myosin performance. Using Drosophila melanogaster indirect flight muscle S1, we performed a kinetic analysis of the effect of mutations in the converter and relay domain. Introduction of a mutation (R759E) in the converter domain inhibits the steady-state ATPase of myosin S1, whereas an additional mutation in the relay domain (N509K) is able to restore the ATPase toward wild-type values. The R759E S1 construct showed little effect on most steps of the actomyosin ATPase cycle. The exception was a 25-30% reduction in the rate constant of the hydrolysis step, the step coupled to the cross-bridge recovery stroke that involves a change in conformation at the relay/converter domain interface. Significantly, the double mutant restored the hydrolysis step to values similar to the wildtype myosin. Modeling the relay/converter interface suggests a possible interaction between converter residue 759 and relay residue 509 in the actin-detached conformation, which is lost in R759E but is restored in N509K/R759E. This detailed kinetic analysis of Drosophila myosin carrying the R759E mutation shows that the interface between the relay loop and converter domain is important for fine-tuning myosin kinetics, in particular ATP binding and hydrolysis.	[Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Melkani, Girish C.; Bernstein, Sanford I.] San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA; [Melkani, Girish C.; Bernstein, Sanford I.] San Diego State Univ, SDSU Heart Inst, San Diego, CA 92182 USA; [Bloemink, Marieke J.] Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury CT1 1QU, Kent, England	University of Kent; California State University System; San Diego State University; California State University System; San Diego State University; Canterbury Christ Church University	Geeves, MA (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.; Bernstein, SI (corresponding author), San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA.; Bernstein, SI (corresponding author), San Diego State Univ, SDSU Heart Inst, San Diego, CA 92182 USA.	sbernstein@mail.sdsu.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Melkani, Girish/0000-0003-0353-4633; Bloemink, Marieke Johanna/0000-0001-9441-2783; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [GM32443]; Wellcome Trust [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM32443 (to S. I. B.) and Wellcome Trust Grant 085309 (to M. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Baumann BAJ, 2012, J MOL BIOL, V415, P274, DOI 10.1016/j.jmb.2011.10.047; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Bloemink MJ, 2011, J BIOL CHEM, V286, P28435, DOI 10.1074/jbc.M111.258228; Clark RJ, 2003, J MUSCLE RES CELL M, V24, P315; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Kronert WA, 2008, J MOL BIOL, V379, P443, DOI 10.1016/j.jmb.2008.04.010; Kronert WA, 2014, J BIOL CHEM, V289, P12779, DOI 10.1074/jbc.M114.550673; Kronert WA, 2010, J MOL BIOL, V398, P625, DOI 10.1016/j.jmb.2010.03.049; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Malnasi-Csizmadia A, 2007, J BIOL CHEM, V282, P17658, DOI 10.1074/jbc.M701447200; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ramanath S, 2011, BIOPHYS J, V101, P1114, DOI 10.1016/j.bpj.2011.07.045; Reggiani C, 2000, NEWS PHYSIOL SCI, V15, P26; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Silva R, 2003, J MUSCLE RES CELL M, V24, P489, DOI 10.1023/B:JURE.0000009809.69829.74; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2002, NAT CELL BIOL, V4, P312, DOI 10.1038/ncb776; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Weiss S, 2000, J MUSCLE RES CELL M, V21, P423, DOI 10.1023/A:1005690106951; Yang CX, 2008, BIOPHYS J, V95, P5228, DOI 10.1529/biophysj.108.136192	36	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1763	1773		10.1074/jbc.M115.688002	http://dx.doi.org/10.1074/jbc.M115.688002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26586917	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000368620700018
J	Strickfaden, H; McDonald, D; Kruhlak, MJ; Haince, JF; Th'ng, JPH; Rouleau, M; Ishibashi, T; Corry, GN; Ausio, J; Underhill, DA; Poirier, GG; Hendzel, MJ				Strickfaden, Hilmar; McDonald, Darin; Kruhlak, Michael J.; Haince, Jean-Francois; Th'ng, John P. H.; Rouleau, Michele; Ishibashi, Toytaka; Corry, Gareth N.; Ausio, Juan; Underhill, D. Alan; Poirier, Guy G.; Hendzel, Michael J.			Poly(ADP-ribosyl)ation-dependent Transient Chromatin Decondensation and Histone Displacement following Laser Microirradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; BINDING-PROPERTIES; ADP-RIBOSYLATION; LIVING CELLS; REPAIR; POLY(ADP-RIBOSE); RECRUITMENT; PARP-1; ATM	Chromatin undergoes a rapid ATP-dependent, ATM and H2AX-independent decondensation when DNA damage is introduced by laser microirradiation. Although the detailed mechanism of this decondensation remains to be determined, the kinetics of decondensation are similar to the kinetics of poly(ADP-ribosyl)ation. We used laser microirradiation to introduce DNA strand breaks into living cells expressing a photoactivatable GFP-tagged histone H2B. We find that poly(ADPribosyl)ation mediated primarily by poly(ADP-ribose) polymerase 1 (PARP1) is responsible for the rapid decondensation of chromatin at sites of DNA damage. This decondensation of chromatin correlates temporally with the displacement of histones, which is sensitive to PARP inhibition and is transient in nature. Contrary to the predictions of the histone shuttle hypothesis, we did not find that histone H1 accumulated on poly(ADP-ribose) (PAR) in vivo. Rather, histone H1, and to a lessor extent, histones H2A and H2B were rapidly depleted from the sites of PAR accumulation. However, histone H1 returns to chromatin and the chromatin recondenses. Thus, the PARP-dependent relaxation of chromatin closely correlates with histone displacement.	[Strickfaden, Hilmar; McDonald, Darin; Corry, Gareth N.; Underhill, D. Alan; Poirier, Guy G.; Hendzel, Michael J.] Univ Alberta, Fac Dent & Med, Dept Oncol, Edmonton, AB T6G IZ2, Canada; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Th'ng, John P. H.] Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada; [Ishibashi, Toytaka; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada; [Ishibashi, Toytaka] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Haince, Jean-Francois; Rouleau, Michele] Univ Laval, Fac Med, CHUQ, Oncol Axis,Laval Univ Hosp,Res Ctr, Quebec City, PQ G1V 4G2, Canada	University of Alberta; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northern Ontario School of Medicine; University of Victoria; Hong Kong University of Science & Technology; Laval University	Hendzel, MJ (corresponding author), Univ Alberta, Dept Oncol, 11560 Univ Ave NW, Edmonton, AB T6G 1Z2, Canada.	mhendzel@ualberta.ca	Strickfaden, Hilmar/AAW-3522-2021; Ishibashi, Toyotaka/AAW-2687-2020; Hendzel, Michael/C-3391-2009	Ishibashi, Toyotaka/0000-0001-8015-2319; Hendzel, Michael/0000-0002-9603-7945; Underhill, Darrell/0000-0003-0957-7407; Poirier, Guy/0000-0002-4869-1424	Canadian Institutes of Health Research; Canadian Cancer Society; Alberta Cancer Research Institute; Alberta Cancer foundation; Bayrische Forschungsallianz; NATIONAL CANCER INSTITUTE [ZICBC010915] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Research Institute; Alberta Cancer foundation; Bayrische Forschungsallianz; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Canadian Institutes of Health Research, the Canadian Cancer Society, and the Alberta Cancer Research Institute. The authors declare that they have no conflicts of interest with the contents of this article.r Holds a postdoctoral fellowship by the Alberta Cancer foundation and supported by the Bayrische Forschungsallianz.	Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; ALTHAUS FR, 1992, J CELL SCI, V102, P663; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gagne JP, 2005, BIOCHEM J, V392, P499, DOI 10.1042/BJ20050792; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Izhar L, 2015, CELL REP, V11, P1486, DOI 10.1016/j.celrep.2015.04.053; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kleinbaum D., 2013, APPL REGRESSION ANAL; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Malanga M, 1998, BBA-GENE STRUCT EXPR, V1399, P154, DOI 10.1016/S0167-4781(98)00110-9; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Morisaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107730; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; PANZETER PL, 1993, J BIOL CHEM, V268, P17662; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Sehnalova P, 2014, BIOL CELL, V106, P151, DOI 10.1111/boc.201300076; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thomas CJ, 2014, MOL CELL, V53, P831, DOI 10.1016/j.molcel.2014.01.005; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	47	63	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1789	1802		10.1074/jbc.M115.694992	http://dx.doi.org/10.1074/jbc.M115.694992			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26559976	Green Published, hybrid			2022-12-28	WOS:000368620700020
J	Pilecki, B; Holm, AT; Schlosser, A; Moeller, JB; Wohl, AP; Zuk, AV; Heumuller, SE; Wallis, R; Moestrup, SK; Sengle, G; Holmskov, U; Sorensen, GL				Pilecki, Bartosz; Holm, Anne T.; Schlosser, Anders; Moeller, Jesper B.; Wohl, Alexander P.; Zuk, Alexandra V.; Heumueller, Stefanie E.; Wallis, Russell; Moestrup, Soren K.; Sengle, Gerhard; Holmskov, Uffe; Sorensen, Grith L.			Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin-and Fibrillin-binding Protein Involved in Elastic Fiber Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; CRYSTAL-STRUCTURE; CROSS-LINKING; LYSYL-OXIDASE; GLYCOPROTEIN MAGP-36; INNATE IMMUNITY; COACERVATION; EXPRESSION; FICOLIN; DOMAIN	MFAP4 (microfibrillar-associated protein 4) is an extracellular glycoprotein found in elastic fibers without a clearly defined role in elastic fiber assembly. In the present study, we characterized molecular interactions between MFAP4 and elastic fiber components. We established that MFAP4 primarily assembles into trimeric and hexameric structures of homodimers. Binding analysis revealed that MFAP4 specifically binds tropoelastin and fibrillin-1 and -2, as well as the elastin cross-linking amino acid desmosine, and that it co-localizes with fibrillin-1-positive fibers in vivo. Site-directed mutagenesis disclosed residues Phe(241) and Ser(203) in MFAP4 as being crucial for type I collagen, elastin, and tropoelastin binding. Furthermore, we found that MFAP4 actively promotes tropoelastin self-assembly. In conclusion, our data identify MFAP4 as a new ligand of microfibrils and tropoelastin involved in proper elastic fiber organization.	[Pilecki, Bartosz; Holm, Anne T.; Schlosser, Anders; Moeller, Jesper B.; Moestrup, Soren K.; Holmskov, Uffe; Sorensen, Grith L.] Univ Southern Denmark, Fac Hlth Sci, Inst Mol Med, Dept Canc & Inflammat Res, DK-5000 Odense C, Denmark; [Wohl, Alexander P.; Zuk, Alexandra V.; Heumueller, Stefanie E.; Sengle, Gerhard] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Heumueller, Stefanie E.; Sengle, Gerhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Wallis, Russell] Univ Leicester, Dept Mol & Cell Biol, Leicester LE1 9HN, Leics, England; [Moestrup, Soren K.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense C, Denmark	University of Southern Denmark; University of Cologne; University of Cologne; University of Leicester; University of Leicester; University of Southern Denmark; Odense University Hospital	Sorensen, GL (corresponding author), Inst Mol Med, JB Winslows Vej 25-3, DK-5000 Odense C, Denmark.	glsorensen@health.sdu.dk	Moestrup, Søren Kragh/AAD-1735-2019; Pilecki, Bartosz/O-5031-2015; Holmskov, Uffe/AAA-3056-2022; Moeller, Jesper B/E-6377-2015; Moestrup, Soren Kragh/A-1403-2014	Pilecki, Bartosz/0000-0001-8636-2245; Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Sorensen, Grith Lykke/0000-0002-5273-1097; Holm, Anne Trommelholt/0000-0001-6090-9820; Wallis, Russell/0000-0002-8705-5295; Moestrup, Soren Kragh/0000-0003-3862-2107	Danish Medical Research Council; Th. Maigaards Benthine Lunds Fond; Familien Hede Nielsens Fond; Fonden til Laegevidenskabens Fremme; Deutsche Forschungsgemeinschaft [SFB829]; Koln Fortune; Lundbeck Foundation [R108-2012-10802, R164-2013-15355, R67-2010-6409] Funding Source: researchfish; Novo Nordisk Fonden [NNF15SA0018400, NNF14OC0011537, NNF15OC0014052] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Th. Maigaards Benthine Lunds Fond; Familien Hede Nielsens Fond; Fonden til Laegevidenskabens Fremme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Medical Research Council, Th. Maigaards Benthine Lunds Fond af 1.6.1978, Familien Hede Nielsens Fond, Fonden til Laegevidenskabens Fremme, Deutsche Forschungsgemeinschaft SFB829/Project B12, and Koln Fortune (to G.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baldwin AK, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.9; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau NL, 2010, J BIOL CHEM, V285, P24943, DOI 10.1074/jbc.M110.130021; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Doolittle RF, 2012, PROTEIN SCI, V21, P1808, DOI 10.1002/pro.2177; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Holm AT, 2015, AM J PHYSIOL-LUNG C, V308, pL1114, DOI 10.1152/ajplung.00351.2014; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KOBAYASHI R, 1989, J BIOL CHEM, V264, P17437; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; Lemaire R, 2007, J BIOL CHEM, V282, P800, DOI 10.1074/jbc.M609692200; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Lindberg CA, 2012, EUR RESPIR J, V39, P839, DOI 10.1183/09031936.00064611; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Ma SR, 2011, J CHROMATOGR B, V879, P1893, DOI 10.1016/j.jchromb.2011.05.011; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; NARAYANAN AS, 1978, BIOCHEM J, V173, P857, DOI 10.1042/bj1730857; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Pilecki B, 2015, THORAX, V70, P862, DOI 10.1136/thoraxjnl-2014-206609; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Saekmose SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082383; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Shrive AK, 2014, J BIOL CHEM, V289, P2880, DOI 10.1074/jbc.M113.520577; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Thomsen T, 2010, J BIOL CHEM, V285, P1229, DOI 10.1074/jbc.M109.061523; Toyoshima T, 2005, EXP CELL RES, V307, P224, DOI 10.1016/j.yexcr.2005.03.005; Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wachi H, 2007, BIOCHEM J, V402, P63, DOI 10.1042/BJ20061145; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x; Wulf-Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082243; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165	65	65	69	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1103	1114		10.1074/jbc.M115.681775	http://dx.doi.org/10.1074/jbc.M115.681775			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601954	Green Published, hybrid			2022-12-28	WOS:000368068300007
J	Verma, N; Manna, SK				Verma, Neeharika; Manna, Sunil K.			Advanced Glycation End Products (AGE) Potently Induce Autophagy through Activation of RAF Protein Kinase and Nuclear Factor kappa B (NF-kappa B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; DIABETIC-PATIENTS; CELLS; PATHWAY; DEGRADATION; LIPOGENESIS; APOPTOSIS; ERK; METHYLGLYOXAL; TRANSCRIPTION	Advanced glycation end products (AGE) accumulate in diabetic patients and aging people because of high amounts of three- or four-carbon sugars derived from glucose, thereby causing multiple consequences, including inflammation, apoptosis, obesity, and age-related disorders. It is important to understand the mechanism of AGE-mediated signaling leading to the activation of autophagy (self-eating) that might result in obesity. We detected AGE as one of the potent inducers of autophagy compared with doxorubicin and TNF. AGE-mediated autophagy is inhibited by suppression of PI3K and potentiated by the autophagosome maturation blocker bafilomycin. It increases autophagy in different cell types, and that correlates with the expression of its receptor, receptor for AGE. LC3B, the marker for autophagosomes, is shown to increase upon AGE stimulation. AGE-mediated autophagy is partially suppressed by inhibitor of NF-kappa B, PKC, or ERK alone and significantly in combination. AGE increases sterol regulatory element binding protein activity, which leads to an increase in lipogenesis. Although AGE-mediated lipogenesis is affected by autophagy inhibitors, AGE-mediated autophagy is not influenced by lipogenesis inhibitors, suggesting that the turnover of lipid droplets overcomes the autophagic clearance. For the first time, we provide data showing that AGE induces several cell signaling cascades, like NF-kappa B, PKC, ERK, and MAPK, that are involved in autophagy and simultaneously help with the accumulation of lipid droplets that are not cleared effectively by autophagy, therefore causing obesity.	[Verma, Neeharika; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Verma, Neeharika] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in	Verma, Neeharika/AAY-9171-2021	verma, neeharika/0000-0003-2086-6795	Centre for DNA Fingerprinting and Diagnostics and fellowship from the University Grant Commission, Government of India	Centre for DNA Fingerprinting and Diagnostics and fellowship from the University Grant Commission, Government of India	This work was supported by a core grant from the Centre for DNA Fingerprinting and Diagnostics and fellowship from the University Grant Commission, Government of India (to N.V.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 2013, BIOMOL THER, V21, P114, DOI 10.4062/biomolther.2013.012; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Cachefo A, 2003, J LIPID RES, V44, P1349, DOI 10.1194/jlr.M300030-JLR200; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dimitrakis P, 2012, CELL TISSUE RES, V350, P361, DOI 10.1007/s00441-012-1475-8; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kaini RR, 2012, PROSTATE, V72, P1412, DOI 10.1002/pros.22489; Khuhawar MY, 2006, ANAL LETT, V39, P2205, DOI 10.1080/00032710600754093; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lappas M, 2007, J ENDOCRINOL, V193, P269, DOI 10.1677/JOE-06-0081; Ma TA, 2013, EXP CELL RES, V319, P779, DOI 10.1016/j.yexcr.2013.01.018; Mahali S, 2011, J BIOL CHEM, V286, P34903, DOI 10.1074/jbc.M111.279190; Mahali SK, 2014, J CELL PHYSIOL, V229, P1972, DOI 10.1002/jcp.24647; Mahali SK, 2012, BIOCHEM PHARMACOL, V84, P1681, DOI 10.1016/j.bcp.2012.09.033; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Rubenstein David A, 2011, J Diabetes Sci Technol, V5, P703; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Skop V, 2012, PHYSIOL RES, V61, P287, DOI 10.33549/physiolres.932285; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yamagishi Sho-ichi, 2006, Curr Drug Discov Technol, V3, P83, DOI 10.2174/157016306776637555; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	38	32	33	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1481	1491		10.1074/jbc.M115.667576	http://dx.doi.org/10.1074/jbc.M115.667576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26586913	Green Published, hybrid			2022-12-28	WOS:000368068300038
J	Mattera, R; Guardia, CM; Sidhu, SS; Bonifacino, JS				Mattera, Rafael; Guardia, Carlos M.; Sidhu, Sachdev S.; Bonifacino, Juan S.			Bivalent Motif-Ear Interactions Mediate the Association of the Accessory Protein Tepsin with the AP-4 Adaptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE SPASTIC PARAPLEGIA; APPENDAGE DOMAIN; STRUCTURAL BASIS; SORTING SIGNALS; INTELLECTUAL DISABILITY; DEFICIENCY CAUSES; ALPHA-APPENDAGE; COATED VESICLES; CLATHRIN; BINDING	The heterotetrameric (epsilon-beta 4-mu 4-sigma 4) complex adaptor protein 4 (AP-4) is a component of a non-clathrin coat involved in protein sorting at the trans-Golgi network (TGN). Considerable interest in this complex has arisen from the recent discovery that mutations in each of its four subunits are the cause of a congenital intellectual disability and movement disorder in humans. Despite its physiological importance, the structure and function of this coat remain poorly understood. To investigate the assembly of the AP-4 coat, we dissected the determinants of interaction of AP-4 with its only known accessory protein, the ENTH/VHS-domain-containing protein tepsin. Using a variety of protein interaction assays, we found that tepsin comprises two phylogenetically conserved peptide motifs, [GS] LFXG [ML] X[LV] and S[AV] F[SA] FLN, within its C-terminal unstructured region, which interact with the C-terminal ear (or appendage) domains of the beta 4 and epsilon subunits of AP-4, respectively. Structure-based mutational analyses mapped the binding site for the [GS] LFXG[ML] X[LV] motif to a conserved, hydrophobic surface on the beta 4-ear platform fold. Both peptide-ear interactions are required for efficient association of tepsin with AP-4, and for recruitment of tepsin to the TGN. The bivalency of the interactions increases the avidity of tepsin for AP-4 and may enable cross-linking of multiple AP-4 heterotetramers, thus contributing to the assembly of the AP-4 coat. In addition to revealing critical aspects of this coat, our findings extend the paradigm of peptide-ear interactions, previously established for clathrin-AP-1/AP-2 coats, to a non-clathrin coat.	[Mattera, Rafael; Guardia, Carlos M.; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto	Bonifacino, JS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bldg 35,Room 2F-226,35A Convent Dr,MSC 3758, Bethesda, MD 20892 USA.	bonifacinoj@helix.nih.gov	Guardia, Carlos M./ABC-8375-2020	Guardia, Carlos/0000-0002-4662-9360; Bonifacino, Juan S./0000-0002-5673-6370	Intramural Program of NICHD, National Institutes of Health [ZIA HD001607]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER	Intramural Program of NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Intramural Program of NICHD, National Institutes of Health (ZIA HD001607). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Bauer P, 2012, NEUROGENETICS, V13, P73, DOI 10.1007/s10048-012-0314-0; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Collins BM, 2003, NAT STRUCT BIOL, V10, P607, DOI 10.1038/nsb955; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Eletsky A, 2013, SOLUTION NMR STRUCTU; Hardies K, 2015, HUM MOL GENET, V24, P2218, DOI 10.1093/hmg/ddu740; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2014, ELIFE, V3, DOI 10.7554/eLife.02866; Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Jurgens MC, 2013, NAT CHEM BIOL, V9, P540, DOI [10.1038/NCHEMBIO.1294, 10.1038/nchembio.1294]; Kametaka S, 2007, MOL BIOL CELL, V18, P2991, DOI 10.1091/mbc.E06-12-1162; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Mardones GA, 2013, J BIOL CHEM, V288, P9563, DOI 10.1074/jbc.M113.450775; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Paczkowski JE, 2012, EMBO J, V31, P4191, DOI 10.1038/emboj.2012.268; Park SY, 2014, BIOSCI REP, V34; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Sen Arpita, 2012, Biomol Concepts, V3, P117; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Yap CC, 2003, MOL CELL NEUROSCI, V24, P283, DOI 10.1016/S1044-7431(03)00164-7	53	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30736	30749		10.1074/jbc.M115.683409	http://dx.doi.org/10.1074/jbc.M115.683409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542808	Green Published, hybrid			2022-12-28	WOS:000367199000008
J	Lee, HJ; Bao, J; Miller, A; Zhang, C; Wu, JB; Baday, YC; Guibao, C; Li, L; Wu, DQ; Zheng, JJ				Lee, Ho-Jin; Bao, Ju; Miller, Ami; Zhang, Chi; Wu, Jibo; Baday, Yiressy C.; Guibao, Cristina; Li, Lin; Wu, Dianqing; Zheng, Jie J.			Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; THERAPEUTIC TARGET; COLORECTAL-CANCER; LUNG-CANCER; PDZ DOMAIN; RECEPTOR; PATHWAY; PROTEIN; ACTIVATION; RECOGNITION	Frizzled is the earliest discovered glycosylated Wnt protein receptor and is critical for the initiation of Wnt signaling. Antagonizing Frizzled is effective in inhibiting the growth of multiple tumor types. The extracellular N terminus of Frizzled contains a conserved cysteine-rich domain that directly interacts with Wnt ligands. Structure-based virtual screening and cell-based assays were used to identify five small molecules that can inhibit canonical Wnt signaling and have low IC50 values in the micromolar range. NMR experiments confirmed that these compounds specifically bind to the Wnt binding site on the Frizzled8 cysteine-rich domain with submicromolar dissociation constants. Our study confirms the feasibility of targeting the Frizzled cysteine-rich domain as an effective way of regulating canonical Wnt signaling. These small molecules can be further optimized into more potent therapeutic agents for regulating abnormal Wnt signaling by targeting Frizzled.	[Lee, Ho-Jin; Bao, Ju; Miller, Ami; Zhang, Chi; Baday, Yiressy C.; Guibao, Cristina; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Zhang, Chi; Zheng, Jie J.] Univ Calif Los Angeles, Stein Eye Inst, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Wu, Jibo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wu, Jibo; Wu, Dianqing] Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06510 USA	St Jude Children's Research Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University	Zheng, JJ (corresponding author), Univ Calif Los Angeles, Stein Eye Inst, David Geffen Sch Med, Dept Ophthalmol, 100 Stein Plaza, Los Angeles, CA 90095 USA.	jzheng@jsei.ucla.edu	Lee, Ho-Jin/N-1973-2015; Wu, Jibo/AAV-7459-2021; Regan, Clinton/E-6250-2012; Lee, Ho-Jin/O-9944-2014	Lee, Ho-Jin/0000-0002-3251-4984; Zheng, Jie/0000-0001-6524-6800	National Institutes of Health [R01 GM081492, R01 GM100909]; Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [R25CA023944] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112182, R01GM100909, R01GM081492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by, in whole or in part, by the National Institutes of Health Grants R01 GM081492 and R01 GM100909 and by Research to Prevent Blindness. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02969; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bravo DT, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-316; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Holmen SL, 2005, BIOCHEM BIOPH RES CO, V328, P533, DOI 10.1016/j.bbrc.2005.01.009; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Koval AV, 2014, BIOCHEM PHARMACOL, V87, P571, DOI 10.1016/j.bcp.2013.12.007; Lee HJ, 2009, ANGEW CHEM INT EDIT, V48, P6448, DOI 10.1002/anie.200902981; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li XF, 2012, P NATL ACAD SCI USA, V109, P11402, DOI 10.1073/pnas.1205015109; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Rana R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3965; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ronchi A, 2010, INT J ONCOL, V37, P745, DOI 10.3892/ijo_00000724; Shan Jufang, 2012, Methods Mol Biol, V928, P17, DOI 10.1007/978-1-62703-008-3_2; Shan JF, 2012, CHEM BIOL DRUG DES, V79, P376, DOI 10.1111/j.1747-0285.2011.01295.x; Simmons GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098861; Smith AJ, 2015, J BIOMOL SCREEN, V20, P437, DOI 10.1177/1087057114562544; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Wang HQ, 2012, BIOCHEM BIOPH RES CO, V417, P62, DOI 10.1016/j.bbrc.2011.11.055; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wuthrich K, 2000, NAT STRUCT BIOL, V7, P188, DOI 10.1038/73278; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zimmerman ZF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008086	46	29	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30596	30606		10.1074/jbc.M115.673202	http://dx.doi.org/10.1074/jbc.M115.673202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26504084	Green Published, hybrid			2022-12-28	WOS:000366738200034
J	Yue, JC; Ben Messaoud, N; Lopez, JM				Yue, Jicheng; Ben Messaoud, Nabil; Lopez, Jose M.			Hyperosmotic Shock Engages Two Positive Feedback Loops through Caspase-3-dependent Proteolysis of JNK1-2 and Bid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; SIGNAL-TRANSDUCTION; DEPENDENT APOPTOSIS; POTASSIUM CHANNELS; CALPAIN INHIBITOR; CYTOCHROME-C; CLEAVAGE; PATHWAY; CASPASE; PROTEIN	Hyperosmotic shock induces early calpain activation, Smac/DIABLO release from the mitochondria, and p38/JNK activation in Xenopus oocytes. These pathways regulate late cytochrome c release and caspase-3 activation. Here, we show that JNK1-1 and JNK1-2 are activated early by osmostress, and sustained activation of both isoforms accelerates the apoptotic program. When caspase-3 is activated, JNK1-2 is proteolyzed at Asp-385 increasing the release of cytochrome c and caspase-3 activity, thereby creating a positive feedback loop. Expression of Bcl-x(L) markedly reduces hyperosmotic shock-induced apoptosis. In contrast, expression of Bid induces rapid caspase-3 activation, even in the absence of osmostress, which is blocked by Bcl-xL co-expression. In these conditions a significant amount of Bid in the cytosol is mono-and bi-ubiquitinated. Caspase-3 activation by hyperosmotic shock induces proteolysis of Bid and mono-ubiquitinated Bid at Asp-52 increasing the release of cytochrome c and caspase-3 activation, and thus creating a second positive feedback loop. Revealing the JNK isoforms and the loops activated by osmostress could help to design better treatments for human diseases caused by perturbations in fluid osmolarity.	[Yue, Jicheng; Ben Messaoud, Nabil; Lopez, Jose M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Unitat Bioquim,Fac Med, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M,Campus Bellaterra, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.cat	Lopez, Jose M/D-1654-2011	Lopez, Jose M/0000-0002-4104-6262	Spanish Ministerio de Economia y Competitividad [BFU2010-15978]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Spanish Ministerio de Economia y Competitividad Grant BFU2010-15978. The authors declare that they have no conflicts of interest with the contents of this article.	Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135249; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124482; Bhuyan AK, 2001, CELL DEATH DIFFER, V8, P63, DOI 10.1038/sj.cdd.4400773; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Desagher S., MOL CELL, V8, P601; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Enomoto A, 2003, BIOCHEM BIOPH RES CO, V306, P837, DOI 10.1016/S0006-291X(03)01050-7; Esposti MD, 2003, J BIOL CHEM, V278, P15749, DOI 10.1074/jbc.M209208200; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kominami K, 2006, GENES CELLS, V11, P701, DOI 10.1111/j.1365-2443.2006.00983.x; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Saitoh T., BIOCH BIOPHYS RES CO, V384, P491; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Thomas D, 2004, CARDIOVASC RES, V64, P467, DOI 10.1016/j.cardiores.2004.07.023; Thomas D, 2001, J PHARMACOL EXP THER, V297, P753; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	40	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30375	30389		10.1074/jbc.M115.660506	http://dx.doi.org/10.1074/jbc.M115.660506			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26511318	Green Published, hybrid			2022-12-28	WOS:000366738200016
J	Uchiyama, S; Kawahara, K; Hosokawa, Y; Fukakusa, S; Oki, H; Nakamura, S; Kojima, Y; Noda, M; Takino, R; Miyahara, Y; Maruno, T; Kobayashi, Y; Ohkubo, T; Fukui, K				Uchiyama, Susumu; Kawahara, Kazuki; Hosokawa, Yuki; Fukakusa, Shunsuke; Oki, Hiroya; Nakamura, Shota; Kojima, Yukiko; Noda, Masanori; Takino, Rie; Miyahara, Yuya; Maruno, Takahiro; Kobayashi, Yuji; Ohkubo, Tadayasu; Fukui, Kiichi			Structural Basis for Dimer Formation of Human Condensin Structural Maintenance of Chromosome Proteins and Its Implications for Single-stranded DNA Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HINGE DOMAIN; CRYSTAL-STRUCTURE; SMC; COHESIN; ARCHITECTURE; BINDING; DIMERIZATION; COMPLEXES	Eukaryotic structural maintenance of chromosome proteins (SMC) are major components of cohesin and condensins that regulate chromosome structure and dynamics during cell cycle. We here determine the crystal structure of human condensin SMC hinge heterodimer with similar to 30 residues of coiled coils. The structure, in conjunction with the hydrogen exchange mass spectrometry analyses, revealed the structural basis for the specific heterodimer formation of eukaryotic SMC and that the coiled coils from two different hinges protrude in the same direction, providing a unique binding surface conducive for binding to single-stranded DNA. The characteristic hydrogen exchange profiles of peptides constituted regions especially across the hinge-hinge dimerization interface, further suggesting the structural alterations upon single-stranded DNA binding and the presence of a half-opened state of hinge heterodimer. This structural change potentially relates to the DNA loading mechanism of SMC, in which the hinge domain functions as an entrance gate as previously proposed for cohesin. Our results, however, indicated that this is not the case for condensins based on the fact that the coiled coils are still interacting with each other, even when DNA binding induces structural changes in the hinge region, suggesting the functional differences of SMC hinge domain between condensins and cohesin in DNA recognition.	[Uchiyama, Susumu; Noda, Masanori; Takino, Rie; Miyahara, Yuya; Maruno, Takahiro; Kobayashi, Yuji; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Uchiyama, Susumu] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kawahara, Kazuki; Hosokawa, Yuki; Fukakusa, Shunsuke; Oki, Hiroya; Kojima, Yukiko; Ohkubo, Tadayasu] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Osaka University; Osaka University	Uchiyama, S (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	suchi@bio.eng.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010; UCHIYAMA, Susumu/F-9590-2017	Nakamura, Shota/0000-0003-2058-5942; UCHIYAMA, Susumu/0000-0002-5181-179X	Japanese Ministry of Education, Culture, Sports, Science, and Technology [18681032, 90335381, 25121722, 26102530]; Japan Society for the Promotion of Science Japanese-German Graduate Externship; Senri-Life Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Japanese-German Graduate Externship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Senri-Life Science Foundation	This work was supported by Grants-in-Aid 18681032, 90335381, 25121722, and 26102530 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to S. U.), the Japan Society for the Promotion of Science Japanese-German Graduate Externship (to S. U.), and the Senri-Life Science Foundation (to S. U.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akai Y, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110023; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barysz H, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150005; Buczek P, 2006, J MOL BIOL, V359, P1217, DOI 10.1016/j.jmb.2006.02.082; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Griese JJ, 2011, PROTEINS, V79, P558, DOI 10.1002/prot.22903; Griese JJ, 2010, NUCLEIC ACIDS RES, V38, P3454, DOI 10.1093/nar/gkq038; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawahara K, 2010, ACTA CRYSTALLOGR F, V66, P1067, DOI 10.1107/S1744309110028721; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Ku B, 2010, PROTEINS, V78, P1483, DOI 10.1002/prot.22664; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Li YY, 2010, J MOL BIOL, V395, P11, DOI 10.1016/j.jmb.2009.10.040; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ono T, 2013, J CELL BIOL, V200, P429, DOI 10.1083/jcb.201208008; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Poonperm R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11916; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Sutani T, 1997, NATURE, V388, P798, DOI 10.1038/42062; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	38	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29461	U428		10.1074/jbc.M115.670794	http://dx.doi.org/10.1074/jbc.M115.670794			28	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26491021	Green Published, hybrid			2022-12-28	WOS:000366613400030
J	Du, JH; Rountree, A; Cleghorn, WM; Contreras, L; Lindsay, KJ; Sadilek, M; Gu, HW; Djukovic, D; Raftery, D; Satrustegui, J; Kanow, M; Chan, L; Tsang, SH; Sweet, IR; Hurley, JB				Du, Jianhai; Rountree, Austin; Cleghorn, Whitney M.; Contreras, Laura; Lindsay, Ken J.; Sadilek, Martin; Gu, Haiwei; Djukovic, Danijel; Raftery, Dan; Satrustegui, Jorgina; Kanow, Mark; Chan, Lawrence; Tsang, Stephen H.; Sweet, Ian R.; Hurley, James B.			Phototransduction Influences Metabolic Flux and Nucleotide Metabolism in Mouse Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-CONSUMPTION; ASPARTATE-GLUTAMATE; MITOCHONDRIAL TRANSPORTER; CALCIUM-REGULATION; INNER RETINA; OUTER RETINA; LIGHT; ROD; VERTEBRATE; GLUCOSE	Production of energy in a cell must keep pace with demand. Photoreceptors use ATP to maintain ion gradients in darkness, whereas in light they use it to support phototransduction. Matching production with consumption can be accomplished by coupling production directly to consumption. Alternatively, production can be set by a signal that anticipates demand. In this report we investigate the hypothesis that signaling through phototransduction controls production of energy in mouse retinas. We found that respiration in mouse retinas is not coupled tightly to ATP consumption. By analyzing metabolic flux in mouse retinas, we also found that phototransduction slows metabolic flux through glycolysis and through intermediates of the citric acid cycle. We also evaluated the relative contributions of regulation of the activities of alpha-ketoglutarate dehydrogenase and the aspartate-glutamate carrier 1. In addition, a comprehensive analysis of the retinal metabolome showed that phototransduction also influences steady-state concentrations of 5'-GMP, ribose-5-phosphate, ketone bodies, and purines.	[Du, Jianhai; Cleghorn, Whitney M.; Lindsay, Ken J.; Kanow, Mark; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98109 USA; [Rountree, Austin; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98109 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98109 USA; [Gu, Haiwei; Djukovic, Danijel; Raftery, Dan] Univ Washington, Northwest Metabol Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98109 USA; [Du, Jianhai; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98109 USA; [Contreras, Laura; Satrustegui, Jorgina] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Mol Biol Severo Ochoa, Dept Mol Biol,CIBER Rare Dis CIBERER, E-28049 Madrid, Spain; [Contreras, Laura; Satrustegui, Jorgina] Autonomous Univ Madrid, Hlth Res Inst, Fdn Jimenez Diaz, E-28049 Madrid, Spain; [Chan, Lawrence; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA; [Chan, Lawrence; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Barbara & Donald Jonas Stem Cell Lab, New York, NY 10027 USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tsang, Stephen H.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Columbia University; Columbia University; Columbia University; Columbia University	Hurley, JB (corresponding author), Univ Washington, Dept Chem, UW Box 357350,1705 NE Pacific St, Seattle, WA 98195 USA.	jbhhh@uw.edu	Satrustegui, Jorgina/R-6732-2019; Contreras, Laura/ABG-7620-2021; Contreras, Laura/A-2296-2015	Contreras, Laura/0000-0003-1157-4942; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	National Institutes of Health [EY06641, EY017863, EY001730]; NATIONAL EYE INSTITUTE [P30EY001730, R01EY006641, F32EY006641, R01EY017863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY06641 and EY017863 (to J. B. H.) and EY001730 (NEI Center Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adler L, 2014, J BIOL CHEM, V289, P1519, DOI 10.1074/jbc.M113.511295; AHMED J, 1993, INVEST OPHTH VIS SCI, V34, P516; Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Becker MA, 2001, PROG NUCLEIC ACID RE, V69, P115, DOI 10.1016/S0079-6603(01)69046-9; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Chandel N. S., 2015, NAVIGATING METABOLIS, P49; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Contreras L, 2015, NEUROCHEM INT, V88, P38, DOI 10.1016/j.neuint.2015.04.001; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; Daiger SP, 2003, ADV EXP MED BIOL, V533, P1; DAWIS SM, 1989, BIOPHYS J, V55, P79, DOI 10.1016/S0006-3495(89)82782-1; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Du JH, 2015, METHOD ENZYMOL, V561, P149, DOI 10.1016/bs.mie.2015.04.002; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Gellerich FN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008181; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gu HW, 2015, ANALYST, V140, P2726, DOI 10.1039/c4an02386b; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Hurley JB, 2014, VERTEBRATE PHOTORECE, P91; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; KIMBLE EA, 1980, EXP EYE RES, V31, P271, DOI 10.1016/S0014-4835(80)80037-6; Krebs HA, 1927, BIOCHEM Z, V189, P57; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lau JCM, 2012, EXP EYE RES, V102, P50, DOI 10.1016/j.exer.2012.07.004; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; LINSENMEIER RA, 1986, J GEN PHYSIOL, V88, P521, DOI 10.1085/jgp.88.4.521; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; Llorente-Folch I, 2013, J NEUROSCI, V33, P13957, DOI 10.1523/JNEUROSCI.0929-13.2013; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Murgia M, 2015, CELL CALCIUM, V58, P11, DOI 10.1016/j.ceca.2014.11.001; MURPHY MP, 1988, EUR J BIOCHEM, V173, P637, DOI 10.1111/j.1432-1033.1988.tb14046.x; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Poitry S, 1996, J GEN PHYSIOL, V108, P75, DOI 10.1085/jgp.108.2.75; Ramos M, 2011, J NEUROSCI RES, V89, P2008, DOI 10.1002/jnr.22639; Satrustegui J, 2007, J NEUROSCI RES, V85, P3359, DOI 10.1002/jnr.21299; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Sickel W, 1972, Adv Exp Med Biol, V24, P101; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Tarboush R, 2012, TISSUE CELL, V44, P264, DOI 10.1016/j.tice.2012.04.004; Wang L, 1997, ACTA PHYSIOL SCAND, V160, P71, DOI 10.1046/j.1365-201X.1997.00203.x; Warburg O, 1924, BIOCHEM Z, V152, P309; WATTS RWE, 1983, ADV ENZYME REGUL, V21, P33, DOI 10.1016/0065-2571(83)90007-9; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zhao H, 2013, CHEM COMMUN, V49, P4444, DOI 10.1039/c3cc41437j; Zhu JJ, 2014, J PROTEOME RES, V13, P4120, DOI 10.1021/pr500494u; ZUCKERMAN R, 1980, EXP EYE RES, V30, P117, DOI 10.1016/0014-4835(80)90106-2	77	62	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4698	4710		10.1074/jbc.M115.698985	http://dx.doi.org/10.1074/jbc.M115.698985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26677218	Green Published, hybrid			2022-12-28	WOS:000371604600036
J	Lin, FY; Zhu, JH; Eng, ET; Hudson, NE; Springer, TA				Lin, Fu-Yang; Zhu, Jianghai; Eng, Edward T.; Hudson, Nathan E.; Springer, Timothy A.			beta-Subunit Binding Is Sufficient for Ligands to Open the Integrin alpha(IIb)beta(3) Headpiece	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-MOLECULAR-WEIGHT; PLATELET RECEPTOR; GAMMA-CHAIN; HUMAN-FIBRINOGEN; STRUCTURAL BASIS; RECOGNITION; COMPLEX; AFFINITY; PEPTIDE; SEGMENT	The platelet integrin alpha(IIb)beta(3) binds to a KQAGDV motif at the fibrinogen gamma-chain C terminus and to RGD motifs present in loops in many extracellular matrix proteins. These ligands bind in a groove between the integrin alpha and beta-subunits; the basic Lys or Arg side chain hydrogen bonds to the alpha(IIb)-subunit, and the acidic Asp side chain coordinates to a metal ion held by the beta(3)-subunit. Ligand binding induces headpiece opening, with conformational change in the beta-subunit. During this opening, RGDslides in the ligand-binding pocket toward alpha(IIb), with movement of the beta I-domain beta 1-alpha 1 loop toward alpha(IIb), enabling formation of direct, charged hydrogen bonds between the Arg side chain and alpha(IIb). Here we test whether ligand interactions with beta(3) suffice for stable ligand binding and headpiece opening. We find that the AGDV tetrapeptide from KQAGDV binds to the alpha(IIb)beta(3) headpiece with affinity comparable with the RGDSP peptide from fibronectin. AGDV induced complete headpiece opening in solution as shown by increase in hydrodynamic radius. Soaking of AGDV into closed alpha(IIb)beta(3) headpiece crystals induced intermediate states similarly to RGDSP. AGDV has very little contact with the alpha-subunit. Furthermore, as measured by epitope exposure, AGDV, like the fibrinogen gamma C-terminal peptide and RGD, caused integrin extension on the cell surface. Thus, pushing by the beta(3)-subunit on Asp is sufficient for headpiece opening and ligand sliding, and no pulling by the alpha(IIb) subunit on Arg is required.	[Lin, Fu-Yang; Zhu, Jianghai; Eng, Edward T.; Hudson, Nathan E.; Springer, Timothy A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA; [Eng, Edward T.] New York Struct Biol Ctr, New York, NY 10027 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu		Hudson, Nathan/0000-0003-0573-7661; Eng, Edward/0000-0002-8014-7269	NCI [ACB-12002]; NIGMS [AGM-12006]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526, R01HL131729] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff of the GM/CA beamline of the Advanced Photon Source (APS). GM/CA@APS has been funded in whole or in part with Federal funds from the NCI (ACB-12002) and the NIGMS (AGM-12006). This research used resources of the Advanced Photon Source, a U. S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract Number DE-AC02-06CH11357. We thank Dr. Paul B. Gillespie from Roche for providing Ro-435054. We also thank Drs. Xianchi Dong and Adem Koksal for collecting part of the x-ray diffraction data, and finally Dr. Jieqing Zhu for helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALIG L, 1992, J MED CHEM, V35, P4393, DOI 10.1021/jm00101a017; ANDRIEUX A, 1989, J BIOL CHEM, V264, P9258; Bednar RA, 1998, J PHARMACOL EXP THER, V285, P1317; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KLOCZEWIAK M, 1989, BIOCHEMISTRY-US, V28, P2915, DOI 10.1021/bi00433a025; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sanchez-Cortes J, 2009, CHEM BIOL, V16, P990, DOI 10.1016/j.chembiol.2009.08.012; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; STRONG DD, 1985, BIOCHEMISTRY-US, V24, P92, DOI 10.1021/bi00322a014; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	28	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4537	4546		10.1074/jbc.M115.705624	http://dx.doi.org/10.1074/jbc.M115.705624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26631735	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000371604600023
J	Patrone, M; Coroadinha, AS; Teixeira, AP; Alves, PM				Patrone, Marco; Coroadinha, Ana Sofia; Teixeira, Ana P.; Alves, Paula M.			Palmitoylation Strengthens Cholesterol- dependent Multimerization and Fusion Activity of Human Cytomegalovirus Glycoprotein B (gB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MEMBRANE; ENTRY; PROTEINS; CELLS; HERPESVIRUSES; INFECTION; TOOLS; RAFTS	Herpesviruses are a large order of animal enveloped viruses displaying a virion fusion mechanism of unusual complexity. Their multipartite machinery has a conserved core made of the gH/gL ancillary complexes and the homo-trimeric fusion protein glycoprotein B (gB). Despite its essential role in starting the viral infection, gB interaction with membrane lipids is still poorly understood. Here, evidence is provided demonstrating that human cytomegalovirus (HCMV) gB depends on the S-palmitoylation of its endodomain for an efficient interaction with cholesterol-rich membrane patches. We found that, unique among herpesviral gB proteins, the HCMV fusion factor has a Cys residue in the C-terminal region that is palmitoylated and mediates methyl-beta-cyclodextrin-sensitive self-association of purified gB. A cholesterol-dependent virus-like particle trap assay, based on co-expression of the HIV Gag protein, confirmed that this post-translational modification is functional in the context of cellular membranes. Mutation of the palmitoylated Cys residue to Ala or inhibition of protein palmitoylation decreased HCMV gB export via Gag particles. Moreover, purified gBC777A showed an increased kinetic sensitivity in a cholesterol depletion test, demonstrating that palmitoyl-gB limits outward cholesterol diffusion. Finally, gB palmitoylation was required for full fusogenic activity in human epithelial cells. Altogether, these results uncover the palmitoylation of HCMV gB and its role in gB multimerization and activity.	[Patrone, Marco; Coroadinha, Ana Sofia; Teixeira, Ana P.; Alves, Paula M.] iBET Inst Biol Expt & Tecnol, Anim Cell Technol Unit, P-2780901 Oeiras, Portugal; [Patrone, Marco] DIBIT Fdn Ctr San Raffaele, Biocrystallog Unit, I-20132 Milan, Italy; [Coroadinha, Ana Sofia; Teixeira, Ana P.; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2784505 Oeiras, Portugal	Universidade Nova de Lisboa	Patrone, M (corresponding author), DIBIT San Raffaele Sci Inst, Biocrystallog Unit, Div Immunol Transplantat & Infect Dis, Via Olgettina 58, I-20132 Milan, Italy.	patrone.marco@hsr.it	Patrone, Marco/M-5672-2013; Coroadinha, Ana/AAS-5733-2021; Alves, Paula M/C-1070-2008; Coroadinha, Ana/L-5693-2013; Palma Teixeira, Ana/F-5594-2011	Patrone, Marco/0000-0002-5164-2877; Alves, Paula M/0000-0003-1445-3556; Coroadinha, Ana/0000-0001-9728-6890; Palma Teixeira, Ana/0000-0002-9208-8737	European Union (EU) project ComplexINC [270089]; Marie Curie Postdoctoral Grant SHerpA [251982]; Fundacao para a Ciencia e a Tecnologia (FCT) [EXPL/BBB-BIO/1541/2013]	European Union (EU) project ComplexINC; Marie Curie Postdoctoral Grant SHerpA; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the European Union (EU) project ComplexINC FP7/2007-2013, Grant 270089 (to P. M. A.) and by Marie Curie Postdoctoral Grant SHerpA FP7-PEOPLE-2009-IEF Grant 251982 and Fundacao para a Ciencia e a Tecnologia (FCT) Grant EXPL/BBB-BIO/1541/2013 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Bentz J, 2000, BIOPHYS J, V78, P227, DOI 10.1016/S0006-3495(00)76587-8; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Carmo M, 2009, HUM GENE THER, V20, P1168, DOI 10.1089/hum.2009.068; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fulop T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00271; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heimburg T, 2003, MEMBR SCI T, V7, P269, DOI 10.1016/S0927-5193(03)80032-3; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Heldwein EE, 2009, STRUCTURE, V17, P147, DOI 10.1016/j.str.2009.01.003; Jarvis MA, 2002, J VIROL, V76, P5147, DOI 10.1128/JVI.76.10.5147-5155.2002; Key T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004023; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Mach M, 2007, J VIROL, V81, P5212, DOI 10.1128/JVI.01463-06; Maurer UE, 2013, STRUCTURE, V21, P1396, DOI 10.1016/j.str.2013.05.018; Patrone M, 2005, J VIROL, V79, P8361, DOI 10.1128/JVI.79.13.8361-8373.2005; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Patrone M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090753; Persaud-Sawin DA, 2009, J LIPID RES, V50, P759, DOI 10.1194/jlr.D800037-JLR200; Schindler J, 2006, PROTEOMICS, V6, P5409, DOI 10.1002/pmic.200600243; Sengupta D, 2015, BBA-BIOMEMBRANES, V1848, P1775, DOI 10.1016/j.bbamem.2015.03.018; Sharma S, 2013, VIROLOGY, V435, P239, DOI 10.1016/j.virol.2012.09.024; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Vanarsdall AL, 2012, CURR OPIN VIROL, V2, P37, DOI 10.1016/j.coviro.2012.01.001; Veit M, 2012, BIOL CELL, V104, P493, DOI 10.1111/boc.201200006; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Yang ST, 2015, NAT CHEM BIOL, V11, P424, DOI [10.1038/NCHEMBIO.1800, 10.1038/nchembio.1800]; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	40	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4711	4722		10.1074/jbc.M115.682252	http://dx.doi.org/10.1074/jbc.M115.682252			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694613	Green Published, hybrid			2022-12-28	WOS:000371604600037
J	Pszenny, V; Ehrenman, K; Romano, JD; Kennard, A; Schultz, A; Roos, DS; Grigg, ME; Carruthers, VB; Coppens, I				Pszenny, Viviana; Ehrenman, Karen; Romano, Julia D.; Kennard, Andrea; Schultz, Aric; Roos, David S.; Grigg, Michael E.; Carruthers, Vern B.; Coppens, Isabelle			A Lipolytic Lecithin:Cholesterol Acyltransferase Secreted by Toxoplasma Facilitates Parasite Replication and Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface enzyme; host-pathogen interaction; parasitology; Phospholipase A; Toxoplasma gondii	LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PHOSPHOLIPASE A(2); PLASMA LECITHIN; HOST-CELLS; DIACYLGLYCEROL ACYLTRANSFERASE; HEADGROUP SPECIFICITY; GONDII; PROTEIN; LYSOPHOSPHATIDYLCHOLINE; CLONING	The protozoan parasite Toxoplasma gondii develops within a parasitophorous vacuole (PV) in mammalian cells, where it scavenges cholesterol. When cholesterol is present in excess in its environment, the parasite expulses this lipid into the PV or esterifies it for storage in lipid bodies. Here, we characterized a unique T. gondii homologue of mammalian lecithin:cholesterol acyltransferase (LCAT), a key enzyme that produces cholesteryl esters via transfer of acyl groups from phospholipids to the 3-OH of free cholesterol, leading to the removal of excess cholesterol from tissues. TgLCAT contains a motif characteristic of serine lipases AHSLG and the catalytic triad consisting of serine, aspartate, and histidine (SDH) from LCAT enzymes. TgLCAT is secreted by the parasite, but unlike other LCAT enzymes it is cleaved into two proteolytic fragments that share the residues of the catalytic triad and need to be reassembled to reconstitute enzymatic activity. TgLCAT uses phosphatidylcholine as substrate to form lysophosphatidylcholine that has the potential to disrupt membranes. The released fatty acid is transferred to cholesterol, but with a lower transesterification activity than mammalian LCAT. TgLCAT is stored in a subpopulation of dense granule secretory organelles, and following secretion, it localizes to the PV and parasite plasma membrane. LCAT-null parasites have impaired growth in vitro, reduced virulence in animals, and exhibit delays in egress from host cells. Parasites overexpressing LCAT show increased virulence and faster egress. These observations demonstrate that TgLCAT influences the outcome of an infection, presumably by facilitating replication and egress depending on the developmental stage of the parasite.	[Pszenny, Viviana; Ehrenman, Karen; Romano, Julia D.; Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Pszenny, Viviana; Kennard, Andrea; Grigg, Michael E.] NIAID, Mol Parasitol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Schultz, Aric; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; University of Pennsylvania	Coppens, I (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	icoppens@jhsph.edu		Romano, Julia/0000-0001-8956-7377; Roos, David Siker/0000-0001-6725-4089; Kennard, Andrea/0000-0001-9419-3680	National Institutes of Health from NIAID [AI060767]; NIAID [AI001018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001018, ZIAAI001017, R01AI060767, R01AI046675] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI060767 from NIAID (to I. C.) and in part by the Intramural Research Program Grant AI001018 from NIAID (to M. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arisue N, 2015, PARASITOL INT, V64, P254, DOI 10.1016/j.parint.2014.10.005; ARON L, 1978, J BIOL CHEM, V253, P7220; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; BIERBAUM TJ, 1979, BIOCHIM BIOPHYS ACTA, V555, P102, DOI 10.1016/0005-2736(79)90075-0; Blackman MJ, 2013, CURR OPIN MICROBIOL, V16, P459, DOI 10.1016/j.mib.2013.04.008; Bougdour A, 2014, CELL MICROBIOL, V16, P334, DOI 10.1111/cmi.12255; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; Caffaro CE, 2011, EUKARYOT CELL, V10, P1095, DOI 10.1128/EC.00002-11; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; CHAWLA D, 1995, BIOCHEM J, V309, P249, DOI 10.1042/bj3090249; Christiaens B, 2000, BBA-MOL CELL BIOL L, V1486, P321, DOI 10.1016/S1388-1981(00)00075-5; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Corbin JD, 2002, INT J CLIN PRACT, V56, P453; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; deMelo EJT, 1996, CELL STRUCT FUNCT, V21, P47, DOI 10.1247/csf.21.47; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Ehrenman K, 2010, MOL MICROBIOL, V76, P1232, DOI 10.1111/j.1365-2958.2010.07169.x; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; FRANCONE OL, 1991, P NATL ACAD SCI USA, V88, P1716, DOI 10.1073/pnas.88.5.1716; GLOMSET JA, 1968, J LIPID RES, V9, P155; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; Hiraoka M, 2002, J BIOL CHEM, V277, P10090, DOI 10.1074/jbc.M111977200; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kabarowski JHS, 2002, BIOCHEM PHARMACOL, V64, P161, DOI 10.1016/S0006-2952(02)01179-6; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lige B, 2013, MOL MICROBIOL, V87, P951, DOI 10.1111/mmi.12142; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MARTIN GP, 1992, J PHARM PHARMACOL, V44, P646, DOI 10.1111/j.2042-7158.1992.tb05486.x; MARTIN I, 1993, FEBS LETT, V333, P325, DOI 10.1016/0014-5793(93)80680-S; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Mercier C, 2015, TRENDS PARASITOL, V31, P60, DOI 10.1016/j.pt.2014.12.002; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Nishikawa Y, 2005, CELL MICROBIOL, V7, P849, DOI 10.1111/j.1462-5822.2005.00518.x; Nissapatorn V, 2004, JPN J INFECT DIS, V57, P160; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Okada T, 2013, MOL BIOCHEM PARASIT, V189, P5, DOI 10.1016/j.molbiopara.2013.04.005; Peelman F, 1998, PROTEIN SCI, V7, P587, DOI 10.1002/pro.5560070307; POWNALL HJ, 1985, J BIOL CHEM, V260, P2146; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Roiko MS, 2013, J BIOL CHEM, V288, P8712, DOI 10.1074/jbc.M113.450932; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Saeedi R, 2015, CLIN BIOCHEM, V48, P472, DOI 10.1016/j.clinbiochem.2014.08.014; Safeukui I, 2012, BLOOD, V120, P424, DOI 10.1182/blood-2012-01-404103; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; SILVERMAN BA, 1984, J IMMUNOL, V132, P386; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Soldati D, 1995, MOL BIOCHEM PARASIT, V74, P87, DOI 10.1016/0166-6851(95)02487-5; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Striepen B, 2013, TOXOPLASMA GONDII MO, P408; dos Santos TAT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027867; Walzer KA, 2013, P NATL ACAD SCI USA, V110, P7446, DOI 10.1073/pnas.1304322110; Wang JC, 1997, J BIOL CHEM, V272, P280; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Yeoh LM, 2015, NUCLEIC ACIDS RES, V43, P4661, DOI 10.1093/nar/gkv311	73	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3725	3746		10.1074/jbc.M115.671974	http://dx.doi.org/10.1074/jbc.M115.671974			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694607	Green Published, hybrid			2022-12-28	WOS:000371338400004
J	Seebacher, NA; Lane, DJR; Jansson, PJ; Richardson, DR				Seebacher, Nicole A.; Lane, Darius J. R.; Jansson, Patric J.; Richardson, Des R.			Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug delivery; drug resistance; drug transport; endocytosis; glucose; lysosome; glucose-induced stress	CLATHRIN-MEDIATED ENDOCYTOSIS; MULTIDRUG-RESISTANCE; IRON CHELATORS; ANTITUMOR-ACTIVITY; REGULATED GENE-1; MEMBRANE PERMEABILIZATION; METASTASIS SUPPRESSOR; HIPPOCAMPAL-NEURONS; LANTHANUM COMPOUND; ENDOTHELIAL-CELLS	Pgp is functional on the plasma membrane and lysosomal membrane. Lysosomal-Pgp can pump substrates into the organelle, thereby trapping certain chemotherapeutics (e.g. doxorubicin; DOX). This mechanism serves as a safe house to protect cells against cytotoxic drugs. Interestingly, in contrast to DOX, lysosomal sequestration of the novel anti-tumor agent and P-glycoprotein (Pgp) substrate, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), induces lysosomal membrane permeabilization. This mechanism of lysosomal-Pgp utilization enhances cytotoxicity to multidrug-resistant cells. Consequently, Dp44mT has greater anti-tumor activity in drug-resistant relative to non-Pgp-expressing tumors. Interestingly, stressors in the tumor microenvironment trigger endocytosis for cell signaling to assist cell survival. Hence, this investigation examined how glucose variation-induced stress regulated early endosome and lysosome formation via endocytosis of the plasma membrane. Furthermore, the impact of glucose variation-induced stress on resistance to DOX was compared with Dp44mT and its structurally related analogue, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC). These studies showed that glucose variation-induced stress-stimulated formation of early endosomes and lysosomes. In fact, through the process of fluid-phase endocytosis, Pgp was redistributed from the plasma membrane to the lysosomal membrane via early endosome formation. This lysosomal-Pgp actively transported the Pgp substrate, DOX, into the lysosome where it became trapped as a result of protonation at pH 5. Due to increased lysosomal DOX trapping, Pgp-expressing cells became more resistant to DOX. In contrast, cytotoxicity of Dp44mT and DpC was potentiated due to more lysosomes containing functional Pgp under glucose-induced stress. These thiosemicarbazones increased lysosomal membrane permeabilization and cell death. This mechanism has critical implications for drug-targeting in multidrug-resistant tumors where a stressful micro-environment exists.	[Seebacher, Nicole A.; Lane, Darius J. R.; Jansson, Patric J.; Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia	University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Jansson, Patric/AAC-4221-2022	Jansson, Patric/0000-0002-9322-653X; Richardson, Des/0000-0003-0960-6415; Lane, Darius/0000-0001-8725-6903; Richardson, Des/0000-0002-5506-3274; Seebacher, Nicole/0000-0002-8616-8407	Tomorrow Fund Award from AMP Foundation; Sydney Medical School Foundation; Cancer Institute New South Wales Early Career Research Fellowship; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia (NHMRC); National Breast Cancer Foundation [PS-16-030] Funding Source: researchfish	Tomorrow Fund Award from AMP Foundation; Sydney Medical School Foundation; Cancer Institute New South Wales Early Career Research Fellowship; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	Supported by a Tomorrow Fund Award from the AMP Foundation and the Sydney Medical School Foundation for Fellowship support.; Supported by a Cancer Institute New South Wales Early Career Research Fellowship. To whom correspondence may be addressed. Tel.: 61-2-9351-6150; Fax: 61-2-9351-3429; E-mail: patric.jansson@sydney.edu.au.; Supported by a Senior Principal Research Fellowship and Project Grant funding from the National Health and Medical Research Council of Australia (NHMRC). To whom correspondence may be addressed. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: d.richardson@med.usyd.edu.au.	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; CANONICO PG, 1969, J CELL BIOL, V43, P367, DOI 10.1083/jcb.43.2.367; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; FISZERSZAFARZ B, 1977, CANCER RES, V37, P354; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; HAWKINS HK, 1972, AM J PATHOL, V68, P255; Heffeter P, 2007, BIOCHEM PHARMACOL, V73, P1873, DOI 10.1016/j.bcp.2007.03.002; Heffeter P, 2006, BIOCHEM PHARMACOL, V71, P426, DOI 10.1016/j.bcp.2005.11.009; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hua CT, 1998, CLIN CHEM, V44, P2094; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; JAFFREZOU JP, 1992, CANCER RES, V52, P6440; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jansson PJ, 2015, J BIOL CHEM, V290, P9588, DOI 10.1074/jbc.M114.631283; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; KARTNER N, 1989, SCI AM, V260, P44, DOI 10.1038/scientificamerican0389-44; Kawabata M, 1997, Rinsho Byori, V45, P891; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kwon Y, 1996, J PHARM SCI, V85, P935, DOI 10.1021/js9600540; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; Marambio P, 2010, BBA-MOL BASIS DIS, V1802, P509, DOI 10.1016/j.bbadis.2010.02.002; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; MORALES C, 1986, BIOL REPROD, V34, P207, DOI 10.1095/biolreprod34.1.207; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Neuzil J, 1999, FEBS LETT, V445, P295, DOI 10.1016/S0014-5793(99)00141-6; Niwa K, 2006, FREE RADICAL RES, V40, P167, DOI 10.1080/10715760500474287; OLLINGER K, 1995, FREE RADICAL BIO MED, V19, P565, DOI 10.1016/0891-5849(95)00062-3; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petriz J, 1997, LEUKEMIA, V11, P1124, DOI 10.1038/sj.leu.2400659; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Seebacher NA, 2015, BRIT J PHARMACOL, V172, P2557, DOI 10.1111/bph.13079; Sharom F. J., 2006, DRUG TRANSPORTERS, P223, DOI [10.1002/9780470140505, DOI 10.1002/9780470140505.CH10]; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shurety W, 1998, MOL BIOL CELL, V9, P957, DOI 10.1091/mbc.9.4.957; Smit JW, 1998, BRIT J PHARMACOL, V123, P361, DOI 10.1038/sj.bjp.0701606; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; SOROKIN LM, 1987, J CELL PHYSIOL, V131, P342, DOI 10.1002/jcp.1041310306; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; SUNDQVIST T, 1993, ACTA PHYSIOL SCAND, V149, P127, DOI 10.1111/j.1748-1716.1993.tb09604.x; THILO L, 1995, J CELL SCI, V108, P1791; TWENTYMAN PR, 1994, EUR J CANCER, V30A, P1360, DOI 10.1016/0959-8049(94)90187-2; Vega VL, 2010, CELL STRESS CHAPERON, V15, P517, DOI 10.1007/s12192-009-0165-2; Wang JB, 2014, ONCOTARGET, V5, P8478, DOI 10.18632/oncotarget.2328; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Wek RC, 2010, EMBO J, V29, P1946, DOI 10.1038/emboj.2010.110; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Xie J, 2013, ONCOL LETT, V6, P232, DOI 10.3892/ol.2013.1321; Yamagishi Tetsuo, 2013, J Biol Chem, V288, P31761, DOI 10.1074/jbc.M113.514091; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484	81	45	44	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3796	3820		10.1074/jbc.M115.682450	http://dx.doi.org/10.1074/jbc.M115.682450			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26601947	Green Published, hybrid			2022-12-28	WOS:000371338400011
J	Yu, W; Denu, RA; Krautkramer, KA; Grindle, KM; Yang, DT; Asimakopoulos, F; Hematti, P; Denu, JM				Yu, Wei; Denu, Ryan A.; Krautkramer, Kimberly A.; Grindle, Kreg M.; Yang, David T.; Asimakopoulos, Fotis; Hematti, Peiman; Denu, John M.			Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; cancer; cell proliferation; superoxide dismutase (SOD); Warburg effect; B cell; ROS; isocitrate dehydrogenase; sirtuins	CHRONIC LYMPHOCYTIC-LEUKEMIA; CALORIE RESTRICTION; ISOCITRATE DEHYDROGENASE; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASE; PROTEIN EXPRESSION; OXIDATIVE DAMAGE; CANCER; SUPPRESSOR; STRESS	B cell malignancies comprise a diverse group of cancers that proliferate in lymph nodes, bone marrow, and peripheral blood. SIRT3 (sirtuin 3) is the major deacetylase within the mitochondrial matrix that promotes aerobic metabolism and controls reactive oxygen species (ROS) by deacetylating and activating isocitrate dehydrogenase 2 (IDH2) and superoxide dismutase 2 (SOD2). There is controversy as to whether SIRT3 acts as an oncogene or a tumor suppressor, and here we investigated its role in B cell malignancies. In mantle cell lymphoma patient samples, we found that lower SIRT3 protein expression was associated with worse overall survival. Further, SIRT3 protein expression was reduced in chronic lymphocytic leukemia primary samples and malignant B cell lines compared to primary B cells from healthy donors. This lower level of expression correlated with hyperacetylation of IDH2 and SOD2 mitochondrial proteins, lowered enzymatic activities, and higher ROS levels. Overexpression of SIRT3 decreased proliferation and diminished the Warburg-like phenotype in SIRT3-deficient cell lines, and this effect is largely dependent on deacetylation of IDH2 and SOD2. Lastly, depletion of SIRT3 from malignant B cell lines resulted in greater susceptibility to treatment with an ROS scavenger but did not result in greater sensitivity to inhibition of the hypoxia-inducible factor-1 pathway, suggesting that loss of SIRT3 increases proliferation via ROS-dependent but hypoxia-inducible factor-1-independent mechanisms. Our study suggests that SIRT3 acts as a tumor suppressor in B cell malignancies, and activating the SIRT3 pathway might represent a novel therapeutic approach for treating B cell malignancies.	[Yu, Wei; Krautkramer, Kimberly A.; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Yu, Wei; Krautkramer, Kimberly A.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Denu, Ryan A.; Krautkramer, Kimberly A.] Univ Wisconsin, Med Scientist Training Program, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Denu, Ryan A.; Grindle, Kreg M.; Asimakopoulos, Fotis; Hematti, Peiman] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Yang, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Asimakopoulos, Fotis; Hematti, Peiman; Denu, John M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hematti, P (corresponding author), Univ Wisconsin, 4033 WIMR,1111 Highland Ave, Madison, WI 53705 USA.; Denu, JM (corresponding author), Univ Wisconsin, 2178 WID,330 N Orchard St, Madison, WI 53715 USA.	pxh@medicine.wisc.edu; jmdenu@wisc.edu	Krautkramer, Kimberly/AAR-7014-2020	Krautkramer, Kimberly/0000-0002-9227-0977; YU, WEI/0000-0001-9898-4607	University of Wisconsin Carbone Cancer Center; University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, TL1TR000429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038679] Funding Source: NIH RePORTER	University of Wisconsin Carbone Cancer Center; University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Special thanks to the Forward Lymphoma Group at the University of Wisconsin-Madison. We thank the University of Wisconsin Carbone Cancer Center for funding to complete this project and the University of Wisconsin Translational Research Initiatives in Pathology Laboratory, in part supported by the University of Wisconsin Department of Pathology and Laboratory Medicine and University of Wisconsin Carbone Cancer Center Grant P30 CA014520, for use of its facilities and services.	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Keating Michael J, 2003, Hematology Am Soc Hematol Educ Program, P153, DOI 10.1182/asheducation-2003.1.153; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lilienthal N, 2011, LEUKEMIA LYMPHOMA, V52, P1407, DOI 10.3109/10428194.2011.568077; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu CY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/871263; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miyamoto S, 2001, INT J ONCOL, V18, P705; Oberley MJ, 2013, HISTOPATHOLOGY, V63, P499, DOI 10.1111/his.12207; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Schedel J, 2004, ANN RHEUM DIS, V63, P1205, DOI 10.1136/ard.2003.006312; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Van Damme M, 2012, EPIGENETICS-US, V7, P1403, DOI 10.4161/epi.22674; Wang JC, 2011, ONCOLOGY-BASEL, V81, P325, DOI 10.1159/000334577; Wang JX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-297; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yan SM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0103-8; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V423, P26, DOI 10.1016/j.bbrc.2012.05.053; Zwiebel JA, 1998, SEMIN ONCOL, V25, P42	49	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3268	3279		10.1074/jbc.M115.702076	http://dx.doi.org/10.1074/jbc.M115.702076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26631723	Green Published, hybrid			2022-12-28	WOS:000370854500013
J	Adhikary, S; Sanyal, S; Basu, M; Sengupta, I; Sen, S; Srivastava, DK; Roy, S; Das, C				Adhikary, Santanu; Sanyal, Sulagna; Basu, Moitri; Sengupta, Isha; Sen, Sabyasachi; Srivastava, Dushyant Kumar; Roy, Siddhartha; Das, Chandrima			Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; HISTONE MODIFICATIONS; METHYLATION STATES; H4K16 ACETYLATION; LYSINE 36; PROTEIN; DEACETYLASE; EXPRESSION; NURD; DIFFERENTIATION	ZMYND8 (zinc finger MYND (Myeloid, Nervy and DEAF-1)-type containing 8), a newly identified component of the transcriptional coregulator network, was found to interact with the Nucleosome Remodeling and Deacetylase (NuRD) complex. Previous reports have shown that ZMYND8 is instrumental in recruiting the NuRD complex to damaged chromatin for repressing transcription and promoting double strand break repair by homologous recombination. However, the mode of transcription regulation by ZMYND8 has remained elusive. Here, we report that through its specific key residues present in its conserved chromatin-binding modules, ZMYND8 interacts with the selective epigenetic marks H3.1K36Me2/H4K16Ac. Furthermore, ZMYND8 shows a clear preference for canonical histone H3.1 over variant H3.3. Interestingly, ZMYND8 was found to be recruited to several developmental genes, including the all-trans-retinoic acid (ATRA)responsive ones, through its modified histone-binding ability. Being itself inducible by ATRA, this zinc finger transcription factor is involved in modulating other ATRA-inducible genes. We found that ZMYND8 interacts with transcription initiation-competent RNA polymerase II phosphorylated at Ser-5 in a DNA template-dependent manner and can alter the global gene transcription. Overall, our study identifies that ZMYND8 has CHD4-independent functions in regulating gene expression through its modified histone-binding ability.	[Adhikary, Santanu; Sanyal, Sulagna; Basu, Moitri; Sengupta, Isha; Sen, Sabyasachi; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India; [Adhikary, Santanu; Srivastava, Dushyant Kumar; Roy, Siddhartha] Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.; Roy, S (corresponding author), Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	roysiddhartha@iicb.res.in; chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021		Biomolecular Assembly, Recognition and Dynamics Project from the Department of Atomic Energy [12-RD-SIN-5.04-0103]; Ramalingaswami Fellowship, Department of Biotechnology, Government of India; Department of Biotechnology; Indian Council of Scientific and Medical Research, Government of India; Department of Science and Technology	Biomolecular Assembly, Recognition and Dynamics Project from the Department of Atomic Energy; Ramalingaswami Fellowship, Department of Biotechnology, Government of India; Department of Biotechnology; Indian Council of Scientific and Medical Research, Government of India; Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by research grants from Biomolecular Assembly, Recognition and Dynamics Project, Grant 12-R&D-SIN-5.04-0103 from the Department of Atomic Energy, and a Ramalingaswami Fellowship, Department of Biotechnology, Government of India to C. D. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of fellowships from Department of Biotechnology and Indian Council of Scientific and Medical Research, Government of India.; Recipient of Indian Council of Scientific and Industrial Research Network Project (UNSEEN) and Ramanujan Fellowship from Department of Science and Technology. To whom correspondence may be addressed: Tel.: 91-33-2499-5733; Fax: 91-33-2473-5197; E-mail: roysiddhartha@iicb.res.in.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bierkens M, 2013, GENE CHROMOSOME CANC, V52, P56, DOI 10.1002/gcc.22006; Chakrabarti S, 2001, BIOPOLYMERS, V56, P85, DOI 10.1002/1097-0282(2000)56:2<85::AID-BIP1054>3.0.CO;2-7; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091793; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Das C, 2014, P NATL ACAD SCI USA, V111, pE1072, DOI 10.1073/pnas.1319122111; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; Fang HB, 2010, NEUROREPORT, V21, P19, DOI 10.1097/WNR.0b013e3283315aec; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gersten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103292; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; Horikoshi Nobuo, 2013, Genome Integr, V4, P3, DOI 10.1186/2041-9414-4-3; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kawamura K, 2007, BIOL REPROD, V76, P611, DOI 10.1095/biolreprod.106.058008; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Larive RM, 2012, MOL BIOL CELL, V23, P2373, DOI 10.1091/mbc.E12-01-0060; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Li YQ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.582; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nishibuchi G, 2014, J BIOL CHEM, V289, P28956, DOI 10.1074/jbc.M114.573725; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Poloni A, 2015, J MOL NEUROSCI, V55, P91, DOI 10.1007/s12031-014-0345-0; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Singh A, 2011, CANCER-AM CANCER SOC, V117, P5189, DOI 10.1002/cncr.26145; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Wernicke C, 2010, PHARMACOL REP, V62, P649, DOI 10.1016/S1734-1140(10)70322-4; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	60	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2664	2681		10.1074/jbc.M115.679985	http://dx.doi.org/10.1074/jbc.M115.679985			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26655721	hybrid, Green Published			2022-12-28	WOS:000369626900011
J	Maklashina, E; Rajagukguk, S; Starbird, CA; McDonald, WH; Koganitsky, A; Eisenbach, M; Iverson, TM; Cecchini, G				Maklashina, Elena; Rajagukguk, Sany; Starbird, Chrystal A.; McDonald, W. Hayes; Koganitsky, Anna; Eisenbach, Michael; Iverson, Tina M.; Cecchini, Gary			Binding of the Covalent Flavin Assembly Factor to the Flavoprotein Subunit of Complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOL-FUMARATE REDUCTASE; L-ASPARTATE OXIDASE; SUCCINATE-DEHYDROGENASE; ESCHERICHIA-COLI; WOLINELLA-SUCCINOGENES; CRYSTAL-STRUCTURE; ACTIVE-SITE; PROTEIN; FLAVINYLATION; ATTACHMENT	Escherichia coli harbors two highly conserved homologs of the essential mitochondrial respiratory complex II (succinate: ubiquinone oxidoreductase). Aerobically the bacterium synthesizes succinate: quinone reductase as part of its respiratory chain, whereas under microaerophilic conditions, the quinol: fumarate reductase can be utilized. All complex II enzymes harbor a covalently bound FAD co-factor that is essential for their ability to oxidize succinate. In eukaryotes and many bacteria, assembly of the covalent flavin linkage is facilitated by a small protein assembly factor, termed SdhE in E. coli. How SdhE assists with formation of the covalent flavin bond and how it binds the flavoprotein subunit of complex II remain unknown. Using photo-cross-linking, we report the interaction site between the flavoprotein of complex II and the SdhE assembly factor. These data indicate that SdhE binds to the flavoprotein between two independently folded domains and that this binding mode likely influences the interdomain orientation. In so doing, SdhE likely orients amino acid residues near the dicarboxylate and FAD binding site, which facilitates formation of the covalent flavin linkage. These studies identify how the conserved SdhE assembly factor and its homologs participate in complex II maturation.	[Maklashina, Elena; Rajagukguk, Sany; Cecchini, Gary] Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Starbird, Chrystal A.] Vanderbilt Univ, Grad Program Chem & Phys Biol, 221 Kirkland Hall, Nashville, TN 37232 USA; [McDonald, W. Hayes; Iverson, Tina M.] Vanderbilt Univ, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA; [McDonald, W. Hayes; Iverson, Tina M.] Vanderbilt Univ, Mass Spectrometry Res Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Dept Pharmacol, 221 Kirkland Hall, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, 221 Kirkland Hall, Nashville, TN 37232 USA; [Koganitsky, Anna; Eisenbach, Michael] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Weizmann Institute of Science	Cecchini, G (corresponding author), VA Med Ctr, Mol Biol 151 S, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu	; McDonald, W. Hayes/B-4109-2016	Eisenbach, Michael/0000-0001-9048-4720; McDonald, W. Hayes/0000-0002-3510-426X	National Institutes of Health [GM61606, 5T32GM008320]; Department of Veterans Affairs Merit Award [BX001077]; Vanderbilt Core Grant in Vision Research [P30EY008126]; U.S.-Israel Binational Science Foundation [BSF 2009161]; National Science Foundation [DGE: 0909667]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, R01GM061606, T32GM008320] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Vanderbilt Core Grant in Vision Research; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant GM61606, Department of Veterans Affairs Merit Award BX001077, Vanderbilt Core Grant in Vision Research P30EY008126, and U.S.-Israel Binational Science Foundation grant BSF 2009161. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Graduate Fellowship DGE: 0909667 and National Institutes of Health Training Grant 5T32GM008320.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLAUT M, 1989, J BIOL CHEM, V264, P13599; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; BRANDSCH R, 1991, J BIOL CHEM, V266, P19056; BRANDSCH R, 1989, EUR J BIOCHEM, V182, P125, DOI 10.1111/j.1432-1033.1989.tb14808.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2013, HANDBOOK OF FLAVOPROTEINS: COMPLEX FLAVOPROTEINS, DEHYDROGENASES AND PHYSICAL METHODS, VOL 2, P141; Cohen-Ben-Lulu GN, 2008, EMBO J, V27, P1134, DOI 10.1038/emboj.2008.48; Cunane LM, 2005, BIOCHEMISTRY-US, V44, P2963, DOI 10.1021/bi048020r; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 2012, J BIOL CHEM, V287, P35430, DOI 10.1074/jbc.R112.408419; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iverson TM, 2000, CURR OPIN STRUC BIOL, V10, P448, DOI 10.1016/S0959-440X(00)00113-5; KEARNEY EB, 1960, J BIOL CHEM, V235, P865; Kim J, 1995, J BIOL CHEM, V270, P31202, DOI 10.1074/jbc.270.52.31202; Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3; Kounosu A, 2014, FEBS LETT, V588, P1058, DOI 10.1016/j.febslet.2014.02.022; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Lancaster CRD, 2001, EUR J BIOCHEM, V268, P1820, DOI 10.1046/j.1432-1327.2001.02053.x; Lancia JK, 2014, BIOPOLYMERS, V101, P391, DOI 10.1002/bip.22395; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P1877, DOI 10.1016/j.bbabio.2010.02.015; Masuda H, 2012, FEMS MICROBIOL LETT, V328, P174, DOI 10.1111/j.1574-6968.2012.02496.x; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; McNeil MB, 2013, BIOCHEMISTRY-US, V52, P7628, DOI 10.1021/bi401006a; McNeil MB, 2013, BBA-BIOENERGETICS, V1827, P637, DOI 10.1016/j.bbabio.2012.09.003; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Melin F, 2014, CHEMPHYSCHEM, V15, P3572, DOI 10.1002/cphc.201402354; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Na U, 2014, CELL METAB, V20, P253, DOI 10.1016/j.cmet.2014.05.014; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Robinson KM, 1996, J BIOL CHEM, V271, P4061; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; WOOD D, 1984, BIOCHEM J, V222, P519, DOI 10.1042/bj2220519; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	59	13	15	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2904	2916		10.1074/jbc.M115.690396	http://dx.doi.org/10.1074/jbc.M115.690396			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644464	hybrid, Green Published			2022-12-28	WOS:000369626900028
J	Sethi, D; Mahajan, S; Singh, C; Lama, A; Nadel, MD; Gupta, P; Dikshit, KL				Sethi, Deepti; Mahajan, Sahil; Singh, Chaahat; Lama, Amrita; Nadel, Mangesh Dattu; Gupta, Pawan; Dikshit, Kanak L.			Lipoprotein LprI of Mycobacterium tuberculosis Acts as a Lysozyme Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; TRUNCATED HEMOGLOBIN; MULTIDRUG-RESISTANCE; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; STRUCTURAL BASIS; OXYGEN-BINDING; NITRIC-OXIDE; CELL-LINES; MACROPHAGES	Mycobacterium tuberculosis executes numerous defense strategies for the successful establishment of infection under a diverse array of challenges inside the host. One such strategy that has been delineated in this study is the abrogation of lytic activity of lysozyme by a novel glycosylated and surface-localized lipoprotein, LprI, which is exclusively present in M. tuberculosis complex. The lprI gene co-transcribes with the glbNgene (encoding hemoglobin (HbN)) and both are synchronously up-regulated in M. tuberculosis during macrophage infection. Recombinant LprI, expressed in Escherichia coli, exhibited strong binding (K-d <= 2 nM) with lysozyme and abrogated its lytic activity completely, thereby conferring protection to fluorescein-labeled Micrococcus lysodeikticus from lysozyme-mediated hydrolysis. Expression of the lprI gene in Mycobacterium smegmatis (8-10-fold) protected its growth from lysozyme inhibition in vitro and enhanced its phagocytosis and survival during intracellular infection of peritoneal and monocyte-derived macrophages, known to secrete lysozyme, and in the presence of exogenously added lysozyme in secondary cell lines where lysozyme levels are low. In contrast, the presence of HbN enhanced phagocytosis and intracellular survival of M. smegmatis only in the absence of lysozyme but not under lysozyme stress. Interestingly, co-expression of the glbN-lprI gene pair elevated the invasion and survival of M. smegmatis 2-3-fold in secondary cell lines in the presence of lysozyme in comparison with isogenic cells expressing these genes individually. Thus, specific advantage against macrophage-generated lysozyme, conferred by the combination of LprI-HbN during invasion of M. tuberculosis, may have vital implications on the pathogenesis of tuberculosis.	[Sethi, Deepti; Mahajan, Sahil; Singh, Chaahat; Lama, Amrita; Nadel, Mangesh Dattu; Gupta, Pawan; Dikshit, Kanak L.] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Dikshit, KL (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	kanak@irntech.res.in	Hade, Mangesh/ABD-8535-2021; Hade, Mangesh/AAF-7217-2019	Hade, Mangesh/0000-0002-5937-9049; Gupta, Pawan/0000-0001-6692-7237	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology; Indian Council of Medical Research, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported in part by the Council of Scientific and Industrial Research (CSIR). The authors declare that they have no conflict of interest.; Supported by Department of Science and Technology, CSIR, and Indian Council of Medical Research, Government of India research fellowships.	Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Arya S, 2013, J BIOL CHEM, V288, P29987, DOI 10.1074/jbc.M113.507301; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; Bartels KM, 2011, J BACTERIOL, V193, P1107, DOI 10.1128/JB.01507-10; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Callewaert L, 2012, TRENDS MICROBIOL, V20, P501, DOI 10.1016/j.tim.2012.06.005; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Chaturvedi V, 2007, J GEN APPL MICROBIOL, V53, P333, DOI 10.2323/jgam.53.333; COHN ZA, 1963, J EXP MED, V118, P991, DOI 10.1084/jem.118.6.991; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Daigle F, 2001, MOL MICROBIOL, V41, P1211, DOI 10.1046/j.1365-2958.2001.02593.x; Dajani R, 2005, AM J RESP CELL MOL, V32, P548, DOI 10.1165/rcmb.2005-0059OC; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Dubnau E, 2005, INFECT IMMUN, V73, P3754, DOI 10.1128/IAI.73.6.3754-3757.2005; Espitia C, 2010, MOL BIOSYST, V6, P775, DOI 10.1039/b916394h; Farrow MF, 2008, J BACTERIOL, V190, P1783, DOI 10.1128/JB.01046-07; GARBE T, 1993, INFECT IMMUN, V61, P260, DOI 10.1128/IAI.61.1.260-267.1993; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; HANEBERG B, 1984, J LEUKOCYTE BIOL, V35, P573; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Helal R, 2008, PHARMAZIE, V63, P415, DOI 10.1691/ph.2008.7846; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanetsuna F., 1980, MICROBIOL IMMUNOL, V24; KASUKABE T, 1979, BIOCHIM BIOPHYS ACTA, V586, P615, DOI 10.1016/0304-4165(79)90052-7; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; KLOCKARS M, 1979, ARCH INTERN MED, V139, P73, DOI 10.1001/archinte.139.1.73; Kopacek P, 1999, INSECT BIOCHEM MOLEC, V29, P989, DOI 10.1016/S0965-1748(99)00075-2; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu CF, 2013, P NATL ACAD SCI USA, V110, P6560, DOI 10.1073/pnas.1219704110; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Martin A, 2007, J ANTIMICROB CHEMOTH, V59, P175, DOI 10.1093/jac/dkl477; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; MYRVIK QN, 1953, AM REV TUBERC PULM, V67, P217; NEAR KA, 1992, J CLIN MICROBIOL, V30, P1105, DOI 10.1128/JCM.30.5.1105-1110.1992; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Severin A, 2007, J BACTERIOL, V189, P1514, DOI 10.1128/JB.01132-06; Smith J B, 1991, J Clin Lab Immunol, V35, P147; SORBER WA, 1973, INFECT IMMUN, V7, P86, DOI 10.1128/IAI.7.1.86-92.1973; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Torrelles JB, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P77; Um SH, 2013, BIOCHEMISTRY-US, V52, P9385, DOI 10.1021/bi401241c; Vanderkelen L, 2011, CELL MOL LIFE SCI, V68, P1053, DOI 10.1007/s00018-010-0507-3; Voet A, 2011, BIOCHEM BIOPH RES CO, V405, P527, DOI 10.1016/j.bbrc.2011.01.053; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	62	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2938	2953		10.1074/jbc.M115.662593	http://dx.doi.org/10.1074/jbc.M115.662593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26589796	Green Published, hybrid			2022-12-28	WOS:000369626900031
J	Grimsey, NJ; Coronel, LJ; Cordova, IC; Trejo, J				Grimsey, Neil J.; Coronel, Luisa J.; Cordova, Isabel Canto; Trejo, JoAnn			Recycling and Endosomal Sorting of Protease-activated Receptor-1 Is Distinctly Regulated by Rab11A and Rab11B Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELL INVASION; COUPLED RECEPTOR; INTRACELLULAR TRAFFICKING; THROMBIN RECEPTORS; EPITHELIAL-CELLS; DOWN-REGULATION; TP-BETA; PHOSPHORYLATION; INTERNALIZATION; RESENSITIZATION	Protease-activated receptor-1 (PAR1) is a G protein-coupled receptor that undergoes proteolytic irreversible activation by coagulant and anti-coagulant proteases. Given the irreversible activation of PAR1, signaling by the receptor is tightly regulated through desensitization and intracellular trafficking. PAR1 displays both constitutive and agonist-induced internalization. Constitutive internalization of PAR1 is important for generating an internal pool of naive receptors that replenish the cell surface and facilitate resensitization, whereas agonist-induced internalization of PAR1 is critical for terminating G protein signaling. We showed that PAR1 constitutive internalization is mediated by the adaptor protein complex-2 (AP-2), whereas AP-2 and epsin control agonist-induced PAR1 internalization. However, the mechanisms that regulate PAR1 recycling are not known. In the present study we screened a siRNA library of 140 different membrane trafficking proteins to identify key regulators of PAR1 intracellular trafficking. In addition to known mediators of PAR1 endocytosis, we identified Rab11B as a critical regulator of PAR1 trafficking. We found that siRNA-mediated depletion of Rab11B and not Rab11A blocks PAR1 recycling, which enhanced receptor lysosomal degradation. Although Rab11A is not required for PAR1 recycling, depletion of Rab11A resulted in intracellular accumulation of PAR1 through disruption of basal lysosomal degradation of the receptor. Moreover, enhanced degradation of PAR1 observed in Rab11B-deficient cells is blocked by depletion of Rab11A and the autophagy related-5 protein, suggesting that PAR1 is shuttled to an autophagic degradation pathway in the absence of Rab11B recycling. Together these findings suggest that Rab11A and Rab11B differentially regulate intracellular trafficking of PAR1 through distinct endosomal sorting mechanisms.	[Grimsey, Neil J.; Coronel, Luisa J.; Cordova, Isabel Canto; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Orlando, Luisa/0000-0002-3177-5242; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [R01 GM090689]; American Heart Association; University of California Tobacco-related Disease Research Program Dissertation Award; Initiative for Maximizing Student Development at University of California, San Diego, La Jolla, CA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of California Tobacco-related Disease Research Program Dissertation Award; Initiative for Maximizing Student Development at University of California, San Diego, La Jolla, CA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090689 (to J. T.) The authors declare they have no conflict of interest with the contents of this article.r Supported by an American Heart Association Postdoctoral Fellowship Award.r Supported by University of California Tobacco-related Disease Research Program Dissertation Award.r Supported by the Initiative for Maximizing Student Development at University of California, San Diego, La Jolla, CA.	Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Bowman SL, 2015, PROG MOL BIOL TRANSL, V132, P189, DOI 10.1016/bs.pmbts.2015.03.005; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Canto I, 2012, MINI-REV MED CHEM, V12, P804, DOI 10.2174/138955712800959116; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Ellis CA, 1999, AM J PHYSIOL-CELL PH, V276, pC38, DOI 10.1152/ajpcell.1999.276.1.C38; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Lapierre LA, 2003, EXP CELL RES, V290, P322, DOI 10.1016/S0014-4827(03)00340-9; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Scapin SMN, 2006, J STRUCT BIOL, V154, P260, DOI 10.1016/j.jsb.2006.01.007; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Theriault C, 2004, BIOCHEMISTRY-US, V43, P5600, DOI 10.1021/bi036268v; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	46	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2223	2236		10.1074/jbc.M115.702993	http://dx.doi.org/10.1074/jbc.M115.702993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26635365	Green Published, hybrid			2022-12-28	WOS:000369610400014
J	Realini, N; Palese, F; Pizzirani, D; Pontis, S; Basit, A; Bach, A; Ganesan, A; Piomelli, D				Realini, Natalia; Palese, Francesca; Pizzirani, Daniela; Pontis, Silvia; Basit, Abdul; Bach, Anders; Ganesan, Anand; Piomelli, Daniele			Acid Ceramidase in Melanoma EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TUMOR-GROWTH; SYNTHASE ACTIVITY; COLON-CANCER; CELLS; THERAPY; SPHINGOLIPIDS; RESISTANCE; APOPTOSIS; TARGET	Acid ceramidase (AC) is a lysosomal cysteine amidase that controls sphingolipid signaling by lowering the levels of ceramides and concomitantly increasing those of sphingosine and its bioactive metabolite, sphingosine 1-phosphate. In the present study, we evaluated the role of AC-regulated sphingolipid signaling in melanoma. We found that AC expression is markedly elevated in normal human melanocytes and proliferative melanoma cell lines, compared with other skin cells (keratinocytes and fibroblasts) and non-melanoma cancer cells. High AC expression was also observed in biopsies from human subjects with Stage II melanoma. Immunofluorescence studies revealed that the subcellular localization of AC differs between melanocytes (where it is found in both cytosol and nucleus) and melanoma cells (where it is primarily localized to cytosol). In addition to having high AC levels, melanoma cells generate lower amounts of ceramides than normal melanocytes do. This down-regulation in ceramide production appears to result from suppression of the de novo biosynthesis pathway. To test whether AC might contribute to melanoma cell proliferation, we blocked AC activity using a new potent (IC50 = 12 nM) and stable inhibitor. AC inhibition increased cellular ceramide levels, decreased sphingosine 1-phosphate levels, and acted synergistically with several, albeit not all, antitumoral agents. The results suggest that AC-controlled sphingolipid metabolism may play an important role in the control of melanoma proliferation.	[Realini, Natalia; Palese, Francesca; Pizzirani, Daniela; Pontis, Silvia; Basit, Abdul; Bach, Anders; Piomelli, Daniele] Fdn Ist Italiano Tecnol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Bach, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Ganesan, Anand] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92617 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92617 USA	Istituto Italiano di Tecnologia - IIT; University of Copenhagen; University of California System; University of California Irvine; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, 3101 Gillespie NRF, Irvine, CA 92697 USA.	piomelli@uci.edu	Basit, Abdul/H-9903-2019	Basit, Abdul/0000-0002-1164-5520; Palese, Francesca/0000-0002-8426-8228; Bach, Anders/0000-0003-4305-9910	NCI NIH HHS [P30 CA062203, R01 CA151513] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA151513, P30CA062203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Basit A, 2015, ANAL BIOANAL CHEM, V407, P5189, DOI 10.1007/s00216-015-8585-6; Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; Bedia C, 2008, CHEM PHYS LIPIDS, V156, P33, DOI 10.1016/j.chemphyslip.2008.07.012; Camacho L, 2013, J LIPID RES, V54, P1207, DOI 10.1194/jlr.M032375; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Feng LX, 2014, INT J MOL SCI, V15, P4201, DOI 10.3390/ijms15034201; Flowers M, 2012, BREAST CANCER RES TR, V133, P447, DOI 10.1007/s10549-011-1768-8; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Halder K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091656; Han WS, 2002, J DERMATOL SCI, V30, P10, DOI 10.1016/S0923-1811(02)00044-0; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Leon F, 2008, CHEM BIODIVERS, V5, P120, DOI 10.1002/cbdv.200890002; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu YS, 2010, J PROTEOME RES, V9, P6044, DOI 10.1021/pr100856k; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Musumarra G, 2003, BIOL CHEM, V384, P321, DOI 10.1515/BC.2003.037; O'Connell MP, 2013, J INVEST DERMATOL, V133, P2316, DOI 10.1038/jid.2013.208; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pizzirani D, 2015, ANGEW CHEM INT EDIT, V54, P485, DOI 10.1002/anie.201409042; Pizzirani D, 2013, J MED CHEM, V56, P3518, DOI 10.1021/jm301879g; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Raisova M, 2000, FEBS LETT, V473, P27, DOI 10.1016/S0014-5793(00)01491-5; Realini N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01035; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Saied EM, 2014, CELL PHYSIOL BIOCHEM, V34, P197, DOI 10.1159/000362995; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Selzner M, 2001, CANCER RES, V61, P1233; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Wang CN, 2010, J HISTOCHEM CYTOCHEM, V58, P611, DOI 10.1369/jhc.2010.954842; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Widmer DS, 2015, EXP DERMATOL, V24, P659, DOI 10.1111/exd.12757; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Yu T, 2010, CANCER CHEMOTH PHARM, V66, P999, DOI 10.1007/s00280-010-1374-1	56	60	64	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2422	2434		10.1074/jbc.M115.666909	http://dx.doi.org/10.1074/jbc.M115.666909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26553872	Green Published, hybrid			2022-12-28	WOS:000369610400031
J	Ando, R; Shima, H; Tamahara, T; Sato, Y; Watanabe-Matsui, M; Kato, H; Sax, N; Motohashi, H; Taguchi, K; Yamamoto, M; Nio, M; Maeda, T; Ochiai, K; Muto, A; Igarashi, K				Ando, Ryo; Shima, Hiroki; Tamahara, Toru; Sato, Yoshihiro; Watanabe-Matsui, Miki; Kato, Hiroki; Sax, Nicolas; Motohashi, Hozumi; Taguchi, Keiko; Yamamoto, Masayuki; Nio, Masaki; Maeda, Tatsuya; Ochiai, Kyoko; Muto, Akihiko; Igarashi, Kazuhiko			The Transcription Factor Bach2 Is Phosphorylated at Multiple Sites in Murine B Cells but a Single Site Prevents Its Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; GENOME-WIDE ASSOCIATION; GENE REGULATORY NETWORK; ANTIBODY CLASS SWITCH; REPRESSOR BACH2; SUSCEPTIBILITY LOCI; HEME OXYGENASE-1; T-CELLS; FACTOR BLIMP-1; RISK LOCI	The transcription factor Bach2 regulates the immune system at multiple points, including class switch recombination (CSR) in activated B cells and the function of T cells in part by restricting their terminal differentiation. However, the regulation of Bach2 expression and its activity in the immune cells are still unclear. Here, we demonstrated that Bach2 mRNA expression decreased in Pten-deficient primary B cells. Bach2 was phosphorylated in primary B cells, which was increased upon the activation of the B cell receptor by an anti-immunoglobulin M (IgM) antibody or CD40 ligand. Using specific inhibitors of kinases, the phosphorylation of Bach2 in activated B cells was shown to depend on the phosphatidylinositol 3-kinase (PI3K)Akt-mammalian target of rapamycin (mTOR) pathway. The complex of mTOR and Raptor phosphorylated Bach2 in vitro. We identified multiple new phosphorylation sites of Bach2 by mass spectrometry analysis of epitope-tagged Bach2 expressed in the mature B cell line BAL17. Among the sites identified, serine 535 (Ser-535) was critical for the regulation of Bach2 because a single mutation of Ser-535 abolished cytoplasmic accumulation of Bach2, promoting its nuclear accumulation in pre-B cells, whereas Ser-509 played an auxiliary role. Bach2 repressor activity was enhanced by the Ser-535 mutation in B cells. These results suggest that the PI3K-Akt-mTOR pathway inhibits Bach2 by both repressing its expression and inducing its phosphorylation in B cells.	[Ando, Ryo; Shima, Hiroki; Tamahara, Toru; Sato, Yoshihiro; Watanabe-Matsui, Miki; Kato, Hiroki; Sax, Nicolas; Ochiai, Kyoko; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Ando, Ryo; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Taguchi, Keiko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Motohashi, Hozumi] Tohoku Univ, Dept Gene Express Regulat, Inst Dev Aging & Canc, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan; [Ochiai, Kyoko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Tamahara, Toru] Tohoku Univ, Grad Sch Dent, Dept Prevent Dent, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan; [Shima, Hiroki; Tamahara, Toru; Sax, Nicolas; Ochiai, Kyoko; Muto, Akihiko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Maeda, Tatsuya] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane Proteins, 1-1-1 Yayoi, Tokyo 1130032, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); University of Tokyo	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Maeda, Tatsuya/L-5540-2019; Yamamoto, Masayuki/A-4873-2010; Nio, Masaki/AAF-4406-2019	Yamamoto, Masayuki/0000-0002-9073-9436; Igarashi, Kazuhiko/0000-0002-2470-2475; Taguchi, Keiko/0000-0002-5798-0076; Sato, Yoshihiro/0000-0003-3722-6815	Japan Society for the Promotion of Science [15H02506, 25670156, 24390066, 23116003, 21249014, 17054028, 25291042]; Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science; Grants-in-Aid for Scientific Research [15H04692, 16J40189] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H02506, 25670156, 24390066, 23116003, 21249014, 17054028, and 25291042 from the Japan Society for the Promotion of Science and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Baretic D, 2014, SEMIN CELL DEV BIOL, V36, P91, DOI 10.1016/j.semcdb.2014.09.024; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoshino H, 2000, J BIOL CHEM, V275, P15370, DOI 10.1074/jbc.275.20.15370; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Li HYS, 2014, IMMUNOL REV, V261, P84, DOI 10.1111/imr.12198; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; McAllister K, 2013, ARTHRITIS RHEUM-US, V65, P3058, DOI 10.1002/art.38183; Medici M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004123; Mizuno T, 2005, J IMMUNOL, V174, P3369, DOI 10.4049/jimmunol.174.6.3369; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nishi H, 2015, J MOL BIOL, V427, P511, DOI 10.1016/j.jmb.2014.11.001; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Watanabe-Matsui M, 2015, ARCH BIOCHEM BIOPHYS, V565, P25, DOI 10.1016/j.abb.2014.11.005; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yoshida C, 2007, BLOOD, V109, P1211, DOI 10.1182/blood-2005-12-040972; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	55	22	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1826	1840		10.1074/jbc.M115.661702	http://dx.doi.org/10.1074/jbc.M115.661702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620562	hybrid, Green Published			2022-12-28	WOS:000368620700023
J	Isasa, M; Suner, C; Diaz, M; Puig-Sarries, P; Zuin, A; Bichman, A; Gygi, SP; Rebollo, E; Crosas, B				Isasa, Marta; Suner, Clara; Diaz, Miguel; Puig-Sarries, Pilar; Zuin, Alice; Bichman, Anne; Gygi, Steven P.; Rebollo, Elena; Crosas, Bernat			Cold Temperature Induces the Reprogramming of Proteolytic Pathways in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; SACCHAROMYCES-CEREVISIAE; UBIQUITIN-LIGASE; MASS-SPECTROMETRY; PROTEIN-TURNOVER; 26S PROTEASOME; MEMBRANE-PROTEINS; DEGRADATION; ENDOCYTOSIS; PROTEOMICS	Despite much evidence of the involvement of the proteasome-ubiquitin signaling system in temperature stress response, the dynamics of the ubiquitylome during cold response has not yet been studied. Here, we have compared quantitative ubiquitylomes from a strain deficient in proteasome substrate recruitment and a reference strain during cold response. We have observed that a large group of proteins showing increased ubiquitylation in the proteasome mutant at low temperature is comprised by reverses suppressor of Ty-phenotype 5 (Rsp5)-regulated plasma membrane proteins. Analysis of internalization and degradation of plasma membrane proteins at low temperature showed that the proteasome becomes determinant for this process, whereas, at 30 degrees C, the proteasome is dispensable. Moreover, our observations indicate that proteasomes have increased capacity to interact with lysine 63-polyubiquitylated proteins during low temperature in vivo. These unanticipated observations indicate that, during cold response, there is a proteolytic cellular reprogramming in which the proteasome acquires a role in the endocytic-vacuolar pathway.	[Isasa, Marta; Suner, Clara; Diaz, Miguel; Puig-Sarries, Pilar; Zuin, Alice; Bichman, Anne; Rebollo, Elena; Crosas, Bernat] Consejo Super lnvest Cient, Inst Biol Mol Barcelona, Barcelona Sci Pk,Baldiri & Reixac 15-21, Barcelona 08028, Spain; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Harvard University; Harvard Medical School	Crosas, B (corresponding author), Consejo Super lnvest Cient, Inst Biol Mol Barcelona, Barcelona Sci Pk,Baldiri & Reixac 15-21, Barcelona 08028, Spain.	bernat.crosas@ibmb.csic.es		Suner Navarro, Clara/0000-0003-2581-8864; Rebollo, Elena/0000-0001-8899-0317	Spanish Government (Ministry of Economy and Competitiveness) [BFU2009-06985, BFU2012-35716]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009SGR-1482, FI-DGR 2013]; European Molecular Biology Organization [ASTF 363.00-2010]	Spanish Government (Ministry of Economy and Competitiveness); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by Spanish Government (Ministry of Economy and Competitiveness) Grants BFU2009-06985 and BFU2012-35716, Agencia de Gestio d'Ajuts Universitaris i de Recerca Grants 2009SGR-1482 and FI-DGR 2013, and European Molecular Biology Organization Fellowship ASTF 363.00-2010. The authors declare no conflict of interest.	Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Brachmann CB, 1998, YEAST, V14, P115; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lambertson D, 1999, GENETICS, V153, P69; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Walther D, 2010, OMICS, V14, P261, DOI 10.1089/omi.2010.0010; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	45	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1664	1675		10.1074/jbc.M115.698662	http://dx.doi.org/10.1074/jbc.M115.698662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601941	hybrid, Green Published			2022-12-28	WOS:000368620700011
J	Jain, D; Narayanan, N; Nair, DT				Jain, Deepti; Narayanan, Naveen; Nair, Deepak T.			Plasticity in Repressor-DNA Interactions Neutralizes Loss of Symmetry in Bipartite Operators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINOSE METABOLISM; PROTEIN-DNA; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; RESPONSE ELEMENT; BINDING DOMAIN; ARAR; TRANSCRIPTION; RECOGNITION; COMPLEX	Transcription factor-DNA interactions are central to gene regulation. Many transcription factors regulate multiple target genes and can bind sequences that do not conform strictly to the consensus. To understand the structural mechanism utilized by the transcription regulators to bind diverse target sequences, we have employed the repressor AraR from Bacillus subtilis as a model system. AraR is known to bind to eight different operator sites in the bacterial genome. Although there are differences in the sequences of four of these operators, ORE1, ORX1, ORA1, and ORR3, the AraR-DNA binding domain (AraR-DBD) as well as full-length AraR unexpectedly binds to each of these sequences with similar affinities as measured by fluorescence anisotropy experiments. We have determined crystal structures of AraR-DBD in complex with two different natural operators ORE1 and ORX1 up to 2.07 and 1.97 angstrom resolution, respectively. These structures were compared with the previously reported structures of AraR-DBD bound to two other natural operators (ORA1 and ORR3). Interactions of two molecules of AraR-DBD with the symmetric operator, ORE1, are identical, but their interaction with the non-symmetric operator ORX1 results in breakdown of the symmetry in protein-DNA interactions. The novel interactions observed are accompanied by local conformational change in the DNA. ChIP-sequencing (ChIP-Seq) data on other transcription factors has shown that they can bind to diverse targets, and hence the plasticity exhibited by AraR may be a general phenomenon. The ability of transcription factors to form alternate interactions may be important for employment in new functions and evolution of novel regulatory circuits.	[Jain, Deepti] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Transcript Regulat Lab, 3rd Milestone,Faridabad Gurgaon Expressway, Faridabad 121001, India; [Narayanan, Naveen; Nair, Deepak T.] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Genom Integr & Plast Lab, Faridabad 121001, India; [Jain, Deepti; Narayanan, Naveen; Nair, Deepak T.] Natl Ctr Biol Sci NCBS TIFR, Bangalore 560065, Karnataka, India; [Narayanan, Naveen] Manipal Univ, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Manipal Academy of Higher Education (MAHE)	Jain, D (corresponding author), NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Transcript Regulat Lab, 3rd Milestone,Faridabad Gurgaon Expressway, Faridabad 121001, India.	deepti@rcb.res.in	Nair, Deepak T/AAR-5234-2020	Nair, Deepak/0000-0002-0677-9444; Jain, Deepti/0000-0002-8631-7230	Department of Biotechnology (Government of India); European Molecular Biology Laboratory (EMBL); ESRF	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); European Molecular Biology Laboratory (EMBL); ESRF	We acknowledge the help rendered by Dr. Hassan Belrhali (European Synchrotron Radiation Facility (ESRF)) and Dr. Babu Manjashetty during data collection at the BM-14 beamline of ESRF. Data collection at the BM14 beamline of ESRF (Grenoble, France) was funded by the BM14 project, a collaboration between Department of Biotechnology (Government of India), European Molecular Biology Laboratory (EMBL), and ESRF.	Abe N, 2015, CELL, V161, P307, DOI 10.1016/j.cell.2015.02.008; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Bonocora RP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-254; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 2000, STRUCT FOLD DES, V8, P419, DOI 10.1016/S0969-2126(00)00123-4; Correia IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111802; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franco IS, 2007, NUCLEIC ACIDS RES, V35, P4755, DOI 10.1093/nar/gkm509; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Jain D, 2015, IUBMB LIFE, V67, P556, DOI 10.1002/iub.1401; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kim JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1311-0; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mota LJ, 2001, J BACTERIOL, V183, P4190, DOI 10.1128/JB.183.14.4190-4201.2001; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prochazkova K, 2012, ACTA CRYSTALLOGR D, V68, P176, DOI 10.1107/S090744491105414X; Raposo MP, 2004, J BACTERIOL, V186, P1287, DOI 10.1128/JB.186.5.1287-1296.2004; RODGERS DW, 1993, STRUCTURE, V1, P227, DOI 10.1016/0969-2126(93)90012-6; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; SaNogueira I, 1997, J BACTERIOL, V179, P1598, DOI 10.1128/jb.179.5.1598-1608.1997; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; SCHWABE JWR, 1995, STRUCTURE, V3, P201, DOI 10.1016/S0969-2126(01)00150-2; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Stringer AM, 2014, J BACTERIOL, V196, P660, DOI 10.1128/JB.01007-13; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; ZHAO NY, 1994, J BACTERIOL, V176, P2393, DOI 10.1128/JB.176.8.2393-2397.1994	41	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1235	1242		10.1074/jbc.M115.689695	http://dx.doi.org/10.1074/jbc.M115.689695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26511320	Green Published, hybrid			2022-12-28	WOS:000368068300019
J	Ryan, ZC; Craig, TA; Folmes, CD; Wang, XW; Lanza, IR; Schaible, NS; Salisbury, JL; Nair, KS; Terzic, A; Sieck, GC; Kumar, R				Ryan, Zachary C.; Craig, Theodore A.; Folmes, Clifford D.; Wang, Xuewei; Lanza, Ian R.; Schaible, Niccole S.; Salisbury, Jeffrey L.; Nair, K. Sreekumaran; Terzic, Andre; Sieck, Gary C.; Kumar, Rajiv			1 alpha,25-Dihydroxyvitamin D-3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; PYRUVATE-DEHYDROGENASE PHOSPHATASE; ANALYSIS PIPELINE; GENE-EXPRESSION; RNA; MORPHOLOGY; DISEASE; CALCITRIOL; SEQUENCES; COMPLEX	Muscle weakness and myopathy are observed in vitamin D deficiency and chronic renal failure, where concentrations of the active vitamin D-3 metabolite, 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3), are low. To evaluate the mechanism of action of 1 alpha,25(OH)(2)D-3 in skeletal muscle, we examined mitochondrial oxygen consumption, dynamics, and biogenesis and changes in expression of nuclear genes encoding mitochondrial proteins in human skeletal muscle cells following treatment with 1 alpha,25(OH)(2)D-3. The mitochondrial oxygen consumption rate (OCR) increased in 1 alpha,25(OH)(2)D-3-treated cells. Vitamin D-3 metabolites lacking a 1 alpha-hydroxyl group (vitamin D-3, 25-hydroxyvitamin D-3, and 24R, 25-dihydroxyvitamin D-3) decreased or failed to increase OCR. 1 alpha-Hydroxyvitamin D-3 did not increase OCR. In 1 alpha,25(OH)(2)D-3-treated cells, mitochondrial volume and branching and expression of the pro-fusion protein OPA1 (optic atrophy 1) increased, whereas expression of the pro-fission proteins Fis1 (fission 1) and Drp1 (dynamin 1-like) decreased. Phosphorylated pyruvate dehydrogenase (PDH) (Ser-293) and PDH kinase 4 (PDK4) decreased in 1 alpha,25 (OH)(2)D-3-treated cells. There was a trend to increased PDH activity in 1 alpha,25(OH)(2)D-3-treated cells (p = 0.09). 83 nuclear mRNAs encoding mitochondrial proteins were changed following 1 alpha,25(OH)(2)D-3 treatment; notably, PDK4 mRNA decreased, and PDP2 mRNA increased. MYC, MAPK13, and EPAS1 mRNAs, which encode proteins that regulate mitochondrial biogenesis, were increased following 1 alpha,25(OH)(2)D-3 treatment. Vitamin D receptor-dependent changes in the expression of 1947 mRNAs encoding proteins involved in muscle contraction, focal adhesion, integrin, JAK/STAT, MAPK, growth factor, and p53 signaling pathways were observed following 1 alpha,25(OH)(2)D-3 treatment. Five micro-RNAs were induced or repressed by 1 alpha,25(OH)(2)D-3. 1 alpha,25(OH)(2)D-3 regulates mitochondrial function, dynamics, and enzyme function, which are likely to influence muscle strength.	[Ryan, Zachary C.; Craig, Theodore A.; Folmes, Clifford D.; Lanza, Ian R.; Nair, K. Sreekumaran; Terzic, Andre; Kumar, Rajiv] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; [Wang, Xuewei] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Schaible, Niccole S.; Sieck, Gary C.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Salisbury, Jeffrey L.; Kumar, Rajiv] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kumar, R (corresponding author), Mayo Clin, MS 1-120,200 First St SW, Rochester, MN 55905 USA.	rkumar@mayo.edu		Kumar, Rajiv/0000-0003-3497-3057; Salisbury, Jeffrey/0000-0001-9257-4578; Wang, Xuewei/0000-0003-3679-7421; Lanza, Ian/0000-0002-9858-3384; Folmes, Clifford/0000-0002-3683-9970; sieck, gary/0000-0003-3040-9424	National Institutes of Health [HL126451, DK066013, AG009531]; Mayo Clinic Grant [CCATS UL1TR000135]; Leducq Foundation; Mayo Clinic Center for Regenerative Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121079, R01HL126451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066013, U01DK066013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Grant; Leducq Foundation(Leducq Foundation); Mayo Clinic Center for Regenerative Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants HL126451 (to G.C.S.), HL126451 (to C.D.L.F.), DK066013 (to R.K.), and AG009531 (to K.S.N.), Mayo Clinic Grant CCATS UL1TR000135, the Leducq Foundation, and the Mayo Clinic Center for Regenerative Medicine. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aravamudan B, 2014, AM J PHYSIOL-LUNG C, V306, pL840, DOI 10.1152/ajplung.00155.2013; BIRGE SJ, 1975, J CLIN INVEST, V56, P1100, DOI 10.1172/JCI108184; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265; Buitrago CG, 2006, J CELL BIOCHEM, V97, P698, DOI 10.1002/jcb.20639; Buitrago CG, 2012, J CELL BIOCHEM, V113, P1170, DOI 10.1002/jcb.23444; Ceglia L, 2013, J CLIN ENDOCR METAB, V98, pE1927, DOI 10.1210/jc.2013-2820; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Craig TA, 2014, ZEBRAFISH, V11, P207, DOI 10.1089/zeb.2013.0899; Craig TA, 2012, MOL ENDOCRINOL, V26, P1630, DOI 10.1210/me.2012-1113; DEBOLAND AR, 1983, BIOCHIM BIOPHYS ACTA, V733, P264, DOI 10.1016/0005-2736(83)90531-X; DEBOLAND AR, 1984, Z NATURFORSCH C, V39, P1015; Delmotte P, 2015, CAN J PHYSIOL PHARM, V93, P97, DOI 10.1139/cjpp-2014-0361; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Domanski M., 2012, J AGING RES, V2012; Dukas L, 2004, J AM GERIATR SOC, V52, P230, DOI 10.1111/j.1532-5415.2004.52060.x; Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Folmes CDL, 2013, CELL CYCLE, V12, P2355, DOI 10.4161/cc.25509; Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389; Frier BC, 2011, AM J PHYSIOL-REG I, V300, pR212, DOI 10.1152/ajpregu.00367.2010; Gallagher JC, 2007, J STEROID BIOCHEM, V103, P610, DOI 10.1016/j.jsbmb.2006.12.082; Gallagher JC, 2004, J STEROID BIOCHEM, V89-90, P497, DOI 10.1016/j.jsbmb.2004.03.059; Girgis CM, 2014, ENDOCRINOLOGY, V155, P3227, DOI 10.1210/en.2014-1016; Girgis CM, 2014, ENDOCRINOLOGY, V155, P347, DOI 10.1210/en.2013-1205; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kao SH, 2015, INVEST OPHTH VIS SCI, V56, P2269, DOI 10.1167/iovs.14-16288; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KUMAR R, 1994, AM J PHYSIOL, V266, pF477, DOI 10.1152/ajprenal.1994.266.3.F477; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanza IR, 2011, J MAGN RESON IMAGING, V34, P1143, DOI 10.1002/jmri.22733; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lee IK, 2014, DIABETES METAB J, V38, P181, DOI 10.4093/dmj.2014.38.3.181; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; PRINEAS JW, 1965, BMJ-BRIT MED J, V1, P1034, DOI 10.1136/bmj.1.5441.1034; REVELLE L, 1984, BIOCHEMISTRY-US, V23, P1983, DOI 10.1021/bi00304a016; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sakai S, 2015, J BONE MINER RES, V30, P128, DOI 10.1002/jbmr.2317; SCHOTT GD, 1976, LANCET, V1, P626, DOI 10.1016/S0140-6736(76)90428-1; Sinha A, 2013, J CLIN ENDOCR METAB, V98, pE509, DOI 10.1210/jc.2012-3592; Srikuea R, 2012, AM J PHYSIOL-CELL PH, V303, pC396, DOI 10.1152/ajpcell.00014.2012; Sugden MC, 2001, DIABETES, V50, P2729, DOI 10.2337/diabetes.50.12.2729; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Sukhorukov VM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002745; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Tanaka M, 2014, MUSCLE NERVE, V49, P700, DOI 10.1002/mus.23950; Thomas GW, 2009, J TRAUMA, V67, P628, DOI 10.1097/TA.0b013e3181a8b415; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109; WASSERMAN RH, 1992, GASTROENTEROLOGY, V102, P886, DOI 10.1016/0016-5085(92)90174-W	80	121	128	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1514	1528		10.1074/jbc.M115.684399	http://dx.doi.org/10.1074/jbc.M115.684399			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601949	hybrid, Green Published			2022-12-28	WOS:000368068300041
J	Yuan, YY; Hakimi, P; Kao, C; Kao, A; Liu, RF; Janocha, A; Boyd-Tressler, A; Hang, X; Alhoraibi, H; Slater, E; Xia, K; Cao, PX; Shue, Q; Ching, TT; Hsu, AL; Erzurum, SC; Dubyak, GR; Berger, NA; Hanson, RW; Feng, ZY				Yuan, Yiyuan; Hakimi, Parvin; Kao, Clara; Kao, Allison; Liu, Ruifu; Janocha, Allison; Boyd-Tressler, Andrea; Hang, Xi; Alhoraibi, Hanna; Slater, Erin; Xia, Kevin; Cao, Pengxiu; Shue, Quinn; Ching, Tsui-Ting; Hsu, Ao-Lin; Erzurum, Serpil C.; Dubyak, George R.; Berger, Nathan A.; Hanson, Richard W.; Feng, Zhaoyang			Reciprocal Changes in Phosphoenolpyruvate Carboxykinase and Pyruvate Kinase with Age Are a Determinant of Aging in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EXTENDS LIFE-SPAN; DIETARY RESTRICTION; CALORIE RESTRICTION; IN-VIVO; ENERGY-METABOLISM; PHYSICAL-ACTIVITY; GENE-EXPRESSION; C-ELEGANS; LONGEVITY	Aging involves progressive loss of cellular function and integrity, presumably caused by accumulated stochastic damage to cells. Alterations in energy metabolism contribute to aging, but how energy metabolism changes with age, how these changes affect aging, and whether they can be modified to modulate aging remain unclear. In locomotory muscle of post-fertile Caenorhabditis elegans, weidentified a progressive decrease in cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C), a longevity-associated metabolic enzyme, and a reciprocal increase in glycolytic pyruvate kinase (PK) that were necessary and sufficient to limit lifespan. Decline in PEPCK-C with age also led to loss of cellular function and integrity including muscle activity, and cell ularsenescence. Genetic and pharmacologic interventions of PEPCK-C, muscle activity, and AMPK signaling demonstrate that declines in PEPCK-C and muscle function with age interacted to limit reproductive life and lifespan via disrupted energy homeostasis. Quantifications of metabolic flux show that reciprocal changes in PEPCK-Cand PK with age shunted energy metabolism toward glycolysis, reducing mitochondrial bioenergetics. Last, calorie restriction countered changes in PEPCK-C and PK with age to elicit antiaging effects via TOR inhibition. Thus, a programmed metabolic event involving PEPCK-Cand PK is a determinan to faging that can be modified to modulate aging.	[Yuan, Yiyuan; Kao, Clara; Kao, Allison; Liu, Ruifu; Boyd-Tressler, Andrea; Hang, Xi; Xia, Kevin; Cao, Pengxiu; Shue, Quinn; Dubyak, George R.; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Boyd-Tressler, Andrea; Dubyak, George R.] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA; [Hakimi, Parvin; Alhoraibi, Hanna; Slater, Erin; Berger, Nathan A.; Hanson, Richard W.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Berger, Nathan A.] Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44106 USA; [Janocha, Allison; Erzurum, Serpil C.] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Hang, Xi] Suzhou Hlth Coll, Sch Pharm, Suzhou 215009, Jiangsu, Peoples R China; [Ching, Tsui-Ting; Hsu, Ao-Lin] Univ Michigan, Dept Internal Med, Div Geriatr Med, Ann Arbor, MI 48109 USA; [Hsu, Ao-Lin] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feng, ZY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	john.feng@case.edu	Hakimi, Parvin/AAB-1643-2021; Hsu, Ao-Lin Allen/AAX-1856-2020	Ching, Tsui-Ting/0000-0001-7650-1766; Dubyak, George/0000-0001-9720-4226; Hsu, Ao-Lin/0000-0002-2864-3134; CAO, PENGXIU/0000-0002-5900-5645	Transdisciplinary Research on Energetics and Cancer Grant [U54-CA-116867]; Whitehall Foundation [2013-08-02]; Ellison Foundation [AG-SS-2420-10]; National Institutes of Health [P20-CA-103736, 1R01AG028516, HL103453, HL60917, HL081064]; NATIONAL CANCER INSTITUTE [U54CA116867, P20CA103736] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109250, R01HL060917, P01HL081064, P01HL103453, R24HL123767, R37HL060917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028516] Funding Source: NIH RePORTER	Transdisciplinary Research on Energetics and Cancer Grant; Whitehall Foundation; Ellison Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Transdisciplinary Research on Energetics and Cancer Grant U54-CA-116867 (directed by Dr. Nathan A. Berger, Nutrition Obesity Research Center, Case Western Reserve University), and Whitehall Foundation Grant 2013-08-02 (to Z. F.), Ellison Foundation Grant AG-SS-2420-10 (to R. W. H. and N. A. B.), and National Institutes of Health Grants P20-CA-103736 (to R. W. H.), 1R01AG028516 (to A. L. H.) and HL103453, HL60917, and HL081064 (to S. C. E.). The authors indicate no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Blouin JM, 2010, BIOCHIMIE, V92, P1772, DOI 10.1016/j.biochi.2010.07.011; Boron W. F., 2003, MED PHYSL CELLULAR M, P858; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Ching TT, 2010, AGING CELL, V9, P545, DOI 10.1111/j.1474-9726.2010.00580.x; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Coyle EF, 2000, AM J CLIN NUTR, V72, p512S, DOI 10.1093/ajcn/72.2.512S; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; Depuydt G, 2014, J PROTEOME RES, V13, P1938, DOI 10.1021/pr401081b; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; dos Santos JM, 2012, CELL BIOCHEM FUNCT, V30, P191, DOI 10.1002/cbf.1834; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; EVANS WJ, 1995, CLIN GERIATR MED, V11, P725, DOI 10.1016/S0749-0690(18)30267-2; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Fujioka H, 2012, ANAT REC, V295, P1455, DOI 10.1002/ar.22523; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jadiya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087635; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kil DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013319; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; MARSHALL CG, 1990, J PHYSIOL-LONDON, V428, P155, DOI 10.1113/jphysiol.1990.sp018205; Meissner B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019937; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Moroz N, 2014, AGING CELL, V13, P1075, DOI 10.1111/acel.12273; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murshid A, 2013, INT J HYPERTHER, V29, P442, DOI 10.3109/02656736.2013.798873; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Sadasivam M, 2014, GENE, V552, P249, DOI 10.1016/j.gene.2014.09.043; Salom D, 2012, FASEB J, V26, P492, DOI 10.1096/fj.11-197780; SALON C, 1988, J BIOL CHEM, V263, P12278; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Shimada N, 2008, GENES CELLS, V13, P245, DOI 10.1111/j.1365-2443.2008.01165.x; STROEHER VL, 1994, DEV BIOL, V163, P367, DOI 10.1006/dbio.1994.1155; Tan W, 2015, J CELL BIOCHEM, V116, P1583, DOI 10.1002/jcb.25112; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Voet D., 1995, BIOCHEMISTRY; Vukoti K, 2015, J PROTEOME RES, V14, P1483, DOI 10.1021/acs.jproteome.5b00021; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei X, 2012, NAT METHODS, V9, P391, DOI [10.1038/nmeth.1929, 10.1038/NMETH.1929]; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Xu WL, 2014, REDOX BIOL, V2, P513, DOI 10.1016/j.redox.2014.01.004; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; Yuan YY, 2012, J BIOL CHEM, V287, P31414, DOI 10.1074/jbc.M112.377275; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	86	18	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1307	1319		10.1074/jbc.M115.691766	http://dx.doi.org/10.1074/jbc.M115.691766			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26631730	Green Published, hybrid			2022-12-28	WOS:000368068300025
J	Bate, C; Nolan, W; Williams, A				Bate, Clive; Nolan, William; Williams, Alun			Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; glycosylphosphatidylinositol (GPI anchor); phospholipase A; prion; sialic acid	LIPID RAFTS; MEMBRANE DOMAINS; PROTEIN; SCRAPIE; RESISTANT; GANGLIOSIDES; DISTINCT; A(2); GLYCOSPHINGOLIPIDS; MICRODOMAINS	The prion diseases occur following the conversion of the cellular prion protein (PrPC) into disease-related isoforms (PrPSc). In this study, the role of the glycosylphosphatidylinositol (GPI) anchor attached to PrPC in prion formation was examined using a cell painting technique. PrPSc formation in two prion-infected neuronal cell lines (ScGT1 and ScN2a cells) and in scrapie-infected primary cortical neurons was increased following the introduction of PrPC. In contrast, PrPC containing a GPI anchor from which the sialic acid had been removed (desialylated PrPC) was not converted to PrPSc. Furthermore, the presence of desialylated PrPC inhibited the production of PrPSc within prion-infected cortical neurons and ScGT1 and ScN2a cells. The membrane rafts surrounding desialylated PrPC contained greater amounts of sialylated gangliosides and cholesterol than membrane rafts surrounding PrPC. Desialylated PrPC was less sensitive to cholesterol depletion than PrPC and was not released from cells by treatment with glimepiride. The presence of desialylated PrPC in neurons caused the dissociation of cytoplasmic phospholipase A(2) from PrP-containing membrane rafts and reduced the activation of cytoplasmic phospholipase A(2). These findings show that the sialic acid moiety of the GPI attached to PrPC modifies local membrane microenvironments that are important in PrP-mediated cell signaling and PrPSc formation. These results suggest that pharmacological modification of GPI glycosylation might constitute a novel therapeutic approach to prion diseases.	[Bate, Clive; Nolan, William] Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms AL9 7TA, Herts, England.	cbate@rvc.ac.uk			European Commission FP6 "Neuroprion" Network of Excellence	European Commission FP6 "Neuroprion" Network of Excellence	This work was supported by a grant from the European Commission FP6 "Neuroprion" Network of Excellence. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; BARBONI E, 1995, J CELL SCI, V108, P487; Bate C, 2004, J BIOL CHEM, V279, P36405, DOI 10.1074/jbc.M404086200; BATE CAW, 1994, INFECT IMMUN, V62, P5261, DOI 10.1128/IAI.62.12.5261-5266.1994; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; Bate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008221; BIANCO ID, 1989, BIOCHEM J, V258, P95, DOI 10.1042/bj2580095; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cantu L, 2011, CHEM PHYS LIPIDS, V164, P796, DOI 10.1016/j.chemphyslip.2011.09.005; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MULLER G, 1993, BIOCHEM J, V289, P509; Nagafuku M, 2003, J BIOL CHEM, V278, P51920, DOI 10.1074/jbc.M307674200; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Schiff E, 2008, TRAFFIC, V9, P1101, DOI 10.1111/j.1600-0854.2008.00746.x; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; YANG HC, 1994, BIOCHEM J, V299, P91, DOI 10.1042/bj2990091	49	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					160	170		10.1074/jbc.M115.672394	http://dx.doi.org/10.1074/jbc.M115.672394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26553874	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000367589500013
J	Kumar, Y; Kapoor, I; Khan, K; Thacker, G; Khan, MP; Shukla, N; Kanaujiya, JK; Sanyal, S; Chattopadhyay, N; Trivedi, AK				Kumar, Yogesh; Kapoor, Isha; Khan, Kainat; Thacker, Gatha; Khan, Mohd. Parvez; Shukla, Nidhi; Kanaujiya, Jitendra Kumar; Sanyal, Sabyasachi; Chattopadhyay, Naibedya; Trivedi, Arun Kumar			RETRACTED: E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation (Retracted article. See vol. 294, pg. 68, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR; C/EBP-ALPHA; CELL-CYCLE; C-MYC; BONE; PHOSPHORYLATION; GENE; CBFA1; SUPPRESSION	Runx2, a master regulator of osteoblast differentiation, is tightly regulated at both transcriptional and post-translational levels. Post-translational modifications such as phosphorylation and ubiquitination have differential effects on Runx2 functions. Here, we show that the reduced expression and functions of Runx2 upon its phosphorylation by GSK3 beta are mediated by its ubiquitin-mediated degradation through E3 ubiquitin ligase Fbw7 alpha. Fbw7 alpha through its WD domain interacts with Runx2 both in a heterologous (HEK293T cells) system as well as in osteoblasts. GSK3 beta was also present in the same complex as determined by co-immunoprecipitation. Furthermore, overexpression of either Fbw7 alpha or GSK3 beta was sufficient to down-regulate endogenous Runx2 expression and function; however, both failed to inhibit endogenous Runx2 when either of them was depleted in osteoblasts. Fbw7 alpha-mediated inhibition of Runx2 expression also led to reduced Runx2 transactivation and osteoblast differentiation. In contrast, inhibition of Fbw7 alpha restored Runx2 levels and promoted osteoblast differentiation. We also observed reciprocal expression levels of Runx2 and Fbw7 alpha in models of bone loss such as lactating (physiological bone loss condition) and ovariectomized (induction of surgical menopause) animals that show reduced Runx2 and enhanced Fbw7 alpha, whereas this was reversed in the estrogen-treated ovariectomized animals. In addition, methylprednisolone (a synthetic glucocorticoid) treatment to neonatal rats showed a temporal decrease in Runx2 with a reciprocal increase in Fbw7 in their calvarium. Taken together, these data demonstrate that Fbw7 alpha negatively regulates osteogenesis by targeting Runx2 for ubiquitin-mediated degradation in a GSK3 beta-dependent manner and thus provides a plausible explanation for GSK3 beta-mediated bone loss as described before.	[Kumar, Yogesh; Kapoor, Isha; Thacker, Gatha; Shukla, Nidhi; Kanaujiya, Jitendra Kumar; Sanyal, Sabyasachi; Trivedi, Arun Kumar] CSIR, Cent Drug Res Inst, Div Biochem, Lucknow 226031, Uttar Pradesh, India; [Khan, Kainat; Khan, Mohd. Parvez; Chattopadhyay, Naibedya] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India; [Khan, Kainat; Khan, Mohd. Parvez; Chattopadhyay, Naibedya] CSIR, Cent Drug Res Inst, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Trivedi, AK (corresponding author), CSIR, Cent Drug Res Inst, Div Biochem, LSS008,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	arun3vedi@cdri.res.in	KUMAR, YOGESH/GXN-1220-2022; Trivedi, Arun Kumar/W-1883-2019; Chattopadhyay, Naibedya/AAQ-3213-2021; Sanyal, Sabyasachi/E-8034-2010; Chattopadhyay, Naibedya/AAF-2058-2019	Trivedi, Arun Kumar/0000-0002-6316-0947; Chattopadhyay, Naibedya/0000-0003-2473-0246; Sanyal, Sabyasachi/0000-0002-8603-3828; 	Council of Scientific and Industrial Research (CSIR) [BSC0201, YSA-0002]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Grants BSC0201 and YSA-0002 from the Council of Scientific and Industrial Research (CSIR) (to A. K. T.). This is manuscript number 9122 from (SIR-Central Drug Research Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Ann EJ, 2011, J BONE MINER RES, V26, P317, DOI 10.1002/jbmr.227; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Choi YH, 2014, FEBS J, V281, P3656, DOI 10.1111/febs.12887; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; GALLAGHER AC, 1995, EUR J ENDOCRINOL, V133, P483, DOI 10.1530/eje.0.1330483; Harrington KS, 2002, J CELL SCI, V115, P4167, DOI 10.1242/jcs.00095; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Karlsson C, 2001, OSTEOPOROSIS INT, V12, P828, DOI 10.1007/s001980170033; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Lochab S, 2013, BBA-MOL CELL RES, V1833, P2639, DOI 10.1016/j.bbamcr.2013.06.018; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065330; Pal P, 2011, PROTEOMICS, V11, P1517, DOI 10.1002/pmic.201000720; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Trivedi R, 2009, MOL CELL ENDOCRINOL, V302, P86, DOI 10.1016/j.mce.2009.01.011; Wang FS, 2009, LIFE SCI, V85, P685, DOI 10.1016/j.lfs.2009.09.009; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Wejheden C, 2010, TOXICOL SCI, V114, P48, DOI 10.1093/toxsci/kfp284; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	48	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30975	30987		10.1074/jbc.M115.669531	http://dx.doi.org/10.1074/jbc.M115.669531			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542806	Green Published, hybrid			2022-12-28	WOS:000367199000028
J	Smilansky, A; Dangoor, L; Nakdimon, I; Ben-Hail, D; Mizrachi, D; Shoshan-Barmatz, V				Smilansky, Angela; Dangoor, Liron; Nakdimon, Itay; Ben-Hail, Danya; Mizrachi, Dario; Shoshan-Barmatz, Varda			The Voltage-dependent Anion Channel 1 Mediates Amyloid beta Toxicity and Represents a Potential Target for Alzheimer Disease Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VDAC1 N-TERMINUS; MITOCHONDRIAL DYSFUNCTION; HEXOKINASE-ACTIVITY; CELL-DEATH; PROTEIN; EXPRESSION; APOPTOSIS; PEPTIDES; BINDING; LIFE	The voltage-dependent anion channel 1 (VDAC1), found in the mitochondrial outer membrane, forms the main interface between mitochondrial and cellular metabolisms, mediates the passage of a variety of molecules across the mitochondrial outer membrane, and is central to mitochondria-mediated apoptosis. VDAC1 is overexpressed in post-mortem brains of Alzheimer disease (AD) patients. The development and progress of AD are associated with mitochondrial dysfunction resulting from the cytotoxic effects of accumulated amyloid beta(A beta). In this study we demonstrate the involvement of VDAC1 and a VDAC1 N-terminal peptide (VDAC1-N-Ter) in A beta cell penetration and cell death induction. A beta directly interacted with VDAC1 and VDAC1-N-Ter, as monitored by VDAC1 channel conductance, surface plasmon resonance, and microscale thermophoresis. Preincubated A beta interacted with bilayer-reconstituted VDAC1 and increased its conductance similar to 2-fold. Incubation of cells with A beta resulted in mitochondria-mediated apoptotic cell death. However, the presence of non-cell-penetrating VDAC1-N-Ter peptide prevented A beta cellular entry and A beta-induced mitochondria-mediated apoptosis. Likewise, silencing VDAC1 expression by specific siRNA prevented A beta entry into the cytosol as well as A beta-induced toxicity. Finally, the mode of A beta-mediated action involves detachment of mitochondria-bound hexokinase, induction of VDAC1 oligomerization, and cytochrome c release, a sequence of events leading to apoptosis. As such, we suggest that A beta-mediated toxicity involves mitochondrial and plasma membrane VDAC1, leading to mitochondrial dysfunction and apoptosis induction. The VDAC1-N-Ter peptide targeting A beta cytotoxicity is thus a potential new therapeutic strategy for AD treatment.	[Smilansky, Angela; Dangoor, Liron; Nakdimon, Itay; Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Smilansky, Angela; Dangoor, Liron; Nakdimon, Itay; Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Mizrachi, Dario] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Ben Gurion University; Ben Gurion University; Cornell University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il		Ben-Hail, Danya/0000-0002-8210-3446	National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev	National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev	This work was supported by a grant from the National Institute for Biotechnology in the Negev (NIBN), Ben-Gurion University of the Negev. This work was also financially supported by Phillip and Sima Needleman. The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Benek O, 2015, CURR MED CHEM, V22, P1056, DOI 10.2174/0929867322666150114163051; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; Cabezas-Opazo FA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/509654; Cardoso SM, 2002, BRAIN RES, V931, P117, DOI 10.1016/S0006-8993(02)02256-4; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clarke DD, 1999, BASIC NEUROCHEMISTRY; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753; Gao JH, 2009, AM J TRANSL RES, V1, P312; Gerber D, 2001, J BIOL CHEM, V276, P31229, DOI 10.1074/jbc.M101889200; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Godoy JA, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-23; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Hertz L, 2015, J NEUROCHEM, V134, P7, DOI 10.1111/jnc.13107; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kung HF, 2012, ACS MED CHEM LETT, V3, P265, DOI 10.1021/ml300058m; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lu AJ, 2007, FISH SHELLFISH IMMUN, V23, P601, DOI 10.1016/j.fsi.2007.01.007; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Marin R, 2007, MOL MEMBR BIOL, V24, P148, DOI 10.1080/09687860601055559; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Prezma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.316; Ramirez CM, 2009, MOL CELL NEUROSCI, V42, P172, DOI 10.1016/j.mcn.2009.07.001; Readnower RD, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/104545, DOI 10.4061/2011/104545]; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P1913, DOI 10.1016/j.bbadis.2013.06.012; Saddar S, 2005, J BIOL CHEM, V280, P24435, DOI 10.1074/jbc.M502804200; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Thinnes FP, 2013, MOL GENET METAB, V108, P212, DOI 10.1016/j.ymgme.2013.01.008; Thinnes FP, 2011, WIEN MED WOCHENSCHR, V161, P274, DOI 10.1007/s10354-011-0887-5; Thinnes FP, 2009, MOL GENET METAB, V97, P241, DOI 10.1016/j.ymgme.2009.04.010; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Weisthal S, 2014, BBA-MOL CELL RES, V1843, P2270, DOI 10.1016/j.bbamcr.2014.03.021; Whittington DA, 2001, P NATL ACAD SCI USA, V98, P9545, DOI 10.1073/pnas.161301298; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599	73	75	77	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30670	30683		10.1074/jbc.M115.691493	http://dx.doi.org/10.1074/jbc.M115.691493			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542804	hybrid, Green Published			2022-12-28	WOS:000367199000002
J	Haigney, A; Ricketts, MD; Marmorstein, R				Haigney, Allison; Ricketts, M. Daniel; Marmorstein, Ronen			Dissecting the Molecular Roles of Histone Chaperones in Histone Acetylation by Type B Histone Acetyltransferases (HAT-B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CHROMATIN REPLICATION; HAT1P/HAT2P COMPLEX; H4; YEAST; H3; DNA; ASF1; H-4; HETERODIMER	The HAT-B enzyme complex is responsible for acetylating newly synthesized histone H4 on lysines K5 and K12. HAT-B is a multisubunit complex composed of the histone acetyltransferase 1 (Hat1) catalytic subunit and the Hat2 (rbap46) histone chaperone. Hat1 is predominantly localized in the nucleus as a member of a trimeric NuB4 complex containing Hat1, Hat2, and a histone H3-H4 specific histone chaperone called Hif1 (NASP). In addition to Hif1 and Hat2, Hat1 interacts with Asf1 (anti-silencing function 1), a histone chaperone that has been reported to be involved in both replication-dependent and-independent chromatin assembly. To elucidate the molecular roles of the Hif1 and Asf1 histone chaperones inHAT-Bhistone binding and acetyltransferase activity, we have characterized the stoichiometry and binding mode of Hif1 and Asf1 to HAT-B and the effect of this binding on the enzymatic activity of HAT-B. We find that Hif1 and Asf1 bind through different modes and independently to HAT-B, whereby Hif1 binds directly to Hat2, and Asf1 is only capable of interactions with HAT-B through contacts with histones H3-H4. We also demonstrate that HAT-B is significantly more active against an intact H3-H4 heterodimer over a histone H4 peptide, independent of either Hif1 or Asf1 binding. Mutational studies further demonstrate that HAT-B binding to the histone tail regions is not sufficient for this enhanced activity. Based on these data, we propose a model for HAT-B/histone chaperone assembly and acetylation of H3-H4 complexes.	[Haigney, Allison; Ricketts, M. Daniel; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ricketts, M. Daniel] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM060293, P01 AG031862, F32CA180504, P30 CA010815, P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520, P30CA010815, F32CA180504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 GM060293 and P01 AG031862 (to R. M.), Training Grant F32CA180504 (to A. H.), Grant P30 CA010815 (to the proteomics core facility at the Wistar Institute), and Grant P30 CA016520 (to the University of Pennsylvania DNA Sequencing Facility at the Perelman School of Medicine). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; COUSENS LS, 1982, J BIOL CHEM, V257, P3945; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Ge ZQ, 2011, J BIOL CHEM, V286, P16790, DOI 10.1074/jbc.M110.216846; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; MINGARRO I, 1993, J BIOL CHEM, V268, P13248; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nagarajan P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003518; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Parthun MR, 2012, BBA-GENE REGUL MECH, V1819, P256, DOI 10.1016/j.bbagrm.2011.07.006; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; RICHMAN R, 1988, J CELL BIOL, V106, P1017, DOI 10.1083/jcb.106.4.1017; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; SOBEL RE, 1994, J BIOL CHEM, V269, P18576; WIEGAND RC, 1981, J BIOL CHEM, V256, P4578; Winkler DD, 2012, NUCLEIC ACIDS RES, V40, P10139, DOI 10.1093/nar/gks812; Wu H, 2012, P NATL ACAD SCI USA, V109, P8925, DOI 10.1073/pnas.1114117109; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	35	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30648	30657		10.1074/jbc.M115.688523	http://dx.doi.org/10.1074/jbc.M115.688523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26522166	Green Published, hybrid			2022-12-28	WOS:000366738200039
J	Shanmugam, NKN; Chen, KJ; Cherayil, BJ				Shanmugam, Nanda Kumar N.; Chen, Kejie; Cherayil, Bobby J.			Commensal Bacteria-induced Interleukin 1 beta (IL-1 beta) Secreted by Macrophages Up-regulates Hepcidin Expression in Hepatocytes by Activating the Bone Morphogenetic Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL INFLAMMATION; IRON; FERROPORTIN; ANEMIA; STAT3; BMP6; SMAD1/5/8; AUTOPHAGY; DISEASE; AXIS	The liver hormone hepcidin is the central regulator of systemic iron metabolism. Its increased expression in inflammatory states leads to hypoferremia and anemia. Elucidation of the mechanisms that up-regulate hepcidin during inflammation is essential for developing rational therapies for this anemia. Using mouse models of inflammatory bowel disease, we have shown previously that colitis-associated hepcidin induction is influenced by intestinal microbiota composition. Here we investigate how two commensal bacteria, Bifidobacterium longum and Bacteroides fragilis, representative members of the gut microbiota, affect hepcidin expression. We found that supernatants of a human macrophage cell line infected with either of the bacteria up-regulated hepcidin when added to a human hepatocyte cell line. This activity was abrogated by neutralization of IL-1 beta. Moreover, purified IL-1 beta increased hepcidin expression when added to the hepatocyte line or primary human hepatocytes and when injected into mice. IL-1 beta activated the bone morphogenetic protein (BMP) signaling pathway in hepatocytes and in mouse liver, as indicated by increased phosphorylation of small mothers against decapentaplegic proteins. Activation of BMP signaling correlated with IL-1 beta -induced expression of BMP2in human hepatocytes and activinBin mouse liver. Treatment of hepatocytes with two different chemical inhibitors of BMP signaling or with a neutralizing antibody to BMP2 prevented IL-1 beta-induced up-regulation of hepcidin. Our results clarify how commensal bacteria affect hepcidin expression and reveal a novel connection between IL-1 beta and activation of BMP signaling. They also suggest that there may be differences between mice and humans with respect to the mechanism by which IL-1 beta up-regulates hepcidin.	[Shanmugam, Nanda Kumar N.; Chen, Kejie; Cherayil, Bobby J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr,Dept Pediat, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Cherayil, BJ (corresponding author), Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Bldg 114,16th St, Charlestown, MA 02129 USA.	cherayil@helix.mgh.harvard.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 AI089700]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 AI089700 (to B. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by funding from the China Scholarship Council.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Core AB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00104; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; DeBleser PJ, 1997, HEPATOLOGY, V26, P905; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Erichsen K, 2005, SCAND J GASTROENTERO, V40, P1058, DOI 10.1080/00365520510023198; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Koening CL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-33; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; Kulnigg S, 2006, ALIMENT PHARM THER, V24, P1507, DOI 10.1111/j.1365-2036.2006.03146.x; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Matak P, 2009, HAEMATOL-HEMATOL J, V94, P773, DOI 10.3324/haematol.2008.003400; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Parrow NL, 2014, ANNU REV NUTR, V34, P77, DOI 10.1146/annurev-nutr-071813-105646; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Shanmugam NKN, 2014, J IMMUNOL, V193, P1398, DOI 10.4049/jimmunol.1400278; Shanmugam NKN, 2013, BIOCHEM BIOPH RES CO, V441, P383, DOI 10.1016/j.bbrc.2013.10.065; Shanmugam NKN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038136; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	46	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30637	30647		10.1074/jbc.M115.689190	http://dx.doi.org/10.1074/jbc.M115.689190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26515063	Green Published, hybrid			2022-12-28	WOS:000366738200038
J	Textoris-Taube, K; Keller, C; Liepe, J; Henklein, P; Sidney, J; Sette, A; Kloetzel, PM; Mishto, M				Textoris-Taube, Kathrin; Keller, Christin; Liepe, Juliane; Henklein, Petra; Sidney, John; Sette, Alessandro; Kloetzel, Peter M.; Mishto, Michele			The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTL EPITOPE; PEPTIDE HYDROLYSIS; IMMUNOPROTEASOMES; RECOGNITION; SEQUENCE; BINDING; INDUCTION; STANDARD; LENGTH	MHC class I-restricted epitopes, which carry a tumor-specific mutation resulting in improved MHC binding affinity, are preferred T cell receptor targets in innovative adoptive T cell therapies. However, T cell therapy requires efficient generation of the selected epitope. How such mutations may affect proteasome-mediated antigen processing has so far not been studied. Therefore, we analyzed by in vitro experiments the effect on antigen processing and recognition of a T210M exchange, which previously had been introduced into the melanoma gp100(209-217) tumor epitope to improve the HLA-A*02: 01 binding and its immunogenicity. A quantitative analysis of the main steps of antigen processing shows that the T210M exchange affects proteasomal cleavage site usage within the (mut)gp100(201-230) polypeptide, leading to the generation of an unique set of cleavage products. The T210M substitution qualitatively affects the proteasome-catalyzed generation of spliced and non-spliced peptides predicted to bind HLA-A or -B complexes. The T210M substitution also induces an enhanced production of the (mut)gp100(209-217) epitope and its N-terminally extended peptides. The T210M exchange revealed no effect on ERAP1-mediated N-terminal trimming of the precursor peptides. However, mutant N-terminally extended peptides exhibited significantly increased HLA-A*02:01 binding affinity and elicited CD8(+) T cell stimulation in vitro similar to the (wt)gp100(209-217) epitope. Thus, our experiments demonstrate that amino acid exchanges within an epitope can result in the generation of an altered peptide pool with new antigenic peptides and in a wider CD8(+) T cell response also towards N-terminally extended versions of the minimal epitope.	[Textoris-Taube, Kathrin; Keller, Christin; Henklein, Petra; Kloetzel, Peter M.; Mishto, Michele] Charite, Inst Biochem, D-10117 Berlin, Germany; [Liepe, Juliane] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; La Jolla Institute for Immunology	Kloetzel, PM (corresponding author), Charite, Inst Biochem, Charitepl 1,Virchowweg 6, D-10117 Berlin, Germany.	p-m.kloetzel@charite.de; michele.mishto@charite.de	mishto, michele/A-5592-2010; Sette, Alessandro/AFO-8916-2022	mishto, michele/0000-0003-3042-2792; Henklein, Petra/0000-0001-7468-8926; Liepe, Juliane/0000-0003-2515-9707	Berlin Institute of Health [CRG1-TP1]; Einstein Stiftung Berlin [A2013-174]; NC3Rs (National Center for the Replacement, Refinement, and Reduction of Animal in Research) through a David Sainsbury Fellowship [NC/K001949/1]; National Centre for the Replacement [NC/K001949/1] Funding Source: researchfish	Berlin Institute of Health; Einstein Stiftung Berlin; NC3Rs (National Center for the Replacement, Refinement, and Reduction of Animal in Research) through a David Sainsbury Fellowship(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This work was supported by a grant of the Berlin Institute of Health (CRG1-TP1) and the Einstein Stiftung Berlin (A2013-174) (to P. M. K.) and by NC3Rs (National Center for the Replacement, Refinement, and Reduction of Animal in Research) through a David Sainsbury Fellowship (to J. L.) (NC/K001949/1). The authors declare that they have no conflict of interest.	Beekman NJ, 2000, J IMMUNOL, V164, P1898, DOI 10.4049/jimmunol.164.4.1898; Blankenstein T, 2015, CURR OPIN IMMUNOL, V33, P112, DOI 10.1016/j.coi.2015.02.005; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Dalet A, 2011, EUR J IMMUNOL, V41, P39, DOI 10.1002/eji.201040750; Dalet A, 2010, J IMMUNOL, V184, P3016, DOI 10.4049/jimmunol.0901277; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Liepe J, 2015, ELIFE, V4, DOI 10.7554/eLife.07545; Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mishto M, 2008, J MOL BIOL, V377, P1607, DOI 10.1016/j.jmb.2008.01.086; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Mishto M, 2012, MOL CELL PROTEOMICS, V11, P1008, DOI 10.1074/mcp.M112.020164; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Ossendorp F, 1996, IMMUNITY, V5, P115, DOI 10.1016/S1074-7613(00)80488-4; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Seifert U, 2004, J CLIN INVEST, V114, P250, DOI 10.1172/JCI200420985; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Theobald M, 1998, J EXP MED, V188, P1017, DOI 10.1084/jem.188.6.1017; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Vigneron N, 2012, CURR OPIN IMMUNOL, V24, P84, DOI 10.1016/j.coi.2011.12.002; Zanker D, 2014, EUR J IMMUNOL, V44, P3500, DOI 10.1002/eji.201445272; Zanker D, 2013, J IMMUNOL, V191, P52, DOI 10.4049/jimmunol.1300802	38	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30417	30428		10.1074/jbc.M115.695189	http://dx.doi.org/10.1074/jbc.M115.695189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26507656	Green Published, hybrid			2022-12-28	WOS:000366738200019
J	Zou, YK; Gong, N; Cui, Y; Wang, XJ; Cui, AF; Chen, Q; Jiao, T; Dong, XY; Yang, H; Zhang, ST; Fang, FD; Chang, YS				Zou, Yongkang; Gong, Ning; Cui, Ying; Wang, Xiaojuan; Cui, Anfang; Chen, Qi; Jiao, Tao; Dong, Xueyu; Yang, Hao; Zhang, Shutian; Fang, Fude; Chang, Yongsheng			Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; COACTIVATOR PGC-1; GENE-EXPRESSION; INSULIN ACTION; FACTOR FOXO1; METABOLISM; BINDING; GLUCONEOGENESIS; PROLIFERATION; PROTEINS	Dysregulation of hepatic gluconeogenesis contributes to the pathogenesis of diabetes, yet the detailed molecular mechanisms remain to be fully elucidated. Here we show that FOXP1, a transcriptional repressor, plays a key role in the regulation of systemic glucose homeostasis. Hepatic expression levels of FOXP1 are decreased in diabetic mice. Modest hepatic overexpression of FOXP1 in mice inhibited the expression of gluconeogenic genes, such as peroxisome proliferators-activated receptor gamma coactivator-1 alpha (PGC-1 alpha), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6PC), leading to a decrease in hepatic glucose production and fasting blood glucose levels in normal mice and different mouse models of diabetes, including db/db diabetic and high-fat diet-induced obese mice. FOXP1 physically interacted with FOXO1 in vivo and competed with FOXO1 for binding to the insulin response element in the promoter region of gluconeogenic genes, thereby interfering expression of these genes. These results identify a previously unrecognized role for FOXP1 in the transcriptional control of hepatic glucose homeostasis.	[Zou, Yongkang; Gong, Ning; Cui, Ying; Wang, Xiaojuan; Cui, Anfang; Chen, Qi; Jiao, Tao; Dong, Xueyu; Yang, Hao; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zou, Yongkang; Gong, Ning; Cui, Ying; Wang, Xiaojuan; Cui, Anfang; Chen, Qi; Jiao, Tao; Dong, Xueyu; Yang, Hao; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Zhang, Shutian] Capital Med Univ, Beijing Digest Dis Ctr, Beijing Key Lab Precancerous Lesion Digest Dis, Beijing Friendship Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Chang, YS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Biol & Biochem, State Key Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	changy@ibms.pumc.edu.cn			Major State Basic Research Development Program of China [2012CB517504]; National Natural Science Foundation of China [81471049, 81170763]; Natural Science Foundation of Beijing [5142018]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the Major State Basic Research Development Program of China 973 program Grant 2012CB517504, National Natural Science Foundation of China Grants 81471049 and 81170763, and Natural Science Foundation of Beijing Grant 5142018. No potential conflicts of interest relevant to this article were reported.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Banham AH, 2001, CANCER RES, V61, P8820; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Orlicky DJ, 2001, J LIPID RES, V42, P460; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang R, 2010, BIOCHEM J, V430, P245, DOI 10.1042/BJ20100701; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	33	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30607	30615		10.1074/jbc.M115.681627	http://dx.doi.org/10.1074/jbc.M115.681627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26504089	Green Published, hybrid			2022-12-28	WOS:000366738200035
J	Xiao, XJ; Lowe, ME				Xiao, Xunjun; Lowe, Mark E.			The 5-Loop and Lid Domain Contribute to the Substrate Specificity of Pancreatic Lipase-related Protein 2 (PNLIPRP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipase; lipid-protein interaction; protein chimera; protein structure; site-directed mutagenesis; structure-function; triglyceride; galactolipid	TRIGLYCERIDE LIPASE; FAT DIGESTION; INTERFACIAL BINDING; CRYSTAL-STRUCTURE; COLIPASE; COMPLEX; DEFICIENCY; ACTIVATION; MUTATION; PROCOLIPASE	Pancreatic triglyceride lipase (PNLIP) is essential for dietary fat digestion in children and adults, whereas a homolog, pancreatic lipase-related protein 2 (PNLIPRP2), is critical in newborns. The two lipases are structurally similar, yet they have different substrate specificities. PNLIP only cleaves neutral fats. PNLIPRP2 cleaves neutral and polar fats. To test the hypothesis that the differences in activity between PNLIP and PNLIPRP2 are governed by surface loops around the active site, we created multiple chimeras of both lipases by exchanging the surface loops singly or in combination. The chimeras were expressed, purified, and tested for activity against various substrates. The structural determinants of PNLIPRP2 galactolipase activity were contained in the N-terminal domain. Of the surface loops tested, the lid domain and the 5-loop influenced activity against triglycerides and galactolipids. Any chimera on PNLIP with the PNLIPRP2 lid domain or 5-loop had decreased triglyceride lipase activity similar to that of PNLIPRP2. The corresponding chimeras of PNLIPRP2 did not increase activity against neutral lipids. Galactolipase activity was abolished by the PNLIP 5-loop and decreased by the PNLIP lid domain. The source of the 9-loop had minimal effect on activity. We conclude that the lid domain and 5-loop contribute to substrate specificity but do not completely account for the differing activities of PNLIP and PNLIPRP2. Other regions in the N-terminal domain must contribute to the galactolipase activity of PNLIPRP2 through direct interactions with the substrate or by altering the conformation of the residues surrounding the hydrophilic cavity in PNLIPRP2.	[Xiao, Xunjun; Lowe, Mark E.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lowe, ME (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, One Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	loweme2@upmc.edu	Regan, Clinton/E-6250-2012	Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [DK080820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK080820 (to M. E. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson L, 1996, BBA-LIPID LIPID MET, V1302, P236, DOI 10.1016/0005-2760(96)00068-9; Arima N, 2012, J LIPID RES, V53, P513, DOI 10.1194/jlr.M022400; Belle V, 2007, BIOCHEMISTRY-US, V46, P2205, DOI 10.1021/bi0616089; BERNBACK S, 1990, J CLIN INVEST, V85, P1221, DOI 10.1172/JCI114556; Berton A, 2007, FEBS J, V274, P6011, DOI 10.1111/j.1742-4658.2007.06123.x; Bezzine S, 1999, BIOCHEMISTRY-US, V38, P5499, DOI 10.1021/bi982601x; BORGSTROM B, 1982, J CLIN INVEST, V70, P30, DOI 10.1172/JCI110599; Carey M.C., 1992, SEMIN GASTROINTEST D, V3, P189; Carriere F, 2000, GASTROENTEROLOGY, V119, P949, DOI 10.1053/gast.2000.18140; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Carriere F, 1997, BIOCHEMISTRY-US, V36, P239, DOI 10.1021/bi961991p; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; Cordle RA, 1998, J LIPID RES, V39, P1759; Crandall WV, 2001, J BIOL CHEM, V276, P12505, DOI 10.1074/jbc.M009986200; Crenon I, 1998, PROTEIN ENG, V11, P135, DOI 10.1093/protein/11.2.135; Crenon I, 1998, BIOCHEM BIOPH RES CO, V246, P513, DOI 10.1006/bbrc.1998.8651; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; EGLOFF MP, 1995, PROTEIN SCI, V4, P44; Eydoux C, 2008, BIOCHEMISTRY-US, V47, P9553, DOI 10.1021/bi8005576; FIGARELL.C, 1972, BIOCHIM BIOPHYS ACTA, V280, P205, DOI 10.1016/0005-2760(72)90227-5; FIGARELLA C, 1980, J PEDIATR-US, V96, P412, DOI 10.1016/S0022-3476(80)80683-4; GHISHAN FK, 1984, GASTROENTEROLOGY, V86, P1580; Hermoso J, 1997, EMBO J, V16, P5531, DOI 10.1093/emboj/16.18.5531; Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007; Hofmann A. F., 1971, THE BILE ACIDS, P103; HOFMANN AF, 1964, J CLIN INVEST, V43, P247, DOI 10.1172/JCI104909; Jayne S, 2002, BBA-PROTEIN STRUCT M, V1594, P255, DOI 10.1016/S0167-4838(01)00309-0; Lowe ME, 2002, J LIPID RES, V43, P2007, DOI 10.1194/jlr.R200012-JLR200; Lowe ME, 1996, BBA-LIPID LIPID MET, V1302, P177, DOI 10.1016/0005-2760(96)00058-6; LOWE ME, 1992, J BIOL CHEM, V267, P17069; Lowe ME, 1997, J BIOL CHEM, V272, P9; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Roussel A, 1998, J BIOL CHEM, V273, P32121, DOI 10.1074/jbc.273.48.32121; Roussel A, 1998, PROTEINS, V32, P523; Sias B, 2004, BIOCHEMISTRY-US, V43, P10138, DOI 10.1021/bi049818d; Szabo A, 2015, BBA-MOL BASIS DIS, V1852, P1372, DOI 10.1016/j.bbadis.2015.04.002; van Tilbeurgh H, 1999, BBA-MOL CELL BIOL L, V1441, P173, DOI 10.1016/S1388-1981(99)00149-3; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; VANTILBEURGH H, 1993, J MOL BIOL, V229, P552, DOI 10.1006/jmbi.1993.1054; Verger R., 1984, LIPASES, P84; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WithersMartinez C, 1996, STRUCTURE, V4, P1363, DOI 10.1016/S0969-2126(96)00143-8; Xiao XJ, 2013, BBA-MOL CELL BIOL L, V1831, P1435, DOI 10.1016/j.bbalip.2013.06.002; Xiao XJ, 2011, J BIOL CHEM, V286, P26353, DOI 10.1074/jbc.M111.249813; Xiao XJ, 2011, J LIPID RES, V52, P982, DOI 10.1194/jlr.M014290; Yang YQ, 2000, J LIPID RES, V41, P48; Yang YQ, 1998, PROTEIN EXPRES PURIF, V13, P36, DOI 10.1006/prep.1998.0874	47	5	6	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28847	28856		10.1074/jbc.M115.683375	http://dx.doi.org/10.1074/jbc.M115.683375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26494624	Green Published, hybrid			2022-12-28	WOS:000365762300026
J	Lim, S; Peshenko, IV; Olshevskaya, EV; Dizhoor, AM; Ames, JB				Lim, Sunghyuk; Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.; Ames, James B.			Structure of Guanylyl Cyclase Activator Protein 1 (GCAP1) Mutant V77E in a Ca2+-free/Mg2+-bound Activator State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR; CA2+-BINDING PROTEINS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; MYRISTOYL SWITCH; BINDING; NMR; CA2+; MECHANISM; TARGET	GCAP1, a member of the neuronal calcium sensor subclass of the calmodulin superfamily, confers Ca2+-sensitive activation of retinal guanylyl cyclase 1 (RetGC1). We present NMR resonance assignments, residual dipolar coupling data, functional analysis, and a structural model of GCAP1 mutant (GCAP1(V77E)) in the Ca2+-free/Mg2+-bound state. NMR chemical shifts and residual dipolar coupling data reveal Ca2+-dependent differences for residues 170-174. An NMR-derived model of GCAP1V77E contains Mg2+ bound at EF2 and looks similar to Ca2+ saturated GCAP1 (root mean square deviations = 2.0 angstrom). Ca2+-dependent structural differences occur in the fourth EF-hand (EF4) and adjacent helical region (residues 164-174 called the Ca2+ switch helix). Ca2+-induced shortening of the Ca2+ switch helix changes solvent accessibility of Thr-171 and Leu-174 that affects the domain interface. Although the Ca2+ switch helix is not part of the RetGC1 binding site, insertion of an extra Gly residue between Ser-173 and Leu-174 as well as deletion of Arg-172, Ser-173, or Leu-174 all caused a decrease in Ca2+-binding affinity and abolished RetGC1 activation. We conclude that Ca2+-dependent conformational changes in the Ca2+ switch helix are important for activating RetGC1 and provide further support for a Ca2+-myristoyl tug mechanism.	[Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA; [Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Res, Elkins Pk, PA 19027 USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA.	jbames@ucdavis.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY012347, EY11522, RR11973]; Pennsylvania Department of Health CURE Formula grant; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011522, R01EY012347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health CURE Formula grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY012347 (to J. B. A.), EY11522 (to A. M. D.), and RR11973 (UC Davis NMR). This work was also supported by a Pennsylvania Department of Health CURE Formula grant (to A. M. D.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081822; Lim S, 2013, BIOMOL NMR ASSIGN, V7, P39, DOI 10.1007/s12104-012-9373-2; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOMOL NMR ASSIGN, V3, P269, DOI 10.1007/s12104-009-9191-3; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Park S, 2014, J BIOL CHEM, V289, P31262, DOI 10.1074/jbc.M114.604439; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senguen FT, 2012, BIOCHEMISTRY-US, V51, P6182, DOI 10.1021/bi300698h; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SKELTON NJ, 1995, J MOL BIOL, V249, P441, DOI 10.1006/jmbi.1995.0308; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Xu XZ, 2011, PROTEINS, V79, P1910, DOI 10.1002/prot.23014; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	63	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4429	4441		10.1074/jbc.M115.696161	http://dx.doi.org/10.1074/jbc.M115.696161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26703466	Green Published, hybrid			2022-12-28	WOS:000371604600015
J	Reidy, M; Sharma, R; Roberts, BL; Masison, DC				Reidy, Michael; Sharma, Ruchika; Roberts, Brittany-Lee; Masison, Daniel C.			Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; chaperone; heat shock protein (HSP); prion; yeast; DnaJB6	YEAST PRIONS; POLYGLUTAMINE AGGREGATION; CHAPERONE SUBFAMILY; HSP104 CHAPERONE; SHUTTLE VECTORS; IN-VITRO; PROPAGATION; HSP40; TOXICITY; HSP70	Human chaperone DnaJB6, an Hsp70 co-chaperone whose defects cause myopathies, protects cells from polyglutamine toxicity and prevents purified polyglutamine and A peptides from forming amyloid. Yeast prions [URE3] and [PSI+] propagate as amyloid forms of Ure2 and Sup35 proteins, respectively. Here we find DnaJB6-protected yeast cells from polyglutamine toxicity and cured yeast of both [URE3] prions and weak variants of [PSI+] prions but not strong [PSI+] prions. Weak and strong variants of [PSI+] differ only in the structural conformation of their amyloid cores. In line with its anti-prion effects, DnaJB6 prevented purified Sup35NM from forming amyloids at 37 degrees C, which produce predominantly weak [PSI+] variants when used to infect yeast, but not at 4 degrees C, which produces mostly strong [PSI+] variants. Thus, structurally distinct amyloids composed of the same protein were differentially sensitive to the anti-amyloid activity of DnaJB6 both in vitro and in vivo. These findings have important implications for strategies using DnaJB6 as a target for therapy in amyloid disorders.	[Reidy, Michael; Sharma, Ruchika; Roberts, Brittany-Lee; Masison, Daniel C.] NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rd 324, Bethesda, MD 20892 USA; [Sharma, Ruchika] Univ Wisconsin, HF DeLuca Biochem Labs, Madison, WI 53706 USA; [Roberts, Brittany-Lee] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; Florida International University	Masison, DC (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rd 324, Bethesda, MD 20892 USA.	danielmas@helix.nih.gov		Reidy, Michael/0000-0002-9290-7595	National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024954] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the National Institutes of Health, NIDDK. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cox B, 2003, GENETICS, V165, P23; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Gong H, 2012, PLOS GENET, V8, P223, DOI 10.1371/journal.pgen.1002634; Gorkovskiy A, 2014, P NATL ACAD SCI USA, V111, pE4615, DOI 10.1073/pnas.1417974111; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Harris JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004510; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; Lian HY, 2007, J BIOL CHEM, V282, P11931, DOI 10.1074/jbc.M606856200; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Reidy M, 2014, CURR PHARM BIOTECHNO, V15, P1008, DOI 10.2174/1389201015666141103021035; Reidy M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004720; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Ruggieri A, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0224-0; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; SIKORSKI RS, 1989, GENETICS, V122, P19; Sporn ZA, 2015, PRION, V9, P80, DOI 10.1080/19336896.2015.1020268; Stein KC, 2014, MOL MICROBIOL, V93, P1156, DOI 10.1111/mmi.12725; Stein KC, 2014, J BIOL CHEM, V289, P21120, DOI 10.1074/jbc.M114.572461; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wong SH, 2015, J BIOL CHEM, V290, P25062, DOI 10.1074/jbc.M115.676379; Zhao XH, 2012, J BIOL CHEM, V287, P23346, DOI 10.1074/jbc.M111.287748	57	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4035	4047		10.1074/jbc.M115.700393	http://dx.doi.org/10.1074/jbc.M115.700393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702057	Green Published, hybrid			2022-12-28	WOS:000371338400029
J	Abbondante, S; Eckel-Mahan, KL; Ceglia, NJ; Baldi, P; Sassone-Corsi, P				Abbondante, Serena; Eckel-Mahan, Kristin L.; Ceglia, Nicholas J.; Baldi, Pierre; Sassone-Corsi, Paolo			Comparative Circadian Metabolomics Reveal Differential Effects of Nutritional Challenge in the Serum and Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; SHIFT WORK; ADIPOSE-TISSUE; INSULIN SENSITIVITY; BETA-SITOSTEROL; KEY PATHWAYS; METABOLISM; CLOCK; OBESITY	Diagnosis and therapeutic interventions in pathological conditions rely upon clinical monitoring of key metabolites in the serum. Recent studies show that a wide range of metabolic pathways are controlled by circadian rhythms whose oscillation is affected by nutritional challenges, underscoring the importance of assessing a temporal window for clinical testing and thereby questioning the accuracy of the reading of critical pathological markers in circulation. We have been interested in studying the communication between peripheral tissues under metabolic homeostasis perturbation. Here we present a comparative circadian metabolomic analysis on serum and liver in mice under high fat diet. Our data reveal that the nutritional challenge induces a loss of serum metabolite rhythmicity compared with liver, indicating a circadian misalignment between the tissues analyzed. Importantly, our results show that the levels of serum metabolites do not reflect the circadian liver metabolic signature or the effect of nutritional challenge. This notion reveals the possibility that misleading reads of metabolites in circulation may result in misdiagnosis and improper treatments. Our findings also demonstrate a tissue-specific and time-dependent disruption of metabolic homeostasis in response to altered nutrition.	[Abbondante, Serena; Eckel-Mahan, Kristin L.; Sassone-Corsi, Paolo] Univ Calif Irvine, INSERM, Ctr Epigenet & Metab, U904, Irvine, CA 92697 USA; [Abbondante, Serena; Eckel-Mahan, Kristin L.; Ceglia, Nicholas J.; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Ceglia, Nicholas J.; Baldi, Pierre] Univ Calif Irvine, Sch Informat & Comp Sci, Inst Genom & Bioinformat, Irvine, CA 92697 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, INSERM, Ctr Epigenet & Metab, U904, Irvine, CA 92697 USA.; Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	psc@uci.edu		Eckel-Mahan, Kristin/0000-0001-8201-1675	National Institutes of Health [GM081634, AG033888]; INSERM; Merieux Research Grant [MRG-53923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Merieux Research Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants GM081634 and AG033888, by INSERM, and by Merieux Research Grant MRG-53923. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Antunes LD, 2010, ARQ BRAS ENDOCRINOL, V54, P652, DOI 10.1590/S0004-27302010000700010; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Baskar AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-24; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Blum R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.38; Brault JJ, 2001, J APPL PHYSIOL, V91, P231, DOI 10.1152/jappl.2001.91.1.231; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chen YM, 2015, INT J OBESITY, V39, P465, DOI 10.1038/ijo.2014.158; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Crisafulli A, 2005, MENOPAUSE, V12, P186, DOI 10.1097/00042192-200512020-00013; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Du FY, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-17; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Eberly R, 2010, INTERNET J ALLIED HE, V8; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Glew RH, 2004, J NATL MED ASSOC, V96, P826; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Kato S, 2013, BIOL PHARM BULL, V36, P1406; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim JJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00396; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086223; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Koch CE, 2014, J NEUROENDOCRINOL, V26, P58, DOI 10.1111/jne.12131; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koopman KE, 2013, MOL METAB, V2, P417, DOI 10.1016/j.molmet.2013.07.006; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lissin LW, 2000, J AM COLL CARDIOL, V35, P1403; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Metwally NS, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-8; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Muti P, 2003, J NUTR, V133, P4252, DOI 10.1093/jn/133.12.4252; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Niwa T, 1998, KIDNEY INT, V53, P1801, DOI 10.1046/j.1523-1755.1998.00944.x; Norrelund H, 2006, J INTERN MED, V260, P11, DOI 10.1111/j.1365-2796.2006.01663.x; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Parkes KR, 2002, SCAND J WORK ENV HEA, V28, P64, DOI 10.5271/sjweh.648; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; PAUL GL, 1989, EUR J APPL PHYSIOL O, V58, P786, DOI 10.1007/BF00637392; Peek CB, 2012, TRENDS ENDOCRIN MET, V23, P312, DOI 10.1016/j.tem.2012.02.003; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qin Y, 2014, J NUTR, V144, P49, DOI 10.3945/jn.113.182725; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; RATHMACHER JA, 1995, AM J PHYSIOL-ENDOC M, V269, pE193, DOI 10.1152/ajpendo.1995.269.1.E193; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Salgado-Delgado RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060052; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Tan BB, 2013, J PROTEOME RES, V12, P3000, DOI 10.1021/pr400337b; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; Travers RL, 2017, EUR J NUTR, V56, P375, DOI 10.1007/s00394-015-1087-7; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Weinstein SJ, 2009, CANCER EPIDEM BIOMAR, V18, P2643, DOI 10.1158/1055-9965.EPI-09-0322; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yang Y, 2010, EXP MOL MED, V42, P768, DOI 10.3858/emm.2010.42.11.078; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	106	43	43	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2812	2828		10.1074/jbc.M115.681130	http://dx.doi.org/10.1074/jbc.M115.681130			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644470	hybrid, Green Published			2022-12-28	WOS:000369626900021
J	Leroy, E; Defour, JP; Sato, T; Dass, S; Gryshkova, V; Shwe, MM; Staerk, J; Constantinescu, SN; Smith, SO				Leroy, Emilie; Defour, Jean-Philippe; Sato, Takeshi; Dass, Sharmila; Gryshkova, Vitalina; Shwe, Myat M.; Staerk, Judith; Constantinescu, Stefan N.; Smith, Steven O.			His(499) Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE LOCALIZATION; GROWTH-FACTOR RECEPTOR; ERYTHROPOIETIN RECEPTOR; TRANSMEMBRANE DOMAIN; CYTOKINE RECEPTORS; LEUCINE-ZIPPER; ASSOCIATION; MPL; JUXTAMEMBRANE; HORMONE	Ligand binding to the extracellular domain of the thrombopoietin receptor (TpoR) imparts a specific orientation on the transmembrane (TM) and intracellular domains of the receptors that is required for physiologic activation via receptor dimerization. To map the inactive and active dimeric orientations of the TM helices, we performed asparagine (Asn)-scanning mutagenesis of the TM domains of the murine and human TpoR. Substitution of Asn at only one position (S505N) activated the human receptor, whereas Asn substitutions at several positions activated the murine receptor. Second site mutational studies indicate that His(499) near the N terminus of the TM domain is responsible for protecting the human receptor from activation by Asn mutations. Structural studies reveal that the sequence preceding His(499) is helical in the murine receptor but non-helical in peptides corresponding to the TM domain of the inactive human receptor. The activating S505N mutation and the small molecule agonist eltrombopag both induce helix in this region of the TM domain and are associated with dimerization and activation of the human receptor. Thus, His(499) regulates the activation of human TpoR and provides additional protection against activating mutations, such as oncogenic Asn mutations in the TM domain.	[Leroy, Emilie; Defour, Jean-Philippe; Gryshkova, Vitalina; Shwe, Myat M.; Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Leroy, Emilie; Defour, Jean-Philippe; Gryshkova, Vitalina; Shwe, Myat M.; Constantinescu, Stefan N.] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Sato, Takeshi] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Leroy, Emilie; Dass, Sharmila; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Staerk, Judith] Nord European Mol Biol Lab Partnership, Stem Cell Grp, N-0318 Oslo, Norway; [Staerk, Judith] Ctr Mol Med, N-0318 Oslo, Norway	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Osaka University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Smith, SO (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	steven.o.smith@stonybrook.edu; steven.o.smith@stonybrook.edu	Smith, Steven/HDM-9496-2022	Defour, Jean-Philippe/0000-0003-3999-5861; Constantinescu, Stefan N./0000-0002-8599-2699; Leroy, Emilie/0000-0001-5897-1713; Staerk, Judith/0000-0001-8698-6998	National Institutes of Health-National Science Foundation Instrumentation [S10 RR13889, DBI-9977553]; National Institutes of Health [GM-46732]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); FRIA Ph.D. fellowship; Cliniques universitaires St. Luc; de Duve Institute postdoctoral fellowship; Belspo Interuniversity Attraction Poles fellowship; Erasmus Mundus Panacea fellowship; Ludwig Cancer Research; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique; Salus Sanguinis; Fondation contre le cancer; Project Action de Recherche Concertee of the Universite catholique de Louvain [ARC10/15-027]; PAI program Belgian Medical Genetics Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM046732, R01GM046732] Funding Source: NIH RePORTER	National Institutes of Health-National Science Foundation Instrumentation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); FRIA Ph.D. fellowship(Fonds de la Recherche Scientifique - FNRS); Cliniques universitaires St. Luc; de Duve Institute postdoctoral fellowship; Belspo Interuniversity Attraction Poles fellowship; Erasmus Mundus Panacea fellowship; Ludwig Cancer Research; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Salus Sanguinis; Fondation contre le cancer; Project Action de Recherche Concertee of the Universite catholique de Louvain; PAI program Belgian Medical Genetics Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health-National Science Foundation Instrumentation Grants S10 RR13889 and DBI-9977553 and National Institutes of Health Grant GM-46732 (to S. O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) Ph.D. fellowship.; Supported by a FRIA Ph.D. fellowship and the Cliniques universitaires St. Luc.; Supported by a de Duve Institute postdoctoral fellowship and a Belspo Interuniversity Attraction Poles fellowship.; Supported by an Erasmus Mundus Panacea fellowship.; Supported by Ludwig Cancer Research, Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique, Salus Sanguinis, Fondation contre le cancer, Project Action de Recherche Concertee of the Universite catholique de Louvain (Grant ARC10/15-027), and the PAI program Belgian Medical Genetics Initiative.	ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; ARKIN IT, 1994, EMBO J, V13, P4757, DOI 10.1002/j.1460-2075.1994.tb06801.x; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Brooks AJ, 2014, CYTOKINE, V70, P22, DOI 10.1016/j.cyto.2014.07.227; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Defour JP, 2013, P NATL ACAD SCI USA, V110, P2540, DOI 10.1073/pnas.1211560110; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Ding F, 2004, BLOOD, V103, P4198, DOI 10.1182/blood-2003-10-3471; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Geddis AE, 2002, CYTOKINE GROWTH F R, V13, P61, DOI 10.1016/S1359-6101(01)00030-2; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Kim MJ, 2007, J BIOL CHEM, V282, P14253, DOI 10.1074/jbc.M611616200; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Liu W, 2005, BIOPHYS J, V89, P1194, DOI 10.1529/biophysj.104.057844; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; Marty C, 2009, J BIOL CHEM, V284, P11781, DOI 10.1074/jbc.M808703200; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; Onishi M, 1996, BLOOD, V88, P1399, DOI 10.1182/blood.V88.4.1399.bloodjournal8841399; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pecquet C, 2010, BLOOD, V115, P1037, DOI 10.1182/blood-2008-10-183558; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; ROTHSCHILD KJ, 1979, BIOPHYS J, V25, P473, DOI 10.1016/S0006-3495(79)85317-5; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sabath DF, 1999, BLOOD, V94, P365, DOI 10.1182/blood.V94.1.365.413a46_365_367; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	52	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2974	2987		10.1074/jbc.M115.696534	http://dx.doi.org/10.1074/jbc.M115.696534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627830	Green Published, hybrid			2022-12-28	WOS:000369626900034
J	Nelson, SM; Shay, AE; James, JL; Carlson, BA; Urban, JF; Prabhu, KS				Nelson, Shakira M.; Shay, Ashley E.; James, Jannaal L.; Carlson, Bradley A.; Urban, Joseph F., Jr.; Prabhu, K. Sandeep			Selenoprotein Expression in Macrophages Is Critical for Optimal Clearance of Parasitic Helminth Nippostrongylus brasiliensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; NEMATODE-INDUCED ALTERATIONS; GENE-EXPRESSION; SELENIUM DEFICIENCY; IMMUNE-RESPONSE; UP-REGULATION; IN-VIVO; CELLS; RECEPTOR; STAT6	The plasticity of macrophages is evident in helminthic parasite infections, providing protection from inflammation. Previously we demonstrated that the micronutrient selenium induces a phenotypic switch in macrophage activation from a classically activated (pro-inflammatory; M1/CAM) toward an alternatively activated (anti-inflammatory; M2/AAM) phenotype, where cyclooxygenase (COX)-dependent cyclopentenone prostaglandin J(2) (15d-PGJ(2)) plays a key role. Here, we hypothesize that dietary selenium modulates macrophage polarization toward an AAM phenotype to assist in the increasing clearance of adult Nippostrongylus brasiliensis, a gastrointestinal nematode parasite. Mice on a selenium-adequate (0.08 ppm) diet significantly augmented intestinal AAM presence while decreasing adult worms and fecal egg production when compared with infection of mice on selenium-deficient (<0.01 ppm) diet. Further increase in dietary selenium to supraphysiological levels (0.4 ppm) had very little or no impact on worm expulsion. Normal adult worm clearance and enhanced AAM marker expression were observed in the selenium-supplemented Trsp(fl/fl)Cre(WT) mice that express selenoproteins driven by tRNA(Sec) (Trsp), whereas N. brasiliensis-infected Trsp(fl/fl)Cre(LysM) selenium-supplemented mice showed a decreased clearance, with lowered intestinal expression of several AAM markers. Inhibition of the COX pathway with indomethacin resulted in delayed worm expulsion in selenium-adequate mice. This was rescued with 15d-PGJ(2), which partially recapitulated the effect of selenium supplementation on fecal egg output in addition to increasing markers of AAMs in the small intestine. Antagonism of PPAR gamma blocked the effect of selenium. These results suggest that optimal expression of selenoproteins and selenium-dependent production of COX-derived endogenous prostanoids, such as Delta(12)-PGJ(2) and 15d-PGJ(2), may regulate AAM activation to enhance anti-helminthic parasite responses.	[Nelson, Shakira M.; Shay, Ashley E.; James, Jannaal L.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Nelson, Shakira M.; Shay, Ashley E.; James, Jannaal L.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Nelson, Shakira M.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Carlson, Bradley A.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Agriculture (USDA)	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 115 Henning Bldg, University Pk, PA 16802 USA.	ksprabhu@psu.edu		Urban, Joseph/0000-0002-1590-8869	National Institutes of Health Public Health Service Grant [DK077152]; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project [4475]; National Institutes of Health Predoctoral Training Grant [T32 AI074551]; Agricultural Research Service of the United States Department of Agriculture [1235-5100-058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grant; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project; National Institutes of Health Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agricultural Research Service of the United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant DK077152 and United States Department of Agriculture National Institute of Food and Agriculture Hatch Project 4475 (to K. S. P.), National Institutes of Health Predoctoral Training Grant T32 AI074551 (to A. E. S.), and the Agricultural Research Service of the United States Department of Agriculture (1235-5100-058) (to J. F. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony BJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/128068; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; de Souza AP, 2010, PARASITOL RES, V106, P1293, DOI 10.1007/s00436-010-1794-1; DUNN A, 1986, J HELMINTHOL, V60, P260, DOI 10.1017/S0022149X00008464; Fredericks GJ, 2015, ANTIOXID REDOX SIGN, V23, P854, DOI 10.1089/ars.2015.6375; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Horsnell WGC, 2010, IMMUNOBIOLOGY, V215, P704, DOI 10.1016/j.imbio.2010.05.011; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Panzer M, 2012, J IMMUNOL, V188, P615, DOI 10.4049/jimmunol.1101164; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; Smith AD, 2013, INFECT IMMUN, V81, P2546, DOI 10.1128/IAI.01047-12; Sotillo J, 2014, MOL CELL PROTEOMICS, V13, P2736, DOI 10.1074/mcp.M114.038950; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Turanov AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140353; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Yeung KJA, 2005, EXP PARASITOL, V109, P201, DOI 10.1016/j.exppara.2004.12.015; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	49	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2787	2798		10.1074/jbc.M115.684738	http://dx.doi.org/10.1074/jbc.M115.684738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644468	hybrid, Green Published			2022-12-28	WOS:000369626900019
J	Majdoul, S; Seye, AK; Kichler, A; Holic, N; Galy, A; Bechinger, B; Fenard, D				Majdoul, Saliha; Seye, Ababacar K.; Kichler, Antoine; Holic, Nathalie; Galy, Anne; Bechinger, Burkhard; Fenard, David			Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APE LEUKEMIA-VIRUS; HISTIDINE-RICH PEPTIDES; VESICULAR STOMATITIS-VIRUS; AVIAN SARCOMA VIRUSES; RETROVIRAL TRANSDUCTION; HYDROPHOBIC MOMENT; MAMMALIAN-CELLS; LDL RECEPTOR; STEM-CELLS; T-CELLS	Gene delivery into hCD34+ hematopoietic stem/progenitor cells (HSPCs) using human immunodeficiency virus, type 1-derived lentiviral vectors (LVs) has several promising therapeutic applications. Numerous clinical trials are currently underway. However, the efficiency, safety, and cost of LV gene therapy could be ameliorated by enhancing target cell transduction levels and reducing the amount of LV used on the cells. Several transduction enhancers already exist, such as fibronectin fragments or cationic compounds. Recently, we discovered Vectofusin-1, a new transduction enhancer, also called LAH4-A4, a short histidine-rich amphipathic peptide derived from the LAH4 family of DNA transfection agents. Vectofusin-1 enhances the infectivity of lentiviral and gamma-retroviral vectors pseudotyped with various envelope glycoproteins. In this study, we compared a family of Vectofusin-1 isomers and showed that Vectofusin-1 remains the lead peptide for HSPC transduction enhancement with LVs pseudotyped with vesicular stomatitis virus glycoproteins and also with modified gibbon ape leukemia virus glycoproteins. By comparing the capacity of numerous Vectofusin-1 variants to promote the modified gibbon ape leukemia virus glycoprotein-pseudotyped lentiviral vector infectivity of HSPCs, the lysine residues on the N-terminal extremity of Vectofusin-1, a hydrophilic angle of 140 degrees formed by the histidine residues in the Schiffer-Edmundson helical wheel representation, hydrophobic residues consisting of leucine were all found to be essential and helped to define a minimal active sequence. The data also show that the critical determinants necessary for lentiviral transduction enhancement are partially different from those necessary for efficient antibiotic or DNA transfection activity of LAH4 derivatives. In conclusion, these results help to decipher the action mechanism of Vectofusin-1 in the context of hCD34+ cell-based gene therapy.	[Majdoul, Saliha; Seye, Ababacar K.; Holic, Nathalie; Galy, Anne; Fenard, David] Genethon, F-91000 Evry, France; [Majdoul, Saliha; Seye, Ababacar K.; Holic, Nathalie; Galy, Anne; Fenard, David] INSERM, UMR S951, F-91000 Evry, France; [Majdoul, Saliha; Holic, Nathalie; Galy, Anne; Fenard, David] Univ Evry, F-91000 Evry, France; [Kichler, Antoine] CNRS, UMR 7199, F-67401 Illkirch Graffenstaden, France; [Kichler, Antoine; Bechinger, Burkhard] Univ Strasbourg, F-67000 Strasbourg, France; [Bechinger, Burkhard] Inst Chim, CNRS, UMR 7177, F-67401 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Galy, A; Fenard, D (corresponding author), INSERM, UMR S951, Genethon, 1 Bis Rue Int, F-91000 Evry, France.	galy@genethon.fr; dfenard@genethon.fr	Galy, Anne HM/J-4439-2013; Holic, Nathalie/U-8979-2018; Fenard, David/D-9533-2011	Galy, Anne HM/0000-0002-0153-4392; Holic, Nathalie/0000-0001-9869-1388; Fenard, David/0000-0003-0242-386X	Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale [DCM2012-1225742]; Agence Nationale de la Recherche Project TRANSPEP [07-PCV-0018]; Agence Nationale de la Recherche Project LabEx Chemistry of Complex Systems [10-LABX-0026_CSC]; RTRA International Center of Frontier Research in Chemistry	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche Project TRANSPEP(French National Research Agency (ANR)); Agence Nationale de la Recherche Project LabEx Chemistry of Complex Systems(French National Research Agency (ANR)); RTRA International Center of Frontier Research in Chemistry	This work was supported by the Association Francaise contre les Myopathies (to A. G. and D. F.) and Fondation pour la Recherche Medicale Grant DCM2012-1225742 (to A. G., B. B., and D. F.). This work was also supported by Agence Nationale de la Recherche Projects TRANSPEP 07-PCV-0018 and LabEx Chemistry of Complex Systems 10-LABX-0026_CSC and the RTRA International Center of Frontier Research in Chemistry (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Amirache F, 2014, BLOOD, V123, P1422, DOI 10.1182/blood-2013-11-540641; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; Bechinger B, 1999, BIOPOLYMERS, V51, P174, DOI 10.1002/(SICI)1097-0282(1999)51:3<174::AID-BIP2>3.0.CO;2-7; Christodoulopoulos I, 2001, J VIROL, V75, P4129, DOI 10.1128/JVI.75.9.4129-4138.2001; CORNETTA K, 1989, J VIROL METHODS, V23, P187, DOI 10.1016/0166-0934(89)90132-8; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fenard D, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.17; Fenard D, 2013, J VIROL METHODS, V189, P375, DOI 10.1016/j.jviromet.2013.02.005; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Georgescu J, 2010, BIOPHYS J, V99, P2507, DOI 10.1016/j.bpj.2010.05.038; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hodgson CP, 1996, NAT BIOTECHNOL, V14, P339, DOI 10.1038/nbt0396-339; Hoefig I, 2012, J GENE MED, V14, P549, DOI 10.1002/jgm.2653; Ingrao D, 2014, HUM GENE THER METHOD, V25, P48, DOI 10.1089/hgtb.2013.090; INNES CL, 1990, J VIROL, V64, P957, DOI 10.1128/JVI.64.2.957-961.1990; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kichler A, 2003, P NATL ACAD SCI USA, V100, P1564, DOI 10.1073/pnas.0337677100; Kichler A, 2007, J MOL MED, V85, P191, DOI 10.1007/s00109-006-0119-4; Kichler A, 2006, BBA-BIOMEMBRANES, V1758, P301, DOI 10.1016/j.bbamem.2006.02.005; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lamers CHJ, 2008, CYTOTHERAPY, V10, P406, DOI 10.1080/14653240801982961; Langlet-Bertin B, 2010, PHARM RES-DORDR, V27, P1426, DOI 10.1007/s11095-010-0138-2; Liang M, 2009, J VIROL, V83, P13026, DOI 10.1128/JVI.01530-09; Marin V, 2015, MOL THER, V23, pS217, DOI 10.1016/S1525-0016(16)34149-1; Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje; Mason AJ, 2006, ANTIMICROB AGENTS CH, V50, P3305, DOI 10.1128/AAC.00490-06; Mason AJ, 2009, J BIOL CHEM, V284, P119, DOI 10.1074/jbc.M806201200; Meier C, 2014, WIRES NANOMED NANOBI, V6, P438, DOI 10.1002/wnan.1275; Merten OW, 2011, HUM GENE THER, V22, P343, DOI 10.1089/hum.2010.060; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; Moritz T, 1996, BLOOD, V88, P855, DOI 10.1182/blood.V88.3.855.bloodjournal883855; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; Uematsu N, 2000, BIOPHYS J, V79, P2075, DOI 10.1016/S0006-3495(00)76455-1; VOGT PK, 1967, VIROLOGY, V33, P175, DOI 10.1016/0042-6822(67)90109-2; Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n; Wurm M, 2010, J GENE MED, V12, P137, DOI 10.1002/jgm.1429; Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]; Zhan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077106; Zhang LS, 2014, J PEPT SCI, V20, P46, DOI 10.1002/psc.2587	51	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2161	2169		10.1074/jbc.M115.675033	http://dx.doi.org/10.1074/jbc.M115.675033			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26668323	hybrid, Green Published			2022-12-28	WOS:000369610400010
J	Musille, PM; Kossmann, BR; Kohn, JA; Ivanov, I; Ortlund, EA				Musille, Paul M.; Kossmann, Bradley R.; Kohn, Jeffrey A.; Ivanov, Ivaylo; Ortlund, Eric A.			Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR LRH-1; DRIVEN GENE-REGULATION; STEROIDOGENIC FACTOR-I; MOLECULAR-DYNAMICS; LIGAND-BINDING; CRYSTAL-STRUCTURES; HORMONE-RECEPTORS; LIVER; ACTIVATION; HOMOLOG-1	Phospholipids (PLs) are unusual signaling hormones sensed by the nuclear receptor liver receptor homolog-1 (LRH-1), which has evolved a novel allosteric pathway to support appropriate interaction with co-regulators depending on ligand status. LRH-1 plays an important role in controlling lipid and cholesterol homeostasis and is a potential target for the treatment of metabolic and neoplastic diseases. Although the prospect of modulating LRH-1 via small molecules is exciting, the molecular mechanism linking PL structure to transcriptional co-regulator preference is unknown. Previous studies showed that binding to an activating PL ligand, such as dilauroylphosphatidylcholine, favors LRH-1's interaction with transcriptional co-activators to up-regulate gene expression. Both crystallographic and solution-based structural studies showed that dilauroylphosphatidylcholine binding drives unanticipated structural fluctuations outside of the canonical activation surface in an alternate activation function (AF) region, encompassing the beta-sheet-H6 region of the protein. However, the mechanism by which dynamics in the alternate AF influences co-regulator selectivity remains elusive. Here, we pair x-ray crystallography with molecular modeling to identify an unexpected allosteric network that traverses the protein ligand binding pocket and links these two elements to dictate selectivity. We show that communication between the alternate AF region and classical AF2 is correlated with the strength of the co-regulator interaction. This work offers the first glimpse into the conformational dynamics that drive this unusual PL-mediated nuclear hormone receptor activation.	[Musille, Paul M.; Kohn, Jeffrey A.; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kossmann, Bradley R.; Ivanov, Ivaylo] Georgia State Univ, Dept Chem, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA	Emory University; University System of Georgia; Georgia State University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019; Ivanov, Ivaylo/A-7613-2013; Kossmann, Bradley/O-5016-2016	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Ivanov, Ivaylo/0000-0002-5306-1005; Kossmann, Bradley/0000-0001-5368-0976	United States Department of Energy Office of Science [DE-AC02-05CH11231]; Div Of Molecular and Cellular Bioscience [1149521] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110387] Funding Source: NIH RePORTER	United States Department of Energy Office of Science(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational resources were provided in part by National Science Foundation XSEDE Allocation CHE110042 and Allocation m1254 at the National Energy Research Scientific Computing Center supported by the United States Department of Energy Office of Science Contract DE-AC02-05CH11231.	Atkins WM, 2015, J STEROID BIOCHEM, V151, P3, DOI 10.1016/j.jsbmb.2014.09.010; Batista MRB, 2013, BIOPHYS J, V105, P1670, DOI 10.1016/j.bpj.2013.07.032; Benod C, 2013, J BIOL CHEM, V288, P19830, DOI 10.1074/jbc.M112.411686; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Blind RD, 2014, P NATL ACAD SCI USA, V111, P15054, DOI 10.1073/pnas.1416740111; Blind RD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003111; Bolado-Carrancio A, 2014, BIOCHEM BIOPH RES CO, V446, P614, DOI 10.1016/j.bbrc.2014.03.010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burendahl S, 2008, BIOCHEMISTRY-US, V47, P5205, DOI 10.1021/bi7025084; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Corzo CA, 2015, MOL PHARMACOL, V87, P296, DOI 10.1124/mol.114.095554; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-Marcos PJ, 2011, BBA-MOL BASIS DIS, V1812, P947, DOI 10.1016/j.bbadis.2010.12.010; Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421; Gerrits H, 2014, REPROD FERT DEVELOP, V26, P293, DOI 10.1071/RD12131; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang HW, 2010, BBA-MOL CELL BIOL L, V1801, P496, DOI 10.1016/j.bbalip.2009.12.013; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Kojetin DJ, 2013, MOL PHARMACOL, V83, P1, DOI 10.1124/mol.112.079285; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; LEVY RM, 1984, BIOPOLYMERS, V23, P1099, DOI 10.1002/bip.360230610; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mackinnon JAG, 2014, MOL CELL ENDOCRINOL, V393, P75, DOI 10.1016/j.mce.2014.05.017; Mamrosh JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01694; Martinez L, 2008, J PHYS CHEM B, V112, P10741, DOI 10.1021/jp803403c; Moore DD, 2010, ENDOCR J, V57, pS260; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Musille PM, 2013, J BIOL CHEM, V288, P20702, DOI 10.1074/jbc.M113.472837; Musille PM, 2013, FEBS LETT, V587, P1238, DOI 10.1016/j.febslet.2013.01.004; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Oosterveer MH, 2014, CELL MOL LIFE SCI, V71, P1453, DOI 10.1007/s00018-013-1505-z; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Stein S, 2015, CURR OPIN CELL BIOL, V33, P26, DOI 10.1016/j.ceb.2014.10.007; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Venteclef N, 2011, TRENDS ENDOCRIN MET, V22, P333, DOI 10.1016/j.tem.2011.04.004; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Whitby RJ, 2006, J MED CHEM, V49, P6652, DOI 10.1021/jm060990k; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192; Zhi XY, 2014, P NATL ACAD SCI USA, V111, P839, DOI 10.1073/pnas.1322827111	63	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1411	1426		10.1074/jbc.M115.662874	http://dx.doi.org/10.1074/jbc.M115.662874			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26553876	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000368068300032
J	Norkett, R; Modi, S; Birsa, N; Atkin, TA; Ivankovic, D; Pathania, M; Trossbach, SV; Korth, C; Hirst, WD; Kittler, JT				Norkett, Rosalind; Modi, Souvik; Birsa, Nicol; Atkin, Talia A.; Ivankovic, Davor; Pathania, Manav; Trossbach, Svenja V.; Korth, Carsten; Hirst, Warren D.; Kittler, Josef T.			DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROGENITOR PROLIFERATION; MITOFUSIN 2; DISC1; SCHIZOPHRENIA; TRANSPORT; PROTEIN; FUSION; TRAFFICKING; KINESIN	The DISC1 protein is implicated in major mental illnesses including schizophrenia, depression, bipolar disorder, and autism. Aberrant mitochondrial dynamics are also associated with major mental illness. DISC1 plays a role in mitochondrial transport in neuronal axons, but its effects in dendrites have yet to be studied. Further, the mechanisms of this regulation and its role in neuronal development and brain function are poorly understood. Here we have demonstrated that DISC1 couples to the mitochondrial transport and fusion machinery via interaction with the outer mitochondrial membrane GTPase proteins Miro1 and Miro2, the TRAK1 and TRAK2 mitochondrial trafficking adaptors, and the mitochondrial fusion proteins (mitofusins). Using live cell imaging, we show that disruption of the DISC1-Miro-TRAK complex inhibits mitochondrial transport in neurons. Wealso show that the fusion protein generated from the originally described DISC1 translocation (DISC1-Boymaw) localizes to the mitochondria, where it similarly disrupts mitochondrial dynamics. We also show by super resolution microscopy that DISC1 is localized to endoplasmic reticulum contact sites and that the DISC1-Boymaw fusion protein decreases the endoplasmic reticulum-mitochondria contact area. Moreover, disruption of mitochondrial dynamics by targeting the DISC1-Miro-TRAK complex or upon expression of the DISC1-Boymaw fusion protein impairs the correct development of neuronal dendrites. Thus, DISC1 acts as an important regulator of mitochondrial dynamics in both axons and dendrites to mediate the transport, fusion, and cross-talk of these organelles, and pathological DISC1 isoforms disrupt this critical function leading to abnormal neuronal development.	[Norkett, Rosalind; Modi, Souvik; Birsa, Nicol; Atkin, Talia A.; Ivankovic, Davor; Pathania, Manav; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Hirst, Warren D.] Pfizer, Neurosci Res Unit, Cambridge, MA 02139 USA; [Trossbach, Svenja V.; Korth, Carsten] Heinrich Heine Univ, Dept Neuropathol, D-40225 Dusseldorf, Germany	University of London; University College London; Pfizer; Heinrich Heine University Dusseldorf	Kittler, JT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	j.kittler@ucl.ac.uk	Cohen Solal, Talia/GQO-9853-2022; Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010	Cohen Solal, Talia/0000-0001-9525-5732; Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456; Modi, Souvik/0000-0001-5474-7765; Birsa, Nicol/0000-0002-8271-540X; Ivankovic, Davor/0000-0002-4881-9096; Pathania, Manav/0000-0001-5635-5028; Norkett, Rosalind/0000-0001-9460-9973; Hirst, Warren/0000-0003-0389-8891	European Research Council (ERC) [282430]; Wellcome Trust; Medical Research Council (MRC); Pfizer; EMBO Long-term Fellowship; Marie Curie International Incoming Fellowship (IIF) award; Brain Behavior and Research Foundation (NARSAD) [20350]; EU-FP7 (MC-ITN "IN-SENS") [607616]; Medical Research Council [MR/K015826/1, G0802377, 1069309] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018870] Funding Source: NIH RePORTER; MRC [G0802377, MR/K015826/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); EMBO Long-term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie International Incoming Fellowship (IIF) award; Brain Behavior and Research Foundation (NARSAD)(NARSAD); EU-FP7 (MC-ITN "IN-SENS"); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Starting Grant 282430 from the European Research Council (ERC), a Research Prize from the Lister Institute of Preventive Medicine, the Wellcome Trust, and a Medical Research Council (MRC) senior non-clinical fellowship (to J. T. K.). The authors declare that they have no conflicts of interest with the contents of this article.; An MRC CASE Award Ph.D. student sponsored by Pfizer.; Recipient of an EMBO Long-term Fellowship and Marie Curie International Incoming Fellowship (IIF) award.; Supported by a grant from the Brain Behavior and Research Foundation (NARSAD Independent Investigator Award 20350) and EU-FP7 (MC-ITN "IN-SENS" 607616).	Atkin TA, 2011, MOL PSYCHIATR, V16, P122, DOI 10.1038/mp.2010.110; Atkin TA, 2012, HUM MOL GENET, V21, P2017, DOI 10.1093/hmg/dds018; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; Birsa N, 2013, BIOCHEM SOC T, V41, P1525, DOI 10.1042/BST20130234; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Brandon NJ, 2005, MOL CELL NEUROSCI, V28, P613, DOI 10.1016/j.mcn.2004.11.003; Cagalinec M, 2013, J CELL SCI, V126, P2187, DOI 10.1242/jcs.118844; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carlyle BC, 2011, MOL PSYCHIATR, V16, P693, DOI 10.1038/mp.2011.17; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Eykelenboom JE, 2012, HUM MOL GENET, V21, P3374, DOI 10.1093/hmg/dds169; Flores R, 2011, NEUROSCI RES, V71, P71, DOI 10.1016/j.neures.2011.05.014; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Ji BH, 2014, HUM MOL GENET, V23, P5683, DOI 10.1093/hmg/ddu285; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kimura T, 2014, J NEUROSCI, V34, P6938, DOI 10.1523/JNEUROSCI.5095-13.2014; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Lee SA, 2015, J BIOL CHEM, V290, P7087, DOI 10.1074/jbc.M114.614750; Lepagnol-Bestel AM, 2013, MOL CELL NEUROSCI, V54, P84, DOI 10.1016/j.mcn.2013.01.006; Loss O, 2015, J NEUROSCI RES, V93, P1056, DOI 10.1002/jnr.23549; Luisier F, 2011, IEEE T IMAGE PROCESS, V20, P696, DOI 10.1109/TIP.2010.2073477; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Malavasi ELV, 2012, HUM MOL GENET, V21, P2779, DOI 10.1093/hmg/dds106; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Muir J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00151; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Ogawa F, 2014, HUM MOL GENET, V23, P906, DOI 10.1093/hmg/ddt485; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Smith KR, 2014, CELL REP, V9, P298, DOI 10.1016/j.celrep.2014.08.061; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Soda T, 2013, MOL PSYCHIATR, V18, P898, DOI 10.1038/mp.2013.38; Somerville SM, 2011, WORLD J BIOL PSYCHIA, V12, P48, DOI 10.3109/15622975.2010.505662; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Trossbach S. V., 2015, MOL PSYCHIA IN PRESS; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Zhou X, 2010, MOL PSYCHIATR, V15, P670, DOI 10.1038/mp.2009.127	75	64	66	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					613	629		10.1074/jbc.M115.699447	http://dx.doi.org/10.1074/jbc.M115.699447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26553875	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000367830500010
J	Nouws, J; Goswami, AV; Bestwick, M; McCann, BJ; Surovtseva, YV; Shadel, GS				Nouws, Jessica; Goswami, Arvind V.; Bestwick, Megan; McCann, Beverly Jo; Surovtseva, Yulia V.; Shadel, Gerald S.			Mitochondrial Ribosomal Protein L12 Is Required for POLRMT Stability and Exists as Two Forms Generated by Alternative Proteolysis during Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA SYNTHESIS; URACIL PHOSPHORIBOSYLTRANSFERASE; TRANSCRIPTION MACHINERY; CALORIE RESTRICTION; POLYMERASE; MRPL12; L7/L12; PHOSPHORYLATION; PEPTIDES; GROWTH	To translate the 13 mtDNA-encoded mRNAs involved in oxidative phosphorylation (OXPHOS), mammalian mitochondria contain a dedicated set of ribosomes comprising rRNAs encoded by the mitochondrial genome and mitochondrial ribosomal proteins (MRPs) that are encoded by nuclear genes and imported into the matrix. In addition to their role in the ribosome, several MRPs have auxiliary functions or have been implicated in other cellular processes like cell cycle regulation and apoptosis. For example, we have shown that human MRPL12 binds and activates mitochondrial RNA polymerase (POLRMT), and hence has distinct functions in the ribosome and mtDNA transcription. Here we provide concrete evidence that there are two mature forms of mammalian MRPL12 that are generated by a two-step cleavage during import, involving efficient cleavage by mitochondrial processing protease and a second inefficient or regulated cleavage by mitochondrial intermediate protease. We also show that knock-down of MRPL12 by RNAi results in instability of POLRMT, but not other primary mitochondrial transcription components, and a corresponding decrease in mitochondrial transcription rates. Knock-down of MRPL10, the binding partner of MRPL12 in the ribosome, results in selective degradation of the mature long form of MRPL12, but has no effect on POLRMT. We propose that the two forms of MRPL12 are involved in homeostatic regulation of mitochondrial transcription and ribosome biogenesis that likely contribute to cell cycle, growth regulation, and longevity pathways to which MRPL12 has been linked.	[Nouws, Jessica; Goswami, Arvind V.; Bestwick, Megan; McCann, Beverly Jo; Surovtseva, Yulia V.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Bestwick, Megan] Linfield Coll, Dept Chem, Mcminnville, OR 97128 USA; [McCann, Beverly Jo] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany	Yale University; Yale University; Linfield University; Technical University of Darmstadt	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA.	gerald.shadel@yale.edu		Bestwick, Megan/0000-0003-3670-5507; Nouws, Jessica/0000-0003-3347-3595	National Institutes of Health [AG047632]; EMBO [EMBO ALTF 1328-2012]; National Institutes of Health NRSA [F32 DK091042, F32 GM093590-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG047632 (to G. S. S.). The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by EMBO postdoctoral fellowship EMBO ALTF 1328-2012.; Supported by National Institutes of Health NRSA F32 DK091042.; Supported by National Institues of Health NRSA F32 GM093590-01.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; Bocharov EV, 1998, FEBS LETT, V423, P347, DOI 10.1016/S0014-5793(98)00121-5; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bralha FN, 2015, ONCOTARGET, V6, P37216, DOI 10.18632/oncotarget.6129; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Cleary MD, 2008, METHOD ENZYMOL, V448, P379, DOI 10.1016/S0076-6879(08)02619-0; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Goertzel B, 2008, REJUV RES, V11, P735, DOI 10.1089/rej.2007.0627; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Han MJ, 2011, PROTEIN EXPRES PURIF, V78, P48, DOI 10.1016/j.pep.2011.03.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Rebelo AP, 2011, J INHERIT METAB DIS, V34, P941, DOI 10.1007/s10545-011-9330-8; Seidel-Rogol BL, 2002, NUCLEIC ACIDS RES, V30, P1929, DOI 10.1093/nar/30.9.1929; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shutt TE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-203; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035	36	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					989	997		10.1074/jbc.M115.689299	http://dx.doi.org/10.1074/jbc.M115.689299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26586915	Green Published, hybrid			2022-12-28	WOS:000367830500044
J	Vidic, J; Richard, CA; Pechoux, C; Da Costa, B; Bertho, N; Mazerat, S; Delmas, B; Chevalier, C				Vidic, Jasmina; Richard, Charles-Adrien; Pechoux, Christine; Da Costa, Bruno; Bertho, Nicolas; Mazerat, Sandra; Delmas, Bernard; Chevalier, Christophe			Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ELECTROCHEMICAL DETECTION; MITOCHONDRIAL-MEMBRANE; MISFOLDING DISEASES; LIPID-MEMBRANES; ALPHA-SYNUCLEIN; INFECTED-CELLS; MESSENGER-RNA; MECHANISM; BINDING	PB1-F2 is a small accessory protein encoded by an alternative open reading frame in PB1 segments of most influenza A virus. PB1-F2 is involved in virulence by inducing mitochondria-mediated immune cells apoptosis, increasing inflammation, and enhancing predisposition to secondary bacterial infections. Using biophysical approaches we characterized membrane disruptive activity of the full-length PB1-F2 (90 amino acids), its N-terminal domain (52 amino acids), expressed by currently circulating H1N1 viruses, and its C-terminal domain (38 amino acids). Both full-length and N-terminal domain of PB1-F2 are soluble at pH values <= 6, whereas the C-terminal fragment was found soluble only at pH <= 3. All three peptides are intrinsically disordered. At pH >= 7, the C-terminal part of PB1-F2 spontaneously switches to amyloid oligomers, whereas full-length and the N-terminal domain of PB1-F2 aggregate to amorphous structures. When incubated with anionic liposomes at pH 5, full-length and the C-terminal part of PB1-F2 assemble into amyloid structures and disrupt membrane at nanomolar concentrations. PB1-F2 and its C-terminal exhibit no significant antimicrobial activity. When added in the culture medium of mammalian cells, PB1-F2 amorphous aggregates show no cytotoxicity, whereas PB1-F2 pre-assembled into amyloid oligomers or fragmented nanoscaled fibrils was highly cytotoxic. Furthermore, the formation of PB1-F2 amyloid oligomers in infected cells was directly reflected by membrane disruption and cell death as observed in U937 and A549 cells. Altogether our results demonstrate that membrane-lytic activity of PB1-F2 is closely linked to supramolecular organization of the protein.	[Vidic, Jasmina; Richard, Charles-Adrien; Da Costa, Bruno; Bertho, Nicolas; Delmas, Bernard; Chevalier, Christophe] INRA, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France; [Pechoux, Christine] INRA, Genet Anim & Biol Integrat, UMR1313, F-78350 Jouy En Josas, France; [Mazerat, Sandra] Univ Paris 11, Inst Chim Mol & Mat Orsay, CNRS, UMR 8182, F-91400 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Vidic, J (corresponding author), INRA, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France.	jasmina.vidic@jouy.inra.fr	Chevalier, Christophe/AAW-5560-2020; Chevalier, Christophe/C-2575-2009; Vidic, Jasmina/AFP-6747-2022; Chevalier, Christophe/AAK-4461-2020; BERTHO, Nicolas/B-8167-2019	Chevalier, Christophe/0000-0003-3231-9027; Vidic, Jasmina/0000-0002-8549-8199; BERTHO, Nicolas/0000-0002-6732-3483; RICHARD, Charles-Adrien/0000-0001-5306-2297				Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chakrabarti AK, 2013, VIROLOGY, V440, P97, DOI 10.1016/j.virol.2013.02.025; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Daude N, 2010, J NEUROCHEM, V113, P92, DOI 10.1111/j.1471-4159.2010.06575.x; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Goodchild SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104492; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kosik I, 2013, VIROLOGY, V447, P1, DOI 10.1016/j.virol.2013.08.022; Krumbholz A, 2011, MED MICROBIOL IMMUN, V200, P69, DOI 10.1007/s00430-010-0176-8; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Li QJ, 2013, BIOCHEM BIOPH RES CO, V438, P519, DOI 10.1016/j.bbrc.2013.07.104; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056; Miodek A, 2014, BIOSENS BIOELECTRON, V59, P6, DOI 10.1016/j.bios.2014.02.037; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Relini A, 2014, ADV COLLOID INTERFAC, V207, P81, DOI 10.1016/j.cis.2013.10.015; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Steunou S, 2010, BIOSENS BIOELECTRON, V26, P1399, DOI 10.1016/j.bios.2010.07.064; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Terakawa MS, 2015, J BIOL CHEM, V290, P815, DOI 10.1074/jbc.M114.592527; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vasin AV, 2014, VIRUS RES, V185, P53, DOI 10.1016/j.virusres.2014.03.015; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Vidic J., 2013, J ANAL BIOANAL TECH, V4, P169; Walsh P, 2014, J BIOL CHEM, V289, P10419, DOI 10.1074/jbc.M113.515866; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wright P., 2007, ORTHOMYXOVIRUSES; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	53	35	38	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					739	751		10.1074/jbc.M115.652917	http://dx.doi.org/10.1074/jbc.M115.652917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601953	Green Published, hybrid			2022-12-28	WOS:000367830500022
J	Gogl, G; Alexa, A; Kiss, B; Katona, G; Kovacs, M; Bodor, A; Remenyi, A; Nyitray, L				Gogl, Gergo; Alexa, Anita; Kiss, Bence; Katona, Gergely; Kovacs, Mihaly; Bodor, Andrea; Remenyi, Attila; Nyitray, Laszlo			Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; crystal structure; extracellular-signal-regulated kinase (ERK); kinetics; melanoma; mitogen-activated protein kinase (MAPK); nuclear magnetic resonance (NMR); RSK; S100 proteins; small-angle X-ray scattering (SAXS)	ACTIVATION; DOMAIN; COMPLEX; PHOSPHORYLATION; EVOLUTION; FAMILY; TARGET	Mitogen-activated protein kinases (MAPK) promote MAPK-activated protein kinase activation. In the MAPK pathway responsible for cell growth, ERK2 initiates the first phosphorylation event on RSK1, which is inhibited by Ca2+-binding S100 proteins in malignant melanomas. Here, we present a detailed in vitro biochemical and structural characterization of the S100B-RSK1 interaction. The Ca2+-dependent binding of S100B to the calcium/calmodulin-dependent protein kinase (CaMK)-type domain of RSK1 is reminiscent of the better known binding of calmodulin to CaMKII. Although S100B-RSK1 and the calmodulin-CAMKII system are clearly distinct functionally, they demonstrate how unrelated intracellular Ca2+-binding proteins could influence the activity of the CaMK domain-containing protein kinases. Our crystallographic, small angle x-ray scattering, and NMR analysis revealed that S100B forms a fuzzy complex with RSK1 peptide ligands. Based on fast-kinetics experiments, we conclude that the binding involves both conformation selection and induced fit steps. Knowledge of the structural basis of this interaction could facilitate therapeutic targeting of melanomas.	[Gogl, Gergo; Kiss, Bence; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, ELTE MTA Momentum Motor Enzymol Res Grp, H-1117 Budapest, Hungary; [Bodor, Andrea] Eotvos Lorand Univ, Inst Chem, H-1117 Budapest, Hungary; [Alexa, Anita; Remenyi, Attila] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Momentum Prot Interact Grp, H-1117 Budapest, Hungary; [Katona, Gergely] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Gothenburg	Remenyi, A (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.	remenyi.attila@ttk.mta.hu; nyitray@elte.hu	Bodor, Andrea/AAL-7854-2020; Nyitray, László/AAE-5910-2020; Kiss, Bence/AAF-1808-2020; Remenyi, Attila/N-1345-2016; Katona, Gergely/B-3491-2008; Gogl, Gergo/ABH-4309-2020; Kovacs, Mihaly/A-6841-2011; Bodor, Andrea/G-1797-2018	Bodor, Andrea/0000-0002-7422-298X; Nyitray, László/0000-0003-4717-5994; Katona, Gergely/0000-0002-2031-8716; Gogl, Gergo/0000-0002-8597-3711; Bodor, Andrea/0000-0002-7422-298X; Remenyi, Attila/0000-0002-8345-1311; Kovacs, Mihaly/0000-0002-1200-4741; Alexa, Anita/0000-0002-5740-7835; Kiss, Bence/0000-0001-5810-5858	Hungarian National Research Fund (OTKA) [K108437, NK101072]; Momentum Program of the Hungarian Academy of Sciences [LP2013-57, LP-006/2011]; Swedish Research Council; MedInProt Program of the Hungarian Academy of Sciences; European Union; European Social Fund Grant [TAMOP4.2.1./B-09/KMR-2010-0003]	Hungarian National Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Momentum Program of the Hungarian Academy of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); MedInProt Program of the Hungarian Academy of Sciences; European Union(European Commission); European Social Fund Grant	This work was supported in part by Hungarian National Research Fund (OTKA) Grants K108437 (to L. N.) and NK101072 (to A. B.), the Momentum Program of the Hungarian Academy of Sciences Grants LP2013-57 (to A. R.) and LP-006/2011 (to M. K.), the Swedish Research Council (to G. K.), the MedInProt Program of the Hungarian Academy of Sciences, the European Union, and the European Social Fund Grant (TAMOP4.2.1./B-09/KMR-2010-0003). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexa A, 2015, P NATL ACAD SCI USA, V112, P2711, DOI 10.1073/pnas.1417571112; Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cavalier MC, 2014, BIOCHEMISTRY-US, V53, P6628, DOI 10.1021/bi5005552; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Gao XL, 2012, MOL BIOL CELL, V23, P503, DOI 10.1091/mbc.E11-07-0658; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Gogas H, 2009, ANN ONCOL, V20, P8, DOI 10.1093/annonc/mdp251; Hartman KG, 2014, J BIOL CHEM, V289, P12886, DOI 10.1074/jbc.M114.561613; Hartman KG, 2013, FUTURE MED CHEM, V5, P97, DOI 10.4155/fmc.12.191; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller R., 2004, COMPUTER AIDED RESON, V1; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Li D, 2012, ACTA CRYSTALLOGR D, V68, P680, DOI 10.1107/S0907444912007457; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Ostendorp T, 2011, BBA-MOL CELL RES, V1813, P1083, DOI 10.1016/j.bbamcr.2010.10.006; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Romeo Y, 2013, ONCOGENE, V32, P2917, DOI 10.1038/onc.2012.312; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Underwood KW, 2003, STRUCTURE, V11, P627, DOI 10.1016/S0969-2126(03)00092-3; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; Weichenberger CX, 2014, ACTA CRYSTALLOGR D, V70, P1579, DOI 10.1107/S1399004714005550; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	41	37	37	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					11	27		10.1074/jbc.M115.684928	http://dx.doi.org/10.1074/jbc.M115.684928			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26527685	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000367589500002
J	Stewart, SE; Bird, CH; Tabor, RF; D'Angelo, ME; Piantavigna, S; Whisstock, JC; Trapani, JA; Martin, LL; Bird, PI				Stewart, Sarah E.; Bird, Catherina H.; Tabor, Rico F.; D'Angelo, Michael E.; Piantavigna, Stefania; Whisstock, James C.; Trapani, Joseph A.; Martin, Lisandra L.; Bird, Phillip I.			Analysis of Perforin Assembly by Quartz Crystal Microbalance Reveals a Role for Cholesterol and Calcium-independent Membrane Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; PORE-FORMING PROTEIN; STREPTOLYSIN-O; TARGET MEMBRANES; PLASMA-MEMBRANE; C2 DOMAIN; GRANZYMES; LYMPHOCYTES; MECHANISM; CYTOLYSIN	Perforin is an essential component in the cytotoxic lymphocyte-mediated cell death pathway. The traditional view holds that perforin monomers assemble into pores in the target cell membrane via a calcium-dependent process and facilitate translocation of cytotoxic proteases into the cytoplasm to induce apoptosis. Although many studies have examined the structure and role of perforin, the mechanics of pore assembly and granzyme delivery remain unclear. Here we have employed quartz crystal microbalance with dissipation monitoring (QCM-D) to investigate binding and assembly of perforin on lipid membranes, and show that perforin monomers bind to the membrane in a cooperative manner. We also found that cholesterol influences perforin binding and activity on intact cells and model membranes. Finally, contrary to current thinking, perforin efficiently binds membranes in the absence of calcium. When calcium is added to perforin already on the membrane, the QCM-D response changes significantly, indicating that perforin becomes membranolytic only after calcium binding.	[Stewart, Sarah E.; Bird, Catherina H.; D'Angelo, Michael E.; Whisstock, James C.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Tabor, Rico F.; Piantavigna, Stefania; Martin, Lisandra L.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Canc Cell Death Lab, East Melbourne, Vic 3002, Australia	Monash University; Monash University; Monash University; Peter Maccallum Cancer Center	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phil.bird@monash.edu	Martin, Lisandra L/E-4482-2010	Martin, Lisandra L/0000-0003-0486-5813; D'Angelo, Michael/0000-0001-9342-0132; Tabor, Rico/0000-0003-2926-0095; Whisstock, James/0000-0003-4200-5611; Bird, Phillip/0000-0002-6695-606X; Trapani, Joseph/0000-0003-0983-1532; Stewart, Sarah E/0000-0003-3712-9898	National Health and Medical Research Council (Australia); Australian Research Council	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (Australia) (to P. I. B. and J. C. W.) and by grants from the Australian Research Council (to L. L. M R. F. T., and J. C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; BHAKDI S, 1985, INFECT IMMUN, V47, P52; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; CRIADO M, 1985, J IMMUNOL, V135, P4245; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Harris JR, 1998, J STRUCT BIOL, V121, P343, DOI 10.1006/jsbi.1998.3989; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Krasilnikov OV, 2007, BIOCHIMIE, V89, P271, DOI 10.1016/j.biochi.2006.12.003; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leung C, 2014, ELIFE, V3, DOI 10.7554/eLife.04247; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; MASSON D, 1985, J BIOL CHEM, V260, P9069; McCubbin GA, 2011, EUR BIOPHYS J BIOPHY, V40, P437, DOI 10.1007/s00249-010-0652-5; Mechler A, 2009, BIOMATERIALS, V30, P682, DOI 10.1016/j.biomaterials.2008.10.016; Metkar SS, 2015, CELL DEATH DIFFER, V22, P74, DOI 10.1038/cdd.2014.110; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; NIEDERMEYER W, 1985, TOXICON, V23, P425, DOI 10.1016/0041-0101(85)90026-1; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Piantavigna S, 2011, BBA-BIOMEMBRANES, V1808, P1811, DOI 10.1016/j.bbamem.2011.03.002; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Ponting CP, 1996, PROTEIN SCI, V5, P162; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; SAUERBREY G, 1959, Z PHYS, V155, P155; Sekiya K, 1993, Kansenshogaku Zasshi, V67, P736; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stewart SE, 2015, BBA-BIOMEMBRANES, V1848, P115, DOI 10.1016/j.bbamem.2014.10.012; Stewart SE, 2014, J BIOL CHEM, V289, P9172, DOI 10.1074/jbc.M113.544890; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Tabor RF, 2010, J COLLOID INTERF SCI, V346, P424, DOI 10.1016/j.jcis.2010.03.047; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Torn LH, 2005, LANGMUIR, V21, P7768, DOI 10.1021/la051102b; Traore DAK, 2013, BIOCHEM J, V456, P323, DOI 10.1042/BJ20130999; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3	45	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31101	31112		10.1074/jbc.M115.683078	http://dx.doi.org/10.1074/jbc.M115.683078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26542805	Green Published, hybrid			2022-12-28	WOS:000367199000038
J	Du, YZ; Nomura, Y; Zhorov, BS; Dong, K				Du, Yuzhe; Nomura, Yoshiko; Zhorov, Boris S.; Dong, Ke			Evidence for Dual Binding Sites for 1,1,1-Trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) in Insect Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRETHROID-RECEPTOR-SITES; CRYSTAL-STRUCTURE; ION CHANNELS; MUTATIONS; PERMETHRIN; POTASSIUM; MECHANISM; LINKER	1,1,1-Trichloro-2,2-bis(p-chlorophenyl) ethane (DDT), the first organochlorine insecticide, and pyrethroid insecticides are sodium channel agonists. Although the use of DDT is banned in most of the world due to its detrimental impact on the ecosystem, indoor residual spraying of DDT is still recommended for malaria control in Africa. Development of resistance to DDT and pyrethroids is a serious global obstacle for managing disease vectors. Mapping DDT binding sites is necessary for understanding mechanisms of resistance and modulation of sodium channels by structurally different ligands. The pioneering model of the housefly sodium channel visualized the first receptor for pyrethroids, PyR1, in the II/III domain interface and suggested thatDDTbinds within PyR1. Previously, we proposed the second pyrethroid receptor, PyR2, at the I/II domain interface. However, whether DDT binds to both pyrethroid receptor sites remains unknown. Here, using computational docking of DDT into the Kv1.2-based mosquito sodium channel model, we predict that two DDT molecules can bind simultaneously within PyR1 and PyR2. The bulky trichloromethyl group of each DDT molecule fits snugly between four helices in the bent domain interface, whereas two p-chlorophenyl rings extend into two wings of the interface. Model-driven mutagenesis and electrophysiological analysis confirmed these propositions and revealed 10 previously unknown DDT-sensing residues within PyR1 and PyR2. Our study proposes a dual DDT-receptor model and provides a structural background for rational development of new insecticides.	[Du, Yuzhe; Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol Genet & Neurosci Programs, E Lansing, MI 48824 USA; [Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia	Michigan State University; McMaster University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Dong, K (corresponding author), Michigan State Univ, Dept Entomol Genet & Neurosci Programs, E Lansing, MI 48824 USA.; Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.; Zhorov, BS (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia.	zhorov@mcmaster.ca; dongk@msu.edu	Zhorov, Boris S./V-8072-2019; Zhorov, Boris/T-9892-2019	Zhorov, Boris/0000-0002-3630-7114	National Institutes of Health from NIGMS [GM057440]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM057440 from NIGMS (to K. D. and B. S. Z.) and the Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04894 (to B. S. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Davies T. G. E., 2009, Bayer CropScience Journal, V62, P159; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Du YZ, 2015, MOL PHARMACOL, V88, P273, DOI 10.1124/mol.115.098707; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Rinkevich FD, 2015, NEUROTOXICOLOGY, V47, P99, DOI 10.1016/j.neuro.2015.02.001; Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7; Soderlund D.M., 2005, P1; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; Usherwood PNR, 2005, FEBS LETT, V579, P6317, DOI 10.1016/j.febslet.2005.09.096; Vais H, 2000, FEBS LETT, V470, P135, DOI 10.1016/S0014-5793(00)01305-3; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; Wang LX, 2015, MOL PHARMACOL, V87, P421, DOI 10.1124/mol.114.094730; Wang SY, 2001, MOL PHARMACOL, V60, P620; Wrzesinska B, 2014, INSECT MOL BIOL, V23, P682, DOI 10.1111/imb.12112; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x	33	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4638	4648		10.1074/jbc.M115.678672	http://dx.doi.org/10.1074/jbc.M115.678672			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26637352	hybrid, Green Published			2022-12-28	WOS:000371604600031
J	Laukka, T; Mariani, CJ; Ihantola, T; Cao, JZ; Hokkanen, J; Kaelin, WG; Godley, LA; Koivunen, P				Laukka, Tuomas; Mariani, Christopher J.; Ihantola, Tuukka; Cao, John Z.; Hokkanen, Juho; Kaelin, William G., Jr.; Godley, Lucy A.; Koivunen, Peppi			Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-hydroxymethylcytosine (5-hmC); epigenetics; hypoxia; hypoxia-inducible factor (HIF); leukemia; AML; TET; fumarate; succinate	HYPERMETHYLATOR PHENOTYPE; PROLYL 4-HYDROXYLASES; SDH MUTATIONS; 5-HYDROXYMETHYLCYTOSINE; PARAGANGLIOMA; CANCER; DNA; PROTEINS; HIF; FH	The TET enzymes are members of the 2-oxoglutarate-dependent dioxygenase family and comprise three isoenzymes in humans: TETs 1-3. These TETs convert 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) in DNA, and high 5-hmC levels are associated with active transcription. The importance of the balance in these modified cytosines is emphasized by the fact that TET2 is mutated in several human cancers, including myeloid malignancies such as acute myeloid leukemia (AML). We characterize here the kinetic and inhibitory properties of Tets and show that the K-m value of Tets 1 and 2 for O-2 is 30 m, indicating that they retain high activity even under hypoxic conditions. The AML-associated mutations in the Fe2+ and 2-oxoglutarate-binding residues increased the K-m values for these factors 30-80-fold and reduced the V-max values. Fumarate and succinate, which can accumulate to millimolar levels in succinate dehydrogenase and fumarate hydratase-mutant tumors, were identified as potent Tet inhibitors in vitro, with IC50 values approximate to 400-500 m. Fumarate and succinate also down-regulated global 5-hmC levels in neuroblastoma cells and the expression levels of some hypoxia-inducible factor (HIF) target genes via TET inhibition, despite simultaneous HIF stabilization. The combination of fumarate or succinate treatment with TET1 or TET3 silencing caused differential effects on the expression of specific HIF target genes. Altogether these data show that hypoxia-inducible genes are regulated in a multilayered manner that includes epigenetic regulation via TETs and 5-hmC levels in addition to HIF stabilization.	[Laukka, Tuomas; Ihantola, Tuukka; Koivunen, Peppi] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; [Mariani, Christopher J.; Cao, John Z.; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Mariani, Christopher J.] Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA; [Cao, John Z.; Godley, Lucy A.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Hokkanen, Juho] Admescope Ltd, Typpitie 1, FIN-90620 Oulu, Finland; [Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Kaelin, William G., Jr.; Koivunen, Peppi] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Oulu; University of Chicago; University of Chicago; University of Chicago; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Koivunen, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland.	peppi.koivunen@oulu.fi		Cao, Zhongyang/0000-0001-7561-235X; Ihantola, Tuukka/0000-0003-4182-2011; Laukka, Tuomas/0000-0003-1152-4515	Academy of Finland [120156, 140765, 218129, 266719]; S. Juselius Foundation; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation; Finnish Cancer Organizations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); S. Juselius Foundation; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation; Finnish Cancer Organizations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Academy of Finland Grants 120156, 140765, 218129, and 266719 (to P. K.), and grants from the S. Juselius Foundation (to P. K.), the Emil Aaltonen Foundation (to P. K.), the Jane and Aatos Erkko Foundation (to P. K.), and the Finnish Cancer Organizations (to P. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Haffner MC, 2011, ONCOTARGET, V2, P627; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vasanthakumar A, 2015, CANCER GENET-NY, V208, P167, DOI 10.1016/j.cancergen.2015.02.009; Vasanthakumar A, 2013, BLOOD, V121, P2059, DOI 10.1182/blood-2012-04-421065; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	185	191	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4256	4265		10.1074/jbc.M115.688762	http://dx.doi.org/10.1074/jbc.M115.688762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703470	hybrid, Green Published			2022-12-28	WOS:000371338400048
J	Luchinat, E; Banci, L				Luchinat, Enrico; Banci, Lucia			A Unique Tool for Cellular Structural Biology: In-cell NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cell compartmentalization; intracellular processing; molecular cell biology; nuclear magnetic resonance (NMR); post-translational modification (PTM); protein folding; structural biology	PROTEIN-PROTEIN INTERACTIONS; SOLID-STATE NMR; MULTIDIMENSIONAL NMR; ESCHERICHIA-COLI; F-19 NMR; SPECTROSCOPY; PHOSPHORYLATION; EXPRESSION; MATURATION; COMPLEXES	Conventional structural and chemical biology approaches are applied to macromolecules extrapolated from their native context. When this is done, important structural and functional features of macromolecules, which depend on their native network of interactions within the cell, may be lost. In-cell nuclear magnetic resonance is a branch of biomolecular NMR spectroscopy that allows macromolecules to be analyzed in living cells, at the atomic level. In-cell NMR can be applied to several cellular systems to obtain biologically relevant structural and functional information. Here we summarize the existing approaches and focus on the applications to protein folding, interactions, and post-translational modifications.	[Luchinat, Enrico; Banci, Lucia] Univ Florence, Magnet Resonance Ctr CERM, I-50121 Florence, Italy; [Luchinat, Enrico] Univ Florence, Dept Biomed Clin & Expt Sci, I-50121 Florence, Italy; [Banci, Lucia] Univ Florence, Dept Chem, I-50121 Florence, Italy	University of Florence; University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, I-50121 Florence, Italy.; Banci, L (corresponding author), Univ Florence, Dept Chem, I-50121 Florence, Italy.	banci@cerm.unifi.it	Luchinat, Enrico/O-1776-2014	Luchinat, Enrico/0000-0003-4183-4311; BANCI, LUCIA/0000-0003-0562-5774				Amata I, 2013, CHEMBIOCHEM, V14, P1820, DOI 10.1002/cbic.201300139; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arnesano F, 2011, J AM CHEM SOC, V133, P18361, DOI 10.1021/ja207346p; Banci L, 2013, CHEM BIOL, V20, P747, DOI 10.1016/j.chembiol.2013.05.007; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023561; Barbieri L, 2014, BBA-MOL CELL RES, V1843, P2492, DOI 10.1016/j.bbamcr.2014.06.009; Barnes CO, 2011, CHEMBIOCHEM, V12, P390, DOI 10.1002/cbic.201000610; Bekei B., 2013, THESIS FREIE U BERLI; Bertini I, 2011, ANGEW CHEM INT EDIT, V50, P2339, DOI 10.1002/anie.201006636; Bertrand K, 2012, J AM CHEM SOC, V134, P12798, DOI 10.1021/ja304809s; Burz DS, 2006, NAT PROTOC, V1, P146, DOI 10.1038/nprot.2006.23; Burz DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002571; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Crowley PB, 2011, CHEMBIOCHEM, V12, P1043, DOI 10.1002/cbic.201100063; Danielsson J, 2013, J AM CHEM SOC, V135, P10266, DOI 10.1021/ja404425r; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Felli IC, 2014, NAT PROTOC, V9, P2005, DOI 10.1038/nprot.2014.124; Felli IC, 2014, J MAGN RESON, V241, P115, DOI 10.1016/j.jmr.2013.10.020; Hansel R, 2013, TOP CURR CHEM, V330, P47, DOI 10.1007/128_2012_332; Hansel R, 2009, J AM CHEM SOC, V131, P15761, DOI 10.1021/ja9052027; Hamatsu J, 2013, J AM CHEM SOC, V135, P1688, DOI 10.1021/ja310928u; Hoch JC, 2014, ACCOUNTS CHEM RES, V47, P708, DOI 10.1021/ar400244v; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Kubo S, 2013, ANGEW CHEM INT EDIT, V52, P1208, DOI 10.1002/anie.201207243; Kyne C, 2015, PROTEIN SCI, V24, P310, DOI 10.1002/pro.2615; Li CG, 2010, J AM CHEM SOC, V132, P321, DOI 10.1021/ja907966n; Luchinat E, 2015, CHEM COMMUN, V51, P584, DOI 10.1039/c4cc08129c; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; Luh LM, 2013, J AM CHEM SOC, V135, P13796, DOI 10.1021/ja405244v; Maldonado AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074576; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Monteith WB, 2014, P NATL ACAD SCI USA, V111, P11335, DOI 10.1073/pnas.1406845111; Ogino S, 2009, J AM CHEM SOC, V131, P10834, DOI 10.1021/ja904407w; Reardon PN, 2005, J AM CHEM SOC, V127, P10848, DOI 10.1021/ja053145k; Reckel S, 2012, CHEMBIOCHEM, V13, P534, DOI 10.1002/cbic.201100721; Renault M, 2012, P NATL ACAD SCI USA, V109, P4863, DOI 10.1073/pnas.1116478109; Renault M, 2012, ANGEW CHEM INT EDIT, V51, P2998, DOI 10.1002/anie.201105984; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schlesinger AP, 2011, J AM CHEM SOC, V133, P8082, DOI 10.1021/ja201206t; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2004, J AM CHEM SOC, V126, P7119, DOI 10.1021/ja049977k; Serber Z, 2001, J AM CHEM SOC, V123, P8895, DOI 10.1021/ja0112846; Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Sharaf NG, 2010, J MAGN RESON, V202, P140, DOI 10.1016/j.jmr.2009.10.008; Smith AE, 2015, PROTEIN SCI, V24, P706, DOI 10.1002/pro.2643; Wang QH, 2011, BIOCHEMISTRY-US, V50, P9225, DOI 10.1021/bi201287e; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wang YQ, 2010, J AM CHEM SOC, V132, P9392, DOI 10.1021/ja102296k; Xie JJ, 2009, J MED CHEM, V52, P3516, DOI 10.1021/jm9000743; Ye YS, 2013, CHEM-EUR J, V19, P12705, DOI 10.1002/chem.201301657; Zhao YG, 2011, J STRUCT BIOL, V175, P209, DOI 10.1016/j.jsb.2011.04.017	57	62	62	5	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3776	3784		10.1074/jbc.R115.643247	http://dx.doi.org/10.1074/jbc.R115.643247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26677229	Green Published, hybrid			2022-12-28	WOS:000371338400009
J	Chen, YY; Maskri, O; Chaminade, F; Rene, B; Benkaroun, J; Godet, J; Mely, Y; Mauffret, O; Fosse, P				Chen, Yingying; Maskri, Ouerdia; Chaminade, Francoise; Rene, Brigitte; Benkaroun, Jessica; Godet, Julien; Mely, Yves; Mauffret, Olivier; Fosse, Philippe			Structural Insights into the HIV-1 Minus-strand Strong-stop DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA structure; DNA-protein interaction; human immunodeficiency virus (HIV); nucleic acid structure; reverse transcription	NUCLEOCAPSID PROTEIN NCP7; SIMIAN IMMUNODEFICIENCY VIRUSES; REVERSE TRANSCRIPTION; RNA DIMERIZATION; VIRAL-DNA; CTAR DNA; TAR RNA; COMPLEMENTARY SEQUENCE; POTASSIUM-PERMANGANATE; DESTABILIZING ACTIVITY	An essential step of human immunodeficiency virus type 1 (HIV-1) reverse transcription is the first strand transfer that requires base pairing of the R region at the 3-end of the genomic RNA with the complementary r region at the 3-end of minus-strand strong-stop DNA (ssDNA). HIV-1 nucleocapsid protein (NC) facilitates this annealing process. Determination of the ssDNA structure is needed to understand the molecular basis of NC-mediated genomic RNA-ssDNA annealing. For this purpose, we investigated ssDNA using structural probes (nucleases and potassium permanganate). This study is the first to determine the secondary structure of the full-length HIV-1 ssDNA in the absence or presence of NC. The probing data and phylogenetic analysis support the folding of ssDNA into three stem-loop structures and the presence of four high-affinity binding sites for NC. Our results support a model for the NC-mediated annealing process in which the preferential binding of NC to four sites triggers unfolding of the three-dimensional structure of ssDNA, thus facilitating interaction of the r sequence of ssDNA with the R sequence of the genomic RNA. In addition, using gel retardation assays and ssDNA mutants, we show that the NC-mediated annealing process does not rely on a single pathway (zipper intermediate or kissing complex).	[Chen, Yingying; Maskri, Ouerdia; Chaminade, Francoise; Rene, Brigitte; Benkaroun, Jessica; Mauffret, Olivier; Fosse, Philippe] Univ Paris Saclay, ENS Cachan, CNRS, LBPA, 61 Ave President Wilson, F-94235 Cachan, France; [Chen, Yingying] E China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Godet, Julien; Mely, Yves] Univ Strasbourg, Fac Pharm, Lab Biophoton & Pharmacol, UMR CNRS 7213, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; East China Normal University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Fosse, P (corresponding author), Univ Paris Saclay, ENS Cachan, CNRS, LBPA, 61 Ave President Wilson, F-94235 Cachan, France.	fosse@ens-cachan.fr	Julien, Godet/A-7250-2015	Julien, Godet/0000-0002-8470-0092; BENKAROUN, JESSICA/0000-0002-5514-6256	Centre National de la Recherche Scientifique [LBPAUMR8113]; Agence Nationale de Recherche sur le Sida; European Project THINPAD "Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance" FP7 [601969]; Ministere des Affaires Etrangeres; China Scholarship Council; East China Normal University; l'ecole doctorale Sciences Pratiques	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); European Project THINPAD "Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance" FP7; Ministere des Affaires Etrangeres; China Scholarship Council(China Scholarship Council); East China Normal University; l'ecole doctorale Sciences Pratiques	This work was supported in part by Centre National de la Recherche Scientifique LBPAUMR8113, Agence Nationale de Recherche sur le Sida, and the European Project THINPAD "Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance" FP7 Grant 601969. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by doctoral fellowships provided by the Ministere des Affaires Etrangeres, China Scholarship Council, and East China Normal University.; Supported by a doctoral fellowship provided by l'ecole doctorale Sciences Pratiques.	Avilov SV, 2009, BIOCHEMISTRY-US, V48, P2422, DOI 10.1021/bi8022366; Azoulay J, 2003, J MOL BIOL, V326, P691, DOI 10.1016/S0022-2836(02)01430-4; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038905; Bazzi A, 2011, NUCLEIC ACIDS RES, V39, P3903, DOI 10.1093/nar/gkq1290; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Beltz H, 2003, J MOL BIOL, V328, P95, DOI 10.1016/S0022-2836(03)00244-4; Ben Ali M, 2007, J MOL BIOL, V372, P1082, DOI 10.1016/j.jmb.2007.07.026; Berkhout B, 1997, NUCLEIC ACIDS RES, V25, P940, DOI 10.1093/nar/25.5.940; BERKHOUT B, 1995, VIROLOGY, V207, P276, DOI 10.1006/viro.1995.1077; BERKHOUT B, 1995, J MOL BIOL, V252, P59, DOI 10.1006/jmbi.1994.0475; BERKHOUT B, 1992, NUCLEIC ACIDS RES, V20, P27, DOI 10.1093/nar/20.1.27; Berkhout B, 2001, RNA, V7, P1097, DOI 10.1017/S1355838201002035; Bernacchi S, 2002, J MOL BIOL, V317, P385, DOI 10.1006/jmbi.2002.5429; Bourbigot S, 2008, J MOL BIOL, V383, P1112, DOI 10.1016/j.jmb.2008.08.046; Chen Y, 2003, J BIOL CHEM, V278, P38368, DOI 10.1074/jbc.M305700200; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Dang Q, 2001, J VIROL, V75, P809, DOI 10.1128/JVI.75.2.809-820.2001; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Fosse P, 1996, BIOCHEMISTRY-US, V35, P16601, DOI 10.1021/bi9613786; Godet J, 2006, J MOL BIOL, V356, P1180, DOI 10.1016/j.jmb.2005.12.038; Godet J, 2013, NUCLEIC ACIDS RES, V41, P5036, DOI 10.1093/nar/gkt164; Godet J, 2010, RNA BIOL, V7, P687, DOI 10.4161/rna.7.6.13616; GOGOS JA, 1990, NUCLEIC ACIDS RES, V18, P6807, DOI 10.1093/nar/18.23.6807; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; Guo JH, 1998, J VIROL, V72, P6716, DOI 10.1128/JVI.72.8.6716-6724.1998; Hampshire AJ, 2007, METHODS, V42, P128, DOI 10.1016/j.ymeth.2007.01.002; Heilman-Miller SL, 2004, J BIOL CHEM, V279, P44154, DOI 10.1074/jbc.M401646200; Holstege FCP, 1997, METHODS, V12, P203, DOI 10.1006/meth.1997.0472; Hong MK, 2003, J MOL BIOL, V325, P1, DOI 10.1016/S0022-2836(02)01177-4; Jeeninga RE, 1998, NUCLEIC ACIDS RES, V26, P5472, DOI 10.1093/nar/26.23.5472; JOHNSON PH, 1970, J BIOL CHEM, V245, P891; Kanevsky I, 2005, J MOL BIOL, V348, P1059, DOI 10.1016/j.jmb.2005.03.046; Kanevsky I, 2011, NUCLEIC ACIDS RES, V39, P8148, DOI 10.1093/nar/gkr526; KLAVER B, 1994, EMBO J, V13, P2650, DOI 10.1002/j.1460-2075.1994.tb06555.x; KLAVER B, 1994, NUCLEIC ACIDS RES, V22, P137, DOI 10.1093/nar/22.2.137; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; Laughrea M, 1996, BIOCHEMISTRY-US, V35, P1589, DOI 10.1021/bi951838f; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Liu HW, 2007, P NATL ACAD SCI USA, V104, P5261, DOI 10.1073/pnas.0700166104; Liu HW, 2005, BIOPHYS J, V89, P3470, DOI 10.1529/biophysj.105.065326; LOBEL LI, 1985, J VIROL, V53, P447, DOI 10.1128/JVI.53.2.447-455.1985; Maxam A M, 1980, Methods Enzymol, V65, P499; Ohi Y, 2000, J VIROL, V74, P8324, DOI 10.1128/JVI.74.18.8324-8334.2000; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; Piekna-Przybylska D, 2011, RNA BIOL, V8, P230, DOI 10.4161/rna.8.2.14802; Polge E, 2000, J MOL BIOL, V300, P41, DOI 10.1006/jmbi.2000.3832; RAMSEY CA, 1993, J VIROL, V67, P4114, DOI 10.1128/JVI.67.7.4114-4121.1993; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider Thomas D, 2002, Appl Bioinformatics, V1, P111; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song M, 2006, J BIOL CHEM, V281, P24227, DOI 10.1074/jbc.M603097200; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vo MN, 2009, J MOL BIOL, V386, P789, DOI 10.1016/j.jmb.2008.12.070; Vuilleumier C, 1999, BIOCHEMISTRY-US, V38, P16816, DOI 10.1021/bi991145p; Wang H, 2009, J AM CHEM SOC, V131, P15534, DOI 10.1021/ja9070046; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; YOU JC, 1994, J BIOL CHEM, V269, P31491; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	71	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3468	3482		10.1074/jbc.M115.708099	http://dx.doi.org/10.1074/jbc.M115.708099			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668324	Green Published, hybrid			2022-12-28	WOS:000370854500028
J	Kienast, Y; Jucknischke, U; Scheiblich, S; Thier, M; de Wouters, M; Haas, A; Lehmann, C; Brand, V; Bernicke, D; Honold, K; Lorenz, S				Kienast, Yvonne; Jucknischke, Ute; Scheiblich, Stefan; Thier, Martina; de Wouters, Mariana; Haas, Alexander; Lehmann, Christian; Brand, Verena; Bernicke, Dirk; Honold, Konrad; Lorenz, Stefan			Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); homeostasis; protein complex; surface plasmon resonance (SPR); transforming growth factor (TGF-B)	HEREDITARY HEMORRHAGIC TELANGIECTASIA; SUPPRESSES TUMOR-GROWTH; MESENCHYMAL STEM-CELLS; KINASE 1 ALK1; BMP9; ANGIOGENESIS; TGF-BETA-1; IDENTIFICATION; MUTATIONS; PRODOMAIN	By non-covalent association after proteolytic cleavage, the pro-domains modulate the activities of the mature growth factor domains across the transforming growth factor- family. In the case of bone morphogenic protein 9 (BMP9), however, the pro-domains do not inhibit the bioactivity of the growth factor, and the BMP9pro-domain complexes have equivalent biological activities as the BMP9 mature ligand dimers. By using real-time surface plasmon resonance, we could demonstrate that either binding of pro-domain-complexed BMP9 to type I receptor activin receptor-like kinase 1 (ALK1), type II receptors, co-receptor endoglin, or to mature BMP9 domain targeting antibodies leads to immediate and complete displacement of the pro-domains from the complex. Vice versa, pro-domain binding by an anti-pro-domain antibody results in release of the mature BMP9 growth factor. Based on these findings, we adjusted ELISA assays to measure the protein levels of different BMP9 variants. Although mature BMP9 and inactive precursor BMP9 protein were directly detectable by ELISA, BMP9pro-domain complex could only be measured indirectly as dissociated fragments due to displacement of mature growth factor and pro-domains after antibody binding. Our studies provide a model in which BMP9 can be readily activated upon getting into contact with its receptors. This increases the understanding of the underlying biology of BMP9 activation and also provides guidance for ELISA development for the detection of circulating BMP9 variants.	[Kienast, Yvonne; Jucknischke, Ute; Scheiblich, Stefan; Thier, Martina; de Wouters, Mariana; Haas, Alexander; Lehmann, Christian; Brand, Verena; Bernicke, Dirk; Honold, Konrad; Lorenz, Stefan] Roche Innovat Ctr Penzberg, Roche Pharma Res & Early Dev pRED, D-82377 Penzberg, Germany; [Kienast, Yvonne; Jucknischke, Ute; Scheiblich, Stefan; Lehmann, Christian; Bernicke, Dirk; Honold, Konrad] Roche Innovat Ctr Penzberg, Discovery Oncol, D-82377 Penzberg, Germany; [Thier, Martina; de Wouters, Mariana] Roche Innovat Ctr, Translat Technol & Bioinformat, CH-4070 Basel, Switzerland; [Haas, Alexander; Lorenz, Stefan] Roche Innovat Ctr Penzberg, Large Mol Res, D-82377 Penzberg, Germany	Roche Holding	Kienast, Y (corresponding author), Roche Diagnost GmbH, Roche Innovat Ctr Penzberg, Roche Pharma Res & Early Dev, Discovery Oncol, Nonnenwald 2, D-82377 Penzberg, Germany.	yvonne.kienast@roche.com						Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burke RM, 2013, P NATL ACAD SCI USA, V110, P19567, DOI 10.1073/pnas.1319297110; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021; Hintze V, 2014, BIOMACROMOLECULES, V15, P3083, DOI 10.1021/bm5006855; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Jiang H., 2015, J BIOL CHEM IN PRESS, V290; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luther G, 2011, CURR GENE THER, V11, P229; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Wei ZQ, 2014, J BIOL CHEM, V289, P31150, DOI 10.1074/jbc.M114.579771; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004	38	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3395	3410		10.1074/jbc.M115.680009	http://dx.doi.org/10.1074/jbc.M115.680009			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677222	Green Published, hybrid			2022-12-28	WOS:000370854500023
J	Kosasih, HJ; Last, K; Rogerson, FM; Golub, SB; Gauci, SJ; Russo, VC; Stanton, H; Wilson, R; Lamande, SR; Holden, P; Fosang, AJ				Kosasih, Hansen J.; Last, Karena; Rogerson, Fraser M.; Golub, Suzanne B.; Gauci, Stephanie J.; Russo, Vincenzo C.; Stanton, Heather; Wilson, Richard; Lamande, Shireen R.; Holden, Paul; Fosang, Amanda J.			A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cartilage; cartilage biology; metalloprotease; oligomer; oligomerization; ADAMTS; ADAMTS5; aggrecan	AGGRECAN INTERGLOBULAR DOMAIN; PROCOLLAGEN N-PROTEINASE; VON-WILLEBRAND-FACTOR; ARTICULAR-CARTILAGE; IN-VIVO; SYNOVIAL-FLUID; OSTEOARTHRITIC CARTILAGE; PROTEOLYTIC ACTIVITIES; FUNCTIONAL DIFFERENCES; NONCATALYTIC DOMAINS	The metalloproteinase ADAMTS-5 (A disintegrin and metalloproteinase with thrombospondin motifs) degrades aggrecan, a proteoglycan essential for cartilage structure and function. ADAMTS-5 is the major aggrecanase in mouse cartilage, and is also likely to be the major aggrecanase in humans. ADAMTS-5 is a multidomain enzyme, but the function of the C-terminal ancillary domains is poorly understood. We show that mutant ADAMTS-5 lacking the catalytic domain, but with a full suite of ancillary domains inhibits wild type ADAMTS activity, in vitro and in vivo, in a dominant-negative manner. The data suggest that mutant ADAMTS-5 binds to wild type ADAMTS-5; thus we tested the hypothesis that ADAMTS-5 associates to form oligomers. Co-elution, competition, and in situ PLA experiments using full-length and truncated recombinant ADAMTS-5 confirmed that ADAMTS-5 molecules interact, and showed that the catalytic and disintegrin-like domains support these intermolecular interactions. Cross-linking experiments revealed that recombinant ADAMTS-5 formed large, reduction-sensitive oligomers with a nominal molecular mass of approximate to 400 kDa. The oligomers were unimolecular and proteolytically active. ADAMTS-5 truncates comprising the disintegrin and/or catalytic domains were able to competitively block full-length ADAMTS-5-mediated aggrecan cleavage, measured by production of the G1-EGE(373) neoepitope. These results show that ADAMTS-5 oligomerization is required for full aggrecanase activity, and they provide evidence that blocking oligomerization inhibits ADAMTS-5 activity. The data identify the surface provided by the catalytic and disintegrin-like domains of ADAMTS-5 as a legitimate target for the design of aggrecanase inhibitors.	[Kosasih, Hansen J.; Last, Karena; Rogerson, Fraser M.; Golub, Suzanne B.; Stanton, Heather; Fosang, Amanda J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Kosasih, Hansen J.; Last, Karena; Rogerson, Fraser M.; Golub, Suzanne B.; Gauci, Stephanie J.; Russo, Vincenzo C.; Stanton, Heather; Lamande, Shireen R.; Fosang, Amanda J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Holden, Paul] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97239 USA; [Wilson, Richard] Univ Tasmania, Hobart, Tas 7000, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Oregon Health & Science University; University of Tasmania	Fosang, AJ (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.; Fosang, AJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	amanda.fosang@mcri.edu.au	Wilson, Richard/H-8429-2012	Wilson, Richard/0000-0003-0152-4394; Kosasih, Hansen/0000-0002-0428-6195; Last, Karena/0000-0002-4396-8404; STANTON, HEATHER/0000-0002-3427-5614; Lamande, Shireen/0000-0003-2938-2711; Fosang, Amanda/0000-0002-5523-5427	National Health & Medical Research Council (Australia); Murdoch Childrens Research Institute; Victorian State Government's Operational Infrastructure Support Program	National Health & Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian State Government's Operational Infrastructure Support Program	This work was supported by the National Health & Medical Research Council (Australia), the Murdoch Childrens Research Institute, and the Victorian State Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chockalingam PS, 2011, OSTEOARTHR CARTILAGE, V19, P315, DOI 10.1016/j.joca.2010.12.004; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; HOJIMA Y, 1989, J BIOL CHEM, V264, P11336; HOJIMA Y, 1994, J BIOL CHEM, V269, P11381; HUGHES CE, 1992, J BIOL CHEM, V267, P16011; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Koo BH, 2012, J BIOL CHEM, V287, P22643, DOI 10.1074/jbc.M111.337949; Larkin J, 2015, OSTEOARTHR CARTILAGE, V23, P1254, DOI 10.1016/j.joca.2015.02.778; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Lorenzen I, 2011, BIOCHEM BIOPH RES CO, V415, P330, DOI 10.1016/j.bbrc.2011.10.056; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Powell AJ, 2007, ARTHRITIS RHEUM-US, V56, P3010, DOI 10.1002/art.22818; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Sohail A, 2011, J BIOL CHEM, V286, P33178, DOI 10.1074/jbc.M111.253369; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Struglics A, 2011, OSTEOARTHR CARTILAGE, V19, P1047, DOI 10.1016/j.joca.2011.05.006; Struglics A, 2012, ARTHRITIS RHEUM-US, V64, P4151, DOI 10.1002/art.34665; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Wilson R, 2008, METHODS, V45, P22, DOI 10.1016/j.ymeth.2008.01.008; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	59	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3197	3208		10.1074/jbc.M115.704817	http://dx.doi.org/10.1074/jbc.M115.704817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668318	hybrid, Green Published			2022-12-28	WOS:000370854500008
J	Bajaj, H; Scorciapino, MA; Moynie, L; Page, MGP; Naismith, JH; Ceccarelli, M; Winterhalter, M				Bajaj, Harsha; Scorciapino, Mariano A.; Moynie, Lucile; Page, Malcolm G. P.; Naismith, James H.; Ceccarelli, Matteo; Winterhalter, Mathias			Molecular Basis of Filtering Carbapenems by Porins from beta-Lactam-resistant Clinical Strains of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; ANTIBACTERIAL RESISTANCE; ANTIBIOTICS; MECHANISM; DYNAMICS; CHANNEL; PROTEIN; OMPF; RECONSTRUCTION; TRANSLOCATION	Integral membrane proteins known as porins are the major pathway by which hydrophilic antibiotics cross the outer membrane of Gram-negative bacteria. Single point mutations in porins can decrease the permeability of an antibiotic, either by reduction of channel size or modification of electrostatics in the channel, and thereby confer clinical resistance. Here, we investigate four mutant OmpC proteins from four different clinical isolates of Escherichia coli obtained sequentially from a single patient during a course of antimicrobial chemotherapy. OmpC porin from the first isolate (OmpC20) undergoes three consecutive and additive substitutions giving rise to OmpC26, OmpC28, and finally OmpC33. The permeability of two zwitterionic carbapenems, imipenem and meropenem, measured using liposome permeation assays and single channel electrophysiology differs significantly between OmpC20 and OmpC33. Molecular dynamic simulations show that the antibiotics must pass through the constriction zone of porins with a specific orientation, where the antibiotic dipole is aligned along the electric field inside the porin. We identify that changes in the vector of the electric field in the mutated porin, OmpC33, create an additional barrier by "trapping" the antibiotic in an unfavorable orientation in the constriction zone that suffers steric hindrance for the reorientation needed for its onward translocation. Identification and understanding the underlying molecular details of such a barrier to translocation will aid in the design of new antibiotics with improved permeation properties in Gram-negative bacteria.	[Bajaj, Harsha; Winterhalter, Mathias] Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany; [Scorciapino, Mariano A.; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, SP Monserrato Sestu Km 0-700, I-09042 Monserrato, CA, Italy; [Moynie, Lucile; Naismith, James H.] Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Page, Malcolm G. P.] Basilea Pharmaceut Int Ltd, Grenzacherstr 487, CH-4058 Basel, Switzerland	Jacobs University; University of Cagliari; University of St Andrews; Basilea Pharmaceutica Ltd.	Winterhalter, M (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany.; Ceccarelli, M (corresponding author), Univ Cagliari, Dept Phys, SP Monserrato Sestu Km 0-700, I-09042 Monserrato, CA, Italy.	matteo.ceccarelli@dsf.unica.it; m.winterhalter@jacobs-university.de	Naismith, James Henderson/H-3408-2012; Scorciapino, Mariano Andrea/AAD-1256-2020; Ceccarelli, Matteo/C-8557-2018; Naismith, James Henderson/AAB-8614-2020; Bajaj, Harsha/AAA-1483-2020	Naismith, James Henderson/0000-0001-6744-5061; Ceccarelli, Matteo/0000-0003-4272-902X; Naismith, James Henderson/0000-0001-6744-5061; Bajaj, Harsha/0000-0001-5422-5182; SCORCIAPINO, MARIANO ANDREA/0000-0001-7502-7265; Moynie, Lucile/0000-0002-4097-4331; Winterhalter, Mathias/0000-0002-1604-3318	Innovative Medicines Initiatives Joint Undertaking Grant [15525]; European Union's seventh framework program; EFPIA	Innovative Medicines Initiatives Joint Undertaking Grant; European Union's seventh framework program; EFPIA	The work was conducted as part of the "Translocation" consortium and supported by Innovative Medicines Initiatives Joint Undertaking Grant 15525, resources which are composed of financial contribution from the European Union's seventh framework program (FP7/2007-2013) and EFPIA. The authors declare that they have no conflicts of interest with the contents of this article.	Acosta-Gutierrez S, 2015, J PHYS CHEM LETT, V6, P1807, DOI 10.1021/acs.jpclett.5b00612; [Anonymous], BIOCHEMISTRY, V49, P6928; Bajaj H, 2012, BIOCHEMISTRY-US, V51, P10244, DOI 10.1021/bi301398j; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; Benz R., 2004, BACTERIAL EUKARYOTIC, DOI [10.1002/3527603875, DOI 10.1002/3527603875]; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Case D. A., 2006, AMBER 9; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001; Frisch M.J., 2016, GAUSSIAN16 REV B01; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kumar A, 2010, J PHYS CHEM B, V114, P9608, DOI 10.1021/jp9110579; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lou H., 2011, J BIOL CHEM, V6; Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x; Mahendran KR, 2010, J PHYS CHEM B, V114, P5170, DOI 10.1021/jp911485k; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; NAKAE T, 1976, J BIOL CHEM, V251, P2176; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Tran QT, 2013, PROTEINS, V81, P291, DOI 10.1002/prot.24185; Raiteri P, 2006, J PHYS CHEM B, V110, P3533, DOI 10.1021/jp054359r; Singh PR, 2012, J PHYS CHEM B, V116, P4433, DOI 10.1021/jp2123136; Stavenger RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008605; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Tran QT, 2014, PROTEINS, V82, P2998, DOI 10.1002/prot.24659; TRIAS J, 1989, ANTIMICROB AGENTS CH, V33, P1201, DOI 10.1128/AAC.33.8.1202; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84	43	50	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2837	2847		10.1074/jbc.M115.690156	http://dx.doi.org/10.1074/jbc.M115.690156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26645688	hybrid, Green Published			2022-12-28	WOS:000369626900023
J	Durning, SP; Flanagan-Steet, H; Prasad, N; Wells, L				Durning, Sean P.; Flanagan-Steet, Heather; Prasad, Nripesh; Wells, Lance			O-Linked beta-N-acetylglucosamine (O-GlcNAc) Acts as a Glucose Sensor to Epigenetically Regulate the Insulin Gene in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC PROTEINS; HISTONE MODIFICATIONS; CYTOPLASMIC PROTEINS; RIBOSOMAL-PROTEINS; MASS-SPECTROMETRY; BINDING-PROTEINS; STRESS-RESPONSE; MESSENGER-RNA; GLYCOSYLATION; GLCNACYLATION	The post-translational protein modification O-linked beta-N-acetylglucosamine (O-GlcNAc) is a proposed nutrient sensor that has been shown to regulate multiple biological pathways. This dynamic and inducible enzymatic modification to intracellular proteins utilizes the end product of the nutrient sensing hexosamine biosynthetic pathway, UDP-GlcNAc, as its substrate donor. Type II diabetic patients have elevated O-GlcNAc-modified proteins within pancreatic beta cells due to chronic hyperglycemia-induced glucose overload, but a molecular role for O-GlcNAc within beta cells remains unclear. Using directed pharmacological approaches in the mouse insulinoma-6 (Min6) cell line, we demonstrate that elevating nuclear O-GlcNAc increases intracellular insulin levels and preserves glucose-stimulated insulin secretion during chronic hyperglycemia. The molecular mechanism for these observed changes appears to be, at least in part, due to elevated O-GlcNAc-dependent increases in Ins1 and Ins2mRNA levels via elevations in histone H3 transcriptional activation marks. Furthermore, RNA deep sequencing reveals that this mechanism of altered gene transcription is restricted and that the majority of genes regulated by elevated O-GlcNAc levels are similarly regulated by a shift from euglycemic to hyperglycemic conditions. These findings implicate the O-GlcNAc modification as a potential mechanism for hyperglycemic-regulated gene expression in the beta cell.	[Durning, Sean P.; Flanagan-Steet, Heather; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Prasad, Nripesh] Genom Serv Lab, HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Durning, Sean P.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	University System of Georgia; University of Georgia; HudsonAlpha Institute for Biotechnology; Yale University	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu		Prasad, Nripesh/0000-0003-4074-2538; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P41GM103490, U01CA128454]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103490 and U01CA128454 (both to L. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Babaya N, 2006, DIABETOLOGIA, V49, P1222, DOI 10.1007/s00125-006-0241-4; BECKNIELSEN H, 1988, DIABETES, V37, P730, DOI 10.2337/diabetes.37.6.730; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Bucher K, 2000, DEV BIOL, V227, P533, DOI 10.1006/dbio.2000.9920; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799; COLELLA RM, 1987, METABOLISM, V36, P335, DOI 10.1016/0026-0495(87)90203-4; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Dassanayaka S, 2014, PHARMACOL THERAPEUT, V142, P62, DOI 10.1016/j.pharmthera.2013.11.005; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Ekanayake D, 2011, EUKARYOT CELL, V10, P1465, DOI 10.1128/EC.05185-11; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; HAMMONDS P, 1987, FEBS LETT, V223, P131, DOI 10.1016/0014-5793(87)80523-9; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HART GW, 1989, CIBA F SYMP, V145, P102; Hayakawa K, 2013, J BIOL CHEM, V288, P17099, DOI 10.1074/jbc.M113.455899; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Imadome K, 2008, CANCER BIOL THER, V7, P208, DOI 10.4161/cbt.7.2.5255; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; JAHR H, 1980, EUR J BIOCHEM, V110, P499, DOI 10.1111/j.1432-1033.1980.tb04892.x; Kochanek Kenneth D, 2015, Natl Vital Stat Rep, V63, P1; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kumar A, 2014, J BIOL CHEM, V289, P13543, DOI 10.1074/jbc.M114.553321; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; MARSHALL S, 1980, J CLIN INVEST, V66, P763, DOI 10.1172/JCI109914; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muller II, 2013, DIS MODEL MECH, V6, P332, DOI 10.1242/dmm.010488; NAGAMATSU S, 1992, ENDOCRINOLOGY, V130, P748, DOI 10.1210/en.130.2.748; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Olivier-Van Stichelen S, 2014, FASEB J, V28, P3325, DOI 10.1096/fj.13-243535; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; PERMUTT MA, 1975, FED PROC, V34, P1549; Poitout V, 1996, ANNU REV MED, V47, P69; PORTE D, 1969, J CLIN INVEST, V48, P2309, DOI 10.1172/JCI106197; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Ruppert V, 2013, GENE, V512, P206, DOI 10.1016/j.gene.2012.10.055; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Soesanto Y, 2011, J BIOL CHEM, V286, P26118, DOI 10.1074/jbc.M111.249508; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	79	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2107	2118		10.1074/jbc.M115.693580	http://dx.doi.org/10.1074/jbc.M115.693580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26598517	Green Published, hybrid			2022-12-28	WOS:000369610400006
J	Korah, J; Canaff, L; Lebrun, JJ				Korah, Juliana; Canaff, Lucie; Lebrun, Jean-Jacques			The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGF beta-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CELL-DEATH; BECLIN 1; REGULATES AUTOPHAGY; EPITHELIAL-CELLS; SELF-DIGESTION; DAP-KINASE; C-MYC; APOPTOSIS; SMAD	TGF beta is a multifunctional cytokine that regulates cell proliferation, cell immortalization, and cell death, acting as a key homeostatic mediator in various cell types and tissues. Autophagy is a programmed mechanism that plays a pivotal role in controlling cell fate and, consequently, many physiological and pathological processes, including carcinogenesis. Although autophagy is often considered a pro-survival mechanism that renders cells viable in stressful conditions and thus might promote tumor growth, emerging evidence suggests that autophagy is also a tumor suppressor pathway. The relationship between TGF beta signaling and autophagy is context-dependent and remains unclear. TGF beta-mediated activation of autophagy has recently been suggested to contribute to the growth inhibitory effect of TGF beta in hepatocarcinoma cells. In the present study, we define a novel process of TGF beta-mediated autophagy in cancer cell lines of various origins. We found that autophagosome initiation and maturation by TGF beta is dependent on the retinoblastoma tumor suppressor protein/E2 promoter binding factor (pRb/E2F1) pathway, which we have previously established as a critical signaling axis leading to various TGF beta tumor suppressive effects. We further determined that TGF beta induces pRb/E2F1-dependent transcriptional activation of several autophagy-related genes. Together, our findings reveal that TGF beta induces autophagy through the pRb/E2F1 pathway and transcriptional activation of autophagy-related genes and further highlight the central relevance of the pRb/E2F1 pathway downstream of TGF beta signaling in tumor suppression.	[Korah, Juliana; Canaff, Lucie; Lebrun, Jean-Jacques] McGill Univ, Ctr Hlth, Dept Med, Canc Res Program, 1001 Decarie Blvd,Bloc E,Suite E02-6224, Montreal, PQ H4A 3J1, Canada	McGill University	Lebrun, JJ (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Canc Res Program, 1001 Decarie Blvd,Bloc E,Suite E02-6224, Montreal, PQ H4A 3J1, Canada.	JJ.Lebrun@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022		Canadian Institutes of Health Research [MOP-114904]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-114904 (to J.-J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Francis JM, 2000, J BIOL CHEM, V275, P39137, DOI 10.1074/jbc.M007212200; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heidari N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.53; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Korah J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.146; Kusama Y, 2009, APOPTOSIS, V14, P1165, DOI 10.1007/s10495-009-0390-2; Lebrun JJ, 2012, ISRN MOL BIOL, V2012, DOI [DOI 10.5402/2012/381428, 10.5402/2012/381428]; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Marquez RT, 2012, AM J CANCER RES, V2, P214; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song JR, 2011, J CELL BIOCHEM, V112, P3406, DOI 10.1002/jcb.23274; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Ueno T, 2008, AUTOPHAGY, V4, P692, DOI 10.4161/auto.6085; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; White EJ, 2011, AM J CANCER RES, V1, P362; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	68	19	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2043	2054		10.1074/jbc.M115.678557	http://dx.doi.org/10.1074/jbc.M115.678557			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26598524	Green Published, hybrid			2022-12-28	WOS:000369610400001
J	Kent, LM; Loo, TS; Melton, LD; Mercadante, D; Williams, MAK; Jameson, GB				Kent, Lisa M.; Loo, Trevor S.; Melton, Laurence D.; Mercadante, Davide; Williams, Martin A. K.; Jameson, Geoffrey B.			Structure and Properties of a Non-processive, Salt-requiring, and Acidophilic Pectin Methylesterase from Aspergillus niger Provide Insights into the Key Determinants of Processivity Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGALACTURONASE-INHIBITING PROTEINS; PLANT-PATHOGEN INTERACTIONS; DE-ESTERIFICATION; MODEL HOMOGALACTURONAN; MOLECULAR REPLACEMENT; TRICHODERMA-REESEI; METHYL ESTERASE; ACTION PATTERNS; ACTIVE-SITE; RICE WEEVIL	Many pectin methylesterases (PMEs) are expressed in plants to modify plant cell-wall pectins for various physiological roles. These pectins are also attacked by PMEs from phytopathogens and phytophagous insects. The de-methylesterification by PMEs of the O6-methyl ester groups of the homogalacturonan component of pectin, exposinggalacturonic acids, canoccurprocessively or non-processively, respectively, describing sequential versus single de-methylesterification events occurring before enzyme-substrate dissociation. The high resolution x-ray structures of a PME from Aspergillus niger in deglycosylated and Asn-linked N-acetylglucosamine-stub forms reveal a 102/3-turn parallel beta-helix (similar to but with less extensive loops than bacterial, plant, and insect PMEs). Capillary electrophoresis shows that this PME is non-processive, halophilic, and acidophilic. Molecular dynamics simulations and electrostatic potential calculations reveal very different behavior and properties compared with processive PMEs. Specifically, uncorrelated rotations are observed about the glycosidic bonds of a partially de-methyl-esterified decasaccharide model substrate, in sharp contrast to the correlated rotations of processive PMEs, and the substrate-binding groove is negatively not positively charged.	[Kent, Lisa M.; Loo, Trevor S.; Melton, Laurence D.; Mercadante, Davide; Williams, Martin A. K.; Jameson, Geoffrey B.] Massey Univ, Riddet Inst, Palmerston North 4442, New Zealand; [Kent, Lisa M.; Loo, Trevor S.; Williams, Martin A. K.; Jameson, Geoffrey B.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand; [Melton, Laurence D.] Univ Auckland, Sch Chem Sci, Auckland 1142, New Zealand; [Mercadante, Davide] Heidelberg Inst Theoret Studies, Mol Biomech Grp, D-69118 Heidelberg, Germany; [Williams, Martin A. K.; Jameson, Geoffrey B.] MacDiarmid Inst Adv Mat & Nanotechnol, Palmerston North 4442, New Zealand	Massey University; Massey University; University of Auckland; Heidelberg Institute for Theoretical Studies	Williams, MAK (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand.	m.williams@massey.ac.nz; g.b.jameson@massey.ac.nz		Jameson, Geoffrey/0000-0003-4839-0784; Loo, Trevor/0000-0002-0501-5522; Mercadante, Davide/0000-0001-6792-7706	Riddet Institute, a Centre of Research Excellence	Riddet Institute, a Centre of Research Excellence	This work was supported by the Riddet Institute, a Centre of Research Excellence. All authors reviewed the results and approved the final version of the manuscript.	ABO-EL-DAHAB M. K., 1964, Phytopathology, V54, P597; Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benoit I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-321; BOCCARA M, 1989, J BACTERIOL, V171, P4085, DOI 10.1128/jb.171.7.4085-4087.1989; Boraston AB, 2012, ACTA CRYSTALLOGR F, V68, P129, DOI 10.1107/S1744309111055400; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cameron RG, 2011, NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND ENERGY, NSTI-NANOTECH 2011, VOL 3, P275; Cameron RG, 2011, J AGR FOOD CHEM, V59, P2717, DOI 10.1021/jf104845j; Cameron RG, 2003, J AGR FOOD CHEM, V51, P2070, DOI 10.1021/jf020933+; Catoire L, 1998, J BIOL CHEM, V273, P33150, DOI 10.1074/jbc.273.50.33150; Christensen TMIE, 1998, PLANTA, V206, P493, DOI 10.1007/s004250050426; D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012; De Lorenzo G, 2002, CURR OPIN PLANT BIOL, V5, P295, DOI 10.1016/S1369-5266(02)00271-6; Dedeurwaerder S, 2009, PLANTA, V229, P311, DOI 10.1007/s00425-008-0831-0; Denes JM, 2000, CARBOHYD RES, V327, P385, DOI 10.1016/S0008-6215(00)00070-7; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; DONGOWSKI G, 1984, NAHRUNG, V28, P507, DOI 10.1002/food.19840280507; Duvetter T, 2006, J AGR FOOD CHEM, V54, P7825, DOI 10.1021/jf060013h; Duwe B, 1996, BIOTECHNOL LETT, V18, P621, DOI 10.1007/BF00130754; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fries M, 2007, EMBO J, V26, P3879, DOI 10.1038/sj.emboj.7601816; GAFFE J, 1994, PLANT PHYSIOL, V105, P199, DOI 10.1104/pp.105.1.199; Glinka EM, 2011, FUNGAL BIOL-UK, V115, P1112, DOI 10.1016/j.funbio.2011.07.005; Goldberg R, 2001, J BIOL CHEM, V276, P8841, DOI 10.1074/jbc.M001791200; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Hsiao ESL, 2009, J AGR FOOD CHEM, V57, P6757, DOI 10.1021/jf9011278; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Jia YJ, 2009, J PHYTOPATHOL, V157, P585, DOI 10.1111/j.1439-0434.2008.01533.x; Jiang XP, 2013, J SCI FOOD AGR, V93, P375, DOI 10.1002/jsfa.5771; Jimenez-Lopez JC, 2012, J MOL MODEL, V18, P4965, DOI 10.1007/s00894-012-1492-2; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kester HCM, 2000, BIOCHEM J, V346, P469, DOI 10.1042/0264-6021:3460469; Kester HCM, 1999, J BIOL CHEM, V274, P37053, DOI 10.1074/jbc.274.52.37053; KHANH NQ, 1991, GENE, V106, P71, DOI 10.1016/0378-1119(91)90567-U; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Kim Y., 2011, 242 ACS NAT M EXP DE; Kim Y, 2013, FOOD HYDROCOLLOID, V33, P132, DOI 10.1016/j.foodhyd.2013.02.015; Knoesel D., 1967, Z PFLANZENK PFLANZEN, V74, P150; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee H, 2008, J SCI FOOD AGR, V88, P2102, DOI 10.1002/jsfa.3320; Li PQ, 2011, J BASIC MICROB, V51, P61, DOI 10.1002/jobm.201000317; Limberg G, 2000, CARBOHYD RES, V327, P293, DOI 10.1016/S0008-6215(00)00067-7; LIN TP, 1989, PLANT PHYSIOL, V91, P1445, DOI 10.1104/pp.91.4.1445; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Liu QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065131; Loo T, 2002, PROTEIN EXPRES PURIF, V24, P90, DOI 10.1006/prep.2001.1555; Luzio GA, 2008, CARBOHYD POLYM, V71, P300, DOI 10.1016/j.carbpol.2007.05.038; MALDONADO MC, 1994, CURR MICROBIOL, V28, P193, DOI 10.1007/BF01575960; Marei GIK, 2012, PESTIC BIOCHEM PHYS, V103, P56, DOI 10.1016/j.pestbp.2012.03.004; Markovic O, 1996, BIOLOGIA, V51, P293; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Markovic O, 2002, CELL MOL LIFE SCI, V59, P513, DOI 10.1007/s00018-002-8442-6; MARKOVIC O, 1984, EXPERIENTIA, V40, P842; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens-Uzunova ES, 2009, FUNGAL GENET BIOL, V46, pS170, DOI 10.1016/j.fgb.2008.07.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mercadante D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087581; Mercadante D, 2013, BIOPHYS J, V104, P1731, DOI 10.1016/j.bpj.2013.02.049; Miller J. W., 2011, 241 ACS NAT M EXP AN; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ortega J, 1998, TEX J SCI, V50, P327; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ralet MC, 2012, BIOMACROMOLECULES, V13, P1615, DOI 10.1021/bm300329r; Ralet MC, 2002, BIOMACROMOLECULES, V3, P917, DOI 10.1021/bm020055o; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rodriguez H, 2009, J PROTEOME RES, V8, P3689, DOI 10.1021/pr900023z; Salamanca G, 2010, FEBS J, V277, P2729, DOI 10.1111/j.1742-4658.2010.07689.x; Savary BJ, 2002, J AGR FOOD CHEM, V50, P3553, DOI 10.1021/jf020060j; Shen ZC, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.21; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Strom A, 2004, CARBOHYD RES, V339, P1711, DOI 10.1016/j.carres.2004.05.010; Tanhatan-Nasseri A, 2011, CARBOHYD POLYM, V86, P1236, DOI 10.1016/j.carbpol.2011.06.019; Teller DC, 2014, ACTA CRYSTALLOGR F, V70, P1480, DOI 10.1107/S2053230X14020433; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Alebeek GJWM, 2003, BIOCHEM J, V372, P211, DOI 10.1042/BJ20021471; VERSTEEG C, 1978, LEBENSM WISS TECHNOL, V11, P267; Videcoq P, 2011, CARBOHYD POLYM, V86, P1657, DOI 10.1016/j.carbpol.2011.06.081; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Warren ME, 2002, CARBOHYD RES, V337, P803, DOI 10.1016/S0008-6215(02)00032-0; WARRILOW AGS, 1995, PHYTOCHEMISTRY, V39, P277, DOI 10.1016/0031-9422(94)00923-H; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Williams B., 2010, PACIFICHEM 2010; Williams MAK, 2010, BIOMACROMOLECULES, V11, P1667, DOI 10.1021/bm1003527; Williams MAK, 2009, BIOMACROMOLECULES, V10, P1523, DOI 10.1021/bm900119u; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zaki M. M., 1979, EGYPT J MICROBIOL, V13, P1	103	17	18	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1289	1306		10.1074/jbc.M115.673152	http://dx.doi.org/10.1074/jbc.M115.673152			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26567911	Green Published, hybrid			2022-12-28	WOS:000368068300024
J	Lanier, MH; McConnell, P; Cooper, JA				Lanier, M. Hunter; McConnell, Patrick; Cooper, John A.			Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPPING PROTEIN; ARP2/3 COMPLEX; BARBED END; N-WASP; ACTIN; VIMENTIN; FILAMENT; INVASION; LAMELLIPODIA; LOCALIZATION	CARMILs regulate capping protein (CP), a critical determinant of actin assembly and actin-based cell motility. Vertebrates have three conserved CARMIL genes with distinct functions. In migrating cells, CARMIL2 is important for cell polarity, lamellipodial assembly, ruffling, and macropinocytosis. In cells, CARMIL2 localizes with a distinctive dual pattern to vimentin intermediate filaments and to membranes at leading edges and macropinosomes. The mechanism by which CARMIL2 localizes to membranes has not been defined. Here, we report that CARMIL2 has a conserved membrane-binding domain composed of basic and hydrophobic residues, which is necessary and sufficient for membrane localization, based on expression studies in cells and on direct binding of purified protein to lipids. Most important, we find that the membrane-binding domain is necessary for CARMIL2 to function in cells, based on rescue expression with a set of biochemically defined mutants. CARMIL1 and CARMIL3 contain similar membrane-binding domains, based on sequence analysis and on experiments, but other CPI motif proteins, such as CD2AP, do not. Based on these results, we propose a model in which the membrane-binding domain of CARMIL2 tethers this multidomain protein to the membrane, where it links dynamic vimentin filaments with regulation of actin assembly via CP.	[Lanier, M. Hunter; McConnell, Patrick; Cooper, John A.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, JA (corresponding author), Campus Box 8231,660 S Euclid Ave, St Louis, MO 63110 USA.	jacooper@wustl.edu	Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571	National Institutes of Health [GM95509]; National Cancer Institute of the National Institutes of Health [F30CA171595]; NATIONAL CANCER INSTITUTE [F30CA171595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM95509 (to J.A.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Cancer Institute of the National Institutes of Health Award F30CA171595.	Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Eckes B, 2000, J CELL SCI, V113, P2455; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Edwards M, 2013, MOL BIOL CELL, V24, P3047, DOI 10.1091/mbc.E13-05-0270; Gilles C, 1999, J CELL SCI, V112, P4615; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson JL, 2012, J BIOL CHEM, V287, P5764, DOI 10.1074/jbc.M111.336487; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Lanier MH, 2015, MOL BIOL CELL, V26, P4577, DOI 10.1091/mbc.E15-08-0552; Liang Y, 2009, MOL BIOL CELL, V20, P5290, DOI 10.1091/mbc.E08-10-1071; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Magalhaes MAO, 2010, J LEUKOCYTE BIOL, V87, P545, DOI 10.1189/jlb.0609390; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; THURSTON G, 1988, CYTOMETRY, V9, P411, DOI 10.1002/cyto.990090502; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Yoneyama MS, 2014, EUR J CELL BIOL, V93, P157, DOI 10.1016/j.ejcb.2014.03.002; Zwolak A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3523; Zwolak A, 2010, J BIOL CHEM, V285, P29014, DOI 10.1074/jbc.M110.134221	46	16	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1076	1091		10.1074/jbc.M115.676882	http://dx.doi.org/10.1074/jbc.M115.676882			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26578515	Green Published, hybrid			2022-12-28	WOS:000368068300005
J	Sun, XW; Haas, ME; Miao, J; Mehta, A; Graham, MJ; Crooke, RM; de Barros, JPP; Wang, JG; Aikawa, M; Masson, D; Biddinger, SB				Sun, Xiaowei; Haas, Mary E.; Miao, Ji; Mehta, Abhiruchi; Graham, Mark J.; Crooke, Rosanne M.; de Barros, Jean-Paul Pais; Wang, Jian-Guo; Aikawa, Masanori; Masson, David; Biddinger, Sudha B.			Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; LXR-ALPHA; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; DENSITY-LIPOPROTEIN; LIPID-METABOLISM; CULTURED-CELLS	Diabetes is characterized by increased lipogenesis as well as increased endoplasmic reticulum (ER) stress and inflammation. The nuclear hormone receptor liver X receptor (LXR) is induced by insulin and is a key regulator of lipid metabolism. It promotes lipogenesis and cholesterol efflux, but suppresses endoplasmic reticulum stress and inflammation. The goal of these studies was to dissect the effects of insulin on LXR action. We used antisense oligonucleotides to knock down Lxr alpha in mice with hepatocytespecific deletion of the insulin receptor and their controls. We found, surprisingly, that knock-out of the insulin receptor and knockdown of Lxr alpha produced equivalent, non-additive effects on the lipogenic genes. Thus, insulin was unable to induce the lipogenic genes in the absence of Lxr alpha, and LXR alpha was unable to induce the lipogenic genes in the absence of insulin. However, insulin was not required for LXR alpha to modulate the phospholipid profile, or to suppress genes in the ER stress or inflammation pathways. These data show that insulin is required specifically for the lipogenic effects of LXR alpha and that manipulation of the insulin signaling pathway could dissociate the beneficial effects of LXR on cholesterol efflux, inflammation, and ER stress from the negative effects on lipogenesis.	[Sun, Xiaowei; Haas, Mary E.; Miao, Ji; Mehta, Abhiruchi; Biddinger, Sudha B.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Graham, Mark J.; Crooke, Rosanne M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [de Barros, Jean-Paul Pais; Masson, David] Univ Bourgogne, Ctr Rech, INSERM, UMR866, F-21000 Dijon, France; [Wang, Jian-Guo; Aikawa, Masanori] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Interdisciplinary Cardiovasc Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Isis Pharmaceuticals Inc; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Biddinger, SB (corresponding author), Childrens Hosp Boston, 3 Blackfan Circle, Boston, MA 02115 USA.	sudha.biddinger@childrens.harvard.edu	MASSON, David/AAC-8896-2022; Miao, Ji/F-9398-2015; Masson, David/R-6633-2019; MASSON, David/R-4557-2017	MASSON, David/0000-0003-1692-0699; Miao, Ji/0000-0003-0869-4492; MASSON, David/0000-0003-1692-0699; Aikawa, Masanori/0000-0002-9275-2079; Haas, Mary Elizabeth/0000-0002-2816-9268; PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283	program "Investissements d'Avenir" [ANR-11-LABX-0021]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK100539, R00DK100539, R01DK094162] Funding Source: NIH RePORTER	program "Investissements d'Avenir"(French National Research Agency (ANR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Davis (Wake Forest University) for FPLC analysis, Drs. Inna Astapova and Tony Hollenberg (Beth Israel Deaconess Medical Center) and David Mangelsdorf (UT Southwestern Medical Center) for the LXRa null liver, and Victoria Bergas (Lipidomics platform at the University of Burgundy) for phospholipid analysis. Lipidomic analysis was supported by a grant for the program "Investissements d'Avenir" with reference ANR-11-LABX-0021 (Lipstic Labex).	Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Diraison F, 1998, AM J PHYSIOL-ENDOC M, V274, pE321, DOI 10.1152/ajpendo.1998.274.2.E321; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hung GN, 2013, NUCLEIC ACID THER, V23, P369, DOI 10.1089/nat.2013.0443; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Miao J, 2014, J LIPID RES, V55, P659, DOI 10.1194/jlr.M043711; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Oosterveer MH, 2008, J BIOL CHEM, V283, P25437, DOI 10.1074/jbc.M801922200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tan KCB, 2009, DIABETES OBES METAB, V11, P534, DOI 10.1111/j.1463-1326.2008.01012.x; Varin A, 2015, ARTERIOSCL THROM VAS, V35, P1357, DOI 10.1161/ATVBAHA.115.305539; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yazdanyar A, 2013, ARTERIOSCL THROM VAS, V33, P2058, DOI 10.1161/ATVBAHA.113.301628; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	42	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1115	1122		10.1074/jbc.M115.668269	http://dx.doi.org/10.1074/jbc.M115.668269			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26511317	hybrid, Green Published			2022-12-28	WOS:000368068300008
J	Vaiana, CA; Kurcon, T; Mahal, LK				Vaiana, Christopher A.; Kurcon, Tomasz; Mahal, Lara K.			MicroRNA-424 Predicts a Role for beta-1,4 Branched Glycosylation in Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; GALECTIN-3; ARREST; TRANSFORMATION; PROLIFERATION; EXPRESSION; ANOIKIS; TARGETS; RNA; DNA	MicroRNA regulation of protein expression plays an important role in mediating many cellular processes, from cell proliferation to cell death. The human microRNA miR-424 is up-regulated in response to anti-proliferative cytokines, such as transforming growth factor beta (TGF beta),and directly represses cell cycle progression. Our laboratory recently established that microRNA can be used as a proxy to identify biological roles of glycosylation enzymes (glycogenes). Herein we identify MGAT4A, OGT, and GALNT13 as targets of miR-424. We demonstrate that MGAT4A, an N-acetylglucosaminyltransferase that installs the beta-1,4 branch of N-glycans, is directly regulated by miR-424 in multiple mammary epithelial cell lines and observe the loss of MGAT4A in response to TGF beta, an inducer of miR-424. Knockdown of MGAT4A induces cell cycle arrest through decreasing CCND1 levels. MGAT4A does not affect levels of beta-1,6 branched N-glycans, arguing that this effect is specific to beta-1,4 branching and not due to gross changes in overall N-linked glycosylation. This work provides insight into the regulation of cell cycle progression by specific N-glycan branching patterns.	[Vaiana, Christopher A.; Kurcon, Tomasz; Mahal, Lara K.] NYU, Dept Chem, Inst Biomed Chem, New York, NY 10003 USA	New York University	Mahal, LK (corresponding author), NYU, Dept Chem, 100 Washington Sq East Rm 1001, New York, NY 10003 USA.	lkmahal@nyu.edu	Mahal, Lara/GRY-7287-2022	Mahal, Lara/0000-0003-4791-8524	Margaret Strauss Kramer Fellowship, New York University; Sokol Foundation	Margaret Strauss Kramer Fellowship, New York University; Sokol Foundation	Supported by a Margaret Strauss Kramer Fellowship, New York University.r Supported by the Sokol Foundation. To whom correspondence should be addressed: Dept. of Chemistry, New York University, 100 Washington Square East Rm. 1001, New York, NY. Tel.: 212-998-3533; Fax: 212-9954475; Email:lkmahal@nyu.edu.	Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Barnes JW, 2015, CIRCULATION, V131, P1260, DOI 10.1161/CIRCULATIONAHA.114.013878; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; CARLBERG M, 1993, ANTICANCER RES, V13, P167; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; Guo YJ, 2014, INT J BIOCHEM CELL B, V53, P1, DOI 10.1016/j.biocel.2014.04.012; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Kasper BT, 2014, BIOCHEM BIOPH RES CO, V445, P774, DOI 10.1016/j.bbrc.2014.01.034; Kim HRC, 1999, CANCER RES, V59, P4148; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kurcon T, 2015, P NATL ACAD SCI USA, V112, P7327, DOI 10.1073/pnas.1502076112; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llobet-Navas D, 2014, MOL CELL BIOL, V34, P4216, DOI 10.1128/MCB.00611-14; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Rahman AMA, 2015, GLYCOBIOLOGY, V25, P225, DOI 10.1093/glycob/cwu105; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Takeuchi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135644; Wahlestedt C, 2013, NAT REV DRUG DISCOV, V12, P433, DOI 10.1038/nrd4018; Walsh STR, 2010, BIOCHEMISTRY-US, V49, P8766, DOI 10.1021/bi101050h; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zhou RW, 2014, NAT IMMUNOL, V15, P1038, DOI 10.1038/ni.3007	47	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1529	1537		10.1074/jbc.M115.672220	http://dx.doi.org/10.1074/jbc.M115.672220			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26589799	hybrid, Green Published			2022-12-28	WOS:000368068300042
J	Watanabe, M; Sawada, R; Aramaki, T; Skerrett, IM; Kondo, S				Watanabe, Masakatsu; Sawada, Risa; Aramaki, Toshihiro; Skerrett, I. Martha; Kondo, Shigeru			The Physiological Characterization of Connexin41.8 and Connexin39.4, Which Are Involved in the Striped Pattern Formation of Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; ADULT PIGMENT PATTERN; FUNCTIONAL-ANALYSIS; CELL-INTERACTIONS; MEDAKA FISH; SKIN; MECHANISM; LINEAGE; VOLTAGE; PROTEIN	The zebrafish has a striped skin pattern on its body, and Connexin41.8 (Cx41.8) and Cx39.4 are involved in striped pattern formation. Mutations in these connexins change the striped pattern to a spot or labyrinth pattern. In this study, we characterized Cx41.8 and Cx39.4 after expression in Xenopus oocytes. In addition, we analyzed Cx41.8 mutants Cx41.8I203F and Cx41.8M7, which caused spot or labyrinth skin patterns, respectively, in transgenic zebrafish. In the electrophysiological analysis, the gap junctions formed by Cx41.8 and Cx39.4 showed distinct sensitivity to transjunctional voltage. Analysis of nonjunctional (hemichannel) currents revealed a large voltage-dependent current in Cx39.4-expressing oocytes that was absent in cells expressing Cx41.8. Junctional currents induced by both Cx41.8 and Cx39.4 were reduced by co-expression of Cx41.8I203F and abolished by co-expression of Cx41.8M7. In the transgenic experiment, Cx41.8I203F partially rescued the Cx41.8 null mutant phenotype, whereas Cx41.8M7 failed to rescue the null mutant, and it elicited a more severe phenotype than the Cx41.8 null mutant, as evidenced by a smaller spot pattern. Our results provide evidence that gap junctions formed by Cx41.8 play an important role in stripe/spot patterning and suggest that mutations in Cx41.8 can effect patterning by way of reduced function (I203F) and dominant negative effects (M7). Our results suggest that functional differences in Cx41.8 and Cx39.4 relate to spot or labyrinth mutant phenotypes and also provide evidence that these two connexins interact in vivo and in vitro.	[Watanabe, Masakatsu; Sawada, Risa; Aramaki, Toshihiro; Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Skerrett, I. Martha] Buffalo State Coll, Dept Biol, Buffalo, NY 14222 USA; [Kondo, Shigeru] Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan	Osaka University; State University of New York (SUNY) System; Buffalo State College; Japan Science & Technology Agency (JST)	Watanabe, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	watanabe-m@fbs.osaka-u.ac.jp	WATANABE, Masakatsu/V-9082-2019	WATANABE, Masakatsu/0000-0002-5744-197X; Kondo, Shigeru/0000-0003-0192-5526	Japanese Society for the Promotion of Science, KAKENHI [26291049, 26650078]; Ministry of Education, Culture, Sports, Science, and Technology in Japan, KAKENHI [25111714, 22127003]; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency	Japanese Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology in Japan, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japanese Society for the Promotion of Science, KAKENHI Grants 26291049, 26650078 (to M.W.), by Ministry of Education, Culture, Sports, Science, and Technology in Japan, KAKENHI Grants 25111714 (to M.W.) and 22127003 (to S.K.), and by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (to S.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2013, BBA-BIOMEMBRANES, V1828, P4, DOI 10.1016/j.bbamem.2012.02.007; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; BRUZZONE R, 1993, MOL BIOL CELL, V4, P7, DOI 10.1091/mbc.4.1.7; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Cao FL, 1998, J CELL SCI, V111, P31; Cermak T, 2015, METHODS MOL BIOL, V1239, P133, DOI 10.1007/978-1-4939-1862-1_7; Christie TL, 2004, AM J PHYSIOL-HEART C, V286, pH1623, DOI 10.1152/ajpheart.00800.2003; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dermietzel R, 2000, J NEUROSCI, V20, P8331, DOI 10.1523/JNEUROSCI.20-22-08331.2000; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; Ebihara L, 1999, BIOPHYS J, V76, P198, DOI 10.1016/S0006-3495(99)77189-4; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Eom DS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002899; Fadeev A, 2015, ELIFE, V4, DOI 10.7554/eLife.06545; Furutani K, 2009, MOL PHARMACOL, V75, P1287, DOI 10.1124/mol.108.052936; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Hamada H, 2014, DEVELOPMENT, V141, P318, DOI 10.1242/dev.099804; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Higdon CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067801; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Inoue S, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12192; Irion U, 2014, ELIFE, V3, DOI 10.7554/eLife.05125; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Kawakami K, 1998, GENE, V225, P17, DOI 10.1016/S0378-1119(98)00537-X; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Kjenseth A, 2012, J BIOL CHEM, V287, P15851, DOI 10.1074/jbc.M111.281832; Kondo S, 2002, GENES CELLS, V7, P535, DOI 10.1046/j.1365-2443.2002.00543.x; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kyle JW, 2008, J CELL SCI, V121, P2744, DOI 10.1242/jcs.032482; Lang MR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000744; Lister JA, 1999, DEVELOPMENT, V126, P3757; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Musa H, 2004, J PHYSIOL-LONDON, V557, P863, DOI 10.1113/jphysiol.2003.059386; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2014, FEBS LETT, V588, P1230, DOI 10.1016/j.febslet.2014.01.042; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Singh AP, 2015, CURR BIOL, V25, pR81, DOI 10.1016/j.cub.2014.11.013; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Watanabe M, 2004, GENE, V343, P263, DOI 10.1016/j.gene.2004.09.013; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Watanabe M, 2015, TRENDS GENET, V31, P88, DOI 10.1016/j.tig.2014.11.005; Watanabe M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00473; Watanabe M, 2012, PIGM CELL MELANOMA R, V25, P326, DOI 10.1111/j.1755-148X.2012.00984.x; WERNER R, 1989, P NATL ACAD SCI USA, V86, P5380, DOI 10.1073/pnas.86.14.5380; WHITE TW, 1995, MOL BIOL CELL, V6, P459, DOI 10.1091/mbc.6.4.459; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111	62	20	21	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1053	1063		10.1074/jbc.M115.673129	http://dx.doi.org/10.1074/jbc.M115.673129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26598520	Green Published, hybrid			2022-12-28	WOS:000368068300003
J	Deak, VA; Skroblin, P; Dittmayer, C; Knobeloch, KP; Bachmann, S; Klussmann, E				Deak, Veronika Anita; Skroblin, Philipp; Dittmayer, Carsten; Knobeloch, Klaus-Peter; Bachmann, Sebastian; Klussmann, Enno			The A-kinase Anchoring Protein GSKIP Regulates GSK3 beta Activity and Controls Palatal Shelf Fusion in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CLEFT-LIP; BETA-CATENIN; HEMIFACIAL MICROSOMIA; SUBSTRATE-SPECIFICITY; CANONICAL WNT; MOUSE; GENE; PHOSPHORYLATION; PATHWAY	A-kinase anchoring proteins (AKAPs) represent a family of structurally diverse proteins, all of which bind PKA. A member of this family is glycogen synthase kinase 3 beta (GSK3 beta) interaction protein (GSKIP). GSKIP interacts with PKA and also directly interacts with GSK3 beta. The physiological function of the GSKIP protein in vivo is unknown. We developed and characterized a conditional knock-out mouse model and found that GSKIP deficiency caused lethality at birth. Embryos obtained through Caesarean section at embryonic day 18.5 were cyanotic, suffered from respiratory distress, and failed to initiate breathing properly. Additionally, all GSKIP-deficient embryos showed an incomplete closure of the palatal shelves accompanied by a delay in ossification along the fusion area of secondary palatal bones. On the molecular level, GSKIP deficiency resulted in decreased phosphorylation of GSK3 beta at Ser-9 starting early in development (embryonic day 10.5), leading to enhanced GSK3 beta activity. At embryonic day 18.5, GSK3 beta activity decreased to levels close to that of wild type. Our findings reveal a novel, crucial role for GSKIP in the coordination of GSK3 beta signaling in palatal shelf fusion.	[Deak, Veronika Anita; Skroblin, Philipp; Klussmann, Enno] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Dittmayer, Carsten; Bachmann, Sebastian] Charite, Inst Anat, D-10115 Berlin, Germany; [Knobeloch, Klaus-Peter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Klussmann, Enno] DZHK German Ctr Cardiovasc Res, D-13347 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; German Centre for Cardiovascular Research	Klussmann, E (corresponding author), Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	enno.klussmann@mdc-berlin.de		Deak, Veronika Anita/0000-0001-8454-837X; Skroblin, Philipp/0000-0003-0321-3493; Klussmann, Enno/0000-0003-4004-5003	Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation [G.I.F. I-1210-286.13/2012]	Else Kroner-Fresenius-Stiftung; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by grants from the Else Kroner-Fresenius-Stiftung (2013_A145) (to E. K.), and the German-Israeli Foundation (G.I.F. I-1210-286.13/2012) (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Capra G, 2012, ADV OTO-RHINO-LARYNG, V73, P137, DOI 10.1159/000334471; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dema A, 2015, CELL SIGNAL, V27, P2474, DOI 10.1016/j.cellsig.2015.09.008; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Funato Noriko, 2015, World J Biol Chem, V6, P121, DOI 10.4331/wjbc.v6.i3.121; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He FL, 2010, DEV DYNAM, V239, P3235, DOI 10.1002/dvdy.22466; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Juriloff DM, 2008, BIRTH DEFECTS RES A, V82, P63, DOI 10.1002/bdra.20430; Juriloff DM, 2006, BIRTH DEFECTS RES A, V76, P574, DOI 10.1002/bdra.20302; Juriloff DM, 2005, BIRTH DEFECTS RES A, V73, P103, DOI 10.1002/bdra.20106; Juriloff DM, 1996, MAMM GENOME, V7, P789, DOI 10.1007/s003359900298; Juriloff DM, 2001, MAMM GENOME, V12, P426, DOI 10.1007/s003350010284; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kelberman D, 2001, HUM GENET, V109, P638, DOI 10.1007/s00439-001-0626-x; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kohli Sarvraj Singh, 2012, J Oral Maxillofac Pathol, V16, P64, DOI 10.4103/0973-029X.92976; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926; Lin CC, 2009, J CELL BIOCHEM, V108, P1325, DOI 10.1002/jcb.22362; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Liu Y, 2015, J DENT RES, V94, P961, DOI 10.1177/0022034515583532; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCormick K, 2014, CURR OPIN GENET DEV, V27, P20, DOI 10.1016/j.gde.2014.02.001; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nelson ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025847; Peker T., 1995, GAZI MED J, V6, P55; POOLE MD, 1989, WORLD J SURG, V13, P396, DOI 10.1007/BF01660752; Sadot E, 2002, J CELL SCI, V115, P2771; Saliba J, 2015, NAT GENET, V47, P1131, DOI 10.1038/ng.3380; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shetty NB, 2014, J CLIN DIAGN RES, V8, P283, DOI 10.7860/JCDR/2014/6220.4188; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Steinberg B, 2012, J ORAL MAXIL SURG, V70, pE137, DOI 10.1016/j.joms.2012.07.034; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Yang Y, 2006, J BIOL CHEM, V281, P22352, DOI 10.1074/jbc.M603626200	50	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					681	690		10.1074/jbc.M115.701177	http://dx.doi.org/10.1074/jbc.M115.701177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582204	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000367830500017
J	Liu, Y; Roth, JP				Liu, Yi; Roth, Justine P.			A Revised Mechanism for Human Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN H SYNTHASE; OXYGEN REACTIVITY; COUPLED ELECTRON; ARACHIDONIC-ACID; SUBSTRATE; OXIDATION; HEME; STEPS; LIPOXYGENASES; ACTIVATION	The mechanism of omega-6 polyunsaturated fatty acid oxidation by wild-type cyclooxygenase 2 and the Y334F variant, lacking a conserved hydrogen bond to the catalytic tyrosyl radical/tyrosine, was examined for the first time under physiologically relevant conditions. The enzymes show apparent bimolecular rate constants and deuterium kinetic isotope effects that increase in proportion to co-substrate concentrations before converging to limiting values. The trends exclude multiple dioxygenase mechanisms as well as the proposal that initial hydrogen atom abstraction from the fatty acid is the first irreversible step in catalysis. Temperature dependent kinetic studies reinforce the novel finding that hydrogen transfer from the reduced catalytic tyrosine to a terminal peroxyl radical is the first irreversible step that controls regio- and stereospecific product formation.	[Liu, Yi; Roth, Justine P.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Roth, JP (corresponding author), Johns Hopkins Univ, Dept Chem, 3400 North Charles St, Baltimore, MD 21218 USA.	jproth@jhu.edu			National Science Foundation [MCB0919898]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB0919898. The authors declare that they have no conflicts of interest with the contents of this article.	BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; Danish HH, 2011, J AM CHEM SOC, V133, P15846, DOI 10.1021/ja2059523; Dorlet P, 2002, BIOCHEMISTRY-US, V41, P6107, DOI 10.1021/bi015871f; EDWARD JT, 1970, J CHEM EDUC, V47, P261, DOI 10.1021/ed047p261; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; Halliwell B., 2006, FREE RADICAL BIO MED, P3; Hammes-Schiffer S, 2010, CHEM REV, V110, P6939, DOI 10.1021/cr1001436; HASINOFF BB, 1982, BIOCHEMISTRY-US, V21, P4275, DOI 10.1021/bi00261a015; Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001; Huff GS, 2011, BIOCHEMISTRY-US, V50, P7375, DOI 10.1021/bi201016h; KLINMAN JP, 1980, J BIOL CHEM, V255, P1648; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Kulmacz RJ, 2003, PROG LIPID RES, V42, P377, DOI 10.1016/S0163-7827(03)00023-7; Layfield JP, 2014, CHEM REV, V114, P3466, DOI 10.1021/cr400400p; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Ludlow MK, 2009, J AM CHEM SOC, V131, P7094, DOI 10.1021/ja9001184; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; McGinley CM, 2003, CHEM COMMUN, P2843, DOI 10.1039/b311008g; Mukherjee A, 2007, BIOCHEMISTRY-US, V46, P3975, DOI 10.1021/bi602502j; Mukherjee A, 2011, J AM CHEM SOC, V133, P227, DOI 10.1021/ja104180v; Peng S, 2003, J AM CHEM SOC, V125, P8988, DOI 10.1021/ja035977t; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Rogge CE, 2006, BIOCHEMISTRY-US, V45, P523, DOI 10.1021/bi051235w; Rogge CE, 2004, BIOCHEMISTRY-US, V43, P1560, DOI 10.1021/bi035717o; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Roth JP, 2009, ACCOUNTS CHEM RES, V42, P399, DOI 10.1021/ar800169z; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Smirnov VV, 2014, J BIOL INORG CHEM, V19, P1137, DOI 10.1007/s00775-014-1169-7; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wilson JC, 2005, J AM CHEM SOC, V127, P1618, DOI 10.1021/ja043853q; Wu G, 2014, CATALYSTS, V4, P174, DOI 10.3390/catal4020174; Wu G, 2011, J INORG BIOCHEM, V105, P382, DOI 10.1016/j.jinorgbio.2010.11.015; Wu G, 2009, BIOCHEMISTRY-US, V48, P11902, DOI 10.1021/bi901600f	40	12	12	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					948	958		10.1074/jbc.M115.668038	http://dx.doi.org/10.1074/jbc.M115.668038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565028	hybrid, Green Published			2022-12-28	WOS:000367830500040
J	Zhou, Y; Chang, RX; Ji, WW; Wang, N; Qi, MY; Xu, Y; Guo, JY; Zhan, LX				Zhou, Yi; Chang, Renxu; Ji, Weiwei; Wang, Na; Qi, Meiyan; Xu, Yi; Guo, Jingyu; Zhan, Lixing			Loss of Scribble Promotes Snail Translation through Translocation of HuR and Enhances Cancer Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cancer biology; cancer therapy; cell polarity; drug resistance; cisplatin; HuR; Scribble; Snail	MESSENGER-RNA CONTROLS; CELL POLARITY; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; COMPETITIVE-BINDING; PARP CLEAVAGE; EMT; PROTEIN; SLUG; ACTIVATION	Drug resistance of cancer cells to various therapeutic agents and molecular targets is a major problem facing current cancer research. The tumor suppressor gene Scribble encodes a polarity protein that is conserved between Drosophila and mammals; loss of the locus disrupts cell polarity, inhibits apoptosis, and mediates cancer process. However, the role of Scribble in drug resistance remains unknown. We show here that knockdown of Scribble enhances drug resistance by permitting accumulation of Snail, which functions as a transcription factor during the epithelial-mesenchymal transition. Then, loss of Scribble activates the mRNA-binding protein human antigen R (HuR) by facilitating translocation of HuR from the nucleus to the cytoplasm. Furthermore, we demonstrate HuR can recognize AU-rich elements of the Snail-encoding mRNA, thereby regulating Snail translation. Moreover, loss of Scribble-induced HuR translocation mediates the accumulation of Snail via activation of the p38 MAPK pathway. Thus, this work clarifies the role of polarity protein Scribble, which is directly implicated in the regulation of developmental transcription factor Snail, and suggesting a mechanism for Scribble mediating cancer drug resistance.	[Zhou, Yi; Chang, Renxu; Ji, Weiwei; Wang, Na; Qi, Meiyan; Xu, Yi; Guo, Jingyu; Zhan, Lixing] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Nutr Sci, Key Lab Nutr & Metab,Key Lab Food Safety Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Zhan, LX (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	lxzhan@sibs.ac.cn	Guo, Jingyu/H-7760-2019	Zhan, Lixing/0000-0003-4949-4358; Guo, Jingyu/0000-0001-7700-6468	National Program on Key Basic Research Project of China 973 Program [2011CB510100, 2012CB945004]; Major Program of the National Natural Sciences Foundation of China [31090362]; National Natural Science Foundation of China [81071684, 81301855]; Hundred Talents Program [2010OHTP11]; Science and Technology Service Network Initiative [KFJ-EW-STS-099]	National Program on Key Basic Research Project of China 973 Program(National Basic Research Program of China); Major Program of the National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program(Chinese Academy of Sciences); Science and Technology Service Network Initiative	This work was supported by National Program on Key Basic Research Project of China 973 Program Grants 2011CB510100 and 2012CB945004, Major Program of the National Natural Sciences Foundation of China Grant 31090362, National Natural Science Foundation of China Grants 81071684 and 81301855, Hundred Talents Program Grant 2010OHTP11, and Science and Technology Service Network Initiative Grant KFJ-EW-STS-099. The authors declare that they have no conflicts of interest with the contents of this article.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong R, 2007, BIOCHEM BIOPH RES CO, V356, P318, DOI 10.1016/j.bbrc.2007.02.145; Elsum IA, 2013, J CELL SCI, V126, P3990, DOI 10.1242/jcs.129387; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Hoey T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001056; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Latorre E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-13; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Tarquini F, 2014, CELL BIOCHEM FUNCT, V32, P87, DOI 10.1002/cbf.2975; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yamben IF, 2013, DEV BIOL, V384, P41, DOI 10.1016/j.ydbio.2013.09.027; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357	40	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					291	302		10.1074/jbc.M115.693853	http://dx.doi.org/10.1074/jbc.M115.693853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26527679	hybrid, Green Published			2022-12-28	WOS:000367589500023
J	Dey, S; North, JA; Sriram, J; Evans, BS; Tabita, FR				Dey, Swati; North, Justin A.; Sriram, Jaya; Evans, Bradley S.; Tabita, F. Robert			In Vivo Studies in Rhodospirillum rubrum Indicate That Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (Rubisco) Catalyzes Two Obligatorily Required and Physiologically Significant Reactions for Distinct Carbon and Sulfur Metabolic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISTIC DIVERSITY; PHOTOSYNTHETIC RUBISCO; CHLOROBIUM-TEPIDUM; PROTEIN; SUPERFAMILY; FIXATION; STRAIN; EXPRESSION; BACTERIA; BACILLUS	All organisms possess fundamental metabolic pathways to ensure that needed carbon and sulfur compounds are provided to the cell in the proper chemical form and oxidation state. For most organisms capable of using CO2 as sole source of carbon, ribulose-1,5-bisphosphate (RuBP) carboxylase/oxygenase (Rubisco) catalyzes primary carbon dioxide assimilation. In addition, sulfur salvage pathways are necessary to ensure that key sulfur-containing compounds are both available and, where necessary, detoxified in the cell. Using knock-out mutations and metabolomics in the bacterium Rhodospirillum rubrum, we show here that Rubisco concurrently catalyzes key and essential reactions for seemingly unrelated but physiologically essential central carbon and sulfur salvage metabolic pathways of the cell. In this study, complementation and mutagenesis studies indicated that representatives of all known extant functional Rubisco forms found in nature are capable of simultaneously catalyzing reactions required for both CO2-dependent growth as well as growth using 5-methylthioadenosine as sole sulfur source under anaerobic photosynthetic conditions. Moreover, specific inactivation of the CO2 fixation reaction did not affect the ability of Rubisco to support anaerobic 5-methylthioadenosine metabolism, suggesting that the active site of Rubisco has evolved to ensure that this enzyme maintains both key functions. Thus, despite the coevolution of both functions, the active site of this protein may be differentially modified to affect only one of its key functions.	[Dey, Swati; North, Justin A.; Sriram, Jaya; Tabita, F. Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Evans, Bradley S.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University System of Ohio; Ohio State University; Donald Danforth Plant Science Center	Tabita, FR (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu	Evans, Bradley S/M-2842-2013	Evans, Bradley S/0000-0002-1207-9006	National Science Foundation [DBI-0922879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109547, R01GM095742] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Kevin Sowers of the University of Maryland, Center of Marine Biotechnology for providing M. burtonii genomic DNA and Dr. Brian Witte for constructing plasmid pRPS-MBR We thank Dr. Sriram Satagopan and Dr Vanessa Varaljay for many useful conversations, This work was also supported by the National Science Foundation under Grant DBI-0922879 for acquisition of the LTQ-Velos Pro Orbitrap LC-MS/MS (to B. S. E.).	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Carre-Mlouka A, 2006, J BIOL CHEM, V281, P24462, DOI 10.1074/jbc.M602973200; Chan CM, 2014, ENVIRON MICROBIOL, V16, P101, DOI 10.1111/1462-2920.12210; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; FALCONE DL, 1993, J BACTERIOL, V175, P5066, DOI 10.1128/JB.175.16.5066-5077.1993; GIBSON JL, 1986, GENE, V44, P271, DOI 10.1016/0378-1119(86)90191-5; Hanson TE, 2003, PHOTOSYNTH RES, V78, P231, DOI 10.1023/B:PRES.0000006829.41444.3d; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; Kim K, 2004, FEBS LETT, V571, P124, DOI 10.1016/j.febslet.2004.06.064; Li HY, 2005, STRUCTURE, V13, P779, DOI 10.1016/j.str.2005.02.017; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; Munk AC, 2011, STAND GENOMIC SCI, V4, P293, DOI 10.4056/sigs.1804360; ORMEROD JG, 1961, ARCH BIOCHEM BIOPHYS, V94, P449, DOI 10.1016/0003-9861(61)90073-X; Peleg M, 2011, CRIT REV FOOD SCI, V51, P917, DOI 10.1080/10408398.2011.570463; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Satagopan S, 2014, J BIOL CHEM, V289, P21433, DOI 10.1074/jbc.M114.578625; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; SCHLENK F, 1964, ARCH BIOCHEM BIOPHYS, V106, P95, DOI 10.1016/0003-9861(64)90161-4; Singh J, 2010, J BACTERIOL, V192, P1324, DOI 10.1128/JB.01442-09; Smith SA, 2004, J BIOL CHEM, V279, P25632, DOI 10.1074/jbc.M401360200; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Wang D, 2011, J BACTERIOL, V193, P3293, DOI 10.1128/JB.00265-11; Wang D, 2010, INT J HYDROGEN ENERG, V35, P7377, DOI 10.1016/j.ijhydene.2010.04.183; Warlick BPE, 2012, BIOCHEMISTRY-US, V51, P9470, DOI 10.1021/bi301311t; Witte B. H., 2012, THESIS	36	19	19	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30658	30668		10.1074/jbc.M115.691295	http://dx.doi.org/10.1074/jbc.M115.691295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511314	Green Published, hybrid			2022-12-28	WOS:000367199000001
J	Harmancey, R; Haight, DL; Watts, KA; Taegtmeyer, H				Harmancey, Romain; Haight, Derek L.; Watts, Kayla A.; Taegtmeyer, Heinrich			Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; GENE-EXPRESSION; DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; ISCHEMIA-REPERFUSION; CARDIAC EFFICIENCY; RECEPTOR-ALPHA; SHORT-TERM; MITOCHONDRIAL	The risk for heart failure and death after myocardial infarction is abnormally high in diabetic subjects. We and others have shown previously that mitochondrial uncoupling protein 3 (UCP3) improves functional recovery of the rodent heart during reperfusion. Here, we demonstrate that pharmacological induction of hyperinsulinemia in mice down-regulates myocardial UCP3. Decreased UCP3 expression was linked to the development of selective insulin resistance in the heart, characterized by decreased basal activity of Akt but preserved activity of the p44/42 mitogen-activated protein kinase, and overactivation of the sterol regulatory element-binding protein (SREBP)-1-mediated lipogenic program. In cultured myocytes, insulin treatment and SREBP-1 overexpression decreased, whereas SREBP-1 interference increased, peroxisome proliferator-activated receptor-stimulated expression of UCP3. Promoter deletion and site-directed mutagenesis identified three functional sterol regulatory elements in the vicinity of a known complex intronic enhancer. Increased binding of SREBP-1 to this DNA region was confirmed in the heart of hyperinsulinemic mice. In conclusion, we describe a hitherto unknown regulatory mechanism by which insulin inhibits cardiac UCP3 expression through activation of the lipogenic factor SREBP-1. Sustained down-regulation of cardiac UCP3 by hyperinsulinemia may partly explain the poor prognosis of type 2 diabetic patients after myocardial infarction.	[Harmancey, Romain; Haight, Derek L.; Taegtmeyer, Heinrich] Univ Texas Hlth Sci Ctr Houston, Univ Texas Houston, Sch Med, Dept Internal Med,Div Cardiol, Houston, TX 77030 USA; [Watts, Kayla A.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Obes Res, Jackson, MS 39216 USA; [Watts, Kayla A.] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA	University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Harmancey, R (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, 2500 N State St, Jackson, MS 39216 USA.	rharmancey@umc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [K99/R00 HL112952, R01 HL061483, P01 HL051971, P20 GM104357, P30 DK-079638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112952, R01HL061483, R00HL112952, P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K99/R00 HL112952 (to R. H.), R01 HL061483 (to H. T.), and P01 HL051971 and P20 GM104357. The Mouse Metabolism Core at Baylor College of Medicine under the Diabetes Research Center is supported by National Institutes of Health Grant P30 DK-079638. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Berti JA, 2003, J LIPID RES, V44, P1870, DOI 10.1194/jlr.M300036-JLR200; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Boudina S, 2006, PHYSIOLOGY, V21, P250, DOI 10.1152/physiol.00008.2006; Boudina S, 2012, DIABETES, V61, P3260, DOI 10.2337/db12-0063; Brener SJ, 2012, AM J CARDIOL, V109, P1111, DOI 10.1016/j.amjcard.2011.11.046; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166; Carson JL, 2002, J AM COLL CARDIOL, V40, P418, DOI 10.1016/S0735-1097(02)01969-1; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chen YX, 2015, CARDIOVASC RES, V105, P192, DOI 10.1093/cvr/cvu256; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Gargiulo S, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-98; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Harmancey R, 2013, FASEB J, V27, P3966, DOI 10.1096/fj.13-234914; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Hidaka S, 1999, DIABETES, V48, P430, DOI 10.2337/diabetes.48.2.430; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083426; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huppertz C, 2001, J BIOL CHEM, V276, P12520, DOI 10.1074/jbc.M011708200; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KOBAYASHI M, 1978, AM J PHYSIOL, V235, pE53, DOI 10.1152/ajpendo.1978.235.1.E53; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Luciani N, 2003, ANN THORAC SURG, V76, P1149, DOI 10.1016/S0003-4975(03)00838-5; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Marfella R, 2009, J LIPID RES, V50, P2314, DOI 10.1194/jlr.P900032-JLR200; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Nabben M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0447-4; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; PEREIRA JN, 1967, J LIPID RES, V8, P239; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Safari F, 2014, LIFE SCI, V98, P68, DOI 10.1016/j.lfs.2013.12.230; Schrauwen P, 2001, DIABETES, V50, P2870, DOI 10.2337/diabetes.50.12.2870; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Son C, 2001, ENDOCRINOLOGY, V142, P4189, DOI 10.1210/en.142.10.4189; Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE878, DOI 10.1152/ajpendo.00189.2004; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Szabo Z, 2002, ANN THORAC SURG, V74, P712, DOI 10.1016/S0003-4975(02)03778-5; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Utz W, 2011, HEART, V97, P1585, DOI 10.1136/hrt.2011.224451; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Wang CM, 2011, STRESS, V14, P66, DOI 10.3109/10253890.2010.506931; Woodfield SL, 1996, J AM COLL CARDIOL, V28, P1661, DOI 10.1016/S0735-1097(96)00397-X; Yadav HN, 2010, MOL CELL BIOCHEM, V343, P75, DOI 10.1007/s11010-010-0500-z; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com	75	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30947	30961		10.1074/jbc.M115.673988	http://dx.doi.org/10.1074/jbc.M115.673988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26555260	hybrid, Green Published			2022-12-28	WOS:000367199000026
J	Nishino, K; Obara, K; Kihara, A				Nishino, Kanako; Obara, Keisuke; Kihara, Akio			The C-terminal Cytosolic Region of Rim21 Senses Alterations in Plasma Membrane Lipid Composition INSIGHTS INTO SENSING MECHANISMS FOR PLASMA MEMBRANE LIPID ASYMMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID TRANSLOCATION; AMBIENT PH; RIM101 PATHWAY; YEAST; PROTEIN; GENE; EXPRESSION; EXPOSURE	Yeast responds to alterations in plasma membrane lipid asymmetry and external alkalization via the sensor protein Rim21 in the Rim101 pathway. However, the sensing mechanism used by Rim21 remains unclear. Here, we found that the C-terminal cytosolic domain of Rim21 (Rim21C) fused with GFP was associated with the plasma membrane under normal conditions but dissociated upon alterations in lipid asymmetry or external alkalization. This indicates that Rim21C contains a sensor motif. Rim21C contains multiple clusters of charged residues. Among them, three consecutive Glu residues (EEE motif) were essential for Rim21 function and dissociation of Rim21C from the plasma membrane in response to changes in lipid asymmetry. In contrast, positively charged residues adjacent to the EEE motif were required for Rim21C to associate with the membrane. We therefore propose an "antenna hypothesis," in which Rim21C moves to or from the plasma membrane and functions as the sensing mechanism of Rim21.	[Nishino, Kanako; Obara, Keisuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Obara, Keisuke/A-3824-2012; KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science [25440038, 23770135, 25650059]; Dr. Yoshifumi Jigami Memorial Fund from the Society of Yeast Scientists; Sumitomo Foundation; Institute for Fermentation (Osaka, Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dr. Yoshifumi Jigami Memorial Fund from the Society of Yeast Scientists; Sumitomo Foundation; Institute for Fermentation (Osaka, Japan)(Institute for Fermentation (IFO))	This work was supported by Grant-in-Aid for Scientific Research C 25440038 and Grant-in-Aid for Young Scientists B 23770135 (to K.O.) and Grant-in-Aid for Challenging Exploratory Research 25650059 (to A. K.) from the Japan Society for the Promotion of Science. This work was also supported by Dr. Yoshifumi Jigami Memorial Fund from the Society of Yeast Scientists, by a Grant for Basic Science Research Projects from the Sumitomo Foundation, and by a grant from the Institute for Fermentation (Osaka, Japan; to K. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; FADOK VA, 1992, J IMMUNOL, V148, P2207; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Galindo A, 2012, J CELL SCI, V125, P1784, DOI 10.1242/jcs.098897; Gomez-Raja J, 2012, EUKARYOT CELL, V11, P683, DOI 10.1128/EC.05211-11; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Herrador A, 2015, MOL BIOL CELL, V26, P2128, DOI 10.1091/mbc.E14-11-1552; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Ikeda M, 2008, MOL BIOL CELL, V19, P1922, DOI 10.1091/mbc.E07-08-0806; Ikeda M, 2006, BIOL PHARM BULL, V29, P1542, DOI 10.1248/bpb.29.1542; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Obara K, 2014, MOL CELL BIOL, V34, P3525, DOI 10.1128/MCB.00408-14; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SIKORSKI RS, 1989, GENETICS, V122, P19; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; Verkleij AJ, 2000, J MEMBRANE BIOL, V178, P1, DOI 10.1007/s002320010009; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamauchi S, 2015, J CELL SCI, V128, P61, DOI 10.1242/jcs.153890	42	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30797	30805		10.1074/jbc.M115.674382	http://dx.doi.org/10.1074/jbc.M115.674382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527678	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000367199000013
J	Kotla, S; Rao, GN				Kotla, Sivareddy; Rao, Gadiparthi N.			Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-gamma in CD36 Protein Expression and Foam Cell Formation (Withdrawn Publication. See vol. 298, 2022)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							LOW-DENSITY-LIPOPROTEIN; 15-LIPOXYGENASE MESSENGER-RNA; TYROSINE KINASE INHIBITOR; SIGNAL TRANSDUCER; OXIDATIVE STRESS; NUCLEAR-FACTOR; ATHEROSCLEROSIS; ACID; LDL; INFLAMMATION	Previously, we have demonstrated that 15(S)- hydroxyeicosatetranoic acid (15(S)- HETE) induces CD36 expression involving STAT1. Many studies have shown that peroxisome proliferator-activated receptor (PPAR)-gamma mediates CD36 expression. Therefore, we asked the question whether these transcriptional factors interact with each other in the regulation of CD36 expression by 15(S)-HETE. Here, we show that STAT1 interacts with PPAR gamma in the induction of CD36 expression and foam cell formation by 15(S)-HETE. In addition, using molecular biological approaches such as EMSA, supershift EMSA, ChIP, reChIP, and promoter- reporter gene assays, we demonstrate that the STAT1 and PPAR gamma complex binds to the STAT-binding site at -107 nucleotides in the CD36 promoter and enhances its activity. Furthermore, the interaction of STAT1 with PPAR gamma depends on STAT1 acetylation, which is mediated by p300. In addition, our findings show that reactive oxygen species- dependentSyk and Pyk2 stimulation is required for p300 tyrosinephos-phorylation and activation. Together, these results demonstrate that an interaction between STAT1, p300, and peroxisome proliferator-activated receptor-gamma is required for 15(S)-HETE-induced CD36 expression, oxidized low density lipoprotein uptake, and foam cell formation, critical events underlying the pathogenesis of atherosclerosis.	[Kotla, Sivareddy; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu		kotla, sivareddy/0000-0001-7516-7647	National Institutes of Health from NHLBI [HL064165, HL074860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074860, R01HL064165] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL064165 and HL074860 (to G. N. R.) from the NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; BAILEY JM, 1995, ATHEROSCLEROSIS, V113, P247, DOI 10.1016/0021-9150(94)05452-O; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Chattopadhyay R, 2015, J LIPID RES, V56, P562, DOI 10.1194/jlr.M055566; Chattopadhyay R, 2014, J BIOL CHEM, V289, P3148, DOI 10.1074/jbc.M113.528190; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; Demer L, 2011, CIRC RES, V108, P1482, DOI 10.1161/CIRCRESAHA.110.234245; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Harmon GS, 2011, CHEM REV, V111, P6321, DOI 10.1021/cr2001355; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hilgendorf I, 2011, ARTERIOSCL THROM VAS, V31, P1991, DOI 10.1161/ATVBAHA.111.230847; HILL CE, 1987, BIOCHEM J, V247, P207, DOI 10.1042/bj2470207; HILTUNEN T, 1995, CIRCULATION, V92, P3297, DOI 10.1161/01.CIR.92.11.3297; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Itoh S, 2002, CIRCULATION, V105, P2288, DOI 10.1161/01.CIR.0000015607.33345.1F; Katsume A, 2011, ARTERIOSCL THROM VAS, V31, P1084, DOI 10.1161/ATVBAHA.110.221804; Kotla S, 2014, FREE RADICAL BIO MED, V76, P147, DOI 10.1016/j.freeradbiomed.2014.08.007; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P15830, DOI 10.1074/jbc.M113.453290; Kundumani-Sridharan V, 2012, J BIOL CHEM, V287, P22463, DOI 10.1074/jbc.M112.362996; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Leopold JA, 2009, FREE RADICAL BIO MED, V47, P1673, DOI 10.1016/j.freeradbiomed.2009.09.009; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; OLEARY VJ, 1992, BIOCHEM J, V282, P631, DOI 10.1042/bj2820631; Pelham CJ, 2013, AM J PHYSIOL-REG I, V304, pR690, DOI 10.1152/ajpregu.00607.2012; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Schroder K, 2006, FREE RADICAL BIO MED, V41, P1353, DOI 10.1016/j.freeradbiomed.2006.03.026; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; SIMON TC, 1989, THROMB RES, V55, P171, DOI 10.1016/0049-3848(89)90433-7; Szanto A., MOL PHARM, V67, P1935; Upston JM, 1996, J LIPID RES, V37, P2650; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Xu WP, 2003, ADV EXP MED BIOL, V525, P181; Xu ZG, 2005, CIRCULATION, V111, P1962, DOI 10.1161/01.CIR.0000161831.07637.63; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yoshida H, 2004, CLIN CHIM ACTA, V345, P161, DOI 10.1016/j.cccn.2004.03.018; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	60	26	29	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30306	30320		10.1074/jbc.M115.686865	http://dx.doi.org/10.1074/jbc.M115.686865			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26504087	Green Published, hybrid			2022-12-28	WOS:000366738200011
J	Baranovskiy, AG; Zhang, YB; Suwa, Y; Gu, JY; Babayeva, ND; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Zhang, Yinbo; Suwa, Yoshiaki; Gu, Jianyou; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.			Insight into the Human DNA Primase Interaction with Template-Primer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; POLYMERASE-ALPHA-PRIMASE; IRON-SULFUR CLUSTER; CRYSTAL-STRUCTURE; P58 SUBUNIT; EUKARYOTIC REPLISOME; CATALYTIC SUBUNIT; CALF THYMUS; REPLICATION; BINDING	DNA replication in almost all organisms depends on the activity of DNA primase, a DNA-dependent RNA polymerase that synthesizes short RNA primers of defined size for DNA polymerases. Eukaryotic and archaeal primases are heterodimers consisting of small catalytic and large accessory subunits, both of which are necessary for the activity. The mode of interaction of primase subunits with substrates during the various steps of primer synthesis that results in the counting of primer length is not clear. Here we show that the C-terminal domain of the large subunit (p58(C)) plays a major role in template-primer binding and also defines the elements of the DNA template and the RNA primer that interact with p58(C). The specific mode of interaction with a template-primer involving the terminal 5'-triphosphate of RNA and the 3'-overhang of DNA results in a stable complex between p58(C) and the DNA/RNA duplex. Our results explain how p58(C) participates in RNA synthesis and primer length counting and also indicate that the binding site for initiating NTP is located on p58(C). These findings provide notable insight into the mechanism of primase function and are applicable for DNA primases from other species.	[Baranovskiy, Andrey G.; Zhang, Yinbo; Suwa, Yoshiaki; Gu, Jianyou; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	; Pavlov, Youri/T-7532-2017	Gu, Jianyou/0000-0003-0285-8919; Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069	National Institutes of Health [GM101167, CA129925]; Fred and Pamela Buffett Cancer Center [P30CA03672]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred and Pamela Buffett Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM101167 (NIGMS; to T. H. T.) and, in part, by CA129925 (NCI; to Y. I. P.). DNA Sequencing Core and Structural Biology Facilities are supported by the Fred and Pamela Buffett Cancer Center Support Grant P30CA03672 (NCI; to Kenneth H. Cowan). The authors declare that they have no competing conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Beck K, 2010, NUCLEIC ACIDS RES, V38, P6707, DOI 10.1093/nar/gkq447; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Cavanaugh NA, 2009, BIOCHEMISTRY-US, V48, P10199, DOI 10.1021/bi9010144; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; FOIANI M, 1989, J BIOL CHEM, V264, P2189; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Geibel S, 2009, P NATL ACAD SCI USA, V106, P7810, DOI 10.1073/pnas.0902910106; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Jozwiakowski SK, 2015, P NATL ACAD SCI USA, V112, pE633, DOI 10.1073/pnas.1412982112; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Liu LL, 2015, PROTEIN CELL, V6, P194, DOI 10.1007/s13238-015-0134-8; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Matsui E, 2003, BIOCHEMISTRY-US, V42, P14968, DOI 10.1021/bi035556o; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Mitchell SF, 2014, METHOD ENZYMOL, V541, P179, DOI 10.1016/B978-0-12-420119-4.00015-X; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; PODUST VN, 1992, EUR J BIOCHEM, V206, P7, DOI 10.1111/j.1432-1033.1992.tb16895.x; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Urban M, 2010, BIOCHEMISTRY-US, V49, P727, DOI 10.1021/bi9019516; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333	46	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4793	4802		10.1074/jbc.M115.704064	http://dx.doi.org/10.1074/jbc.M115.704064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710848	Green Published, hybrid			2022-12-28	WOS:000371604600044
J	Akpa, MM; Iglesias, D; Chu, L; Thiebaut, A; Jentoft, I; Hammond, L; Torban, E; Goodyer, PR				Akpa, Murielle M.; Iglesias, Diana; Chu, LeeLee; Thiebaut, Antonin; Jentoft, Ida; Hammond, Leah; Torban, Elena; Goodyer, Paul R.			Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; dicer; mesenchymal stem cells (MSCs); microRNA (miRNA); polycomb; Enhancer of Zeste 2; kidney development; Wilms tumor 1	GENE; RNA; MUTATIONS; BINDING; LOCALIZATION; BIOGENESIS; PATHWAYS; ROLES	Hereditary forms of Wilms arise from developmentally arrested clones of renal progenitor cells with biallelic mutations of WT1; recently, it has been found that Wilms tumors may also be associated with biallelic mutations in DICER1 or DROSHA, crucial for miRNA biogenesis. We have previously shown that a critical role for WT1 during normal nephrogenesis is to suppress transcription of the Polycomb group protein, EZH2, thereby de-repressing genes in the differentiation cascade. Here we show that WT1 also suppresses translation of EZH2. All major WT1 isoforms induce an array of miRNAs, which target the 3 UTR of EZH2 and other Polycomb-associated transcripts. We show that the WT1(+KTS) isoform binds to the 5 UTR of EZH2 and interacts directly with the miRNA-containing RISC to enhance post-transcriptional inhibition. These observations suggest a novel mechanism through which WT1 regulates the transition from resting stem cell to activated progenitor cell during nephrogenesis. Our findings also offer a plausible explanation for the fact that Wilms tumors can arise either from loss of WT1 or loss of miRNA processing enzymes.	[Akpa, Murielle M.; Goodyer, Paul R.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Torban, Elena; Goodyer, Paul R.] McGill Univ, Dept Expt Med, Montreal, PQ H3A 1A3, Canada; [Iglesias, Diana; Chu, LeeLee; Thiebaut, Antonin; Jentoft, Ida; Hammond, Leah; Goodyer, Paul R.] McGill Univ, Ctr Hlth, Res Inst, Dept Pediat, Montreal, PQ H4A 3J1, Canada	McGill University; McGill University; McGill University	Goodyer, PR (corresponding author), Montreal Childrens Hosp, Dept Human Genet, Res Inst, 1001 Decarie Blvd,Bloc E,Lab E012371, Montreal, PQ H4A 3J1, Canada.; Goodyer, PR (corresponding author), Montreal Childrens Hosp, Dept Pediat, Res Inst, 1001 Decarie Blvd,Bloc E,Lab E012371, Montreal, PQ H4A 3J1, Canada.	paul.goodyer@mcgill.ca	Thiébaut, Antonin/AAR-7016-2020	Thiébaut, Antonin/0000-0002-7587-5587; Jentoft, Ida/0000-0001-7726-1717	Canadian Institutes of Health Research (CIHR) [MOP-119571]; Fonds de la Recherche en Sante du Quebec (FRSQ); James McGill Research Chair	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); James McGill Research Chair	This work was supported in part by Operating Grant MOP-119571 from the Canadian Institutes of Health Research (CIHR) and an infrastructure support grant to the McGill University Health Center Research Institute from the Fonds de la Recherche en Sante du Quebec (FRSQ). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a James McGill Research Chair. To whom correspondence should be addressed: Depts. of Human Genetics and Pediatrics, Montreal Children's Hospital Research Institute, 1001 Decarie Blvd., Bloc E, Lab E012371, Montreal, QC H4A 3J1, Canada. Tel.: 514-412-4400 (ext. 22584); Fax: 514-412-4478; E-mail: paul.goodyer@mcgill.ca.	Aiden AP, 2010, CELL STEM CELL, V6, P591, DOI 10.1016/j.stem.2010.03.016; Akpa MM, 2015, J BIOL CHEM, V290, P2279, DOI 10.1074/jbc.M114.573576; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; Charlieu JP, 1995, J CELL SCI, P95; Cone T E Jr, 1970, Pediatrics, V46, P587; Davies R, 1999, CANCER RES, V59, p1747S; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Friedman JM, 2009, CELL CYCLE, V8, P2313, DOI 10.4161/cc.8.15.9168; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Gagnon KT, 2012, NUCLEIC ACID THER, V22, P3, DOI 10.1089/nat.2011.0330; HUFF V, 1991, AM J HUM GENET, V48, P997; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2004, IUBMB LIFE, V56, P95, DOI 10.1080/15216540410001670142; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Morrison AA, 2008, BBA-REV CANCER, V1785, P55, DOI 10.1016/j.bbcan.2007.10.002; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; O'Rourke Jason R., 2006, Birth Defects Research, V78, P172, DOI 10.1002/bdrc.20071; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Torrezan GT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5039; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Wu MK, 2013, J PATHOL, V230, P154, DOI 10.1002/path.4196; Zhai G, 2001, BIOCHEMISTRY-US, V40, P2032, DOI 10.1021/bi001941r; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	35	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3785	3795		10.1074/jbc.M115.678029	http://dx.doi.org/10.1074/jbc.M115.678029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26655220	Green Published, hybrid			2022-12-28	WOS:000371338400010
J	Charles, R; Namkung, Y; Cotton, M; Laporte, SA; Claing, A				Charles, Ricardo; Namkung, Yoon; Cotton, Mathieu; Laporte, Stephane A.; Claing, Audrey			beta-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; ADP ribosylation factor (ARF); angiotensin II; arrestin; cell migration; vascular smooth muscle cells	GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; B KINASE COMPLEX; BETA(2)-ADRENERGIC RECEPTOR; CLATHRIN ADAPTER; TYPE-1 RECEPTOR; IN-VIVO; MEMBRANE; PHOSPHORYLATION; BETA-ARRESTIN-2	Angiotensin II (Ang II) is a vasopressive hormone but is also a potent activator of cellular migration. We have previously shown that it can promote the activation of the GTPase ARF6 in a heterologous overexpressing system. The molecular mechanisms by which receptors control the activation of this small G protein remain, however, largely unknown. Furthermore, how ARF6 coordinates the activation of complex cellular responses needs to be further elucidated. In this study, we demonstrate that Ang II receptors engage -arrestin, but not G(q), to mediate ARF6 activation in HEK 293 cells. To further confirm the key role of -arrestin proteins, we overexpressed -arrestin2-(1-320), a dominant negative mutant known to block receptor endocytosis. We show that expression of this truncated construct does not support the activation of the GTPase nor cell migration. Interestingly, -arrestin2 can interact with the ARF guanine nucleotide exchange factor ARNO, although the C-terminally lacking mutant does not. We finally examined whether receptor endocytosis controlled ARF6 activation and cell migration. Although the clathrin inhibitor PitStop2 did not impact the ability of Ang II to activate ARF6, cell migration was markedly impaired. To further show that ARF activation regulates key signaling events leading to migration, we also examined MAPK activation. We demonstrate that this signaling axis is relevant in smooth muscle cells of the vasculature. Altogether, our findings show for the first time that Ang II receptor signaling to -arrestin regulates ARF6 activation. These proteins together control receptor endocytosis and ultimately cell migration.	[Charles, Ricardo; Cotton, Mathieu; Claing, Audrey] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Namkung, Yoon; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada	Universite de Montreal; McGill University	Claing, A (corresponding author), Univ Montreal, Dept Pharmacol, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021	Laporte, Stephane/0000-0002-0633-543X	Canadian Institutes of Health Research [MOP-79470, MOP-74603]; Heart and Stroke Foundation of Canada; Fonds de Recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by the Canadian Institutes of Health Research Grants MOP-79470 (to A. C.) and MOP-74603 (to S. A. L.) and the Heart and Stroke Foundation of Canada (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Chercheur-Boursier Senior of the Fonds de Recherche du Quebec-Sante and a member of the Groupe d'Etude des Proteines Membranaires. To whom correspondence should be addressed: Dept. of Pharmacology, Universite de Montreal, P. O. Box 6128, Downtown Station, Montreal, Quebec H3C 3J7, Canada. Tel.: 514-343-6352; Fax: 514-343-2291; E-mail: audrey.claing@umontreal.ca.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; BERK BC, 1993, J CELL PHYSIOL, V154, P368, DOI 10.1002/jcp.1041540221; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chen PW, 2014, J BIOL CHEM, V289, P30237, DOI 10.1074/jbc.M114.596155; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyon P, 2013, ARTERIOSCL THROM VAS, V33, P2850, DOI 10.1161/ATVBAHA.113.302487; Doyon P, 2010, J BIOL CHEM, V285, P30708, DOI 10.1074/jbc.M110.126433; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laursen JB, 1997, CIRCULATION, V95, P588, DOI 10.1161/01.CIR.95.3.588; Lee HM, 2007, J PHARMACOL SCI, V105, P74, DOI 10.1254/jphs.FP0070770; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Li F, 2005, J PHARMACOL EXP THER, V312, P1043, DOI 10.1124/jpet.104.076588; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Macia E, 2012, J CELL SCI, V125, P4026, DOI 10.1242/jcs.102343; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Muniz P, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.suppl_1.14; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Padovani D, 2014, P NATL ACAD SCI USA, V111, P12378, DOI 10.1073/pnas.1409832111; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tilley DG, 2014, CIRCULATION, V130, P1800, DOI 10.1161/CIRCULATIONAHA.114.010434; Touyz RM, 2000, PHARMACOL REV, V52, P639; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	68	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3967	3981		10.1074/jbc.M115.684357	http://dx.doi.org/10.1074/jbc.M115.684357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703465	Green Published, hybrid			2022-12-28	WOS:000371338400024
J	Ho, T; Watt, B; Spruce, LA; Seeholzer, SH; Marks, MS				Ho, Tina; Watt, Brenda; Spruce, Lynn A.; Seeholzer, Steven H.; Marks, Michael S.			The Kringle-like Domain Facilitates Post-endoplasmic Reticulum Changes to Premelanosome Protein (PMEL) Oligomerization and Disulfide Bond Configuration and Promotes Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; disulfide; endosome; fibril; melanogenesis; membrane trafficking; oxidation-reduction (redox); protein aggregation; Pmel17; melanosome	MELANOSOME BIOGENESIS; MOLECULAR CHARACTERIZATION; ELECTRON-MICROSCOPY; MELANOCYTE LINEAGE; ME20 ANTIGEN; 17 SILVER; CELLS; MELANOGENESIS; GLYCOPROTEIN; MUTATION	The formation of functional amyloid must be carefully regulated to prevent the accumulation of potentially toxic products. Premelanosome protein (PMEL) forms non-toxic functional amyloid fibrils that assemble into sheets upon which melanins ultimately are deposited within the melanosomes of pigment cells. PMEL is synthesized in the endoplasmic reticulum but forms amyloid only within post-Golgi melanosome precursors; thus, PMEL must traverse the secretory pathway in a non-amyloid form. Here, we identified two pre-amyloid PMEL intermediates that likely regulate the timing of fibril formation. Analyses by non-reducing SDS-PAGE, size exclusion chromatography, and sedimentation velocity revealed two native high M-r disulfide-bonded species that contain Golgi-modified forms of PMEL. These species correspond to disulfide bond-containing dimeric and monomeric PMEL isoforms that contain no other proteins as judged by two-dimensional PAGE of metabolically labeled/immunoprecipitated PMEL and by mass spectrometry of affinity-purified complexes. Metabolic pulse-chase analyses, small molecule inhibitor treatments, and evaluation of site-directed mutants suggest that the PMEL dimer forms around the time of endoplasmic reticulum exit and is resolved by disulfide bond rearrangement into a monomeric form within the late Golgi or a post-Golgi compartment. Mutagenesis of individual cysteine residues within the non-amyloid cysteine-rich Kringle-like domain stabilizes the disulfide-bonded dimer and impairs fibril formation as determined by electron microscopy. Our data show that the Kringle-like domain facilitates the resolution of disulfide-bonded PMEL dimers and promotes PMEL functional amyloid formation, thereby suggesting that PMEL dimers must be resolved to monomers to generate functional amyloid fibrils.	[Ho, Tina; Watt, Brenda; Spruce, Lynn A.; Seeholzer, Steven H.; Marks, Michael S.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 816G Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Ho, Tina; Watt, Brenda; Marks, Michael S.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Ho, Tina; Watt, Brenda; Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Marks, MS (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 816G Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262	National Institutes of Health [R01 AR048155]; National Institutes of Health from NIAMS [T32 AR007465]; National Institutes of Health from NIA [T32 AG000255]; National Institutes of Health from NIGMS [T32 GM007170]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048155, T32AR007465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NIA; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01 AR048155 and National Institutes of Health Training Program Grants T32 AR007465 from NIAMS, T32 AG000255 from NIA, and T32 GM007170 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Anoop A, 2014, J BIOL CHEM, V289, P16884, DOI 10.1074/jbc.M114.548354; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; BIASELLE CJ, 1975, BIOPHYS CHEM, V3, P355, DOI 10.1016/0301-4622(75)80029-9; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Burgoyne T, 2015, J CELL SCI, V128, P1400, DOI 10.1242/jcs.164400; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Dunn LC, 1930, J HERED, V21, P495, DOI 10.1093/oxfordjournals.jhered.a103275; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hellstrom AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002285; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Kawaguchi M, 2015, J DERMATOL SCI, V78, P133, DOI 10.1016/j.jdermsci.2015.02.020; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1987, MOL BIOL MED, V4, P339; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Leonhardt RM, 2013, MOL BIOL CELL, V24, P964, DOI 10.1091/mbc.E12-10-0742; Leonhardt RM, 2011, J BIOL CHEM, V286, P9321, DOI 10.1074/jbc.M110.168088; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; LORBER B, 1990, BIOCHIM BIOPHYS ACTA, V1023, P254, DOI 10.1016/0005-2736(90)90421-J; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; MARESH GA, 1994, DNA CELL BIOL, V13, P87, DOI 10.1089/dna.1994.13.87; Marks MS, 2001, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0503s00, DOI 10.1002/0471143030.CB0503S00]; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; NISHIGAI M, 1985, BIOCHIM BIOPHYS ACTA, V831, P236, DOI 10.1016/0167-4838(85)90040-8; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rochin L, 2013, P NATL ACAD SCI USA, V110, P10658, DOI 10.1073/pnas.1220748110; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; VENNEGOOR C, 1988, AM J PATHOL, V130, P179; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Watt B, 2013, PIGM CELL MELANOMA R, V26, P300, DOI 10.1111/pcmr.12067; Watt B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002286; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; West LC, 2013, CURR OPIN IMMUNOL, V25, P103, DOI 10.1016/j.coi.2012.11.006	66	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3595	3612		10.1074/jbc.M115.692442	http://dx.doi.org/10.1074/jbc.M115.692442			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26694611	hybrid, Green Published			2022-12-28	WOS:000370854500038
J	Ambadapadi, S; Munuswamy-Ramanujam, G; Zheng, DH; Sullivan, C; Dai, E; Morshed, S; McFadden, B; Feldman, E; Pinard, M; McKenna, R; Tibbetts, S; Lucas, A				Ambadapadi, Sriram; Munuswamy-Ramanujam, Ganesh; Zheng, Donghang; Sullivan, Colin; Dai, Erbin; Morshed, Sufi; McFadden, Baron; Feldman, Emily; Pinard, Melissa; McKenna, Robert; Tibbetts, Scott; Lucas, Alexandra			Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; MYXOMA VIRAL SERPIN; HEPARIN-COFACTOR-II; SERINE PROTEINASE; P-SELECTIN; ACTIVATION; INHIBITOR; SURVIVAL; INJECTION; ANALOGS	Serpins regulate coagulation and inflammation, binding serine proteases in suicide-inhibitory complexes. Target proteases cleave the serpin reactive center loop scissile P1-P1' bond, resulting in serpin-protease suicide-inhibitory complexes. This inhibition requires a near full-length serpin sequence. Myxomavirus Serp-1 inhibits thrombolytic and thrombotic proteases, whereas mammalian neuroserpin (NSP) inhibits only thrombolytic proteases. Both serpins markedly reduce arterial inflammation and plaque in rodent models after single dose infusion. In contrast, Serp-1 but not NSP improves survival in a lethal murine gammaherpesvirus68 (MHV68) infection in interferon gamma-receptor-deficient mice (IFN gamma R-/-). Serp-1 has also been successfully tested in a Phase 2a clinical trial. We postulated that proteolytic cleavage of the reactive center loop produces active peptide derivatives with expanded function. Eight peptides encompassing predicted protease cleavage sites for Serp-1 and NSP were synthesized and tested for inhibitory function in vitro and in vivo. In engrafted aorta, selected peptides containing Arg or Arg-Asn, not Arg-Met, with a 0 or +1 charge, significantly reduced plaque. Conversely, S-6 a hydrophobic peptide of NSP, lacking Arg or Arg-Asn with -4 charge, induced early thrombosis and mortality. S-1 and S-6 also significantly reduced CD11b(+) monocyte counts in mouse splenocytes. S-1 peptide had increased efficacy in plasminogen activator inhibitor-1 serpin-deficient transplants. Plaque reduction correlated with mononuclear cell activation. In a separate study, Serp-1 peptide S-7 improved survival in the MHV68 vasculitis model, whereas an inverse S-7 peptide was inactive. Reactive center peptides derived from Serp-1 and NSP with suitable charge and hydrophobicity have the potential to extend immunomodulatory functions of serpins.	[Ambadapadi, Sriram; Munuswamy-Ramanujam, Ganesh; Zheng, Donghang; Sullivan, Colin; Dai, Erbin; Morshed, Sufi; Lucas, Alexandra] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL 32608 USA; [McFadden, Baron; Feldman, Emily; Pinard, Melissa; McKenna, Robert; Tibbetts, Scott; Lucas, Alexandra] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32608 USA; [Munuswamy-Ramanujam, Ganesh] SRM Univ, Interdisciplinary Inst Indian Syst Med, Kattankulathur 603203, Tamil Nadu, India	State University System of Florida; University of Florida; State University System of Florida; University of Florida; SRM Institute of Science & Technology Chennai	Lucas, A (corresponding author), Univ Florida, Dept Med, Div Cardiol & Rheumatol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	Alexandra.lucas@medicine.ufl.edu	Munuswamy-Ramanujam, Ganesh/ABE-7225-2021	Munuswamy-Ramanujam, Ganesh/0000-0001-8021-601X; Ambadapadi, Sriram/0000-0001-6542-4259	National Institutes of Health [1RC1HL100202-01, 1 R01 AI100987-01A1]; American Heart Association [0855421 E]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health Grants 1RC1HL100202-01 and 1 R01 AI100987-01A1 and American Heart Association Grant 0855421 E. Dr. Lucas consults for and holds minor shares in a small biotechnology company, Viron Therapeutics, Inc. (London, Canada). Viron did not provide research funding for these studies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Anbanandam A, 2008, J MOL BIOL, V384, P219, DOI 10.1016/j.jmb.2008.09.021; Barata TS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002095; Bedard ELR, 2006, TRANSPLANTATION, V81, P908, DOI 10.1097/01.tp.0000203141.02725.8a; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; Bocksch L, 2007, ATHEROSCLEROSIS, V194, P116, DOI 10.1016/j.atherosclerosis.2006.10.014; Chen H, 2013, ANTIMICROB AGENTS CH, V57, P4114, DOI 10.1128/AAC.02594-12; Chen H, 2011, METHOD ENZYMOL, V499, P301, DOI 10.1016/B978-0-12-386471-0.00015-8; Christov A, 2001, LASER SURG MED, V28, P414; Congote LF, 2006, BIOCHEM BIOPH RES CO, V343, P617, DOI 10.1016/j.bbrc.2006.02.190; Dai E, 1997, ARTERIOSCL THROM VAS, V17, P2359, DOI 10.1161/01.ATV.17.11.2359; Dai E, 2003, J BIOL CHEM, V278, P18563, DOI 10.1074/jbc.M209683200; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Doss M, 2012, J IMMUNOL, V188, P2759, DOI 10.4049/jimmunol.1101335; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Jia QY, 2012, BIOORG MED CHEM LETT, V22, P2393, DOI 10.1016/j.bmcl.2012.02.037; Jiang J, 2007, TRANSPLANTATION, V84, P1158, DOI 10.1097/01.tp.0000286099.50532.b0; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee E, 2011, J PEPT SCI, V17, P675, DOI 10.1002/psc.1387; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Lucas A, 2009, ADV EXP MED BIOL, V666, P132; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Raguine L, 2013, CHEM BIOL DRUG DES, V81, P167, DOI 10.1111/cbdd.12080; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Shmueli RB, 2013, BIOMATERIALS, V34, P7544, DOI 10.1016/j.biomaterials.2013.06.044; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064; Sutherland JS, 2007, THROMB HAEMOSTASIS, V98, P1014, DOI 10.1160/TH07-03-0197; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Viswanathan K, 2006, THROMB HAEMOSTASIS, V95, P499, DOI 10.1160/TH05-07-0492; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044694; Viswanathan K, 2009, J LEUKOCYTE BIOL, V85, P418, DOI 10.1189/jlb.0808506; Wang L, 2004, BRAIN RES, V1015, P175, DOI 10.1016/j.brainres.2004.04.053; Zalai CV, 2001, J AM COLL CARDIOL, V38, P1340, DOI 10.1016/S0735-1097(01)01570-4; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	41	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2874	2887		10.1074/jbc.M115.704841	http://dx.doi.org/10.1074/jbc.M115.704841			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26620556	Green Published, hybrid			2022-12-28	WOS:000369626900026
J	Finelli, MJ; Sanchez-Pulido, L; Liu, KX; Davies, KE; Oliver, PL				Finelli, Mattea J.; Sanchez-Pulido, Luis; Liu, Kevin X.; Davies, Kay E.; Oliver, Peter L.			The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOZYGOUS TBC1D24 MUTATION; RESISTANCE 1; OXR1 PROTEIN; 2 SIBLINGS; EXPRESSION; SEQUENCE; EPILEPSY; IDENTIFICATION; PROTECTION; REVEALS	Oxidative stress is a pathological feature of many neurological disorders; therefore, utilizing proteins that are protective against such cellular insults is a potentially valuable therapeutic approach. Oxidation resistance 1 (OXR1) has been shown previously to be critical for oxidative stress resistance in neuronal cells; deletion of this gene causes neurodegeneration in mice, yet conversely, overexpression of OXR1 is protective in cellular and mouse models of amyotrophic lateral sclerosis. However, the molecular mechanisms involved are unclear. OXR1 contains the Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), domain catalytic (TLDc) domain, a motif present in a family of proteins including TBC1 domain family member 24 (TBC1D24), a protein mutated in a range of disorders characterized by seizures, hearing loss, and neurodegeneration. The TLDc domain is highly conserved across species, although the structure-function relationship is unknown. To understand the role of this domain in the stress response, we carried out systematic analysis of all mammalian TLDc domain-containing proteins, investigating their expression and neuroprotective properties in parallel. In addition, we performed a detailed structural and functional study of this domain in which we identified key residues required for its activity. Finally, we present a new mouse insertional mutant of Oxr1, confirming that specific disruption of the TLDc domain in vivo is sufficient to cause neurodegeneration. Our data demonstrate that the integrity of the TLDc domain is essential for conferring neuroprotection, an important step in understanding the functional significance of all TLDc domain-containing proteins in the cellular stress response and disease.	[Finelli, Mattea J.; Sanchez-Pulido, Luis; Liu, Kevin X.; Davies, Kay E.; Oliver, Peter L.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Parks Rd, Oxford OX1 3PT, England	University of Oxford	Oliver, PL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Parks Rd, Oxford OX1 3PT, England.	peter.oliver@dpag.ox.ac.uk	Finelli, Mattea/AAD-5783-2022; Oliver, Peter/AAS-4022-2020; Liu, Kevin X/E-4319-2015	Liu, Kevin X/0000-0003-2071-5137; Oliver, Peter/0000-0003-3347-2461; Sanchez Pulido, Luis/0000-0002-2300-8502; Finelli, Mattea/0000-0002-0152-3642	United Kingdom Medical Research Council; European Research Council under the European Union [311394]; MRC [MC_U137761449, MC_UU_12021/2, MC_UU_12021/1, MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_UU_12021/1, MC_U137761449, MC_U137761446, MC_UU_12021/2] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council under the European Union(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a United Kingdom Medical Research Council Programme grant (to K. E. D.) and funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant 311394 (to P. L. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Afawi Z, 2013, EPILEPSY RES, V105, P240, DOI 10.1016/j.eplepsyres.2013.02.005; Alasoo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12524; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Araii H, 2008, ONCOL REP, V19, P1381; Azaiez H, 2014, HUM MUTAT, V35, P819, DOI 10.1002/humu.22557; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Blaise M, 2012, PROTEINS, V80, P1694, DOI 10.1002/prot.24050; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Campeau PM, 2014, LANCET NEUROL, V13, P44, DOI 10.1016/S1474-4422(13)70265-5; Cardon A., 2015, NEUROLOGY, V84, pS271; Cho SH, 2015, TUBERC RESPIR DIS, V78, P99, DOI 10.4046/trd.2015.78.2.99; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Doummar D, 2015, MOVEMENT DISORD, V30, P1431, DOI 10.1002/mds.26303; Durand M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-13; Elliott NA, 2004, MOL CELL BIOL, V24, P3180, DOI 10.1128/MCB.24.8.3180-3187.2004; Endo S, 2014, DRUG METAB DISPOS, V42, P803, DOI 10.1124/dmd.113.056044; Falace A, 2014, P NATL ACAD SCI USA, V111, P2337, DOI 10.1073/pnas.1316294111; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Fernandes AC, 2014, J CELL BIOL, V207, P453, DOI 10.1083/jcb.201406026; Finelli MJ, 2015, HUM MOL GENET, V24, P3529, DOI 10.1093/hmg/ddv104; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Guven A, 2013, J MED GENET, V50, P199, DOI 10.1136/jmedgenet-2012-101313; Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168; Kobayashi N, 2014, J INSECT PHYSIOL, V68, P58, DOI 10.1016/j.jinsphys.2014.06.020; Li Y, 2014, SCI REP, V4, P1, DOI DOI 10.1038/SREP07186; Liu KX, 2015, BRAIN, V138, P1167, DOI 10.1093/brain/awv039; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Milh M, 2013, HUM MUTAT, V34, P869, DOI 10.1002/humu.22318; Murphy KC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-26; Murray AR, 2013, INVEST OPHTH VIS SCI, V54, P1689, DOI 10.1167/iovs.12-10921; Musaro A, 2007, EXP GERONTOL, V42, P76, DOI 10.1016/j.exger.2006.05.004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliver PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002338; Poulat AL, 2015, EPILEPSY RES, V111, P72, DOI 10.1016/j.eplepsyres.2015.01.008; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanada Y, 2014, FREE RADICAL RES, V48, P919, DOI 10.3109/10715762.2014.927063; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Shkolnik K, 2008, REPRODUCTION, V135, P321, DOI 10.1530/REP-07-0402; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Stamper C, 2008, MOVEMENT DISORD, V23, P1588, DOI 10.1002/mds.22184; Strazisar BG, 2015, EUR J PAEDIATR NEURO, V19, P251, DOI 10.1016/j.ejpn.2014.12.011; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Vinciguerra M, 2010, AGING-US, V2, P43; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Wang ZP, 2012, J IMMUNOL, V188, P3993, DOI 10.4049/jimmunol.1103301; West DB, 2015, GENOME RES, V25, P598, DOI 10.1101/gr.184184.114; Yang MY, 2014, FREE RADICAL BIO MED, V77, P41, DOI 10.1016/j.freeradbiomed.2014.09.003; Yu LA, 2015, FINANC INNOV, V1, DOI 10.1186/s40854-015-0005-6	57	39	40	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2751	2763		10.1074/jbc.M115.685222	http://dx.doi.org/10.1074/jbc.M115.685222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26668325	Green Published, hybrid			2022-12-28	WOS:000369626900016
J	Nakamura, K; Sano, S; Fuster, JJ; Kikuchi, R; Shimizu, I; Ohshima, K; Katanasaka, Y; Ouchi, N; Walsh, K				Nakamura, Kazuto; Sano, Soichi; Fuster, Jose J.; Kikuchi, Ryosuke; Shimizu, Ippei; Ohshima, Kousei; Katanasaka, Yasufumi; Ouchi, Noriyuki; Walsh, Kenneth			Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; WNT SIGNALING PATHWAY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; METABOLIC DYSFUNCTION; ADIPONECTIN PROTECTS; ADIPOSE-TISSUE; SFRP5; OBESITY; HYPERTROPHY	Wnt signaling has diverse actions in cardiovascular development and disease processes. Secreted frizzled-related protein 5 (Sfrp5) has been shown to function as an extracellular inhibitor of non-canonical Wnt signaling that is expressed at relatively high levels in white adipose tissue. The aim of this study was to investigate the role of Sfrp5 in the heart under ischemic stress. Sfrp5 KO and WT mice were subjected to ischemia/reperfusion (I/R). Although Sfrp5-KO mice exhibited no detectable phenotype when compared with WT control at baseline, they displayed larger infarct sizes, enhanced cardiac myocyte apoptosis, and diminished cardiac function following I/R. The ischemic lesions of Sfrp5-KO mice had greater infiltration of Wnt5a-positive macrophages and greater inflammatory cytokine and chemokine gene expression when compared with WT mice. In bone marrow-derived macrophages, Wnt5a promoted JNK activation and increased inflammatory gene expression, whereas treatment with Sfrp5 blocked these effects. These results indicate that Sfrp5 functions to antagonize inflammatory responses after I/R in the heart, possibly through a mechanism involving non-canonical Wnt5a/JNK signaling.	[Nakamura, Kazuto; Sano, Soichi; Fuster, Jose J.; Kikuchi, Ryosuke; Shimizu, Ippei; Ohshima, Kousei; Katanasaka, Yasufumi; Ouchi, Noriyuki; Walsh, Kenneth] Boston Univ Med Campus, Whitaker Cardiovasc Inst, Belmont, MA 02178 USA; [Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan	Nagoya University	Walsh, K (corresponding author), Boston Univ Med Campus, Whitaker Cardiovasc Inst, Mol Cardiol, 700 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Fuster, José J/D-3685-2011; Kikuchi, Ryosuke/AAX-4971-2021	Fuster, José J/0000-0002-5970-629X; Shimizu, Ippei/0000-0003-3333-8131	National Institutes of Health [HL081587, HL116591, HL126141, HL120160]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126141, R01HL131006, R01HL120160, P01HL081587, R01HL116591] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25860052] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grants HL081587, HL116591, HL126141, and HL120160 (to K. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007; Barandon L, 2011, ARTERIOSCL THROM VAS, V31, pE80, DOI 10.1161/ATVBAHA.111.232280; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Dawson K, 2013, J PHYSIOL-LONDON, V591, P1409, DOI 10.1113/jphysiol.2012.235382; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Hagenmueller M, 2014, FEBS LETT, V588, P2230, DOI 10.1016/j.febslet.2014.05.039; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kikuchi R, 2014, NAT MED, V20, P1464, DOI 10.1038/nm.3703; Kim J, 2012, CYTOKINE, V60, P242, DOI 10.1016/j.cyto.2012.06.013; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969; Leaf I, 2006, GENESIS, V44, P573, DOI 10.1002/dvg.20248; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Malekar P, 2010, HYPERTENSION, V55, P939, DOI 10.1161/HYPERTENSIONAHA.109.141127; Mayr T, 1997, MECH DEVELOP, V63, P109, DOI 10.1016/S0925-4773(97)00035-X; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mortensen RM, 2012, CIRCULATION, V125, P1597, DOI 10.1161/CIRCULATIONAHA.112.097832; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Ouchi N, 2012, CIRCULATION, V125, P3066, DOI 10.1161/CIRCULATIONAHA.112.114181; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Prats-Puig A, 2014, PEDIATR RES, V75, P793, DOI 10.1038/pr.2014.29; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; ter Horst P, 2012, ACTA PHYSIOL, V204, P110, DOI 10.1111/j.1748-1716.2011.02309.x; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Wang R, 2014, J MOL ENDOCRINOL, V53, P405, DOI 10.1530/JME-14-0037; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991	58	84	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2566	2575		10.1074/jbc.M115.693937	http://dx.doi.org/10.1074/jbc.M115.693937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26631720	Green Published, hybrid			2022-12-28	WOS:000369626900003
J	Pannen, D; Fabisch, M; Gausling, L; Schnetz, K				Pannen, Derk; Fabisch, Maria; Gausling, Lisa; Schnetz, Karin			Interaction of the RcsB Response Regulator with Auxiliary Transcription Regulators in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE SYNTHESIS; H-NS; ACID RESISTANCE; ANTIBIOTIC-RESISTANCE; SIGNAL-TRANSDUCTION; ENVELOPE STRESS; COLANIC ACID; MAT FIMBRIAE; BGL OPERON; PHOSPHORELAY	The Rcs phosphorelay is a two-component signal transduction system that is induced by cell envelope stress. RcsB, the response regulator of this signaling system, is a pleiotropic transcription regulator, which is involved in the control of various stress responses, cell division, motility, and biofilm formation. RcsB regulates transcription either as a homodimer or together with auxiliary regulators, such as RcsA, BglJ, and GadE in Escherichia coli. In this study, we show that RcsB in addition forms heterodimers with MatA (also known as EcpR) and with DctR. Our data suggest that the MatA-dependent transcription regulation is mediated by the MatA-RcsB heterodimer and is independent of RcsB phosphorylation. Furthermore, we analyzed the relevance of amino acid residues of the active quintet of conserved residues, and of surface-exposed residues for activity of RcsB. The data suggest that the activity of the phosphorylation-dependent dimers, such as RcsA-RcsB and RcsB-RcsB, is affected by mutation of residues in the vicinity of the phosphorylation site, suggesting that a phosphorylation-induced structural change modulates their activity. In contrast, the phosphorylation-independent heterodimers BglJ-RcsB and MatA-RcsB are affected by only very few mutations. Heterodimerization of RcsB with various auxiliary regulators and their differential dependence on phosphorylation add an additional level of control to the Rcs system that is operating at the output level.	[Pannen, Derk; Fabisch, Maria; Gausling, Lisa; Schnetz, Karin] Univ Cologne, Inst Genet, Zulpicher Str 47a, D-50674 Cologne, Germany	University of Cologne	Schnetz, K (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47a, D-50674 Cologne, Germany.	schnetz@uni-koeln.de		Schnetz, Karin/0000-0003-4693-6202	Deutsche Forschungsgemeinschaft [SCHN 371/10-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHN 371/10-2. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baikalov I, 1998, BIOCHEMISTRY-US, V37, P3665, DOI 10.1021/bi972365a; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho SH, 2014, CELL, V159, P1652, DOI 10.1016/j.cell.2014.11.045; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIEDERICH L, 1992, PLASMID, V28, P14, DOI 10.1016/0147-619X(92)90032-6; Dmitrova M, 1998, MOL GEN GENET, V257, P205; Dole S, 2002, MOL MICROBIOL, V43, P217, DOI 10.1046/j.1365-2958.2002.02734.x; Ebel W, 1999, J BACTERIOL, V181, P577, DOI 10.1128/JB.181.2.577-584.1999; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HENIKOFF S, 1990, METHOD ENZYMOL, V183, P111; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lehti TA, 2012, J BACTERIOL, V194, P3475, DOI 10.1128/JB.06596-11; Lehti TA, 2010, MICROBIOL-SGM, V156, P2408, DOI 10.1099/mic.0.039610-0; Leonard PG, 2013, P NATL ACAD SCI USA, V110, P8525, DOI 10.1073/pnas.1302819110; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Martinez-Santos VI, 2012, J BACTERIOL, V194, P5020, DOI 10.1128/JB.00915-12; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Miller J. H, 1972, EXPT MOL GENETICS; Nishino K, 2003, J BACTERIOL, V185, P2667, DOI 10.1128/JB.185.8.2667-2672.2003; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Salscheider SL, 2014, NUCLEIC ACIDS RES, V42, P2999, DOI 10.1093/nar/gkt1298; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; Schnell R, 2008, ACTA CRYSTALLOGR F, V64, P1096, DOI 10.1107/S1744309108035203; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; Stratmann T, 2008, J BACTERIOL, V190, P926, DOI 10.1128/JB.01447-07; Stratmann T, 2012, MOL MICROBIOL, V83, P1109, DOI 10.1111/j.1365-2958.2012.07993.x; Sturny R, 2003, J BACTERIOL, V185, P4298, DOI 10.1128/JB.185.15.4298-4304.2003; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Trajtenberg F, 2014, MBIO, V5, DOI 10.1128/mBio.02105-14; Venkatesh GR, 2010, J BACTERIOL, V192, P6456, DOI 10.1128/JB.00807-10; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiebe H, 2015, J BACTERIOL, V197, P2713, DOI 10.1128/JB.00263-15; WILSON GG, 1979, NATURE, V280, P80, DOI 10.1038/280080a0; Yamanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111962; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	62	40	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2357	2370		10.1074/jbc.M115.696815	http://dx.doi.org/10.1074/jbc.M115.696815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26635367	Green Published, hybrid			2022-12-28	WOS:000369610400025
J	Cottrell, JR; Li, B; Kyung, JW; Ashford, CJ; Mann, JJ; Horvath, TL; Ryan, TA; Kim, SH; Gerber, DJ				Cottrell, Jeffrey R.; Li, Bing; Kyung, Jae Won; Ashford, Crystle J.; Mann, James J.; Horvath, Tamas L.; Ryan, Timothy A.; Kim, Sung Hyun; Gerber, David J.			Calcineurin A gamma is a Functional Phosphatase That Modulates Synaptic Vesicle Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSOCIATION; SCHIZOPHRENIA; PPP3CC; GENE; SUSCEPTIBILITY; HIPPOCAMPAL; EXPRESSION; SUBUNIT; POLYMORPHISMS; ISOFORMS	Variation in PPP3CC, the gene that encodes the gamma isoform of the calcineurin catalytic subunit, has been reported to be associated with schizophrenia. Because of its low expression level in most tissues, there has been little research devoted to the specific function of the calcineurin A gamma (CNA gamma) versus the calcineurin A alpha (CNA alpha) and calcineurin A beta (CNA beta) catalytic isoforms. Consequently, we have a limited understanding of the role of altered CNA gamma function in psychiatric disease. In this study, we demonstrate that CNA gamma is present in the rodent and human brain and dephosphorylates a presynaptic substrate of calcineurin. Through a combination of immunocytochemistry and immuno-EM, we further show that CNA gamma is localized to presynaptic terminals in hippocampal neurons. Critically, we demonstrate that RNAi-mediated knockdown of CNA gamma leads to a disruption of synaptic vesicle cycling in cultured rat hippocampal neurons. These data indicate that CNA gamma regulates a critical aspect of synaptic vesicle cycling and suggest that variation in PPP3CC may contribute to psychiatric disease by altering presynaptic function.	[Cottrell, Jeffrey R.; Li, Bing; Ashford, Crystle J.; Mann, James J.; Gerber, David J.] Galenea Corp, 50C Audubon Rd, Wakefield, MA 01880 USA; [Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, Comparat Med Sect, New Haven, CT 06511 USA; [Kyung, Jae Won; Kim, Sung Hyun] Kyung Hee Univ, Dept Physiol, Neurodegenerat Control Res Ctr, Sch Med, Seoul 02447, South Korea	Cornell University; Yale University; Kyung Hee University	Gerber, DJ (corresponding author), Galenea Corp, 50C Audubon Rd, Wakefield, MA 01880 USA.; Kim, SH (corresponding author), Kyung Hee Univ, Dept Physiol, Neurodegenerat Control Res Ctr, Sch Med, Seoul 02447, South Korea.	sunghyunkim@khu.ac.kr; dgerber@galenea.com	Ryan, Timothy/AAO-8286-2020; Kim, Sung Hyun/AAI-8554-2020	Kim, Sung Hyun/0000-0002-3166-9941	Otsuka Pharmaceutical Co. Ltd.; National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2013R1A1A1063174]; Kyung Hee University [KHU-20140665]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036942] Funding Source: NIH RePORTER	Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical); National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; Kyung Hee University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a research and development collaboration with Otsuka Pharmaceutical Co. Ltd. J. R. C., J. J. M., and D. J. G. are employees and stockholders of Galenea Corp. B. L. and C. J. A. are stockholders of Galenea Corp. T. A. R. is a consultant and stockholder of Galenea Corp.; Supported by the National Research Foundation of Korea (Basic Science Research Program) funded by the Ministry of Science, ICT, and Future Planning (Grant NRF-2013R1A1A1063174), and Kyung Hee University in 2014 (KHU-20140665).	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; Chen Q, 2004, BIOL PSYCHIAT, V56, P177, DOI 10.1016/j.biopsych.2004.05.010; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Cottrell JR, 2013, J NEUROSCI, V33, P10938, DOI 10.1523/JNEUROSCI.5362-12.2013; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Eastwood SL, 2005, EUR J NEUROSCI, V22, P3017, DOI 10.1111/j.1460-9568.2005.04518.x; Eastwood SL, 2005, BIOL PSYCHIAT, V57, P702, DOI 10.1016/j.biopsych.2004.12.029; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gabor F, 2011, INT J DEV NEUROSCI, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Halpain S, 1998, J NEUROSCI, V18, P9835; Horiuchi Y, 2007, MOL PSYCHIATR, V12, P891, DOI 10.1038/sj.mp.4002019; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; Kayyali U. S., 1997, J NEUROCHEM, V68, P1668; Kilka S, 2009, BIOCHEMISTRY-US, V48, P1900, DOI 10.1021/bi8019355; Kim SH, 2013, J NEUROSCI, V33, P8937, DOI 10.1523/JNEUROSCI.4288-12.2013; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Lee HJ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-15; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; Milekic MH, 2015, MOL PSYCHIATR, V20, P995, DOI 10.1038/mp.2014.84; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sacchetti E, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-33; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; Wockner LF, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.111; Wong AHC, 2004, BIOL PSYCHIAT, V56, P24, DOI 10.1016/j.biopsych.2004.03.008; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	42	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1948	1956		10.1074/jbc.M115.705319	http://dx.doi.org/10.1074/jbc.M115.705319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627835	Green Published, hybrid			2022-12-28	WOS:000368620700032
J	Kim, H; Yang, J; Kim, MJ; Choi, S; Chung, JR; Kim, JM; Yoo, YH; Chung, J; Koh, H				Kim, Hyunjin; Yang, Jinsung; Kim, Min Ju; Choi, Sekyu; Chung, Ju-Ryung; Kim, Jong-Min; Yoo, Young Hyun; Chung, Jongkyeong; Koh, Hyongjong			Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS LIFE-SPAN; OXIDATIVE STRESS; CHAPERONE TRAP1; DROSOPHILA; PARKIN; RESPIRATION; KINASE; PINK1; HSP90; DYSFUNCTION	TRAP1 (tumor necrosis factor receptor-associated protein 1), a mitochondrial Hsp90 family chaperone, has been identified as a critical regulator of cell survival and bioenergetics in tumor cells. To discover novel signaling networks regulated by TRAP1, we generated Drosophila TRAP1 mutants. The mutants successfully developed into adults and produced fertile progeny, showing that TRAP1 is dispensable in development and reproduction. Surprisingly, mutation or knockdown of TRAP1 markedly enhanced Drosophila survival under oxidative stress. Moreover, TRAP1 mutation ameliorated mitochondrial dysfunction and dopaminergic (DA) neuron loss induced by deletion of a familial Parkinson disease gene PINK1 (Pten-induced kinase 1) in Drosophila. Gamitrinib-triphenylphosphonium, a mitochondria-targeted Hsp90 inhibitor that increases cell death in HeLa and MCF7 cells, consistently inhibited cell death induced by oxidative stress and mitochondrial dysfunction induced by PINK1 mutation in mouse embryonic fibroblast cells and DA cell models such as SH-SY5Y and SN4741 cells. Additionally, gamitrinib-triphenylphosphonium also suppressed the defective locomotive activity and DA neuron loss in Drosophila PINK1 null mutants. In further genetic analyses, we showed enhanced expression of Thor, a downstream target gene of transcription factor FOXO, in TRAP1 mutants. Furthermore, deletion of FOXO almost nullified the protective roles of TRAP1 mutation against oxidative stress and PINK1 mutation. These results strongly suggest that inhibition of the mitochondrial chaperone TRAP1 generates a retrograde cell protective signal from mitochondria to the nucleus in a FOXO-dependent manner.	[Kim, Hyunjin; Kim, Min Ju; Koh, Hyongjong] Dong A Univ, Coll Med, Dept Pharmacol, Mitochondria Hub Regulat Ctr, Dongdaeshin Dong 3-1, Busan 602714, South Korea; [Kim, Jong-Min; Yoo, Young Hyun] Dong A Univ, Mitochondria Hub Regulat Ctr, Dept Anat & Cell Biol, Coll Med, Busan 602714, South Korea; [Yang, Jinsung; Choi, Sekyu; Chung, Ju-Ryung; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151744, South Korea; [Yang, Jinsung; Choi, Sekyu; Chung, Ju-Ryung; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, San 56-1, Seoul 151744, South Korea	Dong A University; Dong A University; Seoul National University (SNU); Seoul National University (SNU)	Koh, H (corresponding author), Dong A Univ, Coll Med, Dept Pharmacol, Mitochondria Hub Regulat Ctr, Dongdaeshin Dong 3-1, Busan 602714, South Korea.; Chung, J (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, San 56-1, Seoul 151744, South Korea.	jkc@snu.ac.kr; hjkoh@dau.ac.kr	Yang, Jinsung/ABB-7722-2021	Koh, Hyongjong/0000-0003-2594-4799; Choi, Sekyu/0000-0003-2928-0942	National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology) [NRF-2012-R1A1A1012482, NRF-2009-0093188]; National Creative Research Initiatives grant through the National Research Foundation of Korea - Ministry of Science, Information/Communication Technology, and Future Planning (Ministry of Science, ICT, and Future Planning) [2010-0018291]; BK21 Plus Program from Ministry of Education	National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology); National Creative Research Initiatives grant through the National Research Foundation of Korea - Ministry of Science, Information/Communication Technology, and Future Planning (Ministry of Science, ICT, and Future Planning); BK21 Plus Program from Ministry of Education	This work was supported by National Research Foundation of Korea Grants NRF-2012-R1A1A1012482 and NRF-2009-0093188 funded by the Korean government (Ministry of Education, Science, and Technology) (to H. K.) and by the National Creative Research Initiatives grant through the National Research Foundation of Korea funded by Ministry of Science, Information/Communication Technology, and Future Planning (Ministry of Science, ICT, and Future Planning) Grant 2010-0018291 and BK21 Plus Program from Ministry of Education (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	BIEDLER JL, 1978, CANCER RES, V38, P3751; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Cechetto JD, 2000, EXP CELL RES, V260, P30, DOI 10.1006/excr.2000.4983; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2012, BMB REP, V45, P1, DOI 10.5483/BMBRep.2012.45.1.1; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8; Koh H, 2012, J BIOL CHEM, V287, P12750, DOI 10.1074/jbc.M111.337907; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee YN, 2012, BIOCHEM BIOPH RES CO, V420, P851, DOI 10.1016/j.bbrc.2012.03.087; Lisanti S, 2014, CELL REP, V8, P671, DOI 10.1016/j.celrep.2014.06.061; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sciacovelli M, 2013, CELL METAB, V17, P988, DOI 10.1016/j.cmet.2013.04.019; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011	33	28	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1841	1853		10.1074/jbc.M115.656934	http://dx.doi.org/10.1074/jbc.M115.656934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631731	Green Published, hybrid			2022-12-28	WOS:000368620700024
J	Purushothaman, A; Bandari, SK; Liu, J; Mobley, JA; Brown, EE; Sanderson, RD				Purushothaman, Anurag; Bandari, Shyam Kumar; Liu, Jian; Mobley, James A.; Brown, Elizabeth E.; Sanderson, Ralph D.			Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; MULTIPLE-MYELOMA; EXTRACELLULAR VESICLES; PROMOTES; ADHESION; SULFATE; EXPRESSION; SYNDECAN-1; SECRETION; PHENOTYPE	Exosomes regulate cell behavior by binding to and delivering their cargo to target cells; however, the mechanisms mediating exosome-cell interactions are poorly understood. Heparan sulfates on target cell surfaces can act as receptors for exosome uptake, but the ligand for heparan sulfate on exosomes has not been identified. Using exosomes isolated from myeloma cell lines and from myeloma patients, we identify exosomal fibronectin as a key heparan sulfate-binding ligand and mediator of exosome-cell interactions. We discovered that heparan sulfate plays a dual role in exosome-cell interaction; heparan sulfate on exosomes captures fibronectin, and on target cells it acts as a receptor for fibronectin. Removal of heparan sulfate from the exosome surface releases fibronectin and dramatically inhibits exosome-target cell interaction. Antibody specific for the Hep-II heparin-binding domain of fibronectin blocks exosome interaction with tumor cells or with marrow stromal cells. Regarding exosome function, fibronectin-mediated binding of exosomes to myeloma cells activated p38 and pERK signaling and expression of downstream target genes DKK1 and MMP-9, two molecules that promote myeloma progression. Antibody against fibronectin inhibited the ability of myeloma-derived exosomes to stimulate endothelial cell invasion. Heparin or heparin mimetics including Roneparstat, a modified heparin in phase I trials in myeloma patients, significantly inhibited exosome-cell interactions. These studies provide the first evidence that fibronectin binding to heparan sulfate mediates exosome-cell interactions, revealing a fundamental mechanism important for exosome-mediated cross-talk within tumor microenvironments. Moreover, these results imply that therapeutic disruption of fibronectin-heparan sulfate interactions will negatively impact myeloma tumor growth and progression.	[Purushothaman, Anurag; Bandari, Shyam Kumar; Brown, Elizabeth E.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Brown, Elizabeth E.; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Purushothaman, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI 602A,1720 Second Ave S, Birmingham, AL 35294 USA.; Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI 602B,1720 Second Ave S, Birmingham, AL 35294 USA.	anuragp@uab.edu; sanderson@uab.edu			National Institutes of Health [CA138340, CA186646]; National Institute of Health [P30 AR048311, CA013148, AR048311]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA138340, R01CA186646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA138340 (to R. D. S.) and CA186646 (to E. E. B.). This work was also supported in part by National Institute of Health Grants P30 AR048311 (to the University of Alabama at Birmingham Comprehensive Flow Cytometry Core Facility), CA013148 (to the University of Alabama at Birmingham Mass Spectrometry/Proteomics Shared Facility), and CA013148 and AR048311 (to the University of Alabama at Birmingham High Resolution Imaging Shared Facility). R. D. S. is a member of the Scientific Advisory Board of Sigma-Tau Research Switzerland.	Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Atay S, 2011, AM J REPROD IMMUNOL, V66, P259, DOI 10.1111/j.1600-0897.2011.00995.x; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Balaj L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10266; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Borset M, 2000, BLOOD, V96, P2528; Carpentier M, 2014, GLYCOCONJUGATE J, V31, P161, DOI 10.1007/s10719-013-9512-8; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; DALTON BA, 1995, J CELL SCI, V108, P2083; Deng ZB, 2012, AM J PATHOL, V180, P390, DOI 10.1016/j.ajpath.2011.09.023; Di Noto G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00517; Hubbard B, 2014, MATRIX BIOL, V34, P124, DOI 10.1016/j.matbio.2013.10.006; Kelly T, 2003, CANCER RES, V63, P8749; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Raimondi L, 2015, ONCOTARGET, V6, P13772, DOI 10.18632/oncotarget.3830; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Roucourt B, 2015, CELL RES, V25, P412, DOI 10.1038/cr.2015.29; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Szalat R, 2015, CURR OPIN GENET DEV, V30, P56, DOI 10.1016/j.gde.2015.03.008; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; UNDERWOOD PA, 1992, J CELL SCI, V102, P833; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027	41	174	180	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1652	1663		10.1074/jbc.M115.686295	http://dx.doi.org/10.1074/jbc.M115.686295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601950	hybrid, Green Published			2022-12-28	WOS:000368620700010
J	Toth, MA; Majoros, AK; Vig, AT; Migh, E; Nyitrai, M; Mihaly, J; Bugyi, B				Toth, Monika Agnes; Majoros, Andrea Kinga; Vig, Andrea Terez; Migh, Ede; Nyitrai, Miklos; Mihaly, Jozsef; Bugyi, Beata			Biochemical Activities of the Wiskott-Aldrich Syndrome Homology Region 2 Domains of Sarcomere Length Short (SALS) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-FILAMENT NUCLEATION; BACTERIAL EFFECTOR VOPL; X-RAY-SCATTERING; WH2 DOMAINS; CORDON-BLEU; F-ACTIN; PROFILIN; TROPOMYOSIN; MUSCLE; SPIRE	Drosophila melanogaster sarcomere length short (SALS) is a recently identified Wiskott-Aldrich syndrome protein homology 2 (WH2) domain protein involved in skeletal muscle thin filament regulation. SALS was shown to be important for the establishment of the proper length and organization of sarcomeric actin filaments. Here, we present the first detailed characterization of the biochemical activities of the tandem WH2 domains of SALS (SALS-WH2). Our results revealed that SALS-WH2 binds both monomeric and filamentous actin and shifts the monomer-filament equilibrium toward the monomeric actin. In addition, SALS-WH2 can bind to but fails to depolymerize phalloidin-or jasplakinolide-bound actin filaments. These interactions endow SALS-WH2 with the following two major activities in the regulation of actin dynamics: SALS-WH2 sequesters actin monomers into non-polymerizable complexes and enhances actin filament disassembly by severing, which is modulated by tropomyosin. We also show that profilin does not influence the activities of the WH2 domains of SALS in actin dynamics. In conclusion, the tandem WH2 domains of SALS are multifunctional regulators of actin dynamics. Our findings suggest that the activities of the WH2 domains do not reconstitute the presumed biological function of the full-length protein. Consequently, the interactions of the WH2 domains of SALS with actin must be tuned in the cellular context by other modules of the protein and/or sarcomeric components for its proper functioning.	[Toth, Monika Agnes; Majoros, Andrea Kinga; Vig, Andrea Terez; Nyitrai, Miklos; Bugyi, Beata] Univ Pecs, Sch Med, Dept Biophys, H-7624 Pecs, Hungary; [Migh, Ede; Mihaly, Jozsef] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6726 Szeged, Hungary; [Nyitrai, Miklos; Bugyi, Beata] Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Nyitrai, Miklos] Nucl Mitochondrial Interact Res Grp, H-1051 Budapest, Hungary; [Nyitrai, Miklos] Off Subsidized Res Units, H-1051 Budapest, Hungary; [Mihaly, Jozsef] Univ Pecs, Hungarian Acad Sci, H-1051 Budapest, Hungary	University of Pecs; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; University of Pecs	Bugyi, B (corresponding author), Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	beata.bugyi@aok.pte.hu		Mihaly, Jozsef/0000-0003-3399-2424; Bugyi, Beata/0000-0003-4181-3633; Migh, Ede/0000-0002-8312-6463; Nyitrai, Miklos/0000-0002-6229-4337	Hungarian Science Foundation (OTKA) [K109689, K109330, NN 107776]; National Innovation Office "Baross Gabor" Program [REG-DD-09-1-2009-0009 Tirfm 09]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]	Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Innovation Office "Baross Gabor" Program; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This work was supported by Hungarian Science Foundation (OTKA) Grants K109689 (to B. B.), K109330 (to J. M.), and NN 107776 (to M. N.), National Innovation Office "Baross Gabor" Program Grant REG-DD-09-1-2009-0009 Tirfm 09 (to B. B.), and by the European Union and the State of Hungary and co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program." The authors declare that they have no conflicts of interest with the contents of this article.	Avvaru BS, 2015, J STRUCT BIOL, V190, P192, DOI 10.1016/j.jsb.2015.03.008; Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; BROSCHAT KO, 1990, J BIOL CHEM, V265, P21323; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Bugyi B, 2010, EMBO J, V29, P14, DOI 10.1038/emboj.2009.316; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Ducka AM, 2010, P NATL ACAD SCI USA, V107, P11757, DOI 10.1073/pnas.1005347107; Ghoshdastider U, 2013, CYTOSKELETON, V70, P775, DOI 10.1002/cm.21149; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Hanson J., 1963, Journal of Molecular Biology, V6, P46; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hertzog M, 2002, J BIOL CHEM, V277, P14786, DOI 10.1074/jbc.M112064200; Hertzog M., 2005, CURR PROTOC CELL BIO; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; Husson C, 2010, ANN NY ACAD SCI, V1194, P44, DOI 10.1111/j.1749-6632.2010.05473.x; Kis-Bicskei N, 2013, CYTOSKELETON, V70, P755, DOI 10.1002/cm.21143; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; MIKI M, 1987, EUR J BIOCHEM, V168, P339, DOI 10.1111/j.1432-1033.1987.tb13425.x; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Nworu CU, 2015, J CELL SCI, V128, P239, DOI 10.1242/jcs.152702; Nyitrai M, 2003, BIOCHEM J, V370, P839, DOI 10.1042/BJ20021519; Oda T, 2005, BIOPHYS J, V88, P2727, DOI 10.1529/biophysj.104.047753; Olson B. J., 2001, CURR PROTOC PROTEIN; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2013, MOL BIOL CELL, V24, P1103, DOI 10.1091/mbc.E13-01-0030; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rebowski G, 2008, P NATL ACAD SCI USA, V105, P10785, DOI 10.1073/pnas.0801650105; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Renault L, 2013, CYTOSKELETON, V70, P686, DOI 10.1002/cm.21140; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199; Zahm JA, 2013, CELL, V155, P423, DOI 10.1016/j.cell.2013.09.019; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	53	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					667	680		10.1074/jbc.M115.683904	http://dx.doi.org/10.1074/jbc.M115.683904			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26578512	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000367830500016
J	Snodgrass, RG; Boss, M; Zezina, E; Weigert, A; Dehne, N; Fleming, I; Bruene, B; Namgaladze, D				Snodgrass, Ryan G.; Boss, Marcel; Zezina, Ekaterina; Weigert, Andreas; Dehne, Nathalie; Fleming, Ingrid; Bruene, Bernhard; Namgaladze, Dmitry			Hypoxia Potentiates Palmitate-induced Pro-inflammatory Activation of Primary Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; fatty acid; hypoxia; inflammation; macrophage	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL COMPLEX-III; SATURATED FATTY-ACIDS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; OXIDATIVE STRESS; LOCAL PROLIFERATION; JNK ACTIVATION; OBESITY; PHOSPHATASES	Pro-inflammatory cytokines secreted by adipose tissue macrophages (ATMs) contribute to chronic low-grade inflammation and obesity-induced insulin resistance. Recent studies have shown that adipose tissue hypoxia promotes an inflammatory phenotype in ATMs. However, our understanding of how hypoxia modulates the response of ATMs to free fatty acids within obese adipose tissue is limited. We examined the effects of hypoxia (1% O-2) on the pro-inflammatory responses of human monocyte-derived macrophages to the saturated fatty acid palmitate. Compared with normoxia, hypoxia significantly increased palmitate-induced mRNA expression and protein secretion of IL-6 and IL-1. Although palmitate-induced endoplasmic reticulum stress and nuclear factor B pathway activation were not enhanced by hypoxia, hypoxia increased the activation of JNK and p38 mitogen-activated protein kinase signaling in palmitate-treated cells. Inhibition of JNK blocked the hypoxic induction of pro-inflammatory cytokine expression, whereas knockdown of hypoxia-induced transcription factors HIF-1 and HIF-2 alone or in combination failed to reduce IL-6 and only modestly reduced IL-1 gene expression in palmitate-treated hypoxic macrophages. Enhanced pro-inflammatory cytokine production and JNK activity under hypoxia were prevented by inhibiting reactive oxygen species generation. In addition, silencing of dual-specificity phosphatase 16 increased normoxic levels of IL-6 and IL-1 and reduced the hypoxic potentiation in palmitate-treated macrophages. The secretome of hypoxic palmitate-treated macrophages promoted IL-6 and macrophage chemoattractant protein 1 expression in primary human adipocytes, which was sensitive to macrophage JNK inhibition. Our results reveal that the coexistence of hypoxia along with free fatty acids exacerbates macrophage-mediated inflammation.	[Snodgrass, Ryan G.; Boss, Marcel; Zezina, Ekaterina; Weigert, Andreas; Dehne, Nathalie; Bruene, Bernhard; Namgaladze, Dmitry] Goethe Univ Frankfurt, Ctr Mol Med, Inst Biochem 1, D-60590 Frankfurt, Germany; [Fleming, Ingrid] Goethe Univ Frankfurt, Fac Med, Inst Vasc Signaling, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Namgaladze, D (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7,Bldg 74, D-60590 Frankfurt, Germany.	namgaladze@biochem.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Snodgrass, Ryan G./AAH-5110-2021; Weigert, Andreas/E-6540-2010; Fleming, Ingrid/L-1225-2014; Snodgrass, Ryan G/U-1031-2018	Fleming, Ingrid/0000-0003-1881-3635; Snodgrass, Ryan G./0000-0001-9896-5297; Weigert, Andreas/0000-0002-7529-1952; Fleming, Ingrid/0000-0003-1881-3635; Snodgrass, Ryan G/0000-0001-9896-5297; Zezina, Ekaterina/0000-0003-0800-2513	Deutsche Forschungsgemeinschaft [NA429/2-1, Z01, A05, B04]; Else Kroner Fresenius Foundation;  [SFB1039]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Fresenius Foundation; 	This study was supported by Deutsche Forschungsgemeinschaft Grants NA429/2-1, SFB1039 Teilprojekt, A05, B04, and Z01, and SFB815, Teilprojekt A08) and by the Else Kroner Fresenius Foundation (Translational Research Innovation-Pharma, TRIP). The authors declare that they have no conflicts of interest with the contents of this article.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Berdichevsky A, 2010, J BIOL CHEM, V285, P21581, DOI 10.1074/jbc.M109.093633; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Choe SS, 2014, DIABETES, V63, P3359, DOI 10.2337/db13-1965; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dehne N, 2014, J LEUKOCYTE BIOL, V95, P129, DOI 10.1189/jlb.0113045; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Harwood HJ, 2012, NEUROPHARMACOLOGY, V63, P57, DOI 10.1016/j.neuropharm.2011.12.010; Hauner H, 2000, METH MOL B, V155, P239; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Portella AOV, 2004, TRANSPL P, V36, P846, DOI 10.1016/j.transproceed.2004.03.047; Rios P, 2014, ANTIOXID REDOX SIGN, V20, P2251, DOI 10.1089/ars.2013.5709; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Srinivasan S, 2007, ANN NY ACAD SCI, V1117, P51, DOI 10.1196/annals.1402.067; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Wang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108855; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu J, 2009, AM J PHYSIOL-RENAL, V297, pF1622, DOI 10.1152/ajprenal.00078.2009; Ye JP, 2011, CURR DIABETES REP, V11, P203, DOI 10.1007/s11892-011-0183-1	48	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					413	424		10.1074/jbc.M115.686709	http://dx.doi.org/10.1074/jbc.M115.686709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578520	hybrid, Green Published			2022-12-28	WOS:000367589500034
J	Wu, CS; Zou, L				Wu, Ching-Shyi; Zou, Lee			The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						checkpoint control; DNA damage response; DNA repair; DNA replication; small ubiquitin-like modifier (SUMO)	E3 LIGASE; INDUCED SUMOYLATION; DNA; REPAIR; REPLICATION; PATHWAY; COMPLEX; PCNA; RECOMBINATION; EXPRESSION	The maintenance of genomic stability relies on the concerted action of DNA repair and DNA damage signaling pathways. The PIAS (protein inhibitor of activated STAT) family of SUMO (small ubiquitin-like modifier) ligases has been implicated in DNA repair, but whether it plays a role in DNA damage signaling is still unclear. Here, we show that the PIAS3 SUMO ligase is important for activation of the ATR (ataxia telangiectasia and Rad3 related)-regulated DNA damage signaling pathway. PIAS3 is the only member of the PIAS family that is indispensable for ATR activation. In response to different types of DNA damage and replication stress, PIAS3 plays multiple roles in ATR activation. In cells treated with camptothecin (CPT), PIAS3 contributes to formation of DNA double-stranded breaks. In UV (ultraviolet light)- or HU (hydroxyurea)-treated cells, PIAS3 is required for efficient ATR autophosphorylation, one of the earliest events during ATR activation. Although PIAS3 is dispensable for ATRIP (ATR-interacting protein) SUMOylation and the ATR-ATRIP interaction, it is required for maintaining the basal kinase activity of ATR prior to DNA damage. In the absence of PIAS3, ATR fails to display normal kinase activity after DNA damage, which accompanies with reduced phosphorylation of ATR substrates. Together, these results suggest that PIAS3 primes ATR for checkpoint activation by sustaining its basal kinase activity, revealing a new function of the PIAS family in DNA damage signaling.	[Wu, Ching-Shyi; Zou, Lee] Harvard Univ, Sch Med, MGH Canc Ctr, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Zou, L (corresponding author), Harvard Univ, Sch Med, MGH Canc Ctr, Bldg 149-7408,13th St, Charlestown, MA 02129 USA.	zou.lee@mgh.harvard.edu		Zou, Lee/0000-0003-3094-1058; Wu, Ching-Shyi/0000-0001-9800-9844	NIH [GM076388, CA197779]; NATIONAL CANCER INSTITUTE [R01CA197779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants GM076388 and CA197779 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas R, 2015, CANCER MED-US, V4, P325, DOI 10.1002/cam4.372; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chung I, 2015, GENE DEV, V29, P1593, DOI 10.1101/gad.265058.115; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dabir S, 2014, CLIN CANCER RES, V20, P5124, DOI 10.1158/1078-0432.CCR-14-1233; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Li JW, 2015, INT J CLIN EXP MED, V8, P682; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7720; Liu SC, 2013, ONCOL LETT, V6, P1045, DOI 10.3892/ol.2013.1472; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Mohni KN, 2014, CANCER RES, V74, P2835, DOI 10.1158/0008-5472.CAN-13-3229; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ouyang J, 2015, MOL CELL, V57, P108, DOI 10.1016/j.molcel.2014.11.015; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Park Ju Young, 2014, Brain Tumor Res Treat, V2, P1, DOI 10.14791/btrt.2014.2.1.1; Pastuszak-Lewandoska D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104265; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pommier Yves, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P429, DOI 10.2174/1568011043352777; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Sarangi P, 2015, TRENDS BIOCHEM SCI, V40, P233, DOI 10.1016/j.tibs.2015.02.006; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wu CS, 2014, GENE DEV, V28, P1472, DOI 10.1101/gad.238535.114; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	40	14	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					279	290		10.1074/jbc.M115.691170	http://dx.doi.org/10.1074/jbc.M115.691170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26565033	hybrid, Green Published			2022-12-28	WOS:000367589500022
J	Kamano, S; Kume, S; Iida, K; Lei, KJ; Nakano, M; Nakayama, Y; Iida, H				Kamano, Shumpei; Kume, Shinichiro; Iida, Kazuko; Lei, Kai-Jian; Nakano, Masataka; Nakayama, Yoshitaka; Iida, Hidetoshi			Transmembrane Topologies of Ca2+-permeable Mechanosensitive Channels MCA1 and MCA2 in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEIN; CA2+ INFLUX; MECHANICAL-STRESS; PLANT; TOUCH; MSCS; EXPRESSION; PREDICTION; HOMOLOG; SYSTEM	Sensing mechanical stresses, including touch, stretch, compression, and gravity, is crucial for growth and development in plants. A good mechanosensor candidate is the Ca2+-permeable mechanosensitive (MS) channel, the pore of which opens to permeate Ca2+ in response to mechanical stresses. However, the structure-function relationships of plant MS channels are poorly understood. Arabidopsis MCA1 and MCA2 form a homotetramer and exhibit Ca2+-permeable MS channel activity; however, their structures have only been partially elucidated. The transmembrane topologies of these ion channels need to be determined in more detail to elucidate the underlying regulatory mechanisms. We herein determined the topologies of MCA1 and MCA2 using two independent methods, the Suc2C reporter and split-ubiquitin yeast two-hybrid methods, and found that both proteins are single-pass type I integral membrane proteins with extracellular N termini and intracellular C termini. These results imply that an EF hand-like motif, coiled-coil motif, and plac8 motif are all present in the cytoplasm. Thus, the activities of both channels can be regulated by intracellular Ca2+ and protein interactions.	[Kamano, Shumpei; Kume, Shinichiro; Lei, Kai-Jian; Nakano, Masataka; Nakayama, Yoshitaka; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan; [Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Gakugei University; Tokyo Metropolitan Institute of Medical Science	Iida, H (corresponding author), Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan.	iida@u-gakugei.ac.jp	Nakayama, Yoshitaka/J-4973-2014; Nakayama, Yoshitaka/AAT-9699-2020; Iida, Hidetoshi/AAO-5506-2020	Nakayama, Yoshitaka/0000-0001-6797-5556; Nakayama, Yoshitaka/0000-0001-6797-5556; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25120708]; Japan Society for the Promotion of Science [26291026, 10J02008]; Grants-in-Aid for Scientific Research [26291026] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Priority Area 25120708 (to H. I.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Grant-in-Aid for Scientific Research B 26291026 (to H. I.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.; A Japan Society for the Promotion of Science Fellow (Grant 10J02008). Present address: Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.	Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Benikhlef L, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-133; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Coutand C, 2010, PLANT SCI, V179, P168, DOI 10.1016/j.plantsci.2010.05.001; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Furuichi T, 2012, PLANT SIGNAL BEHAV, V7, P1022, DOI 10.4161/psb.20783; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Haswell ES, 2007, CURR TOP MEMBR, V58, P329, DOI 10.1016/S1063-5823(06)58013-5; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iida H, 2014, PLANT BIOLOGY, V16, P39, DOI 10.1111/plb.12044; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00453; Iyer Kavitha, 2005, Sci STKE, V2005, ppl3, DOI 10.1126/stke.2752005pl3; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; Johns S. J., TOPO2 TRANSMEMBRANE; Johnson ME, 2012, EUKARYOT CELL, V11, P952, DOI 10.1128/EC.00082-12; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kurusu T, 2013, TRENDS PLANT SCI, V18, P227, DOI 10.1016/j.tplants.2012.12.002; Kurusu T, 2012, J PLANT RES, V125, P555, DOI 10.1007/s10265-011-0462-6; Kurusu T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-11; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATIMER JG, 1991, HORTSCIENCE, V26, P1456, DOI 10.21273/HORTSCI.26.12.1456; Nacken V, 1996, GENE, V175, P253, DOI 10.1016/0378-1119(96)00171-0; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakano M, 2011, PLANT CELL PHYSIOL, V52, P1915, DOI 10.1093/pcp/pcr131; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Peter B, 2014, BIOCHEMISTRY-US, V53, P57, DOI 10.1021/bi401433f; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J., 2001, MOL CLONING LAB MANU, V3, P2; Sengstag C, 2000, METHOD ENZYMOL, V327, P175, DOI 10.1016/S0076-6879(00)27275-3; Shigematsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087724; Singh H, 2010, FEBS LETT, V584, P2112, DOI 10.1016/j.febslet.2010.03.013; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Teng J, 2013, MICROBIOL-SGM, V159, P970, DOI 10.1099/mic.0.064030-0; Wilson ME, 2013, BIOCHEMISTRY-US, V52, P5708, DOI 10.1021/bi400804z; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593	48	21	22	1	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30901	30909		10.1074/jbc.M115.692574	http://dx.doi.org/10.1074/jbc.M115.692574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26555262	Green Published, hybrid			2022-12-28	WOS:000367199000022
J	Meng, XF; Pijning, T; Dobruchowska, JM; Gerwig, GJ; Dijkhuizen, L				Meng, Xiangfeng; Pijning, Tjaard; Dobruchowska, Justyna M.; Gerwig, Gerrit J.; Dijkhuizen, Lubbert			Characterization of the Functional Roles of Amino Acid Residues in Acceptor-binding Subsite+1 in the Active Site of the Glucansucrase GTF180 from Lactobacillus reuteri 180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GLUCANS; STRUCTURAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; 121 REUTERANSUCRASE; DSR-E; EXOPOLYSACCHARIDES; DEXTRANSUCRASE; SPECIFICITY; ENZYMES; BACTERIA	alpha-Glucans produced by glucansucrase enzymes hold strong potential for industrial applications. The exact determinants of the linkage specificity of glucansucrase enzymes have remained largely unknown, even with the recent elucidation of glucansucrase crystal structures. Guided by the crystal structure of glucansucrase GTF180-Delta N from Lactobacillus reuteri 180 in complex with the acceptor substrate maltose, we identified several residues (Asp-1028 and Asn-1029 from domain A, as well as Leu-938, Ala-978, and Leu-981 from domain B) near subsite + 1 that may be critical for linkage specificity determination, and we investigated these by random site-directed mutagenesis. First, mutants of Ala-978 (to Leu, Pro, Phe, or Tyr) and Asp-1028 (to Tyr or Trp) with larger side chains showed reduced degrees of branching, likely due to the steric hindrance by these bulky residues. Second, Leu-938 mutants (except L938F) and Asp-1028 mutants showed altered linkage specificity, mostly with increased (alpha 1 -> 6) linkage synthesis. Third, mutation of Leu-981 and Asn-1029 significantly affected the transglycosylation reaction, indicating their essential roles in acceptor substrate binding. In conclusion, glucansucrase product specificity is determined by an interplay of domain A and B residues surrounding the acceptor substrate binding groove. Residues surrounding the +1 subsite thus are critical for activity and specificity of the GTF180 enzyme and play different roles in the enzyme functions. This study provides novel insights into the structure-function relationships of glucansucrase enzymes and clearly shows the potential of enzyme engineering to produce tailor-made alpha-glucans.	[Meng, Xiangfeng; Dobruchowska, Justyna M.; Gerwig, Gerrit J.; Dijkhuizen, Lubbert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Pijning, Tjaard] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Microbial Physiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	l.dijkhuizen@rug.nl	DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021; Pijning, Tjaard/ABA-2929-2021; Dijkhuizen, Lubbert/E-9454-2014; Dijkhuizen, Lubbert/K-3539-2019; Pijning, Tjaard/HDO-3704-2022	Pijning, Tjaard/0000-0003-4107-3663; Dijkhuizen, Lubbert/0000-0003-2312-7162; 	China Scholarship Council; European Union [NOVOSIDES FP7-KBBE-2010-4-265854]	China Scholarship Council(China Scholarship Council); European Union(European Commission)	This work was supported by the China Scholarship Council (to X. M.) and by European Union Project NOVOSIDES FP7-KBBE-2010-4-265854 (to L. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2013, CARBOHYD POLYM, V94, P567, DOI 10.1016/j.carbpol.2013.01.064; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cote GL, 2006, CARBOHYD RES, V341, P2066, DOI 10.1016/j.carres.2006.04.044; Cote GL, 2014, APPL MICROBIOL BIOT, V98, P6651, DOI 10.1007/s00253-014-5622-x; Cote GL, 2009, CARBOHYD RES, V344, P187, DOI 10.1016/j.carres.2008.10.017; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Desmet T, 2012, CHEM-EUR J, V18, P10786, DOI 10.1002/chem.201103069; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hellmuth H, 2008, BIOCHEMISTRY-US, V47, P6678, DOI 10.1021/bi800563r; Irague R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077837; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Irague R, 2011, ANAL CHEM, V83, P1202, DOI 10.1021/ac1032148; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Jolly L, 2002, ANTON LEEUW INT J G, V82, P367, DOI 10.1023/A:1020668523541; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2006, FEBS J, V273, P3735, DOI 10.1111/j.1742-4658.2006.05376.x; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Leemhuis H, 2012, BIOCATAL BIOTRANSFOR, V30, P366, DOI 10.3109/10242422.2012.676301; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Meng XF, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602524; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monchois V, 2000, APPL ENVIRON MICROB, V66, P1923, DOI 10.1128/AEM.66.5.1923-1927.2000; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monsan P, 2001, INT DAIRY J, V11, P675, DOI 10.1016/S0958-6946(01)00113-3; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322; Seo ES, 2005, J BIOTECHNOL, V117, P31, DOI 10.1016/j.jbiotec.2004.10.013; Tsumori H, 1997, J BACTERIOL, V179, P3391, DOI 10.1128/jb.179.11.3391-3396.1997; Van Geel-Schutten GH, 1999, APPL ENVIRON MICROB, V65, P3008; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, BIOMACROMOLECULES, V9, P2251, DOI 10.1021/bm800410w; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1114, DOI 10.1016/j.carres.2008.01.043; van Leeuwen SS, 2009, BIOMACROMOLECULES, V10, P580, DOI 10.1021/bm801240r; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Welman AD, 2003, TRENDS BIOTECHNOL, V21, P269, DOI 10.1016/S0167-7799(03)00107-0	42	24	28	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30131	30141		10.1074/jbc.M115.687558	http://dx.doi.org/10.1074/jbc.M115.687558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507662	Green Published, hybrid			2022-12-28	WOS:000366614700043
J	Tischer, A; Campbell, JC; Machha, VR; Moon-Tasson, L; Benson, LM; Sankaran, B; Kim, C; Auton, M				Tischer, Alexander; Campbell, James C.; Machha, Venkata R.; Moon-Tasson, Laurie; Benson, Linda M.; Sankaran, Banumathi; Kim, Choel; Auton, Matthew			Mutational Constraints on Local Unfolding Inhibit the Rheological Adaptation of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); platelet glycoprotein Ib; protein denaturation; protein stability; protein structure; structural biology; surface plasmon resonance; trypsin; von Willebrand factor; x-ray crystallography	FACTOR A1 DOMAIN; PLATELET GLYCOPROTEIN-IB; DISEASE TYPE-B; CRYSTAL-STRUCTURE; CONFORMATIONAL FLEXIBILITY; ADENYLATE KINASE; STRUCTURAL BASIS; FACTOR BINDING; SNAKE-VENOM; ALPHA	Unusually large von Willebrand factor (VWF), the first responder to vascular injury in primary hemostasis, is designed to capture platelets under the high shear stress of rheological blood flow. In type 2M von Willebrand disease, two rare mutations (G1324A and G1324S) within the platelet GPIb binding interface of the VWF A1 domain impair the hemostatic function of VWF. We investigate structural and conformational effects of these mutations on the A1 domain's efficacy to bind collagen and adhere platelets under shear flow. These mutations enhance the thermodynamic stability, reduce the rate of unfolding, and enhance the A1 domain's resistance to limited proteolysis. Collagen binding affinity is not significantly affected indicating that the primary stabilizing effect of these mutations is to diminish the platelet binding efficiency under shear flow. The enhanced stability stems from the steric consequences of adding a side chain (G1324A) and additionally a hydrogen bond (G1324S) to His(1322) across the 2-3 hairpin in the GPIb binding interface, which restrains the conformational degrees of freedom and the overall flexibility of the native state. These studies reveal a novel rheological strategy in which the incorporation of a single glycine within the GPIb binding interface of normal VWF enhances the probability of local unfolding that enables the A1 domain to conformationally adapt to shear flow while maintaining its overall native structure.	[Tischer, Alexander; Machha, Venkata R.; Moon-Tasson, Laurie; Auton, Matthew] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA; [Tischer, Alexander; Machha, Venkata R.; Moon-Tasson, Laurie; Auton, Matthew] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Campbell, James C.; Kim, Choel] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Benson, Linda M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Mayo Clinic; Mayo Clinic; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Auton, M (corresponding author), Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55906 USA.; Auton, M (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55906 USA.	auton.matthew@mayo.edu		Auton, Matthew/0000-0002-4446-6932	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy DE-AC02-05CH11231.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ajzenberg N, 2000, BLOOD, V95, P3796; Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Blenner MA, 2014, J BIOL CHEM, V289, P5565, DOI 10.1074/jbc.M113.511220; Bonnefoy A, 2006, J THROMB HAEMOST, V4, P2151, DOI 10.1111/j.1538-7836.2006.02111.x; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; FIRKIN B, 1973, AUST NZ J MED, V3, P225, DOI 10.1111/j.1445-5994.1973.tb03086.x; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Hilbert L, 2002, THROMB HAEMOSTASIS, V87, P635; HOLMBERG L, 1972, BMJ-BRIT MED J, V3, P317, DOI 10.1136/bmj.3.5822.317; HOWARD MA, 1984, BRIT J HAEMATOL, V57, P25, DOI 10.1111/j.1365-2141.1984.tb02862.x; HOWARD MA, 1982, BLOOD, V60, P1420; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Ju LN, 2015, THROMB RES, V136, P606, DOI 10.1016/j.thromres.2015.06.019; Kitchen S, 2006, SEMIN THROMB HEMOST, V32, P492, DOI 10.1055/s-2006-947863; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Lopez JA, 2005, BLOOD COAGUL FIBRIN, V16, pS11, DOI 10.1097/01.mbc.0000167657.85143.ad; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; RABINOWITZ I, 1992, P NATL ACAD SCI USA, V89, P9846, DOI 10.1073/pnas.89.20.9846; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Tischer A, 2014, BIOPHYS J, V107, P1185, DOI 10.1016/j.bpj.2014.07.026; Tischer A, 2014, PROTEINS, V82, P867, DOI 10.1002/prot.24464; Tischer A, 2013, PROTEIN SCI, V22, P1147, DOI 10.1002/pro.2301; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; WEISS HJ, 1973, J CLIN INVEST, V52, P2708, DOI 10.1172/JCI107465; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhang HJ, 1997, BIOCHEM BIOPH RES CO, V238, P382, DOI 10.1006/bbrc.1997.7301; Zimmermann MT, 2015, BIOPHYS J, V109, P398, DOI 10.1016/j.bpj.2015.06.008; Zoldak G, 2004, EUR J BIOCHEM, V271, P48, DOI 10.1046/j.1432-1033.2003.03900.x	41	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3848	3859		10.1074/jbc.M115.703850	http://dx.doi.org/10.1074/jbc.M115.703850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26677223	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000371338400014
J	Hirata, Y; Brems, H; Suzuki, M; Kanamori, M; Okada, M; Morita, R; Llano-Rivas, I; Ose, T; Messiaen, L; Legius, E; Yoshimura, A				Hirata, Yasuko; Brems, Hilde; Suzuki, Mayu; Kanamori, Mitsuhiro; Okada, Masahiro; Morita, Rimpei; Llano-Rivas, Isabel; Ose, Toyoyuki; Messiaen, Ludwine; Legius, Eric; Yoshimura, Akihiko			Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase-activating protein (GAP); human genetics; mitogen-activated protein kinase (MAPK); protein domain; Ras protein; signal transduction; negative regulation	SPROUTY-RELATED PROTEIN; GAP-RELATED DOMAIN; NF1 GENE; MOLECULAR PATHOLOGY; MUTATIONAL SPECTRUM; TYROSINE KINASE; PHENOTYPE; GROWTH; IDENTIFICATION; RASOPATHIES	Constitutional heterozygous loss-of-function mutations in the SPRED1 gene cause a phenotype known as Legius syndrome, which consists of symptoms of multiple cafe-au-lait macules, axillary freckling, learning disabilities, and macrocephaly. Legius syndrome resembles a mild neurofibromatosis type 1 (NF1) phenotype. It has been demonstrated that SPRED1 functions as a negative regulator of the Ras-ERK pathway and interacts with neurofibromin, the NF1 gene product. However, the molecular details of this interaction and the effects of the mutations identified in Legius syndrome and NF1 on this interaction have not yet been investigated. In this study, using a yeast two-hybrid system and an immunoprecipitation assay in HEK293 cells, we found that the SPRED1 EVH1 domain interacts with the N-terminal 16 amino acids and the C-terminal 20 amino acids of the GTPase-activating protein (GAP)-related domain (GRD) of neurofibromin, which form two crossing -helix coils outside the GAP domain. These regions have been shown to be dispensable for GAP activity and are not present in p120(GAP). Several mutations in these N- and C-terminal regions of the GRD in NF1 patients and pathogenic missense mutations in the EVH1 domain of SPRED1 in Legius syndrome reduced the binding affinity between the EVH1 domain and the GRD. EVH1 domain mutations with reduced binding to the GRD also disrupted the ERK suppression activity of SPRED1. These data clearly demonstrate that SPRED1 inhibits the Ras-ERK pathway by recruiting neurofibromin to Ras through the EVH1-GRD interaction, and this study also provides molecular basis for the pathogenic mutations of NF1 and Legius syndrome.	[Hirata, Yasuko; Suzuki, Mayu; Kanamori, Mitsuhiro; Okada, Masahiro; Morita, Rimpei; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Brems, Hilde; Legius, Eric] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Llano-Rivas, Isabel] Hosp Univ Cruces, BioCruces Hlth Res Inst, Dept Genet, Biscay, Spain; [Ose, Toyoyuki] Hokkaido Univ, Dept Pharmaceut Sci, N12W6, Sapporo, Hokkaido 0600812, Japan; [Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL 35294 USA	Keio University; Universite Catholique Louvain; Hospital Universitario Cruces; Hokkaido University; University of Alabama System; University of Alabama Birmingham	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Brems, Hilde/AAN-4075-2020; Ose, Toyoyuki/AAW-7821-2020; Yoshimura, Akihiko/K-5515-2013	Ose, Toyoyuki/0000-0002-2001-9388; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [25221305]; Takeda Science Foundation; Uehara Memorial Foundation; "Opening the Future" grant from KU Leuven	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); "Opening the Future" grant from KU Leuven	This work was supported by special Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan 25221305, Advanced Research and Development Programs for Medical Innovation (AMED-CREST), the Takeda Science Foundation, the Uehara Memorial Foundation, and "Opening the Future" grant from KU Leuven (to E. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; ANDERSEN LB, 1993, MOL CELL BIOL, V13, P487, DOI 10.1128/MCB.13.1.487; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Brems Hilde, 2013, Keio Journal of Medicine, V62, P107, DOI 10.2302/kjm.2013-0002-RE; Brems H, 2012, HUM MUTAT, V33, P1538, DOI 10.1002/humu.22152; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Denayer E, 2011, HUM MUTAT, V32, pE1985, DOI 10.1002/humu.21404; Endo T, 2003, J BIOCHEM, V133, P109, DOI 10.1093/jb/mvg004; Harmer NJ, 2005, FEBS LETT, V579, P1161, DOI 10.1016/j.febslet.2004.11.114; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lorenz S, 2013, HUM MOL GENET, V22, P1643, DOI 10.1093/hmg/ddt014; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Messiaen L. M., 2008, V16, P63, DOI 10.1159/000126545; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Muram-Zborovski TM, 2010, J CHILD NEUROL, V25, P1203, DOI 10.1177/0883073809359540; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Pasmant E, 2015, ONCOGENE, V34, P631, DOI 10.1038/onc.2013.587; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Thomas L, 2012, HUM MUTAT, V33, P1687, DOI 10.1002/humu.22162; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Yoshimura Akihiko, 2009, Keio Journal of Medicine, V58, P73	38	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3124	3134		10.1074/jbc.M115.703710	http://dx.doi.org/10.1074/jbc.M115.703710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26635368	Green Published, hybrid			2022-12-28	WOS:000370854500001
J	Hien, TT; Turczynska, KM; Dahan, D; Ekman, M; Grossi, M; Sjogren, J; Nilsson, J; Braun, T; Boettger, T; Garcia-Vaz, E; Stenkula, K; Sward, K; Gomez, MF; Albinsson, S				Tran Thi Hien; Turczynska, Karolina M.; Dahan, Diana; Ekman, Mari; Grossi, Mario; Sjogren, Johan; Nilsson, Johan; Braun, Thomas; Boettger, Thomas; Garcia-Vaz, Eliana; Stenkula, Karin; Sward, Karl; Gomez, Maria F.; Albinsson, Sebastian			Elevated Glucose Levels Promote Contractile and Cytoskeletal Gene Expression in Vascular Smooth Muscle via Rho/Protein Kinase C and Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; diabetes; glucose; microRNA (miRNA); Rho (Rho GTPase); vascular smooth muscle cells; actin polymerization	STRETCH-DEPENDENT GROWTH; GLYCATION END-PRODUCTS; RHO-KINASE; UP-REGULATION; INDUCED ACTIVATION; DOWN-REGULATION; BLOOD-GLUCOSE; DIABETIC-RATS; CA2+ CHANNELS; DIFFERENTIATION	Both type 1 and type 2 diabetes are associated with increased risk of cardiovascular disease. This is in part attributed to the effects of hyperglycemia on vascular endothelial and smooth muscle cells, but the underlying mechanisms are not fully understood. In diabetic animal models, hyperglycemia results in hypercontractility of vascular smooth muscle possibly due to increased activation of Rho-kinase. The aim of the present study was to investigate the regulation of contractile smooth muscle markers by glucose and to determine the signaling pathways that are activated by hyperglycemia in smooth muscle cells. Microarray, quantitative PCR, and Western blot analyses revealed that both mRNA and protein expression of contractile smooth muscle markers were increased in isolated smooth muscle cells cultured under high compared with low glucose conditions. This effect was also observed in hyperglycemic Akita mice and in diabetic patients. Elevated glucose activated the protein kinase C and Rho/Rho-kinase signaling pathways and stimulated actin polymerization. Glucose-induced expression of contractile smooth muscle markers in cultured cells could be partially or completely repressed by inhibitors of advanced glycation end products, L-type calcium channels, protein kinase C, Rho-kinase, actin polymerization, and myocardin-related transcription factors. Furthermore, genetic ablation of the miR-143/145 cluster prevented the effects of glucose on smooth muscle marker expression. In conclusion, these data demonstrate a possible link between hyperglycemia and vascular disease states associated with smooth muscle contractility.	[Tran Thi Hien; Turczynska, Karolina M.; Dahan, Diana; Ekman, Mari; Grossi, Mario; Stenkula, Karin; Sward, Karl; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden; [Sjogren, Johan; Nilsson, Johan] Lund Univ, Dept Clin Sci, BMC D12, SE-22184 Lund, Sweden; [Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Garcia-Vaz, Eliana; Gomez, Maria F.] Lund Univ, Dept Clin Sci Malmo, S-20502 Malmo, Sweden	Lund University; Lund University; Max Planck Society; Lund University	Albinsson, S (corresponding author), Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden.	sebastian.albinsson@med.lu.se	Boettger, Thomas/E-3406-2012; Nilsson, Johan/A-4742-2011; Gomez, Maria F/D-3696-2014; Sjögren, Johan/AAZ-6448-2021; Braun, Thomas/B-2310-2008; Albinsson, Sebastian/B-4105-2010	Boettger, Thomas/0000-0003-4280-8449; Nilsson, Johan/0000-0001-6860-6090; Gomez, Maria F/0000-0001-6210-3142; Sjögren, Johan/0000-0001-7965-7491; Stenkula, Karin/0000-0002-0739-1150; Albinsson, Sebastian/0000-0001-6936-3967; Braun, Thomas/0000-0002-6165-4804	Novo Nordisk Foundation; Per-Eric and Ulla Schyberg Foundation; Albert Pahlsson Foundation; Swedish Heart and Lung Foundation [HLF 20130700]; Swedish Research Council [2014-3352]; Swedish Diabetes Association (Diabetesfonden); Innovative Medicines Initiative Joint Undertaking [115006]; European Union; Novo Nordisk Fonden [NNF15OC0016144, NNF12OC1016299] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Per-Eric and Ulla Schyberg Foundation; Albert Pahlsson Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association (Diabetesfonden); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation, the Per-Eric and Ulla Schyberg Foundation, and the Albert Pahlsson Foundation (to S. A.). This work was also supported by Swedish Heart and Lung Foundation Grant HLF 20130700, Swedish Research Council Grant 2014-3352, and Swedish Diabetes Association (Diabetesfonden) (to M. F. G. and K. Stenkula). This work was also supported by Innovative Medicines Initiative Joint Undertaking 115006, comprising funds from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The authors declare that they have no conflicts of interest with the contents of this article.	ABEBE W, 1990, J CARDIOVASC PHARM, V16, P239, DOI 10.1097/00005344-199008000-00010; Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; BARBAGALLO M, 1995, J CLIN INVEST, V95, P763, DOI 10.1172/JCI117724; Bhattachariya A, 2015, ACTA PHYSIOL, V215, P133, DOI 10.1111/apha.12536; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bu DX, 2010, CIRC RES, V106, P1040, DOI 10.1161/CIRCRESAHA.109.201103; Cazzola M, 2012, AM J RESP CELL MOL, V47, P509, DOI 10.1165/rcmb.2011-0449OC; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; Cicek FA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-51; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; Fleischhacker E, 1999, DIABETES, V48, P1323, DOI 10.2337/diabetes.48.6.1323; Goldberg IJ, 2004, J CLIN INVEST, V114, P613, DOI 10.1172/JCI200422826; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Howard RL, 1996, J LAB CLIN MED, V127, P504, DOI 10.1016/S0022-2143(96)90068-2; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; Kawamura H, 2004, ARTERIOSCL THROM VAS, V24, P276, DOI 10.1161/01.ATV.0000112012.33770.2a; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kizub IV, 2010, BRIT J PHARMACOL, V159, P1724, DOI 10.1111/j.1476-5381.2010.00666.x; Lawes CMM, 2004, DIABETES CARE, V27, P2836; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Lin GR, 2007, CARDIOVASC RES, V75, P51, DOI 10.1016/j.cardiores.2007.03.009; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; LUO JH, 1993, J BIOL CHEM, V268, P23580; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; Matsumoto T, 2010, BRIT J PHARMACOL, V160, P1092, DOI 10.1111/j.1476-5381.2010.00753.x; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moreno-Dominguez A, 2013, J PHYSIOL-LONDON, V591, P1235, DOI 10.1113/jphysiol.2012.243576; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Nobe K, 2002, BRIT J PHARMACOL, V136, P441, DOI 10.1038/sj.bjp.0704722; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Pyla R, 2013, AM J PHYSIOL-CELL PH, V304, pC574, DOI 10.1152/ajpcell.00275.2012; Rama A, 2006, EUR J CELL BIOL, V85, P375, DOI 10.1016/j.ejcb.2005.11.007; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Staiculescu MC, 2013, CARDIOVASC RES, V98, P428, DOI 10.1093/cvr/cvt034; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thallas-Bonke V, 2004, DIABETES, V53, P2921, DOI 10.2337/diabetes.53.11.2921; Thomas MC, 2014, ADV CHRONIC KIDNEY D, V21, P311, DOI 10.1053/j.ackd.2014.03.004; Turczynska KM, 2015, ARTERIOSCL THROM VAS, V35, P1489, DOI 10.1161/ATVBAHA.114.305065; Turczynska Karolina M, 2013, Commun Integr Biol, V6, pe22278, DOI 10.4161/cib.22278; Turczynska KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065135; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Ungvari Z, 1999, CARDIOVASC RES, V43, P1018, DOI 10.1016/S0008-6363(99)00106-6; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; WHITE RE, 1988, AM J PHYSIOL, V255, pH1036, DOI 10.1152/ajpheart.1988.255.5.H1036; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang XQ, 2008, CLIN EXP PHARMACOL P, V35, P1097, DOI 10.1111/j.1440-1681.2007.04756.x; Yao L, 2013, CARDIOVASC RES, V97, P509, DOI 10.1093/cvr/cvs371; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zetterqvist AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065020	79	43	44	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3552	3568		10.1074/jbc.M115.654384	http://dx.doi.org/10.1074/jbc.M115.654384			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26683376	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000370854500035
J	Barnoud, T; Donninger, H; Clark, GJ				Barnoud, Thibaut; Donninger, Howard; Clark, Geoffrey J.			Ras Regulates Rb via NORE1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; ONCOGENIC RAS; EFFECTOR NORE1; P53; PHOSPHATASE; SENESCENCE; GROWTH; GENE; EXPRESSION	Mutations in the Ras oncogene are one of the most frequent events in human cancer. Although Ras regulates numerous growth-promoting pathways to drive transformation, it can paradoxically promote an irreversible cell cycle arrest known as oncogene-induced senescence. Although senescence has clearly been implicated as a major defense mechanism against tumorigenesis, the mechanisms by which Ras can promote such a senescent phenotype remain poorly defined. We have shown recently that the Ras death effector NORE1A plays a critical role in promoting Ras-induced senescence and connects Ras to the regulation of the p53 tumor suppressor. We now show that NORE1A also connects Ras to the regulation of a second major prosenescent tumor suppressor, the retinoblastoma (Rb) protein. We show that Ras induces the formation of a complex between NORE1A and the phosphatase PP1A, promoting the activation of the Rb tumor suppressor by dephosphorylation. Furthermore, suppression of Rb reduces NORE1A senescence activity. These results, together with our previous findings, suggest that NORE1A acts as a critical tumor suppressor node, linking Ras to both the p53 and the Rb pathways to drive senescence.	[Barnoud, Thibaut] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Biochem & Mol Genet, Louisville, KY 40202 USA; [Donninger, Howard] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Med, Louisville, KY 40202 USA; [Clark, Geoffrey J.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Pharmacol & Toxicol, 505 S Hancock St, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Clark, GJ (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Pharmacol & Toxicol, 505 S Hancock St, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660; Barnoud, Thibaut/0000-0001-5588-6281	National Institutes of Health [R01 CA133171-01A2]; NATIONAL CANCER INSTITUTE [R01CA133171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA133171-01A2 (to G. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Benavente CA, 2015, ANNU REV PATHOL-MECH, V10, P547, DOI 10.1146/annurev-pathol-012414-040259; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Calvisi DF, 2008, INT J CANCER, V123, P2057, DOI 10.1002/ijc.23720; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Carriere C, 2011, GASTROENTEROLOGY, V141, P1091, DOI 10.1053/j.gastro.2011.05.041; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Contente Sara, 2011, Genes Cancer, V2, P166, DOI 10.1177/1947601911405042; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dannenberg Jan-Hermen, 2006, V42, P183, DOI 10.1007/002; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Donninger H, 2015, J CELL BIOL, V208, P777, DOI 10.1083/jcb.201408087; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUTREAL PA, 1991, ONCOGENE, V6, P1109; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Klumpers F, 2014, SENSOR ACTUAT B-CHEM, V203, P904, DOI 10.1016/j.snb.2014.07.064; Kolupaeva V, 2013, FEBS J, V280, P627, DOI 10.1111/j.1742-4658.2012.08511.x; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kurnari G, 2007, J MOL BIOL, V367, P1294, DOI 10.1016/j.jmb.2007.01.026; Lee D, 2012, EMBO REP, V13, P163, DOI 10.1038/embor.2011.235; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Overmeyer JH, 2011, FRONT BIOSCI-LANDMRK, V16, P1693, DOI 10.2741/3814; Park J, 2010, J BIOL CHEM, V285, P35029, DOI 10.1074/jbc.M110.165506; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; RICHARDS CA, 1990, CANCER RES, V50, P1521; Schmidt ML, 2014, J BIOL CHEM, V289, P31102, DOI 10.1074/jbc.M114.594283; Schwarz D., 2002, THESIS RUHR U BOCHUM; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shinmura K, 2011, LUNG CANCER, V71, P19, DOI 10.1016/j.lungcan.2010.04.006; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Suryaraja R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.91; Tamrakar S, 1999, ONCOGENE, V18, P7803, DOI 10.1038/sj.onc.1203211; Tamrakar S, 2000, J BIOL CHEM, V275, P27784; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Wang RH, 2001, ONCOGENE, V20, P6111, DOI 10.1038/sj.onc.1204829; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Wurzer G, 2001, J CELL BIOCHEM, P1; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129	69	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3114	3123		10.1074/jbc.M115.697557	http://dx.doi.org/10.1074/jbc.M115.697557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26677227	Green Published, hybrid			2022-12-28	WOS:000369626900046
J	Kunze, G; Kohling, S; Vogel, A; Rademann, J; Huster, D				Kuenze, Georg; Koehling, Sebastian; Vogel, Alexander; Rademann, Joerg; Huster, Daniel			Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYTOKINE PRODUCTION; CELL-PROLIFERATION; DERMATAN SULFATE; FORCE-FIELD; B-CELLS; PROTEIN; IL-10; MECHANISM; DYNAMICS	The biological function of interleukin-10 (IL-10), a pleiotropic cytokine with an essential role in inflammatory processes, is known to be affected by glycosaminoglycans (GAGs). GAGs are highly negatively charged polysaccharides and integral components of the extracellular matrix with important functions in the biology of many growth factors and cytokines. The molecular mechanism of the IL-10/GAG interaction is unclear. In particular, experimental evidence about IL-10/GAG binding sites is lacking, despite its importance for understanding the biological role of the interaction. Here, we report the experimental determination of a GAG binding site of IL-10. Although no co-crystal structure of the IL-10.GAG complex could be obtained, its structural characterization was possible by NMR spectroscopy. Chemical shift perturbations of IL-10 induced by GAG binding were used to narrow down the location of the binding site and to assess the affinity for different GAG molecules. Subsequent observation of NMR pseudocontact shifts of IL-10 and its heparin ligand, as induced by a protein-attached lanthanide spin label, provided structural restraints for the protein.ligand complex. Using these restraints, pseudocontact shift-based rigid body docking together with molecular dynamics simulations yielded a GAG binding model. The heparin binding site is located at the C-terminal end of helix D and the adjacent DE loop and coincides with a patch of positively charged residues involving arginines 102, 104, 106, and 107 and lysines 117 and 119. This study represents the first experimental characterization of the IL-10.GAG complex structure and provides the starting point for revealing the biological significance of the interaction of IL-10 with GAGs.	[Kuenze, Georg; Koehling, Sebastian; Vogel, Alexander; Rademann, Joerg; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany; [Koehling, Sebastian; Rademann, Joerg] Free Univ Berlin, Inst Pharm, Med Chem, Konigin Luise Str 2 4, D-14195 Berlin, Germany	Leipzig University; Free University of Berlin	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de	Rademann, Jörg/F-4893-2017	Rademann, Jörg/0000-0001-6678-3165	Deutsche Forschungsgemeinschaft [Transregio-SFB 67]; Verband der Chemischen Industrie e.V. [Do 187/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Verband der Chemischen Industrie e.V.	This work was supported by Deutsche Forschungsgemeinschaft Grants Transregio-SFB 67, A6, and A8 and Grant Do 187/11 from the Verband der Chemischen Industrie e.V. (to G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Angulo J, 2010, CHEM-EUR J, V16, P7803, DOI 10.1002/chem.200903528; Barthelmes K, 2011, J AM CHEM SOC, V133, P808, DOI 10.1021/ja104983t; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertini I, 2001, J AM CHEM SOC, V123, P4181, DOI 10.1021/ja0028626; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BRUNO E, 1995, EXP HEMATOL, V23, P1212; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Canales A, 2014, J AM CHEM SOC, V136, P8011, DOI 10.1021/ja502406x; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DING L, 1992, J IMMUNOL, V148, P3133; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 2009, ESSENTIALS GLYCOBIOL, P501; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Garcia-Mayoral MF, 2013, ACS CHEM BIOL, V8, P144, DOI 10.1021/cb300386v; Gehrcke JP, 2015, J MOL GRAPH MODEL, V62, P97, DOI 10.1016/j.jmgm.2015.09.003; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; HUIGE CJM, 1995, J COMPUT CHEM, V16, P56, DOI 10.1002/jcc.540160106; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kunze G, 2014, GLYCOBIOLOGY, V24, P1036, DOI 10.1093/glycob/cwu069; Kunze G, 2014, BIOMOL NMR ASSIGN, V8, P375, DOI 10.1007/s12104-013-9521-3; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Logsdon NJ, 2012, P NATL ACAD SCI USA, V109, P12704, DOI 10.1073/pnas.1117551109; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mallajosyula SS, 2012, J CHEM THEORY COMPUT, V8, P759, DOI 10.1021/ct200792v; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagelkerken L, 1997, INT IMMUNOL, V9, P1243, DOI 10.1093/intimm/9.9.1243; Nitz M, 2003, CHEMBIOCHEM, V4, P272, DOI 10.1002/cbic.200390047; Otting G, 2010, ANNU REV BIOPHYS, V39, P387, DOI 10.1146/annurev.biophys.093008.131321; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Saio T, 2011, J BIOMOL NMR, V51, P395, DOI 10.1007/s10858-011-9566-5; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schmitz C, 2008, J BIOMOL NMR, V41, P179, DOI 10.1007/s10858-008-9249-z; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shinmyouzu K, 2007, BIOCHEM BIOPH RES CO, V354, P447, DOI 10.1016/j.bbrc.2006.12.221; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P775; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003; Zhuang TD, 2008, PROTEIN SCI, V17, P1220, DOI 10.1110/ps.034561.108	74	29	28	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3100	3113		10.1074/jbc.M115.681759	http://dx.doi.org/10.1074/jbc.M115.681759			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26677224	hybrid, Green Published			2022-12-28	WOS:000369626900045
J	Peskin, AV; Pace, PE; Behring, JB; Paton, LN; Soethoudt, M; Bachschmid, MM; Winterbourn, CC				Peskin, Alexander V.; Pace, Paul E.; Behring, Jessica B.; Paton, Louise N.; Soethoudt, Marjolein; Bachschmid, Markus M.; Winterbourn, Christine C.			Glutathionylation of the Active Site Cysteines of Peroxiredoxin 2 and Recycling by Glutaredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; MAMMALIAN PEROXIREDOXIN; THIOREDOXIN REDUCTASE; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; MECHANISMS; DISULFIDE; HYPEROXIDATION; SIGNAL; GENE	Peroxiredoxin 2 (Prx2) is a thiol protein that functions as an antioxidant, regulator of cellular peroxide concentrations, and sensor of redox signals. Its redox cycle is widely accepted to involve oxidation by a peroxide and reduction by thioredoxin/thioredoxin reductase. Interactions of Prx2 with other thiols are not well characterized. Here we show that the active site Cys residues of Prx2 form stable mixed disulfides with glutathione (GSH). Glutathionylation was reversed by glutaredoxin 1 (Grx1), and GSH plus Grx1 was able to support the peroxidase activity of Prx2. Prx2 became glutathionylated when its disulfide was incubated with GSH and when the reduced protein was treated with H2O2 and GSH. The latter reaction occurred via the sulfenic acid, which reacted sufficiently rapidly (k = 500 M-1 s(-1)) for physiological concentrations of GSH to inhibit Prx disulfide formation and protect against hyperoxidation to the sulfinic acid. Glutathionylated Prx2 was detected in erythrocytes from Grx1 knock-out mice after peroxide challenge. We conclude that Prx2 glutathionylation is a favorable reaction that can occur in cells under oxidative stress and may have a role in redox signaling. GSH/Grx1 provide an alternative mechanism to thioredoxin and thioredoxin reductase for Prx2 recycling.	[Peskin, Alexander V.; Pace, Paul E.; Paton, Louise N.; Soethoudt, Marjolein; Winterbourn, Christine C.] Univ Otago, Ctr Free Radical Res, Christchurch 8140, New Zealand; [Behring, Jessica B.; Bachschmid, Markus M.] Boston Univ Sch Med, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA; [Behring, Jessica B.; Bachschmid, Markus M.] Boston Univ Sch Med, Sch Med, Whitaker Cardiovasc Inst, Cardiovasc Prote Ctr,Dept Med, Boston, MA 02118 USA	University of Otago; Boston University; Boston University	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, POB 4345, Christchurch 8140, New Zealand.	christine.winterbourn@otago.ac.nz	Pace, Paul E/A-3104-2012; Peskin, alexander/R-6457-2019	Pace, Paul E/0000-0003-1855-5760; Paton, Louise N/0000-0002-7055-5170; peskin, alexander/0000-0001-9890-6043; Bachschmid, Markus Michael/0000-0002-0748-5528	Health Research Council of New Zealand; NHLBI, National Institutes of Health, Department of Health and Human Services [HHSN268201000031C]; National Institutes of Health [PO1 HL068758, R01 DK103750, R37 HL104017]; American Heart Association Grant [16GRNT27660006]; National Institutes of Health Training Grant [T32 HL007501]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, R37HL104017, T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); NHLBI, National Institutes of Health, Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Health Research Council of New Zealand; the NHLBI, National Institutes of Health, Department of Health and Human Services, under Contract HHSN268201000031C; National Institutes of Health Grants PO1 HL068758, R01 DK103750, and R37 HL104017; American Heart Association Grant 16GRNT27660006; and National Institutes of Health Training Grant T32 HL007501 (to J.B.). The authors have no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Checconi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127086; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Nagy P., 2010, ADV MOL TOXICOLOGY, P183, DOI DOI 10.1016/S0012-821X(03)00488-6; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2015, NAT CHEM BIOL, V11, P5, DOI 10.1038/nchembio.1722; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zhang HH, 2014, ANTIOXID REDOX SIGN, V21, P669, DOI 10.1089/ars.2013.5499	40	75	76	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3053	3062		10.1074/jbc.M115.692798	http://dx.doi.org/10.1074/jbc.M115.692798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26601956	hybrid, Green Published			2022-12-28	WOS:000369626900041
J	Khandokar, YB; Srivastava, P; Sarker, S; Swarbrick, CMD; Aragao, D; Cowieson, N; Forwood, JK				Khandokar, Yogesh B.; Srivastava, Parul; Sarker, Subir; Swarbrick, Crystall M. D.; Aragao, David; Cowieson, Nathan; Forwood, Jade K.			Structural and Functional Characterization of the PaaI Thioesterase from Streptococcus pneumoniae Reveals a Dual Specificity for Phenylacetyl-CoA and Medium-chain Fatty Acyl-CoAs and a Novel CoA-induced Fit Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE COOPERATIVITY; CATALYTIC MECHANISM; FOLD THIOESTERASE; SITES REACTIVITY; REFINEMENT; PURIFICATION; SELECTIVITY; SCATTERING; SYSTEM; HALF	PaaI thioesterases are members of the TE13 thioesterase family that catalyze the hydrolysis of thioester bonds between coenzyme A and phenylacetyl-CoA. In this study we characterize the PaaI thioesterase from Streptococcus pneumoniae (SpPaaI), including structural analysis based on crystal diffraction data to 1.8-angstrom resolution, to reveal two double hotdog domains arranged in a back to back configuration. Consistent with the crystallography data, both size exclusion chromatography and small angle x-ray scattering data support a tetrameric arrangement of thioesterase domains in solution. Assessment of SpPaaI activity against a range of acyl-CoA substrates showed activity for both phenylacetyl-CoA and medium-chain fatty-acyl CoA substrates. Mutagenesis of putative active site residues reveals Asn37, Asp52, and Thr68 are important for catalysis, and size exclusion chromatography analysis and x-ray crystallography confirm that these mutants retain the same tertiary and quaternary structures, establishing that the reduced activity is not a result of structural perturbations. Interestingly, the structure of SpPaaI in the presence of CoA provides a structural basis for the observed substrate specificity, accommodating a 10-carbon fatty acid chain, and a large conformational change of up to 38 angstrom in the N terminus, and a loop region involving Tyr(38)-Tyr(39). This is the first time PaaI thioesterases have displayed a dual specificity for medium-chain acyl-CoAs substrates and phenylacetyl-CoA substrates, and we provide a structural basis for this specificity, highlighting a novel induced fit mechanism that is likely to be conserved within members of this enzyme family.	[Khandokar, Yogesh B.; Srivastava, Parul; Swarbrick, Crystall M. D.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia; [Sarker, Subir] Charles Sturt Univ, Sch Anim & Vet Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia; [Aragao, David; Cowieson, Nathan] Australian Synchrotron, Blackburn Rd, Clayton, Vic 3168, Australia	Charles Sturt University; Charles Sturt University	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Sarker, Subir/U-8444-2019; Aragao, David/A-1695-2012; Aragao, David/AAV-5514-2021	Sarker, Subir/0000-0002-2685-8377; Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; KHANDOKAR, YOGESH/0000-0002-4630-8508; Swarbrick, Crystall/0000-0002-9337-3361; Forwood, Jade/0000-0003-3267-9997				ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cantu DC, 2014, CHEM-EUR J, V20, P9045, DOI 10.1002/chem.201304228; Cantu DC, 2011, NUCLEIC ACIDS RES, V39, pD342, DOI 10.1093/nar/gkq1072; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3371, DOI 10.1021/bi00794a009; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rodriguez-Guilbe M, 2013, J BIOL CHEM, V288, P10841, DOI 10.1074/jbc.M112.446765; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Song F, 2012, BIOCHEMISTRY-US, V51, P7000, DOI 10.1021/bi301059m; STALLCUP WB, 1973, J MOL BIOL, V80, P41, DOI 10.1016/0022-2836(73)90232-5; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swarbrick CMD, 2014, J BIOL CHEM, V289, P24263, DOI 10.1074/jbc.M114.589408; Tilton GB, 2004, J BIOL CHEM, V279, P7487, DOI 10.1074/jbc.M309532200; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yamada J, 1996, ARCH BIOCHEM BIOPHYS, V326, P106, DOI 10.1006/abbi.1996.0053; Zhuang ZH, 2012, BIOCHEMISTRY-US, V51, P786, DOI 10.1021/bi2013917	36	6	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1866	1876		10.1074/jbc.M115.677484	http://dx.doi.org/10.1074/jbc.M115.677484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26538563	Green Published, hybrid			2022-12-28	WOS:000368620700026
J	Riano-Umbarila, L; Ledeznna-Candanoza, LM; Serrano-Posada, H; Fernandez-Taboada, G; Olamendi-Portugal, T; Rojas-Trejo, S; Gomez-Ramirez, IV; Rudino-Pinera, E; Possani, LD; Becerril, B				Riano-Umbarila, Lidia; Ledeznna-Candanoza, Luis M.; Serrano-Posada, Hugo; Fernandez-Taboada, Guillermo; Olamendi-Portugal, Timoteo; Rojas-Trejo, Sonia; Gomez-Ramirez, Ilse V.; Rudino-Pinera, Enrique; Possani, Lourival D.; Becerril, Baltazar			Optimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE SENSOR; ENHANCED ACTIVATION; SODIUM-CHANNELS; SCORPION; HOFFMANN; ELECTROSTATICS; COMPONENT	The current trend of using recombinant antibody fragments in research to develop novel antidotes against scorpion stings has achieved excellent results. The polyclonal character of commercial antivenoms, obtained through the immunization of animals and which contain several neutralizing antibodies that recognize different epitopes on the toxins, guarantees the neutralization of the venoms. To avoid the use of animals, we aimed to develop an equivalent recombinant antivenom composed of a few neutralizing single chain antibody fragments (scFvs) that bind to two different epitopes on the scorpion toxins. In this study, we obtained scFv RU1 derived from scFv C1. RU1 showed a good capacity to neutralize the Cn2 toxin and whole venom of the scorpion Centruroides noxius. Previously, we had produced scFv LR, obtained from a different parental fragment (scFv 3F). LR also showed a similar neutralizing capacity. The simultaneous administration of both scFvs resulted in improved protection, which was translated as a rapid recovery of previously poisoned animals. The crystallographic structure of the ternary complex scFv LR-Cn2-scFv RU1 allowed us to identify the areas of interaction of both scFvs with the toxin, which correspond to non-overlapping sites. The epitope recognized by scFv RU1 seems to be related to a greater efficiency in the neutralization of the whole venom. In addition, the structural analysis of the complex helped us to explain the cross-reactivity of these scFvs and how they neutralize the venom.	[Riano-Umbarila, Lidia; Ledeznna-Candanoza, Luis M.; Fernandez-Taboada, Guillermo; Olamendi-Portugal, Timoteo; Rojas-Trejo, Sonia; Gomez-Ramirez, Ilse V.; Rudino-Pinera, Enrique; Possani, Lourival D.; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Apartado Postal 510-3, Cuernavaca 62250, Morelos, Mexico; [Serrano-Posada, Hugo] Univ Colima, Lab Bioingn, Km 9 Carretera Coquimatlan Colima, Coquimatlan 28400, Colima, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Colima	Becerril, B (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	baltazar@ibt.unam.mx		Fernandez-Taboada, Guillermo/0000-0002-3224-630X; Serrano-Posada, Hugo/0000-0002-7901-475X; Gomez, Ilse/0000-0001-7200-2310; Riano-Umbarila, Lidia/0000-0002-2531-9232; Rudino-Pinera, Enrique/0000-0001-8170-6379	NIGMS, National Institutes of Health [GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE))	The National Synchrotron Light Source beamline X6A was funded by NIGMS, National Institutes of Health, Grant GM-0080 and U.S. Department of Energy Contract DE-AC02-98CH10886. We thank Dr. Humberto Flores for critically reading the manuscript. We also thank the animal facility services of Biotherium from the Instituto de Biotecnologia-Universidad Nacional Autonoma de Mexico and Cipriano Balderas, Fernando Zamudio, Mario Trejo, Martin Patino, and Fredy Coronas for technical assistance in various aspects of this study. Finally, we thank the staff at National Synchrotron Light Source beamline X6A, particularly Dr. Vivian Stojanoff, for the use of data collection facilities.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALAGON AC, 1988, COMP BIOCHEM PHYS B, V89, P153, DOI 10.1016/0305-0491(88)90277-5; [Anonymous], DESM MOL DYN SYST VE; [Anonymous], MAESTR DESM INT TOOL; [Anonymous], MAESTR VERS 9 3; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Canul-Tec JC, 2011, J BIOL CHEM, V286, P20892, DOI 10.1074/jbc.M111.238410; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chippaux JP, 2012, DRUG DES DEV THER, V6, P165, DOI 10.2147/DDDT.S24754; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Fabrichny IP, 2012, J BIOL CHEM, V287, P14136, DOI 10.1074/jbc.M111.315382; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; RAMIREZ AN, 1994, TOXICON, V32, P479, DOI 10.1016/0041-0101(94)90300-X; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Riano-Umbarila L, 2013, TOXICON, V76, P370, DOI 10.1016/j.toxicon.2013.09.016; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Schiavon E, 2012, TOXICON, V59, P283, DOI 10.1016/j.toxicon.2011.12.003; Selisko B, 1999, PROTEINS, V37, P130, DOI 10.1002/(SICI)1097-0134(19991001)37:1&lt;130::AID-PROT13&gt;3.0.CO;2-S; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tang CL, 2007, J MOL BIOL, V366, P1475, DOI 10.1016/j.jmb.2006.12.001; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x	40	13	14	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1619	1630		10.1074/jbc.M115.685297	http://dx.doi.org/10.1074/jbc.M115.685297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589800	Green Published, hybrid			2022-12-28	WOS:000368620700007
J	Urresti, J; Ruiz-Meana, M; Coccia, E; Arevalo, JC; Castellano, J; Fernandez-Sanz, C; Galenkamp, KMO; Planells-Ferrer, L; Moubarak, RS; Llecha-Cano, N; Reix, S; Garcia-Dorado, D; Barneda-Zahonero, B; Comella, JX				Urresti, Jorge; Ruiz-Meana, Marisol; Coccia, Elena; Carlos Arevalo, Juan; Castellano, Jose; Fernandez-Sanz, Celia; Galenkamp, Koen M. O.; Planells-Ferrer, Laura; Moubarak, Rana S.; Llecha-Cano, Nuria; Reix, Stephanie; Garcia-Dorado, David; Barneda-Zahonero, Bruna; Comella, Joan X.			Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium Release Mandatory for Apoptosis in Type II Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; BAX INHIBITOR-1; NERVOUS-SYSTEM; PROTEIN FAMILY; DEATH; MITOCHONDRIA; MODULATION; EXPRESSION; BRAIN	Death receptors are members of the tumor necrosis factor receptor superfamily involved in the extrinsic apoptotic pathway. Lifeguard (LFG) is a death receptor antagonist mainly expressed in the nervous system that specifically blocks Fas ligand (FasL)-induced apoptosis. To investigate its mechanism of action, we studied its subcellular localization and its interaction with members of the Bcl-2 family proteins. We performed an analysis of LFG subcellular localization in murine cortical neurons and found that LFG localizes mainly to the ER and Golgi. We confirmed these results with subcellular fractionation experiments. Moreover, we show by co-immunoprecipitation experiments that LFG interacts with Bcl-X-L and Bcl-2, but not with Bax or Bak, and this interaction likely occurs in the endoplasmic reticulum. We further investigated the relationship between LFG and Bcl-XL in the inhibition of apoptosis and found that LFG protects only type II apoptotic cells from FasL-induced death in a Bcl-X-L XL dependent manner. The observation that LFG itself is not located in mitochondria raises the question as to whether LFG in the ER participates in FasL-induced death. Indeed, we investigated the degree of calcium mobilization after FasL stimulation and found that LFG inhibits calcium release from the ER, a process that correlates with LFG blockage of cytochrome c release to the cytosol and caspase activation. On the basis of our observations, we propose that there is a required step in the induction of type II apoptotic cell death that involves calcium mobilization from the ER and that this step is modulated by LFG.	[Urresti, Jorge; Coccia, Elena; Planells-Ferrer, Laura; Moubarak, Rana S.; Llecha-Cano, Nuria; Reix, Stephanie; Barneda-Zahonero, Bruna; Comella, Joan X.] Univ Vall Hebron, Cell Signalling & Apoptosis Grp, Inst Recerca Hosp, Barcelona 08035, Spain; [Ruiz-Meana, Marisol; Castellano, Jose; Fernandez-Sanz, Celia; Garcia-Dorado, David] Univ Vall Hebron, Lab Expt Cardiol, Inst Recerca Hosp, Barcelona 08035, Spain; [Urresti, Jorge; Planells-Ferrer, Laura; Barneda-Zahonero, Bruna; Comella, Joan X.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, Bellaterra, Spain; [Carlos Arevalo, Juan] Univ Salamanca, Inst Neurociencias Castilla & Leon, Dept Cell Biol & Pathol, Salamanca 37007, Spain; [Carlos Arevalo, Juan] Inst Biomed Res Salamanca, Salamanca 37007, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; University of Salamanca	Barneda-Zahonero, B (corresponding author), Cell Signalling & Apoptosis Grp, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	bruna.barneda@vhir.org; joan.comella@vhir.org	Galenkamp, Koen/AAH-3593-2020; Comella, Joan/GQA-4279-2022; Comella, Joan X/D-7333-2012; Arévalo, Juan Carlos/J-8154-2014	Galenkamp, Koen/0000-0001-7220-6516; Comella, Joan X/0000-0002-6218-0786; Arévalo, Juan Carlos/0000-0003-1994-3095; Barneda Zahonero, Bruna/0000-0002-6557-5222; Coccia, Elena/0000-0002-9849-2423; Fernandez-Sanz, Celia/0000-0002-3437-7792; Fernandez Sanz, Celia/0000-0002-0809-0675; Moubarak, Rana/0000-0003-2096-1258	Spanish Government Ministerio de Sanidad, Servicios Sociales e Igualdad (CIBERNED) [CB06/05/1104, PIE13/00027, BFU2008-00162]; Ministerio de Economia y Competitividad Grants [SAF2010-19953, SAF2013-47989-R, BFU2011-22898]; Generalitat de Catalunya [2011FI_B 00581, 2014SGR-1609]	Spanish Government Ministerio de Sanidad, Servicios Sociales e Igualdad (CIBERNED); Ministerio de Economia y Competitividad Grants; Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by the Spanish Government Ministerio de Sanidad, Servicios Sociales e Igualdad (CIBERNED) Grants CB06/05/1104 (to J.X.C.), PIE13/00027 (to D.G.-D. and J.X.C. and BFU2008-00162 (to J.C.A.); Ministerio de Economia y Competitividad Grants SAF2010-19953 and SAF2013-47989-R (to J.X.C.) and BFU2011-22898 (to J.C.A.), and Generalitat de Catalunya Grants 2011FI_B 00581 (to J.U.) and 2014SGR-1609 (to J.X.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Beier CP, 2005, J NEUROSCI, V25, P6765, DOI 10.1523/JNEUROSCI.1700-05.2005; Bernard-Marissal N, 2012, J NEUROSCI, V32, P4901, DOI 10.1523/JNEUROSCI.5431-11.2012; Bonneau B, 2013, BBA-MOL CELL RES, V1833, P1755, DOI 10.1016/j.bbamcr.2013.01.021; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de Mendoza TH, 2011, P NATL ACAD SCI USA, V108, P17189, DOI 10.1073/pnas.1114226108; Distelhorst CW, 2004, ONCOGENE, V23, P2875, DOI 10.1038/sj.onc.1207519; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Hunsberger JG, 2011, BRAIN RES, V1403, P19, DOI 10.1016/j.brainres.2011.05.067; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kim JH, 2012, BBA-MOL CELL RES, V1823, P876, DOI 10.1016/j.bbamcr.2012.01.016; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Lisak DA, 2015, BBA-MOL CELL RES, V1853, P2104, DOI 10.1016/j.bbamcr.2015.03.002; Marques-Fernandez F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.25; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; Pasqualetto V, 2005, J LEUKOCYTE BIOL, V78, P1106, DOI 10.1189/jlb.0105047; Reich A, 2011, J NEUROSCI, V31, P225, DOI 10.1523/JNEUROSCI.2188-10.2011; Rovere P, 1996, J IMMUNOL, V156, P4631; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; Schweitzer B, 2002, MOL BRAIN RES, V107, P47, DOI 10.1016/S0169-328X(02)00445-X; Schweitzer B, 1998, MOL CELL NEUROSCI, V11, P260, DOI 10.1006/mcne.1998.0697; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Thomenius MJ, 2003, J CELL SCI, V116, P4493, DOI 10.1242/jcs.00829; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vacher P, 2011, ANTI-CANCER DRUG, V22, P481, DOI 10.1097/CAD.0b013e32834433ea; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200	49	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1221	1234		10.1074/jbc.M115.677682	http://dx.doi.org/10.1074/jbc.M115.677682			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26582200	Green Published, hybrid			2022-12-28	WOS:000368068300018
J	Haruki, H; Hovius, R; Pedersen, MG; Johnsson, K				Haruki, Hirohito; Hovius, Ruud; Pedersen, Miriam Gronlund; Johnsson, Kai			Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPIAPTERIN REDUCTASE; TRYPTOPHAN-HYDROXYLASE; PLASMA PHENYLALANINE; BRAIN; INHIBITION; DEGRADATION; TRANSPORT; REVEALS; LIVER	Tryptophan metabolites in the kynurenine pathway are up-regulated by pro-inflammatory cytokines or glucocorticoids, and are linked to anti-inflammatory and immunosuppressive activities. In addition, they are up-regulated in pathologies such as cancer, autoimmune diseases, and psychiatric disorders. The molecular mechanisms of how kynurenine pathway metabolites cause these effects are incompletely understood. On the other hand, pro-inflammatory cytokines also up-regulate the amounts of tetrahydrobiopterin (BH4), an enzyme cofactor essential for the synthesis of several neurotransmitter and nitric oxide species. Here we show that xanthurenic acid is a potent inhibitor of sepiapterin reductase (SPR), the final enzyme in de novo BH4 synthesis. The crystal structure of xanthurenic acid bound to the active site of SPR reveals why among all kynurenine pathway metabolites xanthurenic acid is the most potent SPR inhibitor. Our findings suggest that increased xanthurenic acid levels resulting from up-regulation of the kynurenine pathway could attenuate BH4 biosynthesis and BH4-dependent enzymatic reactions, linking two major metabolic pathways known to be highly up-regulated in inflammation.	[Haruki, Hirohito; Hovius, Ruud; Pedersen, Miriam Gronlund; Johnsson, Kai] Ecole Polytech Fed Lausanne, Natl Ctr Competence Res NCCR Chem Biol, Inst Bioengn, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Johnsson, K (corresponding author), Ecole Polytech Fed Lausanne, Natl Ctr Competence Res NCCR Chem Biol, Inst Bioengn, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch			EPFL; Swiss National Science Foundation; NCCR in Chemical Biology	EPFL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR in Chemical Biology	This work was supported by the EPFL, the Swiss National Science Foundation, and the NCCR in Chemical Biology. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREWS TM, 1976, CLIN CHIM ACTA, V68, P17, DOI 10.1016/0009-8981(76)90284-9; Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Bartlett RD, 1998, NEUROPHARMACOLOGY, V37, P839, DOI 10.1016/S0028-3908(98)00080-X; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Costigan M, 2012, CURR OPIN PHARMACOL, V12, P92, DOI 10.1016/j.coph.2011.10.019; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; ENGLAND JM, 1972, LANCET, V2, P1341; Felger JC, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu084; Felger JC, 2013, BRAIN BEHAV IMMUN, V31, P153, DOI 10.1016/j.bbi.2012.10.010; Friedman J, 2012, ANN NEUROL, V71, P520, DOI 10.1002/ana.22685; Gobaille S, 2008, J NEUROCHEM, V105, P982, DOI 10.1111/j.1471-4159.2008.05219.x; GUIDETTI P, 1995, J NEUROCHEM, V65, P2621; Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004; Haruki H, 2013, SCIENCE, V340, P987, DOI 10.1126/science.1232972; Hirakawa H, 2009, J BIOCHEM, V146, P51, DOI 10.1093/jb/mvp042; JEQUIER E, 1967, MOL PHARMACOL, V3, P274; KATOH S, 1982, BIOCHEM BIOPH RES CO, V105, P75, DOI 10.1016/S0006-291X(82)80012-0; Klassen P, 2001, AM J CLIN NUTR, V73, P647; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nasser A, 2015, NEUROSCI LETT, V584, P247, DOI 10.1016/j.neulet.2014.10.050; Ocampo JR, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/646909; PATNAIK SK, 1980, J BIOCHEM-TOKYO, V87, P1249; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; SCHIMKE RT, 1965, J BIOL CHEM, V240, P322; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; SMITH GK, 1992, J BIOL CHEM, V267, P5599; Sperner-Unterweger B, 2014, PROG NEURO-PSYCHOPH, V48, P268, DOI 10.1016/j.pnpbp.2012.10.006; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; Taleb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048553; TONG JH, 1975, J BIOL CHEM, V250, P4152; Werner ER, 1998, P SOC EXP BIOL MED, V219, P171; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; YAMAZAKI F, 1985, BIOCHEM J, V230, P635, DOI 10.1042/bj2300635; Yang SJ, 2013, J BIOL CHEM, V288, P19221, DOI 10.1074/jbc.M112.402164; Zoller H, 2012, J INTERF CYTOK RES, V32, P216, DOI 10.1089/jir.2011.0093	39	39	41	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					652	657		10.1074/jbc.C115.680488	http://dx.doi.org/10.1074/jbc.C115.680488			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565027	Green Published, hybrid			2022-12-28	WOS:000367830500013
J	Kuruganti, S; Miersch, S; Deshpande, A; Speir, JA; Harris, BD; Schriewer, JM; Buller, RML; Sidhu, SS; Walter, MR				Kuruganti, Srilalitha; Miersch, Shane; Deshpande, Ashlesha; Speir, Jeffrey A.; Harris, Bethany D.; Schriewer, Jill M.; Buller, R. Mark L.; Sidhu, Sachdev S.; Walter, Mark R.			Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; conformational change; cytokine; interferon; phage display; protein structure; receptor; receptor	I-INTERFERON; BINDING-SITE; TUMOR MICROENVIRONMENT; ELECTRON-MICROSCOPY; ALPHA; RESPONSES; THERAPY; INNATE; APOPTOSIS; SUBTYPES	Background: Cytokines are administered to patients to eliminate viral infections and cancer yet often have side effects. Results: Antibody fragments have been designed that recognize cytokine-receptor complexes and change cytokine biological activity profiles. Conclusion: Designed proteins enhance interferon antiviral activity without inducing antiproliferative signaling pathways. Significance: Antibody fragments targeted to cytokine-receptor complexes provide new tools for manipulating cytokine signaling. Exogenous cytokine therapy can induce systemic toxicity, which might be prevented by activating endogenously produced cytokines in local cell niches. Here we developed antibody-based activators of cytokine signaling (AcCS), which recognize cytokines only when they are bound to their cell surface receptors. AcCS were developed for type I interferons (IFNs), which induce cellular activities by binding to cell surface receptors IFNAR1 and IFNAR2. As a potential alternative to exogenous IFN therapy, AcCS were shown to potentiate the biological activities of natural IFNs by approximate to 100-fold. Biochemical and structural characterization demonstrates that the AcCS stabilize the IFN-IFNAR2 binary complex by recognizing an IFN-induced conformational change in IFNAR2. Using IFN mutants that disrupt IFNAR1 binding, AcCS were able to enhance IFN antiviral potency without activating antiproliferative responses. This suggests AcCS can be used to manipulate cytokine signaling for basic science and possibly for therapeutic applications.	[Kuruganti, Srilalitha; Deshpande, Ashlesha; Harris, Bethany D.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Miersch, Shane; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Sci, Toronto, ON M5G 1L6, Canada; [Speir, Jeffrey A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Schriewer, Jill M.; Buller, R. Mark L.] St Louis Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, St Louis, MO 63104 USA	University of Alabama System; University of Alabama Birmingham; University of Toronto; Scripps Research Institute; Saint Louis University	Walter, MR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 1025 18th St S, Birmingham, AL 35294 USA.	walter@uab.edu			NIGMS, National Institutes of Health [GM103310]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097629, R01AI049342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Access to the Biacore T-200 was made possible by the University of Alabama at Birmingham Multidisciplinary Molecular Interaction Core. EM work was performed at the National Resource for Automated Molecular Microscopy, which is supported by NIGMS, National Institutes of Health Grant GM103310. We thank Bridget Carragher and Carragher/Potter laboratory members for many helpful discussions regarding EM processing, Makoto Hijikata for HuS-E/2 cells and protocols for their growth, and Tamas Jilling for assistance with qPCR studies.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Baldo BA, 2014, DRUG SAFETY, V37, P921, DOI 10.1007/s40264-014-0226-z; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chill JH, 2002, BIOCHEMISTRY-US, V41, P3575, DOI 10.1021/bi011778f; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; DeLano W.L, PYMOL MOL GRAPHICS S; Deshpande A, 2013, PROTEIN SCI, V22, P1100, DOI 10.1002/pro.2285; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kuruganti S, 2014, PROTEIN EXPRES PURIF, V103, P75, DOI 10.1016/j.pep.2014.08.010; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Leonard JP, 1997, BLOOD, V90, P2541; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; POCKAJ BA, 1994, J IMMUNOTHER, V15, P22, DOI 10.1097/00002371-199401000-00003; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Striz I, 2014, CLIN SCI, V126, P593, DOI 10.1042/CS20130497; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tsugawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089869; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004	55	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					447	461		10.1074/jbc.M115.665943	http://dx.doi.org/10.1074/jbc.M115.665943			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546677	hybrid, Green Published			2022-12-28	WOS:000367589500040
J	Yan, XH; Liao, HW; Cheng, MZ; Shi, XJ; Lin, X; Feng, XH; Chen, YG				Yan, Xiaohua; Liao, Hongwei; Cheng, Minzhang; Shi, Xiaojing; Lin, Xia; Feng, Xin-Hua; Chen, Ye-Guang			Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-beta (TGF-beta/Smad Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; protein degradation; protein-protein interaction; SMAD transcription factor; transforming growth factor beta (TGF-B); ubiquitylation (ubiquitination); Smad7; signaling regulation	TGF-BETA; NEGATIVE REGULATION; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; CANCER; PATHWAYS; DOMAIN; DEGRADATION; PROGRESSION; NUCLEUS	TGF-beta is a pleiotropic cytokine that regulates a wide range of cellular actions and pathophysiological processes. TGF-beta signaling is spatiotemporally fine-tuned. As a key negative regulator of TGF-beta signaling, Smad7 exerts its inhibitory effects by blocking receptor activity, inducing receptor degradation or interfering with Smad-DNA binding. However, the functions and the molecular mechanisms underlying the actions of Smad7 in TGF-beta signaling are still not fully understood. In this study we report a novel mechanism whereby Smad7 antagonizes TGF-beta signaling at the Smad level. Smad7 oligomerized with R-Smad proteins upon TGF-beta signaling and directly inhibited R-Smad activity, as assessed by Gal4-luciferase reporter assays. Mechanistically, Smad7 competes with Smad4 to associate with R-Smads and recruits the E3 ubiquitin ligase NEDD4L to activated R-Smads, leading to their polyubiquitination and proteasomal degradation. Similar to the R-Smad-Smad4 oligomerization, the interaction between R-Smads and Smad7 is mediated by their mad homology 2 (MH2) domains. A positive-charged basic region including the L3/beta 8 loop-strand module and adjacent amino acids in the MH2 domain of Smad7 is essential for the interaction. These results shed new light on the regulation of TGF-beta signaling by Smad7.	[Yan, Xiaohua; Liao, Hongwei; Cheng, Minzhang; Shi, Xiaojing; Chen, Ye-Guang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Feng, Xin-Hua] Zhejiang Univ, Life Sci Inst & Innovat Ctr Cell Signaling Networ, Hangzhou 310058, Zhejiang, Peoples R China; [Lin, Xia] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Xia] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Tsinghua University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Yan, XH (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	yanxiaohua06@126.com; ygchen@tsinghua.edu.cn	Yan, Xiaohua/J-4922-2015; Chen, Ye-Guang/L-6998-2019	Yan, Xiaohua/0000-0002-7528-5771; 	National Natural Science Foundation of China (NSFC) [31401198, 31330049]; Ministry of Science and Technology-973 Program [2013CB933700]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology-973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (NSFC) Grants 31401198 (to X.Y.) and 31330049 and the Ministry of Science and Technology-973 Program (2013CB933700; to Y.-G.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Beppu H, 2013, J BIOCHEM, V153, P399, DOI 10.1093/jb/mvt020; Bian L, 2015, PROTEIN CELL, V6, P160, DOI 10.1007/s13238-014-0130-4; Briones-Orta Marco A, 2011, Curr Mol Pharmacol, V4, P141; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding YJ, 2014, J CELL SCI, V127, P4833, DOI 10.1242/jcs.146977; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Herhaus L, 2014, CELL SIGNAL, V26, P2186, DOI 10.1016/j.cellsig.2014.06.012; Thi HTH, 2015, MOL CELL BIOL, V35, P2841, DOI 10.1128/MCB.00274-15; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Luo LY, 2014, TUMOR BIOL, V35, P8379, DOI 10.1007/s13277-014-2203-7; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stolfi C, 2013, INT J MOL SCI, V14, P23774, DOI 10.3390/ijms141223774; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Yan XH, 2014, SCI CHINA LIFE SCI, V57, P128, DOI 10.1007/s11427-013-4581-2; Yan XH, 2012, J BIOL CHEM, V287, P13705, DOI 10.1074/jbc.M112.346221; Yan XH, 2011, MOL CELL BIOL, V31, P3700, DOI 10.1128/MCB.05448-11; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang J, 2014, PROTEIN CELL, V5, P503, DOI 10.1007/s13238-014-0058-8; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200; Zhu L, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-44	47	117	132	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					382	392		10.1074/jbc.M115.694281	http://dx.doi.org/10.1074/jbc.M115.694281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26555259	Green Published, hybrid			2022-12-28	WOS:000367589500031
J	Ainscough, JS; Gerberick, GF; Kimber, I; Dearman, RJ				Ainscough, Joseph S.; Gerberick, G. Frank; Kimber, Ian; Dearman, Rebecca J.			Interleukin-1 beta Processing Is Dependent on a Calcium-mediated Interaction with Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; LIGHT-CHAIN KINASE; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; INNATE IMMUNITY; ACTIVATION; IL-1-BETA; IL-1-ALPHA; PROTEINS; CRYSTALS	The secretion of IL-1 beta is a central event in the initiation of inflammation. Unlike most other cytokines, the secretion of IL-1 beta requires two signals: one signal to induce the intracellular up-regulation of pro-IL-1 beta and a second signal to drive secretion of the bioactive molecule. The release of pro-IL-1 beta is a complex process involving proteolytic cleavage by caspase-1. However, the exact mechanism of secretion is poorly understood. Here we sought to identify novel proteins involved in IL-1 beta secretion and intracellular processing to gain further insights into the mechanism of IL-1 release. A human proteome microarray containing 19,951 unique proteins was used to identify proteins that bind human recombinant pro-IL-1 beta. Probes with a signal-to-noise ratio of >3 were defined as biologically relevant. In these analyses, calmodulin was identified as a particularly strong hit, with a signal-to-noise ratio of similar to 11. Using an ELISA-based protein-binding assay, the interaction of recombinant calmodulin with pro-IL-1 beta, but not mature IL-1 beta, was confirmed and shown to be calcium-dependent. Finally, using small molecule inhibitors, it was demonstrated that both calcium and calmodulin were required for nigericin-induced IL-1 beta secretion in THP-1 cells and primary human monocytes. Together, these data suggest that, following calcium influx into the cell, pro-IL-1 beta interacts with cahnodulin and that this interaction is important for IL-1 beta processing and release.	[Ainscough, Joseph S.; Kimber, Ian; Dearman, Rebecca J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Gerberick, G. Frank] Procter & Gamble Co, Cincinnati, OH 45253 USA	University of Manchester; Procter & Gamble	Ainscough, JS (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	joseph.ainscough@postgrad.manchester.ac.uk		Ainscough, Joseph/0000-0002-8823-3508	Medical Research Council; Procter Gamble Company; Medical Research Council [1067566] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Procter Gamble Company(Procter & Gamble); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Medical Research Council and The Procter & Gamble Company.	Ainscough JS, 2014, J BIOL CHEM, V289, P35582, DOI 10.1074/jbc.M114.595686; Ainscough JS, 2013, J IMMUNOTOXICOL, V10, P223, DOI 10.3109/1547691X.2012.711782; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Ferrari D, 1997, J IMMUNOL, V159, P1451; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; IKURA M, 1983, BIOCHEMISTRY-US, V22, P2573, DOI 10.1021/bi00279a039; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Toutenhoofd SL, 2000, CELL CALCIUM, V28, P83, DOI 10.1054/ceca.2000.0136; Weiss B, 2004, GENES IMMUN, V5, P330, DOI 10.1038/sj.gene.6364104; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007	45	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31151	31161		10.1074/jbc.M115.680694	http://dx.doi.org/10.1074/jbc.M115.680694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26559977	Green Published, hybrid			2022-12-28	WOS:000367199000042
J	Booth, ES; Basran, J; Lee, M; Handa, S; Raven, EL				Booth, Elizabeth S.; Basran, Jaswir; Lee, Michael; Handa, Sandeep; Raven, Emma L.			Substrate Oxidation by Indoleamine 2,3-Dioxygenase EVIDENCE FOR A COMMON REACTION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME CHEMISTRY; MISSING PIECE; TRYPTOPHAN; INHIBITORS; REDOX; SITE	The kynurenine pathway is the major route of L-tryptophan (L-Trp) catabolism in biology, leading ultimately to the formation of NAD(+). The initial and rate-limiting step of the kynurenine pathway involves oxidation of L-Trp to N-formylkynurenine. This is an O-2-dependent process and catalyzed by indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase. More than 60 years after these dioxygenase enzymes were first isolated (Kotake, Y., and Masayama, I. (1936) Z. Physiol. Chem. 243, 237244), the mechanism of the reaction is not established. We examined the mechanism of substrate oxidation for a series of substituted tryptophan analogues by indoleamine 2,3-dioxygenase. We observed formation of a transient intermediate, assigned as a Compound II (ferryl) species, during oxidation of L-Trp, 1-methyl-L-Trp, and a number of other substrate analogues. The data are consistent with a common reaction mechanism for indoleamine 2,3-dioxygenase-catalyzed oxidation of tryptophan and other tryptophan analogues.	[Booth, Elizabeth S.; Lee, Michael; Handa, Sandeep; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Basran, Jaswir] Univ Leicester, Dept Mol & Cellular Biol, Leicester LE1 9HN, Leics, England; [Basran, Jaswir] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester; University of Leicester	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk	Handa, Sandeep/AAV-2646-2021	Raven, Emma/0000-0002-1643-8694; Handa, Sandeep/0000-0002-7109-1523	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/L004585/1]; BBSRC [BB/L004585/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Engineering and Physical Sciences Research Council studentship grant (to E. S. B.) and Biotechnology and Biological Sciences Research Council Fellowship Grant BB/L004585/1 (to E. L. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g; Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w; Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v; Davydov RM, 2010, J AM CHEM SOC, V132, P5494, DOI 10.1021/ja100518z; Dolusic E, 2013, EXPERT OPIN THER PAT, V23, P1367, DOI 10.1517/13543776.2013.827662; Efimov I, 2012, J AM CHEM SOC, V134, P3034, DOI 10.1021/ja208694g; Efimov I, 2011, BIOCHEMISTRY-US, V50, P2717, DOI 10.1021/bi101732n; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Gen JF, 2012, J AM CHEM SOC, V134, P12209, DOI 10.1021/ja304164b; HAMILTON GA, 1969, ADV ENZYMOL RAMB, V32, P55; HO PS, 1983, J BIOL CHEM, V258, P4356; Joule J.A., 2000, HETEROCYCLIC CHEM; Kotake Y., 1936, H-S Z PHYSIOL CHEM, V243, P237; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Makino R, 2015, BIOCHEMISTRY-US, V54, P3604, DOI 10.1021/acs.biochem.5b00048; Meng B, 2014, PROTEINS, V82, P3210, DOI 10.1002/prot.24653; Millett ES, 2012, CURR OPIN CHEM BIOL, V16, P60, DOI 10.1016/j.cbpa.2012.01.014; Pantouris G, 2014, AMINO ACIDS, V46, P2155, DOI 10.1007/s00726-014-1766-3; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Rohrig UF, 2010, J MED CHEM, V53, P1172, DOI 10.1021/jm9014718; Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139; Yanagisawa S, 2010, CHEM LETT, V39, P36, DOI 10.1246/cl.2010.36	28	30	30	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30924	30930		10.1074/jbc.M115.695684	http://dx.doi.org/10.1074/jbc.M115.695684			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511316	Green Published, hybrid			2022-12-28	WOS:000367199000024
J	Fan, MH; Zhu, Q; Li, HH; Ra, HJ; Majumdar, S; Gulick, DL; Jerome, JA; Madsen, DH; Christofidou-Solomidou, M; Speicher, DW; Bachovchin, WW; Feghali-Bostwick, C; Pure, E				Fan, Ming-Hui; Zhu, Qiang; Li, Hui-Hua; Ra, Hyun-Jeong; Majumdar, Sonali; Gulick, Dexter L.; Jerome, Jacob A.; Madsen, Daniel H.; Christofidou-Solomidou, Melpo; Speicher, David W.; Bachovchin, William W.; Feghali-Bostwick, Carol; Pure, Ellen			Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix; fibroblast; pulmonary fibrosis; serine protease; gelatinase; interstitial lung disease	SERINE-PROTEASE; PULMONARY-FIBROSIS; MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; PROTEOLYTIC ACTIVATION; PROCOLLAGEN PRODUCTION; REMODELING INTERFACE; NEUTROPHIL ELASTASE; STROMAL FIBROBLASTS; TISSUE INHIBITORS	Idiopathic pulmonary fibrosis is a disease characterized by progressive, unrelenting lung scarring, with death from respiratory failure within 2-4 years unless lung transplantation is performed. New effective therapies are clearly needed. Fibroblast activation protein (FAP) is a cell surface-associated serine protease up-regulated in the lungs of patients with idiopathic pulmonary fibrosis as well as in wound healing and cancer. We postulate that FAP is not only a marker of disease but influences the development of pulmonary fibrosis after lung injury. In two different models of pulmonary fibrosis, intratracheal bleomycin instillation and thoracic irradiation, we find increased mortality and increased lung fibrosis in FAP-deficient mice compared with wild-type mice. Lung extracellular matrix analysis reveals accumulation of intermediate-sized collagen fragments in FAP-deficient mouse lungs, consistent with in vitro studies showing that FAP mediates ordered proteolytic processing of matrix metalloproteinase (MMP)-derived collagen cleavage products. FAP-mediated collagen processing leads to increased collagen internalization without altering expression of the endocytic collagen receptor, Endo180. Pharmacologic FAP inhibition decreases collagen internalization as expected. Conversely, restoration of FAP expression in the lungs of FAP-deficient mice decreases lung hydroxyproline content after intratracheal bleomycin to levels comparable with that of wild-type controls. Our findings indicate that FAP participates directly, in concert with MMPs, in collagen catabolism and clearance and is an important factor in resolving scar after injury and restoring lung homeostasis. Our study identifies FAP as a novel endogenous regulator of fibrosis and is the first to show FAP's protective effects in the lung.	[Fan, Ming-Hui; Li, Hui-Hua; Gulick, Dexter L.; Jerome, Jacob A.] Univ Pittsburgh, Dept Med, Pulm Allergy & Crit Care Div, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [Zhu, Qiang] Univ N Carolina, Mol & Cellular Pathol Grad Program, Chapel Hill, NC 27599 USA; [Ra, Hyun-Jeong; Christofidou-Solomidou, Melpo] Univ Penn, Dept Hematol & Oncol, Philadelphia, PA 19104 USA; [Pure, Ellen] Univ Penn, Dept Biomed Sci, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Pure, Ellen] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Majumdar, Sonali; Speicher, David W.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Madsen, Daniel H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, Ctr Canc Immune Therapy,NIH, Bethesda, MD 20892 USA; [Bachovchin, William W.] Tufts Univ, Sackler Sch Biomed Grad Sci, Boston, MA 02111 USA; [Feghali-Bostwick, Carol] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tufts University; Medical University of South Carolina	Fan, MH (corresponding author), Univ Pittsburgh, Dept Med, Pulm Allergy & Crit Care Div, 930 Scaife Hall, Pittsburgh, PA 15213 USA.	fanm@upmc.edu	william.bachovchin@tufts.edu/AAA-3538-2022	Madsen, Daniel Hargboel/0000-0002-3183-6201	National Institutes of Health [R01 CA141144, R01 CA133470, K08HL102266, P30AR05891, K24 AR060297, R01 CA131582]; Dalsemer Research Award from the American Lung Association [DA167003]; Intramural Research Program of the National Institutes of Health from NIDCR; NCI [P30 CA010815]; The Danish Cancer Society [R124-A7599] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA131582, R01CA141144, P30CA010815, R01CA133470] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL102266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dalsemer Research Award from the American Lung Association; Intramural Research Program of the National Institutes of Health from NIDCR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Danish Cancer Society(Danish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01 CA141144 (to E. P.), R01 CA133470 (to M. C. S.), K08HL102266 (to M. H. F.), P30AR05891 (to PI Mark Gladwin; funding provided to M. H. F.), and K24 AR060297 (to C. F. B.), Dalsemer Research Award DA167003 (M. H. F.) from the American Lung Association, and in part by the Intramural Research Program of the National Institutes of Health from NIDCR (to D. H. M.), National Institutes of Health Grant R01 CA131582 (to D. W. S.), and Core Grant P30 CA010815 from NCI (to The Wistar Institute). M. C. S. has patents PCT/US14/41636 and PCT/US15/22501 pending and has a founder's equity position in LignaMed, LLC, but these have no connection to the data reported in this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Acharya PS, 2006, HUM PATHOL, V37, P352, DOI 10.1016/j.humpath.2005.11.020; Aggarwal S, 2008, BIOCHEMISTRY-US, V47, P1076, DOI 10.1021/bi701921b; Arnold JN, 2014, CANCER IMMUNOL RES, V2, P121, DOI 10.1158/2326-6066.CIR-13-0150; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Blanc-Brude OP, 2005, EXP CELL RES, V304, P16, DOI 10.1016/j.yexcr.2004.10.021; Bras LED, 2013, J PROTEOMICS, V86, P43, DOI 10.1016/j.jprot.2013.05.004; Brokopp CE, 2011, EUR HEART J, V32, P2713, DOI 10.1093/eurheartj/ehq519; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Checa M, 2008, HUM GENET, V124, P465, DOI 10.1007/s00439-008-0571-z; Cheng JD, 2002, CANCER RES, V62, P4767; Christiansen VJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P177, DOI 10.1016/j.abb.2006.11.006; Chua F, 2007, AM J PATHOL, V170, P65, DOI 10.2353/ajpath.2007.060352; Chung KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088772; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; Dabbagh K, 1998, EUR RESPIR J, V11, P1002, DOI 10.1183/09031936.98.11051002; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Howell DCJ, 2001, AM J PATHOL, V159, P1383, DOI 10.1016/S0002-9440(10)62525-4; Huber MA, 2003, J INVEST DERMATOL, V120, P182, DOI 10.1046/j.1523-1747.2003.12035.x; Iwasa S, 2005, CANCER LETT, V227, P227, DOI 10.1016/j.canlet.2004.06.031; Karimi-Shah BA, 2015, NEW ENGL J MED, V372, P1189, DOI 10.1056/NEJMp1500526; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; Lee TH, 2014, MOL BIOL CELL, V25, P583, DOI 10.1091/mbc.E13-07-0382; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Machtay M, 2006, RADIOTHER ONCOL, V81, P196, DOI 10.1016/j.radonc.2006.09.013; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Meadows SA, 2007, BIOCHEMISTRY-US, V46, P4598, DOI 10.1021/bi062227y; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; MONSKY WL, 1994, CANCER RES, V54, P5702; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, P1, DOI DOI 10.17226/12910; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Niedermeyer J, 2001, INT J DEV BIOL, V45, P445; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Radisky Derek C, 2008, Proc Am Thorac Soc, V5, P316, DOI 10.1513/pats.200711-166DR; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; RILEY DJ, 1988, EXP LUNG RES, V14, P549, DOI 10.3109/01902148809087827; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Taooka Y, 1997, AM J RESP CRIT CARE, V156, P260, DOI 10.1164/ajrccm.156.1.9612077; Tchou J, 2013, HUM PATHOL, V44, P2549, DOI 10.1016/j.humpath.2013.06.016; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Wang XM, 2008, FRONT BIOSCI-LANDMRK, V13, P3168, DOI 10.2741/2918; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yang K, 2007, INT J RADIAT BIOL, V83, P665, DOI 10.1080/09553000701558977	75	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8070	8089		10.1074/jbc.M115.701433	http://dx.doi.org/10.1074/jbc.M115.701433			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26663085	Green Published, hybrid			2022-12-28	WOS:000374056700026
J	Malaisse, J; Pendaries, V; Hontoir, F; De Glas, V; Van Vlaender, D; Simon, M; de Rouvroit, CL; Poumay, Y; Flamion, B				Malaisse, Jeremy; Pendaries, Valerie; Hontoir, Fanny; De Glas, Valerie; Van Vlaender, Daniel; Simon, Michel; de Rouvroit, Catherine Lambert; Poumay, Yves; Flamion, Bruno			Hyaluronan Does Not Regulate Human Epidermal Keratinocyte Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; epidermis; hyaluronan; hyaluronidase; keratinocyte; proliferation; 4-methylumbelliferone	SYNTHESIS INHIBITOR 4-METHYLUMBELLIFERONE; UDP-GLUCOSE DEHYDROGENASE; THYMIDINE PHOSPHORYLASE; DOWN-REGULATION; SYNTHASE 2; ACID; SKIN; GLYCOSAMINOGLYCANS; RECONSTRUCTION; MORPHOGENESIS	Hyaluronan (HA) is synthesized by three HA synthases (HAS1, HAS2, and HAS3) and secreted in the extracellular matrix. In human skin, large amounts of HA are found in the dermis. HA is also synthesized by keratinocytes in the epidermis, although its epidermal functions are not clearly identified yet. To investigate HA functions, we studied the effects of HA depletion on human keratinocyte physiology within in vitro reconstructed human epidermis. Inhibition of HA synthesis with 4-methylumbelliferone (4MU) did not modify the expression profile of the epidermal differentiation markers involucrin, keratin 10, and filaggrin during tissue reconstruction. In contrast, when keratinocytes were incubated with 4MU, cell proliferation was decreased. In an attempt to rescue the proliferation function, HA samples of various mean molecular masses were added to keratinocyte cultures treated with 4MU. These samples were unable to rescue the initial proliferation rate. Furthermore, treatments with HA-specific hyaluronidase, although removing almost all HA from keratinocyte cultures, did not alter the differentiation or proliferation processes. The differences between 4MU and hyaluronidase effects did not result from differences in intracellular HA, sulfated glycosaminoglycan concentration, apoptosis, or levels of HA receptors, all of which remained unchanged. Similarly, knockdown of UDP-glucose 6-dehydrogenase (UGDH) using lentiviral shRNA effectively decreased HA production but did not affect proliferation rate. Overall, these data suggest that HA levels in the human epidermis are not directly correlated with keratinocyte proliferation and differentiation and that incubation of cells with 4MU cannot equate with HA removal.	[Malaisse, Jeremy; De Glas, Valerie; Van Vlaender, Daniel; de Rouvroit, Catherine Lambert; Poumay, Yves; Flamion, Bruno] Univ Namur, NARILIS, URPHYM, B-5000 Namur, Belgium; [Pendaries, Valerie; Simon, Michel] Univ Toulouse, UDEAR, CNRS INSERM, UMR5165 U1056, F-31013 Toulouse 6, France; [Hontoir, Fanny] Univ Namur, NARILIS, URVI, B-5000 Namur, Belgium	University of Namur; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Namur	Flamion, B (corresponding author), Univ Namur, NARILIS, URPHYM, B-5000 Namur, Belgium.	Bruno.Flamion@unamur.be	Simon, Michel/B-7308-2011; Poumay, Yves/G-4525-2016	Simon, Michel/0000-0003-3655-6329; Poumay, Yves/0000-0001-5200-3367; Hontoir, Fanny/0000-0003-0847-8167	FRFC [2.4522.10F]; FNRS [1.5.003.06F]	FRFC(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by FRFC Grant 2.4522.10F and FNRS Grant 1.5.003.06F (to Y. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama S, 2004, CANCER SCI, V95, P851, DOI 10.1111/j.1349-7006.2004.tb02193.x; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; De Vuyst E, 2014, METHODS MOL BIOL, V1195, P191, DOI 10.1007/7651_2013_40; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Frankart A, 2012, EXP DERMATOL, V21, P871, DOI 10.1111/exd.12020; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; Gu H, 2010, EXP DERMATOL, V19, pE336, DOI 10.1111/j.1600-0625.2009.01052.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jokela TA, 2014, J BIOL CHEM, V289, P18569, DOI 10.1074/jbc.M114.551804; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Keller KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048523; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Malaisse J, 2014, J INVEST DERMATOL, V134, P2174, DOI 10.1038/jid.2014.147; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Minner F, 2010, METHODS MOL BIOL, V585, P71, DOI 10.1007/978-1-60761-380-0_6; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Nikitovic D, 2015, TOXICOL LETT, V232, P89, DOI 10.1016/j.toxlet.2014.09.026; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; TAMMI R, 1991, EXP CELL RES, V195, P524, DOI 10.1016/0014-4827(91)90405-J; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tamura R, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0094-2; Urakawa H, 2012, INT J CANCER, V130, P454, DOI 10.1002/ijc.26014; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	42	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6347	6358		10.1074/jbc.M115.661348	http://dx.doi.org/10.1074/jbc.M115.661348			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26627828	Green Published, hybrid			2022-12-28	WOS:000372894200024
J	Kang, S; Dahl, R; Hsieh, W; Shin, A; Zsebo, KM; Buettner, C; Hajjar, RJ; Lebeche, D				Kang, Soojeong; Dahl, Russell; Hsieh, Wilson; Shin, Andrew; Zsebo, Krisztina M.; Buettner, Christoph; Hajjar, Roger J.; Lebeche, Djamel			Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; endoplasmic reticulum stress (ER stress); glucose metabolism; lipid metabolism; Ca2+ homeostasis; SERCA2b; hepatosteatosis; insulin sensitivity; mitochondria efficiency	UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; GENE-TRANSFER; MITOCHONDRIAL DYSFUNCTION; HEPATIC GLUCONEOGENESIS; CELL-DEATH; ERR-ALPHA; STRESS; LIVER; EXPRESSION	Dysregulation of endoplasmic reticulum (ER) Ca2+ homeostasis triggers ER stress leading to the development of insulin resistance in obesity and diabetes. Impaired function of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) has emerged as a major contributor to ER stress. We pharmacologically activated SERCA2b in a genetic model of insulin resistance and type 2 diabetes (ob/ob mice) with a novel allosteric activator, CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls. Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration. CDN1163-treated ob/ob mice showed a significant reduction in adipose tissue weight with no change in lean mass, assessed by magnetic resonance imaging. They also showed an increase in energy expenditure using indirect calorimetry, which was accompanied by increased expression of uncoupling protein 1 (UCP1) and UCP3 in brown adipose tissue. CDN1163 treatment significantly reduced the hepatic expression of genes involved in gluconeogenesis and lipogenesis, attenuated ER stress response and ER stress-induced apoptosis, and improved mitochondrial biogenesis, possibly through SERCA2-mediated activation of AMP-activated protein kinase pathway. The findings suggest that SERCA2b activation may hold promise as an effective therapy for type-2 diabetes and metabolic dysfunction.	[Kang, Soojeong; Hajjar, Roger J.; Lebeche, Djamel] Icahn Sch Med Mt Sinai, Dept Med, Cardiovasc Res Inst, New York, NY 10029 USA; [Kang, Soojeong; Hajjar, Roger J.; Lebeche, Djamel] Icahn Sch Med Mt Sinai, Dept Med, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Dahl, Russell] Rosalind Franklin Univ Med & Sci, Dept Pharmaceut Sci, N Chicago, IL 60064 USA; [Hsieh, Wilson; Shin, Andrew; Buettner, Christoph] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, Dept Med, New York, NY 10029 USA; [Hsieh, Wilson; Shin, Andrew; Buettner, Christoph] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, Dept Neurosci, New York, NY 10029 USA; [Zsebo, Krisztina M.] Celladon Corp, San Diego, CA 92130 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rosalind Franklin University Medical & Science; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Lebeche, D (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Inst, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	djamel.lebeche@mssm.edu	Shin, Andrew/T-6225-2019	Dahl, Russell/0000-0002-2939-1004	National Institutes of Health [HL097375, DK020541, DK083658, K01 DK099463]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129814, R01HL128072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099463, R01DK083658, P60DK020541, P30DK020541, R56DK083658, R01DK111417, R56DK100624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants HL097375 and DK020541 (to D. L.), DK083658 (to C. B.), and K01 DK099463 (to A. S.).	Ashby MC, 2001, SEMIN CELL DEV BIOL, V12, P11, DOI 10.1006/scdb.2000.0212; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Disdier-Flores O M, 2001, P R Health Sci J, V20, P123; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Hadri L, 2010, MOL THER, V18, P1284, DOI 10.1038/mt.2010.77; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Leemand J, 2012, EXP DIABETES RES, DOI 10.1155/2012/242984; Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rieusset J, 2011, INT J BIOCHEM CELL B, V43, P1257, DOI 10.1016/j.biocel.2011.05.006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Williams LM, 2012, P NUTR SOC, V71, P521, DOI 10.1017/S002966511200078X; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	48	98	100	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5185	5198		10.1074/jbc.M115.705012	http://dx.doi.org/10.1074/jbc.M115.705012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26702054	Green Published, hybrid			2022-12-28	WOS:000371640600030
J	Guler, G; Gartner, RM; Ziegler, C; Mantele, W				Gueler, Guennur; Gaertner, Rebecca M.; Ziegler, Christine; Maentele, Werner			Lipid-Protein Interactions in the Regulated Betaine Symporter BetP Probed by Infrared Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; CORYNEBACTERIUM-GLUTAMICUM; TRANSPORTER BETP; CARRIER BETP; GLYCINE-BETAINE; CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; PHASE-TRANSITIONS; K+; SPECIFICITY	The Na+-coupled betaine symporter BetP senses changes in the membrane state and increasing levels of cytoplasmic K+ during hyperosmotic stress latter via its C-terminal domain and regulates transport activity according to both stimuli. This intriguing sensing and regulation behavior of BetP was intensively studied in the past. It was shown by several biochemical studies that activation and regulation depends crucially on the lipid composition of the surrounding membrane. In fact, BetP is active and regulated only when negatively charged lipids are present. Recent structural studies have revealed binding of phosphatidylglycerol lipids to functional important parts of BetP, suggesting a functional role of lipid interactions. However, a regulatory role of lipid interactions could only be speculated from the snapshot provided by the crystal structure. Here, we investigate the nature of lipid-protein interactions of BetP reconstituted in closely packed two-dimensional crystals of negatively charged lipids and probed at the molecular level with Fourier transform infrared (FTIR) spectroscopy. The FTIR data indicate that K+ binding weakens the interaction of BetP especially with the anionic lipid head groups. We suggest a regulation mechanism in which lipid-protein interactions, especially with the C-terminal domain and the functional important gating helices transmembrane helice 3 (TMH3) and TMH12, confine BetP to its down-regulated transport state. As BetP is also activated by changes in the physical state of the membrane, our results point toward a more general mechanism of how active transport can be modified by dynamic lipid-protein interactions.	[Gueler, Guennur; Maentele, Werner] Goethe Univ Frankfurt, Inst Biophys, Max Von Laue Str 1, D-60438 Frankfurt, Germany; [Gaertner, Rebecca M.; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, Max Von Laue Str 3, D-60438 Frankfurt, Germany; [Ziegler, Christine] Univ Regensburg, Fac Biol & Preclin Med, Univ Str 31, D-93051 Regensburg, Germany	Goethe University Frankfurt; Max Planck Society; University of Regensburg	Mantele, W (corresponding author), Goethe Univ Frankfurt, Inst Biophys, Max Von Laue Str 1, D-60438 Frankfurt, Germany.; Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Max Von Laue Str 3, D-60438 Frankfurt, Germany.	Christine.Ziegler@biophys.mpg.de; maentele@biophysik.uni-frankfurt.de	Güler, Günnur/GLQ-7527-2022	Ziegler, Christine Maria/0000-0003-3439-7213; Richter, Rebecca M./0000-0002-3831-7666	Collaborative Research Center "Transport and Communication across Biological Membranes" of Deutsche Forschungsgemeinschaft [SFB 807]	Collaborative Research Center "Transport and Communication across Biological Membranes" of Deutsche Forschungsgemeinschaft	This work was supported by Collaborative Research Center SFB 807 "Transport and Communication across Biological Membranes" of Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Arrondo JLR, 1998, CHEM PHYS LIPIDS, V96, P53, DOI 10.1016/S0009-3084(98)00080-2; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; BLUME A, 1988, BIOCHEMISTRY-US, V27, P8239, DOI 10.1021/bi00421a038; CAMERON DG, 1980, BIOCHEMISTRY-US, V19, P3665, DOI 10.1021/bi00557a005; CASAL HL, 1984, BIOCHIM BIOPHYS ACTA, V779, P381, DOI 10.1016/0304-4157(84)90017-0; Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015; Fabian H., 2001, HDB VIB SPECTROSC, DOI [10.1002/0470027320.s8201, DOI 10.1002/0470027320.S8201, DOI 10.1002/0470027320]; FRINGELI UP, 1976, BIOCHIM BIOPHYS ACTA, V450, P101, DOI 10.1016/0005-2760(76)90302-7; Gartner RM, 2011, J MOL BIOL, V414, P327, DOI 10.1016/j.jmb.2011.10.013; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Korkmaz F, 2008, BIOCHEMISTRY-US, V47, P12126, DOI 10.1021/bi801224y; Korkmaz F, 2013, BBA-BIOMEMBRANES, V1828, P1181, DOI 10.1016/j.bbamem.2013.01.004; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Kramer R, 2009, BIOL CHEM, V390, P685, DOI 10.1515/BC.2009.068; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; LEWIS RNAH, 1994, BIOPHYS J, V67, P2367, DOI 10.1016/S0006-3495(94)80723-4; Lewis RNAH, 2013, BBA-BIOMEMBRANES, V1828, P2347, DOI 10.1016/j.bbamem.2012.10.018; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Moffat D. J., 1986, NRCC B, V18; Nicklisch SCT, 2012, BBA-BIOMEMBRANES, V1818, P359, DOI 10.1016/j.bbamem.2011.10.021; Ozcan N, 2007, J BACTERIOL, V189, P7485, DOI 10.1128/JB.00986-07; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Ozcan N, 2005, J BACTERIOL, V187, P4752, DOI 10.1128/JB.187.14.4752-4759.2005; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; SIEBERT F, 1982, FEBS LETT, V141, P82, DOI 10.1016/0014-5793(82)80021-5; Sukumaran S, 2005, FEBS LETT, V579, P2546, DOI 10.1016/j.febslet.2005.03.059; Szalontai Balazs, 2009, PMC Biophys, V2, P1, DOI 10.1186/1757-5036-2-1; Tsai CJ, 2007, J STRUCT BIOL, V160, P275, DOI 10.1016/j.jsb.2007.09.008; Tsai CJ, 2011, J MOL BIOL, V407, P368, DOI 10.1016/j.jmb.2011.01.028; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	44	30	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4295	4307		10.1074/jbc.M114.621979	http://dx.doi.org/10.1074/jbc.M114.621979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26592930	Green Published, hybrid			2022-12-28	WOS:000371604600003
J	He, ZM; Wu, JY; Su, XN; Zhang, Y; Pan, LX; Wei, HM; Fang, Q; Li, HT; Wang, DL; Sun, FL				He, Zhimin; Wu, Junyu; Su, Xiaonan; Zhang, Ye; Pan, Lixia; Wei, Huimin; Fang, Qiang; Li, Haitao; Wang, Da-Liang; Sun, Fang-Lin			JMJD5 (Jumonji Domain-containing 5) Associates with Spindle Microtubules and Is Required for Proper Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K36ME2 HISTONE DEMETHYLASE; CONTAINING PROTEIN; MITOTIC SPINDLE; CELL-CYCLE; LOCALIZES; TUBULIN; COMPLEX; KINETOCHORE; ACETYLATION; MECHANISMS	Precise mitotic spindle assembly is a guarantee of proper chromosome segregation during mitosis. Chromosome instability caused by disturbed mitosis is one of the major features of various types of cancer. JMJD5 has been reported to be involved in epigenetic regulation of gene expression in the nucleus, but little is known about its function in mitotic process. Here we report the unexpected localization and function of JMJD5 in mitotic progression. JMJD5 partially accumulates on mitotic spindles during mitosis, and depletion of JMJD5 results in significant mitotic arrest, spindle assembly defects, and sustained activation of the spindle assembly checkpoint (SAC). Inactivating SAC can efficiently reverse the mitotic arrest caused by JMJD5 depletion. Moreover, JMJD5 is found to interact with tubulin proteins and associate with microtubules during mitosis. JMJD5-depleted cells show a significant reduction of alpha-tubulin acetylation level on mitotic spindles and fail to generate enough interkinetochore tension to satisfy the SAC. Further, JMJD5 depletion also increases the susceptibility of HeLa cells to the antimicrotubule agent. Taken together, these results suggest that JMJD5 plays an important role in regulating mitotic progression, probably by modulating the stability of spindle microtubules.	[He, Zhimin; Wu, Junyu; Su, Xiaonan; Zhang, Ye; Pan, Lixia; Li, Haitao; Wang, Da-Liang; Sun, Fang-Lin] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Wei, Huimin; Sun, Fang-Lin] Tongji Univ, Sch Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai 200092, Peoples R China	Tsinghua University; Tongji University	Wang, DL; Sun, FL (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Sun, FL (corresponding author), Tongji Univ, Sch Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai 200092, Peoples R China.	wangdaliang@mail.tsinghua.edu.cn; sfl@tongji.edu.cn	Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X; Wu, Junyu/0000-0002-2515-9320	National Natural Science Foundation of China [91419304]; 973 program of the Ministry of Science and Technology of China [2015CB964800, 2015CB856200, 2011CB965300, 2013CB967600, 2013CB967500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of the Ministry of Science and Technology of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China Grant 91419304 and the 973 program of the Ministry of Science and Technology of China Grant 2015CB964800, 2015CB856200, 2011CB965300, 2013CB967600, and 2013CB967500. The authors declare that they have no conflicts of interest with the contents of this article.	Antrobus R, 2011, METHODS MOL BIOL, V777, P273, DOI 10.1007/978-1-61779-252-6_20; Bailey JK, 2015, J BIOL CHEM, V290, P8987, DOI 10.1074/jbc.M114.623611; Bergo A, 2015, J BIOL CHEM, V290, P3223, DOI 10.1074/jbc.M114.608125; Brownlow N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6685; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Castro-Castro A, 2012, EUR J CELL BIOL, V91, P950, DOI 10.1016/j.ejcb.2012.07.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coulombe P, 2002, ANAL BIOCHEM, V310, P219, DOI 10.1016/S0003-2697(02)00319-6; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Farkash-Amar S., 2012, PLOS ONE, P7; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XB, 2015, BBA-MOL CELL RES, V1853, P2286, DOI 10.1016/j.bbamcr.2015.05.026; Huang XB, 2013, BIOCHIMIE, V95, P2114, DOI 10.1016/j.biochi.2013.08.002; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Ishimura A, 2012, DEVELOPMENT, V139, P749, DOI 10.1242/dev.074138; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Juan G., 2004, DETECTION MITOTIC CE; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcon E, 2014, CELL REP, V8, P297, DOI 10.1016/j.celrep.2014.05.050; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Oh S, 2012, BIOCHEM BIOPH RES CO, V420, P61, DOI 10.1016/j.bbrc.2012.02.115; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Wang HP, 2013, ACTA CRYSTALLOGR D, V69, P1911, DOI 10.1107/S0907444913016600; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Youn MY, 2012, J BIOL CHEM, V287, P12994, DOI 10.1074/jbc.M111.323105; Zhu H, 2014, STEM CELLS, V32, P2098, DOI 10.1002/stem.1724	47	13	13	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4684	4697		10.1074/jbc.M115.672642	http://dx.doi.org/10.1074/jbc.M115.672642			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710852	hybrid, Green Published			2022-12-28	WOS:000371604600035
J	Wang, HJ; Song, CH; Ding, YL; Pan, XK; Ge, Z; Tan, BH; Gowda, C; Sachdev, M; Muthusami, S; Ouyang, HS; Lai, LX; Francis, OL; Morris, CL; Abdel-Azim, H; Dorsam, G; Xiang, MX; Payne, KJ; Dovat, S				Wang, Haijun; Song, Chunhua; Ding, Yali; Pan, Xiaokang; Ge, Zheng; Tan, Bi-Hua; Gowda, Chandrika; Sachdev, Mansi; Muthusami, Sunil; Ouyang, Hongsheng; Lai, Liangxue; Francis, Olivia L.; Morris, Christopher L.; Abdel-Azim, Hisham; Dorsam, Glenn; Xiang, Meixian; Payne, Kimberly J.; Dovat, Sinisa			Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hematopoiesis; lymphocyte; signal transduction; transcription regulation; transcription repressor; tumor suppressor gene; ck2; ikzf1	ACUTE MYELOID-LEUKEMIA; DNA-BINDING PROTEINS; GENOME-WIDE ANALYSIS; MYELOPROLIFERATIVE NEOPLASMS; CENTROMERIC HETEROCHROMATIN; NUCLEAR-PROTEIN; BREAST-CANCER; ACTIVE GENES; EXPRESSION; INHIBITORS	Impaired function of the Ikaros (IKZF1) protein is associated with the development of high-risk B-cell precursor acute lymphoblastic leukemia (B-ALL). The mechanisms of Ikaros tumor suppressor activity in leukemia are unknown. Ikaros binds to the upstream regulatory elements of its target genes and regulates their transcription via chromatin remodeling. Here, we report that Ikaros represses transcription of the histone H3K4 demethylase, JARID1B (KDM5B). Transcriptional repression of JARID1B is associated with increased global levels of H3K4 trimethylation. Ikaros-mediated repression of JARID1B is dependent on the activity of the histone deacetylase, HDAC1, which binds to the upstream regulatory element of JARID1B in complex with Ikaros. In leukemia, JARID1B is overexpressed, and its inhibition results in cellular growth arrest. Ikaros-mediated repression of JARID1B in leukemia is impaired by pro-oncogenic casein kinase 2 (CK2). Inhibition of CK2 results in increased binding of the Ikaros-HDAC1 complex to the promoter of JARID1B, with increased formation of trimethylated histone H3 lysine 27 and decreased histone H3 Lys-9 acetylation. In cases of high-risk B-ALL that carry deletion of one Ikaros (IKZF1) allele, targeted inhibition of CK2 restores Ikaros binding to the JARID1B promoter and repression of JARID1B. In summary, the presented data suggest a mechanism through which Ikaros and HDAC1 regulate the epigenetic signature in leukemia: via regulation of JARID1B transcription. The presented data identify JARID1B as a novel therapeutic target in B-ALL and provide a rationale for the use of CK2 inhibitors in the treatment of high-risk B-ALL.	[Wang, Haijun; Ouyang, Hongsheng; Lai, Liangxue] Xinxiang Med Univ, Dept Pathol, Xinxiang 453003, Henan, Peoples R China; [Wang, Haijun; Song, Chunhua; Ding, Yali; Pan, Xiaokang; Ge, Zheng; Tan, Bi-Hua; Gowda, Chandrika; Sachdev, Mansi; Muthusami, Sunil; Dovat, Sinisa] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Francis, Olivia L.; Morris, Christopher L.; Payne, Kimberly J.] Loma Linda Univ, Loma Linda, CA 92350 USA; [Abdel-Azim, Hisham] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Dorsam, Glenn] N Dakota State Univ, Fargo, ND 58108 USA; [Xiang, Meixian] South Cent Univ Nationalities, Coll Pharm, Wuhan 430074, Peoples R China	Xinxiang Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Loma Linda University; Children's Hospital Los Angeles; University of Southern California; North Dakota State University Fargo; South Central Minzu University	Dovat, S (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Div Pediat Hematol Oncol, Hershey, PA 17033 USA.	sdovat@hmc.psu.edu	Payne, Kimberly/AAS-6814-2020; Ding, Yali/AAD-1895-2019; song, chunhua/K-7882-2016; Dorsam, Glenn/GYD-8815-2022; song, chunhua/K-7882-2016	Payne, Kimberly/0000-0002-7025-5821; song, chunhua/0000-0001-7563-0339; Muthusami, Sunil/0000-0003-0497-6142; song, chunhua/0000-0002-4081-2543; Dovat, Sinisa/0000-0003-3906-6165	National Institutes of Health (NIH) [R01 HL095120]; St. Baldrick's Foundation; Hyundai Hope on Wheels Scholar Grant Award; Four Diamonds Fund of the Pennsylvania State University College of Medicine; John Wawrynovic Leukemia Research Scholar Endowment; NIH [R21CA162259, 1R15AI101968-01A1]; Hyundai Hope on Wheels Grant; Department of Pathology and Human Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine (NIH) at Loma Linda University School of Medicine [P20MD006988]; Natural Science Foundation of China [31200264]; Natural Science Foundation of Hubei Province [2015BCA268]; Natural Science Foundation of Wuhan City [2015070404010201, 2014070404010210]; NATIONAL CANCER INSTITUTE [R21CA162259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101968] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; Hyundai Hope on Wheels Scholar Grant Award; Four Diamonds Fund of the Pennsylvania State University College of Medicine; John Wawrynovic Leukemia Research Scholar Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels Grant; Department of Pathology and Human Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine (NIH) at Loma Linda University School of Medicine; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Natural Science Foundation of Wuhan City; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (NIH) Grant R01 HL095120, a St. Baldrick's Foundation Career Development Award, a Hyundai Hope on Wheels Scholar Grant Award, the Four Diamonds Fund of the Pennsylvania State University College of Medicine, and the John Wawrynovic Leukemia Research Scholar Endowment (to S. D.). This work was also supported by NIH grant R21CA162259, a St. Baldrick's Foundation Research Grant, a Hyundai Hope on Wheels Grant (to K. J. P.), the Department of Pathology and Human Anatomy, the Department of Basic Sciences (Grant to Promote Collaborative and Translational Research to K. J. P. and C. L. M.), and the Center for Health Disparities and Molecular Medicine (NIH Grant P20MD006988) at Loma Linda University School of Medicine. This work was supported in part by NIH Grant 1R15AI101968-01A1 (to G. P. D.) and by Natural Science Foundation of China Grant 31200264, Natural Science Foundation of Hubei Province Grant 2015BCA268, and "Chenguang Planning" from Natural Science Foundation of Wuhan City Grants 2015070404010201 and 2014070404010210 (to M. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cellot S, 2013, BLOOD, V122, P1545, DOI 10.1182/blood-2013-04-496281; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; ERNST P, 1993, MOL CELL BIOL, V13, P2982, DOI 10.1128/MCB.13.5.2982; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Jager R, 2010, LEUKEMIA, V24, P1290, DOI 10.1038/leu.2010.99; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koipally J, 2002, J BIOL CHEM, V277, P23143, DOI 10.1074/jbc.M202079200; Li ZJ, 2012, PEDIATR BLOOD CANCER, V59, P69, DOI 10.1002/pbc.23406; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Madsen B, 2002, MECH DEVELOP, V119, pS239, DOI 10.1016/S0925-4773(03)00123-0; Mai A, 2008, BIOORG MED CHEM LETT, V18, P2530, DOI 10.1016/j.bmcl.2008.03.055; Gomes AM, 2014, HAEMATOLOGICA, V99, P1062, DOI 10.3324/haematol.2013.096438; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Rudant J, 2013, LEUKEMIA, V27, P746, DOI 10.1038/leu.2012.244; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Song CH, 2015, BLOOD, V126, P1813, DOI 10.1182/blood-2015-06-651505; Stewart MH, 2015, BLOOD, V125, P2075, DOI 10.1182/blood-2014-08-596734; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Theocharides APA, 2015, LEUKEMIA, V29, P177, DOI 10.1038/leu.2014.150; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	61	39	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4004	4018		10.1074/jbc.M115.679332	http://dx.doi.org/10.1074/jbc.M115.679332			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26655717	hybrid, Green Published			2022-12-28	WOS:000371338400027
J	Owings, JP; Kuiper, EG; Prezioso, SM; Meisner, J; Varga, JJ; Zelinskaya, N; Dammer, EB; Duong, DM; Seyfried, NT; Alberti, S; Conn, GL; Goldberg, JB				Owings, Joshua P.; Kuiper, Emily G.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Zelinskaya, Natalia; Dammer, Eric B.; Duong, Duc M.; Seyfried, Nicholas T.; Alberti, Sebastian; Conn, Graeme L.; Goldberg, Joanna B.			Pseudomonas aeruginosa EftM Is a Thermoregulated Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circular dichroism (CD); homology modeling; mass spectrometry (MS); Pseudomonas aeruginosa (P; aeruginosa); S-adenosylmethionine (SAM); translation elongation factor; EF-Tu; lysine methyltransferase	ELONGATION-FACTOR TU; PROTEIN; METHYLATION; LYSINE; IDENTIFICATION; TEMPERATURE; SPECIFICITY; INTERACTS; GROWTH; REGION	Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that trimethylates elongation factor-thermo-unstable (EF-Tu) on lysine 5. Lysine 5 methylation occurs in a temperature-dependent manner and is generally only seen when P. aeruginosa is grown at temperatures close to ambient (25 degrees C) but not at higher temperatures (37 degrees C). We have previously identified the gene, eftM (for EF-Tu-modifying enzyme), responsible for this modification and shown its activity to be associated with increased bacterial adhesion to and invasion of respiratory epithelial cells. Bioinformatic analyses predicted EftM to be a Class I S-adenosyl-l-methionine (SAM)-dependent methyltransferase. An in vitro methyltransferase assay was employed to show that, in the presence of SAM, EftM directly trimethylates EF-Tu. A natural variant of EftM, with a glycine to arginine substitution at position 50 in the predicted SAM-binding domain, lacks both SAM binding and enzyme activity. Mass spectrometry analysis of the in vitro methyltransferase reaction products revealed that EftM exclusively methylates at lysine 5 of EF-Tu in a distributive manner. Consistent with the in vivo temperature dependence of methylation of EF-Tu, preincubation of EftM at 37 degrees C abolished methyltransferase activity, whereas this activity was retained when EftM was preincubated at 25 degrees C. Irreversible protein unfolding at 37 degrees C was observed, and we propose that this instability is the molecular basis for the temperature dependence of EftM activity. Collectively, our results show that EftM is a thermolabile, SAM-dependent methyltransferase that directly trimethylates lysine 5 of EF-Tu in P. aeruginosa.	[Owings, Joshua P.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Goldberg, Joanna B.] Emory Univ, Dept Pediat, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Goldberg, Joanna B.] Emory Univ, Emory Childrens Ctr Cyst Fibrosis Res, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Goldberg, Joanna B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Owings, Joshua P.; Varga, John J.; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Kuiper, Emily G.; Zelinskaya, Natalia; Dammer, Eric B.; Duong, Duc M.; Seyfried, Nicholas T.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kuiper, Emily G.] Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA; [Prezioso, Samantha M.] Emory Univ, Sch Med, Microbiol & Mol Genet Program, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Alberti, Sebastian] Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Palma De Mallorca 07122, Spain	Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); University of Virginia; Emory University; Emory University; Emory University; Universitat de les Illes Balears	Goldberg, JB (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Pulmonol Allergy Immunol Cyst Fibrosis & Cyst, 1510 Clifton Rd NE,Suite 3009, Atlanta, GA 30322 USA.	joanna.goldberg@emory.edu	Alberti, Sebastian/H-2490-2013; Dammer, Eric B/V-8652-2019; Varga, John J/I-8130-2012	Alberti, Sebastian/0000-0003-0020-6861; Dammer, Eric B/0000-0003-2947-7606; Varga, John J/0000-0002-4868-1971; Duong, Duc/0000-0001-5880-1888	Cystic Fibrosis Foundation [GOLDBE10G0, GOLDBE14P0]; National Institutes of Health [R21AI103651]; Ministerio de Economia y Competitividad of Spain - European Development Regional Fund [SAF2012-38426]; Spanish Network for Research in Infectious Diseases from the Instituto de Salud Carlos III - European Development Regional Fund [REIPI RD12/0015]; Emory Neuroscience NINDS, National Institutes of Health [P30NS055077]; National Science Foundation MRI program [1040177]; NIAID, National Institutes of Health [T32AI007046, T32AI106699]; Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture [2013-67011-21133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432, R21AI103651, T32AI007046, T32AI106699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad of Spain - European Development Regional Fund; Spanish Network for Research in Infectious Diseases from the Instituto de Salud Carlos III - European Development Regional Fund; Emory Neuroscience NINDS, National Institutes of Health; National Science Foundation MRI program(National Science Foundation (NSF)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part through Cystic Fibrosis Foundation Grants GOLDBE10G0 and GOLDBE14P0 (to J. B. G.), National Institutes of Health Grant R21AI103651 (to J. B. G.), and Ministerio de Economia y Competitividad of Spain Grant SAF2012-38426 and Spanish Network for Research in Infectious Diseases Grant REIPI RD12/0015 from the Instituto de Salud Carlos III (both co-financed by the European Development Regional Fund) (to S. A.). Mass spectrometry was supported by Emory Neuroscience NINDS, National Institutes of Health, Core Facilities Grant P30NS055077. The Auto-iTC<INF>200</INF> instrument was purchased with support National Science Foundation MRI program Grant 1040177, the Winship Cancer Institute's shared resource program, and the Biochemistry Department of Emory University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by NIAID, National Institutes of Health, Training Grant T32AI007046 (to the University of Virginia).; Supported by Agriculture and Food Research Initiative Competitive Grant 2013-67011-21133 from the United States Department of Agriculture National Institute of Food and Agriculture.; Supported in part by NIAID, National Institutes of Health, Training Grant T32AI106699 (to Emory University).	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; AMBLER RP, 1959, NATURE, V184, P56, DOI 10.1038/184056b0; Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Barbier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089941; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Burgie ES, 2008, BIOCHEMISTRY-US, V47, P3982, DOI 10.1021/bi800063j; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; CHANG FN, 1974, J BACTERIOL, V120, P651, DOI 10.1128/JB.120.2.651-656.1974; Clark SE, 2013, INFECT IMMUN, V81, P392, DOI 10.1128/IAI.01168-12; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Garcia-Fontana C, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004849; Garcia-Fontana C, 2013, J BIOL CHEM, V288, P18987, DOI 10.1074/jbc.M113.472605; Gozal YM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-82; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Kraal B, 1999, FOLIA MICROBIOL, V44, P131, DOI 10.1007/BF02816232; KROPINSKI AMB, 1987, J BACTERIOL, V169, P1960, DOI 10.1128/jb.169.5.1960-1966.1987; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lam O, 2014, VIRULENCE, V5, P852, DOI 10.4161/21505594.2014.970949; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Laurberg M, 1998, J BIOL CHEM, V273, P4387, DOI 10.1074/jbc.273.8.4387; LITALIEN JJ, 1979, FEBS LETT, V107, P359, DOI 10.1016/0014-5793(79)80407-X; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Porcella SF, 1996, MICROBIOL-SGM, V142, P2481, DOI 10.1099/00221287-142-9-2481; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TSUJI A, 1982, MICROBIOL IMMUNOL, V26, P15, DOI 10.1111/j.1348-0421.1982.tb00149.x; VANNOORT JM, 1986, EUR J BIOCHEM, V160, P557; Weiser JN, 1998, INFECT IMMUN, V66, P4263; Witek MA, 2014, BBA-PROTEINS PROTEOM, V1844, P1648, DOI 10.1016/j.bbapap.2014.06.012; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d	42	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3280	3290		10.1074/jbc.M115.706853	http://dx.doi.org/10.1074/jbc.M115.706853			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677219	Green Published, hybrid			2022-12-28	WOS:000370854500014
J	Syeda, R; Santos, JS; Montal, M				Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio			The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; IDIOPATHIC EPILEPSY; MAMMALIAN-CELLS; KV CHANNEL; KCNQ2; ACTIVATION; MECHANISM; MUTATION; OPENER; RECONSTITUTION	KCNQ (voltage-gated K+ channel family 7 (Kv7)) channels control cellular excitability and underlie the K+ current sensitive to muscarinic receptor signaling (the M current) in sympathetic neurons. Here we show that the novel anti-epileptic drug retigabine (RTG) modulates channel function of pore-only modules (PMs) of the human Kv7.2 and Kv7.3 homomeric channels and of Kv7.2/3 heteromeric channels by prolonging the residence time in the open state. In addition, the Kv7 channel PMs are shown to recapitulate the single-channel permeation and pharmacological specificity characteristics of the corresponding full-length proteins in their native cellular context. A mutation (W265L) in the reconstituted Kv7.3 PM renders the channel insensitive to RTG and favors the conductive conformation of the PM, in agreement to what is observed when the Kv7.3 mutant is heterologously expressed. On the basis of the new findings and homology models of the closed and open conformations of the Kv7.3 PM, we propose a structural mechanism for the gating of the Kv7.3 PM and for the site of action of RTG as a Kv7.2/Kv7.3 K+ current activator. The results validate the modular design of human Kv channels and highlight the PM as a high-fidelity target for drug screening of Kv channels.	[Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Syeda, Ruhma] Scripps Res Inst, La Jolla, CA 92037 USA; [Santos, Jose S.] DART Neurosci, San Diego, CA 92131 USA	University of California System; University of California San Diego; Scripps Research Institute	Montal, M (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu			National Institutes of Health [GM-49711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-49711 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armand V, 1999, N-S ARCH PHARMACOL, V359, P33, DOI 10.1007/PL00005320; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Cheley S, 1997, PROTEIN ENG, V10, P1433, DOI 10.1093/protein/10.12.1433; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Lerche H, 1999, ANN NEUROL, V46, P305, DOI 10.1002/1531-8249(199909)46:3<305::AID-ANA5>3.0.CO;2-5; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Orhan G, 2012, EXPERT OPIN PHARMACO, V13, P1807, DOI 10.1517/14656566.2012.706278; Porter RJ, 2007, NEUROTHERAPEUTICS, V4, P149, DOI 10.1016/j.nurt.2006.11.012; Punke MA, 2007, ANESTH ANALG, V104, P1256, DOI 10.1213/01.ane.0000260310.63117.a2; Santos JS, 2013, J BIOL CHEM, V288, P16619, DOI 10.1074/jbc.M113.468728; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Syeda R, 2014, J BIOL CHEM, V289, P4233, DOI 10.1074/jbc.M113.530055; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Tatulian L, 2003, J PHYSIOL-LONDON, V549, P57, DOI 10.1113/jphysiol.2003.039842; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419	38	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2931	2937		10.1074/jbc.M115.683185	http://dx.doi.org/10.1074/jbc.M115.683185			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627826	Green Published, hybrid			2022-12-28	WOS:000369626900030
J	Garner, KL; Perrett, RM; Voliotis, M; Bowsher, C; Pope, GR; Pham, T; Caunt, CJ; Tsaneva-Atanasova, K; McArdle, CA				Garner, Kathryn L.; Perrett, Rebecca M.; Voliotis, Margaritis; Bowsher, Clive; Pope, George R.; Thanh Pham; Caunt, Christopher J.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Information Transfer in Gonadotropin-releasing Hormone (GnRH) Signaling EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)-MEDIATED FEEDBACK LOOPS CONTROL HORMONE SENSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; PROTEIN-COUPLED RECEPTOR; SPATIOTEMPORAL REGULATION; PULSE-FREQUENCY; ERK; DESENSITIZATION; INTERNALIZATION; PITUITARY; GROWTH; CANCER	Cell signaling pathways are noisy communication channels, and statistical measures derived from information theory can be used to quantify the information they transfer. Here we use single cell signaling measures to calculate mutual information as a measure of information transfer via gonadotropin-releasing hormone (GnRH) receptors (GnRHR) to extracellular signal-regulated kinase (ERK) or nuclear factor of activated T-cells (NFAT). This revealed mutual information values <1 bit, implying that individual GnRH-responsive cells cannot unambiguously differentiate even two equally probable input concentrations. Addressing possible mechanisms for mitigation of information loss, we focused on the ERK pathway and developed a stochastic activation model incorporating negative feedback and constitutive activity. Model simulations revealed interplay between fast (min) and slow (min-h) negative feedback loops with maximal information transfer at intermediate feedback levels. Consistent with this, experiments revealed that reducing negative feedback (by expressing catalytically inactive ERK2) and increasing negative feedback (by Egr1-driven expression of dual-specificity phosphatase 5 (DUSP5)) both reduced information transfer from GnRHR to ERK. It was also reduced by blocking protein synthesis (to prevent GnRH from increasing DUSP expression) but did not differ for different GnRHRs that do or do not undergo rapid homologous desensitization. Thus, the first statistical measures of information transfer via these receptors reveals that individual cells are unreliable sensors of GnRH concentration and that this reliability is maximal at intermediate levels of ERK-mediated negative feedback but is not influenced by receptor desensitization.	[Garner, Kathryn L.; Perrett, Rebecca M.; Pope, George R.; McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Voliotis, Margaritis; Bowsher, Clive] Univ Bristol, Sch Math, Univ Walk, Bristol BS8 1TW, Avon, England; [Thanh Pham] Texas A&M Univ Corpus Christi, Corpus Christi, TX 78412 USA; [Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Tsaneva-Atanasova, Krasimira] Univ Exeter, Coll Engn Math & Phys Sci, Dept Math, Exeter EX4 4QF, Devon, England	University of Bristol; University of Bristol; Texas A&M University System; Texas A&M University Corpus Christi; University of Bath; University of Exeter	McArdle, CA (corresponding author), Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	McArdle, Craig/AAQ-5660-2021; Garner, Kathryn/AAQ-2052-2020; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	McArdle, Craig/0000-0003-4836-5351; Garner, Kathryn/0000-0001-8539-8959; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Voliotis, Margaritis/0000-0001-6488-7198	Biochemical and Biophysical Science Research Council (BBSRC) [BB/J014699/1]; MRC Biomedical Informatics Fellowship [MR/K021826/1]; BBSRC [BB/J014699/1] Funding Source: UKRI; EPSRC [EP/L000296/1, EP/N014391/1] Funding Source: UKRI; MRC [MR/K021826/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014699/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L000296/1, EP/N014391/1] Funding Source: researchfish; Medical Research Council [MR/K021826/1] Funding Source: researchfish	Biochemical and Biophysical Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Biochemical and Biophysical Science Research Council award (BBSRC BB/J014699/1; to C. A. M. and K. T.-A.). The authors declare that they have no conflicts of interest with the contents of this article.r Holds a MRC Biomedical Informatics Fellowship (MR/K021826/1).	Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Bowsher CG, 2014, CURR OPIN BIOTECH, V28, P149, DOI 10.1016/j.copbio.2014.04.010; Bowsher CG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002965; Brennan MD, 2012, SCIENCE, V338, P334, DOI 10.1126/science.1227946; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; DAVIDSON JS, 1994, BIOCHEM J, V300, P299, DOI 10.1042/bj3000299; Heding A, 1998, J BIOL CHEM, V273, P11472, DOI 10.1074/jbc.273.19.11472; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; LOUMAYE E, 1983, J BIOL CHEM, V258, P2002; Luttrell LM, 2002, J CELL SCI, V115, P455; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; McArdle C. A., 2014, KNOBIL NEILLS PHYSL, V1, P399; MCARDLE CA, 1992, MOL CELL ENDOCRINOL, V87, P95, DOI 10.1016/0303-7207(92)90237-Z; McArdle CA, 1999, MOL CELL ENDOCRINOL, V151, P129, DOI 10.1016/S0303-7207(99)00024-6; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Pawson AJ, 2008, ENDOCRINOLOGY, V149, P1415, DOI 10.1210/en.2007-1159; Perrett RM, 2014, J BIOL CHEM, V289, P7873, DOI 10.1074/jbc.M113.532473; Perrett RM, 2013, J BIOL CHEM, V288, P21001, DOI 10.1074/jbc.M113.455345; Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Uda S, 2013, SCIENCE, V341, P558, DOI 10.1126/science.1234511; Voliotis M, 2014, P NATL ACAD SCI USA, V111, pE326, DOI 10.1073/pnas.1314446111; Voliotis M, 2012, NUCLEIC ACIDS RES, V40, P7084, DOI 10.1093/nar/gks385	37	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2246	2259		10.1074/jbc.M115.686964	http://dx.doi.org/10.1074/jbc.M115.686964			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644469	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000369610400016
J	Marland, JRK; Hasel, P; Bonnycastle, K; Cousin, MA				Marland, Jamie Roslin Keynes; Hasel, Philip; Bonnycastle, Katherine; Cousin, Michael Alan			Mitochondrial Calcium Uptake Modulates Synaptic Vesicle Endocytosis in Central Nerve Terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+; KINETICS; RELEASE; INFLUX; MCU; EXOCYTOSIS; RETRIEVAL; MEMBRANE; PROTEIN; ATP	Presynaptic calcium influx triggers synaptic vesicle (SV) exocytosis and modulates subsequent SV endocytosis. A number of calcium clearance mechanisms are present in central nerve terminals that regulate intracellular free calcium levels both during and after stimulation. During action potential stimulation, mitochondria rapidly accumulate presynaptic calcium via the mitochondrial calcium uniporter (MCU). The role of mitochondrial calcium uptake in modulating SV recycling has been debated extensively, but a definitive conclusion has not been achieved. To directly address this question, we manipulated the expression of the MCU channel subunit in primary cultures of neurons expressing a genetically encoded reporter of SV turnover. Knockdown of MCU resulted in ablation of activity-dependent mitochondrial calcium uptake but had no effect on the rate or extent of SV exocytosis. In contrast, the rate of SV endocytosis was increased in the absence of mitochondrial calcium uptake and slowed when MCU was overexpressed. MCU knockdown did not perturb activity-dependent increases in presynaptic free calcium, suggesting that SV endocytosis may be controlled by calcium accumulation and efflux from mitochondria in their immediate vicinity.	[Marland, Jamie Roslin Keynes; Hasel, Philip; Bonnycastle, Katherine; Cousin, Michael Alan] Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	M.Cousin@ed.ac.uk		Marland, Jamie/0000-0001-6442-082X; Hasel, Philip/0000-0003-4378-3685; Cousin, Michael/0000-0002-1762-160X	Medical Research Council [G1002117]; MRC [G1002117] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G1002117 to (M. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Billups B, 2002, J NEUROSCI, V22, P5840; Caldwell L, 2013, SYNAPSE, V67, P729, DOI 10.1002/syn.21678; Chen M, 2011, ACTA BIOCH BIOPH SIN, V43, P822, DOI 10.1093/abbs/gmr075; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chouhan AK, 2012, J NEUROSCI, V32, P1233, DOI 10.1523/JNEUROSCI.1301-11.2012; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Egashira Y, 2015, J NEUROSCI, V35, P3701, DOI 10.1523/JNEUROSCI.4160-14.2015; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Leitz J, 2011, J NEUROSCI, V31, P16318, DOI 10.1523/JNEUROSCI.3358-11.2011; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Patron M, 2013, J BIOL CHEM, V288, P10750, DOI 10.1074/jbc.R112.420752; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Rossano AJ, 2013, J PHYSIOL-LONDON, V591, P1691, DOI 10.1113/jphysiol.2012.248377; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Scott R, 2007, J ANAT, V210, P642, DOI 10.1111/j.1469-7580.2007.00728.x; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Waters J, 2003, PFLUG ARCH EUR J PHY, V447, P363, DOI 10.1007/s00424-003-1182-0; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Wu XS, 2014, J NEUROSCI, V34, P2652, DOI 10.1523/JNEUROSCI.3582-13.2014; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015	44	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2080	2086		10.1074/jbc.M115.686956	http://dx.doi.org/10.1074/jbc.M115.686956			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644474	Green Published, hybrid			2022-12-28	WOS:000369610400004
J	Gu, XD; Huang, Y; Levison, BS; Gerstenecker, G; DiDonato, AJ; Hazen, LB; Lee, J; Gogonea, V; DiDonato, JA; Hazen, SL				Gu, Xiaodong; Huang, Ying; Levison, Bruce S.; Gerstenecker, Gary; DiDonato, Anthony J.; Hazen, Leah B.; Lee, Joonsue; Gogonea, Valentin; DiDonato, Joseph A.; Hazen, Stanley L.			Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; SERUM PARAOXONASE; LIPID-PEROXIDATION; CHOLESTEROL EFFLUX; PROTEOMIC ANALYSIS; LACTONASE ACTIVITY; PROTEIN; MYELOPEROXIDASE; HDL	Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated protein with atherosclerosis-protective and systemic anti-oxidant functions. We recently showed that PON1, myeloperoxidase, and HDL bind to one another in vivo forming a functional ternary complex (Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., Zhang, R., Li, X. M., Didonato, A. J., Gogonea, V., Tang, W. H., et al. (2013) J. Clin. Invest. 123, 3815-3828). However, specific residues onPON1 involved in the HDL-PON1 interaction remain unclear. Unambiguous identification of protein residues involved in docking interactions to lipid surfaces poses considerable methodological challenges. Here we describe a new strategy that uses a novel synthetic photoactivatable and click chemistry-taggable phospholipid probe, which, when incorporated into HDL, was used to identify amino acid residues on PON1 that directly interact with the lipoprotein phospholipid surface. Several specific PON1 residues (Leu-9, Tyr-185, and Tyr-293) were identified through covalent crosslinks with the lipid probes using affinity isolation coupled to liquid chromatography with on-line tandem mass spectrometry. Based upon the crystal structure for PON1, the identified residues are all localized in relatively close proximity on the surface of PON1, defining a domain that binds to the HDL lipid surface. Site-specific mutagenesis of the identified PON1 residues (Leu-9, Tyr-185, and Tyr-293), coupled with functional studies, reveals their importance in PON1 binding to HDL and both PON1 catalytic activity and stability. Specifically, the residues identified on PON1 provide important structural insights into the PON1-HDL interaction. More generally, the new photoactivatable and affinity-tagged lipid probe developed herein should prove to be a valuable tool for identifying contact sites supporting protein interactions with lipid interfaces such as found on cell membranes or lipoproteins.	[Gu, Xiaodong; Huang, Ying; Levison, Bruce S.; DiDonato, Anthony J.; Hazen, Leah B.; Lee, Joonsue; Gogonea, Valentin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gerstenecker, Gary; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Hazen, SL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [P01 HL076491, P01 HL103453]; Esperion; Procter Gamble; Abbott; Astra Zeneca; Liposcience Inc.; Pfizer Inc.; Roche Diagnostics; Takeda; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, U10HL109250, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esperion; Procter Gamble(Procter & Gamble); Abbott(Abbott Laboratories); Astra Zeneca(AstraZeneca); Liposcience Inc.; Pfizer Inc.(Pfizer); Roche Diagnostics; Takeda(Takeda Pharmaceutical Company Ltd); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants P01 HL076491 and P01 HL103453. S. L. H. is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S. L. H. reports having been paid as a consultant for the following companies: Esperion and Procter & Gamble. S. L. H. reports receiving research funds from Abbott, Astra Zeneca, Liposcience Inc., Procter & Gamble, Pfizer Inc., Roche Diagnostics, and Takeda. S. L H. reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from the following companies: Cleveland HeartLab, Siemens, Esperion, Frantz Biomarkers, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Fellowship Award from the American Heart Association.	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Aviram M, 2000, CIRCULATION, V101, P2510, DOI 10.1161/01.CIR.101.21.2510; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Baker PW, 2000, J LIPID RES, V41, P1261; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Best MD, 2011, ACCOUNTS CHEM RES, V44, P686, DOI 10.1021/ar200060y; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Birner-Gruenberger R, 2014, PROG LIPID RES, V56, P36, DOI 10.1016/j.plipres.2014.07.003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Chang CT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164846; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gu XD, 2011, CHEM RES TOXICOL, V24, P1080, DOI 10.1021/tx200093m; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hazen SL, 2004, ARTERIOSCL THROM VAS, V24, P1143, DOI 10.1161/01.ATV.0000135267.82813.52; Heller M, 2005, PROTEOMICS, V5, P2619, DOI 10.1002/pmic.200401233; Hortin GL, 2006, BIOCHEM BIOPH RES CO, V340, P909, DOI 10.1016/j.bbrc.2005.12.098; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Kalantar-Zadeh K, 2006, AM J KIDNEY DIS, V48, P59, DOI 10.1053/j.ajkd.2006.03.047; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Kennedy DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000104; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Kontush A, 2015, HANDB EXP PHARMACOL, V224, P3, DOI 10.1007/978-3-319-09665-0_1; KUO CL, 1995, DRUG METAB DISPOS, V23, P935; Li HL, 2015, J PROTEOME RES, V14, P3082, DOI 10.1021/acs.jproteome.5b00419; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MENASHE M, 1986, J BIOL CHEM, V261, P5328; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; Noto H, 2001, BIOCHEM BIOPH RES CO, V289, P395, DOI 10.1006/bbrc.2001.5985; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Rochu D, 2007, TOXICOLOGY, V233, P47, DOI 10.1016/j.tox.2006.08.037; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; RYE KA, 1992, J LIPID RES, V33, P215; Rye KA, 2014, CIRC RES, V114, P143, DOI 10.1161/CIRCRESAHA.114.300632; Sag D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7354; Schmitt D, 1999, BIOCHEMISTRY-US, V38, P16904, DOI 10.1021/bi991623w; Schmitz E., 1965, ORG SYNTH, V45, P83; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Stevens RC, 2008, P NATL ACAD SCI USA, V105, P12780, DOI 10.1073/pnas.0805865105; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Tang WHW, 2011, CIRC-HEART FAIL, V4, P59, DOI 10.1161/CIRCHEARTFAILURE.110.958348; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Valiyaveettil M, 2012, TOXICOL LETT, V210, P87, DOI 10.1016/j.toxlet.2012.01.013; Vickers KC, 2014, J LIPID RES, V55, P4, DOI 10.1194/jlr.R035964; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	86	21	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1890	1904		10.1074/jbc.M115.678334	http://dx.doi.org/10.1074/jbc.M115.678334			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26567339	Green Published, hybrid			2022-12-28	WOS:000368620700028
J	Urfer, M; Bogdanovic, J; Lo Monte, F; Moehle, K; Zerbe, K; Omasits, U; Ahrens, CH; Pessi, G; Eberl, L; Robinson, JA				Urfer, Matthias; Bogdanovic, Jasmina; Lo Monte, Fabio; Moehle, Kerstin; Zerbe, Katja; Omasits, Ulrich; Ahrens, Christian H.; Pessi, Gabriella; Eberl, Leo; Robinson, John A.			A Peptidomimetic Antibiotic Targets Outer Membrane Proteins and Disrupts Selectively the Outer Membrane in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; GRAM-NEGATIVE BACTERIA; POLYMYXIN-B; CELL-ENVELOPE; LIPOPOLYSACCHARIDE TRANSPORT; CAPSULAR POLYSACCHARIDES; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; PORE FORMATION; STRESS	Increasing antibacterial resistance presents a major challenge in antibiotic discovery. One attractive target in Gram-negative bacteria is the unique asymmetric outer membrane (OM), which acts as a permeability barrier that protects the cell from external stresses, such as the presence of antibiotics. We describe a novel beta-hairpin macrocyclic peptide JB-95 with potent antimicrobial activity against Escherichia coli. This peptide exhibits no cellular lytic activity, but electron microscopy and fluorescence studies reveal an ability to selectively disrupt the OM but not the inner membrane of E. coli. The selective targeting of the OM probably occurs through interactions of JB-95 with selected beta-barrel OM proteins, including BamA and LptD as shown by photolabeling experiments. Membrane proteomic studies reveal rapid depletion of many beta-barrel OM proteins from JB-95-treated E. coli, consistent with induction of a membrane stress response and/or direct inhibition of the Bam folding machine. The results suggest that lethal disruption of the OM by JB-95 occurs through a novel mechanism of action at key interaction sites within clusters of beta-barrel proteins in the OM. These findings open new avenues for developing antibiotics that specifically target beta-barrel proteins and the integrity of the Gram-negative OM.	[Urfer, Matthias; Bogdanovic, Jasmina; Lo Monte, Fabio; Moehle, Kerstin; Zerbe, Katja; Robinson, John A.] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Omasits, Ulrich] Swiss Fed Inst Technol, Inst Mol Syst Biol, Auguste Piccard Hof 1, CH-8093 Zurich, Switzerland; [Ahrens, Christian H.] Inst Plant Prod Sci, Res Grp Mol Diagnost Genom & Bioinformat, Schloss 1, CH-8820 Wadenswil, Switzerland; [Ahrens, Christian H.] Agroscope, Swiss Inst Bioinformat, Schloss 1, CH-8820 Wadenswil, Switzerland; [Pessi, Gabriella; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, Zollikerstr 107, CH-8008 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; Swiss Institute of Bioinformatics; University of Zurich	Robinson, JA (corresponding author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	robinson@oci.uzh.ch	Eberl, Leo/AAE-8165-2019; Eberl, Leo/A-8380-2012; Ahrens, Christian H./F-4656-2011; Pessi, Gabriella/AGW-2342-2022	Eberl, Leo/0000-0002-7241-0864; Ahrens, Christian H./0000-0002-8148-7257; Pessi, Gabriella/0000-0002-8138-5541	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cunningham ML, 2013, J BIOMOL SCREEN, V18, P1018, DOI 10.1177/1087057113487208; da Silva A, 2003, BBA-MOL CELL RES, V1643, P95, DOI 10.1016/j.bbamcr.2003.10.001; Dalebroux ZD, 2014, CURR OPIN MICROBIOL, V17, P106, DOI 10.1016/j.mib.2013.12.005; Deris ZZ, 2014, BIOCONJUGATE CHEM, V25, P750, DOI 10.1021/bc500094d; DIXON RA, 1986, ANTIMICROB AGENTS CH, V29, P781, DOI 10.1128/AAC.29.5.781; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Dunstan RA, 2015, MOL MICROBIOL, V97, P616, DOI 10.1111/mmi.13055; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Galdiero S, 2015, CURR MED CHEM, V22, P1665, DOI 10.2174/0929867322666150311145632; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Jiang LJ, 2000, HELV CHIM ACTA, V83, P3097, DOI 10.1002/1522-2675(20001220)83:12<3097::AID-HLCA3097>3.0.CO;2-1; KOIKE M, 1969, J BACTERIOL, V97, P448, DOI 10.1128/JB.97.1.448-452.1969; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyu ZX, 2015, BIOCHEM SOC T, V43, P133, DOI 10.1042/BST20140217; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; MUHLRADT PF, 1974, EUR J BIOCHEM, V43, P533, DOI 10.1111/j.1432-1033.1974.tb03440.x; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112; Page MGP, 2014, CURR OPIN PHARMACOL, V18, P91, DOI 10.1016/j.coph.2014.09.008; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Roy RN, 2015, NAT STRUCT MOL BIOL, V22, P466, DOI 10.1038/nsmb.3031; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Sahalan AZ, 2008, INT J ANTIMICROB AG, V31, P224, DOI 10.1016/j.ijantimicag.2007.10.005; SCHRODER G, 1992, BIOCHEMISTRY-US, V31, P631, DOI 10.1021/bi00118a001; Seefeldt AC, 2015, NAT STRUCT MOL BIOL, V22, P470, DOI 10.1038/nsmb.3034; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; SMIT J, 1978, J BACTERIOL, V135, P687, DOI 10.1128/JB.135.2.687-702.1978; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Stekhoven DJ, 2014, J PROTEOMICS, V99, P123, DOI 10.1016/j.jprot.2014.01.015; Ursell TS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002680; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Werneburg M, 2012, CHEMBIOCHEM, V13, P1767, DOI 10.1002/cbic.201200276; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wiese A, 1998, J MEMBRANE BIOL, V162, P127, DOI 10.1007/s002329900350; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; YU Z, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/679109; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	73	61	63	5	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1921	+		10.1074/jbc.M115.691725	http://dx.doi.org/10.1074/jbc.M115.691725			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627837	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000368620700030
J	Segawa, K; Kurata, S; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu			Human Type IV P-type ATPases That Work as Plasma Membrane Phospholipid Flippases and Their Regulation by Caspase and Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FAMILY-MEMBERS; PHOSPHATIDYLSERINE EXPOSURE; ENDOPLASMIC-RETICULUM; SCRAMBLASE ACTIVITY; APOPTOTIC CELLS; LIPID ASYMMETRY; EXPRESSION; ACTIVATION; TRANSPORT; CLEAVAGE	In plasma membranes, flippases translocate aminophospholipids such as phosphatidylserine and phosphatidylethanolamine from the extracellular to the cytoplasmic leaflet. Mammalian ATP11C, a type IV P-type ATPase, acts as a flippase at the plasma membrane. Here, by expressing 12 human type IV P-type ATPases in ATP11C-deficient cells, we determined that ATP8A2 and ATP11A can also act as plasma membrane flippases. As with ATP11C, ATP8A2 and ATP11A localized to the plasma membrane in a CDC50A-dependent manner. ATP11A was cleaved by caspases during apoptosis, and a caspase-resistant ATP11A blocked apoptotic PtdSer exposure. In contrast, ATP8A2 was not cleaved by caspase, and cells expressing ATP8A2 did not expose PtdSer during apoptosis. Similarly, high Ca2+ concentrations inhibited the ATP11A and ATP11C PtdSer flippase activity, but ATP8A2 flippase activity was relatively resistant to Ca2+. ATP11A and ATP11C were ubiquitously expressed in human and mouse adult tissues. In contrast, ATP8A2 was expressed in specific tissues, such as the brain and testis. Thus, ATP8A2 may play a specific role in translocating PtdSer in these tissues.	[Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu] Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan	Osaka University	Nagata, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	snagata@ifrec.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture in Japan; CREST, Japan Science Technology Corporation; Grants-in-Aid for Scientific Research [15K08266, 22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, Japan Science Technology Corporation(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture in Japan, and CREST, Japan Science Technology Corporation. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BOWMAN BJ, 1979, J BIOL CHEM, V254, P2928; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gong EY, 2009, REPRODUCTION, V137, P345, DOI 10.1530/REP-08-0048; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; KAMENS J, 1995, J BIOL CHEM, V270, P15250, DOI 10.1074/jbc.270.25.15250; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KORENAGA R, 1993, CELL STRUCT FUNCT, V18, P95, DOI 10.1247/csf.18.95; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lhermusier T, 2011, J THROMB HAEMOST, V9, P1883, DOI 10.1111/j.1538-7836.2011.04478.x; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2014, METHOD ENZYMOL, V544, P381, DOI 10.1016/B978-0-12-417158-9.00015-7; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	59	78	80	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					762	772		10.1074/jbc.M115.690727	http://dx.doi.org/10.1074/jbc.M115.690727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567335	Green Published, hybrid			2022-12-28	WOS:000367830500024
J	Yu, M; Liu, K; Mao, ZB; Luo, JY; Gu, W; Zhao, WH				Yu, Miao; Liu, Kun; Mao, Zebin; Luo, Jianyuan; Gu, Wei; Zhao, Wenhui			USP11 Is a Negative Regulator to gamma H2AX Ubiquitylation by RNF8/RNF168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; GENOME INTEGRITY; HISTONE H2B; UBIQUITIN; RNF168; REPAIR; RNF8; INHIBITION; BRCA1; COUNTERACTS	Ubiquitin modification at double strand breaks (DSB) sites is an essential regulator of signaling and repair. gamma H2AX extends from DSB sites and provides a platform for subsequent recruitment and amplification of DNA repair proteins and signaling factors. Here, we found that RNF8/RNF168 ubiquitylates gamma H2AX. We identified that USP11 is a unique deubiquitylation enzyme for gamma H2AX. USP11 deubiquitylates gamma H2AX both in vivo and in vitro but not the canonical (ub)-K119-H2A and (ub)-K120-H2B in vitro, and USP11 ablation enhances the levels of gamma H2AX ubiquitylation. We also found that USP11 interacts with gamma H2AX both in vivo and in vitro. We found that 53BP1 and ubiquitin-conjugated proteins are misregulated to be retained longer and stronger at DSB sites after knockdown of USP11. We further found that cells are hypersensitive to gamma-irradiation after ablation of USP11. Together, our findings elucidate deeply and extensively the mechanism of RNF8/RNF168 and USP11 to maintain the proper status of ubiquitylation gamma H2AX to repair DSB.	[Yu, Miao; Liu, Kun; Mao, Zebin; Zhao, Wenhui] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Dept Genet, Beijing 100191, Peoples R China; [Gu, Wei] Columbia Univ, Coll Physicians & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Coll Physicians & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Peking University; Peking University; Columbia University; Columbia University	Zhao, WH (corresponding author), Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zhao6025729@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; ZHAO, WENHUI/0000-0002-7703-7106	Peking University Health Science Center Initial Aid Grant [BMU20140379]	Peking University Health Science Center Initial Aid Grant	Supported by Peking University Health Science Center Initial Aid Grant BMU20140379.	Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li ML, 2012, TRENDS BIOCHEM SCI, V37, P418, DOI 10.1016/j.tibs.2012.06.007; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	34	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					959	967		10.1074/jbc.M114.624478	http://dx.doi.org/10.1074/jbc.M114.624478			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26507658	Green Published, hybrid			2022-12-28	WOS:000367830500041
J	Hasemi, T; Kikukawa, T; Kamo, N; Demura, M				Hasemi, Takatoshi; Kikukawa, Takashi; Kamo, Naoki; Demura, Makoto			Characterization of a Cyanobacterial Chloride-pumping Rhodopsin and Its Conversion into a Proton Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; membrane protein; photobiology; photoreceptor; proton pump; microbial rhodopsin; retinal proteins	MARINE-BACTERIA; ION PUMP; NATRONOBACTERIUM-PHARAONIS; HALOBACTERIUM-HALOBIUM; NATRONOMONAS-PHARAONIS; HALORHODOPSIN; BACTERIORHODOPSIN; PROTEIN; CYCLE; PHOTOCYCLE	Light-driven ion-pumping rhodopsins are widely distributed in microorganisms and are now classified into the categories of outward H+ and Na+ pumps and an inward Cl- pump. These different types share a common protein architecture and utilize the photoisomerization of the same chromophore, retinal, to evoke photoreactions. Despite these similarities, successful pump-to-pump conversion had been confined to only the H+ pump bacteriorhodopsin, which was converted to a Cl- pump in 1995 by a single amino acid replacement. In this study we report the first success of the reverse conversion from a Cl- pump to a H+ pump. A novel microbial rhodopsin (MrHR) from the cyanobacterium Mastigocladopsis repens functions as a Cl- pump and belongs to a cluster that is far distant from the known Cl- pumps. With a single amino acid replacement, MrHR is converted to a H+ pump in which dissociable residues function almost completely in the H+ relay reactions. MrHR most likely evolved from a H+ pump, but it has not yet been highly optimized into a mature Cl- pump.	[Hasemi, Takatoshi; Kikukawa, Takashi; Kamo, Naoki; Demura, Makoto] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Kikukawa, T (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	kikukawa@sci.hokudai.ac.jp	Demura, Makoto/F-5272-2011; Kikukawa, Takashi/F-5266-2011	Demura, Makoto/0000-0003-0912-9284; Kikukawa, Takashi/0000-0002-6185-7281	Japan Society for the Promotion of Science KAKENHI [26440042]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI (26440042; to T.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Avetisyan AV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P625; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2013, ENCY BIODIVERSITY, V6, P280; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; Chandrababunaidu MM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00001-15; Das A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00228-15; Das S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00226-15; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Grote M, 2011, FEMS MICROBIOL REV, V35, P1082, DOI 10.1111/j.1574-6976.2011.00281.x; Hasegawa C, 2007, PHOTOCHEM PHOTOBIOL, V83, P293, DOI 10.1562/2006-06-09-RA-916; HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1006/jmbi.1995.0176; Heberle J, 2014, BBA-BIOENERGETICS, V1837, P531, DOI 10.1016/j.bbabio.2014.02.019; HERNANDEZMARINE MC, 1992, CRYPTOGAMIE ALGOL, V13, P113; Ihara K, 2008, FEBS LETT, V582, P2931, DOI 10.1016/j.febslet.2008.07.030; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2014, J PHYS CHEM B, V118, P11190, DOI 10.1021/jp507219q; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung K. H., 2012, 244 AM CHEM SOC NAT; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Keshari N, 2013, BIOFOULING, V29, P525, DOI 10.1080/08927014.2013.794224; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Muroda K, 2012, BIOCHEMISTRY-US, V51, P4677, DOI 10.1021/bi300485r; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Oesterhelt D, 1995, ISR J CHEM, V35, P475; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Sato M, 2003, J BIOCHEM, V134, P151, DOI 10.1093/jb/mvg123; SCHARF B, 1994, BIOCHEMISTRY-US, V33, P6387, DOI 10.1021/bi00187a002; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Singh D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00064-15; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Varo G, 1996, BIOCHEMISTRY-US, V35, P6604, DOI 10.1021/bi9601159; VARO G, 1995, BIOCHEMISTRY-US, V34, P14490, DOI 10.1021/bi00044a027; VARO G, 1995, BIOPHYS J, V68, P2062, DOI 10.1016/S0006-3495(95)80385-1; Yamashita Y, 2011, BBA-BIOMEMBRANES, V1808, P2905, DOI 10.1016/j.bbamem.2011.08.035; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111	44	47	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					355	362		10.1074/jbc.M115.688614	http://dx.doi.org/10.1074/jbc.M115.688614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578511	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000367589500028
J	Sergeev, E; Hansen, AH; Pandey, SK; MacKenzie, AE; Hudson, BD; Ulven, T; Milligan, G				Sergeev, Eugenia; Hansen, Anders Hojgaard; Pandey, Sunil K.; MacKenzie, Amanda E.; Hudson, Brian D.; Ulven, Trond; Milligan, Graeme			Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; G protein-coupled receptor (GPCR); homology modeling; intestinal metabolism; medicinal chemistry; 7 transmembrane domain receptor; free fatty acid	PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; BINDING; FFA2; DISSOCIATION; PHARMACOLOGY; ALLOSTERISM; METABOLITES; GPR43	Short chain fatty acids (SCFAs) are produced in the gut by bacterial fermentation of poorly digested carbohydrates. A key mediator of their actions is the G protein-coupled free fatty acid 2 (FFA2) receptor, and this has been suggested as a therapeutic target for the treatment of both metabolic and inflammatory diseases. However, a lack of understanding of the molecular determinants dictating how ligands bind to this receptor has hindered development. We have developed a novel radiolabeled FFA2 antagonist to probe ligand binding to FFA2, and in combination with mutagenesis and molecular modeling studies, we define how agonist and antagonist ligands interact with the receptor. Although both agonist and antagonist ligands contain negatively charged carboxylates that interact with two key positively charged arginine residues in transmembrane domains V and VII of FFA2, there are clear differences in how these interactions occur. Specifically, although agonists require interaction with both arginine residues to bind the receptor, antagonists require an interaction with only one of the two. Moreover, different chemical series of antagonist interact preferentially with different arginine residues. A homology model capable of rationalizing these observations was developed and provides a tool that will be invaluable for identifying improved FFA2 agonists and antagonists to further define function and therapeutic opportunities of this receptor.	[Sergeev, Eugenia; MacKenzie, Amanda E.; Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Hansen, Anders Hojgaard; Pandey, Sunil K.; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark	University of Glasgow; University of Southern Denmark	Ulven, T (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Campusvej 55, DK-5230 Odense M, Denmark.	ulven@sdu.dk; Graeme.Milligan@glasgow.ac.uk	Pandey, Sunil Kumar/AAP-2234-2021; Ulven, Trond/H-5500-2015; Hudson, Brian/H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Milligan, Graeme/0000-0002-6946-3519; Hudson, Brian/0000-0001-7059-0091; Sergeev, Eugenia/0000-0001-8271-3693	Biotechnology and Biological Sciences Research Council [BB/L027887/1]; BBSRC [BB/L027887/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	[<SUP>3</SUP>H]GLPG0974 was provided by Astra-Zeneca within the terms of Biotechnology and Biological Sciences Research Council Grant BB/L027887/1.	Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; [Anonymous], SCHR SUIT 2013 2 PRO; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cooper T, 2009, METHODS MOL BIOL, V552, P143, DOI 10.1007/978-1-60327-317-6_10; Dowling MR, 2006, BRIT J PHARMACOL, V148, P927, DOI 10.1038/sj.bjp.0706819; Garland SL, 2011, CURR TOP MED CHEM, V11, P1872; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hansen SVF, 2015, ORG LETT, V17, P2832, DOI 10.1021/acs.orglett.5b01252; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hoffmann C, 2015, MOL PHARMACOL, V88, P552, DOI 10.1124/mol.115.099671; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2014, J BIOL CHEM, V289, P20345, DOI 10.1074/jbc.M114.561449; Hudson BD, 2013, J BIOL CHEM, V288, P17296, DOI 10.1074/jbc.M113.455337; Hudson BD, 2013, CURR TOP MED CHEM, V13, P14; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kooistra AJ, 2014, ADV EXP MED BIOL, V796, P129, DOI 10.1007/978-94-007-7423-0_7; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; MacKenzie AE, 2014, MOL PHARMACOL, V85, P91, DOI 10.1124/mol.113.089482; McKeage K, 2015, DRUGS, V75, P809, DOI 10.1007/s40265-015-0393-y; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2014, BRIT J NUTR, V111, pS3, DOI 10.1017/S0007114513002249; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Natarajan N, 2014, AM J PHYSIOL-CELL PH, V307, pC979, DOI 10.1152/ajpcell.00228.2014; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pan AC, 2013, DRUG DISCOV TODAY, V18, P667, DOI 10.1016/j.drudis.2013.02.007; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Shonberg J, 2015, BIOORGAN MED CHEM, V23, P3880, DOI 10.1016/j.bmc.2014.12.034; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sykes DA, 2012, BRIT J PHARMACOL, V165, P2672, DOI 10.1111/j.1476-5381.2011.01639.x; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Watterson KR, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00137	53	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					303	317		10.1074/jbc.M115.687939	http://dx.doi.org/10.1074/jbc.M115.687939			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26518871	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000367589500024
J	Yao, JW; Bruhn, DF; Frank, MW; Lee, RE; Rock, CO				Yao, Jiangwei; Bruhn, David F.; Frank, Matthew W.; Lee, Richard E.; Rock, Charles O.			Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyl carrier protein (ACP); antibiotics; bacterial metabolism; fatty acid; fatty acid synthase (FAS); Neisseria	GRAM-POSITIVE PATHOGENS; IN-VITRO ACTIVITY; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; PHOSPHOLIPID-SYNTHESIS; CHLAMYDIA-TRACHOMATIS; ENOYL REDUCTASE; LIPOIC ACID; GONORRHOEAE; SYNTHETASE	Neisseria is a Gram-negative pathogen with phospholipids composed of straight chain saturated and monounsaturated fatty acids, the ability to incorporate exogenous fatty acids, and lipopolysaccharides that are not essential. The FabI inhibitor, AFN-1252, was deployed as a chemical biology tool to determine whether Neisseria can bypass the inhibition of fatty acid synthesis by incorporating exogenous fatty acids. Neisseria encodes a functional FabI that was potently inhibited by AFN-1252. AFN-1252 caused a dose-dependent inhibition of fatty acid synthesis in growing Neisseria, a delayed inhibition of growth phenotype, and minimal inhibition of DNA, RNA, and protein synthesis, showing that its mode of action is through inhibiting fatty acid synthesis. Isotopic fatty acid labeling experiments showed that Neisseria encodes the ability to incorporate exogenous fatty acids into its phospholipids by an acyl-acyl carrier protein-dependent pathway. However, AFN-1252 remained an effective antibacterial when Neisseria were supplemented with exogenous fatty acids. These results demonstrate that extracellular fatty acids are activated by an acyl-acyl carrier protein synthetase (AasN) and validate type II fatty acid synthesis (FabI) as a therapeutic target against Neisseria.	[Yao, Jiangwei; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Bruhn, David F.; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Lee, Richard/J-4997-2013; Lee, Richard/AAX-3996-2021	Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Frank, Matthew/0000-0002-4914-1440; Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM034496 (to C. O. R) and Cancer Center Support Grant CA21765 and by the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BLACK PN, 1992, J BIOL CHEM, V267, P25513; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; COOPER CL, 1989, J BIOL CHEM, V264, P7384; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Hermes FAM, 2009, J BACTERIOL, V191, P6796, DOI 10.1128/JB.00798-09; HSU L, 1991, J BIOL CHEM, V266, P13783; Isabella VM, 2011, MOL MICROBIOL, V82, P489, DOI 10.1111/j.1365-2958.2011.07826.x; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jiang YF, 2010, BIOCHEMISTRY-US, V49, P718, DOI 10.1021/bi901890a; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Karlowsky JA, 2009, ANTIMICROB AGENTS CH, V53, P3544, DOI 10.1128/AAC.00400-09; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Low N, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001598; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Lu YJ, 2007, J BIOL CHEM, V282, P11339, DOI 10.1074/jbc.M700374200; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Miller J. H., 1972, EXPT MOL GENETICS, P25; MILLER RD, 1977, INFECT IMMUN, V17, P303, DOI 10.1128/IAI.17.2.303-312.1977; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MOSS CW, 1970, J BACTERIOL, V104, P63, DOI 10.1128/JB.104.1.63-68.1970; Muller JA, 2011, APPL ENVIRON MICROB, V77, P6889, DOI 10.1128/AEM.05213-11; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P5729, DOI 10.1128/AAC.01038-13; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Parsons JB, 2011, CURR OPIN MICROBIOL, V14, P544, DOI 10.1016/j.mib.2011.07.029; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Piet JR, 2014, J INFECTION, V69, P352, DOI 10.1016/j.jinf.2014.06.005; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROCK CO, 1979, J BIOL CHEM, V254, P7116; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; SENFF LM, 1976, J BACTERIOL, V127, P874, DOI 10.1128/JB.127.2.874-880.1976; Shih GC, 1999, MOL MICROBIOL, V32, P942, DOI 10.1046/j.1365-2958.1999.01404.x; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; SUD IJ, 1975, J BACTERIOL, V124, P713, DOI 10.1128/JB.124.2.713-717.1975; SWARTLEY JS, 1995, MOL MICROBIOL, V18, P401, DOI 10.1111/j.1365-2958.1995.mmi_18030401.x; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; Wang Y, 2013, CHEMMEDCHEM, V8, P1589, DOI 10.1002/cmdc.201300209; WISEMAN GM, 1977, INFECT IMMUN, V16, P550, DOI 10.1128/IAI.16.2.550-556.1977; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yao JW, 2015, J BIOL CHEM, V290, P22163, DOI 10.1074/jbc.M115.671008; Yao JW, 2015, J BIOL CHEM, V290, P18874, DOI 10.1074/jbc.M115.657148; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y	63	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					171	181		10.1074/jbc.M115.699462	http://dx.doi.org/10.1074/jbc.M115.699462			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26567338	Green Published, hybrid			2022-12-28	WOS:000367589500014
J	Stojanovski, BM; Ferreira, GC				Stojanovski, Bosko M.; Ferreira, Gloria C.			Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID SYNTHASE; SERINE PALMITOYLTRANSFERASE; REACTION-MECHANISM; ESCHERICHIA-COLI; HEME-BIOSYNTHESIS; AUTOINDUCER CAI-1; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENZYME CQSA	5-Aminolevulinate synthase (ALAS) catalyzes the first step in mammalian heme biosynthesis, the pyridoxal 5'-phosphate (PLP)-dependent and reversible reaction between glycine and succinyl-CoA to generate CoA, CO2, and 5-aminolevulinate (ALA). Apart from coordinating the positioning of succinylCoA, Rhodobacter capsulatus ALAS Asn-85 has a proposed role in regulating the opening of an active site channel. Here, we constructed a library of murine erythroid ALAS variants with substitutions at the position occupied by the analogous bacterial asparagine, screened for ALAS function, and characterized the catalytic properties of the N150H and N150F variants. Quinonoid intermediate formation occurred with a significantly reduced rate for either the N150H-or N150F-catalyzed condensation of glycine with succinyl-CoA during a single turnover. The introduced mutations caused modifications in the ALAS active site such that the resulting variants tipped the balance between the forward-and reverse-catalyzed reactions. Although wild-type ALAS catalyzes the conversion of ALA into the quinonoid intermediate at a rate 6.3-fold slower than the formation of the same quinonoid intermediate from glycine and succinyl-CoA, the N150F variant catalyzes the forward reaction at a mere 1.2-fold faster rate than that of the reverse reaction, and the N150H variant reverses the rate values with a 1.7-fold faster rate for the reverse reaction than that for the forward reaction. We conclude that the evolutionary selection of Asn-150 was significant for optimizing the forward enzymatic reaction at the expense of the reverse, thus ensuring that ALA is predominantly available for heme biosynthesis.	[Stojanovski, Bosko M.; Ferreira, Gloria C.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Stojanovski, BM (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012; Regan, Clinton/E-6250-2012	Ferreira, Gloria C/0000-0001-9279-2217; 	National Institutes of Health [GM080270]; American Heart Association, Greater Southeast Affiliate [10GRNT4300073, 13GRNT16970019]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Greater Southeast Affiliate(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080270 and American Heart Association, Greater Southeast Affiliate, Grants 10GRNT4300073 and 13GRNT16970019 (to G. C. F.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Bottomley S. S., 2013, HDB PORPHYRIN SCI, P44; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fratz E. J., 2013, HDB PORPHYRIN SCI, P1; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Ikushiro H, 2011, BBA-PROTEINS PROTEOM, V1814, P1474, DOI 10.1016/j.bbapap.2011.02.005; Ikushiro H, 2009, J BIOCHEM, V146, P549, DOI 10.1093/jb/mvp100; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Johnson K. A., 1992, ENZYMES, P1; Kaufholz AL, 2013, BIOCHEM J, V451, P205, DOI 10.1042/BJ20121041; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; Lendrihas T, 2010, J BIOL CHEM, V285, P3351, DOI 10.1074/jbc.M109.066548; Mann S, 2011, BBA-PROTEINS PROTEOM, V1814, P1459, DOI 10.1016/j.bbapap.2010.12.004; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Reetz MT, 2006, CHEM-EUR J, V12, P6031, DOI 10.1002/chem.200600459; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Stojanovski BM, 2015, FEBS OPEN BIO, V5, P824, DOI 10.1016/j.fob.2015.09.009; Stojanovski BM, 2014, BBA-PROTEINS PROTEOM, V1844, P2145, DOI 10.1016/j.bbapap.2014.09.013; Stojanovski BM, 2014, J BIOL CHEM, V289, P22915, DOI 10.1074/jbc.M114.574731; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	38	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30750	30761		10.1074/jbc.M115.655399	http://dx.doi.org/10.1074/jbc.M115.655399			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511319	hybrid, Green Published			2022-12-28	WOS:000367199000009
J	Lee, D; Goldberg, AL				Lee, Donghoon; Goldberg, Alfred L.			Muscle Wasting in Fasting Requires Activation of NF-kappa B and Inhibition of AKT/Mechanistic Target of Rapamycin (mTOR) by the Protein Acetylase, GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; SKELETAL-MUSCLE; TRANSCRIPTION FACTORS; ATROPHY; AUTOPHAGY; FOXO3; PHOSPHORYLATION; DEGRADATION; PGC-1-ALPHA; REPRESSION	NF-kappa B is best known for its pro-inflammatory and anti-apoptotic actions, but in skeletal muscle, NF-kappa B activation is important for atrophy upon denervation or cancer. Here, we show that also upon fasting, NF-kappa B becomes activated in muscle and is critical for the subsequent atrophy. Following food deprivation, the expression and acetylation of the p65 of NF-kappa B on lysine 310 increase markedly in muscles. NF-kappa B inhibition in mouse muscles by overexpression of the I kappa B alpha superrepressor (I kappa B alpha-SR) or of p65 mutated at Lys-310 prevented atrophy. Knockdown of GCN5 with shRNA or a dominant-negative GCN5 or over-expression of SIRT1 decreased p65K310 acetylation and muscle wasting upon starvation. In addition to reducing atrogene expression, surprisingly inhibiting NF-kappa B with I kappa B alpha-SR or by GCN5 knockdown in these muscles also enhanced AKT and mechanistic target of rapamycin (mTOR) activities, which also contributed to the reduction in atrophy. These new roles of NF-kappa B and GCN5 in regulating muscle proteolysis and AKT/mTOR signaling suggest novel approaches to combat muscle wasting.	[Lee, Donghoon; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu			National Institutes of Health from NIA [2 R01 AR055255-06A1]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 AR055255-06A1 from the NIA and the Muscular Dystrophy Association. The authors declare no conflict of interest.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chamberlain W, 2012, BIOCHEM CELL BIOL, V90, P200, DOI [10.1139/O11-082, 10.1139/o11-082]; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Cornwell EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087776; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Holmlund T, 2013, LEUKEMIA, V27, P578, DOI 10.1038/leu.2012.265; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Lee D, 2013, J BIOL CHEM, V288, P30515, DOI 10.1074/jbc.M113.489716; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liu Y, 2010, GENETICS, V184, P91, DOI 10.1534/genetics.109.110957; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Takahashi H, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411165; Tang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072503; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	37	31	33	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30269	30279		10.1074/jbc.M115.685164	http://dx.doi.org/10.1074/jbc.M115.685164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26515065	Green Published, hybrid			2022-12-28	WOS:000366738200008
J	Zhou, MH; Bavencoffe, A; Pan, HL				Zhou, Meng-Hua; Bavencoffe, Alexis; Pan, Hui-Lin			Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; N-TYPE; SENSORY NEURONS; MICE LACKING; SUBUNIT; RELEASE; TRAFFICKING; RECEPTORS; CURRENTS; TRANSMISSION	Nitric oxide (NO) is involved in a variety of physiological processes, such as vasoregulation and neurotransmission, and has a complex role in the regulation of pain transduction and synaptic transmission. We have shown previously that NO inhibits high voltage-activated Ca2+ channels in primary sensory neurons and excitatory synaptic transmission in the spinal dorsal horn. However, the molecular mechanism involved in this inhibitory action remains unclear. In this study, we investigated the role of S-nitrosylation in the NO regulation of high voltage-activated Ca2+ channels. The NO donor S-nitroso-N-acetyl-DL-penicillamine (SNAP) rapidly reduced N-type currents when Cav2.2 was coexpressed with the Cav beta 1 or Cav beta 3 subunits in HEK293 cells. In contrast, SNAP only slightly inhibited P/Q-type and L-type currents reconstituted with various Cav beta subunits. SNAP caused a depolarizing shift in voltage-dependent N-type channel activation, but it had no effect on Cav2.2 protein levels on the membrane surface. The inhibitory effect of SNAP on N-type currents was blocked by the sulfhydryl-specific modifying reagent methanethiosulfonate ethylammonium. Furthermore, the consensus motifs of S-nitrosylation were much more abundant in Cav2.2 than in Cav1.2 and Cav2.1. Site-directed mutagenesis studies showed that Cys-805, Cys-930, and Cys-1045 in the II-III intracellular loop, Cys-1835 and Cys-2145 in the C terminus of Cav2.2, and Cys-346 in the Cav beta 3 subunit were nitrosylation sites mediating NO sensitivity of N-type channels. Our findings demonstrate that the consensus motifs of S-nitrosylation in cytoplasmically accessible sites are critically involved in post-translational regulation of N-type Ca2+ channels by NO. S-Nitrosylation mediates the feedback regulation of N-type channels by NO.	[Zhou, Meng-Hua; Bavencoffe, Alexis; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Regan, Clinton/E-6250-2012	Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [HL077400, NS073935]; N. G. and Helen T. Hawkins endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077400 and NS073935 and the N. G. and Helen T. Hawkins endowment (to H.-L. P.). The authors declare no conflict of interest.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bao JP, 1998, J NEUROSCI, V18, P8740; Bavencoffe A, 2014, VITAM HORM, V96, P1, DOI 10.1016/B978-0-12-800254-4.00001-5; Buraei Z., 2010, PHYSIOL REV, V90, P1461; Cao XH, 2011, J NEUROCHEM, V119, P594, DOI 10.1111/j.1471-4159.2011.07456.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chen XJ, 1999, J NEUROPHYSIOL, V81, P963, DOI 10.1152/jn.1999.81.3.963; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; FILLOUX F, 1994, NEUROSCI LETT, V178, P263, DOI 10.1016/0304-3940(94)90774-9; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; Gonzalez DR, 2009, J CARDIOVASC PHARM, V54, P188, DOI 10.1097/FJC.0b013e3181b72c9f; Guan Y, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-29; HALL KE, 1995, J PHYSIOL-LONDON, V486, P313, DOI 10.1113/jphysiol.1995.sp020814; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoheisel U, 2000, PAIN, V88, P249, DOI 10.1016/S0304-3959(00)00336-5; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hopper R, 2004, EUR J NEUROSCI, V19, P1675, DOI 10.1111/j.1460-9568.2004.03306.x; Hu H, 1997, CIRC RES, V81, P742; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jin XG, 2011, J BIOL CHEM, V286, P33190, DOI 10.1074/jbc.M111.270967; Kakizawa S, 2012, EMBO J, V31, P417, DOI 10.1038/emboj.2011.386; Li L, 2014, MOL PHARMACOL, V86, P760, DOI 10.1124/mol.114.095505; Li L, 2012, J BIOL CHEM, V287, P6002, DOI 10.1074/jbc.M111.310110; Luvisetto S, 2006, NEUROSCIENCE, V142, P823, DOI 10.1016/j.neuroscience.2006.06.049; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Murali SS, 2012, J PHYSIOL-LONDON, V590, P1655, DOI 10.1113/jphysiol.2012.228429; Nimmervoll B, 2013, NEUROSCIENCE, V253, P330, DOI 10.1016/j.neuroscience.2013.08.052; O'Reilly JP, 2012, BBA-BIOMEMBRANES, V1818, P443, DOI 10.1016/j.bbamem.2011.11.031; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Urbano FJ, 2001, PFLUG ARCH EUR J PHY, V441, P824, DOI 10.1007/s004240000489; Wu Z. Z., 2009, J BIOL CHEM, V284, P36453; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Wu ZZ, 2004, NEUROSCI LETT, V368, P96, DOI 10.1016/j.neulet.2004.06.067; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; ZHUO M, 1993, PAIN, V54, P71, DOI 10.1016/0304-3959(93)90101-T	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30616	30623		10.1074/jbc.M115.685206	http://dx.doi.org/10.1074/jbc.M115.685206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26507659	Green Published, hybrid			2022-12-28	WOS:000366738200036
J	Li, MW; Song, SJ; Li, SJ; Feng, J; Hua, ZY				Li, Mengwen; Song, Sijie; Li, Shengjun; Feng, Jie; Hua, Ziyu			The Blockade of NF-kappa B Activation by a Specific Inhibitory Peptide Has a Strong Neuroprotective Role in a Sprague-Dawley Rat Kernicterus Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSDUCTION; TNF-ALPHA; BILIRUBIN; APOPTOSIS; NEUROTOXICITY; HIPPOCAMPUS; MECHANISMS; EXPRESSION; TOXICITY; DAMAGE	Kernicterus, the permanent nerve damage occurring as a result of bilirubin precipitation, still occurs worldwide and may lead to death or permanent neurological impairments. However, the underlying mechanisms remain unclear, and effective therapeutic strategies are lacking. The present study aims to investigate the activation of NF-kappa B and to identify the effect of NF-kappa B inhibition on the newborn rat kernicterus model. The NF-kappa B essential modifier-binding domain peptide (NBD), coupled with the HIV trans-activator of transcription peptide (TAT) was used to inhibit NF-kappa B. NF-kappa B was significantly activated in the cerebrum at 1 and 3 h (p<0.05) after the model was established, as measured by EMSA. NF-kappa B activation was inhibited by intraperitoneal administration of TAT-NBD. The general conditions of the TAT-NBD-treated rats were improved; meanwhile, these rats performed much better on the neurological evaluation, the rotarod test, and the Morris water maze test (p< 0.05) than the vehicle-treated rats at 28 days. Furthermore, the morphology of the nerve cells was better preserved in the TAT-NBD group, and these cells displayed less neurodegeneration and astrocytosis. Simultaneously, apoptosis in the brain was attenuated, and the levels of the TNF-alpha and IL-1 beta proteins were decreased (p < 0.01). These results suggested that NF-kappa B was activated, and inhibition of NF-kappa B activation by TAT-NBD not only attenuated the acute neurotoxicity, apoptosis, and inflammation, but also improved the long term neurobehavioral impairments in the kernicterus model rats in vivo. Thus, inhibiting NF-kappa B activation might be a potential therapeutic approach for kernicterus.	[Li, Mengwen; Song, Sijie; Li, Shengjun; Feng, Jie; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing 400000, Peoples R China; [Li, Mengwen; Song, Sijie; Li, Shengjun; Feng, Jie; Hua, Ziyu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400000, Peoples R China; [Li, Mengwen] Chongqing Key Lab Translat Med Res Cognit Dev & L, Chongqing 400000, Peoples R China; [Song, Sijie] Key Lab Pediat Chongqing, Chongqing 400000, Peoples R China; [Hua, Ziyu] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing 400000, Peoples R China	Chongqing Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing 400000, Peoples R China.	h_ziyu@163.com			National Natural Science Foundation of China [81200459]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81200459. The authors declare that they have no conflicts of interest with the contents of this article.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Barateiro A, 2014, MOL NEUROBIOL, V49, P424, DOI 10.1007/s12035-013-8530-7; Brites D, 2012, CARE JAUNDICED NEONA, P115; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Chang FY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005876; Denicourt C, 2003, TRENDS PHARMACOL SCI, V24, P216, DOI 10.1016/S0165-6147(03)00074-9; Falcao AS, 2006, ACTA NEUROPATHOL, V112, P95, DOI 10.1007/s00401-006-0078-4; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Fernandes A, 2011, GLIA, V59, P14, DOI 10.1002/glia.21072; Fernandes A, 2009, CURR PHARM DESIGN, V15, P2915, DOI 10.2174/138161209789058165; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Geiger AS, 2007, NEONATOLOGY, V92, P219, DOI 10.1159/000103740; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kevenaar JT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00044; Kim YR, 2015, BEHAV BRAIN RES, V287, P294, DOI 10.1016/j.bbr.2015.03.062; Maisels MJ, 2004, PEDIATRICS, V114, P297; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; Nijboer CHA, 2008, STROKE, V39, P2129, DOI 10.1161/STROKEAHA.107.504175; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Ostrow JD, 2003, EUR J CLIN INVEST, V33, P988, DOI 10.1046/j.1365-2362.2003.01261.x; Panossian L, 2011, J NEUROSCI, V31, P4025, DOI 10.1523/JNEUROSCI.5166-10.2011; Rice AC, 2011, BRAIN RES, V1368, P290, DOI 10.1016/j.brainres.2010.10.052; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Silva SL, 2010, NEUROBIOL DIS, V40, P663, DOI 10.1016/j.nbd.2010.08.010; Song SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096171; Song Sijie, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P172; Springer S. C., 2012, KERNICTERUS MEDSCAPE; Sunico CR, 2010, J NEUROSCI, V30, P973, DOI 10.1523/JNEUROSCI.3911-09.2010; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yang D, 2013, EXP NEUROL, V247, P447, DOI 10.1016/j.expneurol.2013.01.015; Yueh MF, 2014, J BIOL CHEM, V289, P4699, DOI 10.1074/jbc.M113.518613; Zhang TJ, 2006, ANESTH ANALG, V102, P1018, DOI 10.1213/01.ane.0000199221.96250.8c	42	8	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30042	30052		10.1074/jbc.M115.673525	http://dx.doi.org/10.1074/jbc.M115.673525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26499797	Green Published, hybrid			2022-12-28	WOS:000366614700035
J	Rangrez, AY; Eden, M; Poyanmehr, R; Kuhn, C; Stiebeling, K; Dierck, F; Bernt, A; Lullmann-Rauch, R; Weiler, H; Kirchof, P; Frank, D; Frey, N				Rangrez, Ashraf Yusuf; Eden, Matthias; Poyanmehr, Reza; Kuhn, Christian; Stiebeling, Katharina; Dierck, Franziska; Bernt, Alexander; Luellmann-Rauch, Renate; Weiler, Hartmut; Kirchof, Paulus; Frank, Derk; Frey, Norbert			Myozap Deficiency Promotes Adverse Cardiac Remodeling via Differential Regulation of Mitogen-activated Protein Kinase/Serum-response Factor and beta-Catenin/GSK-3 beta Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cadherin; cardiac development; cardiac hypertrophy; cardiac muscle; cardiomyocyte; cardiomyopathy; cardiovascular disease; heart; heart failure	PHOSPHOINOSITIDE 3-KINASE PATHWAY; RIGHT-VENTRICULAR CARDIOMYOPATHY; INTERCALATED DISC; BETA-CATENIN; N-CADHERIN; DILATED CARDIOMYOPATHY; CLINICAL-IMPLICATIONS; EMBRYONIC HEART; TRANSGENIC MICE; UP-REGULATION	Background: Little is known about cardiac function of myozap, a novel intercalated disc (ID) protein. Results: Myozap deficiency leads to the junctional remodeling, cardiomyopathy, heart failure, and increased mortality in response to increased biomechanical stress. Conclusion: Myozap is required for proper adaptation to increased biomechanical stress. Significance: We provide an essential role of the ID in general and myozap in particular in the context of cardiac remodeling. The intercalated disc (ID) is a hot spot for heart disease, as several ID proteins have been found mutated in cardiomyopathy. Myozap is a recent addition to the list of ID proteins and has been implicated in serum-response factor signaling. To elucidate the cardiac consequences of targeted deletion of myozap in vivo, we generated myozap-null mutant (Mzp(-/-)) mice. Although Mzp(-/-) mice did not exhibit a baseline phenotype, increased biomechanical stress due to pressure overload led to accelerated cardiac hypertrophy, accompanied by super-induction of fetal genes, including natriuretic peptides A and B (Nppa/Nppb). Moreover, Mzp(-/-) mice manifested a severe reduction of contractile function, signs of heart failure, and increased mortality. Expression of other ID proteins like N-cadherin, desmoplakin, connexin-43, and ZO-1 was significantly perturbed upon pressure overload, underscored by disorganization of the IDs in Mzp(-/-) mice. Exploration of the molecular causes of enhanced cardiac hypertrophy revealed significant activation of -catenin/GSK-3 signaling, whereas MAPK and MKL1/serum-response factor pathways were inhibited. In summary, myozap is required for proper adaptation to increased biomechanical stress. In broader terms, our data imply an essential function of the ID in cardiac remodeling beyond a mere structural role and emphasize the need for a better understanding of this molecular structure in the context of heart disease.	[Rangrez, Ashraf Yusuf; Eden, Matthias; Poyanmehr, Reza; Kuhn, Christian; Stiebeling, Katharina; Dierck, Franziska; Bernt, Alexander; Frank, Derk; Frey, Norbert] Univ Med Ctr Schleswig Holstein, Dept Internal Med Mol Cardiol & Angiol 3, Campus Kiel, D-24105 Kiel, Germany; [Luellmann-Rauch, Renate] Univ Med Ctr Schleswig Holstein, German Ctr Cardiovasc Res, DZHK, Partner Site Hamburg Kiel Lubeck, D-24105 Kiel, Germany; [Weiler, Hartmut] Univ Kiel, Inst Anat, D-24098 Kiel, Germany; [Kirchof, Paulus] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Poyanmehr, Reza] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Versiti Blood Center of Wisconsin; University of Birmingham; Hannover Medical School	Frey, N (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Internal Med Mol Cardiol & Angiol 3, Campus Kiel, D-24105 Kiel, Germany.	norbert.frey@uk-sh.de	Frey, Norbert/A-9695-2010; Rangrez, Ashraf/H-4988-2016; Frey, Norbert/M-7749-2019	Rangrez, Ashraf/0000-0003-2630-9754; Frey, Norbert/0000-0001-7611-378X	Bundesministerium fur Bildung and Forschung (BMBF/NGFNplus) Grant [BMBF/01GS0902]; German Centre for Cardiovascular Research	Bundesministerium fur Bildung and Forschung (BMBF/NGFNplus) Grant(Federal Ministry of Education & Research (BMBF)); German Centre for Cardiovascular Research	This work was supported in part by Bundesministerium fur Bildung and Forschung (BMBF/NGFNplus) Grant BMBF/01GS0902. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the German Centre for Cardiovascular Research.	Basso C, 2006, HEART, V92, P1559, DOI 10.1136/hrt.2005.086959; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Bisping E, 2014, J CARDIOVASC PHARM, V64, P293, DOI 10.1097/FJC.0000000000000126; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen X, 2006, MOL CELL BIOL, V26, P4462, DOI 10.1128/MCB.02157-05; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; FORBES MS, 1985, TISSUE CELL, V17, P605, DOI 10.1016/0040-8166(85)90001-1; Frank D, 2014, J MOL CELL CARDIOL, V72, P196, DOI 10.1016/j.yjmcc.2014.03.016; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; GERDES AM, 1992, CIRCULATION, V86, P426, DOI 10.1161/01.CIR.86.2.426; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Imanaka-Yoshida K, 1998, CELL MOTIL CYTOSKEL, V39, P52, DOI 10.1002/(SICI)1097-0169(1998)39:1<52::AID-CM5>3.0.CO;2-I; Joshi-Mukherjee R, 2008, HEART RHYTHM, V5, P1715, DOI 10.1016/j.hrthm.2008.09.009; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kuhn C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0262-8; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Li JF, 2011, MOL CELL BIOL, V31, P1134, DOI 10.1128/MCB.01025-10; Linask KK, 1998, DEV BIOL, V202, P85, DOI 10.1006/dbio.1998.9025; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rangrez AY, 2013, J CELL BIOL, V203, P643, DOI 10.1083/jcb.201303052; Rizzo S, 2012, CARDIOVASC RES, V95, P409, DOI 10.1093/cvr/cvs219; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Saffitz JE, 2011, ANNU REV PATHOL-MECH, V6, P299, DOI 10.1146/annurev-pathol-011110-130151; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Seeger TS, 2010, CIRC RES, V106, P880, DOI 10.1161/CIRCRESAHA.109.213256; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sugden PH, 1998, ADV ENZYME REGUL, V38, P87, DOI 10.1016/S0065-2571(97)00010-1; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Zelarayan L, 2007, CELL CYCLE, V6, P2120, DOI 10.4161/cc.6.17.4632; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006	62	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4128	4143		10.1074/jbc.M115.689620	http://dx.doi.org/10.1074/jbc.M115.689620			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26719331	hybrid, Green Published			2022-12-28	WOS:000371338400037
J	Ishibashi, R; Kozuki, S; Kamakura, S; Sumimoto, H; Toyoshima, F				Ishibashi, Riki; Kozuki, Satoshi; Kamakura, Sachiko; Sumimoto, Hideki; Toyoshima, Fumiko			c-Rel Regulates Inscuteable Gene Expression during Mouse Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; cell division; embryonic stem cell; gene transcription; promoter	NF-KAPPA-B; RNA-POLYMERASE-II; DROSOPHILA ASYMMETRIC DIVISIONS; CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; SPINDLE ORIENTATION; SELF-RENEWAL; TRANSCRIPTION FACTOR; ES CELLS; MAINTAINS PLURIPOTENCY	Inscuteable (Insc) regulates cell fate decisions in several types of stem cells. Although it is recognized that the expression levels of mouse INSC govern the balance between symmetric and asymmetric stem cell division, regulation of mouse Insc gene expression remains poorly understood. Here, we showed that mouse Insc expression transiently increases at an early stage of differentiation, when mouse embryonic stem (mES) cells differentiate into bipotent mesendoderm capable of producing both endoderm and mesoderm in defined culture conditions. We identified the minimum transcriptional regulatory element (354 bases) that drives mouse Insc transcription in mES cells within a region >5 kb upstream of the mouse Insc transcription start site. We found that the transcription factor reticuloendotheliosis oncogene (c-Rel) bound to the minimum element and promoted mouse Insc expression in mES cells. In addition, short interfering RNA-mediated knockdown of either mouse INSC or c-Rel protein decreased mesodermal cell populations without affecting differentiation into the mesendoderm or endoderm. Furthermore, overexpression of mouse INSC rescued the mesoderm-reduced phenotype induced by knockdown of c-Rel. We propose that regulation of mouse Insc expression by c-Rel modulates cell fate decisions during mES cell differentiation.	[Ishibashi, Riki; Kozuki, Satoshi; Toyoshima, Fumiko] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan; [Ishibashi, Riki; Kozuki, Satoshi; Toyoshima, Fumiko] Kyoto Univ, Dept Mammalian Regulatory Networks, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Kamakura, Sachiko; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Fukuoka 8128582, Japan	Kyoto University; Kyoto University; Kyushu University	Toyoshima, F (corresponding author), Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan.	ftoyoshi@virus.kyoto-u.ac.jp		Toyoshima, Fumiko/0000-0002-3698-0034	Funding Program for Next Generation World-Leading Researchers [LS069]; Naito Foundation; Platform Project for Dynamic Approaches to Living System from the Japan Agency for Medical Research and Development	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Platform Project for Dynamic Approaches to Living System from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Funding Program for Next Generation World-Leading Researchers (Grant LS069 to F. T.), the Naito Foundation (to F. T.), and the Platform Project for Dynamic Approaches to Living System from the Japan Agency for Medical Research and Development (to A. M. E. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ANG SL, 1993, DEVELOPMENT, V119, P1301; Ballard MS, 2015, CELL REP, V13, P290, DOI 10.1016/j.celrep.2015.09.006; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Chen GB, 2011, J IMMUNOL, V187, P4483, DOI 10.4049/jimmunol.1101757; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fullard N, 2013, AM J PATHOL, V182, P2109, DOI 10.1016/j.ajpath.2013.02.016; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kim YE, 2008, BMB REP, V41, P705, DOI 10.5483/BMBRep.2008.41.10.705; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; van den Ameele J, 2012, EMBO REP, V13, P355, DOI 10.1038/embor.2012.23; Wang C, 2011, DEV CELL, V21, P520, DOI 10.1016/j.devcel.2011.08.002; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Young KM, 2006, J NEUROSCI RES, V83, P39, DOI 10.1002/jnr.20702; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	67	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3333	3345		10.1074/jbc.M115.679563	http://dx.doi.org/10.1074/jbc.M115.679563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26694615	hybrid, Green Published			2022-12-28	WOS:000370854500018
J	Ames, JJ; Contois, L; Caron, JM; Tweedie, E; Yang, XH; Friesel, R; Vary, C; Brooks, PC				Ames, Jacquelyn J.; Contois, Liangru; Caron, Jennifer M.; Tweedie, Eric; Yang, Xuehui; Friesel, Robert; Vary, Calvin; Brooks, Peter C.			Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; TUMOR-GROWTH; CHORIOALLANTOIC MEMBRANE; CELL-MIGRATION; OUTSIDE-IN; ALPHA-V-BETA-3 INTEGRIN; BETA(3) INTEGRIN; CHICK-EMBRYO; ARG; BINDING	Extracellular matrix (ECM) remodeling regulates angiogenesis. However, the precise mechanisms by which structural changes in ECM proteins contribute to angiogenesis are not fully understood. Integrins are molecules with the ability to detect compositional and structural changes within the ECM and integrate this information into a network of signaling circuits that coordinate context-dependent cell behavior. The role of integrin alpha v beta 3 in angiogenesis is complex, as evidence exists for both positive and negative functions. The precise downstream signaling events initiated by alpha v beta 3 may depend on the molecular characteristics of its ligands. Here, we identified an RGD-containing cryptic collagen epitope that is generated in vivo. Surprisingly, rather than inhibiting alpha v beta 3 signaling, this collagen epitope promoted alpha v beta 3 activation and stimulated angiogenesis and inflammation. An antibody directed to this RGDKGE epitope but not other RGD collagen epitopes inhibited angiogenesis and inflammation in vivo. The selective ability of this RGD epitope to promote angiogenesis and inflammation depends in part on its flanking KGE motif. Interestingly, a subset of macrophages may represent a physiologically relevant source of this collagen epitope. Here, we define an endothelial cell mechano-signaling pathway in which a cryptic collagen epitope activates alpha v beta 3 leading to an Src and p38 MAPK-dependent cascade that leads to nuclear accumulation of Yes-associated protein (YAP) and stimulation of endothelial cell growth. Collectively, our findings not only provide evidence for a novel mechano-signaling pathway, but also define a possible therapeutic strategy to control alpha v beta 3 signaling by targeting a proangiogenic and inflammatory ligand of alpha v beta 3 rather than the receptor itself.	[Ames, Jacquelyn J.; Contois, Liangru; Caron, Jennifer M.; Tweedie, Eric; Yang, Xuehui; Friesel, Robert; Vary, Calvin; Brooks, Peter C.] Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA	Maine Medical Center	Brooks, PC (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	brookp1@mmc.org			National Institutes of Health [CA91645, HL65301, HL083151, P20RR15555, P20 RR181789, 5P30GM103392]; Holden Agency and Maine Medical Center; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065301, R01HL083151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P30GM106391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Holden Agency and Maine Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA91645 (to P. C. B.), HL65301 (to R. F.), HL083151 and P20RR15555 (to C. V.), P20 RR181789 (Bioinformatics Core to D. M. Wojchowski), and 5P30GM103392 (to R. F.) and by the Holden Agency and Maine Medical Center. P. C. B. and C. V. hold an equity interest in CryptoMedix, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Atkinson SJ, 2014, BIOCHEM SOC T, V42, P1590, DOI 10.1042/BST20140206; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Contois LW, 2015, ANGIOGENESIS, V18, P31, DOI 10.1007/s10456-014-9445-2; Contois LW, 2012, J BIOL CHEM, V287, P1779, DOI 10.1074/jbc.M111.267732; Cretu A, 2007, CLIN CANCER RES, V13, P3068, DOI 10.1158/1078-0432.CCR-06-2342; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Davis George E, 2011, Drug Discov Today Dis Models, V8, P13; Debefve E, 2008, ANGIOGENESIS, V11, P235, DOI 10.1007/s10456-008-9106-4; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Feng WY, 2008, J CELL BIOL, V183, P1145, DOI 10.1083/jcb.200802179; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Gong Y, 2013, ANGIOGENESIS, V16, P861, DOI 10.1007/s10456-013-9361-x; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kaneko K, 2014, BIOCHEM BIOPH RES CO, V447, P352, DOI 10.1016/j.bbrc.2014.04.006; Kostidis S, 2004, J PEPT SCI, V10, P494, DOI 10.1002/psc.559; Kunicki TJ, 1997, J BIOL CHEM, V272, P4103, DOI 10.1074/jbc.272.7.4103; Legler DF, 2001, J CELL SCI, V114, P1545; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Melkonian G, 2002, J EXP ZOOL, V292, P241, DOI 10.1002/jez.10014; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyoshi T, 2006, FASEB J, V20, P1904, DOI 10.1096/fj.05-5565fje; Mogford JE, 1996, CIRC RES, V79, P821, DOI 10.1161/01.RES.79.4.821; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Moserle L, 2014, CANCER DISCOV, V4, P31, DOI 10.1158/2159-8290.CD-13-0199; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Robinson SD, 2011, CURR OPIN CELL BIOL, V23, P630, DOI 10.1016/j.ceb.2011.03.014; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Shen ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117522; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Steri V, 2014, CIRC RES, V114, P79, DOI 10.1161/CIRCRESAHA.114.301591; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yip KP, 1997, AM J PHYSIOL-RENAL, V273, pF768, DOI 10.1152/ajprenal.1997.273.5.F768; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108; Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001	70	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2731	2750		10.1074/jbc.M115.669614	http://dx.doi.org/10.1074/jbc.M115.669614			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26668310	Green Published, hybrid			2022-12-28	WOS:000369626900015
J	Basu, S; Proweller, A				Basu, Sanchita; Proweller, Aaron			Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; CELL DIFFERENTIATION; MASTER REGULATOR; GROWTH-FACTOR; ALPHA-ACTIN; SRF BINDING; CARG BOX; MYOCARDIN; TRANSCRIPTION	Smooth muscle myosin light chain kinase (SM-MLCK) is the key enzyme responsible for phosphorylation of regulatory myosin light chain (MLC20), resulting in actin-myosin cross-bridging and force generation in vascular smooth muscle required for physiological vasoreactivity and blood pressure control. In this study, we investigated the combinatorial role of myocardin/serum response factor (SRF) and Notch signaling in the transcriptional regulation of MLCK gene expression. Promoter reporter analyses in rat A10 smooth muscle cells revealed a bimodal pattern of MLCK promoter activity and gene expression upon stimulation with constitutively active Notch1 in presence of myocardin or by Jagged1 ligand stimulation. An initial Notch1-induced increase in MLCK transcription was followed by loss in promoter sensitivity, which could be restored with further Notch1 dose escalation. Real-time PCR analyses revealed that endogenous levels of Hairy Related Transcription (HRT) factor 2 (HRT2) peaked concurrently with inhibitory concentrations of Notch1. Forced expression of HRT2 demonstrated simultaneous repression of both myocardin-and Notch1-induced MLCK promoter activity. HRT2-mediated repression was further confirmed by HRT2 truncations and siHRT2 treatments that rescued MLCK promoter activity and gene expression. Chromatin immunoprecipitation studies revealed both Jagged1 ligand-and Notch1-enhanced myocardin/SRF complex formation at the promoter CArG element. In contrast, heightened levels of HRT2 concomitantly disrupted myocardin/SRF and Notch transcription complex formation at respective CArG and CSL binding elements. Taken together, SM-MLCK promoter activity appears highly sensitive to the relative levels of Notch1 signaling, HRT2, and myocardin. These findings identify a novel Notch-dependent HRT2 autoregulatory circuit coordinating transcriptional regulation of SM-MLCK.	Case Western Reserve Univ, Dept Med, Case Cardiovasc Res Inst, Cleveland, OH 44122 USA; Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Cleveland, OH 44122 USA	Case Western Reserve University; Case Western Reserve University	Proweller, A (corresponding author), Case Western Reserve Univ, Dept Med, 4530 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44122 USA.	aaron.proweller@case.edu			National Institutes of Health [R01 HL096603]; Dominic Visconsi Research Scholars' Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dominic Visconsi Research Scholars' Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL096603 and the Dominic Visconsi Research Scholars' Fund (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Babu GJ, 2001, NAT CELL BIOL, V3, P1025, DOI 10.1038/ncb1101-1025; Basu S, 2013, J BIOL CHEM, V288, P11191, DOI 10.1074/jbc.M112.442996; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Chen M, 2013, J BIOL CHEM, V288, P34647, DOI 10.1074/jbc.M113.510362; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2010, GENESIS, V48, P146, DOI 10.1002/dvg.20599; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	43	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2988	2999		10.1074/jbc.M115.679803	http://dx.doi.org/10.1074/jbc.M115.679803			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26703474	hybrid, Green Published			2022-12-28	WOS:000369626900035
J	Mehta, M; Rajmani, RS; Singh, A				Mehta, Mansi; Rajmani, Raju S.; Singh, Amit			Mycobacterium tuberculosis WhiB3 Responds to Vacuolar pH-induced Changes in Mycothiol Redox Potential to Modulate Phagosomal Maturation and Virulence.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MURINE MACROPHAGES; GENE-EXPRESSION; PROTON-ATPASE; ACIDIC PH; STRESS; ACIDIFICATION; SURVIVAL; GROWTH; ACTIVATION	The ability of Mycobacterium tuberculosis to resist intraphagosomal stresses, such as oxygen radicals and low pH, is critical for its persistence. Here, we show that a cytoplasmic redox sensor, WhiB3, and the major M. tuberculosis thiol, mycothiol (MSH), are required to resist acidic stress during infection. WhiB3 regulates the expression of genes involved in lipid anabolism, secretion, and redox metabolism, in response to acidic pH. Furthermore, inactivation of the MSH pathway subverted the expression of whiB3 along with other pH-specific genes in M. tuberculosis. Using a genetic biosensor of mycothiol redox potential (E-MSH), we demonstrated that a modest decrease in phagosomal pH is sufficient to generate redox heterogeneity in E-MSH of the M. tuberculosis population in a WhiB3-dependent manner. Data indicate that M. tuberculosis needs low pH as a signal to alter cytoplasmic E-MSH, which activates WhiB3-mediated gene expression and acid resistance. Importantly, WhiB3 regulates intraphagosomal pH by down-regulating the expression of innate immune genes and blocking phagosomal maturation. We show that this block in phagosomal maturation is in part due to WhiB3-dependent production of polyketide lipids. Consistent with these observations, Mtb Delta whiB3 displayed intramacrophage survival defect, which can be rescued by pharmacological inhibition of phagosomal acidification. Last, Mtb Delta whiB3 displayed marked attenuation in the lungs of guinea pigs. Altogether, our study revealed an intimate link between vacuolar acidification, redox physiology, and virulence in M. tuberculosis and discovered WhiB3 as crucial mediator of phagosomal maturation arrest and acid resistance in M. tuberculosis.	[Mehta, Mansi; Rajmani, Raju S.; Singh, Amit] Indian Inst Sci, Ctr Infect Dis Res, Dept Microbiol & Cell Biol, Bangalore 12, Karnataka, India; [Mehta, Mansi] Int Ctr Genet Engn & Biotechnol, New Delhi 67, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Singh, A (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Dept Microbiol & Cell Biol, Bangalore 12, Karnataka, India.	asingh@mcbl.iisc.ernet.in		Singh, Amit/0000-0001-6761-1664	Department of Biotechnology (DBT), Ministry of Science and Technology, India [BT/PR5020/MED/29/454/2012, BT/03/IYBA/2010]; Wellcome-DBT India Alliance [500034/Z/09/Z]; Council for Scientific and Industrial Research; Department of Biotechnology (DBT) Innovative Young Bio-technologist Award	Department of Biotechnology (DBT), Ministry of Science and Technology, India(Department of Biotechnology (DBT) India); Wellcome-DBT India Alliance(Wellcome Trust DBT India Alliance); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT) Innovative Young Bio-technologist Award	We thank the Department of Biotechnology (DBT), Ministry of Science and Technology, India BT/PR5020/MED/29/454/2012, BT/03/IYBA/2010 [AS]) and Wellcome-DBT India Alliance (500034/Z/09/Z [AS]) for financial support. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the Council for Scientific and Industrial Research.; Recipient of a Department of Biotechnology (DBT) Innovative Young Bio-technologist Award. A fellow of the Wellcome-DBT India Alliance.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Baker JJ, 2014, MOL MICROBIOL, V94, P56, DOI 10.1111/mmi.12688; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bhaskar A, 2015, J BIOL CHEM, V290, P1020, DOI 10.1074/jbc.M114.588913; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; HART P D, 1974, Infection and Immunity, V10, P742; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hostetter JM, 2002, FEMS IMMUNOL MED MIC, V34, P127, DOI 10.1111/j.1574-695X.2002.tb00613.x; Karim AF, 2011, J BIOL CHEM, V286, P40307, DOI 10.1074/jbc.M111.266239; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MAURIN M, 1992, INFECT IMMUN, V60, P5013, DOI 10.1128/IAI.60.12.5013-5016.1992; Metchnikoff E., 1905, IMMUNITY INFECT DIS, P182; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Nambi S, 2015, CELL HOST MICROBE, V17, P829, DOI 10.1016/j.chom.2015.05.008; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Tyagi P, 2015, FREE RADICAL BIO MED, V84, P344, DOI 10.1016/j.freeradbiomed.2015.03.008; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Venkataraman B, 2014, J MICROBIOL METH, V97, P34, DOI 10.1016/j.mimet.2013.12.009; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Via LE, 1998, J CELL SCI, V111, P897; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Woodmansee AN, 2003, MOL MICROBIOL, V49, P11, DOI 10.1046/j.1365-2958.2003.03530.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	49	54	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2888	2903		10.1074/jbc.M115.684597	http://dx.doi.org/10.1074/jbc.M115.684597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26637353	Green Published, hybrid			2022-12-28	WOS:000369626900027
J	Mourier, G; Salinas, M; Kessler, P; Stura, EA; Leblanc, M; Tepshi, L; Besson, T; Diochot, S; Baron, A; Douguet, D; Lingueglia, E; Servent, D				Mourier, Gilles; Salinas, Miguel; Kessler, Pascal; Stura, Enrico A.; Leblanc, Mathieu; Tepshi, Livia; Besson, Thomas; Diochot, Sylvie; Baron, Anne; Douguet, Dominique; Lingueglia, Eric; Servent, Denis			Mambalgin-1 Pain-relieving Peptide, Stepwise Solid-phase Synthesis, Crystal Structure, and Functional Domain for Acid-sensing Ion Channel 1a Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SYNTHESIS; BINDING-SITE; TOXIN; CRYSTALLIZATION	Mambalgins are peptides isolated from mamba venom that specifically inhibit a set of acid-sensing ion channels (ASICs) to relieve pain. We show here the first full stepwise solid phase peptide synthesis of mambalgin-1 and confirm the biological activity of the synthetic toxin both in vitro and in vivo. We also report the determination of its three-dimensional crystal structure showing differences with previously described NMR structures. Finally, the functional domain by which the toxin inhibits ASICla channels was identified in its loop II and more precisely in the face containing Phe-27, Leu-32, and Leu-34 residues. Moreover, proximity between Leu-32 in mambalgin-1 and Phe-350 in rASICia was proposed from double mutant cycle analysis. These data provide information on the structure and on the pharmacophore for ASIC channel inhibition by mambalgins that could have therapeutic value against pain and probably other neurological disorders.	Commissariat Energie Atom, iBiTecS, Serv Ingn Mol Proteines, F-91191 Gif Sur Yvette, France; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Nice Sophia Antipolis, F-06560 Valbonne, France; LabEx Ion Channel Sci & Therapeut, UMR 7275, F-06560 Valbonne, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Lingueglia, E (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France.; Servent, D (corresponding author), CEA, iBiTecS, F-91191 Gif Sur Yvette, France.	lingueglia@ipmc.cnrs.fr; denis.servent@cea.fr	BARON, Anne/N-5691-2016; Diochot, Sylvie/ABG-5495-2020; Stura, Enrico A./A-2793-2010; SALINAS, Miguel/N-6380-2016; LINGUEGLIA, Eric/F-5509-2013; douguet, dominique/D-5644-2017	BARON, Anne/0000-0002-8026-6380; Stura, Enrico A./0000-0001-6718-2118; SALINAS, Miguel/0000-0002-7445-123X; LINGUEGLIA, Eric/0000-0003-3902-3405; Servent, Denis/0000-0002-0774-1691	CNRS; INSERM; Agence Nationale de la Recherche [ANR-13-BSV4-0009]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, INSERM, and Agence Nationale de la Recherche Grant ANR-13-BSV4-0009. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Baron A, 2015, NEUROPHARMACOLOGY, V94, P19, DOI 10.1016/j.neuropharm.2015.01.005; Baron A, 2013, TOXICON, V75, P187, DOI 10.1016/j.toxicon.2013.04.008; Chowdhury S, 2014, J GEN PHYSIOL, V144, P441, DOI 10.1085/jgp.201411184; Ciccone L, 2015, NEW BIOTECHNOL, V32, P54, DOI 10.1016/j.nbt.2014.09.002; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2015, NEUROPHARMACOLOGY, V94, P49, DOI 10.1016/j.neuropharm.2015.02.009; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Diochot S, 2016, PAIN, V157, P552, DOI 10.1097/j.pain.0000000000000397; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duran D., 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Fruchart-Gaillard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039166; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MUTTER M, 1995, PEPTIDE RES, V8, P145; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Noel Jacques, 2010, Expert Rev Clin Pharmacol, V3, P331, DOI 10.1586/ecp.10.13; Pan M, 2014, CHEM COMMUN, V50, P5837, DOI 10.1039/c4cc00779d; Saez NJ, 2015, BRIT J PHARMACOL, V172, P4985, DOI 10.1111/bph.13267; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas M, 2014, J BIOL CHEM, V289, P13363, DOI 10.1074/jbc.M114.561076; Schroeder CI, 2014, ANGEW CHEM INT EDIT, V53, P1017, DOI 10.1002/anie.201308898; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vera L, 2013, CRYST GROWTH DES, V13, P1878, DOI 10.1021/cg301537n; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Woolf CJ, 2013, LANCET NEUROL, V12, P18, DOI 10.1016/S1474-4422(12)70287-9	37	35	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2616	2629		10.1074/jbc.M115.702373	http://dx.doi.org/10.1074/jbc.M115.702373			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26680001	Green Published, hybrid			2022-12-28	WOS:000369626900007
J	Guo, WT; Sun, B; Xiao, ZC; Liu, YJ; Wang, YD; Zhang, L; Wang, RW; Chen, SRW				Guo, Wenting; Sun, Bo; Xiao, Zhichao; Liu, Yingjie; Wang, Yundi; Zhang, Lin; Wang, Ruiwu; Chen, S. R. Wayne			The EF-hand Ca2+ Binding Domain Is Not Required for Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYR2 MUTATIONS; SUDDEN-DEATH; VENTRICULAR-TACHYCARDIA; SARCOPLASMIC-RETICULUM; RELEASE CHANNEL; MOLECULAR-IDENTIFICATION; TERMINATION; THRESHOLD; SENSOR; DYSFUNCTION	Activation of the cardiac ryanodine receptor (RyR2) by elevating cytosolic Ca2+ is a central step in the process of Ca2+-induced Ca2+ release, but the molecular basis of RyR2 activation by cytosolic Ca2+ is poorly defined. It has been proposed recently that the putative Ca2+ binding domain encompassing a pair of EF-hand motifs (EF1 and EF2) in the skeletal muscle ryanodine receptor (RyR1) functions as a Ca2+ sensor that regulates the gating of RyR1. Although the role of the EF-hand domain in RyR1 function has been studied extensively, little is known about the functional significance of the corresponding EF-hand domain in RyR2. Here we investigate the effect of mutations in the EF-hand motifs on the Ca2+ activation of RyR2. We found that mutations in the EF-hand motifs or deletion of the entire EF-hand domain did not affect the Ca2+-dependent activation of [H-3]ryanodine binding or the cytosolic Ca2+ activation of RyR2. On the other hand, deletion of the EF-hand domain markedly suppressed the luminal Ca2+ activation of RyR2 and spontaneous Ca2+ release in HEK293 cells during store Ca2+ overload or store overload-induced Ca2+ release (SOICR). Furthermore, mutations in the EF2 motif, but not EF1 motif, of RyR2 raised the threshold for SOICR termination, whereas deletion of the EF-hand domain of RyR2 increased both the activation and termination thresholds for SOICR. These results indicate that, although the EF-hand domain is not required for RyR2 activation by cytosolic Ca2+, it plays an important role in luminal Ca2+ activation and SOICR.	Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Chen, SRW (corresponding author), HRIC GAC58,3330 Hosp Dr N-W, Calgary, AB, Canada.	swchen@ucalgary.ca			NIGMS/National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; Alberta Innovates [201300501, 201500221, 201400104, 201200822] Funding Source: researchfish	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alberta Innovates	Molecular graphics and analyses were performed with the University of California, San Francisco Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS/National Institutes of Health Grant P41-GM103311).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fessenden JD, 2004, J BIOL CHEM, V279, P53028, DOI 10.1074/jbc.M411136200; Gomez AC, 2014, BIOCHEMISTRY-US, V53, P1373, DOI 10.1021/bi401586h; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HYMEL L, 1988, BIOCHEM BIOPH RES CO, V152, P308, DOI 10.1016/S0006-291X(88)80715-0; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Mi T, 2015, BIOCHEM J, V467, P177, DOI 10.1042/BJ20141263; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	38	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2150	2160		10.1074/jbc.M115.693325	http://dx.doi.org/10.1074/jbc.M115.693325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26663082	Green Published, hybrid			2022-12-28	WOS:000369610400009
J	Hashimoto, M; Murata, K; Ishida, J; Kanou, A; Kasuya, Y; Fukamizu, A				Hashimoto, Misuzu; Murata, Kazuya; Ishida, Junji; Kanou, Akihiko; Kasuya, Yoshitoshi; Fukamizu, Akiyoshi			Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SOX10; OLIGODENDROCYTE DIFFERENTIATION; N-METHYLTRANSFERASE; FACTOR OLIG2; HISTONE H4; METHYLATION; EXPRESSION; GENE; RECEPTOR; CELLS	Protein arginine methyltransferase 1 (PRMT1) is involved in cell proliferation, DNA damage response, and transcriptional regulation. Although PRMT1 is extensively expressed in the CNS at embryonic and perinatal stages, the physiological role of PRMT1 has been poorly understood. Here, to investigate the primary function of PRMT1 in the CNS, we generated CNS-specific PRMT1 knock-out mice by the Cre-loxP system. These mice exhibited postnatal growth retardation with tremors, and most of them died within 2 weeks after birth. Brain histological analyses revealed prominent cell reduction in the white matter tracts of the mutant mice. Furthermore, ultrastructural analysis demonstrated that myelin sheath was almost completely ablated in the CNS of these animals. In agreement with hypomyelination, we also observed that most major myelin proteins including myelin basic protein (MBP), 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase), and myelin-associated glycoprotein (MAG) were dramatically decreased, although neuronal and astrocytic markers were preserved in the brain of CNS-specific PRMT1 knock-out mice. These animals had a reduced number of OLIG2(+) oligodendrocyte lineage cells in the white matter. We found that expressions of transcription factors essential for oligodendrocyte specification and further maturation were significantly suppressed in the brain of the mutant mice. Our findings provide evidence that PRMT1 is required for CNS development, especially for oligodendrocyte maturation processes.	[Hashimoto, Misuzu; Fukamizu, Akiyoshi] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Murata, Kazuya; Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, Life Sci Ctr, TARA, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Ishida, Junji; Kanou, Akihiko; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Kasuya, Yoshitoshi] Chiba Univ, Dept Biochem & Mol Pharmacol, Grad Sch Med, 1-8-1 Inohana, Chiba 2608670, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Chiba University	Fukamizu, A (corresponding author), Univ Tsukuba, Life Sci Ctr, TARA, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Murata, Kazuya/GLR-2334-2022	Murata, Kazuya/0000-0002-3328-069X; Kasuya, Yoshitoshi/0000-0003-0614-5836	JSPS KAKENHI [25252062]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25252062. The authors declare that they have no conflicts of interest with the contents of this article.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Chittka A, 2012, J BIOL CHEM, V287, P42995, DOI 10.1074/jbc.M112.392746; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Hamada J, 2015, AM J PHYSIOL-HEART C, V308, pH931, DOI 10.1152/ajpheart.00703.2013; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Hong E, 2012, BIOGERONTOLOGY, V13, P329, DOI 10.1007/s10522-012-9379-2; Huang JH, 2011, J BIOL CHEM, V286, P44424, DOI 10.1074/jbc.M111.277046; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Kuspert M, 2011, NUCLEIC ACIDS RES, V39, P1280, DOI 10.1093/nar/gkq951; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Qi YC, 2001, DEVELOPMENT, V128, P2723; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	38	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2237	2245		10.1074/jbc.M115.684514	http://dx.doi.org/10.1074/jbc.M115.684514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26637354	Green Published, hybrid			2022-12-28	WOS:000369610400015
J	Gallie, DR				Gallie, Daniel R.			Eukaryotic Initiation Factor eIFiso4G1 and eIFiso4G2 Are Isoforms Exhibiting Distinct Functional Differences in Supporting Translation in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 4G EIF4G; CAP-INDEPENDENT TRANSLATION; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; MESSENGER-RNA; INTERNAL INITIATION; LEADER SEQUENCE; VIRUS; COMPLEX; RECRUITMENT	The eukaryotic translation initiation factor (eIF) 4G is required during protein synthesis to promote the assembly of several factors involved in the recruitment of a 40S ribosomal subunit to an mRNA. Although many eukaryotes express two eIF4G isoforms that are highly similar, the eIF4G isoforms in plants, referred to as eIF4G and eIFiso4G, are highly divergent in size, sequence, and domain organization but both can interact with eIF4A, eIF4B, eIF4E isoforms, and the poly(A)-binding protein. Nevertheless, eIF4G and eIFiso4G from wheat exhibit preferences in the mRNAs they translate optimally. For example, mRNA containing the 5'-leader (called Omega) of tobacco mosaic virus preferentially uses eIF4G in wheat germ lysate. In this study, the eIF4G isoform specificity of Omega was used to examine functional differences of the eIF4G isoforms in Arabidopsis. As in wheat, Omega-mediated translation was reduced in an eif4g null mutant. Loss of the eIFiso4G1 isoform, which is similar in sequence to wheat eIFiso4G, did not substantially affect Omega-mediated translation. However, loss of the eIFiso4G2 isoform substantially reduced Omega-mediated translation. eIFiso4G2 is substantially divergent from eIFiso4G1 and is present only in the Brassicaceae, suggesting a recent evolution. eIFiso4G2 isoforms exhibit sequence-specific differences in regions representing partner protein and RNA binding sites. Loss of any eIF4G isoform also resulted in a substantial reduction in reporter transcript level. These results suggest that eIFiso4G2 appeared late in plant evolution and exhibits more functional similarity with eIF4G than with eIFiso4G1 during Omega-mediated translation.	[Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			National Science Foundation [DBI-0820047]; University of California Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of California Agricultural Experiment Station(University of California System)	This work was supported by National Science Foundation Grant DBI-0820047 and the University of California Agricultural Experiment Station (to D.R.G.). The author declares that he has no conflicts of interest with the contents of this article.	ALTMANN M, 1990, GENE, V91, P127, DOI 10.1016/0378-1119(90)90173-O; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; Chen Z, 2014, J BIOL CHEM, V289, P13926, DOI 10.1074/jbc.M114.555151; Cheng S, 2007, J BIOL CHEM, V282, P25247, DOI 10.1074/jbc.M702193200; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; Cheng SJ, 2010, BIOCHEMISTRY-US, V49, P8251, DOI 10.1021/bi1008529; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Huch S, 2014, WIRES RNA, V5, P747, DOI 10.1002/wrna.1244; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kovtun AA, 2007, BIOCHEM BIOPH RES CO, V358, P368, DOI 10.1016/j.bbrc.2007.04.152; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; MUNDRY KW, 1991, J GEN VIROL, V72, P769, DOI 10.1099/0022-1317-72-4-769; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Patrick RM, 2014, PLANT PHYSIOL, V164, P1820, DOI 10.1104/pp.113.227785; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Singh CR, 2012, MOL CELL BIOL, V32, P3978, DOI 10.1128/MCB.00376-12; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yoshii M, 2004, J VIROL, V78, P6102, DOI 10.1128/JVI.78.12.6102-6111.2004	38	13	13	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1501	1513		10.1074/jbc.M115.692939	http://dx.doi.org/10.1074/jbc.M115.692939			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26578519	Green Published, hybrid			2022-12-28	WOS:000368068300040
J	Goto, A; Charman, M; Ridgway, ND				Goto, Asako; Charman, Mark; Ridgway, Neale D.			Oxysterol-binding Protein Activation at Endoplasmic Reticulum-Golgi Contact Sites Reorganizes Phosphatidylinositol 4-Phosphate Pools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HAMSTER OVARY CELLS; SPHINGOMYELIN SYNTHESIS; CERAMIDE TRANSPORT; CHOLESTEROL; PHOSPHORYLATION; REVEALS; STEROL; 25-HYDROXYCHOLESTEROL; PHOSPHOINOSITIDES	Oxysterol-binding protein (OSBP) exchanges cholesterol and phosphatidylinositol 4-phosphate (PI-4P) at contact sites between the endoplasmic reticulum (ER) and the trans-Golgi/ trans-Golgi network. 25-Hydroxycholesterol (25OH) competitively inhibits this exchange reaction in vitro and causes the constitutive localization of OSBP at the ER/Golgi interface and PI-4P-dependent recruitment of ceramide transfer protein (CERT) for sphingomyelin synthesis. Weused PI-4P probes and mass analysis to determine how OSBP controls the availability of PI-4P for this metabolic pathway. Treatment of fibroblasts or Chinese hamster ovary (CHO) cells with 25OH caused a 50-70% reduction in Golgi-associated immunoreactive PI-4P that correlated with Golgi localization of OSBP. In contrast, 25OH caused an OSBP-dependent enrichment in Golgi PI-4P that was detected with a pleckstrin homology domain probe. The cellular mass of phosphatidylinositol monophosphates and Golgi PI-4P measured with an unbiased PI-4P probe (P4M) was unaffected by 25OH and OSBP silencing, indicating that OSBP shifts the distribution of PI-4P upon localization to ER-Golgi contact sites. The PI-4P and sterol binding activities of OSBP were both required for 25OH activation of sphingomyelin synthesis, suggesting that 25OH must be exchanged for PI-4P to be concentrated at contact sites. We propose a model wherein 25OH activation of OSBP promotes the binding and retention of PI-4P at ER-Golgi contact sites. This pool of PI-4P specifically recruits pleckstrin homology domain-containing proteins involved in lipid transfer and metabolism, such as CERT.	Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4R2, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Rm C306 CRC,5849 Univ Av, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca		Goto, Asako/0000-0002-0002-2619; Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research [MOP-15284]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-15284 from the Canadian Institutes of Health Research. The authors declare that they have no conflict of interest with the content of this article.	Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Gehrig K, 2011, BBA-MOL CELL BIOL L, V1811, P377, DOI 10.1016/j.bbalip.2011.04.001; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; KANDUTSCH AA, 1984, J BIOL CHEM, V259, P2388; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Liu XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108368; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Strating JRPM, 2015, CELL REP, V10, P600, DOI 10.1016/j.celrep.2014.12.054; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Wakelam MJO, 2014, BBA-MOL CELL BIOL L, V1841, P1102, DOI 10.1016/j.bbalip.2014.04.005	40	29	29	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1336	1347		10.1074/jbc.M115.682997	http://dx.doi.org/10.1074/jbc.M115.682997			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601944	hybrid, Green Published			2022-12-28	WOS:000368068300027
J	Belanger, F; Angers, JP; Fortier, E; Hammond-Martel, I; Costantino, S; Drobetsky, E; Wurtele, H				Belanger, Francois; Angers, Jean-Philippe; Fortier, Emile; Hammond-Martel, Ian; Costantino, Santiago; Drobetsky, Elliot; Wurtele, Hugo			Mutations in Replicative Stress Response Pathways Are Associated with S Phase-specific Defects in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HUMAN-CELLS; DEGRON SYSTEM; CHECKPOINT; PROTEIN; ATR; KINASE; ACTIVATION	Nucleotide excision repair (NER) is a highly conserved pathway that removes helix-distorting DNA lesions induced by a plethora of mutagens, including UV light. Our laboratory previously demonstrated that human cells deficient in either ATM and Rad3-related (ATR) kinase or translesion DNA polymerase eta (i.e. key proteins that promote the completion of DNA replication in response to UV-induced replicative stress) are characterized by profound inhibition of NER exclusively during S phase. Toward elucidating the mechanistic basis of this phenomenon, we developed a novel assay to quantify NER kinetics as a function of cell cycle in the model organism Saccharomyces cerevisiae. Using this assay, we demonstrate that in yeast, deficiency of the ATR homologue Mec1 or of any among several other proteins involved in the cellular response to replicative stress significantly abrogates NER uniquely during S phase. Moreover, initiation of DNA replication is required for manifestation of this defect, and S phase NER proficiency is correlated with the capacity of individual mutants to respond to replicative stress. Importantly, we demonstrate that partial depletion of Rfa1 recapitulates defective S phase-specific NER in wild type yeast; moreover, ectopic RPA1-3 overexpression rescues such deficiency in either ATR or polymerase eta-deficient human cells. Our results strongly suggest that reduction of NER capacity during periods of enhanced replicative stress, ostensibly caused by inordinate sequestration of RPA at stalled DNA replication forks, represents a conserved feature of the multifaceted eukaryotic DNA damage response.	[Belanger, Francois; Angers, Jean-Philippe; Fortier, Emile; Hammond-Martel, Ian; Costantino, Santiago; Drobetsky, Elliot; Wurtele, Hugo] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Angers, Jean-Philippe] Univ Montreal, Programme Biol Mol, Montreal, PQ H3T 1J4, Canada; [Costantino, Santiago] Univ Montreal, Dept Ophtalmol, Montreal, PQ H3T 1J4, Canada; [Drobetsky, Elliot; Wurtele, Hugo] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Drobetsky, E (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada.	elliot.drobetsky@umontreal.ca; hugo.wurtele@umontreal.ca	Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635	Canadian Institutes for Health Research [MOP-123438, MOP-133470]; Natural Sciences and Engineering Research Council of Canada [RGPIN 435636-2013, RGPIN 355603-2011, RGPIN-2014-05285]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by Canadian Institutes for Health Research Grants MOP-123438 (to H. W.) and MOP-133470 (to E. D.) and by Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN 435636-2013 (to H. W.), RGPIN 355603-2011 (to S. C.), and RGPIN-2014-05285 (to E. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Auclair Y, 2010, DNA REPAIR, V9, P754, DOI 10.1016/j.dnarep.2010.03.013; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Belanger F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085294; Berens TJ, 2012, MOL BIOL CELL, V23, P1058, DOI 10.1091/mbc.E11-10-0852; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Gerald JNF, 2002, J CELL SCI, V115, P1749; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Johnson R, 2007, PLOS GENET, V3, P2338, DOI 10.1371/journal.pgen.0030223; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Loignon M, 2002, CARCINOGENESIS, V23, P35, DOI 10.1093/carcin/23.1.35; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; REYNOLDS RJ, 1981, J BACTERIOL, V146, P692, DOI 10.1128/JB.146.2.692-704.1981; Sabatinos SA, 2012, MOL CELL BIOL, V32, P4986, DOI 10.1128/MCB.01060-12; Schreier WJ, 2015, ANNU REV PHYS CHEM, V66, P497, DOI 10.1146/annurev-physchem-040214-121821; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Taschner M, 2010, MOL CELL BIOL, V30, P436, DOI 10.1128/MCB.00822-09; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tsaalbi-Shtylik A, 2014, NUCLEIC ACIDS RES, V42, P4406, DOI 10.1093/nar/gkt1412; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; YARBRO JW, 1992, SEMIN ONCOL, V19, P1; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	52	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					522	537		10.1074/jbc.M115.685883	http://dx.doi.org/10.1074/jbc.M115.685883			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26578521	Green Published, hybrid			2022-12-28	WOS:000367830500002
J	Leong, WY; Guo, H; Ma, O; Huang, H; Cantor, AB; Friedman, AD				Leong, Wan Yee; Guo, Hong; Ma, Ou; Huang, Hui; Cantor, Alan B.; Friedman, Alan D.			Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; CBF-BETA-SMMHC; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; ADULT HEMATOPOIESIS; DIFFERENTIATION; AML1; INHIBITION; PROTEINS	Src phosphorylates Runx1 on one central and four C-terminal tyrosines. We find that activated Src synergizes with Runx1 to activate a Runx1 luciferase reporter. Mutation of the four Runx1 C-terminal tyrosines to aspartate or glutamate to mimic phosphorylation increases trans-activation of the reporter in 293T cells and allows induction of Cebpa or Pu.1 mRNAs in 32Dcl3 myeloid cells, whereas mutation of these residues to phenylalanine to prevent phosphorylation obviates these effects. Three mechanisms contribute to increased Runx1 activity upon tyrosine modification as follows: increased stability, reduced histone deacetylase (HDAC) interaction, and increased DNA binding. Mutation of the five modified Runx1 tyrosines to aspartate markedly reduced co-immunoprecipitation with HDAC1 and HDAC3, markedly increased stability in cycloheximide or in the presence of co-expressed Cdh1, an E3 ubiquitin ligase coactivator, with reduced ubiquitination, and allowed DNA-binding in gel shift assay similar to wild-type Runx1. In contrast, mutation of these residues to phenylalanine modestly increased HDAC interaction, modestly reduced stability, and markedly reduced DNA binding in gel shift assays and as assessed by chromatin immunoprecipitation with the -14-kb Pu.1 or +37-kb Cebpa enhancers after stable expression in 32Dcl3 cells. Affinity for CBF beta, the Runx1 DNA-binding partner, was not affected by these tyrosine modifications, and in vitro translated CBF beta markedly increased DNA affinity of both the translated phenylalanine and aspartate Runx1 variants. Finally, further supporting a positive role for Runx1 tyrosine phosphorylation during granulopoiesis, mutation of the five Src-modified residues to aspartate but not phenylalanine allows Runx1 to increase Cebpa and granulocyte colony formation by Runx1-deleted murine marrow.	[Leong, Wan Yee; Guo, Hong; Ma, Ou; Friedman, Alan D.] Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21231 USA; [Huang, Hui; Cantor, Alan B.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Huang, Hui; Cantor, Alan B.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Friedman, AD (corresponding author), Johns Hopkins Univ, CRB 1, Rm 253,1650 Orleans St, Baltimore, MD 21231 USA.	afriedm2@jhmi.edu		Cantor, Alan/0000-0002-5136-028X	National Institutes of Health [U01 HL099775, R01 HL082952]; National Institutes of Health Cancer Center [P30 CA006973]; Gabrielle's Angel Foundation; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA006973, T32CA060441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082952, U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants U01 HL099775 (to A. D. F.) and R01 HL082952 (to A. B. C.), National Institutes of Health Cancer Center Core Grant P30 CA006973, a grant from the Gabrielle's Angel Foundation (to A. B. C.), and by the Giant Food Children's Cancer Research Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Britos-Bray M, 1998, BLOOD, V92, P4344, DOI 10.1182/blood.V92.11.4344.423a01_4344_4352; Cai XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028430; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Friedman AD, 1999, LEUKEMIA, V13, P1932, DOI 10.1038/sj.leu.2401590; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Goyama S, 2015, ONCOGENE, V34, P3483, DOI 10.1038/onc.2014.305; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Guo H, 2014, J LEUKOCYTE BIOL, V96, P419, DOI 10.1189/jlb.2AB0314-145R; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Guo H, 2011, J BIOL CHEM, V286, P208, DOI 10.1074/jbc.M110.149013; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kim J, 2004, BLOOD CELL MOL DIS, V32, P302, DOI 10.1016/j.bcmd.2003.12.004; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Mermel CH, 2006, BLOOD, V108, P2562, DOI 10.1182/blood-2006-05-024307; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Swiers G, 2010, INT J DEV BIOL, V54, P1151, DOI 10.1387/ijdb.103106gs; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	40	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					826	836		10.1074/jbc.M115.674234	http://dx.doi.org/10.1074/jbc.M115.674234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26598521	Green Published, hybrid			2022-12-28	WOS:000367830500029
J	Saha, B; Momen-Heravi, F; Kodys, K; Szabo, G				Saha, Banishree; Momen-Heravi, Fatemeh; Kodys, Karen; Szabo, Gyongyi			MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; exosome (vesicle); extracellular vesicles; liver injury; phagocytosis; alcoholic hepatitis	LIVER-DISEASE; CIRCULATING MICRORNAS; INTERFERON-ALPHA; DENDRITIC CELLS; INNATE IMMUNITY; THP-1 CELLS; PHAGOCYTOSIS; MICROVESICLES; ACTIVATION; EXOSOMES	Membrane-coated extracellular vesicles (EVs) released by cells can serve as vehicles for delivery of biological materials and signals. Recently, we demonstrated that alcohol-treated hepatocytes cross-talk with immune cells via exosomes containing microRNA (miRNAs). Here, we hypothesized that alcohol-exposed monocytes can communicate with naive monocytes via EVs. We observed increased numbers of EVs, mostly exosomes, secreted by primary human monocytes and THP-1 monocytic cells in the presence of alcohol in a concentration- and time-dependent manner. EVs derived from alcohol-treated monocytes stimulated naive monocytes to polarize into M2 macrophages as indicated by increased surface expression of CD68 (macrophage marker), M2 markers (CD206 (mannose receptor) and CD163 (scavenger receptor)), secretion of IL-10, and TGF and increased phagocytic activity. miRNA profiling of the EVs derived from alcohol-treated THP-1 monocytes revealed high expression of the M2-polarizing miRNA, miR-27a. Treatment of naive monocytes with control EVs overexpressing miR-27a reproduced the effect of EVs from alcohol-treated monocytes on naive monocytes and induced M2 polarization, suggesting that the effect of alcohol EVs was mediated by miR-27a. We found that miR-27a modulated the process of phagocytosis by targeting CD206 expression on monocytes. Importantly, analysis of circulating EVs from plasma of alcoholic hepatitis patients revealed increased numbers of EVs that contained high levels of miR-27a as compared with healthy controls. Our results demonstrate the following: first, alcohol increases EV production in monocytes; second, alcohol-exposed monocytes communicate with naive monocytes via EVs; and third, miR-27a cargo in monocyte-derived EVs can program naive monocytes to polarize into M2 macrophages.	[Saha, Banishree; Momen-Heravi, Fatemeh; Kodys, Karen; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, LRB208,364 Plantat St, Worcester, MA 01605 USA.	Gyongyi.Szabo@umassmed.edu	Momen-Heravi, Fatemeh/G-7955-2012	Momen-Heravi, Fatemeh/0000-0003-4534-1450	National Institutes of Health [R01AA011576 UO1, AA021907 UO1, AA021893]; Defeat Alcoholic SteatoHepatitis (DASH) consortium; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011576, U01AA021893, R21AA023628, U01AA021907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defeat Alcoholic SteatoHepatitis (DASH) consortium; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants R01AA011576 UO1, AA021907 UO1, and AA021893 (to G. S.) and the Defeat Alcoholic SteatoHepatitis (DASH) consortium. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Ampel NM, 2005, INFECT IMMUN, V73, P2554, DOI 10.1128/IAI.73.4.2554-2555.2005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bala S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10721; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; Campos JH, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832057; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; de Vrij J, 2015, INT J CANCER, V137, P1630, DOI 10.1002/ijc.29521; den Brouw MLO, 2009, VIROLOGY, V393, P84, DOI 10.1016/j.virol.2009.07.015; El Gazzar M, 2012, IMMUNOL CELL BIOL, V90, P587, DOI 10.1038/icb.2011.74; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Guay C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0097-7; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Julich H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00413; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Karavitis J, 2012, CELL IMMUNOL, V274, P61, DOI 10.1016/j.cellimm.2012.02.002; Karavitis J, 2011, J LEUKOCYTE BIOL, V90, P1065, DOI 10.1189/jlb.0311114; LANDMANN R, 1991, J CELL BIOCHEM, V47, P317, DOI 10.1002/jcb.240470406; Lee J, 2014, EXP MOL PATHOL, V96, P118, DOI 10.1016/j.yexmp.2013.09.004; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mandrekar P., 2012, TRENDS ALCOHOLIC LIV, DOI [10.5772/27412, DOI 10.5772/27412]; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McClain CJ, 2002, ALCOHOL, V27, P53, DOI 10.1016/S0741-8329(02)00212-4; Momen-Heravi F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0623-9; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Momen-Heravi F, 2014, NANOMED-NANOTECHNOL, V10, P1517, DOI 10.1016/j.nano.2014.03.014; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; Moon HG, 2014, J IMMUNOL, V193, P4558, DOI 10.4049/jimmunol.1401372; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naqvi AR, 2015, J IMMUNOL, V194, P1916, DOI 10.4049/jimmunol.1401893; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pap E, 2011, ADV EXP MED BIOL, V714, P183, DOI 10.1007/978-94-007-0782-5_10; Piemonti L, 1999, INT IMMUNOL, V11, P1519, DOI 10.1093/intimm/11.9.1519; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Saha B, 2015, J IMMUNOL, V194, P3079, DOI 10.4049/jimmunol.1402190; Sharbati S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-23; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; Szabo G, 2001, ALCOHOL CLIN EXP RES, V25, P1188; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Szabo G, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341126; Taylor Douglas D., 2013, Frontiers in Genetics, V4, P142, DOI 10.3389/fgene.2013.00142; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260	58	133	139	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					149	159		10.1074/jbc.M115.694133	http://dx.doi.org/10.1074/jbc.M115.694133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26527689	hybrid, Green Published			2022-12-28	WOS:000367589500012
J	Matsuo, S; Ogawa, M; Muckenthaler, MU; Mizui, Y; Sasaki, S; Fujimura, T; Takizawa, M; Ariga, N; Ozaki, H; Sakaguchi, M; Gonzalez, FJ; Inoue, Y				Matsuo, Shunsuke; Ogawa, Masayuki; Muckenthaler, Martina U.; Mizui, Yumiko; Sasaki, Shota; Fujimura, Takafumi; Takizawa, Masayuki; Ariga, Nagayuki; Ozaki, Hiroaki; Sakaguchi, Masakiyo; Gonzalez, Frank J.; Inoue, Yusuke			Hepatocyte Nuclear Factor 4 alpha Controls Iron Metabolism and Regulates Transferrin Receptor 2 in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTORS; GENE-EXPRESSION; HEPCIDIN; PROTEIN; DISRUPTION; HYPOTRANSFERRINEMIA; HOMEOSTASIS; PROMOTER; BINDING; BMP	Iron is an essential element in biological systems, but excess iron promotes the formation of reactive oxygen species, resulting in cellular toxicity. Several iron-related genes are highly expressed in the liver, a tissue in which hepatocyte nuclear factor 4 alpha (HNF4 alpha) plays a critical role in controlling gene expression. Therefore, the role of hepatic HNF4 alpha in iron homeostasis was examined using liver-specific HNF4 alpha-null mice (Hnf4a(Delta H) mice). Hnf4a(Delta H) mice exhibit hypoferremia and a significant change in hepatic gene expression. Notably, the expression of transferrin receptor 2 (Tfr2) mRNA was markedly decreased in Hnf4a(Delta H) mice. Promoter analysis of the Tfr2 gene showed that the basal promoter was located at a GC-rich region upstream of the transcription start site, a region that can be transactivated in an HNF4 alpha-independent manner. HNF4 alpha-dependent expression of Tfr2 was mediated by a proximal promoter containing two HNF4 alpha-binding sites located between the transcription start site and the translation start site. Both the GC-rich region of the basal promoter and the HNF4 alpha-binding sites were required for maximal transactivation. Moreover, siRNA knockdown of HNF4 alpha suppressed TFR2 expression in human HCC cells. These results suggest that Tfr2 is a novel target gene for HNF4 alpha, and hepatic HNF4 alpha plays a critical role in iron homeostasis.	[Matsuo, Shunsuke; Ogawa, Masayuki; Mizui, Yumiko; Sasaki, Shota; Fujimura, Takafumi; Takizawa, Masayuki; Ariga, Nagayuki; Ozaki, Hiroaki; Inoue, Yusuke] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan; [Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20852 USA	Gunma University; Ruprecht Karls University Heidelberg; Okayama University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Inoue, Y (corresponding author), Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, 1-5-1 Tenjin Cho, Kiryu, Gunma 3768515, Japan.	yinoue@gunma-u.ac.jp	Inoue, Yusuke/O-6207-2018; Sakaguchi, Masakiyo/B-2280-2011	Inoue, Yusuke/0000-0002-9710-7482; Muckenthaler, Martina/0000-0002-3778-510X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460490]; Kato Memorial Bioscience Foundation; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research 25460490 (to Y. I.) and Kato Memorial Bioscience Foundation (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; [Anonymous], 2001, NUCL RECEPTORS GENET; Bartnikas TB, 2012, BIOMETALS, V25, P677, DOI 10.1007/s10534-012-9520-3; BERNSTEIN SE, 1987, J LAB CLIN MED, V110, P690; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Core AB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00104; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; HAYASHI A, 1993, AM J HUM GENET, V53, P201; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Inoue Y, 2004, J BIOL CHEM, V279, P44740, DOI 10.1074/jbc.M405177200; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Kardassis D, 2002, BIOCHEMISTRY-US, V41, P1217, DOI 10.1021/bi015618f; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Richter A, 2002, BIOTECHNIQUES, V33, P620, DOI 10.2144/02333rr05_11834a; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; SCHAEFFER E, 1993, J BIOL CHEM, V268, P23399; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Yun S, 2015, CRIT REV ONCOL HEMAT, V95, P12, DOI 10.1016/j.critrevonc.2015.02.006	39	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30855	30865		10.1074/jbc.M115.694414	http://dx.doi.org/10.1074/jbc.M115.694414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527688	hybrid, Green Published			2022-12-28	WOS:000367199000018
J	Jarosz-Griffiths, HH; Noble, E; Rushworth, JV; Hooper, NM				Jarosz-Griffiths, Heledd H.; Noble, Elizabeth; Rushworth, Jo V.; Hooper, Nigel M.			Amyloid- Receptors: The Good, the Bad, and the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Alzheimer disease; amyloid; oligomer; prion; receptor	A-BETA OLIGOMERS; ALZHEIMERS-DISEASE BRAIN; SYNAPTIC PLASTICITY; APOLIPOPROTEIN-E; MEMORY IMPAIRMENT; CLEARANCE; PEPTIDE; FIBRILS; INHIBITION; PATHWAY	Several different receptor proteins have been identified that bind monomeric, oligomeric, or fibrillar forms of amyloid- (A). Good receptors internalize A or promote its transcytosis out of the brain, whereas bad receptors bind oligomeric forms of A that are largely responsible for the synapticloss, memory impairments, and neurotoxicity that underlie Alzheimer disease. The prion protein both removes A from the brain and transduces the toxic actions of A. The clustering of distinct receptors in cell surface signaling platforms likely underlies the actions of distinct oligomeric species of A. These A receptor-signaling platforms provide opportunities for therapeutic intervention in Alzheimer disease.	[Jarosz-Griffiths, Heledd H.; Noble, Elizabeth; Hooper, Nigel M.] Univ Manchester, Inst Brain Behav & Mental Hlth, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Rushworth, Jo V.] De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England	University of Manchester; De Montfort University	Hooper, NM (corresponding author), Univ Manchester, Inst Brain Behav & Mental Hlth, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.	nigel.hooper@manchester.ac.uk	Rushworth, Jo/AAL-2555-2021	Rushworth, Jo/0000-0002-7134-2011; Hooper, Nigel/0000-0002-5811-3484; Jarosz-Griffiths, Heledd/0000-0001-5154-4815	Alzheimer's Research UK [PG2013-12]; Biotechnology and Biological Sciences Research Council; Dr. Donald Dean Fund in Dementia Research; University of Manchester; MRC [MR/L023784/2, MR/L023784/1] Funding Source: UKRI; Alzheimers Research UK [ARUK-PG2013-12] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [1360639] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dr. Donald Dean Fund in Dementia Research; University of Manchester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Alzheimer's Research UK (PG2013-12), the Biotechnology and Biological Sciences Research Council, the Dr. Donald Dean Fund in Dementia Research, and the University of Manchester. The authors declare that they have no conflicts of interest with the contents of this article.	Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bodani RU, 2015, ACS CHEM NEUROSCI, V6, P1981, DOI 10.1021/acschemneuro.5b00231; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Du WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07992; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Fu W, 2012, J BIOL CHEM, V287, P18820, DOI 10.1074/jbc.M111.331181; Garai K, 2014, BIOCHEMISTRY-US, V53, P6323, DOI 10.1021/bi5008172; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goure WF, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt272; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hashimoto Y, 2004, J NEUROCHEM, V90, P549, DOI 10.1111/j.1471-4159.2004.02513.x; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025; Husemann J, 2001, J NEUROIMMUNOL, V114, P142, DOI 10.1016/S0165-5728(01)00239-9; Inoue S, 2008, AMYLOID, V15, P223, DOI 10.1080/13506120802524858; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Marin R, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00023; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]; Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Ohnishi T, 2015, P NATL ACAD SCI USA, V112, pE4465, DOI 10.1073/pnas.1421182112; Origlia N, 2010, J NEUROSCI, V30, P11414, DOI 10.1523/JNEUROSCI.2127-10.2010; Overk CR, 2014, P NATL ACAD SCI USA, V111, P13680, DOI 10.1073/pnas.1414554111; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Risse E, 2015, J BIOL CHEM, V290, P17020, DOI 10.1074/jbc.M115.637124; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Sagare AP, 2013, J BIOL CHEM, V288, P15154, DOI 10.1074/jbc.M112.439570; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Siemers ER, 2016, ALZHEIMERS DEMENT, V12, P110, DOI [10.1016/j.jalz.2015.06.1893, 10.1016/j.dadm.2016.02.006]; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Solis GP, 2010, FRONT BIOSCI-LANDMRK, V15, P1075, DOI 10.2741/3662; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vargas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092309; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wilkinson K., 2012, INT J ALZHEIMERS DIS, V2012, P489456, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025	100	152	154	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3174	3183		10.1074/jbc.R115.702704	http://dx.doi.org/10.1074/jbc.R115.702704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26719327	Green Published, hybrid			2022-12-28	WOS:000370854500006
J	Barr, RK; Verdile, G; Wijaya, LK; Morici, M; Taddei, K; Gupta, VB; Pedrini, S; Jin, L; Nicolazzo, JA; Knock, E; Fraser, PE; Martins, RN				Barr, Renae K.; Verdile, Giuseppe; Wijaya, Linda K.; Morici, Michael; Taddei, Kevin; Gupta, Veer B.; Pedrini, Steve; Jin, Liang; Nicolazzo, Joseph A.; Knock, Erin; Fraser, Paul E.; Martins, Ralph N.			Validation and Characterization of a Novel Peptide That Binds Monomeric and Aggregated beta-Amyloid and Inhibits the Formation of Neurotoxic Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMAGE PHAGE DISPLAY; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; TRANSGENIC MICE; IN-VIVO; NATURAL OLIGOMERS; FIBRIL FORMATION; PROTEIN BINDS; BRAIN	Although the formation of beta-amyloid (A beta) deposits in the brain is a hallmark of Alzheimer disease (AD), the soluble oligomers rather than the mature amyloid fibrils most likely contribute to A beta toxicity and neurodegeneration. Thus, the discovery of agents targeting soluble A beta oligomers is highly desirable for early diagnosis prior to the manifestation of a clinical AD phenotype and also more effective therapies. We have previously reported that a novel 15-amino acid peptide (15-mer), isolated via phage display screening, targeted A beta and attenuated its neurotoxicity (Taddei, K., Laws, S. M., Verdile, G., Munns, S., D'Costa, K., Harvey, A. R., Martins, I. J., Hill, F., Levy, E., Shaw, J. E., and Martins, R. N. (2010) Neurobiol. Aging 31, 203-214). The aim of the current study was to generate and biochemically characterize analogues of this peptide with improved stability and therapeutic potential. We demonstrated that a stable analogue of the 15-amino acid peptide (15M S.A.) retained the activity and potency of the parent peptide and demonstrated improved proteolytic resistance in vitro (stable to t = 300 min, c.f.t = 30 min for the parent peptide). This candidate reduced the formation of soluble A beta 42 oligomers, with the concurrent generation of non-toxic, insoluble aggregates measuring up to 25-30 nm diameter as determined by atomic force microscopy. The 15M S.A. candidate directly interacted with oligomeric A beta 42, as shown by coimmunoprecipitation and surface plasmon resonance/Biacore analysis, with an affinity in the low micromolar range. Furthermore, this peptide bound fibrillar A beta 42 and also stained plaques ex vivo in brain tissue from AD model mice. Given its multifaceted ability to target monomeric and aggregated A beta 42 species, this candidate holds promise for novel preclinical AD imaging and therapeutic strategies.	[Barr, Renae K.; Wijaya, Linda K.; Morici, Michael; Taddei, Kevin; Gupta, Veer B.; Pedrini, Steve; Martins, Ralph N.] Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia; [Barr, Renae K.; Gupta, Veer B.; Pedrini, Steve; Martins, Ralph N.] Alzhyme Pty Ltd, Nedlands, WA 6009, Australia; [Verdile, Giuseppe] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6102, Australia; [Taddei, Kevin; Gupta, Veer B.; Pedrini, Steve; Martins, Ralph N.] Hollywood Med Ctr, Sir James McCusker Alzheimers Dis Res Unit, Nedlands, WA 6009, Australia; [Verdile, Giuseppe; Martins, Ralph N.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA 6009, Australia; [Jin, Liang; Nicolazzo, Joseph A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville, Vic 3052, Australia; [Knock, Erin; Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada	Edith Cowan University; Curtin University; University of Western Australia; Monash University; University of Toronto	Verdile, G (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6102, Australia.	giuseppe.verdile@curtin.edu.au; r.martins@ecu.edu.au	Morici, Michael/AGX-5320-2022; Wijaya, Linda/CAF-1162-2022	Wijaya, Linda/0000-0003-2603-7074; Martins, Ralph/0000-0002-4828-9363; Morici, Michael/0000-0001-7101-0976; Verdile, Giuseppe/0000-0003-2475-0124; Jin, Liang/0000-0003-1695-3300; Gupta, Veer/0000-0003-4989-0764; Pedrini, Steve/0000-0002-6409-8022; Barr, Renae/0000-0003-1601-7299	National Health and Medical Research Council of Australia [595300, 430909]; Alzhyme Pty Ltd.; Edith Cowan University; Curtin University Research Fellowship [CRF140196]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Alzhyme Pty Ltd.; Edith Cowan University; Curtin University Research Fellowship	This work was supported in part by the National Health and Medical Research Council of Australia Project Grant 595300 and Postdoctoral Fellowship 430909 (to R. K. B), Alzhyme Pty Ltd., and Edith Cowan University. R. N. M. is shareholder and CSO of Alzhyme Pty, LTD. No other conflicts of interest to declare.; Supported by Curtin University Research Fellowship CRF140196. To whom correspondence may be addressed:School of Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, WA, Australia. Tel.: 61-89266-5618; Fax: 61-8-9266-1715; E-mail: giuseppe.verdile@curtin.edu.au.	Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bergstrom CAS, 2012, PHARM RES-DORDR, V29, P3131, DOI 10.1007/s11095-012-0806-5; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; BURDICK D, 1992, J BIOL CHEM, V267, P546; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Chacon MA, 2004, MOL PSYCHIATR, V9, P953, DOI 10.1038/sj.mp.4001516; Chakravarthy B, 2013, J NEUROCHEM, V126, P415, DOI 10.1111/jnc.12208; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; DeMattos RB, 2012, NEURON, V76, P908, DOI 10.1016/j.neuron.2012.10.029; Drummond ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059166; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Funamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3529; Funke SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041457; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Granic I, 2010, J ALZHEIMERS DIS, V19, P991, DOI 10.3233/JAD-2010-1297; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin L, 2011, ANTIMICROB AGENTS CH, V55, P502, DOI 10.1128/AAC.01273-10; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Jungbauer LM, 2009, J MOL RECOGNIT, V22, P403, DOI 10.1002/jmr.948; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mathis CA, 2004, CURR PHARM DESIGN, V10, P1469, DOI 10.2174/1381612043384772; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Okamura N, 2010, IDRUGS, V13, P890; Ono K, 2006, CURR PHARM DESIGN, V12, P4357, DOI 10.2174/138161206778793010; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Rinne JO, 2012, ACTA NEUROPATHOL, V124, P833, DOI 10.1007/s00401-012-1051-z; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Sumbria RK, 2012, BIOCONJUGATE CHEM, V23, P1318, DOI 10.1021/bc3001744; Sundaram RK, 2012, INT J PEPT RES THER, V18, P99, DOI 10.1007/s10989-011-9283-7; Taddei K, 2010, NEUROBIOL AGING, V31, P203, DOI 10.1016/j.neurobiolaging.2008.03.023; Tanifum EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048515; Tarawneh R, 2010, NEUROPHARMACOLOGY, V59, P310, DOI 10.1016/j.neuropharm.2010.04.006; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Yates EA, 2013, J MOL BIOL, V425, P1915, DOI 10.1016/j.jmb.2013.03.022; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957	63	12	12	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					547	559		10.1074/jbc.M115.679993	http://dx.doi.org/10.1074/jbc.M115.679993			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26538562	hybrid, Green Published			2022-12-28	WOS:000367830500004
J	Berry, GE; Asokan, A				Berry, Garrett E.; Asokan, Aravind			Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL DEATH; VIRUS TYPE-2; AUTOPHAGY PATHWAY; CAPSID PROTEINS; TRAFFICKING; INFECTION; COMPARTMENT; VECTORS; IDENTIFICATION; ACCUMULATION	Intracellular trafficking of viruses can be influenced by a variety of inter-connected cellular sorting and degradation pathways involving endo-lysosomal vesicles, the ubiquitin-proteasome system, and autophagy-based or endoplasmic reticulum-associated machinery. In the case of recombinant adeno-associated viruses (AAV), proteasome inhibitors are known to prevent degradation of ubiquitinated AAV capsids, thereby leading to increased nuclear accumulation and transduction. However, the impact of other cellular degradation pathways on AAV trafficking is not well understood. In the current study, we screened a panel of small molecules focused on modulating different cellular degradation pathways and identified eeyarestatin I (EerI) as a novel reagent that enhances AAV transduction. EerI improved AAV transduction by an order of magnitude regardless of vector dose, genome architecture, cell type, or serotype. This effect was preceded by sequestration of AAV within enlarged vesicles that were dispersed throughout the cytoplasm. Specifically, EerI treatment redirected AAV particles toward large vesicles positive for late endosomal (Rab7) and lysosomal (LAMP1) markers. Notably, MG132 and EerI (proteasomal and endoplasmic reticulum-associated degradation inhibitors, respectively) appear to enhance AAV transduction by increasing the intracellular accumulation of viral particles in a mutually exclusive fashion. Taken together, our results expand on potential strategies to redirect recombinant AAV vectors toward more productive trafficking pathways by deregulating cellular degradation mechanisms.	[Berry, Garrett E.; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Berry, Garrett E.; Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Berry, Garrett E.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,5123 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu			National Institutes of Health through the NHLBI [R01HL089221, P01HL112761]; National Institutes of Health through the NIGMS [5T32 GM007092]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221, P01HL112761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health Grants R01HL089221 and P01HL112761) (to A. A.) through the NHLBI. This work was also supported by National Institutes of Health Training Grant 5T32 GM007092 (to G. E. B.) through the NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Bar S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003605; Bantel-Schaal U, 2002, J VIROL, V76, P2340, DOI 10.1128/JVI.76.5.2340-2349.2002; Bennett SM, 2013, J VIROL, V87, P8843, DOI 10.1128/JVI.00664-13; Bowles D.E., 2006, PARVOVIRUSES, P15; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Byun H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00330; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Grieger JC, 2006, J VIROL, V80, P5199, DOI 10.1128/JVI.02723-05; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Huang LY, 2014, CURR OPIN VIROL, V7, P108, DOI 10.1016/j.coviro.2014.05.007; Jackson WT, 2015, VIROLOGY, V479, P450, DOI 10.1016/j.virol.2015.03.042; Johnson JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002053; Johnson JS, 2010, J VIROL, V84, P8888, DOI 10.1128/JVI.00687-10; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Kirkegaard K, 2009, CURR TOP MICROBIOL, V335, P323, DOI 10.1007/978-3-642-00302-8_16; Lennemann NJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004685; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Mitchell AM, 2013, J VIROL, V87, P13035, DOI 10.1128/JVI.01826-13; Nathwani AC, 2009, GENE THER, V16, P60, DOI 10.1038/gt.2008.137; Nicolson SC, 2014, J VIROL, V88, P4132, DOI 10.1128/JVI.02660-13; Noack J, 2014, J VIROL, V88, P10272, DOI 10.1128/JVI.00801-14; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; Nonnenmacher ME, 2015, J VIROL, V89, P1673, DOI 10.1128/JVI.02520-14; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Shen S, 2013, J VIROL, V87, P13206, DOI 10.1128/JVI.02109-13; Shen S, 2013, J BIOL CHEM, V288, P28814, DOI 10.1074/jbc.M113.482380; Venkatakrishnan B, 2013, J VIROL, V87, P4974, DOI 10.1128/JVI.02524-12; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Weinberg MS, 2014, J VIROL, V88, P12472, DOI 10.1128/JVI.01971-14; WISTUBA A, 1995, J VIROL, V69, P5311, DOI 10.1128/JVI.69.9.5311-5319.1995; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Xiao PJ, 2012, J VIROL, V86, P10462, DOI 10.1128/JVI.00935-12; Yan ZY, 2002, J VIROL, V76, P2043, DOI 10.1128/JVI.76.5.2043-2053.2002; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516	44	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					939	947		10.1074/jbc.M115.687657	http://dx.doi.org/10.1074/jbc.M115.687657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26527686	Green Published, hybrid			2022-12-28	WOS:000367830500039
J	Guo, SH; Skala, WG; Magdolen, V; Briza, P; Biniossek, ML; Schilling, O; Kellermann, J; Brandstetter, H; Goettig, P				Guo, Shihui; Skala, Wolfgang; Magdolen, Viktor; Briza, Peter; Biniossek, Martin L.; Schilling, Oliver; Kellermann, Josef; Brandstetter, Hans; Goettig, Peter			A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN GLANDULAR KALLIKREIN; HUMAN SEMINAL PLASMA; PROTEASE INHIBITORS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PANCREATIC KALLIKREIN; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; CLEAVAGE SITES	Human kallikrein-related peptidase 2 (KLK2) is a key serine protease in semen liquefaction and prostate cancer together with KLK3/prostate-specific antigen. In order to decipher the function of its potential N-glycosylation site, we produced pro-KLK2 in Leishmania tarentolae cells and compared it with its non-glycosylated counterpart from Escherichia coli expression. Mass spectrometry revealed that Asn-95 carries a core glycan, consisting of two GlcNAc and three hexoses. Autocatalytic activation was retarded in glyco-pro-KLK2, whereas the activated glyco-form exhibited an increased proteolytic resistance. The specificity patterns obtained by the PICS (proteomic identification of protease cleavage sites) method are similar for both KLK2 variants, with a major preference for P1-Arg. However, glycosylation changes the enzymatic activity of KLK2 in a drastically substrate-dependent manner. Although glyco-KLK2 has a considerably lower catalytic efficiency than glycan-free KLK2 toward peptidic substrates with P2-Phe, the situation was reverted toward protein substrates, such as glyco-pro-KLK2 itself. These findings can be rationalized by the glycan-carrying 99-loop that prefers to cover the active site like a lid. By contrast, the non-glycosylated 99-loop seems to favor a wide open conformation, which mostly increases the apparent affinity for the substrates (i.e. by a reduction of Km). Also, the cleavage pattern and kinetics in autolytic inactivation of both KLK2 variants can be explained by a shift of the target sites due to the presence of the glycan. These striking effects of glycosylation pave the way to a deeper understanding of kallikrein-related peptidase biology and pathology.	[Guo, Shihui; Skala, Wolfgang; Briza, Peter; Brandstetter, Hans; Goettig, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Magdolen, Viktor] Tech Univ Munich, Klinikum Rechts Isar, Klin Forschergrp Frauenklin, D-81675 Munich, Germany; [Biniossek, Martin L.; Schilling, Oliver] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Schilling, Oliver] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Schilling, Oliver] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Schilling, Oliver] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Kellermann, Josef] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Salzburg University; Technical University of Munich; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Goettig, P (corresponding author), Salzburg Univ, Dept Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.	peter.goettig@sbg.ac.at	Schilling, O/AAC-8302-2019; Guo, shihui/AAT-2810-2021; guo, shihui/GPX-4901-2022; Goettig, Peter/K-4508-2019; Briza, Peter/D-7309-2012; Esser-Skala, Wolfgang/L-9370-2017; Brandstetter, Hans/E-6754-2011; Goettig, Peter/R-7996-2017	Guo, shihui/0000-0002-0542-1221; guo, shihui/0000-0002-0542-1221; Goettig, Peter/0000-0002-2430-1970; Briza, Peter/0000-0002-4941-6782; Esser-Skala, Wolfgang/0000-0002-7350-4045; Brandstetter, Hans/0000-0002-6089-3045; Goettig, Peter/0000-0002-2430-1970; Schilling, Oliver/0000-0001-7678-7653	Austrian Science Fund FWF D-A-CH Project [I631-B11]; Deutsche Forschungsgemeinschaft D-A-CH Project [MA1236/8-1]; Deutsche Forschungsgemeinschaft [SCHI 871/2, SCHI 871/5, SCHI 871/6, GR 1748/6, INST 39/900-1, SFB850]; European Research Council [ERC-2011-StG 282111-ProteaSys]; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; Austrian Science Fund (FWF) [I 631] Funding Source: researchfish	Austrian Science Fund FWF D-A-CH Project(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft D-A-CH Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF D-A-CH Project I631-B11 (to S. G., W. S., H. B., and P. G.) and Deutsche Forschungsgemeinschaft D-A-CH Project MA1236/8-1 (to V. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Deutsche Forschungsgemeinschaft Grants SCHI 871/2, SCHI 871/5, SCHI 871/6, GR 1748/6, and INST 39/900-1 and Grant SFB850 (Project B8), a starting grant of the European Research Council (Programme "Ideas"; Call identifier: ERC-2011-StG 282111-ProteaSys), and the Excellence Initiative of the German Federal and State Governments (EXC 294, BIOSS).	Aminetzach YT, 2009, CURR BIOL, V19, P1925, DOI 10.1016/j.cub.2009.09.022; Avgeris M, 2012, BIOL CHEM, V393, P301, DOI 10.1515/hsz-2011-0260; Baird TT, 2006, PROTEIN SCI, V15, P1229, DOI 10.1110/ps.062179006; BAKER AR, 1985, DNA-J MOLEC CELL BIO, V4, P445, DOI 10.1089/dna.1985.4.445; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Behnken HN, 2014, J PROTEOME RES, V13, P997, DOI 10.1021/pr400999y; Biniossek ML, 2012, PROTEOMICS, V12, P1303, DOI 10.1002/pmic.201100569; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Bowman KK, 2000, PROTEIN EXPRES PURIF, V20, P405, DOI 10.1006/prep.2000.1342; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Cloutier SM, 2002, EUR J BIOCHEM, V269, P2747, DOI 10.1046/j.1432-1033.2002.02960.x; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Deperthes D, 1996, J ANDROL, V17, P659; Deperthes D, 1995, BBA-GEN SUBJECTS, V1245, P311, DOI 10.1016/0304-4165(95)00118-2; Fenner G, 1931, NATURWISSENSCHAFTEN, V19, P310; Frenette G, 1997, BBA-GEN SUBJECTS, V1334, P109, DOI 10.1016/S0304-4165(96)00080-3; FUKUSHIMA D, 1985, BIOCHEMISTRY-US, V24, P8037, DOI 10.1021/bi00348a030; Gilgunn S, 2013, NAT REV UROL, V10, P99, DOI 10.1038/nrurol.2012.258; Grauer LS, 1998, J ANDROL, V19, P407; Guo SH, 2014, BIOL CHEM, V395, P959, DOI 10.1515/hsz-2014-0140; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Herrala A, 1997, CLIN CHEM, V43, P279; HOWARD S C, 1991, Glycobiology, V1, P411, DOI 10.1093/glycob/1.4.411; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuzmanov U, 2012, PROTEOMICS, V12, P799, DOI 10.1002/pmic.201100371; Kuzmanov U, 2009, MOL CELL PROTEOMICS, V8, P791, DOI 10.1074/mcp.M800516-MCP200; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Lovgren J, 1999, EUR J BIOCHEM, V262, P781, DOI 10.1046/j.1432-1327.1999.00433.x; Lovgren J, 1999, J ANDROL, V20, P348; Lovgren J, 1999, EUR J BIOCHEM, V266, P1050, DOI 10.1046/j.1432-1327.1999.00946.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martens L, 2005, BIOINFORMATICS, V21, P3584, DOI 10.1093/bioinformatics/bti588; Matsuda Y, 2002, ARCH ANDROLOGY, V48, P295, DOI 10.1080/01485010290031600; Meola J, 2006, GENET MOL BIOL, V29, P193, DOI 10.1590/S1415-47572006000200001; Mikolajczyk SD, 2000, UROLOGY, V55, P41, DOI 10.1016/S0090-4295(99)00372-6; Mikolajczyk SD, 1998, PROSTATE, V34, P44; Mikolajczyk SD, 1997, EUR J BIOCHEM, V246, P440, DOI 10.1111/j.1432-1033.1997.00440.x; O'Connor SE, 1998, CHEM BIOL, V5, P427, DOI 10.1016/S1074-5521(98)90159-4; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Rajakoski K, 1997, PROSTATE CANCER P D, V1, P16, DOI 10.1038/sj.pcan.4500206; Raspi G, 1996, J CHROMATOGR B, V684, P265, DOI 10.1016/0378-4347(96)00144-2; Recker F, 1998, CANCER, V83, P2540, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2540::AID-CNCR20>3.0.CO;2-V; REIGMAN PHJ, 1989, BIOCHEM BIOPH RES CO, V159, P95, DOI 10.1016/0006-291X(89)92409-1; RIEGMAN PHJ, 1989, FEBS LETT, V247, P123, DOI 10.1016/0014-5793(89)81253-0; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Ryslava H, 2013, J PROTEOMICS, V92, P80, DOI 10.1016/j.jprot.2013.03.025; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEDLICH LJ, 1987, DNA-J MOLEC CELL BIO, V6, P429, DOI 10.1089/dna.1987.6.429; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Shang ZQ, 2014, TUMOR BIOL, V35, P1881, DOI 10.1007/s13277-013-1253-6; Skala W, 2014, J BIOL CHEM, V289, P34267, DOI 10.1074/jbc.M114.598201; Song HW, 2002, ARCH BIOCHEM BIOPHYS, V400, P1, DOI 10.1006/abbi.2001.2737; Stura EA, 2011, J MOL BIOL, V414, P530, DOI 10.1016/j.jmb.2011.10.007; Takayama TK, 1997, J BIOL CHEM, V272, P21582, DOI 10.1074/jbc.272.34.21582; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; White KY, 2009, J PROTEOME RES, V8, P620, DOI 10.1021/pr8007545; Williams SA, 2010, PROSTATE, V70, P788, DOI 10.1002/pros.21111; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yoon H, 2009, BIOL CHEM, V390, P373, DOI 10.1515/BC.2009.026; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	76	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					593	604		10.1074/jbc.M115.691097	http://dx.doi.org/10.1074/jbc.M115.691097			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582203	hybrid, Green Published			2022-12-28	WOS:000367830500008
J	Macdonald, PJ; Francy, CA; Stepanyants, N; Lehman, L; Baglio, A; Mears, JA; Qi, X; Ramachandran, R				Macdonald, Patrick J.; Francy, Christopher A.; Stepanyants, Natalia; Lehman, Lance; Baglio, Anthony; Mears, Jason A.; Qi, Xin; Ramachandran, Rajesh			Distinct Splice Variants of Dynamin-related Protein 1 Differentially Utilize Mitochondrial Fission Factor as an Effector of Cooperative GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; cardiolipin; fluorescence resonance energy transfer (FRET); GTPase; mitochondria; dynamin-related protein 1; isoforms; mitochondrial dynamics; mitochondrial fission factor	PLECKSTRIN HOMOLOGY DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; DRP1 RECRUITMENT; MEMBRANE; MID51; MFF; CURVATURE; MID49	Multiple isoforms of the mitochondrial fission GTPase dynamin-related protein 1 (Drp1) arise from the alternative splicing of its single gene-encoded pre-mRNA transcript. Among these, the longer Drp1 isoforms, expressed selectively in neurons, bear unique polypeptide sequences within their GTPase and variable domains, known as the A-insert and the B-insert, respectively. Their functions remain unresolved. A comparison of the various biochemical and biophysical properties of the neuronally expressed isoforms with that of the ubiquitously expressed, and shortest, Drp1 isoform (Drp1-short) has revealed the effect of these inserts on Drp1 function. Utilizing various biochemical, biophysical, and cellular approaches, we find that the A- and B-inserts distinctly alter the oligomerization propensity of Drp1 in solution as well as the preferred curvature of helical Drp1 self-assembly on membranes. Consequently, these sequences also suppress Drp1 cooperative GTPase activity. Mitochondrial fission factor (Mff), a tail-anchored membrane protein of the mitochondrial outer membrane that recruits Drp1 to sites of ensuing fission, differentially stimulates the disparate Drp1 isoforms and alleviates the autoinhibitory effect imposed by these sequences on Drp1 function. Moreover, the differential stimulatory effects of Mff on Drp1 isoforms are dependent on the mitochondrial lipid, cardiolipin (CL). Although Mff stimulation of the intrinsically cooperative Drp1-short isoform is relatively modest, CL-independent, and even counter-productive at high CL concentrations, Mff stimulation of the much less cooperative longest Drp1 isoform (Drp1-long) is robust and occurs synergistically with increasing CL content. Thus, membrane-anchored Mff differentially regulates various Drp1 isoforms by functioning as an allosteric effector of cooperative GTPase activity.	[Macdonald, Patrick J.; Stepanyants, Natalia; Lehman, Lance; Baglio, Anthony; Qi, Xin; Ramachandran, Rajesh] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Francy, Christopher A.; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Francy, Christopher A.; Mears, Jason A.; Qi, Xin] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Francy, Christopher A.; Mears, Jason A.; Ramachandran, Rajesh] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Ramachandran, R (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	rxr275@case.edu	Qi, Xin/L-9279-2019; Ramachandran, Rajesh/A-1337-2011; Qi, Xin/D-1512-2013	Qi, Xin/0000-0002-9578-3890; Ramachandran, Rajesh/0000-0002-4645-2841; Qi, Xin/0000-0002-9578-3890; Mears, Jason/0000-0002-5199-4872; Macdonald, Patrick/0000-0002-4641-954X	American Heart Association (AHA) [13BGIA14810010]; AHA Scientist Development Grant [12SDG9130039]; National Institutes of Health R01 Grant [NS088192]; National Institutes of Health Training Grant [2T32GM008803-11A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088192] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); AHA Scientist Development Grant(American Heart Association); National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by American Heart Association (AHA) Beginning Grant-in-Aid (13BGIA14810010) (to R. R.). This work is also supported by the AHA Scientist Development Grant (12SDG9130039) (to J. A. M.), National Institutes of Health R01 Grant NS088192 (to X. Q.), and National Institutes of Health Training Grant 2T32GM008803-11A1 (to C. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Ceppi P, 2005, P NATL ACAD SCI USA, V102, P16269, DOI 10.1073/pnas.0508157102; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Clinton RW, 2016, J BIOL CHEM, V291, P478, DOI 10.1074/jbc.M115.680025; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mattila JP, 2015, NATURE, V524, P109, DOI 10.1038/nature14509; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mehrotra N, 2014, MOL BIOL CELL, V25, P879, DOI 10.1091/mbc.E13-09-0548; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Reubold TF, 2015, NATURE, V525, P404, DOI 10.1038/nature14880; Richter V, 2015, CELL MOL LIFE SCI, V72, P3695, DOI 10.1007/s00018-015-1950-y; Richter V, 2014, J CELL BIOL, V204, P477, DOI 10.1083/jcb.201311014; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9136; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	54	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					493	507		10.1074/jbc.M115.680181	http://dx.doi.org/10.1074/jbc.M115.680181			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578513	hybrid, Green Published			2022-12-28	WOS:000367589500043
J	Nitzsche, R; Zagoriy, V; Lucius, R; Gupta, N				Nitzsche, Richard; Zagoriy, Vyacheslav; Lucius, Richard; Gupta, Nishith			Metabolic Cooperation of Glucose and Glutamine Is Essential for the Lytic Cycle of Obligate Intracellular Parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; energy metabolism; gluconeogenesis; glucose metabolism; glutamine; glycolysis; lipid synthesis; metabolic regulation; parasite metabolism; tricarboxylic acid cycle (TCA cycle) (Krebs cycle)	FUNCTIONAL-ANALYSIS; GAS-CHROMATOGRAPHY; AEROBIC GLYCOLYSIS; MASS-SPECTROMETRY; ACETATE; TACHYZOITES; APICOPLAST; INVASION; BRAIN; GENE	Toxoplasma gondii is a widespread protozoan parasite infecting nearly all warm-blooded organisms. Asexual reproduction of the parasite within its host cells is achieved by consecutive lytic cycles, which necessitates biogenesis of significant energy and biomass. Here we show that glucose and glutamine are the two major physiologically important nutrients used for the synthesis of macromolecules (ATP, nucleic acid, proteins, and lipids) in T. gondii, and either of them is sufficient to ensure the parasite survival. The parasite can counteract genetic ablation of its glucose transporter by increasing the flux of glutamine-derived carbon through the tricarboxylic acid cycle and by concurrently activating gluconeogenesis, which guarantee a continued biogenesis of ATP and biomass for host-cell invasion and parasite replication, respectively. In accord, a pharmacological inhibition of glutaminolysis or oxidative phosphorylation arrests the lytic cycle of the glycolysis-deficient mutant, which is primarily a consequence of impaired invasion due to depletion of ATP. Unexpectedly, however, intracellular parasites continue to proliferate, albeit slower, notwithstanding a simultaneous deprivation of glucose and glutamine. A growth defect in the glycolysis-impaired mutant is caused by a compromised synthesis of lipids, which cannot be counterbalanced by glutamine but can be restored by acetate. Consistently, supplementation of parasite cultures with exogenous acetate can amend the lytic cycle of the glucose transport mutant. Such plasticity in the parasite's carbon flux enables a growth-and-survival trade-off in assorted nutrient milieus, which may underlie the promiscuous survival of T. gondii tachyzoites in diverse host cells. Our results also indicate a convergence of parasite metabolism with cancer cells.	[Nitzsche, Richard; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Zagoriy, Vyacheslav] MetaSysX GmbH, D-14476 Potsdam, Germany; [Gupta, Nishith] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany	Humboldt University of Berlin; Max Planck Society	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10099 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126	German Research Foundation (Deutsche Forschungsgemeinschaft) [GRK1121/A7, GU1100/3-1]; German Research Foundation [GRK1121/A7, GU1100/3-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	The work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grants GRK1121/A7 and GU1100/3-1 (to N. G.). The authors declare that there are no conflicts of interest pertaining to this work.; Supported by German Research Foundation Grants GRK1121/A7 and GU1100/3-1.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Brand A, 1997, CELL MOL BIOL, V43, P645; CERDAN S, 1990, J BIOL CHEM, V265, P12916; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; DUBREMETZ JF, 1985, EXP PARASITOL, V59, P24, DOI 10.1016/0014-4894(85)90053-0; Echeverria PC, 2010, MOL BIOCHEM PARASIT, V172, P129, DOI 10.1016/j.molbiopara.2010.04.004; Fleige T, 2008, INT J PARASITOL, V38, P1121, DOI 10.1016/j.ijpara.2008.01.007; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hummel J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00054; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jung JY, 2015, J CHROMATOGR B, V974, P101, DOI 10.1016/j.jchromb.2014.10.033; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Lin SS, 2011, INT J PARASITOL, V41, P835, DOI 10.1016/j.ijpara.2011.03.005; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; OHSAKA A, 1982, PHYSIOL CHEM PHYS M, V14, P381; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Ramakrishnan S, 2015, MOL MICROBIOL, V97, P64, DOI 10.1111/mmi.13010; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; TOLLINGER CD, 1979, CLIN CHEM, V25, P1787; Tymoshenko S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004261; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998	47	37	37	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					126	141		10.1074/jbc.M114.624619	http://dx.doi.org/10.1074/jbc.M114.624619			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26518878	Green Published, hybrid			2022-12-28	WOS:000367589500010
J	Eckl, JM; Scherr, MJ; Freiburger, L; Daake, MA; Sattler, M; Richter, K				Eckl, Julia M.; Scherr, Matthias J.; Freiburger, Lee; Daake, Marina A.; Sattler, Michael; Richter, Klaus			Hsp90 center dot Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CO-CHAPERONE; HSP90; BINDING; CLIENT; CYCLE; CDC37; RAF; IDENTIFICATION; GELDANAMYCIN	Protein kinases are the most prominent group of heat shock protein 90 (Hsp90) clients and are recruited to the molecular chaperone by the kinase-specific cochaperone cell division cycle 37 (Cdc37). The interaction between Hsp90 and nematode Cdc37 is mediated by binding of the Hsp90 middle domain to an N-terminal region of Caenorhabditis elegans Cdc37 (CeCdc37). Here we map the binding site by NMR spectroscopy and define amino acids relevant for the interaction between CeCdc37 and the middle domain of Hsp90. Apart from these distinct Cdc37/Hsp90 interfaces, binding of the B-Raf protein kinase to the cochaperone is conserved between mammals and nematodes. In both cases, the C-terminal part of Cdc37 is relevant for kinase binding, whereas the N-terminal domain displaces the nucleotide from the kinase. This interaction leads to a cooperative formation of the ternary complex of Cdc37 and kinase with Hsp90. For the mitogen-activated protein kinase extracellular signal-regulated kinase 2 (Erk2), we observe that certain features of the interaction with Cdc37 center dot Hsp90 are conserved, but the contribution of Cdc37 domains varies slightly, implying that different kinases may utilize distinct variations of this binding mode to interact with the Hsp90 chaperone machinery.	[Eckl, Julia M.; Scherr, Matthias J.; Freiburger, Lee; Daake, Marina A.; Sattler, Michael; Richter, Klaus] Tech Univ Munich, Ctr Integrated Prot Sci Munchen, Dept Chem, D-85748 Garching, Germany; [Freiburger, Lee; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Richter, K (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munchen, Lichtenbergstr 4, D-85748 Garching, Germany.	klaus.richter@richterlab.de	Sattler, Michael/A-2407-2012; Richter, Klaus/A-2673-2010	Sattler, Michael/0000-0002-1594-0527; Richter, Klaus/0000-0002-8952-9642; Scherr, Matthias Josef/0000-0003-0110-3709	Deutsche Forschungsgemeinschaft [RI1873/1-3, SFB1035]; Fonds der chemischen Industrie; TUM Graduate School's Faculty Graduate Center of Chemistry at the Technische Universitat Munchen; Center for Integrated Protein Science; European Molecular Biology Organization Long Term Fellowship ALTF [1255-2011]; Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); TUM Graduate School's Faculty Graduate Center of Chemistry at the Technische Universitat Munchen; Center for Integrated Protein Science; European Molecular Biology Organization Long Term Fellowship ALTF; Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme(European Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft Grants RI1873/1-3 (to K. R.) and SFB1035 (to M. J. S.), the Fonds der chemischen Industrie, the TUM Graduate School's Faculty Graduate Center of Chemistry at the Technische Universitat Munchen, and the Center for Integrated Protein Science. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Molecular Biology Organization Long Term Fellowship ALTF 1255-2011 and a Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme.	Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Eckl JM, 2014, BIOCHEMISTRY-US, V53, P2505, DOI 10.1021/bi5000542; Eckl JM, 2013, J BIOL CHEM, V288, P16032, DOI 10.1074/jbc.M112.439257; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hayes DB, 2010, MACROMOL BIOSCI, V10, P731, DOI 10.1002/mabi.201000075; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perdew GH, 1997, BIOCHEMISTRY-US, V36, P3600, DOI 10.1021/bi9612529; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2012, FUTURE ONCOL, V8, P939, DOI [10.2217/FON.12.80, 10.2217/fon.12.80]; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	49	34	34	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30843	30854		10.1074/jbc.M115.693150	http://dx.doi.org/10.1074/jbc.M115.693150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511315	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000367199000017
J	Kolodney, G; Dumin, E; Safory, H; Rosenberg, D; Mori, H; Radzishevisky, I; Wolosker, H				Kolodney, Goren; Dumin, Elena; Safory, Hazem; Rosenberg, Dina; Mori, Hisashi; Radzishevisky, Inna; Wolosker, Herman			Nuclear Compartmentalization of Serine Racemase Regulates D-Serine Production IMPLICATIONS FOR N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROMODULATOR D-SERINE; AMINO-ACID TRANSPORTER; PROGRAMMED CELL-DEATH; ENDOGENOUS D-SERINE; NEURONAL D-SERINE; GLUTAMATE-NEUROTRANSMISSION; CEREBRAL-ISCHEMIA; MOUSE MODEL; APOPTOSIS	D-Serine is a physiological co-agonist that activates N-methyl D-aspartate receptors (NMDARs) and is essential for neurotransmission, synaptic plasticity, and behavior. D-Serine may also trigger NMDAR-mediated neurotoxicity, and its dysregulation may play a role in neurodegeneration. D-Serine is synthesized by the enzyme serine racemase (SR), which directly converts L-serine to D-serine. However, many aspects concerning the regulation of D-serine production under physiological and pathological conditions remain to be elucidated. Here, we investigate possible mechanisms regulating the synthesis of D-serine by SR in paradigms relevant to neurotoxicity. We report that SR undergoes nucleocytoplasmic shuttling and that this process is dysregulated by several insults leading to neuronal death, typically by apoptotic stimuli. Cell death induction promotes nuclear accumulation of SR, in parallel with the nuclear translocation of GAPDH and Siah proteins at an early stage of the cell death process. Mutations in putative SR nuclear export signals (NESs) elicit SR nuclear accumulation and its depletion from the cytosol. Following apoptotic insult, SR associates with nuclear GAPDH along with other nuclear components, and this is accompanied by complete inactivation of the enzyme. As a result, extracellular D-serine concentration is reduced, even though extracellular glutamate concentration increases several-fold. Our observations imply that nuclear translocation of SR provides a fail-safe mechanism to prevent or limit secondary NMDAR-mediated toxicity in nearby synapses.	[Wolosker, Herman] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel; [Wolosker, Herman] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Dumin, Elena] Rambam Hlth Care Campus, Lab Clin Biochem, Metab Unit, IL-31096 Haifa, Israel; [Mori, Hisashi] Toyama Univ, Dept Mol Neurosci, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; University of Toyama		vinna@tx.technion.ac.il; hwolosker@tx.technion.ac.il		Radzishevsky, Inna/0000-0001-7748-7599; Wolosker, Herman/0000-0001-5508-9194	Israel Science Foundation; Legacy Heritage Fund; ALS Research Fund; Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; ALS Research Fund; Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain	This work was supported by the Israel Science Foundation, Legacy Heritage Fund, ALS Research Fund in the memory of Dr. David S. David, and the Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain (to H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2014, J CEREBR BLOOD F MET, V34, P1928, DOI 10.1038/jcbfm.2014.164; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Balu DT, 2012, NEUROSCI LETT, V517, P77, DOI 10.1016/j.neulet.2012.04.020; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Billard JM, 2013, EUR J NEUROSCI, V37, P1931, DOI 10.1111/ejn.12226; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032971; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5; Dikopoltsev E, 2014, J BIOL CHEM, V289, P33904, DOI 10.1074/jbc.M114.618405; Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Esposito S, 2012, AGING CELL, V11, P588, DOI 10.1111/j.1474-9726.2012.00822.x; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harlow E., 1988, ANTIBODIES LAB MANUA, P343; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Inoue R, 2014, J INVEST DERMATOL, V134, P1618, DOI 10.1038/jid.2014.22; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Li X, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1292-z; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Ma TM, 2014, J BIOL CHEM, V289, P29631, DOI 10.1074/jbc.M114.571604; Maucler C, 2013, ACS CHEM NEUROSCI, V4, P772, DOI 10.1021/cn4000549; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; MIZUMOTO K, 1994, MOL PHARMACOL, V46, P890; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Mustafaa AK, 2009, P NATL ACAD SCI USA, V106, P2921, DOI 10.1073/pnas.0813105106; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; O'Brien KB, 2006, ELECTROPHORESIS, V27, P1949, DOI 10.1002/elps.200500770; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Price P.J., 2001, PROTOCOLS NEURAL CEL, P255, DOI 10.1385/1-59259-207-4:255; Radzishevsky I, 2013, CURR OPIN CLIN NUTR, V16, P72, DOI 10.1097/MCO.0b013e32835a3466; Radzishevsky I, 2012, METHODS MOL BIOL, V794, P291, DOI 10.1007/978-1-61779-331-8_19; Ribeiro CS, 2002, BRAIN RES, V929, P202, DOI 10.1016/S0006-8993(01)03390-X; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Rutter AR, 2007, EUR J NEUROSCI, V25, P1757, DOI 10.1111/j.1460-9568.2007.05446.x; Safory H, 2015, EMBO REP, V16, P590, DOI 10.15252/embr.201439561; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Suzuki M, 2015, P NATL ACAD SCI USA, V112, pE2217, DOI 10.1073/pnas.1416117112; Szargel R, 2009, J BIOL CHEM, V284, P11706, DOI 10.1074/jbc.M805990200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yamamoto T, 2004, NEUROSCI RES, V49, P101, DOI 10.1016/j.neures.2004.02.004; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	85	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31037	31050		10.1074/jbc.M115.699496	http://dx.doi.org/10.1074/jbc.M115.699496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26553873	hybrid, Green Published			2022-12-28	WOS:000367199000033
J	Maksimov, MO; Koos, JD; Zong, CH; Lisko, B; Link, AJ				Maksimov, Mikhail O.; Koos, Joseph D.; Zong, Chuhan; Lisko, Bozhena; Link, A. James			Elucidating the Specificity Determinants of the AtxE2 Lasso Peptide Isopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STRUCTURES; MICROCIN J25; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; NATURAL-PRODUCTS; NOESY SPECTRA; I-III; BIOSYNTHESIS; MATURATION; ASSIGNMENT	Lasso peptide isopeptidase is an enzyme that specifically hydrolyzes the isopeptide bond of lasso peptides, rendering these peptides linear. To carry out a detailed structure-activity analysis of the lasso peptide isopeptidase AtxE2 from Asticcacaulis excentricus, we solved NMR structures of its substrates astexin-2 and astexin-3. Using in vitro enzyme assays, we show that the C-terminal tail portion of these peptides is dispensable with regards to isopeptidase activity. A collection of astexin-2 and astexin-3 variants with alanine substitutions at each position within the ring and the loop was constructed, and we showed that all of these peptides except for one were cleaved by the isopeptidase. Thus, much like the lasso peptide biosynthetic enzymes, lasso peptide isopeptidase has broad substrate specificity. Quantitative analysis of the cleavage reactions indicated that alanine substitutions in loop positions of these peptides led to reduced cleavage, suggesting that the loop is serving as a recognition element for the isopeptidase.	[Maksimov, Mikhail O.; Lisko, Bozhena; Link, A. James] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Koos, Joseph D.; Link, A. James] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Zong, Chuhan] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Link, AJ (corresponding author), 207 Hoyt Lab, Princeton, NJ 08544 USA.	ajlink@princeton.edu	Regan, Clinton/E-6250-2012	Link, A. James/0000-0001-5066-9691; Koos, Joseph/0000-0001-9613-7949	National Institutes of Health [R01 GM107036, T32 GM7388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM107036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM107036 and T32 GM7388. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Cooper LE, 2008, CHEM BIOL, V15, P1035, DOI 10.1016/j.chembiol.2008.07.020; Deane CD, 2013, ACS CHEM BIOL, V8, P1998, DOI 10.1021/cb4003392; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hegemann JD, 2015, ACCOUNTS CHEM RES, V48, P1909, DOI 10.1021/acs.accounts.5b00156; Hegemann JD, 2014, ANGEW CHEM INT EDIT, V53, P2230, DOI 10.1002/anie.201309267; Hegemann JD, 2013, BIOPOLYMERS, V100, P527, DOI 10.1002/bip.22326; Hegemann JD, 2013, J AM CHEM SOC, V135, P210, DOI 10.1021/ja308173b; Knappe TA, 2009, CHEM BIOL, V16, P1290, DOI 10.1016/j.chembiol.2009.11.009; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maksimov MO, 2014, J IND MICROBIOL BIOT, V41, P333, DOI 10.1007/s10295-013-1357-4; Maksimov MO, 2013, J AM CHEM SOC, V135, P12038, DOI 10.1021/ja4054256; Maksimov MO, 2012, P NATL ACAD SCI USA, V109, P15223, DOI 10.1073/pnas.1208978109; Maksimov MO, 2012, NAT PROD REP, V29, P996, DOI 10.1039/c2np20070h; MUMENTHALER C, 1995, J MOL BIOL, V254, P465, DOI 10.1006/jmbi.1995.0631; Mumenthaler C, 1997, J BIOMOL NMR, V10, P351, DOI 10.1023/A:1018383106236; Pan SJ, 2012, CHEMBIOCHEM, V13, P367, DOI 10.1002/cbic.201100596; Pan SJ, 2011, J AM CHEM SOC, V133, P5016, DOI 10.1021/ja1109634; Pavlova O, 2008, J BIOL CHEM, V283, P25589, DOI 10.1074/jbc.M803995200; Piscotta FJ, 2015, CHEM COMMUN, V51, P409, DOI 10.1039/c4cc07778d; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Spronk CAEM, 2003, J BIOMOL NMR, V25, P225, DOI 10.1023/A:1022819716110; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Tianero MDB, 2012, J AM CHEM SOC, V134, P418, DOI 10.1021/ja208278k; Yan KP, 2012, CHEMBIOCHEM, V13, P1046, DOI 10.1002/cbic.201200016; Zimmermann M, 2014, CHEM SCI, V5, P4032, DOI 10.1039/c4sc01428f; Zimmermann M, 2013, CHEM BIOL, V20, P558, DOI 10.1016/j.chembiol.2013.03.013	30	22	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30806	30812		10.1074/jbc.M115.694083	http://dx.doi.org/10.1074/jbc.M115.694083			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534965	Green Published, hybrid			2022-12-28	WOS:000367199000014
J	Lee, SM; Meyer, MB; Benkusky, NA; O'Brien, CA; Pike, JW				Lee, Seong Min; Meyer, Mark B.; Benkusky, Nancy A.; O'Brien, Charles A.; Pike, J. Wesley			Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; MICE; DIFFERENTIATION; MOUSE; OSTEOBLASTS; ACTIVATION; PROMOTERS; PHENOTYPE; PANCREAS	The biological actions of 1,25-dihydroxyvitamin D-3 (1,25 (OH)(2)D-3) are mediated by the vitamin D receptor (VDR), whose expression in bone cells is regulated positively by 1,25(OH)(2)D-3, retinoic acid, and parathyroid hormone through both intergenic and intronic enhancers. In this report, we used ChIP-sequencing analysis to confirm the presence of these Vdr gene enhancers in mesenchyme-derived bone cells and to describe the epigenetic histone landscape that spans the Vdr locus. Using bacterial artificial chromosome-minigene stable cell lines, CRISPR/Cas9 enhancer-deleted daughter cell lines, transient transfection/mutagenesis analyses, and transgenic mice, we confirmed the functionality of these bone cell enhancers in vivo as well as in vitro. We also identified VDR-binding sites across the Vdr gene locus in kidney and intestine using ChIP-sequencing analysis, revealing that only one of the bone cell-type enhancers bound VDR in kidney tissue, and none were occupied by the VDR in the intestine, consistent with weak or absent regulation by the 1,25(OH)(2)D-3 hormone in these tissues, respectively. However, a number of additional sites of VDR binding unique to either kidney or intestine were present further upstream of the Vdr gene, suggesting the potential for alternative regulatory loci. Importantly, virtually all of these regions retained histone signatures consistent with those of enhancers and exhibited unique DNase I hypersensitivity profiles that reflected the potential for chromatin access. These studies define mechanisms associated with hormonal regulation of the Vdr and hint at the differential nature of VDR binding activity at the Vdr gene in different primary target tissues in vivo.	[Lee, Seong Min; Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [O'Brien, Charles A.] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA	University of Wisconsin System; University of Wisconsin Madison; University of Arkansas System; University of Arkansas Medical Sciences	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu	O'Brien, Charles A./AAL-5078-2020		National Institutes of Health from NIDDK [DK-45173]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK045173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health Grant DK-45173 from NIDDK (to J. W. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Bishop KA, 2015, J CELL BIOCHEM, V116, P320, DOI 10.1002/jcb.24974; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Cheng Q, 2011, DIABETOLOGIA, V54, P2077, DOI 10.1007/s00125-011-2100-1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COSTA EM, 1985, ENDOCRINOLOGY, V117, P2203, DOI 10.1210/endo-117-5-2203; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; Cui X, 2013, NEUROSCIENCE, V236, P77, DOI 10.1016/j.neuroscience.2013.01.035; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Girgis CM, 2014, ENDOCRINOLOGY, V155, P3227, DOI 10.1210/en.2014-1016; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kovacs CS, 2002, AM J PHYSIOL-ENDOC M, V282, pE721, DOI 10.1152/ajpendo.00369.2001; Lee SM, 2015, J BIOL CHEM, V290, P18199, DOI 10.1074/jbc.M115.665794; Lee SM, 2014, ENDOCRINOLOGY, V155, P4137, DOI 10.1210/en.2014-1417; Lee SM, 2014, ENDOCRINOLOGY, V155, P2064, DOI 10.1210/en.2014-1107; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Mahmoudi AR, 2013, REPROD SCI, V20, P426, DOI 10.1177/1933719112459235; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meyer MB, 2015, J BIOL CHEM, V290, P11093, DOI 10.1074/jbc.M115.648394; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike JW, 2012, REV ENDOCR METAB DIS, V13, P45, DOI 10.1007/s11154-011-9198-9; PIKE JW, 1980, LIFE SCI, V26, P407, DOI 10.1016/0024-3205(80)90158-7; PIKE JW, 1982, J STEROID BIOCHEM, V16, P385, DOI 10.1016/0022-4731(82)90050-4; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; Romanoski CE, 2015, TRENDS IMMUNOL, V36, P507, DOI 10.1016/j.it.2015.07.006; Sakai Y, 2000, ENDOCRINOLOGY, V141, P2043, DOI 10.1210/en.141.6.2043; Shahbazi M, 2011, PLACENTA, V32, P657, DOI 10.1016/j.placenta.2011.06.013; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; STROM M, 1989, P NATL ACAD SCI USA, V86, P9770, DOI 10.1073/pnas.86.24.9770; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wietzke JA, 2003, J STEROID BIOCHEM, V84, P149, DOI 10.1016/S0960-0760(03)00024-4; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zarnani AH, 2010, FERTIL STERIL, V93, P2738, DOI 10.1016/j.fertnstert.2009.09.045; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; Zella LA, 2009, ENDOCRINOLOGY, V150, P3448, DOI 10.1210/en.2009-0113	51	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30573	30586		10.1074/jbc.M115.693614	http://dx.doi.org/10.1074/jbc.M115.693614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26504088	hybrid, Green Published			2022-12-28	WOS:000366738200032
J	Tan, JS; Davies, BA; Payne, JA; Benson, LM; Katzmann, DJ				Tan, Jason; Davies, Brian A.; Payne, Johanna A.; Benson, Linda M.; Katzmann, David J.			Conformational Changes in the Endosomal Sorting Complex Required for the Transport III Subunit Ist1 Lead to Distinct Modes of ATPase Vps4 Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY BIOGENESIS; ESCRT-III; AAA-ATPASE; STRUCTURAL BASIS; MEMBRANE ASSOCIATION; STIMULATORY ELEMENT; PROTEIN CHMP1B; CYTOKINESIS; AUTOINHIBITION; SPASTIN	Intralumenal vesicle formation of the multivesicular body is a critical step in the delivery of endocytic cargoes to the lysosome for degradation. Endosomal sorting complex required for transport III (ESCRT-III) subunits polymerize on endosomal membranes to facilitate membrane budding away from the cytoplasm to generate these intralumenal vesicles. The ATPase Vps4 remodels and disassembles ESCRT-III, but the manner in which Vps4 activity is coordinated with ESCRT-III function remains unclear. Ist1 is structurally homologous to ESCRT-III subunits and has been reported to inhibit Vps4 function despite the presence of a microtubule-interacting and trafficking domain-interacting motif (MIM) capable of stimulating Vps4 in the context of other ESCRT-III subunits. Here we report that Ist1 inhibition of Vps4 ATPase activity involves two elements in Ist1: the MIM itself and a surface containing a conserved ELYC sequence. In contrast, the MIM interaction, in concert with a more open conformation of the Ist1 core, resulted in stimulation of Vps4. Addition of the ESCRT-III subunit binding partner of Ist1, Did2, also converted Ist1 from an inhibitor to a stimulator of Vps4 ATPase activity. Finally, distinct regulation of Vps4 by Ist1 corresponded with altered ESCRT-III disassembly in vitro. Together, these data support a model in which Ist1-Did2 interactions during ESCRT-III polymerization coordinate Vps4 activity with the timing of ESCRT-III disassembly.	[Tan, Jason; Davies, Brian A.; Payne, Johanna A.; Katzmann, David J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Tan, Jason] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Benson, Linda M.] Mayo Clin, Mayo Med Genome Facil Prote Core, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Katzmann, DJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55906 USA.	katzmann.david@mayo.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM73024]; National Institutes of Health F31 Predoctoral Fellowship [F31GM106693]; Fraternal Order of the Eagles postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM106693, R01GM073024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of the Eagles postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM73024 (to D. J. K.) and National Institutes of Health F31 Predoctoral Fellowship F31GM106693 (to J. A. T.). This work was also supported by a Fraternal Order of the Eagles postdoctoral fellowship (to B. A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adell MAY, 2011, FEBS LETT, V585, P3191, DOI 10.1016/j.febslet.2011.09.001; Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Allison R, 2013, J CELL BIOL, V202, P527, DOI 10.1083/jcb.201211045; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cashikar AG, 2014, ELIFE, V3, DOI 10.7554/eLife.02184; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; Davies BA, 2014, J BIOL CHEM, V289, P28707, DOI 10.1074/jbc.M114.580696; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Guo EZ, 2015, J BIOL CHEM, V290, P8396, DOI 10.1074/jbc.M114.607903; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2013, J BIOL CHEM, V288, P26810, DOI 10.1074/jbc.M113.497032; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang B, 2015, NAT STRUCT MOL BIOL, V22, P492, DOI 10.1038/nsmb.3015; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	66	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30053	30065		10.1074/jbc.M115.665604	http://dx.doi.org/10.1074/jbc.M115.665604			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26515066	hybrid, Green Published			2022-12-28	WOS:000366614700036
J	Alagna, F; Geu-Flores, F; Kries, H; Panara, F; Baldoni, L; O'Connor, SE; Osbourn, A				Alagna, Fiammetta; Geu-Flores, Fernando; Kries, Hajo; Panara, Francesco; Baldoni, Luciana; O'Connor, Sarah E.; Osbourn, Anne			Identification and Characterization of the Iridoid Synthase Involved in Oleuropein Biosynthesis in Olive (Olea europaea) Fruits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme; plant; secondary metabolism; transcriptomics; Oleaceae; monoterpenes; phenolic compounds; secoiridoids	TRANSCRIPTOME COEXPRESSION ANALYSIS; PROGESTERONE 5-BETA-REDUCTASE; PHENOLIC-COMPOUNDS; SECOIRIDOID GLUCOSIDES; 7-DEOXYLOGANETIC ACID; GENE-EXPRESSION; OIL; DEFENSE; SYRINGA; STEP	The secoiridoids are the main class of specialized metabolites present in olive (Olea europaea L.) fruit. In particular, the secoiridoid oleuropein strongly influences olive oil quality because of its bitterness, which is a desirable trait. In addition, oleuropein possesses a wide range of pharmacological properties, including antioxidant, anti-inflammatory, and anti-cancer activities. In accordance, obtaining high oleuropein varieties is a main goal of molecular breeding programs. Here we use a transcriptomic approach to identify candidate genes belonging to the secoiridoid pathway in olive. From these candidates, we have functionally characterized the olive homologue of iridoid synthase (OeISY), an unusual terpene cyclase that couples an NAD (P)H-dependent 1,4-reduction step with a subsequent cyclization, and we provide evidence that OeISY likely generates the monoterpene scaffold of oleuropein in olive fruits. OeISY, the first pathway gene characterized for this type of secoiridoid, is a potential target for breeding programs in a high value secoiridoid-accumulating species.	[Alagna, Fiammetta; Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Kries, Hajo; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Alagna, Fiammetta; Baldoni, Luciana] Natl Res Council CNR, Inst Biosci & Bioresources, I-06128 Perugia, Italy; [Geu-Flores, Fernando] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, DK-1871 Frederiksberg C, Denmark; [Geu-Flores, Fernando] Univ Copenhagen, Dept Plant & Environm Sci, Sect Plant Biochem, DK-1871 Frederiksberg C, Denmark; [Panara, Francesco] ENEA Trisaia Res Ctr, I-75026 Rotondella, Matera, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Copenhagen; University of Copenhagen	Alagna, F (corresponding author), CREA Res Council Agr & Agr Econ, Via Casamassima 148, I-70010 Bari, Italy.	fiammetta.alagna@crea.gov.it	Panara, Francesco/ABC-2288-2020; Alagna, Fiammetta/AAF-3169-2020; Baldoni, Luciana/A-4411-2016; O'Connor, Sarah Ellen/X-2893-2019; Geu-Flores, Fernando/B-2737-2015; O'Connor, Sarah/O-5850-2016	Baldoni, Luciana/0000-0002-3221-333X; Geu-Flores, Fernando/0000-0002-5735-9810; BALDONI, LUCIANA/0000-0002-6636-0055; Alagna, Fiammetta/0000-0003-1878-2023; O'Connor, Sarah/0000-0003-0356-6213; Panara, Francesco/0000-0001-9596-7262; Kries, Hajo/0000-0002-4919-2811	I-MOVE FP7 Marie Curie COFUND Program - European Union; Regione Umbria (Italy); Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant [BB/J004561/1]; John Innes Foundation; BBSRC [BB/L014130/1, BBS/E/J/000CA524] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014130/1, BBS/E/J/00000614, BBS/E/J/000CA524] Funding Source: researchfish	I-MOVE FP7 Marie Curie COFUND Program - European Union; Regione Umbria (Italy)(Regione Umbria); Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the I-MOVE FP7 Marie Curie COFUND Program funded by the European Union and Regione Umbria (Italy) and also by the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant BB/J004561/1 ( Understanding and Exploiting Plant and Microbial Metabolism) and by the John Innes Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alagna F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-162; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Asada K, 2013, PLANT CELL, V25, P4123, DOI 10.1105/tpc.113.115154; Bauer P, 2012, PHYTOCHEMISTRY, V77, P53, DOI 10.1016/j.phytochem.2012.01.022; Bauer P, 2010, PHYTOCHEMISTRY, V71, P1495, DOI 10.1016/j.phytochem.2010.06.004; Buckland G, 2015, BRIT J NUTR, V113, pS94, DOI 10.1017/S0007114514003936; DAMTOFT S, 1993, PHYTOCHEMISTRY, V34, P1291, DOI 10.1016/0031-9422(91)80018-V; DAMTOFT S, 1995, PHYTOCHEMISTRY, V40, P785, DOI 10.1016/0031-9422(95)00210-X; DAMTOFT S, 1995, PHYTOCHEMISTRY, V40, P773, DOI 10.1016/0031-9422(95)00211-O; Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Hassen I, 2015, J FUNCT FOODS, V18, P926, DOI 10.1016/j.jff.2014.09.001; Herl V, 2006, PHYTOCHEMISTRY, V67, P225, DOI 10.1016/j.phytochem.2005.11.013; Jensen SR, 2002, PHYTOCHEMISTRY, V60, P213, DOI 10.1016/S0031-9422(02)00102-4; Jensen SR., 1991, P PHYTOCH SOC EUROPE, V31, P133; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Kries H, 2016, NAT CHEM BIOL, V12, P6, DOI 10.1038/nchembio.1955; KUBO I, 1985, J CHEM ECOL, V11, P251, DOI 10.1007/BF00988207; KUWAJIMA H, 1988, PHYTOCHEMISTRY, V27, P1757, DOI 10.1016/0031-9422(88)80438-2; Lindner S, 2014, CHEM BIOL, V21, P1452, DOI 10.1016/j.chembiol.2014.09.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik NSA, 2008, J FOOD AGRIC ENVIRON, V6, P8; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Munkert J, 2015, MOL PLANT, V8, P136, DOI 10.1016/j.molp.2014.11.005; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; Nonis A, 2012, J AGR FOOD CHEM, V60, P6855, DOI 10.1021/jf300419w; Obied HK, 2008, NAT PROD REP, V25, P1167, DOI 10.1039/b719736e; Oh H, 2003, PHYTOTHER RES, V17, P417, DOI 10.1002/ptr.1148; Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18; Ortega-Garcia F, 2010, J AGR FOOD CHEM, V58, P12440, DOI 10.1021/jf102827m; Owen RW, 2003, FOOD CHEM TOXICOL, V41, P703, DOI 10.1016/S0278-6915(03)00011-5; Ozgenturk NO, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/757512; Perez-Bermudez P, 2010, NEW PHYTOL, V185, P687, DOI 10.1111/j.1469-8137.2009.03080.x; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Ryan D, 2002, J AGR FOOD CHEM, V50, P6716, DOI 10.1021/jf025736p; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Salim V, 2014, PHYTOCHEMISTRY, V101, P23, DOI 10.1016/j.phytochem.2014.02.009; Salim V, 2013, PLANT J, V76, P754, DOI 10.1111/tpj.12330; Schilmiller AL, 2012, CURR OPIN PLANT BIOL, V15, P338, DOI 10.1016/j.pbi.2011.12.005; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/S0021-9673(04)01423-2; Servili M, 2002, EUR J LIPID SCI TECH, V104, P602, DOI 10.1002/1438-9312(200210)104:9/10<602::AID-EJLT602>3.0.CO;2-X; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Soler-Rivas C, 2000, J SCI FOOD AGR, V80, P1013, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1013::AID-JSFA571>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1013::AID-JSFA571&gt;3.0.CO;2-C]; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; SUGIYAMA M, 1993, PHYTOCHEMISTRY, V34, P1169, DOI 10.1016/S0031-9422(00)90737-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanahashi T, 1996, PHYTOCHEMISTRY, V41, P1341, DOI 10.1016/0031-9422(95)00747-4; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Van Moerkercke A, 2013, PLANT CELL PHYSIOL, V54, P673, DOI 10.1093/pcp/pct039; Vezzaro A, 2012, J PLANT PHYSIOL, V169, P908, DOI 10.1016/j.jplph.2012.01.021; Waterman E, 2007, ALTERN MED REV, V12, P331; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200	57	50	53	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5542	5554		10.1074/jbc.M115.701276	http://dx.doi.org/10.1074/jbc.M115.701276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26709230	Green Published, hybrid			2022-12-28	WOS:000372551800009
J	Roh, SH; Kasembeli, M; Galaz-Montoya, JG; Trnka, M; Lau, WCY; Burlingame, A; Chiu, W; Tweardy, DJ				Roh, Soung-Hun; Kasembeli, Moses; Galaz-Montoya, Jesus G.; Trnka, Mike; Lau, Wilson Chun-Yu; Burlingame, Alma; Chiu, Wah; Tweardy, David J.			Chaperonin TRiC/CCT Modulates the Folding and Activity of Leukemogenic Fusion Oncoprotein AML1-ETO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; EUKARYOTIC CHAPERONIN; TRANSCRIPTION FACTOR; IN-VIVO; CYTOPLASMIC CHAPERONIN; INTRANUCLEAR MOBILITY; PROTEINS; COMPLEX; CCT; DOMAIN	AML1-ETO is the most common fusion oncoprotein causing acute myeloid leukemia (AML), a disease with a 5-year survival rate of only 24%. AML1-ETO functions as a rogue transcription factor, altering the expression of genes critical for myeloid cell development and differentiation. Currently, there are no specific therapies for AML1-ETO-positive AML. While known for decades to be the translational product of a chimeric gene created by the stable chromosome translocation t(8; 21)(q22; q22), it is not known how AML1-ETO achieves its native and functional conformation or whether this process can be targeted for therapeutic benefit. Here, we show that the biosynthesis and folding of the AML1-ETO protein is facilitated by interaction with the essential eukaryotic chaperonin TRiC (or CCT). We demonstrate that a folding intermediate of AML1-ETO binds to TRiC directly, mainly through its beta-strand rich, DNA-binding domain (AML-(1-175)), with the assistance of HSP70. Our results suggest that TRiC contributes to AML1-ETO proteostasis through specific interactions between the oncoprotein's DNA-binding domain, which may be targeted for therapeutic benefit.	[Roh, Soung-Hun; Galaz-Montoya, Jesus G.; Chiu, Wah; Tweardy, David J.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kasembeli, Moses; Lau, Wilson Chun-Yu; Tweardy, David J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Trnka, Mike; Burlingame, Alma] Univ Calif San Francisco, Natl Bioorgan Biomed Mass Spectrometry Resource C, San Francisco, CA 94158 USA; [Lau, Wilson Chun-Yu] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Lau, Wilson Chun-Yu] Univ Hong Kong, Dept Anat, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of Hong Kong; University of Hong Kong	Chiu, W; Tweardy, DJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Tweardy, DJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.	wah@bcm.edu; dtweardy@bcm.edu	Tweardy, David/L-3929-2019; Galaz-Montoya, Jesus G./Q-7245-2019; Galaz-Montoya, Jesus G/A-8091-2017	Galaz-Montoya, Jesus G./0000-0002-0113-9325; Trnka, Michael/0000-0002-8808-5146	National Institutes of Health [P41GM103832, P41GM103481, PN2EY016525]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110291]; Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT) [RP140113]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research has been supported by National Institutes of Health Grants (P41GM103832, P41GM103481, and PN2EY016525) and Cancer Prevention and Research Institute of Texas (CPRIT) Grant RP110291, as well as a training fellowship (to J. G. G. M.) from the Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT Grant RP140113). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASOU H, 1991, BLOOD, V77, P2031; Bartfeld D, 2002, STRUCTURE, V10, P1395, DOI 10.1016/S0969-2126(02)00853-5; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Corpora T, 2010, J MOL BIOL, V402, P560, DOI 10.1016/j.jmb.2010.08.007; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Downing JR, 1999, BRIT J HAEMATOL, V106, P296, DOI 10.1046/j.1365-2141.1999.01377.x; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Kasembeli M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001844; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; Mitani Kinuko, 1997, Leukemia (Basingstoke), V11, P294; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Priya S, 2013, P NATL ACAD SCI USA, V110, P7199, DOI 10.1073/pnas.1219867110; Qiu J, 2006, ONCOGENE, V25, P3982, DOI 10.1038/sj.onc.1209431; Reikvam H, 2012, BRIT J HAEMATOL, V156, P468, DOI 10.1111/j.1365-2141.2011.08960.x; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Saegusa K, 2014, MOL BIOL CELL, V25, P3095, DOI 10.1091/mbc.E13-09-0530; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Siegers K, 2003, EMBO J, V22, P5230, DOI 10.1093/emboj/cdg483; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Thulasiraman V, 2000, METH MOL B, V140, P169; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003; Yu WJ, 2011, LEUKEMIA RES, V35, P1212, DOI 10.1016/j.leukres.2011.05.014	49	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4732	4741		10.1074/jbc.M115.684878	http://dx.doi.org/10.1074/jbc.M115.684878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26706127	hybrid, Green Published			2022-12-28	WOS:000371604600039
J	Choudhary, S; Goetjen, A; Estus, T; Jacome-Galarza, CE; Aguila, HL; Lorenzo, J; Pilbeam, C				Choudhary, Shilpa; Goetjen, Alexandra; Estus, Thomas; Jacome-Galarza, Christian E.; Aguila, Hector L.; Lorenzo, Joseph; Pilbeam, Carol			Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; cyclooxygenase (COX); G protein-coupled receptor (GPCR); macrophage; osteoporosis; prostaglandin; formyl peptide receptor; ptgs2 knockout; receptor activator of nuclear factor B ligand (RANKL)	MAMMALIAN ADENYLYL CYCLASES; BONE-FORMATION; CONTINUOUS-INFUSION; RECEPTOR ACTIVATOR; PROSTAGLANDIN E-2; STEM-CELLS; IN-VITRO; EXPRESSION; PROTEIN; OSTEOCLASTS	Background: Continuous parathyroid hormone (PTH) is anabolic in cyclooxygenase-2 (Cox2) knock-out, but not WT, mice. Results: Preosteoclasts secreted serum amyloid A3 (Saa3) in response to RANKL only in the presence of Cox2. Saa3 blocked PTH-stimulated cAMP production and osteoblast differentiation. Conclusion: Saa3 is a novel means by which osteoclasts inhibit osteoblasts. Significance: Induction of Saa3 may explain why continuous PTH causes bone loss. Continuous parathyroid hormone (PTH) blocks its own osteogenic actions in marrow stromal cell cultures by inducing Cox2 and receptor activator of nuclear factor B ligand (RANKL) in the osteoblastic lineage cells, which then cause the hematopoietic lineage cells to secrete an inhibitor of PTH-stimulated osteoblast differentiation. To identify this inhibitor, we used bone marrow macrophages (BMMs) and primary osteoblasts (POBs) from WT and Cox2 knock-out (KO) mice. Conditioned medium (CM) from RANKL-treated WT, but not KO, BMMs blocked PTH-stimulated cAMP production in POBs. Inhibition was reversed by pertussis toxin (PTX), which blocks G(i/o) activation. Saa3 was the most highly differentially expressed gene in a microarray comparison of RANKL-treated WT versus Cox2 KO BMMs, and RANKL induced Saa3 protein secretion only from WT BMMs. CM from RANKL-stimulated BMMs with Saa3 knockdown did not inhibit PTH-stimulated responses in POBs. SAA added to POBs inhibited PTH-stimulated cAMP responses, which was reversed by PTX. Selective agonists and antagonists of formyl peptide receptor 2 (Fpr2) suggested that Fpr2 mediated the inhibitory actions of Saa3 on osteoblasts. In BMMs committed to become osteoclasts by RANKL treatment, Saa3 expression peaked prior to appearance of multinucleated cells. Flow sorting of WT marrow revealed that Saa3 was secreted only from the RANKL-stimulated B220(-) CD3(-)CD11b(-/low) CD115(+) preosteoclast population. We conclude that Saa3 secretion from preosteoclasts, induced by RANKL in a Cox2-dependent manner, inhibits PTH-stimulated cAMP signaling and osteoblast differentiation via G(i/o) signaling. The induction of Saa3 by PTH may explain the suppression of bone formation when PTH is applied continuously and may be a new therapeutic target for osteoporosis.	[Choudhary, Shilpa; Lorenzo, Joseph; Pilbeam, Carol] Univ Connecticut Hlth, Dept Med, Farmington, CT 06030 USA; [Jacome-Galarza, Christian E.; Aguila, Hector L.] Univ Connecticut Hlth, Dept Immunol, Farmington, CT 06030 USA; [Choudhary, Shilpa; Goetjen, Alexandra; Estus, Thomas; Lorenzo, Joseph; Pilbeam, Carol] Univ Connecticut Hlth, New England Musculoskeletal Inst, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut; University of Connecticut	Pilbeam, C (corresponding author), MC 5456,263 Farmington Ave, Farmington, CT 06030 USA.	pilbeam@uchc.edu			National Institutes of Health, NIAMS [AR060286, T90DE021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060286] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS Grant AR060286 (to C. P.) and NIDCR Grant T90DE021 (to T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Augustine M, 2013, CURR OSTEOPOROS REP, V11, P400, DOI 10.1007/s11914-013-0171-2; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Choudhary S, 2008, BIOCHEM BIOPH RES CO, V372, P536, DOI 10.1016/j.bbrc.2008.05.050; Choudhary S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120164; Choudhary S, 2013, BONE, V56, P31, DOI 10.1016/j.bone.2013.04.017; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Giebeler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100522; Han SY, 2005, BLOOD, V106, P1240, DOI 10.1182/blood-2004-12-4975; Henriksen K, 2012, BONE, V51, P353, DOI 10.1016/j.bone.2012.06.007; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Jacome-Galarza CE, 2011, J BONE MINER RES, V26, P1207, DOI 10.1002/jbmr.324; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kinugawa S, 2012, J IMMUNOL, V188, P1772, DOI 10.4049/jimmunol.1101174; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Kreja L, 2010, J CELL BIOCHEM, V109, P347, DOI 10.1002/jcb.22406; Lee HY, 2010, EXP MOL MED, V42, P302, DOI 10.3858/emm.2010.42.4.029; Lee SK, 2002, BONE, V31, P252, DOI 10.1016/S8756-3282(02)00804-9; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; McCauley LK, 1997, ENDOCRINOLOGY, V138, P5427, DOI 10.1210/en.138.12.5427; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Migita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096703; Millard SM, 2011, J BONE MINER RES, V26, P822, DOI 10.1002/jbmr.273; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Oldekamp S, 2014, IMMUNOLOGY, V143, P447, DOI 10.1111/imm.12324; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; Phelps E, 2005, CALCIFIED TISSUE INT, V77, P96, DOI 10.1007/s00223-004-0239-1; Pilbeam CC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 2, 3RD EDITION, P1235, DOI 10.1016/B978-0-12-373884-4.00072-0; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Robling AG, 2011, ENDOCRINOLOGY, V152, P2963, DOI 10.1210/en.2011-0049; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; SELLAR GC, 1994, GENOMICS, V23, P492, DOI 10.1006/geno.1994.1530; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Son DS, 2010, ENDOCRINOLOGY, V151, P3407, DOI 10.1210/en.2009-1321; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Tetradis S, 2001, ENDOCRINOLOGY, V142, P663, DOI 10.1210/en.142.2.663; Thaler R, 2015, FASEB J, V29, P1344, DOI 10.1096/fj.14-265512; Thorn CF, 2002, AMYLOID, V9, P229, DOI 10.3109/13506120209114098; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wang DZ, 2013, CANCER J, V19, P502, DOI 10.1097/PPO.0000000000000003; Xu MS, 2010, BONE, V47, P341, DOI 10.1016/j.bone.2010.05.006; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R	65	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3882	3894		10.1074/jbc.M115.686576	http://dx.doi.org/10.1074/jbc.M115.686576			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703472	hybrid, Green Published			2022-12-28	WOS:000371338400017
J	Furukawa, Y; Anzai, I; Akiyama, S; Imai, M; Cruz, FJC; Saio, T; Nagasawa, K; Nomura, T; Ishimori, K				Furukawa, Yoshiaki; Anzai, Itsuki; Akiyama, Shuji; Imai, Mizue; Cruz, Fatima Joy C.; Saio, Tomohide; Nagasawa, Kenichi; Nomura, Takao; Ishimori, Koichiro			Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein aggregation; protein folding; protein misfolding; superoxide dismutase (SOD)	MOTOR-NEURON DEGENERATION; TRANSGENIC MICE; FAMILIAL FORM; COPPER; SOD1; PROTEINS; MUTATIONS; METAL; AGGREGATION; SCATTERING	Misfolding of Cu,Zn-superoxide dismutase (SOD1) is a pathological change in the familial form of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene. SOD1 is an enzyme that matures through the binding of copper and zinc ions and the formation of an intramolecular disulfide bond. Pathogenic mutations are proposed to retard the post-translational maturation, decrease the structural stability, and hence trigger the misfolding of SOD1 proteins. Despite this, a misfolded and potentially pathogenic conformation of immature SOD1 remains obscure. Here, we show significant and distinct conformational changes of apoSOD1 that occur only upon reduction of the intramolecular disulfide bond in solution. In particular, loop regions in SOD1 lose their restraint and become significantly disordered upon dissociation of metal ions and reduction of the disulfide bond. Such drastic changes in the solution structure of SOD1 may trigger misfolding and fibrillar aggregation observed as pathological changes in the familial form of amyotrophic lateral sclerosis.	[Furukawa, Yoshiaki; Anzai, Itsuki; Nagasawa, Kenichi; Nomura, Takao] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Yokohama, Kanagawa 2238522, Japan; [Akiyama, Shuji] Res Ctr Integrat Mol Syst CIMoS, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Akiyama, Shuji] Grad Univ Adv Studies, SOKENDAI, Dept Funct Mol Sci, Okazaki, Aichi 4448585, Japan; [Imai, Mizue; Cruz, Fatima Joy C.; Saio, Tomohide; Ishimori, Koichiro] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Keio University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Hokkaido University; Hokkaido University	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Ishimori, Koichiro/AAQ-4434-2021; Furukawa, Yoshiaki/F-2871-2014; Ishimori, Koichiro/S-1247-2016	Ishimori, Koichiro/0000-0002-5868-0462; Furukawa, Yoshiaki/0000-0002-1918-372X; Ishimori, Koichiro/0000-0002-5868-0462; AKIYAMA, Shuji/0000-0002-7184-189X; Anzai, Itsuki/0000-0001-9307-943X; Saio, Tomohide/0000-0003-3639-7399	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25291028, 15H01566]; Cooperative Research in Joint Studies at Institute for Molecular Science, Japan; Grants-in-Aid for Scientific Research [15K14480] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperative Research in Joint Studies at Institute for Molecular Science, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 25291028 for Scientific Research (B) and 15H01566 for Scientific Research on Innovative Areas (to Y. F.) and a Nanotechnology Platform Program (Molecule and Material Synthesis) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and in part by Cooperative Research in Joint Studies at Institute for Molecular Science, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama S, 2010, J APPL CRYSTALLOGR, V43, P237, DOI 10.1107/S002188981000138X; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2011, J AM CHEM SOC, V133, P345, DOI 10.1021/ja1069689; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P335; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sekhar A, 2015, ELIFE, V4, DOI 10.7554/eLife.07296; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7	54	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4144	4155		10.1074/jbc.M115.683763	http://dx.doi.org/10.1074/jbc.M115.683763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694608	hybrid, Green Published			2022-12-28	WOS:000371338400038
J	Hu, LP; Huang, WQ; Hjort, EE; Bei, L; Platanias, LC; Eklund, EA				Hu, Liping; Huang, Weiqi; Hjort, Elizabeth E.; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.			The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calpain; CD95 (APO-1; Fas); gene expression; hematopoiesis; innate immunity	COLONY-STIMULATING FACTOR; MYELOID PROGENITOR CELLS; BETA-CATENIN ACTIVITY; TRANSCRIPTION FACTOR; PTPN13 GENE; G-CSF; GRANULOCYTE; MICE; PU.1; EXPRESSION	Emergency granulopoiesis occurs in response to infectious or inflammatory challenge and is a component of the innate immune response. Some molecular events involved in initiating emergency granulopoiesis are known, but termination of this process is less well defined. In this study, we found that the interferon consensus sequence binding protein (Icsbp/Irf8) was required to terminate emergency granulopoiesis. Icsbp is an interferon regulatory transcription factor with leukemia suppressor activity. Expression of Icsbp is decreased in chronic myeloid leukemia, and Icsbp(-/-) mice exhibit progressive granulocytosis with evolution to blast crisis, similar to the course of human chronic myeloid leukemia. In this study, we found aberrantly sustained granulocyte production in Icsbp(-/-) mice after stimulation of an emergency granulopoiesis response. Icsbp represses transcription of the genes encoding Fas-associated phosphatase 1 (Fap1) and growth arrest-specific 2 (Gas2) and activates genes encoding Fanconi C and F. After stimulation of emergency granulopoiesis, we found increased and sustained expression of Fap1 and Gas2 in bone marrow myeloid progenitor cells from Icsbp(-/-) mice in comparison with the wild type. This was associated with resistance to Fas-induced apoptosis and increased -catenin activity in these cells. We also found that repeated episodes of emergency granulopoiesis accelerated progression to acute myeloid leukemia in Icsbp(-/-) mice. This was associated with impaired Fanconi C and F expression and increased sensitivity to DNA damage in bone marrow myeloid progenitors. Our results suggest that impaired Icsbp expression enhances leukemogenesis by deregulating processes that normally limit granulocyte expansion during the innate immune response.	[Hu, Liping; Huang, Weiqi; Hjort, Elizabeth E.; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA; [Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA; [Huang, Weiqi; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			National Institutes of Health [R01-DK098812, R01-CA174205, R01-CA77816, CA155566]; Veterans Affairs Grant [IBX002067]; NATIONAL CANCER INSTITUTE [R01CA077816, R01CA155566, P30CA060553, R01CA174205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098812] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01-DK098812 and R01-CA174205 (to E. A. E.) and R01-CA77816 and CA155566 (to L. C. P.) and Veterans Affairs Grant IBX002067 (to E. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basu S, 2000, BLOOD, V95, P3725; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu LP, 2013, J CLIN INVEST, V123, P3952, DOI 10.1172/JCI69032; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Huang WQ, 2013, J BIOL CHEM, V288, P12766, DOI 10.1074/jbc.M112.429696; Huang WQ, 2013, LEUKEMIA LYMPHOMA, V54, P619, DOI 10.3109/10428194.2012.720979; Huang WQ, 2012, J BIOL CHEM, V287, P8110, DOI 10.1074/jbc.M111.294884; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Iwama A, 2002, J EXP MED, V195, P547, DOI 10.1084/jem.20011465; Kakar R, 2005, J LEUKOCYTE BIOL, V77, P120, DOI 10.1189/jlb.0704429; Kim YM, 1999, J IMMUNOL, V163, P2000; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kreisel D, 2011, BLOOD, V118, P6172, DOI 10.1182/blood-2011-04-347823; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LORD BI, 1991, BLOOD, V77, P2154; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Saberwal G, 2009, J BIOL CHEM, V284, P33242, DOI 10.1074/jbc.M109.010231; Salto Y., 2013, EUR J IMMUNOL, V43, P1651; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Stoffel R, 1996, BLOOD, V87, P567, DOI 10.1182/blood.V87.2.567.bloodjournal872567; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zheng C, 2006, LEUKEMIA, V20, P1028, DOI 10.1038/sj.leu.2404227	47	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4107	4120		10.1074/jbc.M115.681361	http://dx.doi.org/10.1074/jbc.M115.681361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26683374	Green Published, hybrid			2022-12-28	WOS:000371338400035
J	Krock, E; Currie, JB; Weber, MH; Ouellet, JA; Stone, LS; Rosenzweig, DH; Haglund, L				Krock, Emerson; Currie, J. Brooke; Weber, Michael H.; Ouellet, Jean A.; Stone, Laura S.; Rosenzweig, Derek H.; Haglund, Lisbet			Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in Human Intervertebral Discs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurotrophin; NF-B (NF-KB); nucleus pulposus; pain; toll-like receptor (TLR); intervertebral disc; low back pain; nerve growth factor	LOW-BACK-PAIN; NUCLEUS PULPOSUS; FIBRONECTIN FRAGMENT; NEUROTROPHIC FACTOR; GENE-EXPRESSION; MESSENGER-RNA; NGF SYNTHESIS; TNF-ALPHA; IN-VIVO; C-FOS	Nerve growth factor (NGF) contributes to the development of chronic pain associated with degenerative connective tissue pathologies, such as intervertebral disc degeneration and osteoarthritis. However, surprisingly little is known about the regulation of NGF in these conditions. Toll-like receptors (TLR) are pattern recognition receptors classically associated with innate immunity but more recently were found to be activated by endogenous alarmins such as fragmented extracellular matrix proteins found in degenerating discs or cartilage. In this study we investigated if TLR activation regulates NGF and which signaling mechanisms control this response in intervertebral discs. TLR2 agonists, TLR4 agonists, or IL-1 (control) treatment increased NGF, brain-derived neurotrophic factor (BDNF), and IL-1 gene expression in human disc cells isolated from healthy, pain-free organ donors. However, only TLR2 activation or IL-1 treatment increased NGF protein secretion. TLR2 activation increased p38, ERK1/2, and p65 activity and increased p65 translocation to the cell nucleus. JNK activity was not affected by TLR2 activation. Inhibition of NF-B, and to a lesser extent p38, but not ERK1/2 activity, blocked TLR2-driven NGF up-regulation at both the transcript and protein levels. These results provide a novel mechanism of NGF regulation in the intervertebral disc and potentially other pathogenic connective tissues. TLR2 and NF-B signaling are known to increase cytokines and proteases, which accelerate matrix degradation. Therefore, TLR2 or NF-B inhibition may both attenuate chronic pain and slow the degenerative progress in vivo.	[Krock, Emerson; Currie, J. Brooke; Rosenzweig, Derek H.; Haglund, Lisbet] McGill Univ, Fac Med, Orthopead Res Lab, Montreal, PQ H3G 1A4, Canada; [Krock, Emerson; Ouellet, Jean A.; Stone, Laura S.] McGill Univ, Fac Med, Alan Edwards Ctr Res Pain, Montreal, PQ H3G 1A4, Canada; [Krock, Emerson; Weber, Michael H.; Ouellet, Jean A.; Stone, Laura S.; Rosenzweig, Derek H.; Haglund, Lisbet] McGill Univ, Fac Med, McGill Scoliosis & Spine Res Grp, Montreal, PQ H3G 1A4, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Integrated Program Neurosci, Montreal, PQ H3G 1A4, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Anesthesiol, Montreal, PQ H3G 1A4, Canada; [Stone, Laura S.] McGill Univ, Fac Med, Dept Pharmacol, Montreal, PQ H3G 1A4, Canada; [Stone, Laura S.] McGill Univ, Fac Dent, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Haglund, L (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal Gen Hosp,Dept Expt Surg, Rm C9-173,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	lisbet.haglund@mcgill.ca	Krock, Emerson/L-3241-2019; Haglund, Lisbet/N-3095-2013	Haglund, Lisbet/0000-0002-1288-2149; Krock, Emerson/0000-0002-8501-2945	Canadian Institutes of Health Research (CIHR) [CIHR MOP-119564]; McGill Faculty of Medicine; Fonds de Recherche du Quebec-Sante; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057289] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Faculty of Medicine; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Canadian Institutes of Health Research (CIHR) Operating Grant CIHR MOP-119564 (to L. H., L. S. S., and J. A. O.) and a studentship from the McGill Faculty of Medicine and a Fonds de Recherche du Quebec-Sante doctoral fellowship (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akhatib B, 2013, J BIOL CHEM, V288, P19280, DOI 10.1074/jbc.M112.443010; Alkhatib B, 2014, EUR CELLS MATER, V28, P98, DOI 10.22203/eCM.v028a08; Anderson DG, 2003, SPINE, V28, P2338, DOI 10.1097/01.BRS.0000096943.27853.BC; Aoki Y, 2004, SPINE, V29, P2621, DOI 10.1097/01.brs.0000146051.11574.b4; Aota Y, 2005, SPINE, V30, P722, DOI 10.1097/01.brs.0000157417.59933.db; Ariga K, 2001, SPINE, V26, P2666, DOI 10.1097/00007632-200112150-00007; Bradshaw Ralph A., 2015, Advances in Biological Regulation, V58, P16, DOI 10.1016/j.jbior.2014.11.003; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Burbach GJ, 2001, J INVEST DERMATOL, V117, P1075, DOI 10.1046/j.0022-202x.2001.01498.x; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Colangelo AM, 1996, MOL BRAIN RES, V35, P1, DOI 10.1016/0169-328X(95)00171-N; Colangelo AM, 1998, P NATL ACAD SCI USA, V95, P10920, DOI 10.1073/pnas.95.18.10920; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Gawri R, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4449; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P506, DOI 10.3109/10520295.2012.703692; Gruber HE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2456; Gruber HE, 2015, EXP MOL PATHOL, V98, P427, DOI 10.1016/j.yexmp.2015.03.001; Hayashi S, 2008, SPINE, V33, P1542, DOI 10.1097/BRS.0b013e318178e5ea; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kivitz AJ, 2013, PAIN, V154, P1009, DOI 10.1016/j.pain.2013.03.006; Klawitter M, 2014, EUR SPINE J, V23, P1878, DOI 10.1007/s00586-014-3442-4; Konttinen YT, 1999, CLIN EXP RHEUMATOL, V17, P197; Krock E, 2015, CURR STEM CELL RES T, V10, P317, DOI 10.2174/1574888X10666150211161956; Krock E, 2014, J CELL MOL MED, V18, P1213, DOI 10.1111/jcmm.12268; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Lees S, 2015, ARTHRITIS RHEUMATOL, V67, P1240, DOI 10.1002/art.39063; Leite VF, 2014, PAIN PHYSICIAN, V17, pE45; Lewin GR, 2014, EUR J NEUROSCI, V39, P363, DOI 10.1111/ejn.12466; Li J, 2015, J BIOL CHEM, V290, P7195, DOI 10.1074/jbc.M114.611483; Lim KC, 2007, BIOCHEM BIOPH RES CO, V361, P599, DOI 10.1016/j.bbrc.2007.07.039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5; Miklic S, 2004, INT J DEV NEUROSCI, V22, P119, DOI 10.1016/j.ijdevenue.2004.03.001; Miyagi M, 2014, SPINE, V39, P1345, DOI 10.1097/BRS.0000000000000334; MOCCHETTI I, 1989, P NATL ACAD SCI USA, V86, P3891, DOI 10.1073/pnas.86.10.3891; Oegema TR, 2000, SPINE, V25, P2742, DOI 10.1097/00007632-200011010-00005; Patel KP, 2007, SPINE, V32, P2596, DOI 10.1097/BRS.0b013e318158cb85; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Purmessur D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2487; Quero L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4274; Richardson SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047735; Ruel N, 2014, SPINE, V39, P1274, DOI 10.1097/BRS.0000000000000397; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Wang XH, 2015, EXP BIOL MED, V240, P411, DOI 10.1177/1535370214554533; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299; Wuertz K, 2012, EUR CELLS MATER, V23, P103; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	56	48	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3541	3551		10.1074/jbc.M115.675900	http://dx.doi.org/10.1074/jbc.M115.675900			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668319	hybrid, Green Published			2022-12-28	WOS:000370854500034
J	Waite, KA; De-La Mota-Peynado, A; Vontz, G; Roelofs, J				Waite, Kenrick A.; De-La Mota-Peynado, Alina; Vontz, Gabrielle; Roelofs, Jeroen			Starvation Induces Proteasome Autophagy with Different Pathways for Core and Regulatory Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; deubiquitylation (deubiquitination); proteasome; protein translocation; vacuole; yeast; nitrogen starvation; proteaphagy; ribophagy	PROTEIN-DEGRADATION; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; NUCLEAR IMPORT; YEAST; LOCALIZATION; COMPLEXES; RIBOSOMES; MECHANISMS	The proteasome is responsible for the degradation of many cellular proteins. If and how this abundant and normally stable complex is degraded by cells is largely unknown. Here we show that in yeast, upon nitrogen starvation, proteasomes are targeted for vacuolar degradation through autophagy. Using GFP-tagged proteasome subunits, we observed that autophagy of a core particle (CP) subunit depends on the deubiquitinating enzyme Ubp3, although a regulatory particle (RP) subunit does not. Furthermore, upon blocking of autophagy, RP remained largely nuclear, although CP largely localized to the cytosol as well as granular structures within the cytosol. In all, our data reveal a regulated process for the removal of proteasomes upon nitrogen starvation. This process involves CP and RP dissociation, nuclear export, and independent vacuolar targeting of CP and RP. Thus, in addition to the well characterized transcriptional up-regulation of genes encoding proteasome subunits, cells are also capable of down-regulating cellular levels of proteasomes through proteaphagy.	[Waite, Kenrick A.; De-La Mota-Peynado, Alina; Vontz, Gabrielle; Roelofs, Jeroen] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, 1717 Claflin Rd,338 Ackert Hall, Manhattan, KS USA.	jroelofs@ksu.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Lang, Angelica/0000-0002-7446-5834	National Institutes of Health from NIGMS [1R15GM112142-01A1]; National Institutes of Health [P20 GM103418]; Johnson Cancer Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118660, P20GM103418, R15GM112142] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 1R15GM112142-01A1 from NIGMS (to J. R.), National Institutes of Health Institutional Development Award (IDeA) P20 GM103418 (to J. R. and G. V.), and by the Johnson Cancer Research Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Athane A, 2015, INT J BIOCHEM CELL B, V64, P167, DOI 10.1016/j.biocel.2015.04.002; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Cebollero Eduardo, 2012, Int J Cell Biol, V2012, P182834, DOI 10.1155/2012/182834; Chari A, 2010, TRENDS BIOCHEM SCI, V35, P676, DOI 10.1016/j.tibs.2010.07.006; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; De La Mota-Peynado A, 2013, J BIOL CHEM, V288, P29467, DOI 10.1074/jbc.M113.491662; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hinnebusch AG, 2009, GENE DEV, V23, P891, DOI 10.1101/gad.1800509; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Karbstein K, 2013, TRENDS CELL BIOL, V23, P242, DOI 10.1016/j.tcb.2013.01.004; Kleijnen MF, 2007, EMBO J, V26, P275, DOI 10.1038/sj.emboj.7601486; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Ossareh-Nazari B, 2014, J CELL BIOL, V204, P909, DOI 10.1083/jcb.201308139; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Peters LZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005178; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Stephan JS, 2006, AUTOPHAGY, V2, P146, DOI 10.4161/auto.2.2.2485; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V159, P1309, DOI 10.1016/0006-291X(89)92253-5; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weberruss MH, 2013, EMBO J, V32, P2697, DOI 10.1038/emboj.2013.192; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	65	71	73	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3239	3253		10.1074/jbc.M115.699124	http://dx.doi.org/10.1074/jbc.M115.699124			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670610	Green Published, hybrid			2022-12-28	WOS:000370854500011
J	Ren, L; Campbell, A; Fang, HQ; Gautam, S; Elavazhagan, S; Fatehchand, K; Mehta, P; Stiff, A; Reader, BF; Mo, XK; Byrd, JC; Carson, WE; Butchar, JP; Tridandapani, S				Ren, Li; Campbell, Amanda; Fang, Huiqing; Gautam, Shalini; Elavazhagan, Saranya; Fatehchand, Kavin; Mehta, Payal; Stiff, Andrew; Reader, Brenda F.; Mo, Xiaokui; Byrd, John C.; Carson, William E., III; Butchar, Jonathan P.; Tridandapani, Susheela			Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fc gamma Receptor (Fc gamma R) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MEDIATED PHAGOCYTOSIS OCCURS; TUMOR-NECROSIS-FACTOR; B-CELL; CROSS-LINKING; XID MICE; ACTIVATION; MACROPHAGES; PCI-32765; RITUXIMAB	The irreversible Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has shown efficacy against B-cell tumors such as chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma. Fc gamma receptors (Fc gamma R) on immune cells such as macrophages play an important role in tumor-specific antibody-mediated immune responses, but many such responses involve Btk. Here we tested the effects of ibrutinib on Fc gamma R-mediated activities in monocytes. We found that ibrutinib did not affect monocyte Fc gamma R-mediated phagocytosis, even at concentrations higher than those achieved physiologically, but suppressed Fc gamma R-mediated cytokine production. We confirmed these findings in macrophages from Xid mice in which Btk signaling is defective. Because calcium flux is a major event downstream of Btk, we tested whether it was involved in phagocytosis. The results showed that blocking intracellular calcium flux decreased Fc gamma R-mediated cytokine production but not phagocytosis. To verify this, we measured activation of the GTPase Rac, which is responsible for actin polymerization. Results showed that ibrutinib did not inhibit Rac activation, nor did the calcium chelator 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid tetrakis( acetoxymethyl ester). We next asked whether the effect of ibrutinib on monocyte Fc gamma R-mediated cytokine production could be rescued by IFN gamma priming because NK cells produce IFN gamma in response to antibody therapy. Pretreatment of monocytes with IFN gamma abrogated the effects of ibrutinib on Fc gamma R-mediated cytokine production, suggesting that IFN gamma priming could overcome this Btk inhibition. Furthermore, in monocyte-natural killer cell co-cultures, ibrutinib did not inhibit Fc gamma R-mediated cytokine production despite doing so in single cultures. These results suggest that combining ibrutinib with monoclonal antibody therapy could enhance chronic lymphocytic leukemia cell killing without affecting macrophage effector function.	[Ren, Li] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130000, Peoples R China; [Campbell, Amanda; Fang, Huiqing; Gautam, Shalini; Elavazhagan, Saranya; Fatehchand, Kavin; Mehta, Payal; Stiff, Andrew; Reader, Brenda F.; Byrd, John C.; Carson, William E., III; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	Jilin University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Butchar, JP; Tridandapani, S (corresponding author), Ohio State Univ, Div Hematol, Wexner Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	butchar.2@osu.edu; tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011		National Institutes of Health [P01-CA095426, R01 CA162411, R01 CA177292, R01 CA183444, T32 HL007946]; Ohio State University College of Medicine McWhinney Bridge Fund [244749]; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA183444, R01CA162411, R01CA177292, P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University College of Medicine McWhinney Bridge Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01-CA095426 and R01 CA162411 (to S. T. and J. C. B.), R01 CA177292 and R01 CA183444 (to J. C. B.), and T32 HL007946 (to B. F. R.) and by Ohio State University College of Medicine McWhinney Bridge Fund 244749 (to J. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borge M, 2015, HAEMATOLOGICA, V100, pE140, DOI 10.3324/haematol.2014.119669; Burger JA, 2014, LANCET ONCOL, V15, P1090, DOI 10.1016/S1470-2045(14)70335-3; Cao XH, 2004, J IMMUNOL, V172, P4851, DOI 10.4049/jimmunol.172.8.4851; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Da Roit F, 2015, HAEMATOLOGICA, V100, P77, DOI 10.3324/haematol.2014.107011; Dasmahapatra G, 2013, BRIT J HAEMATOL, V161, P43, DOI 10.1111/bjh.12206; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Herman SEM, 2014, BLOOD, V123, P3286, DOI 10.1182/blood-2014-02-548610; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Jaglowski SM, 2015, BLOOD, V126, P842, DOI 10.1182/blood-2014-12-617522; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; KARIMI K, 1995, J IMMUNOL, V155, P5786; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kohrt HE, 2014, BLOOD, V123, P1957, DOI 10.1182/blood-2014-01-547869; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LENNARTZ MR, 1993, J LEUKOCYTE BIOL, V54, P389, DOI 10.1002/jlb.54.5.389; Lindvall JM, 2005, IMMUNOL REV, V203, P200, DOI 10.1111/j.0105-2896.2005.00225.x; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Mehta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021175; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Mukhopadhyay S, 1999, J IMMUNOL, V163, P1786; Mukhopadhyay S, 1999, J IMMUNOL, V163, P875; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Ptak W, 1998, SCAND J IMMUNOL, V47, P136; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Roda JM, 2007, CLIN CANCER RES, V13, P6419, DOI 10.1158/1078-0432.CCR-07-0865; RUSSELL PJ, 1983, CLIN IMMUNOL IMMUNOP, V27, P387, DOI 10.1016/0090-1229(83)90091-0; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; SCHER I, 1975, J EXP MED, V142, P637, DOI 10.1084/jem.142.3.637; SCHOLL PR, 1992, J IMMUNOL, V149, P1751; Setoguchi R, 1998, IMMUNOL LETT, V64, P109, DOI 10.1016/S0165-2478(98)00086-8; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	53	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3043	3052		10.1074/jbc.M115.687251	http://dx.doi.org/10.1074/jbc.M115.687251			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627823	hybrid, Green Published			2022-12-28	WOS:000369626900040
J	Speckmann, T; Sabatini, PV; Nian, C; Smith, RG; Lynn, FC				Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Smith, Riley G.; Lynn, Francis C.			Npas4 Transcription Factor Expression Is Regulated by Calcium Signaling Pathways and Prevents Tacrolimus-induced Cytotoxicity in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; INSULIN GENE-EXPRESSION; MAMMALIAN TARGET; INDUCED APOPTOSIS; GROWTH-FACTOR; RISK-FACTORS; GLUCOSE; CYCLOSPORINE; ACTIVATION; SECRETION	Cytosolic calcium influx activates signaling pathways known to support pancreatic beta cell function and survival by modulating gene expression. Impaired calcium signaling leads to decreased beta cell mass and diabetes. To appreciate the causes of these cytotoxic perturbations, a more detailed understanding of the relevant signaling pathways and their respective gene targets is required. In this study, we examined the calcium-induced expression of the cytoprotective beta cell transcription factor Npas4. Pharmacological inhibition implicated the calcineurin, Akt/protein kinase B, and Ca2+/calmodulin-dependent protein kinase signaling pathways in the regulation of Npas4 transcription and translation. Both Npas4 mRNA and protein had high turnover rates, and, at the protein level, degradation was mediated via the ubiquitin-proteasome pathway. Finally, beta cell cytotoxicity of the calcineurin inhibitor and immunosuppressant tacrolimus (FK-506) was prevented by Npas4 overexpression. These results delineate the pathways regulating Npas4 expression and stability and demonstrate its importance in clinical settings such as islet transplantation.	[Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Smith, Riley G.; Lynn, Francis C.] Child & Family Res Inst, Diabet Res Program, Vancouver, BC V5Z 4H4, Canada; [Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada; [Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; University of British Columbia	Lynn, FC (corresponding author), Child & Family Res Inst, Diabet Res Program, Vancouver, BC V5Z 4H4, Canada.; Lynn, FC (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada.; Lynn, FC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	francis.lynn@ubc.ca	Speckmann, Thilo/ABN-7893-2022	Speckmann, Thilo/0000-0001-7265-0879; Lynn, Francis/0000-0001-9318-1063; Sabatini, Paul/0000-0001-6613-566X	Canadian Institutes of Health [MOP 343144]; Canadian Institutes of Health Research-British Columbia transplantation trainee fellowship; University of British Columbia; Canadian Diabetes Association; Michael Smith Foundation for Health Research; Child and Family Research Institute	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research-British Columbia transplantation trainee fellowship(Canadian Institutes of Health Research (CIHR)); University of British Columbia; Canadian Diabetes Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Child and Family Research Institute	This work was supported by Canadian Institutes of Health Research Grant MOP 343144 (to F. C. L.).; Recipient of a Canadian Institutes of Health Research-British Columbia transplantation trainee fellowship.; Supported by doctoral fellowships from the University of British Columbia and the Canadian Diabetes Association.; Supported by the Michael Smith Foundation for Health Research, the Canadian Diabetes Association, and the Child and Family Research Institute.	Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bersten DC, 2014, BBA-GENE REGUL MECH, V1839, P13, DOI 10.1016/j.bbagrm.2013.11.004; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cotovio P, 2013, TRANSPL P, V45, P1079, DOI 10.1016/j.transproceed.2013.03.009; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Dadi PK, 2014, J BIOL CHEM, V289, P12435, DOI 10.1074/jbc.M114.562587; Demirci MS, 2010, CLIN TRANSPLANT, V24, pE170, DOI 10.1111/j.1399-0012.2010.01247.x; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HIRANO Y, 1992, TRANSPLANTATION, V53, P889, DOI 10.1097/00007890-199204000-00033; Huang Y, 2014, PROG MOL BIOL TRANSL, V121, P321, DOI 10.1016/B978-0-12-800101-1.00010-7; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; KRENTZ AJ, 1993, DIABETES, V42, P1753, DOI 10.2337/diabetes.42.12.1753; Leclerc I, 2004, DIABETES, V53, pS67, DOI 10.2337/diabetes.53.suppl_3.S67; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nishimura R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056799; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, BIOCHEM BIOPH RES CO, V378, P761, DOI 10.1016/j.bbrc.2008.11.137; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Sabatini PV, 2015, TRENDS ENDOCRIN MET, V26, P49, DOI 10.1016/j.tem.2014.11.002; Sabatini PV, 2013, DIABETES, V62, P2808, DOI 10.2337/db12-1527; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Santos Gustavo Jorge Dos, 2014, Mol Metab, V3, P484, DOI 10.1016/j.molmet.2014.03.011; Shin S, 2014, MOL METAB, V3, P803, DOI 10.1016/j.molmet.2014.08.001; Soleimanpour SA, 2010, J BIOL CHEM, V285, P40050, DOI 10.1074/jbc.M110.154955; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Srimontri P, 2014, EXP BRAIN RES, V232, P2957, DOI 10.1007/s00221-014-3977-y; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Suefuji M, 2012, BIOCHEM BIOPH RES CO, V421, P801, DOI 10.1016/j.bbrc.2012.04.091; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	67	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2682	2695		10.1074/jbc.M115.704098	http://dx.doi.org/10.1074/jbc.M115.704098			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26663079	Green Published, hybrid			2022-12-28	WOS:000369626900012
J	Chen, LX; Wang, T; Wang, YM; Zhang, JX; Qi, YM; Weng, HB; Kang, QZ; Guo, XH; Baines, AJ; Mohandas, N; An, XL				Chen, Lixiang; Wang, Ting; Wang, Yaomei; Zhang, Jingxin; Qi, Yuanming; Weng, Haibo; Kang, Qiaozhen; Guo, Xinhua; Baines, Anthony J.; Mohandas, Narla; An, Xiuli			Protein 4.1G Regulates Cell Adhesion, Spreading, and Migration of Mouse Embryonic Fibroblasts through the beta 1 Integrin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL-DOMAIN; INTEGRIN ACTIVATION; SURFACE EXPRESSION; IN-VITRO; BINDING; MEMBRANE; COMPLEX; RECEPTOR; MOTILITY; KINASE	Protein 4.1G is a membrane skeletal protein that can serve as an adapter between transmembrane proteins and the underlying membrane skeleton. The function of 4.1G remains largely unexplored. Here, using 4.1G knockout mouse embryonic fibroblasts (MEFs) as a model system, we explored the function of 4.1G in motile cells. We show that the adhesion, spreading, and migration of 4.1G(-/-) MEF cells are impaired significantly. We further show that, although the total cellular expression of beta 1 integrin is unchanged, the surface expression of beta 1 integrin and its active form are decreased significantly in 4.1G(-/-) MEF cells. Moreover, the phosphorylation of focal adhesion kinase, a downstream component of the integrin-mediated signal transduction pathway, is suppressed in 4.1G(-/-) MEF cells. Co-immunoprecipitation experiments and in vitro binding assays showed that 4.1G binds directly to beta 1 integrin via its membrane-binding domain. These findings identified a novel role of 4.1G in cell adhesion, spreading, and migration in MEF cells by modulating the surface expression of beta 1 integrin and subsequent downstream signal transduction.	[Chen, Lixiang; Wang, Ting; Wang, Yaomei; Zhang, Jingxin; Qi, Yuanming; Weng, Haibo; Kang, Qiaozhen; An, Xiuli] Zhengzhou Univ, Coll Life Sci, Sci Rd 100, Zhengzhou 450001, Peoples R China; [Chen, Lixiang; Guo, Xinhua; Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10065 USA; [Weng, Haibo; An, Xiuli] New York Blood Ctr, Membrane Biol Lab, New York, NY 10065 USA; [Baines, Anthony J.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	Zhengzhou University; New York Blood Center; New York Blood Center; University of Kent	An, XL (corresponding author), Membrane Biol Lab, 310 E 67th St, New York, NY 10065 USA.	xan@nybloodcenter.org			Natural Science Foundation of China [81171905, 81272187]; National Institutes of Health [DK26263, DK100180]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants 81171905 and 81272187 from the Natural Science Foundation of China and by National Institutes of Health Grants DK26263 and DK100180. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen LX, 2011, J CELL SCI, V124, P2478, DOI 10.1242/jcs.078170; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Coleman SK, 2003, J NEUROSCI, V23, P798; FATH KR, 1989, J CELL SCI, V92, P67; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hemler M. E., 1999, INTEGRINS GUIDEBOOK, P196; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILLC D, 1995, NATURE, V377, P539; Ivanovic A, 2012, J CELL BIOL, V196, P337, DOI 10.1083/jcb.201111127; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lu DC, 2004, J NEUROSCI RES, V78, P49, DOI 10.1002/jnr.20230; Lu DC, 2004, BIOCHEM J, V377, P51, DOI 10.1042/BJ20030952; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; McCarty JH, 2005, P NATL ACAD SCI USA, V102, P13479, DOI 10.1073/pnas.0506068102; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sieg DJ, 1999, J CELL SCI, V112, P2677; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; vonBallestrem CG, 1996, HYBRIDOMA, V15, P125, DOI 10.1089/hyb.1996.15.125; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; Wang H, 2010, HISTOCHEM CELL BIOL, V134, P411, DOI 10.1007/s00418-010-0749-z; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Xu Z, 2013, BIOCHEM BIOPH RES CO, V434, P382, DOI 10.1016/j.bbrc.2013.03.086; Yang SM, 2011, MOL CELL BIOL, V31, P2276, DOI 10.1128/MCB.01105-10; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022	43	6	6	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2170	2180		10.1074/jbc.M115.658591	http://dx.doi.org/10.1074/jbc.M115.658591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644476	hybrid, Green Published			2022-12-28	WOS:000369610400011
J	Manhas, R; Gowri, VS; Madhubala, R				Manhas, Reetika; Gowri, Venkatraman Subramanian; Madhubala, Rentala			Leishmania donovani Encodes a Functional Selenocysteinyl-tRNA Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN-T; HIGH-THROUGHPUT; IDENTIFICATION; TRYPANOSOMA; COMPLEXES; MECHANISM; EUPATHDB; PATHWAY	The synthesis of selenocysteine, the 21st amino acid, occurs on its transfer RNA (tRNA), tRNA(Sec). tRNASec is initially aminoacylated with serine by seryl-tRNA synthetase and the resulting seryl moiety is converted to phosphoserine by O-phosphoseryl- tRNA kinase (PSTK) in eukaryotes. The selenium donor, selenophosphate is synthesized from selenide and ATP by selenophosphate synthetase. Selenocysteinyl-tRNA synthase (SepSecS) then uses the O-phosphoseryl-tRNA(Sec) and selenophosphate to form Sec-tRNA(Sec) in eukaryotes. Here, we report the characterization of selenocysteinyl-tRNA synthase from Leishmania donovani. Kinetoplastid SepSecS enzymes are phylogenetically closer to worm SepSecS. LdSepSecS was found to exist as a tetramer. Leishmania SepSecS enzyme was found to be active and able to complement the Delta selA deletion in Escherichia coli JS1 strain only in the presence of archaeal PSTK, indicating the conserved nature of the PSTK-SepSecS pathway. LdSepSecS was found to localize in the cytoplasm of the parasite. Gene deletion studies indicate that Leishmania SepSecS is dispensable for the parasite survival. The parasite was found to encode three selenoproteins, which were only expressed in the presence of SepSecS. Selenoproteins of L. donovani are not required for the growth of the promastigotes. Auranofin, a known inhibitor of selenoprotein synthesis showed the same sensitivity toward the wild-type and null mutants suggesting its effect is not through binding to selenoproteins. The three-dimensional structural comparison indicates that human and Leishmania homologs are structurally highly similar but their association modes leading to tetramerization seem different.	[Manhas, Reetika; Gowri, Venkatraman Subramanian; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, New Delhi 110067, India.	rentala@outlook.com		Manhas, Reetika/0000-0002-0220-2330; V Subramanian, Gowri/0000-0002-4404-6401; madhubala, rentala/0000-0002-0034-399X	Department of Biotechnology, Goverment of India; Department of Science and Technology-Promotion of University Research and Scientific Excellence grant; University Grants Commission, India	Department of Biotechnology, Goverment of India; Department of Science and Technology-Promotion of University Research and Scientific Excellence grant; University Grants Commission, India(University Grants Commission, India)	The work was supported by grants from the Department of Biotechnology, Goverment of India, and a Department of Science and Technology-Promotion of University Research and Scientific Excellence grant (to R. Madhubala). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of funding from the University Grants Commission, India.r Kothari post-doctoral fellow supported by the University Grants Commission, India.	Aeby E, 2009, MOL BIOCHEM PARASIT, V168, P191, DOI 10.1016/j.molbiopara.2009.08.007; Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; Cassago A, 2006, MOL BIOCHEM PARASIT, V149, P128, DOI 10.1016/j.molbiopara.2006.05.002; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Darveau A., 1995, METH NEUROSCI, V26, P77, DOI DOI 10.1016/S1043-9471(06)80084-4; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Di Sarra F, 2013, EUR J INORG CHEM, P2718, DOI 10.1002/ejic.201300058; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; Grumolato L, 2008, FASEB J, V22, P1756, DOI 10.1096/fj.06-075820; Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112; Herkel J, 2002, HEPATOLOGY, V35, P403, DOI 10.1053/jhep.2002.30699; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ilari A, 2012, AMINO ACIDS, V42, P803, DOI 10.1007/s00726-011-0997-9; Jackson-Rosario S, 2009, J BIOL INORG CHEM, V14, P507, DOI 10.1007/s00775-009-0466-z; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sambrook J, 1989, MOL CLONING; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sculaccio SA, 2008, MOL BIOCHEM PARASIT, V162, P165, DOI 10.1016/j.molbiopara.2008.08.009; Sengupta A, 2009, BIOCHEM CELL BIOL, V87, P953, DOI [10.1139/O09-064, 10.1139/o09-064]; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Talbot S, 2008, BRIT J PHARMACOL, V154, P940, DOI 10.1038/bjp.2008.161; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	46	12	13	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1203	1220		10.1074/jbc.M115.695007	http://dx.doi.org/10.1074/jbc.M115.695007			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26586914	Green Published, hybrid			2022-12-28	WOS:000368068300017
J	Wei, NN; Lv, HN; Wu, Y; Yang, SL; Sun, XY; Lai, R; Jiang, Y; Wang, KW				Wei, Ning-Ning; Lv, Hai-Ning; Wu, Yang; Yang, Shi-Long; Sun, Xiao-Ying; Lai, Ren; Jiang, Yong; Wang, KeWei			Selective Activation of Nociceptor TRPV1 Channel and Reversal of Inflammatory Pain in Mice by a Novel Coumarin Derivative Muralatin L from Murraya alata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR TRPV1; ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; BLACK PEPPER; MECHANISMS; DESENSITIZATION; HYPERALGESIA; PIPERINE; RAT	Coumarin and its derivatives are fragrant natural compounds isolated from the genus Murraya that are flowering plants widely distributed in East Asia, Australia, and the Pacific Islands. Murraya plants have been widely used as medicinal herbs for relief of pain, such as headache, rheumatic pain, toothache, and snake bites. However, little is known about their analgesic components and the molecular mechanism underlying pain relief. Here, we report the bioassay-guided fractionation and identification of a novel coumarin derivative, named muralatin L, that can specifically activate the nociceptor transient receptor potential vanilloid 1 (TRPV1) channel and reverse the inflammatory pain in mice through channel desensitization. Muralatin L was identified from the active extract of Murraya alata against TRPV1 transiently expressed in HEK-293T cells in fluorescent calcium FlexStation assay. Activation of TRPV1 current by muralatin L and its selectivity were further confirmed by whole-cell patch clamp recordings of TRPV1-expressing HEK-293T cells and dorsal root ganglion neurons isolated from mice. Furthermore, muralatin L could reverse inflammatory pain induced by formalin and acetic acid in mice but not in TRPV1 knock-out mice. Taken together, our findings show that muralatin L specifically activates TRPV1 and reverses inflammatory pain, thus highlighting the potential of coumarin derivatives from Murraya plants for pharmaceutical and medicinal applications such as pain therapy.	[Wei, Ning-Ning; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Beijing 100191, Peoples R China; [Wei, Ning-Ning; Wang, KeWei] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Lv, Hai-Ning; Jiang, Yong] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China; [Wu, Yang; Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, IDG,McGovern Inst Brain Res, Beijing 100191, Peoples R China; [Yang, Shi-Long; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Sun, Xiao-Ying; Wang, KeWei] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao 266021, Peoples R China	Peking University; Peking University; Peking University; Peking University; Chinese Academy of Sciences; Kunming Institute of Zoology; Qingdao University	Jiang, Y (corresponding author), Peking Univ, Xueyuan Rd, Beijing 100191, Peoples R China.	yongjiang@bjmu.edu.cn; wangkw@bjmu.edu.cn	Jiang, Yong/C-4026-2016	Jiang, Yong/0000-0002-8450-7786	Ministry of Science and Technology of China [2013CB531302, 2013ZX09103001-015, 2014 ZX09507003-006-004]; National Natural Sciences Foundation of China [81222051, 81473106]; National Key Technology R&D Program "New Drug Innovation" of China [2012ZX09301002-002-002, 2012ZX09304-005]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program "New Drug Innovation" of China(National Key Technology R&D Program)	This work was supported by Ministry of Science and Technology of China Research Grants 2013CB531302, 2013ZX09103001-015, and 2014 ZX09507003-006-004 (to K. W. W.), National Natural Sciences Foundation of China Grants 81222051 and 81473106, and National Key Technology R&D Program "New Drug Innovation" of China Grants 2012ZX09301002-002-002 and 2012ZX09304-005 (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Almasi R, 2003, BRIT J PHARMACOL, V139, P49, DOI 10.1038/sj.bjp.0705234; Armero P, 2012, MED CLIN-BARCELONA, V139, P1, DOI 10.1016/j.medcli.2011.10.028; Arora RK, 2014, ACTA PHARM SIN B, V4, P368, DOI 10.1016/j.apsb.2014.07.001; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen XJ, 2014, J BIOL CHEM, V289, P9600, DOI 10.1074/jbc.M113.536862; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de la Roche J, 2013, J BIOL CHEM, V288, P20280, DOI 10.1074/jbc.M113.479337; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gao Y., 2009, ZHONGGUO YAOSHI, P691; Jones Virginia M, 2011, J Pain Palliat Care Pharmacother, V25, P32, DOI 10.3109/15360288.2010.547561; Koplas PA, 1997, J NEUROSCI, V17, P3525; Lei L, 2013, J BIOL CHEM, V288, P10427, DOI 10.1074/jbc.M113.457291; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Nahin Richard L, 2009, Natl Health Stat Report, P1; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pearce LV, 2004, ORG BIOMOL CHEM, V2, P2281, DOI 10.1039/b404506h; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Song L. R., 1999, CHINESE MAT MED, V4, P961; Szallasi A, 2000, TRENDS NEUROSCI, V23, P491, DOI 10.1016/S0166-2236(00)01630-1; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Szallasi A, 2012, EXPERT OPIN INV DRUG, V21, P1351, DOI 10.1517/13543784.2012.704021; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu LH, 2010, PHARM BIOL, V48, P1344, DOI 10.3109/13880201003793723; WU TS, 1981, PHYTOCHEMISTRY, V20, P178, DOI 10.1016/0031-9422(81)85247-8; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941; Zou L., 2000, ZHONGGUO YIYAO XUEBA, V15, P298	44	20	21	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					640	651		10.1074/jbc.M115.654392	http://dx.doi.org/10.1074/jbc.M115.654392			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26515068	Green Published, hybrid			2022-12-28	WOS:000367830500012
J	Loftus, RM; Finlay, DK				Loftus, Roisin M.; Finlay, David K.			Immunometabolism: Cellular Metabolism Turns Immune Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						dendritic cell; glycolysis; lymphocyte; macrophage; mitochondria; neutrophil; immunometabolism; inflammatory microenvironment; metabolite; oxidative phosphorylation	T-CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; OXIDATIVE-PHOSPHORYLATION; GLUCOSE-METABOLISM; MECHANISTIC TARGET; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; EFFECTOR FUNCTION; GENE-EXPRESSION; DENDRITIC CELLS	Immune cells are highly dynamic in terms of their growth, proliferation, and effector functions as they respond to immunological challenges. Different immune cells can adopt distinct metabolic configurations that allow the cell to balance its requirements for energy, molecular biosynthesis, and longevity. However, in addition to facilitating immune cell responses, it is now becoming clear that cellular metabolism has direct roles in regulating immune cell function. This review article describes the distinct metabolic signatures of key immune cells, explains how these metabolic setups facilitate immune function, and discusses the emerging evidence that intracellular metabolism has an integral role in controlling immune responses.	[Loftus, Roisin M.; Finlay, David K.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Finlay, David K.] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Finlay, DK (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland.	finlayd@tcd.ie	Finlay, David/H-5840-2018	Finlay, David/0000-0003-2716-6679; Loftus, Roisin/0000-0001-9137-6625	Science Foundation Ireland [12/IP/1286, 13/CDA/2161]; Marie Curie Actions [PCIG11-GA-2012-321603]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie Actions(European Commission)	This work was supported by Science Foundation Ireland (Grants 12/IP/1286 and 13/CDA/2161) and Marie Curie Actions (PCIG11-GA-2012-321603). The authors declare that they have no conflicts of interest with the contents of this article.	Amiel E, 2014, J IMMUNOL, V193, P2821, DOI 10.4049/jimmunol.1302498; Amiel E, 2012, J IMMUNOL, V189, P2151, DOI 10.4049/jimmunol.1103741; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Donnelly RP, 2015, MOL IMMUNOL, V68, P513, DOI 10.1016/j.molimm.2015.07.034; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Leunda-Casi A, 2002, DIABETOLOGIA, V45, P571, DOI 10.1007/s00125-001-0752-y; Lim HW, 2015, J EXP MED, V212, P607, DOI 10.1084/jem.20132378; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; MacFarlane M, 2012, CELL CYCLE, V11, P3919, DOI 10.4161/cc.21804; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Maciolek JA, 2014, CURR OPIN IMMUNOL, V27, P60, DOI 10.1016/j.coi.2014.01.006; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McInturff AM, 2012, BLOOD, V120, P3118, DOI 10.1182/blood-2012-01-405993; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ripoli M, 2010, J VIROL, V84, P647, DOI 10.1128/JVI.00769-09; Rivadeneira DB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1624; Robinson GL, 2012, ONCOGENE, V31, P4996, DOI 10.1038/onc.2012.13; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Six E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.211; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sumbayev VV, 2009, EUR J IMMUNOL, V39, P3511, DOI 10.1002/eji.200939370; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vitko NP, 2015, MBIO, V6, DOI 10.1128/mBio.00045-15; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10; Zang WQ, 1998, VIROLOGY, V248, P46, DOI 10.1006/viro.1998.9255; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	100	247	256	18	113	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					1	10		10.1074/jbc.R115.693903	http://dx.doi.org/10.1074/jbc.R115.693903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26534957	Green Published, hybrid			2022-12-28	WOS:000367589500001
J	Rabadi, SM; Sanchez, BC; Varanat, M; Ma, Z; Catlett, SV; Melendez, JA; Malik, M; Bakshi, CS				Rabadi, Seham M.; Sanchez, Belkys C.; Varanat, Mrudula; Ma, Zhuo; Catlett, Sally V.; Melendez, Juan Andres; Malik, Meenakshi; Bakshi, Chandra Shekhar			Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; cytokine induction; immunosuppression; p38 MAPK; redox signaling	INNATE IMMUNE-RESPONSES; REACTIVE OXYGEN; INTRAMACROPHAGE SURVIVAL; OXIDATIVE STRESS; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR SURVIVAL; MEMBRANE-PROTEIN; IDENTIFICATION; ACTIVATION; TULAREMIA	Francisella tularensis, the causative agent of a fatal human disease known as tularemia, has been used in the bioweapon programs of several countries in the past, and now it is considered a potential bioterror agent. Extreme infectivity and virulence of F. tularensis is due to its ability to evade immune detection and to suppress the host's innate immune responses. However, Francisella-encoded factors and mechanisms responsible for causing immune suppression are not completely understood. Macrophages and neutrophils generate reactive oxygen species (ROS)/reactive nitrogen species as a defense mechanism for the clearance of phagocytosed microorganisms. ROS serve a dual role; at high concentrations they act as microbicidal effector molecules that destroy intracellular pathogens, and at low concentrations they serve as secondary signaling messengers that regulate the expression of various inflammatory mediators. We hypothesized that the antioxidant defenses of F. tularensis maintain redox homeostasis in infected macrophages to prevent activation of redox-sensitive signaling components that ultimately result in suppression of pro-inflammatory cytokine production and macrophage microbicidal activity. We demonstrate that antioxidant enzymes of F. tularensis prevent the activation of redox-sensitive MAPK signaling components, NF-B signaling, and the production of pro-inflammatory cytokines by inhibiting the accumulation of ROS in infected macrophages. We also report that F. tularensis inhibits ROS-dependent autophagy to promote its intramacrophage survival. Collectively, this study reveals novel pathogenic mechanisms adopted by F. tularensis to modulate macrophage innate immune functions to create an environment permissive for its intracellular survival and growth.	[Rabadi, Seham M.; Sanchez, Belkys C.; Varanat, Mrudula; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, BSB 340,15 Dana Rd, Valhalla, NY 10595 USA; [Ma, Zhuo; Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, Albany, NY 12208 USA; [Melendez, Juan Andres] SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Melendez, Juan Andres] SUNY Albany, Polytech Inst, Coll Engn, Albany, NY 12203 USA	New York Medical College; Albany College of Pharmacy & Health Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bakshi, CS (corresponding author), New York Med Coll, Dept Microbiol & Immunol, BSB 340,15 Dana Rd, Valhalla, NY 10595 USA.; Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485; Sanchez, Belkys/0000-0002-7290-1460; Ma, Zhuo/0000-0002-9766-8239; Melendez, Juan/0000-0001-8021-3097	National Institutes of Health [P01AI056320, R56AI101109, R15AI107698]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107698, R56AI101109, P01AI056320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE023526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AI056320 and R56AI101109 (to C. S. B.) and R15AI107698 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen LAH, 2007, IMMUNOL REV, V219, P103, DOI 10.1111/j.1600-065X.2007.00544.x; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Break TJ, 2012, J IMMUNOL, V188, P3342, DOI 10.4049/jimmunol.1102341; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Case ED, 2014, CELL MICROBIOL, V16, P862, DOI 10.1111/cmi.12246; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cremer TJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00013; DEBY C, 1990, BIOCHEM PHARMACOL, V39, P399, DOI 10.1016/0006-2952(90)90043-K; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dieppedale J, 2011, INFECT IMMUN, V79, P1428, DOI 10.1128/IAI.01012-10; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Franchini AM, 2013, J BIOL CHEM, V288, P25098, DOI 10.1074/jbc.M113.474106; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Geier H, 2011, INFECT IMMUN, V79, P2204, DOI 10.1128/IAI.01382-10; Gillette DD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00045; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Halliwell B, 1997, J NEUROCHEM, V69, P1330; Hayakawa T, 2011, GENETICS, V187, P785, DOI 10.1534/genetics.110.124883; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Ichijo Hidenori, 2007, Folia Pharmacologica Japonica, V129, P89, DOI 10.1254/fpj.129.89; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Ma Z, 2014, MOL MICROBIOL, V91, P976, DOI 10.1111/mmi.12509; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Mendez-Samperio P, 2009, MICROB PATHOGENESIS, V47, P252, DOI 10.1016/j.micpath.2009.08.006; Miller JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000864; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Orekhov AN, 2015, EXP MOL PATHOL, V99, P151, DOI 10.1016/j.yexmp.2015.06.011; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Samuel LP, 2007, MICROBIOL-SGM, V153, P529, DOI 10.1099/mic.0.2006/002642-0; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Schwartz JT, 2012, J IMMUNOL, V189, P3064, DOI 10.4049/jimmunol.1200816; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; STEINBECK MJ, 1993, J BIOL CHEM, V268, P15649; Travanty E, 2015, J VIROL, V89, P11935, DOI 10.1128/JVI.01792-15; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Yuk JM, 2009, IMMUNOL CELL BIOL, V87, P100, DOI 10.1038/icb.2008.74; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	73	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5009	5021		10.1074/jbc.M115.681478	http://dx.doi.org/10.1074/jbc.M115.681478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26644475	Green Published, hybrid			2022-12-28	WOS:000371640600016
J	Dawaliby, R; Trubbia, C; Delporte, C; Noyon, C; Ruysschaert, JM; Van Antwerpen, P; Govaerts, C				Dawaliby, Rosie; Trubbia, Cataldo; Delporte, Cedric; Noyon, Caroline; Ruysschaert, Jean-Marie; Van Antwerpen, Pierre; Govaerts, Cedric			Phosphatidylethanolamine Is a Key Regulator of Membrane Fluidity in Eukaryotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; homeostasis; membrane bilayer; membrane lipid; phosphatidylethanolamine	TYPE-2 HYPERCHOLESTEROLEMIA; DROSOPHILA-MELANOGASTER; LIPID FLUIDITY; SREBP PATHWAY; CHOLESTEROL; LOVASTATIN; PHASE	Adequate membrane fluidity is required for a variety of key cellular processes and in particular for proper function of membrane proteins. In most eukaryotic cells, membrane fluidity is known to be regulated by fatty acid desaturation and cholesterol, although some cells, such as insect cells, are almost devoid of sterol synthesis. We show here that insect and mammalian cells present similar microviscosity at their respective physiological temperature. To investigate how both sterols and phospholipids control fluidity homeostasis, we quantified the lipidic composition of insect SF9 and mammalian HEK 293T cells under normal or sterol-modified condition. As expected, insect cells show minimal sterols compared with mammalian cells. A major difference is also observed in phospholipid content as the ratio of phosphatidylethanolamine (PE) to phosphatidylcholine (PC) is inverted (4 times higher in SF9 cells). In vitro studies in liposomes confirm that both cholesterol and PE can increase rigidity of the bilayer, suggesting that both can be used by cells to maintain membrane fluidity. We then show that exogenously increasing the cholesterol amount in SF9 membranes leads to a significant decrease in PE:PC ratio whereas decreasing cholesterol in HEK 293T cells using statin treatment leads to an increase in the PE:PC ratio. In all cases, the membrane fluidity is maintained, indicating that both cell types combine regulation by sterols and phospholipids to control proper membrane fluidity.	[Dawaliby, Rosie; Trubbia, Cataldo; Ruysschaert, Jean-Marie; Govaerts, Cedric] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, CP 206-02,Bd Triomphe, B-1050 Brussels, Belgium; [Delporte, Cedric; Noyon, Caroline; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, B-1050 Brussels, Belgium; [Delporte, Cedric; Noyon, Caroline; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Analyt Platform, B-1050 Brussels, Belgium; [Delporte, Cedric; Noyon, Caroline] FRS FNRS, Molenbeek St Jean, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS	Govaerts, C (corresponding author), Univ Libre Bruxelles, Struct & Funct Biol Membranes, Bldg BC,Rm 1C4 203,Blvd Triomphe,Acces 2, B-1050 Brussels, Belgium.	Cedric.Govaerts@ulb.ac.be	; Delporte, Cedric/C-2228-2013	Dawaliby, Rosie/0000-0001-7476-0350; Delporte, Cedric/0000-0001-7453-7028; Noyon, Caroline/0000-0002-1505-4541; Van Antwerpen, Pierre/0000-0002-4934-8863	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) [F.4523.12, 34553.08, T.0136.13]; "Fond Extraordinaire de Recherche" of the Universite Libre de Bruxelles	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); "Fond Extraordinaire de Recherche" of the Universite Libre de Bruxelles	This work was supported in part by Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) Grants F.4523.12, 34553.08, and T.0136.13 and a grant from "Fond Extraordinaire de Recherche" 2007 of the Universite Libre de Bruxelles. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn T, 1999, ARCH BIOCHEM BIOPHYS, V369, P288, DOI 10.1006/abbi.1999.1376; Allen HG, 2006, NUTRITION, V22, P1096, DOI 10.1016/j.nut.2006.07.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; CHABANEL A, 1983, BIOPHYS J, V44, P171, DOI 10.1016/S0006-3495(83)84288-X; Cooper BS, 2014, FUNCT ECOL, V28, P886, DOI 10.1111/1365-2435.12264; Cooper BS, 2012, EVOLUTION, V66, P1976, DOI 10.1111/j.1558-5646.2011.01566.x; Cybulski LE, 2004, J BIOL CHEM, V279, P39340, DOI 10.1074/jbc.M405150200; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Janosi J, 2004, ANTICANCER RES, V24, P1817; Kaiser RD, 1999, BIOCHEMISTRY-US, V38, P2610, DOI 10.1021/bi985065h; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; LEVY Y, 1992, BRIT J CLIN PHARMACO, V34, P427; Lipowsky R, 2014, BIOL CHEM, V395, P253, DOI 10.1515/hsz-2013-0244; Lockshon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045049; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Pan Q, 2014, LIPIDS, V49, P715, DOI 10.1007/s11745-014-3900-0; QUARFORDT SH, 1970, J LIPID RES, V11, P528; Roy R, 1997, BBA-BIOMEMBRANES, V1323, P65, DOI 10.1016/S0005-2736(96)00176-9; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; SILVIUS JR, 1986, BIOCHIM BIOPHYS ACTA, V857, P217, DOI 10.1016/0005-2736(86)90350-0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; vanVliet AK, 1996, BIOCHEM PHARMACOL, V52, P1387, DOI 10.1016/S0006-2952(96)00467-4; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5	31	182	186	4	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3658	3667		10.1074/jbc.M115.706523	http://dx.doi.org/10.1074/jbc.M115.706523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663081	Green Published, hybrid			2022-12-28	WOS:000370854500043
J	John, CM; Phillips, NJ; Din, R; Liu, MF; Rosenqvist, E; Hoiby, EA; Stein, DC; Jarvis, GA				John, Constance M.; Phillips, Nancy J.; Din, Richard; Liu, Mingfeng; Rosenqvist, Einar; Hoiby, E. Arne; Stein, Daniel C.; Jarvis, Gary A.			Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioinformatics; infection; lipid A; mass spectrometry (MS); phosphorylation; sialic acid; Neisseria meningitidis; acylation; lipooligosaccharide; phosphoethanolamine	LACTO-N-NEOTETRAOSE; GRAM-NEGATIVE BACTERIA; NORMAL HUMAN SERUM; FACTOR-H BINDING; INNER-CORE; SEROGROUP-B; MENINGOCOCCAL DISEASE; ALKALINE-PHOSPHATASE; ENDOTOXIN TOLERANCE; LIPID-A	The degree of phosphorylation and phosphoethanolaminylation of lipid A on neisserial lipooligosaccharide (LOS), a major cell-surface antigen, can be correlated with inflammatory potential and the ability to induce immune tolerance in vitro. On the oligosaccharide of the LOS, the presence of phosphoethanolamine and sialic acid substituents can be correlated with in vitro serum resistance. In this study, we analyzed the structure of the LOS from 40 invasive isolates and 25 isolates from carriers of Neisseria meningitidis without disease. Invasive strains were classified as groups 1-3 that caused meningitis, septicemia without meningitis, and septicemia with meningitis, respectively. Intact LOS was analyzed by high resolution matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Prominent peaks for lipid A fragment ions with three phosphates and one phosphoethanolamine were detected in all LOS analyzed. LOS from groups 2 and 3 had less abundant ions for highly phosphorylated lipid A forms and induced less TNF- in THP-1 monocytic cells compared with LOS from group 1. Lipid A from all invasive strains was hexaacylated, whereas lipid A of 6/25 carrier strains was pentaacylated. There were fewer O-acetyl groups and more phosphoethanolamine and sialic acid substitutions on the oligosaccharide from invasive compared with carrier isolates. Bioinformatic and genomic analysis of LOS biosynthetic genes indicated significant skewing to specific alleles, dependent on the disease outcome. Our results suggest that variable LOS structures have multifaceted effects on homeostatic innate immune responses that have critical impact on the pathophysiology of meningococcal infections.	[John, Constance M.; Din, Richard; Liu, Mingfeng; Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [John, Constance M.; Phillips, Nancy J.; Liu, Mingfeng; Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [John, Constance M.; Phillips, Nancy J.; Jarvis, Gary A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Rosenqvist, Einar; Hoiby, E. Arne] Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway; [Stein, Daniel C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Norwegian Institute of Public Health (NIPH); University System of Maryland; University of Maryland College Park	Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Dept 111W1,4150 Clement St, San Francisco, CA 94121 USA.	gary.jarvis@ucsf.edu		Stein, Daniel/0000-0003-3397-5720; Jarvis, Gary/0000-0002-7576-3702	Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health/NCI Cancer Center Support Grant [P30 CA082103]; Canary Foundation; National Institutes of Health/NCRR Shared Instrumentation Grant [S10 RR029446]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029446] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000727] Funding Source: NIH RePORTER	Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health/NCI Cancer Center Support Grant; Canary Foundation; National Institutes of Health/NCRR Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	We gratefully acknowledge the University of California, San Francisco Sandler-Moore Mass Spectrometry Core Facility, which has received support from the Sandler Family Foundation, the Gordon and Betty Moore Foundation, National Institutes of Health/NCI Cancer Center Support Grant P30 CA082103, the Canary Foundation, and the National Institutes of Health/NCRR Shared Instrumentation Grant S10 RR029446 (to H. E. Witkowska). We thank the laboratory of Dominique Caugant for purification of DNA used in the genomic allele studies.	Balthazar JT, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00030; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Bevanger L, 1998, J MED MICROBIOL, V47, P993, DOI 10.1099/00222615-47-11-993; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Brandtzaeg P, 2012, METHODS MOL BIOL, V799, P21, DOI 10.1007/978-1-61779-346-2_2; Brouwer MC, 2011, J INFECTION, V62, P479, DOI 10.1016/j.jinf.2011.03.010; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Cheng H, 2011, J BIOL CHEM, V286, P43622, DOI 10.1074/jbc.M111.291583; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Conyn-van Spaendonck MAE, 1999, J INFECTION, V39, P42, DOI 10.1016/S0163-4453(99)90101-9; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; du Plessis M, 2014, J INFECTION, V68, P455, DOI 10.1016/j.jinf.2013.12.011; ERWIN AL, 1991, INFECT IMMUN, V59, P1881, DOI 10.1128/IAI.59.6.1881-1887.1991; ERWIN AL, 1990, J BIOL CHEM, V265, P16444; Estabrook MM, 2007, INFECT IMMUN, V75, P1025, DOI 10.1128/IAI.00882-06; ESTABROOK MM, 1992, J INFECT DIS, V166, P1079, DOI 10.1093/infdis/166.5.1079; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fransen F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000396; FROHOLM L O, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P139; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; GRIFFISS JM, 1991, J IMMUNOL, V147, P298; GU XX, 1992, J CLIN MICROBIOL, V30, P2047, DOI 10.1128/JCM.30.8.2047-2053.1992; Gulati S, 2005, INFECT IMMUN, V73, P7390, DOI 10.1128/IAI.73.11.7390-7397.2005; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hellerud BC, 2010, INFECT IMMUN, V78, P802, DOI 10.1128/IAI.01044-09; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; HOIBY E A, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P107; JARVIS GA, 1994, INFECT IMMUN, V62, P1755, DOI 10.1128/IAI.62.5.1755-1760.1994; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; JOHNSON AP, 1983, J CLIN PATHOL, V36, P213, DOI 10.1136/jcp.36.2.213; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones JW, 2008, P NATL ACAD SCI USA, V105, P12742, DOI 10.1073/pnas.0800445105; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; Kahler CM, 1996, J BACTERIOL, V178, P1265, DOI 10.1128/jb.178.5.1265-1273.1996; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288; Lewis LA, 2013, INFECT IMMUN, V81, P33, DOI 10.1128/IAI.00751-12; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Liu MF, 2014, J IMMUNOL, V192, P1768, DOI 10.4049/jimmunol.1301648; Liu MF, 2010, J IMMUNOL, V185, P6974, DOI 10.4049/jimmunol.1000953; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Lu MF, 2011, J IMMUNOL, V187, P3314, DOI 10.4049/jimmunol.1004087; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Persa OD, 2014, LANCET, V384, P1900, DOI 10.1016/S0140-6736(14)61645-7; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Quinn EM, 2012, J LEUKOCYTE BIOL, V91, P721, DOI 10.1189/jlb.1111571; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Rodenburg GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049295; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; SODERSTROM C, 1987, J INFECT DIS, V156, P107, DOI 10.1093/infdis/156.1.107; Steinshamn S, 2000, APMIS, V108, P107, DOI 10.1034/j.1600-0463.2000.d01-33.x; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephenson HN, 2013, J BIOL CHEM, V288, P19661, DOI 10.1074/jbc.M113.468298; Su FH, 2006, CRIT CARE MED, V34, P2182, DOI 10.1097/01.CCM.0000229887.70579.29; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; Tsai CM, 2009, J BIOL CHEM, V284, P4616, DOI 10.1074/jbc.M808209200; Tsai CM, 2002, INFECT IMMUN, V70, P407, DOI 10.1128/IAI.70.1.407-411.2002; TSAI CM, 1987, INFECT IMMUN, V55, P1652, DOI 10.1128/IAI.55.7.1652-1656.1987; Tsai CM, 1998, GLYCOBIOLOGY, V8, P359, DOI 10.1093/glycob/8.4.359; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Vu DM, 2012, INFECT IMMUN, V80, P643, DOI 10.1128/IAI.05604-11; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wong HEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026130; YAMASAKI R, 1991, MOL IMMUNOL, V28, P1233, DOI 10.1016/0161-5890(91)90010-H; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	79	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3224	3238		10.1074/jbc.M115.666214	http://dx.doi.org/10.1074/jbc.M115.666214			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26655715	Green Published, hybrid			2022-12-28	WOS:000370854500010
J	Noy, PJ; Yang, J; Reyat, JS; Matthews, AL; Charlton, AE; Furmston, J; Rogers, DA; Rainger, GE; Tomlinson, MG				Noy, Peter J.; Yang, Jing; Reyat, Jasmeet S.; Matthews, Alexandra L.; Charlton, Alice E.; Furmston, Joanna; Rogers, David A.; Rainger, G. Ed; Tomlinson, Michael G.			TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; cell surface enzyme; endothelial cell; metalloprotease; N-cadherin; platelet; shedding; tetraspanin; GPVI; TspanC8	CELL-SURFACE; COMPLEXES; INTEGRIN; DOMAINS; ANGIOGENESIS; ACTIVATION; COMPONENT; ADHESION; GPVI; WEB	A disintegrin and metalloprotease 10 (ADAM10) is a ubiquitously expressed transmembrane metalloprotease that cleaves the extracellular regions from its transmembrane substrates. ADAM10 is essential for embryonic development and is implicated in cancer, Alzheimer, and inflammatory diseases. The tetraspanins are a superfamily of 33 four-transmembrane proteins in mammals, of which the TspanC8 subgroup (Tspan5, 10, 14, 15, 17, and 33) promote ADAM10 intracellular trafficking and enzymatic maturation. However, the interaction between TspanC8s and ADAM10 has only been demonstrated in overexpression systems and the interaction mechanism remains undefined. To address these issues, an antibody was developed to Tspan14, which was used to show co-immunoprecipitation of Tspan14 with ADAM10 in primary human cells. Chimeric Tspan14 constructs demonstrated that the large extracellular loop of Tspan14 mediated its co-immunoprecipitation with ADAM10, and promoted ADAM10 maturation and trafficking to the cell surface. Chimeric ADAM10 constructs showed that membrane-proximal stalk, cysteine-rich, and disintegrin domains of ADAM10 mediated its co-immunoprecipitation with Tspan14 and other TspanC8s. This TspanC8-interacting region was required for ADAM10 exit from the endoplasmic reticulum. Truncated ADAM10 constructs revealed differential TspanC8 binding requirements for the stalk, cysteine-rich, and disintegrin domains. Moreover, Tspan15was the only TspanC8 to promote cleavage of the ADAM10 substrate N-cadherin, whereas Tspan14 was unique in reducing cleavage of the platelet collagen receptor GPVI. These findings suggest that ADAM10 may adopt distinct conformations in complex with different TspanC8s, which could impact on substrate selectivity. Furthermore, this study identifies regions of TspanC8s and ADAM10 for potential interaction-disrupting therapeutic targeting.	[Rogers, David A.; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Rainger, G. Ed] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Tomlinson, MG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England.	m.g.tomlinson@bham.ac.uk	Reyat, Jasmeet Singh/AAU-1268-2020	Reyat, Jasmeet Singh/0000-0003-3247-9186; Noy, Peter/0000-0001-6142-8957; Tomlinson, Michael/0000-0002-1189-0091	British Heart Foundation [PG/13/92/30587, FS/12/79/29871, FS/08/062/25797]; Biotechnology and Biological Sciences Research Council [1500480] Funding Source: researchfish; British Heart Foundation [RG/12/7/29693] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This study was funded by the British Heart Foundation through a project grant (to M. G. T.), which supported P. N. (PG/13/92/30587), a Ph.D. studentship (to M. G. T. and G. E. R.), which supported J. S. R. (FS/12/79/29871), and a senior fellowship (to M. G. T.), which also supported J. Y. (FS/08/062/25797). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey RL, 2011, BIOCHEM SOC T, V39, P1667, DOI 10.1042/BST20110745; Bender M, 2010, BLOOD, V116, P3347, DOI 10.1182/blood-2010-06-289108; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Berlanga O, 2007, J THROMB HAEMOST, V5, P1026, DOI 10.1111/j.1538-7836.2007.02449.x; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; McCarty OJT, 2006, J THROMB HAEMOST, V4, P1367, DOI 10.1111/j.1538-7836.2006.01966.x; Metharom P, 2015, ARTERIOSCL THROM VAS, V35, P1327, DOI 10.1161/ATVBAHA.114.303413; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Montpellier C, 2011, J BIOL CHEM, V286, P13954, DOI 10.1074/jbc.M111.220103; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Protty MB, 2009, BIOCHEM J, V417, P391, DOI 10.1042/BJ20081126; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rubinstein E., 2013, ORG TETRASPANIN WEB; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Seigneuret M., 2013, STRUCTURAL BASES TET; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tomlinson MG, 2009, J THROMB HAEMOST, V7, P2070, DOI 10.1111/j.1538-7836.2009.03613.x; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4; van der Vorst EPC, 2012, ATHEROSCLEROSIS, V224, P302, DOI 10.1016/j.atherosclerosis.2012.04.023; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Zhou J, 2014, CALCIFIED TISSUE INT, V95, P209, DOI 10.1007/s00223-014-9883-2	40	65	69	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3145	3157		10.1074/jbc.M115.703058	http://dx.doi.org/10.1074/jbc.M115.703058			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668317	hybrid, Green Published			2022-12-28	WOS:000370854500003
J	Sharma, N; Longjam, G; Schreiber, G				Sharma, Nanaocha; Longjam, Geeta; Schreiber, Gideon			Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; interferon; mutagenesis; protein-protein interaction; transmembrane domain; cytokine receptor	RESONANCE ENERGY-TRANSFER; GROWTH-HORMONE RECEPTOR; ERYTHROPOIETIN RECEPTOR; WEB SERVER; STRUCTURAL BASIS; ALPHA RECEPTOR; IFN-BETA; LIGAND; ACTIVATION; DIMERIZATION	Type I interferons serve as the first line of defense against pathogen invasion. Binding of IFNs to its receptors, IFNAR1 and IFNAR2, is leading to activation of the IFN response. To determine whether structural perturbations observed during binding are propagated to the cytoplasmic domain, multiple mutations were introduced into the transmembrane helix and its surroundings. Insertion of one to five alanine residues near either the N or C terminus of the transmembrane domain (TMD) likely promotes a rotation of 100 degrees and a translation of 1.5 per added residue. Surprisingly, the added alanines had little effect on the binding affinity of IFN to the cell surface receptors, STAT phosphorylation, or gene induction. Similarly, substitution of the juxtamembrane residues of the TMD with alanines, or replacement of the TMD of IFNAR1 with that of IFNAR2, did not affect IFN binding or activity. Finally, only the addition of 10 serine residues (but not 2 or 4) between the extracellular domain of IFNAR1 and the TMD had some effect on signaling. Bioinformatic analysis shows a correlation between high sequence conservation of TMDs of cytokine receptors and the ability to transmit structural signals. Sequence conservation near the TMD of IFNAR1 is low, suggesting limited functional importance for this region. Our results suggest that IFN binding to the extracellular domains of IFNAR1 and IFNAR2 promotes proximity between the intracellular domains and that differential signaling is a function of duration of activation and affinity of binding rather than specific conformational changes transmitted from the outside to the inside of the cell.	[Sharma, Nanaocha; Longjam, Geeta; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il			United States-Israel Binational Science Foundation [2011093]; European Community [264399]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Community(European Commission)	This work was supported by United States-Israel Binational Science Foundation Grant 2011093, the European Community 7th Framework Program TRANSPOL, 264399. The authors declare that they have no conflicts of interest with the contents of this article.	Abd Halim KB, 2015, BBA-GEN SUBJECTS, V1850, P1017, DOI 10.1016/j.bbagen.2014.09.006; ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; Bessman NJ, 2014, CURR OPIN STRUC BIOL, V29, P95, DOI 10.1016/j.sbi.2014.10.002; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; COHEN B, 1995, MOL CELL BIOL, V15, P4208; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Defour JP, 2013, P NATL ACAD SCI USA, V110, P2540, DOI 10.1073/pnas.1211560110; Dosch DD, 2010, FASEB J, V24, P32, DOI 10.1096/fj.09-132670; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Freed DM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8380; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Heukers R, 2013, J CELL SCI, V126, P4900, DOI 10.1242/jcs.128611; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Krause CD, 2013, CYTOKINE, V64, P286, DOI 10.1016/j.cyto.2013.06.309; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Lis M, 2006, BIOCHEM BIOPH RES CO, V339, P321, DOI 10.1016/j.bbrc.2005.11.022; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lochte S, 2014, J CELL BIOL, V207, P407, DOI 10.1083/jcb.201406032; Manni S, 2014, STRUCTURE, V22, P1077, DOI 10.1016/j.str.2014.05.010; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Moraga I, 2014, ADV IMMUNOL, V121, P1, DOI 10.1016/B978-0-12-800100-4.00001-5; Pang XD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002427; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Strunk JJ, 2009, BIOCONJUGATE CHEM, V20, P41, DOI 10.1021/bc8002088; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zaks-Zilberman M, 2008, J BIOL CHEM, V283, P13398, DOI 10.1074/jbc.M710230200; Zhao LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-157	65	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3371	3384		10.1074/jbc.M115.686071	http://dx.doi.org/10.1074/jbc.M115.686071			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26679999	Green Published, hybrid			2022-12-28	WOS:000370854500021
J	Tyukhtenko, S; Karageorgos, I; Rajarshi, G; Zvonok, N; Pavlopoulos, S; Janero, DR; Makriyannis, A				Tyukhtenko, Sergiy; Karageorgos, Ioannis; Rajarshi, Girija; Zvonok, Nikolai; Pavlopoulos, Spiro; Janero, David R.; Makriyannis, Alexandros			Specific Inter-residue Interactions as Determinants of Human Monoacylglycerol Lipase Catalytic Competency A ROLE FOR GLOBAL CONFORMATIONAL CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 NMR-SPECTROSCOPY; SERINE-PROTEASE; INTERFACIAL ACTIVATION; CRYSTAL-STRUCTURE; MODULATION; HISTIDINE; ENZYMES; SITE	The serine hydrolase monoacylglycerol lipase (MGL) functions as the main metabolizing enzyme of 2-arachidonoyl glycerol, an endocannabinoid signaling lipid whose elevation through genetic or pharmacological MGL ablation exerts therapeutic effects in various preclinical disease models. To inform structure-based MGL inhibitor design, we report the direct NMR detection of a reversible equilibrium between active and inactive states of human MGL (hMGL) that is slow on the NMR time scale and can be modulated in a controlled manner by pH, temperature, and select point mutations. Kinetic measurements revealed that hMGL substrate turnover is rate-limited across this equilibrium. Weidentify a network of aromatic interactions and hydrogen bonds that regulates hMGL active-inactive state interconversion. The data highlight specific inter-residue interactions within hMGL modulating the enzymes function and implicate transitions between active (open) and inactive (closed) states of the hMGL lid domain in controlling substrate access to the enzymes active site.	[Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Makriyannis, Alexandros] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia	Northeastern University; Northeastern University; Northeastern University; King Abdulaziz University	Makriyannis, A (corresponding author), Ctr Drug Discovery, 116 Mugar Hall,360 Huntington Ave, Boston, MA 02115 USA.	a.makriyannis@neu.edu	Makriyannis, Alexandros/GRF-1518-2022	Makriyannis, Alexandros/0000-0003-3272-3687; TYUKHTENKO, SERGIY/0000-0002-0446-9979	National Institutes of Health-National Institute on Drug Abuse [DA09158, DA03801]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003801, R37DA003801, P01DA009158] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health-National Institute on Drug Abuse Grants DA09158 and DA03801 (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.	BACHOVCHIN WW, 1985, P NATL ACAD SCI USA, V82, P7948, DOI 10.1073/pnas.82.23.7948; BACHOVCHIN WW, 1986, BIOCHEMISTRY-US, V25, P7751, DOI 10.1021/bi00371a070; Bachovchin WW, 2001, MAGN RESON CHEM, V39, pS199, DOI 10.1002/mrc.951; BACHOVCHIN WW, 1988, BIOCHEMISTRY-US, V27, P7689, DOI 10.1021/bi00420a018; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Cleary JA, 2014, BBA-PROTEINS PROTEOM, V1844, P1119, DOI 10.1016/j.bbapap.2014.03.008; Crow JA, 2012, TOXICOL APPL PHARM, V258, P145, DOI 10.1016/j.taap.2011.10.017; DEREWENDA U, 1994, J LIPID RES, V35, P524; Geraldine J, 2008, ANAL CHEM INSIGHTS, V3, P9; Glusker J. P., 1994, CRYSTAL STRUCTURE AN, P799; Janero DR, 2009, INT REV PSYCHIATR, V21, P122, DOI 10.1080/09540260902782778; Karageorgos I, 2012, ACS CHEM NEUROSCI, V3, P393, DOI 10.1021/cn3000263; Karageorgos I, 2010, MOL BIOSYST, V6, P1381, DOI 10.1039/c004515b; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Makriyannis A, 2005, NEUROPHARMACOLOGY, V48, P1068, DOI 10.1016/j.neuropharm.2005.03.012; Miled N, 2005, ANAL BIOCHEM, V338, P171, DOI 10.1016/j.ab.2004.11.046; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nasr ML, 2013, PROTEIN SCI, V22, P774, DOI 10.1002/pro.2257; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; POLGAR L, 1982, BIOCHEM J, V207, P1; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SMITH SO, 1989, SCIENCE, V244, P961, DOI 10.1126/science.2499045; Trodler P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-38; Turner NA, 2001, BIOTECHNOL BIOENG, V72, P108, DOI 10.1002/1097-0290(20010105)72:1<108::AID-BIT14>3.0.CO;2-7; Xu TT, 2012, J STRUCT BIOL, V178, P363, DOI 10.1016/j.jsb.2012.03.006; Yang YQ, 2000, J LIPID RES, V41, P48; Zvonok N, 2008, CHEM BIOL, V15, P854, DOI 10.1016/j.chembiol.2008.06.008	29	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2556	2565		10.1074/jbc.M115.670257	http://dx.doi.org/10.1074/jbc.M115.670257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26555264	hybrid, Green Published			2022-12-28	WOS:000369626900002
J	Gai, ZB; Gui, T; Hiller, C; Kullak-Ublick, GA				Gai, Zhibo; Gui, Ting; Hiller, Christian; Kullak-Ublick, Gerd A.			Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL LIPID-METABOLISM; ENDOPLASMIC-RETICULUM STRESS; DIABETIC-NEPHROPATHY; MITOCHONDRIAL DYSFUNCTION; ACID; FIBROSIS; INFLAMMATION; PROGRESSION; ACTIVATION; GLOMERULOSCLEROSIS	Activation of the farnesoid X receptor (FXR) has indicated a therapeutic potential for this nuclear bile acid receptor in the prevention of diabetic nephropathy and obesity-induced renal damage. Here, we investigated the protective role of FXR against kidney damage induced by obesity in mice that had undergone uninephrectomy, a model resembling the clinical situation of kidney donation by obese individuals. Mice fed a high-fat diet developed the core features of metabolic syndrome, with subsequent renal lipid accumulation and renal injury, including glomerulosclerosis, interstitial fibrosis, and albuminuria. The effects were accentuated by uninephrectomy. In human renal biopsies, staining of 4-hydroxynonenal (4-HNE), glucose-regulated protein 78 (Grp78), and C/EBP-homologous protein, markers of endoplasmic reticulum stress, was more prominent in the proximal tubules of 15 obese patients compared with 16 non-obese patients. In mice treated with the FXR agonist obeticholic acid, renal injury, renal lipid accumulation, apoptosis, and changes in lipid peroxidation were attenuated. Moreover, disturbed mitochondrial function was ameliorated and the mitochondrial respiratory chain recovered following obeticholic acid treatment. Culturing renal proximal tubular cells with free fatty acid and FXR agonists showed that FXR activation protected cells from free fatty acid-induced oxidative stress and endoplasmic reticulum stress, as denoted by a reduction in the level of reactive oxygen species staining and Grp78 immunostaining, respectively. Several genes involved in glutathione metabolism were induced by FXR activation in the remnant kidney, which was consistent with a decreased glutathione disulfide/glutathione ratio. In summary, FXR activation maintains endogenous glutathione homeostasis and protects the kidney in uninephrectomized mice from obesity-induced injury.	[Gai, Zhibo; Hiller, Christian; Kullak-Ublick, Gerd A.] Univ Zurich, Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Ramistr 100, CH-8091 Zurich, Switzerland; [Gui, Ting] Inselspital Bern, Dept Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Kullak-Ublick, GA (corresponding author), Univ Zurich, Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Ramistr 100, CH-8091 Zurich, Switzerland.	gerd.kullak@usz.ch	GAI, ZHIBO/ABE-7650-2020	GAI, ZHIBO/0000-0003-1673-6541	Swiss National Science Foundation [320030-144193]; Swiss National Center for Competence in Research NCCR; International Fellowship Program on Integrative Kidney Physiology and Pathophysiology (IKPP) [246539]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center for Competence in Research NCCR(Swiss National Science Foundation (SNSF)); International Fellowship Program on Integrative Kidney Physiology and Pathophysiology (IKPP)	This study was supported by Grant 320030-144193 from the Swiss National Science Foundation (to G. K.-U.), a grant from the Swiss National Center for Competence in Research NCCR (Kidney.ch), and Grant 246539 from the International Fellowship Program on Integrative Kidney Physiology and Pathophysiology (IKPP). The authors declare that they have no conflicts of interest with the contents of this article.	Abrass CK, 2004, J AM SOC NEPHROL, V15, P2768, DOI 10.1097/01.ASN.0000141963.04540.3E; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bonnet F, 2000, DIABETES METAB, V26, P254; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cao YP, 2014, INT J MOL MED, V33, P809, DOI 10.3892/ijmm.2014.1642; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Cho EJ, 2014, DIGEST DIS SCI, V59, P1461, DOI 10.1007/s10620-014-3217-0; Choi BH, 2014, MOLECULES, V19, P12727, DOI 10.3390/molecules190812727; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fujii H, 2010, AM J NEPHROL, V31, P342, DOI 10.1159/000297290; Gai ZB, 2014, BBA-MOL BASIS DIS, V1842, P1870, DOI 10.1016/j.bbadis.2014.07.001; Gai ZB, 2010, J AM SOC NEPHROL, V21, P1468, DOI 10.1681/ASN.2009121201; Gin H, 2000, DIABETES METAB, V26, P45; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; Habibi J, 2011, ENDOCRINOLOGY, V152, P659, DOI 10.1210/en.2010-1038; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hu ZJ, 2012, KIDNEY BLOOD PRESS R, V36, P85, DOI 10.1159/000341485; Jaimes EA, 2010, AM J PHYSIOL-RENAL, V298, pF125, DOI 10.1152/ajprenal.00248.2009; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Nelson D., 2005, LEHNINGER PRINCIPLES, P647; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Praga M, 2006, CURR OPIN NEPHROL HY, V15, P481, DOI 10.1097/01.mnh.0000242172.06459.7c; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Soumura M, 2010, BIOCHEM BIOPH RES CO, V402, P265, DOI 10.1016/j.bbrc.2010.10.012; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Tan SM, 2014, DIABETES, V63, P3091, DOI 10.2337/db13-1743; Tang JH, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/608397; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Zhan L., PLOS ONE, V9	52	52	56	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2397	2411		10.1074/jbc.M115.694323	http://dx.doi.org/10.1074/jbc.M115.694323			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26655953	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000369610400029
J	Crespo, R; Villar-Alvarez, E; Taboada, P; Rocha, FA; Damas, AM; Martins, PM				Crespo, Rosa; Villar-Alvarez, Eva; Taboada, Pablo; Rocha, Fernando A.; Damas, Ana M.; Martins, Pedro M.			What Can the Kinetics of Amyloid Fibril Formation Tell about Off-pathway Aggregation?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN AGGREGATION; TRANSTHYRETIN AGGREGATION; SERUM-ALBUMIN; OLIGOMERS; NUCLEATION; SUPERSATURATION; PROTOFIBRILS; ULTRASONICATION; MECHANISM; MODEL	Some of the most prevalent neurodegenerative diseases are characterized by the accumulation of amyloid fibrils in organs and tissues. Although the pathogenic role of these fibrils has not been completely established, increasing evidence suggests off-pathway aggregation as a source of toxic/detoxicating deposits that still remains to be targeted. The present work is a step toward the development of off-pathway modulators using the same amyloid-specific dyes as those conventionally employed to screen amyloid inhibitors. We identified a series of kinetic signatures revealing the quantitative importance of off-pathway aggregation relative to amyloid fibrillization; these include nonlinear semilog plots of amyloid progress curves, highly variable end point signals, and half-life coordinates weakly influenced by concentration. Molecules that attenuate/intensify the magnitude of these signals are considered promising off-pathway inhibitors/promoters. An illustrative example shows that amyloid deposits of lysozyme are only the tip of an iceberg hiding a crowd of insoluble aggregates. Thoroughly validated using advanced microscopy techniques and complementary measurements of dynamic light scattering, CD, and soluble protein depletion, the new analytical tools are compatible with the high-throughput methods currently employed in drug discovery.	[Crespo, Rosa; Rocha, Fernando A.; Martins, Pedro M.] Univ Porto, Fac Engn, Dept Engn Quim, Lab Engn Proc Ambiente Biotecnol & Energia, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal; [Villar-Alvarez, Eva; Taboada, Pablo] Univ Santiago de Compostela, Fac Fis, Dept Fis Mat Condensada, Santiago De Compostela 15782, Spain; [Damas, Ana M.; Martins, Pedro M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal	Universidade do Porto; Universidade de Santiago de Compostela; Universidade do Porto	Martins, PM (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	pmmartins@icbas.up.pt	Martins, Pedro M/J-3765-2013; Martins, Pedro/GWC-7702-2022; Taboada, Pablo/C-3000-2015; Rocha, Fernando A/D-4324-2014; Taboada, Pablo/GXA-1489-2022	Taboada, Pablo/0000-0002-2903-7857; Rocha, Fernando A/0000-0002-2778-8374; Crespo Rodriguez, Rosa/0000-0003-4980-2074; Villar-Alvarez, Eva/0000-0003-4023-1375; Martins, Pedro Miguel/0000-0002-6908-1828	FEDER funds through Programa Operational Competitividade e Internacionalizacao COMPETE [UID/EQU/00511/2013-LEPABE, EQU/00511]; Fundacao para a Ciencia e a Tecnologia (FCT); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [SFRH/BD/74174/2010]; Spanish Ministerio de Economia y Competitividad FPU [AP2012-2921]; Ministerio de Economia y Competitividad (MINECO) [MAT 2013-40971-R]; Xunta de Galicia [EM2013-046]; European Union	FEDER funds through Programa Operational Competitividade e Internacionalizacao COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Spanish Ministerio de Economia y Competitividad FPU; Ministerio de Economia y Competitividad (MINECO); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Union(European Commission)	This work was supported by Project UID/EQU/00511/2013-LEPABE (Laboratory for Process Engineering, Environment, Biotechnology, and Energy EQU/00511) by FEDER funds through Programa Operational Competitividade e Internacionalizacao COMPETE2020 and by Fundacao para a Ciencia e a Tecnologia (FCT). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, Grant SFRH/BD/74174/2010.; Recipient of Spanish Ministerio de Economia y Competitividad FPU Fellowship AP2012-2921.; Supported by Ministerio de Economia y Competitividad (MINECO) and Xunta de Galicia Research Projects MAT 2013-40971-R and EM2013-046, respectively.; Recipient of mobility grants from the European Union Iacobus and Erasmus+ Programmes.	Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Brender J. R., 2015, SOFT MATTER, VB119, P2886; Breydo L, 2014, BBA-PROTEINS PROTEOM, V1844, P346, DOI 10.1016/j.bbapap.2013.11.004; Chatani E, 2012, J BIOL CHEM, V287, P22827, DOI 10.1074/jbc.M111.333310; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Crespo R, 2012, J BIOL CHEM, V287, P30585, DOI 10.1074/jbc.M112.375345; Eden K, 2015, BIOPHYS J, V108, P632, DOI 10.1016/j.bpj.2014.11.3465; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Faria TQ, 2015, PHYS CHEM CHEM PHYS, V17, P7255, DOI 10.1039/c4cp04549a; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Gillam JE, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/37/373101; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hall D, 2015, FEBS LETT, V589, P672, DOI 10.1016/j.febslet.2015.01.032; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hopping G, 2014, ELIFE, V3, DOI 10.7554/eLife.01681; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Martins PM, 2013, PRION, V7, P136, DOI 10.4161/pri.23111; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Morris RJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2909; Mulaj M, 2014, J AM CHEM SOC, V136, P8947, DOI 10.1021/ja502529m; Muta H, 2014, J BIOL CHEM, V289, P18228, DOI 10.1074/jbc.M114.566950; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Ruggeri FS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8831; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; Szavits-Nossan J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.098101; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wang Y, 2012, NAT MATER, V11, P724, DOI [10.1038/NMAT3362, 10.1038/nmat3362]; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yagi H, 2014, BBA-PROTEINS PROTEOM, V1844, P1881, DOI 10.1016/j.bbapap.2014.06.014; Yang S, 2012, J MOL BIOL, V421, P364, DOI 10.1016/j.jmb.2012.02.026; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	49	32	32	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					2018	2032		10.1074/jbc.M115.699348	http://dx.doi.org/10.1074/jbc.M115.699348			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601940	Green Published, hybrid			2022-12-28	WOS:000368620700037
J	Gong, XY; Ahner, A; Roldan, A; Lukacs, GL; Thibodeau, PH; Frizzell, RA				Gong, Xiaoyan; Ahner, Annette; Roldan, Ariel; Lukacs, Gergely L.; Thibodeau, Patrick H.; Frizzell, Raymond A.			Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; HEAT-SHOCK PROTEINS; MOLTEN-GLOBULE STATE; ALPHA-CRYSTALLIN; IN-VITRO; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; UBIQUITIN LIGASES; FOLDING DEFECTS; QUALITY-CONTROL	A newly identified pathway for selective degradation of the common mutant of the cystic fibrosis transmembrane conductance regulator (CFTR), F508del, is initiated by binding of the small heat shock protein, Hsp27. Hsp27 collaborates with Ubc9, the E2 enzyme for protein SUMOylation, to selectively degrade F508del CFTR via the SUMO-targeted ubiquitin E3 ligase, RNF4 (RING finger protein 4) (1). Here, we ask what properties of CFTR are sensed by the Hsp27-Ubc9 pathway by examining the ability of NBD1(locus of the F508del mutation) to mimic the disposal of full-length (FL) CFTR. Similar to FL CFTR, F508del NBD1 expression was reduced 50-60% by Hsp27; it interacted preferentially with the mutant and was modified primarily by SUMO-2. Mutation of the consensus SUMOylation site, Lys447, obviated Hsp27-mediated F508del NBD1 SUMOylation and degradation. As for FL CFTR and NBD1 in vivo, SUMO modification using purified components in vitro was greater for F508del NBD1 versus WT and for the SUMO-2 paralog. Several findings indicated that Hsp27-Ubc9 targets the SUMOylation of a transitional, non-native conformation of F508del NBD1: (a) its modification decreased as [ATP] increased, reflecting stabilization of the nucleotide-binding domain by ligand binding; (b) a temperature-induced increase in intrinsic fluorescence, which reflects formation of a transitional NBD1-conformation, was followed by its SUMO modification; and (c) introduction of solubilizing or revertant mutations to stabilize F508del NBD1 reduced its SUMO modification. These findings indicate that the Hsp27-Ubc9 pathway recognizes a non-native conformation of mutant NBD1, which leads to its SUMO-2 conjugation and degradation by the ubiquitin-proteasome system.	[Gong, Xiaoyan; Ahner, Annette; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Roldan, Ariel; Lukacs, Gergely L.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McGill University	Frizzell, RA (corresponding author), Childrens Hosp Pittsburgh UPMC, Rangos Res Ctr, Dept Cell Biol, 4401 Penn Ave,7116, Pittsburgh, PA 15224 USA.	frizzell@pitt.edu		Roldan, Ariel/0000-0002-8159-5450; Lukacs, Gergely/0000-0003-0900-0675	National Institutes of Health [R01-DK068196, R01-DK083284]; Cystic Fibrosis Foundation Therapeutics Grants [FRIZZE05X0, THIBOD09XX0]; Cystic Fibrosis Canada; Canadian Institute of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196, R01DK083284, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics Grants; Cystic Fibrosis Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-DK068196 (to R. A. F.) and R01-DK083284 (to P. H. T.), by Cystic Fibrosis Foundation Therapeutics Grants FRIZZE05X0 (to R. A. F.) and THIBOD09XX0 (to P. H. T.), and by funds from the Cystic Fibrosis Canada and Canadian Institute of Health Research (to G. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Bomberger JM, 2010, CHANNELS, V4, P150, DOI 10.4161/chan.4.3.11223; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Devaraneni PK, 2015, J BIOL CHEM, V290, P7980, DOI 10.1074/jbc.M114.634576; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; DOBSON CM, 1991, CIBA F SYMP, V161, P167; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Loo TW, 2005, J BIOENERG BIOMEMBR, V37, P501, DOI 10.1007/s10863-005-9499-3; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matsuo K, 2007, BIOPHYS J, V92, P4088, DOI 10.1529/biophysj.106.103515; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Patrick AE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00162; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	60	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					2004	2017		10.1074/jbc.M115.685628	http://dx.doi.org/10.1074/jbc.M115.685628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627832	Green Published, hybrid			2022-12-28	WOS:000368620700036
J	Hanna, MG; Mela, I; Wang, L; Henderson, RM; Chapman, ER; Edwardson, JM; Audhya, A				Hanna, Michael G.; Mela, Ioanna; Wang, Lei; Henderson, Robert M.; Chapman, Edwin R.; Edwardson, J. Michael; Audhya, Anjon			Sar1 GTPase Activity Is Regulated by Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPII VESICLE FORMATION; ENDOPLASMIC-RETICULUM; CAENORHABDITIS-ELEGANS; ER; COAT; COMPLEX; TRANSPORT; INSIGHTS; BINDING; PROTEIN	The majority of biosynthetic secretory proteins initiate their journey through the endomembrane system from specific sub-domains of the endoplasmic reticulum. At these locations, coated transport carriers are generated, with the Sar1 GTPase playing a critical role in membrane bending, recruitment of coat components, and nascent vesicle formation. How these events are appropriately coordinated remains poorly understood. Here, we demonstrate that Sar1 acts as the curvature-sensing component of the COPII coat complex and highlight the ability of Sar1 to bind more avidly to membranes of high curvature. Additionally, using an atomic force microscopy-based approach, we further show that the intrinsic GTPase activity of Sar1 is necessary for remodeling lipid bilayers. Consistent with this idea, Sar1-mediated membrane remodeling is dramatically accelerated in the presence of its guanine nucleotide-activating protein (GAP), Sec23-Sec24, and blocked upon addition of guanosine-5 '-[(beta,gamma)-imido] triphosphate, a poorly hydrolysable analog of GTP. Our results also indicate that Sar1 GTPase activity is stimulated by membranes that exhibit elevated curvature, potentially enabling Sar1 membrane scission activity to be spatially restricted to highly bent membranes that are characteristic of a bud neck. Taken together, our data support a stepwise model in which the amino-terminal amphipathic helix of GTP-bound Sar1 stably penetrates the endoplasmic reticulum membrane, promoting local membrane deformation. As membrane bending increases, Sar1 membrane binding is elevated, ultimately culminating in GTP hydrolysis, which may destabilize the bilayer sufficiently to facilitate membrane fission.	[Audhya, Anjon] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA; [Mela, Ioanna; Henderson, Robert M.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Chapman, Edwin R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Cambridge; University of Wisconsin System; University of Wisconsin Madison	Audhya, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA.	audhya@wisc.edu	Mela, Ioanna/T-2085-2019	Mela, Ioanna/0000-0002-2914-9971; Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health [GM110567, GM088151]; Biotechnology and Biological Sciences Research Council [BB/J018236/1]; BBSRC [BB/J018236/1] Funding Source: UKRI; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688, R01GM110567, R01GM088151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants GM110567 and GM088151 (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Grant BB/J018236/1 from the Biotechnology and Biological Sciences Research Council.	Adolf F, 2013, TRAFFIC, V14, P922, DOI 10.1111/tra.12084; Bacia K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00017; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; BOLEN EJ, 1990, BIOCHEMISTRY-US, V29, P9638, DOI 10.1021/bi00493a019; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Daum S, 2014, BIOL CHEM, V395, P801, DOI 10.1515/hsz-2014-0117; DENFERT C, 1991, J CELL BIOL, V114, P663, DOI 10.1083/jcb.114.4.663; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mondal S, 2015, ASSAY DRUG DEV TECHN, V13, P444, DOI 10.1089/adt.2015.643; Montegna EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031156; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Schuh AL, 2015, BIOCHEM J, V466, P625, DOI 10.1042/BJ20141202; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; TALLMADGE DH, 1989, PHOTOCHEM PHOTOBIOL, V49, P381, DOI 10.1111/j.1751-1097.1989.tb09183.x; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Wang L, 2014, METHODS, V68, P518, DOI 10.1016/j.ymeth.2014.03.028; Yorimitsu T, 2012, MOL BIOL CELL, V23, P2930, DOI 10.1091/mbc.E12-05-0356; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	50	33	34	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1014	1027		10.1074/jbc.M115.672287	http://dx.doi.org/10.1074/jbc.M115.672287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26546679	Green Published, hybrid			2022-12-28	WOS:000368068300001
J	Futai, E; Osawa, S; Cai, T; Fujisawa, T; Ishiura, S; Tomita, T				Futai, Eugene; Osawa, Satoko; Cai, Tetsuo; Fujisawa, Tomoya; Ishiura, Shoichi; Tomita, Taisuke			Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate -Secretase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid- (A); -secretase; intramembrane proteolysis; Saccharomyces cerevisiae; yeast	AMYLOID-BETA-PROTEIN; TRANSMEMBRANE DOMAIN 1; TERMINAL PAL MOTIF; GAMMA-SECRETASE; CATALYTIC PORE; C-TERMINUS; TALKING POINT; ACTIVE-SITE; SUBSTRATE; COMPLEX	-Secretase is a multisubunit membrane protein complex containing presenilin (PS1) as a catalytic subunit. Familial Alzheimer disease (FAD) mutations within PS1 were analyzed in yeast cells artificially expressing membrane-bound substrate, amyloid precursor protein, or Notch fused to Gal4 transcriptional activator. The FAD mutations, L166P and G384A (Leu-166 to Pro and Gly-384 to Ala substitution, respectively), were loss-of-function in yeast. We identified five amino acid substitutions that suppress the FAD mutations. The cleavage of amyloid precursor protein or Notch was recovered by the secondary mutations. We also found that secondary mutations alone activated the -secretase activity. FAD mutants with suppressor mutations, L432M or S438P within TMD9 together with a missense mutation in the second or sixth loops, regained -secretase activity when introduced into presenilin null mouse fibroblasts. Notably, the cells with suppressor mutants produced a decreased amount of A42, which is responsible for Alzheimer disease. These results indicate that the yeast system is useful to screen for mutations and chemicals that modulate -secretase activity.	[Futai, Eugene; Fujisawa, Tomoya] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Sendai, Miyagi 9818555, Japan; [Futai, Eugene; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Osawa, Satoko; Cai, Tetsuo; Tomita, Taisuke] Univ Tokyo, Fac Pharmaceut Sci, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo 1130033, Japan; [Cai, Tetsuo; Tomita, Taisuke] Univ Tokyo, Fac Pharmaceut Sci, Lab Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan	Tohoku University; University of Tokyo; University of Tokyo; University of Tokyo	Futai, E (corresponding author), 1-1 Amamiya,Aoba Ku, Sendai, Miyagi 9818555, Japan.	futai@biochem.tohoku.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Futai, Eugene/0000-0002-0879-6117	Ministry of Education, Culture, Sports, Science, and Technology; Japanese Foundation for Applied Enzymology; Tokyo Biochemical Research Foundation; Nagase Science and Technology Foundation; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [15H02492] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Foundation for Applied Enzymology; Tokyo Biochemical Research Foundation; Nagase Science and Technology Foundation; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology (to E. F., T. T., and S. I.), a research grant from Japanese Foundation for Applied Enzymology (to E. F.), the Tokyo Biochemical Research Foundation (to T. T.), Nagase Science and Technology Foundation (to T. T.), and Daiichi Sankyo Foundation of Life Science (to T. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Funamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3529; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; James P, 1996, GENETICS, V144, P1425; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090; Yonemura Y, 2011, J BIOL CHEM, V286, P44569, DOI 10.1074/jbc.M111.270108	57	12	14	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					435	446		10.1074/jbc.M114.629287	http://dx.doi.org/10.1074/jbc.M114.629287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559975	hybrid, Green Published			2022-12-28	WOS:000367589500039
J	Laakso, HA; Marolda, CL; Pinter, TB; Stillman, MJ; Heinrichs, DE				Laakso, Holly A.; Marolda, Cristina L.; Pinter, Tyler B.; Stillman, Martin J.; Heinrichs, David E.			A Heme-responsive Regulator Controls Synthesis of Staphyloferrin B in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial transcription; biosynthesis; iron metabolism; siderophore; Staphylococcus aureus (S; aureus)	L-2,3-DIAMINOPROPIONIC ACID; IRON ACQUISITION; CITRATE SYNTHASE; IRR PROTEIN; SIDEROPHORE; GENE; IDENTIFICATION; BIOSYNTHESIS; TRANSPORT; BINDING	Staphylococcus aureus possesses a multitude of mechanisms by which it can obtain iron during growth under iron starvation conditions. It expresses an effective heme acquisition system (the iron-regulated surface determinant system), it produces two carboxylate-type siderophores staphyloferrin A and staphyloferrin B (SB), and it expresses transporters for many other siderophores that it does not synthesize. The ferric uptake regulator protein regulates expression of genes encoding all of these systems. Mechanisms of fine-tuning expression of iron-regulated genes, beyond simple iron regulation via ferric uptake regulator, have not been uncovered in this organism. Here, we identify the ninth gene of the sbn operon, sbnI, as encoding a ParB/Spo0J-like protein that is required for expression of genes in the sbn operon from sbnD onward. Expression of sbnD-I is drastically decreased in an sbnI mutant, and the mutant does not synthesize detectable SB during early phases of growth. Thus, SB-mediated iron acquisition is impaired in an sbnI mutant strain. We show that the protein forms dimers and tetramers in solution and binds to DNA within the sbnC coding region. Moreover, we show that SbnI binds heme and that heme-bound SbnI does not bind DNA. Finally, we show that providing exogenous heme to S. aureus growing in an iron-free medium results in delayed synthesis of SB. This is the first study in S. aureus that identifies a DNA-binding regulatory protein that senses heme to control gene expression for siderophore synthesis.	[Laakso, Holly A.; Marolda, Cristina L.; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Pinter, Tyler B.; Stillman, Martin J.] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada; [Heinrichs, David E.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Heinrichs, DE (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.	deh@uwo.ca	Heinrichs, David/ABD-5702-2021; Stillman, Martin/O-3191-2016	Stillman, Martin/0000-0001-6799-7560; Pinter, Tyler/0000-0003-4381-3303; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research; Discovery Grant from the Natural Sciences and Engineering Council; Natural Sciences and Engineering Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Discovery Grant from the Natural Sciences and Engineering Council; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by an operating grant from the Canadian Institutes of Health Research (to D. E. H.) and by a Discovery Grant from the Natural Sciences and Engineering Council (to M. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postgraduate scholarship-doctoral from the Natural Sciences and Engineering Council.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Beasley FC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-199; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cheung J, 2012, CHEM BIOL, V19, P1568, DOI 10.1016/j.chembiol.2012.10.003; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Cooper JD, 2014, BIOCHEMISTRY-US, V53, P5060, DOI 10.1021/bi500729h; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; DUMONT ME, 1994, BIOCHEMISTRY-US, V33, P7368, DOI 10.1021/bi00189a043; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Flavier AB, 1997, J BACTERIOL, V179, P7089, DOI 10.1128/jb.179.22.7089-7097.1997; Garnier F, 2006, EMERG INFECT DIS, V12, P498, DOI 10.3201/eid1203.051040; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hannauer M, 2015, FEBS LETT, V589, P730, DOI 10.1016/j.febslet.2015.02.002; Hanses F, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0093-3; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Imbert M, 1998, CURR MICROBIOL, V37, P64, DOI 10.1007/s002849900339; Johnson AP, 2005, J ANTIMICROB CHEMOTH, V56, P455, DOI 10.1093/jac/dki266; Kobylarz MJ, 2014, CHEM BIOL, V21, P379, DOI 10.1016/j.chembiol.2013.12.011; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mesak LR, 2009, PLASMID, V61, P182, DOI 10.1016/j.plasmid.2009.01.003; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nichol KA, 2011, DIAGN MICR INFEC DIS, V69, P320, DOI 10.1016/j.diagmicrobio.2010.10.028; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200	49	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					29	40		10.1074/jbc.M115.696625	http://dx.doi.org/10.1074/jbc.M115.696625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26534960	Green Published, hybrid			2022-12-28	WOS:000367589500003
J	Liu, H; Yue, JP; Huang, H; Gou, XW; Chen, SY; Zhao, YM; Wu, XY				Liu, Han; Yue, Jiping; Huang, He; Gou, Xuewen; Chen, Shao-Yu; Zhao, Yingming; Wu, Xiaoyang			Regulation of Focal Adhesion Dynamics and Cell Motility by the EB2 and Hax1 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; PLUS-END; MIGRATION; MICROTUBULES; SUBSTRATE; ACTIN; SKIN; DISSOCIATION; PROMOTES; KINASE	Cell migration is a fundamental cellular process requiring integrated activities of the cytoskeleton, membrane, and cell/ extracellular matrix adhesions. Many cytoskeletal activities rely on microtubule filaments. It has been speculated that microtubules can serve as tracks to deliver proteins essential for focal adhesion turnover. Three microtubule end-binding proteins (EB1, EB2, and EB3) in mammalian cells can track the plus ends of growing microtubules. EB1 and EB3 together can regulate microtubule dynamics by promoting microtubule growth and suppressing catastrophe, whereas, in contrast, EB2 does not play a direct role in microtubule dynamic instability, and little is known about the cellular function of EB2. By quantitative proteomics, we identified mammalian HCLS1-associated protein X-1 (HAX1) as an EB2-specific interacting protein. Knockdown of HAX1 and EB2 in skin epidermal cells stabilizes focal adhesions and impairs epidermal migration in vitro and in vivo. Our results further demonstrate that cell motility and focal adhesion turnover require interaction between Hax1 and EB2. Together, our findings provide new insights for this critical cellular process, suggesting that EB2 association with Hax1 plays a significant role in focal adhesion turnover and epidermal migration.	[Liu, Han; Yue, Jiping; Huang, He; Gou, Xuewen; Zhao, Yingming; Wu, Xiaoyang] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chen, Shao-Yu] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Chicago; University of Louisville	Wu, XY (corresponding author), Univ Chicago, GCIS W408B,929 E 57th St, Chicago, IL 60637 USA.	xiaoyangwu@uchicago.edu	Regan, Clinton/E-6250-2012	, Jiping/0000-0003-0717-8613	National Institutes of Health [R01-AR063630]; American Cancer Society Research Scholar Grant [RSG-13-198-01]; V Scholar Award from the V Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); V Scholar Award from the V Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01-AR063630, American Cancer Society Research Scholar Grant RSG-13-198-01, and the V Scholar Award from the V Foundation (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrova AY, 1998, CELL MOTIL CYTOSKEL, V39, P147, DOI 10.1002/(SICI)1097-0169(1998)39:2<147::AID-CM5>3.0.CO;2-3; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cavnar PJ, 2011, J CELL BIOL, V193, P465, DOI 10.1083/jcb.201010143; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dixit R, 2010, METHOD CELL BIOL, V95, P543, DOI 10.1016/S0091-679X(10)95027-9; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2002, J CELL SCI, V115, P2283; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mazzalupo S, 2002, J INVEST DERMATOL, V118, P866, DOI 10.1046/j.1523-1747.2002.01736.x; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025	33	20	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30771	30782		10.1074/jbc.M115.671743	http://dx.doi.org/10.1074/jbc.M115.671743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527684	Green Published, hybrid			2022-12-28	WOS:000367199000011
J	Nguyen, QT; Ooi, JSG; Nguyen, NTK; Wang, SJ; Huang, M; Liu, DX; Tam, JP				Phuong Quoc Thuc Nguyen; Ooi, Justin Seng Geap; Ngan Thi Kim Nguyen; Wang, Shujing; Huang, Mei; Liu, Ding Xiang; Tam, James P.			Antiviral Cystine Knot a-Amylase Inhibitors from Alstonia scholaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE; SIGNAL PEPTIDES; DISCOVERY; CYCLOTIDES; PREDICTION	Cystine knot alpha-amylase inhibitors are cysteine-rich, proline-rich peptides found in the Amaranthaceae and Apocynaceae plant species. They are characterized by a pseudocydic backbone with two to four prolines and three disulfides arranged in a knotted motif. Similar to other knottins, cystine knot alpha-amylase inhibitors are highly resistant to degradation by heat and protease treatments. Thus far, only the alpha-amylase inhibition activity has been described for members of this family. Here, we show that cystine knot alpha-amylase inhibitors named alstotides discovered from the Alstonia scholaris plant of the Apocynaceae family display antiviral activity. 'The alstotides (As1-As4) were characterized by both proteomic and genomic methods. All four alsotides are novel, heat-stable and enzyme-stable and contain 30 residues. NMR determination of As1 and As4 structures reveals their conserved structural fold and the presence of one or more cis-proline bonds, characteristics shared by other cystine knot alpha-amylase inhibitors. Genomic analysis showed that they contain a three-domain precursor, an arrangement common to other knottins. We also showed that alstotides are antiviral and cell-permeable to inhibit the early phase of infectious bronchitis virus and Dengue infection, in addition to their ability to inhibit alpha-amylase. Taken together, our results expand membership of cystine knot alpha-amylase inhibitors in the Apocynaceae family and their bioactivity, functional promiscuity that could be exploited as leads in developing therapeutics.	[Phuong Quoc Thuc Nguyen; Ooi, Justin Seng Geap; Ngan Thi Kim Nguyen; Wang, Shujing; Huang, Mei; Liu, Ding Xiang; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Geap, Justin Ooi Seng/AAS-3483-2021; Tam, James P/A-2176-2011	Geap, Justin Ooi Seng/0000-0003-4899-8255; Tam, James P/0000-0003-4433-198X; Nguyen, Thi Kim Ngan/0000-0003-1904-6984; Nguyen, Quoc Thuc Phuong/0000-0002-8273-730X	National Research Foundation in Singapore [NRF-CRP8-2011-05]	National Research Foundation in Singapore(National Research Foundation, Singapore)	This work was supported in part by Competitive Research Grant NRF-CRP8-2011-05 from the National Research Foundation in Singapore. The authors declare that they have no conflicts of interest with the contents of this article.	Baliga MS, 2010, INTEGR CANCER THER, V9, P261, DOI 10.1177/1534735410376068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Craik DJ, 2013, J PEPT SCI, V19, P393, DOI 10.1002/psc.2523; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; deSa MFG, 1997, PLANTA, V203, P295, DOI 10.1007/s004250050195; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LI D, 1992, ARCH VIROL, V122, P307, DOI 10.1007/BF01317192; Martins JC, 2001, EUR J BIOCHEM, V268, P2379, DOI 10.1046/j.1432-1327.2001.02118.x; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nguyen PQT, 2015, J NAT PROD, V78, P695, DOI 10.1021/np500866c; Nguyen PQT, 2014, FEBS J, V281, P4351, DOI 10.1111/febs.12939; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pereira PJB, 1999, STRUCTURE, V7, P1079, DOI 10.1016/S0969-2126(99)80175-0; Pinto MFS, 2012, J EVID-BASED INTEGR, V17, P40, DOI 10.1177/2156587211428077; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953	30	26	26	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31138	31150		10.1074/jbc.M115.654855	http://dx.doi.org/10.1074/jbc.M115.654855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26546678	Green Published, hybrid			2022-12-28	WOS:000367199000041
J	Olivares, S; Henkel, AS				Olivares, Shantel; Henkel, Anne S.			Hepatic Xbp1 Gene Deletion Promotes Endoplasmic Reticulum Stress-induced Liver Injury and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; CELL-DEATH; IRE1; PATHWAY; ACTIVATION; DISEASE; DYSREGULATION	Endoplasmic reticulum (ER) stress activates the unfolded protein response (UPR), a highly conserved signaling cascade that functions to alleviate stress and promote cell survival. If, however, the cell is unable to adapt and restore homeostasis, then the UPR activates pathways that promote apoptotic cell death. The molecular mechanisms governing the critical transition from adaptation and survival to initiation of apoptosis remain poorly understood. We aim to determine the role of hepatic Xbp1, a key mediator of the UPR, in controlling the adaptive response to ER stress in the liver. Liver-specific Xbp1 knockout mice (Xbp1(LKO)) and Xbp1(fl/fl) control mice were subjected to varying levels and durations of pharmacologic ER stress. Xbp1(LKO) and Xbp1(fl/fl) mice showed robust and equal activation of the UPR acutely after induction of ER stress. By 24 h, Xbp1(fl/fl) controls showed complete resolution of UPR activation and no liver injury, indicating successful adaptation to the stress. Conversely, Xbp1(LKO) mice showed ongoing UPR activation associated with progressive liver injury, apoptosis, and, ultimately, fibrosis by day 7 after induction of ER stress. These data indicate that hepatic XBP1 controls the adaptive response of the UPR and is critical to restoring homeostasis in the liver in response to ER stress.	[Olivares, Shantel; Henkel, Anne S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Henkel, AS (corresponding author), 320 E Super St,Tarry 15-705, Chicago, IL 60611 USA.	a-henkel2@northwestern.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [K08DK095992]; American Gastroenterological Association Research Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK095992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association Research Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant K08DK095992 and an American Gastroenterological Association Research Scholar Award. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bruccoleri A, 1997, HEPATOLOGY, V25, P133, DOI 10.1002/hep.510250125; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	40	33	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30142	30151		10.1074/jbc.M115.676239	http://dx.doi.org/10.1074/jbc.M115.676239			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26504083	Green Published, hybrid			2022-12-28	WOS:000366614700044
J	Antoine-Bertrand, J; Duquette, PM; Alchini, R; Kennedy, TE; Fournier, AE; Lamarche-Vane, N				Antoine-Bertrand, Judith; Duquette, Philippe M.; Alchini, Ricardo; Kennedy, Timothy E.; Fournier, Alyson E.; Lamarche-Vane, Nathalie			p120RasGAP Protein Mediates Netrin-1 Protein-induced Cortical Axon Outgrowth and Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESION KINASE; COLORECTAL-CANCER DCC; C-TERMINAL DOMAIN; TYROSINE PHOSPHORYLATION; CARGO RECOGNITION; RAS P21; GAP; RECEPTOR; GROWTH	The receptor deleted in colorectal cancer (DCC) mediates the attraction of growing axons to netrin-1 during brain development. In response to netrin-1 stimulation, DCC becomes a signaling platform to recruit proteins that promote axon outgrowth and guidance. The Ras GTPase-activating protein (GAP) p120RasGAP inhibits Ras activity and mediates neurite retraction and growth cone collapse in response to repulsive guidance cues. Here we show an interaction between p120RasGAP and DCC that positively regulates netrin-1-mediated axon outgrowth and guidance in embryonic cortical neurons. In response to netrin-1, p120RasGAP is recruited to DCC in growth cones and forms a multiprotein complex with focal adhesion kinase and ERK. We found that Ras/ERK activities are elevated aberrantly in p120RasGAP-deficient neurons. Moreover, the expression of p120RasGAP Src homology 2 (SH2)-SH3-SH2 domains, which interact with the C-terminal tail of DCC, is sufficient to restore netrin-1-dependent axon outgrowth in p120RasGAP-deficient neurons. We provide a novel mechanism that exploits the scaffolding properties of the N terminus of p120RasGAP to tightly regulate netrin-1/DCC-dependent axon outgrowth and guidance.	[Antoine-Bertrand, Judith; Duquette, Philippe M.; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H4A 3J1, Canada; [Antoine-Bertrand, Judith; Duquette, Philippe M.; Lamarche-Vane, Nathalie] McGill Univ, Canc Res Program, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H4A 3J1, Canada; [Alchini, Ricardo; Kennedy, Timothy E.; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Lamarche-Vane, N (corresponding author), RI MUHC, Ctr Translat Biol, 1001 Boul Decarie,Rm E02-6230, Montreal, PQ H4A 3J1, Canada.	nathalie.lamarche@mcgill.ca			Canadian Institute of Health Research [MOP-14701]; Canada Foundation for Innovation Leaders Opportunity Fund; Fonds de la Recherche en Sante du Quebec doctoral studentship; Fonds de la Recherche en Sante du Quebec Chercheur-National	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec doctoral studentship; Fonds de la Recherche en Sante du Quebec Chercheur-National	This research was supported by Canadian Institute of Health Research Grant MOP-14701 and the Canada Foundation for Innovation Leaders Opportunity Fund (to N. L. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Fonds de la Recherche en Sante du Quebec doctoral studentship.; Recipient of a Fonds de la Recherche en Sante du Quebec Chercheur-National and a William Dawson scholar. To whom correspondence should be addressed: Centre for Translational Biology, RI-MUHC, 1001 Boul. Decarie, Rm. E02.6230, Montreal, Quebec H4A 3J1, Canada. Tel.: 514-934-1934, ext. 76166; E-mail: nathalie.lamarche@mcgill.ca.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bayrak-Toydemir P., 2014, GENEREVIEWS; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Depienne C, 2011, NEUROLOGY, V76, P260, DOI 10.1212/WNL.0b013e318207b1e0; Duan JH, 2011, NEUROSCI LETT, V496, P70, DOI 10.1016/j.neulet.2011.03.083; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Endo M, 2009, J NEUROSCI, V29, P6649, DOI 10.1523/JNEUROSCI.0927-09.2009; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Ger M, 2011, CELL SIGNAL, V23, P1651, DOI 10.1016/j.cellsig.2011.05.019; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Grant A, 2012, SCHIZOPHR RES, V137, P26, DOI 10.1016/j.schres.2012.02.023; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hancock ML, 2014, J NEUROSCI, V34, P66, DOI 10.1523/JNEUROSCI.3371-13.2014; Hayashi K, 1999, J CELL SCI, V112, P1149; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; Kent CB, 2010, J NEUROSCI, V30, P14059, DOI 10.1523/JNEUROSCI.3883-10.2010; Kim JM, 2011, J HUM GENET, V56, P125, DOI 10.1038/jhg.2010.130; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Larrieu-Lahargue F, 2012, TRENDS CARDIOVAS MED, V22, P44, DOI 10.1016/j.tcm.2012.06.010; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; LIU XQ, 1991, MOL CELL BIOL, V11, P2511, DOI 10.1128/MCB.11.5.2511; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Nakata H, 1996, BIOCHEM BIOPH RES CO, V218, P538, DOI 10.1006/bbrc.1996.0096; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; PARK S, 1992, J BIOL CHEM, V267, P17194; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Revencu N, 2013, HUM MUTAT, V34, P1632, DOI 10.1002/humu.22431; Richards LJ, 1997, J NEUROSCI, V17, P2445; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Serpente N, 1996, MOL CELL NEUROSCI, V7, P391, DOI 10.1006/mcne.1996.0028; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shu TZ, 2000, J COMP NEUROL, V416, P201, DOI 10.1002/(SICI)1096-9861(20000110)416:2<201::AID-CNE6>3.0.CO;2-Z; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Viswanatha R, 2013, J BIOL CHEM, V288, P35437, DOI 10.1074/jbc.M113.505669; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Woodcock SA, 2004, BIOCHEM J, V380, P767, DOI 10.1042/BJ20031848; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Yam PT, 2012, NEURON, V76, P735, DOI 10.1016/j.neuron.2012.09.017; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	87	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4589	4602		10.1074/jbc.M115.674846	http://dx.doi.org/10.1074/jbc.M115.674846			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710849	hybrid, Green Published			2022-12-28	WOS:000371604600027
J	Yao, XQ; Malik, RU; Griggs, NW; Skjaerven, L; Traynor, JR; Sivaramakrishnan, S; Grant, BJ				Yao, Xin-Qiu; Malik, Rabia U.; Griggs, Nicholas W.; Skjaerven, Lars; Traynor, John R.; Sivaramakrishnan, Sivaraj; Grant, Barry J.			Dynamic Coupling and Allosteric Networks in the alpha Subunit of Heterotrimeric G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2) ADRENERGIC-RECEPTOR; MOLECULAR-DYNAMICS; NUCLEOTIDE-EXCHANGE; CRYSTAL-STRUCTURE; GDP RELEASE; ACTIVATION; MECHANISM; CONFORMATIONS; SIMULATIONS; G-ALPHA(I1)	G protein alpha subunits cycle between active and inactive conformations to regulate a multitude of intracellular signaling cascades. Important structural transitions occurring during this cycle have been characterized from extensive crystallographic studies. However, the link between observed conformations and the allosteric regulation of binding events at distal sites critical for signaling through G proteins remain unclear. Here we describe molecular dynamics simulations, bioinformatics analysis, and experimental mutagenesis that identifies residues involved in mediating the allosteric coupling of receptor, nucleotide, and helical domain interfaces of G alpha(i). Most notably, we predict and characterize novel allosteric decoupling mutants, which display enhanced helical domain opening, increased rates of nucleotide exchange, and constitutive activity in the absence of receptor activation. Collectively, our results provide a framework for explaining how binding events and mutations can alter internal dynamic couplings critical for G protein function.	[Yao, Xin-Qiu; Grant, Barry J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Malik, Rabia U.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Griggs, Nicholas W.; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Skjaerven, Lars] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Malik, Rabia U.; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Bergen; University of Minnesota System; University of Minnesota Twin Cities	Grant, BJ (corresponding author), 100 Washtenaw Ave,2017 Palmer Commons Bldg, Ann Arbor, MI 48109 USA.	bjgrant@umich.edu	Skjærven, Lars/C-1919-2017; Yao, Xinqiu/D-3220-2011	Skjærven, Lars/0000-0002-8176-4891; Yao, Xinqiu/0000-0003-2706-2028; Grant, Barry/0000-0002-2215-4196	University of Michigan; National Institutes of Health [R01-GM105646, R01-DA039997]; American Heart Association [14PRE18560010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646, R01GM070862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA039997] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by University of Michigan, National Institutes of Health Grants R01-GM105646 (to S. S.) and R01-DA039997 (to J. R. T.), and American Heart Association Predoctoral Fellowship 14PRE18560010 (to R. U. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case DA, 2012, AMBER 12; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Dubay KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002168; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Gabriel D, 2003, ASSAY DRUG DEV TECHN, V1, P291, DOI 10.1089/15406580360545107; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; GERSTEIN M, 1995, J MOL BIOL, V251, P161, DOI 10.1006/jmbi.1995.0423; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Guo JJ, 2015, STRUCTURE, V23, P237, DOI 10.1016/j.str.2014.11.009; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kaya AI, 2014, J BIOL CHEM, V289, P24475, DOI 10.1074/jbc.M114.572875; Lerman BB, 1998, J CLIN INVEST, V101, P2862, DOI 10.1172/JCI1582; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NISHINA H, 1995, J BIOCHEM-TOKYO, V118, P1083, DOI 10.1093/jb/118.5.1083; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scarabelli G, 2014, BIOPHYS J, V107, P2204, DOI 10.1016/j.bpj.2014.09.019; Scarabelli G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003329; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun DW, 2015, NAT STRUCT MOL BIOL, V22, P686, DOI 10.1038/nsmb.3070; Thaker TM, 2014, J BIOL CHEM, V289, P11331, DOI 10.1074/jbc.M113.539064; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; vanAalten DMF, 1997, BIOPHYS J, V73, P2891, DOI 10.1016/S0006-3495(97)78317-6; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Wu S, 2014, PROTEINS, V82, P2896, DOI 10.1002/prot.24629; Yao XQ, 2013, BIOPHYS J, V105, pL8, DOI [10.1016/j.bpj.2013.06.006, 10.1016/j.bpj.2013.06.00]; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712	54	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4742	4753		10.1074/jbc.M115.702605	http://dx.doi.org/10.1074/jbc.M115.702605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26703464	Green Published, hybrid			2022-12-28	WOS:000371604600040
J	Hover, S; King, B; Hall, B; Loundras, EA; Taqi, H; Daly, J; Dallas, M; Peers, C; Schnettler, E; McKimmie, C; Kohl, A; Barr, JN; Mankouri, J				Hover, Samantha; King, Barnabas; Hall, Bradley; Loundras, Eleni-Anna; Taqi, Hussah; Daly, Janet; Dallas, Mark; Peers, Chris; Schnettler, Esther; McKimmie, Clive; Kohl, Alain; Barr, John N.; Mankouri, Jamel			Modulation of Potassium Channels Inhibits Bunyavirus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; ion channel; negative-strand RNA virus; pathogenesis; potassium channel	NONSTRUCTURAL PROTEIN NSS; BUNYAMWERA-VIRUS; ION CHANNELS; SCHMALLENBERG VIRUS; CELL-PROLIFERATION; GENOME REPLICATION; FEVER VIRUS; K+ CHANNEL; NEURONS; ORTHOBUNYAVIRUS	Bunyaviruses are considered to be emerging pathogens facilitated by the segmented nature of their genome that allows reassortment between different species to generate novel viruses with altered pathogenicity. Bunyaviruses are transmitted via a diverse range of arthropod vectors, as well as rodents, and have established a global disease range with massive importance in healthcare, animal welfare, and economics. There are no vaccines or anti-viral therapies available to treat human bunyavirus infections and so development of new anti-viral strategies is urgently required. Bunyamwera virus (BUNV; genus Orthobunyavirus) is the model bunyavirus, sharing aspects of its molecular and cellular biology with all Bunyaviridae family members. Here, we show for the first time that BUNV activates and requires cellular potassium (K+) channels to infect cells. Time of addition assays using K+ channel modulating agents demonstrated that K+ channel function is critical to events shortly after virus entry but prior to viral RNA synthesis/replication. A similar K+ channel dependence was identified for other bunyaviruses namely Schmallenberg virus (Orthobunyavirus) as well as the more distantly related Hazara virus (Nairovirus). Using a rational pharmacological screening regimen, two-pore domain K+ channels (K-2P) were identified as the K+ channel family mediating BUNV K+ channel dependence. As several K-2P channel modulators are currently in clinical use, our work suggests they may represent a new and safe drug class for the treatment of potentially lethal bunyavirus disease.	[Hover, Samantha; Hall, Bradley; Loundras, Eleni-Anna; Taqi, Hussah; Peers, Chris; Barr, John N.; Mankouri, Jamel] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [King, Barnabas] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Daly, Janet] Univ Nottingham, Vet Med & Sci, Nottingham NG7 2RD, England; [Dallas, Mark] Univ Reading, Sch Pharm, Reading RG6 6AP, Berks, England; [Schnettler, Esther; McKimmie, Clive; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland	University of Leeds; University of Nottingham; University of Nottingham; University of Reading; University of Glasgow	Barr, JN; Mankouri, J (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	J.N.Barr@leeds.ac.uk; J.Mankouri@leeds.ac.uk	Daly, Janet/G-9797-2011; McKimmie, Clive/AAD-9509-2019; Schnettler, Esther/AAV-8774-2020; Dallas, Mark/Q-6117-2019	McKimmie, Clive/0000-0002-7694-9509; Dallas, Mark/0000-0002-5190-0522; Mankouri, Jamel/0000-0002-4325-3687; Peers, Chris/0000-0002-8354-346X; Daly, Janet/0000-0002-1912-4500; Hover, Samantha/0000-0001-9190-5670; Loundras, Eleni-Anna/0000-0002-3485-3111; barr, john/0000-0002-9035-2039	Royal Society [RG110306]; Medical Research Council [G1001724, MC_UU_12014/8] Funding Source: researchfish; MRC [G1001724, MC_UU_12014/8] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the late Richard M. Elliott for contribution of reagents, support, and advice during this and previous studies. The confocal microscope used for imaging was funded by a Royal Society equipment grant (Grant Number RG110306).	Adams MJ, 2013, ARCH VIROL, V158, P2633, DOI 10.1007/s00705-013-1749-9; Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Barr JN, 2003, VIROLOGY, V311, P326, DOI 10.1016/S0042-6822(03)00130-2; Barry G, 2014, J GEN VIROL, V95, P1640, DOI 10.1099/vir.0.065425-0; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Becchetti A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00312; Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12; Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11; Cheng E, 2011, J BIOL CHEM, V286, P11814, DOI 10.1074/jbc.M110.210179; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Davis BA, 2001, J MEMBRANE BIOL, V183, P25, DOI 10.1007/s00232-001-0050-0; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Dowall SD, 2012, J GEN VIROL, V93, P560, DOI 10.1099/vir.0.038455-0; Dwivedi R, 2005, ARTERIOSCL THROM VAS, V25, pE7, DOI 10.1161/01.ATV.0000152610.40086.31; Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108; Elliott RM, 2009, CLIN MICROBIOL INFEC, V15, P510, DOI 10.1111/j.1469-0691.2009.02849.x; Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332; ELLIOTT RM, 1986, VIROLOGY, V150, P21, DOI 10.1016/0042-6822(86)90262-X; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Evangelista S, 2004, CURR PHARM DESIGN, V10, P3561, DOI 10.2174/1381612043382972; FERON O, 1992, BRIT J PHARMACOL, V105, P480, DOI 10.1111/j.1476-5381.1992.tb14279.x; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; FRUGULHETTI ICPP, 1989, J GEN VIROL, V70, P3493, DOI 10.1099/0022-1317-70-12-3493; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002225; Goller KV, 2012, EMERG INFECT DIS, V18, P1644, DOI 10.3201/eid1810.120835; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Igloi Z, 2015, J VIROL, V89, P4023, DOI 10.1128/JVI.02946-14; Irvine E, 2007, J NEUROIMMUNE PHARM, V2, P265, DOI 10.1007/s11481-007-9072-4; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; KAAKKOLA S, 1982, UNDERSEA BIOMED RES, V9, P233; Kainulainen M, 2014, J VIROL, V88, P3464, DOI 10.1128/JVI.02914-13; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Kudo S, 1999, CLIN PHARMACOKINET, V37, P435, DOI 10.2165/00003088-199937060-00001; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meier R, 2014, J VIROL, V88, P8565, DOI 10.1128/JVI.00388-14; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; MURPHY FA, 1968, J VIROL, V2, P1315, DOI 10.1128/JVI.2.11.1315-1325.1968; Musset B, 2006, J PHYSIOL-LONDON, V572, P639, DOI 10.1113/jphysiol.2006.106898; Novoa RR, 2005, J VIROL, V79, P10852, DOI 10.1128/JVI.79.17.10852-10863.2005; Peluffo RD, 2004, J GEN PHYSIOL, V123, P249, DOI 10.1085/jgp.200308872; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; SANCHEZ DY, 1994, J GEN PHYSIOL, V104, P173, DOI 10.1085/jgp.104.1.173; Schoen A, 2015, EUR J CELL BIOL, V94, P384, DOI 10.1016/j.ejcb.2015.06.001; Shi XH, 2004, J VIROL, V78, P10793, DOI 10.1128/JVI.78.19.10793-10802.2004; Shin HW, 2014, J ANESTH, V28, P81, DOI 10.1007/s00540-013-1661-1; Shtanko O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004390; Tauro LB, 2015, VET J, V206, P111, DOI 10.1016/j.tvjl.2015.06.013; Walter CT, 2011, J GEN VIROL, V92, P80, DOI 10.1099/vir.0.024240-0; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Wicher D, 2001, PROG NEUROBIOL, V64, P431, DOI 10.1016/S0301-0082(00)00066-6; Windley MJ, 2011, MOL PHARMACOL, V80, P1, DOI 10.1124/mol.110.070540; Wu WN, 2012, J VIROL, V86, P7777, DOI 10.1128/JVI.00460-12; Zhang AL, 2014, EXP LUNG RES, V40, P237, DOI 10.3109/01902148.2014.905655; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804	71	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3411	3422		10.1074/jbc.M115.692673	http://dx.doi.org/10.1074/jbc.M115.692673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677217	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000370854500024
J	Kishore, A; Purcell, RH; Nassiri-Toosi, Z; Hall, RA				Kishore, Ayush; Purcell, Ryan H.; Nassiri-Toosi, Zahra; Hall, Randy A.			Stalk-dependent and Stalk-independent Signaling by the Adhesion G Protein-coupled Receptors GPR56 (ADGRG1) and BAI1 (ADGRB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; G protein-coupled receptor (GPCR); proteolysis; receptor structure-function; signal transduction; ubiquitylation (ubiquitination)	TETHERED AGONIST; APOPTOTIC CELLS; MYOBLAST FUSION; NUCLEAR FACTOR; GPCR; TRAFFICKING; ACTIVATION; MIGRATION; SUBUNITS; COLLAGEN	The adhesion G protein-coupled receptors (aGPCRs) are a large yet poorly understood family of seven-transmembrane proteins. A defining characteristic of the aGPCR family is the conserved GAIN domain, which has autoproteolytic activity and can cleave the receptors near the first transmembrane domain. Several aGPCRs, including ADGRB1 (BAI1 or B1) and ADGRG1 (GPR56 or G1), have been found to exhibit significantly increased constitutive activity when truncated to mimic GAIN domain cleavage (NT). Recent reports have suggested that the new N-terminal stalk, which is revealed by GAIN domain cleavage, can directly activate aGPCRs as a tethered agonist. We tested this hypothesis in studies on two distinct aGPCRs, B1 and G1, by engineering mutant receptors lacking the entire NT including the stalk (B1- and G1-SL, with SL indicating stalkless). These receptors were evaluated in a battery of signaling assays and compared with full-length wild-type and cleavage-mimicking (NT) forms of the two receptors. We found that B1-SL, in multiple assays, exhibited robust signaling activity, suggesting that the membrane-proximal stalk region is not necessary for its activation. For G1, however, the results were mixed, with the SL mutant exhibiting robust activity in several signaling assays (including TGF shedding, activation of NFAT luciferase, and -arrestin recruitment) but reduced activity relative to NT in a distinct assay (activation of SRF luciferase). These data support a model in which the activation of certain pathways downstream of aGPCRs is stalk-dependent, whereas signaling to other pathways is stalk-independent.	[Kishore, Ayush; Purcell, Ryan H.; Nassiri-Toosi, Zahra; Hall, Randy A.] Emory Univ, Dept Pharmacol, Sch Med, 1510 Clifton Rd NE, Atlanta, GA 30322 USA	Emory University	Hall, RA (corresponding author), Emory Univ, Dept Pharmacol, Sch Med, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	rhall3@emory.edu	Toosi, Zahra Nassiri/AAA-1749-2019	Hall, Randy/0000-0002-8318-8728; Purcell, Ryan/0000-0002-6652-2747	National Institutes of Health [R01 NS072394]; NIH [T32 GM008602, T32 GM008605]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant R01 NS072394 from the National Institutes of Health (to R. A. H.), NIH Training Grant T32 GM008602 (to A. K.), and NIH Training Grant T32 GM008605 (to R. H. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hu QX, 2014, J BIOL CHEM, V289, P24215, DOI 10.1074/jbc.M114.549816; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krasnoperov V, 2009, BIOCHEMISTRY-US, V48, P3230, DOI 10.1021/bi802163p; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2013, TRENDS PHARMACOL SCI, V34, P470, DOI 10.1016/j.tips.2013.06.002; Promel S, 2012, DEV DYNAM, V241, P1591, DOI 10.1002/dvdy.23841; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stephenson JR, 2014, TRENDS PHARMACOL SCI, V35, P208, DOI 10.1016/j.tips.2014.02.002; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Wu MP, 2013, FEBS J, V280, P6097, DOI 10.1111/febs.12529; Zhu D, 2015, J CLIN INVEST, V125, P1497, DOI 10.1172/JCI74603	38	67	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3385	3394		10.1074/jbc.M115.689349	http://dx.doi.org/10.1074/jbc.M115.689349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26710850	hybrid, Green Published			2022-12-28	WOS:000370854500022
J	Qi, YF; Liu, XY; Liang, S; Wang, R; Li, YF; Zhao, J; Shao, JX; An, LJ; Yu, F				Qi, Yafei; Liu, Xiayan; Liang, Shuang; Wang, Rui; Li, Yuanfeng; Zhao, Jun; Shao, Jingxia; An, Lijun; Yu, Fei			A Putative Chloroplast Thylakoid Metalloprotease VIRESCENT3 Regulates Chloroplast Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; chloroplast; membrane protein; metalloprotease; photosynthesis	LEAF VARIEGATION; GENE-EXPRESSION; NUCLEAR GENE; SUBCELLULAR-LOCALIZATION; PROCESSING PEPTIDASE; TARGETING PEPTIDES; PROTEASE COMPLEX; BINDING PROTEIN; REPEAT PROTEIN; BIOGENESIS	The chloroplast is the site of photosynthesis and many other essential plant metabolic processes, and chloroplast development is an integral part of plant growth and development. Mutants defective in chloroplast development can display various color phenotypes including the intriguing virescence phenotype, which shows yellow/white coloration at the leaf base and greening toward the leaf tip. Through large scale genetic screens, we identified a series of new virescent mutants including virescent3-1 (vir3-1), vir4-1, and vir5-1 in Arabidopsis thaliana. We showed that VIR3 encodes a putative chloroplast metalloprotease by map-based cloning. Through site-directed mutagenesis, we showed that the conserved histidine 235 residue in the zinc binding motif HEAGH of VIR3 is indispensable for VIR3 accumulation in the chloroplast. The chloroplast localization of VIR3 was confirmed by the transient expression of VIR3-GFP in leaf protoplasts. Furthermore, taking advantage of transgenic lines expressing VIR3-FLAG, we demonstrated that VIR3 is an intrinsic thylakoid membrane protein that mainly resides in the stromal lamellae. Moreover, topology analysis using transgenic lines expressing a dual epitope-tagged VIR3 indicated that both the N and C termini of VIR3 are located in the stroma, and the catalytic domain of VIR3 is probably facing the stroma. Blue native gel analysis indicated that VIR3 is likely present as a monomer or part of a small complex in the thylakoid membrane. This work not only implicates VIR3 as a new factor involved in early chloroplast development but also provides more insight into the roles of chloroplast proteases in chloroplast biogenesis.	[Qi, Yafei; Liu, Xiayan; Liang, Shuang; Wang, Rui; Li, Yuanfeng; Zhao, Jun; Shao, Jingxia; An, Lijun; Yu, Fei] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Qi, Yafei; Liu, Xiayan; Liang, Shuang; Wang, Rui; Li, Yuanfeng; Zhao, Jun; Shao, Jingxia; An, Lijun; Yu, Fei] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Yu, F (corresponding author), Northwest Agr & Forestry Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	flyfeiyu@gmail.com		Wang, Rui/0000-0002-6196-0780	National Natural Science Foundation of China [31170219, 31300988]; Natural Science Foundation of Shaanxi Province [2014JQ3093]; Fundamental Research Funds for the Central Universities [QN2012022, QN2013034, 2014YB036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31170219 (to F. Y.) and 31300988 (to Y. Q.), by Natural Science Foundation of Shaanxi Province Grants 2014JQ3093 (to J. S.), and by Fundamental Research Funds for the Central Universities Grants QN2012022 (to Y. Q.), QN2013034 (to J. S.), and 2014YB036 (to L. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ARCHER EK, 1987, PLANT PHYSIOL, V83, P920, DOI 10.1104/pp.83.4.920; Armbruster U, 2013, PLANT CELL, V25, P3926, DOI 10.1105/tpc.113.114785; Atanassov II, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-14; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENEDICT CR, 1972, PLANT PHYSIOL, V49, P972, DOI 10.1104/pp.49.6.972; BENEDICT CR, 1968, PLANT PHYSIOL, V43, P1611, DOI 10.1104/pp.43.10.1611; Bhushan S, 2005, PLANT CELL PHYSIOL, V46, P985, DOI 10.1093/pcp/pci107; BRUSSLAN JA, 1995, PHOTOSYNTH RES, V44, P75, DOI 10.1007/BF00018298; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Chaal BK, 1998, J BIOL CHEM, V273, P689, DOI 10.1074/jbc.273.2.689; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Che YF, 2013, P NATL ACAD SCI USA, V110, P16247, DOI 10.1073/pnas.1313894110; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen G, 2012, MOL BIOL REP, V39, P2147, DOI 10.1007/s11033-011-0962-4; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Karnauchov I, 1997, FEBS LETT, V408, P206, DOI 10.1016/S0014-5793(97)00427-4; Kato Y, 2010, INT REV CEL MOL BIO, V280, P185, DOI 10.1016/S1937-6448(10)80004-8; KAY RE, 1956, PLANT PHYSIOL, V31, P415, DOI 10.1104/pp.31.6.415; Kim J, 2009, PLANT CELL, V21, P1669, DOI 10.1105/tpc.108.063784; Koussevitzky S, 2007, PLANT MOL BIOL, V63, P85, DOI 10.1007/s11103-006-9074-2; Kunst L, 1998, METH MOL B, V82, P43; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lopez-Juez E, 1998, PLANT PHYSIOL, V118, P803, DOI 10.1104/pp.118.3.803; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Moberg P, 2003, PLANT J, V36, P616, DOI 10.1046/j.1365-313X.2003.01904.x; Murakami S, 2000, FEBS LETT, V468, P15, DOI 10.1016/S0014-5793(00)01186-8; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Ossenbuhl F, 2002, EUR J BIOCHEM, V269, P3912, DOI 10.1046/j.1432-1033.2002.03057.x; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Poethig RS, 1997, PLANT CELL, V9, P1077, DOI 10.1105/tpc.9.7.1077; Pogson BJ, 2011, PLANT PHYSIOL, V155, P1545, DOI 10.1104/pp.110.170365; POLACCO ML, 1985, PLANT PHYSIOL, V77, P795, DOI 10.1104/pp.77.4.795; Putarjunan A, 2013, PHOTOSYNTH RES, V116, P437, DOI 10.1007/s11120-013-9855-9; Qi YF, 2012, J EXP BOT, V63, P1251, DOI 10.1093/jxb/err347; Qiao JW, 2011, PLANT CELL PHYSIOL, V52, P1017, DOI 10.1093/pcp/pcr054; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Richter S, 1998, P NATL ACAD SCI USA, V95, P7463, DOI 10.1073/pnas.95.13.7463; Rudella A, 2006, PLANT CELL, V18, P1704, DOI 10.1105/tpc.106.042861; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; Wu WJ, 2013, PLANT J, V76, P943, DOI 10.1111/tpj.12344; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Yu F, 2011, MOL PLANT, V4, P229, DOI 10.1093/mp/ssq074; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	62	10	13	2	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3319	3332		10.1074/jbc.M115.681601	http://dx.doi.org/10.1074/jbc.M115.681601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26702056	hybrid, Green Published			2022-12-28	WOS:000370854500017
J	Jia, F; Cui, MX; Than, MT; Han, M				Jia, Fan; Cui, Mingxue; Than, Minh T.; Han, Min			Developmental Defects of Caenorhabditis elegans Lacking Branched-chain alpha-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYRUP-URINE-DISEASE; TERM-FOLLOW-UP; AMINO-ACIDS; C-ELEGANS; LIVER-TRANSPLANTATION; 18-METHYLEICOSANOIC ACID; VERNIX CASEOSA; RAT-BRAIN; BIOSYNTHESIS; GENE	Branched-chain alpha-ketoacid dehydrogenase (BCKDH) catalyzes the critical step in the branched-chain amino acid (BCAA) catabolic pathway and has been the focus of extensive studies. Mutations in the complex disrupt many fundamental metabolic pathways and cause multiple human diseases including maple syrup urine disease (MSUD), autism, and other related neurological disorders. BCKDH may also be required for the synthesis of monomethyl branched-chain fatty acids (mmBCFAs) from BCAAs. The pathology of MSUD has been attributed mainly to BCAA accumulation, but the role of mmBCFA has not been evaluated. Here we show that disrupting BCKDH in Caenorhabditis elegans causes mmBCFA deficiency, in addition to BCAA accumulation. Worms with deficiency in BCKDH function manifest larval arrest and embryonic lethal phenotypes, and mmBCFA supplementation suppressed both without correcting BCAA levels. The majority of developmental defects caused by BCKDH deficiency may thus be attributed to lacking mmBCFAs in worms. Tissue-specific analysis shows that restoration of BCKDH function in multiple tissues can rescue the defects, but is especially effective in neurons. Taken together, we conclude that mmBCFA deficiency is largely responsible for the developmental defects in the worm and conceivably might also be a critical contributor to the pathology of human MSUD.	[Jia, Fan; Cui, Mingxue; Than, Minh T.; Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu			National Institutes of Health [P40OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Kniazeva for advice, A. Sewell for critical reading of the manuscript, the CGC for strains (funded by National Institutes of Health (Grant P40OD010440)), and H. Zhu, H. Tang, and other lab members for helpful discussions.	Amaral AU, 2010, BRAIN RES, V1324, P75, DOI 10.1016/j.brainres.2010.02.018; Caraballo SCG, 2014, J NUTR BIOCHEM, V25, P1263, DOI 10.1016/j.jnutbio.2014.07.005; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Cole JT, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00018; Destaillats F, 2002, LIPIDS, V37, P325, DOI 10.1007/s11745-002-0898-y; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank MP, 2007, J CHROMATOGR B, V852, P646, DOI 10.1016/j.jchromb.2007.01.002; GIBSON RA, 1981, AM J CLIN NUTR, V34, P252, DOI 10.1093/ajcn/34.2.252; HRADEC J, 1994, J CHROMATOGR B, V660, P386, DOI 10.1016/0378-4347(94)00292-4; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kniazeva M, 2015, DEV CELL, V33, P260, DOI 10.1016/j.devcel.2015.02.015; Kniazeva M, 2012, GENE DEV, V26, P554, DOI 10.1101/gad.187054.112; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LAU KS, 1992, J BIOL CHEM, V267, P24090; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Mazariegos GV, 2012, J PEDIATR-US, V160, P116, DOI 10.1016/j.jpeds.2011.06.033; MCGHEE JD, 1990, GENETICS, V125, P505; McLaughlin PM, 2013, CLIN NEUROPSYCHOL, V27, P1199, DOI 10.1080/13854046.2013.816372; MITSUBUCHI H, 1991, J BIOL CHEM, V266, P14686; MORII H, 1982, COMP BIOCHEM PHYS B, V71, P357, DOI 10.1016/0305-0491(82)90395-9; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; Oku H, 2000, LIPIDS, V35, P373, DOI 10.1007/s11745-000-534-x; OKU H, 1994, BBA-LIPID LIPID MET, V1214, P279; Ran-Ressler RR, 2008, PEDIATR RES, V64, P605, DOI 10.1203/PDR.0b013e318184d2e6; Ran-Ressler RR, 2014, BRIT J NUTR, V112, P565, DOI 10.1017/S0007114514001081; Rissmann R, 2006, J INVEST DERMATOL, V126, P1823, DOI 10.1038/sj.jid.5700305; Schonberger S, 2004, MOL GENET METAB, V82, P69, DOI 10.1016/j.ymgme.2004.01.016; Simon E, 2007, J INHERIT METAB DIS, V30, P264, DOI 10.1007/s10545-007-0475-4; Sitta A, 2014, CELL MOL NEUROBIOL, V34, P157, DOI 10.1007/s10571-013-0002-0; Smith JR, 2005, MICRON, V36, P261, DOI 10.1016/j.micron.2004.11.004; Strand JM, 2014, METABOLISM, V63, P1063, DOI 10.1016/j.metabol.2014.05.003; Strauss KA, 2006, AM J TRANSPLANT, V6, P557, DOI 10.1111/j.1600-6143.2005.01209.x; Strauss Kevin A., 2003, Curr Treat Options Neurol, V5, P329, DOI 10.1007/s11940-003-0039-3; Strauss KA, 2010, MOL GENET METAB, V99, P333, DOI 10.1016/j.ymgme.2009.12.007; Su X, 2015, OBESITY, V23, P329, DOI 10.1002/oby.20923; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Tavares RG, 2000, J NEUROL SCI, V181, P44, DOI 10.1016/S0022-510X(00)00402-0; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Walsh KS, 2010, CLIN NEUROPSYCHOL, V24, P689, DOI 10.1080/13854040903527279; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZHANG B, 1991, MOL BIOL MED, V8, P39; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429; Zinnanti WJ, 2009, BRAIN, V132, P903, DOI 10.1093/brain/awp024	48	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2967	2973		10.1074/jbc.M115.676650	http://dx.doi.org/10.1074/jbc.M115.676650			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26683372	Green Published, hybrid			2022-12-28	WOS:000369626900033
J	Martinez, AIC; Weinhaupl, K; Lee, WK; Wolff, NA; Storch, B; Zerko, S; Konrat, R; Kozminski, W; Breuker, K; Thevenod, F; Coudevylle, N				Martinez, Ana-Isabel Cabedo; Weinhaeupl, Katharina; Lee, Wing-Kee; Wolff, Natascha A.; Storch, Barbara; Zerko, Szymon; Konrat, Robert; Kozminski, Wiktor; Breuker, Kathrin; Thevenod, Frank; Coudevylle, Nicolas			Biochemical and Structural Characterization of the Interaction between the Siderocalin NGAL/LCN2 (Neutrophil Gelatinase-associated Lipocalin/Lipocalin 2) and the N-terminal Domain of Its Endocytic Receptor SLC22A17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ASSIGNMENT; LIPOCALIN NGAL; DISTAL NEPHRON; IMMUNE-SYSTEM; PROTEIN; IRON; CELLS; NMR; TRANSPORTERS; ALBUMINURIA	The neutrophil gelatinase-associated lipocalin (NGAL, also known as LCN2) and its cellular receptor (LCN2-R, SLC22A17) are involved in many physiological and pathological processes such as cell differentiation, apoptosis, and inflammation. These pleiotropic functions mainly rely on NGAL's siderophore-mediated iron transport properties. However, the molecular determinants underlying the interaction between NGAL and its cellular receptor remain largely unknown. Here, using solution-state biomolecular NMR in conjunction with other biophysical methods, we show that the N-terminal domain of LCN2-R is a soluble extracellular domain that is intrinsically disordered and interacts with NGAL preferentially in its apo state to form a fuzzy complex. The relatively weak affinity (approximate to 10 mu M) between human LCN2-R-NTD and apo NGAL suggests that the N terminus on its own cannot account for the internalization of NGAL by LCN2-R. However, human LCN2-R-NTD could be involved in the fine-tuning of the interaction between NGAL and its cellular receptor or in a biochemical mechanism allowing the receptor to discriminate between apo- and holo-NGAL.	[Martinez, Ana-Isabel Cabedo; Weinhaeupl, Katharina; Konrat, Robert; Coudevylle, Nicolas] Univ Vienna, Dept Computat & Struct Biol, Max F Perutz Labs, Campus Vienna Bioctr 5, A-1030 Vienna, Austria; [Lee, Wing-Kee; Wolff, Natascha A.; Thevenod, Frank] Univ Witten Herdecke, Fac Hlth, Sch Med, Chair Physiol Pathophysiol & Toxicol, Stockumer Str 12, D-58453 Witten, Germany; [Lee, Wing-Kee; Wolff, Natascha A.; Thevenod, Frank] Univ Witten Herdecke, Fac Hlth, Sch Med, ZBAF, Stockumer Str 12, D-58453 Witten, Germany; [Storch, Barbara; Breuker, Kathrin] Univ Innsbruck, CCB, Inst Organ Chem, Innrain 80-82, A-6020 Innsbruck, Austria; [Zerko, Szymon; Kozminski, Wiktor] Univ Innsbruck, CCB, Ctr Mol Biosci Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria; Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Zwirki i Wigury 101, PL-02089 Warsaw, Poland	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Witten Herdecke University; Witten Herdecke University; University of Innsbruck; University of Innsbruck; University of Warsaw	Coudevylle, N (corresponding author), Univ Vienna, Dept Computat & Struct Biol, Max F Perutz Labs, Campus Vienna Bioctr 5, A-1030 Vienna, Austria.	nicolas.coudevylle@univie.ac.at	Kozminski, Wiktor/M-1561-2013	Kozminski, Wiktor/0000-0003-2319-4525; Zerko, Szymon/0000-0002-0044-1100; Breuker, Kathrin/0000-0002-4978-0883; Lee, Wing-Kee/0000-0002-7352-4679; Weinhaupl, Katharina/0000-0002-9552-9876; Konrat, Robert/0000-0001-6489-4080	European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; Austrian Science Fund (FWF) [Y 372, P 24761, P 27347] Funding Source: researchfish	European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Dr. Roland Strong (Division of Basic Sciences, Fred Hutchinson Cancer Research Center) for the gift of the pGEX-4T-hNGAL(C87S) vector. Part of the study was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Correnti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043696; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dizin E, 2013, AM J PHYSIOL-RENAL, V305, pF1053, DOI 10.1152/ajprenal.00006.2013; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Fila M, 2011, J PHYSIOL-LONDON, V589, P3611, DOI 10.1113/jphysiol.2011.209692; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Ganisl B, 2012, CHEMISTRYOPEN, V1, P260, DOI 10.1002/open.201200038; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Kazimierczuk K, 2006, J BIOMOL NMR, V36, P157, DOI 10.1007/s10858-006-9077-y; Kazimierczuk K, 2010, J MAGN RESON, V205, P286, DOI 10.1016/j.jmr.2010.05.012; Kazimierczuk K, 2009, J MAGN RESON, V197, P219, DOI 10.1016/j.jmr.2009.01.003; Keller R., 2004, COMPUTER AIDED RESON, V1; Koepsell H, 1998, NEWS PHYSIOL SCI, V13, P11; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kurzbach D, 2013, BIOCHEMISTRY-US, V52, P5167, DOI 10.1021/bi400502c; Langelueddecke C, 2014, TOXICOL LETT, V226, P228, DOI 10.1016/j.toxlet.2014.01.049; Langelueddecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071586; Langelueddecke C, 2012, J BIOL CHEM, V287, P159, DOI 10.1074/jbc.M111.308296; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Schneider R, 2015, J AM CHEM SOC, V137, P1220, DOI 10.1021/ja511066q; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Stanek J, 2010, J BIOMOL NMR, V47, P65, DOI 10.1007/s10858-010-9411-2; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tollinger M, 2006, BIOCHEMISTRY-US, V45, P8885, DOI 10.1021/bi0607305; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zawadzka-Kazimierczuk A, 2012, J BIOMOL NMR, V54, P81, DOI 10.1007/s10858-012-9652-3; Zawadzka-Kazimierczuk A, 2012, J BIOMOL NMR, V52, P329, DOI 10.1007/s10858-012-9613-x	47	25	25	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2917	2930		10.1074/jbc.M115.685644	http://dx.doi.org/10.1074/jbc.M115.685644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26635366	Green Published, hybrid			2022-12-28	WOS:000369626900029
J	Wang, B; Merillat, SA; Vincent, M; Huber, AK; Basrur, V; Mangelberger, D; Zeng, L; Elenitoba-Johnson, K; Miller, RA; Irani, DN; Dlugosz, AA; Schnell, S; Scaglione, KM; Paulson, HL				Wang, Bo; Merillat, Sean A.; Vincent, Michael; Huber, Amanda K.; Basrur, Venkatesha; Mangelberger, Doris; Zeng, Li; Elenitoba-Johnson, Kojo; Miller, Richard A.; Irani, David N.; Dlugosz, Andrzej A.; Schnell, Santiago; Scaglione, Kenneth Matthew; Paulson, Henry L.			Loss of the Ubiquitin-conjugating Enzyme UBE2W Results in Susceptibility to Early Postnatal Lethality and Defects in Skin, Immune, and Male Reproductive Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL RESIDUE; EMBRYONIC-DEVELOPMENT; PROTEASOME SYSTEM; TUMOR-SUPPRESSOR; DEGRADATION; PROTEIN; PATHWAY; MICE; PREDICTION; STRESS	UBE2W ubiquitinates N termini of proteins rather than internal lysine residues, showing a preference for substrates with intrinsically disordered N termini. The in vivo functions of this intriguing E2, however, remain unknown. We generated Ube2w germ line KO mice that proved to be susceptible to early postnatal lethality without obvious developmental abnormalities. Although the basis of early death is uncertain, several organ systems manifest changes in Ube2w KO mice. Newborn Ube2w KO mice often show altered epidermal maturation with reduced expression of differentiation markers. Mirroring higher UBE2W expression levels in testis and thymus, Ube2w KO mice showed a disproportionate decrease in weight of these two organs (similar to 50%), suggesting a functional role for UBE2W in the immune and male reproductive systems. Indeed, Ube2w KO mice displayed sustained neutrophilia accompanied by increased G-CSF signaling and testicular vacuolation associated with decreased fertility. Proteomic analysis of a vulnerable organ, presymptomatic testis, showed a preferential accumulation of disordered proteins in the absence of UBE2W, consistent with the view that UBE2W preferentially targets disordered polypeptides. These mice further allowed us to establish that UBE2W is ubiquitously expressed as a single isoform localized to the cytoplasm and that the absence of UBE2W does not alter cell viability in response to various stressors. Our results establish that UBE2W is an important, albeit not essential, protein for early postnatal survival and normal functioning of multiple organ systems.	[Wang, Bo; Merillat, Sean A.; Huber, Amanda K.; Zeng, Li; Irani, David N.; Paulson, Henry L.] Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,Rm 4001, Ann Arbor, MI 48109 USA; [Vincent, Michael; Schnell, Santiago] Univ Michigan, Dept Mol & Integrat Physiol & Computat Med & Bioi, Ann Arbor, MI 48109 USA; [Mangelberger, Doris; Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Wang, Bo] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Pathol & Geriatr Ctr, Ann Arbor, MI 48109 USA; [Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical College of Wisconsin; Medical College of Wisconsin	Paulson, HL (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,Rm 4001, Ann Arbor, MI 48109 USA.	henryp@med.umich.edu	Schnell, Santiago/B-8682-2008; Vincent, Michael/H-4939-2015	Schnell, Santiago/0000-0002-9477-3914; Huber, Amanda/0000-0003-0375-8709; Vincent, Michael/0000-0001-9669-4921; Scaglione, Kenneth/0000-0002-3858-9418; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health [R01 AG034228, U19 AG023122, R01 AR045973, K99 NS073936]; University of Michigan Protein Folding Disease Initiative; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073936, K99NS073936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019899, R01AG034228, U19AG023122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Protein Folding Disease Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was support by National Institutes of Health Grants R01 AG034228 (to H. L. P.), U19 AG023122 (to R. A. M.), R01 AR045973 (to A. A. D.), and K99 NS073936 (to K. M. S.) and the University of Michigan Protein Folding Disease Initiative. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Bedard N, 2005, MOL CELL BIOL, V25, P6346, DOI 10.1128/MCB.25.15.6346-6354.2005; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Bueter W, 2009, PEDIATR RES, V66, P487, DOI 10.1203/PDR.0b013e3181baa083; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Gitto E, 2002, BIOL NEONATE, V81, P146, DOI 10.1159/000051527; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Ikeda M, 2002, VIROLOGY, V300, P153, DOI 10.1006/viro.2002.1562; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lenhoff S, 1999, EUR CYTOKINE NETW, V10, P525; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Marseglia L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/358375; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Starita LM, 2013, P NATL ACAD SCI USA, V110, pE1263, DOI 10.1073/pnas.1303309110; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Vittal V, 2015, NAT CHEM BIOL, V11, P83, DOI [10.1038/NCHEMBIO.1700, 10.1038/nchembio.1700]; Vittal V, 2013, CELL BIOCHEM BIOPHYS, V67, P103, DOI 10.1007/s12013-013-9633-5; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang YY, 2011, MOL CELLS, V31, P113, DOI 10.1007/s10059-011-0015-9; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	46	17	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3030	3042		10.1074/jbc.M115.676601	http://dx.doi.org/10.1074/jbc.M115.676601			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26601958	Green Published, hybrid			2022-12-28	WOS:000369626900039
J	Kroczynska, B; Rafidi, RL; Majchrzak-Kita, B; Kosciuczuk, EM; Blyth, GT; Jemielity, J; Warminska, Z; Saleiro, D; Mehrotra, S; Arslan, AD; Fish, EN; Platanias, LC				Kroczynska, Barbara; Rafidi, Robert L.; Majchrzak-Kita, Beata; Kosciuczuk, Ewa M.; Blyth, Gavin T.; Jemielity, Jacek; Warminska, Zofia; Saleiro, Diana; Mehrotra, Swarna; Arslan, Ahmet Dirim; Fish, Eleanor N.; Platanias, Leonidas C.			Interferon gamma (IFN gamma) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; APLASTIC-ANEMIA; MAMMALIAN TARGET; KINASE; RICTOR; PATHWAY; PROTEIN; PHOSPHORYLATION; ACTIVATION; CANCER	We provide evidence for a unique pathway engaged by the type II IFN receptor, involving mTORC2/AKT-mediated downstream regulation of mTORC1 and effectors. These events are required for formation of the eukaryotic translation initiation factor 4F complex (eIF4F) and initiation of mRNA translation of type II interferon-stimulated genes. Our studies establish that Rictor is essential for the generation of type II IFN-dependent antiviral and antiproliferative responses and that it controls the generation of type II IFN-suppressive effects on normal and malignant hematopoiesis. Together, our findings establish a central role for mTORC2 in IFN gamma signaling and type II IFN responses.	[Kroczynska, Barbara; Rafidi, Robert L.; Kosciuczuk, Ewa M.; Blyth, Gavin T.; Saleiro, Diana; Mehrotra, Swarna; Arslan, Ahmet Dirim; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Kroczynska, Barbara; Rafidi, Robert L.; Kosciuczuk, Ewa M.; Blyth, Gavin T.; Saleiro, Diana; Mehrotra, Swarna; Arslan, Ahmet Dirim; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kroczynska, Barbara] Northwestern Univ, Dept Radiat Oncol, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2MI, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2MI, Canada; [Kosciuczuk, Ewa M.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Jemielity, Jacek; Warminska, Zofia] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland; [Warminska, Zofia] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, PL-02089 Warsaw, Poland	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Warsaw; University of Warsaw	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super Ave,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Jemielity, Jacek/E-2635-2013; Kosciuczuk, Ewa Maria/AAD-2815-2022	Jemielity, Jacek/0000-0001-7633-788X; 	National Institutes of Health [CA77816, CA155566, CA161796]; Department of Veterans Affairs [I01CX000916]; NCI/National Institutes of Health [T32 CA080621, T32 CA070085]; National Science Centre [UMO-2013/09/B/ST5/01341]; Canada Research Chair; NATIONAL CANCER INSTITUTE [R01CA161796, T32CA070085, P30CA060553, R01CA155566, T32CA080621, R01CA077816] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Centre(National Science Centre, Poland); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants CA77816, CA155566, and CA161796. This work was also supported by Grant I01CX000916 from the Department of Veterans Affairs, by NCI/National Institutes of Health Training Grants T32 CA080621 (to D. S.) and T32 CA070085 (to A. D. A), by National Science Centre Grant UMO-2013/09/B/ST5/01341, and by funds made available to E. N. F. as a Tier 1 Canada Research Chair. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aimbetov R, 2012, ONCOGENE, V31, P2115, DOI 10.1038/onc.2011.404; Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jemielity J, 2012, ORG BIOMOL CHEM, V10, P8570, DOI 10.1039/c2ob26060c; Joshi Sonali, 2015, BioMolecular Concepts, V6, P85, DOI 10.1515/bmc-2011-2000; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; Kroczynska B, 2014, P NATL ACAD SCI USA, V111, P11377, DOI 10.1073/pnas.1405250111; Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Larsen TS, 2013, LEUKEMIA RES, V37, P1041, DOI 10.1016/j.leukres.2013.06.012; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin FC, 2014, BLOOD, V124, P3699, DOI 10.1182/blood-2014-01-549527; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2389	2396		10.1074/jbc.M115.664995	http://dx.doi.org/10.1074/jbc.M115.664995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645692	hybrid, Green Published			2022-12-28	WOS:000369610400028
J	Sekiguchi, T; Kuwasako, K; Ogasawara, M; Takahashi, H; Matsubara, S; Osugi, T; Muramatsu, I; Sasayama, Y; Suzuki, N; Satake, H				Sekiguchi, Toshio; Kuwasako, Kenji; Ogasawara, Michio; Takahashi, Hiroki; Matsubara, Shin; Osugi, Tomohiro; Muramatsu, Ikunobu; Sasayama, Yuichi; Suzuki, Nobuo; Satake, Honoo			Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; ACTIVITY-MODIFYING PROTEIN-1; CIONA-INTESTINALIS; AMPHIOXUS GENOME; RECEPTOR; ADRENOMEDULLIN; EXPRESSION; AMYLIN; CGRP; LOCALIZATION	The calcitonin (CT)/CT gene-related peptide (CGRP) family is conserved in vertebrates. The activities of this peptide family are regulated by a combination of two receptors, namely the calcitonin receptor (CTR) and the CTR-like receptor (CLR), and three receptor activity-modifying proteins (RAMPs). Furthermore, RAMPs act as escort proteins by translocating CLR to the cell membrane. Recently, CT/CGRP family peptides have been identified or inferred in several invertebrates. However, the molecular characteristics and relevant functions of the CTR/CLR and RAMPs in invertebrates remain unclear. In this study, we identified three CT/CGRP family peptides (Bf-CTFPs), one CTR/CLR-like receptor (Bf-CTFP-R), and three RAMP-like proteins (Bf-RAMP-LPs) in the basal chordate amphioxus (Branchiostoma floridae). The Bf-CTFPs were shown to possess an N-terminal circular region typical of the CT/CGRP family and a C-terminal Pro-NH2. The Bf-CTFP genes were expressed in the central nervous system and in endocrine cells of the midgut, indicating that Bf-CTFPs serve as brain and/or gut peptides. Cell surface expression of the Bf-CTFP-R was enhanced by co-expression with each Bf-RAMP-LP. Furthermore, Bf-CTFPs activated Bf-CTFP-R.Bf-RAMP-LP complexes, resulting in cAMP accumulation. These results confirmed that Bf-RAMP-LPs, like vertebrate RAMPs, are prerequisites for the function and translocation of the Bf-CTFP-R. The relative potencies of the three peptides at each receptor were similar. Bf-CTFP2 was a potent ligand at all receptors in cAMP assays. Bf-RAMP-LP effects on ligand potency order were distinct to vertebrate CGRP/adrenomedullin/amylin receptors. To the best of our knowledge, this is the first molecular and functional characterization of an authentic invertebrate CT/CGRP family receptor and RAMPs.	[Sekiguchi, Toshio; Sasayama, Yuichi; Suzuki, Nobuo] Kanazawa Univ, Noto Marine Lab, Div Marine Environm Studies, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9270553, Japan; [Kuwasako, Kenji] Miyazaki Univ, Frontier Sci Res Ctr, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Ogasawara, Michio] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan; [Takahashi, Hiroki] Natl Inst Basic Biol, Lab Morphogenesis, 38 Nishigonaka Myodaiji, Okazaki, Aichi 4448585, Japan; [Osugi, Tomohiro; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, 8-1-1,Seikadai,Seika Cho, Kyoto 6190284, Japan; [Muramatsu, Ikunobu] Kanazawa Med Univ, Dept Pharmacol, Sch Med, Uchinada, Ishikawa 9200293, Japan	Kanazawa University; University of Miyazaki; Chiba University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Suntory Holdings Ltd; Kanazawa Medical University	Sekiguchi, T (corresponding author), Kanazawa Univ, Noto Marine Lab, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9270553, Japan.	t-sekiguchi@se.kanazawa-u.ac.jp	SUZUKI, Nobuo/J-8420-2015; Kuwasako, Kenji/H-8065-2016	SUZUKI, Nobuo/0000-0003-0283-9910; Takahashi, Hiroki/0000-0002-7658-0246; Matsubara, Shin/0000-0002-7794-534X; Osugi, Tomohiro/0000-0001-6987-9576	Japan Society for the Promotion of Science [23770069, 15K07126, 25440161]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Japan Society for the Promotion of Science (23770069 and 15K07126, to T. S. and 25440161, to H. S.). The authors declare that they have no conflict of interest with the contents of this article.	AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Bomberger JM, 2012, ADV EXP MED BIOL, V744, P25, DOI 10.1007/978-1-4614-2364-5_3; BRAIN SD, 1993, AGENTS ACTIONS, V38, pC19, DOI 10.1007/BF01991124; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Conner AC, 2004, BIOCHEM SOC T, V32, P843, DOI 10.1042/BST0320843; COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763; COPP DH, 1970, CAN MED ASSOC J, V103, P821; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Flahaut M, 2003, BIOCHEMISTRY-US, V42, P10333, DOI 10.1021/bi0347508; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hiruta J, 2005, DEV DYNAM, V233, P1031, DOI 10.1002/dvdy.20401; Iga M, 2015, BIOSCI BIOTECH BIOCH, V79, P1305, DOI 10.1080/09168451.2015.1018128; Ittner LM, 2004, BIOCHEM BIOPH RES CO, V319, P1203, DOI 10.1016/j.bbrc.2004.05.103; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kitamura K, 2002, MICROSC RES TECHNIQ, V57, P3, DOI 10.1002/jemt.10052; Koller D, 2004, J BIOL CHEM, V279, P20387, DOI 10.1074/jbc.M313058200; Kuwasako K, 2004, PEPTIDES, V25, P2003, DOI 10.1016/j.peptides.2004.06.002; Kuwasako K, 2003, HYPERTENS RES, V26, pS25, DOI 10.1291/hypres.26.S25; Kuwasako K, 2003, J BIOL CHEM, V278, P22623, DOI 10.1074/jbc.M302571200; Kuwasako K, 2012, BRIT J PHARMACOL, V166, P137, DOI 10.1111/j.1476-5381.2011.01803.x; Kuwasako K, 2011, PEPTIDES, V32, P1540, DOI 10.1016/j.peptides.2011.05.022; Lafont AG, 2007, GEN COMP ENDOCR, V153, P155, DOI 10.1016/j.ygcen.2007.01.027; Louis A, 2012, BRIEF FUNCT GENOMICS, V11, P89, DOI 10.1093/bfgp/els003; Martins R, 2014, GEN COMP ENDOCR, V209, P61, DOI 10.1016/j.ygcen.2014.04.025; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MINAMITAKE Y, 1990, CHEM PHARM BULL, V38, P1920; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Mulder H, 1996, REGUL PEPTIDES, V62, P107, DOI 10.1016/0167-0115(96)00005-5; Okuda R, 1999, GEN COMP ENDOCR, V113, P267, DOI 10.1006/gcen.1998.7195; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qi T, 2010, BRIT J PHARMACOL, V159, P1059, DOI 10.1111/j.1476-5381.2009.00541.x; REICHWALD K, 1994, P NATL ACAD SCI USA, V91, P11894, DOI 10.1073/pnas.91.25.11894; ROBERTS AN, 1989, P NATL ACAD SCI USA, V86, P9662, DOI 10.1073/pnas.86.24.9662; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Rowe ML, 2014, GEN COMP ENDOCR, V197, P43, DOI 10.1016/j.ygcen.2013.12.002; Rowe ML, 2012, GEN COMP ENDOCR, V179, P331, DOI 10.1016/j.ygcen.2012.09.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Sakai T, 2012, ENDOCRINOLOGY, V153, P1841, DOI 10.1210/en.2011-1668; Sawada H, 2006, ENDOCRINOLOGY, V147, P2043, DOI 10.1210/en.2005-1226; Sekiguchi T, 2012, J ENDOCRINOL, V213, P99, DOI 10.1530/JOE-11-0410; Sekiguchi T, 2009, FEBS J, V276, P4437, DOI 10.1111/j.1742-4658.2009.07151.x; Sexton PM, 2009, DRUG DISCOV TODAY, V14, P413, DOI 10.1016/j.drudis.2008.12.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Zandawala M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082466; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P816, DOI 10.1016/j.ibmb.2012.06.006	52	20	22	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2345	2356		10.1074/jbc.M115.664003	http://dx.doi.org/10.1074/jbc.M115.664003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644465	Green Published, hybrid			2022-12-28	WOS:000369610400024
J	Chauhan, AK; Moore, TL; Bi, Y; Chen, C				Chauhan, Anil K.; Moore, Terry L.; Bi, Ye; Chen, Chen			Fc gamma RIIIa-Syk Co-signal Modulates CD4(+) T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON-GAMMA; IMMUNE-COMPLEXES; HELPER-CELLS; COSTIMULATORY MOLECULES; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; GERMINAL-CENTERS; TYROSINE KINASE; DENDRITIC CELLS	CD4(+) T-cells in systemic lupus erythematosus (SLE) patients show altered T-cell receptor signaling, which utilizes Fc-receptor gamma-chain FcR gamma-Syk. A role for Fc gamma RIIIa activation from immune complex (IC) ligation and sublytic terminal complement complex (C5b-9) in CD4(+) T-cell responses is not investigated. In this study, we show that the ICs present in SLE patients by ligating to Fc gamma RIIIa on CD4(+) T-cells phosphorylate Syk and provide a co-stimulatory signal to CD4(+) T-cells in the absence of CD28 signal. This led to the development of pathogenic IL-17A(+) and IFN-gamma(high) CD4(+) T-cells in vitro. Cytokines IL-1 beta, IL-6, TGF-beta 1, and IL-23 were the only requirement for the development of both populations. SLE patients CD4(+) T-cells that expressed CD25, CD69, and CD98 bound to ICs showed pSyk and produced IFN-gamma and IL-17A. This Fc gamma RIIIa-mediated co-signal differentially up-regulated the expression of IFN pathway genes compared with CD28 co-signal. Fc gamma RIIIa-pSyk upregulated several toll-like receptor genes as well as the HMGB1 and MyD88 gene transcripts. ICs co-localized with these toll-like receptor pathway proteins. These results suggest a role for the Fc gamma RIIIa-pSyk signal in modulating adaptive immune responses.	[Chauhan, Anil K.; Moore, Terry L.; Bi, Ye; Chen, Chen] St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, 1402 South Grand Blvd, St Louis, MO 63104 USA	Saint Louis University	Chauhan, AK (corresponding author), St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, 1402 South Grand Blvd, St Louis, MO 63104 USA.	chauhana@slu.edu	Bi, Ye/A-6272-2017		National Institutes of Health RO1 Grant [A1098114]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098114] Funding Source: NIH RePORTER	National Institutes of Health RO1 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health RO1 Grant A1098114 (to A.K.C.). The authors declare that they have no conflict of interest with the content of this article.	Agarwal A, 2008, CURR OPIN ORGAN TRAN, V13, P366, DOI 10.1097/MOT.0b013e328306115b; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Amarilyo G, 2014, J IMMUNOL, V193, P540, DOI 10.4049/jimmunol.1400931; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Cai G, 2012, J IMMUNOL, V189, P1294, DOI 10.4049/jimmunol.1102948; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chauhan AK, 2012, CLIN EXP IMMUNOL, V167, P235, DOI 10.1111/j.1365-2249.2011.04505.x; Chauhan AK, 2015, J BIOL CHEM, V290, P5127, DOI 10.1074/jbc.M114.599266; Chauhan AK, 2011, J BIOL CHEM, V286, P38627, DOI 10.1074/jbc.M111.266809; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chiu YY, 1998, J INVEST ALLERG CLIN, V8, P239; Chugh PK, 2012, EUR J INTERN MED, V23, P212, DOI 10.1016/j.ejim.2011.11.001; Conti F, 2011, CLIN REV ALLERG IMMU, V40, P192, DOI 10.1007/s12016-010-8208-0; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Crow MK, 2010, RHEUM DIS CLIN N AM, V36, P173, DOI 10.1016/j.rdc.2009.12.008; Datta SK, 1997, LUPUS, V6, P333, DOI 10.1177/096120339700600330; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; ENGELHARDT W, 1995, IMMUNOBIOLOGY, V192, P297, DOI 10.1016/S0171-2985(11)80172-5; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gordon RA, 2012, ARTHRITIS RHEUM-US, V64, P3119, DOI 10.1002/art.34544; Grammatikos AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074550; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Low JM, 2009, PROTEOM CLIN APPL, V3, P829, DOI 10.1002/prca.200800073; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Miura Y, 1989, Nihon Jinzo Gakkai Shi, V31, P201; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; SANDOR M, 1993, IMMUNOL TODAY, V14, P227, DOI 10.1016/0167-5699(93)90168-K; SANDOR M, 1994, P NATL ACAD SCI USA, V91, P12857, DOI 10.1073/pnas.91.26.12857; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; van Egmond M, 2015, IMMUNOL REV, V268, P311, DOI 10.1111/imr.12333; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermeire K, 1997, J IMMUNOL, V158, P5507; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zhang YB, 2013, J IMMUNOL, V190, P4725, DOI 10.4049/jimmunol.1203024; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	86	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1368	1386		10.1074/jbc.M115.684795	http://dx.doi.org/10.1074/jbc.M115.684795			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26582197	Green Published, hybrid			2022-12-28	WOS:000368068300029
J	Liu, ZH; Zhang, N; Shao, BJ; Panicker, SR; Fu, JX; McEver, RP				Liu, Zhenghui; Zhang, Nan; Shao, Bojing; Panicker, Sumith R.; Fu, Jianxin; McEver, Rodger P.			Replacing the Promoter of the Murine Gene Encoding P-selectin with the Human Promoter Confers Human-like Basal and Inducible Expression in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDE SYNTHASE GENE; IN-VIVO EXPRESSION; ADHESION MOLECULES; TRANSCRIPTIONAL REGULATION; LEUKOCYTE ADHESION; ENDOTHELIAL-CELLS; DEFICIENT MICE; KAPPA-B; CLONING; REQUIREMENTS	In humans and mice, megakaryocytes/platelets and endothelial cells constitutively synthesize P-selectin and mobilize it to the plasma membrane to mediate leukocyte rolling during inflammation. TNF-alpha, interleukin 1 beta, and LPS markedly increase P-selectin mRNA in mice but decrease P-selectin mRNA in humans. Transgenic mice bearing the entire human SELP gene recapitulate basal and inducible expression of human P-selectin and reveal human-specific differences in P-selectin function. Differences in the human SELP and murine Selp promoters account for divergent expression in vitro, but their significance in vivo is not known. Here we generated knockin mice that replace the 1.4-kb proximal Selp promoter with the corresponding SELP sequence (Selp(KI)). Selp(KI/KI) mice constitutively expressed more P-selectin on platelets and more P-selectin mRNA in tissues but only slightly increased P-selectin mRNA after injection of TNF-alpha or LPS. Consistent with higher basal expression, leukocytes rolled more slowly on P-selectin in trauma-stimulated venules of Selp(KI/KI) mice. However, TNF-alpha did not further reduce P-selectin-dependent rolling velocities. Blunted up-regulation of P-selectin mRNA during contact hypersensitivity reduced P-selectin-dependent inflammation in Selp(KI/-) mice. Higher basal P-selectin in Selp(KI/KI) mice compensated for this defect. Therefore, divergent sequences in a short promoter mediate most of the functionally significant differences in expression of human and murine P-selectin in vivo.	[Liu, Zhenghui; Shao, Bojing; Panicker, Sumith R.; Fu, Jianxin; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Zhang, Nan; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Panicker, Sumith/X-8830-2019	Zhang, Nan/0000-0002-6736-2781; Panicker, Sumith/0000-0001-8550-9436	National Institutes of Health [HL034363, HL085607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607, R37HL034363, R01HL034363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL034363 and HL085607. R.P.M. has interests in Selexys and Tetherex. The other authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily	AUCHAMPACH JA, 1994, GENE, V145, P251, DOI 10.1016/0378-1119(94)90015-9; BISCHOFF J, 1995, BIOCHEM BIOPH RES CO, V210, P174, DOI 10.1006/bbrc.1995.1643; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; BURNS SA, 1995, J THORAC CARDIOV SUR, V110, P924, DOI 10.1016/S0022-5223(05)80159-X; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589; Chong BF, 2004, J IMMUNOL, V172, P1575, DOI 10.4049/jimmunol.172.3.1575; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dore M, 1996, VET PATHOL, V33, P662, DOI 10.1177/030098589603300605; Hwang JM, 2004, J EXP MED, V199, P1223, DOI 10.1084/jem.20032016; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 2015, CARDIOVASC RES, V107, P331, DOI 10.1093/cvr/cvv154; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; PAN JL, 1993, J BIOL CHEM, V268, P22600; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; Ramos CL, 1997, BLOOD, V89, P3009, DOI 10.1182/blood.V89.8.3009; Rose SD, 1997, HUM MOL GENET, V6, P897, DOI 10.1093/hmg/6.6.897; SANDERS WE, 1992, BLOOD, V80, P795; Schweitzer KM, 1996, AM J PATHOL, V148, P165; SILBER A, 1994, LAB INVEST, V70, P163; Spitsin SV, 1996, MOL MED, V2, P226, DOI 10.1007/BF03401619; Staite ND, 1996, BLOOD, V88, P2973, DOI 10.1182/blood.V88.8.2973.bloodjournal8882973; Tchernychev B, 2003, J CELL BIOL, V163, P1145, DOI 10.1083/jcb.200310079; Thomas GP, 2000, EXP CELL RES, V258, P395, DOI 10.1006/excr.2000.4912; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; WELLER A, 1992, J BIOL CHEM, V267, P15176; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2015, J EXP MED, V212, P1267, DOI 10.1084/jem.20142358; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Yao LB, 1999, BLOOD, V94, P3820, DOI 10.1182/blood.V94.11.3820; Yu ZY, 2005, AM J PHYSIOL-RENAL, V288, pF214, DOI 10.1152/ajprenal.00258.2004; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307; Zhang XO, 1996, J LEUKOCYTE BIOL, V59, P575, DOI 10.1002/jlb.59.4.575	44	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1441	1447		10.1074/jbc.M115.702126	http://dx.doi.org/10.1074/jbc.M115.702126			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26631722	Green Published, hybrid			2022-12-28	WOS:000368068300034
J	Meissner, C; Jahn, N; Brantl, S				Meissner, Christin; Jahn, Natalie; Brantl, Sabine			In Vitro Characterization of the Type I Toxin-Antitoxin System bsrE/SR5 from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL ATTENUATION; ANTISENSE RNA REGULATION; FAECALIS PLASMID PAD1; BACTERIAL TYPE-I; REGULATORY RNAS; EFFICIENT INHIBITION; MESSENGER-RNA; SOLUBLE-RNAS; TARGET; MECHANISM	BsrE/SR5 is a new type I toxin/antitoxin system located on the prophage-like region P6 of the Bacillus subtilis chromosome. The bsrE gene encoding a 30-amino acid hydrophobic toxin and the antitoxin gene sr5 overlap at their 3' ends by 112 bp. Overexpression of bsrE causes cell lysis on agar plates. Here, we present a detailed in vitro analysis of bsrE/SR5. The secondary structures of SR5, bsrE mRNA, and the SR5/bsrE RNA complex were determined. Apparent binding rate constants (kappa(app)) of wild-type and mutated SR5 species with wild-type bsrE mRNA were calculated, and SR5 regions required for efficient inhibition of bsrE mRNA narrowed down. In vivo studies confirmed the in vitro data but indicated that a so far unknown RNA binding protein might exist in B. subtilis that can promote antitoxin/toxin RNA interaction. Using time course experiments, the binding pathway of SR5 and bsrE RNA was elucidated. A comparison with the previously well characterized type I TA system from the B. subtilis chromosome, bsrG/SR4, reveals similarities but also significant differences.	[Meissner, Christin; Jahn, Natalie; Brantl, Sabine] Univ Jena, AG Bakteriengenet, Lehrstuhl Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Brantl, S (corresponding author), Univ Jena, AG Bakteriengenet, Philosophenweg 12, D-07743 Jena, Germany.	Sabine.Brantl@rz.uni-jena.de			Deutsche Forschungsgemeinschaft [BR1552/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant BR1552/10-1 from the Deutsche Forschungsgemeinschaft (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Brantl S, 2015, FEMS MICROBIOL REV, V39, P413, DOI 10.1093/femsre/fuv003; Brantl S, 2014, RNA BIOL, V11, P443, DOI 10.4161/rna.28036; Brantl S, 2012, RNA BIOL, V9, P1488, DOI 10.4161/rna.23045; Brantl S, 2012, FUTURE MICROBIOL, V7, P853, DOI [10.2217/FMB.12.59, 10.2217/fmb.12.59]; Brantl S, 2009, FUTURE MICROBIOL, V4, P85, DOI 10.2217/17460913.4.1.85; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Durand S, 2012, RNA BIOL, V9, P1491, DOI 10.4161/rna.22358; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003181; Fozo EM, 2012, RNA BIOL, V9, P1504, DOI 10.4161/rna.22568; Franch T, 2000, CURR OPIN MICROBIOL, V3, P159, DOI 10.1016/S1369-5274(00)00069-2; Franch T, 1999, J MOL BIOL, V294, P1115, DOI 10.1006/jmbi.1999.3306; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Greenfield TJ, 2001, MOL MICROBIOL, V42, P527, DOI 10.1046/j.1365-2958.2001.02663.x; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Gurnev PA, 2012, FEBS LETT, V586, P2529, DOI 10.1016/j.febslet.2012.06.021; Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292; Heidrich N, 2003, J MOL BIOL, V333, P917, DOI 10.1016/j.jmb.2003.09.020; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2007, MICROBIOL-SGM, V153, P420, DOI 10.1099/mic.0.2006/002329-0; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jahn N, 2015, MOL MICROBIOL, V98, P651, DOI 10.1111/mmi.13146; Jahn N, 2013, NUCLEIC ACIDS RES, V41, P9870, DOI 10.1093/nar/gkt735; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jorgensen MG, 2013, GENE DEV, V27, P1132, DOI 10.1101/gad.214734.113; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kawano M, 2012, RNA BIOL, V9, P1520, DOI 10.4161/rna.22757; Kolb FA, 2000, EMBO J, V19, P5905, DOI 10.1093/emboj/19.21.5905; Koyanagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054291; Kwong SM, 2015, PLASMID, V78, P17, DOI 10.1016/j.plasmid.2015.01.002; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shokeen S, 2010, PLASMID, V64, P26, DOI 10.1016/j.plasmid.2010.03.002; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; THISTED T, 1994, EMBO J, V13, P1960, DOI 10.1002/j.1460-2075.1994.tb06465.x; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Wagner EGH, 2012, RNA BIOL, V9, P1513, DOI 10.4161/rna.22578; Weaver KE, 2004, J BACTERIOL, V186, P6400, DOI 10.1128/JB.186.19.6400-6408.2004; Weaver KE, 2015, PLASMID, V78, P65, DOI 10.1016/j.plasmid.2014.10.001; Weaver KE, 2012, RNA BIOL, V9, P1498, DOI 10.4161/rna.22311; Weel-Sneve R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003260; Wen J, 2014, NUCLEIC ACIDS RES, V42, P1930, DOI 10.1093/nar/gkt1018	53	11	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					560	571		10.1074/jbc.M115.697524	http://dx.doi.org/10.1074/jbc.M115.697524			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565032	hybrid, Green Published			2022-12-28	WOS:000367830500005
J	Xie, LL; Wartchow, C; Shia, S; Uehara, K; Steffek, M; Warne, R; Sutton, J; Muiru, GT; Leonard, VHJ; Bussiere, DE; Ma, XL				Xie, Lili; Wartchow, Charles; Shia, Steven; Uehara, Kyoko; Steffek, Micah; Warne, Robert; Sutton, James; Muiru, Gladys T.; Leonard, Vincent H. J.; Bussiere, Dirksen E.; Ma, Xiaolei			Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; crystal structure; influenza virus; isothermal titration calorimetry (ITC); ligand-binding protein; DSF; PB2; cap-binding domain; mRNA cap analog	VIRUS POLYMERASE; CRYSTAL-STRUCTURE; A VIRUS; BINDING; TRANSCRIPTION; ENDONUCLEASE; SOFTWARE; PROTEINS; REVEALS; PRIMERS	Influenza virus polymerase catalyzes the transcription of viral mRNAs by a process known as cap-snatching, where the 5-cap of cellular pre-mRNA is recognized by the PB2 subunit and cleaved 10-13 nucleotides downstream of the cap by the endonuclease PA subunit. Although this mechanism is common to both influenza A (FluA) and influenza B (FluB) viruses, FluB PB2 recognizes a wider range of cap structures including m(7)GpppGm-, m(7)GpppG-, and GpppG-RNA, whereas FluA PB2 utilizes methylated G-capped RNA specifically. Biophysical studies with isolated PB2 cap-binding domain (PB2(cap)) confirm that FluB PB2 has expanded mRNA cap recognition capability, although the affinities toward m(7)GTP are significantly reduced when compared with FluA PB2. The x-ray co-structures of the FluB PB2(cap) with bound cap analogs m(7)GTP and GTP reveal an inverted GTP binding mode that is distinct from the cognate m(7)GTP binding mode shared between FluA and FluB PB2. These results delineate the commonalities and differences in the cap-binding site between FluA and FluB PB2 and will aid structure-guided drug design efforts to identify dual inhibitors of both FluA and FluB PB2.	[Xie, Lili; Uehara, Kyoko] Novartis Inst BioMed Res, Div Prot Sci, Emeryville, CA 94608 USA; [Wartchow, Charles; Shia, Steven; Steffek, Micah; Bussiere, Dirksen E.; Ma, Xiaolei] Novartis Inst BioMed Res, Div Struct & Biophys Chem, Global Discovery Chem, Emeryville, CA 94608 USA; [Warne, Robert] Novartis Inst BioMed Res, Div Virol Lead Discovery, Emeryville, CA 94608 USA; [Sutton, James] Novartis Inst BioMed Res, Div Global Discovery Chem, Emeryville, CA 94608 USA; [Muiru, Gladys T.; Leonard, Vincent H. J.] Novartis Inst BioMed Res, Div Virol, Emeryville, CA 94608 USA	Novartis; Novartis; Novartis; Novartis; Novartis	Ma, XL (corresponding author), Novartis Inst BioMed Res, Struct & Biophys Chem, 5300 Chiron Way, Emeryville, CA 94608 USA.	xiaolei.ma@novartis.com	Wartchow, Charles A./W-4985-2019	Ma, Xiaolei/0000-0002-5307-827X; Wartchow, Charles/0000-0002-0123-1455				BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Byrn RA, 2015, ANTIMICROB AGENTS CH, V59, P1574, DOI 10.1128/AAC.04623-14; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Liu Y, 2015, J BIOL CHEM, V290, P9141, DOI 10.1074/jbc.M115.636464; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Tsurumura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082020; Wakai C, 2011, J VIROL, V85, P7504, DOI 10.1128/JVI.02375-10; Worch R, 2008, PROTEINS, V71, P2026, DOI 10.1002/prot.21882; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	27	12	13	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					363	370		10.1074/jbc.M115.693051	http://dx.doi.org/10.1074/jbc.M115.693051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559973	Green Published, hybrid			2022-12-28	WOS:000367589500029
J	Brandstetter, C; Holz, FG; Krohne, TU				Brandstetter, Carolina; Holz, Frank G.; Krohne, Tim U.			Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflamrnasome Activation by Lipofuscin-mediated Photooxidative Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NLRP3 INFLAMMASOME ACTIVATION; MACULAR DEGENERATION; ENDOTHELIAL-CELLS; ARPE-19; DRUSEN; RELEASE; C3A	Complement activation, oxidative damage, and activation of the NLRP3 inflammasome have been implicated in retinal pigment epithelium (RPE) pathology in age-related macular degeneration (AMD). Following priming of RPE cells, the NLRP3 inflammasome can be activated by various stimuli such as lipofuscin-mediated photooxidative damage to lysosomal membranes. We investigated whether products of complement activation are capable of providing the priming signal for inflammasome activation in RPE cells. We found that incubation of primary human RPE cells and ARPE-19 cells with complement-competent human serum resulted in up-regulation of C5a receptor, but not C3a receptor. Furthermore, human serum induced expression of pro-IL-1 beta and enabled IL-1 beta secretion in response to lipoluscin phototoxicity, thus indicating inflammasome priming. Complement heat-inactivation, C5 depletion, and C5a receptor inhibition suppressed the priming effect of human serum whereas recombinant C5a likewise induced priming. Conditioned medium of inflammasome-activated RPE cells provided an additional priming effect that was mediated by the IL-1 receptor. These results identify complement activation product C5a as a priming signal for RPE cells that allows for subsequent inflammasome activation by stimuli such as lipofuscin-mediated photooxidative damage. This molecular pathway provides a functional link between key factors of AMD pathogenesis including lipofuscin accumulation, photooxidative damage, complement activation, and RPE degeneration and may provide novel therapeutic targets in this disease.	[Brandstetter, Carolina; Holz, Frank G.; Krohne, Tim U.] Univ Bonn, Dept Ophthalmol, D-53127 Bonn, Germany	University of Bonn	Krohne, TU (corresponding author), Univ Bonn, Dept Ophthalmol, Ernst Abbe Str 2, D-53127 Bonn, Germany.	krohne@uni-bonn.de	Krohne, Tim/D-1497-2013; Krohne, Tim/AAG-4412-2020	Krohne, Tim/0000-0003-2280-925X; 	German Research Foundation (DFG), Bonn, Germany [KR 2863/7-1]; Pro Retina Foundation, Bonn, Germany; University of Bonn, BONFOR and SciMed Programs, Bonn, Germany; Acucela; Alcon; Allergan; Bayer; Carl Zeiss Meditec; Genentech; Heidelberg Engineering; Novartis; Optos; Roche	German Research Foundation (DFG), Bonn, Germany(German Research Foundation (DFG)); Pro Retina Foundation, Bonn, Germany; University of Bonn, BONFOR and SciMed Programs, Bonn, Germany; Acucela; Alcon(Novartis); Allergan(AbbVieAllergan); Bayer(Bayer AG); Carl Zeiss Meditec; Genentech(Roche HoldingGenentech); Heidelberg Engineering; Novartis(Novartis); Optos; Roche(Roche Holding)	The study was supported by German Research Foundation (DFG), Bonn, Germany, Grant KR 2863/7-1; Pro Retina Foundation, Bonn, Germany; University of Bonn, BONFOR and SciMed Programs, Bonn, Germany; and Dr. Eberhard and Hilde Rudiger Foundation, Bonn, Germany (all to T. U. K.). The paper was presented at the 2014 annual meeting of the Association of Research in Vision and Ophthalmology (ARVO) in Orlando, FL (Brandstetter, C., Holz, F. G., Krohne, T.U. (2014) Complement Component C5a Primes the NLRP3 Inflammasome in Retinal Pigment Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 55: [-Abstract 3444). Conflict of interest: CB, none. FGH, research grants: Acucela, Alcon, Allergan, Bayer, Carl Zeiss Meditec, Genentech, Heidelberg Engineering, Novartis, Optos; consultancy honoraria, lecture fees, travel grants: Acucela, Alcon, Allergan, Bayer, Genentech, Heidelberg Engineering, Novartis, Roche. TUK, research grants: Alcon, Novartis; consultancy honoraria, lecture fees, travel grants: Bayer, Heidelberg Engineering, Novartis.	An LL, 2014, EUR J IMMUNOL, V44, P3669, DOI 10.1002/eji.201444560; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Brandstetter C, 2015, J MOL MED, V93, P905, DOI 10.1007/s00109-015-1275-1; Cao SJ, 2013, AM J OPHTHALMOL, V156, P1176, DOI 10.1016/j.ajo.2013.08.003; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cortright DN, 2009, CURR EYE RES, V34, P57, DOI 10.1080/02713680802546658; Davies S, 2001, FREE RADICAL BIO MED, V31, P256, DOI 10.1016/S0891-5849(01)00582-2; Doyle SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007616; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Hu MJ, 2011, BRIT J OPHTHALMOL, V95, P1738, DOI 10.1136/bjophthalmol-2011-300235; Ijima R, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15367; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Krohne TU, 2010, EXP EYE RES, V90, P465, DOI 10.1016/j.exer.2009.12.011; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu RZT, 2014, EXP EYE RES, V127, P49, DOI 10.1016/j.exer.2014.07.003; Mohr LKM, 2015, INVEST OPHTH VIS SCI, V56, P6404, DOI 10.1167/iovs.15-16898; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Saeed AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106421; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Skeie JM, 2010, INVEST OPHTH VIS SCI, V51, P5336, DOI 10.1167/iovs.10-5322; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Zhao M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125150	38	48	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31189	31198		10.1074/jbc.M115.671180	http://dx.doi.org/10.1074/jbc.M115.671180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26565031	hybrid, Green Published			2022-12-28	WOS:000367199000045
J	Zheng, LS; Khemlani, A; Lorenz, N; Loh, JMS; Langley, RJ; Proft, T				Zheng, Lisa; Khemlani, Adrina; Lorenz, Natalie; Loh, Jacelyn M. S.; Langley, Ries J.; Proft, Thomas			Streptococcal 5 '-Nucleotidase A (S5nA), a Novel Streptococcus pyogenes Virulence Factor That Facilitates Immune Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; ACUTE RHEUMATIC-FEVER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN CD73; ADENOSINE; MACROPHAGES; INVOLVEMENT; GENERATION; NUCLEASE	Streptococcus pyogenes is an important human pathogen that causes a wide range of diseases. Using bioinformatics analysis of the complete S. pyogenes strain SF370 genome, we have identified a novel S. pyogenes virulence factor, which we termed streptococcal 5'-nucleotidaseA(S5nA). A recombinant form of S5nA hydrolyzed AMP and ADP, but not ATP, to generate the immunomodulatory molecule adenosine. Michaelis-Menten kinetics revealed a K-m of 169 mu M and a V-max of 7550 nmol/mg/min for the substrate AMP. Furthermore, recombinant S5nA acted synergistically with S. pyogenes nuclease A to generate macrophagetoxic deoxyadenosine from DNA. The enzyme showed optimal activity between pH5 and pH6.5 and between 37 and 47 degrees C. Like other 5'-nucleotidases, S5nA requires divalent cations and was active in the presence of Mg2+, Ca2+, or Mn2+. However, Zn2+ inhibited the enzymatic activity. Structural modeling combined with mutational analysis revealed a highly conserved catalytic dyad as well as conserved substrate and cation-binding sites. Recombinant S5nA significantly increased the survival of the non-pathogenic bacterium Lactococcus lactis during a human whole blood killing assay in a dose-dependent manner, suggesting a role as an S. pyogenes virulence factor. In conclusion, we have identified a novel S. pyogenes enzyme with 5'-nucleotidase activity and immune evasion properties.	[Zheng, Lisa; Khemlani, Adrina; Lorenz, Natalie; Loh, Jacelyn M. S.; Langley, Ries J.; Proft, Thomas] Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Lorenz, Natalie; Loh, Jacelyn M. S.; Langley, Ries J.; Proft, Thomas] Univ Auckland, Maurice Wilkins Ctr, Auckland 1, New Zealand	University of Auckland; University of Auckland	Proft, T (corresponding author), Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland Mail Ctr, Private Bag 92019, Auckland 1, New Zealand.	t.proft@auckland.ac.nz	Lorenz, Natalie/J-9241-2019; Proft, Thomas/H-4686-2019	Lorenz, Natalie/0000-0002-5480-1714; Proft, Thomas/0000-0002-9275-5042; Langley, Ries/0000-0001-8606-2197; Jethanand-Khemlani, Adrina Hema/0000-0003-3015-090X	Faculty Research Development Fund from the Faculty of Medical and Health Sciences, University of Auckland; Health Research Council New Zealand	Faculty Research Development Fund from the Faculty of Medical and Health Sciences, University of Auckland; Health Research Council New Zealand(Health Research Council of New Zealand)	This work was supported by a research grant from the Faculty Research Development Fund from the Faculty of Medical and Health Sciences, University of Auckland. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Health Research Council New Zealand.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bouma MG, 1997, J IMMUNOL, V158, P5400; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chang A, 2011, MOL MICROBIOL, V79, P1629, DOI 10.1111/j.1365-2958.2011.07550.x; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; EDWARDS CK, 1994, J LEUKOCYTE BIOL, V56, P133, DOI 10.1002/jlb.56.2.133; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Firon A, 2014, J BIOL CHEM, V289, P5479, DOI 10.1074/jbc.M113.545632; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gorini S, 2013, AM J BLOOD RES, V3, P14; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Heuts DPHM, 2012, CHEMBIOCHEM, V13, P2384, DOI 10.1002/cbic.201200426; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Liu P, 2014, J INFECT DIS, V210, P35, DOI 10.1093/infdis/jiu050; Lorenz N, 2013, IMMUNOL CELL BIOL, V91, P469, DOI 10.1038/icb.2013.28; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; NEU HC, 1967, J BIOL CHEM, V242, P3905; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Taylor AR, 2013, PRIMARY CARE, V40, P637, DOI 10.1016/j.pop.2013.06.002; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Xaus J, 1999, J IMMUNOL, V162, P3607; XU B, 1994, BIOL TRACE ELEM RES, V40, P49, DOI 10.1007/BF02916820; Yang L, 2005, J CLIN MICROBIOL, V43, P3570, DOI 10.1128/JCM.43.7.3570-3573.2005	42	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31126	31137		10.1074/jbc.M115.677443	http://dx.doi.org/10.1074/jbc.M115.677443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527680	Green Published, hybrid			2022-12-28	WOS:000367199000040
J	Jansen, RS; Mahakena, S; de Haas, M; Borst, P; van de Wetering, K				Jansen, Robert S.; Mahakena, Sunny; de Haas, Marcel; Borst, Piet; van de Wetering, Koen			ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; CITRYL-L-GLUTAMATE; CENTRAL-NERVOUS-SYSTEM; LENS EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; N-ACETYLASPARTYLGLUTAMATE; CARBOXYPEPTIDASE II; RAT-BRAIN; MOLECULAR-IDENTIFICATION; PEPTIDE NEUROTRANSMITTER	The ubiquitous efflux transporter ABCC5 (ATP-binding cassette subfamily C member 5) is present at high levels in the blood-brain barrier, neurons, and glia, but its in vivo substrates and function are not known. Using untargeted metabolomic screens, we show that Abcc5(-/-) mice accumulate endogenous glutamate conjugates in several tissues, but brain in particular. The abundant neurotransmitter N-acetylaspartylglutamate was 2.4-fold higher in Abcc5(-/-) brain. The metabolites that accumulated in Abcc5(-/-) tissues were depleted in cultured cells that overexpressed human ABCC5. In a vesicular membrane transport assay, ABCC5 also transported exogenous glutamate analogs, like the classic excitotoxic neurotoxins kainic acid, domoic acid, and NMDA; the therapeutic glutamate analog ZJ43; and, as previously shown, the anti-cancer drug methotrexate. Glutamate conjugates and analogs are of physiological relevance because they can affect the function of glutamate, the principal excitatory neurotransmitter in the brain. After CO2 asphyxiation, several immediate early genes were expressed at lower levels in Abcc5(-/-) brains than in wild type brains, suggesting altered glutamate signaling. Our results show that ABCC5 is a general glutamate conjugate and analog transporter that affects the disposition of endogenous metabolites, toxins, and drugs.	[Jansen, Robert S.; Mahakena, Sunny; de Haas, Marcel; Borst, Piet; van de Wetering, Koen] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	van de Wetering, K (corresponding author), Div Mol Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.vd.wetering@nki.nl	Jansen, Robert/AAR-1318-2021	Jansen, Robert/0000-0001-9612-2798				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashraf Tamima, 2014, Adv Pharmacol, V71, P45, DOI 10.1016/bs.apha.2014.06.010; Belinsky MG, 1998, J NATL CANCER I, V90, P1735, DOI 10.1093/jnci/90.22.1735; Berger M L, 1986, Adv Exp Med Biol, V203, P199; Bergeron R, 2012, CURR MED CHEM, V19, P1360, DOI 10.2174/092986712799462685; Bocker S, 2009, BIOINFORMATICS, V25, P218, DOI 10.1093/bioinformatics/btn603; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Collard F, 2011, J BIOL CHEM, V286, P38220, DOI 10.1074/jbc.M111.287318; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Dallas S, 2006, PHARMACOL REV, V58, P140, DOI 10.1124/pr.58.2.3; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Wolf CJF, 2007, FEBS J, V274, P439, DOI 10.1111/j.1742-4658.2006.05591.x; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Garcia-Cairasco N, 2013, ANGEW CHEM INT EDIT, V52, P13067, DOI 10.1002/anie.201305382; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hamada-Kanazawa M, 2013, BIOL PHARM BULL, V36, P1068, DOI 10.1248/bpb.b12-00991; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; Han LQ, 2009, SYNAPSE, V63, P625, DOI 10.1002/syn.20649; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Jansen RS, 2015, P NATL ACAD SCI USA, V112, P6601, DOI 10.1073/pnas.1424638112; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; Kool M, 1997, CANCER RES, V57, P3537; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; KROGSGAARDLARSEN P, 1992, TOXICOL LETT, V64-5, P409, DOI 10.1016/0378-4274(92)90214-5; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerea LS, 1997, CELL SIGNAL, V9, P219, DOI 10.1016/S0898-6568(96)00134-9; Lodder-Gadaczek J, 2013, BIOCHEM J, V454, P31, DOI 10.1042/BJ20130300; Lodder-Gadaczek J, 2011, J BIOL CHEM, V286, P16693, DOI 10.1074/jbc.M111.230136; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; McAleer MA, 1999, J BIOL CHEM, V274, P23541, DOI 10.1074/jbc.274.33.23541; MIYAKE M, 1982, BIOCHIM BIOPHYS ACTA, V719, P495, DOI 10.1016/0304-4165(82)90238-0; MIYAKE M, 1992, J NEUROCHEM, V59, P1654, DOI 10.1111/j.1471-4159.1992.tb10995.x; MIYAKE M, 1978, BIOCHIM BIOPHYS ACTA, V544, P656, DOI 10.1016/0304-4165(78)90340-9; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Mourskaia AA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3361; Narahara M, 2000, BIOL PHARM BULL, V23, P704; Narahara M, 2010, BIOL PHARM BULL, V33, P1938, DOI 10.1248/bpb.33.1938; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; OLNEY JW, 1994, NEUROTOXICOLOGY, V15, P535; Patti GJ, 2012, NAT PROTOC, V7, P508, DOI 10.1038/nprot.2011.454; Plechanovova A, 2011, J MED CHEM, V54, P7535, DOI 10.1021/jm200807m; PRESTON E, 1991, CAN J NEUROL SCI, V18, P39, DOI 10.1017/S0317167100031279; Rasche F, 2011, ANAL CHEM, V83, P1243, DOI 10.1021/ac101825k; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Rowland LM, 2013, SCHIZOPHRENIA BULL, V39, P1096, DOI 10.1093/schbul/sbs092; Sacha P, 2007, NEUROSCIENCE, V144, P1361, DOI 10.1016/j.neuroscience.2006.10.022; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soontornmalai A, 2006, NEUROSCIENCE, V138, P159, DOI 10.1016/j.neuroscience.2005.11.011; Soriano MA, 2000, J CEREBR BLOOD F MET, V20, P1045, DOI 10.1097/00004647-200007000-00004; Stone TW, 1998, ADV EXP MED BIOL, V431, P185; Tautenhahn R, 2011, ANAL CHEM, V83, P696, DOI 10.1021/ac102980g; TSUMORI M, 1995, EXP EYE RES, V61, P403, DOI 10.1016/S0014-4835(05)80135-6; van de Wetering K, 2007, MOL PHARMACOL, V72, P387, DOI 10.1124/mol.107.035592; van de Wetering K, 2012, FASEB J, V26, P4014, DOI 10.1096/fj.12-210039; Van De Wetering K, 2009, GASTROENTEROLOGY, V137, P1725, DOI 10.1053/j.gastro.2009.06.052; VandenBerghe G, 1997, J INHERIT METAB DIS, V20, P193, DOI 10.1023/A:1005304722259; Wielinga P, 2005, CANCER RES, V65, P4425, DOI 10.1158/0008-5472.CAN-04-2810; Wijnholds J, 2000, P NATL ACAD SCI USA, V97, P7476, DOI 10.1073/pnas.120159197; WILLIAMSON LC, 1988, BRAIN RES, V475, P151, DOI 10.1016/0006-8993(88)90209-0; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zhang Y, 2004, J PHARMACOL EXP THER, V311, P449, DOI 10.1124/jpet.104.068528; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903; Zikanova M, 2005, J INHERIT METAB DIS, V28, P493, DOI 10.1007/s10545-005-0493-z; Zuo DY, 2012, J BIOL CHEM, V287, P21773, DOI 10.1074/jbc.M112.363226	77	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30429	30440		10.1074/jbc.M115.692103	http://dx.doi.org/10.1074/jbc.M115.692103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26515061	Green Published, hybrid			2022-12-28	WOS:000366738200020
J	Sui, XW; Golczak, M; Zhang, JY; Kleinberg, KA; von Lintig, J; Palczewski, K; Kiser, PD				Sui, Xuewu; Golczak, Marcin; Zhang, Jianye; Kleinberg, Katie A.; von Lintig, Johannes; Palczewski, Krzysztof; Kiser, Philip D.			Utilization of Dioxygen by Carotenoid Cleavage Oxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL CYCLE; RETINOID ISOMERASE; WEB SERVER; RPE65; SEQUENCE; ENZYME; ISOMERIZATION; MECHANISM; ISOMEROHYDROLASE; SPECIFICITY	Carotenoid cleavage oxygenases (CCOs) are non-heme, Fe(II)-dependent enzymes that participate in biologically important metabolic pathways involving carotenoids and apocarotenoids, including retinoids, stilbenes, and related compounds. CCOs typically catalyze the cleavage of non-aromatic double bonds by dioxygen (O-2) to form aldehyde or ketone products. Expressed only in vertebrates, the RPE65 sub-group of CCOs catalyzes a non-canonical reaction consisting of concerted ester cleavage and trans-cis isomerization of all-trans-retinyl esters. It remains unclear whether the former group of CCOs functions as mono-or di-oxygenases. Additionally, a potential role for O-2 in catalysis by the RPE65 group of CCOs has not been evaluated to date. Here, we investigated the pattern of oxygen incorporation into apocarotenoid products of Synechocystis apocarotenoid oxygenase. Reactions performed in the presence of O-18-labeled water and O-18(2) revealed an unambiguous dioxygenase pattern of O-2 incorporation into the reaction products. Substitution of Ala for Thr at position 136 of apocarotenoid oxygenase, a site predicted to govern the mono-versus dioxygenase tendency of CCOs, greatly reduced enzymatic activity without altering the dioxygenase labeling pattern. Reevaluation of the oxygen-labeling pattern of the resveratrol-cleaving CCO, NOV2, previously reported to be a monooxygenase, using a purified enzyme sample revealed that it too is a dioxygenase. We also demonstrated that bovine RPE65 is not dependent on O-2 for its cleavage/isomerase activity. In conjunction with prior research, the results of this study resolve key issues regarding the utilization of O-2 by CCOs and indicate that dioxygenase activity is a feature common among double bond-cleaving CCOs.	[Sui, Xuewu; Golczak, Marcin; Zhang, Jianye; Kleinberg, Katie A.; von Lintig, Johannes; Palczewski, Krzysztof; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; pdk7@case.edu	Regan, Clinton/E-6250-2012	von Lintig, Johannes/0000-0002-2079-2143	Department of Veterans Affairs Career Development Award [IK2BX002683]; National Institutes of Health [EY009339, EY023948, EY020551]; NCRR [GM103403]; NATIONAL EYE INSTITUTE [R01EY009339, R01EY023948, R01EY020551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Career Development Award IK2BX002683 (to P. D. K.) and National Institutes of Health Grants EY009339 (to K. P.), EY023948 (to M. G.), and EY020551 (to K. P. and J. v. L.). A portion of this work is based upon research conducted at the Advanced Photon National Institutes of Health Grant GM103403 from the NCRR. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albalat R, 2012, MOL BIOL EVOL, V29, P1461, DOI 10.1093/molbev/msr313; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Brefort T, 2011, FUNGAL GENET BIOL, V48, P132, DOI 10.1016/j.fgb.2010.10.009; BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; dela Sena C, 2014, J BIOL CHEM, V289, P13661, DOI 10.1074/jbc.M114.557710; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Marasco EK, 2008, CHEMBIOCHEM, V9, P1450, DOI 10.1002/cbic.200700724; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mutti FG, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/626909; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Poliakov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049975; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ryu JY, 2013, BIOSCI BIOTECH BIOCH, V77, P289, DOI 10.1271/bbb.120715; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012	46	39	42	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30212	30223		10.1074/jbc.M115.696799	http://dx.doi.org/10.1074/jbc.M115.696799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26499794	hybrid, Green Published			2022-12-28	WOS:000366738200002
J	Hidvegi, T; Stolz, DB; Alcorn, JF; Yousem, SA; Wang, JR; Leme, AS; Houghton, AM; Hale, P; Ewing, M; Cai, HM; Garchar, EA; Pastore, N; Annunziata, P; Kaminski, N; Pilewski, J; Shapiro, SD; Pak, SC; Silverman, GA; Brunetti-Pierri, N; Perlmutter, DH				Hidvegi, Tunda; Stolz, Donna B.; Alcorn, John F.; Yousem, Samuel A.; Wang, Jieru; Leme, Adriana S.; Houghton, A. McGarry; Hale, Pamela; Ewing, Michael; Cai, Houming; Garchar, Evelyn Akpadock; Pastore, Nunzia; Annunziata, Patrizia; Kaminski, Naftali; Pilewski, Joseph; Shapiro, Steven D.; Pak, Stephen C.; Silverman, Gary A.; Brunetti-Pierri, Nicola; Perlmutter, David H.			Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; IDIOPATHIC PULMONARY-FIBROSIS; DEPENDENT ADENOVIRAL VECTORS; HERMANSKY-PUDLAK-SYNDROME; ALPHA(1)-ANTITRYPSIN DEFICIENCY; ALPHA-1-ANTITRYPSIN DEFICIENCY; TRANSGENIC MICE; MUTANT ALPHA(1)-ANTITRYPSIN-Z; MESENCHYMAL TRANSITION; STEM-CELLS	Recent studies have shown that autophagy mitigates the pathological effects of proteinopathies in the liver, heart, and skeletal muscle but this has not been investigated for proteinopathies that affect the lung. This may be due at least in part to the lack of an animal model robust enough for spontaneous pathological effects from proteinopathies even though several rare proteinopathies, surfactant protein A and C deficiencies, cause severe pulmonary fibrosis. In this report we show that the PiZ mouse, transgenic for the common misfolded variant alpha 1-antitrypsin Z, is a model of respiratory epithelial cell proteinopathy with spontaneous pulmonary fibrosis. Intracellular accumulation of misfolded alpha 1-antitrypsin Z in respiratory epithelial cells of the PiZ model resulted in activation of autophagy, leukocyte infiltration, and spontaneous pulmonary fibrosis severe enough to elicit functional restrictive deficits. Treatment with autophagy enhancer drugs or lung-directed gene transfer of TFEB, a master transcriptional activator of the autophagolysosomal system, reversed these proteotoxic consequences. We conclude that this mouse is an excellent model of respiratory epithelial proteinopathy with spontaneous pulmonary fibrosis and that autophagy is an important endogenous proteostasis mechanism and an attractive target for therapy.	[Hidvegi, Tunda; Alcorn, John F.; Wang, Jieru; Hale, Pamela; Ewing, Michael; Cai, Houming; Garchar, Evelyn Akpadock; Pak, Stephen C.; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Leme, Adriana S.; Houghton, A. McGarry; Kaminski, Naftali; Pilewski, Joseph; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15224 USA; [Stolz, Donna B.; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15224 USA; [Yousem, Samuel A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15224 USA; [Hidvegi, Tunda; Alcorn, John F.; Hale, Pamela; Ewing, Michael; Cai, Houming; Garchar, Evelyn Akpadock; Pak, Stephen C.; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Brunetti-Pierri, Nicola] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Pastore, Nunzia; Annunziata, Patrizia; Brunetti-Pierri, Nicola] Univ Naples Federico II, Dept Translat Med, I-80138 Naples, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II	Perlmutter, DH (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, UPMC Suite 5300,Adm Off Bldg 4401 Penn Ave, Pittsburgh, PA 15224 USA.	david.perlmutter@chp.edu	Pilewski, Joseph/AAF-5149-2021; Silverman, Gary/AAJ-1269-2020; Pastore, Nunzia/Q-6665-2017; Regan, Clinton/E-6250-2012; Brunetti-Pierri, Nicola/K-8465-2016	Pastore, Nunzia/0000-0002-8701-5592; Pak, Stephen/0000-0002-8089-3237; Kaminski, Naftali/0000-0001-5917-4601; Brunetti-Pierri, Nicola/0000-0002-6895-8819	National Institutes of Health [HL037884, DK084512, DK096990, DK079806, HL113655, AI01953, P30DK072506]; Cystic Fibrosis Foundation [R883]; Telethon Foundation, Italy [TCBP37TELC, TCBMT3TELD]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108642, RC2HL101715, U01HL037884, R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, P01DK096990, R01DK084512, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Telethon Foundation, Italy(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL037884 (to D.H.P.), DK084512 (to D. H. P.), DK096990 (to D. H. P.), DK079806 (to G. A. S.), HL113655 (to J. W.), and AI01953 (to J. W.), P30DK072506 (to J. P.). This work was also supported by Cystic Fibrosis Foundation R883 (to J. P.) and Telethon Foundation, Italy TCBP37TELC and TCBMT3TELD (to N. B.-P). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Carey EJ, 2013, LIVER TRANSPLANT, V19, P1370, DOI 10.1002/lt.23744; CARLSON JA, 1988, J CLIN INVEST, V82, P26, DOI 10.1172/JCI113580; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Cichy J, 1997, J BIOL CHEM, V272, P8250, DOI 10.1074/jbc.272.13.8250; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; DeMaio L, 2012, J PATHOL, V226, P633, DOI 10.1002/path.3016; DeMeo DL, 2007, THORAX, V62, P806, DOI 10.1136/thx.2006.075846; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; Doppler K, 2009, NEUROMUSCULAR DISORD, V19, P406, DOI 10.1016/j.nmd.2009.04.011; Elliott PR, 1998, AM J RESP CELL MOL, V18, P670, DOI 10.1165/ajrcmb.18.5.3065; FULMER JD, 1977, J CLIN INVEST, V60, P595, DOI 10.1172/JCI108811; Gotzsche PC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007851.pub2; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2007, J BIOL CHEM, V282, P27769, DOI 10.1074/jbc.M704330200; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hu CB, 2002, AM J PHYSIOL-LUNG C, V282, pL757, DOI 10.1152/ajplung.00271.2001; HUBBARD RC, 1991, J CLIN INVEST, V88, P891, DOI 10.1172/JCI115391; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; King TE, 2011, NEW ENGL J MED, V364, P968, DOI 10.1056/NEJMe1013966; Koehler DR, 2006, GENE THER, V13, P773, DOI 10.1038/sj.gt.3302712; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; KOOPMAN P, 1989, GENE DEV, V3, P16, DOI 10.1101/gad.3.1.16; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087260; Long OS, 2014, HUM MOL GENET, V23, P5109, DOI 10.1093/hmg/ddu235; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Messier EM, 2012, EXP LUNG RES, V38, P363, DOI 10.3109/01902148.2012.713077; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mulgrew AT, 2004, CHEST, V125, P1952, DOI 10.1378/chest.125.5.1952; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; O'Donnell D. E., 2003, INTERSTITIAL LUNG DI, P54; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Pastore N, 2013, EMBO MOL MED, V5, P397, DOI 10.1002/emmm.201202046; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P795, DOI 10.1073/pnas.82.3.795; Piitulainen E, 2005, CHEST, V128, P2076, DOI 10.1378/chest.128.4.2076; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Puls F, 2013, J HEPATOL, V59, P626, DOI 10.1016/j.jhep.2013.05.018; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Strange C, 2006, RESPIRATION, V73, P185, DOI 10.1159/000088061; Suzuki M, 2010, HUM GENE THER, V21, P120, DOI 10.1089/hum.2009.096; Tafaleng EN, 2015, HEPATOLOGY, V62, P147, DOI 10.1002/hep.27753; Tanash HA, 2011, J HEART LUNG TRANSPL, V30, P1342, DOI 10.1016/j.healun.2011.07.003; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Tomashefski JF, 2004, HUM PATHOL, V35, P1452, DOI 10.1016/j.humpath.2004.08.013; Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086, DOI 10.1164/ajrccm.160.6.9706031; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Wencker M, 2001, CHEST, V119, P737, DOI 10.1378/chest.119.3.737; Woolhouse IS, 2002, THORAX, V57, P709, DOI 10.1136/thorax.57.8.709; Young LR, 2012, AM J RESP CRIT CARE, V186, P1014, DOI 10.1164/rccm.201207-1206OC; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC; Zhou ZH, 2005, AM J PATHOL, V166, P27, DOI 10.1016/S0002-9440(10)62229-8	73	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29742	29757		10.1074/jbc.M115.691253	http://dx.doi.org/10.1074/jbc.M115.691253			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26494620	Green Published, hybrid			2022-12-28	WOS:000366614700007
J	O'Neill, EC; Stevenson, CEM; Tantanarat, K; Latousakis, D; Donaldson, MI; Rejzek, M; Nepogodiev, SA; Limpaseni, T; Field, RA; Lawson, DM				O'Neill, Ellis C.; Stevenson, Clare E. M.; Tantanarat, Krit; Latousakis, Dimitrios; Donaldson, Matthew I.; Rejzek, Martin; Nepogodiev, Sergey A.; Limpaseni, Tipaporn; Field, Robert A.; Lawson, David M.			Structural Dissection of the Maltodextrin Disproportionation Cycle of the Arabidopsis Plastidial Disproportionating Enzyme 1 (DPE1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE; MOLECULAR-GRAPHICS; THERMUS-AQUATICUS; ESCHERICHIA-COLI; STARCH BREAKDOWN; DELIVERY-SYSTEM; AMYLOMALTASE; CYCLOAMYLOSE; ACARBOSE; RESOLUTION	The degradation of transitory starch in the chloroplast to provide fuel for the plant during the night requires a suite of enzymes that generate a series of short chain linear glucans. However, glucans of less than four glucose units are no longer substrates for these enzymes, whereas export from the plastid is only possible in the form of either maltose or glucose. In order to make use of maltotriose, which would otherwise accumulate, disproportionating enzyme 1 (DPE1; a 4-alpha-glucanotransferase) converts two molecules of maltotriose to a molecule of maltopentaose, which can now be acted on by the degradative enzymes, and one molecule of glucose that can be exported. We have determined the structure of the Arabidopsis plastidial DPE1 (AtDPE1), and, through ligand soaking experiments, we have trapped the enzyme in a variety of conformational states. AtDPE1 forms a homodimer with a deep, long, and open-ended active site canyon contained within each subunit. The canyon is divided into donor and acceptor sites with the catalytic residues at their junction; a number of loops around the active site adopt different conformations dependent on the occupancy of these sites. The "gate" is the most dynamic loop and appears to play a role in substrate capture, in particular in the binding of the acceptor molecule. Subtle changes in the configuration of the active site residues may prevent undesirable reactions or abortive hydrolysis of the covalently bound enzyme-substrate intermediate. Together, these observations allow us to delineate the complete AtDPE1 disproportionation cycle in structural terms.	[O'Neill, Ellis C.; Stevenson, Clare E. M.; Latousakis, Dimitrios; Donaldson, Matthew I.; Rejzek, Martin; Nepogodiev, Sergey A.; Field, Robert A.; Lawson, David M.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Tantanarat, Krit; Limpaseni, Tipaporn] Chulalongkorn Univ, Fac Sci, Dept Biochem, Starch & Cyclodextrin Res Unit, Bangkok 10330, Thailand	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Chulalongkorn University	Lawson, DM (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	david.lawson@jic.ac.uk	Latousakis, Dimitrios M/K-6269-2017; O'Neill, Ellis Charles/N-3805-2014	Latousakis, Dimitrios M/0000-0002-2472-9328; O'Neill, Ellis Charles/0000-0002-5941-2806; Field, Rob/0000-0001-8574-0275	Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism (MET) [BB/J004561/1]; John Innes Foundation; Integrated Innovation Academic Center through the Chulalongkorn University Centenary Academic Development Project; Chulalongkorn University Graduate School; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism (MET); John Innes Foundation; Integrated Innovation Academic Center through the Chulalongkorn University Centenary Academic Development Project; Chulalongkorn University Graduate School(Chulalongkorn University); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant on Understanding and Exploiting Metabolism (MET; BB/J004561/1), the John Innes Foundation, and the Integrated Innovation Academic Center through the Chulalongkorn University Centenary Academic Development Project. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral fellowship from Chulalongkorn University Graduate School. Present address: Dept. of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanuloke, Thailand.	Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Bresolin NS, 2006, PLANTA, V224, P20, DOI 10.1007/s00425-005-0187-7; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Davies GJ, 2005, ACTA CRYSTALLOGR D, V61, P190, DOI 10.1107/S0907444904027118; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fujii H, 2014, CANCER SCI, V105, P1616, DOI 10.1111/cas.12547; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geng P, 2008, ANAL CHEM, V80, P7554, DOI 10.1021/ac801117s; Geng P, 2008, CARBOHYD RES, V343, P470, DOI 10.1016/j.carres.2007.11.012; Hancock RD, 2000, J CHEM EDUC, V77, P988, DOI 10.1021/ed077p988; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaper T, 2005, APPL ENVIRON MICROB, V71, P5098, DOI 10.1128/AEM.71.9.5098-5106.2005; Kaur B, 2012, FOOD HYDROCOLLOID, V26, P398, DOI 10.1016/j.foodhyd.2011.02.016; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; LIN TP, 1988, PLANT PHYSIOL, V86, P260, DOI 10.1104/pp.86.1.260; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lyhne-Iversen L, 2006, ACTA CRYSTALLOGR F, V62, P849, DOI 10.1107/S174430910603096X; MacGregor EA, 2005, BIOLOGIA, V60, P5; Machida S, 2000, FEBS LETT, V486, P131, DOI 10.1016/S0014-5793(00)02258-4; Maurus R, 2008, BIOCHEMISTRY-US, V47, P3332, DOI 10.1021/bi701652t; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCranie EK, 2014, NAT PROD REP, V31, P1026, DOI 10.1039/c3np70128j; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill EC, 2014, CHEM SCI, V5, P341, DOI 10.1039/c3sc51829a; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Smirnova J., 2015, STARCH-STARKE, P239, DOI [DOI 10.1007/978-4-431-55495-0_7, 10.1007/978-4-431-55495-0_7]; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; Tagami T, 2013, BIOSCI BIOTECH BIOCH, V77, P312, DOI 10.1271/bbb.120732; Takaha T, 1996, J BIOL CHEM, V271, P2902, DOI 10.1074/jbc.271.6.2902; Tantanarat K, 2014, PROCESS BIOCHEM, V49, P84, DOI 10.1016/j.procbio.2013.10.009; Tantanarat K, 2012, CARBOHYD RES, V358, P12, DOI 10.1016/j.carres.2012.05.026; Toita S, 2010, BIOMACROMOLECULES, V11, P397, DOI 10.1021/bm901109z; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Weiss SC, 2015, J BIOL CHEM, V290, P21352, DOI 10.1074/jbc.M115.667337; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	58	14	14	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29834	29853		10.1074/jbc.M115.682245	http://dx.doi.org/10.1074/jbc.M115.682245			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26504082	hybrid, Green Published			2022-12-28	WOS:000366614700018
J	Tsujii, A; Miyamoto, Y; Moriyama, T; Tsuchiya, Y; Obuse, C; Mizuguchi, K; Oka, M; Yoneda, Y				Tsujii, Akira; Miyamoto, Yoichi; Moriyama, Tetsuji; Tsuchiya, Yuko; Obuse, Chikashi; Mizuguchi, Kenji; Oka, Masahiro; Yoneda, Yoshihiro			Retinoblastoma-binding Protein 4-regulated Classical Nuclear Transport Is Involved in Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-TARGETING COMPLEX; IMPORTIN-ALPHA; LOCALIZATION SIGNAL; STRUCTURAL BASIS; CHROMATIN MAINTENANCE; CELLS; DOMAIN; ORGANIZATION; RECOGNITION; EXPRESSION	Nucleocytoplasmic trafficking is a fundamental cellular process in eukaryotic cells. Here, we demonstrated that retinoblastoma-binding protein 4 (RBBP4) functions as a novel regulatory factor to increase the efficiency of importin alpha/beta-mediated nuclear import. RBBP4 accelerates the release of importin beta 1 from importin alpha via competitive binding to the importin beta-binding domain of importin alpha in the presence of RanGTP. Therefore, it facilitates importin alpha/beta-mediated nuclear import. We showed that the importin alpha/beta pathway is down-regulated in replicative senescent cells, concomitant with a decrease in RBBP4 level. Knockdown of RBBP4 caused both suppression of nuclear transport and induction of cellular senescence. This is the first report to identify a factor that competes with importin beta 1 to bind to importin alpha, and it demonstrates that the loss of this factor can trigger cellular senescence.	[Tsujii, Akira] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Oka, Masahiro; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biomed Innovat, Suita, Osaka 5650871, Japan; [Tsujii, Akira; Miyamoto, Yoichi; Moriyama, Tetsuji; Oka, Masahiro] Natl Inst Biomed Innovat Hlth & Nutr, Lab Nucl Transport Dynam, Ibaraki, Osaka 5670085, Japan; [Tsuchiya, Yuko; Mizuguchi, Kenji] Natl Inst Biomed Innovat Hlth & Nutr, Lab Bioinformat, Ibaraki, Osaka 5670085, Japan; [Yoneda, Yoshihiro] Natl Inst Biomed Innovat Hlth & Nutr, Ibaraki, Osaka 5670085, Japan; [Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan	Osaka University; Osaka University; Hokkaido University	Oka, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Ibaraki, Osaka 5670085, Japan.	moka@nibiohn.go.jp; y-yoneda@nibiohn.go.jp	Mizuguchi, Kenji/GVS-5857-2022; moriyama, tetsuji/ABE-4678-2020	Mizuguchi, Kenji/0000-0003-3021-7078; zhe si, sheng shan/0000-0001-8099-3716; Miyamoto, Yoichi/0000-0003-4016-1119	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by funding from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. Y. and M. O.), a Japan Society for the Promotion of Science grant-in-aid for research activity start-up (to Y. M.), a grant-in-aid for young scientists (B) (to T. M.), and a grant from the Takeda Science Foundation (to A. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; Bai J, 2014, CELL PROLIFERAT, V47, P211, DOI 10.1111/cpr.12103; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Busch A, 2009, EXP CELL RES, V315, P2373, DOI 10.1016/j.yexcr.2009.05.003; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Corpet A, 2014, CHROMOSOMA, V123, P423, DOI 10.1007/s00412-014-0469-6; David-Watine B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022423; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DiMauro T, 2009, AGING-US, V1, P182, DOI 10.18632/aging.100023; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Kim SY, 2010, BIOCHEM BIOPH RES CO, V391, P28, DOI 10.1016/j.bbrc.2009.10.154; Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199; Kimoto C, 2015, BBA-MOL CELL RES, V1853, P2676, DOI 10.1016/j.bbamcr.2015.07.017; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Miyamoto Y, 2012, BBA-GENE REGUL MECH, V1819, P616, DOI 10.1016/j.bbagrm.2012.01.015; Nagai M, 2013, BBA-GEN SUBJECTS, V1830, P2813, DOI 10.1016/j.bbagen.2012.11.001; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ogawa Y, 2012, TRAFFIC, V13, P934, DOI 10.1111/j.1600-0854.2012.01367.x; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Openo KP, 2000, EXP CELL RES, V255, P278, DOI 10.1006/excr.1999.4782; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Pegoraro G, 2009, AGING-US, V1, P1017, DOI 10.18632/aging.100106; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pujol G, 2002, BIOCHEM BIOPH RES CO, V294, P354, DOI 10.1016/S0006-291X(02)00492-8; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Sekimoto T, 2011, J BIOL CHEM, V286, P15126, DOI 10.1074/jbc.M110.213579; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umegaki-Arao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076416; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yasuhara N, 2013, DEV CELL, V26, P123, DOI 10.1016/j.devcel.2013.06.022; Zhang W, 2013, NAT STRUCT MOL BIOL, V20, P29, DOI 10.1038/nsmb.2446	60	21	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29375	29388		10.1074/jbc.M115.681908	http://dx.doi.org/10.1074/jbc.M115.681908			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26491019	Green Published, hybrid			2022-12-28	WOS:000366613400023
J	Helmich, KE; Pereira, JH; Gall, DL; Heins, RA; McAndrew, RP; Bingman, C; Deng, K; Holland, KC; Noguera, DR; Simmons, BA; Sale, KL; Ralph, J; Donohue, TJ; Adams, PD; Phillips, GN				Helmich, Kate E.; Pereira, Jose Henrique; Gall, Daniel L.; Heins, Richard A.; McAndrew, Ryan P.; Bingman, Craig; Deng, Kai; Holland, Keefe C.; Noguera, Daniel R.; Simmons, Blake A.; Sale, Kenneth L.; Ralph, John; Donohue, Timothy J.; Adams, Paul D.; Phillips, George N., Jr.			Structural Basis of Stereospecificity in the Bacterial Enzymatic Cleavage of beta-Aryl Ether Bonds in Lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme structure; lignin degradation; plant cell wall; protein structure; stereoselectivity; X-ray crystallography; structural enzymology	GLUTATHIONE-S-TRANSFERASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; DEGRADATION; REFINEMENT; EVOLUTION; SYSTEM; PHENIX; MUTAGENESIS; DIFFRACTION	Lignin is a combinatorial polymer comprising monoaromatic units that are linked via covalent bonds. Although lignin is a potential source of valuable aromatic chemicals, its recalcitrance to chemical or biological digestion presents major obstacles to both the production of second-generation biofuels and the generation of valuable coproducts from lignin's monoaromatic units. Degradation of lignin has been relatively well characterized in fungi, but it is less well understood in bacteria. A catabolic pathway for the enzymatic breakdown of aromatic oligomers linked via -aryl ether bonds typically found in lignin has been reported in the bacterium Sphingobium sp. SYK-6. Here, we present x-ray crystal structures and biochemical characterization of the glutathione-dependent -etherases, LigE and LigF, from this pathway. The crystal structures show that both enzymes belong to the canonical two-domain fold and glutathione binding site architecture of the glutathione S-transferase family. Mutagenesis of the conserved active site serine in both LigE and LigF shows that, whereas the enzymatic activity is reduced, this amino acid side chain is not absolutely essential for catalysis. The results include descriptions of cofactor binding sites, substrate binding sites, and catalytic mechanisms. Because -aryl ether bonds account for 50-70% of all interunit linkages in lignin, understanding the mechanism of enzymatic -aryl ether cleavage has significant potential for informing ongoing studies on the valorization of lignin.	[Helmich, Kate E.; Bingman, Craig; Ralph, John] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Helmich, Kate E.; Gall, Daniel L.; Noguera, Daniel R.; Ralph, John; Donohue, Timothy J.] Univ Wisconsin, Wisconsin Energy Inst, United States Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Pereira, Jose Henrique; Heins, Richard A.; McAndrew, Ryan P.; Deng, Kai; Holland, Keefe C.; Simmons, Blake A.; Sale, Kenneth L.; Adams, Paul D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Pereira, Jose Henrique; McAndrew, Ryan P.; Adams, Paul D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Gall, Daniel L.; Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Heins, Richard A.; Deng, Kai; Holland, Keefe C.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Biol & Engn Sci Ctr, Livermore, CA 94551 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley; Rice University	Donohue, TJ (corresponding author), Univ Wisconsin, Wisconsin Energy Inst, United States Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA.; Adams, PD (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Adams, PD (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.; Donohue, TJ (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Adams, PD (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Phillips, GN (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA.	tdonohue@bact.wisc.edu; pdadams@lbl.gov; georgep@rice.edu	Ralph, John/C-3161-2009; Simmons, Blake/N-6022-2016; Adams, Paul David/A-1977-2013	Ralph, John/0000-0002-6093-4521; Simmons, Blake/0000-0002-1332-1810; Adams, Paul David/0000-0001-9333-8219; Noguera, Daniel/0000-0003-0372-3063	NIGMS, National Institutes of Health (NIH); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NIH; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NCI; NIH [ACB-12002, AGM-12006, P41GM103399, S10RR027000]; NIGMS; University of Wisconsin (Madison, WI); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, U01GM098248, T32GM008349, R01GM109456] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin (Madison, WI); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the staff of the Berkeley Center for Structural Biology at the Advanced Light Source of Lawrence Berkeley National Laboratory. The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health (NIH). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. The Joint Bio-Energy Institute is supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through Grant DE-AC02-05CH11231. We thank Dr. Brian G. Fox and Dr. Christopher M. Bianchetti for helpful discussion and the NIH-funded Center for Eukaryotic Structural Genomics for general access to computers and equipment for the structural work. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of Life Sciences Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and by Michigan Technology Tri-Corridor Grant 085P1000817. Use of GM/CA@APS Sector 23 was supported by Federal funds NCI, NIH, Grant ACB-12002 and NIGMS, NIH, Grant AGM-12006. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by NIGMS, NIH, Grant P41GM103399. Small angle x-ray scattering studies were supported by funds from NIH Shared Instrumentation Grant S10RR027000 and the University of Wisconsin (Madison, WI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler E., 1957, TAPPI, V40, P294; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; Akiyama T, 2000, J WOOD SCI, V46, P414, DOI 10.1007/BF00776407; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Casalone E, 1998, FEBS LETT, V423, P122, DOI 10.1016/S0014-5793(98)00080-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DIRR H, 1994, J MOL BIOL, V243, P72, DOI 10.1006/jmbi.1994.1631; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2007, BIOCHEM J, V403, P267, DOI 10.1042/BJ20061707; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gall DL, 2014, J BIOL CHEM, V289, P8656, DOI 10.1074/jbc.M113.536250; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; JI XH, 1994, BIOCHEMISTRY-US, V33, P1043, DOI 10.1021/bi00171a002; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leonowicz A, 2001, J BASIC MICROB, V41, P185, DOI 10.1002/1521-4028(200107)41:3/4&lt;185::AID-JOBM185&gt;3.0.CO;2-T; Martinez AT, 2005, INT MICROBIOL, V8, P195; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mathieu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080298; Mathieu Y, 2012, J BIOL CHEM, V287, P39001, DOI 10.1074/jbc.M112.402776; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Mills N, 2006, J AM CHEM SOC, V128, P13649, DOI 10.1021/ja0697875; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picart P, 2015, GREEN CHEM, V17, P4931, DOI [10.1039/C5GC01078K, 10.1039/c5gc01078k]; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ralph J, 1999, J AGR FOOD CHEM, V47, P2991, DOI 10.1021/jf9901136; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reddy A. P., 2013, PLoS ONE, V8, pe77985, DOI 10.1371/journal.pone.0077985; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Simmons CW, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0180-0; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Sugimoto T, 2002, HOLZFORSCHUNG, V56, P416, DOI 10.1515/HF.2002.064; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thuillier Anne, 2011, Int J Evol Biol, V2011, P938308, DOI 10.4061/2011/938308; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; Yennamalli R, 2014, J APPL CRYSTALLOGR, V47, P1153, DOI 10.1107/S160057671400939X; Zhou HN, 2011, J BIOL CHEM, V286, P4271, DOI 10.1074/jbc.M110.197822	70	27	28	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5234	5246		10.1074/jbc.M115.694307	http://dx.doi.org/10.1074/jbc.M115.694307			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26637355	hybrid, Green Published			2022-12-28	WOS:000371640600034
J	Ji, QQ; Fang, ZP; Ye, Q; Ruan, ZR; Zhou, XL; Wang, ED				Ji, Quan-Quan; Fang, Zhi-Peng; Ye, Qing; Ruan, Zhi-Rong; Zhou, Xiao-Long; Wang, En-Duo			C-terminal Domain of Leucyl-tRNA Synthetase from Pathogenic Candida albicans Recognizes both tRNA(Ser) and tRNA(Leu)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl-tRNA synthetase; C-terminal domain (carboxyl tail domain; CTD); Candida albicans; enzyme mechanism; transfer RNA (tRNA); recognition; tRNALeu; tRNASer	SERYL-TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; QUALITY-CONTROL; CUG CODON; AMINOACYLATION; BINDING; ANTICODON; IDENTITY; COMPLEX	Leucyl-tRNA synthetase (LeuRS) is a multidomain enzyme that catalyzes Leu-tRNA(Leu) formation and is classified into bacterial and archaeal/eukaryotic types with significant diversity in the C-terminal domain (CTD). CTDs of both bacterial and archaeal LeuRSs have been reported to recognize tRNA(Leu) through different modes of interaction. In the human pathogen Candida albicans, the cytoplasmic LeuRS (CaLeuRS) is distinguished by its capacity to recognize a uniquely evolved chimeric tRNA(Ser) (CatRNA(Ser)(CAG)) in addition to its cognate CatRNA(Leu), leading to CUG codon reassignment. Our previous study showed that eukaryotic but not archaeal LeuRSs recognize this peculiar tRNA(Ser), suggesting the significance of their highly divergent CTDs in tRNA(Ser) recognition. The results of this study provided the first evidence of the indispensable function of the CTD of eukaryotic LeuRS in recognizing non-cognate CatRNA(Ser) and cognate CatRNA(Leu). Three lysine residues were identified as involved in mediating enzyme-tRNA interaction in the leucylation process: mutation of all three sites totally ablated the leucylation activity. The importance of the three lysine residues was further verified by gel mobility shift assays and complementation of a yeast leuS gene knock-out strain.	[Ji, Quan-Quan; Fang, Zhi-Peng; Ye, Qing; Ruan, Zhi-Rong; Zhou, Xiao-Long; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhou, XL; Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Ruan, Zhi-Rong/0000-0002-1806-2942; Fang, Zhipeng/0000-0001-5720-1709	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]; Youth Innovation Promotion Association, Chinese Academy of Sciences	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); Youth Innovation Promotion Association, Chinese Academy of Sciences	This work was supported in part by National Key Basic Research Foundation of China Grant 2012CB911000, Natural Science Foundation of China Grants 31130064 and 91440204, and Committee of Science and Technology in Shanghai Grants 12JC1409700 and 15ZR1446500. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Youth Innovation Promotion Association, Chinese Academy of Sciences (to X.-L. Z.).	BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; BRENNAN T, 1976, NUCLEIC ACIDS RES, V3, P3235, DOI 10.1093/nar/3.11.3235; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fang ZP, 2014, NUCLEIC ACIDS RES, V42, P5109, DOI 10.1093/nar/gku108; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Moura GR, 2010, FEBS LETT, V584, P334, DOI 10.1016/j.febslet.2009.11.066; O'Sullivan JM, 2001, GENE, V275, P133, DOI 10.1016/S0378-1119(01)00632-1; Perreau VM, 1999, J MOL BIOL, V293, P1039, DOI 10.1006/jmbi.1999.3209; Rocha R, 2011, P NATL ACAD SCI USA, V108, P14091, DOI 10.1073/pnas.1102835108; Rocha R, 2011, ACTA CRYSTALLOGR F, V67, P153, DOI 10.1107/S1744309110048542; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soma A, 1996, J MOL BIOL, V263, P707, DOI 10.1006/jmbi.1996.0610; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; VINCENT C, 1995, NUCLEIC ACIDS RES, V23, P1113, DOI 10.1093/nar/23.7.1113; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Zheng YG, 2004, NUCLEIC ACIDS RES, V32, P3294, DOI 10.1093/nar/gkh665; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P9825, DOI 10.1093/nar/gkt741; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9	42	4	4	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3613	3625		10.1074/jbc.M115.699777	http://dx.doi.org/10.1074/jbc.M115.699777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677220	hybrid, Green Published			2022-12-28	WOS:000370854500039
J	McRae, S; Iqbal, J; Sarkar-Dutta, M; Lane, S; Nagaraj, A; Ali, N; Waris, G				McRae, Steven; Iqbal, Jawed; Sarkar-Dutta, Mehuli; Lane, Samantha; Nagaraj, Abhiram; Ali, Naushad; Waris, Gulam			RETRACTED: The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism (Retracted article. See vol. 293, pg. 20011, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						hepatitis virus; inflammasome; inflammation; lipid metabolism; liver injury; NLRP3 inflammasome; SREBP	OXIDATIVE STRESS; FATTY-ACID; INTERLEUKIN-1-BETA; CHOLESTEROL; EXPRESSION; INFECTION; CASPASES; DROPLETS; PATHWAY; TARGET	Hepatitis C virus (HCV) relies on host lipids and lipid droplets for replication and morphogenesis. The accumulation of lipid droplets in infected hepatocytes manifests as hepatosteatosis, a common pathology observed in chronic hepatitis C patients. One way by which HCV promotes the accumulation of intracellular lipids is through enhancing de novo lipogenesis by activating the sterol regulatory element-binding proteins (SREBPs). In general, activation of SREBPs occurs during cholesterol depletion. Interestingly, during HCV infection, the activation of SREBPs occurs under normal cholesterol levels, but the underlying mechanisms are still elusive. Our previous study has demonstrated the activation of the inflammasome complex in HCV-infected human hepatoma cells. In this study, we elucidate the potential link between chronic hepatitis C-associated inflammation and alteration of lipid homeostasis in infected cells. Our results reveal that the HCV-activated NLRP3 inflammasome is required for the up-regulation of lipogenic genes such as 3-hydroxy-3-methylglutaryl-coenzyme A synthase, fatty acid synthase, and stearoyl-CoA desaturase. Using pharmacological inhibitors and siRNA against the inflammasome components (NLRP3, apoptosis-associated speck-like protein containing a CARD, and caspase-1), we further show that the activation of the NLRP3 inflammasome plays a critical role in lipid droplet formation. NLRP3 inflammasome activation in HCV-infected cells enables caspase-1-mediated degradation of insulin-induced gene proteins. This subsequently leads to the transport of the SREBP cleavage-activating proteinSREBP complex from the endoplasmic reticulum to the Golgi, followed by proteolytic activation of SREBPs by S1P and S2P in the Golgi. Typically, inflammasome activation leads to viral clearance. Paradoxically, here we demonstrate how HCV exploits the NLRP3 inflammasome to activate SREBPs and host lipid metabolism, leading to liver disease pathogenesis associated with chronic HCV.	[McRae, Steven; Iqbal, Jawed; Sarkar-Dutta, Mehuli; Lane, Samantha; Nagaraj, Abhiram; Waris, Gulam] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, Chicago Med Sch, N Chicago, IL 60064 USA; [Ali, Naushad] Univ Oklahoma, Sect Digest Dis & Nutr, Dept Med, Oklahoma City, OK 73104 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Oklahoma System; University of Oklahoma Health Sciences Center	Waris, G (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, Chicago Med Sch, N Chicago, IL 60064 USA.	gulam.waris@rosalindfranklin.edu			National Institutes of Health from NIAID [1R56AI089772-01A1]; Rosalind Franklin University of Medicine and Science; Bligh Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106244] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rosalind Franklin University of Medicine and Science; Bligh Cancer Research Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 1R56AI089772-01A1 from NIAID, the Rosalind Franklin University of Medicine and Science, and the Bligh Cancer Research Fund (to G. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Cunha LD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00076; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Erener S, 2012, MOL CELL, V46, P200, DOI 10.1016/j.molcel.2012.02.016; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gram AM, 2012, J GEN VIROL, V93, P2063, DOI 10.1099/vir.0.042978-0; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iqbal J, 2013, J BIOL CHEM, V288, P36994, DOI 10.1074/jbc.M113.492314; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Lapinski TW, 2001, ARCH IMMUNOL THER EX, V49, P311; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Miyanari Y, 2007, NAT CELL BIOL, V9, P961; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Shrivastava S, 2013, J VIROL, V87, P12284, DOI 10.1128/JVI.01962-13; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sun Q, 2013, J BIOL CHEM, V288, P15947, DOI 10.1074/jbc.M112.426791; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Waris G, 2005, J VIROL, V79, P9725, DOI 10.1128/JVI.79.15.9725-9734.2005; Waris G., 2007, J VIROL, V81, P1; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	45	42	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3254	3267		10.1074/jbc.M115.694059	http://dx.doi.org/10.1074/jbc.M115.694059			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26698881	hybrid, Green Published			2022-12-28	WOS:000370854500012
J	Posner, MG; Upadhyay, A; Abubaker, AA; Fortunato, TM; Vara, D; Canobbio, I; Bagby, S; Pula, G				Posner, Mareike G.; Upadhyay, Abhishek; Abubaker, Aisha Alsheikh; Fortunato, Tiago M.; Vara, Dina; Canobbio, Ilaria; Bagby, Stefan; Pula, Giordano			Extracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; CARDIOVASCULAR-DISEASE; STIMULATED PLATELETS; ACTIVATED PLATELETS; PHAGE DISPLAY; IN-VIVO; AGGREGATION; RECRUITMENT; DOMAINS; IDENTIFICATION	Extracellular fibrinogen-binding protein (Efb) from Staphylococcus aureus inhibits platelet activation, although its mechanism of action has not been established. In this study, we discovered that the N-terminal region of Efb (Efb-N) promotes platelet binding of fibrinogen and that Efb-N binding to platelets proceeds via two independent mechanisms: fibrinogen-mediated and fibrinogen-independent. By proteomic analysis of Efb-interacting proteins within platelets and confirmation by pull-down assays followed by immunoblotting, we identified P-selectin and multimerin-1 as novel Efb interaction partners. The interaction of both P-selectin and multimerin-1 with Efb is independent of fibrinogen. We focused on Efb interaction with P-selectin. Excess of P-selectin extracellular domain significantly impaired Efb binding by activated platelets, suggesting that P-selectin is the main receptor for Efb on the surface of activated platelets. Efb-N interaction with P-selectin inhibited P-selectin binding to its physiological ligand, P-selectin glycoprotein ligand-1 (PSGL-1), both in cell lysates and in cell-free assays. Because of the importance of P-selectin-PSGL-1 binding in the interaction between platelets and leukocytes, we tested human whole blood and found that Efb abolishes the formation of platelet-monocyte and platelet-granulocyte complexes. In summary, we present evidence that in addition to its documented anti-thrombotic activity, Efb can play an immunoregulatory role via inhibition of P-selectin-PSGL-1-dependent formation of platelet-leukocyte complexes.	[Posner, Mareike G.; Upadhyay, Abhishek; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Claverton Campus, Bath BA2 7AY, Avon, England; [Abubaker, Aisha Alsheikh; Fortunato, Tiago M.; Vara, Dina; Pula, Giordano] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Canobbio, Ilaria] Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, PV, Italy	University of Bath; University of Bath; University of Pavia	Bagby, S (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Campus, Bath BA2 7AY, Avon, England.	bsssb@bath.ac.uk	Pula, Giordano/AAU-9164-2021; Pula, Giordano/ABE-8596-2020; Vara, Dina/W-6349-2019; Posner, Mareike/AGK-4002-2022; Canobbio, Ilaria/L-7414-2013	Pula, Giordano/0000-0002-7769-1140; Posner, Mareike/0000-0002-3156-3071; Bagby, Stefan/0000-0003-2302-9511; Vara, Dina/0000-0002-3099-6748; Canobbio, Ilaria/0000-0002-9643-3403	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J002690/1, BB/J008176/1]; Wellcome Trust [ZR-W0258A]; British Heart Foundation [PG/15/40/31522]; Royal Society [RG120494]; Biotechnology and Biological Sciences Research Council [BB/M012409/1, BB/J008176/1] Funding Source: researchfish; BBSRC [BB/J008176/1, BB/M012409/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was possible thanks to grants from Biotechnology and Biological Sciences Research Council (BBSRC) (BB/J002690/1 and BB/J008176/1), Wellcome Trust (ZR-W0258A), British Heart Foundation (PG/15/40/31522), and Royal Society Grant RG120494. The authors declare that they have no conflicts of interest with the contents of this article.	Appeldoorn CCM, 2005, CIRCULATION, V111, P106, DOI 10.1161/01.CIR.0000151307.10576.02; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; Cerletti C, 2012, THROMB RES, V129, P263, DOI 10.1016/j.thromres.2011.10.010; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; COURTOIS G, 1986, EUR J BIOCHEM, V159, P61, DOI 10.1111/j.1432-1033.1986.tb09833.x; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Diaz JA, 2015, ARTERIOSCL THROM VAS, V35, P829, DOI 10.1161/ATVBAHA.114.304457; Fevre C, 2014, CELL MICROBIOL, V16, P1646, DOI 10.1111/cmi.12313; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Gremmel T, 2015, THROMB HAEMOSTASIS, V113, P806, DOI 10.1160/TH14-08-0690; HAMBURGER SA, 1990, BLOOD, V75, P550; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hamzeh-Cognasse H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00082; Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Jongerius I, 2012, J INNATE IMMUN, V4, P301, DOI 10.1159/000334604; KINLOUGHRATHBONE RL, 1977, THROMB HAEMOSTASIS, V37, P291; Ko YP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003816; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Kuligowski MP, 2006, J IMMUNOL, V176, P6991, DOI 10.4049/jimmunol.176.11.6991; Kuznik BI, 2014, AM J MED SCI, V347, P206, DOI 10.1097/MAJ.0b013e3182831726; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Li J, 2015, CELL MOL LIFE SCI, V72, P2627, DOI 10.1007/s00018-015-1845-y; Myers D, 2002, J SURG RES, V108, P212, DOI 10.1006/jsre.2002.6552; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Palma M, 2001, J BIOL CHEM, V276, P31691, DOI 10.1074/jbc.M104554200; Pamuk GE, 2007, BLOOD COAGUL FIBRIN, V18, P297, DOI 10.1097/MBC.0b013e328010bd05; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Rossaint J, 2015, CARDIOVASC RES, V107, P386, DOI 10.1093/cvr/cvv048; Sels JWEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083198; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; Shannon O, 2004, THROMB HAEMOSTASIS, V91, P779, DOI 10.1160/TH03-05-0287; SOUTHAN C, 1985, BIOCHEM J, V229, P723, DOI 10.1042/bj2290723; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; van der Bom JG, 1998, ARTERIOSCL THROM VAS, V18, P621, DOI 10.1161/01.ATV.18.4.621; Vara D, 2013, BRIT J PHARMACOL, V168, P212, DOI 10.1111/j.1476-5381.2012.02130.x; Vara DS, 2013, THROMB HAEMOSTASIS, V109, P1108, DOI 10.1160/TH12-10-0751; Wade D, 1998, BIOCHEM BIOPH RES CO, V248, P690, DOI 10.1006/bbrc.1998.9028; Wu WC, 2015, GLYCOCONJUGATE J, V32, P69, DOI 10.1007/s10719-014-9571-5; Xia Z, 1996, BRIT J HAEMATOL, V93, P204, DOI 10.1046/j.1365-2141.1996.445980.x; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Zhang X, 2011, PLATELETS, V22, P228, DOI 10.3109/09537104.2010.543962	51	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2764	2776		10.1074/jbc.M115.678359	http://dx.doi.org/10.1074/jbc.M115.678359			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627825	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000369626900017
J	Chow, CR; Ebine, K; Knab, LM; Bentrem, DJ; Kumar, K; Munshi, HG				Chow, Christina R.; Ebine, Kazumi; Knab, Lawrence M.; Bentrem, David J.; Kumar, Krishan; Munshi, Hidayatullah G.			Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by G alpha(13) Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PANCREATIC DUCTAL CELLS; STRESS FIBER FORMATION; PAR3 POLARITY PROTEIN; MEDIATED MIGRATION; POOR-PROGNOSIS; G12 FAMILY; EXPRESSION; DDR1; METASTASIS	Cancer cells can invade in three-dimensional collagen as single cells or as a cohesive group of cells that require coordination of cell-cell junctions and the actin cytoskeleton. To examine the role of G alpha(13), a G(12) family heterotrimeric G protein, in regulating cellular invasion in three-dimensional collagen, we established a novel method to track cell invasion by membrane type 1 matrix metalloproteinase-expressing cancer cells. We show that knockdown of G alpha(13) decreased membrane type 1 matrix metalloproteinase-driven proteolytic invasion in three-dimensional collagen and enhanced E-cadherin-mediated cell-cell adhesion. E-cadherin knockdown reversed G alpha(13) siRNA-induced cell-cell adhesion but failed to reverse the effect of G alpha(13) siRNA on proteolytic invasion. Instead, concurrent knockdown of E-cadherin and G alpha(13) led to an increased number of single cells rather than groups of cells. Significantly, knockdown of discoidin domain receptor 1 (DDR1), a collagen-binding protein that also co-localizes to cell-cell junctions, reversed the effects of G alpha(13) knockdown on cell-cell adhesion and proteolytic invasion in three-dimensional collagen. Knockdown of the polarity protein Par3, which can function downstream of DDR1, also reversed the effects of G alpha(13) knockdown on cell-cell adhesion and proteolytic invasion in three-dimensional collagen. Overall, we show that G alpha(13) and DDR1-Par3 differentially regulate cell-cell junctions and the actin cytoskeleton to mediate invasion in three-dimensional collagen.	[Chow, Christina R.; Ebine, Kazumi; Kumar, Krishan; Munshi, Hidayatullah G.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Knab, Lawrence M.; Bentrem, David J.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Ebine, Kazumi; Bentrem, David J.; Kumar, Krishan; Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Chow, Christina R.; Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu		Chow, Christina/0000-0003-3944-4234	NCI/National Institutes of Health [R01CA126888, R01CA186885]; Department of Veterans Affairs Merit Award [I01BX001363]; NCI/National Institutes of Health Training Grant [T32CA070085]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA186885, R01CA126888, T32CA070085] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001363] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); NCI/National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported NCI/National Institutes of Health Grants R01CA126888 and R01CA186885 (to H.G.M.) and Department of Veterans Affairs Merit Award I01BX001363 (to H.G.M.). This work was also supported by NCI/National Institutes of Health Training Grant T32CA070085 (to C.R.C.). The authors declare that they have no conflicts of interest with contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badea L, 2008, PACIFIC S BIOCOMPUTI, V13, P279; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dhanasekaran Danny N, 2006, Sci STKE, V2006, ppe31, DOI 10.1126/stke.3472006pe31; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardner JA, 2013, PANCREAS, V42, P819, DOI 10.1097/MPA.0b013e318279c577; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Hansen C, 2006, EXP CELL RES, V312, P4011, DOI 10.1016/j.yexcr.2006.09.003; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Huo YM, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0202-1; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yang SH, 2010, ONCOL REP, V24, P311, DOI 10.3892/or_00000861; Yeh YC, 2011, MOL BIOL CELL, V22, P940, DOI 10.1091/mbc.E10-08-0678	49	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1605	1618		10.1074/jbc.M115.669606	http://dx.doi.org/10.1074/jbc.M115.669606			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589794	Green Published, hybrid			2022-12-28	WOS:000368620700006
J	Douglas, DN; Pu, CH; Lewis, JT; Bhat, R; Anwar-Mohamed, A; Logan, M; Lund, G; Addison, WR; Lehner, R; Kneteman, NM				Douglas, Donna N.; Pu, Christopher Hao; Lewis, Jamie T.; Bhat, Rakesh; Anwar-Mohamed, Anwar; Logan, Michael; Lund, Garry; Addison, William R.; Lehner, Richard; Kneteman, Norman M.			Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA-CARBOXYLASE; HCV CORE PROTEIN; REACTIVE OXYGEN; ER STRESS; ENDOPLASMIC-RETICULUM; ELECTRON-TRANSPORT; GENE-EXPRESSION; RECEPTOR-ALPHA; MOUSE MODEL	Cytopathic effects are currently believed to contribute to hepatitis C virus (HCV)-induced liver injury and are readily observed in Huh7.5 cells infected with the JFH-1 HCV strain, manifesting as apoptosis highly correlated with growth arrest. Reactive oxygen species, which are induced by HCV infection, have recently emerged as activators of AMP-activated protein kinase. The net effect is ATP conservation via on/off switching of metabolic pathways that produce/consume ATP. Depending on the scenario, this can have either pro-survival or pro-apoptotic effects. We demonstrate reactive oxygen species-mediated activation of AMP-activated kinase in Huh7.5 cells during HCV (JFH-1)-induced growth arrest. Metabolic labeling experiments provided direct evidence that lipid synthesis is attenuated, and beta-oxidation is enhanced in these cells. A striking increase in nuclear peroxisome proliferator-activated receptor alpha, which plays a dominant role in the expression of beta-oxidation genes after ligand-induced activation, was also observed, and we provide evidence that peroxisome proliferator-activated receptor alpha is constitutively activated in these cells. The combination of attenuated lipid synthesis and enhanced beta-oxidation is not conducive to lipid accumulation, yet cellular lipids still accumulated during this stage of infection. Notably, the serum in the culture media was the only available source for polyunsaturated fatty acids, which were elevated (2-fold) in the infected cells, implicating altered lipid import/export pathways in these cells. This study also provided the first in vivo evidence for enhanced beta-oxidation during HCV infection because HCV-infected SCID/Alb-uPA mice accumulated higher plasma ketones while fasting than did control mice. Overall, this study highlights the reprogramming of hepatocellular lipid metabolism and bioenergetics during HCV infection, which are predicted to impact both the HCV life cycle and pathogenesis.	[Douglas, Donna N.; Pu, Christopher Hao; Lewis, Jamie T.; Kneteman, Norman M.] Univ Alberta, Dept Surg, Edmonton, AB T6G 2E1, Canada; [Lehner, Richard] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2E1, Canada; [Lehner, Richard] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2E1, Canada; [Bhat, Rakesh; Anwar-Mohamed, Anwar; Logan, Michael; Addison, William R.] Univ Alberta, Dept Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Lund, Garry] Univ Alberta, KMT Hepatech Inc, Edmonton, AB T6G 2E1, Canada; [Douglas, Donna N.; Pu, Christopher Hao; Lewis, Jamie T.; Logan, Michael; Addison, William R.; Kneteman, Norman M.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Douglas, DN (corresponding author), Univ Alberta, Dept Surg, Katz Grp Rexall Ctr 6 010A, Edmonton, AB T6G 2E1, Canada.	donnad@ualberta.ca	Bhat, Rakesh/B-4320-2009; Anwar-Mohamed, Anwar/J-6973-2015; Bhat, Rakesh Kumar/AID-0687-2022	Anwar-Mohamed, Anwar/0000-0001-9214-7859; Bhat, Rakesh Kumar/0000-0001-7649-0470; Lehner, Richard/0000-0002-6008-1805	Canadian Institute of Health Research (CIHR/IRSC)	Canadian Institute of Health Research (CIHR/IRSC)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR/IRSC) (to N. M. K., D. N. D., and R. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Ando M, 2008, LIVER INT, V28, P1158, DOI 10.1111/j.1478-3231.2008.01720.x; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Bartosch B, 2009, J HEPATOL, V50, P845, DOI 10.1016/j.jhep.2009.02.009; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Bennett MJ, 2007, METHOD CELL BIOL, V80, P179, DOI 10.1016/S0091-679X(06)80009-9; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borowski P, 1999, ARCH VIROL, V144, P687, DOI 10.1007/s007050050536; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Cheng Y, 2005, WORLD J GASTROENTERO, V11, P7591, DOI 10.3748/wjg.v11.i48.7591; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Choi J, 2006, FREE RADICAL BIO MED, V41, P1488, DOI 10.1016/j.freeradbiomed.2006.08.008; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Deeb D, 2010, BIOCHEM PHARMACOL, V79, P350, DOI 10.1016/j.bcp.2009.09.006; Dharancy S, 2009, PPAR RES, V2009, DOI 10.1155/2009/357204; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Douglas DN, 2015, EUR J PHARMACOL, V759, P313, DOI 10.1016/j.ejphar.2015.03.022; Douglas DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009209; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gabriel C, 1997, J PHARMACOL TOXICOL, V38, P93, DOI 10.1016/S1056-8719(97)00066-X; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; GUNASEKAR PG, 1995, J NEUROSCI METH, V61, P15, DOI 10.1016/0165-0270(95)00018-P; Hansson PK, 2004, BBA-MOL CELL BIOL L, V1684, P54, DOI 10.1016/j.bbalip.2004.06.005; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hsieh MJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-74; Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Kneteman NM, 2012, LIVER TRANSPLANT, V18, P38, DOI 10.1002/lt.22400; Kneteman NM, 2009, HEPATOLOGY, V49, P745, DOI 10.1002/hep.22717; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; KRAWCZYNSKI K, 1992, GASTROENTEROLOGY, V103, P622, DOI 10.1016/0016-5085(92)90856-T; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Martinez-Florez S, 2005, J NUTR, V135, P1359, DOI 10.1093/jn/135.6.1359; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meredith LW, 2013, J HEPATOL, V58, P1074, DOI 10.1016/j.jhep.2013.01.019; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; Nelson D R, 2001, Clin Liver Dis, V5, P931, DOI 10.1016/S1089-3261(05)70202-6; Nourbakhsh M, 2013, J HEPATOL, V59, P336, DOI 10.1016/j.jhep.2013.03.022; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x; Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251; Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Robinson LC, 2008, BIOCHEM BIOPH RES CO, V368, P593, DOI 10.1016/j.bbrc.2008.01.127; Rodrigues E, 2012, MAR DRUGS, V10, P1784, DOI 10.3390/md10081784; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Sansonno D, 2004, J VIRAL HEPATITIS, V11, P27, DOI 10.1046/j.1365-2893.2003.00474.x; Schaefer EAK, 2013, SEMIN LIVER DIS, V33, P358, DOI 10.1055/s-0033-1358524; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seronello S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027436; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka N, 2008, INT J CANCER, V122, P124, DOI 10.1002/ijc.23056; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Vance D. E., 1996, BIOCH LIPIDS LIPOPRO; Vescovo T, 2012, GASTROENTEROLOGY, V142, P644, DOI 10.1053/j.gastro.2011.11.033; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wang T, 2010, J VIRAL HEPATITIS, V17, P784, DOI 10.1111/j.1365-2893.2009.01238.x; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Waterfield CJ, 1997, CHEM-BIOL INTERACT, V107, P157, DOI 10.1016/S0009-2797(97)00090-2; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Wen F, 2004, J MED VIROL, V72, P230, DOI 10.1002/jmv.10567; Wu CH, 2011, HEPATOLOGY, V54, P1966, DOI 10.1002/hep.24645; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Zhao LJ, 2005, EXP CELL RES, V305, P23, DOI 10.1016/j.yexcr.2004.12.024; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	127	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1974	1990		10.1074/jbc.M115.674861	http://dx.doi.org/10.1074/jbc.M115.674861			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627833	Green Published, hybrid			2022-12-28	WOS:000368620700034
J	Mueller, SC; Sommer, B; Backes, C; Haas, J; Meder, B; Meese, E; Keller, A				Mueller, Sabine C.; Sommer, Bjoern; Backes, Christina; Haas, Jan; Meder, Benjamin; Meese, Eckart; Keller, Andreas			From Single Variants to Protein Cascades MULTISCALE MODELING OF SINGLE NUCLEOTIDE VARIANT SETS IN GENETIC DISORDERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOINFORMATICS CHALLENGES; SEQUENCE; KNOWLEDGEBASE; INFORMATION; EXPRESSION; RESOURCE; DATABASE; SURFACE; SERVER; ATLAS	Understanding the role of genetics in disease has become a central part of medical research. Non-synonymous single nucleotide variants (nsSNVs) in coding regions of human genes frequently lead to pathological phenotypes. Beyond single variations, the individual combination of nsSNVs may add to pathogenic processes. We developed a multiscale pipeline to systematically analyze the existence of quantitative effects of multiple nsSNVs and gene combinations in single individuals on pathogenicity. Based on this pipeline, we detected in a data set of 842 nsSNVs discovered in 76 genes related to cardiomyopathies, associated nsSNV combinations in seven genes present in at least 70% of all 639 patient samples, but not in a control cohort of healthy humans. Structural analyses of these revealed primarily an influence on the protein stability. For amino acid substitutions located at the protein surface, we generally observed a proximity to putative binding pockets. To computationally analyze cumulative effects and their impact, pathogenicity methods are currently being developed. Our approach supports this process, as shown on the example of a cardiac phenotype but can be likewise applied to other diseases such as cancer.	[Mueller, Sabine C.; Backes, Christina; Keller, Andreas] Univ Saarland, Chair Clin Bioinformat, Campus Bldg E2-1, D-66123 Saarbrucken, Germany; [Mueller, Sabine C.; Meese, Eckart] Univ Saarland, Dept Human Genet, D-66421 Homburg, Germany; [Sommer, Bjoern] Univ Bielefeld, Fac Technol, Biomed Informat Dept, D-33501 Bielefeld, Germany; [Sommer, Bjoern] Monash Univ, Fac Informat Technol, Clayton Sch Informat Technol, Melbourne, Vic 3800, Australia; [Haas, Jan; Meder, Benjamin] Heidelberg Univ, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Haas, Jan; Meder, Benjamin] DZHK German Ctr Cardiovasc Res, D-69120 Heidelberg, Germany	Saarland University; Saarland University; University of Bielefeld; Monash University; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Mueller, SC (corresponding author), Univ Saarland, Chair Clin Bioinformat, Campus Bldg E2-1, D-66123 Saarbrucken, Germany.	sabine.mueller@uniklinikum-saarland.de	Keller, Andreas/ABB-6412-2021; Meese, Eckart Ulrich/ABD-1983-2021	Keller, Andreas/0000-0002-5361-0895; Mueller, Sabine/0000-0001-5184-1254; Sommer, Bjorn/0000-0003-1514-9898	Best Ageing Grant from the European Union [306031]	Best Ageing Grant from the European Union	This work was supported by the Best Ageing Grant 306031 from the European Union. The authors declare that they have no competing interests.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JNC, 2014, GENES-BASEL, V5, P518, DOI 10.3390/genes5030518; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Capriotti E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S3; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de la Cruz X, 2001, J COMPUT AID MOL DES, V15, P521, DOI 10.1023/A:1011133332333; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Giacomini KM, 2007, CLIN PHARMACOL THER, V81, P328, DOI 10.1038/sj.clpt.6100087; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Hahsler M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I15; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jochen Hipp U. G., 2000, SIGKDD EXPLOR NEWSL, V2, P58; Kormeier B., 2014, DATA WAREHOUSES BIOI, P111; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marian AJ, 2013, CARDIOVASC PATHOL, V22, P309, DOI 10.1016/j.carpath.2013.05.002; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Mueller SC, 2015, BRIEF BIOINFORM, V16, P769, DOI 10.1093/bib/bbu054; Mueller SC, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0190-y; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sommer B, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013400052; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Westphal V, 2002, HUM MOL GENET, V11, P599, DOI 10.1093/hmg/11.5.599; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	48	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1582	1590		10.1074/jbc.M115.695247	http://dx.doi.org/10.1074/jbc.M115.695247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601959	Green Published, hybrid			2022-12-28	WOS:000368620700003
J	Landowski, LM; Pavez, M; Brown, LS; Gasperini, R; Taylor, BV; West, AK; Foa, L				Landowski, Lila M.; Pavez, Macarena; Brown, Lachlan S.; Gasperini, Robert; Taylor, Bruce V.; West, Adrian K.; Foa, Lisa			Low-density Lipoprotein Receptor-related Proteins in a Novel Mechanism of Axon Guidance and Peripheral Nerve Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; GROWTH CONES; NEURITE OUTGROWTH; APOLIPOPROTEIN-E; SENSORY NEURONS; DEFICIENT MICE; TRK RECEPTORS; SPINAL-CORD; METALLOTHIONEIN; MEGALIN	The low-density lipoprotein receptor-related protein receptors 1 and 2 (LRP1 and LRP2) are emerging as important cell signaling mediators in modulating neuronal growth and repair. We examined whether LRP1 and LRP2 are able to mediate a specific aspect of neuronal growth: axon guidance. We sought to identify LRP1 and LRP2 ligands that could induce axonal chemoattraction, which might have therapeutic potential. Using embryonic sensory neurons (rat dorsal root ganglia) in a growth cone turning assay, we tested a range of LRP1 and LRP2 ligands for the ability to guide growth cone navigation. Three ligands were chemorepulsive: alpha-2-macroglobulin, tissue plasminogen activator, and metallothionein III. Conversely, only one LRP ligand, metallothionein II, was found to be chemoattractive. Chemoattraction toward a gradient of metallothionein II was calcium-dependent, required the expression of both LRP1 and LRP2, and likely involves further co-receptors such as the tropomyosin- related kinase A (TrkA) receptor. The potential for LRP-mediated chemoattraction to mediate axonal regeneration was examined in vivo in a model of chemical denervation in adult rats. In these in vivo studies, metallothionein II was shown to enhance epidermal nerve fiber regeneration so that it was complete within 7 days compared with 14 days in saline-treated animals. Our data demonstrate that both LRP1 and LRP2 are necessary for metallothionein II-mediated chemotactic signal transduction and that they may form part of a signaling complex. Furthermore, the data suggest that LRP-mediated chemoattraction represents a novel, non-classical signaling system that has therapeutic potential as a disease-modifying agent for the injured peripheral nervous system.	[Landowski, Lila M.; Pavez, Macarena; Brown, Lachlan S.; Gasperini, Robert; West, Adrian K.; Foa, Lisa] Univ Tasmania, Sch Med, 17 Liverpool St, Hobart, Tas 7001, Australia; [Landowski, Lila M.; Gasperini, Robert; Taylor, Bruce V.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7001, Australia	University of Tasmania; University of Tasmania; Menzies Institute for Medical Research	Foa, L (corresponding author), Univ Tasmania, Sch Med, 17 Liverpool St, Hobart, Tas 7001, Australia.	lisa.foa@utas.edu.au	West, Adrian/AAR-8857-2021; Foa, Lisa/J-7781-2014; Landowski, Lila M/AAU-8616-2020	Foa, Lisa/0000-0003-4131-8341; Landowski, Lila M/0000-0001-6195-8536; Pavez, Macarena/0000-0003-0393-2631; Gasperini, Rob/0000-0001-6859-1247; Brown (Brown, LS), Lachlan/0000-0003-3612-8236	National Health and Medical Research Council [1068317, 1088952]; Brain Foundation grant; Australian postgraduate awards	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Brain Foundation grant; Australian postgraduate awards(Australian Government)	This work was supported by National Health and Medical Research Council Grants 1068317 (to L.F., A.W.,and R.G.) and 1088952 (to L.F., B.T., and A.W.)and a Brain Foundation grant (to A.W.). A.W.,B.T., L.F., and L.L. are named on United States Patent 8,691,765, which examines metallothionein function in neural repair, although there are no current competing financial interests.r Supported by Australian postgraduate awards.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2002, EXP NEUROL, V178, P1, DOI 10.1006/exnr.2002.8017; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Flores A J, 2000, Am J Orthop (Belle Mead NJ), V29, P167; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Jung EJ, 2008, EXP MOL MED, V40, P276, DOI 10.3858/emm.2008.40.3.276; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Leung JYK, 2012, CELL MOL LIFE SCI, V69, P809, DOI 10.1007/s00018-011-0790-7; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mitchell CB, 2012, J NEUROCHEM, V122, P1155, DOI 10.1111/j.1471-4159.2012.07840.x; MORI T, 1990, BRAIN RES, V527, P55, DOI 10.1016/0006-8993(90)91059-P; Nusetti S, 2005, NEUROCHEM RES, V30, P1483, DOI 10.1007/s11064-005-8825-9; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Postuma RB, 1998, FEBS LETT, V428, P13, DOI 10.1016/S0014-5793(98)00475-X; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Siddiq MM, 2015, J BIOL CHEM, V290, P16343, DOI 10.1074/jbc.M114.630574; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Vaillant C, 2007, DEVELOPMENT, V134, P1745, DOI 10.1242/dev.02840; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	50	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1092	1102		10.1074/jbc.M115.668996	http://dx.doi.org/10.1074/jbc.M115.668996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26598525	Green Published, hybrid			2022-12-28	WOS:000368068300006
J	Sin, Y; Tanaka, K; Saijo, M				Sin, Yooksil; Tanaka, Kiyoji; Saijo, Masafumi			The C-terminal Region and SUMOylation of Cockayne Syndrome Group B Protein Play Critical Roles in Transcription-coupled Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; UV-SENSITIVE SYNDROME; DNA-REPAIR; COMPLEMENTATION GROUPS; NUCLEAR-MATRIX; CSB PROTEIN; DAMAGE; TFIIH; TRANSLOCATION; DEGRADATION	Cockayne syndrome (CS) is a recessive disorder that results in deficiencies in transcription-coupled nucleotide excision repair (TC-NER), a subpathway of nucleotide excision repair, and cells from CS patients exhibit hypersensitivity to UV light. CS group B protein (CSB), which is the gene product of one of the genes responsible for CS, belongs to the SWI2/SNF2 DNA-dependent ATPase family and has an ATPase domain and an ubiquitinbinding domain (UBD) in the central region and the C-terminal region, respectively. The C-terminal region containing the UBD is essential for the functions of CSB. In this study, we generated several CSB deletion mutants and analyzed the functions of the C-terminal region of CSB in TC-NER. Not only the UBD but also the C-terminal 30-amino acid residues were required for UV light resistance and TC-NER. This region was needed for the interaction of CSB with RNA polymerase II, the translocation of CS group A protein to the nuclear matrix, and the association of CSB with chromatin after UV irradiation. CSB was modified by small ubiquitin-like modifier 2/3 in a UV light-dependent manner. This modification was abolished in a CSB mutant lacking the C-terminal 30 amino acid residues. However, the substitution of lysine residues in this region with arginine did not affect SUMOylation or TC-NER. By contrast, substitution of a lysine residue in the N-terminal region with arginine decreased SUMOylation and resulted in cells with defects in TC-NER. These results indicate that both the most C-terminal region and SUMOylation are important for the functions of CSB in TC-NER.	[Sin, Yooksil; Tanaka, Kiyoji; Saijo, Masafumi] Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan	Osaka University	Tanaka, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	ktanaka@fbs.osaka-u.ac.jp; saijom@fbs.osaka-u.ac.jp			Ministry of Education, Cultures, Sports, Science, and Technology (MEXT) [22131009, 15H02820]	Ministry of Education, Cultures, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas 22131009 (to K.T.) and Grant-in-Aid for Scientific Research (B) 15H02820 (to M.S.) from the Ministry of Education, Cultures, Sports, Science, and Technology (MEXT). The authors declare that they have no conflicts of interest with the contents of this article.	Akita M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10984; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gool AJ, 1997, EMBO J, V16, P5955; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; Imam SZ, 2007, NUCLEIC ACIDS RES, V35, P4941, DOI 10.1093/nar/gkm386; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; Lake RJ, 2013, MECH AGEING DEV, V134, P202, DOI 10.1016/j.mad.2013.02.004; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; LEHMANN AR, 1985, LANCET, V1, P486; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MAYNE LV, 1982, CANCER RES, V42, P1473; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Saijo M, 2007, MOL CELL BIOL, V27, P2538, DOI 10.1128/MCB.01288-06; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang LF, 2014, P NATL ACAD SCI USA, V111, P18566, DOI 10.1073/pnas.1420227112; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wei LZ, 2011, CANCER SCI, V102, P1840, DOI 10.1111/j.1349-7006.2011.02037.x; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	42	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1387	1397		10.1074/jbc.M115.683235	http://dx.doi.org/10.1074/jbc.M115.683235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26620705	Green Published, hybrid			2022-12-28	WOS:000368068300030
J	Brewer, PD; Habtemichael, EN; Romenskaia, I; Mastick, CC; Coster, ACF				Brewer, Paul Duffield; Habtemichael, Estifanos N.; Romenskaia, Irina; Mastick, Cynthia Corley; Coster, Adelle C. F.			Glut4 Is Sorted from a Rab10 GTPase-independent Constitutive Recycling Pathway into a Highly Insulinresponsive Rab10 GTPase-dependent Sequestration Pathway after Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; PLASMA-MEMBRANE; ACTIVATING-PROTEIN; GLUCOSE-TRANSPORT; EXOCYST COMPLEX; MUSCLE-CELLS; VESICLE TRANSLOCATION; 3T3-L1 ADIPOCYTES; INSULIN ACTION; RATE-CONSTANT	The RabGAP AS160/TBC1D4 controls exocytosis of the insulin-sensitive glucose transporter Glut4 in adipocytes. Glut4 is internalized and recycled through a highly regulated secretory pathway in these cells. Glut4 also cycles through a slow constitutive endosomal pathway distinct from the fast transferrin (Tf) receptor recycling pathway. This slow constitutive pathway is the only Glut4 cycling pathway in undifferentiated fibroblasts. The alpha(2)-macroglobulin receptor LRP1 cycles with Glut4 and the Tf receptor through all three exocytic pathways. To further characterize these pathways, the effects of knockdown of AS160 substrates on the trafficking kinetics of Glut4, LRP1, and the Tf receptor were measured in adipocytes and fibroblasts. Rab10 knockdown decreased cell surface Glut4 in insulin-stimulated adipocytes by 65%, but not in basal adipocytes or in fibroblasts. This decrease was due primarily to a 62% decrease in the rate constant of Glut4 exocytosis (k(ex)), although Rab10 knockdown also caused a 1.4-fold increase in the rate constant of Glut4 endocytosis (k(en)). Rab10 knockdown in adipocytes also decreased cell surface LRP1 by 30% by decreasing kex 30-40%. There was no effect on LRP1 trafficking in fibroblasts or on Tf receptor trafficking in either cell type. These data confirm that Rab10 is an AS160 substrate that limits exocytosis through the highly insulin-responsive specialized secretory pathway in adipocytes. They further show that the slow constitutive endosomal (fibroblast) recycling pathway is Rab10-independent. Thus, Rab10 is a marker for the specialized pathway in adipocytes. Interestingly, mathematical modeling shows that Glut4 traffics predominantly through the specialized Rab10-dependent pathway both before and after insulin stimulation.	[Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Habtemichael, Estifanos N.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Dept Appl Math, Sydney, NSW 2052, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University; University of New South Wales Sydney	Mastick, CC (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Coster, Adelle CF/A-7234-2013; Mastick, Cynthia/G-9841-2017; Coster, Adelle/AAX-4829-2020	Coster, Adelle CF/0000-0002-5572-6832; Mastick, Cynthia/0000-0003-4769-5412; Coster, Adelle/0000-0002-5572-6832	American Diabetes Association	American Diabetes Association(American Diabetes Association)	This work was supported by grants from the American Diabetes Association. The authors declare that they have no conflicts of interest with the contents of this article.	Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; Brewer PD, 2014, J BIOL CHEM, V289, P17280, DOI 10.1074/jbc.M114.555714; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, CELL CYCLE, V10, P2299, DOI 10.4161/cc.10.14.16524; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; CORMONT M, 1993, J BIOL CHEM, V268, P19491; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Malide D, 2000, J CELL SCI, V113, P4203; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2015, BIOCHEM BIOPH RES CO, V465, P601, DOI 10.1016/j.bbrc.2015.08.069; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06	50	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					773	789		10.1074/jbc.M115.694919	http://dx.doi.org/10.1074/jbc.M115.694919			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26527681	Green Published, hybrid			2022-12-28	WOS:000367830500025
J	Nadkarni, A; Burns, JA; Gandolfi, A; Chowdhury, MA; Cartularo, L; Berens, C; Geacintov, NE; Scicchitano, DA				Nadkarni, Aditi; Burns, John A.; Gandolfi, Alberto; Chowdhury, Moinuddin A.; Cartularo, Laura; Berens, Christian; Geacintov, Nicholas E.; Scicchitano, David A.			Nucleotide Excision Repair and Transcription-coupled DNA Repair Abrogate the Impact of DNA Damage on Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; OLIGONUCLEOTIDE-DIRECTED CONSTRUCTION; ADDUCT OPPOSITE DT; MOLECULAR-MECHANISMS; SOLUTION CONFORMATION; SITE; RECOGNITION; DUPLEX; STRAND; MUTATIONS	DNA adducts derived from carcinogenic polycyclic aromatic hydrocarbons like benzo[a] pyrene (B[a]P) and benzo[c]phenanthrene (B[c]Ph) impede replication and transcription, resulting in aberrant cell division and gene expression. Global nucleotide excision repair (NER) and transcription-coupled DNA repair (TCR) are among the DNA repair pathways that evolved to maintain genome integrity by removing DNA damage. The interplay between global NER and TCR in repairing the polycyclic aromatic hydrocarbon-derived DNA adducts (+)-trans-anti-B[a]P-N6-dA, which is subject to NER and blocks transcription in vitro, and (+)-trans-anti-B[c]Ph-N6-dA, which is a poor substrate for NER but also blocks transcription in vitro, was tested. The results show that both adducts inhibit transcription in human cells that lack both NER and TCR. The (+)-trans-anti-B[a]P-N6-dA lesion exhibited no detectable effect on transcription in cells proficient in NER but lacking TCR, indicating that NER can remove the lesion in the absence of TCR, which is consistent with in vitro data. In primary human cells lacking NER, (+)-trans-anti-B[a] P-N6-dA exhibited a deleterious effect on transcription that was less severe than in cells lacking both pathways, suggesting that TCR can repair the adduct but not as effectively as global NER. In contrast, (+)-trans-anti-B[c] Ph-N6-dA dramatically reduces transcript production in cells proficient in global NER but lacking TCR, indicating that TCR is necessary for the removal of this adduct, which is consistent with in vitro data showing that it is a poor substrate for NER. Hence, both global NER and TCR enhance the recovery of gene expression following DNA damage, and TCR plays an important role in removing DNA damage that is refractory to NER.	[Nadkarni, Aditi; Burns, John A.; Chowdhury, Moinuddin A.; Cartularo, Laura; Geacintov, Nicholas E.; Scicchitano, David A.] NYU, Dept Biol, New York, NY 10003 USA; [Nadkarni, Aditi; Burns, John A.; Chowdhury, Moinuddin A.; Cartularo, Laura; Geacintov, Nicholas E.; Scicchitano, David A.] NYU, Dept Chem, New York, NY 10003 USA; [Gandolfi, Alberto] Univ Florence, Dipartimento Matemat & Informat Ulisse Dini, I-50134 Florence, Italy; [Berens, Christian] Friedrich Loeffler Inst, Inst Mol Pathogenesis, D-07743 Jena, Germany; [Gandolfi, Alberto; Scicchitano, David A.] New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates	New York University; New York University; University of Florence; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Scicchitano, DA (corresponding author), NYU, Dept Biol, 1009 Silver Ctr,100 Washington Sq E, New York, NY 10003 USA.	das2@nyu.edu		Gandolfi, Alberto/0000-0001-6956-7513; Nadkarni, Aditi/0000-0002-1508-6957; Burns, John/0000-0002-2348-8438	National Institutes of Health [ES-010581]; New York University Abu Dhabi; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Abu Dhabi; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant ES-010581 (to D. A. S.) and funds from New York University Abu Dhabi (to D. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altieri F, 2008, ANTIOXID REDOX SIGN, V10, P891, DOI 10.1089/ars.2007.1830; BAGWELL CB, 1993, ANN NY ACAD SCI, V677, P167, DOI 10.1111/j.1749-6632.1993.tb38775.x; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Benaglia T, 2009, J STAT SOFTW, V32, P1; Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bruzel A, 2006, GENOMICS, V87, P286, DOI 10.1016/j.ygeno.2005.09.021; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Buterin T, 2000, CANCER RES, V60, P1849; Cai YQ, 2012, BIOCHEMISTRY-US, V51, P1486, DOI 10.1021/bi201794x; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P12488, DOI 10.1021/bi00097a029; COSMAN M, 1995, BIOCHEMISTRY-US, V34, P1295, DOI 10.1021/bi00004a024; Danke C, 2010, J GENE MED, V12, P501, DOI 10.1002/jgm.1461; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Dimitri A, 2008, NUCLEIC ACIDS RES, V36, P6459, DOI 10.1093/nar/gkn657; Doetsch PW, 2002, MUTAT RES-FUND MOL M, V510, P131, DOI 10.1016/S0027-5107(02)00258-0; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Dreij K., 2010, CHEM BIOL DNA DAMAGE, P399; Elovaara E, 2007, ARCH TOXICOL, V81, P169, DOI 10.1007/s00204-006-0135-8; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Geacintov NE, 1997, CHEM RES TOXICOL, V10, P111, DOI 10.1021/tx9601418; Geacintov Nicholas E., 2006, P263; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HARVEY RG, 1982, AM SCI, V70, P386; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HSU TM, 1995, CARCINOGENESIS, V16, P2263, DOI 10.1093/carcin/16.9.2263; Huang WD, 2002, CHEM RES TOXICOL, V15, P118, DOI 10.1021/tx010135y; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Izhar L, 2013, P NATL ACAD SCI USA, V110, pE1462, DOI 10.1073/pnas.1216894110; Khobta A, 2012, MUTAT RES-FUND MOL M, V736, P5, DOI 10.1016/j.mrfmmm.2011.07.014; Khobta A, 2010, NUCLEIC ACIDS RES, V38, P4285, DOI 10.1093/nar/gkq170; Kitsera N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094405; Kontanis EJ, 2006, J FORENSIC SCI, V51, P795, DOI 10.1111/j.1556-4029.2006.00182.x; KRAMER W, 1987, METHOD ENZYMOL, V154, P350; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; Langie SAS, 2015, CARCINOGENESIS, V36, pS61, DOI 10.1093/carcin/bgv031; Levsky JM, 2007, J CELL BIOCHEM, V102, P609, DOI 10.1002/jcb.21495; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Liu TM, 1996, CHEM RES TOXICOL, V9, P255, DOI 10.1021/tx9501086; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Perlow RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng040; Perlow RA, 2002, J MOL BIOL, V321, P29, DOI 10.1016/S0022-2836(02)00593-4; R Team C, 2013, R LANG ENV STAT COMP; Rechkunova NI, 2010, SUBCELL BIOCHEM, V50, P251, DOI 10.1007/978-90-481-3471-7_13; Ridley AJ, 2005, J HUM GENET, V50, P151, DOI 10.1007/s10038-004-0228-2; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rodriguez Y, 2015, DNA REPAIR, V32, P113, DOI 10.1016/j.dnarep.2015.04.021; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schinecker TM, 2003, NUCLEIC ACIDS RES, V31, P6004, DOI 10.1093/nar/gkg771; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; Shimada T, 1996, CANCER RES, V56, P2979; Shimada T, 2013, CHEM RES TOXICOL, V26, P529, DOI 10.1021/tx3004906; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; Sugasawa K, 2011, BIOCHEMISTRY-MOSCOW+, V76, P16, DOI 10.1134/S0006297911010044; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; Vasquez KM, 2013, MUTAT RES-FUND MOL M, V743, P118, DOI 10.1016/j.mrfmmm.2012.11.005; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Williams K, 2013, MUTAT RES-FUND MOL M, V743, P1, DOI 10.1016/j.mrfmmm.2013.04.009; Wu JX, 1999, MOL CELL BIOL, V19, P8292; Zhang XD, 2009, PHARMACOGENOMICS, V10, P345, DOI 10.2217/14622416.10.3.345; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	76	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					848	861		10.1074/jbc.M115.685271	http://dx.doi.org/10.1074/jbc.M115.685271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26559971	Green Published, hybrid			2022-12-28	WOS:000367830500031
J	Silva, APG; Ryan, DP; Galanty, Y; Low, JKK; Vandevenne, M; Jackson, SP; Mackay, JP				Silva, Ana P. G.; Ryan, Daniel P.; Galanty, Yaron; Low, Jason K. K.; Vandevenne, Marylene; Jackson, Stephen P.; Mackay, Joel P.			The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; CELL-CYCLE PROGRESSION; HISTONE DEACETYLASE; MI-2/NURD COMPLEX; DAMAGE; TRANSCRIPTION; NURD; ACTIVATION; SUBUNIT; ATPASE	Chromodomain Helicase DNA-binding protein 4(CHD4) is a chromatin-remodeling enzyme that has been reported to regulate DNA-damage responses through its N-terminal region in a poly(ADP-ribose) polymerase-dependent manner. We have identified and determined the structure of a stable domain (CHD4-N) in this N-terminal region. The-fold consists of a four-alpha-helix bundle with structural similarity to the high mobility group box, a domain that is well known as a DNA binding module. We show that the CHD4-N domain binds with higher affinity to poly(ADP-ribose) than to DNA. We also show that the N-terminal region of CHD4, although not CHD4-N alone, is essential for full nucleosome remodeling activity and is important for localizing CHD4 to sites of DNA damage. Overall, these data build on our understanding of how CHD4-NuRD acts to regulate gene expression and participates in the DNA-damage response.	[Silva, Ana P. G.; Low, Jason K. K.; Vandevenne, Marylene; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Ryan, Daniel P.] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT 2601, Australia; [Galanty, Yaron; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Sydney; Australian National University; John Curtin School of Medical Research; University of Cambridge	Silva, APG (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08,Corner Butlin Ave & Maze Crescent, Sydney, NSW 2006, Australia.	ana.silva@sydney.edu.au; joel.mackay@sydney.edu.au	Jackson, Stephen Philip/R-4548-2019; Mackay, Joel/D-6834-2011	Jackson, Stephen Philip/0000-0001-9317-7937; Low, Jason/0000-0003-0862-0012; Galanty, Yaron/0000-0001-7167-9004; Mackay, Joel/0000-0001-7508-8033; Ryan, Daniel/0000-0001-9842-2620	National Health and Medical Research Council of Australia; Cancer Research UK [11224] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK)	This work was supported by Fellowships and Project Grants (to J. P. M. and D. P. R.) from the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brown JS, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150018; Burd CJ, 2008, J BIOL CHEM, V283, P34976, DOI 10.1074/jbc.M805383200; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dow LK, 2000, BIOCHEMISTRY-US, V39, P9725, DOI 10.1021/bi000723v; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Luger K, 1999, METHOD ENZYMOL, V304, P3; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Ng Patricia Miang-Lon, 2011, Biomol Concepts, V2, P13; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Papoulas O, 2001, P NATL ACAD SCI USA, V98, P5728, DOI 10.1073/pnas.091533398; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Ray S, 2009, NUCLEIC ACIDS RES, V37, P6389, DOI 10.1093/nar/gkp695; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva APG, 2014, BIOMOL NMR ASSIGN, V8, P137, DOI 10.1007/s12104-013-9469-3; Sims JK, 2011, MOL BIOL CELL, V22, P3094, DOI 10.1091/mbc.E11-03-0258; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	72	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					924	938		10.1074/jbc.M115.683227	http://dx.doi.org/10.1074/jbc.M115.683227			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565020	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000367830500038
J	Streit, BR; Kant, R; Tokmina-Lukaszewska, M; Celis, AI; Machovina, MM; Skaar, EP; Bothner, B; DuBois, JL				Streit, Bennett R.; Kant, Ravi; Tokmina-Lukaszewska, Monika; Celis, Arianna I.; Machovina, Melodie M.; Skaar, Eric P.; Bothner, Brian; DuBois, Jennifer L.			Time-resolved Studies of IsdG Protein Identify Molecular Signposts along the Non-canonical Heme Oxygenase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS ISDG; PSEUDOMONAS-AERUGINOSA HEME; MYCOBACTERIUM-TUBERCULOSIS; DEGRADING ENZYMES; CRYSTAL-STRUCTURE; DEGRADATION; HYDROXYLATION; MACROCYCLE; MONOXIDE; COMPLEX	IsdGs are heme monooxygenases that break open the tetrapyrrole, releasing the iron, and thereby allowing bacteria expressing this protein to use heme as a nutritional iron source. Little is currently known about the mechanism by which IsdGs degrade heme, although the products differ from those generated by canonical heme oxygenases. A synthesis of time-resolved techniques, including in proteo mass spectrometry and conventional and stopped-flow UV/visible spectroscopy, was used in conjunction with analytical methods to define the reaction steps mediated by IsdG from Staphylococcus aureus and their time scales. An apparent meso-hydroxyheme (forming with k = 0.6 min(-1), pH7.4, 10 mM ascorbate, 10 mu M IsdG-heme, 22 degrees C) was identified as a likely common intermediate with the canonical heme oxygenases. Unlike heme oxygenases, this intermediate does not form with added H2O2 nor does it convert to verdoheme and CO. Rather, the next observable intermediates (k = 0.16 min(-1)) were a set of formyloxobilin isomers, similar to the mycobilin products of the IsdG homolog from Mycobacterium tuberculosis (MhuD). These converted in separate fast and slow phases to beta-/delta-staphylobilin isomers and formaldehyde (CH2O). Controlled release of this unusual C1 product may support IsdG's dual role as both an oxygenase and a sensor of heme availability in S. aureus.	[Streit, Bennett R.; Kant, Ravi; Tokmina-Lukaszewska, Monika; Celis, Arianna I.; Machovina, Melodie M.; Bothner, Brian; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA; [Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Skaar, Eric P.] US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Montana State University System; Montana State University Bozeman; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, 221 Chem & Biochem Bldg, Bozeman, MT 59715 USA.	jdubois@chemistry.montana.edu		Celis, Arianna/0000-0002-5116-9768	Murdock Charitable Trust; National Institutes of Health of the CoBRE program [5P20RR02437]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732, R01GM090260] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health of the CoBRE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Dr. Jonathan Hilmer for sharing technical expertise in mass spectrometry. We thank Garrett Moraski for helpful discussions. Dr. Sunil Ojha is thanked for contributing to the initiation of this project. The mass spectrometry facility at Montana State University receives funding from the Murdock Charitable Trust and National Institutes of Health Grant 5P20RR02437 of the CoBRE program.	Bothner B, 2000, J BIOL CHEM, V275, P13455, DOI 10.1074/jbc.275.18.13455; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Caignan GA, 2003, J AM CHEM SOC, V125, P11842, DOI 10.1021/ja036147i; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Christ B, 2013, PLANT CELL, V25, P1868, DOI 10.1105/tpc.113.112151; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Galbraith R, 1999, P SOC EXP BIOL MED, V222, P299, DOI 10.1046/j.1525-1373.1999.d01-147.x; Graves AB, 2014, INORG CHEM, V53, P5931, DOI 10.1021/ic500033b; Hortensteiner S, 1998, J BIOL CHEM, V273, P15335, DOI 10.1074/jbc.273.25.15335; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Liu Y, 1997, J BIOL CHEM, V272, P6909, DOI 10.1074/jbc.272.11.6909; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Ortiz de Montellano P. R., 2000, ADV INORG CHEM, V51, P359; Pishchany G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002535; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2011, BIOCHEMISTRY-US, V50, P6730, DOI 10.1021/bi200999q; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Sugishima M, 2002, J BIOL CHEM, V277, P45086, DOI 10.1074/jbc.M207267200; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200	31	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					862	871		10.1074/jbc.M115.666560	http://dx.doi.org/10.1074/jbc.M115.666560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26534961	Green Published, hybrid			2022-12-28	WOS:000367830500032
J	Rozycki, M; Bialik, JF; Speight, P; Dan, QH; Knudsen, TET; Szeto, SG; Yuen, DA; Szaszi, K; Pedersen, SF; Kapus, A				Rozycki, Matthew; Bialik, Janne Folke; Speight, Pam; Dan, Qinghong; Knudsen, Teresa E. T.; Szeto, Stephen G.; Yuen, Darren A.; Szaszi, Katalin; Pedersen, Stine F.; Kapus, Andras			Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; epithelium; kidney; myocardin; myofibroblast; NADPH oxidase; promoter; transforming growth factor (TGF-); Yes-associated protein (YAP)	PERICYTE-MYOFIBROBLAST TRANSITION; CELL-CELL CONTACTS; NADPH OXIDASE 4; NAD(P)H OXIDASE; TGF-BETA; KAPPA-B; TUBULOINTERSTITIAL FIBROSIS; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; OXIDATIVE STRESS	Background: Generation of myofibroblasts, the culprit of fibrosis, requires cytoskeleton remodeling and Nox4 (NADPH oxidase) expression. The link between these events is unknown. Results: Down-regulation/inhibition of the cytoskeleton-controlled transcriptional coactivators, myocardin-related transcription factor (MRTF), and TAZ/YAP abrogates Nox4 expression. Conclusion: MRTF and TAZ/YAP are essential for Nox4 expression. Significance: We show new mechanisms whereby the cytoskeleton regulates cellular redox state and fibrogenesis. TGF-induced expression of the NADPH oxidase Nox4 is essential for fibroblast-myofibroblast transition. Rho has been implicated in Nox4 regulation, but the underlying mechanisms are largely unknown. Myocardin-related transcription factor (MRTF), a Rho/actin polymerization-controlled coactivator of serum response factor, drives myofibroblast transition from various precursors. We have shown that TGF is necessary but insufficient for epithelial-myofibroblast transition in intact epithelia; the other prerequisite is the uncoupling of intercellular contacts, which induces Rho-dependent nuclear translocation of MRTF. Because the Nox4 promoter harbors a serum response factor/MRTF cis-element (CC(A/T)(6)GG box), we asked if MRTF (and thus cytoskeleton organization) could regulate Nox4 expression. We show that Nox4 protein is robustly induced in kidney tubular cells exclusively by combined application of contact uncoupling and TGF. Nox4 knockdown abrogates epithelial-myofibroblast transition-associated reactive oxygen species production. Laser capture microdissection reveals increased Nox4 expression in the tubular epithelium also during obstructive nephropathy. MRTF down-regulation/inhibition suppresses TGF/contact disruption-provoked Nox4 protein and mRNA expression, Nox4 promoter activation, and reactive oxygen species production. Mutation of the CC(A/T)(6)GG box eliminates the synergistic activation of the Nox4 promoter. Jasplakinolide-induced actin polymerization synergizes with TGF to facilitate MRTF-dependent Nox4 mRNA expression/promoter activation. Moreover, MRTF inhibition prevents Nox4 expression during TGF-induced fibroblast-myofibroblast transition as well. Although necessary, MRTF is insufficient; Nox4 expression also requires TGF-activated Smad3 and TAZ/YAP, two contact- and cytoskeleton-regulated Smad3-interacting coactivators. Down-regulation/inhibition of TAZ/YAP mitigates injury-induced epithelial Nox4 expression in vitro and in vivo. These findings uncover new MRTF- and TAZ/YAP-dependent mechanisms, which link cytoskeleton remodeling and redox state and impact epithelial plasticity and myofibroblast transition.	[Yuen, Darren A.; Szaszi, Katalin; Kapus, Andras] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1T8, Canada; [Szaszi, Katalin; Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B IT8, Canada; [Kapus, Andras] Univ Toronto, Dept Biochem, Toronto, ON M5B IT8, Canada; [Bialik, Janne Folke; Knudsen, Teresa E. T.; Pedersen, Stine F.] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, DK-2100 Copenhagen, Denmark	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Copenhagen	Kapus, A (corresponding author), Keenan Res Ctr Biomed Sci, Rm 621,209 Victoria St, Toronto, ON M5B 1T8, Canada.	kapusa@smh.ca	Pedersen, Stine Falsig/O-1133-2019; Bialik, Janne Folke/F-5200-2017	Pedersen, Stine Falsig/0000-0002-3044-7714; Kapus, Andras/0000-0002-6610-9530; Bialik, Janne Folke/0000-0003-1042-8169; Knudsen, Teresa/0000-0002-8080-8928	Canadian Institute of Health Research [MOP-86535, MOP-106625, MOP-130463]; Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada [RGPIN227-908-13, RGPIN 327407]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institute of Health Research Grants MOP-86535, MOP-106625, and MOP-130463 (to A. K.), the Kidney Foundation of Canada (to A. K. and K. S.), and by Natural Sciences and Engineering Research Council of Canada Grant RGPIN227-908-13 (to A. K.) and Grant RGPIN 327407 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bai GX, 2014, GENE, V540, P62, DOI 10.1016/j.gene.2014.02.026; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Choy JS, 2014, AM J PHYSIOL-HEART C, V306, pH69, DOI 10.1152/ajpheart.00402.2013; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Ding Y, 2015, J ENDOCRINOL, V224, pR15, DOI 10.1530/JOE-14-0437; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Fan LZ, 2004, BIOCHEM J, V380, P581, DOI 10.1042/BJ20040178; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Holterman CE, 2015, CLIN SCI, V128, P465, DOI 10.1042/CS20140361; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; Kim JH, 2012, STEM CELLS DEV, V21, P2212, DOI 10.1089/scd.2011.0561; Kohda Y, 2000, KIDNEY INT, V57, P321, DOI 10.1046/j.1523-1755.2000.00824.x; Kramann R, 2014, SEMIN NEPHROL, V34, P374, DOI 10.1016/j.semnephrol.2014.06.004; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Manickam N, 2014, AM J PHYSIOL-RENAL, V307, pF159, DOI 10.1152/ajprenal.00546.2013; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nagatoya K, 2002, KIDNEY INT, V61, P1684, DOI 10.1046/j.1523-1755.2002.00328.x; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pendyala S, 2011, FREE RADICAL BIO MED, V50, P1749, DOI 10.1016/j.freeradbiomed.2011.03.022; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rozycki M, 2014, MOL BIOL CELL, V25, P643, DOI 10.1091/mbc.E13-07-0429; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shu XZ, 2015, GENE, V563, P17, DOI 10.1016/j.gene.2015.02.076; Sisson TH, 2015, AM J PATHOL, V185, P969, DOI 10.1016/j.ajpath.2014.12.005; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Speight P, 2013, MOL BIOL CELL, V24, P3326, DOI 10.1091/mbc.E13-04-0220; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wingler K, 2012, CELL MOL LIFE SCI, V69, P3159, DOI 10.1007/s00018-012-1107-1; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Xu YF, 2013, INT J MOL MED, V31, P628, DOI 10.3892/ijmm.2013.1232; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhao QD, 2015, CIRCULATION, V131, P643, DOI 10.1161/CIRCULATIONAHA.114.011079	90	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					227	243		10.1074/jbc.M115.674606	http://dx.doi.org/10.1074/jbc.M115.674606			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26555261	Green Published, hybrid			2022-12-28	WOS:000367589500018
J	Mora, L; Moncoq, K; England, P; Oberto, J; de Zamaroczy, M				Mora, Liliana; Moncoq, Karine; England, Patrick; Oberto, Jacques; de Zamaroczy, Miklos			The Stable Interaction Between Signal Peptidase LepB of Escherichia coli and Nuclease Bacteriocins Promotes Toxin Entry into the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOONLIGHTING PROTEINS; CELLULAR FUNCTIONS; LEADER PEPTIDASE; IMMUNITY PROTEIN; D TRNASE; DOMAIN; TRANSLOCATION; COLICIN-E3; MECHANISM	LepB is a key membrane component of the cellular secretion machinery, which releases secreted proteins into the periplasm by cleaving the inner membrane-bound leader. We showed that LepB is also an essential component of the machinery hijacked by the tRNase colicin D for its import. Here we demonstrate that this non-catalytic activity of LepB is to promote the association of the central domain of colicin D with the inner membrane before the FtsH-dependent proteolytic processing and translocation of the toxic tRNase domain into the cytoplasm. The novel structural role of LepB results in a stable interaction with colicin D, with a stoichiometry of 1: 1 and a nanomolar K-d determined in vitro. LepB provides a chaperone-like function for the penetration of several nuclease-type bacteriocins into target cells. The colicin-LepB interaction is shown to require only a short peptide sequence within the central domain of these bacteriocins and to involve residues present in the short C-terminal Box E of LepB. Genomic screening identified the conserved LepB binding motif in colicin-like ORFs from 13 additional bacterial species. These findings establish a new paradigm for the functional adaptability of an essential inner-membrane enzyme.	[Mora, Liliana; de Zamaroczy, Miklos] CNRS, Inst Biol Physicochim, FRE UPR 3630 9073, F-75005 Paris, France; [Moncoq, Karine] Univ Paris 07, UMR 7099, CNRS, Inst Biol Physicochim, F-75005 Paris, France; [England, Patrick] CNRS, Inst Pasteur, PFBMI, UMR 3528, F-75015 Paris, France; [Oberto, Jacques] Univ Paris 11, CNRS, CEA, Inst Integrat Cellular Biol, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	de Zamaroczy, M (corresponding author), CNRS, IBPC, FRE UPR 3630 9073, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	zamaroczy@ibpc.fr		ENGLAND, Patrick/0000-0001-6410-5918	CNRS (France)	CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNRS (France). The authors declare that they have no conflicts of interest with the contents of this article.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Ayuso-Tejedor S, 2010, J STRUCT BIOL, V171, P117, DOI 10.1016/j.jsb.2010.05.001; Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; BILGIN N, 1990, EMBO J, V9, P2717, DOI 10.1002/j.1460-2075.1990.tb07458.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Chavan M, 2005, J MOL EVOL, V60, P546, DOI 10.1007/s00239-004-0263-9; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; de Zamaroczy M, 2012, BIOCHEM SOC T, V40, P1486, DOI 10.1042/BST20120173; de Zamaroczy M, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P255, DOI 10.1007/978-1-4419-7692-5_14; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; Kageyama M, 1996, J BACTERIOL, V178, P103, DOI 10.1128/jb.178.1.103-110.1996; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Klenotic PA, 2000, J BIOL CHEM, V275, P6490, DOI 10.1074/jbc.275.9.6490; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Mora L, 2008, J BIOL CHEM, V283, P4993, DOI 10.1074/jbc.M706846200; Mora L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096549; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Murphy T, 2007, J BIOTECHNOL, V131, P397, DOI 10.1016/j.jbiotec.2007.07.943; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paetzel M, 2014, BBA-MOL CELL RES, V1843, P1497, DOI 10.1016/j.bbamcr.2013.12.003; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Vankemmelbeke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046656; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	52	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30783	30796		10.1074/jbc.M115.691907	http://dx.doi.org/10.1074/jbc.M115.691907			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26499796	hybrid, Green Published			2022-12-28	WOS:000367199000012
J	Im, I; Jang, MJ; Park, SJ; Lee, SH; Choi, JH; Yoo, HW; Kim, S; Han, YM				Im, Ilkyun; Jang, Mi-jin; Park, Seung Ju; Lee, Sang-Hee; Choi, Jin-Ho; Yoo, Han-Wook; Kim, Seyun; Han, Yong-Mahn			Mitochondrial Respiratory Defect Causes Dysfunctional Lactate Turnover via AMP-activated Protein Kinase Activation in Human-induced Pluripotent Stem Cell-derived Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACIDOSIS; COMPLEX-I; ELECTRON-TRANSPORT; GENE-MUTATIONS; CHAIN COMPLEX; LIVER-DISEASE; DOUBLE-BLIND; ND1 GENE; PATIENT; DIFFERENTIATION	A defective mitochondrial respiratory chain complex (DMRC) causes various metabolic disorders in humans. However, the pathophysiology of DMRC in the liver remains unclear. To understand DMRC pathophysiology in vitro, DMRC-induced pluripotent stem cells were generated from dermal fibroblasts of a DMRC patient who had a homoplasmic mutation (m.3398T -> C) in the mitochondrion-encoded NADH dehydrogenase 1 (MTND1) gene and that differentiated into hepatocytes (DMRC hepatocytes) in vitro. DMRC hepatocytes showed abnormalities in mitochondrial characteristics, the NAD(+)/NADH ratio, the glycogen storage level, the lactate turnover rate, and AMPK activity. Intriguingly, low glycogen storage and transcription of lactate turnover-related genes in DMRC hepatocytes were recovered by inhibition of AMPK activity. Thus, AMPK activation led to metabolic changes in terms of glycogen storage and lactate turnover in DMRC hepatocytes. These data demonstrate for the first time that energy depletion may lead to lactic acidosis in the DMRC patient by reduction of lactate uptake via AMPK in liver.	[Im, Ilkyun; Jang, Mi-jin; Park, Seung Ju; Kim, Seyun; Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Im, Ilkyun; Jang, Mi-jin; Han, Yong-Mahn] Korea Adv Inst Sci & Technol, Ctr Stem Cell Differentiat, Daejeon 34141, South Korea; [Lee, Sang-Hee] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Daejeon 34141, South Korea; [Choi, Jin-Ho; Yoo, Han-Wook] Univ Ulsan, Childrens Hosp, Coll Med, Asan Med Ctr,Dept Pediat, Seoul 05505, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of Ulsan	Han, YM (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.	ymhan@kaist.ac.kr	Han, Yong-Mahn/C-1652-2011; Kim, Seyun/B-3387-2012		National Research Foundation of Korea, Stem Cell Program - Ministry of Science, ICT, and Future Planning [2011-0019509, 2012M3A9C7050175]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120275]	National Research Foundation of Korea, Stem Cell Program - Ministry of Science, ICT, and Future Planning; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea, Stem Cell Program Grants 2011-0019509 and 2012M3A9C7050175 funded by Ministry of Science, ICT, and Future Planning, and Grant A120275 from Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Baharvand Hossein, 2003, Reprod Biomed Online, V7, P330; Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200; Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Chamberlain SJ, 2008, NEUROGENETICS, V9, P227, DOI 10.1007/s10048-008-0147-z; Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445; Chen Y, 2000, DIABETES RES CLIN PR, V48, P29, DOI 10.1016/S0168-8227(99)00138-2; Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; Di Rocco M, 2000, Eur J Paediatr Neurol, V4, P115, DOI 10.1053/ejpn.2000.0278; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; Jaksch M, 1996, HUM MUTAT, V7, P358, DOI 10.1002/(SICI)1098-1004(1996)7:4<358::AID-HUMU11>3.3.CO;2-V; Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008; Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x; Leber T., 1871, ALBRECHT GRAEFES ARC, V17, P249, DOI [10.1007/BF01694557, DOI 10.1007/BF01694557]; Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Mowat D, 1999, J PEDIATR-US, V134, P352, DOI 10.1016/S0022-3476(99)70463-4; Nussbaum RL, 2005, J CLIN INVEST, V115, P2689, DOI 10.1172/JCI26625; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427; Oh SK, 2005, STEM CELLS, V23, P211, DOI 10.1634/stemcells.2004-0122; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park SW, 2014, BIOCHEM BIOPH RES CO, V446, P493, DOI 10.1016/j.bbrc.2014.02.141; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; STACPOOLE PW, 1993, ENDOCRIN METAB CLIN, V22, P221, DOI 10.1016/S0889-8529(18)30163-4; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang S, 2010, MITOCHONDRION, V10, P350, DOI 10.1016/j.mito.2010.02.003; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	58	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29493	29505		10.1074/jbc.M115.670364	http://dx.doi.org/10.1074/jbc.M115.670364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26491018	Green Published, hybrid			2022-12-28	WOS:000366613400032
J	Anamika; Spyracopoulos, L				Anamika; Spyracopoulos, Leo			Molecular Basis for Phosphorylation-dependent SUMO Recognition by the DNA Repair Protein RAP80	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENT; CORRELATING BACKBONE AMIDE; SIDE-CHAIN RESONANCES; DOUBLE-STRAND BREAKS; LABELED PROTEINS; DAMAGE RESPONSE; NMR EXPERIMENTS; CHEMICAL-SHIFT; CRYSTAL-STRUCTURES; MODIFIER SUMO	Recognition and repair of double-stranded DNA breaks (DSB) involves the targeted recruitment of BRCA tumor suppressors to damage foci through binding of both ubiquitin (Ub) and the Ub-like modifier SUMO. RAP80 is a component of the BRCA1 A complex, and plays a key role in the recruitment process through the binding of Lys63-linked poly-Ub chains by tandem Ub interacting motifs (UIM). RAP80 also contains aSUMO interacting motif (SIM) just upstream of the tandem UIMs that has been shown to specifically bind the SUMO-2 isoform. The RAP80 tandem UIMs and SIM function collectively for optimal recruitment of BRCA1 to DSBs, although the molecular basis of this process is not well understood. Using NMR spectroscopy, we demonstrate that the RAP80 SIM binds SUMO-2, and that both specificity and affinity are enhanced through phosphorylation of the canonical CK2 site within the SIM. The affinity increase results from an enhancement of electrostatic interactions between the phosphoserines of RAP80 and the SIM recognition module within SUMO-2. The NMR structure of the SUMO-2 similar to phospho-RAP80 complex reveals that the molecular basis for SUMO-2 specificity is due to isoform-specific sequence differences in electrostatic SIM recognition modules.	[Anamika; Spyracopoulos, Leo] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Spyracopoulos, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	leo.spyracopoulos@ualberta.ca			Canadian Institutes of Health Research [MOP 110964]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP 110964 (to L. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anamika, 2014, J BIOL CHEM, V289, P12852, DOI 10.1074/jbc.M113.538280; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bologna Serena, 2013, Frontiers in Genetics, V4, P106, DOI 10.3389/fgene.2013.00106; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; Case D., 2015, AMBER, V14; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Cheema A, 2010, J CELL PHYSIOL, V225, P371, DOI 10.1002/jcp.22224; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gardner KH, 1996, J BIOMOL NMR, V8, P351, DOI 10.1007/BF00410333; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Goddard D., 2008, SPARKY 3; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hu X, 2012, J BIOL CHEM, V287, P25510, DOI 10.1074/jbc.M112.374116; Huang WC, 2004, EUR J BIOCHEM, V271, P4114, DOI 10.1111/j.1432-1033.2004.04349.x; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller R., 2004, COMPUTER AIDED RESON, V1; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Leonidas DD, 2003, PROTEIN SCI, V12, P2559, DOI 10.1110/ps.03196603; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; LYONS BA, 1993, J MAGN RESON SER B, V101, P206, DOI 10.1006/jmrb.1993.1034; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Markin CJ, 2012, J BIOMOL NMR, V54, P355, DOI 10.1007/s10858-012-9678-6; Markin CJ, 2012, J BIOMOL NMR, V53, P125, DOI 10.1007/s10858-012-9630-9; Markin CJ, 2010, J AM CHEM SOC, V132, P11247, DOI 10.1021/ja103869x; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; RUTERJANS H, 1969, EUR J BIOCHEM, V9, P118, DOI 10.1111/j.1432-1033.1969.tb00584.x; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; SZYPERSKI T, 1995, J MAGN RESON SER B, V108, P197, DOI 10.1006/jmrb.1995.1124; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Tholey A, 1999, BIOPHYS J, V76, P76, DOI 10.1016/S0006-3495(99)77179-1; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yata K, 2012, MOL CELL, V45, P371, DOI 10.1016/j.molcel.2011.12.028	68	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4417	4428		10.1074/jbc.M115.705061	http://dx.doi.org/10.1074/jbc.M115.705061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26719330	Green Published, hybrid			2022-12-28	WOS:000371604600014
J	Zhang, GH; An, YF; Lu, X; Zhong, H; Zhu, YH; Wu, YM; Ma, F; Yang, JM; Liu, YC; Zhou, ZP; Peng, Y; Chen, ZF				Zhang, Guohai; An, Yunfeng; Lu, Xing; Zhong, Hui; Zhu, Yanhong; Wu, Yiming; Ma, Feng'e; Yang, Jingmei; Liu, Yancheng; Zhou, Zuping; Peng, Yan; Chen, Zhenfeng			A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak center dot Bcl-xl Complex and Triggering Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; apoptosis; cell cycle; lung cancer; p53	SER389 PHOSPHORYLATION; DNA-DAMAGE; PROTEIN; APOPTOSIS; PATHWAY; PROLIFERATION; ACCUMULATION; STATISTICS; ACTIVATION; ARREST	p53 inactivation is a hallmark in non-small-cell lung cancer (NSCLC). It is therefore highly desirable to develop tumor-specific treatment for NSCLC therapy by restoring p53 function. Herein, a novel naphthalimide compound, NA-17, was identified as a promising drug candidate in view of both its anticancer activity and mechanism of action. NA-17 exhibited strong anticancer activity on a broad range of cancer cell lines but showed low toxicity to normal cell lines, such as HL-7702 and WI-38. Moreover, NA-17 showed p53-dependent inhibition selectivity in different NSCLC cell lines due to the activation state of endogenous p53 in the background level. Further studies revealed that NA-17 caused cell cycle arrest at the G(1) phase, changed cell size, and induced apoptosis and cell death by increasing the proportion of sub-G(1) cells. Molecular mechanism studies suggested that targeted accumulation of phospho-p53 in mitochondria and nuclei induced by NA-17 resulted in activation of Bak and direct binding of phospho-p53 to the target DNA sequences, thereby evoking cell apoptosis and cell cycle arrest and eventually leading to irreversible cancer cell inhibition. This work provided new insights into the molecular interactions and anticancer mechanisms of phospho-p53-dependent naphthalimide compounds.	[Zhang, Guohai; An, Yunfeng; Lu, Xing; Zhong, Hui; Zhu, Yanhong; Wu, Yiming; Ma, Feng'e; Yang, Jingmei; Liu, Yancheng; Zhou, Zuping; Peng, Yan; Chen, Zhenfeng] Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Yucai Rd 15, Guilin 541004, Peoples R China	Guangxi Normal University	Peng, Y; Chen, ZF (corresponding author), Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Yucai Rd 15, Guilin 541004, Peoples R China.	pengyan630@gxnu.edu.cn; chenzf@gxnu.edu.cn		Lu, Xing/0000-0002-2796-4390	Natural Science Foundation of China [81401912]; Ministry of Education Innovation Team [IRT1225]; Natural Science Foundation of Guangxi Province [2013GXNS-FBA019159, 2014GXNSFAA118165, 2015GXNSFDA139010]; Guangxi Scientific Research and Technology Development Project [13349002]; Guangxi Pharmaceutical Industry Talent Small Highland Project [1309, 1312]; Foundation of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources; Ministry of Science and Technology of China [CMEMR2015-A09, CMEMR2013-A07]; Bagui scholar program	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Innovation Team; Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Guangxi Scientific Research and Technology Development Project; Guangxi Pharmaceutical Industry Talent Small Highland Project; Foundation of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Bagui scholar program	This work was supported by Natural Science Foundation of China Grant 81401912; The Ministry of Education Innovation Team Grant IRT1225; Natural Science Foundation of Guangxi Province Grants 2013GXNS-FBA019159, 2014GXNSFAA118165, and 2015GXNSFDA139010; Guangxi Scientific Research and Technology Development Project Grant 13349002; Guangxi Pharmaceutical Industry Talent Small Highland Project Grants 1309 and 1312; the Foundation of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources; Ministry of Science and Technology of China Grants CMEMR2015-A09 and CMEMR2013-A07; and the Bagui scholar program (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bourouba M, 2011, EUR CYTOKINE NETW, V22, P38, DOI 10.1684/ecn.2011.0270; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Busch SE, 2014, ONCOGENE, V33, P2665, DOI 10.1038/onc.2013.208; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Elias J, 2014, BBA-PROTEINS PROTEOM, V1844, P232, DOI 10.1016/j.bbapap.2013.09.019; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Follis AV, 2014, NAT STRUCT MOL BIOL, V21, P535, DOI 10.1038/nsmb.2829; Freeman CL, 2012, EXPERT REV HEMATOL, V5, P17, DOI [10.1586/ehm.11.68, 10.1586/EHM.11.68]; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hao MM, 1996, J BIOL CHEM, V271, P29380, DOI 10.1074/jbc.271.46.29380; Hoogervorst EM, 2005, CANCER RES, V65, P3610, DOI 10.1158/0008-5472.CAN-04-4328; Ingrassia L, 2009, CURR MED CHEM, V16, P1192, DOI 10.2174/092986709787846659; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Marcel V, 2013, CANCER CELL, V24, P318, DOI 10.1016/j.ccr.2013.08.013; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; MIYASHITA T, 1995, CELL, V80, P293; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mollereau B, 2014, APOPTOSIS, V19, P1421, DOI 10.1007/s10495-014-1035-7; Nieminen AI, 2013, P NATL ACAD SCI USA, V110, pE1839, DOI 10.1073/pnas.1208530110; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Van Quaquebeke E, 2007, J MED CHEM, V50, P4122, DOI 10.1021/jm070315q; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walls TH, 2012, BIOORGAN MED CHEM, V20, P5269, DOI 10.1016/j.bmc.2012.06.042; Wawryk-Gawda E, 2014, PROTOPLASMA, V251, P525, DOI 10.1007/s00709-013-0548-1; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Yao GD, 2014, ARCH BIOCHEM BIOPHYS, V558, P51, DOI 10.1016/j.abb.2014.05.029; Zhang GH, 2013, BIOCHEM PHARMACOL, V86, P1721, DOI 10.1016/j.bcp.2013.10.013; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhu H, 2009, NEOPLASIA, V11, P1226, DOI 10.1593/neo.09986	44	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4211	4225		10.1074/jbc.M115.669978	http://dx.doi.org/10.1074/jbc.M115.669978			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26668309	Green Published, hybrid			2022-12-28	WOS:000371338400044
J	Chang, CW; Chiang, CW; Gaffaney, JD; Chapman, ER; Jackson, MB				Chang, Che-Wei; Chiang, Chung-Wei; Gaffaney, Jon D.; Chapman, Edwin R.; Jackson, Meyer B.			Lipid-anchored Synaptobrevin Provides Little or No Support for Exocytosis or Liposome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED MEMBRANE-FUSION; CA2+-TRIGGERED EXOCYTOSIS; VESICLE FUSION; SNARE COMPLEX; TRANSMEMBRANE-DOMAIN; C-TERMINUS; PORES; SYNAPTOTAGMIN; FORCE; SUFFICIENT	SNARE proteins catalyze many forms of biological membrane fusion, including Ca2+-triggered exocytosis. Although fusion mediated by SNAREs generally involves proteins anchored to each fusing membrane by a transmembrane domain (TMD), the role of TMDs remains unclear, and previous studies diverge on whether SNAREs can drive fusion without a TMD. This issue is important because it relates to the question of the structure and composition of the initial fusion pore, as well as the question of whether SNAREs mediate fusion solely by creating close proximity between two membranes versus a more active role in transmitting force to the membrane to deform and reorganize lipid bilayer structure. To test the role of membrane attachment, we generated four variants of the synaptic v-SNARE synaptobrevin-2 (syb2) anchored to the membrane by lipid instead of protein. These constructs were tested for functional efficacy in three different systems as follows: Ca2+-triggered dense core vesicle exocytosis, spontaneous synaptic vesicle exocytosis, and Ca2+-synaptotagmin-enhanced SNARE-mediated liposome fusion. Lipid-anchoring motifs harboring one or two lipid acylation sites completely failed to support fusion in any of these assays. Only the lipid-anchoring motif from cysteine string protein-alpha, which harbors many lipid acylation sites, provided support for fusion but at levels well below that achieved with wild type syb2. Thus, lipid-anchored syb2 provides little or no support for exocytosis, and anchoring syb2 to a membrane by a TMD greatly improves its function. The low activity seen with syb2-cysteine string protein-alpha may reflect a slower alternative mode of SNARE-mediated membrane fusion.	[Chang, Che-Wei; Jackson, Meyer B.] Univ Wisconsin, Physiol PhD Grad Training Program, Madison, WI 53705 USA; [Chiang, Chung-Wei; Chapman, Edwin R.; Jackson, Meyer B.] Univ Wisconsin, Biophys PhD Program, Madison, WI 53705 USA; [Gaffaney, Jon D.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53705 USA; [Chapman, Edwin R.; Jackson, Meyer B.] Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA.	mbjackso@wisc.edu		Chiang, Chung-Wei/0000-0002-9443-914X; Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health [NS44057, MH061876]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS44057 (to M. B. J.) and MH061876 (to E. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Borisovska M, 2012, J NEUROSCI, V32, P15983, DOI 10.1523/JNEUROSCI.6282-11.2012; Chang CW, 2015, BIOPHYS J, V109, P76, DOI 10.1016/j.bpj.2015.05.021; Chang CW, 2015, J NEUROSCI, V35, P5772, DOI 10.1523/JNEUROSCI.3983-14.2015; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fdez E, 2010, J CELL SCI, V123, P2473, DOI 10.1242/jcs.061325; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Grote E, 2000, J CELL BIOL, V151, P453, DOI 10.1083/jcb.151.2.453; Guzman RE, 2010, J NEUROSCI, V30, P10272, DOI 10.1523/JNEUROSCI.1551-10.2010; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Han X, 2005, BIOPHYS J, V88, pL20, DOI 10.1529/biophysj.104.056739; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jackson MB, 2011, CURR TOP MEMBR, V68, P185, DOI 10.1016/B978-0-12-385891-7.00008-8; Jackson MB, 2010, J MEMBRANE BIOL, V235, P89, DOI 10.1007/s00232-010-9258-1; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Lindau M, 2012, BIOPHYS J, V103, P959, DOI 10.1016/j.bpj.2012.08.007; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Ngatchou AN, 2010, P NATL ACAD SCI USA, V107, P18463, DOI 10.1073/pnas.1006727107; Pieren M, 2015, J BIOL CHEM, V290, P12821, DOI 10.1074/jbc.M115.647776; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Ramirez Denise M O, 2012, Cell Logist, V2, P20; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zhang Z, 2010, BIOPHYS J, V98, P2524, DOI 10.1016/j.bpj.2010.02.043; Zhang ZJ, 2010, BIOPHYS J, V98, P968, DOI 10.1016/j.bpj.2009.11.024; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	47	26	26	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2848	2857		10.1074/jbc.M115.701169	http://dx.doi.org/10.1074/jbc.M115.701169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26663078	hybrid, Green Published			2022-12-28	WOS:000369626900024
J	Henrich, E; Ma, Y; Engels, I; Munch, D; Otten, C; Schneider, T; Henrichfreise, B; Sahl, HG; Dotsch, V; Bernhard, F				Henrich, Erik; Ma, Yi; Engels, Ina; Muench, Daniela; Otten, Christian; Schneider, Tanja; Henrichfreise, Beate; Sahl, Hans-Georg; Doetsch, Volker; Bernhard, Frank			Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOSYNTHESIS; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; FREE EXPRESSION; D-GLUTAMATE; PEPTIDOGLYCAN; LIGASE; IDENTIFICATION; TRANSFERASE; CHLAMYDIA	Screening of new compounds directed against key protein targets must continually keep pace with emerging antibiotic resistances. Although periplasmic enzymes of bacterial cell wall biosynthesis have been among the first drug targets, compounds directed against the membrane-integrated catalysts are hardly available. A promising future target is the integral membrane protein MraY catalyzing the first membrane associated step within the cytoplasmic pathway of bacterial peptidoglycan biosynthesis. However, the expression of most MraY homologues in cellular expression systems is challenging and limits biochemical analysis. We report the efficient production of MraY homologues from various human pathogens by synthetic cell-free expression approaches and their subsequent characterization. MraY homologues originating from Bordetella pertussis, Helicobacter pylori, Chlamydia pneumoniae, Borrelia burgdorferi, and Escherichia coli as well as Bacillus subtilis were co-translationally solubilized using either detergent micelles or preformed nanodiscs assembled with defined membranes. All MraY enzymes originating from Gram-negative bacteria were sensitive to detergents and required nanodiscs containing negatively charged lipids for obtaining a stable and functionally folded conformation. In contrast, the Gram-positive B. subtilis MraY not only tolerates detergent but is also less specific for its lipid environment. The MraY.nanodisc complexes were able to reconstitute a complete in vitro lipid I and lipid II forming pipeline in combination with the cell-free expressed soluble enzymes MurA-F and with the membrane-associated protein MurG. As a proof of principle for future screening platforms, we demonstrate the inhibition of the in vitro lipid II biosynthesis with the specific inhibitors fosfomycin, feglymycin, and tunicamycin.	[Henrich, Erik; Ma, Yi; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Ma, Yi] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Engels, Ina; Muench, Daniela; Otten, Christian; Schneider, Tanja; Henrichfreise, Beate; Sahl, Hans-Georg] Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany; [Ma, Yi; Schneider, Tanja; Sahl, Hans-Georg] German Ctr Infect Res DZIF, Partner Site Cologne Bonn, D-53115 Bonn, Germany; [Otten, Christian] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Goethe University Frankfurt; South China University of Technology; University of Bonn; German Center for Infection Research; Newcastle University - UK	Ma, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.; Bernhard, F (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	bimayikobe@scut.edu.cn; fbern@bpc.uni-frankfurt.de	Schneider, Tanja/L-8049-2013	Schneider, Tanja/0000-0001-7269-4716; Bernhard, Frank/0000-0002-4860-1783; Rausch, Daniela/0000-0003-3211-5745; Dotsch, Volker/0000-0001-5720-212X	Collaborative Research Center (SFB) of the German Research Foundation (Deutsche Forschungsgemeinschaft) [807]; German Ministry of Education and Science (BMBF); Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); National Natural Science Foundation of China [21306055]; Natural Science Foundation of Guangdong Province, China [2014A030313261]	Collaborative Research Center (SFB) of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported in part by the Collaborative Research Center (SFB) Grant 807 of the German Research Foundation (Deutsche Forschungsgemeinschaft), the German Ministry of Education and Science (BMBF), and Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the National Natural Science Foundation of China Grant 21306055 and Natural Science Foundation of Guangdong Province, China Grant 2014A030313261. To whom correspondence may be addressed: School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China. E-mail: bimayikobe@scut.edu.cn.	Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; Benson TE, 1996, STRUCTURE, V4, P47, DOI 10.1016/S0969-2126(96)00008-1; Bertrand JA, 1997, EMBO J, V16, P3416, DOI 10.1093/emboj/16.12.3416; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dini C, 2000, BIOORG MED CHEM LETT, V10, P1839, DOI 10.1016/S0960-894X(00)00349-8; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; ELBEIN AD, 1979, ANNU REV PLANT PHYS, V30, P239, DOI 10.1146/annurev.pp.30.060179.001323; Gordon E, 2001, J BIOL CHEM, V276, P10999, DOI 10.1074/jbc.M009835200; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hein C, 2014, ENG LIFE SCI, V14, P365, DOI 10.1002/elsc.201300050; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Huang LY, 2014, ANGEW CHEM INT EDIT, V53, P8060, DOI 10.1002/anie.201402313; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; INUKAI M, 1993, ANTIMICROB AGENTS CH, V37, P980, DOI 10.1128/AAC.37.5.980; Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Ma Y, 2011, J BIOL CHEM, V286, P38844, DOI 10.1074/jbc.M111.301085; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Mihalyi A, 2014, BIOORGAN MED CHEM, V22, P4566, DOI 10.1016/j.bmc.2014.07.035; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; Muller A, 2012, J BIOL CHEM, V287, P20270, DOI 10.1074/jbc.M112.369561; Packiam M, 2015, P NATL ACAD SCI USA, V112, P11660, DOI 10.1073/pnas.1514026112; Rausch S, 2011, CHEMBIOCHEM, V12, P1171, DOI 10.1002/cbic.201100120; Roos C, 2012, BBA-BIOMEMBRANES, V1818, P3098, DOI 10.1016/j.bbamem.2012.08.007; Rubinchik E, 2011, ANTIMICROB AGENTS CH, V55, P2743, DOI 10.1128/AAC.00170-11; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Sheng JY, 2014, APPL MICROBIOL BIOT, V98, P1785, DOI 10.1007/s00253-013-5467-8; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yan YW, 2000, J MOL BIOL, V304, P435, DOI 10.1006/jmbi.2000.4215	45	43	43	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2535	2546		10.1074/jbc.M115.664292	http://dx.doi.org/10.1074/jbc.M115.664292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26620564	Green Published, hybrid			2022-12-28	WOS:000369610400040
J	Zhang, XJ; MacDonald, BT; Gao, HL; Shamashkin, M; Coyle, AJ; Martinez, RV; He, X				Zhang, Xinjun; MacDonald, Bryan T.; Gao, Huilan; Shamashkin, Michael; Coyle, Anthony J.; Martinez, Robert V.; He, Xi			Characterization of Tiki, a New Family of Wnt-specific Metalloproteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-PHEROMONES; HEAD; OXIDATION; MECHANISM	The Wnt family of secreted glycolipoproteins plays pivotal roles in development and human diseases. Tiki family proteins were identified as novel Wnt inhibitors that act by cleaving the Wnt amino-terminal region to inactivate specific Wnt ligands. Tiki represents a new metalloprotease family that is dependent on Mn2+/Co2+ but lacks known metalloprotease motifs. The Tiki extracellular domain shares homology with bacterial TraB/PrgY proteins, known for their roles in the inhibition of mating pheromones. The TIKI/TraB fold is predicted to be distantly related to structures of additional bacterial proteins and may use a core beta-sheet within an alpha+beta-fold to coordinate conserved residues for catalysis. In this study, using assays for Wnt3a cleavage and signaling inhibition, we performed mutagenesis analyses of human TIKI2 to examine the structural prediction and identify the active site residues. We also established an in vitro assay for TIKI2 protease activity using FRET peptide substrates derived from the cleavage motifs of Wnt3a and Xenopus wnt8 (Xwnt8). We further identified two pairs of potential disulfide bonds that reside outside the beta-sheet catalytic core but likely assist the folding of the TIKI domain. Finally, we systematically analyzed TIKI2 cleavage of the 19 human WNT proteins, of which we identified 10 as potential TIKI2 substrates, revealing the hydrophobic nature of Tiki cleavage sites. Our study provides insights into the Tiki family of proteases and its Wnt substrates.	[Zhang, Xinjun; MacDonald, Bryan T.; He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Gao, Huilan; Shamashkin, Michael; Coyle, Anthony J.; Martinez, Robert V.] Pfizer, Ctr Therapeut Innovat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Pfizer	He, X (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu			National Institutes of Health [RO1-GM057603, RO1-AR060359]; Massachusetts Life Science Center [MLSC 80253-01]; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center - National Institutes of Health [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Science Center; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center - National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	An American Cancer Society Research Professor. Supported by National Institutes of Health Grants RO1-GM057603 and RO1-AR060359, by Grant MLSC 80253-01 from the Massachusetts Life Science Center, and by Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (funded by National Institutes of Health Grant P30 HD-18655). To whom correspondence should be addressed. Tel.: 617-919-2257; Fax: 617-919-2771; E-mail: xi.he@childrens.harvard.edu.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bazan JF, 2013, DEV CELL, V25, P225, DOI 10.1016/j.devcel.2013.04.019; Chandler JR, 2008, J BACTERIOL, V190, P1172, DOI 10.1128/JB.01327-07; Chandler JR, 2005, J BACTERIOL, V187, P4830, DOI 10.1128/JB.187.14.4830-4843.2005; Chandler JR, 2004, PEPTIDES, V25, P1377, DOI 10.1016/j.peptides.2003.10.020; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dunny GM, 2013, ANNU REV GENET, V47, P457, DOI 10.1146/annurev-genet-111212-133449; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Meyer BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371500; Morar M, 2012, BIOCHEMISTRY-US, V51, P1740, DOI 10.1021/bi201790u; Rawlings N. D., 2004, HDB PROTEOLYTIC ENZY, P231; Sanchez-Pulido L, 2013, BIOINFORMATICS, V29, P2371, DOI 10.1093/bioinformatics/btt412; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhang XJ, 2015, DEV CELL, V32, P719, DOI 10.1016/j.devcel.2015.02.014; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	22	30	34	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2435	2443		10.1074/jbc.M115.677807	http://dx.doi.org/10.1074/jbc.M115.677807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26631728	hybrid, Green Published			2022-12-28	WOS:000369610400032
J	Garcia-Melero, A; Reverter, M; Hoque, M; Meneses-Salas, E; Koese, M; Conway, JRW; Johnsen, CH; Alvarez-Guaita, A; Morales-Paytuvi, F; Elmaghrabi, YA; Pol, A; Tebar, F; Murray, RZ; Timpson, P; Enrich, C; Grewal, T; Rentero, C				Garcia-Melero, Ana; Reverter, Meritxell; Hoque, Monira; Meneses-Salas, Elsa; Koese, Meryem; Conway, James R. W.; Johnsen, Camilla H.; Alvarez-Guaita, Anna; Morales-Paytuvi, Frederic; Elmaghrabi, Yasmin A.; Pol, Albert; Tebar, Francesc; Murray, Rachael Z.; Timpson, Paul; Enrich, Carlos; Grewal, Thomas; Rentero, Carles			Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; BREAST-CANCER CELLS; PLASMA-MEMBRANE; MUTANT P53; SYNTAXIN 6; ENDOCYTIC TRANSPORT; C DISEASE; FETUIN-A; TRAFFICKING; COMPLEX	Annexins are a family of proteins that bind to phospholipids in a calcium-dependent manner. Earlier studies implicated annexin A6 (AnxA6) to inhibit secretion and participate in the organization of the extracellular matrix. We recently showed that elevated AnxA6 levels significantly reduced secretion of the extracellular matrix protein fibronectin (FN). Because FN is directly linked to the ability of cells to migrate, this prompted us to investigate the role of AnxA6 in cell migration. Up-regulation of AnxA6 in several cell models was associated with reduced cell migration in wound healing, individual cell tracking and three-dimensional migration/invasion assays. The reduced ability of AnxA6-expressing cells to migrate was associated with decreased cell surface expression of alpha V beta 3 and alpha 5 beta 1 integrins, both FN receptors. Mechanistically, we found that elevated AnxA6 levels interfered with syntaxin-6 (Stx6)-dependent recycling of integrins to the cell surface. AnxA6 overexpression caused mislocalization and accumulation of Stx6 and integrins in recycling endosomes, whereas siRNA-mediated AnxA6 knockdown did not modify the trafficking of integrins. Given our recent findings that inhibition of cholesterol export from late endosomes (LEs) inhibits Stx6-dependent integrin recycling and that elevated AnxA6 levels cause LE cholesterol accumulation, we propose that AnxA6 and blockage of LE cholesterol transport are critical for endosomal function required for Stx6-mediated recycling of integrins in cell migration.	[Garcia-Melero, Ana; Reverter, Meritxell; Meneses-Salas, Elsa; Johnsen, Camilla H.; Alvarez-Guaita, Anna; Morales-Paytuvi, Frederic; Tebar, Francesc; Enrich, Carlos; Rentero, Carles] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, E-08036 Barcelona, Spain; [Hoque, Monira; Koese, Meryem; Elmaghrabi, Yasmin A.; Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Conway, James R. W.; Timpson, Paul] Univ New S Wales, Fac Med, St Vincents Clin Sch, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Conway, James R. W.; Timpson, Paul] Univ New S Wales, Fac Med, Kinghorn Canc Ctr, St Vincents Clin Sch,Canc Res Program, Sydney, NSW 2010, Australia; [Pol, Albert] ICREA, Barcelona 08010, Spain; [Pol, Albert; Tebar, Francesc; Enrich, Carlos; Rentero, Carles] IDIBAPS, Ctr Recerca Biomed CELLEX, Barcelona 08036, Spain; [Murray, Rachael Z.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Brisbane, Qld 4095, Australia	University of Barcelona; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Queensland University of Technology (QUT)	Enrich, C (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, E-08036 Barcelona, Spain.	enrich@ub.edu; thomas.grewal@sydney.edu.au; carles.rentero@ub.edu	Hoque, Monira/AAN-5715-2020; Timpson, Paul/A-9429-2016; Meneses-Salas, Elsa/AGE-7998-2022; Köse, Meryem/K-7399-2013; Rentero Alfonso, Carles/L-4430-2017; Murray, Rachael/J-1370-2012; Tebar, Francesc/H-1498-2015	Köse, Meryem/0000-0002-3391-3418; Rentero Alfonso, Carles/0000-0003-4684-0278; Murray, Rachael/0000-0002-4935-7794; Tebar, Francesc/0000-0002-9522-9726; Grewal, Thomas/0000-0002-7937-8887; Timpson, Paul/0000-0002-5514-7080; Enrich, Carlos/0000-0003-0382-2993; Meneses Salas, Elsa/0000-0001-7550-253X; Morales-Paytuvi, Frederic/0000-0001-6921-5454; Conway, James/0000-0003-3787-277X; Alvarez-Guaita, Anna/0000-0002-9248-2275	Ministerio de Economia y Competitividad (MINECO) [BFU2012-36272, CSD2009-00016]; Fundacio Marato TV3 (Spain) [PI042182]; University of Sydney, Australia [U1758, U7007]; CONSOLIDER-INGENIO (MINECO) [CSD2009-00016]; Fundacio Marato TV3; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad (MINECO); Fundacio Marato TV3 (Spain); University of Sydney, Australia(University of Sydney); CONSOLIDER-INGENIO (MINECO); Fundacio Marato TV3; ICREA(ICREA)	This work was supported by the Ministerio de Economia y Competitividad (MINECO) Grants BFU2012-36272 and CSD2009-00016 and Fundacio Marato TV3 Grant PI042182 (Spain) (to C.E.) and by University of Sydney, Australia Grants U1758 and U7007 (to T.G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by CONSOLIDER-INGENIO (MINECO) Research Program Postdoctoral Fellowship Grant CSD2009-00016 and Fundacio Marato TV3. To whom correspondence may be addressed: Dept. de Biologia Cellular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain. Tel.: 34-934021908; Fax: 34-4021907; E-mail:carles.rentero@ub.edu.	Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Danilo C, 2012, CURR OPIN PHARMACOL, V12, P677, DOI 10.1016/j.coph.2012.07.009; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Domon M, 2012, CELL MOL LIFE SCI, V69, P1773, DOI 10.1007/s00018-011-0894-0; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; ENRICH C, 1987, EXP CELL RES, V173, P99, DOI 10.1016/0014-4827(87)90335-1; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; JACKLE S, 1994, J BIOL CHEM, V269, P1026; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Koese M, 2013, ONCOGENE, V32, P2858, DOI 10.1038/onc.2012.303; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Kundranda MN, 2004, BBA-MOL CELL RES, V1693, P111, DOI 10.1016/j.bbamcr.2004.06.005; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; PUJADES C, 1992, J CELL SCI, V102, P815; Rainero E, 2013, BIOESSAYS, V35, P523, DOI 10.1002/bies.201200160; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Reverter M, 2014, CELL REP, V7, P883, DOI 10.1016/j.celrep.2014.03.043; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; STAMATOGLOU SC, 1992, J CELL BIOL, V116, P1507, DOI 10.1083/jcb.116.6.1507; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Takagi H, 2002, J CELL SCI, V115, P3309; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Timpson P, 2011, JOVE-J VIS EXP, DOI 10.3791/3089; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386	66	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1320	1335		10.1074/jbc.M115.683557	http://dx.doi.org/10.1074/jbc.M115.683557			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26578516	Green Published, hybrid			2022-12-28	WOS:000368068300026
J	Tavoulari, S; Margheritis, E; Nagarajan, A; DeWitt, DC; Zhang, YW; Rosado, E; Ravera, S; Rhoades, E; Forrest, LR; Rudnick, G				Tavoulari, Sotiria; Margheritis, Eleonora; Nagarajan, Anu; DeWitt, David C.; Zhang, Yuan-Wei; Rosado, Edwin; Ravera, Silvia; Rhoades, Elizabeth; Forrest, Lucy R.; Rudnick, Gary			Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; BINDING-SITE; SEROTONIN TRANSPORTER; ALTERNATING-ACCESS; SODIUM SYMPORTERS; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; DOPAMINE TRANSPORTER; POTENTIAL FUNCTIONS	In LeuT, a prokaryotic homolog of neurotransmitter transporters, Na+ stabilizes outward-open conformational states. We examined how each of the two LeuT Na+ binding sites contributes to Na+ -dependent closure of the cytoplasmic pathway using biochemical and biophysical assays of conformation. Mutating either of two residues that contribute to the Na2 site completely prevented cytoplasmic closure in response to Na+, suggesting that Na2 is essential for this conformational change, whereas Na1 mutants retained Na+ responsiveness. However, mutation of Na1 residues also influenced the Na+ -dependent conformational change in ways that varied depending on the position mutated. Computational analyses suggest those mutants influence the ability of Na1 binding to hydrate the substrate pathway and perturb an interaction network leading to the extracellular gate. Overall, the results demonstrate that occupation of Na2 stabilizes outward-facing conformations presumably through a direct interaction between Na+ and transmembrane helices 1 and 8, whereas Na+ binding at Na1 influences conformational change through a network of intermediary interactions. The results also provide evidence that N-terminal release and helix motions represent distinct steps in cytoplasmic pathway opening.	[Tavoulari, Sotiria; Margheritis, Eleonora; Zhang, Yuan-Wei; Rosado, Edwin; Ravera, Silvia; Rudnick, Gary] Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [DeWitt, David C.; Rhoades, Elizabeth] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Nagarajan, Anu; Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Rockville, MD 20852 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rudnick, G (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu	Ravera, Silvia/AAA-7982-2019; Margheritis, Eleonora/W-4750-2019; Rosado-Olivieri, Edwin/ABA-2653-2020; Forrest, Lucy/E-8113-2016	Ravera, Silvia/0000-0002-0803-1042; ZHANG, YUAN-WEI/0000-0002-4276-9251; Margheritis, Eleonora Germana/0000-0003-0571-3563; Forrest, Lucy/0000-0003-1855-7985	Division of Intramural Research of the National Institutes of Health, NINDS; National Institute on Drug Abuse [DA007259, DA008213]; NINDS [NS079955]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003139, R01NS079955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213, R01DA007259] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health, NINDS; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Division of Intramural Research of the National Institutes of Health, NINDS (to L.R.F.), National Institute on Drug Abuse Grants DA007259 and DA008213 (to G.R.), and NINDS Grant NS079955 (to E. Rhoads). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Downloaded from http://www.jbc.org/at ISI, Thomson Scientific on January 17, 2016	Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BIXON M, 1967, TETRAHEDRON, V23, P769, DOI 10.1016/0040-4020(67)85023-3; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Grouleff J, 2015, BIOPHYS J, V108, P1390, DOI 10.1016/j.bpj.2015.02.010; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LAUF PK, 1987, FASEB J, V46, P2377; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Pantano DA, 2009, J PHYS CHEM B, V113, P13715, DOI 10.1021/jp901840u; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rudnick G, 2013, MOL MEMBR BIOL, V30, P355, DOI 10.3109/09687688.2013.842658; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Stolzenberg S, 2015, J BIOL CHEM, V290, P13992, DOI 10.1074/jbc.M114.625343; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555	79	44	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1456	1471		10.1074/jbc.M115.692012	http://dx.doi.org/10.1074/jbc.M115.692012			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26582198	Green Published, hybrid			2022-12-28	WOS:000368068300036
J	Yamada, A; Futagi, M; Fukumoto, E; Saito, K; Yoshizaki, K; Ishikawa, M; Arakaki, M; Hino, R; Sugawara, Y; Ishikawa, M; Naruse, M; Miyazaki, K; Nakamura, T; Fukumoto, S				Yamada, Aya; Futagi, Masaharu; Fukumoto, Emiko; Saito, Kan; Yoshizaki, Keigo; Ishikawa, Masaki; Arakaki, Makiko; Hino, Ryoko; Sugawara, Yu; Ishikawa, Momoko; Naruse, Masahiro; Miyazaki, Kanako; Nakamura, Takashi; Fukumoto, Satoshi			Connexin 43 Is Necessary for Salivary Gland Branching Morphogenesis and FGF10-induced ERK1/2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IP3 RECEPTOR/CA2+ CHANNEL; GAP-JUNCTION CHANNELS; OCULODENTODIGITAL DYSPLASIA; DIFFERENTIAL EXPRESSION; GJA1 MUTATIONS; PROLIFERATION; HEMICHANNELS; DYSFUNCTION; PHENOTYPE; GROWTH	Cell-cell interaction via the gap junction regulates cell growth and differentiation, leading to formation of organs of appropriate size and quality. To determine the role of connexin43 in salivary gland development, we analyzed its expression in developing submandibular glands (SMGs). Connexin43 (Cx43) was found to be expressed in salivary gland epithelium. In ex vivo organ cultures of SMGs, addition of the gap junctional inhibitors 18 alpha-glycyrrhetinic acid (18 alpha-GA) and oleamide inhibited SMG branching morphogenesis, suggesting that gap junctional communication contributes to salivary gland development. In Cx43(-/-) salivary glands, submandibular and sublingual gland size was reduced as compared with those from heterozygotes. The expression of Pdgfa, Pdgfb, Fgf7, and Fgf10, which induced branching of SMGs in Cx43(-/-) samples, were not changed as compared with those from heterozygotes. Furthermore, the blocking peptide for the hemichannel and gap junction channel showed inhibition of terminal bud branching. FGF10 induced branching morphogenesis, while it did not rescue the Cx43(-/-) phenotype, thus Cx43 may regulate FGF10 signaling during salivary gland development. FGF10 is expressed in salivary gland mesenchyme and regulates epithelial proliferation, and was shown to induce ERK1/2 phosphorylation in salivary epithelial cells, while ERK1/2 phosphorylation in HSY cells was dramatically inhibited by 18 alpha-GA, a Cx43 peptide or siRNA. On the other hand, PDGF-AA and PDGF-BB separately induced ERK1/2 phosphorylation in primary cultured salivary mesenchymal cells regardless of the presence of 18 alpha-GA. Together, our results suggest that Cx43 regulates FGF10-induced ERK1/2 phosphorylation in salivary epithelium but not in mesenchyme during the process of SMG branching morphogenesis.	[Yamada, Aya; Futagi, Masaharu; Fukumoto, Emiko; Saito, Kan; Arakaki, Makiko; Hino, Ryoko; Sugawara, Yu; Ishikawa, Momoko; Naruse, Masahiro; Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Ishikawa, Masaki] Tohoku Univ, Grad Sch Dent, Dept Restorat Dent, Operat Dent, Sendai, Miyagi 9808575, Japan; [Yoshizaki, Keigo; Miyazaki, Kanako] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Div Orthodont, Fukuoka 8128582, Japan	Tohoku University; Tohoku University; Kyushu University	Fukumoto, S (corresponding author), Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan.	fukumoto@dent.tohoku.ac.jp	Kim, Ji-Youn/A-5779-2017; Nakamura, Takashi/A-8931-2012; Nakamura, Takashi/P-7796-2016; Saito, Kan/AFS-5564-2022; Saito, Kan/AAG-3507-2020	Nakamura, Takashi/0000-0001-9904-1037; Nakamura, Takashi/0000-0001-9904-1037; Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	Ministry of Education, Science, and Culture of Japan [20679006, 26670880]; NEXT [LS010];  [24390460];  [15H05032];  [15K15752];  [24792294]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; 	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, and Culture of Japan (20679006 and 26670880, to S. F.) and the NEXT program (LS010, to S. F.), a Grant-in-Aid for Scientific Research (24390460, to A. Y.), a Grant-in-Aid for Scientific Research (15H05032 and 15K15752, to T. N.), and a Grant-in-Aid for Young Scientists (24792294, to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Batra N, 2014, J BIOL CHEM, V289, P10582, DOI 10.1074/jbc.M114.550608; Caufield PW, 2012, J DENT RES, V91, P544, DOI 10.1177/0022034512444929; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Hashida Y, 2014, BONE, V61, P19, DOI 10.1016/j.bone.2013.12.031; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Ihara A, 2000, ARCH ORAL BIOL, V45, P227, DOI 10.1016/S0003-9969(99)00128-4; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; MEDA P, 1993, ENDOCRINOLOGY, V133, P2371, DOI 10.1210/en.133.5.2371; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mikoshiba K, 2007, BIOCHEM SOC SYMP, V74, P9, DOI 10.1042/BSS2007c02; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Muramatsu T, 1996, J HISTOCHEM CYTOCHEM, V44, P49, DOI 10.1177/44.1.8543782; Nagata K, 2009, J PEDIATR SURG, V44, P2296, DOI 10.1016/j.jpedsurg.2009.07.070; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Stains JP, 2005, MOL BIOL CELL, V16, P64, DOI 10.1091/mbc.E04-04-0339; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Stephen M, 1997, J Indian Soc Pedod Prev Dent, V15, P109; Yamamoto S, 2008, J BIOL CHEM, V283, P23139, DOI 10.1074/jbc.M710308200; Zappitelli T, 2015, MOL BIOL CELL, V26, P832, DOI 10.1091/mbc.E14-06-1136	35	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					904	912		10.1074/jbc.M115.674663	http://dx.doi.org/10.1074/jbc.M115.674663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565022	hybrid, Green Published			2022-12-28	WOS:000367830500036
J	Das, R; Xu, S; Nguyen, TT; Quan, X; Choi, SK; Kim, SJ; Lee, EY; Cha, SK; Park, KS				Das, Ranjan; Xu, Shanhua; Tuyet Thi Nguyen; Quan, Xianglan; Choi, Seong-Kyung; Kim, Soo-Jin; Lee, Eun Young; Cha, Seung-Kuy; Park, Kyu-Sang			Transforming Growth Factor beta 1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; DIABETIC-NEPHROPATHY; TUBEROUS SCLEROSIS; MTORC1 ACTIVATION; OXIDATIVE STRESS; NADPH OXIDASE; UP-REGULATION; PHOSPHORYLATION; PATHWAY	TGF-beta is a pleiotropic cytokine that accumulates during kidney injuries, resulting in various renal diseases. We have reported previously that TGF-beta 1 induces the selective up-regulation of mitochondrial Nox4, playing critical roles in podocyte apoptosis. Here we investigated the regulatory mechanism of Nox4 up-regulation by mTORC1 activation on TGF-beta 1-induced apoptosis in immortalized podocytes. TGF-beta 1 treatment markedly increased the phosphorylation of mammalian target of rapamycin (mTOR) and its downstream targets p70S6K and 4EBP1. Blocking TGF-beta receptor I with SB431542 completely blunted the phosphorylation of mTOR, p70S6K, and 4EBP1. Transient adenoviral overexpression of mTOR-WT and constitutively active mTOR Delta augmented TGF-beta 1-treated Nox4 expression, reactive oxygen species (ROS) generation, and apoptosis, whereas mTOR kinase-dead suppressed the above changes. In addition, knockdown of mTOR mimicked the effect of mTOR-KD. Inhibition ofmTORC1by low-dose rapamycin or knockdown of p70S6K protected podocytes through attenuation of Nox4 expression and subsequent oxidative stress-induced apoptosis by TGF-beta 1. Pharmacological inhibition of the MEK-ERK cascade, but not the PI3K-Akt-TSC2 pathway, abolished TGF-beta 1-induced mTOR activation. Inhibition of either ERK1/2 or mTORC1 did not reduce the TGF-beta 1-stimulated increase in Nox4 mRNA level but significantly inhibited total Nox4 expression, ROS generation, and apoptosis induced by TGF-beta 1. Moreover, double knockdown of Smad2 and 3 or only Smad4 completely suppressed TGF-beta 1-induced ERK1/2-mTOR activation. Our data suggest that TGF-beta 1 increases translation of Nox4 through the Smad-ERK1/2-mTORC1 axis, which is independent of transcriptional regulation. Activation of this pathway plays a crucial role in ROS generation and mitochondrial dysfunction, leading to podocyte apoptosis. Therefore, inhibition of the ERK1/2-mTORC1 pathway could be a potential therapeutic and preventive target in proteinuric and chronic kidney diseases.	[Das, Ranjan; Xu, Shanhua; Tuyet Thi Nguyen; Quan, Xianglan; Choi, Seong-Kyung; Kim, Soo-Jin; Cha, Seung-Kuy; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Inst Lifestyle Med, Wonju 220701, Gangwon Do, South Korea; [Lee, Eun Young] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan 330721, South Korea	Yonsei University; Soonchunhyang University	Das, R (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju 220701, Gangwon Do, South Korea.	ranjan@yonsei.ac.kr; qsang@yonsei.ac.kr	Das, Ranjan/AFQ-6329-2022; DAS, RANJAN/ABE-4002-2021	Das, Ranjan/0000-0002-7951-4121; Lee, Eun Young/0000-0002-4513-9888; Park, Kyu-Sang/0000-0003-0322-9807	National Research Foundation [NRF-2013R1A1A4A01010780]; Yonsei University Future leading Research Initiative [2014-22-0127]	National Research Foundation; Yonsei University Future leading Research Initiative	This work was supported by National Research Foundation (NRF-2013R1A1A4A01010780) and Yonsei University Future leading Research Initiative of 2014 (2014-22-0127). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2013, AM J PHYSIOL-RENAL, V305, pF1477, DOI 10.1152/ajprenal.00182.2013; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Efeyan A, 2013, BIOCHEM SOC T, V41, P902, DOI 10.1042/BST20130063; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Ghayur A, 2012, AM J PATHOL, V180, P940, DOI 10.1016/j.ajpath.2011.11.023; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P835, DOI 10.1053/j.ajkd.2011.03.033; Kim JH, 2003, KIDNEY INT, V64, P1715, DOI 10.1046/j.1523-1755.2003.00288.x; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Rangan GK, 2007, NEPHROL DIAL TRANSPL, V22, P2175, DOI 10.1093/ndt/gfm191; Rozen-Zvi B, 2013, AM J PHYSIOL-RENAL, V305, pF485, DOI 10.1152/ajprenal.00215.2013; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Simeone DM, 2001, AM J PHYSIOL-CELL PH, V281, pC311, DOI 10.1152/ajpcell.2001.281.1.C311; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Thakur S, 2015, AM J PATHOL, V185, P2168, DOI 10.1016/j.ajpath.2015.04.014; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; Yu LX, 2010, CELL PHYSIOL BIOCHEM, V26, P869, DOI 10.1159/000323996	63	35	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30830	30842		10.1074/jbc.M115.703116	http://dx.doi.org/10.1074/jbc.M115.703116			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26565025	hybrid, Green Published			2022-12-28	WOS:000367199000016
J	Knihtila, R; Holzapfel, G; Weiss, K; Meilleur, F; Mattos, C				Knihtila, Ryan; Holzapfel, Genevieve; Weiss, Kevin; Meilleur, Flora; Mattos, Carla			Neutron Crystal Structure of RAS GTPase Puts in Question the Protonation State of the GTP gamma-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE TRIPHOSPHATE HYDROLYSIS; FREE-ENERGY RELATIONSHIPS; X-RAY; ACTIVATING PROTEIN; EVOLUTIONARY TREE; ATOM POSITIONS; MECHANISM; P21(RAS); COMPLEX; LAUE	RAS GTPase is a prototype for nucleotide-binding proteins that function by cycling between GTP and GDP, with hydrogen atoms playing an important role in the GTP hydrolysis mechanism. It is one of the most well studied proteins in the superfamily of small GTPases, which has representatives in a wide range of cellular functions. These proteins share a GTP-binding pocket with highly conserved motifs that promote hydrolysis to GDP. The neutron crystal structure of RAS presented here strongly supports a protonated gamma-phosphate at physiological pH. This counters the notion that the phosphate groups of GTP are fully deprotonated at the start of the hydrolysis reaction, which has colored the interpretation of experimental and computational data in studies of the hydrolysis mechanism. The neutron crystal structure presented here puts in question our understanding of the pre-catalytic state associated with the hydrolysis reaction central to the function of RAS and other GTPases.	[Knihtila, Ryan; Mattos, Carla] Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA; [Holzapfel, Genevieve; Meilleur, Flora; Mattos, Carla] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Weiss, Kevin; Meilleur, Flora] Oak Ridge Natl Lab, Biol & Soft Matter Div, Neutron Sci Directorate, Oak Ridge, TN 37831 USA	Northeastern University; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Mattos, C (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA.	c.mattos@neu.edu	Weiss, Kevin/I-4669-2013	Weiss, Kevin/0000-0002-6486-8007; Meilleur, Flora/0000-0001-9313-8989	National Science Foundation [CHE-0922719]; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; Div Of Molecular and Cellular Bioscience [1244203] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Matthew Civic for assistance with x-ray data collection. Neutron data were collected at the High Flux Isotope Reactor; Oak Ridge National Laboratory; the IMAGINE beamline was supported by National Science Foundation Grant CHE-0922719, Research conducted at High Flux Isotope Reactor, Oak Ridge National Laboratory, was supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy, Large scale protein expression for crystal optimization was conducted at the Center for Structural Molecular Biology, Oak Ridge National Laboratory, which is supported by the United States Department of Energy, Office of Biological and Environmental Research.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Ankner John F, 2013, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1716s72; [Anonymous], CURR OPIN STRUCT BIO, V16, P630; Arzt S, 1999, J APPL CRYSTALLOGR, V32, P554, DOI 10.1107/S0021889898015350; Bennett BC, 2008, ACTA CRYSTALLOGR D, V64, P764, DOI 10.1107/S0907444908012845; Blum MM, 2009, P NATL ACAD SCI USA, V106, P713, DOI 10.1073/pnas.0807842106; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Campbell JW, 1998, J APPL CRYSTALLOGR, V31, P496, DOI 10.1107/S0021889897016683; Cheng H, 2001, J BIOL CHEM, V276, P9931, DOI 10.1074/jbc.M009295200; Cox Adrienne D, 2010, Small GTPases, V1, P2; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Gardberg AS, 2010, ACTA CRYSTALLOGR D, V66, P558, DOI 10.1107/S0907444910005494; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228; HELLIWELL M, 1989, ACTA CRYSTALLOGR B, V45, P591, DOI 10.1107/S0108768189009328; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1988, J BIOL CHEM, V263, P11792; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Klahn M, 2005, BIOPHYS J, V88, P3829, DOI 10.1529/biophysj.104.058644; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LANGEN R, 1992, BIOCHEMISTRY-US, V31, P8691, DOI 10.1021/bi00152a002; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Martin-Garcia F, 2012, BIOPHYS J, V102, P152, DOI 10.1016/j.bpj.2011.11.4005; Meilleur F, 2006, EUR BIOPHYS J BIOPHY, V35, P611, DOI 10.1007/s00249-006-0074-6; Meilleur F, 2013, ACTA CRYSTALLOGR D, V69, P2157, DOI 10.1107/S0907444913019604; Meilleur F, 2009, METHODS MOL BIOL, V544, P281, DOI 10.1007/978-1-59745-483-4_18; MIKKELSEN K, 1960, J PHYS CHEM-US, V64, P632, DOI 10.1021/j100834a026; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Myles DAA, 2012, J APPL CRYSTALLOGR, V45, P686, DOI 10.1107/S0021889812019784; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Prasad BR, 2013, P NATL ACAD SCI USA, V110, P20509, DOI 10.1073/pnas.1319854110; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14232, DOI 10.1021/bi961119g; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043	58	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31025	31036		10.1074/jbc.M115.679860	http://dx.doi.org/10.1074/jbc.M115.679860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26515069	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000367199000032
J	Mochizuki, S; Nishiyama, R; Inoue, A; Ojima, T				Mochizuki, Shogo; Nishiyama, Ryuji; Inoue, Akira; Ojima, Takao			A Novel Aldo-Keto Reductase, HdRed, from the Pacific Abalone Haliotis discus hannai, Which Reduces Alginate-derived 4-Deoxy-L-erythro-5-hexoseulose Uronic Acid to 2-Keto-3-deoxy-D-gluconate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDNA CLONING; SULFOLOBUS-SOLFATARICUS; ENZYMATIC-PROPERTIES; APLYSIA-KURODAI; LYASE; SUPERFAMILY; METABOLISM; BACTERIA; GROWTH; OLIGOSACCHARIDES	Abalone feeds on brown seaweeds and digests seaweeds' alginate with alginate lyases (EC 4.2.2.3). However, it has been unclear whether the end product of alginate lyases (i.e. unsaturated monouronate-derived 4-deoxy-L-erythro-5-hexoseulose uronic acid (DEH)) is assimilated by abalone itself, because DEH cannot be metabolized via the Embden-Meyerhof pathway of animals. Under these circumstances, we recently noticed the occurrence of an NADPH-dependent reductase, which reduced DEH to 2-keto-3-deoxy-D-gluconate, in hepatopancreas extract of the pacific abalone Haliotis discus hannai. In the present study, we characterized this enzyme to some extent. The DEH reductase, named HdRed in the present study, could be purified from the acetone-dried powder of hepatopancreas by ammonium sulfate fractionation followed by conventional column chromatographies. HdRed showed a single band of similar to 40 kDa on SDS-PAGE and reduced DEH to 2-keto-3-deoxy-D-gluconate with an optimal temperature and pH at around 50 degrees C and 7.0, respectively. HdRed exhibited no appreciable activity toward 28 authentic compounds, including aldehyde, aldose, ketose, alpha-keto-acid, uronic acid, deoxy sugar, sugar alcohol, carboxylic acid, ketone, and ester. The amino acid sequence of 371 residues of HdRed deduced from the cDNA showed 18-60% identities to those of aldo-keto reductase (AKR) superfamily enzymes, such as human aldose reductase, halophilic bacterium reductase, and sea hare norsolorinic acid (a polyketide derivative) reductase-like protein. Catalytic residues and cofactor binding residues known in AKR superfamily enzymes were fairly well conserved in HdRed. Phylogenetic analysis for HdRed and AKR superfamily enzymes indicated that HdRed is an AKR belonging to a novel family.	[Mochizuki, Shogo; Nishiyama, Ryuji; Inoue, Akira; Ojima, Takao] Hokkaido Univ, Fac Fisheries Sci, Lab Marine Biotechnol & Microbiol, Hakodate, Hokkaido 0418611, Japan	Hokkaido University	Ojima, T (corresponding author), Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan.	ojima@fish.hokudai.ac.jp			Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science, and Technology, Japan; Regional Innovation Cluster Program "Universal Marine Industry for Green Innovation" - Ministry of Education, Culture, Sports, Science, and Technology, Japan	Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional Innovation Cluster Program "Universal Marine Industry for Green Innovation" - Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by the Program for Constructing "Tohoku Marine Science Bases" and the Regional Innovation Cluster Program "Universal Marine Industry for Green Innovation" supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	AKIYAMA H, 1992, BIOSCI BIOTECH BIOCH, V56, P355, DOI 10.1271/bbb.56.355; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELKABBANI O, 1994, ACTA CRYSTALLOGR D, V50, P859, DOI 10.1107/S0907444994005275; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Erasmus JH, 1997, AQUACULTURE, V155, P377, DOI 10.1016/S0044-8486(97)00112-9; GACESA P, 1992, INT J BIOCHEM, V24, P545, DOI 10.1016/0020-711X(92)90325-U; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HARA S, 1988, ANAL CHIM ACTA, V215, P267, DOI 10.1016/S0003-2670(00)85285-X; Hata M, 2009, FISHERIES SCI, V75, P755, DOI 10.1007/s12562-009-0079-z; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Inoue A, 2014, MAR DRUGS, V12, P4693, DOI 10.3390/md12084693; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0; Johnston D, 2005, AQUACULTURE, V250, P341, DOI 10.1016/j.aquaculture.2005.03.012; Kavanagh KL, 2002, BIOCHEMISTRY-US, V41, P8785, DOI 10.1021/bi025786n; Kawada A, 1999, ARCH DERMATOL RES, V291, P542, DOI 10.1007/s004030050451; Kozma E, 2002, J BIOL CHEM, V277, P16285, DOI 10.1074/jbc.M110808200; Kumagai Y, 2013, COMP BIOCHEM PHYS B, V164, P80, DOI 10.1016/j.cbpb.2012.11.001; Kumagai Y, 2009, COMP BIOCHEM PHYS B, V154, P113, DOI 10.1016/j.cbpb.2009.05.005; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; LANNING MC, 1951, J BIOL CHEM, V189, P109; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAI KS, 1995, AQUACULTURE, V134, P65, DOI 10.1016/0044-8486(95)00043-2; Ootsuka S, 2006, J BIOTECHNOL, V125, P269, DOI 10.1016/j.jbiotec.2006.03.008; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; PREISS J, 1962, J BIOL CHEM, V237, P309; PREISS J, 1962, J BIOL CHEM, V237, P317; Rahman MM, 2011, BIOCHIMIE, V93, P1720, DOI 10.1016/j.biochi.2011.06.004; Rahman MM, 2010, COMP BIOCHEM PHYS B, V157, P317, DOI 10.1016/j.cbpb.2010.07.006; Sawabe T, 2003, AQUACULTURE, V219, P671, DOI 10.1016/S0044-8486(02)00618-X; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Suzuki K, 2003, EUR J BIOCHEM, V270, P771, DOI 10.1046/j.1432-1033.2003.03443.x; Takami H, 1998, J SHELLFISH RES, V17, P723; Takase R, 2014, J BIOL CHEM, V289, P33198, DOI 10.1074/jbc.M114.585661; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; TOMODA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P202, DOI 10.1271/bbb.58.202; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022	45	14	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30962	30974		10.1074/jbc.M115.686725	http://dx.doi.org/10.1074/jbc.M115.686725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26555267	Green Published, hybrid			2022-12-28	WOS:000367199000027
J	Nakajima-Koyama, M; Lee, J; Ohta, S; Yamamoto, T; Nishida, E				Nakajima-Koyama, May; Lee, Joonseong; Ohta, Sho; Yamamoto, Takuya; Nishida, Eisuke			Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE FIBROBLASTS; SELF-RENEWAL; IPS CELLS; HIPPOCAMPAL NEUROGENESIS; REPROGRAMMING FACTORS; TRANSCRIPTION FACTORS; SOMATIC-CELLS; C-MYC; EXPRESSION; GENERATION	It remains controversial whether the routes from somatic cells to induced pluripotent stem cells (iPSCs) are related to the reverse order of normal developmental processes. Specifically, it remains unaddressed whether or not the differentiated cells become iPSCs through their original tissue stem cell-like state. Previous studies analyzing the reprogramming process mostly used fibroblasts; however, the stem cell characteristics of fibroblasts made it difficult to address this. Here, we generated iPSCs from mouse astrocytes, a type of glial cells, by three (OCT3/4, KI,F4, and SOX2), two (OCT3/4 and KLF4), or four (OCT3/4, KLF, and SOX2 plus c-MYC) factors. Sox1, a neural stein cell (NSC)-specific transcription factor, is transiently up-regulated during reprogramming, and Sox1-positive cells become iPSCs. The up-regulation of Sox1 is essential for OCT3/4- and KLF4-induced reprogramming. Genome-wide analysis revealed that the gene expression profile of Sox1-expressing intermediate-state cells resembles that of NSCs. Furthermore, the intermediate-state cells are able to generate neurospheres, which can differentiate into both neurons and glial cells. Remarkably, during fibroblast reprogramming, neither Sox1 up-regulation nor an increase in neurogenic potential occurs. Our results thus demonstrate that astrocytes are reprogrammed through an NSC-like state.	[Nakajima-Koyama, May; Lee, Joonseong; Ohta, Sho; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Ohta, Sho; Yamamoto, Takuya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Sakyo Ku, Kyoto 6068507, Japan; [Ohta, Sho; Yamamoto, Takuya] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068507, Japan; [Nakajima-Koyama, May; Yamamoto, Takuya; Nishida, Eisuke] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	nishida@lif.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Government (Ministry of Education, Culture, Sports, Science and Technology) Scholarship Program; iPS Cell Research Fund	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government (Ministry of Education, Culture, Sports, Science and Technology) Scholarship Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); iPS Cell Research Fund	This work was supported in part by grants from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Japanese Government (Ministry of Education, Culture, Sports, Science and Technology) Scholarship Program.; Supported by the iPS Cell Research Fund.	Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Imura T, 2003, J NEUROSCI, V23, P2824; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koga M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4197; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Noguchi H, 2015, CELL DEATH DIFFER, V22, P145, DOI 10.1038/cdd.2014.132; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; Wang Y, 2013, DEV DYNAM, V242, P638, DOI 10.1002/dvdy.23962; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	55	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31173	31188		10.1074/jbc.M115.683466	http://dx.doi.org/10.1074/jbc.M115.683466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26553868	hybrid, Green Published			2022-12-28	WOS:000367199000044
J	Kotzsch, A; Pawolski, D; Milentyev, A; Shevchenko, A; Scheffel, A; Poulsen, N; Shevchenko, A; Kroger, N				Kotzsch, Alexander; Pawolski, Damian; Milentyev, Alexander; Shevchenko, Anna; Scheffel, Andre; Poulsen, Nicole; Shevchenko, Andrej; Kroeger, Nils			Biochemical Composition and Assembly of Biosilica-associated Insoluble Organic Matrices from the Diatom Thalassiosira pseudonana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; biomineralization; cell wall; intrinsically disordered protein; morphogenesis; post-translational modification (PTM); protein self-assembly; proteomics	SILICA BIOMINERALIZATION; PROTEIN IDENTIFICATION; AMINO-ACID; SILAFFINS; PRECIPITATION; MORPHOGENESIS; MORPHOLOGY; LESSONS; BIOLOGY	The nano- and micropatterned biosilica cell walls of diatoms are remarkable examples of biological morphogenesis and possess highly interesting material properties. Only recently has it been demonstrated that biosilica-associated organic structures with specific nanopatterns (termed insoluble organic matrices) are general components of diatom biosilica. The model diatom Thalassiosira pseudonana contains three types of insoluble organic matrices: chitin meshworks, organic microrings, and organic microplates, the latter being described in the present study for the first time. To date, little is known about the molecular composition, intracellular assembly, and biological functions of organic matrices. Here we have performed structural and functional analyses of the organic microrings and organic microplates from T. pseudonana. Proteomics analysis yielded seven proteins of unknown function (termed SiMat proteins) together with five known silica biomineralization proteins (four cingulins and one silaffin). The location of SiMat1-GFP in the insoluble organic microrings and the similarity of tyrosine- and lysine-rich functional domains identifies this protein as a new member of the cingulin protein family. Mass spectrometric analysis indicates that most of the lysine residues of cingulins and the other insoluble organic matrix proteins are post-translationally modified by short polyamine groups, which are known to enhance the silica formation activity of proteins. Studies with recombinant cingulins (rCinY2 and rCinW2) demonstrate that acidic conditions (pH 5.5) trigger the assembly of mixed cingulin aggregates that have silica formation activity. Our results suggest an important role for cingulins in the biogenesis of organic microrings and support the hypothesis that this type of insoluble organic matrix functions in biosilica morphogenesis.	[Kotzsch, Alexander; Pawolski, Damian; Poulsen, Nicole; Kroeger, Nils] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany; [Kroeger, Nils] Tech Univ Dresden, Dept Chem & Food Chem, D-01307 Dresden, Germany; [Milentyev, Alexander; Shevchenko, Anna; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Scheffel, Andre] Max Planck Inst Plant Physiol, D-14476 Potsdam, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Max Planck Society	Kroger, N (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany.	kroeger@bcube-dresden.de		Poulsen, Nicole/0000-0002-4533-8860	Deutsche Forschungsgemeinschaft through Research Unit NANOMEE [KR 1853/6-1, SH 94/4-1, 2038]; Max-Planck-Gesellschaft	Deutsche Forschungsgemeinschaft through Research Unit NANOMEE(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the Deutsche Forschungsgemeinschaft through Research Unit 2038 NANOMEE (Grants KR 1853/6-1 and SH 94/4-1). Work in the laboratory of Andrej Shevchenko was supported by the Max-Planck-Gesellschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Assmy P, 2013, P NATL ACAD SCI USA, V110, P20633, DOI 10.1073/pnas.1309345110; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; Buhmann MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110369; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; Davis AK, 2005, J PHYCOL, V41, P577, DOI 10.1111/j.1529-8817.2005.00076.x; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dionex, 2009, 03148113 DION, P33; Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Iler R. K, 1979, CHEM SILICA, P97; Jeffryes C, 2011, ENERG ENVIRON SCI, V4, P3930, DOI 10.1039/c0ee00306a; Junqueira M, 2008, J PROTEOMICS, V71, P346, DOI 10.1016/j.jprot.2008.07.003; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroger N, 2014, WIRES NANOMED NANOBI, V6, P615, DOI 10.1002/wnan.1284; Kroger N, 2010, MRS BULL, V35, P122, DOI 10.1557/mrs2010.631; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Kroger N, 1998, PROTIST, V149, P213, DOI 10.1016/S1434-4610(98)70029-X; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; Kroger N, 2006, ANGEW CHEM INT EDIT, V45, P7239, DOI 10.1002/anie.200601871; Lechner CC, 2015, MAR DRUGS, V13, P5297, DOI 10.3390/md13085297; Lechner CC, 2014, J PEPT SCI, V20, P152, DOI 10.1002/psc.2577; Lopez PJ, 2005, CURR NANOSCI, V1, P73, DOI 10.2174/1573413052953156; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; Lowenstam HA, 1989, BIOMINERALIZATION; Mizutani T, 1998, B CHEM SOC JPN, V71, P2017, DOI 10.1246/bcsj.71.2017; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; NAKAJIMA T, 1969, SCIENCE, V164, P1400, DOI 10.1126/science.164.3886.1400; Nassif N, 2011, CHEM SOC REV, V40, P849, DOI 10.1039/c0cs00122h; Nemoto M, 2014, MAR GENOM, V16, P39, DOI 10.1016/j.margen.2014.01.006; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Poulsen N, 2014, BIOFOULING, V30, P513, DOI 10.1080/08927014.2014.895895; Poulsen N, 2013, J BIOL CHEM, V288, P20100, DOI 10.1074/jbc.M113.469379; RAVEN JA, 1983, BIOL REV, V58, P179, DOI 10.1111/j.1469-185X.1983.tb00385.x; Sandhage KH, 2010, JOM-US, V62, P32, DOI 10.1007/s11837-010-0085-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Shrestha RP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-499; Sumper M, 2006, ADV FUNCT MATER, V16, P17, DOI 10.1002/adfm.200500616; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Sumper M, 2007, ANGEW CHEM INT EDIT, V46, P8405, DOI 10.1002/anie.200702413; Tesson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061675; Vrieling EG, 1999, J BIOTECHNOL, V70, P39, DOI 10.1016/S0168-1656(99)00056-5; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Wielsch N, 2006, J PROTEOME RES, V5, P2448, DOI 10.1021/pr060200v; Wieneke R, 2011, ORG BIOMOL CHEM, V9, P5482, DOI 10.1039/c1ob05406f; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Yang WR, 2011, ANALYST, V136, P42, DOI 10.1039/c0an00602e	64	35	35	4	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4982	4997		10.1074/jbc.M115.706440	http://dx.doi.org/10.1074/jbc.M115.706440			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26710847	Green Published, hybrid			2022-12-28	WOS:000371640600014
J	Law, NC; Hunzicker-Dunn, ME				Law, Nathan C.; Hunzicker-Dunn, Mary E.			Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; RAT GRANULOSA-CELLS; PROTEIN-KINASE-A; ACUTE REGULATORY PROTEIN; ELEMENT-BINDING PROTEIN; NF-KAPPA-B; STEROIDOGENIC FACTOR-I; SIDE-CHAIN CLEAVAGE; LUTEINIZING-HORMONE; SERINE/THREONINE PHOSPHORYLATION	The ubiquitous phosphatidylinositol 3-kinase (PI3K) signaling pathway regulates many cellular functions. However, the mechanism by which G protein-coupled receptors (GPCRs) signal to activate PI3K is poorly understood. We have used ovarian granulosa cells as a model to investigate this pathway, based on evidence that the GPCR agonist follicle-stimulating hormone (FSH) promotes the protein kinase A (PKA)-dependent phosphorylation of insulin receptor substrate 1 (IRS1) on tyrosine residues that activate PI3K. We report that in the absence of FSH, granulosa cells secrete a subthreshold concentration of insulin-like growth factor-1 (IGF-1) that primes the IGF-1 receptor (IGF-1R) but fails to promote tyrosine phosphorylation of IRS1. FSH via PKA acts to sensitize IRS1 to the tyrosine kinase activity of the IGF-1R by activating protein phosphatase 1 (PP1) to promote dephosphorylation of inhibitory Ser/Thr residues on IRS1, including Ser789. Knockdown of PP1 beta blocks the ability of FSH to activate PI3K in the presence of endogenous IGF-1. Activation of PI3K thus requires both PKA-mediated relief of IRS1 inhibition and IGF-1R-dependent tyrosine phosphorylation of IRS1. Treatment with FSH and increasing concentrations of exogenous IGF-1 triggers synergistic IRS1 tyrosine phosphorylation at PI3K-activating residues that persists downstream through protein kinase B (AKT) and FOXO1 (forkhead box protein O1) to drive synergistic expression of genes that underlies follicle maturation. Based on the ability of GPCR agonists to synergize with IGFs to enhance gene expression in other cell types, PP1 activation to relieve IRS1 inhibition may be a more general mechanism by which GPCRs act with the IGF-1R to activate PI3K/AKT.	[Law, Nathan C.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg Rm 233, Pullman, WA 99164 USA	Washington State University	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg Rm 233, Pullman, WA 99164 USA.	mehd@wsu.edu			National Institute of Health (NIH) [R01HD065859, R01HD062053, R01HD059901]; NIH [T32GM083864]; Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059901, R01HD062053, R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institute of Health (NIH) Grants R01HD065859 (to M. H. D.), R01HD062053 (to M. H. D.), and R01HD059901 (to A. J. Z.). N. C. L. was supported by NIH Grant T32GM083864 as well as the Poncin Scholarship Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; ADASHI EY, 1985, ENDOCRINOLOGY, V116, P2135, DOI 10.1210/endo-116-6-2135; ADASHI EY, 1985, ENDOCRINOLOGY, V116, P2369, DOI 10.1210/endo-116-6-2369; ADASHI EY, 1985, ENDOCRINOLOGY, V117, P2313, DOI 10.1210/endo-117-6-2313; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Balasubramanian K, 1997, ENDOCRINOLOGY, V138, P433, DOI 10.1210/en.138.1.433; Baumgarten SC, 2015, J CLIN ENDOCR METAB, V100, pE1046, DOI 10.1210/jc.2015-1504; Bennett J, 2012, ENDOCRINOLOGY, V153, P2474, DOI 10.1210/en.2011-1969; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BROWN JB, 1978, AUST NZ J OBSTET GYN, V18, P47, DOI 10.1111/j.1479-828X.1978.tb00011.x; Burns KH, 2001, ENDOCRINOLOGY, V142, P2742, DOI 10.1210/en.142.7.2742; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; CHENG HC, 1986, J BIOL CHEM, V261, P989; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cottom J, 2003, J BIOL CHEM, V278, P7167, DOI 10.1074/jbc.M203901200; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Cunningham MA, 2004, MOL ENDOCRINOL, V18, P1756, DOI 10.1210/me.2004-0071; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Devoto L, 1999, MOL HUM REPROD, V5, P1003, DOI 10.1093/molehr/5.11.1003; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Eimerl S, 2002, BIOL REPROD, V67, P900, DOI 10.1095/biolreprod.101.002170; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Fukushima T, 2011, MOL CELL ENDOCRINOL, V344, P81, DOI 10.1016/j.mce.2011.06.029; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hsueh AJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099127; Hunzicker-Dunn M, 2015, PHYSL REPROD, P895; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Koopman R, 2010, J PHYSIOL-LONDON, V588, P4811, DOI 10.1113/jphysiol.2010.196725; LaVoie HA, 1999, ENDOCRINOLOGY, V140, P146, DOI 10.1210/en.140.1.146; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; Mack EM, 2012, REPRODUCTION, V144, P595, DOI 10.1530/REP-12-0225; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Meinkoth J L, 1991, Thyroidology, V3, P103; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Schams D, 2001, EXP CLIN ENDOCR DIAB, V109, P155, DOI 10.1055/s-2001-14839; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sekar N, 2000, MOL CELL ENDOCRINOL, V159, P25, DOI 10.1016/S0303-7207(99)00203-8; SHI H, 1995, MOL ENDOCRINOL, V9, P734, DOI 10.1210/me.9.6.734; Shi YJ, 2014, NAT STRUCT MOL BIOL, V21, P522, DOI 10.1038/nsmb.2828; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Swingle Mark, 2007, V365, P23; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang XL, 2012, J BIOL CHEM, V287, P10166, DOI 10.1074/jbc.M111.293274; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Zeleznik Anthony J, 2004, Reprod Biol Endocrinol, V2, P31, DOI 10.1186/1477-7827-2-31; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhou P, 2013, MOL ENDOCRINOL, V27, P511, DOI 10.1210/me.2012-1307	85	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4547	4560		10.1074/jbc.M115.698761	http://dx.doi.org/10.1074/jbc.M115.698761			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26702053	Green Published, hybrid			2022-12-28	WOS:000371604600024
J	Hassan, RH; de Sousa, ACP; Mahfouz, R; Hainault, I; Blachnio-Zabielska, A; Bourron, O; Koskas, F; Gorski, J; Ferre, P; Foufelle, F; Hajduch, E				Hassan, Rima Hage; de Sousa, Ana Catarina Pacheco; Mahfouz, Rana; Hainault, Isabelle; Blachnio-Zabielska, Agnieszka; Bourron, Olivier; Koskas, Fabien; Gorski, Jan; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric			Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; GLUCOSE-TRANSPORT; SERINE-307 PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PKC-ZETA; IN-VIVO; RESISTANCE; APOPTOSIS; RECEPTOR	In vivo, ectopic accumulation of fatty acids in muscles leads to alterations in insulin signaling at both the IRS1 and Akt steps. However, in vitro treatments with saturated fatty acids or their derivative ceramide demonstrate an effect only at the Akt step. In this study, we adapted our experimental procedures to mimic the in vivo situation and show that the double-stranded RNA-dependent protein kinase (PKR) is involved in the long-term effects of saturated fatty acids on IRS1. C2C12 or human muscle cells were incubated with palmitate or directly with ceramide for short or long periods, and insulin signaling pathway activity was evaluated. PKR involvement was assessed through pharmacological and genetic studies. Short-term treatments of myotubes with palmitate, a ceramide precursor, or directly with ceramide induce an inhibition of Akt, whereas prolonged periods of treatment show an additive inhibition of insulin signaling through increased IRS1 serine 307 phosphorylation. PKR mRNA, protein, and phosphorylation are increased in insulin-resistant muscles. When PKR activity is reduced (siRNA or a pharmacological inhibitor), serine phosphorylation of IRS1 is reduced, and insulin-induced phosphorylation of Akt is improved. Finally, we show that JNK mediates ceramide-activated PKR inhibitory action on IRS1. Together, in the long term, our results show that ceramide acts at two distinct levels of the insulin signaling pathway (IRS1 and Akt). PKR, which is induced by both inflammation signals and ceramide, could play a major role in the development of insulin resistance in muscle cells.	[Bourron, Olivier; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric] INSERM, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Hassan, Rima Hage; de Sousa, Ana Catarina Pacheco; Mahfouz, Rana; Hainault, Isabelle; Bourron, Olivier; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Hassan, Rima Hage; de Sousa, Ana Catarina Pacheco; Mahfouz, Rana; Hainault, Isabelle; Bourron, Olivier; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric] Univ Paris 05, Sorbonne Paris Cite, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Blachnio-Zabielska, Agnieszka; Gorski, Jan] Med Univ Bialystok, Dept Physiol, PL-15222 Bialystok, Poland; [Blachnio-Zabielska, Agnieszka; Gorski, Jan] AP HP, Paris, France; [Bourron, Olivier] Hop La Pitie Salpetriere, Dept Diabetol & Malad Metab, F-75013 Paris, France; [Koskas, Fabien] Hop La Pitie Salpetriere, Serv Chirurg Vasc, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Medical University of Bialystok; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hajduch, E (corresponding author), INSERM, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France.	eric.hajduch@crc.jussieu.fr	Hajduch, Eric/B-7332-2008; Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Górski, Jan/T-4828-2018; Ferré, Pascal/K-1250-2013	Hajduch, Eric/0000-0002-0125-7751; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Górski, Jan/0000-0001-9886-5069; Ferré, Pascal/0000-0003-0115-7045; Bourron, Olivier/0000-0001-7348-7161; FOUFELLE, Fabienne/0000-0002-0752-622X	INSERM; Societe Francophone du Diabete (an Association Nationale pour les Traitements a Domicile, les Innovations et la Recherche grant); Agence Nationale de la Recherche [ANR 11 BSV1 03101-Crisalis]; Fondation pour la Recherche Medicale [FRM DEQ20140329504]; French Ministry of Research	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe Francophone du Diabete (an Association Nationale pour les Traitements a Domicile, les Innovations et la Recherche grant); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by INSERM, the Societe Francophone du Diabete (an Association Nationale pour les Traitements a Domicile, les Innovations et la Recherche grant), Agence Nationale de la Recherche Project ANR 11 BSV1 03101-Crisalis, and the Fondation pour la Recherche Medicale (equipe FRM DEQ20140329504). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a fellowship from the French Ministry of Research.	Aas V, 2013, CELL TISSUE RES, V354, P671, DOI 10.1007/s00441-013-1655-1; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bellini L, 2015, EXPERT OPIN THER TAR, V19, P1037, DOI 10.1517/14728222.2015.1028359; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Carvalho BM, 2013, OBESITY, V21, P2452, DOI 10.1002/oby.20410; Carvalho MA, 2012, ENDOCRINOLOGY, V153, P5261, DOI 10.1210/en.2012-1400; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hajduch E, 1999, J BIOL CHEM, V274, P13563, DOI 10.1074/jbc.274.19.13563; Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hassan RH, 2014, WORLD J DIABETES, V5, P244, DOI 10.4239/wjd.v5.i3.244; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Jaiswal N, 2015, EUR J PHARMACOL, V746, P70, DOI 10.1016/j.ejphar.2014.10.049; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Lin SS, 2010, CYTOKINE, V50, P210, DOI 10.1016/j.cyto.2010.01.008; Litherland GJ, 2001, MOL MEMBR BIOL, V18, P195; Mahfouz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101865; Nakamura T, 2014, DIABETES, V63, P526, DOI 10.2337/db13-1019; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Peterson JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE1307, DOI 10.1152/ajpendo.00738.2007; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Silveira LR, 2008, J CELL PHYSIOL, V217, P1, DOI 10.1002/jcp.21514; Taheripak G, 2013, FREE RADICAL BIO MED, V65, P1435, DOI 10.1016/j.freeradbiomed.2013.09.019; Tanti JF, 2004, ANN ENDOCRINOL-PARIS, V65, P43, DOI 10.1016/S0003-4266(04)95629-6; THOMIS DC, 1992, P NATL ACAD SCI USA, V89, P10837, DOI 10.1073/pnas.89.22.10837; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yang XR, 2010, MOL BIOL CELL, V21, P3449, DOI 10.1091/mbc.E10-06-0481; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yuzefovych LV, 2012, ENDOCRINOLOGY, V153, P92, DOI 10.1210/en.2011-1442	48	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3019	3029		10.1074/jbc.M115.686949	http://dx.doi.org/10.1074/jbc.M115.686949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26698173	Green Published, hybrid			2022-12-28	WOS:000369626900038
J	Lin, YB; Bogdanov, M; Tong, SL; Guan, ZQ; Zheng, L				Lin, Yibin; Bogdanov, Mikhail; Tong, Shuilong; Guan, Ziqiang; Zheng, Lei			Substrate Selectivity of Lysophospholipid Transporter LplT Involved in Membrane Phospholipid Remodeling in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOSE PERMEASE; 2-ACYL LYSOPHOSPHOLIPIDS; PROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; HYDROLYSIS; CURVATURE; MECHANISM; PEPTIDES; LIPIDS	Lysophospholipid transporter (LplT) was previously found to be primarily involved in 2-acyl lysophosphatidylethanolamine (lyso-PE) recycling in Gram-negative bacteria. This work identifies the potent role of LplT in maintaining membrane stability and integrity in the Escherichia coli envelope. Here we demonstrate the involvement of LplT in the recycling of three major bacterial phospholipids using a combination of an in vitro lysophospholipid binding assay using purified protein and transport assays with E. coli spheroplasts. Our results show that lyso-PE and lysophosphatidylglycerol, but not lysophosphatidylcholine, are taken up by LplT for reacylation by acyltransferase/acyl-acyl carrier protein synthetase on the inner leaflet of the membrane. We also found a novel cardiolipin hydrolysis reaction by phospholipase A(2) to form diacylated cardiolipin progressing to the completely deacylated headgroup. These two distinct cardiolipin derivatives were both translocated with comparable efficiency to generate triacylated cardiolipin by acyltransferase/acyl-acyl carrier protein synthetase, demonstrating the first evidence of cardiolipin remodeling in bacteria. These findings support that a fatty acid chain is not required for LplT transport. We found that LplT cannot transport lysophosphatidic acid, and its substrate binding was not inhibited by either orthophosphate or glycerol 3-phosphate, indicating that either a glycerol or ethanolamine headgroup is the chemical determinant for substrate recognition. Diacyl forms of PE, phosphatidylglycerol, or the tetra-acylated form of cardiolipin could not serve as a competitive inhibitor in vitro. Based on an evolutionary structural model, we propose a "sideways sliding" mechanism to explain how a conserved membrane-embedded alpha-helical interface excludes diacylphospholipids from the LplT binding site to facilitate efficient flipping of lysophospholipid across the cell membrane.	[Lin, Yibin; Bogdanov, Mikhail; Tong, Shuilong; Zheng, Lei] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Guan, Ziqiang] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27703 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Duke University	Zheng, L (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Crystal, Boy/Q-3005-2019; Bogdanov, Mikhail/J-3695-2017; Lin, B.Y./AAA-7774-2020; Guan, Ziqiang/AAE-5110-2019	Crystal, Boy/0000-0003-0608-7875; 	National Institutes of Health [R01GM098572]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM098572 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Buckland AG, 1998, BBA-LIPID LIPID MET, V1390, P65, DOI 10.1016/S0005-2760(97)00170-7; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DENNIS EA, 1981, MOL CELL BIOCHEM, V36, P37, DOI 10.1007/BF02354830; DOI O, 1972, BIOCHIM BIOPHYS ACTA, V260, P244; DOI O, 1975, J BIOL CHEM, V250, P5208; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guo DG, 2000, BBA-MOL CELL BIOL L, V1483, P263, DOI 10.1016/S1388-1981(99)00193-6; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; HOMMA H, 1981, BIOCHIM BIOPHYS ACTA, V663, P1, DOI 10.1016/0005-2760(81)90189-2; HOMMA H, 1982, J BIOCHEM, V91, P1103, DOI 10.1093/oxfordjournals.jbchem.a133792; Hsu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059267; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Koller D, 2014, BBA-BIOMEMBRANES, V1838, P2250, DOI 10.1016/j.bbamem.2014.05.013; Lin YB, 2013, BBA-BIOMEMBRANES, V1828, P1690, DOI 10.1016/j.bbamem.2013.03.003; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	43	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2136	2149		10.1074/jbc.M115.700419	http://dx.doi.org/10.1074/jbc.M115.700419			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26613781	Green Published, hybrid			2022-12-28	WOS:000369610400008
J	Zhang, P; Feng, S; Liu, GT; Wang, HY; Zhu, HF; Ren, Q; Bai, HY; Fu, CL; Dong, C				Zhang, Pu; Feng, Shan; Liu, Gentao; Wang, Heyong; Zhu, Huifeng; Ren, Qiao; Bai, Huiyuan; Fu, Changliang; Dong, Cheng			Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING TUMOR-CELLS; V600E B-RAF; VE-CADHERIN; TISSUE FACTOR; CANCER-CELLS; IN-VIVO; TRANSENDOTHELIAL MIGRATION; TYROSINE PHOSPHORYLATION; DEPENDENT ENDOCYTOSIS; VASCULAR-PERMEABILITY	Tumor invasiveness depends on the ability of tumor cells to breach endothelial barriers. In this study, we investigated the mechanism by which the adhesion of melanoma cells to endothelium regulates adherens junction integrity and modulates tumor transendothelial migration (TEM) by initiating thrombin generation. We found that the B-Raf(V600E) mutation in metastatic melanoma cells up-regulated tissue factor (TF) expression on cell membranes and promoted thrombin production. Coculture of endothelial monolayers with metastatic melanoma cells mediated the opening of inter-endothelial spaces near melanoma cell contact sites in the presence of platelet-free plasma (PFP). By using small interfering RNA (siRNA), we demonstrated that B-Raf(V600E) and TF silencing attenuated the focal disassembly of adherens junction induced by tumor contact. Vascular endothelial-cadherin (VE-cadherin) disassembly was dependent on phosphorylation of p120-catenin on Ser-879 and VE-cadherin on Tyr-658, Tyr-685, and Tyr-731, which can be prevented by treatment with the thrombin inhibitor, hirudin, or by silencing the thrombin receptor, protease-activated receptor-1, in endothelial cells. We also provided strong evidence that tumor-derived thrombin enhanced melanoma TEM by inducing ubiquitination-coupled VE-cadherin internalization, focal adhesion formation, and actin assembly in endothelium. Confocal microscopic analysis of tumor TEM revealed that junctions transiently opened and resealed as tumor cells accomplished TEM. In addition, in the presence of PFP, tumor cells preferentially transmigrated via paracellular routes. PFP supported melanoma transmigration under shear conditions via a B-Raf(V600E)-thrombin-dependent mechanism. We concluded that the activation of thrombin generation by cancer cells in plasma is an important process regulating melanoma extravasation by disrupting endothelial junction integrity.	[Zhang, Pu; Feng, Shan; Zhu, Huifeng; Ren, Qiao; Bai, Huiyuan] Southwest Univ, Minist Educ, Coll Pharmaceut Sci, Key Lab Luminescence & Real Time Analyt Chem, Chongqing 400715, Peoples R China; [Zhang, Pu; Fu, Changliang; Dong, Cheng] Penn State Univ, Dept Bioengn, University Pk, PA 16801 USA; [Liu, Gentao; Wang, Heyong] Tongji Univ, Sch Med, Shanghai Pulm Hosp, 507 Zhengmin Rd, Shanghai 200433, Peoples R China	Southwest University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tongji University	Zhang, P (corresponding author), Southwest Univ, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China.	pxz122@swu.edu.cn			Fundamental Research Funds for the Central Universities [XDJK2014C176]; Start-up Foundation of Southwest University Grant [SWU114017]; National Natural Science Foundation of China [NSFC-81402393, NSFC-81572678]; National Institutes of Health [CA-125707]; National Science Foundation [CBET-0729091]; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Start-up Foundation of Southwest University Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Fundamental Research Funds for the Central Universities XDJK2014C176 (to P. Z.), Start-up Foundation of Southwest University Grant SWU114017 (to P. Z.), National Natural Science Foundation of China Grants NSFC-81402393 and NSFC-81572678 (to P. Z.) and in part by National Institutes of Health Grant CA-125707 (to C. D) and National Science Foundation Grant CBET-0729091 (to C. D). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Biggerstaff JP, 1999, CLIN EXP METASTAS, V17, P723, DOI 10.1023/A:1006763827882; Brose MS, 2002, CANCER RES, V62, P6997; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Cheung M, 2008, CANCER RES, V68, P3429, DOI 10.1158/0008-5472.CAN-07-5867; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dong C, 2005, FRONT BIOSCI-LANDMRK, V10, P379, DOI 10.2741/1535; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Fu CL, 2011, J BIOL CHEM, V286, P34777, DOI 10.1074/jbc.M111.281642; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Gonzales JN, 2014, VASC PHARMACOL, V62, P63, DOI 10.1016/j.vph.2014.01.005; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Hodgson L, 2003, ONCOGENE, V22, P98, DOI 10.1038/sj.onc.1206059; Hu L, 2004, BLOOD, V104, P2746, DOI 10.1182/blood-2004-03-1047; Huang TG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-3; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Khanna P, 2014, ONCOGENE, V33, P2898, DOI 10.1038/onc.2013.249; Khanna P, 2010, AM J PHYSIOL-CELL PH, V298, pC1140, DOI 10.1152/ajpcell.00242.2009; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Lee AM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00108; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Liang S, 2008, AM J PHYSIOL-CELL PH, V295, pC701, DOI 10.1152/ajpcell.00245.2008; Liang SL, 2007, CANCER RES, V67, P5814, DOI 10.1158/0008-5472.CAN-06-4233; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Millington GWM, 2013, CLIN EXP DERMATOL, V38, P222, DOI 10.1111/ced.12015; MUELLER BM, 1992, P NATL ACAD SCI USA, V89, P11832, DOI 10.1073/pnas.89.24.11832; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Peng HH, 2007, EXP CELL RES, V313, P551, DOI 10.1016/j.yexcr.2006.10.030; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; VANDENBROUCKE ST, 2012, CIRC RES, V111, P739, DOI DOI 10.1161/CIRCRESAHA.112.269654; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Welsh JD, 2012, J THROMB HAEMOST, V10, P2344, DOI 10.1111/j.1538-7836.2012.04928.x; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Whipple CA, 2014, BRIT J CANCER, V111, P1625, DOI 10.1038/bjc.2014.452; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Xu CC, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-63; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yu JL, 2010, THROMB RES, V126, pE6, DOI 10.1016/j.thromres.2010.04.014; Zhang P, 2014, FASEB J, V28, P4591, DOI 10.1096/fj.11-202747; Zhao YH, 2008, BIOCHEM BIOPH RES CO, V370, P509, DOI 10.1016/j.bbrc.2008.03.148	70	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2087	2106		10.1074/jbc.M115.696419	http://dx.doi.org/10.1074/jbc.M115.696419			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26504080	Green Published, hybrid			2022-12-28	WOS:000369610400005
J	Li, X; Li, YJ; Arendt, CS; Hochstrasser, M				Li, Xia; Li, Yanjie; Arendt, Cassandra S.; Hochstrasser, Mark			Distinct Elements in the Proteasomal beta 5 Subunit Propeptide Required for Autocatalytic Processing and Proteasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 20S PROTEASOME; ACTIVE-SITE FORMATION; IN-VIVO DEGRADATION; PROTEIN-DEGRADATION; CRYSTAL-STRUCTURE; S-PROTEASOMES; CORE PARTICLE; YEAST; MATURATION; BIOGENESIS	Eukaryotic 20S proteasome assembly remains poorly understood. The subunits stack into four heteroheptameric rings; three inner-ring subunits (beta 1, beta 2, and beta 5) bear the protease catalytic residues and are synthesized with N-terminal propeptides. These propeptides are removed autocatalytically late in assembly. In Saccharomyces cerevisiae, beta 5 (Doa3/Pre2) has a 75-residue propeptide, beta 5pro, that is essential for proteasome assembly and can work in trans. We show that deletion of the poorly conserved N-terminal half of the beta 5 propeptide nonetheless causes substantial defects in proteasome maturation. Sequences closer to the cleavage site have critical but redundant roles in both assembly and self-cleavage. A conserved histidine two residues upstream of the autocleavage site strongly promotes processing. Surprisingly, although beta 5pro is functionally linked to the Ump1 assembly factor, trans-expressed beta 5pro associates only weakly with Ump1-containing precursors. Several genes were identified as dosage suppressors of trans-expressed beta 5pro mutants; the strongest encoded the beta 7 proteasome subunit. Previous data suggested that beta 7 and beta 5pro have overlapping roles in bringing together two half-proteasomes, but the timing of beta 7 addition relative to half-mer joining was unclear. Here we report conditions where dimerization lags behind beta 7 incorporation into the half-mer. Our results suggest that beta 7 insertion precedes half-mer dimerization, and the beta 7 tail and beta 5 propeptide have unequal roles in half-mer joining.	[Li, Xia; Li, Yanjie; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA; [Arendt, Cassandra S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Li, Xia] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Arendt, Cassandra S.] 13417 Kinder Pass, Austin, TX 78727 USA	Yale University; University of Chicago; University of California System; University of California San Diego	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM046904, GM083050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R37GM046904, R01GM083050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM046904 and GM083050 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Bai M, 2014, BIOMOLECULES, V4, P662, DOI 10.3390/biom4030662; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FRENTZEL S, 1994, J MOL BIOL, V236, P975, DOI 10.1016/0022-2836(94)90003-5; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2011, CURR TOP MED CHEM, V11, P2850, DOI 10.2174/156802611798281320; Gu ZC, 2014, CELL MOL LIFE SCI, V71, P4729, DOI 10.1007/s00018-014-1699-8; Guthrie C., 2002, GUIDE YEAST GENETICS; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kock M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7123; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Li Y., 2015, CURR PROTOC CELL BIO, V67; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Matias AC, 2010, BIOCHEM SOC T, V38, P29, DOI 10.1042/BST0380029; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Velichutina I, 2004, EMBO J, V23, P500, DOI 10.1038/sj.emboj.7600059; Verbrugge SE, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0529-1; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	61	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1991	+		10.1074/jbc.M115.677047	http://dx.doi.org/10.1074/jbc.M115.677047			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627836	Green Published, hybrid			2022-12-28	WOS:000368620700035
J	Liu, YW; Zhang, LX; Wang, C; Roy, S; Shen, JZ				Liu, Yiwei; Zhang, Lingxin; Wang, Chuan; Roy, Shama; Shen, Jianzhong			Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1 EXPRESSION; SMOOTH-MUSCLE-CELLS; P2Y(2) RECEPTOR; P2X7 RECEPTOR; FACTOR GENE; C-FOS; ATHEROSCLEROSIS; MICE; AP-1; THROMBOSIS	We recently reported that the P2Y2 receptor (P2Y2R) is the predominant nucleotide receptor expressed in human coronary artery endothelial cells (HCAEC) and that P2Y2R activation by ATP or UTP induces dramatic up-regulation of tissue factor (TF), a key initiator of the coagulation cascade. However, the molecular mechanism of this P2Y2R-TF axis remains unclear. Here, we report the role of a newly identified AP-1 consensus sequence in the TF gene promoter and its original binding components in P2Y2R regulation of TF transcription. Using bioinformatics tools, we found that a novel AP-1 site at -1363 bp of the human TF promoter region is highly conserved across multiple species. Activation of P2Y2R increased TF promoter activity and mRNA expression in HCAEC. Truncation, deletion, and mutation of this distal AP-1 site all significantly suppressed TF promoter activity in response to P2Y2R activation. EMSA and ChIP assays further confirmed that upon P2Y2R activation, c-Jun, ATF-2, and Fra-1, but not the typical c-Fos, bound to the new AP-1 site. In addition, loss-of-function studies using siRNAs confirmed a positive transactivation role of c-Jun and ATF-2 but unexpectedly revealed a strong negative role of Fra-1 in P2Y2R-induced TF up-regulation. Furthermore, we found that P2Y2R activation promoted ERK1/2 phosphorylation through Src, leading to Fra-1 activation, whereas Rho/JNK mediated P2Y2R-induced activation of c-Jun and ATF-2. These findings reveal the molecular basis for P2Y G protein-coupled receptor control of endothelial TF expression and indicate that targeting the P2Y2R-Fra-1-TF pathway may be an attractive new strategy for controlling vascular inflammation and thrombogenicity associated with endothelial dysfunction.	[Liu, Yiwei; Zhang, Lingxin; Wang, Chuan; Roy, Shama; Shen, Jianzhong] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, 4306G Walker Bldg, Auburn, AL 36849 USA	Auburn University System; Auburn University	Shen, JZ (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, 4306G Walker Bldg, Auburn, AL 36849 USA.	jzs0019@auburn.edu	Shen, Jianzhong/AAH-8184-2019	Liu, Yiwei/0000-0002-9979-6269	American Heart Association [12SDG8850011]; Auburn University [IGP150301]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125279] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Auburn University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Scientist Development Award 12SDG8850011 from the American Heart Association ( to J. S.) and by Auburn University Intramural Grant Program IGP150301 ( to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aljada A, 2002, J CLIN ENDOCR METAB, V87, P1419, DOI 10.1210/jc.87.3.1419; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bickford JS, 2013, J LIPID RES, V54, P1915, DOI 10.1194/jlr.M037382; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Burnstock Geoffrey, 2011, Front Biosci (Elite Ed), V3, P896; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Gavala ML, 2010, J BIOL CHEM, V285, P34288, DOI 10.1074/jbc.M110.142091; Gebhard C, 2012, THROMB HAEMOSTASIS, V107, P884, DOI 10.1160/TH11-09-0624; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Hechler B, 2008, CIRCULATION, V118, P754, DOI 10.1161/CIRCULATIONAHA.108.788927; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Jarvis B, 2000, DRUGS, V60, P347, DOI 10.2165/00003495-200060020-00012; Kellerman D, 2008, PULM PHARMACOL THER, V21, P600, DOI 10.1016/j.pupt.2007.12.003; Lau OCF, 2014, CLIN OPHTHALMOL, V8, P327, DOI 10.2147/OPTH.S39699; Lee R, 2012, J THROMB HAEMOST, V10, P1965, DOI 10.1111/j.1538-7836.2012.04842.x; Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200; Ma WS, 2013, J BIOL CHEM, V288, P15481, DOI 10.1074/jbc.M112.445510; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; Moons AHM, 2002, CARDIOVASC RES, V53, P313, DOI 10.1016/S0008-6363(01)00452-7; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; Rajasekaran S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041611; Robson SC, 2005, SEMIN THROMB HEMOST, V31, P217, DOI 10.1055/s-2005-869527; Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092; Seye CI, 2007, PURINERG SIGNAL, V3, P153, DOI 10.1007/s11302-006-9047-6; Seye CI, 2012, J BIOL CHEM, V287, P10535, DOI 10.1074/jbc.M111.313189; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Shen JZ, 2010, CIRC RES, V106, P902, DOI 10.1161/CIRCRESAHA.109.198069; Shen JZ, 2004, MOL PHARMACOL, V66, P1265, DOI 10.1124/mol.104.002642; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Verheugt FWA, 2013, CIRCULATION, V128, P2058, DOI 10.1161/CIRCULATIONAHA.113.002250; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	46	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1553	1563		10.1074/jbc.M115.681163	http://dx.doi.org/10.1074/jbc.M115.681163			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631725	Green Published, hybrid			2022-12-28	WOS:000368620700001
J	McGregor, N; Morar, M; Fenger, TH; Stogios, P; Lenfant, N; Yin, V; Xu, XH; Evdokimova, E; Cui, H; Henrissat, B; Savchenko, A; Brumer, H				McGregor, Nicholas; Morar, Mariya; Fenger, Thomas Hauch; Stogios, Peter; Lenfant, Nicolas; Yin, Victor; Xu, Xiaohui; Evdokimova, Elena; Cui, Hong; Henrissat, Bernard; Savchenko, Alexei; Brumer, Harry			Structure-Function Analysis of a Mixed-linkage beta-Glucanase/Xyloglucanase from the Key Ruminal Bacteroidetes Prevotella bryantii B(1)4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE NUCLEOPHILE; SUBSTRATE-SPECIFICITY; ENZYMATIC-HYDROLYSIS; XYLOGLUCAN; ENDOGLUCANASE; GENE; RUMINICOLA; CLONING; FAMILY; PLANT	The recent classification of glycoside hydrolase family 5 (GH5) members into subfamilies enhances the prediction of substrate specificity by phylogenetic analysis. However, the small number of well characterized members is a current limitation to understanding the molecular basis of the diverse specificity observed across individual GH5 subfamilies. GH5 subfamily 4 (GH5_4) is one of the largest, with known activities comprising (carboxymethyl) cellulases, mixedlinkage endo-glucanases, and endo-xyloglucanases. Through detailed structure-function analysis, we have revisited the characterization of a classic GH5_4 carboxymethylcellulase, PbGH5A (also known as Orf4, carboxymethylcellulase, and Cel5A), from the symbiotic rumen Bacteroidetes Prevotella bryantii B(1)4. We demonstrate that carboxymethylcellulose and phosphoric acid-swollen cellulose are in fact relatively poor substrates for PbGH5A, which instead exhibits clear primary specificity for the plant storage and cell wall polysaccharide, mixedlinkage beta-glucan. Significant activity toward the plant cell wall polysaccharide xyloglucan was also observed. Determination of PbGH5A crystal structures in the apo-form and in complex with (xylo) glucan oligosaccharides and an active-site affinity label, together with detailed kinetic analysis using a variety of well defined oligosaccharide substrates, revealed the structural determinants of polysaccharide substrate specificity. In particular, this analysis highlighted the PbGH5A active-site motifs that engender predominant mixed-linkage endo-glucanase activity vis a vis predominant endo-xyloglucanases in GH5_4. However the detailed phylogenetic analysis of GH5_4 members did not delineate particular clades of enzymes sharing these sequence motifs; the phylogeny was instead dominated by bacterial taxonomy. Nonetheless, our results provide key enzyme functional and structural reference data for future bioinformatics analyses of (meta) genomes to elucidate the biology of complex gut ecosystems.	[McGregor, Nicholas; Fenger, Thomas Hauch; Yin, Victor; Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [McGregor, Nicholas; Fenger, Thomas Hauch; Yin, Victor; Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada; [Morar, Mariya; Stogios, Peter; Xu, Xiaohui; Evdokimova, Elena; Cui, Hong; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1L6, Canada; [Lenfant, Nicolas; Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia; [Henrissat, Bernard] INRA, AFMB, USC 1408, F-13288 Marseille, France	University of British Columbia; University of British Columbia; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; INRAE; UDICE-French Research Universities; Aix-Marseille Universite	Savchenko, A (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1L6, Canada.	alexei.savchenko@utoronto.ca; brumer@msl.ubc.ca	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Stogios, Peter/0000-0001-8663-1425; McGregor, Nicholas/0000-0003-1075-7368; Lenfant, Nicolas/0000-0002-0519-1120	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; National Institutes of Health [U54-GM074942, U54-GM094585]; Natural Sciences and Engineering Research Council via the Industrial Bio-catalysis Network; Alexander Graham Bell Canada Graduate Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada; Carlsberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council via the Industrial Bio-catalysis Network; Alexander Graham Bell Canada Graduate Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada; Carlsberg Foundation(Carlsberg Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant), the Canada Foundation for Innovation, and the British Columbia Knowledge Development Fund (to H.B.) and by National Institutes of Health Grants U54-GM074942 and U54-GM094585 (to A.S. through the Midwest Center for Structural Genomics). H.B. and A.S. also acknowledge joint funding to their laboratories from the Natural Sciences and Engineering Research Council via the Industrial Bio-catalysis Network. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of an Alexander Graham Bell Canada Graduate Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada.r Supported by the Carlsberg Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERSHEIM P, 2011, PLANT CELL WALLS, P1; Ariza A, 2011, J BIOL CHEM, V286, P33890, DOI 10.1074/jbc.M111.262345; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; BERGER E, 1989, MOL GEN GENET, V219, P193, DOI 10.1007/BF00261176; BLACK TS, 1993, CARBOHYD RES, V250, P195, DOI 10.1016/0008-6215(93)84166-4; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Desmet T, 2007, FEBS J, V274, P356, DOI 10.1111/j.1742-4658.2006.05582.x; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; dos Santos CR, 2015, BIOCHEMISTRY-US, V54, P1930, DOI 10.1021/acs.biochem.5b00011; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eklof JM, 2013, J BIOL CHEM, V288, P15786, DOI 10.1074/jbc.M113.462887; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; FAURE E, 1989, GENE, V84, P39, DOI 10.1016/0378-1119(89)90137-6; Fenger TH, 2015, CHEMBIOCHEM, V16, P575, DOI 10.1002/cbic.201402663; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; FOONG F, 1991, J GEN MICROBIOL, V137, P1729, DOI 10.1099/00221287-137-7-1729; FRY SC, 1989, J EXP BOT, V40, P1, DOI 10.1093/jxb/40.1.1; Fry SC, 2008, NEW PHYTOL, V179, P104, DOI 10.1111/j.1469-8137.2008.02435.x; Gardner RG, 1997, CURR MICROBIOL, V35, P274, DOI 10.1007/s002849900253; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; HAMAMOTO T, 1992, MOL GEN GENET, V231, P472, DOI 10.1007/BF00292718; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ibatullin FM, 2008, BIOCHEMISTRY-US, V47, P7762, DOI 10.1021/bi8009168; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; KITZ R, 1962, J BIOL CHEM, V237, P3245; Larsbrink J, 2014, MOL MICROBIOL, V94, P418, DOI 10.1111/mmi.12776; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Martens EC, 2014, J MOL BIOL, V426, P3851, DOI 10.1016/j.jmb.2014.06.022; MATSUSHITA O, 1990, J BACTERIOL, V172, P3620, DOI 10.1128/jb.172.7.3620-3630.1990; MIAO SC, 1994, J BIOL CHEM, V269, P10975; Michaelis L, 1913, BIOCHEM Z, V49, P333; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Palackal N, 2007, APPL MICROBIOL BIOT, V74, P113, DOI 10.1007/s00253-006-0645-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ravachol J, 2014, J BIOL CHEM, V289, P7335, DOI 10.1074/jbc.M113.545046; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schagerlof H, 2009, ANAL BIOANAL CHEM, V394, P1977, DOI 10.1007/s00216-009-2891-9; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Tseng CW, 2011, ACTA CRYSTALLOGR F, V67, P1189, DOI 10.1107/S1744309111032428; Tull D, 1996, ANAL BIOCHEM, V234, P119, DOI 10.1006/abio.1996.0063; Tuomivaara ST, 2015, CARBOHYD RES, V402, P56, DOI 10.1016/j.carres.2014.06.031; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; WALSETH CS, 1952, TAPPI, V35, P233; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; WITHERS SG, 1992, BIOCHEMISTRY-US, V31, P9979, DOI 10.1021/bi00156a017; Xue XX, 2012, ANN BOT-LONDON, V109, P873, DOI 10.1093/aob/mcs018; YORK WS, 1990, CARBOHYD RES, V200, P9, DOI 10.1016/0008-6215(90)84179-X; YUAN JM, 1994, BIOCHEM J, V299, P527, DOI 10.1042/bj2990527; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhou Q, 2007, CELLULOSE, V14, P625, DOI 10.1007/s10570-007-9109-0	73	31	33	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1175	1197		10.1074/jbc.M115.691659	http://dx.doi.org/10.1074/jbc.M115.691659			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26507654	Green Published, hybrid			2022-12-28	WOS:000368068300013
J	Bruser, A; Schulz, A; Rothemund, S; Ricken, A; Calebiro, D; Kleinau, G; Schoneberg, T				Brueser, Antje; Schulz, Angela; Rothemund, Sven; Ricken, Albert; Calebiro, Davide; Kleinau, Gunnar; Schoeneberg, Torsten			The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; PROTEIN-COUPLED RECEPTORS; THYROTROPIN RECEPTOR; TSH RECEPTOR; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVITY; MOLECULAR-CLONING; THYROID-FUNCTION	Glycoprotein hormones (GPHs) are the main regulators of the pituitary-thyroid and pituitary-gonadal axes. Selective interaction between GPHs and their cognate G protein-coupled receptors ensure specificity in GPH signaling. The mechanisms of how these hormones activate glycoprotein hormone receptors (GPHRs) or how mutations and autoantibodies can alter receptor function were unclear. Based on the hypothesis that GPHRs contain an internal agonist, we systematically screened peptide libraries derived from the ectodomain for agonistic activity on the receptors. We show that a peptide (p10) derived from a conserved sequence in the C-terminal part of the extracellular N terminus can activate all GPHRs in vitro and in GPHR-expressing tissues. Inactivating mutations in this conserved region or in p10 can inhibit activation of the thyroid-stimulating hormone receptor by autoantibodies. Our data suggest an activation mechanism where, upon extracellular ligand binding, this intramolecular agonist isomerizes and induces structural changes in the 7-transmembrane helix domain, triggering G protein activation. This mechanism can explain the pathophysiology of activating autoantibodies and several mutations causing endocrine dysfunctions such as Graves disease and hypo- and hyperthyroidism. Our findings highlight an evolutionarily conserved activation mechanism of GPHRs and will further promote the development of specific ligands useful to treat Graves disease and other dysfunctions of GPHRs.	[Brueser, Antje; Schulz, Angela; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany; [Rothemund, Sven] Univ Leipzig, Core Unit Peptide Technol, D-04103 Leipzig, Germany; [Ricken, Albert] Univ Leipzig, Fac Med, Inst Anat, D-04103 Leipzig, Germany; [Calebiro, Davide] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Calebiro, Davide] Univ Wurzburg, Rudolf Virchow Ctr, Bioimaging Ctr, D-97078 Wurzburg, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany	Leipzig University; Leipzig University; Leipzig University; University of Wurzburg; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schoneberg, T (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Kleinau, Gunnar/GPX-6330-2022	calebiro, davide/0000-0002-3811-1553	Deutsche Forschungsgemeinschaft (SSP ThyroidTransAct) [BR 5108/1-1 AO 619225, SFB/Transregio 166]; BMBF (IFB AdipositasDiseases Leipzig) [FZ: 01EO1001]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Wurzburg [B-281]; University of Leipzig	Deutsche Forschungsgemeinschaft (SSP ThyroidTransAct)(German Research Foundation (DFG)); BMBF (IFB AdipositasDiseases Leipzig)(Federal Ministry of Education & Research (BMBF)); Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Wurzburg; University of Leipzig	The work was supported by the Deutsche Forschungsgemeinschaft (SSP ThyroidTransAct; BR 5108/1-1 AO 619225 and SFB/Transregio 166, project C1), the BMBF (IFB AdipositasDiseases Leipzig, FZ: 01EO1001), Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Wurzburg (B-281) and the University of Leipzig (Junior research grant by the Medical Faculty). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Alvarez CA, 1999, ENDOCRINOLOGY, V140, P1775, DOI 10.1210/en.140.4.1775; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 2001, J CLIN ENDOCR METAB, V86, P4429, DOI 10.1210/jc.86.9.4429; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Chen CR, 2003, ENDOCRINOLOGY, V144, P1324, DOI 10.1210/en.2002-0005; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; Costagliola S, 2004, MOL ENDOCRINOL, V18, P3020, DOI 10.1210/me.2004-0231; Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Heitman LH, 2008, MOL PHARMACOL, V73, P518, DOI 10.1124/mol.107.039875; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majumdar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040291; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Neumann S, 2014, ENDOCRINOLOGY, V155, P310, DOI 10.1210/en.2013-1835; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanders J, 2004, THYROID, V14, P560, DOI 10.1089/1050725041692918; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmutzler C, 1998, EXP CLIN ENDOCR DIAB, V106, pS1, DOI 10.1055/s-0029-1212036; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulz A, 1999, MOL ENDOCRINOL, V13, P181, DOI 10.1210/me.13.2.181; Smith BR, 2007, THYROID, V17, P923, DOI 10.1089/thy.2007.0239; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Stavrou SS, 1998, J CLIN ENDOCR METAB, V83, P2091, DOI 10.1210/jc.83.6.2091; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	58	42	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					508	520		10.1074/jbc.M115.701102	http://dx.doi.org/10.1074/jbc.M115.701102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582202	Green Published, hybrid			2022-12-28	WOS:000367830500001
J	Fichorova, RN; Yamamoto, HS; Fashemi, T; Foley, E; Ryan, S; Beatty, N; Dawood, H; Hayes, GR; St-Pierre, G; Sato, S; Singh, BN				Fichorova, Raina N.; Yamamoto, Hidemi S.; Fashemi, Titilayo; Foley, Evan; Ryan, Stanthia; Beatty, Noah; Dawood, Hassan; Hayes, Gary R.; St-Pierre, Guillaume; Sato, Sachiko; Singh, Bibhuti N.			Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and-3 to Modulate Epithelial Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCAN INTERACTIONS; INNATE IMMUNITY; EXPRESSION; CELLS; RECEPTOR; PROTEIN; MICROBICIDES; RECOGNITION; RECRUITMENT; CYTOKINES	Trichomoniasis is the most common non-viral sexually transmitted infection caused by the vaginotropic extracellular protozoan parasite Trichomonas vaginalis. The infection is recurrent, with no lasting immunity, often asymptomatic, and linked to pregnancy complications and risk of viral infection. The molecular mechanisms of immune evasion by the parasite are poorly understood. We demonstrate that galectin-1 and -3 are expressed by the human cervical and vaginal epithelial cells and act as pathogen-recognition receptors for the ceramide phosphoinositol glycan core (CPI-GC) of the dominant surface protozoan lipophosphoglycan (LPG). We used an in vitro model with siRNA galectin knockdown epithelial clones, recombinant galectins, clinical Trichomonas isolates, and mutant protozoan derivatives to dissect the function of galectin-1 and -3 in the context of Trichomonas infection. Galectin-1 suppressed chemokines that facilitate recruitment of phagocytes, which can eliminate extracellular protozoa (IL-8) or bridge innate to adaptive immunity (MIP-3 alpha and RANTES (regulated on activation normalTcell expressed and secreted)). Silencing galectin-1 increased and adding exogenous galectin-1 suppressed chemokine responses to Trichomonas or CPI-GC/LPG. In contrast, silencing galectin-3 reduced IL-8 response to LPG. Live Trichomonas depleted the extracellular levels of galectin-3. Clinical isolates and mutant Trichomonas CPI-GC that had reduced affinity to galectin-3 but maintained affinity to galectin-1 suppressed chemokine expression. Thus via CPI-GC binding, Trichomonas is capable of regulating galectin bioavailability and function to the benefit of its parasitic survival. These findings suggest novel approaches to control trichomoniasis and warrant further studies of galectin-binding diversity among clinical isolates as a possible source for symptom disparity in parasitic infections.	[Fichorova, Raina N.; Yamamoto, Hidemi S.; Fashemi, Titilayo; Foley, Evan; Ryan, Stanthia; Beatty, Noah; Dawood, Hassan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol,Lab Genital Tra, Boston, MA 02115 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Biochem, Syracuse, NY 13210 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Mol Biol, Syracuse, NY 13210 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Obstet & Gynecol, Syracuse, NY 13210 USA; [St-Pierre, Guillaume; Sato, Sachiko] Univ Laval, Fac Med, Res Ctr Infect Dis, Lab Glycobiol & Bioimaging, Quebec City, PQ G1V 4G2, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Laval University	Fichorova, RN (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 221 Longwood Ave,RF468, Boston, MA 02115 USA.	rfichorova@rics.bwh.harvard.edu			National Institutes of Health from NIAID [5R01AI079085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079085] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 5R01AI079085 from NIAID. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Almkvist J, 2002, J IMMUNOL, V168, P4034, DOI 10.4049/jimmunol.168.8.4034; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; Bhaumik P, 2013, J IMMUNOL, V190, P630, DOI 10.4049/jimmunol.1103197; Blois SM, 2014, J REPROD IMMUNOL, V101, P127, DOI 10.1016/j.jri.2013.05.005; Canny GO, 2006, J INFECT DIS, V194, P498, DOI 10.1086/505712; Chen HY, 2014, CURR OPIN MICROBIOL, V17, P75, DOI 10.1016/j.mib.2013.11.006; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; Demmert M, 2012, CLIN EXP IMMUNOL, V167, P246, DOI 10.1111/j.1365-2249.2011.04509.x; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 2013, SEX TRANSM INFECT, V89, P460, DOI 10.1136/sextrans-2013-051052; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Gilbert RO, 2000, INFECT IMMUN, V68, P4200, DOI 10.1128/IAI.68.7.4200-4206.2000; Guha-Niyogi A, 2001, GLYCOBIOLOGY, V11, p45R, DOI 10.1093/glycob/11.4.45R; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Huppert JS, 2013, J INFECT DIS, V207, P1462, DOI 10.1093/infdis/jit039; Jain A, 2014, HUM REPROD, V29, P242, DOI 10.1093/humrep/det423; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lustig G, 2013, INFECT IMMUN, V81, P1411, DOI 10.1128/IAI.01244-12; Maier O, 2012, J VIROL, V86, P10821, DOI 10.1128/JVI.01428-12; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Nieminen J, 2008, J IMMUNOL, V180, P2466, DOI 10.4049/jimmunol.180.4.2466; Nio-Kobayashi J., 2010, KAIBOUGAKU ZASSHI TO, V85, P58; Nyame AK, 2004, ARCH BIOCHEM BIOPHYS, V426, P182, DOI 10.1016/j.abb.2004.04.004; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Rabinovich GA, 2005, PARASITE IMMUNOL, V27, P103, DOI 10.1111/j.1365-3024.2005.00749.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SATO S, 1994, J BIOL CHEM, V269, P4424; Sato S, 2014, CRIT REV IMMUNOL, V34, P147, DOI 10.1615/CritRevImmunol.2014010154; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; SINGH BN, 1994, ARCH BIOCHEM BIOPHYS, V309, P273, DOI 10.1006/abbi.1994.1113; SINGH BN, 1993, MOL BIOCHEM PARASIT, V57, P281, DOI 10.1016/0166-6851(93)90204-B; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; St-Pierre C, 2010, METHOD ENZYMOL, V480, P267, DOI 10.1016/S0076-6879(10)80013-8; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Trifonova RT, 2006, ANTIMICROB AGENTS CH, V50, P4005, DOI 10.1128/AAC.00588-06; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; WHO, 2012, GLOB INC PREV SEL CU	63	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					998	1013		10.1074/jbc.M115.651497	http://dx.doi.org/10.1074/jbc.M115.651497			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26589797	hybrid, Green Published			2022-12-28	WOS:000367830500045
J	Vicente, JB; Colaco, HG; Sarti, P; Leandro, P; Giuffre, A				Vicente, Joao B.; Colaco, Henrique G.; Sarti, Paolo; Leandro, Paula; Giuffre, Alessandro			S-Adenosyl-L-methionine Modulates CO and NO center dot Binding to the Human H2S-generating Enzyme Cystathionine beta-Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYLMETHIONINE SAM; CELL-PROLIFERATION; HYDROGEN-SULFIDE; STRUCTURAL-BASIS; NITRIC-OXIDE; HEME; KINETICS; DOMAIN; CBS; BIOENERGETICS	Cystathionine beta-synthase (CBS) is a key enzyme in human (patho) physiology with a central role in hydrogen sulfide metabolism. The enzyme is composed of a pyridoxal 5'-phosphate-binding catalytic domain, flanked by the following two domains: a heme-binding N-terminal domain and a regulatory C-terminal domain binding S-adenosyl-L-methionine (AdoMet). CO or NO center dot binding at the ferrous heme negatively modulates the enzyme activity. Conversely, AdoMet binding stimulates CBS activity. Here, we provide experimental evidence for a functional communication between the two domains. We report that AdoMet binding significantly enhances CBS inhibition by CO. Consistently, we observed increased affinity (similar to 5-fold) and faster association (similar to 10-fold) of CO to the ferrous heme at physiological AdoMet concentrations. NO similar to binding to reduced CBS was also enhanced by AdoMet, although to a lesser extent (similar to 2-fold higher affinity) as compared with CO. Importantly, CO and NO center dot binding was unchanged by AdoMet in a truncated form of CBS lacking the C-terminal regulatory domain. These unprecedented observations demonstrate that CBS activation by AdoMet puzzlingly sensitizes the enzyme toward inhibition by exogenous ligands, like CO and NO center dot. This further supports the notion that CBS regulation is a complex process, involving the concerted action of multiple physiologically relevant effectors.	[Vicente, Joao B.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Colaco, Henrique G.; Leandro, Paula] Univ Lisbon, Fac Pharm, Med Res Inst, Metab & Genet Grp, P-1649003 Lisbon, Portugal; [Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sarti, Paolo] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1640003 Lisbon, Portugal; [Giuffre, Alessandro] Natl Res Council Italy, Inst Mol Biol & Pathol, I-00185 Rome, Italy	Universidade Nova de Lisboa; Universidade de Lisboa; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Universidade de Lisboa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Vicente, JB (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780156 Oeiras, Portugal.	jvicente@itqb.unl.pt; alessandro.giuffre@uniroma1.it	Vicente, Joao B/L-8732-2016; Giuffrè, Alessandro/K-4341-2015; iMed.ULisboa, MetGen/B-5293-2014; Leandro, Paula/A-8323-2014; Colaço, Henrique/AAV-2243-2020; Colaco, Henrique/M-5790-2014	Giuffrè, Alessandro/0000-0001-5301-0681; Leandro, Paula/0000-0002-2946-9342; Colaco, Henrique/0000-0002-2026-0163; Vicente, Joao/0000-0001-5244-8059	Fundacao para a Ciencia e Tecnologia [PEst-OE/SAU/UI4013/2011, PTDC/SAU-MIC/111447/2009]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy PNR-CNR Aging; Fondo per gli Investimenti della Ricerca di Base [RBIN06E9Z8]; Progetti di Rilevante Interesse Nazionale [20107Z8XBW_005]; Consiglio Nazionale delle Ricerche of Italy; Fundacao para a Ciencia e Tecnologia of Portugal; Federation of European Biochemical Societies	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy PNR-CNR Aging; Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Progetti di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Consiglio Nazionale delle Ricerche of Italy(Consiglio Nazionale delle Ricerche (CNR)); Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Federation of European Biochemical Societies	This work was supported in part by Fundacao para a Ciencia e Tecnologia Grants PEst-OE/SAU/UI4013/2011 and PTDC/SAU-MIC/111447/2009 (to J. B. V.), Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy PNR-CNR Aging Program 2012-2014 (to A. G.), Fondo per gli Investimenti della Ricerca di Base RBIN06E9Z8 and Progetti di Rilevante Interesse Nazionale 20107Z8XBW_005 (to P. S.), and a bilateral grant award by Consiglio Nazionale delle Ricerche of Italy and Fundacao para a Ciencia e Tecnologia of Portugal (to A. G. and J. B. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a short term fellowship from the Federation of European Biochemical Societies.	Banerjee R, 2011, ANTIOXID REDOX SIGN, V15, P339, DOI 10.1089/ars.2011.3912; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carballal S, 2008, BIOCHEMISTRY-US, V47, P3194, DOI 10.1021/bi700912k; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Ereno-Orbea J, 2014, P NATL ACAD SCI USA, V111, pE3845, DOI 10.1073/pnas.1414545111; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; FINKELSTEIN JD, 1982, J NUTR, V112, P1011, DOI 10.1093/jn/112.5.1011; Gherasim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085544; Hellmich MR, 2015, ANTIOXID REDOX SIGN, V22, P424, DOI 10.1089/ars.2014.5933; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; HINTZ MJ, 1980, J BIOL CHEM, V255, P7317; Hishiki T, 2012, J MOL MED, V90, P245, DOI 10.1007/s00109-012-0875-2; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kluijtmans LAJ, 1996, J CLIN INVEST, V98, P285, DOI 10.1172/JCI118791; Majtan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105290; McCorvie TJ, 2014, J BIOL CHEM, V289, P36018, DOI 10.1074/jbc.M114.610782; Mendes MIS, 2014, HUM MUTAT, V35, P1195, DOI 10.1002/humu.22616; Mendes MIS, 2014, J INHERIT METAB DIS, V37, P245, DOI 10.1007/s10545-013-9647-6; Modis K, 2014, NITRIC OXIDE-BIOL CH, V41, P146, DOI 10.1016/j.niox.2014.03.001; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Smith AT, 2012, BIOCHEMISTRY-US, V51, P6360, DOI 10.1021/bi300421z; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vicente JB, 2014, J BIOL CHEM, V289, P8579, DOI 10.1074/jbc.M113.507533; Yadav PK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414706	46	27	28	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					572	581		10.1074/jbc.M115.681221	http://dx.doi.org/10.1074/jbc.M115.681221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582199	hybrid, Green Published			2022-12-28	WOS:000367830500006
J	Fleck, D; Voss, M; Brankatschk, B; Giudici, C; Hampel, H; Schwenk, B; Edbauer, D; Fukumori, A; Steiner, H; Kremmer, E; Haug-Kroper, M; Rossner, MJ; Fluhrer, R; Willem, M; Haass, C				Fleck, Daniel; Voss, Matthias; Brankatschk, Ben; Giudici, Camilla; Hampel, Heike; Schwenk, Benjamin; Edbauer, Dieter; Fukumori, Akio; Steiner, Harald; Kremmer, Elisabeth; Haug-Kroeper, Martina; Rossner, Moritz J.; Fluhrer, Regina; Willem, Michael; Haass, Christian			Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; Alzheimer disease; amyloid- (AB); -secretase 1 (BACE1); -secretase; neurodegeneration	SIGNAL PEPTIDE PEPTIDASE; AMYLOID PRECURSOR PROTEIN; DEPENDENT GAMMA-SECRETASE; BETA-LIKE PEPTIDE; INTRACELLULAR DOMAIN; TRANSMEMBRANE DOMAIN; ASPARTYL PROTEASES; TNF-ALPHA; CLEAVAGE; BACE1	Numerous membrane-bound proteins undergo regulated intramembrane proteolysis. Regulated intramembrane proteolysis is initiated by shedding, and the remaining stubs are further processed by intramembrane-cleaving proteases (I-CLiPs). Neuregulin 1 type III (NRG1 type III) is a major physiological substrate of -secretase (-site amyloid precursor protein-cleaving enzyme 1 (BACE1)). BACE1-mediated cleavage is required to allow signaling of NRG1 type III. Because of the hairpin nature of NRG1 type III, two membrane-bound stubs with a type 1 and a type 2 orientation are generated by proteolytic processing. We demonstrate that these stubs are substrates for three I-CLiPs. The type 1-oriented stub is further cleaved by -secretase at an E-like site five amino acids N-terminal to the C-terminal membrane anchor and at a -like site in the middle of the transmembrane domain. The E-cleavage site is only one amino acid N-terminal to a Val/Leu substitution associated with schizophrenia. The mutation reduces generation of the NRG1 type III -peptide as well as reverses signaling. Moreover, it affects the cleavage precision of -secretase at the -site similar to certain Alzheimer disease-associated mutations within the amyloid precursor protein. The type 2-oriented membrane-retained stub of NRG1 type III is further processed by signal peptide peptidase-like proteases SPPL2a and SPPL2b. Expression of catalytically inactive aspartate mutations as well as treatment with 2,2-(2-oxo-1,3-propanediyl)bis[(phenylmethoxy)carbonyl]-l-leucyl-l-leucinamide ketone inhibits formation of N-terminal intracellular domains and the corresponding secreted C-peptide. Thus, NRG1 type III is the first protein substrate that is not only cleaved by multiple sheddases but is also processed by three different I-CLiPs.	[Fleck, Daniel; Voss, Matthias; Giudici, Camilla; Hampel, Heike; Steiner, Harald; Haug-Kroeper, Martina; Fluhrer, Regina; Willem, Michael; Haass, Christian] Univ Munich, Biomed Ctr, Biochem, D-81377 Munich, Germany; [Brankatschk, Ben; Rossner, Moritz J.] Univ Munich, Psychiat Clin, Dept Mol Neurobiol, D-80336 Munich, Germany; [Schwenk, Benjamin; Edbauer, Dieter; Fukumori, Akio; Steiner, Harald; Fluhrer, Regina; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany; [Edbauer, Dieter; Kremmer, Elisabeth; Haass, Christian] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Willem, M (corresponding author), Univ Munich, Inst Metab Biochem, Feodor Lynen Str 17, D-81377 Munich, Germany.	Michael.Willem@mail03.med.uni-muenchen.de; christian.haass@mail03.med.uni-muenchen.de	Edbauer, Dieter/M-9906-2019	Edbauer, Dieter/0000-0002-7186-4653; Voss, Matthias/0000-0002-4217-3175	Deutsche Forschungsgemeinschaft [HA 1737-11, FL 635/2-1, FOR2290, HA 1737/13-1]; MetLife Award; Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MetLife Award; Hans and Ilse Breuer Foundation	This work was supported in part by Deutsche Forschungsgemeinschaft Grants HA 1737-11, FL 635/2-1, FOR2290, and HA 1737/13-1 and a MetLife Award. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Ph.D. stipends from the Hans and Ilse Breuer Foundation.	Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Brankatschk B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002351; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chen Y, 2010, J NEUROSCI, V30, P9199, DOI 10.1523/JNEUROSCI.0605-10.2010; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fleck D, 2013, J NEUROSCI, V33, P7856, DOI 10.1523/JNEUROSCI.3372-12.2013; Fleck D, 2012, CURR ALZHEIMER RES, V9, P178, DOI 10.2174/156720512799361637; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; HAASS C, 1993, J BIOL CHEM, V268, P3021; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hogl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021337; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Orozco D, 2012, EMBO REP, V13, P759, DOI 10.1038/embor.2012.90; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 2001, NEUROBIOL DIS, V8, P717, DOI 10.1006/nbdi.2001.0405; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Walss-Bass C, 2006, ACTA PSYCHIAT SCAND, V113, P314, DOI 10.1111/j.1600-0447.2005.00631.x; Walss-Bass C, 2006, BIOL PSYCHIAT, V60, P548, DOI 10.1016/j.biopsych.2006.03.017; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	66	30	30	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					318	333		10.1074/jbc.M115.697995	http://dx.doi.org/10.1074/jbc.M115.697995			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26574544	hybrid, Green Published			2022-12-28	WOS:000367589500025
J	Uchime, O; Dai, Z; Biris, N; Lee, D; Sidhu, SS; Li, S; Lai, JR; Gavathiotis, E				Uchime, Onyinyechukwu; Dai, Zhou; Biris, Nikolaos; Lee, David; Sidhu, Sachdev S.; Li, Sheng; Lai, Jonathan R.; Gavathiotis, Evripidis			Synthetic Antibodies Inhibit Bcl-2-associated X Protein (BAX) through Blockade of the N-terminal Activation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; B cell lymphoma 2 (Bcl-2) family; BAX; mitochondrial apoptosis; protein structure; structure-function; protein targeting; synthetic antibody; phage display	PROAPOPTOTIC BAX; CELL-DEATH; MASS-SPECTROMETRY; APOPTOSIS; BCL-2; MECHANISM; MEMBRANE; FAMILY; PERMEABILIZATION; MITOCHONDRIA	The BCL-2 protein family plays a critical role in regulating cellular commitment to mitochondrial apoptosis. Pro-apoptotic Bcl-2-associated X protein (BAX) is an executioner protein of the BCL-2 family that represents the gateway to mitochondrial apoptosis. Following cellular stresses that induce apoptosis, cytosolic BAX is activated and translocates to the mitochondria, where it inserts into the mitochondrial outer membrane to form a toxic pore. How the BAX activation pathway proceeds and how this may be inhibited is not yet completely understood. Here we describe synthetic antibody fragments (Fabs) as structural and biochemical probes to investigate the potential mechanisms of BAX regulation. These synthetic Fabs bind with high affinity to BAX and inhibit its activation by the BH3-only protein tBID (truncated Bcl2 interacting protein) in assays using liposomal membranes. Inhibition of BAX by a representative Fab, 3G11, prevented mitochondrial translocation of BAX and BAX-mediated cytochrome c release. Using NMR and hydrogen-deuterium exchange mass spectrometry, we showed that 3G11 forms a stoichiometric and stable complex without inducing a significant conformational change on monomeric and inactive BAX. We identified that the Fab-binding site on BAX involves residues of helices 1/6 and the 1-2 loop. Therefore, the inhibitory binding surface of 3G11 overlaps with the N-terminal activation site of BAX, suggesting a novel mechanism of BAX inhibition through direct binding to the BAX N-terminal activation site. The synthetic Fabs reported here reveal, as probes, novel mechanistic insights into BAX inhibition and provide a blueprint for developing inhibitors of BAX activation.	[Uchime, Onyinyechukwu; Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Biochem, Bronx, NY 10461 USA; [Uchime, Onyinyechukwu; Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Med, Bronx, NY 10461 USA; [Dai, Zhou; Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Lee, David; Li, Sheng] Univ Calif San Diego, Sch Med, San Diego, CA 92093 USA; [Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of Toronto; University of Toronto	Lai, JR (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk, Bronx, NY 10461 USA.	jon.lai@einstein.yu.edu; evripidis.gavathiotis@einstein.yu.edu		Lee, David/0000-0001-7232-0968; Dai, Zhou/0000-0001-5333-1178; Biris, Nikolaos/0000-0003-4055-5521; Gavathiotis, Evripidis/0000-0001-6319-8331	National Institutes of Health [R00HL095929, R01CA178394, R21CA155472, R01 GM020501, R56AI110750, R01AI101436, 1S10OD016305, P30 CA013330]; New York Structural Biology Center (NYSBC); Empire State Development's Division of Science, Technology and Innovation (NYSTAR); National Institutes of Health MSTP Training Grant [T32GM007288]; NCI/National Institutes of Health Individual Training Fellowship [F31CA186672]; Sidney Kimmel Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; Alexandrine and Alexander L. Sinsheimer Foundation; NATIONAL CANCER INSTITUTE [R01CA178394, F31CA186672, R21CA155472, P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, R56AI110750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center (NYSBC); Empire State Development's Division of Science, Technology and Innovation (NYSTAR); National Institutes of Health MSTP Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/National Institutes of Health Individual Training Fellowship; Sidney Kimmel Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; Alexandrine and Alexander L. Sinsheimer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health Grants R00HL095929 and R01CA178394 (to E. G.); R21CA155472 (to J. R. L.); and R01 GM020501, R56AI110750, and R01AI101436 (to S. L.). This work was partially supported by contributions to the Albert Einstein Center for Experimental Therapeutics by Pamela and Edward S. Pantzer. NMR data were collected at the Einstein NMR Resource with support from National Institutes of Health Awards 1S10OD016305 and P30 CA013330 and at New York Structural Biology Center (NYSBC) with support from a grant from Empire State Development's Division of Science, Technology and Innovation (NYSTAR). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health MSTP Training Grant T32GM007288 and NCI/National Institutes of Health Individual Training Fellowship F31CA186672.; Supported by the Sidney Kimmel Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, and the Alexandrine and Alexander L. Sinsheimer Foundation. To whom correspondence may be addressed: Albert Einstein College of Medicine, 1300 Morris Park, Forchheimer G46, Bronx, NY 10461. Tel.: 718-430-3725; Fax: 718-430-8989; E-mail: evripidis.gavathiotis@einstein.yu.edu.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Barclay LA, 2015, MOL CELL, V57, P873, DOI 10.1016/j.molcel.2015.01.014; Bleicken S, 2014, MOL CELL, V56, P496, DOI 10.1016/j.molcel.2014.09.022; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Ding JZ, 2014, J BIOL CHEM, V289, P11873, DOI 10.1074/jbc.M114.552562; Ding JZ, 2010, J BIOL CHEM, V285, P28749, DOI 10.1074/jbc.M110.148361; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edwards AL, 2013, CHEM BIOL, V20, P888, DOI 10.1016/j.chembiol.2013.06.007; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gahl RF, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.593897; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Koellhoffer JF, 2012, CHEMBIOCHEM, V13, P2549, DOI 10.1002/cbic.201200493; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Ma JH, 2012, P NATL ACAD SCI USA, V109, P20901, DOI 10.1073/pnas.1217094110; Marcatili P, 2014, NAT PROTOC, V9, P2771, DOI 10.1038/nprot.2014.189; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tsai CJ, 2015, STRUCTURE, V23, P139, DOI 10.1016/j.str.2014.10.016; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	42	22	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					89	102		10.1074/jbc.M115.680918	http://dx.doi.org/10.1074/jbc.M115.680918			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26565029	Green Published, hybrid			2022-12-28	WOS:000367589500007
J	Figarola, JL; Singhal, J; Tompkins, JD; Rogers, GW; Warden, C; Horne, D; Riggs, AD; Awasthi, S; Singhal, SS				Figarola, James L.; Singhal, Jyotsana; Tompkins, Joshua D.; Rogers, George W.; Warden, Charles; Horne, David; Riggs, Arthur D.; Awasthi, Sanjay; Singhal, Sharad S.			SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMP-dependent Kinase (AMPK)-Mammalian Target of Rapamycin (mTOR) Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC APPROACH; CANCER-THERAPY; PROTON LEAK; APOPTOSIS; PROTEIN; 6-KETOCHOLESTANOL; DIFFERENTIATION; EPIDEMIOLOGY	Mitochondrial oxidative phosphorylation produces most of the energy in aerobic cells by coupling respiration to the production of ATP. Mitochondrial uncouplers, which reduce the proton gradient across the mitochondrial inner membrane, create a futile cycle of nutrient oxidation without generating ATP. Regulation of mitochondrial dysfunction and associated cellular bioenergetics has been recently identified as a promising target for anticancer therapy. Here, we show that SR4 is a novel mitochondrial uncoupler that causes dose-dependent increase in mitochondrial respiration and dissipation of mitochondrial membrane potential in HepG2 hepatocarcinoma cells. These effects were reversed by the recoupling agent 6-ketocholestanol but not cyclosporin A and were nonexistent in mitochondrial DNA-depleted HepG2 cells. In isolated mouse liver mitochondria, SR4 similarly increased oxygen consumption independent of adenine nucleotide translocase and uncoupling proteins, decreased mitochondrial membrane potential, and promoted swelling of valinomycin-treated mitochondria in potassium acetate medium. Mitochondrial uncoupling in HepG2 cells by SR4 results in the reduction of cellular ATP production, increased ROS production, activation of the energy-sensing enzyme AMPK, and inhibition of acetyl-CoA carboxylase and mammalian target of rapamycin signaling pathways, leading to cell cycle arrest and apoptosis. Global analysis of SR4-associated differential gene expression confirms these observations, including significant induction of apoptotic genes and down-regulation of cell cycle, mitochondrial, and oxidative phosphorylation pathway transcripts at 24 h post-treatment. Collectively, our studies demonstrate that the previously reported indirect activation of AMPK and in vitro anticancer properties of SR4 as well as its beneficial effects in both animal xenograft and obese mice models could be a direct consequence of its mitochondrial uncoupling activity.	[Figarola, James L.; Singhal, Jyotsana; Tompkins, Joshua D.; Riggs, Arthur D.; Singhal, Sharad S.] Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Horne, David] Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Mol Med, Duarte, CA 91010 USA; [Awasthi, Sanjay] Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Med Oncol, Duarte, CA 91010 USA; [Rogers, George W.] Seahorse Biosci, North Billerica, MA 01862 USA; [Warden, Charles] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Michigan System; University of Michigan	Singhal, SS (corresponding author), Beckman Res Inst City Hope, Ctr Comprehens Canc, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	ssinghal@coh.org	Awasthi, Sanjay/R-4904-2019	Riggs, Arthur/0000-0002-8184-5288; Warden, Charles/0000-0002-1827-4486; Awasthi, Sanjay/0000-0002-5214-5717	Department Chair; Beckman Research Institute of the City of Hope	Department Chair; Beckman Research Institute of the City of Hope	This work was supported by Isaac and Jacquelin Moradi. This work was also supported by the Department Chair (Prof. Arthur Riggs) and Beckman Research Institute of the City of Hope. G. W. R. is an employee of Seahorse Bioscience, which manufactures the XF instruments used in this study. The other authors declare that they have no conflicts of interest with the contents of this article.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Benard G, 2011, MITOCHONDRIAL DYNAMICS AND NEURODEGENERATION, P47, DOI 10.1007/978-94-007-1291-1_2; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Chalmers S, 2012, J AM CHEM SOC, V134, P758, DOI 10.1021/ja2077922; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen SI, 2014, MINI-REV MED CHEM, V14, P642, DOI 10.2174/1389557514666140820104444; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Figarola JL, 2012, INVEST NEW DRUG, V30, P1413, DOI 10.1007/s10637-011-9711-8; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Han YH, 2008, TOXICOL IN VITRO, V22, P659, DOI 10.1016/j.tiv.2007.12.005; Han YH, 2009, TOXICOLOGY, V265, P101, DOI 10.1016/j.tox.2009.10.001; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jara JA, 2014, J MED CHEM, V57, P2440, DOI 10.1021/jm500174v; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kuruvilla S, 2003, TOXICOL SCI, V73, P348, DOI 10.1093/toxsci/kfg084; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marin JJG., 2008, CANC THER, V6, P711; McQuaker SJ, 2013, CHEMBIOCHEM, V14, P993, DOI 10.1002/cbic.201300115; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Pardo-Andreu GL, 2011, MITOCHONDRION, V11, P255, DOI 10.1016/j.mito.2010.10.008; Reis FHZ, 2014, CHEM-BIOL INTERACT, V212, P20, DOI 10.1016/j.cbi.2014.01.015; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shchepinova MM, 2014, BBA-BIOENERGETICS, V1837, P149, DOI 10.1016/j.bbabio.2013.09.011; Singhal SS, 2013, BIOCHEM PHARMACOL, V86, P1664, DOI 10.1016/j.bcp.2013.09.022; Singhal SS, 2012, BIOCHEM PHARMACOL, V84, P1419, DOI 10.1016/j.bcp.2012.08.020; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Starkov AA, 1997, BBA-BIOENERGETICS, V1318, P159, DOI 10.1016/S0005-2728(96)00134-X; STARKOV AA, 1994, FEBS LETT, V355, P305, DOI 10.1016/0014-5793(94)01211-3; Starkov AA, 2006, CHEM-BIOL INTERACT, V163, P133, DOI 10.1016/j.cbi.2006.08.015; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Velez J, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00067; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang F, 2010, MOL ASPECTS MED, V31, P75, DOI 10.1016/j.mam.2009.12.003; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Wen SJ, 2013, FUTURE MED CHEM, V5, P53, DOI 10.4155/fmc.12.190; Weng ZQ, 2015, TOXICOLOGY, V327, P10, DOI 10.1016/j.tox.2014.11.002; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	64	25	25	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30321	30341		10.1074/jbc.M115.686352	http://dx.doi.org/10.1074/jbc.M115.686352			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26534958	hybrid, Green Published			2022-12-28	WOS:000366738200012
J	Zhu, GY; Koszelak-Rosenblum, M; Connelly, SM; Dumont, ME; Malkowski, MG				Zhu, Guangyu; Koszelak-Rosenblum, Mary; Connelly, Sara M.; Dumont, Mark E.; Malkowski, Michael G.			The Crystal Structure of an Integral Membrane Fatty Acid alpha-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-SEQUENCE; HIGH-THROUGHPUT; USER-INTERFACE; FUSION PROTEIN; GENE; COA; IDENTIFICATION; 2-HYDROXYLASE; DESATURASE	Neuronal electrical impulse propagation is facilitated by the myelin sheath, a compact membrane surrounding the axon. The myelin sheath is highly enriched in galactosylceramide (GalCer) and its sulfated derivative sulfatide. Over 50% of GalCer and sulfatide in myelin is hydroxylated by the integral membrane enzyme fatty acid 2-hydroxylase (FA2H). GalCer hydroxylation contributes to the compact nature of the myelin membrane, and mutations in FA2H result in debilitating leukodystrophies and spastic paraparesis. Wereport here the 2.6 angstrom crystal structure of sphingolipid alpha-hydroxylase (Scs7p), a yeast homolog of FA2H. The Scs7p core is composed of a helical catalytic cap domain that sits atop four transmembrane helices that anchor the enzyme in the endoplasmic reticulum. The structure contains two zinc atoms coordinated by the side chains of 10 highly conserved histidines within a dimetal center located near the plane of the cytosolic membrane. We used a yeast genetic approach to confirm the important role of the dimetal-binding histidines in catalysis and identified Tyr-322 and Asp-323 as critical determinants involved in the hydroxylase reaction. Examination of the Scs7p structure, coupled with molecular dynamics simulations, allowed for the generation of a model of ceramide binding to Scs7p. Comparison of the Scs7p structure and substratebinding model to the structure of steroyl-CoA desaturase revealed significant differences in the architecture of the catalytic cap domain and location of the dimetal centers with respect to the membrane. These observations provide insight into the different mechanisms of substrate binding and recognition of substrates by the hydroxylase and desaturase enzymes.	[Zhu, Guangyu; Koszelak-Rosenblum, Mary; Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Connelly, Sara M.; Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), SUNY Buffalo, Hauptman Woodward Inst, Dept Biol Struct, 700 Ellicott St, Buffalo, NY 14203 USA.	mgm22@buffalo.edu	Zhu, Guangyu/F-6279-2011	Zhu, Guangyu/0000-0003-4228-135X; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health from NCI [Y1-CO-1020]; National Institutes of Health from NIGMS [Y1-GM-1104]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094611] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray diffraction experiments and fluorescence scans were conducted at the Advanced Photon Source. Use of IMCACAT beamline 17-ID at the Advanced Photon Source was supported by companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. GM/CA CAT has been funded in whole or in part with federal funds from the National Institutes of Health Grants Y1-CO-1020 from NCI and Y1-GM-1104 from NIGMS. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; AKANUMA H, 1979, J BIOL CHEM, V254, P1050; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; DAILEY HA, 1979, J BIOL CHEM, V254, P5388; Dick KJ, 2010, HUM MUTAT, V31, pE1251, DOI 10.1002/humu.21205; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guo L, 2012, J LIPID RES, V53, P1327, DOI 10.1194/jlr.M025742; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hama H, 2000, FEBS LETT, V478, P26, DOI 10.1016/S0014-5793(00)01821-4; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Napier JA, 1997, BIOCHEM J, V328, P717; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pierson TM, 2012, EUR J HUM GENET, V20, P476, DOI 10.1038/ejhg.2011.222; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	47	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29820	29833		10.1074/jbc.M115.680124	http://dx.doi.org/10.1074/jbc.M115.680124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26515067	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000366614700017
J	Hall, Z; Schmidt, C; Politis, A				Hall, Zoe; Schmidt, Carla; Politis, Argyris			Uncovering the Early Assembly Mechanism for Amyloidogenic beta(2)-Microglobulin Using Cross-linking and Native Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION MOBILITY; PROTEIN COMPLEXES; MOLECULAR ARCHITECTURE; FIBRIL FORMATION; MACROMOLECULAR ASSEMBLIES; DYNAMICS; BETA-2-MICROGLOBULIN; INSIGHTS; REVEALS; TANDEM	beta(2)-Microglobulin (beta(2)m), a key component of the major histocompatibility class I complex, can aggregate into fibrils with severe clinical consequences. As such, investigating the structural aspects of the formation of oligomeric intermediates of beta(2)m and their subsequent progression toward fibrillar aggregates is of great importance. However, beta(2)m aggregates are challenging targets in structural biology, primarily due to their inherent transient and heterogeneous nature. Here we study the oligomeric distributions and structures of the early intermediates of amyloidogenic similar to 2m and its truncated variant Delta N6-beta(2)m. Weestablished compact oligomers for both variants by integrating advanced mass spectrometric techniques with available electron microscopy maps and atomic level structures from NMR spectroscopy and x-ray crystallography. Our results revealed a stepwise assembly mechanism by monomer addition and domain swapping for the oligomeric species of Delta N6-beta(2)m. The observed structural similarity and common oligomerization pathway between the two variants is likely to enable Delta N6-beta 2m to cross-seed beta(2)m fibrillation and allow the formation of mixed fibrils. We further determined the key subunit interactions in Delta N6-beta(2)m tetramer, revealing the importance of a domain-swappedhingeregionforformationofhigherorderoligomers. Overall, we deliver new mechanistic insights into beta(2)m aggregation, paving the way for future studies on the mechanisms and cause of amyloid fibrillation.	[Hall, Zoe] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Hall, Zoe; Schmidt, Carla] Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England; [Politis, Argyris] Kings Coll London, Dept Chem, 7 Trinity St, London SE1 1DB, England	University of Cambridge; University of Oxford; University of London; King's College London	Politis, A (corresponding author), Kings Coll London, Dept Chem, 7 Trinity St, London SE1 1DB, England.	argyris.politis@kcl.ac.uk	Politis, Argyris/R-4333-2019	Schmidt, Carla/0000-0001-9410-1424; Hall, Zoe/0000-0002-1434-8329				Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ashcroft AE, 2010, J AM SOC MASS SPECTR, V21, P1087, DOI 10.1016/j.jasms.2010.02.026; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Benesch JLP, 2006, CHEM BIOL, V13, P597, DOI 10.1016/j.chembiol.2006.04.006; Benesch JLP, 2011, CURR OPIN STRUC BIOL, V21, P641, DOI 10.1016/j.sbi.2011.08.002; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bleiholder C, 2013, J AM CHEM SOC, V135, P16926, DOI 10.1021/ja406197f; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Carulla N, 2010, ACCOUNTS CHEM RES, V43, P1072, DOI 10.1021/ar9002784; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Estacio SG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003606; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hall Z, 2012, STRUCTURE, V20, P1596, DOI 10.1016/j.str.2012.07.001; Hall Z, 2012, J AM CHEM SOC, V134, P3429, DOI 10.1021/ja2096859; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Lane LA, 2009, INT J MASS SPECTROM, V283, P169, DOI 10.1016/j.ijms.2009.03.006; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Mendoza VL, 2011, BIOCHEMISTRY-US, V50, P6711, DOI 10.1021/bi2004894; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Politis A, 2015, CHEM BIOL, V22, P117, DOI 10.1016/j.chembiol.2014.11.010; Politis A, 2014, NAT METHODS, V11, P403, DOI [10.1038/NMETH.2841, 10.1038/nmeth.2841]; Politis A, 2013, J MOL BIOL, V425, P4790, DOI 10.1016/j.jmb.2013.04.006; Politis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012080; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Smith DP, 2011, BIOPHYS J, V101, P1238, DOI 10.1016/j.bpj.2011.07.023; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Su YC, 2014, J AM CHEM SOC, V136, P6313, DOI 10.1021/ja4126092; Tipping KW, 2015, P NATL ACAD SCI USA, V112, P5691, DOI 10.1073/pnas.1423174112; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Williams DM, 2013, MASS SPECTROM REV, V32, P169, DOI 10.1002/mas.21358; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Young LM, 2015, NAT CHEM, V7, P73, DOI [10.1038/nchem.2129, 10.1038/NCHEM.2129]; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	57	22	22	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4626	4637		10.1074/jbc.M115.691063	http://dx.doi.org/10.1074/jbc.M115.691063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26655720	Green Published, hybrid			2022-12-28	WOS:000371604600030
J	Imoto, N; Hayakawa, F; Kurahashi, S; Morishita, T; Kojima, Y; Yasuda, T; Sugimoto, K; Tsuzuki, S; Naoe, T; Kiyoi, H				Imoto, Naoto; Hayakawa, Fumihiko; Kurahashi, Shingo; Morishita, Takanobu; Kojima, Yuki; Yasuda, Takahiko; Sugimoto, Keiki; Tsuzuki, Shinobu; Naoe, Tomoki; Kiyoi, Hitoshi			B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ARSENIC-TRIOXIDE; NUCLEAR-BODIES; FUSION PROTEIN; BSAP PAX-5; PML; ACTIVATION; GENE; ACTS; CD19	PAX5 is a transcription factor that is required for the development and maintenance of B cells. Promyelocytic leukemia (PML) is a tumor suppressor and proapoptotic factor. The fusion gene PAX5-PML has been identified in acute lymphoblastic leukemia with chromosomal translocation t(9;15)(p13;q24). We have reported previously that PAX5-PML dominant-negatively inhibited PAX5 transcriptional activity and impaired PML function by disrupting PML nuclear bodies (NBs). Here we demonstrated the leukemogenicity of PAX5-PML by introducing it into normal mouse pro-B cells. Arrest of differentiation was observed in PAX5-PML-introduced pro-B cells, resulting in the development of acute lymphoblastic leukemia after a long latency in mice. Among the transactivation targets of PAX5, B cell linker protein (BLNK) was repressed selectively in leukemia cells, and enforced BLNK expression abrogated the differentiation block and survival induced by PAX5-PML, indicating the importance of BLNK repression for the formation of preleukemic state. We also showed that PML NBs were intact in leukemia cells and attributed this to the low expression of PAX5-PML, indicating that the disruption of PML NBs was not required for the PAX5-PML-induced onset of leukemia. These results provide novel insights into the molecular mechanisms underlying the onset of leukemia by PAX5 mutations.	[Imoto, Naoto; Hayakawa, Fumihiko; Morishita, Takanobu; Kojima, Yuki; Kiyoi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4668550, Japan; [Kurahashi, Shingo] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi 4418570, Japan; [Yasuda, Takahiko] Univ Tokyo, Grad Sch Med, Dept Cellular Signaling, Tokyo 1138654, Japan; [Sugimoto, Keiki] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Otsu, Shiga 5200106, Japan; [Tsuzuki, Shinobu] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 4648681, Japan; [Naoe, Tomoki] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi 4600001, Japan	Nagoya University; University of Tokyo; Otsuka Pharmaceutical; Aichi Cancer Center; Nagoya Medical Center	Hayakawa, F (corresponding author), Nagoya Univ, Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	bun-hy@med.nagoya-u.ac.jp	Yasuda, Takahiko/AGQ-5448-2022; Naoe, Tomoki/I-1888-2012; Imoto, Naoto/AAB-7504-2022	Yasuda, Takahiko/0000-0002-4686-0976; Imoto, Naoto/0000-0003-0567-8761; Kojima, Yuki/0000-0002-1558-5510; Tsuzuki, Shinobu/0000-0002-3209-3550	MHLW KAKENHI [H22-3jigan-Ippan-010, H26-Kakushintekigan-Ippan-133]; JSPS KAKENHI [23591381, 25118711, 25293218, 25670449]; Program to Disseminate Tenure Tracking System; Ministry of Education, Culture, Sport, Science and Technology, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Otsuka Pharmaceutical Co. Ltd.; Bristol-Myers Squibb; Novartis Pharma; Chugai Pharmaceutical Co. Ltd.; Kyowa Hakko Kirin Co. Ltd.; Dainippon Sumitomo Pharma; Zenyaku Kogyo; Fujifilm Corp.; Grants-in-Aid for Scientific Research [15K09492] Funding Source: KAKEN	MHLW KAKENHI; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program to Disseminate Tenure Tracking System; Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis Pharma; Chugai Pharmaceutical Co. Ltd.; Kyowa Hakko Kirin Co. Ltd.(Kyowa Kirin Ltd); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Zenyaku Kogyo; Fujifilm Corp.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MHLW KAKENHI Grants H22-3jigan-Ippan-010 and H26-Kakushintekigan-Ippan-133 and JSPS KAKENHI Grants 23591381, 25118711, 25293218, and 25670449. This work was also supported by the Program to Disseminate Tenure Tracking System, the Ministry of Education, Culture, Sport, Science and Technology, Japan and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. T.N. received research funding from Otsuka Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Novartis Pharma, Chugai Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Dainippon Sumitomo Pharma, Zenyaku Kogyo, and Fujifilm Corp. K. S. is an employee of Otsuka Pharmaceutical Co., Ltd. H. K. received research funding from Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Dainippon Sumitomo Pharma, Zenyaku Kogyo, and Fujifilm Corp.	Arita K, 2014, LEUKEMIA, V28, P2270, DOI 10.1038/leu.2014.224; Bousquet M, 2007, BLOOD, V109, P3417, DOI 10.1182/blood-2006-05-025221; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chen GQ, 1997, BLOOD, V89, P3345; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Familiades J, 2009, LEUKEMIA, V23, P1989, DOI 10.1038/leu.2009.135; Fazio G, 2008, CANCER RES, V68, P181, DOI 10.1158/0008-5472.CAN-07-2778; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kawamata N, 2008, P NATL ACAD SCI USA, V105, P11921, DOI 10.1073/pnas.0711039105; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kurahashi S, 2011, ONCOGENE, V30, P1822, DOI 10.1038/onc.2010.554; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nebral K, 2007, BRIT J HAEMATOL, V139, P269, DOI 10.1111/j.1365-2141.2007.06731.x; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Tsuzuki S, 2013, STEM CELLS, V31, P236, DOI 10.1002/stem.1277; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	34	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4723	4731		10.1074/jbc.M115.637835	http://dx.doi.org/10.1074/jbc.M115.637835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26703467	hybrid, Green Published			2022-12-28	WOS:000371604600038
J	Jacob, SF; Wurstle, ML; Delgado, ME; Rehm, M				Jacob, Selma F.; Wuerstle, Maximilian L.; Delgado, M. Eugenia; Rehm, Markus			An Analysis of the Truncated Bid- and ROS-dependent Spatial Propagation of Mitochondrial Permeabilization Waves during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; SINGLE-CELL ANALYSIS; MEMBRANE PERMEABILIZATION; CARDIOLIPIN PROVIDES; CASPASE ACTIVATION; SYSTEMS-ANALYSIS; ENDOGENOUS XIAP; OUTER-MEMBRANE; BAX; DEATH	Apoptosis is a form of programmed cell death that is essential for the efficient elimination of surplus, damaged, and transformed cells during metazoan embryonic development and adult tissue homeostasis. Situated at the interface of apoptosis initiation and execution, mitochondrial outer membrane permeabilization (MOMP) represents one of the most fundamental processes during apoptosis signal transduction. It was shown that MOMP can spatiotemporally propagate through cells, in particular in response to extrinsic apoptosis induction. Based on apparently contradictory experimental evidence, two distinct molecular mechanisms have been proposed to underlie the propagation of MOMP signals, namely a reaction-diffusion mechanism governed by anisotropies in the production of the MOMP-inducer truncated Bid (tBid), or a process that drives the spatial propagation of MOMP by sequential bursts of reactive oxygen species. We therefore generated mathematical models for both scenarios and performed in silico simulations of spatiotemporal MOMP signaling to identify which one of the two mechanisms is capable of qualitatively and quantitatively reproducing the existing data. We found that the explanatory power of each model was limited in that only a subset of experimental findings could be replicated. However, the integration of both models into a combined mathematical description of spatiotemporal tBid and reactive oxygen species signaling accurately reproduced all available experimental data and furthermore, provided robustness to spatial MOMP propagation when mitochondria are spatially separated. Our study therefore provides a theoretical framework that is sufficient to describe and mechanistically explain the spatiotemporal propagation of one of the most fundamental processes during apoptotic cell death.	Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; Royal Coll Surgeons Ireland, Ctr Syst Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rehm, M (corresponding author), RCSI York House,York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Delgado, M.Eugenia/ABH-3795-2020; Rehm, Markus/C-3398-2012	Delgado, M.Eugenia/0000-0002-8653-1819; Rehm, Markus/0000-0001-6149-9261	European Community Action Scheme for the Mobility of University Students (ERASMUS); European Union; European Union [642295]	European Community Action Scheme for the Mobility of University Students (ERASMUS); European Union(European Commission); European Union(European Commission)	Supported by the European Community Action Scheme for the Mobility of University Students (ERASMUS).; Supported by European Union Framework Programme 7 Grant FP7 APO-DECIDE, FP7 SYS-MEL and European Union Horizon 2020 research and innovation program (Marie Sklodowska-Curie Grant 642295 (MEL-PLEX)). To whom correspondence should be addressed: RCSI York House, York St., Dublin 2, Ireland. Tel.: 353-1-402-8563; Fax: 353-1-402-2447; E-mail: mrehm@rcsi.ie.	Angermann BR, 2012, NAT METHODS, V9, P283, DOI [10.1038/NMETH.1861, 10.1038/nmeth.1861]; Beaudouin J, 2013, CELL DEATH DIFFER, V20, P599, DOI 10.1038/cdd.2012.156; Chi XK, 2014, BBA-MOL CELL RES, V1843, P2100, DOI 10.1016/j.bbamcr.2014.06.002; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Delgado ME, 2013, BBA-MOL CELL RES, V1833, P2279, DOI 10.1016/j.bbamcr.2013.05.025; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Dussmann H, 2003, J BIOL CHEM, V278, P12645, DOI 10.1074/jbc.M210826200; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Fick A, 1855, POGGENDORFFS ANN PHY, V94, P59, DOI [10.1002/andp.18551700105, DOI 10.1002/ANDP.18551700105]; Garcia-Perez C, 2012, P NATL ACAD SCI USA, V109, P4497, DOI 10.1073/pnas.1118244109; Gauthier LD, 2013, BIOPHYS J, V105, P1045, DOI 10.1016/j.bpj.2013.07.006; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Hellwig CT, 2010, J CELL SCI, V123, P1401, DOI 10.1242/jcs.061143; Huber HJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-9; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kembro JM, 2013, BIOPHYS J, V104, P332, DOI 10.1016/j.bpj.2012.11.3808; Kolmogorov A N, 1937, B MGU A, V1, P1; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindner AU, 2013, CANCER RES, V73, P519, DOI 10.1158/0008-5472.CAN-12-2269; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Rafelski SM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-71; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Smith MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005097; Subburaj Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9042; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	52	5	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4603	4613		10.1074/jbc.M115.689109	http://dx.doi.org/10.1074/jbc.M115.689109			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26699404	hybrid, Green Published			2022-12-28	WOS:000371604600028
J	Nelson, JK; Cook, ECL; Loregger, A; Hoeksema, MA; Scheij, S; Kovacevic, I; Hordijk, PL; Ovaa, H; Zelcer, N				Nelson, Jessica Kristine; Cook, Emma Clare Laura; Loregger, Anke; Hoeksema, Marten Anne; Scheij, Saskia; Kovacevic, Igor; Hordijk, Peter Lodewijk; Ovaa, Huib; Zelcer, Noam			Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LEUCINE ZIPPER PROTEIN; LDL RECEPTOR; INDUCIBLE DEGRADER; LXR-ALPHA; FAMILIAL HYPERCHOLESTEROLEMIA; DEUBIQUITINATING ENZYME; CHOLESTEROL HOMEOSTASIS; LYSOSOMAL DEGRADATION	Cholesterol metabolism is subject to complex transcriptional and nontranscriptional regulation. Herein, the role of ubiquitylation is emerging as an important post-translational modification that regulates cholesterol synthesis and uptake. Similar to other post-translational modifications, ubiquitylation is reversible in a process dependent on activity of deubiquitylating enzymes (DUBs). Yet whether these play a role in cholesterol metabolism is largely unknown. As a first step to test this possibility, we used pharmacological inhibition of cellular DUB activity. Short term (2 h) inhibition of DUBs resulted in accumulation of high molecular weight ubiquitylated proteins. This was accompanied by a dramatic decrease in abundance of the LDLR and attenuated LDL uptake into hepatic cells. Importantly, this occurred in the absence of changes in the mRNA levels of the LDLR or other SREBP2-regulated genes, in line with this phenotype being a post-transcriptional event. Mechanistically, we identify transcriptional induction of the E3 ubiquitin ligase IDOL in human and rodent cells as the underlying cause for ubiquitylation-dependent lysosomal degradation of the LDLR following DUB inhibition. In contrast to the established transcriptional regulation of IDOL by the sterol-responsive liver X receptor (LXR) transcription factors, induction of IDOL by DUB inhibition is LXR-independent and occurs in Lxr alpha beta(-/-) MEFs. Consistent with the role of DUBs in transcriptional regulation, we identified a 70-bp region in the proximal promoter of IDOL, distinct from that containing the LXR-responsive element, which mediates the response to DUB inhibition. In conclusion, we identify a sterol-independent mechanism to regulate IDOL expression and IDOL-mediated lipoprotein receptor degradation.	[Nelson, Jessica Kristine; Cook, Emma Clare Laura; Loregger, Anke; Hoeksema, Marten Anne; Scheij, Saskia; Zelcer, Noam] Univ Amsterdam, Dept Med Biochem, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kovacevic, Igor; Hordijk, Peter Lodewijk] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Ovaa, Huib] Netherlands Canc Inst, Dept Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	Zelcer, N (corresponding author), Univ Amsterdam, Dept Med Biochem, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.	n.zelcer@amc.uva.nl	Cook, Emma/AAA-2707-2020; ovaa, huib/M-2334-2016	Cook, Emma/0000-0002-1415-4049; Hoeksema, Marten/0000-0001-5981-121X; ovaa, huib/0000-0002-0068-054X; Zelcer, Noam/0000-0001-6935-7532; Kovacevic, Igor/0000-0003-1834-2378; Hordijk, Peter/0000-0002-3348-078X	Landsteiner Foundation for Blood Transfusion Research Fellowship [1311]; Netherlands Organization for Scientific Research VICI [724.013.002]; Dutch Heart Foundation Established Investigator Grant [2013T111]; Netherlands Organization of Scientific Research VIDI [17.106.355]; European Research Council Consolidator Grant [617376]	Landsteiner Foundation for Blood Transfusion Research Fellowship; Netherlands Organization for Scientific Research VICI(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation Established Investigator Grant; Netherlands Organization of Scientific Research VIDI; European Research Council Consolidator Grant(European Research Council (ERC))	This work was supported in part by Landsteiner Foundation for Blood Transfusion Research Fellowship 1311 (to I. K.); Netherlands Organization for Scientific Research VICI Grant 724.013.002 (to H. O.); and Dutch Heart Foundation Established Investigator Grant 2013T111, Netherlands Organization of Scientific Research VIDI Grant 17.106.355, and European Research Council Consolidator Grant 617376 (to N. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Bobard A, 2005, J BIOL CHEM, V280, P199, DOI 10.1074/jbc.M406522200; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Dasgupta S, 2014, ANNU REV MED, V65, P279, DOI 10.1146/annurev-med-051812-145316; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Frappier L, 2011, CURR OPIN GENET DEV, V21, P207, DOI 10.1016/j.gde.2011.02.005; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hong C, 2014, CELL METAB, V20, P910, DOI 10.1016/j.cmet.2014.10.001; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Menke JG, 2002, ENDOCRINOLOGY, V143, P2548, DOI 10.1210/en.143.7.2548; Motazacker MM, 2012, EUR HEART J, V33, P1360, DOI 10.1093/eurheartj/ehs010; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Rohrl C, 2014, J LIPID RES, V55, P94, DOI 10.1194/jlr.M043299; Schaefer A, 2014, J CELL SCI, V127, P4470, DOI 10.1242/jcs.154708; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Scotti E, 2011, MOL CELL BIOL, V31, P1885, DOI 10.1128/MCB.01469-10; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Sorrentino V, 2013, J LIPID RES, V54, P2174, DOI 10.1194/jlr.M037713; Sorrentino V, 2013, EUR HEART J, V34, P1292, DOI 10.1093/eurheartj/ehs472; Sorrentino V, 2012, CURR OPIN LIPIDOL, V23, P213, DOI 10.1097/MOL.0b013e3283532947; Sorrentino V, 2011, J BIOL CHEM, V286, P30190, DOI 10.1074/jbc.M111.249557; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang L, 2011, GENE DEV, V25, P1262, DOI 10.1101/gad.2056211	59	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4813	4825		10.1074/jbc.M115.698688	http://dx.doi.org/10.1074/jbc.M115.698688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26719329	hybrid, Green Published			2022-12-28	WOS:000371604600046
J	Walter, J				Walter, Jochen			The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NASU-HAKOLA-DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; GAMMA-SECRETASE; A-BETA; MICROGLIAL RESPONSE; MISSENSE MUTATIONS; TYPE-4 ALLELE	The triggering receptor expressed on myeloid cells (TREM) 2 is a member of the immunoglobulin superfamily of receptors and mediates signaling in immune cells via engagement of its co-receptor DNAX-activating protein of 12 kDa (DAP12). Homozygous mutations in TREM2 or DAP12 cause Nasu-Ha-kola disease, which is characterized by bone abnormalities and dementia. Recently, a variant of TREM2 has also been associated with an increased risk for Alzheimer disease. The selective expression of TREM2 on immune cells and its association with different forms of dementia indicate a contribution of this receptor in common pathways of neurodegeneration.	[Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Mol Cell Biol Unit, Sigmund Freud Str 25, D-53757 Bonn, Germany.	jochen.walter@ukb.uni-bonn.de	Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft (DFG); Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Federal Ministry of Education and Research (BMBF). The author declares that he has no conflicts of interest with the contents of this article.	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bianchin MM, 2013, JAMA NEUROL, V70, P805, DOI 10.1001/jamaneurol.2013.453; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; BIRD TD, 1983, NEUROLOGY, V33, P81, DOI 10.1212/WNL.33.1.81; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Colonna M, 2003, J CLIN INVEST, V111, P313, DOI 10.1172/JCI200317745; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fisher Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010830; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Glebov K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0479-9; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Guerreiro R, 2014, NEUROTHERAPEUTICS, V11, P732, DOI 10.1007/s13311-014-0295-9; Guerreiro R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.06.005; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Holtzman DM, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A011585; Irwin DJ, 2015, ACTA NEUROPATHOL, V129, P469, DOI 10.1007/s00401-014-1380-1; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jiang T, 2015, NEUROBIOL AGING, V36, P3176, DOI 10.1016/j.neurobiolaging.2015.08.019; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kaneko M, 2010, NEUROPATHOLOGY, V30, P463, DOI 10.1111/j.1440-1789.2010.01127.x; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Koevari Enikoe, 2009, V24, P149, DOI 10.1159/000197894; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Lambert JC, 2011, CURR OPIN GENET DEV, V21, P295, DOI 10.1016/j.gde.2011.02.002; Landreth G, 2007, J NEUROIMMUNE PHARM, V2, P131, DOI 10.1007/s11481-007-9067-1; Lattante S, 2015, TRENDS GENET, V31, P263, DOI 10.1016/j.tig.2015.03.005; Le Ber I, 2014, NEUROBIOL AGING, V35; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Lill CM, 2015, ALZHEIMERS DEMENT, V11, P1407, DOI 10.1016/j.jalz.2014.12.009; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Painter MM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0040-9; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003; Park JS, 2015, TRAFFIC, V16, P510, DOI 10.1111/tra.12264; Phimister EG, 2015, NEW ENGL J MED, V372, P2564, DOI 10.1056/NEJMcibr1503954; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schmidt V, 2014, WIRES SYST BIOL MED, V6, P255, DOI 10.1002/wsbm.1262; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Walter J, 2012, CURR ALZHEIMER RES, V9, P189, DOI 10.2174/156720512799361583; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xing JJ, 2015, RES REP BIOCHEM, V5, P89, DOI 10.2147/RRBC.S58057; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	93	49	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4334	4341		10.1074/jbc.R115.704981	http://dx.doi.org/10.1074/jbc.R115.704981			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694609	Green Published, hybrid			2022-12-28	WOS:000371604600006
J	Farnsworth, NL; Walter, RL; Hemmati, A; Westacott, MJ; Benninger, RKP				Farnsworth, Nikki L.; Walter, Rachelle L.; Hemmati, Alireza; Westacott, Matthew J.; Benninger, Richard K. P.			Low Level Pro-inflammatory Cytokines Decrease Connexin36 Gap Junction Coupling in Mouse and Human Islets through Nitric Oxide-mediated Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; diabetes; gap junction; islet; nitric oxide; PKC-; connexin36	PANCREATIC BETA-CELLS; K-ATP CHANNELS; INSULIN-SECRETION; DIABETES-MELLITUS; PKC-DELTA; INTRACELLULAR CA2+; LANGERHANS; GLUCOSE; TYPE-1; PHOSPHORYLATION	Pro-inflammatory cytokines contribute to the decline in islet function during the development of diabetes. Cytokines can disrupt insulin secretion and calcium dynamics; however, the mechanisms underlying this are poorly understood. Connexin36 gap junctions coordinate glucose-induced calcium oscillations and pulsatile insulin secretion across the islet. Loss of gap junction coupling disrupts these dynamics, similar to that observed during the development of diabetes. This study investigates the mechanisms by which pro-inflammatory cytokines mediate gap junction coupling. Specifically, as cytokine-induced NO can activate PKC, we aimed to understand the role of PKC in modulating cytokine-induced changes in gap junction coupling. Isolated mouse and human islets were treated with varying levels of a cytokine mixture containing TNF-, IL-1, and IFN-. Islet dysfunction was measured by insulin secretion, calcium dynamics, and gap junction coupling. Modulators of PKC and NO were applied to determine their respective roles in modulating gap junction coupling. High levels of cytokines caused cell death and decreased insulin secretion. Low levels of cytokine treatment disrupted calcium dynamics and decreased gap junction coupling, in the absence of disruptions to insulin secretion. Decreases in gap junction coupling were dependent on NO-regulated PKC, and altered membrane organization of connexin36. This study defines several mechanisms underlying the disruption to gap junction coupling under conditions associated with the development of diabetes. These mechanisms will allow for greater understanding of islet dysfunction and suggest ways to ameliorate this dysfunction during the development of diabetes.	[Farnsworth, Nikki L.; Benninger, Richard K. P.] Univ Colorado, Anschutz Med Campus, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Farnsworth, Nikki L.; Walter, Rachelle L.; Hemmati, Alireza; Westacott, Matthew J.; Benninger, Richard K. P.] Univ Colorado, Anschutz Med Campus, Dept Bioengn, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Benninger, RKP (corresponding author), Univ Colorado, Anschutz Med Campus, 1775 Aurora Ct,M20-4306D,Mail Stop B140, Aurora, CO 80045 USA.	richard.benninger@ucdenver.edu		benninger, richard/0000-0002-5063-6096; Farnsworth, Nikki/0000-0002-9834-9168	National Institutes of Health [R00 DK085145, R01 DK102950, R01 DK106412, F32 DK102276, UL1 TR001082, P30 NS048154]; Juvenile Diabetes Research Foundation [5-CDA-2014-198-A-N]; Blum-Kovler Scholarship; University of Colorado; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK102276, R01DK106412, R01DK102950, P30DK057516, R00DK085145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Blum-Kovler Scholarship; University of Colorado; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 DK085145, R01 DK102950, and R01 DK106412, and Juvenile Diabetes Research Foundation Grant 5-CDA-2014-198-A-N (to R. K. P. B.), National Institutes of Health Grant F32 DK102276 and a Blum-Kovler Scholarship (to N. L. F.), and University of Colorado internal funds. Imaging experiments performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core were supported in part by National Institutes of Health Grants UL1 TR001082 and P30 NS048154. Islet isolation performed in the Barbara Davis Center Islet Core was supported in part by P30 DK057516. Authors declare no conflict of interest.	Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Allagnat F, 2013, CELL DEATH DIFFER, V20, P1742, DOI 10.1038/cdd.2013.134; Allagnat F, 2008, J BIOL CHEM, V283, P5226, DOI 10.1074/jbc.M708181200; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cantley J, 2011, DIABETOLOGIA, V54, P380, DOI 10.1007/s00125-010-1962-y; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Carvalho CPF, 2012, AM J PHYSIOL-ENDOC M, V303, pE144, DOI 10.1152/ajpendo.00489.2011; CERASI E, 1967, ACTA ENDOCRINOL-COP, V55, P278, DOI 10.1530/acta.0.0550278; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Eckersten D, 2012, REGUL PEPTIDES, V174, P32, DOI 10.1016/j.regpep.2011.11.006; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Farnsworth NL, 2014, J PHYSIOL-LONDON, V592, P4431, DOI 10.1113/jphysiol.2014.276733; Farnsworth NL, 2014, FEBS LETT, V588, P1278, DOI 10.1016/j.febslet.2014.02.035; Grapengiesser E, 2001, PANCREAS, V23, P387, DOI 10.1097/00006676-200111000-00009; Haefliger JA, 2013, J MOL ENDOCRINOL, V51, P49, DOI 10.1530/JME-13-0054; Harada N, 2004, J CARDIOVASC PHARM, V44, P35, DOI 10.1097/00005344-200407000-00005; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Hendey B, 2002, J LEUKOCYTE BIOL, V71, P863; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hraha TH, 2014, BIOPHYS J, V106, P299, DOI 10.1016/j.bpj.2013.11.026; Imai Y, 2013, TRENDS ENDOCRIN MET, V24, P351, DOI 10.1016/j.tem.2013.01.007; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; KANATSUKA A, 1988, METABOLISM, V37, P878, DOI 10.1016/0026-0495(88)90123-0; KANETO H, 1995, DIABETES, V44, P733, DOI 10.2337/diabetes.44.7.733; KAWAHARA DJ, 1991, CYTOKINE, V3, P117, DOI 10.1016/1043-4666(91)90031-8; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Koster JC, 2002, P NATL ACAD SCI USA, V99, P16992, DOI 10.1073/pnas.012479199; Kothmann WW, 2007, VISUAL NEUROSCI, V24, P363, DOI 10.1017/S095252380707037X; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LO SSS, 1992, DIABETOLOGIA, V35, P277, DOI 10.1007/BF00400930; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Niger C, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-14; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; PANAGIOTIDIS G, 1992, EUR J PHARMACOL, V229, P277, DOI 10.1016/0014-2999(92)90568-O; Perkins G, 1997, BIOPHYS J, V72, P533, DOI 10.1016/S0006-3495(97)78693-4; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; ROE MW, 1994, J BIOL CHEM, V269, P18279; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Verrilli G. M., 2011, FASEB J, V25, P1063; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; Yoshida K, 1999, BBA-MOL BASIS DIS, V1453, P230, DOI 10.1016/S0925-4439(98)00105-7	66	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3184	3196		10.1074/jbc.M115.679506	http://dx.doi.org/10.1074/jbc.M115.679506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668311	hybrid, Green Published			2022-12-28	WOS:000370854500007
J	Montaville, P; Kuhn, S; Compper, C; Carlier, MF				Montaville, Pierre; Kuehn, Sonja; Compper, Christel; Carlier, Marie-France			Role of the C-terminal Extension of Formin 2 in Its Activation by Spire Protein and Processive Assembly of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; fluorescence anisotropy; fluorescence correlation spectroscopy (FCS); formin; processivity; profilin	MOUSE OOCYTES; DROSOPHILA OOCYTE; HOMOLOGY-2 DOMAIN; WH2 DOMAINS; BARBED ENDS; NUCLEATION; DYNAMICS; CAPPUCCINO; SEQUENCE; SPINDLE	Formin 2 (Fmn2), a member of the FMN family of formins, plays an important role in early development. This formin cooperates with profilin and Spire, a WASP homology domain 2 (WH2) repeat protein, to stimulate assembly of a dynamic cytoplasmic actin meshwork that facilitates translocation of the meiotic spindle in asymmetric division of mouse oocytes. The kinase-like non-catalytic domain (KIND) of Spire directly interacts with the C-terminal extension of the formin homology domain 2 (FH2) domain of Fmn2, called FSI. This direct interaction is required for the synergy between the two proteins in actin assembly. We have recently demonstrated how Spire, which caps barbed ends via its WH2 domains, activates Fmn2. Fmn2 by itself associates very poorly to filament barbed ends but is rapidly recruited to Spire-capped barbed ends via the KIND domain, and it subsequently displaces Spire from the barbed end to elicit rapid processive assembly from profilinactin. Here, we address the mechanism by which Spire and Fmn2 compete at barbed ends and the role of FSI in orchestrating this competition as well as in the processivity of Fmn2. We have combined microcalorimetric, fluorescence, and hydrodynamic binding assays, as well as bulk solution and single filament measurements of actin assembly, to show that removal of FSI converts Fmn2 into a Capping Protein. This activity is mimicked by association of KIND to Fmn2. In addition, FSI binds actin at filament barbed ends as a weak capper and plays a role in displacing the WH2 domains of Spire from actin, thus allowing the association of actin-binding regions of FH2 to the barbed end.	[Montaville, Pierre; Kuehn, Sonja; Compper, Christel; Carlier, Marie-France] CNRS, Inst Biol Integrat Cellule, Cytoskeleton Dynam & Motil, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Carlier, MF (corresponding author), CNRS, Inst Biol Integrat Cellule, Cytoskeleton Dynam & Motil, F-91198 Gif Sur Yvette, France.	marie-france.carlier@i2bc.paris-saclay.fr		montaville, Pierre/0000-0002-9931-3482	European Research Council [249982, 241548]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Advanced Grant 249982 "Forcefulactin" and FP7 Program 241548 "MitoSys" (to M. F. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Almonacid M, 2015, NAT CELL BIOL, V17, P470, DOI 10.1038/ncb3131; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Baker JL, 2015, STRUCTURE, V23, P68, DOI 10.1016/j.str.2014.10.014; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Carlier MF, 2014, METHOD ENZYMOL, V540, P3, DOI 10.1016/B978-0-12-397924-7.00001-7; Carlier MF, 2013, CYTOSKELETON, V70, P540, DOI 10.1002/cm.21124; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Manseau L, 1996, DEVELOPMENT, V122, P2109; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Park E, 2015, STRUCTURE, V23, P1492, DOI 10.1016/j.str.2015.05.015; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Shekhar S, 2016, MOL BIOL CELL, V27, P1, DOI 10.1091/mbc.E15-06-0352; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Tu DQ, 2012, P NATL ACAD SCI USA, V109, pE3424, DOI 10.1073/pnas.1203035109; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wellington A, 1999, DEVELOPMENT, V126, P5267; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782	38	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3302	3318		10.1074/jbc.M115.681379	http://dx.doi.org/10.1074/jbc.M115.681379			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668326	Green Published, hybrid			2022-12-28	WOS:000370854500016
J	Dearborn, AD; Wall, JS; Cheng, NQ; Heymann, JB; Kajava, AV; Varkey, J; Langen, R; Steven, AC				Dearborn, Altaira D.; Wall, Joseph S.; Cheng, Naiqian; Heymann, J. Bernard; Kajava, Andrey V.; Varkey, Jobin; Langen, Ralf; Steven, Alasdair C.			alpha-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; ATOMIC-FORCE MICROSCOPY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VITRO; CORE STRUCTURE; MASS ANALYSIS; FILAMENTS; PROTEIN	Parkinson disease and other progressive neurodegenerative conditions are characterized by the intracerebral presence of Lewy bodies, containing amyloid fibrils of alpha-synuclein. We used cryo-electron microscopy and scanning transmission electron microscopy (STEM) to study in vitro-assembled fibrils. These fibrils are highly polymorphic. Focusing on twisting fibrils with an inter-crossover spacing of 77 nm, our reconstructions showed them to consist of paired protofibrils. STEM mass per length data gave one subunit per 0.47 nm axial rise per protofibril, consistent with a superpleated beta-structure. The STEM images show two thread-like densities running along each of these fibrils, which we interpret as ladders of metal ions. These threads confirmed the two-protofibril architecture of the 77-nm twisting fibrils and allowed us to identify this morphotype in STEM micrographs. Some other, but not all, fibril morphotypes also exhibit dense threads, implying that they also present a putative metal binding site. We propose a molecular model for the protofibril and suggest that polymorphic variant fibrils have different numbers of protofibrils that are associated differently.	[Dearborn, Altaira D.; Cheng, Naiqian; Heymann, J. Bernard; Steven, Alasdair C.] Natl Inst Hlth, Struct Biol Res Lab, Natl Inst Arthrit & Musculoskeletal & Skin Dis, Bethesda, MD 20892 USA; [Wall, Joseph S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Kajava, Andrey V.] Univ Montpellier, Ctr Rech Biochim Macromol, CNRS, F-34172 Montpellier, France; [Kajava, Andrey V.] Univ ITMO, Inst Bioengn, St Petersburg 197101, Russia; [Varkey, Jobin; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Varkey, Jobin] Karunya Univ, Coimbatore 641114, Tamil Nadu, India; Natl Inst Hlth, NIAMS, Struct Biol Res Lab, Bldg 50,Rm 1517,50 South Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Energy (DOE); Brookhaven National Laboratory; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; ITMO University; University of Southern California; Karunya Institute of Technology & Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steven, AC (corresponding author), Natl Inst Hlth, NIAMS, Struct Biol Res Lab, Bldg 50,Rm 1517,50 South Dr, Bethesda, MD 20892 USA.	stevena@mail.nih.gov	Kajava, Andrey V/E-1107-2014; Heymann, Bernard/H-8265-2019; Varkey, Jobin/I-5845-2019	Kajava, Andrey V/0000-0002-2342-6886; Heymann, Bernard/0000-0002-8872-5326; Dearborn, Altaira/0000-0003-0463-5233	NIAMS/National Institutes of Health; National Institutes of Health [1R01NS084345]; DBT-Ramalingaswami fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBT-Ramalingaswami fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the intramural research program of NIAMS/National Institutes of Health (to A. C. S.) and National Institutes of Health Grant 1R01NS084345 (to R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a DBT-Ramalingaswami fellowship.	Adamcik J, 2010, NAT NANOTECHNOL, V5, P423, DOI [10.1038/nnano.2010.59, 10.1038/NNANO.2010.59]; Ahmed AB, 2015, ALZHEIMERS DEMENT, V11, P681, DOI 10.1016/j.jalz.2014.06.007; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Goedert M, 1998, BIOCHEM SOC T, V26, P463, DOI 10.1042/bst0260463; Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Santner A, 2010, METALLOMICS, V2, P378, DOI 10.1039/b926659c; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050	43	38	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2310	2318		10.1074/jbc.M115.698787	http://dx.doi.org/10.1074/jbc.M115.698787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644467	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000369610400021
J	Hidaka, M; Gotoh, A; Shimizu, T; Minamisawa, K; Imamura, H; Uchida, T				Hidaka, Masafumi; Gotoh, Aina; Shimizu, Taiki; Minamisawa, Kiwamu; Imamura, Hiromi; Uchida, Takafumi			Visualization of NO3-/NO2- Dynamics in Living Cells by Fluorescence Resonance Energy Transfer ( FRET) Imaging Employing a Rhizobial Two-component Regulatory System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; BRADYRHIZOBIUM-JAPONICUM; NITRATE ASSIMILATION; VEGETABLE INTAKE; IN-VIVO; PROTEIN; ANTITERMINATION; OPERON; THERAPEUTICS; REDUCTASE	Nitrate (NO3-) and nitrite (NO2-) are the physiological sources of nitric oxide (NO), a key biological messenger molecule. NO3-/NO2- exerts a beneficial impact on NO homeostasis and its related cardiovascular functions. To visualize the physiological dynamics of NO3-/NO2- for assessing the precise roles of these anions, we developed a genetically encoded intermolecular fluorescence resonance energy transfer (FRET)-based indicator, named sNOOOpy (sensor for NO3-/NO2- in physiology), by employing NO3-/NO2--induced dissociation of NasST involved in the denitrification system of rhizobia. The in vitro use of sNOOOpy shows high specificity for NO3- and NO2-, and its FRET signal is changed in response to NO3-/NO2- in the micromolar range. Furthermore, both an increase and decrease in cellular NO3- concentration can be detected. sNOOOpy is very simple and potentially applicable to a wide variety of living cells and is expected to provide insights into NO3-/NO2- dynamics in various organisms, including plants and animals.	[Hidaka, Masafumi; Gotoh, Aina; Shimizu, Taiki; Uchida, Takafumi] Tohoku Univ, Dept Mol Cell Sci, Sendai, Miyagi 9818555, Japan; [Minamisawa, Kiwamu] Tohoku Univ, Dept Environm Life Sci, Sendai, Miyagi 9808577, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan	Tohoku University; Tohoku University; Kyoto University	Uchida, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci,Mol Enzymol, Aoba Ku, 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	uchidat@biochem.tohoku.ac.jp	Imamura, Hiromi/AAD-5109-2019; Minamisawa, Kiwamu/C-1585-2017	Imamura, Hiromi/0000-0002-1896-0443; Minamisawa, Kiwamu/0000-0001-7302-4079; Gotoh, Aina/0000-0002-0979-2265; Uchida, Takafumi/0000-0003-3665-4906	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24780092, 26850042, 26252065, 26252064, 26660287]; BRAIN; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry [25028A]; Grants-in-Aid for Scientific Research [26850042, 26252065, 26291027, 26252064] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BRAIN; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by Grants-in-aid for Young Scientist (B) 24780092 and 26850042 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.r Supported by BRAIN and Grant-in-aid for Scientific Research (A) 26252065 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.r Supported by Grant-in-aid for Scientific Research (A) 26252064, Grant-in-aid for Challenging Exploratory Research 26660287 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry Grant 25028A. To whom correspondence should be addressed: Molecular Enzymology, Dept. of Molecular Cell Science, Graduate School of Agricultural Science, Tohoku University, 1-1 Amamiya, Tsutsumidori, Aoba, Sendai, Miyagi 981-8555, Japan. Tel.: 81-22-717-8775; Fax: 81-22-717-8778; E-mail: uchidat@biochem.tohoku.ac.jp.	Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Butler AR, 2008, CIRCULATION, V117, P2151, DOI 10.1161/CIRCULATIONAHA.107.753814; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2006, NITRIC OXIDE-BIOL CH, V15, P359, DOI 10.1016/j.niox.2006.01.013; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Luque-Almagro VM, 2013, J BIOL CHEM, V288, P29692, DOI 10.1074/jbc.M113.459032; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; McKnight GM, 1999, BRIT J NUTR, V81, P349, DOI 10.1017/S000711459900063X; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; Patterson G, 2001, J CELL SCI, V114, P837; Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Sanchez C, 2014, ENVIRON MICROBIOL, V16, P3263, DOI 10.1111/1462-2920.12546; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang YP, 2011, CURR OPIN LIPIDOL, V22, P11, DOI 10.1097/MOL.0b013e328341942c; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Wang BM, 2012, APPL ENVIRON MICROB, V78, P6558, DOI 10.1128/AEM.01720-12; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wilson SA, 1996, EMBO J, V15, P5907, DOI 10.1002/j.1460-2075.1996.tb00977.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	37	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2260	2269		10.1074/jbc.M115.687632	http://dx.doi.org/10.1074/jbc.M115.687632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26631727	Green Published, hybrid			2022-12-28	WOS:000369610400017
J	Moeller, HB; Slengerik-Hansen, J; Aroankins, T; Assentoft, M; MacAulay, N; Moestrup, SK; Bhalla, V; Fenton, RA				Moeller, Hanne B.; Slengerik-Hansen, Joachim; Aroankins, Takwa; Assentoft, Mette; MacAulay, Nanna; Moestrup, Soeren K.; Bhalla, Vivek; Fenton, Robert A.			Regulation of the Water Channel Aquaporin-2 via 14-3-3 theta and-zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE; PHOSPHORYLATION; PROTEINS; ENDOCYTOSIS; CELLS; IDENTIFICATION; EXPRESSION; SERUM; AQP2; 14-3-3-PROTEINS	The 14-3-3 family of proteins are multifunctional proteins that interact with many of their cellular targets in a phosphorylation-dependent manner. Here, we determined that 14-3-3 proteins interact with phosphorylated forms of the water channel aquaporin-2 (AQP2) and modulate its function. With the exception of sigma, all 14-3-3 isoforms were abundantly expressed in mouse kidney and mouse kidney collecting duct cells (mpkCCD(14)). Long-term treatment of mpkCCD(14) cells with the type 2 vasopressin receptor agonist dDAVP increased mRNA and protein levels of AQP2 alongside 14-3-3 beta and -zeta, whereas levels of 14-3-3 eta and -theta were decreased. Co-immunoprecipitation (co-IP) studies in mpkCCD(14) cells uncovered an AQP2/14-3-3 interaction that was modulated by acute dDAVP treatment. Additional co-IP studies in HEK293 cells determined that AQP2 interacts selectively with 14-3-3 zeta and -theta. Use of phosphatase inhibitors in mpkCCD(14) cells, co-IP with phosphorylation deficient forms of AQP2 expressed in HEK293 cells, or surface plasmon resonance studies determined that the AQP2/14-3-3 interaction was modulated by phosphorylation of AQP2 at various sites in its carboxyl terminus, with Ser-256 phosphorylation critical for the interactions. shRNA-mediated knockdown of 14-3-3 zeta in mpkCCD(14) cells resulted in increased AQP2 ubiquitylation, decreased AQP2 protein half-life, and reduced AQP2 levels. In contrast, knockdown of 14-3-3 theta resulted in increased AQP2 half-life and increased AQP2 levels. In conclusion, this study demonstrates phosphorylation-dependent interactions of AQP2 with 14-3-3 theta and -zeta. These interactions play divergent roles in modulating AQP2 trafficking, phosphorylation, ubiquitylation, and degradation.	[Moeller, Hanne B.; Slengerik-Hansen, Joachim; Aroankins, Takwa; Moestrup, Soeren K.; Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Moeller, Hanne B.; Slengerik-Hansen, Joachim; Aroankins, Takwa; Moestrup, Soeren K.; Fenton, Robert A.] Aarhus Univ, Ctr Interact Proteins Epithelial Transport, DK-8000 Aarhus, Denmark; [Assentoft, Mette; MacAulay, Nanna] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Moestrup, Soeren K.] Univ Southern Denmark, Inst Mol Med, DK-5000 Odense, Denmark; [Bhalla, Vivek] Stanford Univ, Dept Med, Div Nephrol, Palo Alto, CA 94305 USA	Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Stanford University	Fenton, RA (corresponding author), Bldg 1233,Rm 213,Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	robert.a.fenton@biomed.au.dk	Fenton, Robert A/ABD-9824-2021; Moestrup, Søren Kragh/AAD-1735-2019; Fenton, Robert/AFR-6983-2022; MacAulay, Nanna/AER-7709-2022; Moestrup, Soren Kragh/A-1403-2014	Fenton, Robert/0000-0003-1623-199X; MacAulay, Nanna/0000-0002-7800-6600; Bhalla, Vivek/0000-0002-5420-9657; Moestrup, Soren Kragh/0000-0003-3862-2107	Danish Medical Research Council; Lundbeck Foundation; Novo Nordisk Foundation; Carlsberg Foundation; MEMBRANES; Aarhus University Research Foundation; Lundbeck Foundation [R54-2010-5398] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); MEMBRANES; Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation, MEMBRANES, and the Aarhus University Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Chandran S, 2011, J BIOL CHEM, V286, P37830, DOI 10.1074/jbc.M111.293233; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Feng XY, 2015, AM J PHYSIOL-RENAL, V309, pF71, DOI 10.1152/ajprenal.00546.2014; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; He YF, 2009, PROTEOMICS, V9, P5414, DOI 10.1002/pmic.200800864; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kortenoeven MLA, 2015, AM J PHYSIOL-RENAL, V309, pF280, DOI 10.1152/ajprenal.00093.2015; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Liang SF, 2009, ELECTROPHORESIS, V30, P4152, DOI 10.1002/elps.200900249; Liang SF, 2009, J CHROMATOGR B, V877, P627, DOI 10.1016/j.jchromb.2009.01.023; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Pisitkun T, 2006, PHYSIOL GENOMICS, V25, P263, DOI 10.1152/physiolgenomics.00214.2005; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106	49	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2469	2484		10.1074/jbc.M115.691121	http://dx.doi.org/10.1074/jbc.M115.691121			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645691	hybrid, Green Published			2022-12-28	WOS:000369610400035
J	Comba, A; Ainnada, LL; Tolosa, EJ; Iguchi, E; Marks, DL; Messler, MV; Silva, R; Fernandez-Barrena, MG; Enriquez-Hesles, E; Vrabel, AL; Botta, B; Di Marcotulio, L; Ellenrieder, V; Eynard, AR; Pasqualini, ME; Fernandez-Zapico, ME				Comba, Andrea; Ainnada, Luciana L.; Tolosa, Ezequiel J.; Iguchi, Eriko; Marks, David L.; Messler, Marianela Vara; Silva, Renata; Fernandez-Barrena, Maite G.; Enriquez-Hesles, Elisa; Vrabel, Anne L.; Botta, Bruno; Di Marcotulio, Lucia; Ellenrieder, Volker; Eynard, Aldo R.; Pasqualini, Maria E.; Fernandez-Zapico, Martin E.			Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; GAMMA-LINOLENIC ACID; INDUCED GENE-EXPRESSION; IN-VITRO; CANCER CELLS; MOLECULAR PATHWAYS; SIGNALING PATHWAY; FACTOR-BETA; CYCLIN D1; APOPTOSIS	Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells. We demonstrated that down-regulation of the transcription factor glioma-associated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed that AA represses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AA-induced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.	[Comba, Andrea; Ainnada, Luciana L.; Tolosa, Ezequiel J.; Iguchi, Eriko; Marks, David L.; Fernandez-Barrena, Maite G.; Enriquez-Hesles, Elisa; Vrabel, Anne L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Comba, Andrea; Messler, Marianela Vara; Silva, Renata; Eynard, Aldo R.; Pasqualini, Maria E.] Univ Nacl Cordoba, Inst lnvest Ciencias Salud, Consejo Nacl lnvest Cient & Tecn, Ciudad Univ, RA-5000 Cordoba, Argentina; [Comba, Andrea; Messler, Marianela Vara; Silva, Renata; Eynard, Aldo R.; Pasqualini, Maria E.] Univ Nacl Cordoba, Fac Ciencias, Ciudad Univ, RA-5000 Cordoba, Argentina; [Botta, Bruno] Univ Roma La Sapienza, Ctr Life Nano Sci Sapienza, Ist Italiano Tecnol, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Di Marcotulio, Lucia] Univ Roma La Sapienza, Dept Mol Med, Pasteur lnst, Cenci Bolognetti Fdn, I-00161 Rome, Italy; [Ellenrieder, Volker] Univ Med Ctr Gottingen, Gastroenterol & Gastrointestinal Oncol, D-37075 Gottingen, Germany; [Comba, Andrea] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Mayo Clinic; National University of Cordoba; National University of Cordoba; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Gottingen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014; Tolosa, Ezequiel J/AAD-9799-2019; Messler, Marianela Vara/AAB-7729-2020	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Tolosa, Ezequiel J/0000-0001-5167-0782; Messler, Marianela Vara/0000-0003-0493-7071; Botta, Bruno/0000-0001-8707-4333	National Institutes of Health from the NCI [CA136526]; National Institutes of Health through the Mayo Clinic Pancreatic Specialized Program of Research Excellence [P50 CA102701]; National Institutes of Health through the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina (CONICET)-PIP [11220080103014, 11220110101010]; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba-Argentina (SECYT-UNC) [214/10]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148, R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through the Mayo Clinic Pancreatic Specialized Program of Research Excellence; National Institutes of Health through the Mayo Clinic Center for Cell Signaling in Gastroenterology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina (CONICET)-PIP; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba-Argentina (SECYT-UNC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health Grants CA136526 from the NCI, P50 CA102701 through the Mayo Clinic Pancreatic Specialized Program of Research Excellence, and P30 DK84567 through the Mayo Clinic Center for Cell Signaling in Gastroenterology (to M. E. F.-Z.), Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina (CONICET)-PIP 2009-2011 Grant 11220080103014 and (CONICET)-PIP 2012-2014 Grant 11220110101010 (to A. R. E.), and Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba-Argentina (SECYT-UNC) Grants 214/10 (to M. E. P.). The authors have declared that no conflict of interest exists. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita K, 2001, BIOCHEM PHARMACOL, V62, P821, DOI 10.1016/S0006-2952(01)00723-7; Azrad M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00224; Bakshi A, 2003, NUTRITION, V19, P305, DOI 10.1016/S0899-9007(02)00862-6; Baumgart S, 2014, CANCER DISCOV, V4, P688, DOI 10.1158/2159-8290.CD-13-0593; Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bocca C, 2008, BRIT J NUTR, V100, P739, DOI 10.1017/S0007114508942161; Comba A, 2009, PANCREATOLOGY, V9, P724, DOI 10.1159/000235623; Comba A, 2011, CANCER METAST REV, V30, P325, DOI 10.1007/s10555-011-9308-x; Dahm CC, 2012, AM J CLIN NUTR, V96, P1354, DOI 10.3945/ajcn.112.034157; Dai JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-71; DAS UN, 1995, CANCER LETT, V94, P147, DOI 10.1016/0304-3835(95)03844-M; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-159; de Lorgeril M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-50; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dymkowska D, 2009, ACTA BIOCHIM POL, V56, P711; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Eynard AR, 2013, NUTRITION, V29, P930, DOI 10.1016/j.nut.2012.12.014; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Farago N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-173; Fenton JI, 2013, PROSTAG LEUKOTR ESS, V89, P379, DOI 10.1016/j.plefa.2013.09.011; Foy KC, 2012, ONCOIMMUNOLOGY, V1, P1004, DOI 10.4161/onci.21057; Fukui M, 2013, J CELL BIOCHEM, V114, P192, DOI 10.1002/jcb.24354; GARDELL SJ, 1983, J BIOL CHEM, V258, P6198; Giamarellos-Bourboulis EJ, 2002, PROSTAG LEUKOTR ESS, V67, P57, DOI 10.1054/plef.2002.0382; Gleissman H, 2010, EXP CELL RES, V316, P1365, DOI 10.1016/j.yexcr.2010.02.039; Gong PF, 2006, J BIOL CHEM, V281, P14573, DOI 10.1074/jbc.M600613200; Gurda GT, 2008, MOL BIOL CELL, V19, P198, DOI 10.1091/mbc.E07-05-0430; Hammamieh R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-138; HICKS M, 1979, ANAL BIOCHEM, V99, P249, DOI 10.1016/S0003-2697(79)80003-2; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Konig A, 2010, PANCREATOLOGY, V10, P416, DOI 10.1159/000315035; Kundumani-Sridharan V, 2012, J BIOL CHEM, V287, P22463, DOI 10.1074/jbc.M112.362996; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Leaver HA, 2002, PROSTAG LEUKOTR ESS, V67, P283, DOI 10.1054/plef.2002.0431; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu WH, 2009, TOXICOL LETT, V191, P140, DOI 10.1016/j.toxlet.2009.08.016; Lo Re AE, 2012, J BIOL CHEM, V287, P25325, DOI 10.1074/jbc.M112.370809; Lu J, 2008, AM J PHYSIOL-GASTR L, V294, pG1181, DOI 10.1152/ajpgi.00343.2007; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Miyake JA, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-8; Monjazeb AM, 2006, CARCINOGENESIS, V27, P1950, DOI 10.1093/carcin/bgl023; NARIAI T, 1993, CLIN EXP METASTAS, V11, P141, DOI 10.1007/BF00114972; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Oraldi M, 2009, J ONCOL, V2009, DOI 10.1155/2009/867915; Pasqualini ME, 2008, CURR NUTR FOOD SCI, V4, P161, DOI 10.2174/157340108785133356; Prasad A, 2010, J CELL PHYSIOL, V225, P829, DOI 10.1002/jcp.22290; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P947, DOI 10.1016/j.intimp.2004.12.013; Sandrone SS, 2014, NUTRITION, V30, P1104, DOI 10.1016/j.nut.2014.01.009; Schonfeld P, 2011, J NEUROCHEM, V118, P69, DOI 10.1111/j.1471-4159.2011.07286.x; Senft D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030821; Shaikh IAA, 2010, NUTR CANCER, V62, P284, DOI 10.1080/01635580903407189; SIEGEL I, 1987, J NATL CANCER I, V78, P271; Soria EA, 2007, LIFE SCI, V81, P1397, DOI 10.1016/j.lfs.2007.09.008; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Urtreger AJ, 1997, INT J ONCOL, V11, P489; Wang WC, 2014, PROSTAG OTH LIPID M, V113, P13, DOI 10.1016/j.prostaglandins.2014.07.002; Yang X, 2014, J PHARM SCI-US, V103, P305, DOI 10.1002/jps.23800; Yin HY, 2013, MITOCHONDRION, V13, P209, DOI 10.1016/j.mito.2012.10.003; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	73	14	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1933	1947		10.1074/jbc.M115.691972	http://dx.doi.org/10.1074/jbc.M115.691972			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601952	Green Published, hybrid			2022-12-28	WOS:000368620700031
J	Vo, U; Vajpai, N; Flavell, L; Bobby, R; Breeze, AL; Embrey, KJ; Golovanov, AP				Vo, Uybach; Vajpai, Navratna; Flavell, Liz; Bobby, Romel; Breeze, Alexander L.; Embrey, Kevin J.; Golovanov, Alexander P.			Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR SON; STRUCTURAL BASIS; COLORECTAL-CANCER; HISTONE DOMAIN; TARGETING RAS; K-RAS; BINDING; PROTEIN; GTP; DYNAMICS	The activity of Ras is controlled by the interconversion between GTP- and GDP-bound forms partly regulated by the binding of the guanine nucleotide exchange factor Son of Sevenless (Sos). The details of Sos binding, leading to nucleotide exchange and subsequent dissociation of the complex, are not completely understood. Here, we used uniformly N-15-labeled Ras as well as [C-13] methyl-Met, Ile-labeled Sos for observing site-specific details of Ras-Sos interactions in solution. Binding of various forms of Ras (loaded with GDP and mimics of GTP or nucleotide-free) at the allosteric and catalytic sites of Sos was comprehensively characterized by monitoring signal perturbations in the NMR spectra. The overall affinity of binding between these protein variants as well as their selected functional mutants was also investigated using intrinsic fluorescence. The data support a positive feedback activation of Sos by Ras-GTP with Ras-GTP binding as a substrate for the catalytic site of activated Sos more weakly than Ras-GDP, suggesting that Sos should actively promote unidirectional GDP -> GTP exchange on Ras in preference of passive homonucleotide exchange. Ras-GDP weakly binds to the catalytic but not to the allosteric site of Sos. This confirms that Ras-GDP cannot properly activate Sos at the allosteric site. The novel site-specific assay described may be useful for design of drugs aimed at perturbing Ras-Sos interactions.	[Vo, Uybach; Golovanov, Alexander P.] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Vo, Uybach; Golovanov, Alexander P.] Univ Manchester, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England; [Vajpai, Navratna; Flavell, Liz; Bobby, Romel; Breeze, Alexander L.; Embrey, Kevin J.] AstraZeneca, Discovery Sci, Alderley Pk SK10 4TF, Cheshire, England; [Breeze, Alexander L.] Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Manchester; University of Manchester; AstraZeneca; University of Leeds	Golovanov, AP (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.; Golovanov, AP (corresponding author), Univ Manchester, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.; Embrey, KJ (corresponding author), AstraZeneca, Discovery Sci, Alderley Pk SK10 4TF, Cheshire, England.	Kevin.Embrey@astrazeneca.com; A.Golovanov@manchester.ac.uk	Golovanov, Alexander P./ABN-0572-2022	Golovanov, Alexander P./0000-0002-8592-3984; Breeze, Alexander/0000-0001-9723-3350	Medical Research Council Industrial CASE Studentship [G1000399-3/1]; Medical Research Council [1089592] Funding Source: researchfish	Medical Research Council Industrial CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Industrial CASE Studentship G1000399-3/1 (to A. P. G. and K. J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Iversen L, 2014, SCIENCE, V345, P50, DOI 10.1126/science.1250373; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3; Krishnarjuna B, 2011, J BIOMOL NMR, V49, P39, DOI 10.1007/s10858-010-9459-z; Kunzelmann S, 2011, BIOCHEM J, V440, P43, DOI 10.1042/BJ20110349; Leatherbarrow R. J, 1992, GRAFIT VERSION 3 0 D; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mas G, 2013, J BIOMOL NMR, V57, P251, DOI 10.1007/s10858-013-9785-z; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stoffregen MC, 2012, STRUCTURE, V20, P573, DOI 10.1016/j.str.2012.02.012; Tan C, 2012, WORLD J GASTROENTERO, V18, P5171, DOI 10.3748/wjg.v18.i37.5171; Vo U, 2013, BIOMOL NMR ASSIGN, V7, P215, DOI 10.1007/s12104-012-9413-y; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Winter JJG, 2015, J MED CHEM, V58, P2265, DOI 10.1021/jm501660t	42	21	22	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1703	1718		10.1074/jbc.M115.691238	http://dx.doi.org/10.1074/jbc.M115.691238			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26565026	hybrid, Green Published			2022-12-28	WOS:000368620700014
J	Garcia-Trejo, JJ; Zarco-Zavala, M; Mendoza-Hoffmann, F; Hernandez-Luna, E; Ortega, R; Mendoza-Hernandez, G				Garcia-Trejo, Jose J.; Zarco-Zavala, Mariel; Mendoza-Hoffmann, Francisco; Hernandez-Luna, Eduardo; Ortega, Raquel; Mendoza-Hernandez, Guillermo			The Inhibitory Mechanism of the zeta Subunit of the F1FO-ATPase Nanomotor of Paracoccus denitrificans and Related alpha-Proteobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; ESCHERICHIA-COLI; EPSILON-SUBUNIT; REGULATORY PROTEIN; BETA-SUBUNITS; F-1-ATPASE; COMPLEX; GAMMA; IF1; BACTERIAL	The zeta subunit is a novel inhibitor of the F1FO-ATPase of Paracoccus denitrificans and related alpha-proteobacteria. It is different from the bacterial (is an element of) and mitochondrial (IF1) inhibitors. The N terminus of zeta blocks rotation of the gamma subunit of the F-1-ATPase of P. denitrificans (Zarco-Zavala, M., Morales-Rios, E., Mendoza-Hernandez, G., Ramirez-Silva, L., Perez-Hernandez, G., and Garcia-Trejo, J. J. (2014) FASEB J. 24, 599 - 608) by a hitherto unknown quaternary structure that was first modeled here by structural homology and protein docking. The F-1-ATPase and F-1-zeta models of P. denitrificans were supported by cross-linking, limited proteolysis, mass spectrometry, and functional data. The final models show that zeta enters into F-1-ATPase at the open catalytic alpha(E)/beta(E) interface, and two partial gamma rotations lock the N terminus of zeta in an "inhibition-general core region," blocking further gamma rotation, while the zeta globular domain anchors it to the closed alpha(DP)/beta(DP) interface. Heterologous inhibition of the F-1-ATPase of P. denitrificans by the mitochondrial IF1 supported both the modeled zeta binding site at the alpha(DP)/beta(DP)/gamma interface and the endosymbiotic alpha-proteobacterial origin of mitochondria. In summary, the zeta subunit blocks the intrinsic rotation of the nanomotor by inserting its N-terminal inhibitory domain at the same rotor/stator interface where the mitochondrial IF1 or the bacterial is an element of binds. The proposed pawl mechanism is coupled to the rotation of the central gamma subunit working as a ratchet but with structural differences that make it a unique control mechanism of the nanomotor to favor the ATP synthase activity over the ATPase turnover in the alpha-proteobacteria.	[Garcia-Trejo, Jose J.; Zarco-Zavala, Mariel; Mendoza-Hoffmann, Francisco; Hernandez-Luna, Eduardo; Ortega, Raquel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Delegacion Coyoacan 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Delegacion Coyoacan 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Garcia-Trejo, JJ (corresponding author), Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Lab 206, Edificio F,S-N Ciudad Univ, Delegacion Coyoacan 04510, DF, Mexico.	jjgartre@unam.mx		Mendoza-Hoffmann, Francisco/0000-0002-2166-6632	Mexico (CONACyT) [CB-2011-01-167622]; U.N.A.M. (DGAPA) [PAPIIT-IN211012]	Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); U.N.A.M. (DGAPA)(Universidad Nacional Autonoma de Mexico)	This work was supported by Mexico (CONACyT) Grant CB-2011-01-167622 and U.N.A.M. (DGAPA) Grant PAPIIT-IN211012 (to J. J. G.-T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; DEGOMEZPUYOU MT, 1983, J BIOL CHEM, V258, P3680; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Garcia-Trejo JJ, 2008, J BIOL PHYS, V34, P197, DOI 10.1007/s10867-008-9114-z; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Margulis L, 1998, TRENDS MICROBIOL, V6, P342, DOI 10.1016/S0966-842X(98)01325-0; Minauro-Sanmiguel F, 2002, J BIOENERG BIOMEMBR, V34, P433, DOI 10.1023/A:1022514008462; Morales-Rios E, 2015, ACTA CRYSTALLOGR F, V71, P1309, DOI 10.1107/S2053230X15016076; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Serrano P, 2014, J MOL BIOL, V426, P2547, DOI 10.1016/j.jmb.2014.05.004; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Zarco-Zavala M, 2013, BBA-BIOENERGETICS, V1827, P60, DOI 10.1016/j.bbabio.2012.09.010; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430	28	14	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					538	546		10.1074/jbc.M115.688143	http://dx.doi.org/10.1074/jbc.M115.688143			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26546676	hybrid, Green Published			2022-12-28	WOS:000367830500003
J	Kwon, MJ; Park, J; Jang, S; Eom, CY; Oh, ES				Kwon, Mi-Jung; Park, Jisu; Jang, Sinae; Eom, Chi-Yong; Oh, Eok-Soo			The Conserved Phenylalanine in the Transmembrane Domain Enhances Heteromeric Interactions of Syndecans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GROWTH-FACTOR; HETEROTYPIC INTERACTIONS; TYROSINE KINASES; RECEPTOR; CANCER; OLIGOMERIZATION; DIMERIZATION; HELICES; PROTEIN	The transmembrane domain (TMD) of the syndecans, a family of transmembrane heparin sulfate proteoglycans, is involved in forming homo-and heterodimers and oligomers that transmit signaling events. Recently, we reported that the unique phenylalanine in TMD positively regulates intramolecular interactions of syndecan-2. Besides the unique phenylalanine, syndecan-2 contains a conserved phenylalanine (SDC2-Phe-169) that is present in all syndecan TMDs, but its function has not been determined. We therefore investigated the structural role of SDC2-Phe-169 in syndecan TMDs. Replacement of SDC2-Phe-169 by tyrosine (S2F169Y) did not affect SDS-resistant homodimer formation but significantly reduced SDS-resistant heterodimer formation between syndecan-2 and -4, suggesting that SDC2-Phe-169 is involved in the heterodimerization/oligomerization of syndecans. Similarly, in an in vitro binding assay, a syndecan-2 mutant (S2(F169Y)) showed a significantly reduced interaction with syndecan-4. FRET assays showed that heteromolecular interactions between syndecan-2 and -4 were reduced in HEK293T cells transfected with S2(F169Y) compared with syndecan-2. Moreover, S2(F169Y) reduced downstream reactions mediated by the heterodimerization of syndecan-2 and -4, including Rac activity, cell migration, membrane localization of PKC alpha, and focal adhesion formation. The conserved phenylalanine in syndecan-1 and -3 also showed heterodimeric interaction with syndecan-2 and -4. Taken together, these findings suggest that the conserved phenylalanine in the TMD of syndecans is crucial in regulating heteromeric interactions of syndecans.	[Kwon, Mi-Jung; Park, Jisu; Oh, Eok-Soo] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul 120750, South Korea; [Jang, Sinae; Eom, Chi-Yong] Korea Basic Sci Inst, Seoul Ctr, Seoul 136075, South Korea	Ewha Womans University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr			National Research Foundation of Korea - Korean government (MSIP) [2012R1A5A1048236, 2013R1A2A2A01013565]	National Research Foundation of Korea - Korean government (MSIP)	This work was supported by National Research Foundation of Korea grants 2012R1A5A1048236 and 2013R1A2A2A01013565 funded by the Korean government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; Carey DJ, 1997, BIOCHEM J, V327, P1; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Choi Y, 2015, J BIOL CHEM, V290, P16943, DOI 10.1074/jbc.M114.611798; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Hecker TP, 2002, CANCER RES, V62, P2699; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HELDIN CH, 1992, KIDNEY INT, V41, P571, DOI 10.1038/ki.1992.84; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kwon MJ, 2015, J BIOL CHEM, V290, P5772, DOI 10.1074/jbc.M114.599845; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Okolicsanyi RK, 2014, J CELL BIOCHEM, V115, P967, DOI 10.1002/jcb.24746; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ortega DR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3881; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Sawma P, 2014, J MOL BIOL, V426, P4099, DOI 10.1016/j.jmb.2014.10.007; Schlesinger TK, 1999, BIOCHEM J, V344, P519, DOI 10.1042/0264-6021:3440519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Yamashita H, 2015, BBA-BIOMEMBRANES, V1848, P1359, DOI 10.1016/j.bbamem.2015.03.004; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121513	39	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					872	881		10.1074/jbc.M115.685040	http://dx.doi.org/10.1074/jbc.M115.685040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601939	Green Published, hybrid			2022-12-28	WOS:000367830500033
J	Simon, K; Hennen, S; Merten, N; Blattermann, S; Gillard, M; Kostenis, E; Gomeza, J				Simon, Katharina; Hennen, Stephanie; Merten, Nicole; Blaettermann, Stefanie; Gillard, Michel; Kostenis, Evi; Gomeza, Jesus			The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via G alpha(i/o) and Its Downstream Effector Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; NUCLEOTIDE-EXCHANGE FACTOR; ELEMENT-BINDING PROTEIN; CYCLIC-AMP; KINASE-C; PRECURSOR DIFFERENTIATION; CELL-DIFFERENTIATION; SIGNALING PATHWAYS; AXON GROWTH; MAP KINASE	Recent studies have recognized G protein-coupled receptors as important regulators of oligodendrocyte development. GPR17, in particular, is an orphan G protein-coupled receptor that has been identified as oligodendroglial maturation inhibitor because its stimulation arrests primary mouse oligodendrocytes at a less differentiated stage. However, the intracellular signaling effectors transducing its activation remain poorly understood. Here, we use Oli-neu cells, an immortalized cell line derived from primary murine oligodendrocytes, and primary rat oligodendrocyte cultures as model systems to identify molecular targets that link cell surface GPR17 to oligodendrocyte maturation blockade. We demonstrate that stimulation of GPR17 by the small molecule agonist MDL29,951 (2-carboxy-4,6-dichloro-1H-indole-3-propionic acid) decreases myelin basic protein expression levels mainly by triggering the G alpha(i/o) signaling pathway, which in turn leads to reduced activity of the downstream cascade adenylyl cyclase-cAMP-PKA-cAMP response element-binding protein (CREB). In addition, we show that GPR17 activation also diminishes myelin basic protein abundance by lessening stimulation of the exchange protein directly activated by cAMP (EPAC), thus uncovering a previously unrecognized role for EPAC to regulate oligodendrocyte differentiation. Together, our data establish PKA and EPAC as key downstream effectors of GPR17 that inhibit oligodendrocyte maturation. We envisage that treatments augmenting PKA and/or EPAC activity represent a beneficial approach for therapeutic enhancement of remyelination in those demyelinating diseases where GPR17 is highly expressed, such as multiple sclerosis.	[Simon, Katharina; Hennen, Stephanie; Merten, Nicole; Blaettermann, Stefanie; Kostenis, Evi; Gomeza, Jesus] Univ Bonn, Inst Pharmaceut Biol, Sect Mol Cellular & Pharmacobiol, D-53115 Bonn, Germany; [Gillard, Michel] CNS Res, UCB Pharma, B-1420 Braine Lalleud, Belgium	University of Bonn; UCB Pharma SA	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Sect Mol Cellular & Pharmacobiol, D-53115 Bonn, Germany.	kostenis@uni-bonn.de; jgomeza@uni-bonn.de			German Federal Ministry for Education and Research (BMBF) within the BioPharma Initiative "Neuroallianz" [1615609B]; German Research Foundation (DFG) [RTG1873]	German Federal Ministry for Education and Research (BMBF) within the BioPharma Initiative "Neuroallianz"(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Federal Ministry for Education and Research (BMBF) within the BioPharma Initiative "Neuroallianz" (Grant 1615609B; to E. K.). K. S. is a member of the German Research Foundation (DFG)-funded Research Training Group RTG1873. The authors declare that they have no conflicts of interest with the contents of this article.; K. S. is a member of the German Research Foundation (DFG)-funded Research Training Group RTG1873.	Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122; Afshari FS, 2001, J NEUROSCI RES, V66, P37, DOI 10.1002/jnr.1195; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Baron W, 2000, J NEUROSCI RES, V59, P74, DOI 10.1002/(SICI)1097-4547(20000101)59:1<74::AID-JNR9>3.0.CO;2-P; Bhat NR, 2007, NEUROCHEM RES, V32, P293, DOI 10.1007/s11064-006-9274-9; Bhat NR, 1996, J NEUROCHEM, V66, P1986; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Chepurny OG, 2013, MOL ENDOCRINOL, V27, P1267, DOI 10.1210/me.2013-1029; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fratangeli A, 2013, J BIOL CHEM, V288, P5241, DOI 10.1074/jbc.M112.404996; Fyffe-Maricich SL, 2011, J NEUROSCI, V31, P843, DOI 10.1523/JNEUROSCI.3239-10.2011; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Hedegaard ER, 2014, EUR J PHARMACOL, V723, P216, DOI 10.1016/j.ejphar.2013.11.029; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; JENSEN NA, 1993, J NEUROSCI RES, V35, P288, DOI 10.1002/jnr.490350308; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kankaanranta H, 2011, PULM PHARMACOL THER, V24, P394, DOI 10.1016/j.pupt.2011.03.002; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Laursen LS, 2007, NEURON GLIA BIOL, V3, P367, DOI 10.1017/S1740925X08000161; McNulty S, 2001, NEUROSCI RES, V41, P217, DOI 10.1016/S0168-0102(01)00280-2; Medina-Rodriguez EM, 2013, CELL MOL LIFE SCI, V70, P3449, DOI 10.1007/s00018-013-1340-2; Meffre D, 2015, NEUROSCIENCE, V284, P962, DOI 10.1016/j.neuroscience.2014.10.064; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Mir F, 2008, MOL CELL BIOL, V28, P6329, DOI 10.1128/MCB.00482-08; Mironov SL, 2011, J NEUROCHEM, V117, P295, DOI 10.1111/j.1471-4159.2011.07202.x; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Parnell E, 2015, TRENDS PHARMACOL SCI, V36, P203, DOI 10.1016/j.tips.2015.02.003; Pende M, 1997, J NEUROSCI, V17, P1291; PLEASURE D, 1986, J NEUROCHEM, V46, P300, DOI 10.1111/j.1471-4159.1986.tb12963.x; Qi AD, 2013, J PHARMACOL EXP THER, V347, P38, DOI 10.1124/jpet.113.207647; RAIBLE DW, 1990, J NEUROSCI RES, V27, P43, DOI 10.1002/jnr.490270107; Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; SatoBigbee C, 1996, J NEUROSCI RES, V46, P98, DOI 10.1002/(SICI)1097-4547(19961001)46:1<98::AID-JNR12>3.0.CO;2-8; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Syed YA, 2013, EMBO MOL MED, V5, P1918, DOI 10.1002/emmm.201303123; VARTANIAN T, 1986, SCIENCE, V234, P1395, DOI 10.1126/science.2431483; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489; Xiao L, 2012, GLIA, V60, P1037, DOI 10.1002/glia.22333; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	60	52	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					705	718		10.1074/jbc.M115.683953	http://dx.doi.org/10.1074/jbc.M115.683953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26620557	Green Published, hybrid			2022-12-28	WOS:000367830500019
J	Banerjee, R; Mukhopadhyay, R				Banerjee, Ruma; Mukhopadhyay, Rajendrani			When the Good and the Bad Make the Ugly: The Discovery of Peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Banerjee, Ruma] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.								0	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30726	30727		10.1074/jbc.O115.000001	http://dx.doi.org/10.1074/jbc.O115.000001			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26706866	Green Published, hybrid			2022-12-28	WOS:000367199000006
J	Kadri, F; Pacifici, M; Wilk, A; Parker-Struckhoff, A; Del Valle, L; Hauser, KF; Knapp, PE; Parsons, C; Jeansonne, D; Lassak, A; Peruzzi, F				Kadri, Ferdous; Pacifici, Marco; Wilk, Anna; Parker-Struckhoff, Amanda; Del Valle, Luis; Hauser, Kurt F.; Knapp, Pamela E.; Parsons, Christopher; Jeansonne, Duane; Lassak, Adam; Peruzzi, Francesca			HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY VIRUS-1 TAT; SPLICING FACTOR SC35; HIV-TAT; FRONTOTEMPORAL DEMENTIA; DOWN-SYNDROME; SR PROTEINS; PHOSPHORYLATION; EXPRESSION; TRANSCRIPTION; ISOFORMS	The HIV-1 transactivator protein Tat is implicated in the neuronal damage that contributes to neurocognitive impairment affecting people living with HIV/AIDS. Aberrant splicing of TAU exon 10 results in tauopathies characterized by alterations in the proportion of TAU isoforms containing three (3R) or four (4R) microtubule-binding repeats. The splicing factor SC35/SRSF2 binds to nuclear RNA and facilitates the incorporation of exon 10 in the TAU molecule. Here, we utilized clinical samples, an animal model, and neuronal cell cultures and found that Tat promotes TAU3R up-regulation through increased levels of phosphorylated SC35, which is retained in nuclear speckles. This mechanism involved Tat-mediated increased expression of DYRK1A and was prevented by DYRK1A silencing. In addition, we found that Tat associates with TAU RNA, further demonstrating that Tat interferes with host RNA metabolism in the absence of viral infection. Altogether, our data unravel a novel mechanism of Tat-mediated neuronal toxicity through dysregulation of the SC35-dependent alternative splicing of TAU exon 10. Furthermore, the increased immunostaining of DYRK1A in HIV+ brains without pathology points at dysregulation of DYRK1A as an early event in the neuronal complications of HIV infection.	[Kadri, Ferdous; Pacifici, Marco; Wilk, Anna; Parker-Struckhoff, Amanda; Del Valle, Luis; Parsons, Christopher; Jeansonne, Duane; Lassak, Adam; Peruzzi, Francesca] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Kadri, Ferdous] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Hauser, Kurt F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Virginia Commonwealth University; Virginia Commonwealth University	Peruzzi, F (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Med, 1700 Tulane Ave, New Orleans, LA 70112 USA.	fperuz@lsuhsc.edu	Del Valle, Luis/J-4085-2015; Regan, Clinton/E-6250-2012; Hauser, Kurt/AAX-8361-2020	Del Valle, Luis/0000-0003-3894-9206; Hauser, Kurt/0000-0001-7886-0332	National Institutes of Health NIGMS [1U54 GM104940]; National Institutes of Health [P20 GM103501, R01 DA034231, K02 DA027374]; Louisiana Cancer Research Center; Stanley S. Scott Cancer Research Center at Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P20GM103501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034231, K02DA027374] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Center; Stanley S. Scott Cancer Research Center at Louisiana State University Health Sciences Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institutes of Health NIGMS Grant 1U54 GM104940 (to F. P.), which funds the Louisiana Clinical and Translational Science Center, by the National Institutes of Health Grants P20 GM103501 (to F. P. and C. P.), R01 DA034231 (to P. E. K.), and K02 DA027374 (to K. F. H.) and by the Louisiana Cancer Research Center and the Stanley S. Scott Cancer Research Center at Louisiana State University Health Sciences Center. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2013, NEUROBIOL DIS, V52, P117, DOI 10.1016/j.nbd.2012.11.017; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bachani M, 2013, J NEUROVIROL, V19, P82, DOI 10.1007/s13365-012-0144-8; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Bouwman RD, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-53; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Bruce-Keller AJ, 2008, GLIA, V56, P1414, DOI 10.1002/glia.20708; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chen CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5246; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091793; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Del Valle L, 2000, J NEUROVIROL, V6, P221, DOI 10.3109/13550280009015824; Dewhurst S, 2007, J NEUROIMMUNE PHARM, V2, P93, DOI 10.1007/s11481-006-9051-1; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fitting S, 2013, BIOL PSYCHIAT, V73, P443, DOI 10.1016/j.biopsych.2012.09.026; Fitting S, 2012, EUR J PHARMACOL, V689, P96, DOI 10.1016/j.ejphar.2012.05.029; Fitting S, 2010, AM J PATHOL, V177, P1397, DOI 10.2353/ajpath.2010.090945; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Grau C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00331; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Jablonski JA, 2010, NUCLEIC ACIDS RES, V38, P1249, DOI 10.1093/nar/gkp1105; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jeansonne D, 2015, J BIOL CHEM, V290, P8067, DOI 10.1074/jbc.M114.633081; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Johnson TP, 2014, CURR OPIN HIV AIDS, V9, P572, DOI 10.1097/COH.0000000000000107; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Lovestone S, 1999, BIOL PSYCHIAT, V45, P995, DOI 10.1016/S0006-3223(98)00183-8; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Ma Xiaoyun, 2003, Genomics Proteomics & Bioinformatics, V1, P2; Maldarelli F, 1998, VIRUS RES, V53, P39, DOI 10.1016/S0168-1702(97)00130-5; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Passiatore G, 2009, BBA-MOL CELL RES, V1793, P378, DOI 10.1016/j.bbamcr.2008.10.010; Paz S, 2014, NUCLEIC ACIDS RES, V42, P13812, DOI 10.1093/nar/gku1170; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Qian W, 2011, FEBS LETT, V585, P875, DOI 10.1016/j.febslet.2011.02.017; Rom S, 2011, BBA-MOL CELL RES, V1813, P1836, DOI 10.1016/j.bbamcr.2011.06.012; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Wegiel J, 2011, J NEUROPATH EXP NEUR, V70, P36, DOI 10.1097/NEN.0b013e318202bfa1; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	82	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30931	30946		10.1074/jbc.M115.675751	http://dx.doi.org/10.1074/jbc.M115.675751			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26534959	Green Published, hybrid			2022-12-28	WOS:000367199000025
J	Hauf, K; Kayumov, A; Gloge, F; Forchhammer, K				Hauf, Ksenia; Kayumov, Airat; Gloge, Felix; Forchhammer, Karl			The Molecular Basis of TnrA Control by Glutamine Synthetase in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; ATP; glutamate; glutamine; transcription regulation; transcription factor TnrA; glutamine synthetase; Bacillus subtilis	TRANSCRIPTION FACTOR TNRA; GENE-EXPRESSION; NITROGEN-METABOLISM; ESCHERICHIA-COLI; PROTEIN; COMPLEXES; MECHANISM; INSIGHTS; RECOGNITION; HOMEOSTASIS	TnrA is a master regulator of nitrogen assimilation in Bacillus subtilis. This study focuses on the mechanism of how glutamine synthetase (GS) inhibits TnrA function in response to key metabolites ATP, AMP, glutamine, and glutamate. We suggest a model of two mutually exclusive GS conformations governing the interaction with TnrA. In the ATP-bound state (A-state), GS is catalytically active but unable to interact with TnrA. This conformation was stabilized by phosphorylated l-methionine sulfoximine (MSX), fixing the enzyme in the transition state. When occupied by glutamine (or its analogue MSX), GS resides in a conformation that has high affinity for TnrA (Q-state). The A- and Q-state are mutually exclusive, and in agreement, ATP and glutamine bind to GS in a competitive manner. At elevated concentrations of glutamine, ATP is no longer able to bind GS and to bring it into the A-state. AMP efficiently competes with ATP and prevents formation of the A-state, thereby favoring GS-TnrA interaction. Surface plasmon resonance analysis shows that TnrA bound to a positively regulated promoter fragment binds GS in the Q-state, whereas it rapidly dissociates from a negatively regulated promoter fragment. These data imply that GS controls TnrA activity at positively controlled promoters by shielding the transcription factor in the DNA-bound state. According to size exclusion and multiangle light scattering analysis, the dodecameric GS can bind three TnrA dimers. The highly interdependent ligand binding properties of GS reveal this enzyme as a sophisticated sensor of the nitrogen and energy state of the cell to control the activity of DNA-bound TnrA.	[Hauf, Ksenia; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany; [Kayumov, Airat] Kazan Fed Univ, Dept Genet, Kremlevskaya 18, Kazan 420008, Russia; [Gloge, Felix] Wyatt Technol Europe, Hochstr 12a, D-56307 Dernbach, Germany	Eberhard Karls University of Tubingen; Kazan Federal University	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de	Kayumov, Airat/M-6725-2013	Kayumov, Airat/0000-0001-7195-1557	Deutsche Forschungsgemeinschaft [Fo195/9-2]; German Academic Exchange Service (DAAD) Russian-German Program "Michail Lomonosov" [A/12/75478, A/12/25777, 91583699]; DAAD [50015537]; Russian Foundation for Basic Research (RFBR) [15-04-02583a]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service (DAAD) Russian-German Program "Michail Lomonosov"(Deutscher Akademischer Austausch Dienst (DAAD)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fo195/9-2; German Academic Exchange Service (DAAD) Russian-German Program "Michail Lomonosov" Grants A/12/75478, A/12/25777, and 91583699; DAAD research fellowship for Ph.D. students and young scientists 50015537; and Russian Foundation for Basic Research (RFBR) Grant 15-04-02583a. The authors declare that they have no conflicts of interest with the contents of this article.	ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blencke HM, 2006, ARCH MICROBIOL, V185, P136, DOI 10.1007/s00203-005-0078-0; Brown SW, 1996, J BACTERIOL, V178, P2450, DOI 10.1128/jb.178.8.2450-2454.1996; Commichau FM, 2008, J BACTERIOL, V190, P3557, DOI 10.1128/JB.00099-08; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; DEUEL TF, 1974, J BIOL CHEM, V249, P257; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Fedorova K, 2013, FEBS LETT, V587, P1293, DOI 10.1016/j.febslet.2013.03.015; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Forchhammer K, 2016, FEBS J, V283, P425, DOI 10.1111/febs.13584; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Hart DJ, 1999, NUCLEIC ACIDS RES, V27, P1063, DOI 10.1093/nar/27.4.1063; Heinrich A, 2006, J BIOL CHEM, V281, P34909, DOI 10.1074/jbc.M607582200; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Kayumov A, 2011, FEBS J, V278, P1779, DOI 10.1111/j.1742-4658.2011.08102.x; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; MARTINVERSTRAETE I, 1994, J MOL BIOL, V241, P178, DOI 10.1006/jmbi.1994.1487; Matos RG, 2010, PROTEIN J, V29, P394, DOI 10.1007/s10930-010-9265-1; MEEK TD, 1980, BIOCHEMISTRY-US, V19, P5513, DOI 10.1021/bi00565a008; Mirouze N, 2015, MICROBIOLOGYOPEN, V4, P423, DOI 10.1002/mbo3.249; Murray DS, 2013, J BIOL CHEM, V288, P35801, DOI 10.1074/jbc.M113.519496; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; SAXILD HH, 1987, J BACTERIOL, V169, P2977, DOI 10.1128/jb.169.7.2977-2983.1987; Schumacher MA, 2015, GENE DEV, V29, P451, DOI 10.1101/gad.254714.114; Stevenson CEM, 2013, NUCLEIC ACIDS RES, V41, P7009, DOI 10.1093/nar/gkt523; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; WEDLER FC, 1976, J BIOL CHEM, V251, P7530; Wray LV, 2008, MOL MICROBIOL, V68, P277, DOI 10.1111/j.1365-2958.2008.06162.x; Wray LV, 2007, J BACTERIOL, V189, P20, DOI 10.1128/JB.01238-06; Wray LV, 2010, J BACTERIOL, V192, P5018, DOI 10.1128/JB.00509-10; Wray LV, 2000, J MOL BIOL, V300, P29, DOI 10.1006/jmbi.2000.3846; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x	42	18	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3483	3495		10.1074/jbc.M115.680991	http://dx.doi.org/10.1074/jbc.M115.680991			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26635369	hybrid, Green Published			2022-12-28	WOS:000370854500029
J	Korneeva, NL; Song, AR; Gram, H; Edens, MA; Rhoads, RE				Korneeva, Nadejda L.; Song, Anren; Gram, Hermann; Edens, Mary Ann; Rhoads, Robert E.			Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5-Terminal Cap and Hairpin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation; eukaryotic translation initiation factor 4E (eIF4E); eukaryotic translation initiation factor 4G (eIF4G); mRNA; phosphorylation	INITIATION-FACTOR 4E; FACTOR 4G EIF4G; CELL-CYCLE PROGRESSION; ENTRY SITE; ENCEPHALOMYOCARDITIS VIRUS; DEPENDENT TRANSLATION; PHOSPHORYLATED EIF4E; SECONDARY STRUCTURE; BINDING PROTEIN; FACTOR EIF-4E	The MAPK-interacting kinases 1 and 2 (MNK1 and MNK2) are activated by extracellular signal-regulated kinases 1 and 2 (ERK1/2) or p38 in response to cellular stress and extracellular stimuli that include growth factors, cytokines, and hormones. Modulation of MNK activity affects translation of mRNAs involved in the cell cycle, cancer progression, and cell survival. However, the mechanism by which MNK selectively affects translation of these mRNAs is not understood. MNK binds eukaryotic translation initiation factor 4G (eIF4G) and phosphorylates the cap-binding protein eIF4E. Using a cell-free translation system from rabbit reticulocytes programmed with mRNAs containing different 5-ends, we show that an MNK inhibitor, CGP57380, affects translation of only those mRNAs that contain both a cap and a hairpin in the 5-UTR. Similarly, a C-terminal fragment of human eIF4G-1, eIF4G(1357-1600), which prevents binding of MNK to intact eIF4G, reduces eIF4E phosphorylation and inhibits translation of only capped and hairpin-containing mRNAs. Analysis of proteins bound to m(7)GTP-Sepharose reveals that both CGP and eIF4G(1357-1600) decrease binding of eIF4E to eIF4G. These data suggest that MNK stimulates translation only of mRNAs containing both a cap and 5-terminal RNA duplex via eIF4E phosphorylation, thereby enhancing the coupled cap-binding and RNA-unwinding activities of eIF4F.	[Korneeva, Nadejda L.; Edens, Mary Ann] Louisiana State Univ, Dept Emergency Med, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Korneeva, Nadejda L.; Song, Anren; Rhoads, Robert E.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Gram, Hermann] Novartis Inst Biomed Res, Forum 1, CH-4002 Basel, Switzerland; [Song, Anren] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Novartis; University of Texas System; University of Texas Health Science Center Houston	Korneeva, NL (corresponding author), BRI, F5-23 1501 Kings Hwy, Shreveport, LA 71130 USA.	nkorne@lsuhsc.edu			NIGMS, National Institutes of Health [2R01GM20818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant 2R01GM20818 (to R. E. R.). Hermann Gram is an employee and shareholder of Novartis AG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Adesso L, 2013, ONCOGENE, V32, P2848, DOI 10.1038/onc.2012.306; Altman JK, 2013, BLOOD, V121, P3675, DOI 10.1182/blood-2013-01-477216; Astanehe A, 2012, ONCOGENE, V31, P4434, DOI 10.1038/onc.2011.617; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Brown MC, 2014, J VIROL, V88, P13149, DOI 10.1128/JVI.01884-14; Brown MA, 2014, CURR CLIN IMAG, P88; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Byrd MP, 2002, MOL CELL BIOL, V22, P4499, DOI 10.1128/MCB.22.13.4499-4511.2002; Carroll M, 2013, J INTERF CYTOK RES, V33, P227, DOI 10.1089/jir.2012.0142; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Chrestensen CA, 2007, GENES CELLS, V12, P1133, DOI 10.1111/j.1365-2443.2007.01122.x; Chrestensen CA, 2007, J BIOL CHEM, V282, P4243, DOI 10.1074/jbc.M607368200; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Cuesta R, 2004, J VIROL, V78, P7707, DOI 10.1128/JVI.78.14.7707-7716.2004; Das F, 2013, J CELL PHYSIOL, V228, P1617, DOI 10.1002/jcp.24327; De Gregorio E, 1998, RNA, V4, P828, DOI 10.1017/S1355838298980372; Dobrikov M, 2011, MOL CELL BIOL, V31, P2947, DOI 10.1128/MCB.05589-11; Dobrikov MI, 2014, MOL CELL BIOL, V34, P439, DOI 10.1128/MCB.01046-13; Dyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074085; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Flynn A, 1996, EUR J BIOCHEM, V236, P40, DOI 10.1111/j.1432-1033.1996.00040.x; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Grudzien E, 2006, J BIOL CHEM, V281, P1857, DOI 10.1074/jbc.M509121200; Grzmil M, 2014, J CLIN INVEST, V124, P742, DOI 10.1172/JCI70198; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Jemielity J, 2003, RNA, V9, P1108, DOI 10.1261/rna.5430403; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Joshi Sonali, 2014, World J Biol Chem, V5, P321, DOI 10.4331/wjbc.v5.i3.321; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Korneeva NL, 2010, MOL CANCER RES, V8, P1571, DOI 10.1158/1541-7786.MCR-10-0091; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Landon AL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6413; Lawson SK, 2013, MOL CELL BIOL, V33, P127, DOI 10.1128/MCB.00695-12; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Lim S, 2013, P NATL ACAD SCI USA, V110, pE2298, DOI 10.1073/pnas.1301838110; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKendrick L, 2001, EUR J BIOCHEM, V268, P5375, DOI 10.1046/j.0014-2956.2001.02478.x; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Orton KC, 2004, J BIOL CHEM, V279, P38649, DOI 10.1074/jbc.M407337200; Paix A, 2011, DEV BIOL, V357, P211, DOI 10.1016/j.ydbio.2011.06.019; Panja D, 2014, CELL REP, V9, P1430, DOI 10.1016/j.celrep.2014.10.016; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PELLETIER J, 1987, BIOCHEM CELL BIOL, V65, P576, DOI 10.1139/o87-074; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ramalingam S, 2014, ONCOTARGET, V5, P530, DOI 10.18632/oncotarget.1528; RAY BK, 1985, J BIOL CHEM, V260, P7651; Ross G, 2006, J NEUROCHEM, V97, P79, DOI 10.1111/j.1471-4159.2006.03704.x; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shi Y, 2013, ONCOGENE, V32, P190, DOI 10.1038/onc.2012.43; Shi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094011; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stepinski J, 2001, RNA, V7, P1486; Svitkin YV, 2001, RNA, V7, P1743; Teo T, 2015, CANCER LETT, V357, P612, DOI 10.1016/j.canlet.2014.12.029; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Tschopp C., 2000, Molecular Cell Biology Research Communications, V3, P205, DOI 10.1006/mcbr.2000.0217; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; YAN RQ, 1992, J BIOL CHEM, V267, P23226; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08; Zhang Y, 2008, BIOCHEM BIOPH RES CO, V367, P54, DOI 10.1016/j.bbrc.2007.12.118; Zhao XH, 2003, J BIOL CHEM, V278, P4449, DOI 10.1074/jbc.M212393200; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220	106	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3455	3467		10.1074/jbc.M115.694190	http://dx.doi.org/10.1074/jbc.M115.694190			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668315	hybrid, Green Published			2022-12-28	WOS:000370854500027
J	Schumacher, MA; Zeng, WJ; Huang, KH; Tchorzewski, L; Janakiraman, A				Schumacher, Maria A.; Zeng, Wenjie; Huang, Kuo-Hsiang; Tchorzewski, Lukasz; Janakiraman, Anuradha			Structural and Functional Analyses Reveal Insights into the Molecular Properties of the Escherichia coli Z Ring Stabilizing Protein, ZapC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEINS; BACTERIAL CYTOKINESIS; CYTOSKELETAL PROTEIN; CRYSTAL-STRUCTURE; FTSZ; PROMOTES; ZIPA; GTP; IDENTIFICATION; BINDING	In Escherichia coli cell division is driven by the tubulin-like GTPase, FtsZ, which forms the cytokinetic Z-ring. The Z-ring serves as a dynamic platform for the assembly of the multiprotein divisome, which catalyzes membrane cleavage to create equal daughter cells. Several proteins effect FtsZ assembly, thereby providing spatiotemporal control over cell division. One important class of FtsZ interacting/regulatory proteins is the Z-ring-associated proteins, Zaps, which typically modulate Z-ring formation by increasing lateral interactions between FtsZ protofilaments. Strikingly, these Zap proteins show no discernable sequence similarity, suggesting that they likely harbor distinct structures and mechanisms. The 19.8-kDa ZapC in particular shows no homology to any known protein. To gain insight into ZapC function, we determined its structure to 2.15 angstrom and performed genetic and biochemical studies. ZapC is a monomer composed of two domains, an N-terminal alpha/beta region and a C-terminal twisted beta barrel-like domain. The structure contains two pockets, one on each domain. The N-domain pocket is lined with residues previously implicated to be important for ZapC function as an FtsZ bundler. The adjacent C-domain pocket contains a hydrophobic center surrounded by conserved basic residues. Mutagenesis analyses indicate that this pocket is critical for FtsZ binding. An extensive FtsZ binding surface is consistent with the fact that, unlike many FtsZ regulators, ZapC binds the large FtsZ globular core rather than C-terminal tail, and the presence of two adjacent pockets suggests possible mechanisms for ZapC-mediated FtsZ bundling.	[Schumacher, Maria A.; Zeng, Wenjie] Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,Box 3711, Durham, NC 27710 USA; [Huang, Kuo-Hsiang; Tchorzewski, Lukasz; Janakiraman, Anuradha] CUNY City Coll, Dept Biol, MR 526, New York, NY 10031 USA; [Huang, Kuo-Hsiang; Janakiraman, Anuradha] CUNY, Grad Ctr, New York, NY 10016 USA	Duke University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,Box 3711, Durham, NC 27710 USA.; Janakiraman, A (corresponding author), CUNY City Coll, Dept Biol, MR 526, New York, NY 10031 USA.	maria.schumacher@duke.edu; anuj@ccny.cuny.edu			National Institutes of Health [GM074815, 8G12MD007603-29]; National Science Foundation [MCB1158059]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants GM074815 (to M. A. S.) and 8G12MD007603-29 (NIMHD, for core facility support to CCNY). This work was also supported by National Science Foundation Grant MCB1158059 (to A. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhattacharya A, 2015, INT J BIOL MACROMOL, V81, P435, DOI 10.1016/j.ijbiomac.2015.08.030; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DeLano W.L, PYMOL MOL GRAPHICS S; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Espeli O, 2012, EMBO J, V31, P3198, DOI 10.1038/emboj.2012.128; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Marteyn BS, 2014, MBIO, V5, DOI 10.1128/mBio.00022-14; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Ortiz C., 2015, FEMS MICROBIOL REV; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Roach EJ, 2014, J BIOL CHEM, V289, P23276, DOI 10.1074/jbc.M114.561928; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsang MJ, 2015, CURR OPIN MICROBIOL, V24, P60, DOI 10.1016/j.mib.2015.01.002; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003	49	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2485	2498		10.1074/jbc.M115.697037	http://dx.doi.org/10.1074/jbc.M115.697037			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26655719	Green Published, hybrid			2022-12-28	WOS:000369610400036
J	Woodfolk, JA; Glesner, J; Wright, PW; Kepley, CL; Li, M; Himly, M; Muehling, LM; Gustchina, A; Wlodawer, A; Chapman, MD; Pomes, A				Woodfolk, Judith A.; Glesner, Jill; Wright, Paul W.; Kepley, Christopher L.; Li, Mi; Himly, Martin; Muehling, Lyndsey M.; Gustchina, Alla; Wlodawer, Alexander; Chapman, Martin D.; Pomes, Anna			Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOUSE-DUST MITE; FLUORESCENT MULTIPLEX ARRAY; SITE-DIRECTED MUTAGENESIS; HUMAN IGE ANTIBODIES; AMINO-ACID-RESIDUES; B-CELL EPITOPES; RECOMBINANT ALLERGENS; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-E; GRASS-POLLEN	Bla g 2 is a major indoor cockroach allergen associated with the development of asthma. Antigenic determinants on Bla g 2 were analyzed by mutagenesis based on the structure of the allergen alone and in complex with monoclonal antibodies that interfere with IgE antibody binding. The structural analysis revealed mechanisms of allergen-antibody recognition through cation-pi interactions. Single and multiple Bla g 2 mutants were expressed in Pichia pastoris and purified. The triple mutant K132A/K251A/F162Y showed an similar to 100-fold reduced capacity to bind IgE, while preserving the native molecular fold, as proven by x-ray crystallography. This mutant was still able to induce mast cell release. T-cell responses were assessed by analyzing Th1/Th2 cytokine production and the CD4(+) T-cell phenotype in peripheral blood mononuclear cell cultures. Although T-cell activating capacity was similar for the KKF mutant and Bla g 2 based on CD25 expression, the KKF mutant was a weaker inducer of the Th2 cytokine IL-13. Furthermore, this mutant induced IL-10 from a non-T-cell source at higher levels that those induced by Bla g 2. Our findings demonstrate that a rational design of site-directed mutagenesis was effective in producing a mutant with only 3 amino acid substitutions that maintained the same fold as wild type Bla g 2. These residues, which were involved in IgE antibody binding, endowed Bla g 2 with a T-cell modulatory capacity. The antigenic analysis of Bla g 2 will be useful for the subsequent development of recombinant allergen vaccines.	[Woodfolk, Judith A.; Wright, Paul W.; Muehling, Lyndsey M.] Univ Virginia, Dept Med, Div Allergy, Charlottesville, VA 22903 USA; [Glesner, Jill; Chapman, Martin D.; Pomes, Anna] INDOOR Biotechnol Inc, 700 Harris St, Charlottesville, VA 22908 USA; [Kepley, Christopher L.] Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27401 USA; [Li, Mi; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Li, Mi] Leidos Biomed Res Inc, Frederick Natl Lab, Basic Sci Program, Frederick, MD 21702 USA; [Himly, Martin] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	University of Virginia; INDOOR Biotechnologies; University of North Carolina; University of North Carolina Greensboro; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salzburg University	Pomes, A (corresponding author), INDOOR Biotechnol Inc, 700 Harris St, Charlottesville, VA 22908 USA.	apomes@inbio.com	Pomés, Anna/H-7010-2019; Himly, Martin/D-1568-2015	Pomés, Anna/0000-0002-8729-1829; Chapman, Martin/0000-0002-0845-3632; Muehling, Lyndsey/0000-0003-3203-3264; Himly, Martin/0000-0001-5416-085X	National Institutes of Health from NIAID [R01AI077653, R01AI77653-01A2S1]; Intramural Research Program of the National Institutes of Health, NCI Center for Cancer Research; National Institutes of Health from NCI [HHSN26120080001E]; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI077653] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the National Institutes of Health, NCI Center for Cancer Research; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI077653 and R01AI77653-01A2S1 from NIAID, in part by the Intramural Research Program of the National Institutes of Health, NCI Center for Cancer Research, and in part by National Institutes of Health Contract HHSN26120080001E from NCI. M. D. C is a co-owner and has a financial interest in Indoor Biotechnologies, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Health and Human Services.	Arruda LK, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0428-6; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; BERNTON HS, 1964, J ALLERGY, V35, P506, DOI 10.1016/0021-8707(64)90082-6; Cheng TT, 2008, BIOCHEM BIOPH RES CO, V375, P671, DOI 10.1016/j.bbrc.2008.08.097; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Cong YJ, 2013, J DAIRY SCI, V96, P6870, DOI 10.3168/jds.2013-6880; Davies JM, 2004, CLIN EXP ALLERGY, V34, P429, DOI 10.1111/j.1365-2222.2004.01900.x; DeLano W.L, PYMOL MOL GRAPHICS S; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Flicker S, 2006, J ALLERGY CLIN IMMUN, V117, P1336, DOI 10.1016/j.jaci.2006.02.012; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Glesner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022223; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; GREENE WK, 1991, J IMMUNOL, V147, P3768; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Hulse KE, 2010, J ALLERGY CLIN IMMUN, V125, P247, DOI 10.1016/j.jaci.2009.10.027; Huss K, 2001, J ALLERGY CLIN IMMUN, V107, P48, DOI 10.1067/mai.2001.111146; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kepley CL, 2005, INT ARCH ALLERGY IMM, V138, P29, DOI 10.1159/000087355; Kepley CL, 2004, J BIOL CHEM, V279, P35139, DOI 10.1074/jbc.M404318200; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Lee MF, 2012, ANN ALLERG ASTHMA IM, V108, P243, DOI 10.1016/j.anai.2012.01.014; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Lin J, 2012, J ALLERGY CLIN IMMUN, V129, P1321, DOI 10.1016/j.jaci.2012.02.012; Linhart B, 2004, INT ARCH ALLERGY IMM, V134, P324, DOI 10.1159/000079535; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; Lustrek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078605; Mao Jian-hua, 2004, Zhejiang Da Xue Xue Bao Yi Xue Ban, V33, P155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLLER BK, 1990, FEBS LETT, V276, P59, DOI 10.1016/0014-5793(90)80506-E; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Page K, 2008, J IMMUNOL, V180, P6317, DOI 10.4049/jimmunol.180.9.6317; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Roulias A, 2014, ALLERGY, V69, P208, DOI 10.1111/all.12306; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Smith AM, 1998, J ALLERGY CLIN IMMUN, V101, P423, DOI 10.1016/S0091-6749(98)70259-3; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Takai T, 1997, NAT BIOTECHNOL, V15, P754, DOI 10.1038/nbt0897-754; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P846, DOI 10.1016/j.jaci.2013.08.047; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024; Zhang GL, 2011, J IMMUNOL METHODS, V374, P53, DOI 10.1016/j.jim.2010.11.009	56	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2288	2301		10.1074/jbc.M115.702324	http://dx.doi.org/10.1074/jbc.M115.702324			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644466	Green Published, hybrid			2022-12-28	WOS:000369610400019
J	Hong, CF; Lin, SY; Chou, YT; Wu, CW				Hong, Chun-Fu; Lin, Shu-Yu; Chou, Yu-Ting; Wu, Cheng-Wen			MicroRNA-7 Compromises p53 Protein-dependent Apoptosis by Controlling the Expression of the Chromatin Remodeling Factor SMARCD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; DRUG-RESISTANCE; CLIP-SEQ; CHEMOTHERAPY; COMPLEX; BAF60A; GROWTH; RNAS; CHEMORESISTANCE; ADENOCARCINOMA	We previously demonstrated that the epidermal growth factor receptor (EGFR) up-regulated miR-7 to promote tumor growth during lung cancer oncogenesis. Several lines of evidence have suggested that alterations in chromatin remodeling components contribute to cancer initiation and progression. In this study, we identified SMARCD1 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 1) as a novel target gene of miR-7. miR-7 expression reduced SMARCD1 protein expression in lung cancer cell lines. We used luciferase reporters carrying wild type or mutated 3'UTR of SMARCD1 and found that miR-7 blocked SMARCD1 expression by binding to two seed regions in the 3'UTR of SMARCD1 and down-regulated SMARCD1 mRNA expression. Additionally, upon chemotherapy drug treatment, miR-7 downregulated p53-dependent apoptosis-related gene BAX (BCL2-associated X protein) and p21 expression by interfering with the interaction between SMARCD1 and p53, thereby reducing caspase3 cleavage and the downstream apoptosis cascades. We found that although SMARCD1 sensitized lung cancer cells to chemotherapy drug-induced apoptosis, miR-7 enhanced the drug resistance potential of lung cancer cells against chemotherapy drugs. SMARCD1 was down-regulated in patients with non-small cell lung cancer and lung adenocarcinoma cell lines, and SMARCD1 and miR-7 expression levels were negatively correlated in clinical samples. Our investigation into the involvement of the EGFR-regulated microRNA pathway in the SWI/SNF chromatin remodeling complex suggests that EGFR-mediated miR-7 suppresses the coupling of the chromatin remodeling factor SMARCD1 with p53, resulting in increased chemo-resistance of lung cancer cells.	[Hong, Chun-Fu] Natl Quemoy Univ, Dept Long Term Care, Jinning Township 89250, Kinmen County, Taiwan; [Lin, Shu-Yu] Acad Sinica, Inst Biol Chem, Natl Res Program Genom Med Core Facil Prote & Gly, Taipei 11529, Taiwan; [Chou, Yu-Ting] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Wu, Cheng-Wen] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan; [Wu, Cheng-Wen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Wu, Cheng-Wen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan; [Wu, Cheng-Wen] Acad Sinica, Inst Biomed Sci, Taipei 11221, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chou, YT (corresponding author), Natl Tsing Hua Univ, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.; Wu, CW (corresponding author), Natl Yang Ming Univ, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	ytchou@life.nthu.edu.tw; cwwu@ym.edu.tw	lin, shuyu/GRF-5383-2022		Ministry of Science and Technology [MOST 104-2321-B-010-007, MOST 104-2325-B-010-003]; Ministry of Health and Welfare, Taiwan [MOHW104- TDU-B-211-124-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare, Taiwan	This work was supported by Ministry of Science and Technology Grants MOST 104-2321-B-010-007 and MOST 104-2325-B-010-003 and Ministry of Health and Welfare Grant MOHW104- TDU-B-211-124-001, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida GM, 2008, INT J CANCER, V122, P1810, DOI 10.1002/ijc.23188; Cortes AA, 2015, TRANSL LUNG CANCER R, V4, P191, DOI 10.3978/j.issn.2218-6751.2014.06.01; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Chang A, 2011, LUNG CANCER, V71, P3, DOI 10.1016/j.lungcan.2010.08.022; Chang GC, 2008, EUR J PHARMACOL, V600, P37, DOI 10.1016/j.ejphar.2008.10.024; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meza-Sosa KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103987; MIYASHITA T, 1995, CELL, V80, P293; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Reisman DN, 2003, CANCER RES, V63, P560; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sanchez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065671; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shanker M, 2010, LUNG CANCER-TARGETS, V1, P23; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sturm I, 2003, CELL DEATH DIFFER, V10, P477, DOI 10.1038/sj.cdd.4401194; Wu Shun-Quan, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P1056; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056	36	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1877	1889		10.1074/jbc.M115.667568	http://dx.doi.org/10.1074/jbc.M115.667568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26542803	hybrid, Green Published			2022-12-28	WOS:000368620700027
J	Ludolphs, M; Schneeberger, D; Soykan, T; Schafer, J; Papadopoulos, T; Brose, N; Schindelin, H; Steinem, C				Ludolphs, Michaela; Schneeberger, Daniela; Soykan, Tolga; Schaefer, Jonas; Papadopoulos, Theofilos; Brose, Nils; Schindelin, Hermann; Steinem, Claudia			Specificity of Collybistin-Phosphoinositide Interactions: IMPACT OF THE INDIVIDUAL PROTEIN DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; inositol phospholipid; lipid bilayer; lipid-protein interaction; membrane function	PLECKSTRIN HOMOLOGY DOMAINS; SOLID SUPPORTED MEMBRANES; PLASMA-MEMBRANE; PH-DOMAIN; INOSITOL PHOSPHATES; CDC42 ACTIVATION; STRUCTURAL BASIS; EXCHANGE FACTOR; HIGH-AFFINITY; BINDING	The regulatory protein collybistin (CB) recruits the receptor-scaffolding protein gephyrin to mammalian inhibitory glycinergic and GABAergic postsynaptic membranes in nerve cells. CB is tethered to the membrane via phosphoinositides. We developed an in vitro assay based on solid-supported 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine membranes doped with different phosphoinositides on silicon/silicon dioxide substrates to quantify the binding of various CB2 constructs using reflectometric interference spectroscopy. Based on adsorption isotherms, we obtained dissociation constants and binding capacities of the membranes. Our results show that full-length CB2 harboring the N-terminal Src homology 3 (SH3) domain (CB2(SH3+)) adopts a closed and autoinhibited conformation that largely prevents membrane binding. This autoinhibition is relieved upon introduction of the W24A/E262A mutation, which conformationally opens CB2(SH3+) and allows the pleckstrin homology domain to properly bind lipids depending on the phosphoinositide species with a preference for phosphatidylinositol 3-monophosphate and phosphatidylinositol 4-monophosphate. This type of membrane tethering under the control of the release of the SH3 domain of CB is essential for regulating gephyrin clustering.	[Ludolphs, Michaela; Schaefer, Jonas; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Schneeberger, Daniela; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Soykan, Tolga; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Papadopoulos, Theofilos] Univ Med Gottingen, Dept Mol Biol, D-37073 Gottingen, Germany	University of Gottingen; University of Wurzburg; Max Planck Society; University of Gottingen	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.	csteine@gwdg.de	Schindelin, Hermann/Q-2697-2019; Steinem, Claudia/O-4801-2019; Steinem, Claudia/K-7534-2018	Steinem, Claudia/0000-0001-8778-9283; Papadopoulos, Theofilos/0000-0002-0684-2407	Max Planck Society; German Research Foundation (a Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant); German Research Foundation [PA 2087/1-1, SCHI 425/8-1]; Rudolf Virchow Center for Experimental Biomedicine; European Commission Innovative Medicines Initiative [FP7-115300]	Max Planck Society(Max Planck Society); German Research Foundation (a Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant); German Research Foundation(German Research Foundation (DFG)); Rudolf Virchow Center for Experimental Biomedicine; European Commission Innovative Medicines Initiative	This work was supported by the Max Planck Society (to N. B.), the German Research Foundation (a Center of Nanoscale Microscopy and Molecular Physiology of the Brain grant (to N. B.) and Grants PA 2087/1-1 (to T. P.) and SCHI 425/8-1 (to H. S.)) as well as funding through the Rudolf Virchow Center for Experimental Biomedicine (to H. S.), and European Commission Innovative Medicines Initiative FP7-115300 (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Braunger JA, 2013, LANGMUIR, V29, P14204, DOI 10.1021/la402646k; Busse RA, 2013, AUTOPHAGY, V9, P770, DOI 10.4161/auto.23978; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Faiss S, 2008, BBA-BIOMEMBRANES, V1778, P1601, DOI 10.1016/j.bbamem.2008.01.003; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Ferguson CG, 2005, BIOCONJUGATE CHEM, V16, P1475, DOI 10.1021/bc050197q; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fernandes F, 2006, J LIPID RES, V47, P1521, DOI 10.1194/jlr.M600121-JLR200; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; GAUGLITZ G, 1993, SENSOR ACTUAT B-CHEM, V11, P21, DOI 10.1016/0925-4005(93)85234-2; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kuerka N., 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI DOI 10.1016/J.BBAMEM.2011.07.022; Larson I, 2000, J COLLOID INTERF SCI, V227, P152, DOI 10.1006/jcis.2000.6847; Latour RA, 2015, J BIOMED MATER RES A, V103, P949, DOI 10.1002/jbm.a.35235; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Mayer S, 2013, P NATL ACAD SCI USA, V110, P20795, DOI 10.1073/pnas.1309078110; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos T, 2015, J BIOL CHEM, V290, P8256, DOI 10.1074/jbc.M114.633024; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Proll Guenther, 2009, V503, P167, DOI 10.1007/978-1-60327-567-5_8; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Roth G, 2007, CHEMBIOCHEM, V8, P323, DOI 10.1002/cbic.200600254; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Schutte OM, 2015, BIOPHYS J, V108, P2775, DOI 10.1016/j.bpj.2015.05.009; Soykan T, 2014, EMBO J, V33, P2113, DOI 10.15252/embj.201488143; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stephan M, 2014, ANALYST, V139, P1987, DOI 10.1039/c4an00009a; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Vilardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085033; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019	52	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					244	254		10.1074/jbc.M115.673400	http://dx.doi.org/10.1074/jbc.M115.673400			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26546675	Green Published, hybrid			2022-12-28	WOS:000367589500019
J	Liu, RP; Li, XJY; Qiang, XY; Luo, L; Hylemon, PB; Jiang, ZZ; Zhang, LY; Zhou, HP				Liu, Runping; Li, Xiaojiaoyang; Qiang, Xiaoyan; Luo, Lan; Hylemon, Phillip B.; Jiang, Zhenzhou; Zhang, Luyong; Zhou, Huiping			Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BILE-ACIDS ACTIVATE; NF-KAPPA-B; COX-2 EXPRESSION; INTRAHEPATIC CHOLANGIOCARCINOMA; INDUCTION; PATHWAY; CANCER; PATHOGENESIS; INVOLVEMENT	Cholangiocarcinoma (CCA) is a rare, but highly malignant primary hepatobiliary cancer with a very poor prognosis and limited treatment options. Our recent studies reported that conjugated bile acids (CBAs) promote the invasive growth of CCA via activation of sphingosine 1-phosphate receptor 2 (S1PR2). Cyclooxygenase-2 (COX-2)-derived prostaglandin E-2 (PGE(2)) is the most abundant prostaglandin in various human malignancies including CCA. Previous studies have indicated that COX-2 was highly expressed in CCA tissues, and the survival rate of CCA patients was negatively associated with high COX-2 expression levels. It has also been reported that CBAs induce COX-2 expression, whereas free bile acids inhibit COX-2 expression in CCA mouse models. However, the underlying cellular mechanisms and connection between S1PR2 and COX-2 expression in CCA cells have still not been fully elucidated. In the current study, we examined the role of S1PR2 in conjugated bile acid (taurocholate, (TCA))-induced COX-2 expression in a human HuCCT1 CCA cell line and further identified the potential underlying cellular mechanisms. The results indicated that TCA-induced invasive growth of human CCA cells was correlated with S1PR2-medated up-regulation of COX-2 expression and PGE(2) production. Inhibition of S1PR2 activation with chemical antagonist (JTE-013) or down-regulation of S1PR2 expression with gene-specific shRNA not only reduced COX-2 expression, but also inhibited TCA-induced activation of EGFR and the ERK1/2/Akt-NF-kappa B signaling cascade. In conclusion, S1PR2 plays a critical role in TCA-induced COX-2 expression and CCA growth and may represent a novel therapeutic target for CCA.	[Liu, Runping; Li, Xiaojiaoyang; Qiang, Xiaoyan; Jiang, Zhenzhou; Zhang, Luyong] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Runping; Qiang, Xiaoyan; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Luo, Lan; Jiang, Zhenzhou; Zhang, Luyong] Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing 210009, Jiangsu, Peoples R China; [Hylemon, Phillip B.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	China Pharmaceutical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Jiang, ZZ (corresponding author), China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing 210009, Jiangsu, Peoples R China.	beaglejiang@cpu.edu.cn; lyzhang@cpu.edu.cn; hzhou@vcu.edu	Regan, Clinton/E-6250-2012; Zhou, Huiping/J-3639-2015; Zhou, Huiping/H-6875-2019; Li, Xiaojiaoyang/CAG-6603-2022	Zhou, Huiping/0000-0002-0050-372X; Li, Xiaojiaoyang/0000-0003-0291-5856	National Natural Science Foundation of China [81320108029, 81070245, 81270489]; China National 12th Five-year Plan "Major Project of Science and Technologies for Significant Drug Discovery" [2012Z X09504001-001]; National Institutes of Health [R01 DK-057543]; Veterans Affairs Merit Awards; Virginia Commonwealth University Massey Cancer Pilot [A35362]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National 12th Five-year Plan "Major Project of Science and Technologies for Significant Drug Discovery"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); Virginia Commonwealth University Massey Cancer Pilot; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grants 81320108029 (to L. Z.), 81070245 and 81270489 (to H. Z.), China National 12th Five-year Plan "Major Project of Science and Technologies for Significant Drug Discovery" Grant 2012Z X09504001-001 (to L. Z.), National Institutes of Health Grant R01 DK-057543 (to P. B. H. and H. Z.), Veterans Affairs Merit Awards (to H. Z.), and Virginia Commonwealth University Massey Cancer Pilot Grant A35362 (to H. Z.). The authors declare no competing financial interest with the contents of this article.	Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Aishima S, 2013, HUM PATHOL, V44, P1031, DOI 10.1016/j.humpath.2012.09.004; Al-Bahrani R, 2013, ANN CLIN LAB SCI, V43, P195; Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; Amonyingcharoen S, 2015, INT J ONCOL, V46, P2317, DOI 10.3892/ijo.2015.2939; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Bocca C, 2014, EXPERT OPIN THER TAR, V18, P121, DOI 10.1517/14728222.2014.860447; Dai JQ, 2013, CANCER INVEST, V31, P111, DOI 10.3109/07357907.2012.762781; Dai JQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-41; Eo SH, 2014, EXP THER MED, V7, P640, DOI 10.3892/etm.2014.1484; Fukazawa EM, 2014, INT J GYNECOL PATHOL, V33, P225, DOI 10.1097/PGP.0b013e318290405a; Generali D, 2014, BRIT J CANCER, V111, P46, DOI 10.1038/bjc.2014.236; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Ghouri Yezaz Ahmed, 2015, J Carcinog, V14, P1, DOI 10.4103/1477-3163.151940; Glinghammar B, 2002, CARCINOGENESIS, V23, P839, DOI 10.1093/carcin/23.5.839; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; Han C, 2004, CANCER RES, V64, P1369, DOI 10.1158/0008-5472.CAN-03-1086; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishii Y, 2013, INT J ONCOL, V43, P1073, DOI 10.3892/ijo.2013.2038; Jongthawin J, 2014, TUMOR BIOL, V35, P8051, DOI 10.1007/s13277-014-2021-y; Jusakul A, 2012, ASIAN PAC J CANCER P, V13, P77, DOI 10.7314/APJCP.2012.13.KKSuppl.77; Kiguchi K, 2014, J HEPATO-BIL-PAN SCI, V21, P371, DOI 10.1002/jhbp.66; Kim HG, 2015, ARCH TOXICOL, V89, P2039, DOI 10.1007/s00204-014-1359-7; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Lozano E, 2014, MOL CANCER RES, V12, P91, DOI 10.1158/1541-7786.MCR-13-0503; Ma YZ, 2014, J CARDIOVASC PHARM, V64, P28, DOI 10.1097/FJC.0000000000000086; Martinez ON, 2003, MED CLIN-BARCELONA, V121, P743, DOI 10.1016/S0025-7753(03)74082-2; Mathema Vivek Bhakta, 2015, Asian Pac J Cancer Prev, V16, P1307; Mercau ME, 2014, MOL CELL ENDOCRINOL, V384, P43, DOI 10.1016/j.mce.2014.01.007; Nzeako UC, 2002, HEPATOLOGY, V35, P552, DOI 10.1053/jhep.2002.31774; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Rizvi S, 2014, DIGEST DIS, V32, P564, DOI 10.1159/000360502; Roelle S, 2003, J BIOL CHEM, V278, P47307, DOI 10.1074/jbc.M304377200; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Sirica AE, 2002, SEMIN LIVER DIS, V22, P303, DOI 10.1055/s-2002-34507; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Sun B, 2013, MOL CELL BIOCHEM, V378, P195, DOI 10.1007/s11010-013-1610-1; Surh I, 2011, MOL CARCINOGEN, V50, P458, DOI 10.1002/mc.20730; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Wu T, 2005, BBA-REV CANCER, V1755, P135, DOI 10.1016/j.bbcan.2005.04.002; Xia XF, 2006, WORLD J GASTROENTERO, V12, P3553, DOI 10.3748/wjg.v12.i22.3553; Yeh CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069928; Yoon JH, 2002, GASTROENTEROLOGY, V122, P985, DOI 10.1053/gast.2002.32410; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhang L, 2007, MOL CELL BIOCHEM, V305, P19, DOI 10.1007/s11010-007-9523-5	48	46	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30988	31002		10.1074/jbc.M115.668277	http://dx.doi.org/10.1074/jbc.M115.668277			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26518876	hybrid, Green Published			2022-12-28	WOS:000367199000029
J	Nesan, D; Tavallaee, G; Koh, D; Bashiri, A; Abdin, R; Ng, DS				Nesan, Dinushan; Tavallaee, Ghazaleh; Koh, Deborah; Bashiri, Amir; Abdin, Rawand; Ng, Dominic S.			Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency Promotes Differentiation of Satellite Cells to Brown Adipocytes in a Cholesterol-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; LECITHIN/CHOLESTEROL ACYLTRANSFERASE; GENE-EXPRESSION; NULL MICE; FAT; METABOLISM; PRDM16; HUMANS; BEIGE; ATHEROSCLEROSIS	Our laboratory previously reported that lecithin: cholesterol acyltransferase (LCAT) and LDL receptor double knock-out mice (Ldlr(-/-) xLcat(-/-) or DKO) spontaneously develop functioning ectopic brown adipose tissue (BAT) in skeletal muscle, putatively contributing to protection from the diet-induced obesity phenotype. Here we further investigated their developmental origin and the mechanistic role of LCAT deficiency. Gene profiling of skeletal muscle in DKO newborns and adults revealed a classical lineage. Primary quiescent satellite cells (SC) from chow-fed DKO mice, not in Ldlr(-/-) xLcat(-/-) single-knock-out (SKO) or C57BL/6 wild type, were found to (i) express exclusively classical BAT-selective genes, (ii) be primed to express key functional BAT genes, and (iii) exhibit markedly increased ex vivo adipogenic differentiation into brown adipocytes. This gene priming effect was abrogated upon feeding the mice a 2% high cholesterol diet in association with accumulation of excess intracellular cholesterol. Ex vivo cholesterol loading of chow-fed DKO SC recapitulated the effect, indicating that cellular cholesterol is a key regulator of SC-to-BAT differentiation. Comparing adipogenicity of Ldlr(-/-) xLcat(-/-) (LCAT-KO) SC with DKO SC identified a role for LCAT deficiency in priming SC to express BAT genes. Additionally, we found that reduced cellular cholesterol is important for adipogenic differentiation, evidenced by increased induction of adipogenesis in cholesterol-depleted SC from both LCAT-KO and SKO mice. Taken together, we conclude that ectopic BAT in DKO mice is classical in origin, and its development begins in utero. Wefurther showed complementary roles of LCAT deficiency and cellular cholesterol reduction in the SC-to-BAT adipogenesis.	[Nesan, Dinushan; Tavallaee, Ghazaleh; Koh, Deborah; Bashiri, Amir; Abdin, Rawand; Ng, Dominic S.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Med, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Nesan, Dinushan; Bashiri, Amir; Ng, Dominic S.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Ng, Dominic S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Ng, DS (corresponding author), St Michaels Hosp, Keenan Res Ctr, 30 Bond St,Shuter Wing 3-041, Toronto, ON M5B 1W8, Canada.	ngd@smh.ca	Bashiri, Amir/ABB-8712-2021		Banting & Best Diabetes Centre Fellowship in Diabetes Care - Eli Lilly; Banting & Best Diabetes Centre Fellowship in Diabetes Care - Boehringer Ingelheim; Canadian Institutes of Health Research [MOP 275369]	Banting & Best Diabetes Centre Fellowship in Diabetes Care - Eli Lilly; Banting & Best Diabetes Centre Fellowship in Diabetes Care - Boehringer Ingelheim; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Banting & Best Diabetes Centre Fellowship in Diabetes Care (funded by Eli Lilly and Boehringer Ingelheim) (to D. N.) and Canadian Institutes of Health Research Operating Grant MOP 275369 (to D. S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200; Cereijo R, 2015, ANN MED, V47, P169, DOI 10.3109/07853890.2014.952328; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Danoviz ME, 2012, METHODS MOL BIOL, V798, P21, DOI 10.1007/978-1-61779-343-1_2; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Elattar S, 2015, J CELL PHYSIOL, V230, P2311, DOI 10.1002/jcp.24986; Hager L, 2012, J BIOL CHEM, V287, P20755, DOI 10.1074/jbc.M112.340919; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kang MH, 2013, ARTERIOSCL THROM VAS, V33, P2724, DOI 10.1161/ATVBAHA.113.302004; Kavanagh K, 2009, ARTERIOSCL THROM VAS, V29, P1471, DOI 10.1161/ATVBAHA.109.191825; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez D, 2002, ENDOCRINOLOGY, V143, P2155, DOI 10.1210/en.143.6.2155; Lynes MD, 2014, P NATL ACAD SCI USA, V111, P14318, DOI 10.1073/pnas.1416145111; Machado RM, 2012, ATHEROSCLEROSIS, V224, P66, DOI 10.1016/j.atherosclerosis.2012.06.059; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Ng DS, 2012, BBA-MOL CELL BIOL L, V1821, P654, DOI 10.1016/j.bbalip.2011.12.012; Ng DS, 1997, J BIOL CHEM, V272, P15777, DOI 10.1074/jbc.272.25.15777; Nikolaou S, 2011, J BONE JOINT SURG AM, V93A, P461, DOI 10.2106/JBJS.J.00943; Oosthuyse T, 2012, CURR OPIN PHARMACOL, V12, P363, DOI 10.1016/j.coph.2012.02.008; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Song H, 2006, AM J PHYSIOL-ENDOC M, V290, pE17, DOI 10.1152/ajpendo.00597.2004; Subramanian VS, 1999, BBA-MOL CELL BIOL L, V1439, P95, DOI 10.1016/S1388-1981(99)00072-4; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595	36	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30514	30529		10.1074/jbc.M115.676056	http://dx.doi.org/10.1074/jbc.M115.676056			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26494623	Green Published, hybrid			2022-12-28	WOS:000366738200027
J	Gunn, AP; Wong, BX; Johanssen, T; Griffith, JC; Masters, CL; Bush, AI; Barnham, KJ; Duce, JA; Cherny, RA				Gunn, Adam P.; Wong, Bruce X.; Johanssen, Timothy; Griffith, James C.; Masters, Colin L.; Bush, Ashley I.; Barnham, Kevin J.; Duce, James A.; Cherny, Robert A.			Amyloid- Peptide A3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (A); lipid peroxidation; oligomer; reactive oxygen species (ROS); dityrosine; pyroglutamate	PYROGLUTAMATE-A-BETA; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; GLUTAMINYL CYCLASE; TRANSGENIC MICE; BEHAVIORAL DEFICITS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MOUSE MODEL; IN-VITRO	Pyroglutamate-modified amyloid- (pE-A) is a highly neurotoxic amyloid- (A) isoform and is enriched in the brains of individuals with Alzheimer disease compared with healthy aged controls. Pyroglutamate formation increases the rate of A oligomerization and alters the interactions of A with Cu2+ and lipids; however, a link between these properties and the toxicity of pE-A peptides has not been established. We report here that A3pE-42 has an enhanced capacity to cause lipid peroxidation in primary cortical mouse neurons compared with the full-length isoform (A(1-42)). In contrast, A(1-42) caused a significant elevation in cytosolic reactive oxygen species, whereas A3pE-42 did not. We also report that A3pE-42 preferentially associates with neuronal membranes and triggers Ca2+ influx that can be partially blocked by the N-methyl-d-aspartate receptor antagonist MK-801. A3pE-42 further caused a loss of plasma membrane integrity and remained bound to neurons at significantly higher levels than A(1-42) over extended incubations. Pyroglutamate formation was additionally found to increase the relative efficiency of A-dityrosine oligomer formation mediated by copper-redox cycling.	[Gunn, Adam P.; Wong, Bruce X.; Masters, Colin L.; Bush, Ashley I.; Barnham, Kevin J.; Duce, James A.; Cherny, Robert A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Johanssen, Timothy; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Griffith, James C.] Univ Melbourne, Dept Mat Characterisat & Fabricat Platform, Melbourne, Vic 3010, Australia; [Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Leeds	Cherny, RA (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia.	rcherny@unimelb.edu.au	Gunn, Adam P/D-5437-2012; Wong, Bruce/AAY-5884-2020; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Johanssen, Timothy/G-6106-2014	Gunn, Adam P/0000-0002-8181-4975; Wong, Bruce/0000-0002-1687-4138; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Duce, James/0000-0002-8762-2245; Masters, Colin/0000-0003-3072-7940; Johanssen, Timothy/0000-0001-6757-586X; Griffith, James/0000-0002-4911-4223	National Health and Medical Research Council (NHMRC) of Australia [628946]; Senior Research Fellowship [APP1002373]; Australia Fellowship [GNT1037234]; Operational Infrastructure Support Grant from the Victorian Government; Alzheimers Research UK [ART-SRF2011-1] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowship; Australia Fellowship; Operational Infrastructure Support Grant from the Victorian Government; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Program Grant 628946 (to R. A. C., K. J. B., A. I. B., and C. L. M.), Senior Research Fellowship APP1002373 (to K. J. B.), Australia Fellowship GNT1037234 (to A. I. B.), and Operational Infrastructure Support Grant from the Victorian Government (to Florey Institute of Neuroscience and Mental Health). The authors declare that they have no conflicts of interest with the contents of this article.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Alies B, 2012, INORG CHEM, V51, P12988, DOI 10.1021/ic302097d; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; De Kimpe L, 2013, AGE, V35, P673, DOI 10.1007/s11357-012-9403-0; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Drew SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015875; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; Galante D, 2012, INT J BIOCHEM CELL B, V44, P2085, DOI 10.1016/j.biocel.2012.08.010; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Gillman AL, 2014, J PHYS CHEM B, V118, P7335, DOI 10.1021/jp5040954; Greilberger J, 2008, FREE RADICAL RES, V42, P633, DOI 10.1080/10715760802255764; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Guilloreau L, 2007, CHEMBIOCHEM, V8, P1317, DOI 10.1002/cbic.200700111; Gunn AP, 2012, METHODS MOL BIOL, V849, P3, DOI 10.1007/978-1-61779-551-0_1; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hensley K, 1998, J NEUROSCI, V18, P8126; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Kowalik-Jankowska T, 2004, J INORG BIOCHEM, V98, P940, DOI 10.1016/j.jinorgbio.2004.03.001; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee J, 2014, BIOCHEMISTRY-US, V53, P4704, DOI 10.1021/bi500587p; Mandler M, 2014, ACTA NEUROPATHOL, V128, P67, DOI 10.1007/s00401-014-1296-9; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; Mark RJ, 1997, J NEUROCHEM, V68, P255; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Morawski M, 2014, J ALZHEIMERS DIS, V39, P385, DOI 10.3233/JAD-131535; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Oberstein TJ, 2015, NEUROBIOL DIS, V73, P24, DOI 10.1016/j.nbd.2014.08.031; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Portelius E, 2015, NEURODEGENER DIS, V15, P50, DOI 10.1159/000369465; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Sanders HM, 2009, PEPTIDES, V30, P849, DOI 10.1016/j.peptides.2009.01.027; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Shirotani K, 2002, NEUROSCI LETT, V327, P25, DOI 10.1016/S0304-3940(02)00351-8; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Sullivan CP, 2011, NEUROSCI LETT, V505, P109, DOI 10.1016/j.neulet.2011.09.071; Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Takahashi M, 2001, FREE RADICAL BIO MED, V31, P164, DOI 10.1016/S0891-5849(01)00575-5; Tekirian TL, 1999, J NEUROCHEM, V73, P1584, DOI 10.1046/j.1471-4159.1999.0731584.x; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Watt AD, 2014, ACTA NEUROPATHOL, V127, P803, DOI 10.1007/s00401-014-1290-2; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; Wittnam JL, 2012, J BIOL CHEM, V287, P8154, DOI 10.1074/jbc.M111.308601; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005	71	61	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6134	6145		10.1074/jbc.M115.655183	http://dx.doi.org/10.1074/jbc.M115.655183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26697885	Green Published, hybrid			2022-12-28	WOS:000372894200008
J	Dunne, M; Leicht, S; Krichel, B; Mertens, HDT; Thompson, A; Krijgsveld, J; Svergun, DI; Gomez-Torres, N; Garde, S; Uetrecht, C; Narbad, A; Mayer, MJ; Meijers, R				Dunne, Matthew; Leicht, Stefan; Krichel, Boris; Mertens, Haydyn D. T.; Thompson, Andrew; Krijgsveld, Jeroen; Svergun, Dmitri I.; Gomez-Torres, Natalia; Garde, Sonia; Uetrecht, Charlotte; Narbad, Arjan; Mayer, Melinda J.; Meijers, Rob			Crystal Structure of the CTP1L Endolysin Reveals How Its Activity Is Regulated by a Secondary Translation Product	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; enzyme catalysis; mass spectrometry (MS); oligomerization; protein structure; Clostridia; antimicrobial; endolysin; native mass spectrometry; secondary translation	SMALL-ANGLE SCATTERING; OF-FLIGHT INSTRUMENT; BIOLOGICAL MACROMOLECULES; BACTERIOPHAGE ENDOLYSINS; CLOSTRIDIUM-PERFRINGENS; PROTEIN ASSEMBLIES; MASS-SPECTROMETRY; OVERLAPPING GENES; GENOMIC SEQUENCE; PHAGE	Bacteriophages produce endolysins, which lyse the bacterial host cell to release newly produced virions. The timing of lysis is regulated and is thought to involve the activation of a molecular switch. We present a crystal structure of the activated endolysin CTP1L that targets Clostridium tyrobutyricum, consisting of a complex between the full-length protein and an N-terminally truncated C-terminal cell wall binding domain (CBD). The truncated CBD is produced through an internal translation start site within the endolysin gene. Mutants affecting the internal translation site change the oligomeric state of the endolysin and reduce lytic activity. The activity can be modulated by reconstitution of the full-length endolysin-CBD complex with free CBD. The same oligomerization mechanism applies to the CD27L endolysin that targets Clostridium difficile and the CS74L endolysin that targets Clostridium sporogenes. When the CTP1L endolysin gene is introduced into the commensal bacterium Lactococcus lactis, the truncated CBD is also produced, showing that the alternative start codon can be used in other bacterial species. The identification of a translational switch affecting oligomerization presented here has implications for the design of effective endolysins for the treatment of bacterial infections.	[Dunne, Matthew; Mertens, Haydyn D. T.; Svergun, Dmitri I.; Meijers, Rob] European Mol Biol Lab, Notkestr 85, D-22607 Hamburg, Germany; [Leicht, Stefan; Krijgsveld, Jeroen] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Krichel, Boris; Uetrecht, Charlotte] Leibniz Inst Expt Virol, Heinrich Pette Inst, Martinistr 52, D-20251 Hamburg, Germany; [Thompson, Andrew] Synchrotron Soleil, BP 48, F-91192 Gif Sur Yvette, France; [Gomez-Torres, Natalia; Garde, Sonia] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Tecnol Alimentos, Carretera La Coruna Km 7, Madrid 28040, Spain; [Uetrecht, Charlotte] European XFEL GmbH, Notkestr 85, D-22607 Hamburg, Germany; [Narbad, Arjan; Mayer, Melinda J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Heinrich Pette Institute; SOLEIL Synchrotron; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); European XFEL; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Meijers, R (corresponding author), European Mol Biol Lab, Notkestr 85, D-22607 Hamburg, Germany.; Mayer, MJ (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.	melinda.mayer@ifr.ac.uk; r.meijers@embl-hamburg.de	Uetrecht, Charlotte/D-1883-2010; Dunne, Matthew/J-4751-2019; Krichel, Boris/GXH-3060-2022; Garde, Sonia/J-7994-2014	Uetrecht, Charlotte/0000-0002-1991-7922; Dunne, Matthew/0000-0002-2329-8183; Krichel, Boris/0000-0001-9667-0719; Gomez-Torres, Natalia/0000-0003-4279-2977; Meijers, Rob/0000-0003-2872-6279; Krijgsveld, Jeroen/0000-0001-7549-9326; Svergun, Dmitri/0000-0003-0830-5696; Garde, Sonia/0000-0002-5180-766X; Mertens, Haydyn/0000-0002-5664-744X	Spanish Ministry of Economy and Competitiveness Project [RTA 2011-00024-C02-01]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria grant; Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant [BB/J004529/1]; Leibniz Association Grant [SAW-2014-HPI-4]; EU FP7 e-Infrastructures Program, Grant WeNMR [261572]; BBSRC [BBS/E/F/00044453] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044453] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness Project(Spanish Government); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria grant; Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leibniz Association Grant; EU FP7 e-Infrastructures Program, Grant WeNMR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Spanish Ministry of Economy and Competitiveness Project RTA 2011-00024-C02-01 (to S. G.), an Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria grant (to N. G. T.), Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant BB/J004529/1 (to M. M. and A. N.), and Leibniz Association Grant SAW-2014-HPI-4 (to B. K. and C. U.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the EU FP7 e-Infrastructures Program, Grant WeNMR, Contract 261572.	Abaev I, 2013, APPL MICROBIOL BIOT, V97, P3449, DOI 10.1007/s00253-012-4252-4; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunne M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004228; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez A, 2009, APPL ENVIRON MICROB, V75, P869, DOI 10.1128/AEM.01728-08; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gervasi T, 2014, APPL MICROBIOL BIOT, V98, P2495, DOI 10.1007/s00253-013-5128-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuty GF, 2010, J BACTERIOL, V192, P5682, DOI 10.1128/JB.00674-10; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lorenzen K, 2007, INT J MASS SPECTROM, V268, P198, DOI 10.1016/j.ijms.2007.06.012; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; Mayer MJ, 2012, APPL ENVIRON MICROB, V78, P3685, DOI 10.1128/AEM.07884-11; Mayer MJ, 2011, J BACTERIOL, V193, P5477, DOI 10.1128/JB.00439-11; Mayer MJ, 2010, APPL ENVIRON MICROB, V76, P5415, DOI 10.1128/AEM.00989-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGowan S, 2012, P NATL ACAD SCI USA, V109, P12752, DOI 10.1073/pnas.1208424109; Morgner N, 2012, ANAL CHEM, V84, P2939, DOI 10.1021/ac300056a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nascimento JG, 2008, J BACTERIOL, V190, P457, DOI 10.1128/JB.01195-07; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Parreira R, 1999, GENE, V226, P83, DOI 10.1016/S0378-1119(98)00554-X; Polonio-Vallon T, 2014, CELL CYCLE, V13, P115, DOI 10.4161/cc.26857; Proenca D, 2015, MOL MICROBIOL, V95, P739, DOI 10.1111/mmi.12857; Rau A, 2001, J BIOL CHEM, V276, P31994, DOI 10.1074/jbc.M102591200; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Resch G, 2011, INT J ANTIMICROB AG, V38, P516, DOI 10.1016/j.ijantimicag.2011.08.009; Scherbakov DV, 2000, MOL BIOL+, V34, P485, DOI 10.1007/BF02759558; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]; SHEARMAN CA, 1994, APPL ENVIRON MICROB, V60, P3063, DOI 10.1128/AEM.60.9.3063-3073.1994; Sun QG, 2009, NAT STRUCT MOL BIOL, V16, P1192, DOI 10.1038/nsmb.1681; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; Tamai E, 2014, MOL MICROBIOL, V92, P326, DOI 10.1111/mmi.12559; Uetrecht C, 2011, ANGEW CHEM INT EDIT, V50, P8248, DOI 10.1002/anie.201008120; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008	49	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4882	4893		10.1074/jbc.M115.671172	http://dx.doi.org/10.1074/jbc.M115.671172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26683375	Green Published, hybrid			2022-12-28	WOS:000371640600004
J	An, B; Abbonante, V; Xu, HF; Gavriilidou, D; Yoshizumi, A; Bihan, D; Farndale, RW; Kaplan, DL; Balduini, A; Leitinger, B; Brodsky, B				An, Bo; Abbonante, Vittorio; Xu, Huifang; Gavriilidou, Despoina; Yoshizumi, Ayumi; Bihan, Dominique; Farndale, Richard W.; Kaplan, David L.; Balduini, Alessandra; Leitinger, Birgit; Brodsky, Barbara			Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PYOGENES; TYROSINE KINASES; TRIPLE-HELICES; PROTEIN; IDENTIFICATION; DDR2; PEPTIDES; SITES; STABILITY; CLEAVAGE	A bacterial collagen-like protein Scl2 has been developed as a recombinant collagen model system to host human collagen ligand-binding sequences, with the goal of generating biomaterials with selective collagen bioactivities. Defined binding sites in human collagen for integrins, fibronectin, heparin, and MMP-1 have been introduced into the triple-helical domain of the bacterial collagen and led to the expected biological activities. The modular insertion of activities is extended here to the discoidin domain receptors (DDRs), which are collagen-activated receptor tyrosine kinases. Insertion of the DDR-binding sequence from human collagen III into bacterial collagen led to specific receptor binding. However, even at the highest testable concentrations, the construct was unable to stimulate DDR autophosphorylation. The recombinant collagen expressed in Escherichia coli does not contain hydroxyproline (Hyp), and complementary synthetic peptide studies showed that replacement of Hyp by Pro at the critical Gly-Val-Met-Gly-Phe-Hyp position decreased the DDR-binding affinity and consequently required a higher concentration for the induction of receptor activation. The ability of the recombinant bacterial collagen to bind the DDRs without inducing kinase activation suggested it could interfere with the interactions between animal collagen and the DDRs, and such an inhibitory role was confirmed in vitro and with a cell migration assay. This study illustrates that recombinant collagen can complement synthetic peptides in investigating structure-activity relationships, and this system has the potential for the introduction or inhibition of specific biological activities.	[An, Bo; Kaplan, David L.; Balduini, Alessandra; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Abbonante, Vittorio; Balduini, Alessandra] Univ Pavia, Ist Ric & Cura Carattere Sci San Matteo Fdn, Dept Mol Med, I-27100 Pavia, Italy; [Xu, Huifang; Gavriilidou, Despoina; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, Sir Alexander Fleming Bldg, London SW7 2AZ, England; [Yoshizumi, Ayumi] Toho Univ, Sch Med, Fac Med, Dept Microbiol & Infect Dis, Tokyo 1438540, Japan; [Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Xu, Huifang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao, Peoples R China	Tufts University; University of Pavia; Imperial College London; Toho University; University of Cambridge; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Leitinger, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	b.leitinger@imperial.ac.uk; barbara.brodsky@tufts.edu	BALDUINI, ALESSANDRA/AAC-3363-2022; Abbonante, Vittorio/K-4028-2016; Abbonante, Vittorio/AAA-9303-2020; Balduini, Alessandra/K-6802-2016	BALDUINI, ALESSANDRA/0000-0003-3145-1245; Abbonante, Vittorio/0000-0001-8066-9895; Abbonante, Vittorio/0000-0001-8066-9895; Balduini, Alessandra/0000-0003-3145-1245	National Institutes of Health [EB011620, GM60048]; Medical Research Council United Kingdom [G0701121]; Biotechnology and Biological Sciences Research Council United Kingdom [BB/I011226/1]; Biomedical Resource Grant from Wellcome Trust [094470/Z/10/Z]; CARIPLO13-ICH (Cariplo Foundation) [2013.0717]; BBSRC [BB/I011226/1] Funding Source: UKRI; MRC [G0701121, G0500707] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I011226/1] Funding Source: researchfish; British Heart Foundation [RG/15/4/31268] Funding Source: researchfish; Medical Research Council [G0701121, G0500707] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biomedical Resource Grant from Wellcome Trust; CARIPLO13-ICH (Cariplo Foundation)(Fondazione Cariplo); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institutes of Health Grants EB011620 (to B. B. and D. L. K.) and GM60048 (to B. B.), CARIPLO13-ICH (Cariplo Foundation) Contract 2013.0717 (to A. B.), and in part by Medical Research Council United Kingdom Grant G0701121 (to B. L. and R. W. F.) and Biotechnology and Biological Sciences Research Council United Kingdom Grant BB/I011226/1 (to B. L.). Peptide synthesis was supported by Biomedical Resource Grant 094470/Z/10/Z (to R. W. F.) from the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbonante V, 2013, J BIOL CHEM, V288, P16738, DOI 10.1074/jbc.M112.431528; An B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00040; An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Browning MB, 2014, TISSUE ENG PT A, V20, P3130, DOI [10.1089/ten.tea.2013.0602, 10.1089/ten.TEA.2013.0602]; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; KADLER K, 1994, PROTEIN PROFILE, V1, P519; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898; Peng YY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-146; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Pinkas DM, 2011, ACS CHEM BIOL, V6, P320, DOI 10.1021/cb100298r; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Sekiya A, 2011, J BIOL CHEM, V286, P26364, DOI 10.1074/jbc.M111.252684; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Silva T, 2005, J AGR FOOD CHEM, V53, P7802, DOI 10.1021/jf050944d; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	45	29	29	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4343	4355		10.1074/jbc.M115.674507	http://dx.doi.org/10.1074/jbc.M115.674507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26702058	Green Published, hybrid			2022-12-28	WOS:000371604600008
J	Lutsenko, S				Lutsenko, Svetlana			Introduction to the Minireview Series on Modern Technologies for In-cell Biochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						cell culture; molecular dynamics; nuclear magnetic resonance (NMR); protein conformation; single-domain antibody (sdAb; nanobody); organoids; nanobody; protein folding; protein dynamics; conformational transitions; protein-protein interactions		The last decade has seen enormous progress in the exploration and understanding of the behavior of molecules in their natural cellular environments at increasingly high spatial and temporal resolution. Advances in microscopy and the development of new fluorescent reagents as well as genetic editing techniques have enabled quantitative analysis of protein interactions, intracellular trafficking, metabolic changes, and signaling. Modern biochemistry now faces new and exciting challenges. Can traditionally in vitro experiments, e.g. analysis of protein folding and conformational transitions, be done in cells? Can the structure and behavior of endogenous and/or non-tagged recombinant proteins be analyzed and altered within the cell or in cellular compartments? How can molecules and their actions be studied mechanistically in tissues and organs? Is personalized cellular biochemistry a reality? This thematic series summarizes recent studies that illustrate some first steps toward successfully answering these modern biochemical questions. The first minireview focuses on utilization of three-dimensional primary enteroids and organoids for mechanistic studies of intestinal biology with molecular resolution. The second minireview describes application of single chain antibodies (nanobodies) for monitoring and regulating protein dynamics in vitro and in cells. The third minireview highlights advances in using NMR spectroscopy for analysis of protein folding and assembly in cells.	[Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	Lutsenko@jhmi.edu						De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; Dmitriev OY, 2016, J BIOL CHEM, V291, P3767, DOI 10.1074/jbc.R115.679811; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Luchinat E, 2016, J BIOL CHEM, V291, P3776, DOI 10.1074/jbc.R115.643247; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Proserpio V, 2016, IMMUNOL CELL BIOL, V94, P225, DOI 10.1038/icb.2015.106; Yang C, 2014, PHOTOCH PHOTOBIO SCI, V13, P190, DOI 10.1039/c3pp50255d; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995	11	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3757	3758		10.1074/jbc.R115.709444	http://dx.doi.org/10.1074/jbc.R115.709444			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26677225	hybrid, Green Published			2022-12-28	WOS:000371338400006
J	Mangan, MSJ; Bird, CH; Kaiserman, D; Matthews, AY; Hitchen, C; Steer, DL; Thompson, PE; Bird, PI				Mangan, Matthew S. J.; Bird, Catherina H.; Kaiserman, Dion; Matthews, Anthony Y.; Hitchen, Corinne; Steer, David L.; Thompson, Philip E.; Bird, Phillip I.			A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; lysosome; natural killer cells (NK cells); protease; reactive oxygen species (ROS); serpin; T cell; SerpinB9; granzyme B; lysosomal membrane permeabilization	GRANZYME-B INHIBITOR; CELL-RECEPTOR STIMULATION; NEUTROPHIL EXTRACELLULAR TRAPS; T-CELL; PROTEASE INHIBITOR-9; SELECTIVE REGULATION; MEDIATED APOPTOSIS; CYTOTOXIC PATHWAYS; HYDROGEN-PEROXIDE; OXYGEN	The intracellular protease inhibitor Sb9 (SerpinB9) is a regulator of the cytotoxic lymphocyte protease GzmB (granzyme B). Although GzmB is primarily involved in the destruction of compromised cells, recent evidence suggests that it is also involved in lysosome-mediated death of the cytotoxic lymphocyte itself. Sb9 protects the cell from GzmB released from lysosomes into the cytosol. Here we show that reactive oxygen species (ROS) generated within cytotoxic lymphocytes by receptor stimulation are required for lyososomal permeabilization and release of GzmB into the cytosol. Importantly, ROS also inactivate Sb9 by oxidizing a highly conserved cysteine pair (P1-P1 in rodents and P1-P2 in other mammals) in the reactive center loop to form a vicinal disulfide bond. Replacement of the P4-P3 reactive center loop residues of the prototype serpin, SERPINA1, with the P4-P5 residues of Sb9 containing the cysteine pair is sufficient to convert SERPINA1 into a ROS-sensitive GzmB inhibitor. Conversion of the cysteine pair to serines in either human or mouse Sb9 results in a functional serpin that inhibits GzmB and resists ROS inactivation. We conclude that ROS sensitivity of Sb9 allows the threshold for GzmB-mediated suicide to be lowered, as part of a conserved post-translational homeostatic mechanism regulating lymphocyte numbers or activity. It follows, for example, that antioxidants may improve NK cell viability in adoptive immunotherapy applications by stabilizing Sb9.	[Mangan, Matthew S. J.; Bird, Catherina H.; Kaiserman, Dion; Matthews, Anthony Y.; Hitchen, Corinne; Steer, David L.; Bird, Phillip I.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Thompson, Philip E.] Monash Univ, Monash Inst Pharmaceut Sci, Dept Med Chem, Parkville, Vic 3052, Australia	Monash University; Monash University	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	phil.bird@monash.edu		Bird, Phillip/0000-0002-6695-606X; Thompson, Philip/0000-0002-5910-7625	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Ansari AW, 2010, J IMMUNOL, V185, P877, DOI 10.4049/jimmunol.1000651; Azzi J, 2013, J IMMUNOL, V191, P2319, DOI 10.4049/jimmunol.1300851; Bajor-Dattilo EB, 2013, BEST PRACT RES CL HA, V26, P75, DOI 10.1016/j.beha.2013.04.007; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bird CH, 2014, CELL DEATH DIFFER, V21, P876, DOI 10.1038/cdd.2014.7; Bird CH, 2010, BIOL CHEM, V391, P999, DOI 10.1515/BC.2010.099; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; BRIGGS RT, 1975, J CELL BIOL, V64, P254, DOI 10.1083/jcb.64.1.254; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buzza MS, 2001, CELL IMMUNOL, V210, P21, DOI 10.1006/cimm.2001.1806; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Classen CF, 2006, CLIN EXP IMMUNOL, V143, P534, DOI 10.1111/j.1365-2249.2006.03006.x; Classen CF, 2004, HAEMATOLOGICA, V89, P1314; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Godal R, 2006, BLOOD, V107, P3205, DOI 10.1182/blood-2005-07-2880; Hansson M, 1996, J IMMUNOL, V156, P42; Hildeman DA, 2004, FREE RADICAL BIO MED, V36, P1496, DOI 10.1016/j.freeradbiomed.2004.03.023; Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Horvath AJ, 2011, METHOD ENZYMOL, V501, P223, DOI 10.1016/B978-0-12-385950-1.00011-0; Hughes K, 2012, HORM MOL BIOL CLIN I, V10, P211, DOI 10.1515/hmbci-2012-0008; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kaiserman D, 2011, METHOD ENZYMOL, V501, P1, DOI 10.1016/B978-0-12-385950-1.00001-8; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lapteva Natalia, 2014, Critical Reviews in Oncogenesis, V19, P121; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Morris EC, 2003, BIOCHEM J, V371, P165, DOI 10.1042/BJ20021567; Muris JJF, 2004, LEUKEMIA, V18, P589, DOI 10.1038/sj.leu.2403240; Northfield SE, 2010, INT J PEPT RES THER, V16, P159, DOI 10.1007/s10989-010-9220-1; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; de Hooge ASK, 2007, CLIN CANCER RES, V13, P206, DOI 10.1158/1078-0432.CCR-06-1457; Salti SM, 2011, J IMMUNOL, V187, P6301, DOI 10.4049/jimmunol.1100891; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Scott FL, 1999, BLOOD, V93, P2089, DOI 10.1182/blood.V93.6.2089.406k10_2089_2097; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Taggart C, 2000, J BIOL CHEM, V275, P27258; Tatla S, 1999, FREE RADICAL BIO MED, V26, P14, DOI 10.1016/S0891-5849(98)00133-6; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TRAPANI JA, 1993, BIOCHEM BIOPH RES CO, V195, P910, DOI 10.1006/bbrc.1993.2131; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Willoughby CA, 2002, BIOORG MED CHEM LETT, V12, P2197, DOI 10.1016/S0960-894X(02)00363-3; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	64	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3626	3638		10.1074/jbc.M115.699298	http://dx.doi.org/10.1074/jbc.M115.699298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670609	hybrid, Green Published			2022-12-28	WOS:000370854500040
J	AlSudais, H; Aabed, K; Nicola, W; Dixon, K; Chen, JH; Li, Q				AlSudais, Hamood; Aabed, Kawther; Nicola, William; Dixon, Katherine; Chen, Jihong; Li, Qiao			Retinoid X Receptor-selective Signaling in the Regulation of Akt/Protein Kinase B Isoform-specific Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CACHEXIA; SKELETAL-MUSCLE; RXR-ALPHA; MICE LACKING; MUTANT MICE; MYOD; DIFFERENTIATION; AKT; PATHWAYS; ACETYLTRANSFERASE	The differentiation and fusion of myoblasts into mature myotubes are complex processes responding to multiple signaling pathways. The function of Akt/PKB is critical for myogenesis, but less is clear as to the regulation of its isoform-specific expression. Bexarotene is a drug already used clinically to treat cancer, and it has the ability to enhance the commitment of embryonic stem cells into skeletal muscle lineage. Whereas bexarotene regulates fundamental biological processes through retinoid X receptor (RXR)-mediated gene expression, molecular pathways underlying its positive effects on myogenesis remain unclear. In this study, we have examined the signaling pathways that transmit bexarotene action in the context of myoblast differentiation. We show that bexarotene promotes myoblast differentiation and fusion through the activation of RXR and the regulation of Akt/PKB isoform-specific expression. Interestingly, bexarotene signaling appears to correlate with residuespecific histone acetylation and is able to counteract the detrimental effects of cachectic factors on myogenic differentiation. We also signify an isoform-specific role for Akt/PKB in RXR-selective signaling to promote and to retain myoblast differentiation. Taken together, our findings establish the viability of applying bexarotene in the prevention and treatment of muscle-wasting disorders, particularly given the lack of drugs that promote myogenic differentiation available for potential clinical applications. Furthermore, the model of bexarotene-enhanced myogenic differentiation will provide an important avenue to identify additional genetic targets and specific molecular interactions that we can study and apply for the development of potential therapeutics in muscle regeneration and repair.	[AlSudais, Hamood; Nicola, William; Dixon, Katherine; Li, Qiao] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada; [Aabed, Kawther; Chen, Jihong; Li, Qiao] Univ Ottawa, Dept Pathol & Lab Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Li, Q (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada.; Li, Q (corresponding author), Univ Ottawa, Dept Pathol & Lab Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada.	qiao.li@uottawa.ca	AlSudais, Hamood/AGI-7624-2022; Aabed, Kawther/AAD-8205-2020	AlSudais, Hamood/0000-0001-8228-1392; Aabed, Kawther/0000-0002-9927-5308; Li, Qiao/0000-0002-5941-1985; Dixon, Katherine/0000-0002-7334-888X; Chen, Jihong/0000-0001-7336-8808	operating grant from Natural Sciences and Engineering Research Council of Canada	operating grant from Natural Sciences and Engineering Research Council of Canada	This work was supported in part by an operating grant from Natural Sciences and Engineering Research Council of Canada (to Q. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen JH, 2005, MOL CELL BIOL, V25, P525, DOI 10.1128/MCB.25.2.525-532.2005; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Folkers GE, 1998, J BIOL CHEM, V273, P32200, DOI 10.1074/jbc.273.48.32200; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gardner S, 2012, AM J PHYSIOL-CELL PH, V303, pC1292, DOI 10.1152/ajpcell.00259.2012; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gniadecki R, 2007, BRIT J DERMATOL, V157, P433, DOI 10.1111/j.1365-2133.2007.07975.x; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hamed M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02390; Higazi A, 2011, EPIGENETICS-US, V6, P202, DOI 10.4161/epi.6.2.13658; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Jiang ZL, 2006, FASEB J, V20, P2570, DOI 10.1096/fj.06-6347fje; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Kaplan R, 2002, J LIPID RES, V43, P952; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Le May M, 2011, J BIOL CHEM, V286, P26806, DOI 10.1074/jbc.M111.227058; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Lokireddy S, 2012, BIOCHEM J, V446, P23, DOI 10.1042/BJ20112024; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Rajagopal N, 2014, G3-GENES GENOM GENET, V4, P2051, DOI 10.1534/g3.114.013565; Sapin V, 1997, DEV BIOL, V191, P29, DOI 10.1006/dbio.1997.8687; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Szalay K, 1997, EUR J CELL BIOL, V74, P391; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	10	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3090	3099		10.1074/jbc.M115.692707	http://dx.doi.org/10.1074/jbc.M115.692707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26668312	hybrid, Green Published			2022-12-28	WOS:000369626900044
J	Khatun, I; Clark, RW; Vera, NB; Kou, K; Erion, DM; Coskran, T; Bobrowski, WF; Okerberg, C; Goodwin, B				Khatun, Irani; Clark, Ronald W.; Vera, Nicholas B.; Kou, Kou; Erion, Derek M.; Coskran, Timothy; Bobrowski, Walter F.; Okerberg, Carlin; Goodwin, Bryan			Characterization of a Novel Intestinal Glycerol-3-phosphate Acyltransferase Pathway and Its Role in Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-IV; PHARMACOLOGICAL INHIBITION; TRIGLYCERIDE SYNTHESIS; PROTECTS MICE; 1 DGAT1; ABSORPTION; IDENTIFICATION; BIOSYNTHESIS; ENZYME; ENTEROCYTES	Dietary triglycerides (TG) are absorbed by the enterocytes of the small intestine after luminal hydrolysis into monacylglycerol and fatty acids. Before secretion on chylomicrons, these lipids are reesterified into TG, primarily through the monoacylglycerol pathway. However, targeted deletion of the primary murine monoacylglycerol acyltransferase does not quantitatively affect lipid absorption, suggesting the existence of alternative pathways. Therefore, we investigated the role of the glycerol 3-phosphate pathway in dietary lipid absorption. The expression of glycerol-3-phosphate acyltransferase (GPAT3) was examined throughout the small intestine. To evaluate the role for GPAT3 in lipid absorption, mice harboring a disrupted GPAT3 gene (Gpat3(-/-)) were subjected to an oral lipid challenge and fed a Western-type diet to characterize the role in lipid and cholesterol homeostasis. Additional mechanistic studies were performed in primary enterocytes. GPAT3 was abundantly expressed in the apical surface of enterocytes in the small intestine. After an oral lipid bolus, Gpat3(-/-) mice exhibited attenuated plasma TG excursion and accumulated lipid in the enterocytes. Electron microscopy studies revealed a lack of lipids in the lamina propria and intercellular space in Gpat3(-/-) mice. Gpat3(-/-) enterocytes displayed a compensatory increase in the synthesis of phospholipid and cholesteryl ester. When fed a Western-type diet, hepatic TG and cholesteryl ester accumulation was significantly higher in Gpat3(-/-) mice compared with the wild-type mice accompanied by elevated levels of alanine aminotransferase, a marker of liver injury. Dysregulation of bile acid metabolism was also evident in Gpat3-null mice. These studies identify GPAT3 as a novel enzyme involved in intestinal lipid metabolism.	[Khatun, Irani; Clark, Ronald W.; Vera, Nicholas B.; Kou, Kou; Erion, Derek M.; Goodwin, Bryan] Pfizer Worldwide Res & Dev, Cardiovasc & Metab Dis Res Unit, 610 Main St, Cambridge, MA 02139 USA; [Coskran, Timothy; Bobrowski, Walter F.; Okerberg, Carlin] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT 06340 USA	Pfizer; Pfizer	Goodwin, B (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc & Metab Dis Res Unit, 610 Main St, Cambridge, MA 02139 USA.	bryan.goodwin@pfizer.com						Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1176, DOI 10.1152/ajpendo.00666.2013; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cartwright IJ, 1999, J LIPID RES, V40, P1357; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; CLARK B, 1961, BIOCHIM BIOPHYS ACTA, V46, P479, DOI 10.1016/0006-3002(61)90579-0; CLARK B, 1960, NATURE, V185, P35, DOI 10.1038/185035b0; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Gao Y, 2013, J LIPID RES, V54, P1644, DOI 10.1194/jlr.M035493; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; JOHNSTON JM, 1967, BIOCHIM BIOPHYS ACTA, V137, P578, DOI 10.1016/0005-2760(67)90140-3; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KERN F, 1965, BIOCHIM BIOPHYS ACTA, V98, P520; Kieffer TJ, 2003, TRENDS PHARMACOL SCI, V24, P110, DOI 10.1016/S0165-6147(03)00031-2; Kohan AB, 2013, AM J PHYSIOL-GASTR L, V304, pG1128, DOI 10.1152/ajpgi.00409.2012; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lewin TM, 2008, BBA-MOL CELL BIOL L, V1781, P352, DOI 10.1016/j.bbalip.2008.05.001; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Liu JQ, 2013, OBESITY, V21, P1406, DOI 10.1002/oby.20193; Ma SZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07633; Maciejewski BS, 2013, AM J PHYSIOL-GASTR L, V304, pG958, DOI 10.1152/ajpgi.00384.2012; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Xu JH, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/272715; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	43	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2602	2615		10.1074/jbc.M115.683359	http://dx.doi.org/10.1074/jbc.M115.683359			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644473	Green Published, hybrid			2022-12-28	WOS:000369626900006
J	da Palma, JR; Cendron, L; Seidah, NG; Pasquato, A; Kunz, S				da Palma, Joel Ramos; Cendron, Laura; Seidah, Nabil Georges; Pasquato, Antonella; Kunz, Stefan			Mechanism of Folding and Activation of Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORIOMENINGITIS VIRUS GLYCOPROTEIN; ARENAVIRUS ENVELOPE GLYCOPROTEINS; PROPROTEIN CONVERTASE SKI-1/S1P; ELEMENT-BINDING PROTEINS; INTRAMOLECULAR CHAPERONE; SUBTILASE SKI-1/S1P; SITE-1 PROTEASE; LDL RECEPTOR; CLEAVAGE; SEQUENCE	The proprotein convertase subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P) is implicated in lipid homeostasis, the unfolded protein response, and lysosome biogenesis. The protease is further hijacked by highly pathogenic emerging viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI-1/S1P requires removal of an N-terminal prodomain, by a multistep process, generating the mature enzyme. Here, we uncover a modular structure of the human SKI-1/S1P prodomain and define its function in folding and activation. We provide evidence that the N-terminal AB fragment of the prodomain represents an autonomous structural and functional unit that is necessary and sufficient for folding and partial activation. In contrast, the C-terminal BC fragment lacks a defined structure but is crucial for autoprocessing and full catalytic activity. Phylogenetic analysis revealed that the sequence of the AB domain is highly conserved, whereas the BC fragment shows considerable variation and seems even absent in some species. Notably, SKI-1/S1P of arthropods, like the fruit fly Drosophila melanogaster, contains a shorter prodomain comprised of full-length AB and truncated BC regions. Swapping the prodomain fragments between fly and human resulted in a fully mature and active SKI-1/S1P chimera. Our study suggests that primordial SKI-1/S1P likely contained a simpler prodomain consisting of the highly conserved AB fragment that represents an independent folding unit. The BC region appears as a later evolutionary acquisition, possibly allowing more subtle fine-tuning of the maturation process.	[da Palma, Joel Ramos; Pasquato, Antonella; Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland; [da Palma, Joel Ramos; Pasquato, Antonella; Kunz, Stefan] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Cendron, Laura] Univ Padua, Dept Biol, I-35122 Padua, Italy; [Seidah, Nabil Georges] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Lausanne; University of Padua; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Pasquato, A; Kunz, S (corresponding author), Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.; Pasquato, A; Kunz, S (corresponding author), Univ Lausanne, CH-1011 Lausanne, Switzerland.	Antonella.Pasquato@chuv.ch; Stefan.Kunz@chuv.ch	Seidah, Nabil/I-3596-2013; Kunz, Stefan/K-5840-2017	Seidah, Nabil/0000-0001-6503-9342; Cendron, Laura/0000-0002-0125-0461; Pasquato, Antonella/0000-0002-9428-0722; Kunz, Stefan/0000-0001-6030-9550	Swiss National Science Foundation [FN 31003A-135536, FN 310030_149746]; Novartis Stiftung fur Medizinisch-Biologische Forschung [14B086]; University of Lausanne; Canadian Institutes of Health Research [93792]; Canada Chair Grant [216684]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung fur Medizinisch-Biologische Forschung; University of Lausanne; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant	This work was supported by Swiss National Science Foundation Grants FN 31003A-135536 and FN 310030_149746 (to S. K.), Grant 14B086 from the Novartis Stiftung fur Medizinisch-Biologische Forschung, and funds from the University of Lausanne (to S. K.), as well as by Canadian Institutes of Health Research Grant 93792 and Canada Chair Grant 216684 (to N. G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Blanchet M, 2015, ANTIVIR RES, V115, P94, DOI 10.1016/j.antiviral.2014.12.017; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burri DJ, 2013, J VIROL, V87, P6406, DOI 10.1128/JVI.00072-13; Burri DJ, 2012, J VIROL, V86, P4935, DOI 10.1128/JVI.00024-12; da Palma JR, 2014, J BIOL CHEM, V289, P35743, DOI 10.1074/jbc.M114.588525; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Lesage G, 2000, MOL BIOL CELL, V11, P1947, DOI 10.1091/mbc.11.6.1947; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Pasquato A, 2011, VIROLOGY, V417, P18, DOI 10.1016/j.virol.2011.04.021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; WEBER EL, 1988, VIROLOGY, V164, P30, DOI 10.1016/0042-6822(88)90616-2; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	37	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2055	2066		10.1074/jbc.M115.677757	http://dx.doi.org/10.1074/jbc.M115.677757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645686	Green Published, hybrid			2022-12-28	WOS:000369610400002
J	Canalis, E; Schilling, L; Yee, SP; Lee, SK; Zanotti, S				Canalis, Ernesto; Schilling, Lauren; Yee, Siu-Pok; Lee, Sun-Kyeong; Zanotti, Stefano			Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Notch receptors are determinants of cell fate and function and play a central role in skeletal development and bone remodeling. Hajdu Cheney syndrome, a disease characterized by osteoporosis and fractures, is associated with NOTCH2 mutations resulting in a truncated stable protein and gain-of-function. We created a mouse model reproducing the Hajdu Cheney syndrome by introducing a 6955C -> T mutation in the Notch2 locus leading to a Q2319X change at the amino acid level. Notch2Q2319X heterozygous mutants were smaller and had shorter femurs than controls; and at 1 month of age they exhibited cancellous and cortical bone osteopenia. As the mice matured, cancellous bone volume was restored partially in male but not female mice, whereas cortical osteopenia persisted in both sexes. Cancellous bone histomorphometry revealed an increased number of osteoclasts and bone resorption, without a decrease in osteoblast number or bone formation. Osteoblast differentiation and function were not affected in Notch2(Q2319X) cells. The pre-osteoclast cell pool, osteoclast differentiation, and bone resorption in response to receptor activator of nuclear factor kappa B ligand in vitro were increased in Notch2(Q2319X) mutants. These effects were suppressed by the gamma-secretase inhibitor LY450139. In conclusion, Notch2(Q2319X) mice exhibit cancellous and cortical bone osteopenia, enhanced osteoclastogenesis, and increased bone resorption.	[Canalis, Ernesto; Schilling, Lauren; Zanotti, Stefano] Univ Connecticut, Hlth Ctr, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto; Lee, Sun-Kyeong; Zanotti, Stefano] Univ Connecticut, Hlth Ctr, Dept Med, Farmington, CT 06030 USA; [Yee, Siu-Pok] Univ Connecticut, Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Yee, Siu-Pok] Univ Connecticut, Hlth Ctr, Dept Genet, Farmington, CT 06030 USA; [Yee, Siu-Pok] Univ Connecticut, Hlth Ctr, Dept Genome Sci Biol, Farmington, CT 06030 USA; [Lee, Sun-Kyeong] Univ Connecticut, Hlth Ctr, Ctr Aging, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut	Canalis, E (corresponding author), Univ Connecticut, Hlth Ctr, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), Univ Connecticut, Hlth Ctr, Dept Med, Farmington, CT 06030 USA.	canalis@uchc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK045227 from the National Institute of Diabetes and Digestive and Kidney Diseases. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguila HL, 2012, J BONE MINER RES, V27, P1030, DOI 10.1002/jbmr.1553; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Avela K, 2011, AM J MED GENET A, V155A, P595, DOI 10.1002/ajmg.a.33510; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Blumenauer BT, 2002, CLIN EXP RHEUMATOL, V20, P574; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Breit S, 2006, BLOOD, V108, P1151, DOI 10.1182/blood-2005-12-4956; BROWN DM, 1976, J PEDIATR-US, V88, P573, DOI 10.1016/S0022-3476(76)80009-1; Canalis E, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0200-y; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; CHENEY WD, 1965, AMER J ROENTGENOL RA, V94, P595; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dallas DJ, 1999, BONE, V25, P9, DOI 10.1016/S8756-3282(99)00099-X; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Descartes M, 2014, CLIN DYSMORPHOL, V23, P88, DOI 10.1097/MCD.0000000000000034; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gray MJ, 2012, EUR J HUM GENET, V20, P122, DOI 10.1038/ejhg.2011.125; Habets RAJ, 2015, J BIOL CHEM, V290, P14705, DOI 10.1074/jbc.M115.643676; HAJDU N, 1948, BRIT J RADIOL, V21, P42, DOI 10.1259/0007-1285-21-241-42; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; HEFLEY T, 1981, AM J PHYSIOL, V240, pC234, DOI 10.1152/ajpcell.1981.240.5.C234; Herrmann M, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P57, DOI 10.1007/978-0-85729-293-3_6; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Jacome-Galarza CE, 2011, J BONE MINER RES, V26, P1207, DOI 10.1002/jbmr.324; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Mun SH, 2014, ARTHRITIS RHEUMATOL, V66, P2482, DOI 10.1002/art.38723; Mun SH, 2013, J BONE MINER RES, V28, P948, DOI 10.1002/jbmr.1787; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pereira RMR, 2002, J CELL BIOCHEM, V85, P252, DOI 10.1002/jcb.10125; Plotkin LI, 2015, J BIOL CHEM, V290, P18934, DOI 10.1074/jbc.M115.642090; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sahlgren C, 2006, REGEN MED, V1, P195, DOI 10.2217/17460751.1.2.195; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; UDELL J, 1986, ARTHRITIS RHEUM, V29, P1032, DOI 10.1002/art.1780290815; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2015, J CELL PHYSIOL, V230, P1689, DOI 10.1002/jcp.24928; Zanotti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086757; Zanotti S, 2013, J BIOL CHEM, V288, P624, DOI 10.1074/jbc.M112.340455; Zanotti S, 2012, CALCIFIED TISSUE INT, V90, P69, DOI 10.1007/s00223-011-9541-x; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5	82	55	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	191	4					1538	1551		10.1074/jbc.M115.685453	http://dx.doi.org/10.1074/jbc.M115.685453			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VC7QW	26627824	hybrid, Green Published			2022-12-28	WOS:000434592700001
J	Spencer, B; Potkar, R; Metcalf, J; Thrin, I; Adame, A; Rockenstein, E; Masliah, E				Spencer, Brian; Potkar, Rewati; Metcalf, Jeff; Thrin, Ivy; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer			Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN ACCUMULATION; APP TRANSGENIC MODEL; CEREBROSPINAL-FLUID; SUBVENTRICULAR ZONE; ALTERED EXPRESSION; LENTIVIRAL VECTORS; FUSION PROTEIN; WEIGHT-LOSS; IN-VIVO; DEMENTIA	Neuropeptide Y (NPY) is one of the most abundant protein transmitters in the central nervous system with roles in a variety of biological functions including: food intake, cardiovascular regulation, cognition, seizure activity, circadian rhythms, and neurogenesis. Reduced NPY and NPY receptor expression is associated with numerous neurodegenerative disorders including Alzheimer disease (AD). To determine whether replacement of NPY could ameliorate some of the neurodegenerative and behavioral pathology associated with AD, we generated a lentiviral vector expressing NPY fused to a brain transport peptide (apoB) for widespread CNS delivery in an APP-transgenic (tg) mouse model of AD. The recombinant NPY-apoB effectively reversed neurodegenerative pathology and behavioral deficits although it had no effect on accumulation of A beta. The subgranular zone of the hippocampus showed a significant increase in proliferation of neural precursor cells without further differentiation into neurons. The neuroprotective and neurogenic effects of NPY-apoB appeared to involve signaling via ERK and Akt through the NPY R1 and NPY R2 receptors. Thus, widespread CNS-targeted delivery of NPY appears to be effective at reversing the neuronal and glial pathology associated with A beta accumulation while also increasing NPC proliferation. Overall, increased delivery of NPY to the CNS for AD might be an effective therapy especially if combined with an anti-A beta therapeutic.	[Spencer, Brian; Potkar, Rewati; Metcalf, Jeff; Thrin, Ivy; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92102 USA; [Metcalf, Jeff; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92102 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), 9500 Gilman Dr,0624, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			National Institutes of Health [AG022074, AG018440, AG010435]; NATIONAL INSTITUTE ON AGING [P01AG022074, P01AG010435, R37AG018440, R01AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG022074, AG018440, and AG010435. The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; ALOM J, 1990, EUR NEUROL, V30, P207; Angelucci F, 2014, CAN J PHYSIOL PHARM, V92, P621, DOI 10.1139/cjpp-2014-0099; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Baptista S, 2012, NEUROPHARMACOLOGY, V62, P2413, DOI 10.1016/j.neuropharm.2012.02.015; BarrettConnor E, 1996, J AM GERIATR SOC, V44, P1147, DOI 10.1111/j.1532-5415.1996.tb01362.x; BEAL MF, 1986, ANN NEUROL, V20, P282, DOI 10.1002/ana.410200303; Buchman AS, 2005, NEUROLOGY, V65, P892, DOI 10.1212/01.wnl.0000176061.33817.90; CHANPALAY V, 1985, J COMP NEUROL, V238, P390, DOI 10.1002/cne.902380404; CHANPALAY V, 1986, J COMP NEUROL, V248, P376, DOI 10.1002/cne.902480307; Corvino V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088294; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Croce N, 2012, ACS CHEM NEUROSCI, V3, P312, DOI 10.1021/cn200127e; Croce N, 2011, NEURODEGENER DIS, V8, P300, DOI 10.1159/000323468; DAVIES CA, 1990, J NEUROL SCI, V96, P59, DOI 10.1016/0022-510X(90)90057-T; Decressac M, 2012, EXP NEUROL, V238, P265, DOI 10.1016/j.expneurol.2012.09.004; Diez M, 2003, NEUROBIOL DIS, V14, P579, DOI 10.1016/j.nbd.2003.08.003; EDVINSSON L, 1993, DEMENTIA, V4, P167, DOI 10.1159/000107318; Ferreira R, 2010, J BIOL CHEM, V285, P41921, DOI 10.1074/jbc.M110.164020; Goncalves J, 2012, J NEUROCHEM, V123, P1041, DOI 10.1111/jnc.12052; Goncalves J, 2012, EUR J NEUROSCI, V36, P3173, DOI 10.1111/j.1460-9568.2012.08232.x; Hernandez S, 2012, NEUROPEPTIDES, V46, P29, DOI 10.1016/j.npep.2011.10.002; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Howell OW, 2007, NEUROBIOL DIS, V26, P174, DOI 10.1016/j.nbd.2006.12.014; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Jin HK, 2009, CELL PROLIFERAT, V42, P571, DOI 10.1111/j.1365-2184.2009.00625.x; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; KOIDE S, 1995, NEUROSCI LETT, V198, P149, DOI 10.1016/0304-3940(95)11973-Z; KOWALL NW, 1988, ANN NEUROL, V23, P105, DOI 10.1002/ana.410230202; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; MARTEL JC, 1990, BRAIN RES, V519, P228, DOI 10.1016/0006-8993(90)90082-M; MARTIGNONI E, 1992, J NEURAL TRANSM-PARK, V4, P191, DOI 10.1007/BF02260903; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Minthon L, 1990, J Neural Transm Suppl, V30, P57; Minthon L, 1996, ALZ DIS ASSOC DIS, V10, P197, DOI 10.1097/00002093-199601040-00005; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Musiek ES, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00029; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Ray J, 1997, P NATL ACAD SCI USA, V94, P7047, DOI 10.1073/pnas.94.13.7047; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Shaw JL, 2003, J CHEM NEUROANAT, V26, P179, DOI 10.1016/j.jchemneu.2003.07.003; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Spencer B, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0043-6; Spencer B, 2014, MOL THER, V22, P1753, DOI 10.1038/mt.2014.129; Spencer B, 2014, J BIOL CHEM, V289, P17917, DOI 10.1074/jbc.M114.557439; Spencer B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00114; Spencer B, 2013, MOL THER, V21, P31, DOI 10.1038/mt.2012.66; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; St-Pierre JA, 2000, GLIA, V30, P82, DOI 10.1002/(SICI)1098-1136(200003)30:1<82::AID-GLIA9>3.3.CO;2-#; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Terry Robert D., 1994, P179; Thiriet N, 2011, J NEUROCHEM, V116, P1018, DOI 10.1111/j.1471-4159.2010.07154.x; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tsigelny IF, 2014, J ALZHEIMERS DIS, V39, P583, DOI 10.3233/JAD-131589; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; van Wamelen DJ, 2013, J NEUROENDOCRINOL, V25, P198, DOI 10.1111/j.1365-2826.2012.02379.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; White H, 1998, J AM GERIATR SOC, V46, P1223, DOI 10.1111/j.1532-5415.1998.tb04537.x; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Xapelli S, 2007, PEPTIDES, V28, P288, DOI 10.1016/j.peptides.2006.09.031; Xapelli Sara, 2006, Recent Pat CNS Drug Discov, V1, P315, DOI 10.2174/157488906778773689	72	37	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1905	1920		10.1074/jbc.M115.678185	http://dx.doi.org/10.1074/jbc.M115.678185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620558	hybrid, Green Published			2022-12-28	WOS:000368620700029
J	Poddar, R; Rajagopal, S; Shuttleworth, CW; Paul, S				Poddar, Ranjana; Rajagopal, Sathyanarayanan; Shuttleworth, C. William; Paul, Surojit			Zn2+-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP MOLECULAR BASIS FOR ZN2+-INDUCED ERK MAPK ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-SENSING RECEPTOR; PROTEIN-KINASE-C; NEUROTROPHIC FACTOR; EXTRACELLULAR ZINC; NEURONAL INJURY; PTP-SL; BDNF; RAT; FAMILY; DEATH	Excessive release of Zn2+ in the brain is implicated in the progression of acute brain injuries. Although several signaling cascades have been reported to be involved in Zn2+-induced neurotoxicity, a potential contribution of tyrosine phosphatases in this process has not been well explored. Here we show that exposure to high concentrations of Zn2+ led to a progressive increase in phosphorylation of the striatal-enriched phosphatase (STEP), a component of the excitotoxic-signaling pathway that plays a role in neuroprotection. Zn2+-mediated phosphorylation of STEP61 at multiple sites (hyperphosphorylation) was induced by the up-regulation of brain-derived neurotropic factor (BDNF), tropomyosin receptor kinase (Trk) signaling, and activation of cAMP-dependent PKA (protein kinase A). Mutational studies further show that differential phosphorylation of STEP61 at the PKA sites, Ser-160 and Ser-221 regulates the affinity of STEP61 toward its substrates. Consistent with these findings we also show that BDNF/Trk/PKA mediated signaling is required for Zn2+-induced phosphorylation of extracellular regulated kinase 2 (ERK2), a substrate of STEP that is involved in Zn2+-dependent neurotoxicity. The strong correlation between the temporal profile of STEP61 hyperphosphorylation and ERK2 phosphorylation indicates that loss of function of STEP61 through phosphorylation is necessary for maintaining sustained ERK2 phosphorylation. This interpretation is further supported by the findings that deletion of the STEP gene led to a rapid and sustained increase in ERK2 phosphorylation within minutes of exposure to Zn2+. The study provides further insight into the mechanisms of regulation of STEP61 and also offers a molecular basis for the Zn2+-induced sustained activation of ERK2.	[Poddar, Ranjana; Rajagopal, Sathyanarayanan; Paul, Surojit] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; [Shuttleworth, C. William] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Paul, S (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, 1 Univ New Mexico, Albuquerque, NM 87131 USA.	spaul@salud.unm.edu			NINDS, National Institutes of Health [R01 NS059962, NS083914, NS051288]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059962, R01NS051288, R01NS083914] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS059962 (to S. P.), NS083914 (to R. P.), and NS051288 (to C. W. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Binder DK, 1999, J NEUROSCI, V19, P1424; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Bult A, 1997, EUR J CELL BIOL, V72, P337; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Corona C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.73; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Deb I, 2013, J NEUROSCI, V33, P17814, DOI 10.1523/JNEUROSCI.2346-12.2013; Franco JL, 2008, BEHAV BRAIN RES, V188, P316, DOI 10.1016/j.bbr.2007.11.012; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; FREUND WD, 1994, BRAIN RES, V654, P257, DOI 10.1016/0006-8993(94)90487-1; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kerchner G. A., 2000, J PHYSL; Kim HJ, 2003, NEUROBIOL DIS, V14, P110, DOI 10.1016/S0969-9961(03)00103-7; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Koyama R, 2005, NEUROSCIENTIST, V11, P282, DOI 10.1177/1073858405278266; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Manzerra P, 2001, P NATL ACAD SCI USA, V98, P11055, DOI 10.1073/pnas.191353598; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Martinez-Galan JR, 2003, BRAIN RES, V963, P156, DOI 10.1016/S0006-8993(02)03964-1; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Morris DR, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/785647; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; MURAKAMI K, 1987, J BIOL CHEM, V262, P13902; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Nowak G, 2003, POL J PHARMACOL, V55, P1143; Nowak G, 2004, EUR J PHARMACOL, V492, P57, DOI 10.1016/j.ejphar.2004.03.038; Park JA, 2000, J NEUROSCI, V20, P9096; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pochwat B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/591563; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; SHIRAISHI K, 1993, NEUROL RES, V15, P113; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TAPLEY P, 1992, ONCOGENE, V7, P371; Tokuoka H, 2000, J CELL SCI, V113, P1059; Venkitaramani DV, 2009, SYNAPSE, V63, P69, DOI 10.1002/syn.20608; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471	58	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					813	825		10.1074/jbc.M115.663468	http://dx.doi.org/10.1074/jbc.M115.663468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26574547	Green Published, hybrid			2022-12-28	WOS:000367830500028
J	Xue, JH; Xu, GF; Gu, TP; Chen, GD; Han, BB; Xu, ZM; Bjoras, M; Krokan, HE; Xu, GL; Du, YR				Xue, Jian-Huang; Xu, Gui-Fang; Gu, Tian-Peng; Chen, Guo-Dong; Han, Bin-Bin; Xu, Zhi-Mei; Bjoras, Magnar; Krokan, Hans E.; Xu, Guo-Liang; Du, Ya-Rui			Uracil-DNA Glycosylase UNG Promotes Tet-mediated DNA Demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-DEMETHYLATION; CRYSTAL-STRUCTURE; TDG; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; METHYLATION; OXIDATION; EXCISION; 5-HYDROXYMETHYLCYTOSINE	In mammals, active DNA demethylation involves oxidation of 5-methylcytosine (5mC) into 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) by Tet dioxygenases and excision of these two oxidized bases by thymine DNA glycosylase (TDG). Although TDG is essential for active demethylation in embryonic stem cells and induced pluripotent stem cells, it is hardly expressed in mouse zygotes and dispensable in pronuclear DNA demethylation. To search for other factors that might contribute to demethylation in mammalian cells, we performed a functional genomics screen based on a methylated luciferase reporter assay. UNG2, one of the glycosylases known to excise uracil residues from DNA, was found to reduce DNA methylation, thus activating transcription of a methylation-silenced reporter gene when co-transfected with Tet2 into HEK293T cells. Interestingly, UNG2 could decrease 5caC from the genomic DNA and a reporter plasmid in transfected cells, like TDG. Furthermore, deficiency in Ung partially impaired DNA demethylation in mouse zygotes. Our results suggest that UNG might be involved in Tet-mediated DNA demethylation.	[Xue, Jian-Huang; Xu, Gui-Fang; Gu, Tian-Peng; Chen, Guo-Dong; Han, Bin-Bin; Xu, Zhi-Mei; Xu, Guo-Liang; Du, Ya-Rui] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Xu, Gui-Fang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Bjoras, Magnar] Natl Hosp Norway, Oslo Univ Hosp, Clin Diagnost & Intervent, Dept Microbiol, N-0424 Oslo, Norway; [Krokan, Hans E.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway; [Xu, Guo-Liang] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of Oslo; National Hospital Norway; Norwegian University of Science & Technology (NTNU); ShanghaiTech University	Du, YR (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	yrdu@sibcb.ac.cn	Xue, Jianhuang/AAE-3589-2021; Bjørås, Magnar/N-9286-2017	Xue, Jianhuang/0000-0003-0623-2200	National Natural Science Foundation of China [31430049, 31230039, 31471213]; National Basic Research Program of China [2014CB965200]; Breakthrough Project of Strategic Priority Program of the Chinese Academy of Sciences [XDB13000000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Breakthrough Project of Strategic Priority Program of the Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China Grants 31430049 and 31230039 (to G.-L. X.) and 31471213 (to Y.-R. D.), National Basic Research Program of China Grant 2014CB965200 (to Y.-R. D.), and the Breakthrough Project of Strategic Priority Program of the Chinese Academy of Sciences Grant XDB13000000. The authors declare that they have no conflicts of interest with the contents of this article.	Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokeide SZ, 2009, PROTEIN EXPRES PURIF, V65, P160, DOI 10.1016/j.pep.2008.11.014; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Li Z, 2015, NUCLEIC ACIDS RES, V43, P3986, DOI 10.1093/nar/gkv283; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Muller U, 2014, NUCLEIC ACIDS RES, V42, P8592, DOI 10.1093/nar/gku552; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Wheldon LM, 2014, CELL REP, V7, P1353, DOI 10.1016/j.celrep.2014.05.003; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu D, 2014, J BIOL CHEM, V289, P15463, DOI 10.1074/jbc.M114.561019; Xu GL, 2015, NATL SCI REV, V2, P318, DOI 10.1093/nsr/nwv029; Xu GL, 2014, BMB REP, V47, P609, DOI 10.5483/BMBRep.2014.47.11.223; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	38	26	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					731	738		10.1074/jbc.M115.693861	http://dx.doi.org/10.1074/jbc.M115.693861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26620559	hybrid, Green Published			2022-12-28	WOS:000367830500021
J	Yu-Kemp, HC; Brieher, WM				Yu-Kemp, Hui-Chia; Brieher, William M.			Collapsin Response Mediator Protein-1 Regulates Arp2/3-dependent Actin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE COLLAPSE; ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; FILAMENT NUCLEATION; RHO-KINASE; MOTILITY; PHOSPHORYLATION; FAMILY; CYTOSKELETON; SURFACE	Listeria monocytogenes is a bacterial parasite that uses host proteins to assemble an Arp2/3-dependent actin comet tail to power its movement through the host cell. Initiation of comet tail assembly is more efficient in cytosol than it is under defined conditions, indicating that unknown factors contribute to the reaction. We therefore fractionated cytosol and identified CRMP-1 as a factor that facilitates Arp2/3-dependent Listeria actin cloud formation in the presence of Arp2/3 and actin alone. It also scored as an important factor for Listeria actin comet tail formation in brain cytosol. CRMP-1 does not nucleate actin assembly on its own, nor does it directly activate the Arp2/3 complex. Rather, CRMP-1 scored as an auxiliary factor that promoted the ability of Listeria ActA protein to activate the Arp2/3 complex to trigger actin assembly. CRMP-1 is one member of a family of five related proteins that modulate cell motility in response to extracellular signals. Our results demonstrate an important role for CRMP-1 in Listeria actin comet tail formation and open the possibility that CRMP-1 controls cell motility by modulating Arp2/3 activation.	[Yu-Kemp, Hui-Chia; Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Brieher, WM (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61820 USA.	wbrieher@illinois.edu		Brieher, William/0000-0002-3168-6688	National Institutes of Health [R01-GM106106-01]; American Heart Association [0930282G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM106106-01 (to W. M. B.) and by American Heart Association Scientist Development Grant 0930282G (to W. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; Buel GR, 2010, J CELL BIOCHEM, V111, P20, DOI 10.1002/jcb.22659; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Khazaei MR, 2014, J BIOL CHEM, V289, P30133, DOI 10.1074/jbc.M114.570440; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; KOCKS C, 1995, MOL MICROBIOL, V18, P413, DOI 10.1111/j.1365-2958.1995.mmi_18030413.x; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ponnusamy R, 2013, J NEUROCHEM, V125, P855, DOI 10.1111/jnc.12188; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; SHIZUTA Y, 1976, J BIOL CHEM, V251, P6562; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; Wagner AR, 2013, CURR BIOL, V23, P1990, DOI 10.1016/j.cub.2013.08.029; Wang LH, 1996, J NEUROSCI, V16, P6197; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Welch MD, 1998, METHOD ENZYMOL, V298, P52, DOI 10.1016/S0076-6879(98)98008-9; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	45	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					658	664		10.1074/jbc.C115.689265	http://dx.doi.org/10.1074/jbc.C115.689265			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26598519	hybrid, Green Published			2022-12-28	WOS:000367830500014
J	Halasi, M; Varaljai, R; Benevolenskaya, E; Gartel, AL				Halasi, Marianna; Varaljai, Renata; Benevolenskaya, Elizaveta; Gartel, Andrei L.			A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kD heat shock protein (Hsp70); anticancer drug; cell death; gene expression; protein-protein interaction; FOXM1	PROTEASOME INHIBITORS; TRANSCRIPTION FACTOR; TARGETING FOXM1; CANCER; APOPTOSIS; IDENTIFICATION; RESISTANCE; INDUCTION	The oncogenic transcription factor FOXM1 is overexpressed in the majority of human cancers, and it is a potential target for anticancer therapy. We identified proteasome inhibitors as the first type of drugs that target FOXM1 in cancer cells. Here we found that HSP90 inhibitor PF-4942847 and heat shock also suppress FOXM1. The common effector, which was induced after treatment with proteasome and HSP90 inhibitors or heat shock, was the molecular chaperone HSP70. We show that HSP70 binds to FOXM1 following proteotoxic stress and that HSP70 inhibits FOXM1 DNA-binding ability. Inhibition of FOXM1 transcriptional autoregulation by HSP70 leads to the suppression of FOXM1 protein expression. In addition, HSP70 suppression elevates FOXM1 expression, and simultaneous inhibition of FOXM1 and HSP70 increases the sensitivity of human cancer cells to anticancer drug-induced apoptosis. Overall, we determined the unique and novel mechanism of FOXM1 suppression by proteasome inhibitors.	[Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Varaljai, Renata; Benevolenskaya, Elizaveta; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gartel, AL (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,Rm 1041, Chicago, IL 60612 USA.	agartel@uic.edu	Varaljai, Renata/AAR-3119-2020	Varaljai, Renata/0000-0001-6852-6859	National Institutes of Health [5R01CA138409, 5 T32 DK007788-14]; University of Illinois at Chicago; NATIONAL CANCER INSTITUTE [R01CA138409, R01CA138631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants 5R01CA138409 (to A. L. G.) and 5 T32 DK007788-14 (to M. H.) and a bridge funding grant from the University of Illinois at Chicago (to A. L. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Beshiri Michael L, 2010, J Vis Exp, DOI 10.3791/2101; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Crawford LJ, 2011, J CELL COMMUN SIGNAL, V5, P101, DOI 10.1007/s12079-011-0121-7; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Gartel AL, 2015, CANCER BIOL THER, V16, P185, DOI 10.4161/15384047.2014.987566; Gartel AL, 2011, CELL CYCLE, V10, P4341, DOI 10.4161/cc.10.24.18544; Gartel AL, 2010, EXPERT OPIN INV DRUG, V19, P235, DOI 10.1517/13543780903563364; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Grossin L, 2004, BIORHEOLOGY, V41, P521; Halasi M, 2013, BIOCHEM J, V454, P201, DOI 10.1042/BJ20130282; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2013, BIOCHEM PHARMACOL, V85, P644, DOI 10.1016/j.bcp.2012.10.013; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Jiang P, 2015, P NATL ACAD SCI USA, V112, P7731, DOI 10.1073/pnas.1424272112; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Matokanovic M, 2013, EUR J PHARM SCI, V50, P149, DOI 10.1016/j.ejps.2013.04.001; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Neznanov N, 2009, CELL CYCLE, V8, P3960, DOI 10.4161/cc.8.23.10179; Pandit B, 2011, CELL CYCLE, V10, P3269, DOI 10.4161/cc.10.19.17735; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349	37	24	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					142	148		10.1074/jbc.M115.678227	http://dx.doi.org/10.1074/jbc.M115.678227			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559972	Green Published, hybrid			2022-12-28	WOS:000367589500011
J	Fura, JM; Kearns, D; Pires, MM				Fura, Jonathan M.; Kearns, Daniel; Pires, Marcos M.			D-Amino Acid Probes for Penicillin Binding Protein-based Bacterial Surface Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; PEPTIDOGLYCAN BIOSYNTHESIS; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; CROSS-LINKING; INTRACELLULAR PATHOGEN; IN-VITRO; DIVISION; ANTIBIOTICS; REVEAL	Peptidoglycan is an essential and highly conserved mesh structure that surrounds bacterial cells. It plays a critical role in retaining a defined cell shape, and, in the case of pathogenic Gram-positive bacteria, it lies at the interface between bacterial cells and the host organism. Intriguingly, bacteria can metabolically incorporate unnatural D-amino acids into the peptidoglycan stem peptide directly from the surrounding medium, a process mediated by penicillin binding proteins (PBPs). Metabolic peptidoglycan remodeling via unnatural D-amino acids has provided unique insights into peptidoglycan biosynthesis of live bacteria and has also served as the basis of a synthetic immunology strategy with potential therapeutic implications. A striking feature of this process is the vast promiscuity displayed by PBPs in tolerating entirely unnatural side chains. However, the chemical space and physical features of this side chain promiscuity have not been determined systematically. In this report, we designed and synthesized a library of variants displaying diverse side chains to comprehensively establish the tolerability of unnatural D-amino acids by PBPs in both Gram-positive and Gram-negative organisms. In addition, nine Bacillus subtilis PBP-null mutants were evaluated with the goal of identifying a potential primary PBP responsible for unnatural D-amino acid incorporation and gaining insights into the temporal control of PBP activity. We empirically established the scope of physical parameters that govern the metabolic incorporation of unnatural D-amino acids into bacterial peptidoglycan.	[Fura, Jonathan M.; Pires, Marcos M.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Kearns, Daniel] Indiana Univ, Dept Biol, Bloomington, IN USA	Lehigh University; Indiana University System; Indiana University Bloomington	Pires, MM (corresponding author), Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA.	map311@lehigh.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-GM113172]; Lehigh University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lehigh University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM113172 (to D. K.) and by Lehigh University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen NE, 1997, ANTIMICROB AGENTS CH, V41, P66, DOI 10.1128/AAC.41.1.66; Alvarez L, 2014, MICROB DRUG RESIST, V20, P190, DOI 10.1089/mdr.2014.0047; ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; BUGG TDH, 1992, NAT PROD REP, V9, P199, DOI 10.1039/np9920900199; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Fleurie A, 2014, NATURE, V516, P259, DOI 10.1038/nature13966; FRERE JM, 1985, CRC CR REV MICROBIOL, V11, P299; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fura JM, 2015, BIOPOLYMERS, V104, P351, DOI 10.1002/bip.22618; Fura JM, 2014, ACS CHEM BIOL, V9, P1480, DOI 10.1021/cb5002685; Gautam S, 2015, J AM CHEM SOC, V137, P7441, DOI 10.1021/jacs.5b02972; Jacquier N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4578; Kocaoglu O, 2012, ACS CHEM BIOL, V7, P1746, DOI 10.1021/cb300329r; Kuru E, 2015, NAT PROTOC, V10, P33, DOI 10.1038/nprot.2014.197; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lebar MD, 2014, J AM CHEM SOC, V136, P10874, DOI 10.1021/ja505668f; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Loskill P, 2014, BIOPHYS J, V107, P1082, DOI 10.1016/j.bpj.2014.07.029; Lupoli TJ, 2011, J AM CHEM SOC, V133, P10748, DOI 10.1021/ja2040656; MacKenzie DA, 2015, CHEM COMMUN, V51, P12501, DOI 10.1039/c5cc04901f; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Monteiro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9055; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Pidgeon SE, 2015, ANGEW CHEM INT EDIT, V54, P6158, DOI 10.1002/anie.201409927; Reed P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004891; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schouten JA, 2006, MOL BIOSYST, V2, P484, DOI 10.1039/b607908c; Shieh P, 2014, P NATL ACAD SCI USA, V111, P5456, DOI 10.1073/pnas.1322727111; Siegrist MS, 2015, CELL REP, V11, P499, DOI 10.1016/j.celrep.2015.03.046; Siegrist MS, 2013, ACS CHEM BIOL, V8, P500, DOI 10.1021/cb3004995; Sonenshein AL, 1993, BACILLUS SUBTILIS OT; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; UTSUI Y, 1985, ANTIMICROB AGENTS CH, V28, P397, DOI 10.1128/AAC.28.3.397; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141	44	34	35	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30540	30550		10.1074/jbc.M115.683342	http://dx.doi.org/10.1074/jbc.M115.683342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26499795	hybrid, Green Published			2022-12-28	WOS:000366738200029
J	Reiter, KH; Ramachandran, A; Xia, X; Boucher, LE; Bosch, J; Matunis, MJ				Reiter, Katherine H.; Ramachandran, Anita; Xia, Xue; Boucher, Lauren E.; Bosch, Juergen; Matunis, Michael J.			Characterization and Structural Insights into Selective E1-E2 Interactions in the Human and Plasmodium falciparum SUMO Conjugation Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; malaria; oxidative stress; plasmodium; small ubiquitin-like modifier (SUMO); ubiquitin-conjugating enzyme (E2 enzyme); ubiquitin fold domain (Ufd)	PROTEIN SUMOYLATION; UBIQUITIN; IDENTIFICATION; ENZYME; E2; RECRUITMENT; ACTIVATION; MECHANISM; SURVIVAL; DOMAIN	Protein modification by small ubiquitin-related modifiers (SUMOs) is essential and conserved in the malaria parasite, Plasmodium falciparum. We have previously shown that interactions between the SUMO E1-activating and E2-conjugating enzyme in P. falciparum are distinct compared with human, suggesting a potential target for development of parasite-specific inhibitors of SUMOylation. The parasite asexual trophozoite stage is susceptible to iron-induced oxidative stress and is subsequently a target for many of the current anti-malarial drugs. Here, we provide evidence that SUMOylation plays a role in the parasite response to oxidative stress during red blood cell stages, indicative of a protective role seen in other organisms. Using x-ray crystallography, we solved the structure of the human SUMO E1 ubiquitin fold domain in complex with the E2, Ubc9. The interface defined in this structure guided in silico modeling, mutagenesis, and in vitro biochemical studies of the P. falciparum SUMO E1 and E2 enzymes, resulting in the identification of surface residues that explain species-specific interactions. Our findings suggest that parasite-specific inhibitors of SUMOylation could be developed and used in combination therapies with drugs that induce oxidative stress.	[Reiter, Katherine H.; Ramachandran, Anita; Xia, Xue; Boucher, Lauren E.; Bosch, Juergen; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Boucher, Lauren E.; Bosch, Juergen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Matunis, MJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	mmatuni1@jhu.edu	; Bosch, Jurgen/E-9370-2011	Boucher, Lauren/0000-0003-3152-6155; Matunis, Michael/0000-0002-9350-6611; Bosch, Jurgen/0000-0002-2624-4105	National Institutes of Health [GM060980]; Sommer Scholar's Program; Bloomberg Family Foundation; National Institutes of Health Chemistry-Biology Interface Training Grant [T32GM080189]; Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sommer Scholar's Program; Bloomberg Family Foundation; National Institutes of Health Chemistry-Biology Interface Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health Grant GM060980 (to M. J. M.), the Sommer Scholar's Program (to K. H. R.), the Bloomberg Family Foundation (to J. B.), the National Institutes of Health Chemistry-Biology Interface Training Grant T32GM080189, and a predoctoral Fellowship from Johns Hopkins Malaria Research Institute (to L. E. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Conti L, 2009, PLANT SIGNAL BEHAV, V4, P225, DOI 10.4161/psb.4.3.7867; Doerig C, 2015, NAT REV MICROBIOL, V13, P160, DOI 10.1038/nrmicro3402; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Reiter K, 2013, J BIOL CHEM, V288, P27724, DOI 10.1074/jbc.M113.498410; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015805; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	46	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3860	3870		10.1074/jbc.M115.680801	http://dx.doi.org/10.1074/jbc.M115.680801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26697886	hybrid, Green Published			2022-12-28	WOS:000371338400015
J	Bhogal, MS; Lanyon-Hogg, T; Johnston, KA; Warriner, SL; Baker, A				Bhogal, Moninder S.; Lanyon-Hogg, Thomas; Johnston, Katherine A.; Warriner, Stuart L.; Baker, Alison			Covalent Label Transfer between Peroxisomal Importomer Components Reveals Export-driven Import Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN IMPORT; TARGETING SIGNAL RECEPTOR; SACCHAROMYCES-CEREVISIAE; IN-VITRO; CYCLING RECEPTOR; PLANT PEROXISOMES; ISOCITRATE LYASE; TYPE-1 RECEPTOR; PTS2 RECEPTOR; HUMAN PEX5	Peroxisomes are vital metabolic organelles found in almost all eukaryotic organisms, and they rely exclusively on import of their matrix protein content from the cytosol. In vitro import of proteins into isolated peroxisomal fractions has provided a wealth of knowledge on the import process. However, the common method of protease protection garnered no information on the import of an N-terminally truncated PEX5 (PEX5C) receptor construct or peroxisomal malate dehydrogenase 1 (pMDH1) cargo protein into sunflower peroxisomes because of high degrees of protease susceptibility or resistance, respectively. Here we present a means for analysis of in vitro import through a covalent biotin label transfer and employ this method to the import of PEX5C. Label transfer demonstrates that the PEX5C construct is monomeric under the conditions of the import assay. This technique was capable of identifying the PEX5-PEX14 interaction as the first interaction of the import process through competition experiments. Labeling of the peroxisomal protein import machinery by PEX5C demonstrated that this interaction was independent of added cargo protein, and, strikingly, the interaction between PEX5C and the import machinery was shown to be ATP-dependent. These important mechanistic insights highlight the power of label transfer in studying interactions, rather than proteins, of interest and demonstrate that this technique should be applied to future studies of peroxisomal in vitro import.	[Bhogal, Moninder S.; Lanyon-Hogg, Thomas; Johnston, Katherine A.; Baker, Alison] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Bhogal, Moninder S.; Lanyon-Hogg, Thomas; Johnston, Katherine A.; Baker, Alison] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Lanyon-Hogg, Thomas; Warriner, Stuart L.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Lanyon-Hogg, Thomas; Warriner, Stuart L.] Univ Leeds, Astbury Ctr, Leeds LS2 9JT, W Yorkshire, England; [Bhogal, Moninder S.] Univ Leeds, Leeds Inst Clin Trials Res, Leeds LS2 9JT, W Yorkshire, England; [Lanyon-Hogg, Thomas] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds; Imperial College London	Baker, A (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Ctr Plant Sci, Manton 9-05, Leeds LS2 9JT, W Yorkshire, England.	a.baker@leeds.ac.uk		Lanyon-Hogg, Thomas/0000-0002-7092-8096; Warriner, Stuart/0000-0002-7589-6011	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; University of Leeds Centre for Plant Sciences;  [BB/D D000904/1]; Biotechnology and Biological Sciences Research Council [BB/D000904/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leeds Centre for Plant Sciences; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a BB/D D000904/1 grant to A.B. Present address: Leeds Institute of Clinical Trials Research, University of Leeds, Leeds LS2 9JT, UK.r Supported by the Engineering and Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, and the University of Leeds Centre for Plant Sciences doctoral training studentship. Present address: Department of Chemistry, Imperial College London, London SW7 2AZ, UK.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Baker A, 2014, CURR OPIN PLANT BIOL, V22, P39, DOI 10.1016/j.pbi.2014.09.003; BEHARI R, 1993, J BIOL CHEM, V268, P7315; Brickner DG, 1997, PLANT PHYSIOL, V113, P1213, DOI 10.1104/pp.113.4.1213; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brown AI, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003426; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Cui S, 2013, J BIOL CHEM, V288, P6014, DOI 10.1074/jbc.M112.438143; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Francisco T, 2014, BIOCHIMIE, V98, P29, DOI 10.1016/j.biochi.2013.08.003; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Gao XP, 1996, PLANT PHYSIOL, V112, P1457, DOI 10.1104/pp.112.4.1457; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Hagstrom D, 2014, MOL BIOL CELL, V25, P2634, DOI 10.1091/mbc.E13-12-0716; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Harper CC, 2003, J BIOL CHEM, V278, P7897, DOI 10.1074/jbc.M206651200; Helm M, 2007, P NATL ACAD SCI USA, V104, P11501, DOI 10.1073/pnas.0704733104; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; HORNG JT, 1995, EUR J BIOCHEM, V230, P157, DOI 10.1111/j.1432-1033.1995.tb20546.x; Johnson TL, 2003, PLANT PHYSIOL, V133, P1991, DOI 10.1104/pp.103.028217; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Kunau WH, 2001, CURR BIOL, V11, pR659, DOI 10.1016/S0960-9822(01)00386-4; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Lanyon-Hogg T, 2014, FEBS LETT, V588, P2223, DOI 10.1016/j.febslet.2014.05.038; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyauchi-Nanri Y, 2014, BIOCHEM J, V463, P65, DOI 10.1042/BJ20130861; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Pool MR, 1998, EMBO J, V17, P6854, DOI 10.1093/emboj/17.23.6854; Pracharoenwattana I, 2007, PLANT J, V50, P381, DOI 10.1111/j.1365-313X.2007.03055.x; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Rodrigues TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11806; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schuhmann H, 2008, PLANT PHYSIOL, V148, P1847, DOI 10.1104/pp.108.125377; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; Skoulding NS, 2015, J MOL BIOL, V427, P1085, DOI 10.1016/j.jmb.2014.12.003; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	70	7	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2460	2468		10.1074/jbc.M115.686501	http://dx.doi.org/10.1074/jbc.M115.686501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26567336	Green Published, hybrid			2022-12-28	WOS:000369610400034
J	Jain, N; Morgan, CE; Rife, BD; Salemi, M; Tolbert, BS				Jain, Niyati; Morgan, Christopher E.; Rife, Brittany D.; Salemi, Marco; Tolbert, Blanton S.			Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA STRUCTURE; BIOLOGICAL MACROMOLECULES; STRUCTURE PREDICTION; SECONDARY STRUCTURE; SOLUTION SCATTERING; EXON; BINDING; NMR; TAT	Splicing patterns in human immunodeficiency virus type 1 (HIV-1) are maintained through cis regulatory elements that recruit antagonistic host RNA-binding proteins. The activity of the 3' acceptor site A7 is tightly regulated through a complex network of an intronic splicing silencer (ISS), a bipartite exonic splicing silencer (ESS3a/b), and an exonic splicing enhancer (ESE3). Because HIV-1 splicing depends on protein-RNA interactions, it is important to know the tertiary structures surrounding the splice sites. Herein, we present the NMR solution structure of the phylogenetically conserved ISS stem loop. ISS adopts a stable structure consisting of conserved UG wobble pairs, a folded 2X2 (GU/UA) internal loop, a UU bulge, and a flexible AGUGA apical loop. Calorimetric and biochemical titrations indicate that the UP1 domain of heterogeneous nuclear ribonucleoprotein A1 binds the ISS apical loop site-specifically and with nanomolar affinity. Collectively, this work provides additional insights into how HIV-1 uses a conserved RNA structure to commandeer a host RNA-binding protein.	[Jain, Niyati; Morgan, Christopher E.; Tolbert, Blanton S.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Rife, Brittany D.; Salemi, Marco] Univ Florida, Dept Pathol Immunol, Gainesville, FL 32610 USA; [Rife, Brittany D.; Salemi, Marco] Univ Florida, Lab Med, Coll Med, Gainesville, FL 32610 USA; [Rife, Brittany D.; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA	Case Western Reserve University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tolbert, BS (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.	bst18@case.edu		Rife Magalis, Brittany/0000-0001-6088-4651	National Science Foundation [1334048]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [P41 GM103622]; National Institutes of Health [1S10OD018090-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101979, P50GM103297, P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Bruker Avance III HD (500-MHz) spectrometer and Prodigy broadband cryoprobe were purchased using funds provided by National Science Foundation Grant 1334048. This research also used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This project was also supported by Grant P41 GM103622 from the National Institute of General Medical Sciences of the National Institutes of Health. Use of the Pilatus 3 1M detector was provided by National Institutes of Health Grant 1S10OD018090-1.	Al-Hashimi HM, 2002, J MOL BIOL, V315, P95, DOI 10.1006/jmbi.2001.5235; AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Asai K, 2003, VIROLOGY, V314, P229, DOI 10.1016/S0042-6822(03)00400-8; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clore GM, 2003, J AM CHEM SOC, V125, P1518, DOI 10.1021/ja028383j; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lavender CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004230; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Levengood JD, 2012, J MOL BIOL, V415, P680, DOI 10.1016/j.jmb.2011.11.034; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; Morgan CE, 2015, J MOL BIOL, V427, P3241, DOI 10.1016/j.jmb.2015.05.009; Mueller N, 2015, J GEN VIROL, V96, P1906, DOI 10.1099/vir.0.000122; Mueller N, 2014, VIROLOGY, V468, P609, DOI 10.1016/j.virol.2014.09.018; Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rollins C, 2014, BIOCHEMISTRY-US, V53, P2172, DOI 10.1021/bi500180p; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Sukosd Z, 2015, NUCLEIC ACIDS RES, V43, P10168, DOI 10.1093/nar/gkv1039; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tange TO, 2001, J MOL BIOL, V312, P649, DOI 10.1006/jmbi.2001.4971; Tange TO, 2001, EMBO J, V20, P5748; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolbert BS, 2010, J BIOMOL NMR, V47, P205, DOI 10.1007/s10858-010-9424-x; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wu XW, 2013, J STRUCT BIOL, V183, P429, DOI 10.1016/j.jsb.2013.07.006	51	21	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2331	2344		10.1074/jbc.M115.674564	http://dx.doi.org/10.1074/jbc.M115.674564			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26607354	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000369610400023
J	Abbadi, A; Lauer, M; Swaidani, S; Wang, AM; Hascall, V				Abbadi, Amina; Lauer, Mark; Swaidani, Shadi; Wang, Aimin; Hascall, Vincent			Hyaluronan Rafts on Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; SMOOTH-MUSCLE-CELLS; ENDOPLASMIC-RETICULUM STRESS; HEAVY-CHAIN TRANSFER; TRYPSIN INHIBITOR; LEUKOCYTE ADHESION; PROTEIN TSG-6; GLYCOSAMINOGLYCANS; SYNTHESIZE	Many cells, including murine airway epithelial cells, respond to a variety of inflammatory stimuli by synthesizing leukocyteadhesive hyaluronan (HA) cables that remain attached to their cell surfaces. This study shows that air-liquid interface cultures of murine airway epithelial cells (AECs) also actively synthesize and release a majority of their HA onto their ciliated apical surfaces to form a heavy chain hyaluronan (HC-HA) matrix in the absence of inflammatory stimuli. These matrices do not resemble the rope-like HA cables but occur in distinct sheets or rafts that can capture and embed leukocytes from cell suspensions. The HC-HA modification involves the transfer of heavy chains from the inter-alpha-inhibitor (I alpha I) proteoglycan, which has two heavy chains (HC1 and HC2) on its chondroitin sulfate chain. The transesterification transfer of HCs from chondroitin sulfate to HA is mediated by tumor necrosis factor-induced gene 6 (TSG-6), which is up-regulated in inflammatory reactions. Because the AEC cultures do not have TSG-6 nor serum, the source of I alpha I, assays for HCs and TSG-6 were done. The results show that AECs synthesize TSG-6 and their own heavy chain donor (pre-I alpha I) with a single heavy chain 3 (HC3), which are also constitutively expressed by human renal proximal tubular epithelial cells. These leukocyte adhesive HC3-HA structures were also found in the bronchoalveolar lavage of naive mice and were observed on their apical ciliated surfaces. Thus, these leukocyte-adhesive HA rafts are now identified as HC3-HA complexes that could be part of a host defense mechanism filling some important gaps in our current understanding of murine airway epithelial biology and secretions.	[Abbadi, Amina; Lauer, Mark; Wang, Aimin; Hascall, Vincent] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Swaidani, Shadi] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Abbadi, Amina] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Hascall, V (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.	hascalv@ccf.org		Swaidani, Shadi/0000-0003-1506-4472	National Institutes of Health [P01HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL113325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL107147 (NHLBI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Janssen U, 2001, KIDNEY INT, V60, P126, DOI 10.1046/j.1523-1755.2001.00779.x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Zhang XL, 2004, AM J PATHOL, V165, P763, DOI 10.1016/S0002-9440(10)63339-1; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	40	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1448	1455		10.1074/jbc.M115.704288	http://dx.doi.org/10.1074/jbc.M115.704288			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601955	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000368068300035
J	Shi, W; Zeng, Q; Kunkel, BN; Running, MP				Shi, Wan; Zeng, Qin; Kunkel, Barbara N.; Running, Mark P.			Arabidopsis Rab Geranylgeranyltransferases Demonstrate Redundancy and Broad Substrate Specificity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE BETA-SUBUNIT; PROTEIN GAMMA-SUBUNIT; ABSCISIC-ACID; COMPONENT-A; TIP GROWTH; PRENYLATION; GTPASE; RESOURCE; GENE; FARNESYLTRANSFERASE	Posttranslational lipid modifications mediate the membrane attachment of Rab GTPases, facilitating their function in regulating intracellular vesicular trafficking. In Arabidopsis, most Rab GTPases have two C-terminal cysteines and potentially can be double-geranylgeranylated by heterodimeric Rab geranylgeranyltransferases (Rab-GGTs). Genes encoding two putative alpha subunits and two putative beta subunits of Rab-GGTs have been annotated in the Arabidopsis thaliana genome, but little is known about Rab-GGT activity in Arabidopsis. In this study, we demonstrate that four different heterodimers can be formed between putative Arabidopsis Rab-GGT alpha subunits RGTA1/ RGTA2 and beta subunits RGTB1/RGTB2, but only RGTA1.RGTB1 and RGTA1.RGTB2 exhibit bona fide Rab-GGT activity, and they are biochemically redundant in vitro. We hypothesize that RGTA2 function might be disrupted by a 12-amino acid insertion in a conserved motif. We present evidence that Arabidopsis Rab-GGTs may have preference for prenylation of C-terminal cysteines in particular positions. We also demonstrate that Arabidopsis Rab-GGTs can not only prenylate a great variety of Rab GTPases in the presence of Rab escort protein but, unlike Rab-GGT in yeast and mammals, can also prenylate certain non-Rab GTPases independently of Rab escort protein. Our findings may help to explain some of the phenotypes of Arabidopsis protein prenyltransferase mutants.	[Shi, Wan; Kunkel, Barbara N.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zeng, Qin] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Running, Mark P.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; University of Louisville	Running, MP (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	mark.running@louisville.edu	Running, Mark P./R-8950-2019		Kentucky Science and Engineering Foundation [KSEF-2841-RDE-016]; National Science Foundation [NSF-IIA-1355438, NSF-IOS-1456884]; Direct For Biological Sciences [1456884] Funding Source: National Science Foundation; Office of Integrative Activities [1355438] Funding Source: National Science Foundation	Kentucky Science and Engineering Foundation; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by Kentucky Science and Engineering Foundation Grant KSEF-2841-RDE-016 and National Science Foundation Grants NSF-IIA-1355438 and NSF-IOS-1456884 (to M.P.R.). The authors declare that they have no conflicts of interest with the contents of this article.	Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; Baron RA, 2008, BIOCHEM J, V415, P67, DOI 10.1042/BJ20080662; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biermann B, 1996, PLANT MOL BIOL, V31, P1021, DOI 10.1007/BF00040720; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Charng WL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001777; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Durek T, 2004, J AM CHEM SOC, V126, P16368, DOI 10.1021/ja046164n; Dursina B, 2002, BIOCHEMISTRY-US, V41, P6805, DOI 10.1021/bi016067w; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Galichet A, 2003, CURR OPIN PLANT BIOL, V6, P530, DOI 10.1016/j.pbi.2003.09.005; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Gutkowska M, 2015, J EXP BOT, V66, P213, DOI 10.1093/jxb/eru412; Hala M, 2005, J MOL BIOL, V348, P1299, DOI 10.1016/j.jmb.2005.02.002; Hala M, 2010, PLANT J, V62, P615, DOI 10.1111/j.1365-313X.2010.04172.x; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; Loraine AE, 1996, PLANT PHYSIOL, V110, P1337, DOI 10.1104/pp.110.4.1337; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Maurer-Stroh S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-212; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Molendijk AJ, 2004, CURR OPIN PLANT BIOL, V7, P694, DOI 10.1016/j.pbi.2004.09.014; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pinheiro H, 2009, J CELL SCI, V122, P3749, DOI 10.1242/jcs.050625; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rasteiro R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-140; Running MP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00050; Running MP, 1998, DEVELOPMENT, V125, P2545; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; SANFORD JC, 1995, ANAL BIOCHEM, V224, P547, DOI 10.1006/abio.1995.1086; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; Shi W, 2013, METHODS MOL BIOL, V1043, P147, DOI 10.1007/978-1-62703-532-3_16; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sorek N, 2011, PLANT PHYSIOL, V155, P706, DOI 10.1104/pp.110.166850; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Tanaka D, 2008, GENES CELLS, V13, P1141, DOI 10.1111/j.1365-2443.2008.01232.x; Thole JM, 2014, PLANT J, V78, P441, DOI 10.1111/tpj.12484; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Wu YW, 2009, J BIOL CHEM, V284, P13185, DOI 10.1074/jbc.M900579200; Yalovsky S, 1996, PLANT PHYSIOL, V110, P1349, DOI 10.1104/pp.110.4.1349; Yalovsky S, 2000, PLANT CELL, V12, P1267, DOI 10.1105/tpc.12.8.1267; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7; Zhang H., 2006, HDB METALLOPROTEINS, DOI [10.1002/0470028637.met002, DOI 10.1002/0470028637.MET002]	70	6	12	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1398	1410		10.1074/jbc.M115.673491	http://dx.doi.org/10.1074/jbc.M115.673491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26589801	hybrid, Green Published			2022-12-28	WOS:000368068300031
J	Ghanem, SS; Heinrich, G; Lester, SG; Pfeiffer, V; Bhattacharya, S; Patel, PR; DeAngelis, AM; Dai, T; Ramakrishnan, SK; Smiley, ZN; Jung, DY; Lee, Y; Kitamura, T; Ergun, S; Kulkarni, RN; Kim, JK; Giovannucci, DR; Najjar, SM				Ghanem, Simona S.; Heinrich, Garrett; Lester, Sumona G.; Pfeiffer, Verena; Bhattacharya, Sumit; Patel, Payal R.; DeAngelis, Anthony M.; Dai, Tong; Ramakrishnan, Sadeesh K.; Smiley, Zachary N.; Jung, Dae Y.; Lee, Yongjin; Kitamura, Tadahiro; Ergun, Suleyman; Kulkarni, Rohit N.; Kim, Jason K.; Giovannucci, David R.; Najjar, Sonia M.			Increased Glucose-induced Secretion of Glucagon-like Peptide-1 in Mice Lacking the Carcinoembryonic Antigenrelated Cell Adhesion Molecule 2 (CEACAM2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; ENERGY-BALANCE; BETA-CELL; HOMEOSTASIS; EXPRESSION; SUBSTRATE; KINASE; BRAIN; MODEL	Carcinoembryonic antigen-related cell adhesion molecule 2 (CEACAM2) regulates food intake as demonstrated by hyperphagia in mice with the Ceacam2 null mutation (Cc2(-/-)). This study investigated whether CEACAM2 also regulates insulin secretion. Ceacam2 deletion caused an increase in beta-cell secretory function, as assessed by hyperglycemic clamp analysis, without affecting insulin response. Although CEACAM2 is expressed in pancreatic islets predominantly in non-beta-cells, basal plasma levels of insulin, glucagon and somatostatin, islet areas, and glucose-induced insulin secretion in pooled Cc2(-/-) islets were all normal. Consistent with immunofluorescence analysis showing CEACAM2 expression in distal intestinal villi, Cc2(-/-) mice exhibited a higher release of oral glucose-mediated GLP-1, an incretin that potentiates insulin secretion in response to glucose. Compared with wild type, Cc2(-/-) mice also showed a higher insulin excursion during the oral glucose tolerance test. Pretreating with exendin(9-39), a GLP-1 receptor antagonist, suppressed the effect of Ceacam2 deletion on glucose-induced insulin secretion. Moreover, GLP-1 release into the medium of GLU Tag enteroendocrine cells was increased with siRNA-mediated Ceacam2 down-regulation in parallel to an increase in Ca2+ entry through L-type voltage-dependent Ca2+ channels. Thus, CEACAM2 regulates insulinsecretion, atleastinpart, by a GLP-1-mediated mechanism, independent of confounding metabolic factors.	[Ghanem, Simona S.; Heinrich, Garrett; Lester, Sumona G.; Patel, Payal R.; DeAngelis, Anthony M.; Dai, Tong; Ramakrishnan, Sadeesh K.; Smiley, Zachary N.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Ghanem, Simona S.; Heinrich, Garrett; Lester, Sumona G.; Patel, Payal R.; DeAngelis, Anthony M.; Dai, Tong; Ramakrishnan, Sadeesh K.; Smiley, Zachary N.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, Dept Neurosci, Toledo, OH 43614 USA; [Pfeiffer, Verena] Univ Wurzburg, Inst Anat & Zellbiol, D-97070 Wurzburg, Germany; [Jung, Dae Y.; Lee, Yongjin; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kitamura, Tadahiro] Gunma Univ, Metab Signal Res Ctr, Inst Mol & Cellular Regulat, Gunma 3718512, Japan; [Kulkarni, Rohit N.] Brigham & Womens Hosp, Joslin Diabet Ctr, Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Kulkarni, Rohit N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University of Wurzburg; University of Massachusetts System; University of Massachusetts Worcester; Gunma University; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital	Najjar, SM (corresponding author), Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, 3000 Arlington Ave,Mail Stop 1009, Toledo, OH 43614 USA.	sonia.najjar@utoledo.edu	Giovannucci, David R/A-5657-2018; Najjar, Sonia M/GXW-2217-2022	Kim, Jason/0000-0002-7185-042X	National Institutes of Health [R01 DK054254, R01 DK083850, R01 HL112248, R01 DK67536, R01 DK103215, R21 DE023418, U24-DK093000]; United States Department of Agriculture Grant USDA [38903-19826]; Deutsche Forschungsgemeinschaft [ER 276/9-1 TI 690/3-1, SFB 688/3 A19]; Middle-East Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE023418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, U2CDK093000, R01DK083850, R01DK103215, P30DK036836, R01DK067536, U24DK093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Grant USDA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Middle-East Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S. M. N.), Grants R01 DK67536 and R01 DK103215 (to R. N. K.), Grant R21 DE023418 (to D. R. G.), and Grant U24-DK093000 (to the National Mouse Metabolic Phenotyping Center at University of Massachusetts), United States Department of Agriculture Grant USDA 38903-19826 (to S. M. N.), and Deutsche Forschungsgemeinschaft Grants ER 276/9-1 TI 690/3-1 and SFB 688/3 A19 (to S. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a predoctoral fellowship from the Middle-East Diabetes Research Center.	Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Alshahrani MM, 2014, BLOOD, V124, P2431, DOI 10.1182/blood-2014-04-569707; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chan O, 2013, TRENDS ENDOCRIN MET, V24, P616, DOI 10.1016/j.tem.2013.08.005; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; DALESSIO DA, 1994, J CLIN INVEST, V93, P2263, DOI 10.1172/JCI117225; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Habib AM, 2013, DIABETOLOGIA, V56, P1413, DOI 10.1007/s00125-013-2887-z; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Heinrich G, 2010, GASTROENTEROLOGY, V139, P644, DOI 10.1053/j.gastro.2010.03.056; Iakoubov R, 2007, ENDOCRINOLOGY, V148, P1089, DOI 10.1210/en.2006-1403; Josefsen K, 1996, J ENDOCRINOL, V149, P145, DOI 10.1677/joe.0.1490145; Kedees MH, 2013, PEPTIDES, V48, P36, DOI 10.1016/j.peptides.2013.07.022; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Osundiji MA, 2012, DIABETES, V61, P321, DOI 10.2337/db11-1050; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Patel PR, 2012, DIABETOLOGIA, V55, P763, DOI 10.1007/s00125-011-2388-x; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Reimann F, 2005, J PHYSIOL-LONDON, V563, P161, DOI 10.1113/jphysiol.2004.076414; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Robitaille J, 1999, EUR J BIOCHEM, V264, P534, DOI 10.1046/j.1432-1327.1999.00660.x; Salaheldeen E, 2012, MOL REPROD DEV, V79, P843, DOI 10.1002/mrd.22123; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Shalev A, 1997, EUR J ENDOCRINOL, V137, P220, DOI 10.1530/eje.0.1370220; Sidhu SS, 2000, J PHYSIOL-LONDON, V528, P165, DOI 10.1111/j.1469-7793.2000.00165.x; Thorens B, 2010, DIABETES METAB, V36, pS45, DOI 10.1016/S1262-3636(10)70466-3; Xu E, 2009, ENDOCRINOLOGY, V150, P3503, DOI 10.1210/en.2008-1439; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	36	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					980	988		10.1074/jbc.M115.692582	http://dx.doi.org/10.1074/jbc.M115.692582			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26586918	Green Published, hybrid			2022-12-28	WOS:000367830500043
J	Lim, HJ; Kim, J; Park, CH; Lee, SA; Lee, MR; Kim, KS; Kim, J; Bae, YS				Lim, Hee Jung; Kim, Jusong; Park, Chang-Hwan; Lee, Sang A.; Lee, Man Ryul; Kim, Kye-Seong; Kim, Jaesang; Bae, Yun Soo			Regulation of c-Myc Expression by Ahnak Promotes Induced Pluripotent Stem Cell Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTORS; TRANSCRIPTION FACTOR; SOMATIC-CELLS; PROTEIN; MOUSE; INHIBITION; EFFICIENCY; INDUCTION	We have previously reported that Ahnak-mediated TGF beta signaling leads to down-regulation of c-Myc expression. Here, we show that inhibition of Ahnak can promote generation of induced pluripotent stem cells (iPSC) via up-regulation of endogenous c-Myc. Consistent with the c-Myc inhibitory role of Ahnak, mouse embryonic fibroblasts from Ahnak-deficient mouse (Ahnak(-/-) MEF) show an increased level of c-Myc expression compared with wild type MEF. Generation of iPSC with just three of the four Yamanaka factors, Oct4, Sox2, and Klf4 (hereafter 3F), was significantly enhanced in Ahnak(-/-) MEF. Similar results were obtained when Ahnak-specific shRNA was applied to wild type MEF. Of note, expression of Ahnak was significantly induced during the formation of embryoid bodies from embryonic stem cells, suggesting that Ahnak-mediated c-Myc inhibition is involved in embryoid body formation and the initial differentiation of pluripotent stem cells. The iPSC from 3F-infected Ahnak(-/-) MEF cells (Ahnak(-/-) - iPSC-3F) showed expression of all stem cell markers examined and the capability to form three primary germ layers. Moreover, injection of Ahnak(-/-) - iPSC-3F into athymic nude mice led to development of teratoma containing tissues from all three primary germ layers, indicating that iPSC from Ahnak(-/-) MEF are bona fide pluripotent stem cells. Taken together, these data provide evidence for a new role for Ahnak in cell fate determination during development and suggest that manipulation of Ahnak and the associated signaling pathway may provide a means to regulate iPSC generation.	[Lim, Hee Jung; Kim, Jusong; Kim, Jaesang; Bae, Yun Soo] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Park, Chang-Hwan; Kim, Kye-Seong] Hanyang Univ, Dept Biomed Sci, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Lee, Sang A.; Lee, Man Ryul] Soon Chun Hyang Univ, Soonchunhyang Inst Med Biosci, Cheonan 31538, South Korea	Ewha Womans University; Hanyang University; Soonchunhyang University	Kim, J (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea.	jkim1964@ewha.ac.kr; baeys@ewha.ac.kr			National Research Foundation of Korea [2012R1A5A1048236]; Bio & Medical Technology Development Program [2012M3A9B4028785]; Redoxomics Grant - Ministry of Science, ICT & Future Planning [2012M3A9C5048708]; Ministry of Health & Welfare, Republic of Korea [A120262]	National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program; Redoxomics Grant - Ministry of Science, ICT & Future Planning; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant 2012R1A5A1048236, by Bio & Medical Technology Development Program Grant 2012M3A9B4028785, Redoxomics Grant 2012M3A9C5048708 funded by the Ministry of Science, ICT & Future Planning. This work was also supported by Grant A120262 from the Ministry of Health & Welfare, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chiou SH, 2013, J EXP MED, V210, P85, DOI 10.1084/jem.20121044; Choi MK, 2014, MOL CELLS, V37, P337, DOI 10.14348/molcells.2014.0021; Dai P, 2014, SCI REP-UK, V4, DOI 10.1038/srep07323; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lim HJ, 2013, CARDIOVASC RES, V97, P302, DOI 10.1093/cvr/cvs311; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sekiya F, 1999, J BIOL CHEM, V274, P13900, DOI 10.1074/jbc.274.20.13900; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan FZ, 2015, J BIOL CHEM, V290, P4500, DOI 10.1074/jbc.M114.609016; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Vrbsky J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127739; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	29	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					752	761		10.1074/jbc.M115.659276	http://dx.doi.org/10.1074/jbc.M115.659276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26598518	Green Published, hybrid			2022-12-28	WOS:000367830500023
J	Bhardwaj, A; Sankhala, RS; Olia, AS; Brooke, D; Casjens, SR; Taylor, DJ; Prevelige, PE; Cingolani, G				Bhardwaj, Anshul; Sankhala, Rajeshwer S.; Olia, Adam S.; Brooke, Dewey; Casjens, Sherwood R.; Taylor, Derek J.; Prevelige, Peter E., Jr.; Cingolani, Gino			Structural Plasticity of the Protein Plug That Traps Newly Packaged Genomes in Podoviridae Virions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; hydrogen-deuterium exchange; infection; protein folding; x-ray crystallography; DNA packaging; tail needle; trimer of hairpins; viral genome ejection	TAIL NEEDLE GP26; ATOMIC-STRUCTURE; 3-DIMENSIONAL STRUCTURE; MOLECULAR REPLACEMENT; PHAGE-P22; BACTERIOPHAGE-P22; DNA; ARCHITECTURE; EVOLUTION; REVEALS	Bacterial viruses of the P22-like family encode a specialized tail needle essential for genome stabilization after DNA packaging and implicated in Gram-negative cell envelope penetration. The atomic structure of P22 tail needle (gp26) crystallized at acidic pH reveals a slender fiber containing an N-terminal trimer of hairpins tip. Although the length and composition of tail needles vary significantly in Podoviridae, unexpectedly, the amino acid sequence of the N-terminal tip is exceptionally conserved in more than 200 genomes of P22-like phages and prophages. In this paper, we used x-ray crystallography and EM to investigate the neutral pH structure of three tail needles from bacteriophage P22, HK620, and Sf6. In all cases, we found that the N-terminal tip is poorly structured, in stark contrast to the compact trimer of hairpins seen in gp26 crystallized at acidic pH. Hydrogen-deuterium exchange mass spectrometry, limited proteolysis, circular dichroism spectroscopy, and gel filtration chromatography revealed that the N-terminal tip is highly dynamic in solution and unlikely to adopt a stable trimeric conformation at physiological pH. This is supported by the cryo-EM reconstruction of P22 mature virion tail, where the density of gp26 N-terminal tip is incompatible with a trimer of hairpins. We propose the tail needle N-terminal tip exists in two conformations: a pre-ejection extended conformation, which seals the portal vertex after genome packaging, and a postejection trimer of hairpins, which forms upon its release from the virion. The conformational plasticity of the tail needle N-terminal tip is built in the amino acid sequence, explaining its extraordinary conservation in nature.	[Bhardwaj, Anshul; Sankhala, Rajeshwer S.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Olia, Adam S.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Brooke, Dewey; Prevelige, Peter E., Jr.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Taylor, Derek J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Cingolani, Gino] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy	Jefferson University; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Case Western Reserve University; Consiglio Nazionale delle Ricerche (CNR)	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	Brooke, Dewey/AAZ-8307-2021	Brooke, Dewey/0000-0003-4290-3809; Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [GM100888, GM114817]; NCI Cancer Center [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM114817, R01GM100888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants GM100888 (to G. C.) and GM114817 (to S. R. C.). Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Andrews D, 2005, J BIOL CHEM, V280, P5929, DOI 10.1074/jbc.C400513200; BERGET PB, 1980, J VIROL, V34, P234, DOI 10.1128/JVI.34.1.234-243.1980; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; Bhardwaj A, 2014, ACTA CRYSTALLOGR D, V70, P342, DOI 10.1107/S1399004713027685; Bhardwaj A, 2011, J BIOL CHEM, V286, P30867, DOI 10.1074/jbc.M111.260877; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2006, ACTA CRYSTALLOGR F, V62, P477, DOI 10.1107/S1744309106013856; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; ISRAEL V, 1978, J GEN VIROL, V40, P669, DOI 10.1099/0022-1317-40-3-669; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Jin Y, 2015, VIROLOGY, V485, P128, DOI 10.1016/j.virol.2015.07.006; KASHKET ER, 1982, BIOCHEMISTRY-US, V21, P5534, DOI 10.1021/bi00265a024; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Leavitt JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070936; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNulty R, 2015, J MOL BIOL, V427, P3285, DOI 10.1016/j.jmb.2015.08.013; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parent KN, 2012, VIROLOGY, V427, P177, DOI 10.1016/j.virol.2012.01.040; POTEETE AR, 1977, VIROLOGY, V76, P725, DOI 10.1016/0042-6822(77)90254-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Roy A, 2012, J BIOL CHEM, V287, P28196, DOI 10.1074/jbc.M112.349894; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880	53	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					215	226		10.1074/jbc.M115.696260	http://dx.doi.org/10.1074/jbc.M115.696260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26574546	Green Published, hybrid			2022-12-28	WOS:000367589500017
J	Rakers, C; Schumacher, F; Meinl, W; Glatt, H; Kleuser, B; Wolber, G				Rakers, Christin; Schumacher, Fabian; Meinl, Walter; Glatt, Hansruedi; Kleuser, Burkhard; Wolber, Gerhard			In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; drug metabolism; liver metabolism; molecular dynamics; molecular modeling; sulfotransferase	HUMAN ESTROGEN SULFOTRANSFERASE; SULFURYL TRANSFER; SUBSTRATE-INHIBITION; BINDING-SITE; FORCE-FIELD; METABOLISM; MECHANISM; ACTIVATION; CELLS; PAPS	Acting during phase II metabolism, sulfotransferases (SULTs) serve detoxification by transforming a broad spectrum of compounds from pharmaceutical, nutritional, or environmental sources into more easily excretable metabolites. However, SULT activity has also been shown to promote formation of reactive metabolites that may have genotoxic effects. SULT subtype 1E1 (SULT1E1) was identified as a key player in estrogen homeostasis, which is involved in many physiological processes and the pathogenesis of breast and endometrial cancer. The development of an in silico prediction model for SULT1E1 ligands would therefore support the development of metabolically inert drugs and help to assess health risks related to hormonal imbalances. Here, we report on a novel approach to develop a model that enables prediction of substrates and inhibitors of SULT1E1. Molecular dynamics simulations were performed to investigate enzyme flexibility and sample protein conformations. Pharmacophores were developed that served as a cornerstone of the model, and machine learning techniques were applied for prediction refinement. The prediction model was used to screen the DrugBank (a database of experimental and approved drugs): 28% of the predicted hits were reported in literature as ligands of SULT1E1. From the remaining hits, a selection of nine molecules was subjected to biochemical assay validation and experimental results were in accordance with the in silico prediction of SULT1E1 inhibitors and substrates, thus affirming our prediction hypotheses.	[Rakers, Christin; Wolber, Gerhard] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany; [Meinl, Walter] German Inst Human Nutr DIfE Potsdam Rehbrucke, Dept Mol Toxicol, D-14558 Nuthetal, Germany; [Meinl, Walter; Glatt, Hansruedi] German Inst Human Nutr DIfE Potsdam Rehbrucke, Dept Nutr Toxicol, D-14558 Nuthetal, Germany; [Schumacher, Fabian; Kleuser, Burkhard] Univ Potsdam, Inst Nutr Sci, Dept Toxicol, D-14558 Nuthetal, Germany; [Schumacher, Fabian] Univ Duisburg Essen, Dept Mol Biol, D-45147 Essen, Germany	Free University of Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam; University of Duisburg Essen	Wolber, G (corresponding author), Free Univ Berlin, Inst Pharm, Konigin Luise Str 2-4, D-14195 Berlin, Germany.	gerhard.wolber@fu-berlin.de	Schumacher, Fabian/ABC-1750-2020; Wolber, Gerhard/C-7133-2008; Wolber, Gerhard/ABD-4955-2020	Schumacher, Fabian/0000-0001-8703-3275; Wolber, Gerhard/0000-0002-5344-0048; Wolber, Gerhard/0000-0002-5344-0048; Meinl, Walter/0000-0003-3836-9164; Kleuser, Burkhard/0000-0002-1888-9595; Rakers, Christin/0000-0002-5668-6844	Elsa-Neumann Stipendium of the state Berlin	Elsa-Neumann Stipendium of the state Berlin	This work was supported by a Elsa-Neumann Stipendium of the state Berlin (to C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; BAMFORTH KJ, 1993, BIOCHEM PHARMACOL, V46, P1713, DOI 10.1016/0006-2952(93)90575-H; BAMFORTH KJ, 1992, EUR J PHARM-ENVIRON, V228, P15, DOI 10.1016/0926-6917(92)90006-X; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Butt CM, 2013, CHEM RES TOXICOL, V26, P1692, DOI 10.1021/tx400342k; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Coughtrie MWH, 2001, DRUG METAB DISPOS, V29, P522; Engst W, 2002, ENVIRON TOXICOL PHAR, V11, P243, DOI 10.1016/S1382-6689(02)00022-4; Falany JL, 1996, CANCER RES, V56, P1551; Feixas F, 2014, BIOPHYS CHEM, V186, P31, DOI 10.1016/j.bpc.2013.10.007; GIBB C, 1987, BIOCHEM PHARMACOL, V36, P2325, DOI 10.1016/0006-2952(87)90598-3; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Gosavi RA, 2013, ENVIRON HEALTH PERSP, V121, P1194, DOI 10.1289/ehp.1306902; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hagen M, 1998, CHEM-BIOL INTERACT, V109, P249, DOI 10.1016/S0009-2797(97)00136-1; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Iyer LV, 2012, CHIRALITY, V24, P796, DOI 10.1002/chir.22072; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; KIM HJ, 1995, J PHARMACOL EXP THER, V275, P654; Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li L, 2007, J CYST FIBROS, V6, P23, DOI 10.1016/j.jcf.2006.05.001; Lin ES, 2003, J CHIN CHEM SOC-TAIP, V50, P655, DOI 10.1002/jccs.200300095; Lin P, 2006, INT J QUANTUM CHEM, V106, P2981, DOI 10.1002/qua.21123; Martiny VY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073587; Meinl W, 2006, INT J CANCER, V118, P1090, DOI 10.1002/ijc.21480; Meinl W, 2002, PHARMACOGENETICS, V12, P677, DOI 10.1097/00008571-200212000-00002; Meng SN, 2012, MOL PHARMACEUT, V9, P862, DOI 10.1021/mp200400s; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Mortier J, 2015, DRUG DISCOV TODAY, V20, P686, DOI 10.1016/j.drudis.2015.01.003; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Najmanovich RJ, 2007, BIOINFORMATICS, V23, pE104, DOI 10.1093/bioinformatics/btl292; Ohkimoto K, 2005, PESTIC BIOCHEM PHYS, V81, P32, DOI 10.1016/j.pestbp.2004.08.003; Pasqualini JR, 2009, MATURITAS, V65, pS17, DOI 10.1016/j.maturitas.2009.11.006; Pasqualini JR, 2009, ANN NY ACAD SCI, V1155, P88, DOI 10.1111/j.1749-6632.2009.04113.x; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Reinen J, 2015, CURR MED CHEM, V22, P500; Reinen J, 2006, ANAL BIOCHEM, V357, P85, DOI 10.1016/j.ab.2006.07.015; Rizner TL, 2013, MOL CELL ENDOCRINOL, V381, P124, DOI [10.1016/j.mce.213.07.026, 10.1016/j.mce.2013.07.026]; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shevtsov S, 2003, ENVIRON HEALTH PERSP, V111, P884, DOI 10.1289/ehp.6056; STEVENTON GB, 1989, NEUROLOGY, V39, P883, DOI 10.1212/WNL.39.7.883; Testa B, 2012, DRUG DISCOV TODAY, V17, P549, DOI 10.1016/j.drudis.2012.01.017; Tian XG, 2015, BIOCHEM PHARMACOL, V94, P282, DOI 10.1016/j.bcp.2015.02.010; Tibbs ZE, 2015, DRUG METAB PHARMACOK, V30, P3, DOI 10.1016/j.dmpk.2014.10.004; Vietri M, 2000, EUR J CLIN PHARMACOL, V56, P81, DOI 10.1007/s002280050725; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Witten I. H., 2005, DATA MINING PRACTICA, p[65, 214]; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7; Wu BJ, 2011, DRUG METAB REV, V43, P440, DOI 10.3109/03602532.2011.615320; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	72	20	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					58	71		10.1074/jbc.M115.685610	http://dx.doi.org/10.1074/jbc.M115.685610			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26542807	Green Published, hybrid			2022-12-28	WOS:000367589500005
J	Ma, D; Liu, TY; Chang, L; Rui, C; Xiao, YY; Li, SM; Hogenesch, JB; Chen, YE; Lin, JD				Ma, Di; Liu, Tongyu; Chang, Lin; Rui, Crystal; Xiao, Yuanyuan; Li, Siming; Hogenesch, John B.; Chen, Y. Eugene; Lin, Jiandie D.			The Liver Clock Controls Cholesterol Homeostasis through Trib1 Protein-mediated Regulation of PCSK9/Low Density Lipoprotein Receptor (LDLR) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN AUTOPHAGY RHYTHM; GENE-EXPRESSION; GLUCOSE-METABOLISM; LOCI; SLEEP; TRANSCRIPTION; COMPONENTS; BIOLOGY; OBESITY; VARIANT	Disruption of the body clock has been recognized as a risk factor for cardiovascular disease. How the circadian pacemaker interacts with the genetic factors associated with plasma lipid traits remains poorly understood. Recent genome-wide association studies have identified an expanding list of genetic variants that influence plasma cholesterol and triglyceride levels. Here we analyzed circadian regulation of lipid-associated candidate genes in the liver and identified two distinct groups exhibiting rhythmic and non-rhythmic patterns of expression during light-dark cycles. Liver-specific inactivation of Bmal1 led to elevated plasma LDL/VLDL cholesterol levels as a consequence of the disruption of the PCSK9/LDL receptor regulatory axis. Ablation of the liver clock perturbed diurnal regulation of lipid-associated genes in the liver and markedly reduced the expression of the non-rhythmically expressed gene Trib1. Adenovirus-mediated rescue of Trib1 expression lowered plasma PCSK9 levels, increased LDL receptor protein expression, and restored plasma cholesterol homeostasis in mice lacking a functional liver clock. These results illustrate an unexpected mechanism through which the biological clock regulates cholesterol homeostasis through its regulation of non-rhythmic genes in the liver.	[Ma, Di; Liu, Tongyu; Rui, Crystal; Xiao, Yuanyuan; Li, Siming; Lin, Jiandie D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ma, Di; Liu, Tongyu; Rui, Crystal; Xiao, Yuanyuan; Li, Siming; Lin, Jiandie D.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Chang, Lin; Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI 48109 USA; [Hogenesch, John B.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine	Lin, JD (corresponding author), Univ Michigan, 5437 Life Sci Inst,210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK077086, DK102456, NS054794]; Defense Advanced Research Projects Agency [DARPA-D12AP00025]; Penn Genome Frontiers Institute under a Health Research Formula Fund grant; Pennsylvania Department of Health; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK077086, R01DK102456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Penn Genome Frontiers Institute under a Health Research Formula Fund grant; Pennsylvania Department of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants DK077086 and DK102456 (to J. D. L.) and NS054794 (to J. B. H.), Defense Advanced Research Projects Agency Grant DARPA-D12AP00025, and the Penn Genome Frontiers Institute under a Health Research Formula Fund grant with the Pennsylvania Department of Health. The authors declare no competing financial interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a predoctoral fellowship from the American Heart Association.	Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Copinschi G, 2000, Novartis Found Symp, V227, P143; Czeisler CA, 1999, RECENT PROG HORM RES, V54, P97; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Desai NR, 2015, TRENDS CARDIOVAS MED, V25, P567, DOI 10.1016/j.tcm.2015.01.009; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Ma D, 2012, TRENDS ENDOCRIN MET, V23, P319, DOI 10.1016/j.tem.2012.03.004; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	47	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31003	31012		10.1074/jbc.M115.685982	http://dx.doi.org/10.1074/jbc.M115.685982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26547624	Green Published, hybrid			2022-12-28	WOS:000367199000030
J	Gomes, FR; Romaniello, V; Sanchez, A; Weber, C; Narayanan, P; Psol, M; Pardo, LA				Gomes, Fernanda Ramos; Romaniello, Vincenzo; Sanchez, Araceli; Weber, Claudia; Narayanan, Pratibha; Psol, Maryna; Pardo, Luis A.			Alternatively Spliced Isoforms of K(V)10.1 Potassium Channels Modulate Channel Properties and Can Activate Cyclin-dependent Kinase in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-GO-GO; SURFACE EXPRESSION; HUMAN ETHER; K+ CHANNELS; EAG; CALCIUM; PROTEIN; RAT; IDENTIFICATION; SENSITIVITY	K(V)10.1 is a voltage-gated potassium channel expressed selectively in the mammalian brain but also aberrantly in cancer cells. In this study we identified short splice variants of K(V)10.1 resulting from exon-skipping events (E65 and E70) in human brain and cancer cell lines. The presence of the variants was confirmed by Northern blot and RNase protection assays. Both variants completely lacked the transmembrane domains of the channel and produced cytoplasmic proteins without channel function. In a reconstituted system, both variants co-precipitated with the full-length channel and induced a robust down-regulation of K(V)10.1 current when co-expressed with the full-length form, but their effect was mechanistically different. E65 required a tetramerization domain and induced a reduction in the overall expression of full-length K(V)10.1, whereas E70 mainly affected its glycosylation pattern. E65 triggered the activation of cyclin-dependent kinases in Xenopus laevis oocytes, suggesting a role in cell cycle control. Our observations highlight the relevance of noncanonical functions for the oncogenicity of K(V)10.1, which need to be considered when ion channels are targeted for cancer therapy.	[Gomes, Fernanda Ramos; Weber, Claudia; Narayanan, Pratibha; Psol, Maryna] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Romaniello, Vincenzo; Sanchez, Araceli; Pardo, Luis A.] Max Planck Inst Expt Med, Oncophysiol Grp, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Pardo, LA (corresponding author), Max Planck Inst Expt Med, Oncophysiol Grp, Hermann Rein Str 3, D-37075 Gottingen, Germany.	pardo@em.mpg.de	Romaniello, Vincenzo/AAQ-2957-2020; Pardo, Luis/C-5066-2013	Pardo, Luis/0000-0003-1375-4349; Narayanan, Pratibha/0000-0002-8998-5170	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	Supported by a scholarship from the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Adaixo R, 2010, ACTA CRYSTALLOGR F, V66, P1056, DOI 10.1107/S1744309110027880; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bidaux G, 2012, J BIOL CHEM, V287, P2948, DOI 10.1074/jbc.M111.270256; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bruggemann A, 1997, P NATL ACAD SCI USA, V94, P537, DOI 10.1073/pnas.94.2.537; Camacho J, 2000, PFLUG ARCH EUR J PHY, V441, P167, DOI 10.1007/s004240000420; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chavez-Lopez MD, 2014, INT J GYNECOL CANCER, V24, P824, DOI 10.1097/IGC.0000000000000151; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Garcia-Ferreiro RE, 2004, J GEN PHYSIOL, V124, P301, DOI 10.1085/jgp.200409041; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Goncalves JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010873; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hartung F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-109; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Herrmann S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00201; Herrmann S, 2012, J BIOL CHEM, V287, P44151, DOI 10.1074/jbc.M112.372540; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Hsu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041203; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Kohl T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026329; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Kuzhikandathil EV, 2000, J GEN PHYSIOL, V115, P697, DOI 10.1085/jgp.115.6.697; Lin TF, 2014, J BIOL CHEM, V289, P22815, DOI 10.1074/jbc.M114.574814; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; McCartney CE, 2005, P NATL ACAD SCI USA, V102, P17870, DOI 10.1073/pnas.0505270102; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Mortensen LS, 2015, J PHYSIOL-LONDON, V593, P181, DOI 10.1113/jphysiol.2014.281600; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Ninkovic M, 2012, FEBS LETT, V586, P3077, DOI 10.1016/j.febslet.2012.07.055; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Piros ET, 1999, J BIOL CHEM, V274, P33677, DOI 10.1074/jbc.274.47.33677; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Shi XZ, 2006, ANAL BIOCHEM, V356, P222, DOI 10.1016/j.ab.2006.06.028; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Sun XX, 2009, MOL CELL NEUROSCI, V40, P338, DOI 10.1016/j.mcn.2008.11.005; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Veale EL, 2010, J BIOL CHEM, V285, P29295, DOI 10.1074/jbc.M110.108423; Wagner V, 2010, J CELL BIOCHEM, V110, P598, DOI 10.1002/jcb.22564; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zhang HY, 2010, BRIT J PHARMACOL, V160, P1631, DOI 10.1111/j.1476-5381.2010.00798.x; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	63	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30351	30365		10.1074/jbc.M115.668749	http://dx.doi.org/10.1074/jbc.M115.668749			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26518875	Green Published, hybrid			2022-12-28	WOS:000366738200014
J	Jamwal, A; Round, AR; Bannwarth, L; Venien-Bryan, C; Belrhali, H; Yogavel, M; Sharma, A				Jamwal, Abhishek; Round, Adam R.; Bannwarth, Ludovic; Venien-Bryan, Catherine; Belrhali, Hassan; Yogavel, Manickam; Sharma, Amit			Structural and Functional Highlights of Vacuolar Soluble Protein 1 from Pathogen Trypanosoma brucei brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SMALL-ANGLE SCATTERING; INORGANIC PYROPHOSPHATASE; POLYPHOSPHATE METABOLISM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ACIDOCALCISOMES; MACROMOLECULES; FAMILY; GROWTH	Trypanosoma brucei (T. brucei) is responsible for the fatal human disease called African trypanosomiasis, or sleeping sickness. The causative parasite, Trypanosoma, encodes soluble versions of inorganic pyrophosphatases (PPase), also called vacuolar soluble proteins (VSPs), which are localized to its acidocalcisomes. The latter are acidic membrane-enclosed organelles rich in polyphosphate chains and divalent cations whose significance in these parasites remains unclear. We here report the crystal structure of T. brucei brucei acidocalcisomal PPases in a ternary complex with Mg2+ and imidodiphosphate. The crystal structure reveals a novel structural architecture distinct from known class I PPases in its tetrameric oligomeric state in which a fused EF hand domain arranges around the catalytic PPase domain. This unprecedented assembly evident from Tb(b)VSP1 crystal structure is further confirmed by SAXS and TEM data. SAXS data suggest structural flexibility in EF hand domains indicative of conformational plasticity within Tb(b)VSP1.	[Jamwal, Abhishek; Yogavel, Manickam; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Round, Adam R.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; [Round, Adam R.; Belrhali, Hassan] Univ Grenoble Alpes, Unit Virus Host Cell Interact, EMBL, CNRS, F-38042 Grenoble, France; [Bannwarth, Ludovic; Venien-Bryan, Catherine] CNRS UPMC IRD, IMPMC, UMR7590, F-75252 Paris, France	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India.	amit.icgeb@gmail.com	Manickam, Yogavel/O-4570-2015	Manickam, Yogavel/0000-0002-2119-062X; Venien-Bryan, Catherine/0000-0002-7328-3764	Department of Biotechnology of the Government of India [PR6303, PR3084]; Indian Council of Medical Research-Senior Research Fellowship; J. C. Bose fellowship	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research-Senior Research Fellowship; J. C. Bose fellowship	This work was supported by Outstanding Scientist Research Programme Grants PR6303 (to A. S.) and PR3084 (to A. S. and M. Y.) from the Department of Biotechnology of the Government of India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Indian Council of Medical Research-Senior Research Fellowship.; Supported by the J. C. Bose fellowship. To whom correspondence should be addressed. E-mail: amit.icgeb@gmail.com.	Antolinos AD, 2015, ACTA CRYSTALLOGR D, V71, P76, DOI 10.1107/S1399004714019609; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; Docampo R, 2008, CURR PHARM DESIGN, V14, P882, DOI 10.2174/138161208784041079; Espiau B, 2006, J BIOL CHEM, V281, P1516, DOI 10.1074/jbc.M506947200; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Galizzi M, 2013, MOL MICROBIOL, V90, P699, DOI 10.1111/mmi.12392; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Keita M, 1997, EXP PARASITOL, V85, P183, DOI 10.1006/expr.1996.4136; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kirchhoff L. V., 2000, Current Treatment Options in Infectious Diseases, V2, P66; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kornberg A., 1962, HORIZONS BIOCH, P251; Kotsikorou E, 2005, J MED CHEM, V48, P6128, DOI 10.1021/jm058220g; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER W, 1995, ARCH BIOCHEM BIOPHYS, V319, P149, DOI 10.1006/abbi.1995.1277; Minor W., 1997, METHODS ENZYMOLOGY A, V276, P307; Permyakov E. Y., 2009, METALLOPROTEOMICS; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Samygina VR, 2001, J MOL BIOL, V314, P633, DOI 10.1006/jmbi.2001.5149; Shintani T, 1998, FEBS LETT, V439, P263, DOI 10.1016/S0014-5793(98)01381-7; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tammenkoski M, 2005, J BIOL CHEM, V280, P41819, DOI 10.1074/jbc.M509489200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Van Voorhis WC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000530; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Young TW, 1998, MICROBIOL-SGM, V144, P2563, DOI 10.1099/00221287-144-9-2563; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172; Zyryanov AB, 2002, BIOCHEM J, V367, P901, DOI 10.1042/BJ20020880	48	8	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30498	30513		10.1074/jbc.M115.674176	http://dx.doi.org/10.1074/jbc.M115.674176			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26494625	hybrid, Green Published			2022-12-28	WOS:000366738200026
J	Li, M; Quan, C; Toth, R; Campbell, DG; MacKintosh, C; Wang, HY; Chen, S				Li, Min; Quan, Chao; Toth, Rachel; Campbell, David G.; MacKintosh, Carol; Wang, Hong Yu; Chen, Shuai			Fasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMERS-DISEASE; BODY-WEIGHT; IN-VIVO; KINASE; RESISTANCE; RECEPTOR; COMPLEX; MEMORY; MECHANISMS	Diabetes is strongly associated with cognitive decline, but the molecular reasons are unknown. We found that fasting and peripheral insulin promote phosphorylation and dephosphorylation, respectively, of specific residues on brain proteins including cytoskeletal regulators such as slit-robo GTPase-activating protein 3 (srGAP3) and microtubule affinity-regulating protein kinases (MARKs), in which deficiency or dysregulation is linked to neurological disorders. Fasting activates protein kinase A (PKA) but not PKB/Akt signaling in the brain, and PKA can phosphorylate the purified srGAP3. The phosphorylation of srGAP3 and MARKs were increased when PKA signaling was activated in primary neurons. Knockdown of PKA decreased the phosphorylation of srGAP3. Furthermore, WAVE1, a protein kinase A-anchoring protein, formed a complex with srGAP3 and PKA in the brain of fasted mice to facilitate the phosphorylation of srGAP3 by PKA. Although brain cells have insulin receptors, our findings are inconsistent with the down-regulation of phosphorylation of target proteins being mediated by insulin signaling within the brain. Rather, our findings infer that systemic insulin, through a yet unknown mechanism, inhibits PKA or protein kinase(s) with similar specificity and/or activates an unknown phosphatase in the brain. Ser(858) of srGAP3 was identified as a key regulatory residue in which phosphorylation by PKA enhanced the GAP activity of srGAP3 toward its substrate, Rac1, in cells, thereby inhibiting the action of this GTPase in cytoskeletal regulation. Our findings reveal novel mechanisms linking peripheral insulin sensitivity with cytoskeletal remodeling in neurons, which may help to explain the association of diabetes with neurological disorders such as Alzheimer disease.	[Li, Min; Quan, Chao; Wang, Hong Yu; Chen, Shuai] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China; [Li, Min; Quan, Chao; Wang, Hong Yu; Chen, Shuai] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210061, Jiangsu, Peoples R China; [Toth, Rachel; Campbell, David G.] Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [MacKintosh, Carol] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland	Nanjing University; Nanjing University; University of Dundee; University of Dundee	MacKintosh, C (corresponding author), Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland.	c.mackintosh@dundee.ac.uk; wanghy@nicemice.cn; schen6@163.com	MacKintosh, Carol/B-8210-2011	MacKintosh, Carol/0000-0001-9166-589X	AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck Serono; Pfizer	AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Pfizer(Pfizer)	We thank AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Serono, and Pfizer for their sponsorship of the Division of Signal Transduction Therapy (University of Dundee).	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beharry C, 2014, NEUROSCI BULL, V30, P346, DOI 10.1007/s12264-013-1414-z; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chan CB, 2011, EMBO J, V30, P4274, DOI 10.1038/emboj.2011.281; Chen QL, 2014, CELL SIGNAL, V26, P1636, DOI 10.1016/j.cellsig.2014.04.012; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Garcia-Alvarez G, 2015, MOL BIOL CELL, V26, P1141, DOI 10.1091/mbc.E14-07-1222; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gridley S, 2006, CELL SIGNAL, V18, P1626, DOI 10.1016/j.cellsig.2006.01.002; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Li BJ, 2014, PROG NEURO-PSYCHOPH, V48, P199, DOI 10.1016/j.pnpbp.2013.08.015; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Padmanabhan A, 2013, J BIOL CHEM, V288, P14158, DOI 10.1074/jbc.M112.432377; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Qi YJ, 2013, DIABETES, V62, P3887, DOI 10.2337/db13-0095; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Shimizu-Albergine M, 2001, J NEUROSCI, V21, P1238; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Song J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.220; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Timm T, 2006, NEURODEGENER DIS, V3, P207, DOI 10.1159/000095258; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Waltereit R, 2012, FASEB J, V26, P4418, DOI 10.1096/fj.11-202317; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Yu WD, 2012, HUM MOL GENET, V21, P1384, DOI 10.1093/hmg/ddr576	48	7	7	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30030	30041		10.1074/jbc.M115.668103	http://dx.doi.org/10.1074/jbc.M115.668103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26499801	hybrid, Green Published			2022-12-28	WOS:000366614700034
J	Nagy, Z; Wynne, K; von Kriegsheim, A; Gambaryan, S; Smolenski, A				Nagy, Zoltan; Wynne, Kieran; von Kriegsheim, Alexander; Gambaryan, Stepan; Smolenski, Albert			Cyclic Nucleotide-dependent Protein Kinases Target ARHGAP17 and ARHGEF6 Complexes in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; PDZ DOMAIN; PHOSPHORYLATION; BINDING; RHO; FAMILY; INHIBITION; REQUIRES; ROLES; RAC1	Endothelial cells release prostacyclin (PGI(2)) and nitric oxide (NO) to inhibit platelet functions. PGI(2) and NO effects are mediated by cyclic nucleotides, cAMP-and cGMP-dependent protein kinases (PKA, PKG), and largely unknown PKA and PKG substrate proteins. The small G-protein Rac1 plays a key role in platelets and was suggested to be a target of cyclic nucleotide signaling. We confirm that PKA and PKG activation reduces Rac1-GTP levels. Screening for potential mediators of this effect resulted in the identification of the Rac1-specific GTPase-activating protein ARHGAP17 and the guanine nucleotide exchange factor ARHGEF6 as new PKA and PKG substrates in platelets. We mapped the PKA/PKG phosphorylation sites to serine 702 on ARHGAP17 using Phos-tag gels and to serine 684 on ARHGEF6. We show that ARHGAP17 binds to the actin-regulating CIP4 protein in platelets and that Ser-702 phosphorylation interferes with this interaction. Reduced CIP4 binding results in enhanced inhibition of cell migration by ARHGAP17. Furthermore, we show that ARHGEF6 is constitutively linked to GIT1, a GAP of Arf family small G proteins, and that ARHGEF6 phosphorylation enables binding of the 14-3-3 adaptor protein to the ARHGEF6/GIT1 complex. PKA and PKG induced rearrangement of ARHGAP17- and ARHGEF6-associated protein complexes might contribute to Rac1 regulation and platelet inhibition.	[Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, UCD Conway Inst, Dublin 4, Ireland; [Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Wynne, Kieran] Univ Coll Dublin, UCD Conway Inst, Mass Spectrometry Resource, Dublin 4, Ireland; [von Kriegsheim, Alexander] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Gambaryan, Stepan] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia	University College Dublin; University College Dublin; University College Dublin; University College Dublin; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Smolenski, A (corresponding author), Univ Coll Dublin, Sch Med, UCD Conway Inst, Dublin 4, Ireland.	albert.smolenski@ucd.ie	Gambaryan, Stepan/I-3940-2016; Nagy, Zoltan/ABE-3429-2020; von Kriegsheim, Alex/C-2371-2016	Gambaryan, Stepan/0000-0002-1470-0791; Nagy, Zoltan/0000-0001-6517-2071; von Kriegsheim, Alex/0000-0002-4952-8573; WYNNE, KIERAN/0000-0001-5759-5285; Smolenski, Albert/0000-0001-9210-9406	Science Foundation Ireland; Irish Research Council	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council(Irish Research Council for Science, Engineering and Technology)	This work was supported by funding from the Science Foundation Ireland and the Irish Research Council (to A. S.). The authors declare that have no conflict of interest with the contents of this article.	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Aslan JE, 2013, AM J PHYSIOL-CELL PH, V305, pC519, DOI 10.1152/ajpcell.00418.2012; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Beck F, 2014, BLOOD, V123, pE1, DOI 10.1182/blood-2013-07-512384; Beck S, 2014, CELL SIGNAL, V26, P1975, DOI 10.1016/j.cellsig.2014.03.024; Beck S, 2013, CELL SIGNAL, V25, P236, DOI 10.1016/j.cellsig.2012.09.005; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chen YLD, 2013, BLOOD, V122, P1695, DOI 10.1182/blood-2013-03-484550; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Csepanyi-Komi Roland, 2013, Small GTPases, V4, P90, DOI 10.4161/sgtp.23708; Delaney MK, 2012, ARTERIOSCL THROM VAS, V32, P2761, DOI 10.1161/ATVBAHA.112.254920; Delaney MK, 2014, BLOOD, V124, P1957, DOI 10.1182/blood-2014-03-560821; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Guidetti GF, 2013, BIOCHEM J, V453, P115, DOI 10.1042/BJ20130131; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Karim ZA, 2008, J BIOL CHEM, V283, P11995, DOI 10.1074/jbc.M800146200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Nishiya N, 2002, J BIOCHEM, V132, P279, DOI 10.1093/oxfordjournals.jbchem.a003222; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P181, DOI 10.1111/j.1476-5381.1987.tb11310.x; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richnau N, 2004, BIOCHEM BIOPH RES CO, V320, P1034, DOI 10.1016/j.bbrc.2004.05.221; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saengsawang W, 2013, J CELL SCI, V126, P2411, DOI 10.1242/jcs.117473; Sato H, 2008, BIOCHEM BIOPH RES CO, V368, P157, DOI 10.1016/j.bbrc.2008.01.064; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Soulet C, 2001, FEBS LETT, V507, P253, DOI 10.1016/S0014-5793(01)02984-2; Subramanian H, 2013, J THROMB HAEMOST, V11, P1574, DOI 10.1111/jth.12271; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; van den Bosch MTJ, 2014, J THROMB HAEMOST, V12, P726, DOI 10.1111/jth.12542; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	58	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29974	29983		10.1074/jbc.M115.678003	http://dx.doi.org/10.1074/jbc.M115.678003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507661	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000366614700029
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-BINDING; NUCLEOTIDE-BINDING; ATPASE ACTIVITY; FUNCTIONAL CONSEQUENCES; CONFORMATIONAL-CHANGES; PROMOTE MATURATION; CROSS-LINKING; RESISTANCE; MUTATIONS; MUTANTS	ABC (ATP-binding cassette) transporters are clinically important because drug pumps like P-glycoprotein (P-gp, ABCB1) confer multidrug resistance and mutant ABC proteins are responsible for many protein-folding diseases such as cystic fibrosis. Identification of the tariquidar-binding site has been the subject of intensive molecular modeling studies because it is the most potent inhibitor and corrector of P-gp. Tariquidar is a unique P-gp inhibitor because it locks the pump in a conformation that blocks drug efflux but activates ATPase activity. In silico docking studies have identified several potential tariquidar-binding sites. Here, we show through cross-linking studies that tariquidar most likely binds to sites within the transmembrane (TM) segments located in one wing or at the interface between the two wings (12 TM segments form 2 divergent wings). We then introduced arginine residues at all positions in the 12 TM segments (223 mutants) of P-gp. The rationale was that a charged residue in the drug-binding pocket would disrupt hydrophobic interaction with tariquidar and inhibit its ability to rescue processing mutants or stimulate ATPase activity. Arginines introduced at 30 positions significantly inhibited tariquidar rescue of a processing mutant and activation of ATPase activity. The results suggest that tariquidar binds to a site within the drug-binding pocket at the interface between the TM segments of both structural wings. Tariquidar differed from other drug substrates, however, as it stabilized the first TM domain. Stabilization of the first TM domain appears to be a key mechanism for high efficiency rescue of ABC processing mutants that cause disease.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research; Cystic Fibrosis Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This work was supported in part by a grant from the Canadian Institutes of Health Research and Cystic Fibrosis Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chen EYJ, 2000, BIOCHEMISTRY-US, V39, P3797, DOI 10.1021/bi992620m; Chen YC, 2015, TRENDS PHARMACOL SCI, V36, P78, DOI 10.1016/j.tips.2014.12.001; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; Jara GE, 2013, J MOL GRAPH MODEL, V46, P10, DOI 10.1016/j.jmgm.2013.09.001; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Kong LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11747; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Loo TW, 2014, BIOCHEM PHARMACOL, V92, P558, DOI 10.1016/j.bcp.2014.10.006; Loo TW, 2014, J BIOL CHEM, V289, P24749, DOI 10.1074/jbc.M114.583021; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2013, BIOCHEMISTRY-US, V52, P7167, DOI 10.1021/bi401269m; Loo TW, 2013, BIOCHEMISTRY-US, V52, P5161, DOI 10.1021/bi4008758; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Loo TW, 2013, J BIOL CHEM, V288, P20326, DOI 10.1074/jbc.M113.484550; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2012, BIOCHEM PHARMACOL, V83, P345, DOI 10.1016/j.bcp.2011.11.014; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; LOO TW, 1993, J BIOL CHEM, V268, P3143; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1993, J BIOL CHEM, V268, P19965; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; McCormick JW, 2015, BIOCHEMISTRY-US, V54, P4374, DOI 10.1021/acs.biochem.5b00018; Pajeva IK, 2013, CHEMMEDCHEM, V8, P1701, DOI 10.1002/cmdc.201300233; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Prajapati R, 2014, BBA-BIOMEMBRANES, V1838, P2882, DOI 10.1016/j.bbamem.2014.07.018; SARKADI B, 1992, J BIOL CHEM, V267, P4854; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wagner CC, 2009, J NUCL MED, V50, P1954, DOI 10.2967/jnumed.109.063289; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114	69	30	31	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29389	29401		10.1074/jbc.M115.695171	http://dx.doi.org/10.1074/jbc.M115.695171			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26507655	Green Published, hybrid			2022-12-28	WOS:000366613400024
J	Li, CW; Menconi, F; Osman, R; Mezei, M; Jacobson, EM; Concepcion, E; David, CS; Kastrinsky, DB; Ohlmeyer, M; Tomer, Y				Li, Cheuk Wun; Menconi, Francesca; Osman, Roman; Mezei, Mihaly; Jacobson, Eric M.; Concepcion, Erlinda; David, Chella S.; Kastrinsky, David B.; Ohlmeyer, Michael; Tomer, Yaron			Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface protein; endocrinology; major histocompatibility complex (MHC); peptides; small molecule; structural model; thyroid; thyroid hormone; thyroglobulin; thyroiditis	MYELIN BASIC-PROTEIN; HLA-DR; TRANSGENIC MICE; GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; THYROGLOBULIN PEPTIDES; MULTIPLE-SCLEROSIS; UNITED-STATES; L-THYROXINE; CEPHARANTHINE	We previously showed that an HLA-DR variant containing arginine at position 74 of the DR1 chain (DR1-Arg74) is the specific HLA class II variant conferring risk for autoimmune thyroid diseases (AITD). We also identified 5 thyroglobulin (Tg) peptides that bound to DR1-Arg74. We hypothesized that blocking the binding of these peptides to DR1-Arg74 could block the continuous T-cell activation in thyroiditis needed to maintain the autoimmune response to the thyroid. The aim of the current study was to identify small molecules that can block T-cell activation by Tg peptides presented within DR1-Arg74 pockets. We screened a large and diverse library of compounds and identified one compound, cepharanthine that was able to block peptide binding to DR1-Arg74. We then showed that Tg.2098 is the dominant peptide when inducing experimental autoimmune thyroiditis (EAT) in NOD mice expressing human DR1-Arg74. Furthermore, cepharanthine blocked T-cell activation by thyroglobulin peptides, in particular Tg.2098 in mice that were induced with EAT. For the first time we identified a small molecule that can block Tg peptide binding and presentation to T-cells in autoimmune thyroiditis. If confirmed cepharanthine could potentially have a role in treating human AITD.	[Li, Cheuk Wun; Menconi, Francesca; Jacobson, Eric M.; Concepcion, Erlinda; Tomer, Yaron] Icahn Sch Med Mt Sinai, Div Endocrinol, Box 1055,One Gustave L Levy Pl, New York, NY 10029 USA; [Osman, Roman; Mezei, Mihaly; Kastrinsky, David B.; Ohlmeyer, Michael] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, Box 1055,One Gustave L Levy Pl, New York, NY 10029 USA; [David, Chella S.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Tomer, Yaron] Bronx Vet Affairs Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Tomer, Y (corresponding author), Icahn Sch Med Mt Sinai, Div Endocrinol, Box 1055,One Gustave L Levy Pl, New York, NY 10029 USA.	Yaron.Tomer@mssm.edu	Tomer, Yaron/GWU-8933-2022		National Institutes of Health from NIDDK [DK061659, DK073681]; NIAID [T32 AI007605]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061659, R01DK073681] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DK061659 and DK073681 from the NIDDK (to Y. T.) and Grant T32 AI007605 from the NIAID (to C. W. L.). This material is based upon work supported in part by the Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article.	Adedapo K. S., 2012, AFR J MED MED SCI, V41, P193; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bradley DS, 1997, J CLIN INVEST, V100, P2227, DOI 10.1172/JCI119760; Brocke S, 1996, NATURE, V379, P343, DOI 10.1038/379343a0; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; Ebina T, 1990, Gan To Kagaku Ryoho, V17, P1165; EDASHIGE K, 1991, BIOCHEM PHARMACOL, V41, P71, DOI 10.1016/0006-2952(91)90012-T; Flynn JC, 2004, CELL IMMUNOL, V229, P79, DOI 10.1016/j.cellimm.2004.07.002; Flynn JC, 2001, J AUTOIMMUN, V17, P7, DOI 10.1006/jaut.2001.0528; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; FUJIMURA T, 1990, JPN J PHARMACOL, V54, P464, DOI 10.1254/jjp.54.464; Geluk A, 1998, J AUTOIMMUN, V11, P353, DOI 10.1006/jaut.1998.0207; Harada K, 2009, INT J ONCOL, V35, P1025, DOI 10.3892/ijo_00000417; Hasham A, 2012, IMMUNOL RES, V54, P204, DOI 10.1007/s12026-012-8302-x; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jacobson EM, 2009, J BIOL CHEM, V284, P34231, DOI 10.1074/jbc.M109.041574; Ji NN, 2013, J IMMUNOL, V191, P5074, DOI 10.4049/jimmunol.1300407; Kimoto T, 1997, Nihon Geka Hokan, V66, P71; Koehler NKU, 2004, J MED CHEM, V47, P4989, DOI 10.1021/jm030362s; KOHNO H, 1986, FOLIA PHARMACOL JPN, V88, P71, DOI 10.1254/fpj.88.71; KOHNO H, 1987, FOLIA PHARMACOL JPN, V90, P205, DOI 10.1254/fpj.90.205; Kong YCM, 1996, J EXP MED, V184, P1167, DOI 10.1084/jem.184.3.1167; Kong Yi-Chi M, 2007, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1507s78; Liu ZM, 2011, J CHEM INF MODEL, V51, P326, DOI 10.1021/ci100444c; McLachlan SM, 2014, ENDOCR REV, V35, P59, DOI 10.1210/er.2013-1055; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Menconi F, 2010, J AUTOIMMUN, V35, P45, DOI 10.1016/j.jaut.2010.01.004; Mezei M, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-2; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Morita K, 2002, J DERMATOL, V29, P661, DOI 10.1111/j.1346-8138.2002.tb00199.x; Muixi L, 2008, J IMMUNOL, V181, P795, DOI 10.4049/jimmunol.181.1.795; Mukai M, 2003, CANCER SCI, V94, P557, DOI 10.1111/j.1349-7006.2003.tb01482.x; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Niwa Y, 1969, Hifuka Kiyo, V64, P47; Ohta T, 1990, Rinsho Hoshasen, V35, P471; Ozen S, 2011, J CLIN RES PEDIATR E, V3, P192, DOI 10.4274/jcrpe.425; Ravitz O, 2011, J COMPUT AID MOL DES, V25, P1033, DOI 10.1007/s10822-011-9482-5; Rivkees SA, 2009, NEW ENGL J MED, V360, P1574, DOI 10.1056/NEJMc0809750; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Rogosnitzky M, 2011, PHARMACOL REP, V63, P337, DOI 10.1016/S1734-1140(11)70500-X; Rose Noel R., 2002, Autoimmunity Reviews, V1, P97, DOI 10.1016/S1568-9972(01)00016-7; Saito R, 1989, Nihon Gan Chiryo Gakkai Shi, V24, P2587; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Slatosky J, 2000, AM FAM PHYSICIAN, V61, P1047; Stasiolek M, 2014, FOLIA HISTOCHEM CYTO, V52, P138, DOI 10.5603/FHC.2014.0013; STRAUSS G, 1994, IMMUNOGENETICS, V40, P104; Suzuki R, 1992, Gan To Kagaku Ryoho, V19, P647; Tabata R, 2012, INT IMMUNOPHARMACOL, V13, P242, DOI 10.1016/j.intimp.2012.04.015; Teyton L, 2007, J CLIN INVEST, V117, P3164, DOI 10.1172/JCI33997; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Topliss DJ, 2004, MED J AUSTRALIA, V180, P186, DOI 10.5694/j.1326-5377.2004.tb05866.x; Toulis KA, 2010, THYROID, V20, P1163, DOI 10.1089/thy.2009.0351; Ushiki N, 1988, Gan To Kagaku Ryoho, V15, P2701; Uto T, 2011, INT IMMUNOPHARMACOL, V11, P1932, DOI 10.1016/j.intimp.2011.08.003	66	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4079	4090		10.1074/jbc.M115.694687	http://dx.doi.org/10.1074/jbc.M115.694687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703475	Green Published, hybrid			2022-12-28	WOS:000371338400033
J	Johnson, JL; He, J; Ramadass, M; Pestonjamasp, K; Kiosses, WB; Zhang, JZ; Catz, SD				Johnson, Jennifer L.; He, Jing; Ramadass, Mahalakshmi; Pestonjamasp, Kersi; Kiosses, William B.; Zhang, Jinzhong; Catz, Sergio D.			Munc13-4 Is a Rab11-binding Protein That Regulates Rab11-positive Vesicle Trafficking and Docking at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; intracellular trafficking; NADPH oxidase; neutrophil; Rab; Munc13-4; Rab11; Rab27; recycling endosome; super-resolution microscopy	FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; OPTICAL RECONSTRUCTION MICROSCOPY; BLADDER UMBRELLA CELLS; HUMAN-NEUTROPHILS; STRUCTURAL BASIS; NADPH OXIDASE; MYOSIN-V; EXOCYTOSIS; RAB11; SECRETION	The small GTPase Rab11 and its effectors control trafficking of recycling endosomes, receptor replenishment and the up-regulation of adhesion and adaptor molecules at the plasma membrane. Despite recent advances in the understanding of Rab11-regulated mechanisms, the final steps mediating docking and fusion of Rab11-positive vesicles at the plasma membrane are not fully understood. Munc13-4 is a docking factor proposed to regulate fusion through interactions with SNAREs. In hematopoietic cells, including neutrophils, Munc13-4 regulates exocytosis in a Rab27a-dependent manner, but its possible regulation of other GTPases has not been explored in detail. Here, we show that Munc13-4 binds to Rab11 and regulates the trafficking of Rab11-containing vesicles. Using a novel Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) assay, we demonstrate that Munc13-4 binds to Rab11a but not to dominant negative Rab11a. Immunoprecipitation analysis confirmed the specificity of the interaction between Munc13-4 and Rab11, and super-resolution microscopy studies support the interaction of endogenous Munc13-4 with Rab11 at the single molecule level in neutrophils. Vesicular dynamic analysis shows the common spatio-temporal distribution of Munc13-4 and Rab11, while expression of a calcium binding-deficient mutant of Munc13-4 significantly affected Rab11 trafficking. Munc13-4-deficient neutrophils showed normal endocytosis, but the trafficking, up-regulation, and retention of Rab11-positive vesicles at the plasma membrane was significantly impaired. This correlated with deficient NADPH oxidase activation at the plasma membrane in response to Rab11 interference. Our data demonstrate that Munc13-4 is a Rab11-binding partner that regulates the final steps of Rab11-positive vesicle docking at the plasma membrane.	[Johnson, Jennifer L.; He, Jing; Ramadass, Mahalakshmi; Zhang, Jinzhong; Catz, Sergio D.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Light Microscopy Core Facil, La Jolla, CA 92037 USA; [Pestonjamasp, Kersi] Univ Calif San Diego, Canc Ctr Microscopy Shared Resource, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Zhang, Jinzhong/E-5670-2012	Zhang, Jinzhong/0000-0002-2540-2749; Catz, Sergio/0000-0002-1873-0277; Pestonjamasp, Kersi/0000-0001-8586-303X	U.S. Public Health Service [HL088256, GM105894]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105894] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service Grants HL088256 and GM105894 (to S. D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Catz SD, 2013, J LEUKOCYTE BIOL, V94, P613, DOI 10.1189/jlb.1112600; COCKCROFT S, 1991, BIOCHEM J, V275, P127, DOI 10.1042/bj2750127; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnson JL, 2011, J BIOL CHEM, V286, P5647, DOI 10.1074/jbc.M110.184762; Johnson JL, 2005, TRAFFIC, V6, P667, DOI 10.1111/j.1600-0854.2005.00308.x; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Khandelwal P, 2013, MOL BIOL CELL, V24, P1007, DOI 10.1091/mbc.E12-08-0568; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Lall P, 2013, BBA-PROTEINS PROTEOM, V1834, P2679, DOI 10.1016/j.bbapap.2013.09.005; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Meeager M. M., 2007, NAT IMMUNOL, V8, P257; Monfregola J, 2012, J BIOL CHEM, V287, P44603, DOI 10.1074/jbc.M112.414029; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359; Xu K., 2013, FAR FIELD OPTICAL NA, P27; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888	45	43	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3423	3438		10.1074/jbc.M115.705871	http://dx.doi.org/10.1074/jbc.M115.705871			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26637356	Green Published, hybrid			2022-12-28	WOS:000370854500025
J	Markwardt, ML; Seckinger, KM; Rizzo, MA				Markwardt, Michele L.; Seckinger, Kendra M.; Rizzo, Mark A.			Regulation of Glucokinase by Intracellular Calcium Levels in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; NITRIC-OXIDE SYNTHASE; CA2+-INDUCED CA2+ RELEASE; INSULIN-SECRETION; GLUCOSE-METABOLISM; OSCILLATIONS; ACTIVATION; CALMODULIN; RETICULUM; ASSOCIATION	Glucokinase (GCK) controls the rate of glucose metabolism in pancreatic beta cells, and its activity is rate-limiting for insulin secretion. Posttranslational GCK activation can be stimulated through either G protein-coupled receptors or receptor tyrosine kinase signaling pathways, suggesting a common mechanism. Here we show that inhibiting Ca2+ release from the endoplasmic reticulum (ER) decouples GCK activation from receptor stimulation. Furthermore, pharmacological release of ER Ca2+ stimulates activation of a GCK optical biosensor and potentiates glucose metabolism, implicating rises in cytoplasmic Ca2+ as a critical regulatory mechanism. To explore the potential for glucose-stimulated GCK activation, the GCK biosensor was optimized using circularly permuted mCerulean3 proteins. This new sensor sensitively reports activation in response to insulin, glucagon-like peptide 1, and agents that raise cAMP levels. Transient, glucose-stimulated GCK activation was observed in beta TC3 and MIN6 cells. An ER-localized channelrhodopsin was used to manipulate the cytoplasmic Ca2+ concentration in cells expressing the optimized FRET-GCK sensor. This permitted quantification of the relationship between cytoplasmic Ca2+ concentrations and GCK activation. Half-maximal activation of the FRET-GCK sensor was estimated to occur at similar to 400 nM Ca2+. When expressed in islets, fluctuations in GCK activation were observed in response to glucose, and we estimated that post-translational activation of GCK enhances glucose metabolism by similar to 35%. These results suggest a mechanism for integrative control over GCK activation and, therefore, glucose metabolism and insulin secretion through regulation of cytoplasmic Ca2+ levels.	[Markwardt, Michele L.; Seckinger, Kendra M.; Rizzo, Mark A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Rizzo, MA (corresponding author), 660 W Redwood St,HH 525B, Baltimore, MD 21201 USA.	mrizzo@sorn.umaryland.edu			National Institutes of Health [R21-DK067415, R01-DK077140, P60-DK079637, P30-DK072488, T32-GM008181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077140, P60DK079637, P30DK072488, R21DK067415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R21-DK067415 and R01-DK077140 (to M. A. R.), P60-DK079637, and P30-DK072488. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32-GM008181.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Baltrusch S, 2007, DIABETES, V56, P1305, DOI 10.2337/db06-0894; Baltrusch S, 2006, ENDOCRINOLOGY, V147, P5768, DOI 10.1210/en.2006-0694; Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertram R, 2010, ADV EXP MED BIOL, V654, P261, DOI 10.1007/978-90-481-3271-3_12; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Diederichs F, 2008, BIOPHYS J, V94, P5079, DOI 10.1529/biophysj.107.127613; Ding SY, 2011, J BIOL CHEM, V286, P16768, DOI 10.1074/jbc.M110.192799; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Fridlyand LE, 2011, ISLETS, V3, P224, DOI 10.4161/isl.3.5.16409; Gloyn AL, 2004, FRONT DIABETES, V16, P92; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; LAI FA, 1988, BIOCHEM BIOPH RES CO, V151, P441, DOI 10.1016/0006-291X(88)90613-4; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Larion M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001452; Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Markwardt ML, 2012, MOL ENDOCRINOL, V26, P1617, DOI 10.1210/me.2012-1183; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; McMurry JL, 2011, FEBS J, V278, P4943, DOI 10.1111/j.1742-4658.2011.08395.x; Mehta S, 2014, ELIFE, V3, DOI 10.7554/eLife.03765; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nakazaki M, 1998, DIABETOLOGIA, V41, P279, DOI 10.1007/s001250050904; Ni QA, 2011, NAT CHEM BIOL, V7, P34, DOI 10.1038/NCHEMBIO.478; Nunemaker CS, 2007, AM J PHYSIOL-ENDOC M, V292, pE907, DOI 10.1152/ajpendo.00518.2006; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Park JH, 2012, ENDOCRINOLOGY, V153, P574, DOI 10.1210/en.2011-0259; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Quesada I, 2000, J PHYSIOL-LONDON, V525, P159, DOI 10.1111/j.1469-7793.2000.t01-1-00159.x; Rhodes CJ, 2013, DIABETES, V62, P2157, DOI 10.2337/db13-0246; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Rizzo MA, 2002, J BIOL CHEM, V277, P34168, DOI 10.1074/jbc.M112478200; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Roper MG, 2002, DIABETES, V51, pS43, DOI 10.2337/diabetes.51.2007.S43; Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014; Schwetz TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113020; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Stubbs M, 2000, DIABETES, V49, P2048, DOI 10.2337/diabetes.49.12.2048; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhu SS, 2016, DIABETES, V65, P699, DOI 10.2337/db15-1264	67	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3000	3009		10.1074/jbc.M115.692160	http://dx.doi.org/10.1074/jbc.M115.692160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26698632	Green Published, hybrid			2022-12-28	WOS:000369626900036
J	Carter, EL; Gupta, N; Ragsdale, SW				Carter, Eric L.; Gupta, Nirupama; Ragsdale, Stephen W.			High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erb beta Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; HORMONE RECEPTORS; MOLECULAR-CLONING; GENE-EXPRESSION; HIGH-THROUGHPUT; NITRIC-OXIDE; ALPHA; PROTEIN; DOMAIN; IDENTIFICATION	Rev-erb beta and Rev-erb beta are heme-binding nuclear receptors (NR) that repress the transcription of genes involved in regulating metabolism, inflammation, and the circadian clock. Previous gene expression and co-immunoprecipitation studies led to a model in which heme binding to Rev-erb beta recruits nuclear receptor corepressor 1 (NCoR1) into an active repressor complex. However, in contradiction, biochemical and crystallographic studies have shown that heme decreases the affinity of the ligand-binding domain of Rev-erb NRs for NCoR1 peptides. One explanation for this discrepancy is that the ligand-binding domain and NCoR1 peptides used for in vitro studies cannot replicate the key features of the full-length proteins used in cellular studies. However, the combined in vitro and cellular results described here demonstrate that heme does not directly promote interactions between full-length Rev-erb beta (FLRev-erb beta) and an NCoR1 construct encompassing all three NR interaction domains. NCoR1 tightly binds both apo- and heme-replete FLRev-erb beta.DNA complexes; furthermore, heme, at high concentrations, destabilizes the FLRev-erb beta-NCoR1 complex. The interaction between FLRev-erb beta and NCoR1 as well as Rev-erb beta repression at the Bmal1 promoter appear to be modulated by another cellular factor(s), at least one of which is related to the ubiquitin-proteasome pathway. Our studies suggest that heme is involved in regulating the degradation of Rev-erb beta in a manner consistent with its role in circadian rhythm maintenance. Finally, the very slow rate constant (10(-6) s(-1)) of heme dissociation from Rev-erb beta rules out a prior proposal that Rev-erb beta acts as an intracellular heme sensor.	[Carter, Eric L.; Gupta, Nirupama; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Carter, Eric/0000-0003-2877-3411	National Institutes of Health [5R01-HL-102662, 1F32HL114150]; NIEHS [T32ES007062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102662, F32HL114150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062, P30ES017885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants 5R01-HL-102662 (to S. W. R.) and 1F32HL114150 (to E. L. C.) and by Grant T32ES007062 from the NIEHS (to E. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Airola MV, 2010, BIOCHEMISTRY-US, V49, P4327, DOI 10.1021/bi901945w; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bagai I, 2015, BIOCHEMISTRY-US, V54, P2693, DOI 10.1021/bi501489r; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bergen JM, 2008, BIOCONJUGATE CHEM, V19, P377, DOI 10.1021/bc700315v; BONNELYE E, 1994, CELL GROWTH DIFFER, V5, P1357; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Carter EL, 2014, J INORG BIOCHEM, V133, P92, DOI 10.1016/j.jinorgbio.2014.01.005; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Chen Y, 2010, MOL ENDOCRINOL, V24, P1650, DOI 10.1210/me.2010-0129; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chopin-Delannoy S, 2003, J MOL ENDOCRINOL, V30, P197, DOI 10.1677/jme.0.0300197; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Copeland R. A., 2002, ENZYMES, P76; Coste H, 2002, J BIOL CHEM, V277, P27120, DOI 10.1074/jbc.M203421200; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; ENMARK E, 1994, BIOCHEM BIOPH RES CO, V204, P49, DOI 10.1006/bbrc.1994.2424; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fleischhacker AS, 2015, BIOCHEMISTRY-US, V54, P2709, DOI 10.1021/acs.biochem.5b00266; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Garrick MD, 1999, BBA-MOL CELL RES, V1449, P125, DOI 10.1016/S0167-4889(99)00006-3; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guenthner CJ, 2009, NEUROSCIENCE, V164, P832, DOI 10.1016/j.neuroscience.2009.08.022; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hen T, 2000, BIOCHEM BIOPH RES CO, V273, P584, DOI 10.1006/bbrc.2000.2995; Hogan KA, 2013, CYTOKINE, V64, P652, DOI 10.1016/j.cyto.2013.09.004; Igarashi J, 2004, J BIOL CHEM, V279, P15752, DOI 10.1074/jbc.M310273200; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Jin LH, 2010, ADV DRUG DELIVER REV, V62, P1218, DOI 10.1016/j.addr.2010.08.007; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; LIU SC, 1988, BLOOD, V71, P1755; Lukat-Rodgers GS, 2010, INORG CHEM, V49, P6349, DOI 10.1021/ic902388q; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; Miksanova M, 2006, BIOCHEMISTRY-US, V45, P9894, DOI 10.1021/bi060556k; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; MORRISON GR, 1965, ANAL CHEM, V37, P1124, DOI 10.1021/ac60228a014; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; OMURA T, 1984, J BIOCHEM-TOKYO, V96, P1491, DOI 10.1093/oxfordjournals.jbchem.a134978; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; PenadeOrtiz S, 1997, J NEUROBIOL, V32, P341, DOI 10.1002/(SICI)1097-4695(199703)32:3<341::AID-NEU7>3.0.CO;2-7; Phelan CA, 2010, NAT STRUCT MOL BIOL, V17, P808, DOI 10.1038/nsmb.1860; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2009, BIOCHEM BIOPH RES CO, V388, P654, DOI 10.1016/j.bbrc.2009.08.045; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simcox JA, 2015, DIABETES, V64, P1108, DOI 10.2337/db14-0646; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUZUKI H, 1989, J BIOL CHEM, V264, P920; Terenzi H, 1996, PROTEIN EXPRES PURIF, V8, P313, DOI 10.1006/prep.1996.0106; Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799; Uchida T, 2012, J INORG BIOCHEM, V108, P188, DOI 10.1016/j.jinorgbio.2011.12.005; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; VOZ ML, 1991, J BIOL CHEM, V266, P13397; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Wang JD, 2007, FEBS J, V274, P5370, DOI 10.1111/j.1742-4658.2007.06062.x; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Wu YF, 2001, J BIOL CHEM, V276, P3929, DOI 10.1074/jbc.M006743200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	110	35	35	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2196	2222		10.1074/jbc.M115.670281	http://dx.doi.org/10.1074/jbc.M115.670281			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26670607	hybrid, Green Published			2022-12-28	WOS:000369610400013
J	Bergeron, JRC; Fernandez, L; Wasney, GA; Vuckovic, M; Reffuveille, F; Hancock, REW; Strynadka, NCJ				Bergeron, Julien R. C.; Fernandez, Lucia; Wasney, Gregory A.; Vuckovic, Marija; Reffuveille, Fany; Hancock, Robert E. W.; Strynadka, Natalie C. J.			The Structure of a Type 3 Secretion System (T3SS) Ruler Protein Suggests a Molecular Mechanism for Needle Length Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLAR HOOK-LENGTH; ENTEROPATHOGENIC ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY SWITCH; III SECRETION; YERSINIA-ENTEROCOLITICA; SHIGELLA-FLEXNERI; SALMONELLA-TYPHIMURIUM; YOP SECRETION; INJECTISOME NEEDLE; BASAL BODY	The type 3 secretion system (T3SS) and the bacterial flagellum are related pathogenicity-associated appendages found at the surface of many disease-causing bacteria. These appendages consist of long tubular structures that protrude away from the bacterial surface to interact with the host cell and/or promote motility. A proposed "ruler" protein tightly regulates the length of both the T3SS and the flagellum, but the molecular basis for this length control has remained poorly characterized and controversial. Using the Pseudomonas aeruginosa T3SS as a model system, we report the first structure of a T3SS ruler protein, revealing a "ball-and-chain" architecture, with a globular C-terminal domain (the ball) preceded by a long intrinsically disordered N-terminal polypeptide chain. The dimensions and stability of the globular domain do not support its potential passage through the inner lumen of the T3SS needle. We further demonstrate that a conserved motif at the N terminus of the ruler protein interacts with the T3SS autoprotease in the cytosolic side. Collectively, these data suggest a potential mechanism for needle length sensing by ruler proteins, whereby upon T3SS needle assembly, the ruler protein's N-terminal end is anchored on the cytosolic side, with the globular domain located on the extracellular end of the growing needle. Sequence analysis of T3SS and flagellar ruler proteins shows that this mechanism is probably conserved across systems.	[Bergeron, Julien R. C.; Wasney, Gregory A.; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Bergeron, Julien R. C.; Hancock, Robert E. W.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Fernandez, Lucia; Reffuveille, Fany; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca	Fernández, Lucía/ADE-1414-2022; Bergeron, Julien/AGY-1707-2022; Hancock, Robert E. W./E-1145-2013; Reffuveille, Fany/AAG-4488-2019; Fernández, Lucía/F-9858-2016	Fernández, Lucía/0000-0002-7383-7595; Hancock, Robert E. W./0000-0001-5989-8503; Reffuveille, Fany/0000-0002-0753-3761	Canadian Institute of Health Research; Howard Hughes Medical Institute International Scholar Program; Fundacion Alfonso Martin Escudero (Spain)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Scholar Program(Howard Hughes Medical Institute); Fundacion Alfonso Martin Escudero (Spain)	This work was supported by operating grants from the Canadian Institute of Health Research (to R. E. W. H and to N. C. J. S.) and the Howard Hughes Medical Institute International Scholar Program (to N. C. J. S.). X-ray diffraction data were collected at beamline 08B1-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Instrument support was provided by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the University of British Columbia Blusson Fund, and the Michael Smith Foundation for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral fellowship from the Fundacion Alfonso Martin Escudero (Spain).	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Aizawa S, 2012, J BACTERIOL, V194, P4797, DOI 10.1128/JB.06333-11; Aizawa S, 2012, J BACTERIOL, V194, P4798, DOI 10.1128/JB.06239-11; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Botteaux A, 2008, MOL MICROBIOL, V70, P1515, DOI 10.1111/j.1365-2958.2008.06499.x; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Burkinshaw BJ, 2015, J BIOL CHEM, V290, P10406, DOI 10.1074/jbc.M115.639013; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demers JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5976; Demers JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003245; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Dohlich K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003881; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hughes KT, 2012, J BACTERIOL, V194, P4793, DOI 10.1128/JB.00343-12; Hughes KT, 2012, J BACTERIOL, V194, P4801, DOI 10.1128/JB.06454-11; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kawagishi I, 1996, J BACTERIOL, V178, P2954, DOI 10.1128/jb.178.10.2954-2959.1996; Kawamoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03369; Kobayashi K, 2003, J BACTERIOL, V185, P5295, DOI 10.1128/JB.185.17.5295-5300.2003; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McMurry JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134884; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Mizuno S, 2011, J MOL BIOL, V409, P558, DOI 10.1016/j.jmb.2011.04.008; Feria JM, 2012, J BACTERIOL, V194, P6029, DOI 10.1128/JB.01215-12; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Ryan KA, 2005, J BACTERIOL, V187, P5742, DOI 10.1128/JB.187.16.5742-5750.2005; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Small J, 1983, Geriatr Nurs, V4, P166, DOI 10.1016/S0197-4572(83)80079-2; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Steadman D, 2014, FUTURE MICROBIOL, V9, P887, DOI [10.2217/FMB.14.46, 10.2217/fmb.14.46]; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Wagner S, 2010, P NATL ACAD SCI USA, V107, P13860, DOI 10.1073/pnas.1006985107; Wagner S, 2009, MOL MICROBIOL, V71, P692, DOI 10.1111/j.1365-2958.2008.06556.x; Wee DH, 2015, P NATL ACAD SCI USA, V112, P4098, DOI 10.1073/pnas.1423492112; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832	69	22	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1676	1691		10.1074/jbc.M115.684423	http://dx.doi.org/10.1074/jbc.M115.684423			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589798	Green Published, hybrid			2022-12-28	WOS:000368620700012
J	Shi, M; Zhang, YF; Liu, LY; Zhang, TT; Han, F; Cleveland, J; Wang, F; McKeehan, WL; Li, Y; Zhang, DK				Shi, Ming; Zhang, Yifan; Liu, Leyuan; Zhang, Tingting; Han, Fang; Cleveland, Joseph; Wang, Fen; McKeehan, Wallace L.; Li, Yu; Zhang, Dekai			MAP1S Protein Regulates the Phagocytosis of Bacteria and Toll-like Receptor (TLR) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; STIMULATED PHAGOCYTOSIS; PHAGOSOME MATURATION; AUTOPHAGY; ACTIVATION; MICROTUBULE; RECOGNITION; PATHWAY; CELLS; INFECTION	Phagocytosis is a critical cellular process for innate immune defense against microbial infection. The regulation of phagocytosis process is complex and has not been well defined. An intracellular molecule might regulate cell surface-initiated phagocytosis, but the underlying molecular mechanism is poorly understood (1). In this study, we found that microtubule-associated protein 1S (MAP1S), a protein identified recently that is involved in autophagy (2), is expressed primarily in macrophages. MAP1S-deficient macrophages are impaired in the phagocytosis of bacteria. Furthermore, we demonstrate that MAP1S interacts directly with MyD88, a key adaptor of Toll-like receptors (TLRs), upon TLR activation and affects the TLR signaling pathway. Intriguingly, we also observe that, upon TLR activation, MyD88 participates in autophagy processing in a MAP1S-dependent manner by co-localizing with MAP1 light chain 3 (MAP1-LC3 or LC3). Therefore, we reveal that an intracellular autophagy-related molecule of MAP1S controls bacterial phagocytosis through TLR signaling.	[Shi, Ming; Zhang, Yifan; Zhang, Tingting; Han, Fang; Cleveland, Joseph; Zhang, Dekai] Texas A&M Univ, Ctr Infect & Inflammatory Dis, Hlth Sci Ctr, Houston, TX 77030 USA; [Liu, Leyuan; Wang, Fen; McKeehan, Wallace L.] Texas A&M Univ, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Hlth Sci Ctr, Houston, TX 77030 USA; [Shi, Ming; Han, Fang; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	liyugene@hit.edu.cn; dzhang@ibt.tamhsc.edu			National Institutes of Health [CA176698, CA142862]; Texas AAMP;M Health Science Center; National Natural Science Foundation of China; DOD New Investigator Award [W81XWH]; John S. Dunn Foundation; NATIONAL CANCER INSTITUTE [R01CA142862, R21CA176698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AAMP;M Health Science Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DOD New Investigator Award; John S. Dunn Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA176698 and the Texas A&M Health Science Center (to D.Z.), the National Natural Science Foundation of China (to Y.L.), National Institutes of Health Grant CA142862 and DOD New Investigator Award W81XWH (to L.L.), and the John S. Dunn Foundation (to W.M. and F.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Granick JL, 2013, BLOOD, V122, P1770, DOI 10.1182/blood-2012-11-466268; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	35	13	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1243	1250		10.1074/jbc.M115.687376	http://dx.doi.org/10.1074/jbc.M115.687376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26565030	hybrid, Green Published			2022-12-28	WOS:000368068300020
J	Taga, Y; Kusubata, M; Ogawa-Goto, K; Hattori, S				Taga, Yuki; Kusubata, Masashi; Ogawa-Goto, Kiyoko; Hattori, Shunji			Developmental Stage-dependent Regulation of Prolyl 3-Hydroxylation in Tendon Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED VARIATIONS; RAT-TAIL TENDON; AMINO-ACID; ENDOPLASMIC-RETICULUM; 3-HYDROXYPROLINE; BONE; HYDROXYPROLINE; GLYCOSYLATION; HYDROXYLATION; RESIDUES	3-Hydroxyproline (3-Hyp), which is unique to collagen, is a fairly rare post-translational modification. Recent studies have suggested a function of prolyl 3-hydroxylation in fibril assembly and its relationships with certain disorders, including recessive osteogenesis imperfecta and high myopia. However, no direct evidence for the physiological and pathological roles of 3-Hyp has been presented. In this study, we first estimated the overall alterations in prolyl hydroxylation in collagens purified from skin, bone, and tail tendon of 0.5-18-month-old rats by LC-MS analysis with stable isotope-labeled collagen, which was recently developed as an internal standard for highly accurate collagen analyses. 3-Hyp was found to significantly increase in tendon collagen until 3 months after birth and then remain constant, whereas increased prolyl 3-hydroxylation was not observed in skin and bone collagen. Site-specific analysis further revealed that 3-Hyp was increased in tendon type I collagen in a specific sequence region, including a previously known modification site at Pro(707) and newly identified sites at Pro(716) and Pro(719), at the early ages. The site-specific alterations in prolyl 3-hydroxylation with aging were also observed in bovine Achilles tendon. We postulate that significant increases in 3-Hyp at the consecutive modification sites are correlated with tissue development in tendon. The present findings suggest that prolyl 3-hydroxylation incrementally regulates collagen fibril diameter in tendon.	[Taga, Yuki; Kusubata, Masashi; Ogawa-Goto, Kiyoko; Hattori, Shunji] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan		Taga, Y (corresponding author), Nippi Res Inst Biomatrix, Kuwabara 520-11, Toride, Ibaraki 3020017, Japan.	y-taga@nippi-inc.co.jp	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X				BARNES MJ, 1974, BIOCHEM J, V139, P461, DOI 10.1042/bj1390461; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MURAI A, 1975, BIOCHIM BIOPHYS ACTA, V404, P345, DOI 10.1016/0304-4165(75)90343-8; OGLE JD, 1962, J BIOL CHEM, V237, P3667; PARRY DAD, 1977, BIOPOLYMERS, V16, P1015, DOI 10.1002/bip.1977.360160506; PARRY DAD, 1978, BIOPOLYMERS, V17, P843, DOI 10.1002/bip.1978.360170404; Perdivara I, 2013, AUST J CHEM, V66, P760, DOI 10.1071/CH13174; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; STOLTZ M, 1973, BIOCHIM BIOPHYS ACTA, V310, P461, DOI 10.1016/0005-2795(73)90130-X; Taga Y, 2014, J AGR FOOD CHEM, V62, P12096, DOI 10.1021/jf5039597; Taga Y, 2014, J PROTEOME RES, V13, P3671, DOI 10.1021/pr500213a; Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850	36	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					837	847		10.1074/jbc.M115.686105	http://dx.doi.org/10.1074/jbc.M115.686105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567337	Green Published, hybrid			2022-12-28	WOS:000367830500030
J	Yin, DL; Yang, XH; Li, H; Fan, HM; Zhang, XL; Feng, YM; Stuart, C; Hu, D; Caudle, Y; Xie, NC; Liu, ZM; LeSage, G				Yin, Deling; Yang, Xiaohua; Li, Hui; Fan, Huimin; Zhang, Xiaoli; Feng, Yimin; Stuart, Charles; Hu, Dan; Caudle, Yi; Xie, Nanchang; Liu, Zhongmin; LeSage, Gene			beta-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BILE-DUCT LIGATION; LIVER-INJURY; PHOSPHOINOSITIDE 3-KINASE; P38 MAPK; RECEPTOR; ROLES; MOUSE; ACTIVATION; REGULATOR	Recent studies reveal that multifunctional protein beta-arrestin 2 (Arrb2) modulates cell apoptosis. Survival and various aspects of liver injury were investigated in WT and Arrb2 KO mice after bile duct ligation ( BDL). We found that deficiency of Arrb2 enhances survival and attenuates hepatic injury and fibrosis. Following BDL, Arrb2-deficient mice as compared with WT controls displayed a significant reduction of hepatocyte apoptosis as demonstrated by the TUNEL assay. Following BDL, the levels of phospho-Akt and phospho-glycogen synthase kinase 3 beta(GSK3 beta) in the livers were significantly increased in Arrb2 KO compared with WT mice, although p-p38 increased in WT but not in Arrb2-deficient mice. Inhibition of GSK3 beta following BDL decreases hepatic apoptosis and decreased p-p38 in WT mice but not in Arrb2 KO mice. Activation of Fas receptor with Jo2 reduces phospho-Akt and increases apoptosis in WT cells and WT mice but not in Arrb2-deficient cells and Arrb2-deficient mice. Consistent with direct interaction of Arrb2 with and regulating Akt phosphorylation, the expression of a full-length or N terminus but not the C terminus of Arrb2 reduces Akt phosphorylation and coimmunoprecipates with Akt. These results reveal that the protective effect of deficiency of Arrb2 is due to loss of negative regulation of Akt due to BDL and decreased downstream GSK3 beta and p38 MAPK signaling pathways.	[Yin, Deling; Yang, Xiaohua; Li, Hui; Zhang, Xiaoli; Feng, Yimin; Stuart, Charles; Hu, Dan; Caudle, Yi; Xie, Nanchang; LeSage, Gene] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37604 USA; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Dept Cardiothorac Surg, Shanghai East Hosp, Shanghai 200120, Peoples R China	East Tennessee State University; Tongji University	Yin, DL (corresponding author), E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37604 USA.	yin@etsu.edu; gene_lesage@yahoo.com		Yin, Deling/0000-0003-3215-7566	National Institutes of Health from NIDDK [RO1 DK54208]; NIDA [020120]; NIGMS [094740, 114716]; National Natural Science Foundation of China [81570454, 81370433];  [C06RR0306551]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094740, R15GM114716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA020120] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant RO1 DK54208 from NIDDK (to G. L.), Grant 020120 from NIDA, Grants 094740 and 114716 from NIGMS (to D. Y.), and Grant C06RR0306551 and by National Natural Science Foundation of China Grants 81570454 and 81370433. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Buchanan FG, 2006, CELL CYCLE, V5, P2060, DOI 10.4161/cc.5.18.3212; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Grambihler A, 2003, J BIOL CHEM, V278, P26831, DOI 10.1074/jbc.M303229200; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LeSage GD, 2004, HEPATOLOGY, V40, P1116, DOI 10.1002/hep.20424; Li H, 2014, J BIOL CHEM, V289, P23075, DOI 10.1074/jbc.M114.591495; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Manson MM, 2003, TRENDS MOL MED, V9, P11, DOI 10.1016/S1471-4914(02)00002-3; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Menon B, 2007, J MOL CELL CARDIOL, V42, P653, DOI 10.1016/j.yjmcc.2006.12.011; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Nalapareddy PD, 2009, AM J PATHOL, V175, P1077, DOI 10.2353/ajpath.2009.090304; O'Brien WT, 2011, J CLIN INVEST, V121, P3756, DOI 10.1172/JCI45194; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2010, HEPATOLOGY, V51, P237, DOI 10.1002/hep.23262; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Schoemaker MH, 2004, CLIN SCI, V107, P13, DOI 10.1042/CS20040090; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Wang KPC, 2011, J SURG RES, V167, P237, DOI 10.1016/j.jss.2009.07.051; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Zhang Y, 2008, J NEUROIMMUNOL, V200, P71, DOI 10.1016/j.jneuroim.2008.06.014	35	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					605	612		10.1074/jbc.M115.655829	http://dx.doi.org/10.1074/jbc.M115.655829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582201	Green Published, hybrid			2022-12-28	WOS:000367830500009
J	Clinton, RW; Francy, CA; Ramachandran, R; Qi, X; Mears, JA				Clinton, Ryan W.; Francy, Christopher A.; Ramachandran, Rajesh; Qi, Xin; Mears, Jason A.			Dynamin-related Protein 1 Oligomerization in Solution Impairs Functional Interactions with Membrane-anchored Mitochondrial Fission Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynamin; electron microscopy (EM); GTPase; mitochondria; protein-protein interaction; dynamin-related protein 1; membrane remodeling; mitochondrial fission; mitochondrial fission factor; dynamin	DRP1; MFF; INHIBITION; DIVISION; DOMAIN; FRAGMENTATION; RECRUITMENT; MUTATION; FUSION	Mitochondrial fission is a crucial cellular process mediated by the mechanoenzymatic GTPase, dynamin-related protein 1 (Drp1). During mitochondrial division, Drp1 is recruited from the cytosol to the outer mitochondrial membrane by one, or several, integral membrane proteins. One such Drp1 partner protein, mitochondrial fission factor (Mff), is essential for mitochondrial division, but its mechanism of action remains unexplored. Previous studies have been limited by a weak interaction between Drp1 and Mff in vitro. Through refined in vitro reconstitution approaches and multiple independent assays, we show that removal of the regulatory variable domain (VD) in Drp1 enhances formation of a functional Drp1-Mff copolymer. This protein assembly exhibits greatly stimulated cooperative GTPase activity in solution. Moreover, when Mff was anchored to a lipid template, to mimic a more physiologic environment, significant stimulation of GTPase activity was observed with both WT and VD Drp1. Contrary to recent findings, we show that premature Drp1 self-assembly in solution impairs functional interactions with membrane-anchored Mff. Instead, dimeric Drp1 species are selectively recruited by Mff to initiate assembly of a functional fission complex. Correspondingly, we also found that the coiled-coil motif in Mff is not essential for Drp1 interactions, but rather serves to augment cooperative self-assembly of Drp1 proximal to the membrane. Taken together, our findings provide a mechanism wherein the multimeric states of both Mff and Drp1 regulate their collaborative interaction.	[Clinton, Ryan W.; Francy, Christopher A.; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Clinton, Ryan W.; Francy, Christopher A.; Qi, Xin; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Clinton, Ryan W.; Francy, Christopher A.; Ramachandran, Rajesh; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Ramachandran, Rajesh; Qi, Xin] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mears, JA (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	jason.mears@case.edu	Qi, Xin/L-9279-2019; Qi, Xin/D-1512-2013; Ramachandran, Rajesh/A-1337-2011	Qi, Xin/0000-0002-9578-3890; Qi, Xin/0000-0002-9578-3890; Ramachandran, Rajesh/0000-0002-4645-2841; Mears, Jason/0000-0002-5199-4872; Clinton, Ryan/0000-0002-4058-6726	American Heart Association [SDG12SDG9130039, 13BGIA14810010]; National Institutes of Health [2T32GM008803-11A1, R01 NS088192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088192] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Grants SDG12SDG9130039 (to J. A. M.) and 13BGIA14810010 (to R. R.) and National Institutes of Health Training Grant 2T32GM008803-11A1 (to C. A. F.). This work was also supported by National Institutes of Health Grant R01 NS088192 (to X. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen CH, 2000, DNA CELL BIOL, V19, P189, DOI 10.1089/104454900314573; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Esposito EA, 2008, J BIOMOL SCREEN, V13, P810, DOI 10.1177/1087057108322062; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera Hidenori, 2011, Small GTPases, V2, P167; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Shrout AL, 2008, CHEM BIOL DRUG DES, V71, P278, DOI 10.1111/j.1747-0285.2008.00627.x; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; Ugarte-Uribe B, 2014, J BIOL CHEM, V289, P30645, DOI 10.1074/jbc.M114.575779; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	42	52	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					478	492		10.1074/jbc.M115.680025	http://dx.doi.org/10.1074/jbc.M115.680025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578514	Green Published, hybrid			2022-12-28	WOS:000367589500042
J	Poisson, LM; Suhail, H; Singh, J; Datta, I; Denic, A; Labuzek, K; Hoda, MN; Shankar, A; Kumar, A; Cerghet, M; Elias, S; Mohney, RP; Rodriguez, M; Rattan, R; Mangalam, AK; Giri, S				Poisson, Laila M.; Suhail, Hamid; Singh, Jaspreet; Datta, Indrani; Denic, Aleksandar; Labuzek, Krzysztof; Hoda, Md Nasrul; Shankar, Ashray; Kumar, Ashok; Cerghet, Mirela; Elias, Stanton; Mohney, Robert P.; Rodriguez, Moses; Rattan, Ramandeep; Mangalam, Ashutosh K.; Giri, Shailendra			Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRORESOLVING LIPID MEDIATORS; CENTRAL-NERVOUS-SYSTEM; TRIGGERED RESOLVIN D1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYLOID-BETA PHAGOCYTOSIS; DOCOSAHEXAENOIC ACID; FATTY-ACIDS; SUPPRESSOR-CELLS; OMEGA-3 SUPPLEMENTATION; PROMOTE RESOLUTION	We performed untargeted metabolomics in plasma of B6 mice with experimental autoimmune encephalitis (EAE) at the chronic phase of the disease in search of an altered metabolic pathway(s). Of 324 metabolites measured, 100 metabolites that mapped to various pathways (mainly lipids) linked to mitochondrial function, inflammation, and membrane stability were observed to be significantly altered between EAE and control (p < 0.05, false discovery rate < 0.10). Bioinformatics analysis revealed six metabolic pathways being impacted and altered in EAE, including alpha-linolenic acid and linoleic acid metabolism (PUFA). The metabolites of PUFAs, including omega-3 and omega-6 fatty acids, are commonly decreased in mouse models of multiple sclerosis (MS) and in patients with MS. Daily oral administration of resolvin D1, a downstream metabolite of omega-3, decreased disease progression by suppressing autoreactive T cells and inducing an M2 phenotype of monocytes/macrophages and resident brain microglial cells. This study provides a proof of principle for the application of metabolomics to identify an endogenous metabolite(s) possessing drug-like properties, which is assessed for therapy in preclinical mouse models of MS.	[Poisson, Laila M.; Datta, Indrani] Henry Ford Hlth Syst, Ctr Bioinformat, Detroit, MI 48202 USA; [Poisson, Laila M.; Datta, Indrani] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Suhail, Hamid; Singh, Jaspreet; Shankar, Ashray; Cerghet, Mirela; Elias, Stanton; Giri, Shailendra] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Rattan, Ramandeep] Henry Ford Hlth Syst, Div Gynecol Oncol, Dept Womens Hlth Serv, Detroit, MI 48202 USA; [Denic, Aleksandar; Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55906 USA; [Rodriguez, Moses] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55906 USA; [Labuzek, Krzysztof] Med Univ Silesia, Dept Pharmacol, PL-40752 Katowice, Poland; [Hoda, Md Nasrul] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA; [Hoda, Md Nasrul] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA 30912 USA; [Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Mohney, Robert P.] Metabolon Inc, Durham, NC 27713 USA; [Mangalam, Ashutosh K.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Mayo Clinic; Mayo Clinic; Medical University Silesia; University System of Georgia; Augusta University; University System of Georgia; University of Georgia; Wayne State University; Metabolon; University of Iowa	Giri, S (corresponding author), Henry Ford Hosp, Dept Neurol, Div Res, Educ & Res Bldg,Rm 4051,2799 W Grand Blvd, Detroit, MI 48202 USA.	SGiri1@hfhs.org	Mangalam, Ashutosh/I-8565-2017; Regan, Clinton/E-6250-2012	Mangalam, Ashutosh/0000-0002-9926-2531; Giri, Shailendra/0000-0002-7123-829X; Denic, Aleksandar/0000-0001-9157-5405; Rodriguez, Moses/0000-0001-6328-6497; Rattan, Ramandeep/0000-0002-3532-6057	Henry Ford Hospital [A20020]; National Multiple Sclerosis Society [RG 4311A4/4, RG 5112A5/2]; National Institutes of Health [R01 GM092993]; Metabolon, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092993] Funding Source: NIH RePORTER	Henry Ford Hospital; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolon, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Henry Ford Hospital Internal Funding Grant A20020, in part by National Multiple Sclerosis Society Research Grants RG 4311A4/4 and RG 5112A5/2 (to S. G.), and by National Institutes of Health Grant R01 GM092993 (to M. R). R. M. is an employee of Metabolon, Inc., and as such has affiliations with or financial involvement with Metabolon, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Chen F, 2014, EUR J CLIN MICROBIOL, V33, P457, DOI 10.1007/s10096-013-1978-6; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Croasdell A, 2015, AM J PHYSIOL-LUNG C, V309, pL888, DOI 10.1152/ajplung.00125.2015; CUNNANE SC, 1989, AM J CLIN NUTR, V50, P801, DOI 10.1093/ajcn/50.4.801; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gebregiworgis T, 2013, ACS CHEM BIOL, V8, P684, DOI 10.1021/cb300673e; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; GUL S, 1970, J NEUROL NEUROSUR PS, V33, P506, DOI 10.1136/jnnp.33.4.506; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Ho PP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003831; HOLMAN RT, 1989, P NATL ACAD SCI USA, V86, P4720, DOI 10.1073/pnas.86.12.4720; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jelinek GA, 2013, INT J NEUROSCI, V123, P792, DOI 10.3109/00207454.2013.803104; Johansen KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007551; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Johnston J, 2012, DRUGS, V72, P1195, DOI 10.2165/11634010-000000000-00000; Koivisto H, 2014, J NUTR BIOCHEM, V25, P157, DOI 10.1016/j.jnutbio.2013.09.015; Kong WM, 2011, BRAIN BEHAV IMMUN, V25, P872, DOI 10.1016/j.bbi.2010.09.012; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; Lin L, 2011, J PROTEOME RES, V10, P1396, DOI 10.1021/pr101161u; Lourenco AST, 2011, CURR MOL MED, V11, P326; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Lutz NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056101; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Mangalam Ak, 2013, J Clin Cell Immunol, V4, DOI 10.4172/2155-9899.1000150; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Melzer N, 2014, CLIN EXP IMMUNOL, V175, P359, DOI 10.1111/cei.12195; Miller James R, 2004, J Manag Care Pharm, V10, pS4; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nath N, 2009, BIOCHEM BIOPH RES CO, V386, P16, DOI 10.1016/j.bbrc.2009.05.106; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; NIGHTINGALE S, 1990, ACTA NEUROL SCAND, V82, P43; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Nordvik I, 2000, ACTA NEUROL SCAND, V102, P143, DOI 10.1034/j.1600-0404.2000.102003143.x; Ochando JC, 2012, IMMUNOL RES, V54, P275, DOI 10.1007/s12026-012-8335-1; OKAJIMA K, 1985, J LAB CLIN MED, V105, P132; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; ROSSI S, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/149381; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Schulze-Topphoff U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033797; Seki H, 2010, THESCIENTIFICWORLDJO, V10, P818, DOI 10.1100/tsw.2010.72; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Skripuletz T, 2015, BRAIN, V138, P398, DOI 10.1093/brain/awu358; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; Tang HF, 2014, J IMMUNOL, V193, P3769, DOI 10.4049/jimmunol.1400942; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Wang XZ, 2015, ALZHEIMERS DEMENT, V11, P40, DOI 10.1016/j.jalz.2013.12.024; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weinstock-Guttman B, 2005, PROSTAG LEUKOTR ESS, V73, P397, DOI 10.1016/j.plefa.2005.05.024; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhang AH, 2013, ANAL BIOANAL CHEM, V405, P8143, DOI 10.1007/s00216-013-7061-4; Zhang AH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354671; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	87	53	54	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30697	+		10.1074/jbc.M115.679068	http://dx.doi.org/10.1074/jbc.M115.679068			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26546682	hybrid, Green Published			2022-12-28	WOS:000367199000004
J	Chattopadhyay, M; Nwadibia, E; Strong, CD; Gralla, EB; Valentine, JS; Whitelegge, JP				Chattopadhyay, Madhuri; Nwadibia, Ekeoma; Strong, Cynthia D.; Gralla, Edith Butler; Valentine, Joan Selverstone; Whitelegge, Julian P.			The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu, Zn Superoxide Dismutase (SOD1) Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER CHAPERONE CCS; METAL-ION BINDING; FAMILIAL ALS; WILD-TYPE; CU,ZN-SUPEROXIDE DISMUTASE; MUTANT SOD1; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; IN-VITRO; AGGREGATION	Aggregation of copper-zinc superoxide dismutase (SOD1) is a defining feature of familial ALS caused by inherited mutations in the sod1 gene, and misfolded and aggregated forms of wildtype SOD1 are found in both sporadic and familial ALS cases. Mature SOD1 owes its exceptional stability to a number of post-translational modifications as follows: formation of the intramolecular disulfide bond, binding of copper and zinc, and dimerization. Loss of stability due to the failure to acquire one or more of these modifications is proposed to lead to aggregation in vivo. Previously, we showed that the presence of apo-, disulfide-reduced SOD1, the most immature form of SOD1, results in initiation of fibrillation of more mature forms that have an intact Cys-57-Cys-146 disulfide bond and are partially metallated. In this study, we examine the ability of each of the above post-translational modifications to modulate fibril initiation and seeded growth. Cobalt or zinc binding, despite conferring great structural stability, neither inhibits the initiation propensity of disulfide-reduced SOD1 nor consistently protects disulfide-oxidized SOD1 from being recruited into growing fibrils across wild-type and a number of ALS mutants. In contrast, reduction of the disulfide bond, known to be necessary for fibril initiation, also allows for faster recruitment during seeded amyloid growth. These results identify separate factors that differently influence seeded growth and initiation and indicate a lack of correlation between the overall thermodynamic stability of partially mature SOD1 states and their ability to initiate fibrillation or be recruited by a growing fibril.	[Chattopadhyay, Madhuri; Nwadibia, Ekeoma; Gralla, Edith Butler; Valentine, Joan Selverstone; Whitelegge, Julian P.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Strong, Cynthia D.] Cornell Coll, Dept Chem, Mt Vernon, IA 52314 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chattopadhyay, M (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	madhuri@gmail.com; jpw@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X; Whitelegge, Julian/0000-0003-2763-7733	National Institutes of Health from NINDS [P01 NS049134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Program Project Grant P01 NS049134 from NINDS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023561; Bhatia NK, 2015, BBA-PROTEINS PROTEOM, V1854, P426, DOI 10.1016/j.bbapap.2015.01.014; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chan PK, 2013, P NATL ACAD SCI USA, V110, P10934, DOI 10.1073/pnas.1309613110; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Durazo A, 2009, J BIOL CHEM, V284, P34382, DOI 10.1074/jbc.M109.052076; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2013, FEBS LETT, V587, P2500, DOI 10.1016/j.febslet.2013.06.046; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Leinartaite L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078060; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MING LJ, 1988, INORG CHEM, V27, P728, DOI 10.1021/ic00277a029; MING LJ, 1990, J AM CHEM SOC, V112, P4256, DOI 10.1021/ja00167a021; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Mulligan VK, 2008, J MOL BIOL, V383, P424, DOI 10.1016/j.jmb.2008.08.024; PANTOLIANO MW, 1982, J AM CHEM SOC, V104, P1717, DOI 10.1021/ja00370a045; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Svensson AKE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010064; Synofzik M, 2012, HUM MOL GENET, V21, P3568, DOI 10.1093/hmg/dds188; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wright GSA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2750; Xu GL, 2015, HUM MOL GENET, V24, P1019, DOI 10.1093/hmg/ddu517	66	41	42	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30624	30636		10.1074/jbc.M115.666503	http://dx.doi.org/10.1074/jbc.M115.666503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26511321	hybrid, Green Published			2022-12-28	WOS:000366738200037
J	Le Quiniou, C; van Oort, B; Drop, B; van Stokkum, HM; Croce, R				Le Quiniou, Clotilde; van Oort, Bart; Drop, Bartlomiej; van Stokkum, H. M.; Croce, Roberta			The High Efficiency of Photosystem I in the Green Alga Chlamydomonas reinhardtii Is Maintained after the Antenna Size Is Substantially Increased by the Association of Light-harvesting Complexes II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE TRANSITIONS; PSI-LHCI; SUPRAMOLECULAR ORGANIZATION; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; THYLAKOID MEMBRANE; FLUORESCENCE; SUPERCOMPLEX; MUTANTS; YIELD	Photosystems (PS) I and II activities depend on their light-harvesting capacity and trapping efficiency, which vary in different environmental conditions. For optimal functioning, these activities need to be balanced. This is achieved by redistribution of excitation energy between the two photosystems via the association and disassociation of light-harvesting complexes (LHC) II, in a process known as state transitions. Here we study the effect of LHCII binding to PSI on its absorption properties and trapping efficiency by comparing time-resolved fluorescence kinetics of PSI-LHCI and PSI-LHCI-LHCII complexes of Chlamydomonas reinhardtii. PSI-LHCI-LHCII of C. reinhardtii is the largest PSI supercomplex isolated so far and contains seven Lhcbs, in addition to the PSI core and the nine Lhcas that compose PSI-LHCI, together binding similar to 320 chlorophylls. The average decay time for PSI-LHCI-LHCII is similar to 65 ps upon 400 nm excitation (15 ps slower than PSI-LHCI) and similar to 78 ps upon 475 nm excitation (27 ps slower). The transfer of excitation energy from LHCII to PSI-LHCI occurs in similar to 60 ps. This relatively slow transfer, as compared with that from LHCI to the PSI core, suggests loose connectivity between LHCII and PSI-LHCI. Despite the relatively slow transfer, the overall decay time of PSI-LHCI-LHCII remains fast enough to assure a 96% trapping efficiency, which is only 1.4% lower than that of PSI-LHCI, concomitant with an increase of the absorption cross section of 47%. This indicates that, at variance with PSII, the design of PSI allows for a large increase of its light-harvesting capacities.	[Croce, Roberta] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; LaserLaB Amsterdam, Inst Lasers Life & Biophoton Amsterdam, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Croce, R (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Le Quiniou, Clotilde/AAZ-8936-2020; van Oort, Bart/C-4674-2008; Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014	van Oort, Bart/0000-0002-5470-1545; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X	European Research Council (ERC) [281341]; Netherlands Organization for Scientific Research (NWO) through Vici grant; Netherlands Organization for Scientific Research (NWO) through Veni grant	European Research Council (ERC)(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO) through Vici grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO) through Veni grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by the European Research Council (ERC) Consolidator Grant 281341 (ASAP) (to R. C.) and by the Netherlands Organization for Scientific Research (NWO) through a Vici grant (to R. C.) and a Veni grant (to B. v. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar P, 2015, J BIOL CHEM, V290, P4877, DOI 10.1074/jbc.M114.607770; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Bell AJ, 2015, J BIOL CHEM, V290, P18429, DOI 10.1074/jbc.M115.663872; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; de Weerd FL, 2003, J PHYS CHEM B, V107, P5995, DOI 10.1021/jp027758k; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; FORSTER T, 1946, NATURWISSENSCHAFTEN, V33, P166, DOI 10.1007/BF00585226; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; GARNIER J, 1979, PLANT CELL PHYSIOL, V20, P1013; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Gobets B, 2001, BIOPHYS J, V81, P407, DOI 10.1016/S0006-3495(01)75709-8; Hippler M, 2002, PROTIST, V153, P197, DOI 10.1078/1434-4610-00098; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jennings RC, 2003, BBA-BIOENERGETICS, V1557, P91, DOI 10.1016/S0005-2728(02)00399-7; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Le Quiniou C, 2015, BBA-BIOENERGETICS, V1847, P458, DOI 10.1016/j.bbabio.2015.02.001; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MAROC J, 1989, J PHOTOCH PHOTOBIO B, V4, P97, DOI 10.1016/1011-1344(89)80105-8; Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Mullen KM, 2009, NUMER ALGORITHMS, V51, P319, DOI 10.1007/s11075-008-9235-2; Nagy G, 2014, P NATL ACAD SCI USA, V111, P5042, DOI 10.1073/pnas.1322494111; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Pan XW, 2013, CURR OPIN STRUC BIOL, V23, P515, DOI 10.1016/j.sbi.2013.04.004; Passarini F, 2010, BBA-BIOENERGETICS, V1797, P501, DOI 10.1016/j.bbabio.2010.01.015; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; SAUER K, 1966, J AM CHEM SOC, V88, P2681, DOI 10.1021/ja00964a011; Snellenburg J. J., 2012, J STAT SOFTWARE, V49; Snellenburg JJ, 2013, J PHYS CHEM B, V117, P11363, DOI 10.1021/jp4031283; Stauber EJ, 2009, PROTEOMICS, V9, P398, DOI 10.1002/pmic.200700620; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Takahashi H, 2014, PLANT CELL PHYSIOL, V55, P1437, DOI 10.1093/pcp/pcu071; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; Valkunas L., 2000, PHOTOSYNTHETIC EXCIT, P401; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; van Stokkum Ivo H. M., 2008, V26, P223; Wientjes E, 2013, J PHYS CHEM B, V117, P11200, DOI 10.1021/jp401663w; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009; Wientjes E, 2011, BIOPHYS J, V101, P745, DOI 10.1016/j.bpj.2011.06.045; Wientjes E, 2011, BIOCHEM J, V433, P477, DOI 10.1042/BJ20101538; Wientjes E, 2009, J BIOL CHEM, V284, P7803, DOI 10.1074/jbc.M808395200; Wlodarczyk LM, 2015, BIOPHYS J, V108, P261, DOI 10.1016/j.bpj.2014.11.3470	63	20	20	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30587	+		10.1074/jbc.M115.687970	http://dx.doi.org/10.1074/jbc.M115.687970			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26504081	Green Published, hybrid			2022-12-28	WOS:000366738200033
J	Shinzawa-Itoh, K; Shimomura, H; Yanagisawa, S; Shimada, S; Takahashi, R; Oosaki, M; Ogura, T; Tsukihara, T				Shinzawa-Itoh, Kyoko; Shimomura, Harunobu; Yanagisawa, Sachiko; Shimada, Satoru; Takahashi, Ryoko; Oosaki, Marika; Ogura, Takashi; Tsukihara, Tomitake			Purification of Active Respiratory Supercomplex from Bovine Heart Mitochondria Enables Functional Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; complex I; cytochrome c oxidase (complex IV); membrane protein; protein purification; Raman spectroscopy; complex III; respiratory supercomplex	CYTOCHROME-C-OXIDASE; ELECTRON-TRANSPORT CHAIN; COMPLEX-I; BC(1) COMPLEX; 2.8 ANGSTROM; MAMMALIAN MITOCHONDRIA; CRYSTAL-STRUCTURE; UBIQUINONE; YEAST; ARRANGEMENT	To understand the roles of mitochondrial respiratory chain supercomplexes, methods for consistently separating and preparing supercomplexes must be established. To this end, we solubilized supercomplexes from bovine heart mitochondria with digitonin and then replaced digitonin with amphipol (A8-35), an amphiphilic polymer. Afterward, supercomplexes were separated from other complexes by sucrose density gradient centrifugation. Twenty-six grams of bovine myocardium yielded 3.2 mg of amphipol-stabilized supercomplex. The purified supercomplexes were analyzed based on their absorption spectra as well as Q(10) (ubiquinone with ten isoprene units) and lipid assays. The supercomplex sample did not contain cytochrome c but did contain complexes I, III, and IV at a ratio of 1:2:1, 6 molecules of Q(10), and 623 atoms of phosphorus. When cytochrome c was added, the supercomplex exhibited KCN-sensitive NADH oxidation; thus, the purified supercomplex was active. Reduced complex IV absorbs at 444 nm, so we measured the resonance Raman spectrum of the reduced amphipol-solubilized supercomplex and the mixture of amphipol-solubilized complexes I-1, III2, and IV1 using an excitation wavelength of 441.6 nm, allowing measurement precision comparable with that obtained for complex IV alone. Use of the purified active sample provides insights into the effects of supercomplex formation.	[Shinzawa-Itoh, Kyoko; Shimomura, Harunobu; Yanagisawa, Sachiko; Shimada, Satoru; Takahashi, Ryoko; Oosaki, Marika; Ogura, Takashi; Tsukihara, Tomitake] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Shimada, Satoru; Tsukihara, Tomitake] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	University of Hyogo; Japan Science & Technology Agency (JST); Osaka University	Shinzawa-Itoh, K (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan.	shinzawa@sci.u-hyogo.ac.jp			CREST/JST; MEXT, Japan [(2503) 26104532]; Grants-in-Aid for Scientific Research [15K21295] Funding Source: KAKEN	CREST/JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST/JST and Grant-in-aid for Scientific Research on Innovative Areas (2503) 26104532, MEXT, Japan (to T. O.).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; CHANCE B, 1955, J BIOL CHEM, V217, P409; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HATEFI Y, 1962, J BIOL CHEM, V237, P1681; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Markwell M A, 1981, Methods Enzymol, V72, P296; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Murakami S, 1998, ACTA CRYSTALLOGR D, V54, P146, DOI 10.1107/S0907444997007245; OGURA T, 1985, BIOCHEMISTRY-US, V24, P7746, DOI 10.1021/bi00347a037; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shimada S, 2014, MICROSCOPY-JPN, V63, P167, DOI 10.1093/jmicro/dft082; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	39	31	31	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4178	4184		10.1074/jbc.M115.680553	http://dx.doi.org/10.1074/jbc.M115.680553			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26698328	Green Published, hybrid			2022-12-28	WOS:000371338400041
J	Gunawardane, RN; Fordstrom, P; Piper, DE; Masterman, S; Siu, S; Liu, DM; Brown, M; Lu, M; Tang, J; Zhang, R; Cheng, J; Gates, A; Meininger, D; Chan, J; Carlson, T; Walker, N; Schwarz, M; Delaney, J; Zhou, MY				Gunawardane, Ruwanthi N.; Fordstrom, Preston; Piper, Derek E.; Masterman, Stephanie; Siu, Sophia; Liu, Dongming; Brown, Mike; Lu, Mei; Tang, Jie; Zhang, Richard; Cheng, Janet; Gates, Andrew; Meininger, David; Chan, Joyce; Carlson, Tim; Walker, Nigel; Schwarz, Margrit; Delaney, John; Zhou, Mingyue			Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA LECITHIN; LECITHINCHOLESTEROL ACYLTRANSFERASE; MYOCARDIAL-INFARCTION; HDL CONCENTRATIONS; ATHEROSCLEROSIS; ATHEROPROTECTION; DEFICIENCY; DISEASE; RISK; LOCI	Drug discovery opportunities where loss-of-function alleles of a target gene link to a disease-relevant phenotype often require an agonism approach to up-regulate or re-establish the activity of the target gene. Antibody therapy is increasingly recognized as a favored drug modality due to multiple desirable pharmacological properties. However, agonistic antibodies that enhance the activities of the target enzymes are rarely developed because the discovery of agonistic antibodies remains elusive. Here we report an innovative scheme of discovery and characterization of human antibodies capable of binding to and agonizing a circulating enzyme lecithin cholesterol acyltransferase (LCAT). Utilizing a modified human LCAT protein with enhanced enzymatic activity as an immunogen, we generated fully human monoclonal antibodies using the XenoMouse (TM) platform. One of the resultant agonistic antibodies, 27C3, binds to and substantially enhances the activity of LCAT from humans and cynomolgus macaques. X-ray crystallographic analysis of the 2.45 angstrom LCAT-27C3 complex shows that 27C3 binding does not induce notable structural changes in LCAT. A single administration of 27C3 to cynomolgus monkeys led to a rapid increase of plasma LCAT enzymatic activity and a 35% increase of the high density lipoprotein cholesterol that was observed up to 32 days after 27C3 administration. Thus, this novel scheme of immunization in conjunction with high throughput screening may represent an effective strategy for discovering agonistic antibodies against other enzyme targets. 27C3 and other agonistic human anti-human LCAT monoclonal antibodies described herein hold potential for therapeutic development for the treaent of dyslipidemia and cardiovascular disease.	[Gunawardane, Ruwanthi N.; Siu, Sophia; Brown, Mike; Cheng, Janet; Gates, Andrew; Meininger, David] Amgen Inc, Therapeut Discovery, Seattle, WA 98119 USA; [Fordstrom, Preston; Liu, Dongming; Chan, Joyce; Schwarz, Margrit; Zhou, Mingyue] Amgen Inc, Cardiometab Disorders, San Francisco, CA 94080 USA; [Piper, Derek E.; Lu, Mei; Tang, Jie; Zhang, Richard; Walker, Nigel] Amgen Inc, Therapeut Discovery, San Francisco, CA 94080 USA; [Carlson, Tim] Amgen Inc, PKDM Dept, San Francisco, CA 94080 USA; [Masterman, Stephanie; Delaney, John] Amgen Inc, Therapeut Discovery, Burnaby, BC VSA 1V7, Canada	Amgen; Amgen; Amgen; Amgen	Zhou, MY (corresponding author), Amgen Inc, Cardio Metab Disorders, Therapeut Area, 1120 Vet Blvd, San Francisco, CA 94080 USA.	mzhou@amgen.com						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ayyobi AF, 2004, ATHEROSCLEROSIS, V177, P361, DOI 10.1016/j.atherosclerosis.2004.07.018; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Belmont W., 2012, International Patent Application, Patent No. [WO 98/24893, 9824893]; Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; Boone T., 2015, U.S. Patent, Patent No. [US9006408 B2, 9006408]; Brousseau ME, 2000, ARTERIOSCL THROM VAS, V20, P450, DOI 10.1161/01.ATV.20.2.450; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calabresi L, 2005, ARTERIOSCL THROM VAS, V25, P1972, DOI 10.1161/01.ATV.0000175751.30616.13; Calabresi L, 2010, TRENDS CARDIOVAS MED, V20, P50, DOI 10.1016/j.tcm.2010.03.007; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; CARLSON LA, 1979, LANCET, V2, P921; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; CHEN CH, 1982, J LIPID RES, V23, P680; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Z, 2012, METABOLISM, V61, P470, DOI 10.1016/j.metabol.2011.08.006; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Dullaart RPF, 2008, J CLIN ENDOCR METAB, V93, P4860, DOI 10.1210/jc.2008-1213; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GLOMSET JA, 1966, J LIPID RES, V7, P638; GLOMSET JA, 1968, J LIPID RES, V9, P155; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Green L. L., 2000, International Patent Application, Patent No. [WO 00/76310, 0076310]; Hall CM, 2013, J IMMUNOL METHODS, V393, P70, DOI 10.1016/j.jim.2013.03.011; Hoeg JM, 1996, P NATL ACAD SCI USA, V93, P11448, DOI 10.1073/pnas.93.21.11448; Holleboom AG, 2010, J LIPID RES, V51, P416, DOI 10.1194/P900038-JLR200; Hovingh GK, 2005, CIRCULATION, V112, P879, DOI 10.1161/CIRCULATIONAHA.105.540427; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; JAUHIAINEN M, 1989, J BIOL CHEM, V264, P1963; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kuivenhoven JA, 1996, ARTERIOSCL THROM VAS, V16, P294, DOI 10.1161/01.ATV.16.2.294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; NORUM KR, 1967, BIOCHIM BIOPHYS ACTA, V144, P698, DOI 10.1016/0005-2760(67)90064-1; Piper DE, 2015, J LIPID RES, V56, P1711, DOI 10.1194/jlr.M059873; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Rousset X, 2011, CURR ATHEROSCLER REP, V13, P249, DOI 10.1007/s11883-011-0171-6; Schreiber J. R., 2011, U.S. Patent Application, Patent No. [08/759,620, 08759620]; Sethi AA, 2010, CLIN CHEM, V56, P1128, DOI 10.1373/clinchem.2009.139931; SOLAJICBOZICEVIC N, 1991, ARTERY, V18, P326; Spahr C, 2013, PROTEIN SCI, V22, P1739, DOI 10.1002/pro.2373; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Van Craeyveld E, 2009, GENE THER, V16, P757, DOI 10.1038/gt.2009.8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang AH, 2004, FEBS LETT, V570, P25, DOI 10.1016/j.febslet.2004.06.017; Zhou M, 2008, THROMB VASC BIOL ANN, pe65; Zhou MY, 2009, CIRCULATION, V120, pS1175	50	19	27	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2799	2811		10.1074/jbc.M115.672790	http://dx.doi.org/10.1074/jbc.M115.672790			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644477	Green Published, hybrid			2022-12-28	WOS:000369626900020
J	Chen, Q; Lu, MJ; Monks, BR; Birnbaum, MJ				Chen, Qing; Lu, Mingjian; Monks, Bobby R.; Birnbaum, Morris J.			Insulin Is Required to Maintain Albumin Expression by Inhibiting Forkhead Box O1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTION FACTOR FKHR; TREATED DIABETIC-RATS; MTOR COMPLEX 1; GENE-EXPRESSION; PRIMARY CULTURES; MESSENGER-RNA; NUCLEAR EXCLUSION; LIPID-METABOLISM; SERUM-ALBUMIN	Diabetes is accompanied by dysregulation of glucose, lipid, and protein metabolism. In recent years, much effort has been spent on understanding how insulin regulates glucose and lipid metabolism, whereas the effect of insulin on protein metabolism has received less attention. In diabetes, hepatic production of serum albumin decreases, and it has been long established that insulin positively controls albumin gene expression. In this study, we used a genetic approach in mice to identify the mechanism by which insulin regulates albumin gene transcription. Albumin expression was decreased significantly in livers with insulin signaling disrupted by ablation of the insulin receptor or Akt. Concomitant deletion of Forkhead Box O1 (Foxo1) in these livers rescued the decreased albumin secretion. Furthermore, activation of Foxo1 in the liver is sufficient to suppress albumin expression. These results suggest that Foxo1 acts as a repressor of albumin expression.	[Chen, Qing; Lu, Mingjian; Monks, Bobby R.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Qing; Birnbaum, Morris J.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Qing; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Birnbaum, Morris J.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA 02140 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pfizer	Birnbaum, MJ (corresponding author), Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA 02140 USA.	birnbaum@mail.med.upenn.edu	Lu, Mingjian/AGK-0751-2022; Lu, Mingjian/AAO-6179-2021	Lu, Mingjian/0000-0001-9328-4935; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [RO1 DK56886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK56886. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DEFEO P, 1991, J CLIN INVEST, V88, P833, DOI 10.1172/JCI115384; Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; HUTSON SM, 1987, AM J PHYSIOL, V252, pE291, DOI 10.1152/ajpendo.1987.252.3.E291; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JEFFERSON LS, 1983, J BIOL CHEM, V258, P1369; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; KIMBALL SR, 1995, AM J PHYSIOL-ENDOC M, V268, pE6, DOI 10.1152/ajpendo.1995.268.1.E6; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; LLOYD CE, 1987, AM J PHYSIOL, V252, pC205, DOI 10.1152/ajpcell.1987.252.2.C205; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; PEAVY DE, 1978, P NATL ACAD SCI USA, V75, P5879, DOI 10.1073/pnas.75.12.5879; PEAVY DE, 1985, AM J PHYSIOL, V248, pE656, DOI 10.1152/ajpendo.1985.248.6.E656; PIETRANGELO A, 1992, J CLIN INVEST, V89, P1755, DOI 10.1172/JCI115778; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; SAKUMA K, 1987, J NUTR, V117, P1141, DOI 10.1093/jn/117.6.1141; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Sekine K, 2007, EMBO J, V26, P3607, DOI 10.1038/sj.emboj.7601784; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tuteja G, 2008, NUCLEIC ACIDS RES, V36, P4149, DOI 10.1093/nar/gkn366; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Xiong XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074340; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	49	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2371	2378		10.1074/jbc.M115.677351	http://dx.doi.org/10.1074/jbc.M115.677351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26668316	Green Published, hybrid			2022-12-28	WOS:000369610400026
J	Sihn, CR; Kim, HJ; Woltz, RL; Yarov-Yarovoy, V; Yang, PC; Xu, J; Clancy, CE; Zhang, XD; Chiamvimonvat, N; Yamoah, EN				Sihn, Choong-Ryoul; Kim, Hyo Jeong; Woltz, Ryan L.; Yarov-Yarovoy, Vladimir; Yang, Pei-Chi; Xu, Jun; Clancy, Colleen E.; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan; Yamoah, Ebenezer N.			Mechanisms of Calmodulin Regulation of Different Isoforms of Kv7.4 K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEARING-LOSS; HAIR-CELLS; POTASSIUM CHANNELS; VOLTAGE SENSOR; PROTEIN INTERACTIONS; ELECTRICAL-ACTIVITY; CALCIUM-CHANNELS; STRUCTURAL BASIS; SODIUM-CHANNEL; CA2+ CHANNEL	Calmodulin (CaM), a Ca2+-sensing protein, is constitutively bound to IQ domains of the C termini of human Kv7 (hKv7, KCNQ) channels to mediate Ca2+-dependent reduction of Kv7 currents. However, the mechanism remains unclear. We report that CaM binds to two isoforms of the hKv7.4 channel in a Ca2+-independent manner but that only the long isoform (hKv7.4a) is regulated by Ca2+/CaM. Ca2+/CaM mediate reduction of the hKv7.4a channel by decreasing the channel open probability and altering activation kinetics. We took advantage of a known missense mutation (G321S) that has been linked to progressive hearing loss to further examine the inhibitory effects of Ca2+/CaM on the Kv7.4 channel. Using multidisciplinary techniques, we demonstrate that the G321S mutation may destabilize CaM binding, leading to a decrease in the inhibitory effects of Ca2+ on the channels. Our study utilizes an expression system to dissect the biophysical properties of the WT and mutant Kv7.4 channels. This report provides mechanistic insights into the critical roles of Ca2+/CaM regulation of the Kv7.4 channel under physiological and pathological conditions.	[Sihn, Choong-Ryoul; Yamoah, Ebenezer N.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Program Commun Sci, Reno, NV 89557 USA; [Kim, Hyo Jeong; Woltz, Ryan L.; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Yang, Pei-Chi; Clancy, Colleen E.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Yarov-Yarovoy, Vladimir; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan] Dept Vet Affairs, Northern Calif Hlth Care Syst, Mather, CA 95655 USA; [Xu, Jun] Tarleton State Univ, Coll Sci & Technol, Dept Engn Technol, Stephenville, TX 76402 USA; Univ Nevada, Dept Physiol & Cell Biol, Program Commun Sci, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Texas A&M University System; Tarleton State University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Yamoah, EN (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Program Commun Sci, Reno, NV 89557 USA.	enyamoah@gmail.com	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; woltz, ryan/0000-0002-0446-2478; Chiamvimonvat, Nipavan/0000-0001-9499-8817	National Institutes of Health [R01 DC0100386, R01 DC007592, DC003826, R01 HL085844, R01 HL085727, R01 HL085844-S1]; Department of Veterans Affairs [I01BX000576]; American Heart Association Western States Beginning Grant [14BGIA18870087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137228, R01HL085844, R01HL085727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003826, R01DC007592] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576, I01CX001490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association Western States Beginning Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01 DC0100386, R01 DC007592, and DC003826 (to E. N. Y.); R01 HL085844 and R01 HL085727 (to N. C.); and R01 HL085844-S1 (to R. L. W.). This work was also supported by Department of Veterans Affairs Merit Review Grant I01BX000576 (to N. C.) and American Heart Association Western States Beginning Grant-in-Aid 14BGIA18870087 (to X. D. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Bonneau R, 2001, PROTEINS, V43, P1, DOI 10.1002/1097-0134(20010401)43:1<1::AID-PROT1012>3.0.CO;2-A; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Kalluri R, 2010, J NEUROPHYSIOL, V104, P2034, DOI 10.1152/jn.00396.2010; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; PASIC TR, 1989, J COMP NEUROL, V283, P474, DOI 10.1002/cne.902830403; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Roehm PC, 2008, MOL CELL NEUROSCI, V37, P376, DOI 10.1016/j.mcn.2007.10.014; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; Rusch A, 1998, J NEUROSCI, V18, P7487; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Van Hauwe P, 2000, AM J MED GENET, V93, P184, DOI 10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	53	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2499	2509		10.1074/jbc.M115.668236	http://dx.doi.org/10.1074/jbc.M115.668236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26515070	Green Published, hybrid			2022-12-28	WOS:000369610400037
J	Li, J; Du, XR; Shi, H; Deng, KJ; Chi, HB; Tao, WF				Li, Jiang; Du, Xingrong; Shi, Hao; Deng, Kejing; Chi, Hongbo; Tao, Wufan			Mammalian Sterile 20-like Kinase 1 (Mst1) Enhances the Stability of Forkhead Box P3 (Foxp3) and the Function of Regulatory T Cells by Modulating Foxp3 Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASES; HIPPO; PROMOTES; PROLIFERATION; PROTEIN; GROWTH; SCURFY; TRANSCRIPTION; TRAFFICKING; INHIBITION	Regulatory T cells (Tregs) play crucial roles in maintaining immune tolerance. The transcription factor Foxp3 is a critical regulator of Treg development and function, and its expression is regulated at both transcriptional and post-translational levels. Acetylation by lysine acetyl transferases/lysine deacetylases is one of the main post-translational modifications of Foxp3, which regulate Foxp3's stability and transcriptional activity. However, the mechanism(s) by which the activities of these lysine acetyl transferases/lysine deacetylases are regulated to preserve proper Foxp3 acetylation during Treg development and maintenance of Treg function remains to be determined. Here we report that Mst1 can enhance Foxp3 stability, its transcriptional activity, and Treg function by modulating the Foxp3 protein at the post-translational level. We discovered that Mst1 could increase the acetylation of Foxp3 by inhibiting Sirt1 activity, which requires the Mst1 kinase activity. We also found that Mst1 could attenuate Sirt1-mediated deacetylation of Foxp3 through directly interacting with Foxp3 to prevent or interfere the interaction between Sirt1 and Foxp3. Therefore, Mst1 can regulate Foxp3 stability in kinase-dependent and kinase-independent manners. Finally, we showed that treatment of Mst1(-/-) Tregs with Ex-527, a Sirt1-specific inhibitor, partially restored the suppressive function of Mst1(-/-) Tregs. Our studies reveal a novel mechanism by which Mst1 enhances Foxp3 expression and Treg function at the post-translational level.	[Li, Jiang; Du, Xingrong; Shi, Hao; Deng, Kejing; Tao, Wufan] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Li, Jiang; Tao, Wufan] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Li, Jiang; Tao, Wufan] Fudan Univ, Inst Reprod & Dev, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Du, Xingrong; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Fudan University; Fudan University; Fudan University; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	hongbo.chi@stjude.org; wufan_tao@fudan.edu.cn	SHI, HAO/ABE-4662-2020; Du, Xinrong/GWU-9803-2022; Chi, Hongbo/M-9397-2018	SHI, HAO/0000-0002-2796-629X; Chi, Hongbo/0000-0002-9997-2496; Du, Xingrong/0000-0001-6427-9600	National Basic Research Program of China [2013CB945304, 2011CB510102]; National Natural Science Foundation of China [31471380, 31171406, 30971666]; Science and Technology Committee of Shanghai Municipality [12JC1400600]; 211 project of the Chinese Ministry of Education; 985 project of the Chinese Ministry of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); 211 project of the Chinese Ministry of Education(Ministry of Education, China); 985 project of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by National Basic Research Program of China (Grants 2013CB945304 and 2011CB510102); National Natural Science Foundation of China (Grants 31471380, 31171406, and 30971666); Key Projects Grant for Basic Research (Grant 12JC1400600) from the Science and Technology Committee of Shanghai Municipality; and the 211 and 985 projects of the Chinese Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Du TF, 2013, EXP MOL PATHOL, V95, P38, DOI 10.1016/j.yexmp.2013.04.003; Du XR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090701; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Einarson M. B., 2007, CSH PROTOC; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Ueda Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2105; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yan SQ, 2000, DNA CELL BIOL, V19, P79, DOI 10.1089/104454900314591; Yuan F, 2011, J BIOL CHEM, V286, P6940, DOI 10.1074/jbc.M110.182543; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	36	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30762	30770		10.1074/jbc.M115.668442	http://dx.doi.org/10.1074/jbc.M115.668442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26538561	hybrid, Green Published			2022-12-28	WOS:000367199000010
J	Dmitriev, OY; Lutsenko, S; Muyldermans, S				Dmitriev, Oleg Y.; Lutsenko, Svetlana; Muyldermans, Serge			Nanobodies as Probes for Protein Dynamics in Vitro and in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						nuclear magnetic resonance (NMR); protein domain; protein dynamic; single-domain antibody (sdAb; nanobody); X-ray crystallography; nanobody; protein dynamics; protein structure; protein engineering	BETA(2)-ADRENERGIC RECEPTOR FUNCTION; SINGLE-DOMAIN ANTIBODIES; WILSONS-DISEASE PROTEIN; HEAVY-CHAIN ANTIBODIES; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; BINDING-PROTEINS; MULTIDRUG TRANSPORTER; COUPLED RECEPTOR	Nanobodies are the recombinant antigen-recognizing domains of the minimalistic heavy chain-only antibodies produced by camels and llamas. Nanobodies can be easily generated, effectively optimized, and variously derivatized with standard molecular biology protocols. These properties have triggered the recent explosion in the nanobody use in basic and clinical research. This review focuses on the emerging use of nanobodies for understanding and monitoring protein dynamics on the scales ranging from isolated protein domains to live cells, from nanoseconds to hours. The small size and high solubility make nanobodies uniquely suited for studying protein dynamics by NMR. The ability to produce conformation-sensitive nanobodies in cells enables studies that link structural dynamics of a target protein to its cellular behavior. The link between in vitro and in-cell dynamics, afforded by nanobodies, brings the analysis of such important events as receptor signaling, membrane protein trafficking, and protein interactions to the next level of resolution.	[Dmitriev, Oleg Y.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Muyldermans, Serge] Vrije Univ Brussel, Unit Cellular & Mol Immunol, B-1050 Brussels, Belgium	University of Saskatchewan; Johns Hopkins University; Vrije Universiteit Brussel	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Oleg.Dmitriev@usask.ca	Muyldermans, Serge/AAC-7374-2019; Dmitriev, Oleg/AAB-7830-2019	Muyldermans, Serge/0000-0002-3678-3575; 	Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; National Institutes of Health [GM067166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institutes of Health Research and Saskatchewan Health Research Foundation grants (to O. Y. D.) and by National Institutes of Health Grant GM067166 (to S. L.). This is the second article in the Thematic Minireview series "Modern Technologies for In-cell Biochemistry." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Abskharon RNN, 2014, J AM CHEM SOC, V136, P937, DOI 10.1021/ja407527p; Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Ashour J, 2015, J VIROL, V89, P2792, DOI 10.1128/JVI.02693-14; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Banner DW, 2013, ACTA CRYSTALLOGR D, V69, P1124, DOI 10.1107/S0907444913006574; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Broisat A, 2012, CIRC RES, V110, P927, DOI 10.1161/CIRCRESAHA.112.265140; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chaikuad A, 2014, BIOCHEM J, V459, P59, DOI 10.1042/BJ20131399; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Genst E, 2013, J PHYS CHEM B, V117, P13245, DOI 10.1021/jp403425z; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Dolgova NV, 2013, BIOCHEM J, V454, P147, DOI 10.1042/BJ20121656; Dreier B, 2012, METHODS MOL BIOL, V805, P261, DOI 10.1007/978-1-61779-379-0_15; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Eicher T, 2014, ELIFE, V3, DOI 10.7554/eLife.03145; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Even-Desrumeaux K, 2014, MOL CELL PROTEOMICS, V13, P653, DOI 10.1074/mcp.O112.025486; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Guilliams T, 2013, J MOL BIOL, V425, P2397, DOI 10.1016/j.jmb.2013.01.040; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hasan NM, 2012, CURR TOP MEMBR, V69, P137, DOI 10.1016/B978-0-12-394390-3.00006-9; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Huang YP, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.580845; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koromyslova AD, 2015, J VIROL, V89, P2718, DOI 10.1128/JVI.03176-14; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; Li ZY, 2015, ANGEW CHEM INT EDIT, V54, P11706, DOI 10.1002/anie.201505277; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nevoltris D, 2015, ACS NANO, V9, P1388, DOI 10.1021/nn505752u; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Oyen D, 2013, BBA-PROTEINS PROTEOM, V1834, P2147, DOI 10.1016/j.bbapap.2013.07.010; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P1828, DOI 10.1093/nar/gkr867; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Platonova E, 2015, METHODS, V88, P89, DOI 10.1016/j.ymeth.2015.06.018; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; Schmitz KR, 2013, STRUCTURE, V21, P1214, DOI 10.1016/j.str.2013.05.008; Schotte L, 2015, ANTIMICROB AGENTS CH, V59, P4695, DOI 10.1128/AAC.00878-15; Schushan M, 2012, METALLOMICS, V4, P669, DOI 10.1039/c2mt20025b; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Skrlec K, 2015, TRENDS BIOTECHNOL, V33, P408, DOI 10.1016/j.tibtech.2015.03.012; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Stockbridge RB, 2015, NATURE, V525, P548, DOI 10.1038/nature14981; Tanha J, 2006, PROTEIN ENG DES SEL, V19, P503, DOI 10.1093/protein/gzl037; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Zielonka S, 2015, MABS-AUSTIN, V7, P15, DOI 10.4161/19420862.2015.989032	84	73	75	5	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3767	3775		10.1074/jbc.R115.679811	http://dx.doi.org/10.1074/jbc.R115.679811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26677230	hybrid, Green Published			2022-12-28	WOS:000371338400008
J	Masuzaki, R; Zhao, S; Valerius, MT; Tsugawa, D; Oya, Y; Ray, KC; Karp, SJ				Masuzaki, Ryota; Zhao, Sophia; Valerius, M. Todd; Tsugawa, Daisuke; Oya, Yuki; Ray, Kevin C.; Karp, Seth J.			SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth hormone; insulin-like growth factor (IGF); liver injury; regeneration; ubiquitylation (ubiquitination); socs2	CYTOKINE SIGNALING-2; RAPID ACTIVATION; DNA-SYNTHESIS; GROWTH; MICE; SUPPRESSOR; HEPATECTOMY; BLOOD; GH	After significant injury, the liver must maintain homeostasis during the regenerative process. We hypothesized the existence of mechanisms to limit hepatocyte proliferation after injury to maintain metabolic and synthetic function. A screen for candidates revealed suppressor of cytokine signaling 2 (SOCS2), an inhibitor of growth hormone (GH) signaling, was strongly induced after partial hepatectomy. Using genetic deletion and administration of various factors we investigated the role of SOCS2 during liver regeneration. SOCS2 preserves liver function by restraining the first round of hepatocyte proliferation after partial hepatectomy by preventing increases in growth hormone receptor (GHR) via ubiquitination, suppressing GH pathway activity. At later times, SOCS2 enhances hepatocyte proliferation by modulating a decrease in serum insulin-like growth factor 1 (IGF-1) that allows GH release from the pituitary. SOCS2, therefore, plays a dual role in modulating the rate of hepatocyte proliferation. In particular, this is the first demonstration of an endogenous mechanism to limit hepatocyte proliferation after injury.	[Masuzaki, Ryota; Tsugawa, Daisuke; Oya, Yuki; Ray, Kevin C.; Karp, Seth J.] Vanderbilt Univ, Dept Surg, Transplant Ctr, Med Ctr, Nashville, TN 37232 USA; [Zhao, Sophia] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Valerius, M. Todd] Harvard Univ, Brigham & Womens Hosp, Div Renal, Dept Med,Med Sch, Boston, MA 02115 USA; [Valerius, M. Todd] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Karp, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, D-4313 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	seth.karp@vanderbilt.edu	Valerius, M. Todd/AAK-3063-2020	Valerius, M. Todd/0000-0001-8143-9231	National Institutes of Health [7R01DK081387]; Vanderbilt University Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081387, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 7R01DK081387 (to S. J. K.) and Vanderbilt University Medical Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown-Borg HM, 2003, MECH AGEING DEV, V124, P1013, DOI 10.1016/j.mad.2003.07.001; BUCHER NLR, 1975, P NATL ACAD SCI USA, V72, P1157, DOI 10.1073/pnas.72.3.1157; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Do N, 2012, AM J PHYSIOL-GASTR L, V303, pG1220, DOI 10.1152/ajpgi.00105.2012; FEINGOLD KR, 1988, BIOCHEM BIOPH RES CO, V153, P576, DOI 10.1016/S0006-291X(88)81134-3; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Ho KJ, 2010, J EXP MED, V207, P1197, DOI 10.1084/jem.20092434; Hu ZY, 2014, THERANOSTICS, V4, P215, DOI 10.7150/thno.7868; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; JONES DE, 1995, AM J PHYSIOL-GASTR L, V268, pG872, DOI 10.1152/ajpgi.1995.268.5.G872; Krebs DL, 2000, J CELL SCI, V113, P2813; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Pennisi PA, 2004, ENDOCRINOLOGY, V145, P4748, DOI 10.1210/en.2004-0655; Rico-Bautista E, 2005, MOL ENDOCRINOL, V19, P781, DOI 10.1210/me.2004-0040; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; RUSSELL WE, 1988, J CELL PHYSIOL, V135, P253, DOI 10.1002/jcp.1041350212; Sakamoto T., HEPATOLOGY, V29, P403; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Zellmer S, 2009, J ANAT, V215, P176, DOI 10.1111/j.1469-7580.2009.01085.x; Zerrad-Saadi A, 2011, ENDOCRINOLOGY, V152, P2731, DOI 10.1210/en.2010-1193	26	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3346	3358		10.1074/jbc.M115.703264	http://dx.doi.org/10.1074/jbc.M115.703264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26703468	Green Published, hybrid			2022-12-28	WOS:000370854500019
J	Ruscica, M; Ricci, C; Macchi, C; Magni, P; Cristofani, R; Liu, JW; Corsini, A; Ferri, N				Ruscica, Massimiliano; Ricci, Chiara; Macchi, Chiara; Magni, Paolo; Cristofani, Riccardo; Liu, Jingwen; Corsini, Alberto; Ferri, Nicola			Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocyte; insulin; proprotein convertase subtilisin; kexin type 9 (PCSK9); suppressor of cytokine signaling 3 (SOCS3); tumor necrosis factor (TNF); HepG2; stat-3	SMOOTH-MUSCLE-CELLS; HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; PLASMA PCSK9; INSULIN-RESISTANCE; APOLIPOPROTEIN-B; PROTEIN; CHOLESTEROL; ACTIVATION; MUTATIONS	The suppressor of cytokine signaling (SOCS) proteins are negative regulators of the JAK/STAT pathway activated by proinflammatory cytokines, including the tumor necrosis factor- (TNF-). SOCS3 is also implicated in hypertriglyceridemia associated to insulin resistance. Proprotein convertase subtilisin kexin type 9 (PCSK9) levels are frequently found to be positively correlated to insulin resistance and plasma very low density lipoprotein (VLDL) triglycerides concentrations. The present study aimed to investigate the possible role of TNF- and JAK/STAT pathway on de novo lipogenesis and PCSK9 expression in HepG2 cells. TNF- induced both SOCS3 and PCSK9 in a concentration-dependent manner. This effect was inhibited by transfection with siRNA anti-STAT3, suggesting the involvement of the JAK/STAT pathway. Retroviral overexpression of SOCS3 in HepG2 cells (HepG2(SOCS3)) strongly inhibited STAT3 phosphorylation and induced PCSK9 mRNA and protein, with no effect on its promoter activity and mRNA stability. Consistently, siRNA anti-SOCS3 reduced PCSK9 mRNA levels, whereas an opposite effect was observed with siRNA anti-STAT3. In addition, HepG2(SOCS3) express higher mRNA levels of key enzymes involved in the de novo lipogenesis, such as fattyacid synthase, stearoyl-CoA desaturase (SCD)-1, and apoB. These responses were associated with a significant increase of SCD-1 protein, activation of sterol regulatory element-binding protein-1c (SREBP-1), accumulation of cellular triglycerides, and secretion of apoB. HepG2(SOCS3) show lower phosphorylation levels of insulin receptor substrate 1 (IRS-1) Tyr(896) and Akt Ser(473) in response to insulin. Finally, insulin stimulation produced an additive effect with SOCS3 overexpression, further inducing PCSK9, SREBP-1, fatty acid synthase, and apoB mRNA. In conclusion, our data candidate PCSK9 as a gene involved in lipid metabolism regulated by proinflammatory cytokine TNF- in a SOCS3-dependent manner.	[Ruscica, Massimiliano; Ricci, Chiara; Macchi, Chiara; Magni, Paolo; Cristofani, Riccardo; Corsini, Alberto] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Liu, Jingwen] Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Corsini, Alberto] Multimed IRCCS, I-20099 Milan, Italy; [Magni, Paolo] Univ Milan, Ctr Studio Malattie Dismetab & Iperlipemie Enrica, I-20162 Milan, Italy; [Cristofani, Riccardo] Univ Milan, Ctr Eccellenza Malattie Neurodegenerat, Milan, Italy; [Ferri, Nicola] Univ Padua, Dipartimento Sci Farm, I-35131 Padua, Italy	University of Milan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; IRCCS Multimedica; University of Milan; University of Milan; University of Padua	Ferri, N (corresponding author), Dipartimento Sci Farm, Largo Meneghetti 2, I-35131 Padua, Italy.	nicola.ferri@unipd.it	ferri, nicola/K-7085-2019; Ruscica, Massimiliano/AAP-8672-2020; Macchi, Chiara/AAH-5753-2020; Ruscica, Massimiliano/K-7133-2012; Cristofani, Riccardo/P-1245-2014	ferri, nicola/0000-0001-8898-7441; Ruscica, Massimiliano/0000-0002-0195-7061; Macchi, Chiara/0000-0002-5919-989X; Ruscica, Massimiliano/0000-0002-0195-7061; Cristofani, Riccardo/0000-0003-2719-846X; MAGNI, PAOLO/0000-0002-2254-8881	Fondazione Cariplo [2012-0549]; Piano di Sviluppo Universita degli Studi di Milano	Fondazione Cariplo(Fondazione Cariplo); Piano di Sviluppo Universita degli Studi di Milano	This work was supported by Fondazione Cariplo Grant Rif. 2012-0549 (to A. C. and N. F.) and Piano di Sviluppo Universita degli Studi di Milano 2014 linea B (to N. F. and M. R.). All the authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adorni MP, 2011, ATHEROSCLEROSIS, V215, P70, DOI 10.1016/j.atherosclerosis.2010.12.004; Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Baass A, 2009, CLIN CHEM, V55, P1637, DOI 10.1373/clinchem.2009.126987; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cariou B, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-4; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; CORSINI A, 1995, ARTERIOSCL THROM VAS, V15, P420, DOI 10.1161/01.ATV.15.3.420; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Elam MB, 2010, METABOLISM, V59, P587, DOI 10.1016/j.metabol.2009.09.001; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Ferri N, 2003, J BIOL CHEM, V278, P19757, DOI 10.1074/jbc.M212714200; Ferri N, 2007, ARTERIOSCL THROM VAS, V27, P1043, DOI 10.1161/ATVBAHA.107.139881; Ferri N, 2016, TRANSL RES, V173, P19, DOI 10.1016/j.trsl.2015.10.004; Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026; Galic S, 2014, BIOCHEM J, V461, P177, DOI 10.1042/BJ20140143; Garton KJ, 2002, BIOTECHNIQUES, V32, P830, DOI 10.2144/02324rr01; Giunzioni I, 2016, J PATHOL, V238, P52, DOI 10.1002/path.4630; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Greco CM, 2012, CARDIOVASC RES, V95, P366, DOI 10.1093/cvr/cvs204; Guo YL, 2013, CLIN DRUG INVEST, V33, P877, DOI 10.1007/s40261-013-0129-2; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huijgen R, 2012, J AM COLL CARDIOL, V59, P1778, DOI 10.1016/j.jacc.2011.12.043; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Masciocchi D, 2012, MEDCHEMCOMM, V3, P592, DOI 10.1039/c2md20018j; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Melone M, 2012, J AM COLL CARDIOL, V59, P1697, DOI 10.1016/j.jacc.2011.11.064; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Norata GD, 2004, BRIT J HAEMATOL, V127, P97, DOI 10.1111/j.1365-2141.2004.05163.x; Ouguerram K, 2004, ARTERIOSCL THROM VAS, V24, P1448, DOI 10.1161/01.ATV.0000133684.77013.88; Pellegrino S, 2009, BIOORG MED CHEM LETT, V19, P6298, DOI 10.1016/j.bmcl.2009.09.105; Pirvulescu M, 2012, BIOCHEM BIOPH RES CO, V422, P321, DOI 10.1016/j.bbrc.2012.04.159; Rashid S, 2014, CIRCULATION, V130, P431, DOI 10.1161/CIRCULATIONAHA.113.006720; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shende VR, 2015, J LIPID RES, V56, P801, DOI 10.1194/jlr.M052969; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101	54	77	81	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3508	3519		10.1074/jbc.M115.664706	http://dx.doi.org/10.1074/jbc.M115.664706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668321	Green Published, hybrid			2022-12-28	WOS:000370854500031
J	Abu-Fanne, R; Maraga, E; Abd-Elrahman, I; Hankin, A; Blum, G; Abdeen, S; Hijazi, N; Cines, DB; Higazi, A				Abu-Fanne, Rami; Maraga, Emad; Abd-Elrahman, Ihab; Hankin, Aviel; Blum, Galia; Abdeen, Suhair; Hijazi, Nuha; Cines, Douglas B.; Higazi, Abd Al-Roof			alpha-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PLASMINOGEN-ACTIVATOR; FACTOR-VIII; CELLS; NEUTROPHILS; DEFICIENCY; BINDING; APOLIPOPROTEIN; LL-37	Approximately one-half of the patients who develop clinical atherosclerosis have normal or only modest elevations in plasma lipids, indicating that additional mechanisms contribute to pathogenesis. In view of increasing evidence that inflammation contributes to atherogenesis, we studied the effect of human neutrophil alpha-defensins on low density lipoprotein (LDL) trafficking, metabolism, vascular deposition, and atherogenesis using transgenic mice expressing human alpha-defensins in their polymorphonuclear leukocytes (Def(+/+)). Accelerated Def(+/+) mice developed alpha-defensin.LDL complexes that accelerate the clearance of LDL from the circulation accompanied by enhanced vascular deposition and retention of LDL, induction of endothelial cathepsins, increased endothelial permeability to LDL, and the development of lipid streaks in the aortic roots when fed a regular diet and at normal plasma levels of LDL. Transplantation of bone marrow from Def(+/+) to WT mice increased LDL clearance, increased vascular permeability, and increased vascular deposition of LDL, whereas transplantation of WT bone marrow to Def(+/+) mice prevented these outcomes. The same outcome was obtained by treating Def(+/+) mice with colchicine to inhibit the release of alpha-defensins. These studies identify a potential new link between inflammation and the development of atherosclerosis.	[Abu-Fanne, Rami; Maraga, Emad; Hankin, Aviel; Abdeen, Suhair; Hijazi, Nuha; Higazi, Abd Al-Roof] Hadassah Hebrew Univ, Dept Clin Biochem, IL-91120 Jerusalem, Israel; [Abd-Elrahman, Ihab; Blum, Galia] Hadassah Hebrew Univ, Sch Pharm, IL-91120 Jerusalem, Israel; [Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 513A Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Pennsylvania; Pennsylvania Medicine	Higazi, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 513A Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.	higazi@mail.med.upenn.edu		Cines, Douglas/0000-0001-5986-504X	National Institutes of Health [HL077760, HL805429, HL82545, HL123912]; Israeli Science Foundation [930/04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123912, R01HL077760, R56HL123912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Science Foundation(Israel Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL077760, HL805429, HL82545, and HL123912 and by Grant 930/04 from the Israeli Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Barnathan ES, 1997, AM J PATHOL, V150, P1009; Bdeir K, 1999, BLOOD, V94, P2007; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Blum G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006374; Chen Y, 2015, BBA-MOL CELL RES, V1853, P396, DOI 10.1016/j.bbamcr.2014.11.012; Christensen HM, 2012, EUR J HEART FAIL, V14, P387, DOI 10.1093/eurjhf/hfs021; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Greene TK, 2014, J THROMB HAEMOST, V12, P2102, DOI 10.1111/jth.12749; Greene TK, 2010, BLOOD, V116, P6114, DOI 10.1182/blood-2010-06-293308; Higazi AA, 2000, BLOOD, V96, P1393; Higazi AAR, 1997, BLOOD, V89, P4290, DOI 10.1182/blood.V89.12.4290; HIGAZI AAR, 1995, J BIOL CHEM, V270, P9472, DOI 10.1074/jbc.270.16.9472; Higazi AAR, 1996, J BIOL CHEM, V271, P17650, DOI 10.1074/jbc.271.30.17650; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kim DE, 2009, MOL IMAGING, V8, P291, DOI 10.2310/7290.2009.00027; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Kougias P, 2006, J VASC SURG, V43, P357, DOI 10.1016/j.jvs.2005.10.019; Nassar T, 2002, BLOOD, V100, P4026, DOI 10.1182/blood-2002-04-1080; Nidorf SM, 2013, J AM COLL CARDIOL, V61, P404, DOI 10.1016/j.jacc.2012.10.027; NISHINA PM, 1990, J LIPID RES, V31, P859; Nuki George, 2008, Curr Rheumatol Rep, V10, P218; PETERSON MW, 1989, J IMMUNOL, V143, P609; Quinn KL, 2011, ARTERIOSCL THROM VAS, V31, P2070, DOI 10.1161/ATVBAHA.111.227116; Rodriguez-Garcia M, 2007, J LEUKOCYTE BIOL, V82, P1143, DOI 10.1189/jlb.0507295; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sasaki T, 2010, ATHEROSCLEROSIS, V210, P430, DOI 10.1016/j.atherosclerosis.2009.12.031; Schraufstatter IU, 2003, J IMMUNOL, V171, P6714, DOI 10.4049/jimmunol.171.12.6714; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Urbonaviciene G, 2012, INT J CARDIOL, V160, P89, DOI 10.1016/j.ijcard.2011.03.030; Wong BW, 2011, J HEART LUNG TRANSPL, V30, P955, DOI 10.1016/j.healun.2011.04.007; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhao HJ, 2012, J ATHEROSCLER THROMB, V19, P357, DOI 10.5551/jat.10108; Zhou Q, 2012, CIRCULATION, V126, P2236, DOI 10.1161/CIRCULATIONAHA.111.086041; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x	42	11	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2777	2786		10.1074/jbc.M115.669812	http://dx.doi.org/10.1074/jbc.M115.669812			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26518877	Green Published, hybrid			2022-12-28	WOS:000369626900018
J	Moxley, MA; Beard, DA; Bazil, JN				Moxley, Michael A.; Beard, Daniel A.; Bazil, Jason N.			Global Kinetic Analysis of Mammalian E3 Reveals pH-dependent NAD(+)/NADH Regulation, Physiological Kinetic Reversibility, and Catalytic Optimum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; HEART LIPOAMIDE DEHYDROGENASE; NICOTINAMIDE-ADENINE-DINUCLEOTIDE; STEADY-STATE KINETICS; ACETYL-COENZYME-A; ESCHERICHIA-COLI; DIHYDROLIPOAMIDE DEHYDROGENASE; CRYSTAL-STRUCTURE; RAT-HEART; REDOX STATE	Mammalian E3 is an essential mitochondrial enzyme responsible for catalyzing the terminal reaction in the oxidative catabolism of several metabolites. E3 is a key regulator of metabolic fuel selection as a component of the pyruvate dehydrogenase complex (PDHc). E3 regulates PDHc activity by altering the affinity of pyruvate dehydrogenase kinase, an inhibitor of the enzyme complex, through changes in reduction and acetylation state of lipoamide moieties set by the NAD(+)/NADH ratio. Thus, an accurate kinetic model of E3 is needed to predict overall mammalian PDHc activity. Here, we have combined numerous literature data sets and new equilibrium spectroscopic experiments with a multitude of independently collected forward and reverse steady-state kinetic assays using pig heart E3. The latter kinetic assays demonstrate a pH-dependent transition of NAD(+) activation to inhibition, shown here, to our knowledge, for the first time in a single consistent data set. Experimental data were analyzed to yield a thermodynamically constrained four-redoxstate model of E3 that simulates pH-dependent activation/inhibition and active site redox states for various conditions. The developed model was used to determine substrate/product conditions that give maximal E3 rates and show that, due to non-Michaelis-Menten behavior, the maximal flux is different compared with the classically defined k(cat).	[Moxley, Michael A.; Beard, Daniel A.; Bazil, Jason N.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48709 USA	University of Michigan System; University of Michigan	Beard, DA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48709 USA.	beardda@umich.edu			National Institutes of Health [R01-DK095210, R01-HL072011, T32-HL094273, K99-HL121160]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094273, R00HL121160, R01HL072011, K99HL121160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-DK095210, R01-HL072011, T32-HL094273, and K99-HL121160. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Argyrou A, 2003, BIOCHEMISTRY-US, V42, P2218, DOI 10.1021/bi020654f; Argyrou A, 2002, BIOCHEMISTRY-US, V41, P14580, DOI 10.1021/bi020376k; Bazil JN, 2013, BIOPHYS J, V105, P343, DOI 10.1016/j.bpj.2013.05.033; Beard DA, 2008, CAMB TEXT BIOMED ENG, P1, DOI 10.1017/CBO9780511803345; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Bryk R, 2013, BIOCHEMISTRY-US, V52, P9375, DOI 10.1021/bi401077f; CATE RL, 1978, J BIOL CHEM, V253, P496; Clark W. M., 1960, OXIDATION REDUCTION, P321; Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301; Cook P. F., 2007, ENZYME KINETICS MECH, p[37, 128, 354]; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME, P33; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; DUGGLEBY RG, 1989, EXPERIENTIA, V45, P87, DOI 10.1007/BF01990457; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Frey P. A., 2007, ENZYMATIC REACTION M, P129; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; HANSFORD RG, 1976, J BIOL CHEM, V251, P5483; Hong YS, 1999, FREE RADICAL BIO MED, V26, P685, DOI 10.1016/S0891-5849(98)00243-3; IDE S, 1967, J BIOL CHEM, V242, P54; Johson K. A., 2013, FEBS LETT, V587, P2753; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; KERBEY AL, 1976, BIOCHEM J, V154, P327, DOI 10.1042/bj1540327; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; KOIKE M, 1963, J BIOL CHEM, V238, P30; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P55; LEICHUS BN, 1992, BIOCHEMISTRY-US, V31, P3065, DOI 10.1021/bi00127a006; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; LOFFELHARDT S, 1995, BIOCHEM PHARMACOL, V50, P637, DOI 10.1016/0006-2952(95)00175-Y; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Maeder M, 2007, PRACTICAL DATA ANAL; MASSEY V, 1961, BIOCHIM BIOPHYS ACTA, V48, P33, DOI 10.1016/0006-3002(61)90512-1; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V37, P314, DOI 10.1016/0006-3002(60)90239-0; MASSEY V, 1960, BIOCHEM J, V77, P341, DOI 10.1042/bj0770341; Massey V., 1966, METHOD ENZYMOL, V9, P272; MATTHEWS J, 1963, J BIOL CHEM, V238, P1869; MATTHEWS RG, 1976, J BIOL CHEM, V251, P3956; MATTHEWS RG, 1979, J BIOL CHEM, V254, P4974; MATTHEWS RG, 1977, J BIOL CHEM, V252, P3199; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Moxley MA, 2014, BIOPHYS J, V107, P2984, DOI 10.1016/j.bpj.2014.09.025; Neuhold Y.-M., 2007, PRACTICAL DATA ANAL, P33; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Raddatz G, 1997, J BIOTECHNOL, V58, P89, DOI 10.1016/S0168-1656(97)00135-1; Rahimi Y, 2014, P NATL ACAD SCI USA, V111, P16508, DOI 10.1073/pnas.1419104111; Ravindran S, 1996, J BIOL CHEM, V271, P653, DOI 10.1074/jbc.271.2.653; REED JK, 1973, J BIOL CHEM, V248, P4834; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; SAHLMAN L, 1989, J BIOL CHEM, V264, P8039; Schrodinger L, 2010, PYMOL MOL GRAPH SYST; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; SCHWARTZ ER, 1970, BIOCHEMISTRY-US, V9, P1434, DOI 10.1021/bi00808a019; SCOTT DA, 1994, AM J PHYSIOL, V267, pH636, DOI 10.1152/ajpheart.1994.267.2.H636; Segel I. H., 1993, ENZYME KINETICS BEHA, p[657, 884]; Sidhu S, 2008, AM J PHYSIOL-HEART C, V295, pH946, DOI 10.1152/ajpheart.00363.2008; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; Teodoro JS, 2013, MOL CELL BIOCHEM, V376, P103, DOI 10.1007/s11010-012-1555-9; TSAI CS, 1992, INT J BIOCHEM, V24, P1801, DOI 10.1016/0020-711X(92)90131-J; TSAI CS, 1980, INT J BIOCHEM, V11, P407, DOI 10.1016/0020-711X(80)90311-0; Ussher JR, 2012, CIRC RES, V111, P628, DOI 10.1161/CIRCRESAHA.111.246371; v Muiswinkel-Voetberg H, 1973, Eur J Biochem, V33, P285; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; WILKINSON KD, 1981, J BIOL CHEM, V256, P2307; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	77	7	7	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2712	+		10.1074/jbc.M115.676619	http://dx.doi.org/10.1074/jbc.M115.676619			41	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644471	Green Published, hybrid			2022-12-28	WOS:000369626900014
J	Risor, MW; Thomsen, LR; Sanggaard, KW; Nielsen, TA; Thogersen, IB; Lukassen, MV; Rossen, L; Garcia-Ferrer, I; Guevara, T; Scavenius, C; Meinjohanns, E; Gomis-Ruth, FX; Enghild, JJ				Risor, Michael W.; Thomsen, Line R.; Sanggaard, Kristian W.; Nielsen, Tania A.; Thogersen, Ida B.; Lukassen, Marie V.; Rossen, Litten; Garcia-Ferrer, Irene; Guevara, Tibisay; Scavenius, Carsten; Meinjohanns, Ernst; Gomis-Rueth, F. Xavier; Enghild, Jan J.			Enzymatic and Structural Characterization of the Major Endopeptidase in the Venus Flytrap Digestion Fluid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CATHEPSIN-B; CRYSTAL-STRUCTURE; CYSTEINE PROTEASES; PAPAIN PRECURSOR; IONIZATION CHARACTERISTICS; SUBSTRATE-SPECIFICITY; STRUCTURE VALIDATION; PEPTIDE LIBRARY; PROTEIN; PLANTS	Carnivorous plants primarily use aspartic proteases during digestion of captured prey. In contrast, the major endopeptidases in the digestive fluid of the Venus flytrap (Dionaea muscipula) are cysteine proteases (dionain-1 to -4). Here, we present the crystal structure of mature dionain-1 in covalent complex with inhibitor E-64 at 1.5 angstrom resolution. The enzyme exhibits an overall protein fold reminiscent of other plant cysteine proteases. The inactive glycosylated pro-form undergoes autoprocessing and self-activation, optimally at the physiologically relevant pH value of 3.6, at which the protective effect of the pro-domain is lost. The mature enzyme was able to efficiently degrade a Drosophila fly protein extract at pH 4 showing high activity against the abundant Lys- and Arg-rich protein, myosin. The substrate specificity of dionain-1 was largely similar to that of papain with a preference for hydrophobic and aliphatic residues in subsite S-2 and for positively charged residues in S-1. A tentative structure of the pro-domain was obtained by homology modeling and suggested that a pro-peptide Lys residue intrudes into the S-2 pocket, which is more spacious than in papain. This study provides the first analysis of a cysteine protease from the digestive fluid of a carnivorous plant and confirms the close relationship between carnivorous action and plant defense mechanisms.	[Risor, Michael W.; Thomsen, Line R.; Sanggaard, Kristian W.; Thogersen, Ida B.; Lukassen, Marie V.; Rossen, Litten; Scavenius, Carsten; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Risor, Michael W.; Thomsen, Line R.; Sanggaard, Kristian W.; Nielsen, Tania A.; Enghild, Jan J.] Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Garcia-Ferrer, Irene; Guevara, Tibisay; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab,Dept Struct Biol, Maria Maeztu Unit Excellence, Barcelona Sci Pk,C Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain; [Meinjohanns, Ernst] DuPont Ind Biosci, DK-8220 Brabrand, Denmark	Aarhus University; Aarhus University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.; Enghild, JJ (corresponding author), Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.	jje@mbg.au.dk	; Scavenius, Carsten/Q-5941-2017	Vestergaard Lukassen, Marie/0000-0003-3237-2696; Scavenius, Carsten/0000-0002-4304-0681; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Enghild, Jan Johannes/0000-0001-9292-9172	European agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]; Danish agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]; Spanish agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]; Catalan agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]	European agency; Danish agency; Spanish agency; Catalan agency	This work was supported in part by grants from European, Danish, Spanish, and Catalan agencies (FP7-PEOPLE-2011-ITN-290246 "RAPID"; FP7-HEALTH-2012-306029-2 "TRIGGER"; BFU2012-32862; MDM-2014-0435; BIO2013-49320-EXP; and 2014SGR9). The Department of Structural Biology of the Institut de Biologia Molecular de Barcelona is a "Maria de Maeztu" Unit of Excellence of the Spanish Ministry of Economy and Competitiveness. Traveling and synchrotron data collection were supported in part by the European Synchrotron Radiation Facility. The authors declare that they have no conflicts of interest with the contents of this article.	Adlassnig W, 2012, PLANT J, V71, P303, DOI 10.1111/j.1365-313X.2012.04997.x; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Santamaria ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128323; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Ghosh R, 2008, FEBS J, V275, P421, DOI 10.1111/j.1742-4658.2007.06211.x; GREENAWAY W, 1990, NEW PHYTOL, V114, P581, DOI 10.1111/j.1469-8137.1990.tb00428.x; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HASNAIN S, 1992, J BIOL CHEM, V267, P4713; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Katerelos NA, 1996, FEBS LETT, V392, P35, DOI 10.1016/0014-5793(96)00697-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konno K, 2004, PLANT J, V37, P370, DOI 10.1046/j.1365-313X.2003.01968.x; Kreuzwieser J, 2014, J EXP BOT, V65, P755, DOI 10.1093/jxb/ert455; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Libiakova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104424; Maciel FM, 2011, ACTA PHYSIOL PLANT, V33, P1867, DOI 10.1007/s11738-011-0730-z; Markin VS, 2008, PLANT SIGNAL BEHAV, V3, P778, DOI 10.4161/psb.3.10.6041; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; MELLOR GW, 1993, BIOCHEM J, V290, P289, DOI 10.1042/bj2900289; MELLOR GW, 1993, BIOCHEM J, V294, P201, DOI 10.1042/bj2940201; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Noble MA, 2000, BIOCHEM J, V351, P723, DOI 10.1042/0264-6021:3510723; Paszota P, 2014, BBA-PROTEINS PROTEOM, V1844, P374, DOI 10.1016/j.bbapap.2013.11.009; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinitglang S, 1997, BIOCHEMISTRY-US, V36, P9968, DOI 10.1021/bi9705974; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; REA PA, 1984, PLANT CELL ENVIRON, V7, P363, DOI 10.1111/j.1365-3040.1984.tb01424.x; Reis FCG, 2007, FEBS J, V274, P1224, DOI 10.1111/j.1742-4658.2007.05666.x; REVELL DF, 1993, GENE, V127, P221, DOI 10.1016/0378-1119(93)90723-G; ROBINS RI, 1980, NEW PHYTOL, V86, P401, DOI 10.1111/j.1469-8137.1980.tb01681.x; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; SCALA J, 1969, PLANT PHYSIOL, V44, P367, DOI 10.1104/pp.44.3.367; Scherzer S, 2013, CURR BIOL, V23, P1649, DOI 10.1016/j.cub.2013.07.028; Schmid M, 2001, P NATL ACAD SCI USA, V98, P5353, DOI 10.1073/pnas.061038298; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Takahashi K, 2009, CARNIV PL NEWSL, V38, P75; Takahashi K, 2011, BIOSCI BIOTECH BIOCH, V75, P346, DOI 10.1271/bbb.100546; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; VERNET T, 1991, J BIOL CHEM, V266, P21451; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; VERNET T, 1990, J BIOL CHEM, V265, P16661; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	76	13	14	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2271	2287		10.1074/jbc.M115.672550	http://dx.doi.org/10.1074/jbc.M115.672550			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26627834	Green Published, hybrid			2022-12-28	WOS:000369610400018
J	Niks, D; Duvvuru, J; Escalona, M; Hille, R				Niks, Dimitri; Duvvuru, Jayant; Escalona, Miguel; Hille, Russ			Spectroscopic and Kinetic Properties of the Molybdenum-containing, NAD(+) - dependent Formate Dehydrogenase from Ralstonia eutropha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTIVE HALF-REACTION; PARAMAGNETIC-RESONANCE SIGNALS; RESPIRATORY COMPLEX-I; XANTHINE-OXIDASE; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; ALCALIGENES-EUTROPHUS; ENZYMES; OXYGEN; MECHANISM	We have examined the rapid reaction kinetics and spectroscopic properties of the molybdenum-containing, NAD(+) -dependent FdsABG formate dehydrogenase from Ralstonia eutropha. We confirm previous steady-state studies of the enzyme and extend its characterization to a rapid kinetic study of the reductive half-reaction (the reaction of formate with oxidized enzyme). We have also characterized the electron paramagnetic resonance signal of the molybdenum center in its Mo-V state and demonstrated the direct transfer of the substrate C alpha hydrogen to the molybdenum center in the course of the reaction. Varying temperature, microwave power, and level of enzyme reduction, we are able to clearly identify the electron paramagnetic resonance signals for four of the iron/sulfur clusters of the enzyme and find suggestive evidence for two others; we observe a magnetic interaction between the molybdenum center and one of the iron/sulfur centers, permitting assignment of this signal to a specific iron/sulfur cluster in the enzyme. In light of recent advances in our understanding of the structure of the molybdenum center, we propose a reaction mechanism involving direct hydride transfer from formate to a molybdenum-sulfur group of the molybdenum center.	[Niks, Dimitri; Duvvuru, Jayant; Escalona, Miguel; Hille, Russ] Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu			U.S. Department of Energy [DE-FG02-13ER16411]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by U.S. Department of Energy Grant DE-FG02-13ER16411 (to R.H.). The authors declare that they have no conflicts of interest with the contents of this article.	BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; BORDWELL FG, 1978, J ORG CHEM, V43, P3113, DOI 10.1021/jo00410a004; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; BRAY RC, 1968, BIOCHEM J, V107, P601, DOI 10.1042/bj1070601; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; FRIEDEBOLD J, 1993, J BACTERIOL, V175, P4719, DOI 10.1128/JB.175.15.4719-4728.1993; FRIEDEBOLD J, 1995, BIOL CHEM H-S, V376, P561, DOI 10.1515/bchm3.1995.376.9.561; George GN, 1998, J AM CHEM SOC, V120, P1267, DOI 10.1021/ja973004l; George GN, 1999, J AM CHEM SOC, V121, P2625, DOI 10.1021/ja9841761; GUTTERIDGE S, 1978, BIOCHEM J, V175, P887, DOI 10.1042/bj1750887; GUTTERIDGE S, 1980, BIOCHEM J, V189, P615, DOI 10.1042/bj1890615; GUTTERIDGE S, 1978, BIOCHEM J, V175, P869, DOI 10.1042/bj1750869; Hartmann T, 2013, FEBS J, V280, P6083, DOI 10.1111/febs.12528; HILLE R, 1993, BIOCHEMISTRY-US, V32, P3973, DOI 10.1021/bi00066a018; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; MALTHOUSE JPG, 1980, BIOCHEM J, V185, P767, DOI 10.1042/bj1850767; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; OLSON JS, 1974, J BIOL CHEM, V249, P4363; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schrapers P, 2015, INORG CHEM, V54, P3260, DOI 10.1021/ic502880y; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Xia M, 1999, J BIOL CHEM, V274, P3323, DOI 10.1074/jbc.274.6.3323	33	50	50	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1162	1174		10.1074/jbc.M115.688457	http://dx.doi.org/10.1074/jbc.M115.688457			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26553877	Green Published, hybrid			2022-12-28	WOS:000368068300012
J	Sharma, A; Bruce, KL; Chen, BX; Gyoneva, S; Behrens, SH; Bommarius, AS; Chernoff, YO				Sharma, Aditi; Bruce, Kathryn L.; Chen, Buxin; Gyoneva, Stefka; Behrens, Sven H.; Bommarius, Andreas S.; Chernoff, Yury O.			Contributions of the Prion Protein Sequence, Strain, and Environment to the Species Barrier.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSION BARRIERS; SACCHAROMYCES; BSE; TRANSFORMATION; AGGREGATION; CONVERSION; FIDELITY; DISEASES	Amyloid propagation requires high levels of sequence specificity so that only molecules with very high sequence identity can form cross-beta-sheet structures of sufficient stringency for incorporation into the amyloid fibril. This sequence specificity presents a barrier to the transmission of prions between two species with divergent sequences, termed a species barrier. Here we study the relative effects of protein sequence, seed conformation, and environment on the species barrier strength and specificity for the yeast prion protein Sup35p from three closely related species of the Saccharomyces sensu stricto group; namely, Saccharomyces cerevisiae, Saccharomyces bayanus, and Saccharomyces paradoxus. Through in vivo plasmid shuffle experiments, we show that the major characteristics of the transmission barrier and conformational fidelity are determined by the protein sequence rather than by the cellular environment. In vitro data confirm that the kinetics and structural preferences of aggregation of the S. paradoxus and S. bayanus proteins are influenced by anions in accordance with their positions in the Hofmeister series, as observed previously for S. cerevisiae. However, the specificity of the species barrier is primarily affected by the sequence and the type of anion present during the formation of the initial seed, whereas anions present during the seeded aggregation process typically influence kinetics rather than the specificity of prion conversion. Therefore, our work shows that the protein sequence and the conformation variant (strain) of the prion seed are the primary determinants of cross-species prion specificity both in vivo and in vitro.	[Sharma, Aditi; Behrens, Sven H.; Bommarius, Andreas S.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Bruce, Kathryn L.; Chen, Buxin; Gyoneva, Stefka; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Engn Biosyst Bldg,M-C 2000,950 Atlantic Dr, Atlanta, GA 30332 USA; [Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia; [Chernoff, Yury O.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg 199034, Russia	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Saint Petersburg State University; Saint Petersburg State University	Chernoff, YO (corresponding author), Georgia Inst Technol, Sch Biol, Engn Biosyst Bldg,M-C 2000,950 Atlantic Dr, Atlanta, GA 30332 USA.	yury.chernoff@biology.gatech.edu	Chernoff, Yury O/J-2833-2014; Sharma, Aditi/HHM-9116-2022	Behrens, Sven/0000-0002-3528-4053; Chernoff, Yury/0000-0002-8934-9051	National Science Foundation - Industry/University Cooperative Research Center, Center for Pharmaceutical Development (National Science Foundation) [0969003]; Graduate Assistance in the Areas of National Need fellowship from the U.S. Department of Education; Petite undergraduate research scholarship from the Institute for Bioengineering and Bioscience; Russian Science Foundation [14-50-00069]; Russian Foundation for Basic Research [15-04-06650]	National Science Foundation - Industry/University Cooperative Research Center, Center for Pharmaceutical Development (National Science Foundation); Graduate Assistance in the Areas of National Need fellowship from the U.S. Department of Education; Petite undergraduate research scholarship from the Institute for Bioengineering and Bioscience; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Supported by the National Science Foundation - Industry/University Cooperative Research Center, Center for Pharmaceutical Development (National Science Foundation Grant 0969003).r Supported by a Graduate Assistance in the Areas of National Need fellowship from the U.S. Department of Education.r Supported by a Petite undergraduate research scholarship from the Institute for Bioengineering and Bioscience.r Supported by Russian Science Foundation Grant 14-50-00069 and Russian Foundation for Basic Research Grant 15-04-06650.	Afanasieva EG, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.183889; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Bateman DA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003257; Bateman DA, 2012, GENETICS, V190, P569, DOI 10.1534/genetics.111.136655; Broering JM, 2007, BIOCHEM SOC T, V35, P1602, DOI 10.1042/BST0351602; Broering JM, 2008, J PHYS CHEM B, V112, P12768, DOI 10.1021/jp7120164; Broering JM, 2005, J PHYS CHEM B, V109, P20612, DOI 10.1021/jp053618+; Bruce KL, 2011, SEMIN CELL DEV BIOL, V22, P444, DOI 10.1016/j.semcdb.2011.03.005; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chernova TA, 2014, FEMS MICROBIOL REV, V38, P326, DOI 10.1111/1574-6976.12053; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collinge J, 1997, NATURE, V386, P564, DOI 10.1038/386564b0; Derkatch IL, 1996, GENETICS, V144, P1375; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Ferguson N. M., 1999, British Food Journal, V101, P86, DOI 10.1108/00070709910261891; Gambetti P, 2011, ACTA NEUROPATHOL, V121, P79, DOI 10.1007/s00401-010-0761-3; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghani AC, 2002, CR BIOL, V325, P37, DOI 10.1016/S1631-0691(02)01389-6; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill Andrew F., 2004, V11, P33; Hofmeister F, 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI [10.1007/BF01918191, DOI 10.1007/BF01918191]; Huang YW, 2015, PRION, V9, P207, DOI 10.1080/19336896.2015.1039217; Hueston WD, 2013, PREV VET MED, V109, P179, DOI 10.1016/j.prevetmed.2012.11.023; Jackson GS, 2000, CURR OPIN STRUC BIOL, V10, P69, DOI 10.1016/S0959-440X(99)00051-2; Kaiser C., 1994, METHODS YEAST GENETI; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Kretzschmar H, 2013, BRAIN PATHOL, V23, P321, DOI 10.1111/bpa.12045; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; NGUYEN J, 1995, BIOCHEMISTRY-US, V34, P4186, DOI 10.1021/bi00013a006; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Rubin J, 2013, J BIOL CHEM, V288, P30300, DOI 10.1074/jbc.M113.467829; SANDULA J, 1974, FOLIA MICROBIOL, V19, P94, DOI 10.1007/BF02872841; Stein KC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004328; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281	57	18	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1277	1288		10.1074/jbc.M115.684100	http://dx.doi.org/10.1074/jbc.M115.684100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26565023	hybrid, Green Published			2022-12-28	WOS:000368068300023
J	Tu, C; Terraube, V; Tam, ASP; Stochaj, W; Fennell, BJ; Lin, L; Stahl, M; LaVallie, ER; Somers, W; Finlay, WJJ; Mosyak, L; Bard, J; Cunningham, O				Tu, Chao; Terraube, Virginie; Tam, Amy Sze Pui; Stochaj, Wayne; Fennell, Brian J.; Lin, Laura; Stahl, Mark; LaVallie, Edward R.; Somers, Will; Finlay, William J. J.; Mosyak, Lydia; Bard, Joel; Cunningham, Orla			A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISPECIFIC ANTIBODIES; BIOPHYSICAL PROPERTIES; COMPUTATIONAL DESIGN; VARIABLE DOMAINS; IN-VIVO; FAB; LIBRARY; LIGAND; MATURATION; FRAGMENTS	Fully-human single-chain Fv (scFv) proteins are key potential building blocks of bispecific therapeutic antibodies, but they often suffer from manufacturability and clinical development limitations such as instability and aggregation. The causes of these scFv instability problems, in proteins that should be theoretically stable, remains poorly understood. To inform the future development of such molecules, we carried out a comprehensive structural analysis of the highly stabilized anti-CXCL13 scFv E10. E10 was derived from the parental 3B4 using complementarity-determining region (CDR)-restricted mutagenesis and tailored selection and screening strategies, and carries four mutations in V-L-CDR3. High-resolution crystal structures of parental 3B4 and optimized E10 scFvs were solved in the presence and absence of human CXCL13. In parallel, a series of scFv mutants was generated to interrogate the individual contribution of each of the four mutations to stability and affinity improvements. In combination, these analyses demonstrated that the optimization of E10 was primarily mediated by removing clashes between both the V-L and the V-H, and between the V-L and CXCL13. Importantly, a single, germline-encoded V-L-CDR3 residue mediated the key difference between the stable and unstable forms of the scFv. This work demonstrates that, aside from being the critical mediators of specificity and affinity, CDRs may also be the primary drivers of biotherapeutic developability.	[Tu, Chao; Tam, Amy Sze Pui; Stochaj, Wayne; Lin, Laura; Stahl, Mark; LaVallie, Edward R.; Somers, Will; Mosyak, Lydia; Bard, Joel] Pfizer R&D, Global Biotherapeut Technol, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA; [Terraube, Virginie; Fennell, Brian J.; Finlay, William J. J.; Cunningham, Orla] Pfizer R&D, Global Biotherapeut Technol, Dublin D22, Ireland	Pfizer; Pfizer	Bard, J (corresponding author), Pfizer R&D, Global Biotherapeut Technol, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	joel.bard@pfizer.com; orla.cunningham@pfizer.com			Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almagro JC, 2014, PROTEINS, V82, P1553, DOI 10.1002/prot.24567; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Blanc E., 2011, BUSTER VERSION 2 11; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Corrada D, 2013, J CHEM INF MODEL, V53, P2937, DOI 10.1021/ci400416e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Fennell BJ, 2013, MABS-AUSTIN, V5, P882, DOI 10.4161/mabs.26201; Fitzgerald JB, 2014, MOL CANCER THER, V13, P410, DOI 10.1158/1535-7163.MCT-13-0255; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Jordan JL, 2009, PROTEINS, V77, P832, DOI 10.1002/prot.22502; Kortt AA, 1997, J MOL RECOGNIT, V10, P148, DOI 10.1002/(SICI)1099-1352(199705/06)10:3<148::AID-JMR360>3.0.CO;2-F; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Mabry R, 2010, IDRUGS, V13, P543; Mabry R, 2010, MABS-AUSTIN, V2, P20, DOI 10.4161/mabs.2.1.10498; Mabry R, 2010, PROTEIN ENG DES SEL, V23, P115, DOI 10.1093/protein/gzp073; Mahon CM, 2013, J MOL BIOL, V425, P1712, DOI 10.1016/j.jmb.2013.02.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Moore PA, 2011, BLOOD, V117, P4542, DOI 10.1182/blood-2010-09-306449; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Orcutt KD, 2010, PROTEIN ENG DES SEL, V23, P221, DOI 10.1093/protein/gzp077; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Sun SB, 2013, J AM CHEM SOC, V135, P9980, DOI 10.1021/ja402927u; Tiller T, 2013, MABS-AUSTIN, V5, P445, DOI 10.4161/mabs.24218; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Zhai WW, 2011, J MOL BIOL, V412, P55, DOI 10.1016/j.jmb.2011.07.018; Zhang K, 2015, MABS-AUSTIN, V7, P42, DOI 10.4161/19420862.2014.985933	37	16	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1267	1276		10.1074/jbc.M115.688010	http://dx.doi.org/10.1074/jbc.M115.688010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26515064	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000368068300022
J	Martinez, S; Scerbo, P; Giordano, M; Daulat, AM; Lhoumeau, AC; Thome, V; Kodjabachian, L; Borg, JP				Martinez, Sebastien; Scerbo, Pierluigi; Giordano, Marilyn; Daulat, Avais M.; Lhoumeau, Anne-Catherine; Thome, Virginie; Kodjabachian, Laurent; Borg, Jean-Paul			The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE ROR2; PLANAR CELL; MIGRATION; MORPHOGENESIS; DEFECTS; CHUZHOI	The non-canonical WNT/planar cell polarity(WNT/PCP) pathway plays important roles in morphogenetic processes in vertebrates. Among WNT/PCP components, protein tyrosine kinase 7 (PTK7) is a tyrosine kinase receptor with poorly defined functions lacking catalytic activity. Here we show that PTK7 associates with receptor tyrosine kinase-like orphan receptor 2 (ROR2) to form a heterodimeric complex in mammalian cells. We demonstrate that PTK7 and ROR2 physically and functionally interact with the non-canonical WNT5A ligand, leading to JNK activation and cell movements. In the Xenopus embryo, Ptk7 functionally interacts with Ror2 to regulate protocadherin papc expression and morphogenesis. Furthermore, we show that Ptk7 is required for papc activation induced by Wnt5a. Interestingly, we find that Wnt5a stimulates the release of the tagged Ptk7 intracellular domain, which can translocate into the nucleus and activate papc expression. This study reveals novel molecular mechanisms of action of PTK7 in non-canonical WNT/PCP signaling that may promote cell and tissue movements.	[Martinez, Sebastien; Giordano, Marilyn; Daulat, Avais M.; Lhoumeau, Anne-Catherine; Borg, Jean-Paul] INSERM U1068, CRCM, Team Cell Polar Cell Signaling & Canc, Equipe Labellisee Ligue Canc, F-13009 Marseille, France; [Martinez, Sebastien; Giordano, Marilyn; Daulat, Avais M.; Lhoumeau, Anne-Catherine; Borg, Jean-Paul] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Martinez, Sebastien; Giordano, Marilyn; Daulat, Avais M.; Lhoumeau, Anne-Catherine; Borg, Jean-Paul] Aix Marseille Univ, F-13284 Marseille, France; [Martinez, Sebastien; Giordano, Marilyn; Daulat, Avais M.; Lhoumeau, Anne-Catherine; Borg, Jean-Paul] CNRS, UMR7258, F-13009 Marseille, France; [Scerbo, Pierluigi; Thome, Virginie; Kodjabachian, Laurent] Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Borg, JP (corresponding author), INSERM U1068, CRCM, Team Cell Polar Cell Signaling & Canc, F-13009 Marseille, France.	jean-paul.borg@inserm.fr	Borg, Jean-Paul/AAX-8096-2020	Borg, Jean-Paul/0000-0001-8418-3382; Scerbo, Pierluigi/0000-0002-3360-4367; Daulat, Avais/0000-0002-3076-2132; Kodjabachian, Laurent/0000-0002-4000-612X	La Ligue Nationale Contre le Cancer (Label Ligue); Institut National du Cancer [INCa 2012-108]; Fondation Association pour la Recherche sur le Cancer Grant [SFI20121205675]; Site de Recherche Integree en Cancerologie Grant INCa-DGOS-INSERM [6038]; Bourse du Conseil Regional PACA-INSERM; La Ligue Contre le Cancer; Fondation de France	La Ligue Nationale Contre le Cancer (Label Ligue); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Association pour la Recherche sur le Cancer Grant; Site de Recherche Integree en Cancerologie Grant INCa-DGOS-INSERM; Bourse du Conseil Regional PACA-INSERM(Region Provence-Alpes-Cote d'Azur); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France)	This work was funded by La Ligue Nationale Contre le Cancer (Label Ligue, to J. P. B.), Institut National du Cancer Grant P. L. INCa 2012-108 (to J. P. B. and L. K.) and a postdoctoral fellowship (to P. S.), Fondation Association pour la Recherche sur le Cancer Grant SFI20121205675 (to L. K.), and Site de Recherche Integree en Cancerologie Grant INCa-DGOS-INSERM 6038. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Bourse du Conseil Regional PACA-INSERM and La Ligue Contre le Cancer.; Scholar of the Institut Universitaire de France and holder of fellowships from La Ligue Contre Le Cancer and Fondation de France. To whom correspondence should be addressed: CRCM, Team Cell Polarity, Cell Signaling and Cancer, INSERM U1068, 13009 Marseille, France. Tel.: 33-4-8697-7201; Fax: 33-4-8697-7499; E-mail: jean-paul.borg@inserm.fr.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Golubkov VS, 2012, J BIOL CHEM, V287, P42009, DOI 10.1074/jbc.M112.371153; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Hayes M, 2013, DEVELOPMENT, V140, P1807, DOI 10.1242/dev.090183; Lee HK, 2011, BLOOD, V117, P5762, DOI 10.1182/blood-2010-09-306928; Lhoumeau AC, 2011, CELL CYCLE, V10, P1233, DOI 10.4161/cc.10.8.15368; Linnemannstons K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004443; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Luxardi G, 2010, DEVELOPMENT, V137, P417, DOI 10.1242/dev.039735; Marchal L, 2009, P NATL ACAD SCI USA, V106, P17437, DOI 10.1073/pnas.0906352106; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Sebbagh M, 2014, EXP CELL RES, V328, P284, DOI 10.1016/j.yexcr.2014.09.005; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	32	55	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30562	30572		10.1074/jbc.M115.697615	http://dx.doi.org/10.1074/jbc.M115.697615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26499793	Green Published, hybrid			2022-12-28	WOS:000366738200031
J	Qu, DB; Hage, A; Don-Carolis, K; Huang, E; Joselin, A; Safarpour, F; Marcogliese, PC; Rousseaux, MWC; Hewitt, SJ; Huang, TW; Im, DS; Callaghan, S; Dewar-Darch, D; Figeys, D; Slack, RS; Park, DS				Qu, Dianbo; Hage, Ali; Don-Carolis, Katie; Huang, En; Joselin, Alvin; Safarpour, Farzaneh; Marcogliese, Paul C.; Rousseaux, Maxime W. C.; Hewitt, Sarah J.; Huang, Tianwen; Im, Doo-Soon; Callaghan, Steve; Dewar-Darch, Danielle; Figeys, Daniel; Slack, Ruth S.; Park, David S.			BAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK1/PARKIN-MEDIATED MITOPHAGY; DAMAGED MITOCHONDRIA; UBIQUITIN LIGASE; DEGENERATION; DISEASE; DEGRADATION; DYSFUNCTION; PATHWAY; DROSOPHILA-PINK1; PHOSPHORYLATION	Emerging evidence has demonstrated a growing genetic component in Parkinson disease (PD). For instance, loss-of-function mutations in PINK1 or PARKIN can cause autosomal recessive PD. Recently, PINK1 and PARKIN have been implicated in the same signaling pathway to regulate mitochondrial clearance through recruitment of PARKIN by stabilization of PINK1 on the outer membrane of depolarized mitochondria. The precise mechanisms that govern this process remain enigmatic. In this study, we identify Bcl2-associated athanogene 2 (BAG2) as a factor that promotes mitophagy. BAG2 inhibits PINK1 degradation by blocking the ubiquitination pathway. Stabilization of PINK1 by BAG2 triggers PARKIN-mediated mitophagy and protects neurons against 1-methyl-4-phenylpyridinium-induced oxidative stress in an in vitro cell model of PD. Collectively, our findings support the notion that BAG2 is an upstream regulator of the PINK1/PARKIN signaling pathway.	[Qu, Dianbo; Hage, Ali; Don-Carolis, Katie; Huang, En; Joselin, Alvin; Safarpour, Farzaneh; Marcogliese, Paul C.; Rousseaux, Maxime W. C.; Hewitt, Sarah J.; Huang, Tianwen; Im, Doo-Soon; Callaghan, Steve; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Qu, Dianbo; Hage, Ali; Don-Carolis, Katie; Huang, En; Joselin, Alvin; Safarpour, Farzaneh; Marcogliese, Paul C.; Rousseaux, Maxime W. C.; Hewitt, Sarah J.; Huang, Tianwen; Im, Doo-Soon; Callaghan, Steve; Dewar-Darch, Danielle; Figeys, Daniel; Slack, Ruth S.; Park, David S.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON K1H 8M5, Canada; [Dewar-Darch, Danielle; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	Marcogliese, Paul/GQY-7404-2022; , Dianbo/AAU-8480-2021	, Dianbo/0000-0002-0435-9585; Slack, Ruth/0000-0002-1552-2835; Marcogliese, Paul/0000-0002-8011-7852; Rousseaux, Maxime/0000-0002-2737-6193; Figeys, Daniel/0000-0002-5373-7546; Park, David/0000-0002-4490-3784; Im, Doo Soon/0000-0001-5713-3849; Joselin, Alvin/0000-0002-9010-0421	Canadian Institutes of Health Research; Parkinson's Society Canada; Parkinson's Research Consortium Ottawa; Network of Centers of Excellence in Neurodegeneration; Heart and Stroke Foundation of Ontario; Neuroscience Brain Canada/Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson's Society Canada; Parkinson's Research Consortium Ottawa; Network of Centers of Excellence in Neurodegeneration; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Neuroscience Brain Canada/Krembil Foundation	This work was supported by grants from the Canadian Institutes of Health Research, the Parkinson's Society Canada, the Parkinson's Research Consortium Ottawa, the Network of Centers of Excellence in Neurodegeneration, the Heart and Stroke Foundation of Ontario, and the Neuroscience Brain Canada/Krembil Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Martella G, 2009, EXP NEUROL, V215, P388, DOI 10.1016/j.expneurol.2008.11.001; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	55	43	44	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30441	30452		10.1074/jbc.M115.677815	http://dx.doi.org/10.1074/jbc.M115.677815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26538564	Green Published, hybrid			2022-12-28	WOS:000366738200021
J	Macauley, MS; Kawasaki, N; Peng, WJ; Wang, SH; He, Y; Arlian, BM; McBride, R; Kannagi, R; Khoo, KH; Paulson, JC				Macauley, Matthew S.; Kawasaki, Norihito; Peng, Wenjie; Wang, Shui-Hua; He, Yuan; Arlian, Britni M.; McBride, Ryan; Kannagi, Reiji; Khoo, Kay-Hooi; Paulson, James C.			Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS LIGANDS; SIGLECS; ANTIGEN; BINDING; ACID; ACTIVATION; RECEPTOR; PROBES; IDENTIFICATION; TOLERANCE	CD22 is an inhibitory B-cell co-receptor whose function is modulated by sialic acid (Sia)-bearing glycan ligands. Glycan remodeling in the germinal center (GC) alters CD22 ligands, with as yet no ascribed biological consequence. Here, we show in both mice and humans that loss of high affinity ligands on GC B-cells unmasks the binding site of CD22 relative to naive and memory B-cells, promoting recognition of trans ligands. The conserved modulation of CD22 ligands on GC B-cells is striking because high affinity glycan ligands of CD22 are species-specific. In both species, the high affinity ligand is based on the sequence Sia alpha 2-6Gal beta 1-4GlcNAc, which terminates N-glycans. The human ligand has N-acetylneuraminic acid (Neu5Ac) as the sialic acid, and the high affinity ligand on naive B-cells contains 6-O-sulfate on the GlcNAc. On human GC B-cells, this sulfate modification is lost, giving rise to lower affinity CD22 ligands. Ligands of CD22 on naive murine B-cells do not contain the 6-O-sulfate modification. Instead, the high affinity ligand for mouse CD22 hasN-glycolylneuraminic acid (Neu5Gc) as the sialic acid, which is replaced on GC B-cells with Neu5Ac. Human naive and memory B-cells express sulfated glycans as high affinity CD22 ligands, which are lost on GCB-cells. In mice, Neu5Gc-containing glycans serve as high affinity CD22 ligands that are replaced by Neu5Ac-containing glycans on GC B-cells. Our results demonstrate that loss of high affinity CD22 ligands on GC B-cells occurs in both mice and humans through alternative mechanisms, unmasking CD22 relative to naive and memory B-cells.	[Macauley, Matthew S.; Kawasaki, Norihito; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Peng, Wenjie; He, Yuan; Arlian, Britni M.; McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wang, Shui-Hua; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Kannagi, Reiji] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Paulson, JC (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd,MB-202, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019; Khoo, Kay-Hooi/E-1989-2019; He, Yuan/GQP-4216-2022; Kannagi, Reiji/Q-6459-2018	Khoo, Kay-Hooi/0000-0003-2906-406X; Kannagi, Reiji/0000-0003-4202-2921; He, Yuan/0000-0002-1712-0776; Macauley, Matthew/0000-0003-4579-1048; Peng, Wenjie/0000-0001-5093-7115	Taiwan National Core Facility Program for Biotechnology, NSC [101-2319-B-001-003, 102-2319-B-001-003]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044486] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143, R01AI099141] Funding Source: NIH RePORTER; BBSRC [BBS/E/F/00044486] Funding Source: UKRI	Taiwan National Core Facility Program for Biotechnology, NSC; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Professor Anne Feeney for coordinating the receipt of human tonsils through the Scripps Green hospital. The MS data were acquired at the Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC Grants 101-2319-B-001-003 and 102-2319-B-001-003.	ARUFFO A, 1992, P NATL ACAD SCI USA, V89, P10242, DOI 10.1073/pnas.89.21.10242; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Fujimoto M, 2006, J IMMUNOL, V176, P873, DOI 10.4049/jimmunol.176.2.873; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Macauley MS, 2014, J IMMUNOL, V193, P4312, DOI 10.4049/jimmunol.1401723; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Muller J, 2013, P NATL ACAD SCI USA, V110, P12402, DOI 10.1073/pnas.1304888110; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Naito-Matsui Y, 2014, J BIOL CHEM, V289, P1564, DOI 10.1074/jbc.M113.523753; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Nitschke L, 2014, GLYCOBIOLOGY, V24, P807, DOI 10.1093/glycob/cwu066; Nycholat CM, 2012, ANGEW CHEM INT EDIT, V51, P4860, DOI 10.1002/anie.201200596; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Rillahan CD, 2014, CHEM SCI, V5, P2398, DOI 10.1039/c4sc00451e; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sakuma K, 2012, BBA-GEN SUBJECTS, V1820, P841, DOI 10.1016/j.bbagen.2012.03.005; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang SH, 2013, GLYCOBIOLOGY, V23, P677, DOI 10.1093/glycob/cwt008; Yuan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064572	35	36	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30066	30077		10.1074/jbc.M115.691337	http://dx.doi.org/10.1074/jbc.M115.691337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507663	hybrid, Green Published			2022-12-28	WOS:000366614700037
J	Nigg, PE; Pavlovic, J				Nigg, Patricia E.; Pavlovic, Jovan			Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; SMOOTH ENDOPLASMIC-RETICULUM; PROTEIN; NUCLEOPROTEIN; RESISTANCE; TRANSCRIPTION; INFECTION; GENES; OVEREXPRESSION; IDENTIFICATION	The IFN-induced human myxovirus resistance protein A (MxA) exhibits a broad antiviral activity against many viruses, including influenza A virus (IAV). MxA belongs to the family of dynamin-like GTPases and assembles in vitro into dimers, tetramers, and oligomeric ring-like structures. The molecular mechanism of action remains to be elucidated. Furthermore, it is not clear whether MxA exerts its antiviral activity in a monomeric and/or multimeric form. Using a set of MxA mutants that form complexes with defined stoichiometry, we observed that, in the presence of guanosine 5'-O-(thiotriphosphate), purified MxA disassembled into tetramers and dimers. Dimeric forms did not further disassemble into monomers. Infection experiments revealed that besides wild-type MxA, dimeric and monomeric variants of MxA also efficiently restricted IAV at a replication step after primary transcription. Moreover, only dimeric MxA was able to form stable complexes with the nucleoprotein (NP) of IAV. MxA interacted with NP independently of other viral components. Interestingly, the dimeric form of MxA was able to efficiently bind to NP from several MxA-sensitive strains but interacted much more weakly with NP from the MxA-resistant PR8 strain derived from the H1N1 1918 lineage. Taken together, these data suggest that, during infection, a fraction of MxA disassembles into dimers that bind to NP synthesized following primary transcription in the cytoplasm, thereby preventing viral replication.	[Nigg, Patricia E.; Pavlovic, Jovan] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland	University of Zurich	Pavlovic, J (corresponding author), Univ Zurich, Inst Med Virol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pavlovic.jovan@virology.uzh.ch			Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [31003A_143834]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was funded by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant 31003A_143834. The authors declare that they have no conflicts of interest with the contents of this article.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Dicks MDJ, 2016, J VIROL, V90, P22, DOI 10.1128/JVI.02247-15; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164; Fribourgh JL, 2014, CELL HOST MICROBE, V16, P627, DOI 10.1016/j.chom.2014.09.021; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rennie ML, 2014, STRUCTURE, V22, P1433, DOI 10.1016/j.str.2014.08.015; Riegger D, 2015, J VIROL, V89, P2241, DOI 10.1128/JVI.02406-14; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; SCHNEIDERSCHAULIES S, 1994, J VIROL, V68, P6910, DOI 10.1128/JVI.68.11.6910-6917.1994; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Tarus B, 2012, BIOCHIMIE, V94, P776, DOI 10.1016/j.biochi.2011.11.009; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Walker J M, 1994, Methods Mol Biol, V32, P17; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wisskirchen C, 2011, J BIOL CHEM, V286, P34743, DOI 10.1074/jbc.M111.251843; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	47	44	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29893	29906		10.1074/jbc.M115.681494	http://dx.doi.org/10.1074/jbc.M115.681494			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507657	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000366614700022
J	He, Q; Wang, F; Liu, SH; Zhu, DY; Cong, HJ; Gao, F; Li, BQ; Wang, HW; Lin, Z; Liao, J; Gu, LC				He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Lin, Zong; Liao, Jun; Gu, Lichuan			Structural and biochemical insight into the mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP phosphodiesterase (vol 291, pg 3668, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Cong, Hengjiang/ABA-2924-2020; Cong, Hengjiang/ABA-2928-2020	Cong, Hengjiang/0000-0002-9225-0095; Liao, Jun/0000-0001-7487-5545				He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]	1	40	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14386	14387		10.1074/jbc.A115.699801	http://dx.doi.org/10.1074/jbc.A115.699801			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371563	Green Published, hybrid			2022-12-28	WOS:000379975100041
J	He, Q; Wang, F; Liu, SH; Zhu, DY; Cong, HJ; Gao, F; Li, BQ; Wang, HW; Lin, Z; Liao, J; Gu, LC				He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Lin, Zong; Liao, Jun; Gu, Lichuan			Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic diadenosine monophosphate (c-di-AMP); enzyme degradation; Mycobacterium tuberculosis; phosphodiesterases; structure-function	AFFECT BACTERIAL-GROWTH; LONG-TERM SURVIVAL; AMP PHOSPHODIESTERASE; GMP; IDENTIFICATION; SPORULATION; RESOLUTION; REVEALS; PROTEIN; LEADS	The intracellular infections of Mycobacterium tuberculosis, which is the causative agent of tuberculosis, are regulated by many cyclic dinucleotide signaling. Rv2837c from M. tuberculosis is a soluble, stand-alone DHH-DHHA1 domain phosphodiesterase that down-regulates c-di-AMP through catalytic degradation and plays an important role in M. tuberculosis infections. Here, we report the crystal structure of Rv2837c (2.0 angstrom), and its complex with hydrolysis intermediate 5-pApA (2.35 angstrom). Our structures indicate that both DHH and DHHA1 domains are essential for c-di-AMP degradation. Further structural analysis shows that Rv2837c does not distinguish adenine from guanine, which explains why Rv2837c hydrolyzes all linear dinucleotides with almost the same efficiency. We observed that Rv2837c degraded other c-di-NMPs at a lower rate than it did on c-di-AMP. Nevertheless, our data also showed that Rv2837c significantly decreases concentrations of both c-di-AMP and c-di-GMP in vivo. Our results suggest that beside its major role in c-di-AMP degradation Rv2837c could also regulate c-di-GMP signaling pathways in bacterial cell.	[He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Gu, Lichuan] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Lin, Zong] Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, Jiaxing 314006, Zhejiang, Peoples R China; [Liao, Jun] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Shandong University; Tsinghua University; ShanghaiTech University	Gu, LC (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lcgu@sdu.edu.cn	Cong, Hengjiang/ABA-2924-2020; Cong, Hengjiang/ABA-2928-2020	Cong, Hengjiang/0000-0002-9225-0095; Liao, Jun/0000-0001-7487-5545	National Natural Science Foundation of China [31470732]; Shandong Provincial Funds for Distinguished Young Scientists Grant [JQ201307]; Zhejiang Natural Science Foundation [LR12C05001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Funds for Distinguished Young Scientists Grant; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 31470732 (to L.G.) and Shandong Provincial Funds for Distinguished Young Scientists Grant JQ201307 (to L.G.), This work was also supported by Zhejiang Natural Science Foundation Grant LR12C05001 (to Z.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao J, 2015, CELL RES, V25, P539, DOI 10.1038/cr.2015.40; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; GUAN Y, 1993, J BIOMOL STRUCT DYN, V11, P253, DOI 10.1080/07391102.1993.10508725; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Postic G, 2012, RNA, V18, P155, DOI 10.1261/rna.029132.111; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Srivastav R, 2014, NUCLEIC ACIDS RES, V42, P7894, DOI 10.1093/nar/gku425; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhu DY, 2014, MOL CELL, V55, P931, DOI 10.1016/j.molcel.2014.08.001; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	41	40	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3668	3681		10.1074/jbc.M115.699801	http://dx.doi.org/10.1074/jbc.M115.699801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	27371563	Green Published, hybrid			2022-12-28	WOS:000370854500044
